Provinces Employee strata Cohorts ERTEs Demographic Concepts Periodo Total National Total Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" National Total Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" National Total Total Cohort January 1 Total Number at the start of the quarter 2022QII "" National Total Total Cohort January 1 Total Number at the start of the quarter 2022QI 1.175.582 National Total Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" National Total Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" National Total Total Cohort January 1 Total Number at the start of the quarter 2021QII "" National Total Total Cohort January 1 Total Number at the start of the quarter 2021QI 1.136.561 National Total Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" National Total Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" National Total Total Cohort January 1 Total Number at the start of the quarter 2020QII "" National Total Total Cohort January 1 Total Number at the start of the quarter 2020QI 1.190.870 National Total Total Cohort January 1 Total Survival in the first trimester 2022QIV "" National Total Total Cohort January 1 Total Survival in the first trimester 2022QIII "" National Total Total Cohort January 1 Total Survival in the first trimester 2022QII "" National Total Total Cohort January 1 Total Survival in the first trimester 2022QI 1.110.581 National Total Total Cohort January 1 Total Survival in the first trimester 2021QIV "" National Total Total Cohort January 1 Total Survival in the first trimester 2021QIII "" National Total Total Cohort January 1 Total Survival in the first trimester 2021QII "" National Total Total Cohort January 1 Total Survival in the first trimester 2021QI 1.074.320 National Total Total Cohort January 1 Total Survival in the first trimester 2020QIV "" National Total Total Cohort January 1 Total Survival in the first trimester 2020QIII "" National Total Total Cohort January 1 Total Survival in the first trimester 2020QII "" National Total Total Cohort January 1 Total Survival in the first trimester 2020QI 1.050.404 National Total Total Cohort January 1 Total Survival in the second trimester 2022QIV "" National Total Total Cohort January 1 Total Survival in the second trimester 2022QIII "" National Total Total Cohort January 1 Total Survival in the second trimester 2022QII 1.062.357 National Total Total Cohort January 1 Total Survival in the second trimester 2022QI "" National Total Total Cohort January 1 Total Survival in the second trimester 2021QIV "" National Total Total Cohort January 1 Total Survival in the second trimester 2021QIII "" National Total Total Cohort January 1 Total Survival in the second trimester 2021QII 1.035.575 National Total Total Cohort January 1 Total Survival in the second trimester 2021QI "" National Total Total Cohort January 1 Total Survival in the second trimester 2020QIV "" National Total Total Cohort January 1 Total Survival in the second trimester 2020QIII "" National Total Total Cohort January 1 Total Survival in the second trimester 2020QII 1.014.398 National Total Total Cohort January 1 Total Survival in the second trimester 2020QI "" National Total Total Cohort January 1 Total Survival in the third trimester 2022QIV "" National Total Total Cohort January 1 Total Survival in the third trimester 2022QIII 1.024.559 National Total Total Cohort January 1 Total Survival in the third trimester 2022QII "" National Total Total Cohort January 1 Total Survival in the third trimester 2022QI "" National Total Total Cohort January 1 Total Survival in the third trimester 2021QIV "" National Total Total Cohort January 1 Total Survival in the third trimester 2021QIII 1.003.536 National Total Total Cohort January 1 Total Survival in the third trimester 2021QII "" National Total Total Cohort January 1 Total Survival in the third trimester 2021QI "" National Total Total Cohort January 1 Total Survival in the third trimester 2020QIV "" National Total Total Cohort January 1 Total Survival in the third trimester 2020QIII 983.011 National Total Total Cohort January 1 Total Survival in the third trimester 2020QII "" National Total Total Cohort January 1 Total Survival in the third trimester 2020QI "" National Total Total Cohort January 1 Total Survival in the third trimester 2022QIV 994.419 National Total Total Cohort January 1 Total Survival in the third trimester 2022QIII "" National Total Total Cohort January 1 Total Survival in the third trimester 2022QII "" National Total Total Cohort January 1 Total Survival in the third trimester 2022QI "" National Total Total Cohort January 1 Total Survival in the third trimester 2021QIV 976.592 National Total Total Cohort January 1 Total Survival in the third trimester 2021QIII "" National Total Total Cohort January 1 Total Survival in the third trimester 2021QII "" National Total Total Cohort January 1 Total Survival in the third trimester 2021QI "" National Total Total Cohort January 1 Total Survival in the third trimester 2020QIV 952.502 National Total Total Cohort January 1 Total Survival in the third trimester 2020QIII "" National Total Total Cohort January 1 Total Survival in the third trimester 2020QII "" National Total Total Cohort January 1 Total Survival in the third trimester 2020QI "" National Total Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" National Total Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" National Total Total Cohort January 1 Total Number at the start of the quarter 2022QII "" National Total Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 National Total Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" National Total Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" National Total Total Cohort January 1 Total Number at the start of the quarter 2021QII "" National Total Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 National Total Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" National Total Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" National Total Total Cohort January 1 Total Number at the start of the quarter 2020QII "" National Total Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 National Total Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" National Total Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,47 National Total Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" National Total Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,52 National Total Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" National Total Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 88,2 National Total Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" National Total Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" National Total Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,37 National Total Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" National Total Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" National Total Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" National Total Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,11 National Total Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" National Total Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" National Total Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" National Total Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 85,18 National Total Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" National Total Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" National Total Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 87,15 National Total Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" National Total Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" National Total Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" National Total Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 88,3 National Total Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" National Total Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" National Total Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" National Total Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 82,55 National Total Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" National Total Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" National Total Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 84,59 National Total Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,93 National Total Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 79,98 National Total Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.116.307 National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 972.382 National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" National Total Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.053.423 National Total Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" National Total Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 915.073 National Total Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" National Total Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" National Total Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.006.960 National Total Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" National Total Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 879.880 National Total Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" National Total Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" National Total Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 970.603 National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 850.920 National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 941.626 National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 827.437 National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" National Total Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,37 National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,11 National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,2 National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,49 National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,95 National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,51 National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 84,35 National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,09 National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 59.275 National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 164.179 National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" National Total Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" National Total Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" National Total Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 57.158 National Total Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" National Total Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" National Total Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" National Total Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 159.247 National Total Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" National Total Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" National Total Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" National Total Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" National Total Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" National Total Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" National Total Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 55.397 National Total Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" National Total Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" National Total Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" National Total Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 155.695 National Total Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" National Total Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" National Total Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" National Total Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" National Total Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 53.956 National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 152.616 National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 52.793 National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 149.155 National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" National Total Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" National Total Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,43 National Total Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97 National Total Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,46 National Total Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,83 National Total Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 91,03 National Total Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,96 National Total Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 89,06 National Total Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 90,85 National Total Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" National Total Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" National Total Total Cohort April 1 Total Number at the start of the quarter 2022QII 1.180.282 National Total Total Cohort April 1 Total Number at the start of the quarter 2022QI "" National Total Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" National Total Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" National Total Total Cohort April 1 Total Number at the start of the quarter 2021QII 1.137.018 National Total Total Cohort April 1 Total Number at the start of the quarter 2021QI "" National Total Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" National Total Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" National Total Total Cohort April 1 Total Number at the start of the quarter 2020QII 1.102.738 National Total Total Cohort April 1 Total Number at the start of the quarter 2020QI "" National Total Total Cohort April 1 Total Survival in the first trimester 2022QIV "" National Total Total Cohort April 1 Total Survival in the first trimester 2022QIII "" National Total Total Cohort April 1 Total Survival in the first trimester 2022QII 1.119.786 National Total Total Cohort April 1 Total Survival in the first trimester 2022QI "" National Total Total Cohort April 1 Total Survival in the first trimester 2021QIV "" National Total Total Cohort April 1 Total Survival in the first trimester 2021QIII "" National Total Total Cohort April 1 Total Survival in the first trimester 2021QII 1.087.341 National Total Total Cohort April 1 Total Survival in the first trimester 2021QI "" National Total Total Cohort April 1 Total Survival in the first trimester 2020QIV "" National Total Total Cohort April 1 Total Survival in the first trimester 2020QIII "" National Total Total Cohort April 1 Total Survival in the first trimester 2020QII 1.059.378 National Total Total Cohort April 1 Total Survival in the first trimester 2020QI "" National Total Total Cohort April 1 Total Survival in the second trimester 2022QIV "" National Total Total Cohort April 1 Total Survival in the second trimester 2022QIII 1.073.841 National Total Total Cohort April 1 Total Survival in the second trimester 2022QII "" National Total Total Cohort April 1 Total Survival in the second trimester 2022QI "" National Total Total Cohort April 1 Total Survival in the second trimester 2021QIV "" National Total Total Cohort April 1 Total Survival in the second trimester 2021QIII 1.047.638 National Total Total Cohort April 1 Total Survival in the second trimester 2021QII "" National Total Total Cohort April 1 Total Survival in the second trimester 2021QI "" National Total Total Cohort April 1 Total Survival in the second trimester 2020QIV "" National Total Total Cohort April 1 Total Survival in the second trimester 2020QIII 1.022.614 National Total Total Cohort April 1 Total Survival in the second trimester 2020QII "" National Total Total Cohort April 1 Total Survival in the second trimester 2020QI "" National Total Total Cohort April 1 Total Survival in the third trimester 2022QIV 1.034.840 National Total Total Cohort April 1 Total Survival in the third trimester 2022QIII "" National Total Total Cohort April 1 Total Survival in the third trimester 2022QII "" National Total Total Cohort April 1 Total Survival in the third trimester 2022QI "" National Total Total Cohort April 1 Total Survival in the third trimester 2021QIV 1.013.467 National Total Total Cohort April 1 Total Survival in the third trimester 2021QIII "" National Total Total Cohort April 1 Total Survival in the third trimester 2021QII "" National Total Total Cohort April 1 Total Survival in the third trimester 2021QI "" National Total Total Cohort April 1 Total Survival in the third trimester 2020QIV 986.485 National Total Total Cohort April 1 Total Survival in the third trimester 2020QIII "" National Total Total Cohort April 1 Total Survival in the third trimester 2020QII "" National Total Total Cohort April 1 Total Survival in the third trimester 2020QI "" National Total Total Cohort April 1 Total Survival in the third trimester 2022QIV "" National Total Total Cohort April 1 Total Survival in the third trimester 2022QIII "" National Total Total Cohort April 1 Total Survival in the third trimester 2022QII "" National Total Total Cohort April 1 Total Survival in the third trimester 2022QI 976.815 National Total Total Cohort April 1 Total Survival in the third trimester 2021QIV "" National Total Total Cohort April 1 Total Survival in the third trimester 2021QIII "" National Total Total Cohort April 1 Total Survival in the third trimester 2021QII "" National Total Total Cohort April 1 Total Survival in the third trimester 2021QI 950.014 National Total Total Cohort April 1 Total Survival in the third trimester 2020QIV "" National Total Total Cohort April 1 Total Survival in the third trimester 2020QIII "" National Total Total Cohort April 1 Total Survival in the third trimester 2020QII "" National Total Total Cohort April 1 Total Survival in the third trimester 2020QI "" National Total Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" National Total Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" National Total Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 National Total Total Cohort April 1 Total Number at the start of the quarter 2022QI "" National Total Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" National Total Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" National Total Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 National Total Total Cohort April 1 Total Number at the start of the quarter 2021QI "" National Total Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" National Total Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" National Total Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 National Total Total Cohort April 1 Total Number at the start of the quarter 2020QI "" National Total Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,87 National Total Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" National Total Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,63 National Total Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" National Total Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,07 National Total Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" National Total Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" National Total Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,98 National Total Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" National Total Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" National Total Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" National Total Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,14 National Total Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" National Total Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" National Total Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" National Total Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,73 National Total Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" National Total Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" National Total Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,68 National Total Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" National Total Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" National Total Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" National Total Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 89,13 National Total Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" National Total Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" National Total Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" National Total Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,46 National Total Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" National Total Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" National Total Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" National Total Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 85,91 National Total Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 86,15 National Total Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.122.675 National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 981.798 National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 852.306 National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.064.037 National Total Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" National Total Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 935.775 National Total Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" National Total Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 812.240 National Total Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" National Total Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.019.625 National Total Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" National Total Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" National Total Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 899.208 National Total Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" National Total Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" National Total Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 781.490 National Total Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" National Total Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 982.021 National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 868.703 National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 753.187 National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 835.962 National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 724.018 National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" National Total Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 National Total Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,78 National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,31 National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,3 National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,82 National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,59 National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,69 National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,47 National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 88,48 National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,37 National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 85,15 National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,95 National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 57.607 National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 155.220 National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 250.432 National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" National Total Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" National Total Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 55.749 National Total Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" National Total Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" National Total Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" National Total Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 151.566 National Total Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" National Total Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" National Total Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" National Total Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 247.138 National Total Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" National Total Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" National Total Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 54.216 National Total Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" National Total Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" National Total Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" National Total Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 148.430 National Total Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" National Total Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" National Total Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" National Total Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 241.124 National Total Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" National Total Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 52.819 National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 144.764 National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 233.298 National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 140.853 National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 225.996 National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" National Total Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 National Total Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,77 National Total Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,65 National Total Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,68 National Total Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,11 National Total Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,63 National Total Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,28 National Total Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,69 National Total Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,26 National Total Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,16 National Total Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 90,74 National Total Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 90,24 National Total Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" National Total Total Cohort July 1 Total Number at the start of the quarter 2022QIII 1.200.910 National Total Total Cohort July 1 Total Number at the start of the quarter 2022QII "" National Total Total Cohort July 1 Total Number at the start of the quarter 2022QI "" National Total Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" National Total Total Cohort July 1 Total Number at the start of the quarter 2021QIII 1.175.049 National Total Total Cohort July 1 Total Number at the start of the quarter 2021QII "" National Total Total Cohort July 1 Total Number at the start of the quarter 2021QI "" National Total Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" National Total Total Cohort July 1 Total Number at the start of the quarter 2020QIII 1.141.253 National Total Total Cohort July 1 Total Number at the start of the quarter 2020QII "" National Total Total Cohort July 1 Total Number at the start of the quarter 2020QI "" National Total Total Cohort July 1 Total Survival in the first trimester 2022QIV "" National Total Total Cohort July 1 Total Survival in the first trimester 2022QIII 1.133.593 National Total Total Cohort July 1 Total Survival in the first trimester 2022QII "" National Total Total Cohort July 1 Total Survival in the first trimester 2022QI "" National Total Total Cohort July 1 Total Survival in the first trimester 2021QIV "" National Total Total Cohort July 1 Total Survival in the first trimester 2021QIII 1.112.584 National Total Total Cohort July 1 Total Survival in the first trimester 2021QII "" National Total Total Cohort July 1 Total Survival in the first trimester 2021QI "" National Total Total Cohort July 1 Total Survival in the first trimester 2020QIV "" National Total Total Cohort July 1 Total Survival in the first trimester 2020QIII 1.085.053 National Total Total Cohort July 1 Total Survival in the first trimester 2020QII "" National Total Total Cohort July 1 Total Survival in the first trimester 2020QI "" National Total Total Cohort July 1 Total Survival in the second trimester 2022QIV 1.077.291 National Total Total Cohort July 1 Total Survival in the second trimester 2022QIII "" National Total Total Cohort July 1 Total Survival in the second trimester 2022QII "" National Total Total Cohort July 1 Total Survival in the second trimester 2022QI "" National Total Total Cohort July 1 Total Survival in the second trimester 2021QIV 1.060.988 National Total Total Cohort July 1 Total Survival in the second trimester 2021QIII "" National Total Total Cohort July 1 Total Survival in the second trimester 2021QII "" National Total Total Cohort July 1 Total Survival in the second trimester 2021QI "" National Total Total Cohort July 1 Total Survival in the second trimester 2020QIV 1.033.148 National Total Total Cohort July 1 Total Survival in the second trimester 2020QIII "" National Total Total Cohort July 1 Total Survival in the second trimester 2020QII "" National Total Total Cohort July 1 Total Survival in the second trimester 2020QI "" National Total Total Cohort July 1 Total Survival in the third trimester 2022QIV "" National Total Total Cohort July 1 Total Survival in the third trimester 2022QIII "" National Total Total Cohort July 1 Total Survival in the third trimester 2022QII "" National Total Total Cohort July 1 Total Survival in the third trimester 2022QI 1.018.275 National Total Total Cohort July 1 Total Survival in the third trimester 2021QIV "" National Total Total Cohort July 1 Total Survival in the third trimester 2021QIII "" National Total Total Cohort July 1 Total Survival in the third trimester 2021QII "" National Total Total Cohort July 1 Total Survival in the third trimester 2021QI 991.293 National Total Total Cohort July 1 Total Survival in the third trimester 2020QIV "" National Total Total Cohort July 1 Total Survival in the third trimester 2020QIII "" National Total Total Cohort July 1 Total Survival in the third trimester 2020QII "" National Total Total Cohort July 1 Total Survival in the third trimester 2020QI "" National Total Total Cohort July 1 Total Survival in the third trimester 2022QIV "" National Total Total Cohort July 1 Total Survival in the third trimester 2022QIII "" National Total Total Cohort July 1 Total Survival in the third trimester 2022QII 987.625 National Total Total Cohort July 1 Total Survival in the third trimester 2022QI "" National Total Total Cohort July 1 Total Survival in the third trimester 2021QIV "" National Total Total Cohort July 1 Total Survival in the third trimester 2021QIII "" National Total Total Cohort July 1 Total Survival in the third trimester 2021QII 966.184 National Total Total Cohort July 1 Total Survival in the third trimester 2021QI "" National Total Total Cohort July 1 Total Survival in the third trimester 2020QIV "" National Total Total Cohort July 1 Total Survival in the third trimester 2020QIII "" National Total Total Cohort July 1 Total Survival in the third trimester 2020QII "" National Total Total Cohort July 1 Total Survival in the third trimester 2020QI "" National Total Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" National Total Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 National Total Total Cohort July 1 Total Number at the start of the quarter 2022QII "" National Total Total Cohort July 1 Total Number at the start of the quarter 2022QI "" National Total Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" National Total Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 National Total Total Cohort July 1 Total Number at the start of the quarter 2021QII "" National Total Total Cohort July 1 Total Number at the start of the quarter 2021QI "" National Total Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" National Total Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 National Total Total Cohort July 1 Total Number at the start of the quarter 2020QII "" National Total Total Cohort July 1 Total Number at the start of the quarter 2020QI "" National Total Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,39 National Total Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" National Total Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" National Total Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,68 National Total Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" National Total Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" National Total Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,08 National Total Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" National Total Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" National Total Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,71 National Total Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" National Total Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" National Total Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" National Total Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,29 National Total Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" National Total Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" National Total Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" National Total Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,53 National Total Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" National Total Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" National Total Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" National Total Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" National Total Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" National Total Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" National Total Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 86,66 National Total Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" National Total Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" National Total Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" National Total Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,86 National Total Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" National Total Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" National Total Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" National Total Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" National Total Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 84,05 National Total Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,66 National Total Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.166.975 National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.123.921 National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 962.702 National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.100.667 National Total Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" National Total Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" National Total Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.062.703 National Total Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" National Total Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" National Total Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 910.591 National Total Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" National Total Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" National Total Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.045.250 National Total Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" National Total Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" National Total Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.012.815 National Total Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" National Total Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" National Total Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 865.189 National Total Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" National Total Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 971.426 National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 828.387 National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 941.834 National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 806.621 National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" National Total Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,32 National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,55 National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,59 National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,57 National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 90,11 National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,87 National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 86,43 National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,05 National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 83,8 National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 83,79 National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 33.935 National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 51.128 National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 178.551 National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" National Total Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 32.926 National Total Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" National Total Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" National Total Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" National Total Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 49.881 National Total Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" National Total Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" National Total Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" National Total Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 174.462 National Total Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" National Total Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" National Total Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 32.041 National Total Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" National Total Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" National Total Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" National Total Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 48.173 National Total Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" National Total Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" National Total Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" National Total Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 167.959 National Total Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" National Total Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" National Total Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 46.849 National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 162.906 National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 45.791 National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 159.563 National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" National Total Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" National Total Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,03 National Total Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,56 National Total Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,71 National Total Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,42 National Total Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 94,22 National Total Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,07 National Total Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 91,63 National Total Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 91,24 National Total Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 89,56 National Total Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 89,37 National Total Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total Total Cohort October 1 Total Number at the start of the quarter 2022QIV 1.189.333 National Total Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" National Total Total Cohort October 1 Total Number at the start of the quarter 2022QII "" National Total Total Cohort October 1 Total Number at the start of the quarter 2022QI "" National Total Total Cohort October 1 Total Number at the start of the quarter 2021QIV 1.173.766 National Total Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" National Total Total Cohort October 1 Total Number at the start of the quarter 2021QII "" National Total Total Cohort October 1 Total Number at the start of the quarter 2021QI "" National Total Total Cohort October 1 Total Number at the start of the quarter 2020QIV 1.149.469 National Total Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" National Total Total Cohort October 1 Total Number at the start of the quarter 2020QII "" National Total Total Cohort October 1 Total Number at the start of the quarter 2020QI "" National Total Total Cohort October 1 Total Survival in the first trimester 2022QIV 1.121.025 National Total Total Cohort October 1 Total Survival in the first trimester 2022QIII "" National Total Total Cohort October 1 Total Survival in the first trimester 2022QII "" National Total Total Cohort October 1 Total Survival in the first trimester 2022QI "" National Total Total Cohort October 1 Total Survival in the first trimester 2021QIV 1.108.131 National Total Total Cohort October 1 Total Survival in the first trimester 2021QIII "" National Total Total Cohort October 1 Total Survival in the first trimester 2021QII "" National Total Total Cohort October 1 Total Survival in the first trimester 2021QI "" National Total Total Cohort October 1 Total Survival in the first trimester 2020QIV 1.080.193 National Total Total Cohort October 1 Total Survival in the first trimester 2020QIII "" National Total Total Cohort October 1 Total Survival in the first trimester 2020QII "" National Total Total Cohort October 1 Total Survival in the first trimester 2020QI "" National Total Total Cohort October 1 Total Survival in the second trimester 2022QIV "" National Total Total Cohort October 1 Total Survival in the second trimester 2022QIII "" National Total Total Cohort October 1 Total Survival in the second trimester 2022QII "" National Total Total Cohort October 1 Total Survival in the second trimester 2022QI 1.058.391 National Total Total Cohort October 1 Total Survival in the second trimester 2021QIV "" National Total Total Cohort October 1 Total Survival in the second trimester 2021QIII "" National Total Total Cohort October 1 Total Survival in the second trimester 2021QII "" National Total Total Cohort October 1 Total Survival in the second trimester 2021QI 1.031.022 National Total Total Cohort October 1 Total Survival in the second trimester 2020QIV "" National Total Total Cohort October 1 Total Survival in the second trimester 2020QIII "" National Total Total Cohort October 1 Total Survival in the second trimester 2020QII "" National Total Total Cohort October 1 Total Survival in the second trimester 2020QI "" National Total Total Cohort October 1 Total Survival in the third trimester 2022QIV "" National Total Total Cohort October 1 Total Survival in the third trimester 2022QIII "" National Total Total Cohort October 1 Total Survival in the third trimester 2022QII 1.020.827 National Total Total Cohort October 1 Total Survival in the third trimester 2022QI "" National Total Total Cohort October 1 Total Survival in the third trimester 2021QIV "" National Total Total Cohort October 1 Total Survival in the third trimester 2021QIII "" National Total Total Cohort October 1 Total Survival in the third trimester 2021QII 1.000.340 National Total Total Cohort October 1 Total Survival in the third trimester 2021QI "" National Total Total Cohort October 1 Total Survival in the third trimester 2020QIV "" National Total Total Cohort October 1 Total Survival in the third trimester 2020QIII "" National Total Total Cohort October 1 Total Survival in the third trimester 2020QII "" National Total Total Cohort October 1 Total Survival in the third trimester 2020QI "" National Total Total Cohort October 1 Total Survival in the third trimester 2022QIV "" National Total Total Cohort October 1 Total Survival in the third trimester 2022QIII 988.984 National Total Total Cohort October 1 Total Survival in the third trimester 2022QII "" National Total Total Cohort October 1 Total Survival in the third trimester 2022QI "" National Total Total Cohort October 1 Total Survival in the third trimester 2021QIV "" National Total Total Cohort October 1 Total Survival in the third trimester 2021QIII 973.266 National Total Total Cohort October 1 Total Survival in the third trimester 2021QII "" National Total Total Cohort October 1 Total Survival in the third trimester 2021QI "" National Total Total Cohort October 1 Total Survival in the third trimester 2020QIV "" National Total Total Cohort October 1 Total Survival in the third trimester 2020QIII "" National Total Total Cohort October 1 Total Survival in the third trimester 2020QII "" National Total Total Cohort October 1 Total Survival in the third trimester 2020QI "" National Total Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 National Total Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" National Total Total Cohort October 1 Total Number at the start of the quarter 2022QII "" National Total Total Cohort October 1 Total Number at the start of the quarter 2022QI "" National Total Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 National Total Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" National Total Total Cohort October 1 Total Number at the start of the quarter 2021QII "" National Total Total Cohort October 1 Total Number at the start of the quarter 2021QI "" National Total Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 National Total Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" National Total Total Cohort October 1 Total Number at the start of the quarter 2020QII "" National Total Total Cohort October 1 Total Number at the start of the quarter 2020QI "" National Total Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,26 National Total Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" National Total Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" National Total Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,41 National Total Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" National Total Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" National Total Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,97 National Total Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" National Total Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" National Total Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" National Total Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" National Total Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" National Total Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,17 National Total Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" National Total Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" National Total Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" National Total Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,7 National Total Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" National Total Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" National Total Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" National Total Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" National Total Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" National Total Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" National Total Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 86,97 National Total Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" National Total Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" National Total Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" National Total Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 87,03 National Total Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" National Total Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" National Total Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" National Total Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" National Total Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" National Total Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 84,26 National Total Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 84,67 National Total Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.160.407 National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.109.995 National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 962.114 National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.092.834 National Total Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" National Total Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" National Total Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.046.546 National Total Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" National Total Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" National Total Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 899.731 National Total Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" National Total Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" National Total Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" National Total Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 998.931 National Total Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" National Total Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 855.977 National Total Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" National Total Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 963.203 National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 828.952 National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 932.892 National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 805.210 National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" National Total Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,18 National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,28 National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,52 National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,99 National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88,97 National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 86,78 National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,16 National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 84,04 National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 83,69 National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 28.926 National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 63.771 National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 187.355 National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 28.191 National Total Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" National Total Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" National Total Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" National Total Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 61.585 National Total Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" National Total Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" National Total Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" National Total Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 180.462 National Total Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" National Total Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" National Total Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" National Total Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" National Total Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" National Total Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" National Total Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 59.460 National Total Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" National Total Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" National Total Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" National Total Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 175.045 National Total Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" National Total Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" National Total Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" National Total Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 57.624 National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 171.388 National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 56.092 National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 168.056 National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" National Total Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" National Total Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,46 National Total Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,57 National Total Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,32 National Total Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,24 National Total Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 93,43 National Total Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 90,36 National Total Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 91,48 National Total Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 87,96 National Total Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 89,7 National Total Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 874.114 National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 855.490 National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 886.684 National Total From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" National Total From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" National Total From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" National Total From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 812.905 National Total From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" National Total From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" National Total From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" National Total From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 796.794 National Total From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 756.210 National Total From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" National Total From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" National Total From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 769.343 National Total From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" National Total From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" National Total From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" National Total From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 761.641 National Total From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" National Total From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 723.750 National Total From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 734.959 National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 732.347 National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 695.670 National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 707.744 National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 708.023 National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 668.592 National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,14 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 85,29 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,01 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 89,03 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 81,62 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 84,08 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 85,61 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 78,46 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 80,97 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 82,76 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 75,4 National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 837.215 National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 768.170 National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 777.875 National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 713.559 National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 735.791 National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 681.184 National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 702.623 National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 654.274 National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 676.390 National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 632.648 National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,91 National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 92,89 National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 87,89 National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 88,68 National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 83,92 National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 85,17 National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 80,79 National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 82,36 National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 36.899 National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 87.320 National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 35.030 National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 83.235 National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 33.552 National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 80.457 National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 32.336 National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 78.073 National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 31.354 National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 75.375 National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,93 National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,32 National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,93 National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 92,14 National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 87,63 National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 89,41 National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 84,97 National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 86,32 National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 874.197 National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 854.310 National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 825.970 National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" National Total From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" National Total From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 818.113 National Total From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" National Total From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" National Total From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" National Total From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 808.026 National Total From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" National Total From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" National Total From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" National Total From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 785.210 National Total From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" National Total From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 775.542 National Total From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" National Total From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" National Total From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" National Total From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 771.127 National Total From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" National Total From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" National Total From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" National Total From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 751.083 National Total From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" National Total From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 740.395 National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 740.136 National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 718.066 National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 707.163 National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 685.318 National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 National Total From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,58 National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,58 National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,07 National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 88,71 National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,26 National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 90,93 National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 84,69 National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 86,64 National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 86,94 National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 82,78 National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 82,97 National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 838.776 National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 769.732 National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 676.830 National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 784.297 National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 726.460 National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 638.724 National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 743.050 National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 692.118 National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 609.668 National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 709.047 National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 664.072 National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 583.024 National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 634.180 National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 556.127 National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 National Total From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,5 National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,38 National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,37 National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 88,59 National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,92 National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,08 National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 84,53 National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 86,27 National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 86,14 National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 82,39 National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 82,17 National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 35.421 National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 84.578 National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 149.140 National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 33.816 National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 81.566 National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 146.486 National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 32.492 National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 79.009 National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 141.415 National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 31.348 National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 76.064 National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 135.042 National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 72.983 National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 129.191 National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 National Total From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,47 National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,44 National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,22 National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,73 National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,42 National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,82 National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,5 National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 89,93 National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 90,55 National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 86,29 National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 86,62 National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 883.149 National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 874.571 National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 853.778 National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" National Total From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 820.049 National Total From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" National Total From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" National Total From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" National Total From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 815.824 National Total From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" National Total From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" National Total From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" National Total From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 800.979 National Total From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 771.171 National Total From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" National Total From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" National Total From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" National Total From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 770.295 National Total From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" National Total From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" National Total From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" National Total From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 754.275 National Total From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" National Total From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 731.887 National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 716.603 National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 704.284 National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 694.215 National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,86 National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,28 National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 93,82 National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 87,32 National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 88,08 National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 88,35 National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 83,69 National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 83,93 National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 80,53 National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 81,31 National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 861.875 National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 846.766 National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 759.705 National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 799.681 National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 789.096 National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 710.308 National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 751.489 National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 744.825 National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 668.408 National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 707.461 National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 634.589 National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 680.705 National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 614.694 National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,78 National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,19 National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,5 National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,19 National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 87,96 National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 87,98 National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 83,55 National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 83,53 National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 80,39 National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 80,91 National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 21.274 National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 27.805 National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 94.073 National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 20.368 National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 26.728 National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 90.671 National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 19.682 National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 25.470 National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 85.867 National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 24.426 National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 82.014 National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 23.579 National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 79.521 National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,74 National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,13 National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,38 National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 92,52 National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 91,6 National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 91,28 National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 87,85 National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 87,18 National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 84,8 National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 84,53 National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 876.949 National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 873.692 National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 861.639 National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 814.659 National Total From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" National Total From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" National Total From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" National Total From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 813.113 National Total From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" National Total From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" National Total From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" National Total From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 796.865 National Total From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" National Total From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" National Total From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" National Total From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 767.484 National Total From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" National Total From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" National Total From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" National Total From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 751.794 National Total From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" National Total From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 733.651 National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 724.273 National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 704.836 National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 699.781 National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 92,9 National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,07 National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 92,48 National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 87,84 National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 87,25 National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 83,97 National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 84,06 National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 80,67 National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 81,22 National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 859.355 National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 832.620 National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 764.014 National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 797.673 National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 773.929 National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 704.637 National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 730.155 National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 663.810 National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 697.930 National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 639.048 National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 670.420 National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 617.075 National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 92,82 National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 92,95 National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,23 National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 87,69 National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 86,88 National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 83,82 National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 83,64 National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 80,52 National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 80,77 National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 17.594 National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 41.072 National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 97.625 National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 16.986 National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 39.184 National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 92.228 National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 37.329 National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 87.984 National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 35.721 National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 85.225 National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 34.416 National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 82.706 National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,54 National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,4 National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 94,47 National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 90,89 National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 90,12 National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 86,97 National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 87,3 National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 83,79 National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 84,72 National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 124.549 National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 116.998 National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 125.748 National Total From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 122.442 National Total From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 115.037 National Total From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 119.746 National Total From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 119.929 National Total From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 113.082 National Total From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 117.857 National Total From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 118.092 National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 111.610 National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 116.016 National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 116.475 National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 110.232 National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 114.126 National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,31 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,32 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 95,23 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,29 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,65 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 93,72 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,82 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,39 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 92,26 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,52 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,22 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 90,76 National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 116.252 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 89.900 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 114.291 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 88.368 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 111.916 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 86.777 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 110.189 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 85.631 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 108.663 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 84.625 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,31 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,3 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,27 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,53 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,78 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,25 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,47 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,13 National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 8.297 National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 27.098 National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 8.151 National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 26.669 National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 8.013 National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 26.305 National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 7.903 National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 25.979 National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 7.812 National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 25.607 National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,24 National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,42 National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96,58 National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,07 National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 95,25 National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,87 National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,15 National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 94,5 National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 125.746 National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 117.333 National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 113.956 National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 123.339 National Total From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 115.449 National Total From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 112.601 National Total From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 121.490 National Total From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 113.946 National Total From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 111.102 National Total From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 119.297 National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 112.122 National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 109.297 National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 110.064 National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 107.283 National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 National Total From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,09 National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,39 National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,81 National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,62 National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,11 National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,5 National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 94,87 National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,56 National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,91 National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,8 National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,14 National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 117.702 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 92.334 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 73.717 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 115.409 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 90.772 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 72.663 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 113.675 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 89.553 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 71.705 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 111.618 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 88.101 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 70.739 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 86.453 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 69.483 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,05 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,31 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,57 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,58 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,99 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,27 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 94,83 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,42 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,96 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,63 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,26 National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 8.044 National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 24.999 National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 40.239 National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 7.930 National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 24.677 National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 39.938 National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 7.815 National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 24.393 National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 39.397 National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 7.679 National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 24.021 National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 38.558 National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 23.611 National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 37.800 National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 National Total From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,58 National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,71 National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,25 National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,15 National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,58 National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,91 National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 95,46 National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,09 National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,82 National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 94,45 National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 93,94 National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 130.132 National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 124.765 National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 119.956 National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 127.777 National Total From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 122.694 National Total From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 117.978 National Total From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 123.924 National Total From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 119.394 National Total From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 114.960 National Total From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 116.989 National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 112.670 National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 115.333 National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 111.210 National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,19 National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,34 National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,35 National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 95,23 National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 95,7 National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 95,84 National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 93,77 National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 93,93 National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 92,44 National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 92,71 National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 125.390 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 116.697 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 90.074 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 123.085 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 114.694 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 88.484 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 119.321 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 111.607 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 86.341 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 109.334 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 84.652 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 107.792 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 83.598 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,16 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,28 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,23 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 95,16 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 95,64 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 95,86 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 93,69 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 93,98 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 92,37 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 92,81 National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 4.742 National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 8.068 National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 29.882 National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 4.692 National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 8.000 National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 29.494 National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 4.603 National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 7.787 National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 28.619 National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 7.655 National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 28.018 National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 7.541 National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 27.612 National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,95 National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,16 National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,7 National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,07 National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,52 National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,77 National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 94,88 National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,76 National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,47 National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,4 National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 127.463 National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 123.997 National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 119.747 National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 124.148 National Total From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 121.155 National Total From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 117.016 National Total From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 118.849 National Total From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 114.737 National Total From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 116.838 National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 113.058 National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 115.212 National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 111.718 National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,4 National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 97,71 National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 97,72 National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 95,85 National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 95,82 National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 94,23 National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 94,41 National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 92,92 National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 93,3 National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 123.328 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 115.622 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 88.359 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 120.065 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 112.939 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 86.418 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 110.785 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 84.738 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 108.872 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 83.486 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 107.369 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 82.513 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,35 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 97,68 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,8 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 95,82 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 95,9 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 94,16 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 94,48 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 92,86 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,38 National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 4.135 National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 8.375 National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 31.388 National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 4.083 National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 8.216 National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 30.598 National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 8.064 National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 29.999 National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 7.966 National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 29.572 National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 7.843 National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 29.205 National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,74 National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,1 National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,48 National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 96,29 National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,57 National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 95,12 National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,21 National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 93,65 National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,05 National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 163.320 National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 151.266 National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 164.940 National Total From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" National Total From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" National Total From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" National Total From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 161.717 National Total From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" National Total From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" National Total From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" National Total From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 149.762 National Total From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 161.052 National Total From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" National Total From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" National Total From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 159.625 National Total From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" National Total From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" National Total From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" National Total From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 148.171 National Total From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" National Total From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 159.443 National Total From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 158.127 National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 146.961 National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 158.052 National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 156.876 National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 145.782 National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 156.571 National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,02 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,01 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,64 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,74 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,95 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,67 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,82 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,15 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,82 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,05 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,37 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,93 National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 150.543 National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 106.288 National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 149.040 National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 105.181 National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 147.087 National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 103.991 National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 145.695 National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 103.131 National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 144.529 National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 102.326 National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99 National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,96 National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,7 National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,84 National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,78 National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,03 National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,01 National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,27 National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 12.777 National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 44.978 National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 12.677 National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 44.581 National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 12.538 National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 44.180 National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 12.432 National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 43.830 National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 12.347 National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 43.456 National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,22 National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,12 National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,13 National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,23 National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,3 National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,45 National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,63 National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,62 National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 166.450 National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 152.636 National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 150.040 National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" National Total From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" National Total From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 164.493 National Total From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" National Total From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" National Total From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" National Total From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 151.161 National Total From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" National Total From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" National Total From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" National Total From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 148.830 National Total From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" National Total From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 163.054 National Total From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" National Total From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" National Total From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" National Total From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 149.932 National Total From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" National Total From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" National Total From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" National Total From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 147.755 National Total From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" National Total From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 161.455 National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 148.639 National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 146.511 National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 147.097 National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 144.878 National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 National Total From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,82 National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,03 National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,19 National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,96 National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,23 National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,48 National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97 National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,38 National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,65 National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,37 National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,56 National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 153.606 National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 111.384 National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 93.261 National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 151.785 National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 110.222 National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 92.383 National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 150.432 National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 109.269 National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 91.698 National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 148.945 National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 108.311 National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 91.053 National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 107.167 National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 90.090 National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 National Total From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,81 National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,96 National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,06 National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,93 National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,1 National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,32 National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,97 National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,24 National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,63 National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,21 National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,6 National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 12.844 National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 41.252 National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 56.779 National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 12.708 National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 40.939 National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 56.447 National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 12.622 National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 40.663 National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 56.057 National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 12.510 National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 40.328 National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 55.458 National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 39.930 National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 54.788 National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 National Total From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,94 National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,24 National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,42 National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,27 National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,57 National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,73 National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,4 National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,76 National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,67 National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,8 National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,49 National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 173.380 National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 162.690 National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 155.017 National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" National Total From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 171.583 National Total From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" National Total From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" National Total From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" National Total From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 161.089 National Total From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" National Total From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" National Total From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" National Total From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 153.646 National Total From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 168.075 National Total From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" National Total From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" National Total From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" National Total From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 158.391 National Total From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" National Total From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" National Total From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" National Total From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 151.519 National Total From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" National Total From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 156.573 National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 149.706 National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 155.225 National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 148.479 National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,96 National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,02 National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,12 National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,94 National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,36 National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,74 National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,24 National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,57 National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,41 National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,78 National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 166.164 National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 148.996 National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 105.363 National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 164.417 National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 147.492 National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 104.280 National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 161.016 National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 145.023 National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 102.959 National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 143.349 National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 101.717 National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 142.095 National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 100.927 National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,95 National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,99 National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,97 National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,9 National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,33 National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,72 National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,21 National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,54 National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,37 National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,79 National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 7.216 National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 13.694 National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 49.654 National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 7.166 National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 13.597 National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 49.366 National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 7.059 National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 13.368 National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 48.560 National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 13.224 National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 47.989 National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 13.130 National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 47.552 National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,31 National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,29 National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,42 National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,82 National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,62 National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,8 National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 96,57 National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,65 National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 95,88 National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,77 National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 170.547 National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 162.696 National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 155.216 National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 167.898 National Total From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" National Total From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" National Total From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" National Total From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 160.551 National Total From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" National Total From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" National Total From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" National Total From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 153.508 National Total From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" National Total From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" National Total From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" National Total From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 158.833 National Total From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" National Total From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" National Total From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" National Total From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 151.765 National Total From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" National Total From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 157.160 National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 150.320 National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 155.826 National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 149.131 National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,45 National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,68 National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,9 National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,63 National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,78 National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,6 National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,85 National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,78 National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,08 National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 163.975 National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 149.747 National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 102.151 National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 161.397 National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 147.739 National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 101.131 National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 146.137 National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 99.937 National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 144.590 National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 98.954 National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 143.354 National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 98.189 National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,43 National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,66 National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99 National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,59 National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,83 National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,56 National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,87 National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,73 National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,12 National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 6.572 National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 12.949 National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 53.065 National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 6.501 National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 12.812 National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 52.377 National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 12.696 National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 51.828 National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 12.570 National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 51.366 National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 12.472 National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 50.942 National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,92 National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,94 National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,7 National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,05 National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,67 National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,07 National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 96,8 National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96,32 National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96 National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 8.758 National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 8.219 National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 8.715 National Total from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" National Total from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" National Total from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" National Total from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 8.715 National Total from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" National Total from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" National Total from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" National Total from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 8.160 National Total from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 8.634 National Total from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" National Total from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" National Total from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 8.673 National Total from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" National Total from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" National Total from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" National Total from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 8.128 National Total from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" National Total from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 8.600 National Total from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 8.617 National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 8.088 National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 8.549 National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 8.576 National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 8.046 National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 8.509 National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,51 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,28 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,07 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,03 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,89 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,68 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,39 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,41 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,1 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,92 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,9 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,64 National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 7.908 National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 5.257 National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 7.866 National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 5.213 National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 7.829 National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 5.187 National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 7.780 National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 5.161 National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 7.743 National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 5.129 National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,47 National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,16 National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99 National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,67 National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,38 National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,17 National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,91 National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,57 National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 850 National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2.962 National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 849 National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2.947 National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 844 National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2.941 National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 837 National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2.927 National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 833 National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2.917 National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,88 National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,49 National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 99,29 National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 99,29 National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 98,47 National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,82 National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 98 National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,48 National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 8.978 National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 8.170 National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 8.183 National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" National Total from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" National Total from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 8.942 National Total from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" National Total from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" National Total from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" National Total from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 8.148 National Total from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" National Total from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" National Total from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" National Total from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 8.155 National Total from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" National Total from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 8.878 National Total from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" National Total from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" National Total from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" National Total from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 8.094 National Total from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" National Total from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" National Total from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" National Total from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 8.119 National Total from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" National Total from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 8.830 National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 8.052 National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 8.078 National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 8.012 National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 8.025 National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 National Total from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,6 National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,73 National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,66 National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,89 National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,07 National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,22 National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,35 National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,56 National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,72 National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,07 National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,07 National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 8.143 National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 5.493 National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 5.426 National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 8.108 National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 5.475 National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 5.402 National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 8.050 National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 5.435 National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 5.375 National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 8.004 National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 5.402 National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 5.344 National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 5.377 National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 5.309 National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 National Total from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,57 National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,67 National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,56 National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,86 National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,94 National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,06 National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,29 National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98,34 National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,49 National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,89 National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,84 National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 835 National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 2.677 National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.757 National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 834 National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 2.673 National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.753 National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 828 National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 2.659 National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.744 National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 826 National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 2.650 National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.734 National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 2.635 National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.716 National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 National Total from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,88 National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,85 National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,85 National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 99,16 National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,33 National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,53 National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 98,92 National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,99 National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 99,17 National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 98,43 National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,51 National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 9.297 National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 8.416 National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 8.063 National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" National Total from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 9.247 National Total from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" National Total from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" National Total from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" National Total from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 8.379 National Total from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" National Total from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" National Total from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" National Total from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 8.025 National Total from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 9.198 National Total from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" National Total from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" National Total from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" National Total from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 8.331 National Total from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" National Total from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" National Total from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" National Total from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 7.991 National Total from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" National Total from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 8.288 National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 7.932 National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 8.257 National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 7.907 National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,46 National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,56 National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,53 National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,94 National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,99 National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,11 National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,48 National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,38 National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,11 National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,07 National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 8.817 National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 7.463 National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 4.935 National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 8.769 National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 7.429 National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 4.907 National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 8.721 National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 7.385 National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 4.885 National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 7.346 National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 4.848 National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 7.318 National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 4.828 National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,46 National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,54 National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,43 National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,91 National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,95 National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,99 National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,43 National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,24 National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,06 National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,83 National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 480 National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 953 National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 3.128 National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 478 National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 950 National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 3.118 National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 477 National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 946 National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 3.106 National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 942 National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 3.084 National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 939 National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 3.079 National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,58 National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,69 National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,68 National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 99,38 National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,27 National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,3 National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 98,85 National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,59 National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 98,53 National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,43 National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 9.311 National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 8.634 National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 8.288 National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 9.273 National Total from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" National Total from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" National Total from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" National Total from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 8.585 National Total from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" National Total from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" National Total from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" National Total from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 8.247 National Total from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" National Total from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" National Total from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" National Total from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 8.541 National Total from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" National Total from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" National Total from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" National Total from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 8.189 National Total from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" National Total from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 8.509 National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 8.164 National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 8.459 National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 8.128 National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,59 National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,43 National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,51 National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,92 National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,81 National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,55 National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,5 National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,97 National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,07 National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 8.889 National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 7.774 National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 4.950 National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 8.854 National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 7.726 National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 4.920 National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 7.683 National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 4.881 National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 7.654 National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 4.861 National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 7.608 National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 4.840 National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,61 National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,38 National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,39 National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,83 National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,61 National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,46 National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,2 National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,86 National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,78 National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 422 National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 860 National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 3.338 National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 419 National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 859 National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 3.327 National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 858 National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 3.308 National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 855 National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 3.303 National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 851 National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 3.288 National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,29 National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,88 National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,67 National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 99,77 National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 99,1 National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 99,42 National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,95 National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 98,95 National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,5 National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 4.841 National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 4.588 National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 4.783 National Total De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" National Total De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" National Total De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" National Total De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 4.802 National Total De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" National Total De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" National Total De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" National Total De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 4.567 National Total De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" National Total De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" National Total De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" National Total De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 4.762 National Total De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" National Total De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" National Total De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 4.787 National Total De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" National Total De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" National Total De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" National Total De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 4.553 National Total De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" National Total De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" National Total De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" National Total De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 4.748 National Total De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 4.764 National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 4.530 National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 4.724 National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 4.748 National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 4.509 National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 4.704 National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" National Total De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,19 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,54 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,56 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,88 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 99,24 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 99,27 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,41 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,74 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,77 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,08 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,28 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,35 National Total De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 4.389 National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.767 National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 4.351 National Total De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2.752 National Total De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 4.337 National Total De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.741 National Total De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 4.316 National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.723 National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 4.301 National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2.709 National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,13 National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,46 National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,82 National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 99,06 National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,34 National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,41 National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,99 National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,9 National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 452 National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.821 National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 451 National Total De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.815 National Total De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 450 National Total De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.812 National Total De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 448 National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.807 National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 447 National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.800 National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,78 National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,67 National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 99,56 National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 99,51 National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 99,12 National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 99,23 National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 98,89 National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,85 National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 4.911 National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 4.569 National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 4.589 National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" National Total De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" National Total De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 4.899 National Total De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" National Total De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" National Total De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" National Total De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 4.557 National Total De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" National Total De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" National Total De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" National Total De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 4.582 National Total De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" National Total De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" National Total De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 4.877 National Total De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" National Total De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" National Total De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" National Total De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 4.539 National Total De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" National Total De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" National Total De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" National Total De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 4.555 National Total De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" National Total De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 4.863 National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 4.518 National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 4.533 National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 4.479 National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 4.510 National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" National Total De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 National Total De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,76 National Total De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,74 National Total De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,85 National Total De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,31 National Total De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,34 National Total De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,26 National Total De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 99,02 National Total De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,88 National Total De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,78 National Total De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,03 National Total De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,28 National Total De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 4.448 National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.855 National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 3.072 National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 4.438 National Total De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.846 National Total De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 3.068 National Total De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 4.418 National Total De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.833 National Total De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 3.044 National Total De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 4.407 National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.817 National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 3.027 National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.785 National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 3.009 National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 National Total De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,78 National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,68 National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,87 National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 99,33 National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 99,23 National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,09 National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 99,08 National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98,67 National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,54 National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,55 National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,95 National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 463 National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.714 National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.517 National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 461 National Total De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.711 National Total De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.514 National Total De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 459 National Total De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.706 National Total De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.511 National Total De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 456 National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.701 National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.506 National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.694 National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.501 National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 National Total De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,57 National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,82 National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,8 National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 99,14 National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,53 National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,6 National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 98,49 National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 99,24 National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 99,27 National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 98,83 National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,95 National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 4.952 National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 4.607 National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 4.439 National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" National Total De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 4.937 National Total De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" National Total De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" National Total De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" National Total De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 4.598 National Total De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" National Total De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" National Total De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" National Total De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 4.425 National Total De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" National Total De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" National Total De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 4.923 National Total De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" National Total De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" National Total De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" National Total De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 4.577 National Total De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" National Total De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" National Total De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" National Total De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 4.403 National Total De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" National Total De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" National Total De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 4.538 National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 4.382 National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 4.526 National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 4.373 National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" National Total De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,7 National Total De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,8 National Total De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,68 National Total De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 99,41 National Total De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,35 National Total De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,19 National Total De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,5 National Total De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,72 National Total De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,24 National Total De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,51 National Total De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 4.729 National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 3.999 National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2.625 National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 4.715 National Total De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 3.992 National Total De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.612 National Total De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 4.703 National Total De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 3.975 National Total De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.596 National Total De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 3.936 National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.581 National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 3.924 National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.574 National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,7 National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,82 National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,5 National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 99,45 National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 99,4 National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,9 National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,42 National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,32 National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,12 National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 98,06 National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 223 National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 608 National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.814 National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 222 National Total De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 606 National Total De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.813 National Total De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 220 National Total De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 602 National Total De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.807 National Total De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 602 National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.801 National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 602 National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.799 National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,55 National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,67 National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,94 National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,65 National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,01 National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,61 National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 99,01 National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 99,28 National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 99,01 National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 99,17 National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 5.063 National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 4.747 National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 4.579 National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 5.047 National Total De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" National Total De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" National Total De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" National Total De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 4.727 National Total De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" National Total De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" National Total De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" National Total De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 4.557 National Total De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" National Total De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" National Total De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" National Total De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" National Total De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" National Total De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" National Total De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 4.684 National Total De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" National Total De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" National Total De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" National Total De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 4.537 National Total De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" National Total De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" National Total De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" National Total De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 4.669 National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 4.525 National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 4.651 National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 4.508 National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" National Total De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,68 National Total De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,58 National Total De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,52 National Total De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,67 National Total De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 99,08 National Total De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,36 National Total De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,82 National Total De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,98 National Total De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,45 National Total De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" National Total De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 4.860 National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 4.232 National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2.640 National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 4.845 National Total De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 4.213 National Total De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2.625 National Total De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 4.171 National Total De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.611 National Total De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 4.157 National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2.603 National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 4.141 National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.593 National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,69 National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,55 National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,43 National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,56 National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,9 National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,23 National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,6 National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,85 National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,22 National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" National Total De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 203 National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 515 National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.939 National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 202 National Total De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 514 National Total De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.932 National Total De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 513 National Total De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.926 National Total De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 512 National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.922 National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 510 National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.915 National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" National Total De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" National Total De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,51 National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,81 National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,64 National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 99,61 National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 99,33 National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 99,42 National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 99,12 National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 99,03 National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,76 National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" National Total De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 02 Albacete Total Cohort January 1 Total Number at the start of the quarter 2022QI 9.442 02 Albacete Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 02 Albacete Total Cohort January 1 Total Number at the start of the quarter 2021QI 9.135 02 Albacete Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 02 Albacete Total Cohort January 1 Total Number at the start of the quarter 2020QI 9.476 02 Albacete Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 02 Albacete Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 02 Albacete Total Cohort January 1 Total Survival in the first trimester 2022QII "" 02 Albacete Total Cohort January 1 Total Survival in the first trimester 2022QI 8.916 02 Albacete Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 02 Albacete Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 02 Albacete Total Cohort January 1 Total Survival in the first trimester 2021QII "" 02 Albacete Total Cohort January 1 Total Survival in the first trimester 2021QI 8.645 02 Albacete Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 02 Albacete Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 02 Albacete Total Cohort January 1 Total Survival in the first trimester 2020QII "" 02 Albacete Total Cohort January 1 Total Survival in the first trimester 2020QI 8.300 02 Albacete Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 02 Albacete Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 02 Albacete Total Cohort January 1 Total Survival in the second trimester 2022QII 8.521 02 Albacete Total Cohort January 1 Total Survival in the second trimester 2022QI "" 02 Albacete Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 02 Albacete Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 02 Albacete Total Cohort January 1 Total Survival in the second trimester 2021QII 8.333 02 Albacete Total Cohort January 1 Total Survival in the second trimester 2021QI "" 02 Albacete Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 02 Albacete Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 02 Albacete Total Cohort January 1 Total Survival in the second trimester 2020QII 8.036 02 Albacete Total Cohort January 1 Total Survival in the second trimester 2020QI "" 02 Albacete Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 02 Albacete Total Cohort January 1 Total Survival in the third trimester 2022QIII 8.215 02 Albacete Total Cohort January 1 Total Survival in the third trimester 2022QII "" 02 Albacete Total Cohort January 1 Total Survival in the third trimester 2022QI "" 02 Albacete Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 02 Albacete Total Cohort January 1 Total Survival in the third trimester 2021QIII 8.063 02 Albacete Total Cohort January 1 Total Survival in the third trimester 2021QII "" 02 Albacete Total Cohort January 1 Total Survival in the third trimester 2021QI "" 02 Albacete Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 02 Albacete Total Cohort January 1 Total Survival in the third trimester 2020QIII 7.804 02 Albacete Total Cohort January 1 Total Survival in the third trimester 2020QII "" 02 Albacete Total Cohort January 1 Total Survival in the third trimester 2020QI "" 02 Albacete Total Cohort January 1 Total Survival in the third trimester 2022QIV 7.956 02 Albacete Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 02 Albacete Total Cohort January 1 Total Survival in the third trimester 2022QII "" 02 Albacete Total Cohort January 1 Total Survival in the third trimester 2022QI "" 02 Albacete Total Cohort January 1 Total Survival in the third trimester 2021QIV 7.875 02 Albacete Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 02 Albacete Total Cohort January 1 Total Survival in the third trimester 2021QII "" 02 Albacete Total Cohort January 1 Total Survival in the third trimester 2021QI "" 02 Albacete Total Cohort January 1 Total Survival in the third trimester 2020QIV 7.605 02 Albacete Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 02 Albacete Total Cohort January 1 Total Survival in the third trimester 2020QII "" 02 Albacete Total Cohort January 1 Total Survival in the third trimester 2020QI "" 02 Albacete Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 02 Albacete Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 02 Albacete Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 02 Albacete Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 02 Albacete Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 02 Albacete Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 02 Albacete Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,43 02 Albacete Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,64 02 Albacete Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 87,59 02 Albacete Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,25 02 Albacete Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,22 02 Albacete Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 84,8 02 Albacete Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 87 02 Albacete Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 88,26 02 Albacete Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 82,36 02 Albacete Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 84,26 02 Albacete Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 86,21 02 Albacete Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 80,26 02 Albacete Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Albacete Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Albacete Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 9.058 02 Albacete Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 8.142 02 Albacete Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 8.546 02 Albacete Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 7.683 02 Albacete Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 8.165 02 Albacete Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 7.390 02 Albacete Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 7.869 02 Albacete Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 7.133 02 Albacete Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 7.616 02 Albacete Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 6.959 02 Albacete Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 02 Albacete Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 02 Albacete Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,35 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,36 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,14 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,76 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,87 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,61 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 84,08 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,47 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 384 02 Albacete Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 993 02 Albacete Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 370 02 Albacete Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 962 02 Albacete Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 356 02 Albacete Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 943 02 Albacete Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 346 02 Albacete Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 930 02 Albacete Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 340 02 Albacete Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 916 02 Albacete Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 02 Albacete Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 02 Albacete Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,35 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,88 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,71 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,96 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,1 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 93,66 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,54 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 92,25 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete Total Cohort April 1 Total Number at the start of the quarter 2022QII 9.411 02 Albacete Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 02 Albacete Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete Total Cohort April 1 Total Number at the start of the quarter 2021QII 9.169 02 Albacete Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 02 Albacete Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete Total Cohort April 1 Total Number at the start of the quarter 2020QII 8.731 02 Albacete Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 02 Albacete Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 02 Albacete Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 02 Albacete Total Cohort April 1 Total Survival in the first trimester 2022QII 8.906 02 Albacete Total Cohort April 1 Total Survival in the first trimester 2022QI "" 02 Albacete Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 02 Albacete Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 02 Albacete Total Cohort April 1 Total Survival in the first trimester 2021QII 8.731 02 Albacete Total Cohort April 1 Total Survival in the first trimester 2021QI "" 02 Albacete Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 02 Albacete Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 02 Albacete Total Cohort April 1 Total Survival in the first trimester 2020QII 8.403 02 Albacete Total Cohort April 1 Total Survival in the first trimester 2020QI "" 02 Albacete Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 02 Albacete Total Cohort April 1 Total Survival in the second trimester 2022QIII 8.516 02 Albacete Total Cohort April 1 Total Survival in the second trimester 2022QII "" 02 Albacete Total Cohort April 1 Total Survival in the second trimester 2022QI "" 02 Albacete Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 02 Albacete Total Cohort April 1 Total Survival in the second trimester 2021QIII 8.371 02 Albacete Total Cohort April 1 Total Survival in the second trimester 2021QII "" 02 Albacete Total Cohort April 1 Total Survival in the second trimester 2021QI "" 02 Albacete Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 02 Albacete Total Cohort April 1 Total Survival in the second trimester 2020QIII 8.128 02 Albacete Total Cohort April 1 Total Survival in the second trimester 2020QII "" 02 Albacete Total Cohort April 1 Total Survival in the second trimester 2020QI "" 02 Albacete Total Cohort April 1 Total Survival in the third trimester 2022QIV 8.214 02 Albacete Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 02 Albacete Total Cohort April 1 Total Survival in the third trimester 2022QII "" 02 Albacete Total Cohort April 1 Total Survival in the third trimester 2022QI "" 02 Albacete Total Cohort April 1 Total Survival in the third trimester 2021QIV 8.129 02 Albacete Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 02 Albacete Total Cohort April 1 Total Survival in the third trimester 2021QII "" 02 Albacete Total Cohort April 1 Total Survival in the third trimester 2021QI "" 02 Albacete Total Cohort April 1 Total Survival in the third trimester 2020QIV 7.893 02 Albacete Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 02 Albacete Total Cohort April 1 Total Survival in the third trimester 2020QII "" 02 Albacete Total Cohort April 1 Total Survival in the third trimester 2020QI "" 02 Albacete Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 02 Albacete Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 02 Albacete Total Cohort April 1 Total Survival in the third trimester 2022QII "" 02 Albacete Total Cohort April 1 Total Survival in the third trimester 2022QI 7.850 02 Albacete Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 02 Albacete Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 02 Albacete Total Cohort April 1 Total Survival in the third trimester 2021QII "" 02 Albacete Total Cohort April 1 Total Survival in the third trimester 2021QI 7.646 02 Albacete Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 02 Albacete Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 02 Albacete Total Cohort April 1 Total Survival in the third trimester 2020QII "" 02 Albacete Total Cohort April 1 Total Survival in the third trimester 2020QI "" 02 Albacete Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 02 Albacete Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 02 Albacete Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 02 Albacete Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 02 Albacete Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 02 Albacete Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,63 02 Albacete Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,22 02 Albacete Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,24 02 Albacete Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,49 02 Albacete Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,3 02 Albacete Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,09 02 Albacete Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,28 02 Albacete Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 88,66 02 Albacete Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,4 02 Albacete Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 85,61 02 Albacete Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87,57 02 Albacete Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Albacete Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Albacete Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 9.036 02 Albacete Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 8.356 02 Albacete Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 6.521 02 Albacete Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 8.545 02 Albacete Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 7.937 02 Albacete Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 6.219 02 Albacete Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 8.166 02 Albacete Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 7.587 02 Albacete Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 5.989 02 Albacete Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 7.872 02 Albacete Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 7.361 02 Albacete Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 5.816 02 Albacete Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 7.105 02 Albacete Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 5.630 02 Albacete Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 02 Albacete Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 02 Albacete Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 02 Albacete Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,57 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,99 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,37 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,37 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 90,8 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,84 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,12 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 88,09 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 89,19 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 85,03 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 86,34 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 375 02 Albacete Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 813 02 Albacete Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.210 02 Albacete Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 361 02 Albacete Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 794 02 Albacete Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.184 02 Albacete Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 350 02 Albacete Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 784 02 Albacete Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.139 02 Albacete Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 342 02 Albacete Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 768 02 Albacete Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.077 02 Albacete Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 745 02 Albacete Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.016 02 Albacete Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 02 Albacete Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 02 Albacete Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 02 Albacete Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,27 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,66 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,82 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,33 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,43 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,79 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,2 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,46 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,98 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 91,64 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,22 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete Total Cohort July 1 Total Number at the start of the quarter 2022QIII 9.415 02 Albacete Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 02 Albacete Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 02 Albacete Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete Total Cohort July 1 Total Number at the start of the quarter 2021QIII 9.356 02 Albacete Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 02 Albacete Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 02 Albacete Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete Total Cohort July 1 Total Number at the start of the quarter 2020QIII 9.171 02 Albacete Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 02 Albacete Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 02 Albacete Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 02 Albacete Total Cohort July 1 Total Survival in the first trimester 2022QIII 8.836 02 Albacete Total Cohort July 1 Total Survival in the first trimester 2022QII "" 02 Albacete Total Cohort July 1 Total Survival in the first trimester 2022QI "" 02 Albacete Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 02 Albacete Total Cohort July 1 Total Survival in the first trimester 2021QIII 8.791 02 Albacete Total Cohort July 1 Total Survival in the first trimester 2021QII "" 02 Albacete Total Cohort July 1 Total Survival in the first trimester 2021QI "" 02 Albacete Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 02 Albacete Total Cohort July 1 Total Survival in the first trimester 2020QIII 8.679 02 Albacete Total Cohort July 1 Total Survival in the first trimester 2020QII "" 02 Albacete Total Cohort July 1 Total Survival in the first trimester 2020QI "" 02 Albacete Total Cohort July 1 Total Survival in the second trimester 2022QIV 8.466 02 Albacete Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 02 Albacete Total Cohort July 1 Total Survival in the second trimester 2022QII "" 02 Albacete Total Cohort July 1 Total Survival in the second trimester 2022QI "" 02 Albacete Total Cohort July 1 Total Survival in the second trimester 2021QIV 8.472 02 Albacete Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 02 Albacete Total Cohort July 1 Total Survival in the second trimester 2021QII "" 02 Albacete Total Cohort July 1 Total Survival in the second trimester 2021QI "" 02 Albacete Total Cohort July 1 Total Survival in the second trimester 2020QIV 8.314 02 Albacete Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 02 Albacete Total Cohort July 1 Total Survival in the second trimester 2020QII "" 02 Albacete Total Cohort July 1 Total Survival in the second trimester 2020QI "" 02 Albacete Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 02 Albacete Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 02 Albacete Total Cohort July 1 Total Survival in the third trimester 2022QII "" 02 Albacete Total Cohort July 1 Total Survival in the third trimester 2022QI 8.152 02 Albacete Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 02 Albacete Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 02 Albacete Total Cohort July 1 Total Survival in the third trimester 2021QII "" 02 Albacete Total Cohort July 1 Total Survival in the third trimester 2021QI 8.011 02 Albacete Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 02 Albacete Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 02 Albacete Total Cohort July 1 Total Survival in the third trimester 2020QII "" 02 Albacete Total Cohort July 1 Total Survival in the third trimester 2020QI "" 02 Albacete Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 02 Albacete Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 02 Albacete Total Cohort July 1 Total Survival in the third trimester 2022QII 7.933 02 Albacete Total Cohort July 1 Total Survival in the third trimester 2022QI "" 02 Albacete Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 02 Albacete Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 02 Albacete Total Cohort July 1 Total Survival in the third trimester 2021QII 7.828 02 Albacete Total Cohort July 1 Total Survival in the third trimester 2021QI "" 02 Albacete Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 02 Albacete Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 02 Albacete Total Cohort July 1 Total Survival in the third trimester 2020QII "" 02 Albacete Total Cohort July 1 Total Survival in the third trimester 2020QI "" 02 Albacete Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 02 Albacete Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 02 Albacete Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 02 Albacete Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 02 Albacete Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 02 Albacete Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 02 Albacete Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 02 Albacete Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 02 Albacete Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,85 02 Albacete Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,96 02 Albacete Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,64 02 Albacete Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,92 02 Albacete Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,55 02 Albacete Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,66 02 Albacete Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 87,13 02 Albacete Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 87,35 02 Albacete Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 84,79 02 Albacete Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 85,36 02 Albacete Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Albacete Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Albacete Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 9.314 02 Albacete Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 9.045 02 Albacete Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 8.114 02 Albacete Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 8.737 02 Albacete Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 8.490 02 Albacete Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 7.645 02 Albacete Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 8.372 02 Albacete Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 8.179 02 Albacete Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 7.306 02 Albacete Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 7.866 02 Albacete Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 7.031 02 Albacete Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 7.652 02 Albacete Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 6.861 02 Albacete Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 02 Albacete Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 02 Albacete Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 02 Albacete Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,81 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,86 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,22 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,89 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 90,43 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,04 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 86,97 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,65 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 84,6 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 84,56 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 101 02 Albacete Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 311 02 Albacete Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.057 02 Albacete Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 99 02 Albacete Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 301 02 Albacete Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.034 02 Albacete Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 94 02 Albacete Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 293 02 Albacete Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.008 02 Albacete Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 286 02 Albacete Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 980 02 Albacete Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 281 02 Albacete Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 967 02 Albacete Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 02 Albacete Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 02 Albacete Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 02 Albacete Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,02 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,78 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,82 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,07 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 94,21 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,36 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 91,96 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 92,72 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 90,35 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,49 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete Total Cohort October 1 Total Number at the start of the quarter 2022QIV 9.272 02 Albacete Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 02 Albacete Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 02 Albacete Total Cohort October 1 Total Number at the start of the quarter 2021QIV 9.303 02 Albacete Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 02 Albacete Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 02 Albacete Total Cohort October 1 Total Number at the start of the quarter 2020QIV 9.171 02 Albacete Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 02 Albacete Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 02 Albacete Total Cohort October 1 Total Survival in the first trimester 2022QIV 8.780 02 Albacete Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 02 Albacete Total Cohort October 1 Total Survival in the first trimester 2022QII "" 02 Albacete Total Cohort October 1 Total Survival in the first trimester 2022QI "" 02 Albacete Total Cohort October 1 Total Survival in the first trimester 2021QIV 8.862 02 Albacete Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 02 Albacete Total Cohort October 1 Total Survival in the first trimester 2021QII "" 02 Albacete Total Cohort October 1 Total Survival in the first trimester 2021QI "" 02 Albacete Total Cohort October 1 Total Survival in the first trimester 2020QIV 8.674 02 Albacete Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 02 Albacete Total Cohort October 1 Total Survival in the first trimester 2020QII "" 02 Albacete Total Cohort October 1 Total Survival in the first trimester 2020QI "" 02 Albacete Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 02 Albacete Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 02 Albacete Total Cohort October 1 Total Survival in the second trimester 2022QII "" 02 Albacete Total Cohort October 1 Total Survival in the second trimester 2022QI 8.476 02 Albacete Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 02 Albacete Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 02 Albacete Total Cohort October 1 Total Survival in the second trimester 2021QII "" 02 Albacete Total Cohort October 1 Total Survival in the second trimester 2021QI 8.313 02 Albacete Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 02 Albacete Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 02 Albacete Total Cohort October 1 Total Survival in the second trimester 2020QII "" 02 Albacete Total Cohort October 1 Total Survival in the second trimester 2020QI "" 02 Albacete Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 02 Albacete Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 02 Albacete Total Cohort October 1 Total Survival in the third trimester 2022QII 8.191 02 Albacete Total Cohort October 1 Total Survival in the third trimester 2022QI "" 02 Albacete Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 02 Albacete Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 02 Albacete Total Cohort October 1 Total Survival in the third trimester 2021QII 8.077 02 Albacete Total Cohort October 1 Total Survival in the third trimester 2021QI "" 02 Albacete Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 02 Albacete Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 02 Albacete Total Cohort October 1 Total Survival in the third trimester 2020QII "" 02 Albacete Total Cohort October 1 Total Survival in the third trimester 2020QI "" 02 Albacete Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 02 Albacete Total Cohort October 1 Total Survival in the third trimester 2022QIII 7.931 02 Albacete Total Cohort October 1 Total Survival in the third trimester 2022QII "" 02 Albacete Total Cohort October 1 Total Survival in the third trimester 2022QI "" 02 Albacete Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 02 Albacete Total Cohort October 1 Total Survival in the third trimester 2021QIII 7.865 02 Albacete Total Cohort October 1 Total Survival in the third trimester 2021QII "" 02 Albacete Total Cohort October 1 Total Survival in the third trimester 2021QI "" 02 Albacete Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 02 Albacete Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 02 Albacete Total Cohort October 1 Total Survival in the third trimester 2020QII "" 02 Albacete Total Cohort October 1 Total Survival in the third trimester 2020QI "" 02 Albacete Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 02 Albacete Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 02 Albacete Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 02 Albacete Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 02 Albacete Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 02 Albacete Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 02 Albacete Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 02 Albacete Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 02 Albacete Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,69 02 Albacete Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,26 02 Albacete Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,58 02 Albacete Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 91,11 02 Albacete Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,64 02 Albacete Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 88,05 02 Albacete Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 88,07 02 Albacete Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 85,25 02 Albacete Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 85,76 02 Albacete Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Albacete Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Albacete Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 9.186 02 Albacete Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 8.894 02 Albacete Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 7.978 02 Albacete Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 8.699 02 Albacete Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 8.465 02 Albacete Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 7.513 02 Albacete Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 8.089 02 Albacete Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 7.181 02 Albacete Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 7.815 02 Albacete Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 6.965 02 Albacete Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 7.569 02 Albacete Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 6.770 02 Albacete Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 02 Albacete Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 02 Albacete Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 02 Albacete Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,7 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,18 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,17 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,95 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 90,01 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 87,87 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 87,3 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 85,1 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 84,86 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 86 02 Albacete Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 409 02 Albacete Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.193 02 Albacete Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 81 02 Albacete Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 397 02 Albacete Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.161 02 Albacete Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 387 02 Albacete Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.132 02 Albacete Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 376 02 Albacete Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.112 02 Albacete Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 362 02 Albacete Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.095 02 Albacete Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 02 Albacete Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 02 Albacete Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 02 Albacete Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 94,19 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,07 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,32 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,62 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,89 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 91,93 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,21 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 88,51 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 91,79 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 02 Albacete From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 7.144 02 Albacete From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 02 Albacete From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 7.026 02 Albacete From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 7.195 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 6.646 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 6.558 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 6.092 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 6.292 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 6.279 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 5.855 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 6.008 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 6.020 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 5.654 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 5.771 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 5.851 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 5.482 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 02 Albacete From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 02 Albacete From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 02 Albacete From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 02 Albacete From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,03 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,34 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 84,67 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,07 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 89,37 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 81,38 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 84,1 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 85,68 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 78,58 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 80,78 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 83,28 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 76,19 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 6.909 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 6.478 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 6.423 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 6.036 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 6.079 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 5.772 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 5.804 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 5.525 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 5.571 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 5.366 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,97 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,18 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 87,99 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,1 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 84,01 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 85,29 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 80,63 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 82,83 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 235 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 548 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 223 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 522 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 213 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 507 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 204 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 495 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 200 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 485 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,89 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,26 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,64 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 92,52 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 86,81 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 90,33 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 85,11 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 88,5 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 7.121 02 Albacete From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 7.046 02 Albacete From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 6.732 02 Albacete From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 6.656 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 6.643 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 6.427 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 6.297 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 6.306 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 6.177 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 6.023 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 6.086 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 5.960 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 5.828 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 5.733 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 02 Albacete From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 02 Albacete From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 02 Albacete From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 02 Albacete From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,47 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,28 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,47 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 88,43 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 89,5 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,76 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 84,58 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 86,38 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,53 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 82,71 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,16 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 6.899 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 6.580 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 5.328 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 6.446 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 6.191 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 5.045 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 6.096 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 5.864 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 4.834 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 5.828 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 5.654 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 4.674 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 5.417 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 4.495 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,43 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,09 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,69 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 88,36 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,12 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,73 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 84,48 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 85,93 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 87,73 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 82,33 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,37 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 222 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 466 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.404 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 210 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 452 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.382 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 201 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 442 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.343 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 195 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 432 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.286 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 411 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.238 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 94,59 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,43 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 90,54 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,85 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,66 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 87,84 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 92,7 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,6 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 88,2 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 88,18 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 7.055 02 Albacete From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 7.119 02 Albacete From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 7.035 02 Albacete From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 6.517 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 6.583 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 6.572 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 6.182 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 6.288 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 6.243 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 5.997 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 5.969 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 5.796 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 5.807 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 02 Albacete From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 02 Albacete From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 02 Albacete From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,37 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,47 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 93,42 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 87,63 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 88,33 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 88,74 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 84,24 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 84,85 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 81,42 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 82,54 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 6.989 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 6.936 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 6.512 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 6.453 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 6.410 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 6.067 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 6.122 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 6.121 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 5.758 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 5.837 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 5.502 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 5.641 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 5.349 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,33 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,42 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,17 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,59 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 88,25 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 88,42 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 84,16 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 84,49 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 81,33 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 82,14 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 66 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 183 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 523 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 64 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 173 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 505 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 60 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 167 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 485 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 160 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 467 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 155 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 458 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,97 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 94,54 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,56 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 90,91 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 91,26 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 92,73 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 87,43 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 89,29 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 84,7 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 87,57 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 6.961 02 Albacete From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 7.063 02 Albacete From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 7.039 02 Albacete From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 6.499 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 6.646 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 6.569 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 6.289 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 6.235 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 6.032 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 6.024 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 5.789 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 5.822 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 02 Albacete From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 02 Albacete From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 02 Albacete From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,36 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,1 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,32 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,04 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 88,58 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 85,4 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 85,58 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 81,96 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 82,71 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 6.911 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 6.801 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 6.403 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 6.453 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 6.395 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 5.959 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 6.047 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 5.648 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 5.798 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 5.453 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 5.568 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 5.267 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,37 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,03 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,07 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,91 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88,21 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 85,25 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 85,16 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 81,87 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 82,26 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 50 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 262 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 636 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 46 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 251 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 610 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 242 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 587 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 234 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 571 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 221 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 555 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 92 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,8 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 95,91 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 92,37 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 92,3 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 89,31 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 89,78 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 84,35 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 87,26 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 1.017 02 Albacete From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 922 02 Albacete From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 1.008 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 1.001 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 910 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 963 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 981 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 891 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 954 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 968 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 884 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 938 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 958 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 870 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 922 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 02 Albacete From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 02 Albacete From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,43 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,7 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 95,54 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,46 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,64 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 94,64 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 95,18 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,88 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 93,06 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 94,2 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,36 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 91,47 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 955 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 744 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 940 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 734 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 924 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 718 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 911 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 712 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 901 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 700 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,43 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,66 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,75 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,51 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,39 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,7 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 94,35 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,09 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 62 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 178 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 61 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 176 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 57 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 173 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 57 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 172 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 57 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 170 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,39 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,88 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 91,94 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,19 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 91,94 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,63 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 91,94 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,51 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 976 02 Albacete From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 933 02 Albacete From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 871 02 Albacete From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 954 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 914 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 861 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 935 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 902 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 848 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 921 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 887 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 838 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 876 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 827 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 02 Albacete From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 02 Albacete From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 02 Albacete From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,75 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 97,96 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,85 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 95,8 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,68 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,36 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 94,36 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,07 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,21 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,89 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,95 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 923 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 789 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 520 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 901 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 773 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 513 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 884 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 761 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 502 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 871 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 750 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 493 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 740 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 489 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,62 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 97,97 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,65 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 95,77 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,45 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 96,54 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 94,37 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,06 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 94,81 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,79 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,04 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 53 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 144 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 351 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 53 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 141 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 348 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 51 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 141 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 346 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 50 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 137 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 345 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 136 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 338 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,92 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,15 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 96,23 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,92 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,58 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 94,34 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 95,14 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,29 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 94,44 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,3 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 1.034 02 Albacete From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 984 02 Albacete From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 943 02 Albacete From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 1.011 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 970 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 931 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 993 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 959 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 904 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 942 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 889 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 931 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 873 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 02 Albacete From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 02 Albacete From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 02 Albacete From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,78 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,58 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,73 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,03 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,46 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 95,86 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,73 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 94,27 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 94,61 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 92,58 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.022 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 932 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 754 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 999 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 918 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 744 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 982 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 908 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 719 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 891 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 708 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 880 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 694 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,75 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,5 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,67 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,09 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,42 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 95,36 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,6 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 93,9 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,42 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 92,04 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 12 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 52 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 189 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 12 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 52 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 187 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 11 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 51 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 185 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 51 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 181 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 51 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 179 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,94 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 91,67 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,08 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,88 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 98,08 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95,77 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 98,08 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 94,71 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 1.007 02 Albacete From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 969 02 Albacete From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 922 02 Albacete From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 992 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 955 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 903 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 939 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 887 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 923 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 873 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 914 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 867 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 02 Albacete From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 02 Albacete From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 02 Albacete From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,51 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,56 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 97,94 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,9 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,2 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95,25 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 94,69 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 94,32 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 94,03 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 995 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 905 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 710 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 981 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 891 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 695 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 875 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 682 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 861 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 671 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 853 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 666 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,59 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,45 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,89 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,69 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,06 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,14 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 94,51 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 94,25 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,8 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 12 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 64 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 212 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 11 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 64 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 208 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 64 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 205 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 62 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 202 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 61 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 201 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 91,67 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,11 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,7 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,88 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,28 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 95,31 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 94,81 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 02 Albacete From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 1.223 02 Albacete From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 02 Albacete From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 1.134 02 Albacete From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 1.217 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 1.211 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 1.125 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 1.189 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 1.190 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 1.111 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 1.171 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 1.181 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 1.107 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 1.157 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 1.169 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 1.102 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 1.146 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 02 Albacete From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 02 Albacete From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 02 Albacete From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 02 Albacete From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,02 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,21 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,7 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,3 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,97 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,22 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,57 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,62 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,07 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,58 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,18 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,17 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.141 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 880 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.130 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 874 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.109 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 861 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.101 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 857 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.091 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 854 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,04 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,32 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,2 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,84 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,49 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,39 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,62 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,05 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 82 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 254 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 81 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 251 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 81 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 250 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 80 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 250 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 78 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 248 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,78 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,82 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,78 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,43 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,56 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,43 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 95,12 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,64 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 1.256 02 Albacete From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 1.139 02 Albacete From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 1.076 02 Albacete From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 1.238 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 1.123 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 1.063 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 1.226 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 1.112 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 1.052 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 1.212 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 1.105 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 1.044 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 1.095 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 1.035 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 02 Albacete From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 02 Albacete From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 02 Albacete From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 02 Albacete From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,57 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,6 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,79 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,61 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,63 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,77 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,5 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,01 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,03 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,14 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,19 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.159 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 947 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 636 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.143 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 933 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 624 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.131 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 922 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 617 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.118 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 917 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 613 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 908 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 610 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,62 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,52 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,11 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,58 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,36 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,01 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,46 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,83 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,38 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,88 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,91 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 97 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 192 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 440 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 95 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 190 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 439 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 95 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 190 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 435 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 94 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 188 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 431 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 187 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 425 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,94 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,96 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,77 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,94 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,96 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,86 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,91 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,92 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,95 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,4 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,59 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 1.264 02 Albacete From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 1.198 02 Albacete From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.138 02 Albacete From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 1.246 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 1.183 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 1.122 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 1.229 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 1.170 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 1.113 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 1.159 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 1.099 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 1.152 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 1.094 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 02 Albacete From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 02 Albacete From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 02 Albacete From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,58 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,75 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,59 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,23 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,66 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,8 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,74 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,57 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,16 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,13 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.241 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.124 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 808 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.223 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.109 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 795 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.206 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.097 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 790 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.086 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 782 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.079 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 779 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,55 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,67 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,39 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,18 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,6 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,77 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,62 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,78 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,41 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 23 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 74 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 330 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 23 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 74 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 327 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 23 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 73 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 323 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 73 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 317 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 73 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 315 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,09 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,65 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,88 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 98,65 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,06 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 98,65 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,45 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 1.246 02 Albacete From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 1.210 02 Albacete From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.155 02 Albacete From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 1.231 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 1.200 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 1.147 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 1.188 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 1.136 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 1.176 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 1.125 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 1.168 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 1.121 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 02 Albacete From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 02 Albacete From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 02 Albacete From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,8 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,17 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,31 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,18 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,35 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,19 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,4 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,53 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,06 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.223 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.133 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 828 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.208 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.124 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 822 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.113 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 814 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.102 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 804 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.094 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 800 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,77 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,21 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,28 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,23 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,31 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,26 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,1 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,56 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,62 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 23 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 77 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 327 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 23 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 76 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 325 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 75 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 322 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 74 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 321 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 74 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 321 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,7 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,39 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 97,4 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,47 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,1 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,17 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96,1 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,17 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 02 Albacete from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 38 02 Albacete from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 02 Albacete from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 34 02 Albacete from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 38 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 38 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 33 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 38 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 38 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 33 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 38 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 38 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 33 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 37 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 38 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 33 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 37 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 02 Albacete from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 02 Albacete from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 02 Albacete from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 02 Albacete from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 97,06 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,06 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,06 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,37 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,06 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,37 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 36 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 25 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 36 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 24 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 36 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 24 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 36 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 24 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 36 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 24 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 96 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 9 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 9 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 9 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 9 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 9 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 37 02 Albacete from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 31 02 Albacete from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 34 02 Albacete from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 37 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 31 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 34 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 37 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 31 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 33 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 37 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 31 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 33 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 31 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 33 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 02 Albacete from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 02 Albacete from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 02 Albacete from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 02 Albacete from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,06 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,06 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,06 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Albacete from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 34 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 25 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 25 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 34 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 25 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 25 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 34 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 25 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 24 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 34 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 25 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 24 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 25 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 24 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 96 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 3 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 6 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 9 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 3 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 6 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 9 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 3 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 6 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 9 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 3 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 6 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 9 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 6 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 9 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 44 02 Albacete from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 35 02 Albacete from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 34 02 Albacete from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 44 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 35 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 33 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 44 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 35 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 33 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 35 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 33 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 35 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 33 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 02 Albacete from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 02 Albacete from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 02 Albacete from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 97,06 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,06 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,06 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,06 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 44 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 33 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 26 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 44 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 33 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 25 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 44 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 33 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 25 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 33 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 25 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 33 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 25 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 96,15 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,15 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,15 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,15 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 2 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 8 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 2 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 8 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 2 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 8 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 2 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 8 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 2 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 8 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII .. 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII .. 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 38 02 Albacete from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 41 02 Albacete from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 36 02 Albacete from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 38 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 41 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 36 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 41 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 36 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 41 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 36 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 41 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 36 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 02 Albacete from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 02 Albacete from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 02 Albacete from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 37 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 37 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 24 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 37 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 37 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 24 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 37 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 24 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 37 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 24 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 37 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 24 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 4 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 12 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 4 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 12 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 4 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 12 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 4 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 12 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 4 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 12 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 02 Albacete De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 20 02 Albacete De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 02 Albacete De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 19 02 Albacete De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 02 Albacete De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 18 02 Albacete De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 20 02 Albacete De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 19 02 Albacete De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 18 02 Albacete De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 20 02 Albacete De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 19 02 Albacete De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 18 02 Albacete De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 20 02 Albacete De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 19 02 Albacete De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 18 02 Albacete De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 20 02 Albacete De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 19 02 Albacete De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 18 02 Albacete De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 02 Albacete De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 02 Albacete De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 02 Albacete De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 02 Albacete De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 02 Albacete De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 02 Albacete De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 02 Albacete De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Albacete De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 17 02 Albacete De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 15 02 Albacete De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 17 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 15 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 17 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 15 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 17 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 15 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 17 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 15 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 02 Albacete De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 02 Albacete De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 3 02 Albacete De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 4 02 Albacete De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 3 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 4 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 3 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 4 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 3 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 4 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 3 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 4 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 02 Albacete De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 02 Albacete De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 21 02 Albacete De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 02 Albacete De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 20 02 Albacete De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 02 Albacete De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 18 02 Albacete De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 21 02 Albacete De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 20 02 Albacete De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 18 02 Albacete De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 21 02 Albacete De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 20 02 Albacete De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 18 02 Albacete De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 21 02 Albacete De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 20 02 Albacete De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 18 02 Albacete De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 20 02 Albacete De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 18 02 Albacete De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 02 Albacete De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 02 Albacete De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 02 Albacete De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 02 Albacete De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 02 Albacete De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 02 Albacete De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 02 Albacete De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Albacete De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 21 02 Albacete De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 15 02 Albacete De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 12 02 Albacete De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 21 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 15 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 12 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 21 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 15 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 12 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 21 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 15 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 12 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 15 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 12 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 02 Albacete De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 02 Albacete De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 02 Albacete De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 0 02 Albacete De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 5 02 Albacete De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 6 02 Albacete De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 0 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 5 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 6 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 0 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 5 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 6 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 0 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 5 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 6 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 5 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 6 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII .. 02 Albacete De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 02 Albacete De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 02 Albacete De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII .. 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII .. 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 0 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 18 02 Albacete De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 02 Albacete De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 02 Albacete De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 20 02 Albacete De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 02 Albacete De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 02 Albacete De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 21 02 Albacete De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 02 Albacete De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 18 02 Albacete De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 20 02 Albacete De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 21 02 Albacete De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 18 02 Albacete De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 20 02 Albacete De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 21 02 Albacete De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 19 02 Albacete De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 21 02 Albacete De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 19 02 Albacete De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 21 02 Albacete De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 02 Albacete De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 02 Albacete De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 02 Albacete De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 02 Albacete De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 02 Albacete De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 02 Albacete De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 02 Albacete De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 02 Albacete De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 02 Albacete De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 02 Albacete De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 02 Albacete De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 02 Albacete De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 02 Albacete De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Albacete De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 18 02 Albacete De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 20 02 Albacete De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 14 02 Albacete De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 18 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 20 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 14 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 18 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 20 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 14 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 19 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 14 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 19 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 14 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 02 Albacete De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 02 Albacete De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 02 Albacete De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 02 Albacete De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 0 02 Albacete De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 7 02 Albacete De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 0 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 7 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 0 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 7 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 0 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 7 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 0 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 7 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII .. 02 Albacete De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII .. 02 Albacete De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 02 Albacete De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII .. 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII .. 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV .. 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI .. 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII .. 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 20 02 Albacete De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 02 Albacete De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 02 Albacete De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 20 02 Albacete De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 02 Albacete De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 02 Albacete De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 19 02 Albacete De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 02 Albacete De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 20 02 Albacete De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 20 02 Albacete De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 19 02 Albacete De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 19 02 Albacete De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 19 02 Albacete De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 19 02 Albacete De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 19 02 Albacete De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 19 02 Albacete De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 19 02 Albacete De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 02 Albacete De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 02 Albacete De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 02 Albacete De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 02 Albacete De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 02 Albacete De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 02 Albacete De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 02 Albacete De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 02 Albacete De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 02 Albacete De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 02 Albacete De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 02 Albacete De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 02 Albacete De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 95 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 02 Albacete De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 20 02 Albacete De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 18 02 Albacete De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 13 02 Albacete De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 20 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 18 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 13 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 17 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 13 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 17 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 13 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 17 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 13 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 02 Albacete De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 02 Albacete De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 02 Albacete De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 94,44 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 94,44 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 94,44 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 02 Albacete De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 2 02 Albacete De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 6 02 Albacete De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 2 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 6 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 2 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 6 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 2 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 6 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 2 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 6 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 02 Albacete De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 02 Albacete De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 02 Albacete De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 02 Albacete De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant Total Cohort January 1 Total Number at the start of the quarter 2022QI 51.511 03 Alicante/Alacant Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant Total Cohort January 1 Total Number at the start of the quarter 2021QI 49.912 03 Alicante/Alacant Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Total Number at the start of the quarter 2020QI 52.882 03 Alicante/Alacant Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the first trimester 2022QII "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the first trimester 2022QI 48.503 03 Alicante/Alacant Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the first trimester 2021QII "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the first trimester 2021QI 46.277 03 Alicante/Alacant Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the first trimester 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the first trimester 2020QI 45.511 03 Alicante/Alacant Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the second trimester 2022QII 46.343 03 Alicante/Alacant Total Cohort January 1 Total Survival in the second trimester 2022QI "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the second trimester 2021QII 44.486 03 Alicante/Alacant Total Cohort January 1 Total Survival in the second trimester 2021QI "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the second trimester 2020QII 43.752 03 Alicante/Alacant Total Cohort January 1 Total Survival in the second trimester 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the third trimester 2022QIII 44.583 03 Alicante/Alacant Total Cohort January 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the third trimester 2021QIII 42.941 03 Alicante/Alacant Total Cohort January 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the third trimester 2020QIII 42.152 03 Alicante/Alacant Total Cohort January 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the third trimester 2022QIV 43.144 03 Alicante/Alacant Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the third trimester 2021QIV 41.654 03 Alicante/Alacant Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the third trimester 2020QIV 40.568 03 Alicante/Alacant Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 03 Alicante/Alacant Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 03 Alicante/Alacant Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,16 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 92,72 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 86,06 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,97 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 89,13 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 82,74 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,55 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 86,03 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 79,71 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 83,76 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 83,45 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 76,71 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 48.727 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 42.724 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 45.833 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 39.404 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 43.760 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 37.790 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 42.065 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 36.382 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 40.680 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 35.268 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,06 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 92,23 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,81 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 88,45 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,33 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 85,16 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 83,49 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 82,55 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2.784 03 Alicante/Alacant Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 7.188 03 Alicante/Alacant Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2.670 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 6.873 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2.583 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 6.696 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2.518 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 6.559 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2.464 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 6.386 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 03 Alicante/Alacant Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 03 Alicante/Alacant Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,91 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,62 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,78 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 93,16 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,45 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 91,25 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,51 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 88,84 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant Total Cohort April 1 Total Number at the start of the quarter 2022QII 52.209 03 Alicante/Alacant Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant Total Cohort April 1 Total Number at the start of the quarter 2021QII 49.218 03 Alicante/Alacant Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant Total Cohort April 1 Total Number at the start of the quarter 2020QII 48.159 03 Alicante/Alacant Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the first trimester 2022QII 49.451 03 Alicante/Alacant Total Cohort April 1 Total Survival in the first trimester 2022QI "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the first trimester 2021QII 46.956 03 Alicante/Alacant Total Cohort April 1 Total Survival in the first trimester 2021QI "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the first trimester 2020QII 46.026 03 Alicante/Alacant Total Cohort April 1 Total Survival in the first trimester 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the second trimester 2022QIII 47.213 03 Alicante/Alacant Total Cohort April 1 Total Survival in the second trimester 2022QII "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the second trimester 2022QI "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the second trimester 2021QIII 45.046 03 Alicante/Alacant Total Cohort April 1 Total Survival in the second trimester 2021QII "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the second trimester 2021QI "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the second trimester 2020QIII 44.107 03 Alicante/Alacant Total Cohort April 1 Total Survival in the second trimester 2020QII "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the second trimester 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the third trimester 2022QIV 45.252 03 Alicante/Alacant Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the third trimester 2021QIV 43.391 03 Alicante/Alacant Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the third trimester 2020QIV 42.226 03 Alicante/Alacant Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the third trimester 2022QI 41.781 03 Alicante/Alacant Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the third trimester 2021QI 40.164 03 Alicante/Alacant Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant Total Cohort April 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 03 Alicante/Alacant Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 03 Alicante/Alacant Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 03 Alicante/Alacant Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,72 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,4 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,57 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,43 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,52 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,59 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 86,67 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 88,16 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 87,68 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 84,89 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 83,4 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 49.437 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 41.587 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 36.711 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 46.760 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 39.534 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 34.719 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 44.599 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 37.782 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 33.112 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 42.709 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 36.343 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 31.688 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 34.939 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 30.112 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,59 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,06 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,57 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,21 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 90,85 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,2 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 86,39 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 87,39 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 86,32 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 84,01 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 82,02 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 2.772 03 Alicante/Alacant Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 7.631 03 Alicante/Alacant Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 11.448 03 Alicante/Alacant Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 2.691 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 7.422 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 11.307 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 2.614 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 7.264 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 10.995 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 2.543 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 7.048 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 10.538 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 6.842 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 10.052 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 03 Alicante/Alacant Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 03 Alicante/Alacant Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 03 Alicante/Alacant Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,08 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,26 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,77 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,3 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,19 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,04 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,74 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 92,36 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 92,05 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 89,66 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 87,81 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant Total Cohort July 1 Total Number at the start of the quarter 2022QIII 53.507 03 Alicante/Alacant Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant Total Cohort July 1 Total Number at the start of the quarter 2021QIII 51.544 03 Alicante/Alacant Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant Total Cohort July 1 Total Number at the start of the quarter 2020QIII 50.230 03 Alicante/Alacant Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the first trimester 2022QIII 50.218 03 Alicante/Alacant Total Cohort July 1 Total Survival in the first trimester 2022QII "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the first trimester 2022QI "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the first trimester 2021QIII 48.536 03 Alicante/Alacant Total Cohort July 1 Total Survival in the first trimester 2021QII "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the first trimester 2021QI "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the first trimester 2020QIII 47.303 03 Alicante/Alacant Total Cohort July 1 Total Survival in the first trimester 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the first trimester 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the second trimester 2022QIV 47.556 03 Alicante/Alacant Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the second trimester 2022QII "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the second trimester 2022QI "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the second trimester 2021QIV 46.075 03 Alicante/Alacant Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the second trimester 2021QII "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the second trimester 2021QI "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the second trimester 2020QIV 44.733 03 Alicante/Alacant Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the second trimester 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the second trimester 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the third trimester 2022QI 44.118 03 Alicante/Alacant Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the third trimester 2021QI 42.285 03 Alicante/Alacant Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the third trimester 2022QII 42.700 03 Alicante/Alacant Total Cohort July 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the third trimester 2021QII 41.115 03 Alicante/Alacant Total Cohort July 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 03 Alicante/Alacant Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 03 Alicante/Alacant Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 03 Alicante/Alacant Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,85 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,16 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,17 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 88,88 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,39 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 89,06 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 85,59 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 84,18 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 82,84 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 81,85 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 51.704 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 49.183 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 42.779 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 48.470 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 46.242 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 40.024 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 45.860 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 43.862 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 37.709 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 41.988 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 35.564 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 40.623 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 34.572 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,75 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,02 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,56 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 88,7 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,18 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 88,15 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 85,37 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 83,13 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 82,6 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 80,82 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1.803 03 Alicante/Alacant Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 2.361 03 Alicante/Alacant Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 7.451 03 Alicante/Alacant Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1.748 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 2.294 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 7.279 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1.696 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 2.213 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 7.024 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 2.130 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 6.721 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 2.077 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 6.543 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 03 Alicante/Alacant Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 03 Alicante/Alacant Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 03 Alicante/Alacant Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,95 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,16 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,69 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,07 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,73 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,27 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 90,22 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 90,2 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 87,97 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 87,81 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Total Number at the start of the quarter 2022QIV 52.801 03 Alicante/Alacant Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant Total Cohort October 1 Total Number at the start of the quarter 2021QIV 51.528 03 Alicante/Alacant Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant Total Cohort October 1 Total Number at the start of the quarter 2020QIV 50.527 03 Alicante/Alacant Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the first trimester 2022QIV 49.611 03 Alicante/Alacant Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the first trimester 2022QII "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the first trimester 2022QI "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the first trimester 2021QIV 48.323 03 Alicante/Alacant Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the first trimester 2021QII "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the first trimester 2021QI "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the first trimester 2020QIV 47.057 03 Alicante/Alacant Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the first trimester 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the first trimester 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the second trimester 2022QII "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the second trimester 2022QI 46.001 03 Alicante/Alacant Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the second trimester 2021QII "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the second trimester 2021QI 44.112 03 Alicante/Alacant Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the second trimester 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the second trimester 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the third trimester 2022QII 44.302 03 Alicante/Alacant Total Cohort October 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the third trimester 2021QII 42.717 03 Alicante/Alacant Total Cohort October 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the third trimester 2022QIII 42.862 03 Alicante/Alacant Total Cohort October 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the third trimester 2021QIII 41.464 03 Alicante/Alacant Total Cohort October 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 03 Alicante/Alacant Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 03 Alicante/Alacant Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 03 Alicante/Alacant Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,96 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,78 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,13 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,27 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 87,3 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 85,98 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 84,54 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 83,18 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 82,06 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 51.305 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 48.523 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 41.945 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 48.156 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 45.432 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 38.790 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 43.219 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 36.202 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 41.611 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 35.009 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 40.255 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 33.919 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,86 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 93,63 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,48 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,07 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 86,31 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 85,76 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 83,46 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 82,96 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 80,87 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1.496 03 Alicante/Alacant Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 3.005 03 Alicante/Alacant Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 8.582 03 Alicante/Alacant Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1.455 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 2.891 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 8.267 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 2.782 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 7.910 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 2.691 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 7.708 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 2.607 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 7.545 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 03 Alicante/Alacant Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 03 Alicante/Alacant Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 03 Alicante/Alacant Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,26 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,21 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,33 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 92,58 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 92,17 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 89,55 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 89,82 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 86,76 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 87,92 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 39.113 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 38.439 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 40.097 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 36.280 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 34.991 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 33.356 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 34.324 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 33.375 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 31.777 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 32.723 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 31.965 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 30.372 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 31.404 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 30.796 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 28.995 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 92,76 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 91,03 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 83,19 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 87,76 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 86,83 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 79,25 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 83,66 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 83,16 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 75,75 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 80,29 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 80,12 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 72,31 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 37.311 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 34.444 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 34.577 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 31.273 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 32.695 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 29.792 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 31.151 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 28.493 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 29.881 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 27.469 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,67 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 90,79 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 87,63 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 86,49 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 83,49 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 82,72 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 80,09 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 79,75 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.802 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 3.995 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.703 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 3.718 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.629 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 3.583 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.572 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 3.472 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.523 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 3.327 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,51 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 93,07 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,4 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 89,69 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 87,24 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 86,91 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 84,52 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 83,28 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 39.472 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 37.888 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 37.107 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 36.917 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 35.778 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 35.104 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 34.840 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 34.016 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 33.317 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 33.090 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 32.509 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 31.605 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 31.049 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 29.728 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,53 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,43 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,6 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 88,27 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 89,78 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 89,79 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 83,83 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 85,8 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 85,17 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 81,95 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 80,11 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 37.670 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 33.362 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 29.877 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 35.187 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 31.427 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 27.987 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 33.179 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 29.800 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 26.472 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 31.491 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 28.474 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 25.138 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 27.182 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 23.667 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,41 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,2 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 93,67 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 88,08 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,32 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 88,6 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 83,6 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 85,35 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 84,14 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 81,48 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 79,21 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.802 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 4.526 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 7.230 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.730 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 4.351 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 7.117 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.661 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 4.216 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 6.845 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.599 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 4.035 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 6.467 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 3.867 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 6.061 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,13 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,44 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 92,18 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,15 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,67 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,73 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 89,15 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 89,45 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 85,44 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 83,83 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 39.892 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 39.071 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 38.350 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 36.810 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 36.243 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 35.610 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 34.537 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 34.086 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 33.320 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 32.333 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 31.105 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 31.062 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 30.064 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,27 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,76 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 92,86 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 86,58 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 87,24 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 86,88 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 82,75 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 81,11 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 79,5 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 78,39 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 38.781 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 37.685 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 34.314 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 35.748 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 34.915 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 31.719 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 33.514 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 32.826 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 29.629 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 31.143 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 27.653 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 29.916 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 26.743 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,18 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,65 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 92,44 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 86,42 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 87,11 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 86,35 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 82,64 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 80,59 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 79,38 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 77,94 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1.111 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.386 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 4.036 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1.062 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.328 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 3.891 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1.023 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1.260 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 3.691 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1.190 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 3.452 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1.146 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 3.321 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,59 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 95,82 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,41 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 92,08 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 90,91 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 91,45 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 85,86 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 85,53 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 82,68 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 82,28 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 39.595 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 39.077 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 38.667 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 36.713 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 36.117 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 35.421 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 33.993 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 32.722 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 32.463 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 31.483 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 31.151 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 30.342 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 92,72 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 92,43 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 91,61 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 86,99 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 84,63 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 83,07 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 81,42 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 79,72 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 78,47 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 38.714 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 37.056 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 33.955 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 35.866 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 34.195 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 30.974 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 32.157 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 28.566 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 30.708 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 27.479 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 29.472 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 26.469 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 92,64 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 92,28 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 91,22 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 86,78 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 84,13 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 82,87 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 80,93 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 79,53 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 77,95 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 881 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 2.021 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 4.712 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 847 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.922 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 4.447 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.836 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 4.156 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.755 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 4.004 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.679 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 3.873 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,14 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,1 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 94,38 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 90,85 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 88,2 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 86,84 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 84,97 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 83,08 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 82,19 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 5.427 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 5.132 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 5.562 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 5.322 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 5.008 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 5.201 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 5.220 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 4.918 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 5.117 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 5.133 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 4.848 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 5.003 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 5.069 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 4.775 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 4.879 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,07 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 97,58 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 93,51 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,19 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 95,83 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 92 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,58 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 94,47 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 89,95 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,4 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 93,04 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 87,72 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 5.042 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 3.925 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 4.946 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 3.825 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 4.851 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 3.757 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 4.767 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 3.699 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 4.707 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 3.645 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,1 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97,45 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,21 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 95,72 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,55 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 94,24 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,36 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 92,87 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 385 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.207 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 376 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.183 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 369 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.161 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 366 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.149 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 362 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.130 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,66 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,01 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 95,84 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,19 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 95,06 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,19 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,03 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 93,62 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 5.493 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 4.981 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 4.879 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 5.394 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 4.905 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 4.824 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 5.302 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 4.829 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 4.748 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 5.176 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 4.734 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 4.641 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 4.648 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 4.525 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,2 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,47 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,87 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,52 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,95 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,32 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 94,23 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,04 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,12 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,31 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 92,74 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 5.126 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 3.770 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 3.126 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 5.033 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 3.711 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 3.084 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 4.945 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 3.648 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 3.031 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 4.825 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 3.576 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.974 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 3.512 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.908 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,19 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,44 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,66 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,47 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,76 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 96,96 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 94,13 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 94,85 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,14 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,16 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 93,03 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 367 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.211 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.753 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 361 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.194 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.740 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 357 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.181 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.717 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 351 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.158 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.667 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.136 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.617 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,37 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,6 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,26 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,28 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,52 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,95 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 95,64 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 95,62 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,09 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 93,81 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 92,24 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 5.871 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 5.474 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 5.303 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 5.748 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 5.373 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 5.189 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 5.539 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 5.201 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 5.022 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 5.083 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 4.879 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 4.995 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 4.813 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,9 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,15 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 97,85 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 94,35 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 95,01 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 94,7 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 92,86 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 92 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 91,25 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 90,76 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 5.608 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 5.129 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 4.046 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 5.486 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 5.033 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 3.946 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 5.285 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 4.864 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 3.817 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 4.755 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 3.711 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 4.671 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 3.668 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,82 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,13 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 97,53 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 94,24 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 94,83 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 94,34 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 92,71 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 91,72 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 91,07 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 90,66 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 263 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 345 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.257 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 262 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 340 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.243 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 254 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 337 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.205 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 328 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.168 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 324 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.145 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,62 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,55 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,89 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 96,58 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,68 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,86 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,07 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 92,92 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,91 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,09 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 5.731 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 5.453 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 5.314 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 5.549 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 5.307 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 5.168 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 5.196 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 5.004 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 5.104 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 4.917 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 5.022 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 4.854 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 96,82 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 97,32 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 97,25 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 95,29 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 94,17 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 93,6 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 92,53 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 92,1 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 91,34 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 5.502 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 5.052 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 3.868 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 5.323 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 4.915 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 3.754 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 4.819 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 3.633 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 4.734 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 3.571 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 4.657 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 3.523 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 96,75 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 97,29 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,05 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 95,39 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 93,92 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 93,71 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 92,32 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 92,18 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 91,08 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 229 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 401 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.446 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 226 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 392 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.414 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 377 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.371 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 370 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.346 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 365 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.331 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,69 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,76 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,79 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,01 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,81 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 92,27 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,08 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 91,02 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 92,05 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 6.647 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 6.051 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 6.915 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 6.579 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 5.990 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 6.648 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 6.480 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 5.907 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 6.554 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 6.409 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 5.843 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 6.473 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 6.355 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 5.800 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 6.390 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,98 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,99 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,14 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,49 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,62 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 94,78 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,42 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,56 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 93,61 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,61 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,85 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 92,41 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 6.079 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 4.176 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 6.017 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 4.128 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 5.924 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 4.065 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 5.858 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 4.015 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 5.804 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 3.980 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,98 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,85 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,45 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,34 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,36 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,14 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,48 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,31 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 568 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.875 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 562 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.862 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 556 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.842 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 551 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.828 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 551 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.820 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,94 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,31 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,89 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,24 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,01 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,49 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 97,01 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,07 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 6.905 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 6.059 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 5.898 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 6.804 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 5.985 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 5.825 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 6.736 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 5.914 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 5.769 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 6.653 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 5.863 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 5.707 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 5.800 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 5.639 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,54 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,78 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,76 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,55 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,61 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,81 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,35 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,77 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,76 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 95,73 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,61 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 6.336 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 4.261 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 3.528 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 6.238 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 4.204 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 3.470 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 6.174 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 4.143 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 3.431 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 6.093 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 4.103 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 3.398 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 4.056 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 3.360 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,45 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,66 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,36 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,44 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,23 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,25 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,16 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,29 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,32 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,19 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,24 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 569 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.798 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.370 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 566 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.781 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.355 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 562 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.771 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.338 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 560 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.760 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.309 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.744 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.279 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,47 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,05 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,37 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,77 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,5 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,65 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 98,42 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,89 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,43 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,16 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 7.394 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 6.687 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 6.300 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 7.310 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 6.609 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 6.227 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 7.132 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 6.478 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 6.114 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 6.393 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 6.025 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 6.336 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 5.962 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,86 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,83 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,84 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,46 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 96,87 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,05 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,6 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,63 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 94,75 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 94,63 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 6.987 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 6.092 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 4.267 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 6.908 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 6.018 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 4.207 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 6.734 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 5.897 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 4.111 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 5.816 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 4.048 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 5.764 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 4.009 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,87 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,79 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,59 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,38 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 96,8 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,34 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,47 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 94,87 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,62 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 93,95 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 407 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 595 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2.033 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 402 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 591 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2.020 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 398 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 581 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 2.003 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 577 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.977 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 572 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.953 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,77 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,33 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,36 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,79 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,65 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,52 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 96,97 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,25 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,13 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,06 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 7.121 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 6.674 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 6.264 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 6.997 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 6.576 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 6.187 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 6.491 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 6.106 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 6.417 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 6.038 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 6.372 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 5.990 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,26 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,53 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,77 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,26 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,48 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,15 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,39 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,47 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,63 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 6.757 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 6.127 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 3.969 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 6.636 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 6.035 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 3.910 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 5.958 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 3.851 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 5.887 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 3.808 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 5.845 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 3.777 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,21 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,5 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,51 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,24 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,03 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,08 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,94 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,4 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,16 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 364 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 547 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 2.295 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 361 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 541 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2.277 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 533 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2.255 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 530 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2.230 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 527 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2.213 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,18 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,9 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,22 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 97,44 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,26 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,89 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,17 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96,34 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,43 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 226 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 199 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 217 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 224 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 198 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 215 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 223 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 197 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 214 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 223 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 196 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 214 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 221 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 195 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 214 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,12 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,5 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,08 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,67 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,99 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,62 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,67 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,49 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,62 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,79 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,99 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,62 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 205 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 123 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 203 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 122 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 202 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 121 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 202 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 120 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 201 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 120 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,02 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,19 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,54 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,37 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,54 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,56 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,05 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,56 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 21 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 76 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 21 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 76 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 21 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 76 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 21 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 76 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 20 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 75 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 95,24 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,68 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 237 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 199 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 190 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 235 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 198 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 188 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 235 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 197 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 188 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 233 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 196 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 188 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 195 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 187 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,16 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,5 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,95 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,16 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,99 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,95 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,31 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,49 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,95 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,99 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,42 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 208 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 132 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 122 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 206 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 131 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 120 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 206 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 130 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 120 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 205 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 130 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 120 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 129 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 119 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,04 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,24 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,36 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 99,04 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,48 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,36 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,56 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98,48 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,36 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,73 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,54 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 29 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 67 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 68 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 29 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 67 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 68 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 29 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 67 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 68 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 28 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 66 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 68 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 66 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 68 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,55 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,51 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 98,51 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 245 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 216 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 190 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 245 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 215 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 190 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 243 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 215 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 190 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 214 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 189 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 214 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 189 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,54 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 99,18 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,54 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 99,07 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 99,47 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 99,07 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 99,47 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 226 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 191 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 104 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 226 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 190 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 104 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 225 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 190 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 104 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 189 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 104 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 189 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 104 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,48 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 99,56 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 99,48 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,95 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,95 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 19 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 25 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 86 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 19 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 25 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 86 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 18 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 25 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 86 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 25 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 85 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 25 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 85 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,74 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,84 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,84 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 247 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 223 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 187 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 245 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 223 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 186 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 221 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 185 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 220 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 185 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 220 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 184 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,19 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,47 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,1 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,93 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,65 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,93 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,65 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,4 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 229 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 198 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 97 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 228 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 198 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 96 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 196 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 96 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 195 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 96 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 195 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 95 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,56 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,97 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,99 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,97 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,48 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,97 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,48 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,94 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 18 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 25 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 90 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 17 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 25 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 90 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 25 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 89 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 25 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 89 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 25 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 89 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 94,44 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,89 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,89 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,89 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 98 03 Alicante/Alacant De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 91 03 Alicante/Alacant De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 91 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 98 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 90 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 91 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 96 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 89 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 90 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 95 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 89 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 90 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 95 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 88 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 90 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 03 Alicante/Alacant De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 03 Alicante/Alacant De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,9 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,96 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,8 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,9 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,94 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,8 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,9 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,94 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,7 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,9 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 90 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 56 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 90 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 56 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 88 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 55 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 87 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 55 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 87 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 54 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,78 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,21 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,67 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,21 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,67 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,43 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 8 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 35 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 8 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 34 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 8 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 34 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 8 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 34 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 8 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 34 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,14 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,14 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,14 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,14 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 102 03 Alicante/Alacant De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 91 03 Alicante/Alacant De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 85 03 Alicante/Alacant De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 101 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 90 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 85 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 100 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 90 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 85 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 100 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 89 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 85 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 89 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 85 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 03 Alicante/Alacant De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 03 Alicante/Alacant De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 03 Alicante/Alacant De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,02 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,9 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,04 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,9 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,04 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,8 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,8 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 97 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 62 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 58 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 96 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 61 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 58 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 95 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 61 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 58 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 95 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 60 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 58 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 60 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 58 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,97 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,39 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,94 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,39 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,94 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,77 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,77 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 5 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 29 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 27 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 5 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 29 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 27 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 5 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 29 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 27 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 5 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 29 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 27 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 29 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 27 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 105 03 Alicante/Alacant De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 96 03 Alicante/Alacant De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 87 03 Alicante/Alacant De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 105 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 96 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 87 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 105 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 95 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 87 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 95 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 87 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 93 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 87 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 03 Alicante/Alacant De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 03 Alicante/Alacant De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 03 Alicante/Alacant De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,96 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,96 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,88 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 102 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 86 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 48 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 102 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 86 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 48 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 102 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 85 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 48 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 85 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 48 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 83 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 48 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,84 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,84 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,51 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 3 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 10 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 39 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 3 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 10 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 39 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 3 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 10 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 39 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 10 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 39 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 10 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 39 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 107 03 Alicante/Alacant De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 101 03 Alicante/Alacant De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 95 03 Alicante/Alacant De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 107 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 100 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 95 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 100 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 95 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 98 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 94 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 97 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 94 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 03 Alicante/Alacant De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 03 Alicante/Alacant De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 03 Alicante/Alacant De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,01 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,01 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,03 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,95 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,04 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,95 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 103 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 90 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 56 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 103 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 89 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 56 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 89 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 56 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 87 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 55 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 86 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 55 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,89 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,89 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,67 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,21 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,56 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,21 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 4 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 11 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 39 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 4 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 11 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 39 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 11 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 39 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 11 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 39 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 11 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 39 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 03 Alicante/Alacant De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 04 Almería Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 04 Almería Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 04 Almería Total Cohort January 1 Total Number at the start of the quarter 2022QI 16.455 04 Almería Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 04 Almería Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 04 Almería Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 04 Almería Total Cohort January 1 Total Number at the start of the quarter 2021QI 15.931 04 Almería Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 04 Almería Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 04 Almería Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 04 Almería Total Cohort January 1 Total Number at the start of the quarter 2020QI 16.540 04 Almería Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 04 Almería Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 04 Almería Total Cohort January 1 Total Survival in the first trimester 2022QII "" 04 Almería Total Cohort January 1 Total Survival in the first trimester 2022QI 15.431 04 Almería Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 04 Almería Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 04 Almería Total Cohort January 1 Total Survival in the first trimester 2021QII "" 04 Almería Total Cohort January 1 Total Survival in the first trimester 2021QI 14.874 04 Almería Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 04 Almería Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 04 Almería Total Cohort January 1 Total Survival in the first trimester 2020QII "" 04 Almería Total Cohort January 1 Total Survival in the first trimester 2020QI 14.170 04 Almería Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 04 Almería Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 04 Almería Total Cohort January 1 Total Survival in the second trimester 2022QII 14.656 04 Almería Total Cohort January 1 Total Survival in the second trimester 2022QI "" 04 Almería Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 04 Almería Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 04 Almería Total Cohort January 1 Total Survival in the second trimester 2021QII 14.202 04 Almería Total Cohort January 1 Total Survival in the second trimester 2021QI "" 04 Almería Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 04 Almería Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 04 Almería Total Cohort January 1 Total Survival in the second trimester 2020QII 13.621 04 Almería Total Cohort January 1 Total Survival in the second trimester 2020QI "" 04 Almería Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 04 Almería Total Cohort January 1 Total Survival in the third trimester 2022QIII 13.983 04 Almería Total Cohort January 1 Total Survival in the third trimester 2022QII "" 04 Almería Total Cohort January 1 Total Survival in the third trimester 2022QI "" 04 Almería Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 04 Almería Total Cohort January 1 Total Survival in the third trimester 2021QIII 13.640 04 Almería Total Cohort January 1 Total Survival in the third trimester 2021QII "" 04 Almería Total Cohort January 1 Total Survival in the third trimester 2021QI "" 04 Almería Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 04 Almería Total Cohort January 1 Total Survival in the third trimester 2020QIII 13.028 04 Almería Total Cohort January 1 Total Survival in the third trimester 2020QII "" 04 Almería Total Cohort January 1 Total Survival in the third trimester 2020QI "" 04 Almería Total Cohort January 1 Total Survival in the third trimester 2022QIV 13.507 04 Almería Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 04 Almería Total Cohort January 1 Total Survival in the third trimester 2022QII "" 04 Almería Total Cohort January 1 Total Survival in the third trimester 2022QI "" 04 Almería Total Cohort January 1 Total Survival in the third trimester 2021QIV 13.242 04 Almería Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 04 Almería Total Cohort January 1 Total Survival in the third trimester 2021QII "" 04 Almería Total Cohort January 1 Total Survival in the third trimester 2021QI "" 04 Almería Total Cohort January 1 Total Survival in the third trimester 2020QIV 12.578 04 Almería Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 04 Almería Total Cohort January 1 Total Survival in the third trimester 2020QII "" 04 Almería Total Cohort January 1 Total Survival in the third trimester 2020QI "" 04 Almería Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 04 Almería Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 04 Almería Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 04 Almería Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 04 Almería Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 04 Almería Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 04 Almería Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 04 Almería Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 04 Almería Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 04 Almería Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 04 Almería Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 04 Almería Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 04 Almería Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,78 04 Almería Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,37 04 Almería Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 85,67 04 Almería Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,07 04 Almería Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 89,15 04 Almería Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 82,35 04 Almería Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 84,98 04 Almería Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 85,62 04 Almería Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 78,77 04 Almería Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 82,08 04 Almería Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 83,12 04 Almería Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 76,05 04 Almería Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Almería Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Almería Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 15.854 04 Almería Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 14.694 04 Almería Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 14.854 04 Almería Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 13.671 04 Almería Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 14.102 04 Almería Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 13.026 04 Almería Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 13.453 04 Almería Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 12.497 04 Almería Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 12.989 04 Almería Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 12.129 04 Almería Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 04 Almería Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 04 Almería Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,69 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,04 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,95 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 88,65 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 84,86 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 85,05 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 81,93 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 82,54 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 601 04 Almería Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.237 04 Almería Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Almería Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Almería Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 04 Almería Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 577 04 Almería Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Almería Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Almería Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 04 Almería Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.203 04 Almería Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Almería Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Almería Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 04 Almería Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 04 Almería Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Almería Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Almería Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 554 04 Almería Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 04 Almería Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Almería Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Almería Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.176 04 Almería Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 04 Almería Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Almería Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Almería Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 04 Almería Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 04 Almería Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 530 04 Almería Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.143 04 Almería Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 518 04 Almería Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.113 04 Almería Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 04 Almería Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 04 Almería Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,01 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,25 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,18 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,07 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 88,19 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,4 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 86,19 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 89,98 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 04 Almería Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 04 Almería Total Cohort April 1 Total Number at the start of the quarter 2022QII 16.534 04 Almería Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 04 Almería Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 04 Almería Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 04 Almería Total Cohort April 1 Total Number at the start of the quarter 2021QII 15.956 04 Almería Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 04 Almería Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 04 Almería Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 04 Almería Total Cohort April 1 Total Number at the start of the quarter 2020QII 15.020 04 Almería Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 04 Almería Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 04 Almería Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 04 Almería Total Cohort April 1 Total Survival in the first trimester 2022QII 15.536 04 Almería Total Cohort April 1 Total Survival in the first trimester 2022QI "" 04 Almería Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 04 Almería Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 04 Almería Total Cohort April 1 Total Survival in the first trimester 2021QII 15.092 04 Almería Total Cohort April 1 Total Survival in the first trimester 2021QI "" 04 Almería Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 04 Almería Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 04 Almería Total Cohort April 1 Total Survival in the first trimester 2020QII 14.334 04 Almería Total Cohort April 1 Total Survival in the first trimester 2020QI "" 04 Almería Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 04 Almería Total Cohort April 1 Total Survival in the second trimester 2022QIII 14.718 04 Almería Total Cohort April 1 Total Survival in the second trimester 2022QII "" 04 Almería Total Cohort April 1 Total Survival in the second trimester 2022QI "" 04 Almería Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 04 Almería Total Cohort April 1 Total Survival in the second trimester 2021QIII 14.376 04 Almería Total Cohort April 1 Total Survival in the second trimester 2021QII "" 04 Almería Total Cohort April 1 Total Survival in the second trimester 2021QI "" 04 Almería Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 04 Almería Total Cohort April 1 Total Survival in the second trimester 2020QIII 13.646 04 Almería Total Cohort April 1 Total Survival in the second trimester 2020QII "" 04 Almería Total Cohort April 1 Total Survival in the second trimester 2020QI "" 04 Almería Total Cohort April 1 Total Survival in the third trimester 2022QIV 14.085 04 Almería Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 04 Almería Total Cohort April 1 Total Survival in the third trimester 2022QII "" 04 Almería Total Cohort April 1 Total Survival in the third trimester 2022QI "" 04 Almería Total Cohort April 1 Total Survival in the third trimester 2021QIV 13.813 04 Almería Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 04 Almería Total Cohort April 1 Total Survival in the third trimester 2021QII "" 04 Almería Total Cohort April 1 Total Survival in the third trimester 2021QI "" 04 Almería Total Cohort April 1 Total Survival in the third trimester 2020QIV 13.105 04 Almería Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 04 Almería Total Cohort April 1 Total Survival in the third trimester 2020QII "" 04 Almería Total Cohort April 1 Total Survival in the third trimester 2020QI "" 04 Almería Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 04 Almería Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 04 Almería Total Cohort April 1 Total Survival in the third trimester 2022QII "" 04 Almería Total Cohort April 1 Total Survival in the third trimester 2022QI 13.265 04 Almería Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 04 Almería Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 04 Almería Total Cohort April 1 Total Survival in the third trimester 2021QII "" 04 Almería Total Cohort April 1 Total Survival in the third trimester 2021QI 12.573 04 Almería Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 04 Almería Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 04 Almería Total Cohort April 1 Total Survival in the third trimester 2020QII "" 04 Almería Total Cohort April 1 Total Survival in the third trimester 2020QI "" 04 Almería Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 04 Almería Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 04 Almería Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 04 Almería Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 04 Almería Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 04 Almería Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 04 Almería Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 04 Almería Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 04 Almería Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 04 Almería Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 04 Almería Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 04 Almería Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,96 04 Almería Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,59 04 Almería Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,43 04 Almería Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,02 04 Almería Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,1 04 Almería Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 90,85 04 Almería Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 85,19 04 Almería Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 86,57 04 Almería Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 87,25 04 Almería Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 83,13 04 Almería Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 83,71 04 Almería Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Almería Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Almería Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 15.985 04 Almería Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 14.647 04 Almería Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 13.261 04 Almería Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 15.003 04 Almería Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 13.815 04 Almería Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 12.601 04 Almería Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 14.202 04 Almería Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 13.142 04 Almería Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 11.970 04 Almería Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 13.589 04 Almería Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 12.611 04 Almería Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 11.493 04 Almería Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 12.095 04 Almería Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 11.008 04 Almería Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 04 Almería Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 04 Almería Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 04 Almería Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,86 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,32 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,02 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 88,85 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,72 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,26 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 85,01 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 86,1 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 86,67 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 82,58 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 83,01 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 549 04 Almería Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.309 04 Almería Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.759 04 Almería Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Almería Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Almería Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 533 04 Almería Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 04 Almería Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Almería Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Almería Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.277 04 Almería Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 04 Almería Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Almería Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Almería Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.733 04 Almería Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 04 Almería Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Almería Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 516 04 Almería Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 04 Almería Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 04 Almería Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Almería Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.234 04 Almería Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 04 Almería Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 04 Almería Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Almería Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.676 04 Almería Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 04 Almería Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 04 Almería Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 496 04 Almería Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.202 04 Almería Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.612 04 Almería Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.170 04 Almería Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.565 04 Almería Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 04 Almería Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 04 Almería Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 04 Almería Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,09 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,56 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,52 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,99 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,27 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,28 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 90,35 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 91,83 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,64 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 89,38 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 88,97 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 04 Almería Total Cohort July 1 Total Number at the start of the quarter 2022QIII 16.907 04 Almería Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 04 Almería Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 04 Almería Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 04 Almería Total Cohort July 1 Total Number at the start of the quarter 2021QIII 16.545 04 Almería Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 04 Almería Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 04 Almería Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 04 Almería Total Cohort July 1 Total Number at the start of the quarter 2020QIII 15.959 04 Almería Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 04 Almería Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 04 Almería Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 04 Almería Total Cohort July 1 Total Survival in the first trimester 2022QIII 15.666 04 Almería Total Cohort July 1 Total Survival in the first trimester 2022QII "" 04 Almería Total Cohort July 1 Total Survival in the first trimester 2022QI "" 04 Almería Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 04 Almería Total Cohort July 1 Total Survival in the first trimester 2021QIII 15.407 04 Almería Total Cohort July 1 Total Survival in the first trimester 2021QII "" 04 Almería Total Cohort July 1 Total Survival in the first trimester 2021QI "" 04 Almería Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 04 Almería Total Cohort July 1 Total Survival in the first trimester 2020QIII 14.838 04 Almería Total Cohort July 1 Total Survival in the first trimester 2020QII "" 04 Almería Total Cohort July 1 Total Survival in the first trimester 2020QI "" 04 Almería Total Cohort July 1 Total Survival in the second trimester 2022QIV 14.748 04 Almería Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 04 Almería Total Cohort July 1 Total Survival in the second trimester 2022QII "" 04 Almería Total Cohort July 1 Total Survival in the second trimester 2022QI "" 04 Almería Total Cohort July 1 Total Survival in the second trimester 2021QIV 14.565 04 Almería Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 04 Almería Total Cohort July 1 Total Survival in the second trimester 2021QII "" 04 Almería Total Cohort July 1 Total Survival in the second trimester 2021QI "" 04 Almería Total Cohort July 1 Total Survival in the second trimester 2020QIV 14.007 04 Almería Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 04 Almería Total Cohort July 1 Total Survival in the second trimester 2020QII "" 04 Almería Total Cohort July 1 Total Survival in the second trimester 2020QI "" 04 Almería Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 04 Almería Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 04 Almería Total Cohort July 1 Total Survival in the third trimester 2022QII "" 04 Almería Total Cohort July 1 Total Survival in the third trimester 2022QI 13.910 04 Almería Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 04 Almería Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 04 Almería Total Cohort July 1 Total Survival in the third trimester 2021QII "" 04 Almería Total Cohort July 1 Total Survival in the third trimester 2021QI 13.366 04 Almería Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 04 Almería Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 04 Almería Total Cohort July 1 Total Survival in the third trimester 2020QII "" 04 Almería Total Cohort July 1 Total Survival in the third trimester 2020QI "" 04 Almería Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 04 Almería Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 04 Almería Total Cohort July 1 Total Survival in the third trimester 2022QII 13.443 04 Almería Total Cohort July 1 Total Survival in the third trimester 2022QI "" 04 Almería Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 04 Almería Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 04 Almería Total Cohort July 1 Total Survival in the third trimester 2021QII 12.953 04 Almería Total Cohort July 1 Total Survival in the third trimester 2021QI "" 04 Almería Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 04 Almería Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 04 Almería Total Cohort July 1 Total Survival in the third trimester 2020QII "" 04 Almería Total Cohort July 1 Total Survival in the third trimester 2020QI "" 04 Almería Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 04 Almería Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 04 Almería Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 04 Almería Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 04 Almería Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 04 Almería Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 04 Almería Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 04 Almería Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 04 Almería Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 04 Almería Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 04 Almería Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 04 Almería Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,66 04 Almería Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,12 04 Almería Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 92,98 04 Almería Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 87,23 04 Almería Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 88,03 04 Almería Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 87,77 04 Almería Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 84,07 04 Almería Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 83,75 04 Almería Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 81,25 04 Almería Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 81,16 04 Almería Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Almería Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Almería Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 16.492 04 Almería Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 16.113 04 Almería Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 14.810 04 Almería Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 15.263 04 Almería Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 14.990 04 Almería Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 13.724 04 Almería Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 14.358 04 Almería Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 14.166 04 Almería Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 12.932 04 Almería Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 13.523 04 Almería Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 12.318 04 Almería Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 13.065 04 Almería Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 11.924 04 Almería Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 04 Almería Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 04 Almería Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 04 Almería Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,55 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,03 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 92,67 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,06 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 87,92 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 87,32 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 83,93 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 83,17 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 81,08 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 80,51 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 415 04 Almería Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 432 04 Almería Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.149 04 Almería Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Almería Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 403 04 Almería Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 04 Almería Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 04 Almería Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Almería Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 417 04 Almería Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 04 Almería Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 04 Almería Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Almería Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.114 04 Almería Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 04 Almería Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 04 Almería Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 390 04 Almería Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Almería Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 04 Almería Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 04 Almería Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 399 04 Almería Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Almería Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 04 Almería Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 04 Almería Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.075 04 Almería Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Almería Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 04 Almería Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 04 Almería Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 387 04 Almería Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.048 04 Almería Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 378 04 Almería Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.029 04 Almería Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 04 Almería Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 04 Almería Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 04 Almería Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,11 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,53 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,95 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,98 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 92,36 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,56 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 89,58 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 91,21 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 87,5 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 89,56 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería Total Cohort October 1 Total Number at the start of the quarter 2022QIV 16.625 04 Almería Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 04 Almería Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 04 Almería Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 04 Almería Total Cohort October 1 Total Number at the start of the quarter 2021QIV 16.400 04 Almería Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 04 Almería Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 04 Almería Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 04 Almería Total Cohort October 1 Total Number at the start of the quarter 2020QIV 15.980 04 Almería Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 04 Almería Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 04 Almería Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 04 Almería Total Cohort October 1 Total Survival in the first trimester 2022QIV 15.465 04 Almería Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 04 Almería Total Cohort October 1 Total Survival in the first trimester 2022QII "" 04 Almería Total Cohort October 1 Total Survival in the first trimester 2022QI "" 04 Almería Total Cohort October 1 Total Survival in the first trimester 2021QIV 15.312 04 Almería Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 04 Almería Total Cohort October 1 Total Survival in the first trimester 2021QII "" 04 Almería Total Cohort October 1 Total Survival in the first trimester 2021QI "" 04 Almería Total Cohort October 1 Total Survival in the first trimester 2020QIV 14.808 04 Almería Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 04 Almería Total Cohort October 1 Total Survival in the first trimester 2020QII "" 04 Almería Total Cohort October 1 Total Survival in the first trimester 2020QI "" 04 Almería Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 04 Almería Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 04 Almería Total Cohort October 1 Total Survival in the second trimester 2022QII "" 04 Almería Total Cohort October 1 Total Survival in the second trimester 2022QI 14.538 04 Almería Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 04 Almería Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 04 Almería Total Cohort October 1 Total Survival in the second trimester 2021QII "" 04 Almería Total Cohort October 1 Total Survival in the second trimester 2021QI 14.019 04 Almería Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 04 Almería Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 04 Almería Total Cohort October 1 Total Survival in the second trimester 2020QII "" 04 Almería Total Cohort October 1 Total Survival in the second trimester 2020QI "" 04 Almería Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 04 Almería Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 04 Almería Total Cohort October 1 Total Survival in the third trimester 2022QII 13.969 04 Almería Total Cohort October 1 Total Survival in the third trimester 2022QI "" 04 Almería Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 04 Almería Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 04 Almería Total Cohort October 1 Total Survival in the third trimester 2021QII 13.512 04 Almería Total Cohort October 1 Total Survival in the third trimester 2021QI "" 04 Almería Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 04 Almería Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 04 Almería Total Cohort October 1 Total Survival in the third trimester 2020QII "" 04 Almería Total Cohort October 1 Total Survival in the third trimester 2020QI "" 04 Almería Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 04 Almería Total Cohort October 1 Total Survival in the third trimester 2022QIII 13.419 04 Almería Total Cohort October 1 Total Survival in the third trimester 2022QII "" 04 Almería Total Cohort October 1 Total Survival in the third trimester 2022QI "" 04 Almería Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 04 Almería Total Cohort October 1 Total Survival in the third trimester 2021QIII 13.080 04 Almería Total Cohort October 1 Total Survival in the third trimester 2021QII "" 04 Almería Total Cohort October 1 Total Survival in the third trimester 2021QI "" 04 Almería Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 04 Almería Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 04 Almería Total Cohort October 1 Total Survival in the third trimester 2020QII "" 04 Almería Total Cohort October 1 Total Survival in the third trimester 2020QI "" 04 Almería Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 04 Almería Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 04 Almería Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 04 Almería Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 04 Almería Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 04 Almería Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 04 Almería Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 04 Almería Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 04 Almería Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 04 Almería Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 04 Almería Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 04 Almería Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,02 04 Almería Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,37 04 Almería Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 92,67 04 Almería Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,65 04 Almería Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 87,73 04 Almería Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 85,18 04 Almería Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 84,56 04 Almería Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 81,82 04 Almería Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 81,85 04 Almería Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Almería Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Almería Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 16.255 04 Almería Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 15.764 04 Almería Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 14.830 04 Almería Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 15.103 04 Almería Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 14.697 04 Almería Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 13.696 04 Almería Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 13.945 04 Almería Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 12.938 04 Almería Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 13.393 04 Almería Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 12.450 04 Almería Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 12.871 04 Almería Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 12.045 04 Almería Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 04 Almería Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 04 Almería Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 04 Almería Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 92,91 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 93,23 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,35 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,46 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 87,24 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 84,96 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 83,95 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 81,65 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 81,22 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 370 04 Almería Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 636 04 Almería Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.150 04 Almería Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 362 04 Almería Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Almería Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 04 Almería Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 04 Almería Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 615 04 Almería Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Almería Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 04 Almería Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 04 Almería Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.112 04 Almería Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Almería Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 04 Almería Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 04 Almería Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Almería Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Almería Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 04 Almería Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 593 04 Almería Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Almería Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Almería Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 04 Almería Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.081 04 Almería Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Almería Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Almería Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 04 Almería Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 04 Almería Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 576 04 Almería Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.062 04 Almería Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 548 04 Almería Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.035 04 Almería Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 04 Almería Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 04 Almería Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 04 Almería Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,84 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,7 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,7 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,24 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 90,57 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,35 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 86,16 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 90 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 04 Almería From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 04 Almería From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 04 Almería From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 12.720 04 Almería From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 04 Almería From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 04 Almería From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 04 Almería From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 12.459 04 Almería From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 12.835 04 Almería From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 11.746 04 Almería From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 11.451 04 Almería From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 10.626 04 Almería From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 11.046 04 Almería From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 10.844 04 Almería From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 10.135 04 Almería From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 10.425 04 Almería From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 10.338 04 Almería From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 9.595 04 Almería From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 10.001 04 Almería From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 9.973 04 Almería From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 9.198 04 Almería From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 04 Almería From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 04 Almería From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 04 Almería From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 04 Almería From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 04 Almería From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 04 Almería From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 04 Almería From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 04 Almería From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 92,34 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 91,91 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 82,79 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 86,84 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 87,04 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 78,96 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 81,96 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 82,98 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 74,76 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 78,62 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 80,05 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 71,66 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 12.290 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 11.796 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 11.335 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 10.818 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 10.655 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 10.236 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 10.058 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 9.758 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 9.646 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 9.416 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,23 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 91,71 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 86,7 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 86,78 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 81,84 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 82,72 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 78,49 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 79,82 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 430 04 Almería From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 663 04 Almería From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 411 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 633 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 391 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 608 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 367 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 580 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 355 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 557 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 04 Almería From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 04 Almería From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,58 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,48 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,93 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 91,7 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 85,35 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 87,48 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 82,56 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 84,01 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 04 Almería From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 04 Almería From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 12.739 04 Almería From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 04 Almería From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 04 Almería From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 04 Almería From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 12.450 04 Almería From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 04 Almería From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 04 Almería From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 04 Almería From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 11.713 04 Almería From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 11.810 04 Almería From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 11.651 04 Almería From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 11.075 04 Almería From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 11.045 04 Almería From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 10.988 04 Almería From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 10.432 04 Almería From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 10.480 04 Almería From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 10.475 04 Almería From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 9.935 04 Almería From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 9.976 04 Almería From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 9.455 04 Almería From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 04 Almería From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 04 Almería From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 04 Almería From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 04 Almería From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 04 Almería From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 04 Almería From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 04 Almería From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 04 Almería From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 04 Almería From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 04 Almería From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 04 Almería From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 04 Almería From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 92,71 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 93,58 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,55 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 86,7 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 88,26 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 89,06 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 82,27 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 84,14 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 84,82 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 80,13 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 80,72 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 12.357 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 11.668 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 10.695 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 11.443 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 10.898 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 10.077 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 10.694 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 10.274 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 9.481 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 10.147 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 9.788 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 9.035 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 9.318 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 8.591 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 92,6 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 93,4 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,22 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 86,54 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 88,05 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 88,65 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 82,12 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 83,89 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 84,48 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 79,86 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 80,33 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 382 04 Almería From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 782 04 Almería From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.018 04 Almería From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 367 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 753 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 998 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 351 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 714 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 951 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 333 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 687 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 900 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 658 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 864 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 04 Almería From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 04 Almería From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 04 Almería From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,07 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,29 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,04 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,88 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 91,3 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 93,42 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 87,17 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 87,85 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 88,41 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 84,14 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 84,87 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 04 Almería From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 12.942 04 Almería From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 04 Almería From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 04 Almería From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 04 Almería From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 12.740 04 Almería From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 04 Almería From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 04 Almería From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 04 Almería From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 12.411 04 Almería From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 11.773 04 Almería From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 11.676 04 Almería From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 11.360 04 Almería From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 10.979 04 Almería From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 10.941 04 Almería From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 10.619 04 Almería From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 10.347 04 Almería From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 10.035 04 Almería From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 9.920 04 Almería From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 9.662 04 Almería From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 04 Almería From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 04 Almería From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 04 Almería From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 04 Almería From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 04 Almería From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 04 Almería From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 04 Almería From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 04 Almería From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 04 Almería From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 04 Almería From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 90,97 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 91,65 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 91,53 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 84,83 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 85,88 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 85,56 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 81,22 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 80,86 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 77,86 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 77,85 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 12.662 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 12.475 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 11.873 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 11.505 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 11.426 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 10.850 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 10.723 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 10.702 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 10.136 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 10.118 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 9.569 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 9.699 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 9.209 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 90,86 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 91,59 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 91,38 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 84,69 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 85,79 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 85,37 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 81,11 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 80,59 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 77,75 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 77,56 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 280 04 Almería From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 265 04 Almería From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 538 04 Almería From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 268 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 250 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 510 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 256 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 239 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 483 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 229 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 466 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 221 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 453 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 04 Almería From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 04 Almería From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 04 Almería From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,71 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 94,34 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 94,8 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 91,43 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 90,19 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 89,78 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 86,42 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 86,62 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 83,4 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 84,2 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 12.801 04 Almería From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 04 Almería From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 04 Almería From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 12.716 04 Almería From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 04 Almería From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 04 Almería From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 12.495 04 Almería From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 11.737 04 Almería From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 11.709 04 Almería From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 11.405 04 Almería From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 10.992 04 Almería From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 10.667 04 Almería From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 10.473 04 Almería From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 10.213 04 Almería From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 9.960 04 Almería From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 9.819 04 Almería From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 04 Almería From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 04 Almería From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 04 Almería From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 04 Almería From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 04 Almería From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 04 Almería From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 04 Almería From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 91,69 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 92,08 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 91,28 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 86,44 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 85,37 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 82,36 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 81,74 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 78,33 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 78,58 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 12.555 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 12.269 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 11.928 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 11.498 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 11.281 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 10.870 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 10.583 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 10.156 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 10.079 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 9.717 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 9.591 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 9.346 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 91,58 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 91,95 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 91,13 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 86,26 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 85,14 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 82,15 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 81,46 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 78,17 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 78,35 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 246 04 Almería From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 447 04 Almería From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 567 04 Almería From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 239 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 428 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 535 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 409 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 511 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 394 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 496 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 369 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 473 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 04 Almería From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 04 Almería From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 04 Almería From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,15 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,75 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 94,36 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91,5 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 90,12 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 88,14 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 87,48 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 82,55 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 83,42 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 1.658 04 Almería From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 1.551 04 Almería From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 1.650 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 1.628 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 1.514 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 1.552 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 1.592 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 1.488 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 1.530 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 1.565 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 1.459 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 1.502 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 1.533 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 1.440 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 1.467 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 04 Almería From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 04 Almería From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,19 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 97,61 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 94,06 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,02 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 95,94 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 92,73 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,39 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 94,07 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 91,03 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 92,46 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 92,84 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 88,91 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.585 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.349 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.558 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.315 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.524 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.290 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.497 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.264 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.465 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.248 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,3 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97,48 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,15 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 95,63 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,45 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 93,7 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 92,43 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 92,51 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 73 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 202 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 70 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 199 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 68 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 198 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 68 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 195 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 68 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 192 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,89 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,51 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,15 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,02 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 93,15 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,53 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 93,15 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,05 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 1.691 04 Almería From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 1.584 04 Almería From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 1.468 04 Almería From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 1.660 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 1.560 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 1.455 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 1.632 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 1.532 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 1.431 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 1.590 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 1.502 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 1.403 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 1.470 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 1.368 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 04 Almería From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 04 Almería From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 04 Almería From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,17 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,48 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,11 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,51 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,72 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,48 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 94,03 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 94,82 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,57 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 92,8 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 93,19 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.620 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.370 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.188 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.589 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.347 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.175 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.562 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.321 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.157 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.522 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.292 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.136 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.263 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.109 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,09 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,32 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,91 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,42 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,42 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,39 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 93,95 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 94,31 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,62 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 92,19 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 93,35 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 71 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 214 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 280 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 71 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 213 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 280 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 70 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 211 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 274 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 68 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 210 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 267 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 207 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 259 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,53 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,59 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,6 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,86 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 95,77 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,13 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,36 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,73 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 92,5 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 1.738 04 Almería From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 1.714 04 Almería From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 1.631 04 Almería From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 1.694 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 1.676 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 1.589 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 1.627 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 1.613 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 1.529 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 1.579 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 1.495 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 1.551 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 1.473 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 04 Almería From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 04 Almería From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 04 Almería From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,47 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 97,78 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 97,42 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 93,61 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 94,11 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 93,75 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 92,12 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 91,66 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 90,49 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 90,31 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.683 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.647 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.430 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.639 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.609 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.391 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.572 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.549 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.336 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.517 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.308 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.490 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.290 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,39 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 97,69 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 97,27 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 93,4 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 94,05 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 93,43 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 92,11 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 91,47 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 90,47 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 90,21 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 55 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 67 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 201 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 55 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 67 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 198 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 55 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 64 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 193 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 62 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 187 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 61 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 183 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,51 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,52 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,02 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 92,54 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,03 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 91,04 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,04 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 1.728 04 Almería From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 1.662 04 Almería From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 1.602 04 Almería From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 1.677 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 1.607 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 1.543 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 1.571 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 1.507 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 1.540 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 1.484 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 1.521 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 1.462 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 04 Almería From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 04 Almería From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 04 Almería From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,05 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 96,69 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 96,32 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 94,52 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 94,07 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 92,66 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 92,63 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 91,52 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 91,26 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.673 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.578 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.407 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.622 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.524 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.353 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.490 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.323 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.461 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.303 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.444 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.282 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 96,95 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 96,58 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 96,16 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 94,42 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 94,03 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 92,59 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 92,61 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 91,51 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 91,12 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 55 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 84 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 195 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 55 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 83 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 190 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 81 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 184 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 79 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 181 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 77 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 180 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,81 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,44 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 96,43 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,36 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 94,05 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,82 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 91,67 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 92,31 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 04 Almería From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 04 Almería From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 04 Almería From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 1.922 04 Almería From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 04 Almería From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 04 Almería From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 04 Almería From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 1.774 04 Almería From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 1.907 04 Almería From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 1.903 04 Almería From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 1.762 04 Almería From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 1.845 04 Almería From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 1.866 04 Almería From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 1.729 04 Almería From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 1.813 04 Almería From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 1.844 04 Almería From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 1.706 04 Almería From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 1.790 04 Almería From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 1.824 04 Almería From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 1.692 04 Almería From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 1.772 04 Almería From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 04 Almería From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 04 Almería From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 04 Almería From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 04 Almería From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 04 Almería From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 04 Almería From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 04 Almería From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 04 Almería From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,01 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,32 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,75 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,09 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,46 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,07 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 95,94 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,17 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 93,86 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 94,9 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,38 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 92,92 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.830 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.420 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.813 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.409 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.777 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.376 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.755 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.355 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.735 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.345 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,07 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,23 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,1 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,9 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,9 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,42 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 94,81 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,72 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 92 04 Almería From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 354 04 Almería From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 90 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 353 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 89 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 353 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 89 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 351 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 89 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 347 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 04 Almería From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 04 Almería From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,83 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,72 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96,74 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 99,72 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,74 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 99,15 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,74 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,02 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 04 Almería From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 04 Almería From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 1.949 04 Almería From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 04 Almería From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 04 Almería From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 04 Almería From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 1.778 04 Almería From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 04 Almería From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 04 Almería From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 04 Almería From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 1.694 04 Almería From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 1.914 04 Almería From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 1.742 04 Almería From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 1.666 04 Almería From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 1.891 04 Almería From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 1.721 04 Almería From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 1.647 04 Almería From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 1.865 04 Almería From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 1.701 04 Almería From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 1.631 04 Almería From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 1.685 04 Almería From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 1.614 04 Almería From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 04 Almería From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 04 Almería From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 04 Almería From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 04 Almería From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 04 Almería From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 04 Almería From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 04 Almería From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 04 Almería From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 04 Almería From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 04 Almería From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 04 Almería From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 04 Almería From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,2 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 97,98 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,35 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,02 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,79 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,23 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,69 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,67 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,28 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,77 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,28 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.859 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.478 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.249 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.825 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.443 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.226 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.802 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.424 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.211 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.776 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.408 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.201 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.392 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.187 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,17 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 97,63 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,16 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,93 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,35 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 96,96 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,54 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,26 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,16 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 94,18 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,04 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 90 04 Almería From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 300 04 Almería From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 445 04 Almería From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 89 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 299 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 440 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 89 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 297 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 436 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 89 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 293 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 430 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 293 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 427 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 04 Almería From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 04 Almería From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 04 Almería From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,89 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,67 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,88 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,89 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,98 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 98,89 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,67 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,63 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,67 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,96 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 04 Almería From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 2.085 04 Almería From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 04 Almería From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 04 Almería From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 04 Almería From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 1.966 04 Almería From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 04 Almería From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 04 Almería From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 04 Almería From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.805 04 Almería From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 2.058 04 Almería From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 1.933 04 Almería From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 1.781 04 Almería From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 2.002 04 Almería From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 1.889 04 Almería From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 1.751 04 Almería From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 1.863 04 Almería From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 1.728 04 Almería From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 1.851 04 Almería From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 1.712 04 Almería From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 04 Almería From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 04 Almería From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 04 Almería From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 04 Almería From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 04 Almería From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 04 Almería From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 04 Almería From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 04 Almería From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 04 Almería From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 04 Almería From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,71 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,32 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,67 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,02 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 96,08 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,01 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 94,76 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,73 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 94,15 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 94,85 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.009 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.870 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.416 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.982 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.837 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.396 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.927 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.797 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.373 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.771 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.354 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.759 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.340 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,66 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,24 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,59 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 95,92 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 96,1 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,96 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 94,71 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,62 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,06 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,63 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 76 04 Almería From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 96 04 Almería From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 389 04 Almería From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 76 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 96 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 385 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 75 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 92 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 378 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 92 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 374 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 92 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 372 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 04 Almería From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 04 Almería From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 04 Almería From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,97 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,68 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,83 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,17 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,83 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,14 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 95,83 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,63 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 1.952 04 Almería From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 04 Almería From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 04 Almería From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 1.889 04 Almería From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 04 Almería From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 04 Almería From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.761 04 Almería From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 1.908 04 Almería From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 1.864 04 Almería From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 1.738 04 Almería From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 1.844 04 Almería From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 1.723 04 Almería From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 1.825 04 Almería From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 1.695 04 Almería From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 1.808 04 Almería From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 1.680 04 Almería From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 04 Almería From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 04 Almería From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 04 Almería From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 04 Almería From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 04 Almería From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 04 Almería From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 04 Almería From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,75 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,68 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,69 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,62 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,84 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,61 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,25 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,71 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,4 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.888 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.791 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.395 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.845 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.767 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.373 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.748 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.359 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.729 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.331 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.713 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.319 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,72 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,66 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,42 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,6 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,42 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,54 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,41 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,64 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 94,55 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 64 04 Almería From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 98 04 Almería From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 366 04 Almería From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 63 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 97 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 365 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 96 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 364 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 96 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 364 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 95 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 361 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 04 Almería From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 04 Almería From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 04 Almería From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,44 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,98 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,73 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 97,96 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 99,45 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,96 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 99,45 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96,94 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,63 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 04 Almería from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 04 Almería from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 04 Almería from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 90 04 Almería from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 04 Almería from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 04 Almería from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 04 Almería from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 89 04 Almería from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 94 04 Almería from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 90 04 Almería from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 89 04 Almería from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 93 04 Almería from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 88 04 Almería from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 85 04 Almería from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 90 04 Almería from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 87 04 Almería from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 82 04 Almería from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 89 04 Almería from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 87 04 Almería from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 82 04 Almería from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 89 04 Almería from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 04 Almería from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 04 Almería from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 04 Almería from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 04 Almería from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 04 Almería from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 04 Almería from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 04 Almería from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 04 Almería from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,94 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,78 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 95,51 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,74 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,67 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 92,13 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,68 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,67 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 92,13 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,68 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 88 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 80 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 88 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 80 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 86 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 77 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 85 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 74 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 85 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 74 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,73 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,25 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,59 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 92,5 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,59 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 92,5 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2 04 Almería from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 9 04 Almería from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 9 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 8 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 8 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 8 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 04 Almería from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 04 Almería from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 88,89 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 88,89 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 88,89 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 04 Almería from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 04 Almería from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 91 04 Almería from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 04 Almería from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 04 Almería from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 04 Almería from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 88 04 Almería from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 04 Almería from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 04 Almería from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 04 Almería from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 87 04 Almería from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 89 04 Almería from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 84 04 Almería from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 81 04 Almería from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 89 04 Almería from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 81 04 Almería from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 81 04 Almería from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 89 04 Almería from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 81 04 Almería from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 81 04 Almería from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 81 04 Almería from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 81 04 Almería from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 04 Almería from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 04 Almería from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 04 Almería from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 04 Almería from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 04 Almería from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 04 Almería from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 04 Almería from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 04 Almería from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 04 Almería from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 04 Almería from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 04 Almería from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 04 Almería from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,8 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,45 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 93,1 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,8 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,05 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,1 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,8 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 92,05 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 93,1 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 92,05 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 93,1 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Almería from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 89 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 83 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 79 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 87 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 80 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 74 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 87 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 77 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 74 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 87 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 77 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 74 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 77 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 74 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,75 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 96,39 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 93,67 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,75 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,77 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 93,67 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,75 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 92,77 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 93,67 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 92,77 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 93,67 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 2 04 Almería from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 5 04 Almería from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 8 04 Almería from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 2 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 4 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 7 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 2 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 4 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 7 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 2 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 4 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 7 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 4 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 7 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 04 Almería from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 04 Almería from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 04 Almería from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 80 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 87,5 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 80 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 87,5 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 80 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 87,5 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 80 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 87,5 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 04 Almería from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 88 04 Almería from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 04 Almería from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 04 Almería from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 04 Almería from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 80 04 Almería from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 04 Almería from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 04 Almería from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 04 Almería from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 75 04 Almería from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 87 04 Almería from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 77 04 Almería from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 71 04 Almería from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 86 04 Almería from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 77 04 Almería from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 71 04 Almería from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 77 04 Almería from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 71 04 Almería from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 77 04 Almería from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 69 04 Almería from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 04 Almería from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 04 Almería from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 04 Almería from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 04 Almería from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 04 Almería from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 04 Almería from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 04 Almería from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 04 Almería from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 04 Almería from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 04 Almería from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,86 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 96,25 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,67 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,73 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 96,25 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 94,67 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,25 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 94,67 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,25 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 92 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 86 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 79 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 62 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 85 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 76 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 58 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 84 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 76 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 58 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 76 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 58 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 76 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 56 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,84 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 96,2 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,55 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,67 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 96,2 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 93,55 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,2 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 93,55 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,2 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 90,32 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 2 04 Almería from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1 04 Almería from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 13 04 Almería from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 2 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 13 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 2 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 13 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 13 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 13 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 04 Almería from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 04 Almería from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 04 Almería from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 94 04 Almería from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 04 Almería from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 04 Almería from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 85 04 Almería from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 04 Almería from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 04 Almería from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 76 04 Almería from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 94 04 Almería from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 84 04 Almería from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 76 04 Almería from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 84 04 Almería from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 76 04 Almería from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 84 04 Almería from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 74 04 Almería from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 83 04 Almería from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 73 04 Almería from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 04 Almería from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 04 Almería from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 04 Almería from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 04 Almería from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 04 Almería from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 04 Almería from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 04 Almería from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,82 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,82 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,82 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,37 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,65 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,05 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 91 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 82 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 64 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 91 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 81 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 64 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 81 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 64 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 81 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 63 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 80 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 62 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,78 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,78 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,78 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,44 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,56 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,88 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 3 04 Almería from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 3 04 Almería from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 12 04 Almería from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 3 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 3 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 12 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 3 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 12 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 3 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 11 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 3 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 11 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 04 Almería from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 04 Almería from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 04 Almería from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 91,67 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 91,67 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 04 Almería De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 04 Almería De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 04 Almería De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 65 04 Almería De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 04 Almería De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 04 Almería De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 04 Almería De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 58 04 Almería De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 04 Almería De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 04 Almería De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 04 Almería De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 54 04 Almería De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 04 Almería De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 04 Almería De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 04 Almería De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 64 04 Almería De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 04 Almería De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 04 Almería De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 04 Almería De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 58 04 Almería De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 04 Almería De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 04 Almería De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 04 Almería De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 54 04 Almería De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 04 Almería De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 04 Almería De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 64 04 Almería De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 04 Almería De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 04 Almería De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 04 Almería De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 56 04 Almería De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 04 Almería De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 04 Almería De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 04 Almería De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 53 04 Almería De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 04 Almería De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 04 Almería De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 62 04 Almería De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 04 Almería De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 04 Almería De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 04 Almería De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 55 04 Almería De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 04 Almería De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 04 Almería De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 04 Almería De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 52 04 Almería De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 04 Almería De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 04 Almería De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 62 04 Almería De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 04 Almería De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 04 Almería De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 04 Almería De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 55 04 Almería De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 04 Almería De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 04 Almería De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 04 Almería De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 52 04 Almería De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 04 Almería De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 04 Almería De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 04 Almería De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 04 Almería De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 04 Almería De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 04 Almería De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 04 Almería De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 04 Almería De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 04 Almería De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 04 Almería De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 04 Almería De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 04 Almería De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 04 Almería De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 04 Almería De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,46 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,46 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,55 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,15 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 95,38 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 94,83 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,3 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,38 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,83 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,3 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Almería De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 61 04 Almería De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 49 04 Almería De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 60 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 49 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 60 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 47 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 58 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 46 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 58 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 46 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 04 Almería De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 04 Almería De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,36 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,36 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 95,92 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,08 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 93,88 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,08 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 93,88 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 4 04 Almería De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 9 04 Almería De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 4 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 9 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 4 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 9 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 4 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 9 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 4 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 9 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 04 Almería De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 04 Almería De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 04 Almería De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 04 Almería De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 64 04 Almería De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 04 Almería De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 04 Almería De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 04 Almería De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 56 04 Almería De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 04 Almería De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 04 Almería De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 04 Almería De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 58 04 Almería De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 04 Almería De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 04 Almería De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 04 Almería De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 63 04 Almería De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 04 Almería De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 04 Almería De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 04 Almería De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 55 04 Almería De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 04 Almería De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 04 Almería De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 04 Almería De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 57 04 Almería De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 04 Almería De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 04 Almería De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 61 04 Almería De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 04 Almería De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 04 Almería De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 04 Almería De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 54 04 Almería De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 04 Almería De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 04 Almería De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 04 Almería De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 55 04 Almería De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 04 Almería De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 04 Almería De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 61 04 Almería De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 04 Almería De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 04 Almería De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 04 Almería De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 54 04 Almería De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 04 Almería De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 04 Almería De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 04 Almería De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 55 04 Almería De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 04 Almería De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 04 Almería De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 04 Almería De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 04 Almería De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 04 Almería De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 04 Almería De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 53 04 Almería De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 04 Almería De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 04 Almería De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 04 Almería De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 55 04 Almería De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 04 Almería De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 04 Almería De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 04 Almería De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 04 Almería De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 04 Almería De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 04 Almería De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 04 Almería De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 04 Almería De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 04 Almería De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 04 Almería De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 04 Almería De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 04 Almería De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 04 Almería De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 04 Almería De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 04 Almería De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,44 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,21 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,28 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 95,31 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,43 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 94,83 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,31 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,43 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 94,83 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,64 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,83 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Almería De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 60 04 Almería De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 48 04 Almería De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 50 04 Almería De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 59 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 47 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 49 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 57 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 46 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 47 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 57 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 46 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 47 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 45 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 47 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 04 Almería De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 04 Almería De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 04 Almería De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,33 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 97,92 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 95 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 95,83 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 94 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,83 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 94 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,75 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 4 04 Almería De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 8 04 Almería De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 8 04 Almería De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 4 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 8 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 8 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 4 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 8 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 8 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 4 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 8 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 8 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 8 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 8 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 04 Almería De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 04 Almería De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 04 Almería De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 04 Almería De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 54 04 Almería De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 04 Almería De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 04 Almería De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 04 Almería De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 45 04 Almería De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 04 Almería De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 04 Almería De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 04 Almería De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 37 04 Almería De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 04 Almería De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 04 Almería De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 04 Almería De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 54 04 Almería De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 04 Almería De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 04 Almería De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 04 Almería De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 45 04 Almería De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 04 Almería De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 04 Almería De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 04 Almería De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 37 04 Almería De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 04 Almería De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 04 Almería De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 54 04 Almería De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 04 Almería De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 04 Almería De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 04 Almería De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 45 04 Almería De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 04 Almería De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 04 Almería De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 04 Almería De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 37 04 Almería De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 04 Almería De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 04 Almería De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 04 Almería De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 04 Almería De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 04 Almería De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 04 Almería De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 44 04 Almería De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 04 Almería De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 04 Almería De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 04 Almería De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 37 04 Almería De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 04 Almería De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 04 Almería De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 04 Almería De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 04 Almería De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 04 Almería De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 04 Almería De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 44 04 Almería De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 04 Almería De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 04 Almería De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 04 Almería De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 37 04 Almería De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 04 Almería De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 04 Almería De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 04 Almería De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 04 Almería De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 04 Almería De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 04 Almería De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 04 Almería De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 04 Almería De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 04 Almería De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 04 Almería De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 04 Almería De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 04 Almería De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 04 Almería De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 04 Almería De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 04 Almería De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 04 Almería De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,78 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,78 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Almería De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 52 04 Almería De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 42 04 Almería De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 29 04 Almería De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 52 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 42 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 29 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 52 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 42 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 29 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 41 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 29 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 41 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 29 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 04 Almería De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 04 Almería De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 04 Almería De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,62 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,62 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 2 04 Almería De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 3 04 Almería De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 8 04 Almería De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 2 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 3 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 8 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 2 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 3 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 8 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 3 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 8 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 3 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 8 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 04 Almería De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 04 Almería De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 04 Almería De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 04 Almería De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 04 Almería De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 04 Almería De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 50 04 Almería De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 04 Almería De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 04 Almería De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 04 Almería De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 48 04 Almería De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 04 Almería De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 04 Almería De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 04 Almería De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 46 04 Almería De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 04 Almería De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 04 Almería De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 04 Almería De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 49 04 Almería De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 04 Almería De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 04 Almería De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 04 Almería De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 48 04 Almería De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 04 Almería De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 04 Almería De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 04 Almería De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 46 04 Almería De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 04 Almería De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 04 Almería De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 04 Almería De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 04 Almería De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 04 Almería De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 04 Almería De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 47 04 Almería De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 04 Almería De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 04 Almería De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 04 Almería De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 46 04 Almería De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 04 Almería De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 04 Almería De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 04 Almería De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 04 Almería De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 04 Almería De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 04 Almería De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 47 04 Almería De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 04 Almería De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 04 Almería De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 04 Almería De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 46 04 Almería De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 04 Almería De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 04 Almería De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 04 Almería De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 04 Almería De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 04 Almería De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 04 Almería De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 47 04 Almería De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 04 Almería De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 04 Almería De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 04 Almería De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 46 04 Almería De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 04 Almería De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 04 Almería De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 04 Almería De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 04 Almería De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 04 Almería De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 04 Almería De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 04 Almería De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 04 Almería De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 04 Almería De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 04 Almería De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 04 Almería De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 04 Almería De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 04 Almería De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 04 Almería De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 04 Almería De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 04 Almería De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 04 Almería De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,92 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,92 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,92 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 04 Almería De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 48 04 Almería De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 44 04 Almería De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 36 04 Almería De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 47 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 44 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 36 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 43 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 36 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 43 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 36 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 43 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 36 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 04 Almería De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 04 Almería De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 04 Almería De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,92 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,73 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,73 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,73 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 2 04 Almería De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 4 04 Almería De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 10 04 Almería De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 2 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 4 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 10 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 4 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 10 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 4 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 10 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 4 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 10 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 04 Almería De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 04 Almería De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 04 Almería De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 04 Almería De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava Total Cohort January 1 Total Number at the start of the quarter 2022QI 7.691 01 Araba/Álava Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava Total Cohort January 1 Total Number at the start of the quarter 2021QI 7.644 01 Araba/Álava Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava Total Cohort January 1 Total Number at the start of the quarter 2020QI 7.944 01 Araba/Álava Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 01 Araba/Álava Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 01 Araba/Álava Total Cohort January 1 Total Survival in the first trimester 2022QII "" 01 Araba/Álava Total Cohort January 1 Total Survival in the first trimester 2022QI 7.346 01 Araba/Álava Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 01 Araba/Álava Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 01 Araba/Álava Total Cohort January 1 Total Survival in the first trimester 2021QII "" 01 Araba/Álava Total Cohort January 1 Total Survival in the first trimester 2021QI 7.311 01 Araba/Álava Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 01 Araba/Álava Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 01 Araba/Álava Total Cohort January 1 Total Survival in the first trimester 2020QII "" 01 Araba/Álava Total Cohort January 1 Total Survival in the first trimester 2020QI 7.307 01 Araba/Álava Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 01 Araba/Álava Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 01 Araba/Álava Total Cohort January 1 Total Survival in the second trimester 2022QII 7.019 01 Araba/Álava Total Cohort January 1 Total Survival in the second trimester 2022QI "" 01 Araba/Álava Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 01 Araba/Álava Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 01 Araba/Álava Total Cohort January 1 Total Survival in the second trimester 2021QII 7.067 01 Araba/Álava Total Cohort January 1 Total Survival in the second trimester 2021QI "" 01 Araba/Álava Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 01 Araba/Álava Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 01 Araba/Álava Total Cohort January 1 Total Survival in the second trimester 2020QII 7.055 01 Araba/Álava Total Cohort January 1 Total Survival in the second trimester 2020QI "" 01 Araba/Álava Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava Total Cohort January 1 Total Survival in the third trimester 2022QIII 6.785 01 Araba/Álava Total Cohort January 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava Total Cohort January 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava Total Cohort January 1 Total Survival in the third trimester 2021QIII 6.887 01 Araba/Álava Total Cohort January 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava Total Cohort January 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava Total Cohort January 1 Total Survival in the third trimester 2020QIII 6.863 01 Araba/Álava Total Cohort January 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava Total Cohort January 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava Total Cohort January 1 Total Survival in the third trimester 2022QIV 6.601 01 Araba/Álava Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava Total Cohort January 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava Total Cohort January 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava Total Cohort January 1 Total Survival in the third trimester 2021QIV 6.708 01 Araba/Álava Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava Total Cohort January 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava Total Cohort January 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava Total Cohort January 1 Total Survival in the third trimester 2020QIV 6.705 01 Araba/Álava Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava Total Cohort January 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava Total Cohort January 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 01 Araba/Álava Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 01 Araba/Álava Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,51 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,64 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 91,98 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 91,26 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 92,45 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 88,81 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 88,22 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 90,1 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 86,39 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 85,83 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 87,76 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 84,4 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 7.278 01 Araba/Álava Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 6.403 01 Araba/Álava Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 6.940 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 6.095 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 6.619 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 5.874 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 6.398 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 5.715 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 6.221 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 5.558 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 01 Araba/Álava Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 01 Araba/Álava Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 95,36 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 95,19 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,95 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 91,74 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 87,91 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 89,26 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 85,48 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 86,8 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 413 01 Araba/Álava Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.241 01 Araba/Álava Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 406 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.216 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 400 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.193 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 387 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.172 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 380 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.150 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 01 Araba/Álava Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 01 Araba/Álava Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,31 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,99 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96,85 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,13 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 93,7 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,44 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 92,01 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 92,67 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava Total Cohort April 1 Total Number at the start of the quarter 2022QII 7.651 01 Araba/Álava Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava Total Cohort April 1 Total Number at the start of the quarter 2021QII 7.619 01 Araba/Álava Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava Total Cohort April 1 Total Number at the start of the quarter 2020QII 7.585 01 Araba/Álava Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 01 Araba/Álava Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 01 Araba/Álava Total Cohort April 1 Total Survival in the first trimester 2022QII 7.257 01 Araba/Álava Total Cohort April 1 Total Survival in the first trimester 2022QI "" 01 Araba/Álava Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 01 Araba/Álava Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 01 Araba/Álava Total Cohort April 1 Total Survival in the first trimester 2021QII 7.302 01 Araba/Álava Total Cohort April 1 Total Survival in the first trimester 2021QI "" 01 Araba/Álava Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 01 Araba/Álava Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 01 Araba/Álava Total Cohort April 1 Total Survival in the first trimester 2020QII 7.293 01 Araba/Álava Total Cohort April 1 Total Survival in the first trimester 2020QI "" 01 Araba/Álava Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 01 Araba/Álava Total Cohort April 1 Total Survival in the second trimester 2022QIII 6.980 01 Araba/Álava Total Cohort April 1 Total Survival in the second trimester 2022QII "" 01 Araba/Álava Total Cohort April 1 Total Survival in the second trimester 2022QI "" 01 Araba/Álava Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 01 Araba/Álava Total Cohort April 1 Total Survival in the second trimester 2021QIII 7.084 01 Araba/Álava Total Cohort April 1 Total Survival in the second trimester 2021QII "" 01 Araba/Álava Total Cohort April 1 Total Survival in the second trimester 2021QI "" 01 Araba/Álava Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 01 Araba/Álava Total Cohort April 1 Total Survival in the second trimester 2020QIII 7.072 01 Araba/Álava Total Cohort April 1 Total Survival in the second trimester 2020QII "" 01 Araba/Álava Total Cohort April 1 Total Survival in the second trimester 2020QI "" 01 Araba/Álava Total Cohort April 1 Total Survival in the third trimester 2022QIV 6.767 01 Araba/Álava Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava Total Cohort April 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava Total Cohort April 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava Total Cohort April 1 Total Survival in the third trimester 2021QIV 6.883 01 Araba/Álava Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava Total Cohort April 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava Total Cohort April 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava Total Cohort April 1 Total Survival in the third trimester 2020QIV 6.891 01 Araba/Álava Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava Total Cohort April 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava Total Cohort April 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava Total Cohort April 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava Total Cohort April 1 Total Survival in the third trimester 2022QI 6.673 01 Araba/Álava Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava Total Cohort April 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava Total Cohort April 1 Total Survival in the third trimester 2021QI 6.678 01 Araba/Álava Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava Total Cohort April 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava Total Cohort April 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 01 Araba/Álava Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 01 Araba/Álava Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 01 Araba/Álava Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,85 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,84 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,15 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 91,23 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,98 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,24 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 88,45 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 90,34 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,85 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 87,58 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 88,04 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 7.266 01 Araba/Álava Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 6.389 01 Araba/Álava Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 5.637 01 Araba/Álava Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 6.883 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 6.097 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 5.383 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 6.613 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 5.898 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 5.210 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 6.408 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 5.718 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 5.067 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 5.523 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 4.900 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 01 Araba/Álava Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 01 Araba/Álava Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 01 Araba/Álava Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,73 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,43 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,49 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,01 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,31 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,43 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 88,19 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 89,5 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 89,89 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 86,45 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 86,93 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 385 01 Araba/Álava Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.230 01 Araba/Álava Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.948 01 Araba/Álava Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 374 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.205 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.910 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 367 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.186 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.862 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 359 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.165 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.824 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.150 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.778 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 01 Araba/Álava Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 01 Araba/Álava Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 01 Araba/Álava Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,14 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,97 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,05 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 95,32 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,42 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,59 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 93,25 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,72 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,63 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 93,5 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,27 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava Total Cohort July 1 Total Number at the start of the quarter 2022QIII 7.610 01 Araba/Álava Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava Total Cohort July 1 Total Number at the start of the quarter 2021QIII 7.662 01 Araba/Álava Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava Total Cohort July 1 Total Number at the start of the quarter 2020QIII 7.619 01 Araba/Álava Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 01 Araba/Álava Total Cohort July 1 Total Survival in the first trimester 2022QIII 7.233 01 Araba/Álava Total Cohort July 1 Total Survival in the first trimester 2022QII "" 01 Araba/Álava Total Cohort July 1 Total Survival in the first trimester 2022QI "" 01 Araba/Álava Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 01 Araba/Álava Total Cohort July 1 Total Survival in the first trimester 2021QIII 7.332 01 Araba/Álava Total Cohort July 1 Total Survival in the first trimester 2021QII "" 01 Araba/Álava Total Cohort July 1 Total Survival in the first trimester 2021QI "" 01 Araba/Álava Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 01 Araba/Álava Total Cohort July 1 Total Survival in the first trimester 2020QIII 7.314 01 Araba/Álava Total Cohort July 1 Total Survival in the first trimester 2020QII "" 01 Araba/Álava Total Cohort July 1 Total Survival in the first trimester 2020QI "" 01 Araba/Álava Total Cohort July 1 Total Survival in the second trimester 2022QIV 6.974 01 Araba/Álava Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 01 Araba/Álava Total Cohort July 1 Total Survival in the second trimester 2022QII "" 01 Araba/Álava Total Cohort July 1 Total Survival in the second trimester 2022QI "" 01 Araba/Álava Total Cohort July 1 Total Survival in the second trimester 2021QIV 7.088 01 Araba/Álava Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 01 Araba/Álava Total Cohort July 1 Total Survival in the second trimester 2021QII "" 01 Araba/Álava Total Cohort July 1 Total Survival in the second trimester 2021QI "" 01 Araba/Álava Total Cohort July 1 Total Survival in the second trimester 2020QIV 7.083 01 Araba/Álava Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 01 Araba/Álava Total Cohort July 1 Total Survival in the second trimester 2020QII "" 01 Araba/Álava Total Cohort July 1 Total Survival in the second trimester 2020QI "" 01 Araba/Álava Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava Total Cohort July 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava Total Cohort July 1 Total Survival in the third trimester 2022QI 6.853 01 Araba/Álava Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava Total Cohort July 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava Total Cohort July 1 Total Survival in the third trimester 2021QI 6.853 01 Araba/Álava Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava Total Cohort July 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava Total Cohort July 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava Total Cohort July 1 Total Survival in the third trimester 2022QII 6.644 01 Araba/Álava Total Cohort July 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava Total Cohort July 1 Total Survival in the third trimester 2021QII 6.708 01 Araba/Álava Total Cohort July 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava Total Cohort July 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava Total Cohort July 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 01 Araba/Álava Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 01 Araba/Álava Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 01 Araba/Álava Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 95,05 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,69 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 96 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 91,64 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 92,51 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 92,96 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 89,44 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 89,95 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 86,71 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 88,04 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 7.468 01 Araba/Álava Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 7.310 01 Araba/Álava Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 6.267 01 Araba/Álava Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 7.094 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 6.990 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 5.992 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 6.839 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 6.749 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 5.779 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 6.517 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 5.579 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 6.311 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 5.457 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 01 Araba/Álava Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 01 Araba/Álava Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 01 Araba/Álava Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,99 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,62 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,61 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 91,58 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 92,33 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 92,21 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 89,15 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 89,02 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 86,33 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 87,08 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 142 01 Araba/Álava Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 352 01 Araba/Álava Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.352 01 Araba/Álava Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 139 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 342 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.322 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 135 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 339 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.304 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 336 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.274 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 333 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.251 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 01 Araba/Álava Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 01 Araba/Álava Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 01 Araba/Álava Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,89 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,16 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,78 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95,07 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,31 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,45 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,45 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,23 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 94,6 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,53 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava Total Cohort October 1 Total Number at the start of the quarter 2022QIV 7.552 01 Araba/Álava Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava Total Cohort October 1 Total Number at the start of the quarter 2021QIV 7.631 01 Araba/Álava Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava Total Cohort October 1 Total Number at the start of the quarter 2020QIV 7.619 01 Araba/Álava Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava Total Cohort October 1 Total Survival in the first trimester 2022QIV 7.240 01 Araba/Álava Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 01 Araba/Álava Total Cohort October 1 Total Survival in the first trimester 2022QII "" 01 Araba/Álava Total Cohort October 1 Total Survival in the first trimester 2022QI "" 01 Araba/Álava Total Cohort October 1 Total Survival in the first trimester 2021QIV 7.328 01 Araba/Álava Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 01 Araba/Álava Total Cohort October 1 Total Survival in the first trimester 2021QII "" 01 Araba/Álava Total Cohort October 1 Total Survival in the first trimester 2021QI "" 01 Araba/Álava Total Cohort October 1 Total Survival in the first trimester 2020QIV 7.315 01 Araba/Álava Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 01 Araba/Álava Total Cohort October 1 Total Survival in the first trimester 2020QII "" 01 Araba/Álava Total Cohort October 1 Total Survival in the first trimester 2020QI "" 01 Araba/Álava Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 01 Araba/Álava Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 01 Araba/Álava Total Cohort October 1 Total Survival in the second trimester 2022QII "" 01 Araba/Álava Total Cohort October 1 Total Survival in the second trimester 2022QI 7.059 01 Araba/Álava Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 01 Araba/Álava Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 01 Araba/Álava Total Cohort October 1 Total Survival in the second trimester 2021QII "" 01 Araba/Álava Total Cohort October 1 Total Survival in the second trimester 2021QI 7.057 01 Araba/Álava Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 01 Araba/Álava Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 01 Araba/Álava Total Cohort October 1 Total Survival in the second trimester 2020QII "" 01 Araba/Álava Total Cohort October 1 Total Survival in the second trimester 2020QI "" 01 Araba/Álava Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava Total Cohort October 1 Total Survival in the third trimester 2022QII 6.796 01 Araba/Álava Total Cohort October 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava Total Cohort October 1 Total Survival in the third trimester 2021QII 6.873 01 Araba/Álava Total Cohort October 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava Total Cohort October 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava Total Cohort October 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava Total Cohort October 1 Total Survival in the third trimester 2022QIII 6.603 01 Araba/Álava Total Cohort October 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava Total Cohort October 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava Total Cohort October 1 Total Survival in the third trimester 2021QIII 6.719 01 Araba/Álava Total Cohort October 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava Total Cohort October 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava Total Cohort October 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava Total Cohort October 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 01 Araba/Álava Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 01 Araba/Álava Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 01 Araba/Álava Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,87 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 96,03 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 96,01 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 92,5 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 92,62 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 89,06 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 90,21 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 86,53 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 88,19 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 7.452 01 Araba/Álava Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 7.236 01 Araba/Álava Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 6.212 01 Araba/Álava Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 7.143 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 6.940 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 5.930 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 6.675 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 5.701 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 6.421 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 5.540 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 6.240 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 5.406 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 01 Araba/Álava Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 01 Araba/Álava Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 01 Araba/Álava Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95,85 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,91 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 95,46 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 92,25 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 91,77 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 88,74 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 89,18 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 86,24 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 87,03 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 01 Araba/Álava Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 395 01 Araba/Álava Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.407 01 Araba/Álava Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 97 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 388 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.385 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 384 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.356 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 375 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.333 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 363 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.313 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 01 Araba/Álava Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 01 Araba/Álava Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 01 Araba/Álava Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,23 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,44 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 97,22 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,38 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 94,94 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,74 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 91,9 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,32 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 5.328 01 Araba/Álava From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 5.358 01 Araba/Álava From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 5.452 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 5.007 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 5.046 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 4.869 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 4.726 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 4.830 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 4.642 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 4.521 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 4.669 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 4.480 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 4.365 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 4.509 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 4.337 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 01 Araba/Álava From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 01 Araba/Álava From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,98 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,18 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 89,31 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,7 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,15 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 85,14 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 84,85 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,14 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 82,17 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 81,93 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 84,15 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 79,55 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 5.111 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 4.733 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 4.797 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 4.444 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 4.521 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 4.248 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 4.323 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 4.104 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 4.171 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 3.958 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,86 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,89 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,46 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,75 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 84,58 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,71 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 81,61 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 83,63 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 217 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 625 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 210 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 602 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 205 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 582 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 198 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 565 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 194 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 551 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,77 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,32 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 94,47 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 93,12 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 91,24 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 90,4 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 89,4 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 88,16 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 5.271 01 Araba/Álava From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 5.340 01 Araba/Álava From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 5.263 01 Araba/Álava From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 4.919 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 5.051 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 4.997 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 4.672 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 4.851 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 4.803 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 4.486 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 4.669 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 4.632 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 4.481 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 4.440 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 01 Araba/Álava From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 01 Araba/Álava From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 01 Araba/Álava From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,32 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,59 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,95 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 88,64 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,84 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,26 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 85,11 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 87,43 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,01 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 83,91 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 84,36 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 5.074 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 4.733 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 4.111 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 4.732 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 4.466 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 3.876 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 4.491 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 4.282 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 3.720 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 4.312 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 4.113 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 3.584 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 3.936 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 3.432 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,26 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,36 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,28 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 88,51 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 90,47 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,49 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 84,98 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 86,9 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 87,18 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 83,16 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 83,48 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 197 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 607 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.152 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 187 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 585 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.121 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 181 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 569 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.083 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 174 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 556 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.048 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 545 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.008 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 94,92 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,38 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,31 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,88 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,74 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,01 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,32 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 91,6 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 90,97 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 89,79 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 87,5 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 5.199 01 Araba/Álava From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 5.344 01 Araba/Álava From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 5.298 01 Araba/Álava From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 4.847 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 5.033 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 5.017 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 4.622 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 4.813 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 4.798 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 4.604 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 4.592 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 4.424 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 4.464 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 01 Araba/Álava From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 01 Araba/Álava From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 01 Araba/Álava From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,23 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,18 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,7 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 88,9 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,06 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,56 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 86,15 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,67 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 82,78 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,26 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 5.125 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 5.183 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 4.638 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 4.776 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 4.881 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 4.382 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 4.555 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 4.662 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 4.178 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 4.456 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 3.999 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 4.278 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 3.893 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,19 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,17 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,48 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 88,88 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,95 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,08 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 85,97 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,22 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 82,54 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 83,94 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 74 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 161 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 660 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 71 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 152 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 635 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 67 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 151 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 620 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 148 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 593 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 146 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 571 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,95 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 94,41 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,21 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 90,54 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,79 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,94 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 91,93 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 89,85 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 90,68 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 86,52 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 5.172 01 Araba/Álava From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 5.317 01 Araba/Álava From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 5.315 01 Araba/Álava From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 4.887 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 5.035 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 5.024 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 4.791 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 4.792 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 4.568 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 4.629 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 4.394 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 4.490 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 01 Araba/Álava From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 01 Araba/Álava From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 01 Araba/Álava From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,49 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,7 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,52 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,11 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,16 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 85,91 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 87,09 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 82,64 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 84,48 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 5.128 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 5.113 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 4.653 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 4.846 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 4.837 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 4.381 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 4.595 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 4.176 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 4.381 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 4.034 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 4.214 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 3.911 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,5 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,6 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,15 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,87 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,75 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 85,68 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,7 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 82,42 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 84,05 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 44 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 204 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 662 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 41 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 198 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 643 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 196 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 616 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 187 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 595 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 180 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 579 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 93,18 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,06 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,13 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 96,08 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 93,05 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 91,67 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 89,88 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 88,24 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 87,46 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 868 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 847 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 933 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 859 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 836 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 903 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 840 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 820 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 892 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 824 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 810 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 876 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 807 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 799 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 867 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,96 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,7 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,78 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,77 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,81 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,61 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,93 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,63 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 93,89 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 92,97 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,33 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 92,93 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 798 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 641 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 789 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 631 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 770 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 617 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 757 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 608 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 741 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 601 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,87 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,44 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,49 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,26 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,86 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 94,85 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 92,86 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 93,76 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 70 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 206 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 70 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 205 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 70 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 203 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 67 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 202 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 66 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 198 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,51 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,54 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 95,71 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,06 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,29 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,12 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 888 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 842 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 855 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 865 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 827 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 844 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 847 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 818 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 832 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 828 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 807 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 828 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 802 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 816 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,41 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,22 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,71 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 95,38 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,15 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,31 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 93,24 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,84 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,84 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 95,25 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,44 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 824 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 626 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 541 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 801 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 612 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 530 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 784 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 603 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 525 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 766 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 596 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 523 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 592 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 515 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,21 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 97,76 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 97,97 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 95,15 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,33 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,04 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 92,96 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,21 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,67 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 94,57 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,19 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 64 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 216 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 314 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 64 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 215 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 314 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 63 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 215 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 307 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 62 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 211 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 305 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 210 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 301 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,54 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,44 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,54 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,77 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,88 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,69 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,13 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,22 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,86 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 898 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 875 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 884 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 885 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 867 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 874 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 864 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 853 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 868 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 843 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 853 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 827 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 844 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,55 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,09 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,87 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,21 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,49 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,19 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,34 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,49 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 94,51 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,48 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 875 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 819 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 645 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 862 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 811 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 637 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 841 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 799 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 634 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 789 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 620 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 773 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 611 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,51 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,02 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,76 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,11 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,56 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,29 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,34 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,12 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,38 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,73 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 23 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 56 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 239 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 23 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 56 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 237 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 23 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 54 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 234 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 54 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 233 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 54 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 233 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,16 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,43 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,91 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 96,43 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,49 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,43 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,49 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 878 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 861 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 871 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 860 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 849 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 864 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 839 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 847 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 819 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 834 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 807 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 826 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,95 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,61 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,2 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,44 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,24 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95,12 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 95,75 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 93,73 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 94,83 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 867 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 801 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 639 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 849 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 790 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 634 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 782 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 618 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 762 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 606 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 753 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 599 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,92 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,63 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,22 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,63 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,71 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,13 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 94,84 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 94,01 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,74 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 11 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 60 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 232 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 11 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 59 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 230 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 57 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 229 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 57 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 228 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 54 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 227 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,33 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,14 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 95 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,71 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 95 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,28 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 90 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 97,84 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 1.377 01 Araba/Álava From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 1.325 01 Araba/Álava From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 1.445 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 1.363 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 1.315 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 1.421 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 1.337 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 1.304 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 1.408 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 1.325 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 1.295 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 1.395 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 1.315 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 1.288 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 1.389 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 01 Araba/Álava From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 01 Araba/Álava From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,98 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,25 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,34 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,1 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,42 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,44 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,22 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,74 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,54 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,5 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,21 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,12 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.268 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 959 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.254 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 950 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.229 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 940 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.220 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 934 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.211 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 931 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,9 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,06 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,92 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,02 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,21 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,39 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,5 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,08 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 109 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 366 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 109 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 365 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 108 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 364 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 105 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 361 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 104 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 357 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,73 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 99,08 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 99,45 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,33 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,63 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 95,41 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,54 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 1.371 01 Araba/Álava From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 1.324 01 Araba/Álava From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 1.356 01 Araba/Álava From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 1.353 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 1.312 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 1.342 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 1.342 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 1.303 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 1.328 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 1.334 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 1.296 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 1.322 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 1.280 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 1.313 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 01 Araba/Álava From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 01 Araba/Álava From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 01 Araba/Álava From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,69 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,09 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,97 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,88 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,41 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,94 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,3 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,89 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,49 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,68 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,83 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.261 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 960 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 907 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.244 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 950 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 900 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.233 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 944 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 889 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.225 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 941 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 884 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 928 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 877 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,65 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,96 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,23 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,78 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,33 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,02 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,15 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98,02 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,46 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,67 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,69 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 110 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 364 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 449 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 109 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 362 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 442 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 109 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 359 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 439 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 109 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 355 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 438 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 352 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 436 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,09 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,45 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,44 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 99,09 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,63 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,77 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 99,09 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,53 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,55 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,7 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 97,1 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 1.393 01 Araba/Álava From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 1.330 01 Araba/Álava From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.332 01 Araba/Álava From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 1.382 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 1.319 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 1.319 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 1.369 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 1.310 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 1.313 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 1.295 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 1.304 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 1.283 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 1.296 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 01 Araba/Álava From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 01 Araba/Álava From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 01 Araba/Álava From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,21 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,17 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,02 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,28 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,5 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,57 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,37 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,9 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,47 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,3 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.357 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.214 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 918 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.346 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.204 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 908 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.333 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.195 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 902 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.180 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 895 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.169 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 888 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,19 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,18 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,91 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,23 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,43 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,26 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,2 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,49 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,29 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,73 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 36 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 116 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 414 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 36 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 115 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 411 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 36 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 115 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 411 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 115 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 409 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 114 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 408 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,14 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,28 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,14 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,28 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 99,14 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,79 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 98,28 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,55 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 1.383 01 Araba/Álava From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 1.338 01 Araba/Álava From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.321 01 Araba/Álava From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 1.374 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 1.330 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 1.315 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 1.316 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 1.306 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 1.297 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 1.298 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 1.290 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 1.291 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 01 Araba/Álava From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 01 Araba/Álava From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 01 Araba/Álava From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,35 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,4 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,55 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,36 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,86 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,94 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,26 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,41 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,73 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.347 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.224 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 856 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.338 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.216 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 851 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.202 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 843 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.183 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 836 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.178 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 832 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,33 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,35 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,42 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,2 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,48 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,65 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,66 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,24 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,2 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 36 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 114 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 465 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 36 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 114 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 464 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 114 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 463 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 114 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 462 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 112 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 459 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,78 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 99,57 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 99,35 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 98,25 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,71 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 93 01 Araba/Álava from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 89 01 Araba/Álava from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 85 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 92 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 89 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 85 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 91 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 88 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 84 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 90 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 88 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 83 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 89 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 88 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 83 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 01 Araba/Álava from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 01 Araba/Álava from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,92 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,85 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,88 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,82 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,77 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,88 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,65 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,7 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,88 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,65 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 79 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 60 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 78 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 60 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 77 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 59 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 76 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 59 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 76 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 59 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,73 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,47 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,33 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,2 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,33 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,2 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,33 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 14 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 29 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 14 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 29 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 14 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 29 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 14 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 29 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 13 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 29 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 92,86 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 94 01 Araba/Álava from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 87 01 Araba/Álava from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 84 01 Araba/Álava from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 93 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 86 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 83 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 92 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 86 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 82 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 92 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 86 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 82 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 85 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 82 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 01 Araba/Álava from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 01 Araba/Álava from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 01 Araba/Álava from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,94 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,85 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,81 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,87 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,85 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,62 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,87 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,85 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,62 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,7 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,62 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 87 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 58 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 63 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 86 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 57 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 62 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 85 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 57 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 61 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 85 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 57 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 61 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 56 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 61 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,85 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,28 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,41 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,7 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,28 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 96,83 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,7 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98,28 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,83 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,55 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,83 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 7 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 29 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 21 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 7 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 29 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 21 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 7 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 29 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 21 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 7 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 29 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 21 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 29 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 21 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 95 01 Araba/Álava from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 86 01 Araba/Álava from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 80 01 Araba/Álava from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 94 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 86 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 79 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 94 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 86 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 79 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 85 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 79 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 84 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 79 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 01 Araba/Álava from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 01 Araba/Álava from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 01 Araba/Álava from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,95 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,75 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,95 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,75 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,84 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,75 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,67 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,75 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 90 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 73 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 55 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 89 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 73 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 54 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 89 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 73 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 54 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 72 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 54 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 71 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 54 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,89 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,18 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,89 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,18 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,63 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,18 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,26 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 98,18 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 5 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 13 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 25 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 5 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 13 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 25 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 5 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 13 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 25 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 13 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 25 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 13 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 25 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 93 01 Araba/Álava from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 90 01 Araba/Álava from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 86 01 Araba/Álava from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 93 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 90 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 86 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 89 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 86 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 88 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 86 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 88 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 86 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 01 Araba/Álava from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 01 Araba/Álava from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 01 Araba/Álava from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,89 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,78 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,78 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 88 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 76 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 52 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 88 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 76 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 52 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 75 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 52 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 74 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 52 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 74 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 52 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,68 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,37 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,37 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 5 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 14 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 34 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 5 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 14 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 34 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 14 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 34 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 14 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 34 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 14 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 34 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 25 01 Araba/Álava De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 25 01 Araba/Álava De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 29 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 25 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 25 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 29 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 25 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 25 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 29 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 25 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 25 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 29 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 25 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 24 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 29 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 01 Araba/Álava De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 01 Araba/Álava De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 22 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 10 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 22 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 10 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 22 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 10 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 22 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 10 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 22 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 9 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 90 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 3 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 15 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 3 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 15 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 3 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 15 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 3 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 15 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 3 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 15 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 27 01 Araba/Álava De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 26 01 Araba/Álava De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 27 01 Araba/Álava De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 27 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 26 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 27 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 27 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 26 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 27 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 27 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 25 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 27 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 25 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 27 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 01 Araba/Álava De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 01 Araba/Álava De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 01 Araba/Álava De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,15 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,15 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 20 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 12 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 15 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 20 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 12 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 15 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 20 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 12 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 15 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 20 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 11 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 15 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 11 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 15 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 91,67 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 91,67 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 7 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 14 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 12 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 7 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 14 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 12 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 7 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 14 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 12 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 7 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 14 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 12 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 14 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 12 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 25 01 Araba/Álava De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 27 01 Araba/Álava De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 25 01 Araba/Álava De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 25 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 27 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 25 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 25 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 26 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 25 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 26 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 25 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 26 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 25 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 01 Araba/Álava De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 01 Araba/Álava De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 01 Araba/Álava De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 96,3 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,3 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,3 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 21 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 21 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 11 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 21 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 21 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 11 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 21 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 20 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 11 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 20 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 11 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 20 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 11 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 95,24 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,24 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,24 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 4 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 6 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 14 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 4 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 6 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 14 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 4 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 6 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 14 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 6 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 14 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 6 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 14 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 26 01 Araba/Álava De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 25 01 Araba/Álava De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 26 01 Araba/Álava De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 26 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 24 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 26 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 24 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 26 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 24 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 26 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 24 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 26 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 01 Araba/Álava De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 01 Araba/Álava De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 01 Araba/Álava De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 96 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 22 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 22 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 12 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 22 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 21 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 12 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 21 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 12 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 21 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 12 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 21 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 12 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,45 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 95,45 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,45 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,45 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 4 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 3 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 14 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 4 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 3 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 14 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 3 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 14 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 3 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 14 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 3 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 14 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 01 Araba/Álava De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 33 Asturias Total Cohort January 1 Total Number at the start of the quarter 2022QI 24.026 33 Asturias Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 33 Asturias Total Cohort January 1 Total Number at the start of the quarter 2021QI 23.402 33 Asturias Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 33 Asturias Total Cohort January 1 Total Number at the start of the quarter 2020QI 24.500 33 Asturias Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 33 Asturias Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 33 Asturias Total Cohort January 1 Total Survival in the first trimester 2022QII "" 33 Asturias Total Cohort January 1 Total Survival in the first trimester 2022QI 22.763 33 Asturias Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 33 Asturias Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 33 Asturias Total Cohort January 1 Total Survival in the first trimester 2021QII "" 33 Asturias Total Cohort January 1 Total Survival in the first trimester 2021QI 22.239 33 Asturias Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 33 Asturias Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 33 Asturias Total Cohort January 1 Total Survival in the first trimester 2020QII "" 33 Asturias Total Cohort January 1 Total Survival in the first trimester 2020QI 22.090 33 Asturias Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 33 Asturias Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 33 Asturias Total Cohort January 1 Total Survival in the second trimester 2022QII 21.761 33 Asturias Total Cohort January 1 Total Survival in the second trimester 2022QI "" 33 Asturias Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 33 Asturias Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 33 Asturias Total Cohort January 1 Total Survival in the second trimester 2021QII 21.463 33 Asturias Total Cohort January 1 Total Survival in the second trimester 2021QI "" 33 Asturias Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 33 Asturias Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 33 Asturias Total Cohort January 1 Total Survival in the second trimester 2020QII 21.448 33 Asturias Total Cohort January 1 Total Survival in the second trimester 2020QI "" 33 Asturias Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 33 Asturias Total Cohort January 1 Total Survival in the third trimester 2022QIII 21.033 33 Asturias Total Cohort January 1 Total Survival in the third trimester 2022QII "" 33 Asturias Total Cohort January 1 Total Survival in the third trimester 2022QI "" 33 Asturias Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 33 Asturias Total Cohort January 1 Total Survival in the third trimester 2021QIII 20.878 33 Asturias Total Cohort January 1 Total Survival in the third trimester 2021QII "" 33 Asturias Total Cohort January 1 Total Survival in the third trimester 2021QI "" 33 Asturias Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 33 Asturias Total Cohort January 1 Total Survival in the third trimester 2020QIII 20.840 33 Asturias Total Cohort January 1 Total Survival in the third trimester 2020QII "" 33 Asturias Total Cohort January 1 Total Survival in the third trimester 2020QI "" 33 Asturias Total Cohort January 1 Total Survival in the third trimester 2022QIV 20.386 33 Asturias Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 33 Asturias Total Cohort January 1 Total Survival in the third trimester 2022QII "" 33 Asturias Total Cohort January 1 Total Survival in the third trimester 2022QI "" 33 Asturias Total Cohort January 1 Total Survival in the third trimester 2021QIV 20.309 33 Asturias Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 33 Asturias Total Cohort January 1 Total Survival in the third trimester 2021QII "" 33 Asturias Total Cohort January 1 Total Survival in the third trimester 2021QI "" 33 Asturias Total Cohort January 1 Total Survival in the third trimester 2020QIV 20.228 33 Asturias Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 33 Asturias Total Cohort January 1 Total Survival in the third trimester 2020QII "" 33 Asturias Total Cohort January 1 Total Survival in the third trimester 2020QI "" 33 Asturias Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 33 Asturias Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 33 Asturias Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 33 Asturias Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 33 Asturias Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 33 Asturias Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 33 Asturias Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,74 33 Asturias Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,03 33 Asturias Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 90,16 33 Asturias Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,57 33 Asturias Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,71 33 Asturias Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 87,54 33 Asturias Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 87,54 33 Asturias Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 89,21 33 Asturias Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 85,06 33 Asturias Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 84,85 33 Asturias Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 86,78 33 Asturias Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 82,56 33 Asturias Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 33 Asturias Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 33 Asturias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 22.873 33 Asturias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 20.307 33 Asturias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 21.649 33 Asturias Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 19.229 33 Asturias Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 20.696 33 Asturias Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 18.508 33 Asturias Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 19.997 33 Asturias Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 17.981 33 Asturias Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 19.380 33 Asturias Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 17.480 33 Asturias Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 33 Asturias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 33 Asturias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,65 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,69 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,48 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 91,14 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 87,43 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 88,55 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 84,73 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 86,08 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.153 33 Asturias Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 3.095 33 Asturias Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.114 33 Asturias Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 3.010 33 Asturias Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.065 33 Asturias Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2.955 33 Asturias Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.036 33 Asturias Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2.897 33 Asturias Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.006 33 Asturias Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2.829 33 Asturias Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 33 Asturias Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 33 Asturias Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,62 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,25 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,37 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,48 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 89,85 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 93,6 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 87,25 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 91,41 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias Total Cohort April 1 Total Number at the start of the quarter 2022QII 23.955 33 Asturias Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 33 Asturias Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias Total Cohort April 1 Total Number at the start of the quarter 2021QII 23.336 33 Asturias Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 33 Asturias Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias Total Cohort April 1 Total Number at the start of the quarter 2020QII 22.988 33 Asturias Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 33 Asturias Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 33 Asturias Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 33 Asturias Total Cohort April 1 Total Survival in the first trimester 2022QII 22.724 33 Asturias Total Cohort April 1 Total Survival in the first trimester 2022QI "" 33 Asturias Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 33 Asturias Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 33 Asturias Total Cohort April 1 Total Survival in the first trimester 2021QII 22.342 33 Asturias Total Cohort April 1 Total Survival in the first trimester 2021QI "" 33 Asturias Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 33 Asturias Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 33 Asturias Total Cohort April 1 Total Survival in the first trimester 2020QII 22.216 33 Asturias Total Cohort April 1 Total Survival in the first trimester 2020QI "" 33 Asturias Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 33 Asturias Total Cohort April 1 Total Survival in the second trimester 2022QIII 21.869 33 Asturias Total Cohort April 1 Total Survival in the second trimester 2022QII "" 33 Asturias Total Cohort April 1 Total Survival in the second trimester 2022QI "" 33 Asturias Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 33 Asturias Total Cohort April 1 Total Survival in the second trimester 2021QIII 21.636 33 Asturias Total Cohort April 1 Total Survival in the second trimester 2021QII "" 33 Asturias Total Cohort April 1 Total Survival in the second trimester 2021QI "" 33 Asturias Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 33 Asturias Total Cohort April 1 Total Survival in the second trimester 2020QIII 21.523 33 Asturias Total Cohort April 1 Total Survival in the second trimester 2020QII "" 33 Asturias Total Cohort April 1 Total Survival in the second trimester 2020QI "" 33 Asturias Total Cohort April 1 Total Survival in the third trimester 2022QIV 21.052 33 Asturias Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 33 Asturias Total Cohort April 1 Total Survival in the third trimester 2022QII "" 33 Asturias Total Cohort April 1 Total Survival in the third trimester 2022QI "" 33 Asturias Total Cohort April 1 Total Survival in the third trimester 2021QIV 20.948 33 Asturias Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 33 Asturias Total Cohort April 1 Total Survival in the third trimester 2021QII "" 33 Asturias Total Cohort April 1 Total Survival in the third trimester 2021QI "" 33 Asturias Total Cohort April 1 Total Survival in the third trimester 2020QIV 20.826 33 Asturias Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 33 Asturias Total Cohort April 1 Total Survival in the third trimester 2020QII "" 33 Asturias Total Cohort April 1 Total Survival in the third trimester 2020QI "" 33 Asturias Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 33 Asturias Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 33 Asturias Total Cohort April 1 Total Survival in the third trimester 2022QII "" 33 Asturias Total Cohort April 1 Total Survival in the third trimester 2022QI 20.214 33 Asturias Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 33 Asturias Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 33 Asturias Total Cohort April 1 Total Survival in the third trimester 2021QII "" 33 Asturias Total Cohort April 1 Total Survival in the third trimester 2021QI 20.109 33 Asturias Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 33 Asturias Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 33 Asturias Total Cohort April 1 Total Survival in the third trimester 2020QII "" 33 Asturias Total Cohort April 1 Total Survival in the third trimester 2020QI "" 33 Asturias Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 33 Asturias Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 33 Asturias Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 33 Asturias Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 33 Asturias Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 33 Asturias Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,86 33 Asturias Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,74 33 Asturias Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,64 33 Asturias Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 91,29 33 Asturias Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,72 33 Asturias Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,63 33 Asturias Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,88 33 Asturias Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 89,77 33 Asturias Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,6 33 Asturias Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 86,62 33 Asturias Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87,48 33 Asturias Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 33 Asturias Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 33 Asturias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 22.824 33 Asturias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 20.233 33 Asturias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 18.009 33 Asturias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 21.629 33 Asturias Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 19.291 33 Asturias Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 17.316 33 Asturias Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 20.806 33 Asturias Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 18.645 33 Asturias Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 16.729 33 Asturias Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 20.021 33 Asturias Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 18.029 33 Asturias Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 16.154 33 Asturias Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 17.372 33 Asturias Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 15.577 33 Asturias Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 33 Asturias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 33 Asturias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 33 Asturias Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,76 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,34 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 96,15 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,16 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,15 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,89 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,72 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 89,11 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 89,7 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 85,86 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 86,5 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.131 33 Asturias Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 3.103 33 Asturias Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 4.979 33 Asturias Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.095 33 Asturias Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 3.051 33 Asturias Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 4.900 33 Asturias Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.063 33 Asturias Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 2.991 33 Asturias Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 4.794 33 Asturias Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.031 33 Asturias Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 2.919 33 Asturias Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 4.672 33 Asturias Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 2.842 33 Asturias Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 4.532 33 Asturias Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 33 Asturias Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 33 Asturias Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 33 Asturias Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,82 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,32 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,41 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,99 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,39 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,28 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,16 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,07 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,83 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 91,59 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,02 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias Total Cohort July 1 Total Number at the start of the quarter 2022QIII 24.276 33 Asturias Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 33 Asturias Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 33 Asturias Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias Total Cohort July 1 Total Number at the start of the quarter 2021QIII 24.075 33 Asturias Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 33 Asturias Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 33 Asturias Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias Total Cohort July 1 Total Number at the start of the quarter 2020QIII 23.579 33 Asturias Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 33 Asturias Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 33 Asturias Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 33 Asturias Total Cohort July 1 Total Survival in the first trimester 2022QIII 22.946 33 Asturias Total Cohort July 1 Total Survival in the first trimester 2022QII "" 33 Asturias Total Cohort July 1 Total Survival in the first trimester 2022QI "" 33 Asturias Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 33 Asturias Total Cohort July 1 Total Survival in the first trimester 2021QIII 22.894 33 Asturias Total Cohort July 1 Total Survival in the first trimester 2021QII "" 33 Asturias Total Cohort July 1 Total Survival in the first trimester 2021QI "" 33 Asturias Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 33 Asturias Total Cohort July 1 Total Survival in the first trimester 2020QIII 22.528 33 Asturias Total Cohort July 1 Total Survival in the first trimester 2020QII "" 33 Asturias Total Cohort July 1 Total Survival in the first trimester 2020QI "" 33 Asturias Total Cohort July 1 Total Survival in the second trimester 2022QIV 21.779 33 Asturias Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 33 Asturias Total Cohort July 1 Total Survival in the second trimester 2022QII "" 33 Asturias Total Cohort July 1 Total Survival in the second trimester 2022QI "" 33 Asturias Total Cohort July 1 Total Survival in the second trimester 2021QIV 21.832 33 Asturias Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 33 Asturias Total Cohort July 1 Total Survival in the second trimester 2021QII "" 33 Asturias Total Cohort July 1 Total Survival in the second trimester 2021QI "" 33 Asturias Total Cohort July 1 Total Survival in the second trimester 2020QIV 21.530 33 Asturias Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 33 Asturias Total Cohort July 1 Total Survival in the second trimester 2020QII "" 33 Asturias Total Cohort July 1 Total Survival in the second trimester 2020QI "" 33 Asturias Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 33 Asturias Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 33 Asturias Total Cohort July 1 Total Survival in the third trimester 2022QII "" 33 Asturias Total Cohort July 1 Total Survival in the third trimester 2022QI 20.986 33 Asturias Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 33 Asturias Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 33 Asturias Total Cohort July 1 Total Survival in the third trimester 2021QII "" 33 Asturias Total Cohort July 1 Total Survival in the third trimester 2021QI 20.733 33 Asturias Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 33 Asturias Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 33 Asturias Total Cohort July 1 Total Survival in the third trimester 2020QII "" 33 Asturias Total Cohort July 1 Total Survival in the third trimester 2020QI "" 33 Asturias Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 33 Asturias Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 33 Asturias Total Cohort July 1 Total Survival in the third trimester 2022QII 20.359 33 Asturias Total Cohort July 1 Total Survival in the third trimester 2022QI "" 33 Asturias Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 33 Asturias Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 33 Asturias Total Cohort July 1 Total Survival in the third trimester 2021QII 20.238 33 Asturias Total Cohort July 1 Total Survival in the third trimester 2021QI "" 33 Asturias Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 33 Asturias Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 33 Asturias Total Cohort July 1 Total Survival in the third trimester 2020QII "" 33 Asturias Total Cohort July 1 Total Survival in the third trimester 2020QI "" 33 Asturias Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 33 Asturias Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 33 Asturias Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 33 Asturias Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 33 Asturias Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 33 Asturias Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 33 Asturias Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 33 Asturias Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 33 Asturias Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,52 33 Asturias Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,09 33 Asturias Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,54 33 Asturias Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,71 33 Asturias Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,68 33 Asturias Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 91,31 33 Asturias Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 87,17 33 Asturias Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 87,93 33 Asturias Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 84,56 33 Asturias Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 85,83 33 Asturias Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 33 Asturias Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 33 Asturias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 23.538 33 Asturias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 23.209 33 Asturias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 20.656 33 Asturias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 22.229 33 Asturias Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 22.044 33 Asturias Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 19.664 33 Asturias Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 21.086 33 Asturias Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 21.008 33 Asturias Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 18.730 33 Asturias Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 20.191 33 Asturias Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 18.014 33 Asturias Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 19.586 33 Asturias Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 17.563 33 Asturias Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 33 Asturias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 33 Asturias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 33 Asturias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,44 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,98 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,2 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,58 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 90,52 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,68 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 87 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 87,21 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 84,39 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 85,03 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 738 33 Asturias Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 866 33 Asturias Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2.923 33 Asturias Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 717 33 Asturias Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 850 33 Asturias Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2.864 33 Asturias Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 693 33 Asturias Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 824 33 Asturias Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 2.800 33 Asturias Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 795 33 Asturias Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2.719 33 Asturias Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 773 33 Asturias Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 2.675 33 Asturias Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 33 Asturias Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 33 Asturias Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 33 Asturias Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,15 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,15 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,98 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,9 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,15 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,79 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 91,8 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,02 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 89,26 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,52 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias Total Cohort October 1 Total Number at the start of the quarter 2022QIV 24.015 33 Asturias Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 33 Asturias Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 33 Asturias Total Cohort October 1 Total Number at the start of the quarter 2021QIV 24.078 33 Asturias Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 33 Asturias Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 33 Asturias Total Cohort October 1 Total Number at the start of the quarter 2020QIV 23.870 33 Asturias Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 33 Asturias Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 33 Asturias Total Cohort October 1 Total Survival in the first trimester 2022QIV 22.595 33 Asturias Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 33 Asturias Total Cohort October 1 Total Survival in the first trimester 2022QII "" 33 Asturias Total Cohort October 1 Total Survival in the first trimester 2022QI "" 33 Asturias Total Cohort October 1 Total Survival in the first trimester 2021QIV 22.721 33 Asturias Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 33 Asturias Total Cohort October 1 Total Survival in the first trimester 2021QII "" 33 Asturias Total Cohort October 1 Total Survival in the first trimester 2021QI "" 33 Asturias Total Cohort October 1 Total Survival in the first trimester 2020QIV 22.416 33 Asturias Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 33 Asturias Total Cohort October 1 Total Survival in the first trimester 2020QII "" 33 Asturias Total Cohort October 1 Total Survival in the first trimester 2020QI "" 33 Asturias Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 33 Asturias Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 33 Asturias Total Cohort October 1 Total Survival in the second trimester 2022QII "" 33 Asturias Total Cohort October 1 Total Survival in the second trimester 2022QI 21.732 33 Asturias Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 33 Asturias Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 33 Asturias Total Cohort October 1 Total Survival in the second trimester 2021QII "" 33 Asturias Total Cohort October 1 Total Survival in the second trimester 2021QI 21.488 33 Asturias Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 33 Asturias Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 33 Asturias Total Cohort October 1 Total Survival in the second trimester 2020QII "" 33 Asturias Total Cohort October 1 Total Survival in the second trimester 2020QI "" 33 Asturias Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 33 Asturias Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 33 Asturias Total Cohort October 1 Total Survival in the third trimester 2022QII 20.957 33 Asturias Total Cohort October 1 Total Survival in the third trimester 2022QI "" 33 Asturias Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 33 Asturias Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 33 Asturias Total Cohort October 1 Total Survival in the third trimester 2021QII 20.868 33 Asturias Total Cohort October 1 Total Survival in the third trimester 2021QI "" 33 Asturias Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 33 Asturias Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 33 Asturias Total Cohort October 1 Total Survival in the third trimester 2020QII "" 33 Asturias Total Cohort October 1 Total Survival in the third trimester 2020QI "" 33 Asturias Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 33 Asturias Total Cohort October 1 Total Survival in the third trimester 2022QIII 20.344 33 Asturias Total Cohort October 1 Total Survival in the third trimester 2022QII "" 33 Asturias Total Cohort October 1 Total Survival in the third trimester 2022QI "" 33 Asturias Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 33 Asturias Total Cohort October 1 Total Survival in the third trimester 2021QIII 20.368 33 Asturias Total Cohort October 1 Total Survival in the third trimester 2021QII "" 33 Asturias Total Cohort October 1 Total Survival in the third trimester 2021QI "" 33 Asturias Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 33 Asturias Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 33 Asturias Total Cohort October 1 Total Survival in the third trimester 2020QII "" 33 Asturias Total Cohort October 1 Total Survival in the third trimester 2020QI "" 33 Asturias Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 33 Asturias Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 33 Asturias Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 33 Asturias Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 33 Asturias Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 33 Asturias Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 33 Asturias Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 33 Asturias Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 33 Asturias Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,09 33 Asturias Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,36 33 Asturias Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,91 33 Asturias Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,26 33 Asturias Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,02 33 Asturias Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,04 33 Asturias Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 87,42 33 Asturias Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 84,49 33 Asturias Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 85,33 33 Asturias Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 33 Asturias Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 33 Asturias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 23.341 33 Asturias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 22.849 33 Asturias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 20.721 33 Asturias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 21.943 33 Asturias Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 21.542 33 Asturias Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 19.342 33 Asturias Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 20.606 33 Asturias Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 18.494 33 Asturias Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 19.868 33 Asturias Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 17.927 33 Asturias Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 19.276 33 Asturias Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 17.483 33 Asturias Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 33 Asturias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 33 Asturias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 33 Asturias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,01 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,28 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,34 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,18 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,25 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 86,95 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,52 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 84,36 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 84,37 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 674 33 Asturias Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.229 33 Asturias Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 3.149 33 Asturias Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 652 33 Asturias Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.179 33 Asturias Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 3.074 33 Asturias Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.126 33 Asturias Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2.994 33 Asturias Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.089 33 Asturias Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2.941 33 Asturias Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.068 33 Asturias Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2.885 33 Asturias Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 33 Asturias Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 33 Asturias Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 33 Asturias Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,74 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,93 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,62 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91,62 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,08 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 88,61 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,39 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 86,9 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 91,62 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 33 Asturias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 18.671 33 Asturias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 33 Asturias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 18.410 33 Asturias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 19.043 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 17.485 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 17.295 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 16.755 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 16.560 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 16.582 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 16.162 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 15.893 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 16.045 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 15.597 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 15.290 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 15.513 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 15.029 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 33 Asturias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 33 Asturias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 33 Asturias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 33 Asturias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,65 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,94 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 87,99 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,69 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,07 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 84,87 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 85,12 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,15 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 81,9 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 81,89 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 84,26 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 78,92 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 17.874 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 16.628 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 16.725 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 15.587 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 15.841 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 14.922 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 15.200 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 14.432 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 14.623 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 13.955 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,57 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,74 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,63 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,74 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 85,04 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,79 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 81,81 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 83,92 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 797 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.782 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 760 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.708 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 719 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.660 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 693 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.613 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 667 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.558 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,36 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,85 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,21 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 93,15 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 86,95 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 90,52 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 83,69 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 87,43 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 18.561 33 Asturias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 18.319 33 Asturias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 17.995 33 Asturias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 17.411 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 17.395 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 17.266 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 16.618 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 16.733 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 16.608 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 15.861 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 16.084 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 15.948 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 15.424 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 15.277 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 33 Asturias From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 33 Asturias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 33 Asturias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 33 Asturias From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,8 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,96 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,95 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,53 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,34 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,29 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 85,45 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 87,8 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,62 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 84,2 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 84,9 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 17.765 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 16.528 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 14.857 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 16.648 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 15.652 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 14.191 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 15.885 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 15.043 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 13.628 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 15.158 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 14.455 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 13.073 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 13.859 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 12.520 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,71 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,7 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,52 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 89,42 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,02 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,73 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 85,33 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 87,46 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 87,99 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 83,85 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,27 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 796 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.791 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 3.138 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 763 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.743 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 3.075 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 733 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.690 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.980 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 703 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.629 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.875 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.565 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.757 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,85 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,32 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,99 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 92,09 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,36 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,96 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,32 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 90,95 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,62 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 87,38 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 87,86 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 18.646 33 Asturias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 18.737 33 Asturias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 18.439 33 Asturias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 17.381 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 17.608 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 17.433 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 16.325 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 16.641 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 16.499 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 15.879 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 15.754 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 15.291 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 15.303 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 33 Asturias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 33 Asturias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 33 Asturias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,22 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,97 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,54 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 87,55 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 88,81 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 89,48 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 84,75 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 85,44 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 81,61 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 82,99 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 18.121 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 18.213 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 16.881 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 16.876 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 17.100 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 15.927 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 15.843 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 16.154 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 15.046 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 15.417 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 14.368 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 14.849 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 13.952 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,13 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,89 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,35 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,43 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 88,69 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,13 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 84,65 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 85,11 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 81,53 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 82,65 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 525 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 524 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.558 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 505 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 508 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.506 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 482 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 487 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.453 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 462 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.386 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 442 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.351 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,19 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,95 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,66 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 91,81 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 92,94 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,26 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 88,17 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 88,96 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 84,35 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 86,71 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 18.491 33 Asturias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 18.705 33 Asturias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 18.644 33 Asturias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 17.137 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 17.402 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 17.240 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 16.490 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 16.366 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 15.773 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 15.802 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 15.215 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 15.346 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 33 Asturias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 33 Asturias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 33 Asturias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 92,68 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,03 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 92,47 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,16 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 87,78 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 84,33 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 84,76 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 81,34 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 82,31 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 18.027 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 17.857 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 16.948 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 16.695 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 16.600 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 15.610 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 15.735 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 14.801 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 15.051 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 14.279 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 14.512 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 13.869 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 92,61 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 92,96 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,11 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,12 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 87,33 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 84,29 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 84,25 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 81,27 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 81,83 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 464 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 848 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.696 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 442 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 802 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.630 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 755 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.565 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 722 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.523 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 703 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.477 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 95,26 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 94,58 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,11 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 89,03 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 92,28 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 85,14 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 89,8 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 82,9 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 87,09 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 2.285 33 Asturias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 2.133 33 Asturias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 2.390 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 2.238 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 2.103 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 2.309 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 2.193 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 2.068 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 2.283 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 2.163 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 2.038 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 2.258 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 2.137 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 2.015 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 2.229 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 33 Asturias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 33 Asturias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 97,94 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,59 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,61 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 95,97 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,95 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,52 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,66 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,55 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,48 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,52 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,47 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 93,26 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.146 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.601 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.100 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.576 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.058 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.545 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.030 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.523 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.005 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.508 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 97,86 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,44 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 95,9 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,5 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,59 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,13 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,43 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,19 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 139 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 532 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 138 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 527 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 135 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 523 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 133 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 515 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 132 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 507 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,28 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,06 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,12 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,31 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 95,68 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,8 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,96 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,3 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 2.288 33 Asturias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 2.156 33 Asturias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 2.139 33 Asturias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 2.239 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 2.114 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 2.114 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 2.210 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 2.084 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 2.092 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 2.173 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 2.058 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 2.069 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 2.007 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 2.045 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 33 Asturias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 33 Asturias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 33 Asturias From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,86 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,05 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,83 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,59 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,66 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,8 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 94,97 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,45 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,73 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,09 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,61 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.159 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.636 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.325 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.110 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.595 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.309 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.081 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.570 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.292 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.045 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.550 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.278 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.505 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.264 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,73 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 97,49 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,79 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,39 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 95,97 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,51 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 94,72 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 94,74 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,45 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 91,99 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,4 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 129 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 520 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 814 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 129 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 519 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 805 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 129 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 514 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 800 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 128 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 508 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 791 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 502 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 781 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,81 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,89 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,85 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,28 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 99,22 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,69 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,17 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,54 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,95 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 2.412 33 Asturias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 2.321 33 Asturias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 2.252 33 Asturias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 2.372 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 2.287 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 2.219 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 2.304 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 2.218 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 2.172 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 2.162 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 2.140 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 2.138 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 2.114 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 33 Asturias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 33 Asturias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 33 Asturias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,34 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,54 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,53 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 95,52 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 95,56 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 96,45 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 93,15 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,03 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 92,12 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 93,87 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.318 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.189 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.707 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.278 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.155 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.678 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.211 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.090 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.637 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.038 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.612 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.014 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.591 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,27 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,45 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,3 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 95,38 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 95,48 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 95,9 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 93,1 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 94,43 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 92,01 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 93,2 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 94 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 132 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 545 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 94 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 132 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 541 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 93 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 128 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 535 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 124 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 528 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 124 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 523 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,27 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,94 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,97 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,17 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93,94 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,88 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,94 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,96 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 2.315 33 Asturias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 2.299 33 Asturias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 2.268 33 Asturias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 2.275 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 2.261 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 2.237 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 2.214 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 2.206 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 2.182 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 2.172 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 2.156 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 2.145 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 33 Asturias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 33 Asturias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 33 Asturias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,27 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,35 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,63 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,3 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,27 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 94,91 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 95,77 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 93,78 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 94,58 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.219 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.133 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.720 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.179 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.098 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.693 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.055 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.668 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.023 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.640 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.998 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.617 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,2 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,36 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,43 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,34 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,98 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 94,84 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,35 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 93,67 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 94,01 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 96 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 166 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 548 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 96 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 163 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 544 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 159 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 538 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 159 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 532 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 158 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 528 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,19 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,27 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 95,78 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,18 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 95,78 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,08 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 95,18 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,35 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 33 Asturias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 2.874 33 Asturias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 33 Asturias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 2.669 33 Asturias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 2.874 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 2.844 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 2.651 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 2.834 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 2.812 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 2.623 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 2.812 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 2.782 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 2.607 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 2.794 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 2.765 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 2.593 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 2.779 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 33 Asturias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 33 Asturias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 33 Asturias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 33 Asturias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,96 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,33 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,61 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,84 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,28 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,84 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,8 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,68 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,22 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,21 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,15 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,69 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.675 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.953 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.646 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.941 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.619 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.916 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.590 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.903 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.576 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.894 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,92 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,39 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,91 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,11 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,82 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,44 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,3 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,98 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 199 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 716 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 198 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 710 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 193 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 707 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 192 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 704 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 189 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 699 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,5 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,16 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96,98 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,74 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,48 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,32 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,97 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,63 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 2.900 33 Asturias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 2.665 33 Asturias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 2.669 33 Asturias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 2.868 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 2.637 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 2.651 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 2.836 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 2.625 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 2.638 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 2.814 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 2.612 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 2.624 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 2.589 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 2.602 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 33 Asturias From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 33 Asturias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 33 Asturias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 33 Asturias From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,9 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,95 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,33 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,79 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,5 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,84 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,03 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,01 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,31 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,15 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,49 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.714 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.935 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.693 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.685 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.910 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.682 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.655 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.900 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.675 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.634 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.892 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.669 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.876 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.659 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,93 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,71 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,35 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,83 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,19 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,94 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,05 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,78 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,58 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,95 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,99 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 186 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 730 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 976 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 183 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 727 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 969 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 181 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 725 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 963 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 180 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 720 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 955 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 713 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 943 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,39 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,59 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,28 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,31 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,32 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,67 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,77 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,63 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,85 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,67 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,62 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 3.009 33 Asturias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 2.823 33 Asturias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 2.701 33 Asturias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 2.985 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 2.807 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 2.689 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 2.943 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 2.781 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 2.672 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 2.753 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 2.652 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 2.738 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 2.634 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 33 Asturias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 33 Asturias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 33 Asturias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,2 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,43 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,56 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,81 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,51 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,93 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,52 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,19 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,99 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,52 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.903 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.627 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.940 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.880 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.611 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.931 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.838 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.586 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.919 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.558 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.906 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.545 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.892 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,21 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,39 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,54 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,76 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,44 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,92 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,37 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,25 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,88 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,53 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 106 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 196 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 761 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 105 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 196 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 758 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 105 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 195 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 753 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 195 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 746 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 193 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 742 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,06 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,61 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 99,06 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,49 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,95 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 99,49 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,03 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 98,47 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,5 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 3.003 33 Asturias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 2.881 33 Asturias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 2.767 33 Asturias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 2.978 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 2.865 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 2.748 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 2.835 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 2.725 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 2.809 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 2.703 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 2.781 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 2.688 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 33 Asturias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 33 Asturias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 33 Asturias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,17 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,44 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,31 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,4 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,48 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,5 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,69 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,53 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,14 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.901 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.681 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.930 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.876 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.666 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.916 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.638 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.902 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.616 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.885 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.589 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.876 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,14 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,44 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,27 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,4 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,55 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,58 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,67 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,57 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,2 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 102 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 200 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 837 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 102 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 199 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 832 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 197 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 823 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 193 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 818 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 192 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 812 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,5 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,4 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,5 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,33 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,5 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,73 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 97,01 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 33 Asturias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 134 33 Asturias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 33 Asturias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 128 33 Asturias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 127 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 134 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 128 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 127 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 134 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 128 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 126 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 133 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 127 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 126 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 133 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 127 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 126 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 33 Asturias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 33 Asturias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 33 Asturias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 33 Asturias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 99,21 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 99,25 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 99,22 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 99,21 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 99,25 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 99,22 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 99,21 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 120 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 89 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 120 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 89 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 120 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 89 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 119 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 88 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 119 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 88 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 99,17 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,88 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 99,17 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,88 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 14 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 39 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 14 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 39 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 14 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 39 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 14 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 39 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 14 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 39 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 142 33 Asturias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 134 33 Asturias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 123 33 Asturias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 142 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 134 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 123 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 141 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 133 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 123 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 141 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 133 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 123 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 133 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 123 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 33 Asturias from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 33 Asturias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 33 Asturias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 33 Asturias from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,3 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,25 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 99,3 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 99,25 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 99,25 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 33 Asturias from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 127 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 95 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 90 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 127 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 95 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 90 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 126 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 94 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 90 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 126 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 94 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 90 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 94 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 90 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 99,21 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,95 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 99,21 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98,95 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 98,95 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 15 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 39 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 33 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 15 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 39 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 33 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 15 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 39 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 33 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 15 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 39 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 33 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 39 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 33 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 147 33 Asturias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 133 33 Asturias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 130 33 Asturias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 146 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 132 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 130 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 146 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 132 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 130 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 132 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 130 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 132 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 130 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 33 Asturias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 33 Asturias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 33 Asturias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,32 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,25 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 99,32 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,25 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 99,25 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 99,25 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 138 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 125 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 87 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 137 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 124 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 87 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 137 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 124 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 87 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 124 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 87 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 124 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 87 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,28 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,2 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 99,28 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 99,2 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 99,2 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 99,2 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 9 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 8 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 43 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 9 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 8 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 43 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 9 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 8 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 43 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 8 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 43 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 8 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 43 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 139 33 Asturias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 131 33 Asturias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 130 33 Asturias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 139 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 131 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 130 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 131 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 130 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 131 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 130 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 130 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 129 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 33 Asturias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 33 Asturias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 33 Asturias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 99,24 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 99,23 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 131 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 122 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 88 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 131 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 122 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 88 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 122 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 88 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 122 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 88 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 121 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 87 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 99,18 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,86 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 8 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 9 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 42 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 8 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 9 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 42 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 9 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 42 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 9 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 42 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 9 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 42 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 33 Asturias De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 62 33 Asturias De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 33 Asturias De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 62 33 Asturias De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 33 Asturias De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 66 33 Asturias De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 62 33 Asturias De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 62 33 Asturias De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 65 33 Asturias De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 62 33 Asturias De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 62 33 Asturias De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 65 33 Asturias De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 62 33 Asturias De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 61 33 Asturias De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 65 33 Asturias De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 61 33 Asturias De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 61 33 Asturias De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 65 33 Asturias De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 33 Asturias De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 33 Asturias De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 33 Asturias De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 33 Asturias De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 33 Asturias De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 33 Asturias De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 33 Asturias De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,48 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,48 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,39 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,48 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,39 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,39 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,48 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 33 Asturias De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 58 33 Asturias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 36 33 Asturias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 58 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 36 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 58 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 36 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 58 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 35 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 57 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 35 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 33 Asturias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 33 Asturias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,22 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,28 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,22 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 4 33 Asturias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 26 33 Asturias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 4 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 26 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 4 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 26 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 4 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 26 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 4 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 26 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 33 Asturias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 33 Asturias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 64 33 Asturias De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 33 Asturias De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 62 33 Asturias De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 33 Asturias De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 62 33 Asturias De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 64 33 Asturias De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 62 33 Asturias De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 62 33 Asturias De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 64 33 Asturias De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 61 33 Asturias De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 62 33 Asturias De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 63 33 Asturias De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 61 33 Asturias De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 62 33 Asturias De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 61 33 Asturias De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 62 33 Asturias De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 33 Asturias De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 33 Asturias De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 33 Asturias De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 33 Asturias De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 33 Asturias De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 33 Asturias De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 33 Asturias De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,39 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,44 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,39 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,39 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 33 Asturias De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 59 33 Asturias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 39 33 Asturias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 44 33 Asturias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 59 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 39 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 44 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 59 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 38 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 44 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 58 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 38 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 44 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 38 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 44 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 33 Asturias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 33 Asturias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 33 Asturias De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,44 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,31 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,44 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,44 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 5 33 Asturias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 23 33 Asturias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 18 33 Asturias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 5 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 23 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 18 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 5 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 23 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 18 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 5 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 23 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 18 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 23 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 18 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 33 Asturias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 33 Asturias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 33 Asturias De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 62 33 Asturias De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 33 Asturias De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 33 Asturias De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 61 33 Asturias De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 33 Asturias De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 33 Asturias De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 57 33 Asturias De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 33 Asturias De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 62 33 Asturias De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 60 33 Asturias De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 57 33 Asturias De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 61 33 Asturias De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 60 33 Asturias De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 57 33 Asturias De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 60 33 Asturias De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 57 33 Asturias De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 60 33 Asturias De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 57 33 Asturias De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 33 Asturias De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 33 Asturias De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 33 Asturias De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 33 Asturias De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 33 Asturias De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 33 Asturias De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 33 Asturias De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 33 Asturias De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 33 Asturias De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 33 Asturias De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 33 Asturias De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 33 Asturias De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 33 Asturias De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,36 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,39 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,36 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,36 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,36 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 33 Asturias De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 58 33 Asturias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 55 33 Asturias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 41 33 Asturias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 58 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 54 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 41 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 57 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 54 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 41 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 54 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 41 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 54 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 41 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 33 Asturias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 33 Asturias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 33 Asturias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,18 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,28 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,18 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,18 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,18 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 4 33 Asturias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 6 33 Asturias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 16 33 Asturias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 4 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 6 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 16 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 4 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 6 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 16 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 6 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 16 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 6 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 16 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 33 Asturias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 33 Asturias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 33 Asturias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 67 33 Asturias De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 33 Asturias De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 33 Asturias De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 62 33 Asturias De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 33 Asturias De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 33 Asturias De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 61 33 Asturias De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 33 Asturias De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 66 33 Asturias De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 62 33 Asturias De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 61 33 Asturias De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 62 33 Asturias De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 61 33 Asturias De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 62 33 Asturias De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 61 33 Asturias De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 62 33 Asturias De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 60 33 Asturias De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 33 Asturias De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 33 Asturias De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 33 Asturias De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 33 Asturias De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 33 Asturias De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 33 Asturias De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 33 Asturias De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 33 Asturias De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 33 Asturias De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 33 Asturias De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 33 Asturias De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 33 Asturias De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,51 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,36 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 33 Asturias De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 63 33 Asturias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 56 33 Asturias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 35 33 Asturias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 62 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 56 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 35 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 56 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 35 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 56 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 35 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 56 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 34 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 33 Asturias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 33 Asturias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 33 Asturias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,41 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,14 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 4 33 Asturias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 6 33 Asturias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 26 33 Asturias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 4 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 6 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 26 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 6 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 26 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 6 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 26 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 6 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 26 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 33 Asturias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 33 Asturias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 33 Asturias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 33 Asturias De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 05 Ávila Total Cohort January 1 Total Number at the start of the quarter 2022QI 3.691 05 Ávila Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 05 Ávila Total Cohort January 1 Total Number at the start of the quarter 2021QI 3.578 05 Ávila Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 05 Ávila Total Cohort January 1 Total Number at the start of the quarter 2020QI 3.807 05 Ávila Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 05 Ávila Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 05 Ávila Total Cohort January 1 Total Survival in the first trimester 2022QII "" 05 Ávila Total Cohort January 1 Total Survival in the first trimester 2022QI 3.531 05 Ávila Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 05 Ávila Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 05 Ávila Total Cohort January 1 Total Survival in the first trimester 2021QII "" 05 Ávila Total Cohort January 1 Total Survival in the first trimester 2021QI 3.408 05 Ávila Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 05 Ávila Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 05 Ávila Total Cohort January 1 Total Survival in the first trimester 2020QII "" 05 Ávila Total Cohort January 1 Total Survival in the first trimester 2020QI 3.379 05 Ávila Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 05 Ávila Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 05 Ávila Total Cohort January 1 Total Survival in the second trimester 2022QII 3.410 05 Ávila Total Cohort January 1 Total Survival in the second trimester 2022QI "" 05 Ávila Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 05 Ávila Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 05 Ávila Total Cohort January 1 Total Survival in the second trimester 2021QII 3.317 05 Ávila Total Cohort January 1 Total Survival in the second trimester 2021QI "" 05 Ávila Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 05 Ávila Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 05 Ávila Total Cohort January 1 Total Survival in the second trimester 2020QII 3.278 05 Ávila Total Cohort January 1 Total Survival in the second trimester 2020QI "" 05 Ávila Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 05 Ávila Total Cohort January 1 Total Survival in the third trimester 2022QIII 3.317 05 Ávila Total Cohort January 1 Total Survival in the third trimester 2022QII "" 05 Ávila Total Cohort January 1 Total Survival in the third trimester 2022QI "" 05 Ávila Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 05 Ávila Total Cohort January 1 Total Survival in the third trimester 2021QIII 3.236 05 Ávila Total Cohort January 1 Total Survival in the third trimester 2021QII "" 05 Ávila Total Cohort January 1 Total Survival in the third trimester 2021QI "" 05 Ávila Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 05 Ávila Total Cohort January 1 Total Survival in the third trimester 2020QIII 3.183 05 Ávila Total Cohort January 1 Total Survival in the third trimester 2020QII "" 05 Ávila Total Cohort January 1 Total Survival in the third trimester 2020QI "" 05 Ávila Total Cohort January 1 Total Survival in the third trimester 2022QIV 3.239 05 Ávila Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 05 Ávila Total Cohort January 1 Total Survival in the third trimester 2022QII "" 05 Ávila Total Cohort January 1 Total Survival in the third trimester 2022QI "" 05 Ávila Total Cohort January 1 Total Survival in the third trimester 2021QIV 3.146 05 Ávila Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 05 Ávila Total Cohort January 1 Total Survival in the third trimester 2021QII "" 05 Ávila Total Cohort January 1 Total Survival in the third trimester 2021QI "" 05 Ávila Total Cohort January 1 Total Survival in the third trimester 2020QIV 3.096 05 Ávila Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 05 Ávila Total Cohort January 1 Total Survival in the third trimester 2020QII "" 05 Ávila Total Cohort January 1 Total Survival in the third trimester 2020QI "" 05 Ávila Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 05 Ávila Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 05 Ávila Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 05 Ávila Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 05 Ávila Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 05 Ávila Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 05 Ávila Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,67 05 Ávila Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,25 05 Ávila Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 88,76 05 Ávila Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 92,39 05 Ávila Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 92,71 05 Ávila Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 86,1 05 Ávila Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 89,87 05 Ávila Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 90,44 05 Ávila Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 83,61 05 Ávila Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 87,75 05 Ávila Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 87,93 05 Ávila Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 81,32 05 Ávila Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Ávila Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Ávila Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 3.561 05 Ávila Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 3.240 05 Ávila Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 3.405 05 Ávila Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 3.077 05 Ávila Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 3.287 05 Ávila Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.996 05 Ávila Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 3.201 05 Ávila Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.920 05 Ávila Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 3.123 05 Ávila Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2.835 05 Ávila Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 05 Ávila Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 05 Ávila Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 95,62 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,97 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 92,31 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 92,47 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 89,89 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 90,12 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 87,7 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 87,5 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 130 05 Ávila Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 338 05 Ávila Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 126 05 Ávila Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 331 05 Ávila Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 123 05 Ávila Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 321 05 Ávila Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 116 05 Ávila Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 316 05 Ávila Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 116 05 Ávila Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 311 05 Ávila Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 05 Ávila Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 05 Ávila Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,92 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,93 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 94,62 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,97 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 89,23 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 93,49 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 89,23 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 92,01 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila Total Cohort April 1 Total Number at the start of the quarter 2022QII 3.708 05 Ávila Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 05 Ávila Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila Total Cohort April 1 Total Number at the start of the quarter 2021QII 3.595 05 Ávila Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 05 Ávila Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila Total Cohort April 1 Total Number at the start of the quarter 2020QII 3.517 05 Ávila Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 05 Ávila Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 05 Ávila Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 05 Ávila Total Cohort April 1 Total Survival in the first trimester 2022QII 3.557 05 Ávila Total Cohort April 1 Total Survival in the first trimester 2022QI "" 05 Ávila Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 05 Ávila Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 05 Ávila Total Cohort April 1 Total Survival in the first trimester 2021QII 3.478 05 Ávila Total Cohort April 1 Total Survival in the first trimester 2021QI "" 05 Ávila Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 05 Ávila Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 05 Ávila Total Cohort April 1 Total Survival in the first trimester 2020QII 3.396 05 Ávila Total Cohort April 1 Total Survival in the first trimester 2020QI "" 05 Ávila Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 05 Ávila Total Cohort April 1 Total Survival in the second trimester 2022QIII 3.433 05 Ávila Total Cohort April 1 Total Survival in the second trimester 2022QII "" 05 Ávila Total Cohort April 1 Total Survival in the second trimester 2022QI "" 05 Ávila Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 05 Ávila Total Cohort April 1 Total Survival in the second trimester 2021QIII 3.362 05 Ávila Total Cohort April 1 Total Survival in the second trimester 2021QII "" 05 Ávila Total Cohort April 1 Total Survival in the second trimester 2021QI "" 05 Ávila Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 05 Ávila Total Cohort April 1 Total Survival in the second trimester 2020QIII 3.287 05 Ávila Total Cohort April 1 Total Survival in the second trimester 2020QII "" 05 Ávila Total Cohort April 1 Total Survival in the second trimester 2020QI "" 05 Ávila Total Cohort April 1 Total Survival in the third trimester 2022QIV 3.337 05 Ávila Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 05 Ávila Total Cohort April 1 Total Survival in the third trimester 2022QII "" 05 Ávila Total Cohort April 1 Total Survival in the third trimester 2022QI "" 05 Ávila Total Cohort April 1 Total Survival in the third trimester 2021QIV 3.254 05 Ávila Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 05 Ávila Total Cohort April 1 Total Survival in the third trimester 2021QII "" 05 Ávila Total Cohort April 1 Total Survival in the third trimester 2021QI "" 05 Ávila Total Cohort April 1 Total Survival in the third trimester 2020QIV 3.188 05 Ávila Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 05 Ávila Total Cohort April 1 Total Survival in the third trimester 2020QII "" 05 Ávila Total Cohort April 1 Total Survival in the third trimester 2020QI "" 05 Ávila Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 05 Ávila Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 05 Ávila Total Cohort April 1 Total Survival in the third trimester 2022QII "" 05 Ávila Total Cohort April 1 Total Survival in the third trimester 2022QI 3.166 05 Ávila Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 05 Ávila Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 05 Ávila Total Cohort April 1 Total Survival in the third trimester 2021QII "" 05 Ávila Total Cohort April 1 Total Survival in the third trimester 2021QI 3.076 05 Ávila Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 05 Ávila Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 05 Ávila Total Cohort April 1 Total Survival in the third trimester 2020QII "" 05 Ávila Total Cohort April 1 Total Survival in the third trimester 2020QI "" 05 Ávila Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 05 Ávila Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 05 Ávila Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 05 Ávila Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 05 Ávila Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 05 Ávila Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,93 05 Ávila Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,75 05 Ávila Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,56 05 Ávila Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 92,58 05 Ávila Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 93,52 05 Ávila Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,46 05 Ávila Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 89,99 05 Ávila Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 90,51 05 Ávila Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,65 05 Ávila Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 88,07 05 Ávila Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87,46 05 Ávila Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Ávila Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Ávila Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 3.589 05 Ávila Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 3.241 05 Ávila Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2.828 05 Ávila Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 3.443 05 Ávila Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 3.134 05 Ávila Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2.713 05 Ávila Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 3.324 05 Ávila Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 3.023 05 Ávila Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2.615 05 Ávila Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 3.229 05 Ávila Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.922 05 Ávila Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.532 05 Ávila Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.838 05 Ávila Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.437 05 Ávila Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 05 Ávila Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 05 Ávila Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 05 Ávila Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,93 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 96,7 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,93 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 92,62 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 93,27 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,47 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 89,97 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 90,16 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 89,53 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 87,57 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 86,17 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 119 05 Ávila Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 354 05 Ávila Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 689 05 Ávila Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 114 05 Ávila Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 344 05 Ávila Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 683 05 Ávila Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 109 05 Ávila Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 339 05 Ávila Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 672 05 Ávila Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 108 05 Ávila Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 332 05 Ávila Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 656 05 Ávila Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 328 05 Ávila Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 639 05 Ávila Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 05 Ávila Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 05 Ávila Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 05 Ávila Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,8 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,18 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,13 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,6 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,76 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,53 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 90,76 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,79 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,21 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 92,66 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 92,74 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila Total Cohort July 1 Total Number at the start of the quarter 2022QIII 3.836 05 Ávila Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 05 Ávila Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 05 Ávila Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila Total Cohort July 1 Total Number at the start of the quarter 2021QIII 3.782 05 Ávila Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 05 Ávila Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 05 Ávila Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila Total Cohort July 1 Total Number at the start of the quarter 2020QIII 3.646 05 Ávila Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 05 Ávila Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 05 Ávila Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 05 Ávila Total Cohort July 1 Total Survival in the first trimester 2022QIII 3.612 05 Ávila Total Cohort July 1 Total Survival in the first trimester 2022QII "" 05 Ávila Total Cohort July 1 Total Survival in the first trimester 2022QI "" 05 Ávila Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 05 Ávila Total Cohort July 1 Total Survival in the first trimester 2021QIII 3.545 05 Ávila Total Cohort July 1 Total Survival in the first trimester 2021QII "" 05 Ávila Total Cohort July 1 Total Survival in the first trimester 2021QI "" 05 Ávila Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 05 Ávila Total Cohort July 1 Total Survival in the first trimester 2020QIII 3.467 05 Ávila Total Cohort July 1 Total Survival in the first trimester 2020QII "" 05 Ávila Total Cohort July 1 Total Survival in the first trimester 2020QI "" 05 Ávila Total Cohort July 1 Total Survival in the second trimester 2022QIV 3.476 05 Ávila Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 05 Ávila Total Cohort July 1 Total Survival in the second trimester 2022QII "" 05 Ávila Total Cohort July 1 Total Survival in the second trimester 2022QI "" 05 Ávila Total Cohort July 1 Total Survival in the second trimester 2021QIV 3.393 05 Ávila Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 05 Ávila Total Cohort July 1 Total Survival in the second trimester 2021QII "" 05 Ávila Total Cohort July 1 Total Survival in the second trimester 2021QI "" 05 Ávila Total Cohort July 1 Total Survival in the second trimester 2020QIV 3.323 05 Ávila Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 05 Ávila Total Cohort July 1 Total Survival in the second trimester 2020QII "" 05 Ávila Total Cohort July 1 Total Survival in the second trimester 2020QI "" 05 Ávila Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 05 Ávila Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 05 Ávila Total Cohort July 1 Total Survival in the third trimester 2022QII "" 05 Ávila Total Cohort July 1 Total Survival in the third trimester 2022QI 3.288 05 Ávila Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 05 Ávila Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 05 Ávila Total Cohort July 1 Total Survival in the third trimester 2021QII "" 05 Ávila Total Cohort July 1 Total Survival in the third trimester 2021QI 3.195 05 Ávila Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 05 Ávila Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 05 Ávila Total Cohort July 1 Total Survival in the third trimester 2020QII "" 05 Ávila Total Cohort July 1 Total Survival in the third trimester 2020QI "" 05 Ávila Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 05 Ávila Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 05 Ávila Total Cohort July 1 Total Survival in the third trimester 2022QII 3.204 05 Ávila Total Cohort July 1 Total Survival in the third trimester 2022QI "" 05 Ávila Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 05 Ávila Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 05 Ávila Total Cohort July 1 Total Survival in the third trimester 2021QII 3.137 05 Ávila Total Cohort July 1 Total Survival in the third trimester 2021QI "" 05 Ávila Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 05 Ávila Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 05 Ávila Total Cohort July 1 Total Survival in the third trimester 2020QII "" 05 Ávila Total Cohort July 1 Total Survival in the third trimester 2020QI "" 05 Ávila Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 05 Ávila Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 05 Ávila Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 05 Ávila Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 05 Ávila Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 05 Ávila Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 05 Ávila Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 05 Ávila Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 05 Ávila Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,16 05 Ávila Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,73 05 Ávila Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,09 05 Ávila Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 90,62 05 Ávila Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,71 05 Ávila Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 91,14 05 Ávila Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 86,94 05 Ávila Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 87,63 05 Ávila Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 84,72 05 Ávila Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 86,04 05 Ávila Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Ávila Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Ávila Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 3.740 05 Ávila Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 3.694 05 Ávila Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 3.114 05 Ávila Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 3.520 05 Ávila Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 3.460 05 Ávila Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.944 05 Ávila Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 3.385 05 Ávila Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 3.311 05 Ávila Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.815 05 Ávila Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 3.208 05 Ávila Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.701 05 Ávila Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 3.126 05 Ávila Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.653 05 Ávila Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 05 Ávila Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 05 Ávila Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 05 Ávila Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,12 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,67 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,54 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 90,51 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,63 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,4 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 86,84 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,74 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 84,62 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 85,2 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 96 05 Ávila Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 88 05 Ávila Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 532 05 Ávila Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 92 05 Ávila Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 85 05 Ávila Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 523 05 Ávila Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 91 05 Ávila Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 82 05 Ávila Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 508 05 Ávila Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 80 05 Ávila Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 494 05 Ávila Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 78 05 Ávila Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 484 05 Ávila Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 05 Ávila Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 05 Ávila Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 05 Ávila Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,83 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,59 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,31 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,79 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,18 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,49 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 90,91 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 92,86 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 88,64 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 90,98 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila Total Cohort October 1 Total Number at the start of the quarter 2022QIV 3.747 05 Ávila Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 05 Ávila Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 05 Ávila Total Cohort October 1 Total Number at the start of the quarter 2021QIV 3.718 05 Ávila Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 05 Ávila Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 05 Ávila Total Cohort October 1 Total Number at the start of the quarter 2020QIV 3.666 05 Ávila Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 05 Ávila Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 05 Ávila Total Cohort October 1 Total Survival in the first trimester 2022QIV 3.587 05 Ávila Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 05 Ávila Total Cohort October 1 Total Survival in the first trimester 2022QII "" 05 Ávila Total Cohort October 1 Total Survival in the first trimester 2022QI "" 05 Ávila Total Cohort October 1 Total Survival in the first trimester 2021QIV 3.514 05 Ávila Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 05 Ávila Total Cohort October 1 Total Survival in the first trimester 2021QII "" 05 Ávila Total Cohort October 1 Total Survival in the first trimester 2021QI "" 05 Ávila Total Cohort October 1 Total Survival in the first trimester 2020QIV 3.456 05 Ávila Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 05 Ávila Total Cohort October 1 Total Survival in the first trimester 2020QII "" 05 Ávila Total Cohort October 1 Total Survival in the first trimester 2020QI "" 05 Ávila Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 05 Ávila Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 05 Ávila Total Cohort October 1 Total Survival in the second trimester 2022QII "" 05 Ávila Total Cohort October 1 Total Survival in the second trimester 2022QI 3.386 05 Ávila Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 05 Ávila Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 05 Ávila Total Cohort October 1 Total Survival in the second trimester 2021QII "" 05 Ávila Total Cohort October 1 Total Survival in the second trimester 2021QI 3.317 05 Ávila Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 05 Ávila Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 05 Ávila Total Cohort October 1 Total Survival in the second trimester 2020QII "" 05 Ávila Total Cohort October 1 Total Survival in the second trimester 2020QI "" 05 Ávila Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 05 Ávila Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 05 Ávila Total Cohort October 1 Total Survival in the third trimester 2022QII 3.291 05 Ávila Total Cohort October 1 Total Survival in the third trimester 2022QI "" 05 Ávila Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 05 Ávila Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 05 Ávila Total Cohort October 1 Total Survival in the third trimester 2021QII 3.240 05 Ávila Total Cohort October 1 Total Survival in the third trimester 2021QI "" 05 Ávila Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 05 Ávila Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 05 Ávila Total Cohort October 1 Total Survival in the third trimester 2020QII "" 05 Ávila Total Cohort October 1 Total Survival in the third trimester 2020QI "" 05 Ávila Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 05 Ávila Total Cohort October 1 Total Survival in the third trimester 2022QIII 3.210 05 Ávila Total Cohort October 1 Total Survival in the third trimester 2022QII "" 05 Ávila Total Cohort October 1 Total Survival in the third trimester 2022QI "" 05 Ávila Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 05 Ávila Total Cohort October 1 Total Survival in the third trimester 2021QIII 3.167 05 Ávila Total Cohort October 1 Total Survival in the third trimester 2021QII "" 05 Ávila Total Cohort October 1 Total Survival in the third trimester 2021QI "" 05 Ávila Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 05 Ávila Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 05 Ávila Total Cohort October 1 Total Survival in the third trimester 2020QII "" 05 Ávila Total Cohort October 1 Total Survival in the third trimester 2020QI "" 05 Ávila Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 05 Ávila Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 05 Ávila Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 05 Ávila Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 05 Ávila Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 05 Ávila Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 05 Ávila Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 05 Ávila Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 05 Ávila Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,73 05 Ávila Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,51 05 Ávila Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,27 05 Ávila Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 91,07 05 Ávila Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,48 05 Ávila Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 88,52 05 Ávila Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 88,38 05 Ávila Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 86,34 05 Ávila Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 86,39 05 Ávila Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Ávila Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Ávila Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 3.661 05 Ávila Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3.576 05 Ávila Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 3.296 05 Ávila Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 3.502 05 Ávila Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 3.377 05 Ávila Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 3.098 05 Ávila Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 3.256 05 Ávila Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.966 05 Ávila Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 3.168 05 Ávila Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2.898 05 Ávila Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 3.091 05 Ávila Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.830 05 Ávila Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 05 Ávila Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 05 Ávila Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 05 Ávila Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95,66 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,44 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,99 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 91,05 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,99 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 88,59 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 87,92 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 86,44 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 85,86 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 86 05 Ávila Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 142 05 Ávila Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 370 05 Ávila Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 85 05 Ávila Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 137 05 Ávila Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 358 05 Ávila Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 130 05 Ávila Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 351 05 Ávila Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 123 05 Ávila Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 342 05 Ávila Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 119 05 Ávila Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 337 05 Ávila Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 05 Ávila Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 05 Ávila Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 05 Ávila Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,84 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,48 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,76 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91,55 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,86 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 86,62 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,43 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 83,8 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 91,08 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 05 Ávila From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 2.965 05 Ávila From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 05 Ávila From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 2.925 05 Ávila From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 3.063 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 2.811 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 2.763 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 2.656 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 2.697 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 2.677 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 2.564 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 2.609 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 2.598 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 2.479 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 2.534 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 2.514 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 2.400 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 05 Ávila From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 05 Ávila From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 05 Ávila From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 05 Ávila From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,81 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,46 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 86,71 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,96 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,52 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 83,71 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 87,99 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 88,82 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 80,93 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 85,46 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,95 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 78,35 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.865 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.717 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.715 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2.560 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.604 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.484 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.522 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.410 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.447 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2.330 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,76 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,22 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,89 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 91,42 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 88,03 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 88,7 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 85,41 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,76 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 208 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 96 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 203 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 93 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 193 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 87 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 188 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 87 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 184 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,6 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 92,79 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 87 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 90,38 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 87 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 88,46 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 2.966 05 Ávila From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 2.938 05 Ávila From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 2.852 05 Ávila From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 2.823 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 2.826 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 2.737 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 2.702 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 2.714 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 2.637 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 2.611 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 2.612 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 2.544 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 2.530 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 2.440 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 05 Ávila From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 05 Ávila From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 05 Ávila From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 05 Ávila From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,18 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,19 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,97 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 91,1 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,38 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,46 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 88,03 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 88,9 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,2 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 86,11 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,55 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.876 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.721 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2.390 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.737 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.619 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2.279 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.620 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.512 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2.188 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.530 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.417 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.109 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.339 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.019 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,17 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 96,25 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,36 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,1 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,32 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,55 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,97 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 88,83 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,24 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 85,96 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,48 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 90 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 217 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 462 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 86 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 207 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 458 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 82 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 202 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 449 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 81 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 195 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 435 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 191 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 421 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,56 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 95,39 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,13 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,11 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,09 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,19 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 90 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 89,86 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 94,16 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 88,02 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,13 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 3.045 05 Ávila From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 3.037 05 Ávila From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 2.954 05 Ávila From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 2.829 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 2.810 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 2.786 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 2.703 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 2.669 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 2.650 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 2.570 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 2.533 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 2.491 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 2.478 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 05 Ávila From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 05 Ávila From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 05 Ávila From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,91 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,53 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,31 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 88,77 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 87,88 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 89,71 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 84,62 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 85,75 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 82,02 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 83,89 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.972 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.977 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2.617 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.759 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.753 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.457 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.634 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.615 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.335 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.518 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.230 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.440 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.184 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,83 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,48 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,89 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 88,63 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 87,84 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,22 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 84,58 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 85,21 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 81,96 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 83,45 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 73 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 60 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 337 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 70 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 57 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 329 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 69 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 54 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 315 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 52 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 303 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 51 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 294 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,89 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 95 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,63 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,52 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 90 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,47 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 86,67 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 89,91 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 85 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 87,24 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 2.970 05 Ávila From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 3.002 05 Ávila From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 2.983 05 Ávila From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 2.819 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 2.808 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 2.780 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 2.685 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 2.651 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 2.597 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 2.580 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 2.520 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 2.511 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 05 Ávila From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 05 Ávila From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 05 Ávila From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,92 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,54 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,19 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,44 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 88,87 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 86,51 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 86,49 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 83,94 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 84,18 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.903 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.887 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2.756 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.753 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.698 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2.565 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.582 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.440 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.501 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2.377 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.427 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.313 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,83 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 93,45 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,07 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,44 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88,53 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 86,63 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,25 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 84,07 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 83,93 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 67 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 115 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 227 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 66 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 110 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 215 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 103 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 211 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 96 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 203 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 93 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 198 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,51 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,65 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 94,71 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 89,57 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 92,95 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 83,48 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 89,43 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 80,87 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 87,22 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 348 05 Ávila From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 306 05 Ávila From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 375 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 346 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 304 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 359 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 342 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 300 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 353 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 337 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 300 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 347 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 336 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 298 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 342 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 05 Ávila From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 05 Ávila From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,43 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,35 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 95,73 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,28 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,04 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 94,13 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,84 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,04 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 92,53 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,55 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,39 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 91,2 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 333 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 255 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 331 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 254 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 327 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 250 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 323 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 250 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 322 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 248 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,4 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,61 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,2 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,04 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,04 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,7 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,25 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 15 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 51 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 15 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 50 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 15 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 50 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 14 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 50 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 14 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 50 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,04 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,04 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 93,33 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,04 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 93,33 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,04 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 367 05 Ávila From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 325 05 Ávila From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 325 05 Ávila From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 363 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 322 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 321 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 360 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 320 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 316 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 356 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 318 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 311 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 315 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 307 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 05 Ávila From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 05 Ávila From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 05 Ávila From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,91 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,08 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,77 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,09 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,46 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,23 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,85 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,69 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,92 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,46 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 351 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 267 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 222 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 347 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 264 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 220 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 345 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 262 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 216 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 341 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 260 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 213 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 257 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 212 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,86 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,88 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,1 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,29 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,13 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,3 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,15 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,38 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,95 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,25 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,5 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 16 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 58 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 103 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 16 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 58 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 101 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 15 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 58 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 100 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 15 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 58 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 98 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 58 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 95 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,06 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,75 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,09 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 93,75 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,15 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 92,23 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 401 05 Ávila From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 367 05 Ávila From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 338 05 Ávila From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 394 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 359 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 331 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 389 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 353 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 325 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 350 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 318 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 347 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 315 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 05 Ávila From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 05 Ávila From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 05 Ávila From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,25 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 97,82 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 97,93 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,01 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 96,19 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 96,15 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,37 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 94,08 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 94,55 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 93,2 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 392 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 356 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 255 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 386 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 348 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 249 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 381 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 342 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 244 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 339 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 239 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 336 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 237 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,47 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 97,75 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 97,65 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,19 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 96,07 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 95,69 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,22 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 93,73 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,38 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 92,94 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 9 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 11 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 83 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 8 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 11 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 82 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 8 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 11 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 81 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 11 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 79 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 11 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 78 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 88,89 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,8 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 88,89 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,59 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95,18 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 93,98 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 391 05 Ávila From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 344 05 Ávila From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 325 05 Ávila From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 389 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 340 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 319 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 338 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 313 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 334 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 308 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 330 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 307 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 05 Ávila From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 05 Ávila From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 05 Ávila From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,49 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,84 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,15 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,26 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,31 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,09 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 94,77 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,93 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 94,46 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 384 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 331 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 269 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 382 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 327 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 263 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 325 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 259 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 321 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 255 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 318 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 254 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,48 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,79 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,77 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,19 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,28 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,98 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 94,8 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,07 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 94,42 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 7 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 13 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 56 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 7 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 13 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 56 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 13 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 54 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 13 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 53 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 12 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 53 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,43 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,64 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 92,31 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 94,64 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 05 Ávila From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 363 05 Ávila From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 05 Ávila From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 333 05 Ávila From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 355 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 359 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 327 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 350 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 356 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 326 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 347 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 356 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 324 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 343 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 354 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 320 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 340 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 05 Ávila From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 05 Ávila From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 05 Ávila From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 05 Ávila From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,9 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,2 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,59 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,07 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,9 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,75 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,07 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,3 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,62 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,52 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,1 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 95,77 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 349 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 258 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 345 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 253 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 342 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 252 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 342 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 250 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 340 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 247 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,85 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,06 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,99 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,67 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,99 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,9 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,42 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,74 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 14 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 75 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 14 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 74 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 14 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 74 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 14 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 74 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 14 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 73 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,67 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,67 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,67 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,33 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 363 05 Ávila From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 320 05 Ávila From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 327 05 Ávila From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 359 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 318 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 325 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 359 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 316 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 321 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 358 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 312 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 320 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 309 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 316 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 05 Ávila From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 05 Ávila From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 05 Ávila From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 05 Ávila From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,9 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,38 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,39 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,9 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,75 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,17 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,62 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,5 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,86 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,56 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,64 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 351 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 244 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 208 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 348 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 242 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 206 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 348 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 240 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 203 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 347 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 236 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 202 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 233 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 198 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,15 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,18 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,04 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 99,15 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,36 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,6 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,86 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,72 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,12 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,49 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,19 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 12 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 76 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 119 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 11 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 76 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 119 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 11 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 76 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 118 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 11 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 76 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 118 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 76 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 118 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 91,67 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,67 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,16 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,67 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 99,16 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 99,16 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 377 05 Ávila From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 365 05 Ávila From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 342 05 Ávila From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 376 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 363 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 338 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 371 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 358 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 336 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 355 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 332 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 353 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 332 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 05 Ávila From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 05 Ávila From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 05 Ávila From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,73 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,45 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,83 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,41 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,08 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,25 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,26 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,08 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,71 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,08 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 364 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 348 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 233 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 363 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 346 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 229 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 358 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 341 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 227 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 338 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 223 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 337 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 223 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,73 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,43 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,28 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,35 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,99 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,42 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,13 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,71 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,84 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,71 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 13 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 17 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 109 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 13 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 17 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 109 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 13 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 17 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 109 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 17 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 109 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 16 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 109 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 94,12 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 371 05 Ávila From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 359 05 Ávila From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 346 05 Ávila From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 364 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 353 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 345 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 350 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 341 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 347 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 340 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 347 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 337 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 05 Ávila From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 05 Ávila From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 05 Ávila From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,11 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,33 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,71 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,49 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,55 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,66 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,27 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,66 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,4 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 360 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 345 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 262 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 353 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 339 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 261 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 336 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 258 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 333 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 257 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 333 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 254 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,06 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,26 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,62 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,39 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,47 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,52 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,09 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,52 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,95 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 11 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 14 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 84 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 11 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 14 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 84 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 14 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 83 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 14 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 83 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 14 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 83 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,81 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,81 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,81 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 05 Ávila from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 11 05 Ávila from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 05 Ávila from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 10 05 Ávila from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 11 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 11 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 10 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 11 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 11 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 10 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 11 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 11 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 10 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 11 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 11 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 10 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 11 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 05 Ávila from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 05 Ávila from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 05 Ávila from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 05 Ávila from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 10 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 7 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 10 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 7 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 10 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 7 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 10 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 7 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 10 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 7 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 3 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 3 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 3 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 3 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 3 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 8 05 Ávila from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 8 05 Ávila from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 10 05 Ávila from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 8 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 8 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 10 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 8 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 8 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 10 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 8 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 8 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 10 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 8 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 10 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 05 Ávila from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 05 Ávila from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 05 Ávila from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 05 Ávila from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Ávila from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 7 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 6 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 6 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 7 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 6 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 6 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 7 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 6 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 6 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 7 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 6 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 6 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 6 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 6 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 2 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 4 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 2 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 4 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 2 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 4 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 2 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 4 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 2 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 4 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 9 05 Ávila from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 10 05 Ávila from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 10 05 Ávila from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 9 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 10 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 10 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 9 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 10 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 10 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 10 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 10 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 10 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 10 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 05 Ávila from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 05 Ávila from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 05 Ávila from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 8 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 10 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 7 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 8 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 10 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 7 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 8 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 10 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 7 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 10 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 7 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 10 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 7 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 0 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 3 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 0 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 3 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 0 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 3 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 0 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 3 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 0 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 3 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII .. 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII .. 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV .. 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI .. 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII .. 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 12 05 Ávila from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 10 05 Ávila from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 9 05 Ávila from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 12 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 10 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 9 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 10 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 9 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 10 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 9 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 10 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 9 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 05 Ávila from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 05 Ávila from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 05 Ávila from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 11 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 10 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 7 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 11 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 10 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 7 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 10 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 7 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 10 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 7 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 10 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 7 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 0 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 2 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 0 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 0 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 0 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 0 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV .. 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV .. 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI .. 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII .. 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII .. 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 05 Ávila De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 4 05 Ávila De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 05 Ávila De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 4 05 Ávila De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 05 Ávila De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 3 05 Ávila De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 4 05 Ávila De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 4 05 Ávila De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 3 05 Ávila De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 4 05 Ávila De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 4 05 Ávila De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 3 05 Ávila De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 4 05 Ávila De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 4 05 Ávila De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 3 05 Ávila De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 4 05 Ávila De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 4 05 Ávila De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 3 05 Ávila De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 05 Ávila De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 05 Ávila De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 05 Ávila De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 05 Ávila De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 05 Ávila De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 05 Ávila De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 05 Ávila De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Ávila De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 4 05 Ávila De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 3 05 Ávila De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 4 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 3 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 4 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 3 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 4 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 3 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 4 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 3 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 05 Ávila De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 05 Ávila De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 0 05 Ávila De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1 05 Ávila De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 0 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 0 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 0 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 0 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI .. 05 Ávila De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 05 Ávila De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI .. 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII .. 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII .. 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 0 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 4 05 Ávila De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 05 Ávila De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 4 05 Ávila De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 05 Ávila De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 3 05 Ávila De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 4 05 Ávila De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 4 05 Ávila De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 3 05 Ávila De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 4 05 Ávila De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 4 05 Ávila De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 3 05 Ávila De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 4 05 Ávila De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 4 05 Ávila De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 3 05 Ávila De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 4 05 Ávila De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 3 05 Ávila De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 05 Ávila De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 05 Ávila De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 05 Ávila De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 05 Ávila De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 05 Ávila De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 05 Ávila De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 05 Ávila De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Ávila De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 4 05 Ávila De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 3 05 Ávila De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2 05 Ávila De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 4 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 3 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 4 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 3 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 4 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 3 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 3 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 05 Ávila De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 05 Ávila De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 05 Ávila De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 0 05 Ávila De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1 05 Ávila De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1 05 Ávila De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 0 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 0 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 0 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII .. 05 Ávila De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 05 Ávila De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 05 Ávila De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII .. 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII .. 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 0 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 4 05 Ávila De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 05 Ávila De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 05 Ávila De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 3 05 Ávila De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 05 Ávila De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 05 Ávila De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 2 05 Ávila De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 05 Ávila De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 4 05 Ávila De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 3 05 Ávila De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 2 05 Ávila De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 4 05 Ávila De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 3 05 Ávila De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 2 05 Ávila De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 3 05 Ávila De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 2 05 Ávila De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 3 05 Ávila De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 2 05 Ávila De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 05 Ávila De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 05 Ávila De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 05 Ávila De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 05 Ávila De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 05 Ávila De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 05 Ávila De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 05 Ávila De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 05 Ávila De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 05 Ávila De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 05 Ávila De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 05 Ávila De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 05 Ávila De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 05 Ávila De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Ávila De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 4 05 Ávila De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 3 05 Ávila De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2 05 Ávila De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 4 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 3 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 4 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 3 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 3 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 3 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 05 Ávila De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 05 Ávila De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 05 Ávila De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 05 Ávila De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 0 05 Ávila De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 0 05 Ávila De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 0 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 0 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 0 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 0 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 0 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 0 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 0 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 0 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII .. 05 Ávila De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII .. 05 Ávila De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII .. 05 Ávila De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII .. 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII .. 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII .. 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV .. 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV .. 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI .. 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI .. 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII .. 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII .. 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 3 05 Ávila De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 05 Ávila De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 05 Ávila De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 3 05 Ávila De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 05 Ávila De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 05 Ávila De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 3 05 Ávila De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 05 Ávila De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 3 05 Ávila De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 3 05 Ávila De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 3 05 Ávila De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 3 05 Ávila De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 3 05 Ávila De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 3 05 Ávila De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 3 05 Ávila De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 3 05 Ávila De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 3 05 Ávila De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 05 Ávila De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 05 Ávila De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 05 Ávila De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 05 Ávila De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 05 Ávila De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 05 Ávila De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 05 Ávila De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 05 Ávila De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 05 Ávila De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 05 Ávila De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 05 Ávila De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 05 Ávila De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 05 Ávila De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 3 05 Ávila De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3 05 Ávila De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2 05 Ávila De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 3 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 3 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 3 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 3 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 3 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 05 Ávila De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 05 Ávila De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 05 Ávila De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 05 Ávila De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 0 05 Ávila De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1 05 Ávila De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 0 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 0 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 0 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 0 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 05 Ávila De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV .. 05 Ávila De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 05 Ávila De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV .. 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI .. 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII .. 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII .. 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 05 Ávila De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz Total Cohort January 1 Total Number at the start of the quarter 2022QI 14.795 06 Badajoz Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz Total Cohort January 1 Total Number at the start of the quarter 2021QI 14.290 06 Badajoz Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz Total Cohort January 1 Total Number at the start of the quarter 2020QI 14.865 06 Badajoz Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 06 Badajoz Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 06 Badajoz Total Cohort January 1 Total Survival in the first trimester 2022QII "" 06 Badajoz Total Cohort January 1 Total Survival in the first trimester 2022QI 13.768 06 Badajoz Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 06 Badajoz Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 06 Badajoz Total Cohort January 1 Total Survival in the first trimester 2021QII "" 06 Badajoz Total Cohort January 1 Total Survival in the first trimester 2021QI 13.301 06 Badajoz Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 06 Badajoz Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 06 Badajoz Total Cohort January 1 Total Survival in the first trimester 2020QII "" 06 Badajoz Total Cohort January 1 Total Survival in the first trimester 2020QI 12.562 06 Badajoz Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 06 Badajoz Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 06 Badajoz Total Cohort January 1 Total Survival in the second trimester 2022QII 13.120 06 Badajoz Total Cohort January 1 Total Survival in the second trimester 2022QI "" 06 Badajoz Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 06 Badajoz Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 06 Badajoz Total Cohort January 1 Total Survival in the second trimester 2021QII 12.765 06 Badajoz Total Cohort January 1 Total Survival in the second trimester 2021QI "" 06 Badajoz Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 06 Badajoz Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 06 Badajoz Total Cohort January 1 Total Survival in the second trimester 2020QII 12.124 06 Badajoz Total Cohort January 1 Total Survival in the second trimester 2020QI "" 06 Badajoz Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz Total Cohort January 1 Total Survival in the third trimester 2022QIII 12.637 06 Badajoz Total Cohort January 1 Total Survival in the third trimester 2022QII "" 06 Badajoz Total Cohort January 1 Total Survival in the third trimester 2022QI "" 06 Badajoz Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz Total Cohort January 1 Total Survival in the third trimester 2021QIII 12.320 06 Badajoz Total Cohort January 1 Total Survival in the third trimester 2021QII "" 06 Badajoz Total Cohort January 1 Total Survival in the third trimester 2021QI "" 06 Badajoz Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz Total Cohort January 1 Total Survival in the third trimester 2020QIII 11.789 06 Badajoz Total Cohort January 1 Total Survival in the third trimester 2020QII "" 06 Badajoz Total Cohort January 1 Total Survival in the third trimester 2020QI "" 06 Badajoz Total Cohort January 1 Total Survival in the third trimester 2022QIV 12.282 06 Badajoz Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz Total Cohort January 1 Total Survival in the third trimester 2022QII "" 06 Badajoz Total Cohort January 1 Total Survival in the third trimester 2022QI "" 06 Badajoz Total Cohort January 1 Total Survival in the third trimester 2021QIV 11.982 06 Badajoz Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz Total Cohort January 1 Total Survival in the third trimester 2021QII "" 06 Badajoz Total Cohort January 1 Total Survival in the third trimester 2021QI "" 06 Badajoz Total Cohort January 1 Total Survival in the third trimester 2020QIV 11.438 06 Badajoz Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz Total Cohort January 1 Total Survival in the third trimester 2020QII "" 06 Badajoz Total Cohort January 1 Total Survival in the third trimester 2020QI "" 06 Badajoz Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 06 Badajoz Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 06 Badajoz Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,06 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,08 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 84,51 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,68 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 89,33 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 81,56 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 85,41 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 86,21 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 79,31 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 83,01 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 83,85 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 76,95 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 14.327 06 Badajoz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 13.260 06 Badajoz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 13.318 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 12.296 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 12.683 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 11.779 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 12.214 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 11.354 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 11.864 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 11.032 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 06 Badajoz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 06 Badajoz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,96 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 92,73 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,53 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 88,83 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 85,25 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 85,63 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 82,81 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 83,2 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 468 06 Badajoz Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.030 06 Badajoz Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 450 06 Badajoz Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.005 06 Badajoz Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 437 06 Badajoz Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 986 06 Badajoz Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 423 06 Badajoz Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 966 06 Badajoz Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 418 06 Badajoz Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 950 06 Badajoz Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 06 Badajoz Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 06 Badajoz Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,15 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,57 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,38 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,73 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,38 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 93,79 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 89,32 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 92,23 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz Total Cohort April 1 Total Number at the start of the quarter 2022QII 14.699 06 Badajoz Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz Total Cohort April 1 Total Number at the start of the quarter 2021QII 14.201 06 Badajoz Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz Total Cohort April 1 Total Number at the start of the quarter 2020QII 13.258 06 Badajoz Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 06 Badajoz Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 06 Badajoz Total Cohort April 1 Total Survival in the first trimester 2022QII 13.866 06 Badajoz Total Cohort April 1 Total Survival in the first trimester 2022QI "" 06 Badajoz Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 06 Badajoz Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 06 Badajoz Total Cohort April 1 Total Survival in the first trimester 2021QII 13.464 06 Badajoz Total Cohort April 1 Total Survival in the first trimester 2021QI "" 06 Badajoz Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 06 Badajoz Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 06 Badajoz Total Cohort April 1 Total Survival in the first trimester 2020QII 12.694 06 Badajoz Total Cohort April 1 Total Survival in the first trimester 2020QI "" 06 Badajoz Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 06 Badajoz Total Cohort April 1 Total Survival in the second trimester 2022QIII 13.272 06 Badajoz Total Cohort April 1 Total Survival in the second trimester 2022QII "" 06 Badajoz Total Cohort April 1 Total Survival in the second trimester 2022QI "" 06 Badajoz Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 06 Badajoz Total Cohort April 1 Total Survival in the second trimester 2021QIII 12.882 06 Badajoz Total Cohort April 1 Total Survival in the second trimester 2021QII "" 06 Badajoz Total Cohort April 1 Total Survival in the second trimester 2021QI "" 06 Badajoz Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 06 Badajoz Total Cohort April 1 Total Survival in the second trimester 2020QIII 12.280 06 Badajoz Total Cohort April 1 Total Survival in the second trimester 2020QII "" 06 Badajoz Total Cohort April 1 Total Survival in the second trimester 2020QI "" 06 Badajoz Total Cohort April 1 Total Survival in the third trimester 2022QIV 12.844 06 Badajoz Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz Total Cohort April 1 Total Survival in the third trimester 2022QII "" 06 Badajoz Total Cohort April 1 Total Survival in the third trimester 2022QI "" 06 Badajoz Total Cohort April 1 Total Survival in the third trimester 2021QIV 12.460 06 Badajoz Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz Total Cohort April 1 Total Survival in the third trimester 2021QII "" 06 Badajoz Total Cohort April 1 Total Survival in the third trimester 2021QI "" 06 Badajoz Total Cohort April 1 Total Survival in the third trimester 2020QIV 11.867 06 Badajoz Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz Total Cohort April 1 Total Survival in the third trimester 2020QII "" 06 Badajoz Total Cohort April 1 Total Survival in the third trimester 2020QI "" 06 Badajoz Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz Total Cohort April 1 Total Survival in the third trimester 2022QII "" 06 Badajoz Total Cohort April 1 Total Survival in the third trimester 2022QI 11.925 06 Badajoz Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz Total Cohort April 1 Total Survival in the third trimester 2021QII "" 06 Badajoz Total Cohort April 1 Total Survival in the third trimester 2021QI 11.393 06 Badajoz Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz Total Cohort April 1 Total Survival in the third trimester 2020QII "" 06 Badajoz Total Cohort April 1 Total Survival in the third trimester 2020QI "" 06 Badajoz Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 06 Badajoz Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 06 Badajoz Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 06 Badajoz Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,33 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,81 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,75 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,29 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,71 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,62 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,38 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 87,74 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,51 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 83,97 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,93 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 14.258 06 Badajoz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 13.391 06 Badajoz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 11.078 06 Badajoz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 13.441 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 12.678 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 10.544 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 12.868 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 12.115 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 10.170 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 12.448 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 11.705 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 9.807 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 11.192 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 9.391 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 06 Badajoz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 06 Badajoz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 06 Badajoz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,27 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,68 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,18 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,25 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 90,47 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,8 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,31 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 87,41 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,53 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 83,58 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,77 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 441 06 Badajoz Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 810 06 Badajoz Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.180 06 Badajoz Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 425 06 Badajoz Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 786 06 Badajoz Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.150 06 Badajoz Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 404 06 Badajoz Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 767 06 Badajoz Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.110 06 Badajoz Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 396 06 Badajoz Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 755 06 Badajoz Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.060 06 Badajoz Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 733 06 Badajoz Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.002 06 Badajoz Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 06 Badajoz Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 06 Badajoz Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 06 Badajoz Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,37 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,04 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,62 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,61 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,69 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,79 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 89,8 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,21 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 94,5 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 90,49 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,83 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz Total Cohort July 1 Total Number at the start of the quarter 2022QIII 14.999 06 Badajoz Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz Total Cohort July 1 Total Number at the start of the quarter 2021QIII 14.562 06 Badajoz Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz Total Cohort July 1 Total Number at the start of the quarter 2020QIII 14.137 06 Badajoz Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 06 Badajoz Total Cohort July 1 Total Survival in the first trimester 2022QIII 14.099 06 Badajoz Total Cohort July 1 Total Survival in the first trimester 2022QII "" 06 Badajoz Total Cohort July 1 Total Survival in the first trimester 2022QI "" 06 Badajoz Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 06 Badajoz Total Cohort July 1 Total Survival in the first trimester 2021QIII 13.619 06 Badajoz Total Cohort July 1 Total Survival in the first trimester 2021QII "" 06 Badajoz Total Cohort July 1 Total Survival in the first trimester 2021QI "" 06 Badajoz Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 06 Badajoz Total Cohort July 1 Total Survival in the first trimester 2020QIII 13.395 06 Badajoz Total Cohort July 1 Total Survival in the first trimester 2020QII "" 06 Badajoz Total Cohort July 1 Total Survival in the first trimester 2020QI "" 06 Badajoz Total Cohort July 1 Total Survival in the second trimester 2022QIV 13.497 06 Badajoz Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 06 Badajoz Total Cohort July 1 Total Survival in the second trimester 2022QII "" 06 Badajoz Total Cohort July 1 Total Survival in the second trimester 2022QI "" 06 Badajoz Total Cohort July 1 Total Survival in the second trimester 2021QIV 13.030 06 Badajoz Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 06 Badajoz Total Cohort July 1 Total Survival in the second trimester 2021QII "" 06 Badajoz Total Cohort July 1 Total Survival in the second trimester 2021QI "" 06 Badajoz Total Cohort July 1 Total Survival in the second trimester 2020QIV 12.772 06 Badajoz Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 06 Badajoz Total Cohort July 1 Total Survival in the second trimester 2020QII "" 06 Badajoz Total Cohort July 1 Total Survival in the second trimester 2020QI "" 06 Badajoz Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz Total Cohort July 1 Total Survival in the third trimester 2022QII "" 06 Badajoz Total Cohort July 1 Total Survival in the third trimester 2022QI 12.432 06 Badajoz Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz Total Cohort July 1 Total Survival in the third trimester 2021QII "" 06 Badajoz Total Cohort July 1 Total Survival in the third trimester 2021QI 12.176 06 Badajoz Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz Total Cohort July 1 Total Survival in the third trimester 2020QII "" 06 Badajoz Total Cohort July 1 Total Survival in the third trimester 2020QI "" 06 Badajoz Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz Total Cohort July 1 Total Survival in the third trimester 2022QII 12.051 06 Badajoz Total Cohort July 1 Total Survival in the third trimester 2022QI "" 06 Badajoz Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz Total Cohort July 1 Total Survival in the third trimester 2021QII 11.847 06 Badajoz Total Cohort July 1 Total Survival in the third trimester 2021QI "" 06 Badajoz Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz Total Cohort July 1 Total Survival in the third trimester 2020QII "" 06 Badajoz Total Cohort July 1 Total Survival in the third trimester 2020QI "" 06 Badajoz Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 06 Badajoz Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 06 Badajoz Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 06 Badajoz Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,52 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,75 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,99 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,48 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,34 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 85,37 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,13 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 82,76 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 83,8 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 14.613 06 Badajoz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 14.245 06 Badajoz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 12.820 06 Badajoz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 13.733 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 13.312 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 12.105 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 13.137 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 12.727 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 11.508 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 12.138 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 10.945 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 11.763 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 10.633 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 06 Badajoz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 06 Badajoz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 06 Badajoz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,98 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,45 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,42 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,9 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,34 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,77 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 85,21 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 85,37 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 82,58 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 82,94 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 386 06 Badajoz Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 317 06 Badajoz Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.317 06 Badajoz Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 366 06 Badajoz Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 307 06 Badajoz Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.290 06 Badajoz Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 360 06 Badajoz Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 303 06 Badajoz Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.264 06 Badajoz Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 294 06 Badajoz Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.231 06 Badajoz Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 288 06 Badajoz Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.214 06 Badajoz Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 06 Badajoz Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 06 Badajoz Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 06 Badajoz Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 94,82 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,85 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,95 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,26 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,58 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,98 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 92,74 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,47 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 90,85 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,18 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz Total Cohort October 1 Total Number at the start of the quarter 2022QIV 15.173 06 Badajoz Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz Total Cohort October 1 Total Number at the start of the quarter 2021QIV 14.536 06 Badajoz Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz Total Cohort October 1 Total Number at the start of the quarter 2020QIV 14.377 06 Badajoz Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz Total Cohort October 1 Total Survival in the first trimester 2022QIV 14.342 06 Badajoz Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 06 Badajoz Total Cohort October 1 Total Survival in the first trimester 2022QII "" 06 Badajoz Total Cohort October 1 Total Survival in the first trimester 2022QI "" 06 Badajoz Total Cohort October 1 Total Survival in the first trimester 2021QIV 13.705 06 Badajoz Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 06 Badajoz Total Cohort October 1 Total Survival in the first trimester 2021QII "" 06 Badajoz Total Cohort October 1 Total Survival in the first trimester 2021QI "" 06 Badajoz Total Cohort October 1 Total Survival in the first trimester 2020QIV 13.474 06 Badajoz Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 06 Badajoz Total Cohort October 1 Total Survival in the first trimester 2020QII "" 06 Badajoz Total Cohort October 1 Total Survival in the first trimester 2020QI "" 06 Badajoz Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 06 Badajoz Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 06 Badajoz Total Cohort October 1 Total Survival in the second trimester 2022QII "" 06 Badajoz Total Cohort October 1 Total Survival in the second trimester 2022QI 12.972 06 Badajoz Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 06 Badajoz Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 06 Badajoz Total Cohort October 1 Total Survival in the second trimester 2021QII "" 06 Badajoz Total Cohort October 1 Total Survival in the second trimester 2021QI 12.752 06 Badajoz Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 06 Badajoz Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 06 Badajoz Total Cohort October 1 Total Survival in the second trimester 2020QII "" 06 Badajoz Total Cohort October 1 Total Survival in the second trimester 2020QI "" 06 Badajoz Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz Total Cohort October 1 Total Survival in the third trimester 2022QII 12.493 06 Badajoz Total Cohort October 1 Total Survival in the third trimester 2022QI "" 06 Badajoz Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz Total Cohort October 1 Total Survival in the third trimester 2021QII 12.327 06 Badajoz Total Cohort October 1 Total Survival in the third trimester 2021QI "" 06 Badajoz Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz Total Cohort October 1 Total Survival in the third trimester 2020QII "" 06 Badajoz Total Cohort October 1 Total Survival in the third trimester 2020QI "" 06 Badajoz Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz Total Cohort October 1 Total Survival in the third trimester 2022QIII 12.101 06 Badajoz Total Cohort October 1 Total Survival in the third trimester 2022QII "" 06 Badajoz Total Cohort October 1 Total Survival in the third trimester 2022QI "" 06 Badajoz Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz Total Cohort October 1 Total Survival in the third trimester 2021QIII 11.946 06 Badajoz Total Cohort October 1 Total Survival in the third trimester 2021QII "" 06 Badajoz Total Cohort October 1 Total Survival in the third trimester 2021QI "" 06 Badajoz Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz Total Cohort October 1 Total Survival in the third trimester 2020QII "" 06 Badajoz Total Cohort October 1 Total Survival in the third trimester 2020QI "" 06 Badajoz Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 06 Badajoz Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 06 Badajoz Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 06 Badajoz Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,52 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,28 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,72 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,24 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 88,7 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 85,95 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 85,74 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 83,25 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 83,09 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 14.817 06 Badajoz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 14.048 06 Badajoz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 13.069 06 Badajoz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 13.992 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 13.226 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 12.192 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 12.512 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 11.501 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 12.047 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 11.099 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 11.675 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 10.738 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 06 Badajoz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 06 Badajoz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 06 Badajoz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,43 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,15 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,29 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,07 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 85,76 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 84,93 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 83,11 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 82,16 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 356 06 Badajoz Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 488 06 Badajoz Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.308 06 Badajoz Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 350 06 Badajoz Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 479 06 Badajoz Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.282 06 Badajoz Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 460 06 Badajoz Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.251 06 Badajoz Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 446 06 Badajoz Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.228 06 Badajoz Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 426 06 Badajoz Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.208 06 Badajoz Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 06 Badajoz Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 06 Badajoz Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 06 Badajoz Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,31 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,16 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,01 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,26 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,64 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 91,39 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,88 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 87,3 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 92,35 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 11.547 06 Badajoz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 11.297 06 Badajoz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 11.687 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 10.570 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 10.368 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 9.502 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 9.983 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 9.871 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 9.100 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 9.538 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 9.457 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 8.795 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 9.214 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 9.139 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 8.478 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 06 Badajoz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 06 Badajoz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 91,54 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 91,78 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 81,3 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 86,46 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 87,38 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 77,86 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 82,6 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 83,71 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 75,25 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 79,8 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 80,9 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 72,54 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 11.241 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 10.753 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 10.280 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 9.842 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 9.703 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 9.360 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 9.271 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 8.957 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 8.951 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 8.652 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 91,45 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 91,53 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 86,32 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 87,05 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 82,47 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 83,3 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 79,63 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 80,46 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 306 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 544 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 290 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 526 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 280 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 511 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 267 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 500 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 263 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 487 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,77 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,69 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 91,5 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 93,93 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 87,25 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 91,91 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 85,95 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 89,52 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 11.491 06 Badajoz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 11.193 06 Badajoz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 10.485 06 Badajoz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 10.721 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 10.496 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 9.950 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 10.163 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 9.948 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 9.559 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 9.768 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 9.549 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 9.169 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 9.063 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 8.737 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 06 Badajoz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 06 Badajoz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 06 Badajoz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,3 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 93,77 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,9 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 88,44 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 88,88 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,17 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 85,01 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 85,31 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 87,45 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 80,97 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 83,33 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 11.191 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 10.742 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 9.107 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 10.436 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 10.067 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 8.597 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 9.894 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 9.531 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 8.241 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 9.506 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 9.142 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 7.897 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 8.673 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 7.507 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,25 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 93,72 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,4 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 88,41 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 88,73 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,49 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 84,94 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 85,11 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 86,71 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 80,74 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 82,43 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 300 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 451 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.378 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 285 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 429 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.353 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 269 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 417 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.318 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 262 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 407 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.272 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 390 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.230 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 95,12 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,19 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 89,67 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 92,46 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,65 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 87,33 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 90,24 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 92,31 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 86,47 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 89,26 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 11.644 06 Badajoz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 11.369 06 Badajoz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 11.158 06 Badajoz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 10.792 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 10.468 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 10.453 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 10.242 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 9.910 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 9.867 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 9.365 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 9.323 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 9.021 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 9.020 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 06 Badajoz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 06 Badajoz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 06 Badajoz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,68 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,07 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 93,68 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 87,96 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 87,17 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 88,43 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 82,37 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 83,55 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 79,35 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 80,84 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 11.379 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 11.192 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 10.420 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 10.544 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 10.297 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 9.737 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 10.000 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 9.743 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 9.174 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 9.204 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 8.650 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 8.863 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 8.363 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,66 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,45 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,88 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 87,05 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 88,04 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 82,24 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 83,01 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 79,19 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 80,26 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 265 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 177 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 738 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 248 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 171 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 716 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 242 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 167 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 693 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 161 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 673 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 158 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 657 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 93,58 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,61 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,02 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 91,32 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 94,35 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,9 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 90,96 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 91,19 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 89,27 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 89,02 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 11.788 06 Badajoz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 11.336 06 Badajoz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 11.346 06 Badajoz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 11.024 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 10.534 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 10.487 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 9.856 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 9.816 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 9.431 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 9.425 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 9.074 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 9.073 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 06 Badajoz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 06 Badajoz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 06 Badajoz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,52 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 92,93 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 92,43 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 86,94 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 86,52 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 83,2 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 83,07 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 80,05 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 79,97 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 11.556 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 10.989 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 10.640 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 10.797 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 10.195 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 9.805 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 9.535 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 9.153 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 9.121 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 8.781 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 8.780 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 8.441 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,43 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 92,77 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,15 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 86,77 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 86,02 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 83 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 82,53 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 79,9 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 79,33 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 232 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 347 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 706 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 227 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 339 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 682 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 321 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 663 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 310 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 644 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 294 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 632 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,84 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,69 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,6 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 92,51 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 93,91 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 89,34 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 91,22 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 84,73 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 89,52 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 1.501 06 Badajoz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 1.390 06 Badajoz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 1.472 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 1.470 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 1.351 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 1.402 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 1.437 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 1.326 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 1.380 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 1.416 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 1.309 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 1.363 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 1.395 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 1.297 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 1.340 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 06 Badajoz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 06 Badajoz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 97,93 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 97,19 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 95,24 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 95,74 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 95,4 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 93,75 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,34 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 94,17 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 92,6 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 92,94 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 93,31 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 91,03 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.436 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.201 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.406 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.165 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.375 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.141 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.355 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.130 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.335 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.120 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 97,91 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 95,75 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 95 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,36 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 94,09 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 92,97 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 93,26 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 65 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 189 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 64 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 186 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 62 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 185 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 61 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 179 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 60 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 177 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,46 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,41 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 95,38 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,88 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 93,85 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,71 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 92,31 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 93,65 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 1.457 06 Badajoz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 1.390 06 Badajoz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 1.301 06 Badajoz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 1.423 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 1.368 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 1.283 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 1.406 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 1.351 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 1.269 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 1.385 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 1.336 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 1.255 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 1.301 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 1.231 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 06 Badajoz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 06 Badajoz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 06 Badajoz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,67 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,42 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,62 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,5 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,19 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,54 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,06 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,12 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,46 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,6 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,62 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.400 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.256 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 964 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.367 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.235 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 947 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.354 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.222 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 936 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.333 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.208 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 926 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.175 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 912 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,64 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,33 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,24 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,71 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,29 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,1 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,21 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,18 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,06 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,55 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,61 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 57 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 134 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 337 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 56 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 133 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 336 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 52 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 129 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 333 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 52 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 128 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 329 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 126 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 319 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,25 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,25 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,7 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,23 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,27 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,81 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,23 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 95,52 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,63 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 94,03 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,66 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 1.539 06 Badajoz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 1.481 06 Badajoz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 1.390 06 Badajoz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 1.517 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 1.461 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 1.367 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 1.485 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 1.441 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 1.344 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 1.408 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 1.314 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 1.391 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 1.297 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 06 Badajoz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 06 Badajoz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 06 Badajoz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,57 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,65 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,35 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,49 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,3 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 96,69 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,07 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 94,53 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 93,92 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 93,31 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.500 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.426 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.171 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.480 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.407 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.152 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.448 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.387 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.130 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.355 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.106 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.341 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.089 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,67 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,67 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,38 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,53 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,27 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,5 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,02 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 94,45 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,04 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 93 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 39 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 55 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 219 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 37 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 54 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 215 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 37 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 54 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 214 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 53 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 208 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 50 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 208 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 94,87 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,18 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,17 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,87 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,18 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,72 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 96,36 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,98 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 90,91 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 94,98 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 1.564 06 Badajoz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 1.457 06 Badajoz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 1.375 06 Badajoz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 1.525 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 1.440 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 1.346 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 1.402 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 1.316 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 1.370 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 1.296 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 1.351 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 1.281 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 06 Badajoz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 06 Badajoz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 06 Badajoz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,51 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,83 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 97,89 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,23 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 95,71 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 94,03 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 94,25 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 92,72 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 93,16 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.515 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.398 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.153 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.477 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.381 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.125 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.344 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.100 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.313 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.081 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.296 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.072 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,49 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,78 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,57 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,14 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 95,4 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 93,92 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 93,76 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 92,7 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 92,97 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 49 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 59 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 222 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 48 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 59 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 221 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 58 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 216 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 57 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 215 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 55 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 209 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,96 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,55 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,31 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,3 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,61 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 96,85 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 93,22 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 94,14 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 1.645 06 Badajoz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 1.508 06 Badajoz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 1.596 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 1.626 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 1.488 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 1.548 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 1.598 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 1.474 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 1.534 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 1.581 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 1.460 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 1.521 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 1.571 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 1.452 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 1.512 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 06 Badajoz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 06 Badajoz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,84 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,67 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,99 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,14 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,75 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,12 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,11 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,82 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,3 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,5 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,29 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,74 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.561 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.234 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.543 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.218 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.516 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.207 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.499 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.196 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.489 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.189 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,85 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,7 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,12 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,81 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,03 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,92 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,39 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,35 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 84 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 274 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 83 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 270 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 82 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 267 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 82 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 264 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 82 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 263 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,81 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,54 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,62 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,45 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,62 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,35 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 97,62 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,99 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 1.647 06 Badajoz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 1.526 06 Badajoz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 1.379 06 Badajoz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 1.618 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 1.508 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 1.368 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 1.599 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 1.491 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 1.359 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 1.587 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 1.483 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 1.350 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 1.469 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 1.333 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 06 Badajoz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 06 Badajoz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 06 Badajoz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,24 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,82 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,2 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,09 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,71 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,55 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,36 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,18 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,9 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,26 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,66 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.572 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.321 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 941 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.543 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.304 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 934 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.525 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.290 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 927 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.514 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.283 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 918 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.272 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 907 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,16 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,71 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,26 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,01 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,65 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,51 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,31 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,12 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,56 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,29 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,39 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 75 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 205 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 438 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 75 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 204 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 434 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 74 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 201 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 432 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 73 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 200 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 432 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 197 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 426 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,51 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,09 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,67 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,05 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,63 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,33 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,56 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,63 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,1 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 97,26 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 1.705 06 Badajoz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 1.616 06 Badajoz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.501 06 Badajoz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 1.679 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 1.595 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 1.487 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 1.659 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 1.584 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 1.473 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 1.564 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 1.452 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 1.544 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 1.443 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 06 Badajoz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 06 Badajoz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 06 Badajoz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,48 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,7 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,07 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,3 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,02 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,13 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,78 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,74 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,54 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,14 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.632 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.540 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.165 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.607 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.522 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.152 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.587 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.511 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.140 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.493 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.126 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.473 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.118 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,47 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,83 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,88 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,24 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,12 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,85 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,95 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,65 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,65 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,97 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 73 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 76 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 336 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 72 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 73 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 335 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 72 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 73 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 333 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 71 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 326 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 71 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 325 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,63 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,05 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,7 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,63 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,05 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,11 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93,42 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,02 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,42 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,73 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 1.707 06 Badajoz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 1.640 06 Badajoz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.561 06 Badajoz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 1.679 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 1.628 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 1.546 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 1.611 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 1.526 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 1.589 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 1.512 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 1.573 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 1.498 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 06 Badajoz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 06 Badajoz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 06 Badajoz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,36 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,27 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,04 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,23 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,76 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,89 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,86 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,91 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,96 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.643 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.565 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.206 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.615 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.554 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.192 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.537 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.179 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.517 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.168 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.503 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.156 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,3 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,3 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,84 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,21 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,76 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,93 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,85 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,04 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,85 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 64 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 75 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 355 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 64 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 74 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 354 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 74 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 347 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 72 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 344 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 70 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 342 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,67 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,72 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,67 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,75 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 96,9 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 93,33 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,34 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 79 06 Badajoz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 73 06 Badajoz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 89 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 79 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 72 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 89 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 79 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 72 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 89 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 79 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 72 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 89 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 79 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 72 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 87 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 06 Badajoz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 06 Badajoz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,63 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,63 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,63 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,63 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,75 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 70 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 56 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 70 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 55 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 70 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 55 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 70 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 55 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 70 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 55 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,21 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,21 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,21 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,21 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 9 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 17 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 9 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 17 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 9 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 17 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 9 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 17 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 9 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 17 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 80 06 Badajoz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 69 06 Badajoz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 73 06 Badajoz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 80 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 69 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 73 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 80 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 69 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 73 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 80 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 69 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 73 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 69 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 72 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 06 Badajoz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 06 Badajoz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 06 Badajoz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,63 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 73 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 55 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 51 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 73 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 55 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 51 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 73 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 55 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 51 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 73 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 55 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 51 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 55 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 50 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 98,04 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 7 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 14 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 22 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 7 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 14 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 22 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 7 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 14 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 22 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 7 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 14 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 22 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 14 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 22 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 88 06 Badajoz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 73 06 Badajoz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 67 06 Badajoz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 88 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 72 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 67 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 88 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 72 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 67 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 72 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 66 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 72 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 66 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 06 Badajoz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 06 Badajoz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 06 Badajoz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,63 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,63 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,63 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,51 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,63 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,51 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 81 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 67 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 50 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 81 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 66 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 50 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 81 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 66 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 50 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 66 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 49 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 66 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 49 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,51 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,51 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,51 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,51 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 98 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 7 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 6 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 17 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 7 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 6 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 17 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 7 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 6 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 17 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 6 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 17 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 6 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 17 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 89 06 Badajoz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 76 06 Badajoz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 72 06 Badajoz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 89 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 76 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 72 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 76 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 71 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 76 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 71 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 76 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 71 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 06 Badajoz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 06 Badajoz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 06 Badajoz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,61 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,61 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,61 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 80 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 72 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 53 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 80 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 72 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 53 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 72 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 52 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 72 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 52 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 72 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 52 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,11 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,11 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,11 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 9 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 4 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 19 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 9 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 4 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 19 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 4 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 19 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 4 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 19 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 4 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 19 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 23 06 Badajoz De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 22 06 Badajoz De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 21 06 Badajoz De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 23 06 Badajoz De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 22 06 Badajoz De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 21 06 Badajoz De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 23 06 Badajoz De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 22 06 Badajoz De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 21 06 Badajoz De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 23 06 Badajoz De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 22 06 Badajoz De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 21 06 Badajoz De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 23 06 Badajoz De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 22 06 Badajoz De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 21 06 Badajoz De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 06 Badajoz De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 06 Badajoz De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 19 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 16 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 19 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 16 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 19 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 16 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 19 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 16 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 19 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 16 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 4 06 Badajoz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 6 06 Badajoz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 4 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 6 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 4 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 6 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 4 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 6 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 4 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 6 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 06 Badajoz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 06 Badajoz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 24 06 Badajoz De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 23 06 Badajoz De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 20 06 Badajoz De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 24 06 Badajoz De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 23 06 Badajoz De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 20 06 Badajoz De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 24 06 Badajoz De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 23 06 Badajoz De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 20 06 Badajoz De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 24 06 Badajoz De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 23 06 Badajoz De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 20 06 Badajoz De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 23 06 Badajoz De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 20 06 Badajoz De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 06 Badajoz De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 06 Badajoz De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 06 Badajoz De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 06 Badajoz De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 22 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 17 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 15 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 22 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 17 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 15 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 22 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 17 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 15 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 22 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 17 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 15 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 17 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 15 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 2 06 Badajoz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 6 06 Badajoz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 5 06 Badajoz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 2 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 6 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 5 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 2 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 6 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 5 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 2 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 6 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 5 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 6 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 5 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 06 Badajoz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 06 Badajoz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 06 Badajoz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 23 06 Badajoz De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 23 06 Badajoz De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 21 06 Badajoz De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 23 06 Badajoz De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 23 06 Badajoz De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 21 06 Badajoz De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 23 06 Badajoz De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 23 06 Badajoz De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 21 06 Badajoz De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 23 06 Badajoz De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 21 06 Badajoz De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 23 06 Badajoz De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 21 06 Badajoz De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 06 Badajoz De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 06 Badajoz De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 06 Badajoz De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 06 Badajoz De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 06 Badajoz De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 06 Badajoz De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 21 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 20 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 14 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 21 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 20 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 14 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 21 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 20 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 14 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 20 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 14 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 20 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 14 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 2 06 Badajoz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 3 06 Badajoz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 7 06 Badajoz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 2 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 3 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 7 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 2 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 3 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 7 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 3 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 7 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 3 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 7 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 06 Badajoz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 06 Badajoz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 06 Badajoz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 25 06 Badajoz De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 27 06 Badajoz De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 23 06 Badajoz De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 25 06 Badajoz De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 27 06 Badajoz De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 23 06 Badajoz De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 27 06 Badajoz De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 23 06 Badajoz De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 27 06 Badajoz De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 23 06 Badajoz De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 27 06 Badajoz De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 23 06 Badajoz De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 06 Badajoz De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 06 Badajoz De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 06 Badajoz De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 06 Badajoz De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 06 Badajoz De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 06 Badajoz De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 06 Badajoz De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 23 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 24 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 17 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 23 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 24 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 17 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 24 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 17 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 24 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 17 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 24 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 17 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 2 06 Badajoz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 3 06 Badajoz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 6 06 Badajoz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 2 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 3 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 6 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 3 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 6 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 3 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 6 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 3 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 6 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 06 Badajoz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 06 Badajoz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 06 Badajoz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 06 Badajoz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2022QI 33.288 07 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2021QI 32.023 07 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2020QI 34.322 07 Balears, Illes Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 07 Balears, Illes Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 07 Balears, Illes Total Cohort January 1 Total Survival in the first trimester 2022QII "" 07 Balears, Illes Total Cohort January 1 Total Survival in the first trimester 2022QI 31.182 07 Balears, Illes Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 07 Balears, Illes Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 07 Balears, Illes Total Cohort January 1 Total Survival in the first trimester 2021QII "" 07 Balears, Illes Total Cohort January 1 Total Survival in the first trimester 2021QI 29.995 07 Balears, Illes Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 07 Balears, Illes Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 07 Balears, Illes Total Cohort January 1 Total Survival in the first trimester 2020QII "" 07 Balears, Illes Total Cohort January 1 Total Survival in the first trimester 2020QI 30.573 07 Balears, Illes Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 07 Balears, Illes Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 07 Balears, Illes Total Cohort January 1 Total Survival in the second trimester 2022QII 29.863 07 Balears, Illes Total Cohort January 1 Total Survival in the second trimester 2022QI "" 07 Balears, Illes Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 07 Balears, Illes Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 07 Balears, Illes Total Cohort January 1 Total Survival in the second trimester 2021QII 28.916 07 Balears, Illes Total Cohort January 1 Total Survival in the second trimester 2021QI "" 07 Balears, Illes Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 07 Balears, Illes Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 07 Balears, Illes Total Cohort January 1 Total Survival in the second trimester 2020QII 29.544 07 Balears, Illes Total Cohort January 1 Total Survival in the second trimester 2020QI "" 07 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2022QIII 28.832 07 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2021QIII 28.086 07 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2020QIII 28.523 07 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2022QIV 27.653 07 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2021QIV 27.084 07 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2020QIV 26.886 07 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes Total Cohort January 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 07 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 07 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,67 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,67 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 89,08 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,71 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,3 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 86,08 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,61 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,71 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 83,1 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 83,07 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 84,58 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 78,33 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 31.816 07 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 25.693 07 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 29.774 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 23.922 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 28.499 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 22.965 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 27.501 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 22.227 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 26.375 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 21.438 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 07 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 07 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,58 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,11 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,57 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,38 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,44 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,51 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 82,9 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 83,44 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.472 07 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 6.330 07 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.408 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 6.073 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.364 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 5.951 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.331 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 5.859 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.278 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 5.646 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 07 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 07 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,65 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,94 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,66 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,01 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,42 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,56 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 86,82 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 89,19 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2022QII 35.038 07 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2021QII 32.278 07 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2020QII 33.451 07 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 07 Balears, Illes Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 07 Balears, Illes Total Cohort April 1 Total Survival in the first trimester 2022QII 33.330 07 Balears, Illes Total Cohort April 1 Total Survival in the first trimester 2022QI "" 07 Balears, Illes Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 07 Balears, Illes Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 07 Balears, Illes Total Cohort April 1 Total Survival in the first trimester 2021QII 30.906 07 Balears, Illes Total Cohort April 1 Total Survival in the first trimester 2021QI "" 07 Balears, Illes Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 07 Balears, Illes Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 07 Balears, Illes Total Cohort April 1 Total Survival in the first trimester 2020QII 32.101 07 Balears, Illes Total Cohort April 1 Total Survival in the first trimester 2020QI "" 07 Balears, Illes Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 07 Balears, Illes Total Cohort April 1 Total Survival in the second trimester 2022QIII 31.994 07 Balears, Illes Total Cohort April 1 Total Survival in the second trimester 2022QII "" 07 Balears, Illes Total Cohort April 1 Total Survival in the second trimester 2022QI "" 07 Balears, Illes Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 07 Balears, Illes Total Cohort April 1 Total Survival in the second trimester 2021QIII 29.829 07 Balears, Illes Total Cohort April 1 Total Survival in the second trimester 2021QII "" 07 Balears, Illes Total Cohort April 1 Total Survival in the second trimester 2021QI "" 07 Balears, Illes Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 07 Balears, Illes Total Cohort April 1 Total Survival in the second trimester 2020QIII 30.758 07 Balears, Illes Total Cohort April 1 Total Survival in the second trimester 2020QII "" 07 Balears, Illes Total Cohort April 1 Total Survival in the second trimester 2020QI "" 07 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2022QIV 29.161 07 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2021QIV 28.166 07 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2020QIV 28.059 07 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2022QI 27.037 07 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2021QI 26.834 07 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes Total Cohort April 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 07 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 07 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 07 Balears, Illes Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,13 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,75 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,96 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 91,31 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,41 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,95 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 83,23 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 87,26 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 83,88 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 83,76 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 80,22 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 33.535 07 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 25.544 07 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 24.206 07 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 31.868 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 24.307 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 23.005 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 30.569 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 23.343 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 21.931 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 27.887 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 22.050 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 20.290 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 21.098 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 19.372 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 07 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 07 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 07 Balears, Illes Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,03 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,16 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,04 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,16 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,38 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,6 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 83,16 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 86,32 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 83,82 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 82,59 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 80,03 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.503 07 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 6.734 07 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 9.245 07 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.462 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 6.599 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 9.096 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.425 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 6.486 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 8.827 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.274 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 6.116 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 7.769 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 5.939 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 7.462 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 07 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 07 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 07 Balears, Illes Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,27 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,39 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,81 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,32 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,48 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 84,76 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 90,82 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 84,03 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 88,19 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 80,71 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2022QIII 40.810 07 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2021QIII 38.501 07 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2020QIII 36.918 07 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 07 Balears, Illes Total Cohort July 1 Total Survival in the first trimester 2022QIII 38.310 07 Balears, Illes Total Cohort July 1 Total Survival in the first trimester 2022QII "" 07 Balears, Illes Total Cohort July 1 Total Survival in the first trimester 2022QI "" 07 Balears, Illes Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 07 Balears, Illes Total Cohort July 1 Total Survival in the first trimester 2021QIII 36.338 07 Balears, Illes Total Cohort July 1 Total Survival in the first trimester 2021QII "" 07 Balears, Illes Total Cohort July 1 Total Survival in the first trimester 2021QI "" 07 Balears, Illes Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 07 Balears, Illes Total Cohort July 1 Total Survival in the first trimester 2020QIII 34.742 07 Balears, Illes Total Cohort July 1 Total Survival in the first trimester 2020QII "" 07 Balears, Illes Total Cohort July 1 Total Survival in the first trimester 2020QI "" 07 Balears, Illes Total Cohort July 1 Total Survival in the second trimester 2022QIV 30.997 07 Balears, Illes Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 07 Balears, Illes Total Cohort July 1 Total Survival in the second trimester 2022QII "" 07 Balears, Illes Total Cohort July 1 Total Survival in the second trimester 2022QI "" 07 Balears, Illes Total Cohort July 1 Total Survival in the second trimester 2021QIV 30.207 07 Balears, Illes Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 07 Balears, Illes Total Cohort July 1 Total Survival in the second trimester 2021QII "" 07 Balears, Illes Total Cohort July 1 Total Survival in the second trimester 2021QI "" 07 Balears, Illes Total Cohort July 1 Total Survival in the second trimester 2020QIV 29.248 07 Balears, Illes Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 07 Balears, Illes Total Cohort July 1 Total Survival in the second trimester 2020QII "" 07 Balears, Illes Total Cohort July 1 Total Survival in the second trimester 2020QI "" 07 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2022QI 28.680 07 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2021QI 27.807 07 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2022QII 27.816 07 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2021QII 27.078 07 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes Total Cohort July 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 07 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 07 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 07 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,87 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,38 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,11 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 75,95 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 78,46 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 79,22 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 74,49 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 75,32 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 72,25 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 73,35 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 40.203 07 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 36.567 07 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 27.196 07 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 37.721 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 34.465 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 25.322 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 30.470 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 28.833 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 21.749 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 27.356 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 20.608 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 26.515 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 20.012 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 07 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 07 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 07 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,83 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,25 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,11 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 75,79 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 78,85 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 79,97 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 74,81 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 75,78 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 72,51 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 73,58 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 607 07 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.934 07 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 9.722 07 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 589 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.873 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 9.420 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 527 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1.374 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 7.499 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1.324 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 7.199 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1.301 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 7.066 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 07 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 07 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 07 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,03 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,85 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,89 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 86,82 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 71,04 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 77,13 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 68,46 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 74,05 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 67,27 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 72,68 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2022QIV 40.038 07 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2021QIV 38.595 07 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2020QIV 36.940 07 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes Total Cohort October 1 Total Survival in the first trimester 2022QIV 32.235 07 Balears, Illes Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 07 Balears, Illes Total Cohort October 1 Total Survival in the first trimester 2022QII "" 07 Balears, Illes Total Cohort October 1 Total Survival in the first trimester 2022QI "" 07 Balears, Illes Total Cohort October 1 Total Survival in the first trimester 2021QIV 31.600 07 Balears, Illes Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 07 Balears, Illes Total Cohort October 1 Total Survival in the first trimester 2021QII "" 07 Balears, Illes Total Cohort October 1 Total Survival in the first trimester 2021QI "" 07 Balears, Illes Total Cohort October 1 Total Survival in the first trimester 2020QIV 30.588 07 Balears, Illes Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 07 Balears, Illes Total Cohort October 1 Total Survival in the first trimester 2020QII "" 07 Balears, Illes Total Cohort October 1 Total Survival in the first trimester 2020QI "" 07 Balears, Illes Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 07 Balears, Illes Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 07 Balears, Illes Total Cohort October 1 Total Survival in the second trimester 2022QII "" 07 Balears, Illes Total Cohort October 1 Total Survival in the second trimester 2022QI 29.856 07 Balears, Illes Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 07 Balears, Illes Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 07 Balears, Illes Total Cohort October 1 Total Survival in the second trimester 2021QII "" 07 Balears, Illes Total Cohort October 1 Total Survival in the second trimester 2021QI 28.879 07 Balears, Illes Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 07 Balears, Illes Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 07 Balears, Illes Total Cohort October 1 Total Survival in the second trimester 2020QII "" 07 Balears, Illes Total Cohort October 1 Total Survival in the second trimester 2020QI "" 07 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2022QII 28.793 07 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2021QII 28.001 07 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2022QIII 27.917 07 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2021QIII 27.299 07 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes Total Cohort October 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 07 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 07 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 07 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 80,51 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 81,88 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 82,8 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 77,36 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 78,18 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 74,6 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 75,8 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 72,33 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 73,9 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 39.560 07 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 36.755 07 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 28.303 07 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 31.805 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 30.098 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 23.825 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 28.421 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 22.399 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 27.392 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 21.639 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 26.547 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 21.032 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 07 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 07 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 07 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 80,4 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 81,89 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 84,18 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 77,33 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 79,14 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 74,53 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 76,45 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 72,23 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 74,31 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 478 07 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.840 07 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 8.637 07 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 430 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.502 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 6.763 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.435 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 6.480 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.401 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 6.362 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.370 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 6.267 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 07 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 07 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 07 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 89,96 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 81,63 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 78,3 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 77,99 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 75,03 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 76,14 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 73,66 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 74,46 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 72,56 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 25.327 07 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 24.640 07 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 25.805 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 23.334 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 22.715 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 22.292 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 22.117 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 21.717 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 21.357 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 21.166 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 20.960 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 20.428 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 20.080 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 20.037 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 18.957 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 07 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 07 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 92,13 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 92,19 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 86,39 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 87,33 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 88,14 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 82,76 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 83,57 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 85,06 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 79,16 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 79,28 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 81,32 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 73,46 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 24.362 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 20.938 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 22.423 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 19.235 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 21.243 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 18.332 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 20.319 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 17.649 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 19.278 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 16.910 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,04 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 91,87 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 87,2 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 87,55 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 83,4 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 84,29 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 79,13 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 80,76 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 965 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 3.702 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 911 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 3.480 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 874 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 3.385 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 847 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 3.311 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 802 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 3.127 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,4 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 94 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,57 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 91,44 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 87,77 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 89,44 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 83,11 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 84,47 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 25.945 07 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 24.661 07 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 25.034 07 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 24.351 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 23.373 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 23.760 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 23.107 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 22.370 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 22.509 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 20.689 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 20.851 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 20.136 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 19.817 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 19.044 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 07 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 07 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 07 Balears, Illes From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,86 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,78 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,91 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,06 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,71 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 89,91 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 79,74 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 84,55 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 80,43 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 80,36 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 76,07 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 25.018 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 20.668 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 19.546 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 23.460 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 19.490 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 18.398 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 22.246 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 18.583 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 17.384 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 19.948 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 17.387 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 15.846 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 16.503 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 14.996 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,77 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,3 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,13 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 88,92 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,91 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 88,94 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 79,73 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 84,13 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 81,07 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 79,85 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 76,72 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 927 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 3.993 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 5.488 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 891 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 3.883 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 5.362 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 861 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 3.787 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 5.125 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 741 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 3.464 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 4.290 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 3.314 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 4.048 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,12 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,25 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,7 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 92,88 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,84 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 93,39 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 79,94 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 86,75 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 78,17 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 83 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 73,76 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 29.272 07 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 28.195 07 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 27.189 07 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 26.911 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 26.169 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 25.133 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 21.374 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 21.266 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 20.633 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 19.906 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 19.359 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 19.123 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 18.730 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 07 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 07 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 07 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 91,93 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,81 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 92,44 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 73,02 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 75,42 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 75,89 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 70,6 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 71,2 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 67,82 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 68,89 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 28.926 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 27.174 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 22.277 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 26.580 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 25.202 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 20.475 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 21.082 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 20.602 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 17.219 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 19.282 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 16.162 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 18.517 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 15.616 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 91,89 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,74 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 91,91 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 72,88 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 75,82 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 77,29 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 70,96 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 72,55 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 68,14 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 70,1 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 346 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.021 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 4.912 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 331 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 967 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 4.658 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 292 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 664 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 3.414 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 624 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 3.197 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 606 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 3.114 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,66 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 94,71 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 94,83 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 84,39 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 65,03 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 69,5 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 61,12 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 65,09 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 59,35 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 63,4 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 28.950 07 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 28.385 07 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 27.501 07 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 22.691 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 22.581 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 22.073 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 21.009 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 20.528 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 20.040 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 19.752 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 19.250 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 19.123 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 07 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 07 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 07 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 78,38 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 79,55 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 80,26 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 74,01 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 74,64 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 70,6 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 71,82 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 67,82 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 69,54 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 28.686 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 27.256 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 23.160 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 22.456 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 21.697 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 18.996 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 20.179 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 17.653 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 19.238 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 16.951 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 18.475 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 16.394 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 78,28 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 79,6 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 82,02 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 74,04 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 76,22 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 70,58 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 73,19 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 67,78 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 70,79 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 264 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.129 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 4.341 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 235 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 884 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 3.077 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 830 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2.875 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 802 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2.801 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 775 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2.729 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 89,02 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 78,3 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 70,88 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 73,52 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 66,23 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 71,04 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 64,52 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 68,64 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 62,87 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 3.450 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 3.291 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 3.760 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 3.379 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 3.222 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 3.605 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 3.330 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 3.191 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 3.554 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 3.288 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 3.149 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 3.494 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 3.234 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 3.105 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 3.391 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 97,94 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 97,9 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 95,88 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,52 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,96 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 94,52 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 95,3 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,69 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 92,93 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,74 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,35 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 90,19 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 3.256 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.329 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 3.192 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2.281 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 3.147 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.259 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 3.107 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.226 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 3.056 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2.198 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,03 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97,94 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,65 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,99 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,42 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,58 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,86 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,38 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 194 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 962 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 187 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 941 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 183 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 932 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 181 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 923 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 178 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 907 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,39 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,82 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 94,33 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,88 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 93,3 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,95 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 91,75 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 94,28 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 3.887 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 3.355 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 3.663 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 3.826 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 3.312 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 3.623 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 3.776 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 3.274 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 3.563 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 3.514 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 3.177 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 3.360 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 3.123 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 3.278 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,43 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,72 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,91 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,14 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,59 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,27 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 90,4 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 94,69 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 91,73 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,08 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 89,49 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 3.681 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.352 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2.264 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 3.621 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.319 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2.233 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 3.574 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.290 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2.191 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 3.330 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.223 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.122 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.183 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.079 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,37 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,6 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,63 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,09 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,36 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 96,78 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 90,46 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 94,52 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 93,73 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 92,81 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 91,83 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 206 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.003 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.399 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 205 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 993 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.390 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 202 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 984 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.372 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 184 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 954 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.238 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 940 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.199 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,51 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,36 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,06 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,11 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,07 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 89,32 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 95,11 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 88,49 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 93,72 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 85,7 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 4.657 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 4.298 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 4.164 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 4.577 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 4.221 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 4.083 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 3.749 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 3.572 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 3.517 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 3.480 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 3.424 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 3.433 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 3.379 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,28 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,21 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,05 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 80,5 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 83,11 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 84,46 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 80,97 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 82,23 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 79,87 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 81,15 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 4.570 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 3.986 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2.505 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 4.490 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 3.911 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.453 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 3.673 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 3.355 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.226 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 3.266 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.174 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 3.222 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.149 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,25 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,12 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 97,92 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 80,37 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 84,17 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 88,86 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 81,94 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,79 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 80,83 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 85,79 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 87 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 312 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.659 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 87 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 310 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.630 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 76 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 217 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.291 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 214 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.250 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 211 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.230 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,36 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,25 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 87,36 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 69,55 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 77,82 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 68,59 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 75,35 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 67,63 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 74,14 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 4.487 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 4.248 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 4.009 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 3.746 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 3.622 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 3.483 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 3.525 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 3.385 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 3.476 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 3.338 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 3.427 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 3.301 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 83,49 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 85,26 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 86,88 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 82,98 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 84,44 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 81,83 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 83,26 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 80,67 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 82,34 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 4.426 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3.991 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2.581 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 3.691 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 3.411 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2.373 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 3.321 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.317 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 3.274 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2.288 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 3.226 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.259 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 83,39 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 85,47 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 91,94 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 83,21 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,77 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 82,03 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 88,65 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 80,83 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 87,52 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 61 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 257 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.428 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 55 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 211 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.110 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 204 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.068 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 202 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.050 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 201 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.042 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 90,16 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 82,1 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 77,73 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 79,38 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 74,79 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 78,6 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 73,53 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 78,21 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 72,97 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 4.252 07 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 3.854 07 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 4.492 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 4.211 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 3.821 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 4.412 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 4.159 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 3.771 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 4.369 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 4.124 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 3.743 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 4.338 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 4.089 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 3.708 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 4.276 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 07 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 07 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,04 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,14 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,22 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,81 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,85 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,26 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,99 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,12 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,57 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,17 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,21 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 95,19 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 3.963 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.331 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 3.925 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2.311 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 3.876 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.279 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 3.845 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.257 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 3.814 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2.235 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,04 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,14 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,8 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,77 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,02 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,83 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,24 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,88 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 289 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.523 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 286 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.510 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 283 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.492 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 279 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.486 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 275 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.473 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,96 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,15 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,92 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,96 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,54 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,57 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 95,16 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,72 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 4.907 07 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 4.020 07 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 4.480 07 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 4.854 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 3.979 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 4.444 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 4.815 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 3.946 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 4.413 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 4.667 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 3.899 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 4.291 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 3.859 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 4.241 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 07 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 07 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 07 Balears, Illes From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,92 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,98 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,2 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,13 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,16 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,5 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,11 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,99 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,78 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,67 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 4.561 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.419 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2.280 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 4.512 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.393 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2.258 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 4.476 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.365 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2.241 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 4.341 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.335 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.208 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.308 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.183 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,93 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,93 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,04 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,14 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,77 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,29 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,18 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,53 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,84 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,41 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,75 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 346 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.601 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.200 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 342 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.586 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.186 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 339 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.581 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.172 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 326 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.564 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.083 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.551 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.058 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,84 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,06 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,36 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,98 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,75 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,73 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 94,22 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,69 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 94,68 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,88 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 93,55 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 6.444 07 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 5.656 07 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 5.228 07 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 6.387 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 5.600 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 5.190 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 5.447 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 5.024 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 4.765 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 4.950 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 4.692 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 4.917 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 4.637 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 07 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 07 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 07 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,12 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,01 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,27 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 84,53 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 88,83 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 91,14 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 87,52 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 89,75 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 86,93 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 88,7 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 6.292 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 5.101 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2.329 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 6.237 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 5.050 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.310 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 5.309 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 4.576 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.220 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 4.509 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.188 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 4.478 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.163 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,13 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,18 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 84,38 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,71 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 95,32 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 88,39 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 93,95 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 87,79 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 92,87 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 152 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 555 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2.899 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 150 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 550 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2.880 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 138 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 448 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 2.545 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 441 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2.504 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 439 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 2.474 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,68 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,1 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,34 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 90,79 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 80,72 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 87,79 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 79,46 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 86,37 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 79,1 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 85,34 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 6.174 07 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 5.597 07 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 5.108 07 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 5.376 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 5.034 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 4.713 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 4.960 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 4.648 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 4.916 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 4.593 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 4.881 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 4.560 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 07 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 07 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 07 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 87,07 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 89,94 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 92,27 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,62 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,99 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,83 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 89,92 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 87,21 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 89,27 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 6.039 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 5.169 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2.469 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 5.254 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 4.653 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2.363 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 4.585 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.336 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 4.545 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2.307 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 4.512 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.286 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 87 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 90,02 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 95,71 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,7 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 94,61 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 87,93 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 93,44 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 87,29 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 92,59 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 135 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 428 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 2.639 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 122 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 381 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2.350 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 375 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2.312 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 371 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2.286 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 369 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2.274 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 90,37 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 89,02 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 89,05 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 87,62 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 87,61 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 86,68 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 86,62 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 86,21 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 86,17 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 188 07 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 171 07 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 184 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 188 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 170 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 183 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 187 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 170 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 183 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 184 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 167 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 182 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 180 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 167 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 181 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 07 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 07 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,42 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,46 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,47 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 99,42 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 99,46 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,87 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,66 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,91 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,74 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,66 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,37 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 171 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 69 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 171 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 69 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 170 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 69 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 167 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 69 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 164 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 69 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,42 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,66 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,91 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 17 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 102 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 17 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 101 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 17 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 101 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 17 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 98 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 16 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 98 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,02 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 99,02 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,08 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,12 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,08 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 213 07 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 175 07 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 194 07 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 213 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 175 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 194 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 210 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 172 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 193 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 206 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 172 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 192 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 172 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 191 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 07 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 07 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 07 Balears, Illes from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,59 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,29 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,48 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,71 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,29 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,97 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,29 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,45 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 198 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 75 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 85 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 198 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 75 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 85 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 196 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 75 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 84 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 192 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 75 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 83 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 75 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 83 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,99 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,82 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,97 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,65 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,65 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 15 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 109 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 15 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 100 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 109 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 14 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 97 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 109 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 14 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 97 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 109 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 97 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 108 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,33 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 93,33 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 99,08 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 303 07 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 249 07 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 234 07 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 301 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 246 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 233 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 293 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 243 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 230 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 243 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 229 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 242 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 229 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 07 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 07 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 07 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,34 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,8 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,57 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,7 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,59 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,29 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,59 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,86 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,19 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,86 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 288 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 225 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 59 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 287 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 222 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 58 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 279 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 220 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 58 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 220 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 58 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 219 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 58 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,65 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,67 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,31 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,88 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,78 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,31 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,78 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,31 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,33 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 98,31 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 15 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 24 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 175 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 14 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 24 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 175 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 14 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 23 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 172 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 23 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 171 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 23 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 171 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 93,33 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,33 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,83 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,29 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,83 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,71 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 95,83 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,71 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 296 07 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 261 07 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 223 07 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 292 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 260 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 220 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 260 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 219 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 259 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 219 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 257 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 217 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 07 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 07 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 07 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,65 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,62 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,65 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,62 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,21 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 99,23 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,21 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,47 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,31 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 284 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 247 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 68 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 280 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 246 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 68 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 246 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 68 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 245 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 68 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 244 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 68 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,59 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,6 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 99,6 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 99,19 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,79 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 12 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 14 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 155 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 12 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 14 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 152 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 14 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 151 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 14 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 151 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 13 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 149 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,06 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,42 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,42 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 92,86 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,13 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 71 07 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 67 07 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 81 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 70 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 67 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 81 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 70 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 67 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 81 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 70 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 67 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 81 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 70 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 67 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 81 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 07 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 07 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,59 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,59 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,59 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,59 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 64 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 26 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 63 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 26 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 63 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 26 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 63 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 26 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 63 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 26 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,44 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,44 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,44 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,44 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 7 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 41 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 7 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 41 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 7 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 41 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 7 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 41 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 7 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 41 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 86 07 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 67 07 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 80 07 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 86 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 67 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 80 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 86 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 67 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 80 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 85 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 67 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 80 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 66 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 80 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 07 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 07 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 07 Balears, Illes De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,84 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,51 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 77 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 30 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 31 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 77 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 30 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 31 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 77 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 30 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 31 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 76 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 30 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 31 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 29 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 31 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,7 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,67 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 9 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 37 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 49 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 9 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 37 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 49 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 9 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 37 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 49 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 9 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 37 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 49 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 37 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 49 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 134 07 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 103 07 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 103 07 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 134 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 102 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 103 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 134 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 102 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 103 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 101 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 103 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 101 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 103 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 07 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 07 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 07 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,03 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,03 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,06 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,06 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 127 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 81 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 26 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 127 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 80 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 26 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 127 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 80 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 26 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 79 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 26 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 79 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 26 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,77 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,77 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,53 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,53 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 7 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 22 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 77 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 7 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 22 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 77 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 7 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 22 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 77 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 22 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 77 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 22 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 77 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 131 07 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 104 07 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 99 07 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 130 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 103 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 99 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 102 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 99 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 102 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 99 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 102 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 98 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 07 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 07 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 07 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,24 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,04 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,08 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,08 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,08 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,99 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 125 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 92 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 25 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 124 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 91 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 25 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 90 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 25 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 90 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 25 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 90 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 25 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,2 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,91 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,83 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,83 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,83 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 6 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 12 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 74 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 6 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 12 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 74 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 12 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 74 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 12 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 74 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 12 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 73 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,65 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 07 Balears, Illes De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona Total Cohort January 1 Total Number at the start of the quarter 2022QI 156.161 08 Barcelona Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona Total Cohort January 1 Total Number at the start of the quarter 2021QI 151.735 08 Barcelona Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona Total Cohort January 1 Total Number at the start of the quarter 2020QI 157.466 08 Barcelona Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 08 Barcelona Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 08 Barcelona Total Cohort January 1 Total Survival in the first trimester 2022QII "" 08 Barcelona Total Cohort January 1 Total Survival in the first trimester 2022QI 148.033 08 Barcelona Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 08 Barcelona Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 08 Barcelona Total Cohort January 1 Total Survival in the first trimester 2021QII "" 08 Barcelona Total Cohort January 1 Total Survival in the first trimester 2021QI 144.660 08 Barcelona Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 08 Barcelona Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 08 Barcelona Total Cohort January 1 Total Survival in the first trimester 2020QII "" 08 Barcelona Total Cohort January 1 Total Survival in the first trimester 2020QI 142.756 08 Barcelona Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 08 Barcelona Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 08 Barcelona Total Cohort January 1 Total Survival in the second trimester 2022QII 142.132 08 Barcelona Total Cohort January 1 Total Survival in the second trimester 2022QI "" 08 Barcelona Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 08 Barcelona Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 08 Barcelona Total Cohort January 1 Total Survival in the second trimester 2021QII 139.848 08 Barcelona Total Cohort January 1 Total Survival in the second trimester 2021QI "" 08 Barcelona Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 08 Barcelona Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 08 Barcelona Total Cohort January 1 Total Survival in the second trimester 2020QII 138.227 08 Barcelona Total Cohort January 1 Total Survival in the second trimester 2020QI "" 08 Barcelona Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona Total Cohort January 1 Total Survival in the third trimester 2022QIII 137.442 08 Barcelona Total Cohort January 1 Total Survival in the third trimester 2022QII "" 08 Barcelona Total Cohort January 1 Total Survival in the third trimester 2022QI "" 08 Barcelona Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona Total Cohort January 1 Total Survival in the third trimester 2021QIII 135.683 08 Barcelona Total Cohort January 1 Total Survival in the third trimester 2021QII "" 08 Barcelona Total Cohort January 1 Total Survival in the third trimester 2021QI "" 08 Barcelona Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona Total Cohort January 1 Total Survival in the third trimester 2020QIII 134.149 08 Barcelona Total Cohort January 1 Total Survival in the third trimester 2020QII "" 08 Barcelona Total Cohort January 1 Total Survival in the third trimester 2020QI "" 08 Barcelona Total Cohort January 1 Total Survival in the third trimester 2022QIV 133.579 08 Barcelona Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona Total Cohort January 1 Total Survival in the third trimester 2022QII "" 08 Barcelona Total Cohort January 1 Total Survival in the third trimester 2022QI "" 08 Barcelona Total Cohort January 1 Total Survival in the third trimester 2021QIV 132.195 08 Barcelona Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona Total Cohort January 1 Total Survival in the third trimester 2021QII "" 08 Barcelona Total Cohort January 1 Total Survival in the third trimester 2021QI "" 08 Barcelona Total Cohort January 1 Total Survival in the third trimester 2020QIV 130.358 08 Barcelona Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona Total Cohort January 1 Total Survival in the third trimester 2020QII "" 08 Barcelona Total Cohort January 1 Total Survival in the third trimester 2020QI "" 08 Barcelona Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 08 Barcelona Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 08 Barcelona Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,8 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,34 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 90,66 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 91,02 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 92,17 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 87,78 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 88,01 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 89,42 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 85,19 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 85,54 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 87,12 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 82,78 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 147.867 08 Barcelona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 125.638 08 Barcelona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 140.047 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 119.302 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 134.375 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 115.098 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 129.879 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 111.418 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 126.174 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 108.412 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 08 Barcelona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 08 Barcelona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,71 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,96 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,88 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 91,61 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 87,84 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 88,68 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 85,33 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 86,29 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 8.294 08 Barcelona Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 26.097 08 Barcelona Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 7.986 08 Barcelona Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 25.358 08 Barcelona Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 7.757 08 Barcelona Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 24.750 08 Barcelona Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 7.563 08 Barcelona Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 24.265 08 Barcelona Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 7.405 08 Barcelona Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 23.783 08 Barcelona Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 08 Barcelona Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 08 Barcelona Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,29 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,17 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,53 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,84 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 91,19 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,98 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 89,28 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 91,13 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona Total Cohort April 1 Total Number at the start of the quarter 2022QII 156.279 08 Barcelona Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona Total Cohort April 1 Total Number at the start of the quarter 2021QII 151.968 08 Barcelona Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona Total Cohort April 1 Total Number at the start of the quarter 2020QII 149.494 08 Barcelona Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 08 Barcelona Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 08 Barcelona Total Cohort April 1 Total Survival in the first trimester 2022QII 149.119 08 Barcelona Total Cohort April 1 Total Survival in the first trimester 2022QI "" 08 Barcelona Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 08 Barcelona Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 08 Barcelona Total Cohort April 1 Total Survival in the first trimester 2021QII 146.045 08 Barcelona Total Cohort April 1 Total Survival in the first trimester 2021QI "" 08 Barcelona Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 08 Barcelona Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 08 Barcelona Total Cohort April 1 Total Survival in the first trimester 2020QII 144.128 08 Barcelona Total Cohort April 1 Total Survival in the first trimester 2020QI "" 08 Barcelona Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 08 Barcelona Total Cohort April 1 Total Survival in the second trimester 2022QIII 143.603 08 Barcelona Total Cohort April 1 Total Survival in the second trimester 2022QII "" 08 Barcelona Total Cohort April 1 Total Survival in the second trimester 2022QI "" 08 Barcelona Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 08 Barcelona Total Cohort April 1 Total Survival in the second trimester 2021QIII 141.084 08 Barcelona Total Cohort April 1 Total Survival in the second trimester 2021QII "" 08 Barcelona Total Cohort April 1 Total Survival in the second trimester 2021QI "" 08 Barcelona Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 08 Barcelona Total Cohort April 1 Total Survival in the second trimester 2020QIII 139.395 08 Barcelona Total Cohort April 1 Total Survival in the second trimester 2020QII "" 08 Barcelona Total Cohort April 1 Total Survival in the second trimester 2020QI "" 08 Barcelona Total Cohort April 1 Total Survival in the third trimester 2022QIV 139.116 08 Barcelona Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona Total Cohort April 1 Total Survival in the third trimester 2022QII "" 08 Barcelona Total Cohort April 1 Total Survival in the third trimester 2022QI "" 08 Barcelona Total Cohort April 1 Total Survival in the third trimester 2021QIV 137.091 08 Barcelona Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona Total Cohort April 1 Total Survival in the third trimester 2021QII "" 08 Barcelona Total Cohort April 1 Total Survival in the third trimester 2021QI "" 08 Barcelona Total Cohort April 1 Total Survival in the third trimester 2020QIV 135.168 08 Barcelona Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona Total Cohort April 1 Total Survival in the third trimester 2020QII "" 08 Barcelona Total Cohort April 1 Total Survival in the third trimester 2020QI "" 08 Barcelona Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona Total Cohort April 1 Total Survival in the third trimester 2022QII "" 08 Barcelona Total Cohort April 1 Total Survival in the third trimester 2022QI 131.943 08 Barcelona Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona Total Cohort April 1 Total Survival in the third trimester 2021QII "" 08 Barcelona Total Cohort April 1 Total Survival in the third trimester 2021QI 130.495 08 Barcelona Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona Total Cohort April 1 Total Survival in the third trimester 2020QII "" 08 Barcelona Total Cohort April 1 Total Survival in the third trimester 2020QI "" 08 Barcelona Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 08 Barcelona Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 08 Barcelona Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 08 Barcelona Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,42 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,1 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,41 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 91,89 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,84 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,24 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 89,02 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 90,21 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,42 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 86,82 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87,29 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 148.307 08 Barcelona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 128.939 08 Barcelona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 111.903 08 Barcelona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 141.387 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 123.587 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 106.943 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 136.058 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 119.065 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 103.110 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 131.727 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 115.513 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 99.822 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 110.979 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 96.165 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 08 Barcelona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 08 Barcelona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 08 Barcelona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,33 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,85 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,57 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,74 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,34 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,14 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 88,82 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 89,59 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 89,2 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 86,07 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 85,94 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 7.972 08 Barcelona Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 23.029 08 Barcelona Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 37.591 08 Barcelona Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 7.732 08 Barcelona Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 22.458 08 Barcelona Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 37.185 08 Barcelona Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 7.545 08 Barcelona Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 22.019 08 Barcelona Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 36.285 08 Barcelona Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 7.389 08 Barcelona Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 21.578 08 Barcelona Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 35.346 08 Barcelona Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 20.964 08 Barcelona Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 34.330 08 Barcelona Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 08 Barcelona Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 08 Barcelona Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 08 Barcelona Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,99 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,52 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,92 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,64 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,61 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,53 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 92,69 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,7 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 94,03 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 91,03 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,33 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona Total Cohort July 1 Total Number at the start of the quarter 2022QIII 157.317 08 Barcelona Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona Total Cohort July 1 Total Number at the start of the quarter 2021QIII 154.736 08 Barcelona Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona Total Cohort July 1 Total Number at the start of the quarter 2020QIII 150.936 08 Barcelona Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 08 Barcelona Total Cohort July 1 Total Survival in the first trimester 2022QIII 150.020 08 Barcelona Total Cohort July 1 Total Survival in the first trimester 2022QII "" 08 Barcelona Total Cohort July 1 Total Survival in the first trimester 2022QI "" 08 Barcelona Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 08 Barcelona Total Cohort July 1 Total Survival in the first trimester 2021QIII 147.772 08 Barcelona Total Cohort July 1 Total Survival in the first trimester 2021QII "" 08 Barcelona Total Cohort July 1 Total Survival in the first trimester 2021QI "" 08 Barcelona Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 08 Barcelona Total Cohort July 1 Total Survival in the first trimester 2020QIII 144.797 08 Barcelona Total Cohort July 1 Total Survival in the first trimester 2020QII "" 08 Barcelona Total Cohort July 1 Total Survival in the first trimester 2020QI "" 08 Barcelona Total Cohort July 1 Total Survival in the second trimester 2022QIV 144.444 08 Barcelona Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 08 Barcelona Total Cohort July 1 Total Survival in the second trimester 2022QII "" 08 Barcelona Total Cohort July 1 Total Survival in the second trimester 2022QI "" 08 Barcelona Total Cohort July 1 Total Survival in the second trimester 2021QIV 142.785 08 Barcelona Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 08 Barcelona Total Cohort July 1 Total Survival in the second trimester 2021QII "" 08 Barcelona Total Cohort July 1 Total Survival in the second trimester 2021QI "" 08 Barcelona Total Cohort July 1 Total Survival in the second trimester 2020QIV 139.590 08 Barcelona Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 08 Barcelona Total Cohort July 1 Total Survival in the second trimester 2020QII "" 08 Barcelona Total Cohort July 1 Total Survival in the second trimester 2020QI "" 08 Barcelona Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona Total Cohort July 1 Total Survival in the third trimester 2022QII "" 08 Barcelona Total Cohort July 1 Total Survival in the third trimester 2022QI 136.977 08 Barcelona Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona Total Cohort July 1 Total Survival in the third trimester 2021QII "" 08 Barcelona Total Cohort July 1 Total Survival in the third trimester 2021QI 134.475 08 Barcelona Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona Total Cohort July 1 Total Survival in the third trimester 2020QII "" 08 Barcelona Total Cohort July 1 Total Survival in the third trimester 2020QI "" 08 Barcelona Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona Total Cohort July 1 Total Survival in the third trimester 2022QII 132.768 08 Barcelona Total Cohort July 1 Total Survival in the third trimester 2022QI "" 08 Barcelona Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona Total Cohort July 1 Total Survival in the third trimester 2021QII 131.060 08 Barcelona Total Cohort July 1 Total Survival in the third trimester 2021QI "" 08 Barcelona Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona Total Cohort July 1 Total Survival in the third trimester 2020QII "" 08 Barcelona Total Cohort July 1 Total Survival in the third trimester 2020QI "" 08 Barcelona Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 08 Barcelona Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 08 Barcelona Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 08 Barcelona Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 95,36 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,5 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,93 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 91,82 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 92,28 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 92,48 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 88,52 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 89,09 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 85,8 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 86,83 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 152.731 08 Barcelona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 147.211 08 Barcelona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 128.412 08 Barcelona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 145.560 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 140.423 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 122.797 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 140.081 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 135.608 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 118.178 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 129.991 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 113.658 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 125.953 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 110.713 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 08 Barcelona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 08 Barcelona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 08 Barcelona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 95,3 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,39 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,63 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 91,72 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 92,12 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 92,03 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 88,3 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 88,51 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 85,56 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 86,22 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 4.586 08 Barcelona Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 7.525 08 Barcelona Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 22.524 08 Barcelona Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 4.460 08 Barcelona Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 7.349 08 Barcelona Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 22.000 08 Barcelona Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 4.363 08 Barcelona Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 7.177 08 Barcelona Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 21.412 08 Barcelona Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 6.986 08 Barcelona Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 20.817 08 Barcelona Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 6.815 08 Barcelona Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 20.347 08 Barcelona Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 08 Barcelona Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 08 Barcelona Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 08 Barcelona Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,25 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,66 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,67 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95,14 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,38 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,06 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 92,84 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 92,42 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 90,56 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 90,33 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona Total Cohort October 1 Total Number at the start of the quarter 2022QIV 156.465 08 Barcelona Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona Total Cohort October 1 Total Number at the start of the quarter 2021QIV 154.574 08 Barcelona Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona Total Cohort October 1 Total Number at the start of the quarter 2020QIV 151.732 08 Barcelona Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona Total Cohort October 1 Total Survival in the first trimester 2022QIV 149.850 08 Barcelona Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 08 Barcelona Total Cohort October 1 Total Survival in the first trimester 2022QII "" 08 Barcelona Total Cohort October 1 Total Survival in the first trimester 2022QI "" 08 Barcelona Total Cohort October 1 Total Survival in the first trimester 2021QIV 148.432 08 Barcelona Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 08 Barcelona Total Cohort October 1 Total Survival in the first trimester 2021QII "" 08 Barcelona Total Cohort October 1 Total Survival in the first trimester 2021QI "" 08 Barcelona Total Cohort October 1 Total Survival in the first trimester 2020QIV 145.051 08 Barcelona Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 08 Barcelona Total Cohort October 1 Total Survival in the first trimester 2020QII "" 08 Barcelona Total Cohort October 1 Total Survival in the first trimester 2020QI "" 08 Barcelona Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 08 Barcelona Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 08 Barcelona Total Cohort October 1 Total Survival in the second trimester 2022QII "" 08 Barcelona Total Cohort October 1 Total Survival in the second trimester 2022QI 141.873 08 Barcelona Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 08 Barcelona Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 08 Barcelona Total Cohort October 1 Total Survival in the second trimester 2021QII "" 08 Barcelona Total Cohort October 1 Total Survival in the second trimester 2021QI 139.249 08 Barcelona Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 08 Barcelona Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 08 Barcelona Total Cohort October 1 Total Survival in the second trimester 2020QII "" 08 Barcelona Total Cohort October 1 Total Survival in the second trimester 2020QI "" 08 Barcelona Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona Total Cohort October 1 Total Survival in the third trimester 2022QII 137.003 08 Barcelona Total Cohort October 1 Total Survival in the third trimester 2022QI "" 08 Barcelona Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona Total Cohort October 1 Total Survival in the third trimester 2021QII 135.196 08 Barcelona Total Cohort October 1 Total Survival in the third trimester 2021QI "" 08 Barcelona Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona Total Cohort October 1 Total Survival in the third trimester 2020QII "" 08 Barcelona Total Cohort October 1 Total Survival in the third trimester 2020QI "" 08 Barcelona Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona Total Cohort October 1 Total Survival in the third trimester 2022QIII 132.916 08 Barcelona Total Cohort October 1 Total Survival in the third trimester 2022QII "" 08 Barcelona Total Cohort October 1 Total Survival in the third trimester 2022QI "" 08 Barcelona Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona Total Cohort October 1 Total Survival in the third trimester 2021QIII 131.560 08 Barcelona Total Cohort October 1 Total Survival in the third trimester 2021QII "" 08 Barcelona Total Cohort October 1 Total Survival in the third trimester 2021QI "" 08 Barcelona Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona Total Cohort October 1 Total Survival in the third trimester 2020QII "" 08 Barcelona Total Cohort October 1 Total Survival in the third trimester 2020QI "" 08 Barcelona Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 08 Barcelona Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 08 Barcelona Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 08 Barcelona Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,77 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 96,03 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 95,6 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 91,78 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 91,77 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 88,63 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 89,1 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 85,99 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 86,71 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 152.697 08 Barcelona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 145.822 08 Barcelona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 119.702 08 Barcelona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 146.162 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 139.893 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 113.841 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 133.616 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 108.930 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 129.001 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 105.558 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 125.118 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 102.510 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 08 Barcelona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 08 Barcelona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 08 Barcelona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95,72 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,93 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 95,1 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 91,63 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 91 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 88,46 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 88,18 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 85,8 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 85,64 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 3.768 08 Barcelona Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 8.752 08 Barcelona Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 32.030 08 Barcelona Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 3.688 08 Barcelona Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 8.539 08 Barcelona Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 31.210 08 Barcelona Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 8.257 08 Barcelona Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 30.319 08 Barcelona Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 8.002 08 Barcelona Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 29.638 08 Barcelona Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 7.798 08 Barcelona Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 29.050 08 Barcelona Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 08 Barcelona Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 08 Barcelona Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 08 Barcelona Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,88 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,57 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,44 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,34 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,66 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 91,43 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,53 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 89,1 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 90,7 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 112.367 08 Barcelona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 110.049 08 Barcelona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 113.139 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 104.758 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 103.418 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 99.502 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 99.366 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 99.092 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 95.399 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 95.135 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 95.306 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 91.792 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 91.699 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 92.237 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 88.451 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 08 Barcelona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 08 Barcelona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,23 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,97 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 87,95 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,43 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,04 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 84,32 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 84,66 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 86,6 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 81,13 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 81,61 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 83,81 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 78,18 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 107.637 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 96.950 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 100.296 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 90.924 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 95.097 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 87.057 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 91.026 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 83.645 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 87.720 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 80.924 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,18 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,78 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,35 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,8 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 84,57 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,28 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 81,5 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 83,47 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 4.730 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 13.099 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 4.462 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 12.494 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 4.269 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 12.035 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 4.109 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 11.661 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 3.979 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 11.313 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,33 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,38 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,25 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 91,88 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 86,87 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 89,02 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 84,12 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 86,37 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 111.933 08 Barcelona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 110.083 08 Barcelona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 107.651 08 Barcelona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 105.241 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 104.578 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 102.597 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 100.159 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 99.996 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 98.252 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 96.121 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 96.431 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 94.423 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 91.848 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 90.279 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 08 Barcelona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 08 Barcelona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 08 Barcelona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,02 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,31 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,48 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,84 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,27 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 85,87 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 87,6 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 87,71 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 83,44 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 83,86 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 107.437 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 98.461 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 86.632 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 100.951 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 93.418 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 81.896 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 96.025 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 89.189 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 78.291 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 92.110 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 85.954 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 75.210 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 81.846 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 71.872 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,96 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,88 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,53 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 89,38 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 90,58 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,37 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 85,73 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 87,3 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 86,82 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 83,13 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 82,96 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 4.496 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 11.622 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 21.019 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 4.290 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 11.160 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 20.701 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 4.134 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 10.807 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 19.961 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 4.011 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 10.477 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 19.213 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 10.002 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 18.407 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,42 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,02 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,49 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,95 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 92,99 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,97 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 89,21 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 90,15 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,41 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 86,06 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 87,57 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 112.164 08 Barcelona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 111.604 08 Barcelona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 109.070 08 Barcelona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 105.329 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 105.090 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 103.344 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 100.315 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 100.604 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 98.597 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 95.405 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 94.011 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 91.621 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 91.008 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 08 Barcelona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 08 Barcelona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 08 Barcelona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,91 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,16 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,75 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,44 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,14 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,4 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 85,49 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,19 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 82,09 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 83,44 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 109.472 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 107.766 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 97.559 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 102.748 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 101.401 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 92.266 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 97.807 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 97.045 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 87.982 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 91.993 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 83.851 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 88.351 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 81.200 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,86 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,09 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,57 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,34 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 90,05 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,18 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 85,36 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 85,95 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 81,98 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 83,23 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 2.692 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 3.838 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 11.511 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 2.581 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 3.689 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 11.078 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 2.508 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 3.559 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 10.615 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 3.412 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 10.160 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 3.270 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 9.808 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,88 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,12 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,24 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,16 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 92,73 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 92,22 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 88,9 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 88,26 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 85,2 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 85,21 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 111.823 08 Barcelona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 111.455 08 Barcelona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 109.908 08 Barcelona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 105.619 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 105.701 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 103.593 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 99.719 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 98.301 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 95.333 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 94.715 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 91.664 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 91.452 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 08 Barcelona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 08 Barcelona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 08 Barcelona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,45 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,84 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,25 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,47 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,44 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 85,53 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 86,18 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 82,24 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 83,21 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 109.709 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 106.290 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 93.752 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 103.571 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 100.728 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 88.115 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 94.990 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 83.517 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 90.829 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 80.431 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 87.335 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 77.602 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,41 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,77 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,99 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,37 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,08 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 85,45 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 85,79 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 82,17 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 82,77 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 2.114 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 5.165 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 16.156 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 2.048 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 4.973 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 15.478 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 4.729 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 14.784 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 4.504 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 14.284 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 4.329 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 13.850 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,88 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,28 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 95,8 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91,56 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 91,51 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 87,2 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 88,41 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 83,81 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 85,73 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 16.894 08 Barcelona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 16.189 08 Barcelona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 16.998 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 16.613 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 15.950 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 16.397 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 16.348 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 15.697 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 16.186 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 16.116 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 15.513 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 15.939 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 15.893 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 15.309 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 15.722 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 08 Barcelona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 08 Barcelona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,34 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,52 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,46 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,77 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,96 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,22 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 95,39 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,82 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 93,77 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 94,07 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,56 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 92,49 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 15.723 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 12.004 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 15.467 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 11.824 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 15.214 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 11.638 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 14.998 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 11.499 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 14.785 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 11.352 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,37 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,5 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,76 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,95 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,39 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,79 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 94,03 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,57 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.171 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 4.185 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.146 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 4.126 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.134 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 4.059 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.118 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 4.014 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.108 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 3.957 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,87 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,59 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96,84 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,99 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 95,47 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,91 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,62 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 94,55 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 17.040 08 Barcelona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 16.240 08 Barcelona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 16.122 08 Barcelona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 16.762 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 16.022 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 15.969 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 16.549 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 15.845 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 15.751 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 16.321 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 15.626 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 15.526 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 15.323 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 15.242 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 08 Barcelona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 08 Barcelona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 08 Barcelona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,37 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,66 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,05 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,12 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,57 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,7 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,78 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,22 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,3 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,35 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,54 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 15.909 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 12.575 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 9.911 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 15.646 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 12.405 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 9.790 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 15.444 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 12.263 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 9.658 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 15.230 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 12.100 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 9.539 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 11.864 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 9.354 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,35 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,65 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,78 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,08 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,52 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,45 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,73 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,22 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,25 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 94,35 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,38 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.131 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 3.665 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 6.211 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.116 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 3.617 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 6.179 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.105 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 3.582 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 6.093 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.091 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 3.526 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 5.987 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 3.459 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 5.888 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,67 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,69 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,48 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,7 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,74 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,1 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,46 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,21 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,39 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 94,38 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,8 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 17.353 08 Barcelona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 16.811 08 Barcelona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 16.259 08 Barcelona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 17.120 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 16.572 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 16.030 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 16.842 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 16.306 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 15.765 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 15.975 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 15.473 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 15.750 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 15.280 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 08 Barcelona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 08 Barcelona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 08 Barcelona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,66 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,58 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,59 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,06 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 96,96 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,03 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,17 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 93,69 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 93,98 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 16.686 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 15.642 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 12.704 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 16.457 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 15.416 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 12.521 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 16.188 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 15.171 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 12.322 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 14.856 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 12.099 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 14.648 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 11.949 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,63 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,56 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,56 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,02 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 96,99 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,99 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 94,98 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,24 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 93,65 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,06 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 667 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.169 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 3.555 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 663 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.156 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 3.509 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 654 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1.135 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 3.443 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1.119 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 3.374 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1.102 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 3.331 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,4 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,89 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,71 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,05 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,09 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,85 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,72 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,91 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 94,27 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 93,7 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 17.003 08 Barcelona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 16.714 08 Barcelona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 16.235 08 Barcelona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 16.791 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 16.507 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 16.020 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 16.198 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 15.742 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 15.947 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 15.510 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 15.758 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 15.330 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 08 Barcelona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 08 Barcelona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 08 Barcelona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,75 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,76 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,68 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,91 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,96 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95,41 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 95,53 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 94,28 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 94,43 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 16.419 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 15.526 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 10.989 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 16.213 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 15.330 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 10.843 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 15.038 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 10.654 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 14.797 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 10.499 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 14.625 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 10.382 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,75 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,74 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,67 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,86 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,95 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,3 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,54 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 94,2 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 94,48 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 584 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.188 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 5.246 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 578 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.177 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 5.177 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.160 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 5.088 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.150 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 5.011 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.133 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 4.948 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,97 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,07 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,68 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 97,64 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,99 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,8 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,52 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 95,37 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 94,32 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 24.471 08 Barcelona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 23.160 08 Barcelona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 24.857 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 24.242 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 22.964 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 24.398 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 24.006 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 22.739 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 24.195 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 23.789 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 22.552 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 23.979 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 23.593 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 22.347 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 23.758 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 08 Barcelona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 08 Barcelona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,06 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,15 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,15 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,1 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,18 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,34 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,21 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,37 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,47 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,41 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,49 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 95,58 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 22.348 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 15.372 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 22.134 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 15.248 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 21.919 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 15.102 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 21.718 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 14.977 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 21.538 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 14.845 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,04 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,19 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,08 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,24 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,18 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,43 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,38 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,57 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2.123 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 7.788 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2.108 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 7.716 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2.087 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 7.637 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2.071 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 7.575 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2.055 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 7.502 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,29 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,08 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,3 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,06 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,55 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,27 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,8 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,33 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 24.835 08 Barcelona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 23.322 08 Barcelona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 23.348 08 Barcelona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 24.650 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 23.127 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 23.196 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 24.438 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 22.933 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 23.032 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 24.223 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 22.734 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 22.869 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 22.482 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 22.638 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 08 Barcelona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 08 Barcelona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 08 Barcelona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,26 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,16 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,35 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,4 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,33 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,65 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,54 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,48 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,95 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,4 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,96 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 22.760 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 16.493 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 13.916 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 22.594 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 16.357 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 13.817 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 22.400 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 16.210 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 13.725 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 22.203 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 16.063 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 13.644 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 15.880 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 13.517 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,27 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,18 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,29 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,42 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,28 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,63 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,55 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,39 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,05 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,28 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,13 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 2.075 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 6.829 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 9.432 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 2.056 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 6.770 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 9.379 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 2.038 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 6.723 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 9.307 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 2.020 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 6.671 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 9.225 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 6.602 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 9.121 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,08 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,14 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,44 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,22 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,45 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,67 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,35 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,69 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,81 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,68 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,7 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 25.273 08 Barcelona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 23.984 08 Barcelona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 23.315 08 Barcelona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 25.049 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 23.777 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 23.134 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 24.771 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 23.551 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 22.948 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 23.280 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 22.723 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 23.089 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 22.511 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 08 Barcelona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 08 Barcelona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 08 Barcelona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,11 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,14 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,22 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,01 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,19 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,43 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,06 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,46 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,27 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,55 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 24.200 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 21.783 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 16.802 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 23.987 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 21.589 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 16.665 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 23.723 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 21.381 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 16.535 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 21.138 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 16.375 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 20.959 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 16.236 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,12 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,11 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,18 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,03 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,15 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,41 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,04 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,46 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,22 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,63 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1.073 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 2.201 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 6.513 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1.062 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 2.188 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 6.469 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1.048 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 2.170 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 6.413 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 2.142 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 6.348 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 2.130 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 6.275 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,97 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,41 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,32 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,67 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,59 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,46 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,32 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,47 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,77 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,35 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 25.077 08 Barcelona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 24.019 08 Barcelona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 23.257 08 Barcelona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 24.883 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 23.846 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 23.113 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 23.588 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 22.894 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 23.362 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 22.667 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 23.142 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 22.483 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 08 Barcelona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 08 Barcelona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 08 Barcelona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,23 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,28 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,38 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,21 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,44 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,26 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,46 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,35 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,67 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 24.135 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 21.912 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 13.765 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 23.948 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 21.748 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 13.691 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 21.510 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 13.575 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 21.304 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 13.449 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 21.094 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 13.351 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,23 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,25 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,46 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,17 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,62 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,23 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,7 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,27 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,99 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 942 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 2.107 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 9.492 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 935 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 2.098 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 9.422 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 2.078 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 9.319 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 2.058 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 9.218 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 2.048 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 9.132 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,26 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,57 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,26 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,62 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,18 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,67 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,11 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 97,2 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,21 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 1.592 08 Barcelona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 1.539 08 Barcelona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 1.635 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 1.585 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 1.530 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 1.625 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 1.577 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 1.524 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 1.617 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 1.568 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 1.519 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 1.611 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 1.563 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 1.512 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 1.599 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 08 Barcelona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 08 Barcelona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,56 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,42 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,39 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,06 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 99,03 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,9 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,49 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,7 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,53 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,18 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,25 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,8 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.413 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 885 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.406 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 879 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.401 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 876 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.394 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 874 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.390 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 869 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,5 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,32 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,15 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,98 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,66 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,76 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,37 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,19 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 179 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 654 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 179 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 651 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 176 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 648 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 174 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 645 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 173 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 643 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,54 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,32 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 99,08 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,21 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,62 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,65 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,32 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 1.615 08 Barcelona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 1.518 08 Barcelona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 1.562 08 Barcelona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 1.611 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 1.516 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 1.558 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 1.603 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 1.510 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 1.554 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 1.598 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 1.502 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 1.544 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 1.493 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 1.532 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 08 Barcelona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 08 Barcelona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 08 Barcelona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,75 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,87 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,74 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,26 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,47 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,49 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,95 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,95 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,85 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,35 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,08 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.442 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 959 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 947 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.438 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 958 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 944 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.432 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 955 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 942 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.427 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 948 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 935 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 942 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 929 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,72 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,9 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,68 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 99,31 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 99,58 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,47 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,96 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98,85 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,73 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 98,23 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 98,1 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 173 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 559 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 615 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 173 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 558 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 614 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 171 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 555 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 612 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 171 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 554 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 609 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 551 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 603 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,82 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,84 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,84 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,28 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,51 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 98,84 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 99,11 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 99,02 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 98,57 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,05 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 1.664 08 Barcelona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 1.531 08 Barcelona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.513 08 Barcelona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 1.661 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 1.528 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 1.512 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 1.656 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 1.521 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 1.503 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 1.515 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 1.493 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 1.506 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 1.487 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 08 Barcelona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 08 Barcelona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 08 Barcelona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,82 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,8 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,93 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 99,52 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,35 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,34 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,95 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,68 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,37 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,28 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.560 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.331 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 911 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.557 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.328 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 911 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.552 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.322 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 905 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.316 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 900 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.307 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 896 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,81 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,77 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 99,49 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 99,32 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 99,34 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,87 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,79 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,2 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 98,35 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 104 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 200 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 602 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 104 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 200 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 601 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 104 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 199 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 598 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 199 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 593 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 199 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 591 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,83 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,5 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,34 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 99,5 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,5 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 99,5 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,17 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 1.683 08 Barcelona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 1.554 08 Barcelona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.529 08 Barcelona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 1.680 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 1.548 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 1.522 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 1.540 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 1.511 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 1.533 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 1.505 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 1.527 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 1.499 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 08 Barcelona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 08 Barcelona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 08 Barcelona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,82 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,61 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,54 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,1 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,82 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,65 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,43 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,26 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,04 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.597 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.365 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 789 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.594 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.359 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 785 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.351 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 778 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.344 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 774 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.339 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 771 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,81 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,56 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,49 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,97 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,61 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,46 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,1 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,1 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,72 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 86 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 189 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 740 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 86 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 189 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 737 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 189 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 733 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 189 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 731 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 188 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 728 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,59 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 99,05 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,78 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 99,47 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,38 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 837 08 Barcelona De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 798 08 Barcelona De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 837 08 Barcelona De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 835 08 Barcelona De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 798 08 Barcelona De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 834 08 Barcelona De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 835 08 Barcelona De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 796 08 Barcelona De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 830 08 Barcelona De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 834 08 Barcelona De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 793 08 Barcelona De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 828 08 Barcelona De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 831 08 Barcelona De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 790 08 Barcelona De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 828 08 Barcelona De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 08 Barcelona De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 08 Barcelona De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,76 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,64 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,76 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 99,75 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 99,16 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 99,64 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 99,37 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,92 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 99,28 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 99 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,92 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 746 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 427 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 744 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 427 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 744 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 425 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 743 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 423 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 741 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 422 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,73 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,73 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 99,53 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 99,6 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 99,06 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 99,33 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,83 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 91 08 Barcelona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 371 08 Barcelona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 91 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 371 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 91 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 371 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 91 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 370 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 90 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 368 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 08 Barcelona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 08 Barcelona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 99,73 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 98,9 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 99,19 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 856 08 Barcelona De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 805 08 Barcelona De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 811 08 Barcelona De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 855 08 Barcelona De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 802 08 Barcelona De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 808 08 Barcelona De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 854 08 Barcelona De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 800 08 Barcelona De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 806 08 Barcelona De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 853 08 Barcelona De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 798 08 Barcelona De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 806 08 Barcelona De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 797 08 Barcelona De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 804 08 Barcelona De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 08 Barcelona De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 08 Barcelona De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 08 Barcelona De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 08 Barcelona De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,88 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,63 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,63 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,77 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,38 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,38 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 99,65 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 99,13 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 99,38 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 99,01 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 99,14 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 759 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 451 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 497 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 758 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 449 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 496 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 757 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 448 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 494 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 757 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 448 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 494 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 447 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 493 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,87 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,56 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,8 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 99,74 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 99,33 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,4 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 99,74 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 99,33 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 99,4 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 99,11 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 99,2 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 97 08 Barcelona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 354 08 Barcelona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 314 08 Barcelona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 97 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 353 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 312 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 97 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 352 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 312 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 96 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 350 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 312 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 350 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 311 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 08 Barcelona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 08 Barcelona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 08 Barcelona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,72 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,36 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,44 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,36 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 98,97 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,87 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 99,36 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 98,87 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 99,04 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 863 08 Barcelona De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 806 08 Barcelona De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 779 08 Barcelona De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 861 08 Barcelona De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 805 08 Barcelona De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 777 08 Barcelona De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 860 08 Barcelona De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 803 08 Barcelona De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 777 08 Barcelona De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 802 08 Barcelona De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 775 08 Barcelona De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 802 08 Barcelona De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 774 08 Barcelona De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 08 Barcelona De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 08 Barcelona De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 08 Barcelona De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 08 Barcelona De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 08 Barcelona De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 08 Barcelona De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,77 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,88 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,74 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 99,65 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,63 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,74 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 99,5 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 99,49 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 99,5 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 99,36 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 813 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 689 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 436 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 811 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 689 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 434 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 811 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 689 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 434 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 688 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 433 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 688 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 432 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,75 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,54 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 99,75 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 99,54 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 99,85 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 99,31 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 99,85 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 99,08 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 50 08 Barcelona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 117 08 Barcelona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 343 08 Barcelona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 50 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 116 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 343 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 49 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 114 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 343 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 114 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 342 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 114 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 342 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 08 Barcelona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 08 Barcelona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 08 Barcelona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,15 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,44 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,44 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 99,71 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 97,44 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 99,71 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 879 08 Barcelona De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 832 08 Barcelona De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 803 08 Barcelona De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 877 08 Barcelona De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 830 08 Barcelona De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 803 08 Barcelona De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 828 08 Barcelona De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 801 08 Barcelona De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 828 08 Barcelona De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 799 08 Barcelona De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 825 08 Barcelona De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 796 08 Barcelona De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 08 Barcelona De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 08 Barcelona De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 08 Barcelona De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 08 Barcelona De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 08 Barcelona De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 08 Barcelona De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 08 Barcelona De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,77 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,76 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,52 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 99,75 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 99,52 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 99,5 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 99,16 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 99,13 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 837 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 729 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 407 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 836 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 728 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 407 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 727 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 406 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 727 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 405 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 725 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 404 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,88 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,86 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 99,73 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 99,75 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 99,73 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 99,51 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 99,45 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 99,26 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 42 08 Barcelona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 103 08 Barcelona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 396 08 Barcelona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 41 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 102 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 396 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 101 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 395 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 101 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 394 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 100 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 392 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 08 Barcelona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 08 Barcelona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 08 Barcelona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,62 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,03 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,06 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 99,75 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 98,06 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 99,49 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 97,09 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,99 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 08 Barcelona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia Total Cohort January 1 Total Number at the start of the quarter 2022QI 26.609 48 Bizkaia Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia Total Cohort January 1 Total Number at the start of the quarter 2021QI 26.281 48 Bizkaia Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia Total Cohort January 1 Total Number at the start of the quarter 2020QI 27.072 48 Bizkaia Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 48 Bizkaia Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 48 Bizkaia Total Cohort January 1 Total Survival in the first trimester 2022QII "" 48 Bizkaia Total Cohort January 1 Total Survival in the first trimester 2022QI 25.312 48 Bizkaia Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 48 Bizkaia Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 48 Bizkaia Total Cohort January 1 Total Survival in the first trimester 2021QII "" 48 Bizkaia Total Cohort January 1 Total Survival in the first trimester 2021QI 25.107 48 Bizkaia Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 48 Bizkaia Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 48 Bizkaia Total Cohort January 1 Total Survival in the first trimester 2020QII "" 48 Bizkaia Total Cohort January 1 Total Survival in the first trimester 2020QI 24.999 48 Bizkaia Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 48 Bizkaia Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 48 Bizkaia Total Cohort January 1 Total Survival in the second trimester 2022QII 24.191 48 Bizkaia Total Cohort January 1 Total Survival in the second trimester 2022QI "" 48 Bizkaia Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 48 Bizkaia Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 48 Bizkaia Total Cohort January 1 Total Survival in the second trimester 2021QII 24.172 48 Bizkaia Total Cohort January 1 Total Survival in the second trimester 2021QI "" 48 Bizkaia Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 48 Bizkaia Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 48 Bizkaia Total Cohort January 1 Total Survival in the second trimester 2020QII 24.205 48 Bizkaia Total Cohort January 1 Total Survival in the second trimester 2020QI "" 48 Bizkaia Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia Total Cohort January 1 Total Survival in the third trimester 2022QIII 23.432 48 Bizkaia Total Cohort January 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia Total Cohort January 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia Total Cohort January 1 Total Survival in the third trimester 2021QIII 23.479 48 Bizkaia Total Cohort January 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia Total Cohort January 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia Total Cohort January 1 Total Survival in the third trimester 2020QIII 23.534 48 Bizkaia Total Cohort January 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia Total Cohort January 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia Total Cohort January 1 Total Survival in the third trimester 2022QIV 22.855 48 Bizkaia Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia Total Cohort January 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia Total Cohort January 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia Total Cohort January 1 Total Survival in the third trimester 2021QIV 22.926 48 Bizkaia Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia Total Cohort January 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia Total Cohort January 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia Total Cohort January 1 Total Survival in the third trimester 2020QIV 22.920 48 Bizkaia Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia Total Cohort January 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia Total Cohort January 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 48 Bizkaia Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 48 Bizkaia Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,13 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,53 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 92,34 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,91 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,98 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 89,41 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 88,06 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 89,34 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 86,93 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 85,89 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 87,23 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 84,66 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 25.411 48 Bizkaia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 22.473 48 Bizkaia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 24.157 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 21.409 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 23.076 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 20.562 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 22.344 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 19.949 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 21.786 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 19.479 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 48 Bizkaia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 48 Bizkaia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 95,07 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 95,27 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,81 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 91,5 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 87,93 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 88,77 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 85,73 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 86,68 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.198 48 Bizkaia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 3.808 48 Bizkaia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.155 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 3.698 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.115 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 3.610 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.088 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 3.530 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.069 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 3.447 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 48 Bizkaia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 48 Bizkaia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,41 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,11 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,07 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,8 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,82 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,7 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 89,23 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 90,52 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia Total Cohort April 1 Total Number at the start of the quarter 2022QII 26.402 48 Bizkaia Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia Total Cohort April 1 Total Number at the start of the quarter 2021QII 26.244 48 Bizkaia Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia Total Cohort April 1 Total Number at the start of the quarter 2020QII 26.011 48 Bizkaia Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 48 Bizkaia Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 48 Bizkaia Total Cohort April 1 Total Survival in the first trimester 2022QII 25.060 48 Bizkaia Total Cohort April 1 Total Survival in the first trimester 2022QI "" 48 Bizkaia Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 48 Bizkaia Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 48 Bizkaia Total Cohort April 1 Total Survival in the first trimester 2021QII 25.094 48 Bizkaia Total Cohort April 1 Total Survival in the first trimester 2021QI "" 48 Bizkaia Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 48 Bizkaia Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 48 Bizkaia Total Cohort April 1 Total Survival in the first trimester 2020QII 25.101 48 Bizkaia Total Cohort April 1 Total Survival in the first trimester 2020QI "" 48 Bizkaia Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 48 Bizkaia Total Cohort April 1 Total Survival in the second trimester 2022QIII 24.184 48 Bizkaia Total Cohort April 1 Total Survival in the second trimester 2022QII "" 48 Bizkaia Total Cohort April 1 Total Survival in the second trimester 2022QI "" 48 Bizkaia Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 48 Bizkaia Total Cohort April 1 Total Survival in the second trimester 2021QIII 24.271 48 Bizkaia Total Cohort April 1 Total Survival in the second trimester 2021QII "" 48 Bizkaia Total Cohort April 1 Total Survival in the second trimester 2021QI "" 48 Bizkaia Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 48 Bizkaia Total Cohort April 1 Total Survival in the second trimester 2020QIII 24.329 48 Bizkaia Total Cohort April 1 Total Survival in the second trimester 2020QII "" 48 Bizkaia Total Cohort April 1 Total Survival in the second trimester 2020QI "" 48 Bizkaia Total Cohort April 1 Total Survival in the third trimester 2022QIV 23.522 48 Bizkaia Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia Total Cohort April 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia Total Cohort April 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia Total Cohort April 1 Total Survival in the third trimester 2021QIV 23.624 48 Bizkaia Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia Total Cohort April 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia Total Cohort April 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia Total Cohort April 1 Total Survival in the third trimester 2020QIV 23.634 48 Bizkaia Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia Total Cohort April 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia Total Cohort April 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia Total Cohort April 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia Total Cohort April 1 Total Survival in the third trimester 2022QI 22.799 48 Bizkaia Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia Total Cohort April 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia Total Cohort April 1 Total Survival in the third trimester 2021QI 22.865 48 Bizkaia Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia Total Cohort April 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia Total Cohort April 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 48 Bizkaia Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 48 Bizkaia Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 48 Bizkaia Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,92 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,62 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,5 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 91,6 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,48 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,53 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 89,09 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 90,02 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,86 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 86,87 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87,91 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 25.256 48 Bizkaia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 22.396 48 Bizkaia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 19.794 48 Bizkaia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 23.952 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 21.342 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 18.990 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 23.104 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 20.600 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 18.383 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 22.461 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 20.042 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 17.825 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 19.311 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 17.221 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 48 Bizkaia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 48 Bizkaia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 48 Bizkaia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,84 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,29 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,94 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,48 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,98 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,87 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 88,93 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 89,49 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 90,05 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 86,23 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 87 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.146 48 Bizkaia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 3.848 48 Bizkaia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 6.217 48 Bizkaia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.108 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 3.752 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 6.111 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.080 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 3.671 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 5.946 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.061 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 3.582 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 5.809 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 3.488 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 5.644 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 48 Bizkaia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 48 Bizkaia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 48 Bizkaia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,68 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,51 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,29 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,24 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,4 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,64 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 92,58 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,09 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,44 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 90,64 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 90,78 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia Total Cohort July 1 Total Number at the start of the quarter 2022QIII 26.258 48 Bizkaia Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia Total Cohort July 1 Total Number at the start of the quarter 2021QIII 26.308 48 Bizkaia Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia Total Cohort July 1 Total Number at the start of the quarter 2020QIII 26.100 48 Bizkaia Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 48 Bizkaia Total Cohort July 1 Total Survival in the first trimester 2022QIII 25.095 48 Bizkaia Total Cohort July 1 Total Survival in the first trimester 2022QII "" 48 Bizkaia Total Cohort July 1 Total Survival in the first trimester 2022QI "" 48 Bizkaia Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 48 Bizkaia Total Cohort July 1 Total Survival in the first trimester 2021QIII 25.184 48 Bizkaia Total Cohort July 1 Total Survival in the first trimester 2021QII "" 48 Bizkaia Total Cohort July 1 Total Survival in the first trimester 2021QI "" 48 Bizkaia Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 48 Bizkaia Total Cohort July 1 Total Survival in the first trimester 2020QIII 25.103 48 Bizkaia Total Cohort July 1 Total Survival in the first trimester 2020QII "" 48 Bizkaia Total Cohort July 1 Total Survival in the first trimester 2020QI "" 48 Bizkaia Total Cohort July 1 Total Survival in the second trimester 2022QIV 24.297 48 Bizkaia Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 48 Bizkaia Total Cohort July 1 Total Survival in the second trimester 2022QII "" 48 Bizkaia Total Cohort July 1 Total Survival in the second trimester 2022QI "" 48 Bizkaia Total Cohort July 1 Total Survival in the second trimester 2021QIV 24.392 48 Bizkaia Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 48 Bizkaia Total Cohort July 1 Total Survival in the second trimester 2021QII "" 48 Bizkaia Total Cohort July 1 Total Survival in the second trimester 2021QI "" 48 Bizkaia Total Cohort July 1 Total Survival in the second trimester 2020QIV 24.271 48 Bizkaia Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 48 Bizkaia Total Cohort July 1 Total Survival in the second trimester 2020QII "" 48 Bizkaia Total Cohort July 1 Total Survival in the second trimester 2020QI "" 48 Bizkaia Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia Total Cohort July 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia Total Cohort July 1 Total Survival in the third trimester 2022QI 23.478 48 Bizkaia Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia Total Cohort July 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia Total Cohort July 1 Total Survival in the third trimester 2021QI 23.444 48 Bizkaia Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia Total Cohort July 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia Total Cohort July 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia Total Cohort July 1 Total Survival in the third trimester 2022QII 22.781 48 Bizkaia Total Cohort July 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia Total Cohort July 1 Total Survival in the third trimester 2021QII 22.852 48 Bizkaia Total Cohort July 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia Total Cohort July 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia Total Cohort July 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 48 Bizkaia Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 48 Bizkaia Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 48 Bizkaia Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 95,57 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,73 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 96,18 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 92,53 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 92,72 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 92,99 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 89,24 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 89,82 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 86,59 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 87,56 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 25.666 48 Bizkaia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 25.283 48 Bizkaia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 22.472 48 Bizkaia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 24.521 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 24.174 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 21.564 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 23.737 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 23.407 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 20.802 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 22.519 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 20.070 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 21.841 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 19.549 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 48 Bizkaia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 48 Bizkaia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 48 Bizkaia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 95,54 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,61 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,96 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 92,48 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 92,58 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 92,57 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 89,07 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 89,31 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 86,39 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 86,99 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 592 48 Bizkaia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.025 48 Bizkaia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 3.628 48 Bizkaia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 574 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.010 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 3.539 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 560 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 985 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 3.469 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 959 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 3.374 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 940 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 3.303 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 48 Bizkaia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 48 Bizkaia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 48 Bizkaia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,96 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,54 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,55 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,59 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,1 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,62 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93,56 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 91,71 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,04 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia Total Cohort October 1 Total Number at the start of the quarter 2022QIV 26.129 48 Bizkaia Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia Total Cohort October 1 Total Number at the start of the quarter 2021QIV 26.296 48 Bizkaia Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia Total Cohort October 1 Total Number at the start of the quarter 2020QIV 26.156 48 Bizkaia Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia Total Cohort October 1 Total Survival in the first trimester 2022QIV 25.155 48 Bizkaia Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 48 Bizkaia Total Cohort October 1 Total Survival in the first trimester 2022QII "" 48 Bizkaia Total Cohort October 1 Total Survival in the first trimester 2022QI "" 48 Bizkaia Total Cohort October 1 Total Survival in the first trimester 2021QIV 25.297 48 Bizkaia Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 48 Bizkaia Total Cohort October 1 Total Survival in the first trimester 2021QII "" 48 Bizkaia Total Cohort October 1 Total Survival in the first trimester 2021QI "" 48 Bizkaia Total Cohort October 1 Total Survival in the first trimester 2020QIV 25.116 48 Bizkaia Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 48 Bizkaia Total Cohort October 1 Total Survival in the first trimester 2020QII "" 48 Bizkaia Total Cohort October 1 Total Survival in the first trimester 2020QI "" 48 Bizkaia Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 48 Bizkaia Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 48 Bizkaia Total Cohort October 1 Total Survival in the second trimester 2022QII "" 48 Bizkaia Total Cohort October 1 Total Survival in the second trimester 2022QI 24.255 48 Bizkaia Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 48 Bizkaia Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 48 Bizkaia Total Cohort October 1 Total Survival in the second trimester 2021QII "" 48 Bizkaia Total Cohort October 1 Total Survival in the second trimester 2021QI 24.163 48 Bizkaia Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 48 Bizkaia Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 48 Bizkaia Total Cohort October 1 Total Survival in the second trimester 2020QII "" 48 Bizkaia Total Cohort October 1 Total Survival in the second trimester 2020QI "" 48 Bizkaia Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia Total Cohort October 1 Total Survival in the third trimester 2022QII 23.375 48 Bizkaia Total Cohort October 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia Total Cohort October 1 Total Survival in the third trimester 2021QII 23.445 48 Bizkaia Total Cohort October 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia Total Cohort October 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia Total Cohort October 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia Total Cohort October 1 Total Survival in the third trimester 2022QIII 22.737 48 Bizkaia Total Cohort October 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia Total Cohort October 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia Total Cohort October 1 Total Survival in the third trimester 2021QIII 22.855 48 Bizkaia Total Cohort October 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia Total Cohort October 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia Total Cohort October 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia Total Cohort October 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 48 Bizkaia Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 48 Bizkaia Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 48 Bizkaia Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 96,27 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 96,2 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 96,02 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 92,24 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 92,38 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 88,89 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 89,64 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 86,47 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 87,38 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 25.653 48 Bizkaia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 25.039 48 Bizkaia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 21.920 48 Bizkaia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 24.691 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 24.082 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 20.968 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 23.082 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 20.129 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 22.243 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 19.493 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 21.625 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 18.988 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 48 Bizkaia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 48 Bizkaia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 48 Bizkaia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 96,25 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 96,18 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 95,66 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 92,18 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 91,83 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 88,83 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 88,93 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 86,37 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 86,62 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 476 48 Bizkaia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.257 48 Bizkaia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 4.236 48 Bizkaia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 464 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.215 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 4.148 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.173 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 4.034 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.132 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 3.952 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.112 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 3.867 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 48 Bizkaia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 48 Bizkaia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 48 Bizkaia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,48 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,66 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,92 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,32 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,23 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 90,06 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,3 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 88,46 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 91,29 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 19.212 48 Bizkaia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 19.127 48 Bizkaia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 19.562 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 17.997 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 18.039 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 17.648 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 16.986 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 17.198 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 16.945 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 16.297 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 16.574 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 16.358 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 15.775 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 16.086 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 15.805 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 48 Bizkaia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 48 Bizkaia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,68 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,31 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 90,22 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,41 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 89,91 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 86,62 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 84,83 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 86,65 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 83,62 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 82,11 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 84,1 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 80,79 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 18.485 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 17.139 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 17.310 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 16.142 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 16.333 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 15.375 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 15.669 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 14.812 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 15.161 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 14.389 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,64 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,18 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,36 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,71 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 84,77 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,42 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 82,02 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 83,95 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 727 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.988 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 687 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.897 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 653 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.823 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 628 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.762 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 614 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.697 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,5 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,42 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 89,82 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 91,7 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 86,38 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 88,63 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 84,46 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 85,36 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 18.958 48 Bizkaia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 19.067 48 Bizkaia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 18.842 48 Bizkaia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 17.729 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 18.006 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 18.009 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 16.921 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 17.247 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 17.310 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 16.315 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 16.672 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 16.671 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 15.937 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 15.999 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 48 Bizkaia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 48 Bizkaia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 48 Bizkaia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,52 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,44 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,58 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,26 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,45 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,87 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 86,06 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 87,44 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,48 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 83,58 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 84,91 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 18.284 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 17.068 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 14.976 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 17.088 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 16.089 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 14.222 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 16.306 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 15.394 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 13.652 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 15.716 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 14.891 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 13.132 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 14.227 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 12.590 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,46 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,26 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,97 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 89,18 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 90,19 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,16 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 85,95 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 87,25 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 87,69 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 83,35 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,07 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 674 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.999 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 3.866 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 641 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.917 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 3.787 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 615 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.853 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 3.658 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 599 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.781 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 3.539 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.710 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 3.409 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,1 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 95,9 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,96 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,25 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 92,7 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,62 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,87 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 89,09 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,54 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 85,54 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 88,18 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 18.823 48 Bizkaia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 19.016 48 Bizkaia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 18.968 48 Bizkaia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 17.725 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 17.969 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 18.042 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 16.992 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 17.248 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 17.272 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 16.426 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 16.542 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 15.783 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 16.013 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 48 Bizkaia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 48 Bizkaia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 48 Bizkaia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,17 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,49 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,12 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 90,27 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,7 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 91,06 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 86,38 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 87,21 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 83 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,42 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 18.417 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 18.483 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 17.103 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 17.337 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 17.446 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 16.242 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 16.616 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 16.746 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 15.531 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 15.940 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 14.870 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 15.313 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 14.396 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,14 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,39 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,97 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 90,22 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 90,6 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,81 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 86,24 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,94 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 82,85 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 84,17 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 406 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 533 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.865 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 388 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 523 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.800 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 376 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 502 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.741 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 486 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.672 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 470 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.617 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,57 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,12 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,51 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 92,61 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 94,18 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,35 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 91,18 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 89,65 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 88,18 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 86,7 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 18.687 48 Bizkaia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 19.027 48 Bizkaia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 19.004 48 Bizkaia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 17.763 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 18.096 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 18.019 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 17.140 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 17.160 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 16.342 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 16.511 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 15.766 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 15.990 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 48 Bizkaia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 48 Bizkaia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 48 Bizkaia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,06 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,11 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,82 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,08 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,3 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 85,89 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 86,88 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 82,86 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 84,14 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 18.370 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 18.239 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 16.811 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 17.457 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 17.348 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 15.901 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 16.431 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 15.132 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 15.669 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 14.549 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 15.110 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 14.090 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95,03 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,11 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,59 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,09 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 90,01 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 85,91 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,54 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 82,84 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 83,81 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 317 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 788 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 2.193 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 306 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 748 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2.118 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 709 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2.028 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 673 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.962 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 656 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.900 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,53 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 94,92 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,58 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 89,97 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 92,48 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 85,41 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 89,47 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 83,25 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 86,64 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 2.751 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 2.721 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 2.823 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 2.712 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 2.681 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 2.722 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 2.658 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 2.631 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 2.675 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 2.619 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 2.601 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 2.632 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 2.591 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 2.565 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 2.603 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,58 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,53 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,42 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,62 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,69 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 94,76 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 95,2 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,59 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 93,23 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 94,18 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,27 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 92,21 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.614 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.111 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.575 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2.077 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.521 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.034 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.482 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.012 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.458 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.986 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,51 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,39 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,44 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,35 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,95 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,31 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 94,03 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,08 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 137 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 610 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 137 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 604 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 137 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 597 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 137 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 589 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 133 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 579 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,02 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,87 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,56 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 97,08 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 94,92 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 2.781 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 2.736 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 2.690 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 2.723 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 2.689 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 2.651 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 2.685 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 2.662 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 2.615 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 2.654 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 2.621 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 2.592 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 2.572 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 2.549 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,91 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,28 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,55 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,55 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,3 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,21 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,43 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,8 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,36 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,01 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,76 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.643 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.114 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.769 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.589 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.075 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.745 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.551 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.054 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.728 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.521 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.022 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.713 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.984 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.682 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,96 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,16 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,64 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,52 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,16 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,68 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,38 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,65 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,83 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,85 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,08 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 138 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 622 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 921 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 134 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 614 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 906 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 134 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 608 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 887 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 133 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 599 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 879 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 588 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 867 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,1 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,71 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,37 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,1 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,75 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,31 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,38 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,3 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,44 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 94,53 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,14 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 2.789 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 2.772 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 2.724 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 2.755 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 2.736 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 2.685 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 2.719 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 2.704 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 2.654 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 2.656 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 2.610 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 2.634 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 2.576 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,78 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,7 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,57 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,49 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,55 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,43 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,82 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,81 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,02 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 94,57 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.724 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.636 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2.139 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.690 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.600 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.113 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.655 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.569 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.085 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.523 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.049 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.501 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.022 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,75 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,63 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,78 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,47 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,46 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,48 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,71 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,79 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,88 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,53 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 65 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 136 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 585 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 65 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 136 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 572 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 64 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 135 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 569 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 133 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 561 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 133 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 554 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,78 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,46 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,26 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,26 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,79 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95,9 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 97,79 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 94,7 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 2.788 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 2.734 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 2.710 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 2.765 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 2.699 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 2.683 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 2.653 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 2.645 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 2.613 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 2.612 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 2.576 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 2.574 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,18 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,72 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,04 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,6 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95,57 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,38 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 94,22 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 94,98 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.731 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.590 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2.021 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.708 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.555 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.999 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.510 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.967 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.471 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.941 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.436 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.914 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,16 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,65 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,91 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,91 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,33 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,41 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,04 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 94,05 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 94,71 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 57 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 144 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 689 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 57 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 144 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 684 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 143 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 678 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 142 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 671 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 140 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 660 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,27 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 99,31 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,4 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 98,61 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,39 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 97,22 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 95,79 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 4.229 48 Bizkaia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 4.034 48 Bizkaia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 4.252 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 4.189 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 3.989 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 4.197 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 4.133 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 3.948 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 4.153 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 4.103 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 3.911 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 4.117 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 4.078 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 3.885 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 4.089 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 48 Bizkaia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 48 Bizkaia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,05 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,88 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,71 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,73 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,87 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,67 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,02 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,95 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,83 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,43 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,31 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,17 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 3.930 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.962 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 3.893 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2.930 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 3.843 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.896 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 3.814 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.869 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 3.790 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2.850 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,06 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,92 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,79 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,77 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,05 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,86 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,44 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,22 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 299 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.072 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 296 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.059 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 290 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.052 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 289 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.042 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 288 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.035 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,79 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96,99 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,13 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,66 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,2 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,32 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,55 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 4.249 48 Bizkaia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 4.052 48 Bizkaia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 4.063 48 Bizkaia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 4.194 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 4.012 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 4.025 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 4.165 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 3.977 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 3.993 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 4.141 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 3.949 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 3.964 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 3.911 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 3.911 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 48 Bizkaia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 48 Bizkaia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 48 Bizkaia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,71 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,01 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,06 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,02 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,15 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,28 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,46 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,46 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,56 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,52 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,26 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 3.950 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.961 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2.752 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 3.896 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.927 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2.726 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 3.868 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.902 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2.709 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 3.846 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.881 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.690 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.855 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.660 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,63 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,85 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,06 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,92 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,01 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,44 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,37 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,3 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,75 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,42 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,66 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 299 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.091 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.311 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 298 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.085 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.299 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 297 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.075 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.284 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 295 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.068 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.274 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.056 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.251 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,67 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,45 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,08 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 99,33 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,53 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,94 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 98,66 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,89 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,18 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,79 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,42 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 4.237 48 Bizkaia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 4.120 48 Bizkaia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 4.018 48 Bizkaia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 4.207 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 4.080 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 3.990 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 4.179 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 4.045 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 3.963 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 4.004 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 3.911 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 3.972 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 3.886 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 48 Bizkaia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 48 Bizkaia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 48 Bizkaia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,29 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,03 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,3 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,63 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,18 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,63 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,18 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,34 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,41 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,71 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 4.128 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 3.804 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2.968 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 4.098 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 3.769 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.949 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 4.071 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 3.737 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.930 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 3.704 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.896 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 3.675 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.880 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,27 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,08 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,36 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,62 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,24 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,72 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,37 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,57 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,61 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,04 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 109 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 316 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.050 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 109 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 311 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.041 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 108 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 308 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.033 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 300 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.015 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 297 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.006 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,42 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,14 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 99,08 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,47 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,38 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 94,94 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,67 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,99 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,81 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 4.235 48 Bizkaia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 4.132 48 Bizkaia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 4.048 48 Bizkaia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 4.209 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 4.101 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 4.023 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 4.064 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 3.968 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 4.022 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 3.935 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 3.998 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 3.905 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 48 Bizkaia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 48 Bizkaia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 48 Bizkaia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,39 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,25 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,38 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,35 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,02 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,34 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,21 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,76 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,47 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 4.142 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3.852 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2.850 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 4.117 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 3.823 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2.833 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 3.788 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.796 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 3.750 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2.772 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 3.727 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.753 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,4 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,25 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,4 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,34 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,11 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,35 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,26 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,75 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,6 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 93 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 280 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.198 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 92 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 278 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.190 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 276 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.172 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 272 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.163 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 271 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.152 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,92 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,29 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,33 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,57 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,83 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,14 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,08 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96,79 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,16 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 277 48 Bizkaia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 257 48 Bizkaia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 278 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 276 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 256 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 276 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 276 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 254 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 276 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 275 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 252 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 274 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 273 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 250 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 273 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 48 Bizkaia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 48 Bizkaia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,64 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,61 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,28 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,64 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,83 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 99,28 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 99,28 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,05 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,56 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,56 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,28 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,2 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 254 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 174 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 253 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 173 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 253 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 171 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 253 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 170 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 251 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 168 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,61 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,43 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,61 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,28 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 99,61 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,7 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,82 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,55 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 23 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 83 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 23 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 83 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 23 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 83 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 22 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 82 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 22 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 82 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 95,65 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,8 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 95,65 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,8 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 277 48 Bizkaia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 253 48 Bizkaia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 270 48 Bizkaia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 277 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 251 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 270 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 276 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 249 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 268 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 275 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 246 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 267 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 245 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 266 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 48 Bizkaia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 48 Bizkaia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 48 Bizkaia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,21 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,64 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,42 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,26 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 99,28 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,23 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,89 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,84 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,52 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 255 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 168 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 194 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 255 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 166 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 194 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 255 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 165 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 193 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 254 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 163 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 192 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 162 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 191 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,81 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,21 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,48 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 99,61 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,02 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,97 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,43 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 98,45 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 22 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 85 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 76 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 22 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 85 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 76 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 21 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 84 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 75 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 21 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 83 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 75 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 83 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 75 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 95,45 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,82 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,68 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 95,45 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,65 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,68 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,65 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,68 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 274 48 Bizkaia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 262 48 Bizkaia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 247 48 Bizkaia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 273 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 261 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 244 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 272 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 257 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 243 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 256 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 242 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 256 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 239 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 48 Bizkaia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 48 Bizkaia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 48 Bizkaia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,64 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,62 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,79 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 99,27 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,09 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,38 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,71 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,98 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,71 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,76 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 265 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 234 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 169 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 264 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 233 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 167 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 263 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 229 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 166 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 228 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 165 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 228 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 162 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,62 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,57 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,82 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 99,25 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,86 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,22 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,44 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,63 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,44 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,86 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 9 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 28 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 78 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 9 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 28 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 77 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 9 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 28 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 77 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 28 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 77 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 28 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 77 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,72 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,72 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,72 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,72 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 276 48 Bizkaia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 264 48 Bizkaia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 251 48 Bizkaia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 275 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 262 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 251 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 261 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 250 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 261 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 248 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 260 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 247 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 48 Bizkaia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 48 Bizkaia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 48 Bizkaia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,64 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,24 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,86 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 99,6 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,86 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,8 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,48 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,41 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 268 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 231 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 153 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 267 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 229 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 153 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 228 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 152 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 228 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 150 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 227 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 150 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,63 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,13 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,7 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 99,35 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,7 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,04 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,27 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,04 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 8 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 33 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 98 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 8 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 33 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 98 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 33 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 98 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 33 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 98 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 33 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 97 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,98 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 140 48 Bizkaia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 142 48 Bizkaia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 157 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 138 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 142 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 156 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 138 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 141 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 156 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 138 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 141 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 153 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 138 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 140 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 150 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 48 Bizkaia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 48 Bizkaia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,57 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,36 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,57 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 99,3 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 99,36 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,57 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 99,3 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,45 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,57 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,59 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 95,54 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 128 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 87 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 126 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 87 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 126 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 86 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 126 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 86 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 126 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 86 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,44 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,44 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,85 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,44 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,85 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,44 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,85 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 12 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 55 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 12 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 55 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 12 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 55 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 12 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 55 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 12 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 54 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,18 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 137 48 Bizkaia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 136 48 Bizkaia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 146 48 Bizkaia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 137 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 136 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 146 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 137 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 136 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 143 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 137 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 136 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 140 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 134 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 140 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 48 Bizkaia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 48 Bizkaia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 48 Bizkaia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,95 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,89 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,53 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,89 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 124 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 85 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 103 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 124 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 85 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 103 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 124 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 85 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 101 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 124 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 85 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 98 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 83 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 98 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,06 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,15 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,65 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,15 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 13 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 51 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 43 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 13 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 51 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 43 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 13 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 51 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 42 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 13 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 51 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 42 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 51 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 42 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,67 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,67 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 97,67 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 135 48 Bizkaia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 138 48 Bizkaia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 143 48 Bizkaia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 135 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 138 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 142 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 135 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 138 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 139 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 136 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 139 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 136 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 138 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 48 Bizkaia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 48 Bizkaia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 48 Bizkaia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 48 Bizkaia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 48 Bizkaia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 48 Bizkaia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,3 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,2 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,55 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,2 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,55 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,5 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 132 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 126 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 93 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 132 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 126 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 93 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 132 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 126 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 90 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 124 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 90 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 124 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 89 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,77 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,41 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,77 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,41 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,7 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 3 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 12 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 50 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 3 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 12 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 49 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 3 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 12 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 49 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 12 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 49 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 12 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 49 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 143 48 Bizkaia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 139 48 Bizkaia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 143 48 Bizkaia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 143 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 139 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 140 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 137 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 140 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 137 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 139 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 137 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 139 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 48 Bizkaia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 48 Bizkaia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 48 Bizkaia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 97,9 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,56 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,9 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,56 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,2 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,56 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,2 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 142 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 127 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 85 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 142 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 127 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 82 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 125 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 82 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 125 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 81 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 125 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 81 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 96,47 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,43 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,47 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,43 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,29 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,43 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,29 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 12 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 58 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 12 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 58 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 12 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 58 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 12 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 58 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 12 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 58 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 48 Bizkaia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 09 Burgos Total Cohort January 1 Total Number at the start of the quarter 2022QI 8.534 09 Burgos Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 09 Burgos Total Cohort January 1 Total Number at the start of the quarter 2021QI 8.392 09 Burgos Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 09 Burgos Total Cohort January 1 Total Number at the start of the quarter 2020QI 8.821 09 Burgos Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 09 Burgos Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 09 Burgos Total Cohort January 1 Total Survival in the first trimester 2022QII "" 09 Burgos Total Cohort January 1 Total Survival in the first trimester 2022QI 8.153 09 Burgos Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 09 Burgos Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 09 Burgos Total Cohort January 1 Total Survival in the first trimester 2021QII "" 09 Burgos Total Cohort January 1 Total Survival in the first trimester 2021QI 8.039 09 Burgos Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 09 Burgos Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 09 Burgos Total Cohort January 1 Total Survival in the first trimester 2020QII "" 09 Burgos Total Cohort January 1 Total Survival in the first trimester 2020QI 8.117 09 Burgos Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 09 Burgos Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 09 Burgos Total Cohort January 1 Total Survival in the second trimester 2022QII 7.896 09 Burgos Total Cohort January 1 Total Survival in the second trimester 2022QI "" 09 Burgos Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 09 Burgos Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 09 Burgos Total Cohort January 1 Total Survival in the second trimester 2021QII 7.816 09 Burgos Total Cohort January 1 Total Survival in the second trimester 2021QI "" 09 Burgos Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 09 Burgos Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 09 Burgos Total Cohort January 1 Total Survival in the second trimester 2020QII 7.901 09 Burgos Total Cohort January 1 Total Survival in the second trimester 2020QI "" 09 Burgos Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 09 Burgos Total Cohort January 1 Total Survival in the third trimester 2022QIII 7.664 09 Burgos Total Cohort January 1 Total Survival in the third trimester 2022QII "" 09 Burgos Total Cohort January 1 Total Survival in the third trimester 2022QI "" 09 Burgos Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 09 Burgos Total Cohort January 1 Total Survival in the third trimester 2021QIII 7.602 09 Burgos Total Cohort January 1 Total Survival in the third trimester 2021QII "" 09 Burgos Total Cohort January 1 Total Survival in the third trimester 2021QI "" 09 Burgos Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 09 Burgos Total Cohort January 1 Total Survival in the third trimester 2020QIII 7.693 09 Burgos Total Cohort January 1 Total Survival in the third trimester 2020QII "" 09 Burgos Total Cohort January 1 Total Survival in the third trimester 2020QI "" 09 Burgos Total Cohort January 1 Total Survival in the third trimester 2022QIV 7.469 09 Burgos Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 09 Burgos Total Cohort January 1 Total Survival in the third trimester 2022QII "" 09 Burgos Total Cohort January 1 Total Survival in the third trimester 2022QI "" 09 Burgos Total Cohort January 1 Total Survival in the third trimester 2021QIV 7.409 09 Burgos Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 09 Burgos Total Cohort January 1 Total Survival in the third trimester 2021QII "" 09 Burgos Total Cohort January 1 Total Survival in the third trimester 2021QI "" 09 Burgos Total Cohort January 1 Total Survival in the third trimester 2020QIV 7.521 09 Burgos Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 09 Burgos Total Cohort January 1 Total Survival in the third trimester 2020QII "" 09 Burgos Total Cohort January 1 Total Survival in the third trimester 2020QI "" 09 Burgos Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 09 Burgos Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 09 Burgos Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 09 Burgos Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 09 Burgos Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 09 Burgos Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 09 Burgos Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,54 09 Burgos Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,79 09 Burgos Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 92,02 09 Burgos Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 92,52 09 Burgos Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 93,14 09 Burgos Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 89,57 09 Burgos Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 89,81 09 Burgos Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 90,59 09 Burgos Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 87,21 09 Burgos Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 87,52 09 Burgos Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 88,29 09 Burgos Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 85,26 09 Burgos Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Burgos Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Burgos Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 8.177 09 Burgos Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 7.345 09 Burgos Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 7.812 09 Burgos Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 7.006 09 Burgos Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 7.557 09 Burgos Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 6.800 09 Burgos Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 7.333 09 Burgos Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 6.603 09 Burgos Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 7.148 09 Burgos Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 6.428 09 Burgos Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 09 Burgos Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 09 Burgos Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 95,54 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 95,38 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 92,42 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 92,58 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 89,68 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 89,9 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 87,42 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 87,52 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 357 09 Burgos Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.047 09 Burgos Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 341 09 Burgos Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.033 09 Burgos Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 339 09 Burgos Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.016 09 Burgos Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 331 09 Burgos Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 999 09 Burgos Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 321 09 Burgos Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 981 09 Burgos Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 09 Burgos Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 09 Burgos Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,52 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,66 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 94,96 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,04 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 92,72 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,42 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 89,92 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 93,7 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos Total Cohort April 1 Total Number at the start of the quarter 2022QII 8.534 09 Burgos Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 09 Burgos Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos Total Cohort April 1 Total Number at the start of the quarter 2021QII 8.400 09 Burgos Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 09 Burgos Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos Total Cohort April 1 Total Number at the start of the quarter 2020QII 8.374 09 Burgos Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 09 Burgos Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 09 Burgos Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 09 Burgos Total Cohort April 1 Total Survival in the first trimester 2022QII 8.199 09 Burgos Total Cohort April 1 Total Survival in the first trimester 2022QI "" 09 Burgos Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 09 Burgos Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 09 Burgos Total Cohort April 1 Total Survival in the first trimester 2021QII 8.109 09 Burgos Total Cohort April 1 Total Survival in the first trimester 2021QI "" 09 Burgos Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 09 Burgos Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 09 Burgos Total Cohort April 1 Total Survival in the first trimester 2020QII 8.126 09 Burgos Total Cohort April 1 Total Survival in the first trimester 2020QI "" 09 Burgos Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 09 Burgos Total Cohort April 1 Total Survival in the second trimester 2022QIII 7.929 09 Burgos Total Cohort April 1 Total Survival in the second trimester 2022QII "" 09 Burgos Total Cohort April 1 Total Survival in the second trimester 2022QI "" 09 Burgos Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 09 Burgos Total Cohort April 1 Total Survival in the second trimester 2021QIII 7.845 09 Burgos Total Cohort April 1 Total Survival in the second trimester 2021QII "" 09 Burgos Total Cohort April 1 Total Survival in the second trimester 2021QI "" 09 Burgos Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 09 Burgos Total Cohort April 1 Total Survival in the second trimester 2020QIII 7.885 09 Burgos Total Cohort April 1 Total Survival in the second trimester 2020QII "" 09 Burgos Total Cohort April 1 Total Survival in the second trimester 2020QI "" 09 Burgos Total Cohort April 1 Total Survival in the third trimester 2022QIV 7.690 09 Burgos Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 09 Burgos Total Cohort April 1 Total Survival in the third trimester 2022QII "" 09 Burgos Total Cohort April 1 Total Survival in the third trimester 2022QI "" 09 Burgos Total Cohort April 1 Total Survival in the third trimester 2021QIV 7.616 09 Burgos Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 09 Burgos Total Cohort April 1 Total Survival in the third trimester 2021QII "" 09 Burgos Total Cohort April 1 Total Survival in the third trimester 2021QI "" 09 Burgos Total Cohort April 1 Total Survival in the third trimester 2020QIV 7.683 09 Burgos Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 09 Burgos Total Cohort April 1 Total Survival in the third trimester 2020QII "" 09 Burgos Total Cohort April 1 Total Survival in the third trimester 2020QI "" 09 Burgos Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 09 Burgos Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 09 Burgos Total Cohort April 1 Total Survival in the third trimester 2022QII "" 09 Burgos Total Cohort April 1 Total Survival in the third trimester 2022QI 7.388 09 Burgos Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 09 Burgos Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 09 Burgos Total Cohort April 1 Total Survival in the third trimester 2021QII "" 09 Burgos Total Cohort April 1 Total Survival in the third trimester 2021QI 7.453 09 Burgos Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 09 Burgos Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 09 Burgos Total Cohort April 1 Total Survival in the third trimester 2020QII "" 09 Burgos Total Cohort April 1 Total Survival in the third trimester 2020QI "" 09 Burgos Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 09 Burgos Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 09 Burgos Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 09 Burgos Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 09 Burgos Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 09 Burgos Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 96,07 09 Burgos Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,54 09 Burgos Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 97,04 09 Burgos Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 92,91 09 Burgos Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 93,39 09 Burgos Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 94,16 09 Burgos Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 90,11 09 Burgos Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 90,67 09 Burgos Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 91,75 09 Burgos Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 87,95 09 Burgos Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 89 09 Burgos Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Burgos Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Burgos Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 8.198 09 Burgos Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 7.341 09 Burgos Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 6.381 09 Burgos Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 7.869 09 Burgos Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 7.067 09 Burgos Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 6.159 09 Burgos Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 7.610 09 Burgos Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 6.821 09 Burgos Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 5.965 09 Burgos Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 7.381 09 Burgos Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 6.613 09 Burgos Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 5.799 09 Burgos Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 6.401 09 Burgos Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 5.598 09 Burgos Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 09 Burgos Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 09 Burgos Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 09 Burgos Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,99 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 96,27 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 96,52 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 92,83 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,92 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 93,48 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 90,03 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 90,08 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 90,88 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 87,2 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 87,73 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 336 09 Burgos Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.059 09 Burgos Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.993 09 Burgos Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 330 09 Burgos Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.042 09 Burgos Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.967 09 Burgos Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 319 09 Burgos Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.024 09 Burgos Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.920 09 Burgos Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 309 09 Burgos Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.003 09 Burgos Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.884 09 Burgos Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 987 09 Burgos Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.855 09 Burgos Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 09 Burgos Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 09 Burgos Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 09 Burgos Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,21 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,39 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,7 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,94 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,69 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,34 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,96 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,71 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 94,53 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 93,2 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 93,08 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos Total Cohort July 1 Total Number at the start of the quarter 2022QIII 8.652 09 Burgos Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 09 Burgos Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 09 Burgos Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos Total Cohort July 1 Total Number at the start of the quarter 2021QIII 8.606 09 Burgos Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 09 Burgos Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 09 Burgos Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos Total Cohort July 1 Total Number at the start of the quarter 2020QIII 8.498 09 Burgos Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 09 Burgos Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 09 Burgos Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 09 Burgos Total Cohort July 1 Total Survival in the first trimester 2022QIII 8.232 09 Burgos Total Cohort July 1 Total Survival in the first trimester 2022QII "" 09 Burgos Total Cohort July 1 Total Survival in the first trimester 2022QI "" 09 Burgos Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 09 Burgos Total Cohort July 1 Total Survival in the first trimester 2021QIII 8.219 09 Burgos Total Cohort July 1 Total Survival in the first trimester 2021QII "" 09 Burgos Total Cohort July 1 Total Survival in the first trimester 2021QI "" 09 Burgos Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 09 Burgos Total Cohort July 1 Total Survival in the first trimester 2020QIII 8.150 09 Burgos Total Cohort July 1 Total Survival in the first trimester 2020QII "" 09 Burgos Total Cohort July 1 Total Survival in the first trimester 2020QI "" 09 Burgos Total Cohort July 1 Total Survival in the second trimester 2022QIV 7.904 09 Burgos Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 09 Burgos Total Cohort July 1 Total Survival in the second trimester 2022QII "" 09 Burgos Total Cohort July 1 Total Survival in the second trimester 2022QI "" 09 Burgos Total Cohort July 1 Total Survival in the second trimester 2021QIV 7.888 09 Burgos Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 09 Burgos Total Cohort July 1 Total Survival in the second trimester 2021QII "" 09 Burgos Total Cohort July 1 Total Survival in the second trimester 2021QI "" 09 Burgos Total Cohort July 1 Total Survival in the second trimester 2020QIV 7.868 09 Burgos Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 09 Burgos Total Cohort July 1 Total Survival in the second trimester 2020QII "" 09 Burgos Total Cohort July 1 Total Survival in the second trimester 2020QI "" 09 Burgos Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 09 Burgos Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 09 Burgos Total Cohort July 1 Total Survival in the third trimester 2022QII "" 09 Burgos Total Cohort July 1 Total Survival in the third trimester 2022QI 7.622 09 Burgos Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 09 Burgos Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 09 Burgos Total Cohort July 1 Total Survival in the third trimester 2021QII "" 09 Burgos Total Cohort July 1 Total Survival in the third trimester 2021QI 7.607 09 Burgos Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 09 Burgos Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 09 Burgos Total Cohort July 1 Total Survival in the third trimester 2020QII "" 09 Burgos Total Cohort July 1 Total Survival in the third trimester 2020QI "" 09 Burgos Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 09 Burgos Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 09 Burgos Total Cohort July 1 Total Survival in the third trimester 2022QII 7.459 09 Burgos Total Cohort July 1 Total Survival in the third trimester 2022QI "" 09 Burgos Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 09 Burgos Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 09 Burgos Total Cohort July 1 Total Survival in the third trimester 2021QII 7.460 09 Burgos Total Cohort July 1 Total Survival in the third trimester 2021QI "" 09 Burgos Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 09 Burgos Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 09 Burgos Total Cohort July 1 Total Survival in the third trimester 2020QII "" 09 Burgos Total Cohort July 1 Total Survival in the third trimester 2020QI "" 09 Burgos Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 09 Burgos Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 09 Burgos Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 09 Burgos Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 09 Burgos Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 09 Burgos Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 09 Burgos Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 09 Burgos Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 09 Burgos Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 95,15 09 Burgos Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,5 09 Burgos Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,9 09 Burgos Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 91,35 09 Burgos Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 91,66 09 Burgos Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 92,59 09 Burgos Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 88,57 09 Burgos Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 89,52 09 Burgos Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 86,67 09 Burgos Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 87,79 09 Burgos Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Burgos Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Burgos Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 8.520 09 Burgos Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 8.334 09 Burgos Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 7.225 09 Burgos Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 8.106 09 Burgos Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 7.953 09 Burgos Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 6.909 09 Burgos Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 7.784 09 Burgos Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 7.625 09 Burgos Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 6.648 09 Burgos Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 7.362 09 Burgos Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 6.405 09 Burgos Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 7.203 09 Burgos Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 6.277 09 Burgos Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 09 Burgos Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 09 Burgos Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 09 Burgos Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 95,14 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,43 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,63 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 91,36 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 91,49 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 92,01 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 88,34 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 88,65 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 86,43 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 86,88 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 132 09 Burgos Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 272 09 Burgos Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.273 09 Burgos Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 126 09 Burgos Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 266 09 Burgos Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.241 09 Burgos Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 120 09 Burgos Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 263 09 Burgos Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.220 09 Burgos Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 260 09 Burgos Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.202 09 Burgos Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 256 09 Burgos Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.183 09 Burgos Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 09 Burgos Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 09 Burgos Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 09 Burgos Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,45 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,79 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,49 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 90,91 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,69 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,84 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,59 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,42 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 94,12 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,93 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos Total Cohort October 1 Total Number at the start of the quarter 2022QIV 8.536 09 Burgos Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 09 Burgos Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 09 Burgos Total Cohort October 1 Total Number at the start of the quarter 2021QIV 8.578 09 Burgos Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 09 Burgos Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 09 Burgos Total Cohort October 1 Total Number at the start of the quarter 2020QIV 8.503 09 Burgos Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 09 Burgos Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 09 Burgos Total Cohort October 1 Total Survival in the first trimester 2022QIV 8.116 09 Burgos Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 09 Burgos Total Cohort October 1 Total Survival in the first trimester 2022QII "" 09 Burgos Total Cohort October 1 Total Survival in the first trimester 2022QI "" 09 Burgos Total Cohort October 1 Total Survival in the first trimester 2021QIV 8.152 09 Burgos Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 09 Burgos Total Cohort October 1 Total Survival in the first trimester 2021QII "" 09 Burgos Total Cohort October 1 Total Survival in the first trimester 2021QI "" 09 Burgos Total Cohort October 1 Total Survival in the first trimester 2020QIV 8.097 09 Burgos Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 09 Burgos Total Cohort October 1 Total Survival in the first trimester 2020QII "" 09 Burgos Total Cohort October 1 Total Survival in the first trimester 2020QI "" 09 Burgos Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 09 Burgos Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 09 Burgos Total Cohort October 1 Total Survival in the second trimester 2022QII "" 09 Burgos Total Cohort October 1 Total Survival in the second trimester 2022QI 7.859 09 Burgos Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 09 Burgos Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 09 Burgos Total Cohort October 1 Total Survival in the second trimester 2021QII "" 09 Burgos Total Cohort October 1 Total Survival in the second trimester 2021QI 7.810 09 Burgos Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 09 Burgos Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 09 Burgos Total Cohort October 1 Total Survival in the second trimester 2020QII "" 09 Burgos Total Cohort October 1 Total Survival in the second trimester 2020QI "" 09 Burgos Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 09 Burgos Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 09 Burgos Total Cohort October 1 Total Survival in the third trimester 2022QII 7.657 09 Burgos Total Cohort October 1 Total Survival in the third trimester 2022QI "" 09 Burgos Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 09 Burgos Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 09 Burgos Total Cohort October 1 Total Survival in the third trimester 2021QII 7.629 09 Burgos Total Cohort October 1 Total Survival in the third trimester 2021QI "" 09 Burgos Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 09 Burgos Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 09 Burgos Total Cohort October 1 Total Survival in the third trimester 2020QII "" 09 Burgos Total Cohort October 1 Total Survival in the third trimester 2020QI "" 09 Burgos Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 09 Burgos Total Cohort October 1 Total Survival in the third trimester 2022QIII 7.471 09 Burgos Total Cohort October 1 Total Survival in the third trimester 2022QII "" 09 Burgos Total Cohort October 1 Total Survival in the third trimester 2022QI "" 09 Burgos Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 09 Burgos Total Cohort October 1 Total Survival in the third trimester 2021QIII 7.447 09 Burgos Total Cohort October 1 Total Survival in the third trimester 2021QII "" 09 Burgos Total Cohort October 1 Total Survival in the third trimester 2021QI "" 09 Burgos Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 09 Burgos Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 09 Burgos Total Cohort October 1 Total Survival in the third trimester 2020QII "" 09 Burgos Total Cohort October 1 Total Survival in the third trimester 2020QI "" 09 Burgos Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 09 Burgos Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 09 Burgos Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 09 Burgos Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 09 Burgos Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 09 Burgos Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 09 Burgos Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 09 Burgos Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 09 Burgos Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,08 09 Burgos Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,03 09 Burgos Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 95,23 09 Burgos Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 91,62 09 Burgos Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 91,85 09 Burgos Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 89,26 09 Burgos Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 89,72 09 Burgos Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 87,09 09 Burgos Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 87,58 09 Burgos Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Burgos Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Burgos Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 8.432 09 Burgos Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 8.210 09 Burgos Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 7.217 09 Burgos Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 8.017 09 Burgos Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 7.789 09 Burgos Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 6.834 09 Burgos Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 7.511 09 Burgos Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 6.559 09 Burgos Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 7.314 09 Burgos Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 6.399 09 Burgos Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 7.138 09 Burgos Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 6.240 09 Burgos Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 09 Burgos Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 09 Burgos Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 09 Burgos Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95,08 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,87 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,69 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 91,49 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 90,88 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 89,09 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 88,67 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 86,94 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 86,46 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 104 09 Burgos Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 368 09 Burgos Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.286 09 Burgos Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 99 09 Burgos Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 363 09 Burgos Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.263 09 Burgos Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 348 09 Burgos Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.251 09 Burgos Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 343 09 Burgos Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.230 09 Burgos Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 333 09 Burgos Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.207 09 Burgos Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 09 Burgos Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 09 Burgos Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 09 Burgos Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 95,19 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,64 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,21 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,57 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,28 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 93,21 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,65 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 90,49 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,86 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 09 Burgos From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 6.321 09 Burgos From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 09 Burgos From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 6.273 09 Burgos From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 6.509 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 5.967 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 5.941 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 5.845 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 5.733 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 5.734 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 5.653 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 5.524 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 5.540 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 5.466 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 5.342 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 5.358 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 5.312 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 09 Burgos From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 09 Burgos From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 09 Burgos From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 09 Burgos From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,4 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,71 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 89,8 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,7 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,41 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 86,85 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 87,39 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 88,32 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 83,98 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 84,51 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,41 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 81,61 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 6.101 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 5.737 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 5.759 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 5.419 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 5.527 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 5.226 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 5.325 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 5.045 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 5.153 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 4.880 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,39 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,46 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,59 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 91,09 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 87,28 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,94 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 84,46 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,06 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 220 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 536 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 208 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 522 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 206 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 508 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 199 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 495 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 189 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 478 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,55 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,39 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,64 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,78 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,45 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,35 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 85,91 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 89,18 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 6.292 09 Burgos From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 6.263 09 Burgos From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 6.238 09 Burgos From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 5.981 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 5.988 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 6.010 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 5.730 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 5.742 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 5.784 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 5.509 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 5.524 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 5.597 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 5.325 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 5.391 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 09 Burgos From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 09 Burgos From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 09 Burgos From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 09 Burgos From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,06 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,61 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,34 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 91,07 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,68 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,72 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,56 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 88,2 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,72 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 85,02 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 86,42 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 6.102 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 5.726 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 5.072 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 5.795 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 5.465 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 4.864 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 5.554 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 5.233 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 4.677 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 5.341 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 5.035 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 4.520 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 4.844 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 4.337 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,97 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,44 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,9 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,02 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,39 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,21 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,53 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 87,93 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 89,12 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 84,6 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 85,51 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 190 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 537 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.166 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 186 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 523 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.146 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 176 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 509 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.107 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 168 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 489 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.077 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 481 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.054 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,89 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,39 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,28 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 92,63 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,79 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,94 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,42 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 91,06 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 92,37 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 89,57 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 90,39 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 6.360 09 Burgos From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 6.394 09 Burgos From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 6.357 09 Burgos From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 5.962 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 6.024 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 6.024 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 5.663 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 5.711 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 5.760 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 5.475 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 5.526 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 5.327 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 5.390 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 09 Burgos From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 09 Burgos From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 09 Burgos From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,74 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,21 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,76 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,04 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,32 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,61 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 85,63 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,93 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 83,31 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,79 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 6.268 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 6.266 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 5.700 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 5.875 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 5.902 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 5.395 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 5.581 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 5.591 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 5.147 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 5.356 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 4.926 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 5.211 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 4.807 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,73 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,19 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,65 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,04 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,23 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,3 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 85,48 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,42 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 83,16 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 84,33 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 92 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 128 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 657 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 87 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 122 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 629 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 82 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 120 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 613 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 119 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 600 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 116 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 583 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 94,57 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 95,31 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 95,74 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 89,13 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,75 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,3 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 92,97 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 91,32 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 90,63 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 88,74 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 6.258 09 Burgos From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 6.362 09 Burgos From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 6.322 09 Burgos From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 5.859 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 5.951 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 5.930 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 5.691 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 5.669 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 5.507 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 5.503 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 5.343 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 5.337 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 09 Burgos From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 09 Burgos From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 09 Burgos From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,62 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,54 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,8 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,45 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,67 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 86,56 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 87,05 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 83,98 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 84,42 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 6.192 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 6.139 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 5.682 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 5.797 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 5.732 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 5.310 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 5.483 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 5.059 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 5.304 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 4.912 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 5.148 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 4.765 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,62 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 93,37 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,45 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,31 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,04 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 86,4 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,45 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 83,86 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 83,86 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 66 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 223 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 640 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 62 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 219 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 620 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 208 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 610 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 203 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 591 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 195 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 572 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 93,94 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,21 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,88 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,27 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,31 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 91,03 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,34 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 87,44 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 89,38 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 894 09 Burgos From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 876 09 Burgos From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 963 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 884 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 861 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 940 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 872 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 856 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 927 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 858 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 844 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 914 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 851 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 840 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 905 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 09 Burgos From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 09 Burgos From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,88 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,29 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,61 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,54 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,72 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,26 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 95,97 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,35 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,91 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,19 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,89 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 93,98 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 836 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 678 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 828 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 663 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 816 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 658 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 803 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 649 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 796 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 646 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,04 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97,79 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,61 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,05 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,05 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,72 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,22 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,28 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 58 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 198 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 56 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 198 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 56 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 198 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 55 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 195 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 55 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 194 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,55 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96,55 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 94,83 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,48 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,83 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,98 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 918 09 Burgos From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 875 09 Burgos From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 874 09 Burgos From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 903 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 871 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 861 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 891 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 861 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 852 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 879 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 857 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 842 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 840 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 826 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 09 Burgos From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 09 Burgos From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 09 Burgos From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,37 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,54 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,51 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,06 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,4 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,48 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,75 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,94 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,34 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,51 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 859 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 668 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 554 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 845 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 664 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 544 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 833 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 657 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 540 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 822 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 654 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 534 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 641 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 523 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,37 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,4 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,19 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,97 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,35 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,47 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,69 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,9 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,39 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,96 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,4 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 59 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 207 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 320 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 58 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 207 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 317 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 58 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 204 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 312 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 57 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 203 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 308 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 199 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 303 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,31 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,06 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,31 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,55 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,5 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,61 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,07 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,25 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,14 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,69 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 942 09 Burgos From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 913 09 Burgos From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 871 09 Burgos From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 931 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 901 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 864 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 911 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 894 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 854 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 880 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 833 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 874 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 829 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 09 Burgos From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 09 Burgos From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 09 Burgos From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,83 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,69 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,2 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,71 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,92 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,05 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,39 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,64 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,73 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,18 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 929 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 862 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 658 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 918 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 850 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 654 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 898 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 843 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 648 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 831 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 632 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 825 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 628 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,82 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,61 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,39 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,66 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,8 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,48 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,4 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,05 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,71 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,44 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 13 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 51 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 213 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 13 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 51 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 210 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 13 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 51 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 206 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 49 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 201 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 49 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 201 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,59 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,71 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 96,08 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,37 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,08 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 94,37 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 936 09 Burgos From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 904 09 Burgos From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 900 09 Burgos From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 926 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 899 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 893 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 882 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 874 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 872 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 869 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 859 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 862 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 09 Burgos From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 09 Burgos From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 09 Burgos From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,93 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,45 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,22 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,57 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,11 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,46 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,56 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,02 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,78 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 924 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 844 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 659 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 914 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 840 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 653 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 826 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 636 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 816 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 631 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 805 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 626 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,92 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,53 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,09 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,87 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,51 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,68 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,75 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,38 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 94,99 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 12 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 60 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 241 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 12 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 59 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 240 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 56 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 238 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 56 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 238 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 54 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 236 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,33 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,59 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,33 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,76 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 93,33 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,76 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 90 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 97,93 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 09 Burgos From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 1.228 09 Burgos From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 09 Burgos From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 1.156 09 Burgos From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 1.256 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 1.211 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 1.151 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 1.241 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 1.200 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 1.140 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 1.230 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 1.191 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 1.132 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 1.222 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 1.186 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 1.125 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 1.213 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 09 Burgos From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 09 Burgos From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 09 Burgos From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 09 Burgos From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,62 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,57 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,81 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,72 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,62 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,93 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,99 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,92 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,29 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,58 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,32 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,58 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.153 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 865 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.138 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 860 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.127 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 852 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.118 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 845 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.113 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 838 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,7 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,42 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,75 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,5 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,96 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,69 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,53 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,88 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 75 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 291 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 73 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 291 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 73 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 288 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 73 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 287 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 73 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 287 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,33 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,33 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,97 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,33 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,63 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 97,33 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,63 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 1.229 09 Burgos From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 1.175 09 Burgos From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 1.176 09 Burgos From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 1.220 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 1.163 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 1.169 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 1.213 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 1.155 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 1.163 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 1.208 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 1.148 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 1.158 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 1.136 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 1.151 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 09 Burgos From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 09 Burgos From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 09 Burgos From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 09 Burgos From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,27 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,98 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,4 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,7 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,3 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,89 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,29 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,7 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,47 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,68 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,87 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.148 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 879 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 703 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.140 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 870 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 699 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.134 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 863 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 696 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.129 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 856 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 693 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 848 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 687 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,3 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,98 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,43 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,78 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,18 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,34 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,38 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,58 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,47 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,72 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 81 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 296 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 473 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 80 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 293 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 470 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 79 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 292 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 467 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 79 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 292 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 465 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 288 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 464 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,77 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,99 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,37 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,53 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,65 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,73 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,53 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,65 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,31 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,3 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,1 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 1.254 09 Burgos From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 1.210 09 Burgos From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.183 09 Burgos From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 1.243 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 1.205 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 1.175 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 1.235 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 1.194 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 1.167 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 1.178 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 1.162 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 1.169 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 1.155 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 09 Burgos From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 09 Burgos From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 09 Burgos From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,12 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,59 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,32 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,48 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,68 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,65 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,36 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,22 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,61 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,63 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.230 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.122 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 808 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.220 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.117 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 801 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.212 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.107 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 794 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.091 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 789 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.083 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 784 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,19 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,55 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,13 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,54 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,66 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,27 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,24 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,65 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,52 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,03 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 24 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 88 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 375 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 23 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 88 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 374 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 23 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 87 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 373 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 87 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 373 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 86 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 371 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,83 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,73 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95,83 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,86 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,47 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 98,86 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 99,47 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 97,73 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,93 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 1.246 09 Burgos From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 1.223 09 Burgos From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.195 09 Burgos From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 1.236 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 1.213 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 1.188 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 1.197 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 1.182 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 1.189 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 1.172 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 1.180 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 1.163 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 09 Burgos From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 09 Burgos From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 09 Burgos From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,2 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,18 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,41 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,87 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,91 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,22 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,08 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,48 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,32 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.222 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.143 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 820 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.212 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.133 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 815 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.118 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 809 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.110 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 801 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.101 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 794 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,18 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,13 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,39 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,81 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,66 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,11 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,68 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,33 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,83 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 24 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 80 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 375 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 24 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 80 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 373 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 79 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 373 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 79 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 371 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 79 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 369 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,47 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,75 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 99,47 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 98,75 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,93 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 98,75 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,4 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 09 Burgos from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 56 09 Burgos from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 09 Burgos from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 55 09 Burgos from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 61 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 56 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 54 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 59 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 56 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 54 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 59 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 56 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 54 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 59 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 56 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 54 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 59 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 09 Burgos from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 09 Burgos from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 09 Burgos from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 09 Burgos from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,18 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,72 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,18 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,72 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,18 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,72 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,18 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,72 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 54 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 45 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 54 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 44 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 54 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 44 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 54 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 44 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 54 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 44 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97,78 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,78 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,78 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,78 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 10 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 10 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 10 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 10 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 10 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 59 09 Burgos from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 56 09 Burgos from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 54 09 Burgos from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 59 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 56 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 54 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 59 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 56 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 54 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 59 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 56 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 54 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 56 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 53 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 09 Burgos from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 09 Burgos from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 09 Burgos from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 09 Burgos from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,15 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Burgos from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 57 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 47 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 31 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 57 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 47 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 31 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 57 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 47 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 31 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 57 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 47 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 31 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 47 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 30 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,77 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 2 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 9 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 23 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 2 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 9 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 23 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 2 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 9 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 23 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 2 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 9 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 23 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 9 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 23 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 62 09 Burgos from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 59 09 Burgos from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 56 09 Burgos from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 62 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 59 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 56 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 62 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 59 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 56 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 59 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 55 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 59 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 55 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 09 Burgos from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 09 Burgos from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 09 Burgos from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,21 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,21 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 61 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 57 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 40 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 61 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 57 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 40 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 61 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 57 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 40 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 57 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 39 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 57 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 39 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,5 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,5 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 2 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 16 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 2 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 16 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 2 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 16 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 2 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 16 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 2 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 16 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 62 09 Burgos from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 58 09 Burgos from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 53 09 Burgos from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 61 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 58 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 53 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 58 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 52 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 58 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 52 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 58 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 52 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 09 Burgos from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 09 Burgos from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 09 Burgos from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,39 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,11 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,11 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,11 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 61 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 57 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 38 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 61 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 57 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 38 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 57 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 37 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 57 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 37 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 57 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 37 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,37 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,37 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,37 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 15 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 15 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 15 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 15 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 15 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 09 Burgos De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 35 09 Burgos De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 09 Burgos De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 32 09 Burgos De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 09 Burgos De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 32 09 Burgos De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 35 09 Burgos De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 32 09 Burgos De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 32 09 Burgos De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 35 09 Burgos De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 32 09 Burgos De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 32 09 Burgos De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 35 09 Burgos De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 32 09 Burgos De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 32 09 Burgos De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 34 09 Burgos De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 32 09 Burgos De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 32 09 Burgos De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 09 Burgos De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 09 Burgos De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 09 Burgos De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 09 Burgos De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 09 Burgos De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 09 Burgos De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 09 Burgos De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,14 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Burgos De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 33 09 Burgos De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 20 09 Burgos De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 33 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 20 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 33 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 20 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 33 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 20 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 32 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 20 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 09 Burgos De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 09 Burgos De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,97 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2 09 Burgos De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 12 09 Burgos De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 12 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 12 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 12 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 12 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 09 Burgos De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 09 Burgos De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 36 09 Burgos De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 09 Burgos De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 31 09 Burgos De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 09 Burgos De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 32 09 Burgos De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 36 09 Burgos De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 31 09 Burgos De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 32 09 Burgos De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 36 09 Burgos De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 31 09 Burgos De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 32 09 Burgos De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 35 09 Burgos De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 31 09 Burgos De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 32 09 Burgos De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 31 09 Burgos De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 32 09 Burgos De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 09 Burgos De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 09 Burgos De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 09 Burgos De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 09 Burgos De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 09 Burgos De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 09 Burgos De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 09 Burgos De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,22 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Burgos De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 32 09 Burgos De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 21 09 Burgos De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 21 09 Burgos De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 32 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 21 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 21 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 32 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 21 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 21 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 32 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 21 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 21 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 21 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 21 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 09 Burgos De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 09 Burgos De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 09 Burgos De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 4 09 Burgos De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 10 09 Burgos De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 11 09 Burgos De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 4 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 10 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 11 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 4 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 10 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 11 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 3 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 10 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 11 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 10 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 11 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 09 Burgos De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 09 Burgos De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 09 Burgos De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 75 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 34 09 Burgos De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 09 Burgos De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 09 Burgos De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 30 09 Burgos De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 09 Burgos De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 09 Burgos De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 31 09 Burgos De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 09 Burgos De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 34 09 Burgos De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 30 09 Burgos De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 31 09 Burgos De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 33 09 Burgos De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 30 09 Burgos De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 31 09 Burgos De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 30 09 Burgos De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 31 09 Burgos De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 30 09 Burgos De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 31 09 Burgos De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 09 Burgos De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 09 Burgos De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 09 Burgos De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 09 Burgos De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 09 Burgos De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 09 Burgos De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 09 Burgos De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 09 Burgos De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 09 Burgos De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 09 Burgos De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 09 Burgos De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 09 Burgos De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 09 Burgos De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,06 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Burgos De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 32 09 Burgos De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 27 09 Burgos De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 19 09 Burgos De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 32 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 27 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 19 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 32 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 27 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 19 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 27 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 19 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 27 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 19 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 09 Burgos De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 09 Burgos De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 09 Burgos De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 2 09 Burgos De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 3 09 Burgos De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 12 09 Burgos De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 2 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 3 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 12 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 3 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 12 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 3 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 12 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 3 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 12 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 09 Burgos De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 09 Burgos De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 09 Burgos De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 50 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 34 09 Burgos De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 09 Burgos De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 09 Burgos De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 31 09 Burgos De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 09 Burgos De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 09 Burgos De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 33 09 Burgos De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 09 Burgos De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 34 09 Burgos De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 31 09 Burgos De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 33 09 Burgos De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 31 09 Burgos De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 33 09 Burgos De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 31 09 Burgos De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 33 09 Burgos De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 31 09 Burgos De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 33 09 Burgos De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 09 Burgos De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 09 Burgos De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 09 Burgos De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 09 Burgos De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 09 Burgos De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 09 Burgos De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 09 Burgos De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 09 Burgos De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 09 Burgos De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 09 Burgos De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 09 Burgos De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 09 Burgos De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 09 Burgos De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 33 09 Burgos De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 27 09 Burgos De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 18 09 Burgos De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 33 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 27 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 18 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 27 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 18 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 27 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 18 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 27 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 18 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 09 Burgos De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 09 Burgos De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 09 Burgos De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1 09 Burgos De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 4 09 Burgos De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 15 09 Burgos De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 4 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 15 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 4 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 15 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 4 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 15 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 4 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 15 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 09 Burgos De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 09 Burgos De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 09 Burgos De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 09 Burgos De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres Total Cohort January 1 Total Number at the start of the quarter 2022QI 8.776 10 Cáceres Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres Total Cohort January 1 Total Number at the start of the quarter 2021QI 8.494 10 Cáceres Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres Total Cohort January 1 Total Number at the start of the quarter 2020QI 8.831 10 Cáceres Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 10 Cáceres Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 10 Cáceres Total Cohort January 1 Total Survival in the first trimester 2022QII "" 10 Cáceres Total Cohort January 1 Total Survival in the first trimester 2022QI 8.233 10 Cáceres Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 10 Cáceres Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 10 Cáceres Total Cohort January 1 Total Survival in the first trimester 2021QII "" 10 Cáceres Total Cohort January 1 Total Survival in the first trimester 2021QI 7.989 10 Cáceres Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 10 Cáceres Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 10 Cáceres Total Cohort January 1 Total Survival in the first trimester 2020QII "" 10 Cáceres Total Cohort January 1 Total Survival in the first trimester 2020QI 7.598 10 Cáceres Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 10 Cáceres Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 10 Cáceres Total Cohort January 1 Total Survival in the second trimester 2022QII 7.818 10 Cáceres Total Cohort January 1 Total Survival in the second trimester 2022QI "" 10 Cáceres Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 10 Cáceres Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 10 Cáceres Total Cohort January 1 Total Survival in the second trimester 2021QII 7.642 10 Cáceres Total Cohort January 1 Total Survival in the second trimester 2021QI "" 10 Cáceres Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 10 Cáceres Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 10 Cáceres Total Cohort January 1 Total Survival in the second trimester 2020QII 7.303 10 Cáceres Total Cohort January 1 Total Survival in the second trimester 2020QI "" 10 Cáceres Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres Total Cohort January 1 Total Survival in the third trimester 2022QIII 7.508 10 Cáceres Total Cohort January 1 Total Survival in the third trimester 2022QII "" 10 Cáceres Total Cohort January 1 Total Survival in the third trimester 2022QI "" 10 Cáceres Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres Total Cohort January 1 Total Survival in the third trimester 2021QIII 7.402 10 Cáceres Total Cohort January 1 Total Survival in the third trimester 2021QII "" 10 Cáceres Total Cohort January 1 Total Survival in the third trimester 2021QI "" 10 Cáceres Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres Total Cohort January 1 Total Survival in the third trimester 2020QIII 7.087 10 Cáceres Total Cohort January 1 Total Survival in the third trimester 2020QII "" 10 Cáceres Total Cohort January 1 Total Survival in the third trimester 2020QI "" 10 Cáceres Total Cohort January 1 Total Survival in the third trimester 2022QIV 7.273 10 Cáceres Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres Total Cohort January 1 Total Survival in the third trimester 2022QII "" 10 Cáceres Total Cohort January 1 Total Survival in the third trimester 2022QI "" 10 Cáceres Total Cohort January 1 Total Survival in the third trimester 2021QIV 7.197 10 Cáceres Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres Total Cohort January 1 Total Survival in the third trimester 2021QII "" 10 Cáceres Total Cohort January 1 Total Survival in the third trimester 2021QI "" 10 Cáceres Total Cohort January 1 Total Survival in the third trimester 2020QIV 6.887 10 Cáceres Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres Total Cohort January 1 Total Survival in the third trimester 2020QII "" 10 Cáceres Total Cohort January 1 Total Survival in the third trimester 2020QI "" 10 Cáceres Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 10 Cáceres Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 10 Cáceres Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,81 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,05 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 86,04 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,08 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 89,97 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 82,7 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 85,55 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,14 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 80,25 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 82,87 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 84,73 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 77,99 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 8.499 10 Cáceres Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 7.673 10 Cáceres Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 7.964 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 7.195 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 7.560 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 6.863 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 7.258 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 6.638 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 7.028 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 6.454 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 10 Cáceres Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 10 Cáceres Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,71 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,77 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,95 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,44 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 85,4 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,51 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 82,69 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 84,11 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 277 10 Cáceres Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 821 10 Cáceres Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 269 10 Cáceres Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 794 10 Cáceres Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 258 10 Cáceres Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 779 10 Cáceres Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 250 10 Cáceres Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 764 10 Cáceres Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 245 10 Cáceres Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 743 10 Cáceres Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 10 Cáceres Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 10 Cáceres Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,11 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,71 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,14 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,88 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,25 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 93,06 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,45 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 90,5 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres Total Cohort April 1 Total Number at the start of the quarter 2022QII 8.784 10 Cáceres Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres Total Cohort April 1 Total Number at the start of the quarter 2021QII 8.485 10 Cáceres Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres Total Cohort April 1 Total Number at the start of the quarter 2020QII 7.931 10 Cáceres Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 10 Cáceres Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 10 Cáceres Total Cohort April 1 Total Survival in the first trimester 2022QII 8.250 10 Cáceres Total Cohort April 1 Total Survival in the first trimester 2022QI "" 10 Cáceres Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 10 Cáceres Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 10 Cáceres Total Cohort April 1 Total Survival in the first trimester 2021QII 8.017 10 Cáceres Total Cohort April 1 Total Survival in the first trimester 2021QI "" 10 Cáceres Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 10 Cáceres Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 10 Cáceres Total Cohort April 1 Total Survival in the first trimester 2020QII 7.574 10 Cáceres Total Cohort April 1 Total Survival in the first trimester 2020QI "" 10 Cáceres Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 10 Cáceres Total Cohort April 1 Total Survival in the second trimester 2022QIII 7.860 10 Cáceres Total Cohort April 1 Total Survival in the second trimester 2022QII "" 10 Cáceres Total Cohort April 1 Total Survival in the second trimester 2022QI "" 10 Cáceres Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 10 Cáceres Total Cohort April 1 Total Survival in the second trimester 2021QIII 7.713 10 Cáceres Total Cohort April 1 Total Survival in the second trimester 2021QII "" 10 Cáceres Total Cohort April 1 Total Survival in the second trimester 2021QI "" 10 Cáceres Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 10 Cáceres Total Cohort April 1 Total Survival in the second trimester 2020QIII 7.321 10 Cáceres Total Cohort April 1 Total Survival in the second trimester 2020QII "" 10 Cáceres Total Cohort April 1 Total Survival in the second trimester 2020QI "" 10 Cáceres Total Cohort April 1 Total Survival in the third trimester 2022QIV 7.571 10 Cáceres Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres Total Cohort April 1 Total Survival in the third trimester 2022QII "" 10 Cáceres Total Cohort April 1 Total Survival in the third trimester 2022QI "" 10 Cáceres Total Cohort April 1 Total Survival in the third trimester 2021QIV 7.459 10 Cáceres Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres Total Cohort April 1 Total Survival in the third trimester 2021QII "" 10 Cáceres Total Cohort April 1 Total Survival in the third trimester 2021QI "" 10 Cáceres Total Cohort April 1 Total Survival in the third trimester 2020QIV 7.098 10 Cáceres Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres Total Cohort April 1 Total Survival in the third trimester 2020QII "" 10 Cáceres Total Cohort April 1 Total Survival in the third trimester 2020QI "" 10 Cáceres Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres Total Cohort April 1 Total Survival in the third trimester 2022QII "" 10 Cáceres Total Cohort April 1 Total Survival in the third trimester 2022QI 7.199 10 Cáceres Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres Total Cohort April 1 Total Survival in the third trimester 2021QII "" 10 Cáceres Total Cohort April 1 Total Survival in the third trimester 2021QI 6.846 10 Cáceres Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres Total Cohort April 1 Total Survival in the third trimester 2020QII "" 10 Cáceres Total Cohort April 1 Total Survival in the third trimester 2020QI "" 10 Cáceres Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 10 Cáceres Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 10 Cáceres Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 10 Cáceres Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,92 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,48 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,5 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,48 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,9 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,31 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 86,19 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 87,91 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,5 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 84,84 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 86,32 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 8.500 10 Cáceres Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 7.805 10 Cáceres Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 6.309 10 Cáceres Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 7.980 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 7.352 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 5.973 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 7.603 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 7.060 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 5.758 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 7.323 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 6.824 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 5.574 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 6.580 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 5.366 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 10 Cáceres Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 10 Cáceres Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 10 Cáceres Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,88 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,2 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,67 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 89,45 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 90,45 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,27 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 86,15 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 87,43 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,35 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 84,3 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 85,05 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 284 10 Cáceres Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 680 10 Cáceres Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.622 10 Cáceres Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 270 10 Cáceres Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 665 10 Cáceres Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.601 10 Cáceres Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 257 10 Cáceres Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 653 10 Cáceres Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.563 10 Cáceres Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 248 10 Cáceres Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 635 10 Cáceres Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.524 10 Cáceres Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 619 10 Cáceres Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.480 10 Cáceres Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 10 Cáceres Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 10 Cáceres Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 10 Cáceres Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,07 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,79 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,71 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 90,49 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,03 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,36 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 87,32 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,38 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,96 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 91,03 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,25 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres Total Cohort July 1 Total Number at the start of the quarter 2022QIII 8.915 10 Cáceres Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres Total Cohort July 1 Total Number at the start of the quarter 2021QIII 8.678 10 Cáceres Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres Total Cohort July 1 Total Number at the start of the quarter 2020QIII 8.347 10 Cáceres Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 10 Cáceres Total Cohort July 1 Total Survival in the first trimester 2022QIII 8.281 10 Cáceres Total Cohort July 1 Total Survival in the first trimester 2022QII "" 10 Cáceres Total Cohort July 1 Total Survival in the first trimester 2022QI "" 10 Cáceres Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 10 Cáceres Total Cohort July 1 Total Survival in the first trimester 2021QIII 8.132 10 Cáceres Total Cohort July 1 Total Survival in the first trimester 2021QII "" 10 Cáceres Total Cohort July 1 Total Survival in the first trimester 2021QI "" 10 Cáceres Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 10 Cáceres Total Cohort July 1 Total Survival in the first trimester 2020QIII 7.907 10 Cáceres Total Cohort July 1 Total Survival in the first trimester 2020QII "" 10 Cáceres Total Cohort July 1 Total Survival in the first trimester 2020QI "" 10 Cáceres Total Cohort July 1 Total Survival in the second trimester 2022QIV 7.887 10 Cáceres Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 10 Cáceres Total Cohort July 1 Total Survival in the second trimester 2022QII "" 10 Cáceres Total Cohort July 1 Total Survival in the second trimester 2022QI "" 10 Cáceres Total Cohort July 1 Total Survival in the second trimester 2021QIV 7.792 10 Cáceres Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 10 Cáceres Total Cohort July 1 Total Survival in the second trimester 2021QII "" 10 Cáceres Total Cohort July 1 Total Survival in the second trimester 2021QI "" 10 Cáceres Total Cohort July 1 Total Survival in the second trimester 2020QIV 7.563 10 Cáceres Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 10 Cáceres Total Cohort July 1 Total Survival in the second trimester 2020QII "" 10 Cáceres Total Cohort July 1 Total Survival in the second trimester 2020QI "" 10 Cáceres Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres Total Cohort July 1 Total Survival in the third trimester 2022QII "" 10 Cáceres Total Cohort July 1 Total Survival in the third trimester 2022QI 7.487 10 Cáceres Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres Total Cohort July 1 Total Survival in the third trimester 2021QII "" 10 Cáceres Total Cohort July 1 Total Survival in the third trimester 2021QI 7.246 10 Cáceres Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres Total Cohort July 1 Total Survival in the third trimester 2020QII "" 10 Cáceres Total Cohort July 1 Total Survival in the third trimester 2020QI "" 10 Cáceres Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres Total Cohort July 1 Total Survival in the third trimester 2022QII 7.250 10 Cáceres Total Cohort July 1 Total Survival in the third trimester 2022QI "" 10 Cáceres Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres Total Cohort July 1 Total Survival in the third trimester 2021QII 7.050 10 Cáceres Total Cohort July 1 Total Survival in the third trimester 2021QI "" 10 Cáceres Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres Total Cohort July 1 Total Survival in the third trimester 2020QII "" 10 Cáceres Total Cohort July 1 Total Survival in the third trimester 2020QI "" 10 Cáceres Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 10 Cáceres Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 10 Cáceres Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 10 Cáceres Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,89 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,71 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,73 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 88,47 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,79 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,61 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 86,28 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,81 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 83,54 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,46 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 8.795 10 Cáceres Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 8.468 10 Cáceres Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 7.319 10 Cáceres Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 8.167 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 7.928 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 6.900 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 7.780 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 7.592 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 6.583 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 7.291 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 6.291 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 7.059 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 6.111 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 10 Cáceres Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 10 Cáceres Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 10 Cáceres Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,86 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,62 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,28 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 88,46 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,66 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,94 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 86,1 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 85,95 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 83,36 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 83,5 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 120 10 Cáceres Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 210 10 Cáceres Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.028 10 Cáceres Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 114 10 Cáceres Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 204 10 Cáceres Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.007 10 Cáceres Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 107 10 Cáceres Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 200 10 Cáceres Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 980 10 Cáceres Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 196 10 Cáceres Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 955 10 Cáceres Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 191 10 Cáceres Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 939 10 Cáceres Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 10 Cáceres Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 10 Cáceres Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 10 Cáceres Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,14 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,96 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 89,17 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,24 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,33 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93,33 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 92,9 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 90,95 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,34 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres Total Cohort October 1 Total Number at the start of the quarter 2022QIV 8.882 10 Cáceres Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres Total Cohort October 1 Total Number at the start of the quarter 2021QIV 8.699 10 Cáceres Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres Total Cohort October 1 Total Number at the start of the quarter 2020QIV 8.549 10 Cáceres Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres Total Cohort October 1 Total Survival in the first trimester 2022QIV 8.350 10 Cáceres Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 10 Cáceres Total Cohort October 1 Total Survival in the first trimester 2022QII "" 10 Cáceres Total Cohort October 1 Total Survival in the first trimester 2022QI "" 10 Cáceres Total Cohort October 1 Total Survival in the first trimester 2021QIV 8.212 10 Cáceres Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 10 Cáceres Total Cohort October 1 Total Survival in the first trimester 2021QII "" 10 Cáceres Total Cohort October 1 Total Survival in the first trimester 2021QI "" 10 Cáceres Total Cohort October 1 Total Survival in the first trimester 2020QIV 8.013 10 Cáceres Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 10 Cáceres Total Cohort October 1 Total Survival in the first trimester 2020QII "" 10 Cáceres Total Cohort October 1 Total Survival in the first trimester 2020QI "" 10 Cáceres Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 10 Cáceres Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 10 Cáceres Total Cohort October 1 Total Survival in the second trimester 2022QII "" 10 Cáceres Total Cohort October 1 Total Survival in the second trimester 2022QI 7.845 10 Cáceres Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 10 Cáceres Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 10 Cáceres Total Cohort October 1 Total Survival in the second trimester 2021QII "" 10 Cáceres Total Cohort October 1 Total Survival in the second trimester 2021QI 7.639 10 Cáceres Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 10 Cáceres Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 10 Cáceres Total Cohort October 1 Total Survival in the second trimester 2020QII "" 10 Cáceres Total Cohort October 1 Total Survival in the second trimester 2020QI "" 10 Cáceres Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres Total Cohort October 1 Total Survival in the third trimester 2022QII 7.521 10 Cáceres Total Cohort October 1 Total Survival in the third trimester 2022QI "" 10 Cáceres Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres Total Cohort October 1 Total Survival in the third trimester 2021QII 7.370 10 Cáceres Total Cohort October 1 Total Survival in the third trimester 2021QI "" 10 Cáceres Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres Total Cohort October 1 Total Survival in the third trimester 2020QII "" 10 Cáceres Total Cohort October 1 Total Survival in the third trimester 2020QI "" 10 Cáceres Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres Total Cohort October 1 Total Survival in the third trimester 2022QIII 7.265 10 Cáceres Total Cohort October 1 Total Survival in the third trimester 2022QII "" 10 Cáceres Total Cohort October 1 Total Survival in the third trimester 2022QI "" 10 Cáceres Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres Total Cohort October 1 Total Survival in the third trimester 2021QIII 7.176 10 Cáceres Total Cohort October 1 Total Survival in the third trimester 2021QII "" 10 Cáceres Total Cohort October 1 Total Survival in the third trimester 2021QI "" 10 Cáceres Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres Total Cohort October 1 Total Survival in the third trimester 2020QII "" 10 Cáceres Total Cohort October 1 Total Survival in the third trimester 2020QI "" 10 Cáceres Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 10 Cáceres Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 10 Cáceres Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 10 Cáceres Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,01 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,4 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,73 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,18 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,36 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 86,46 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 86,21 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 83,52 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 83,94 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 8.777 10 Cáceres Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 8.383 10 Cáceres Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 7.549 10 Cáceres Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 8.252 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 7.912 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 7.042 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 7.552 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 6.696 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 7.237 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 6.443 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 6.990 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 6.266 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 10 Cáceres Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 10 Cáceres Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 10 Cáceres Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,02 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,38 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,28 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,09 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88,7 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 86,33 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 85,35 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 83,38 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 83 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 105 10 Cáceres Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 316 10 Cáceres Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.000 10 Cáceres Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 98 10 Cáceres Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 300 10 Cáceres Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 971 10 Cáceres Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 293 10 Cáceres Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 943 10 Cáceres Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 284 10 Cáceres Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 927 10 Cáceres Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 275 10 Cáceres Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 910 10 Cáceres Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 10 Cáceres Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 10 Cáceres Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 10 Cáceres Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 93,33 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 94,94 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,1 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 92,72 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,3 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 89,87 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,7 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 87,03 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 91 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 6.903 10 Cáceres From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 6.792 10 Cáceres From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 6.986 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 6.373 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 6.306 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 5.814 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 5.988 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 5.983 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 5.542 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 5.704 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 5.762 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 5.343 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 5.489 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 5.569 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 5.161 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 10 Cáceres From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 10 Cáceres From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 92,32 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 92,84 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 83,22 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 86,74 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 88,09 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 79,33 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 82,63 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 84,84 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 76,48 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 79,52 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 81,99 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 73,88 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 6.721 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 6.304 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 6.199 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 5.842 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 5.825 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 5.531 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 5.549 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 5.321 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 5.339 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 5.146 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,23 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 92,67 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 86,67 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 87,74 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 82,56 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 84,41 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 79,44 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 81,63 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 182 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 488 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 174 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 464 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 163 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 452 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 155 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 441 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 150 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 423 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,6 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,08 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 89,56 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 92,62 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 85,16 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 90,37 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 82,42 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 86,68 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 6.874 10 Cáceres From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 6.753 10 Cáceres From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 6.343 10 Cáceres From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 6.373 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 6.305 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 6.001 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 6.008 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 6.019 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 5.762 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 5.742 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 5.780 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 5.555 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 5.531 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 5.321 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 10 Cáceres From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 10 Cáceres From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 10 Cáceres From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 92,71 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 93,37 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,61 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 87,4 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 89,13 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 90,84 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 83,53 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 85,59 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 87,58 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 81,9 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 83,89 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 6.676 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 6.349 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 5.301 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 6.188 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 5.914 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 4.977 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 5.836 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 5.638 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 4.771 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 5.579 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 5.414 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 4.596 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 5.178 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 4.397 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 92,69 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 93,15 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 93,89 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 87,42 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 88,8 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 83,57 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 85,27 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 86,7 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 81,56 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 82,95 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 198 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 404 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.042 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 185 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 391 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.024 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 172 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 381 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 991 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 163 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 366 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 959 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 353 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 924 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 93,43 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,78 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,27 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 86,87 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,31 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,11 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 82,32 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 90,59 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 92,03 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 87,38 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 88,68 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 6.939 10 Cáceres From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 6.844 10 Cáceres From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 6.611 10 Cáceres From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 6.348 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 6.330 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 6.189 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 5.984 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 6.011 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 5.878 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 5.720 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 5.579 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 5.503 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 5.401 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 10 Cáceres From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 10 Cáceres From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 10 Cáceres From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 91,48 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,49 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 93,62 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 86,24 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 87,83 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 88,91 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 83,58 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 84,39 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 80,41 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 81,7 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 6.847 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 6.711 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 6.008 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 6.262 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 6.202 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 5.603 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 5.904 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 5.887 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 5.312 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 5.600 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 5.033 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 5.386 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 4.869 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 91,46 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,42 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,26 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 86,23 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 87,72 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 88,42 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 83,45 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 83,77 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 80,26 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 81,04 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 92 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 133 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 603 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 86 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 128 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 586 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 80 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 124 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 566 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 120 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 546 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 117 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 532 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 93,48 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,24 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,18 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 86,96 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,23 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,86 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 90,23 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 90,55 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 87,97 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 88,23 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 6.952 10 Cáceres From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 6.842 10 Cáceres From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 6.768 10 Cáceres From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 6.447 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 6.377 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 6.261 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 6.022 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 5.907 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 5.728 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 5.659 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 5.487 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 5.481 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 10 Cáceres From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 10 Cáceres From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 10 Cáceres From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 92,74 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,2 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 92,51 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,02 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 87,28 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 83,72 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 83,61 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 80,2 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 80,98 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 6.870 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 6.609 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 6.182 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 6.372 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 6.160 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 5.697 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 5.812 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 5.366 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 5.526 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 5.132 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 5.294 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 4.967 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 92,75 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 93,21 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,15 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 87,94 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 86,8 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 83,61 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 83,02 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 80,1 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 80,35 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 82 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 233 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 586 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 75 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 217 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 564 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 210 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 541 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 202 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 527 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 193 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 514 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 91,46 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 93,13 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,25 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 90,13 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 92,32 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 86,7 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 89,93 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 82,83 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 87,71 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 850 10 Cáceres From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 784 10 Cáceres From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 864 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 842 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 777 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 825 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 824 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 759 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 810 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 817 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 753 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 802 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 808 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 749 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 794 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 10 Cáceres From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 10 Cáceres From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,06 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,11 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 95,49 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,94 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,81 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 93,75 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,12 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,05 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 92,82 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,06 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,54 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 91,9 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 797 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 651 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 789 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 645 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 771 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 629 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 764 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 625 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 755 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 622 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,08 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,74 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,62 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,86 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,01 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 94,73 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,55 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 53 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 133 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 53 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 132 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 53 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 130 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 53 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 128 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 53 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 127 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,25 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,74 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,24 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,49 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 872 10 Cáceres From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 817 10 Cáceres From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 718 10 Cáceres From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 854 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 804 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 709 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 847 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 796 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 703 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 834 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 787 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 697 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 780 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 687 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 10 Cáceres From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 10 Cáceres From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 10 Cáceres From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,94 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,41 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,75 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,13 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,43 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,91 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,64 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,33 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,08 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 95,47 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,68 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 834 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 700 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 461 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 817 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 688 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 454 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 810 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 681 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 450 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 797 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 674 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 448 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 668 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 445 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,96 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,29 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,48 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,12 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,29 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,61 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,56 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,29 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,18 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,43 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,53 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 38 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 117 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 257 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 37 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 116 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 255 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 37 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 115 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 253 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 37 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 113 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 249 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 112 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 242 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,37 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,15 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,22 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,37 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,29 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,44 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,37 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,58 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,89 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 95,73 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,16 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 923 10 Cáceres From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 852 10 Cáceres From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 806 10 Cáceres From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 903 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 836 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 798 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 888 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 825 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 780 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 818 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 772 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 805 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 760 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 10 Cáceres From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 10 Cáceres From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 10 Cáceres From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,83 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,12 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,01 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,21 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 96,83 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 96,77 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,01 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,78 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 94,48 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 94,29 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 906 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 818 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 629 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 886 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 802 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 622 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 872 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 791 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 607 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 784 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 603 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 773 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 592 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,79 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,04 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,89 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,25 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 96,7 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,5 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,84 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,87 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,5 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,12 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 17 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 34 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 177 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 17 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 34 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 176 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 16 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 34 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 173 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 34 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 169 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 32 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 168 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,44 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,12 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,74 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95,48 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 94,12 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 94,92 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 873 10 Cáceres From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 850 10 Cáceres From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 833 10 Cáceres From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 856 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 838 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 819 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 830 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 810 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 814 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 797 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 809 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 789 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 10 Cáceres From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 10 Cáceres From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 10 Cáceres From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,05 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,59 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,32 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,65 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,24 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95,76 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 95,68 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,18 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 94,72 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 862 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 810 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 660 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 845 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 798 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 652 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 790 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 646 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 774 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 634 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 769 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 627 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,03 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,52 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,79 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,53 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,88 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,56 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,06 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 94,94 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 11 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 40 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 173 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 11 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 40 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 167 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 40 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 164 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 40 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 163 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 40 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 162 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,53 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,8 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,22 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,64 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 971 10 Cáceres From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 875 10 Cáceres From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 939 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 966 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 864 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 917 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 955 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 858 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 909 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 936 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 845 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 901 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 925 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 837 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 891 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 10 Cáceres From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 10 Cáceres From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,49 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,74 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,66 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,35 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,06 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,81 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,4 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,57 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,95 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,26 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,66 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,89 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 931 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 687 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 926 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 678 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 915 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 673 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 896 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 662 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 885 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 656 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,46 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,69 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,28 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,96 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,24 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,36 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,06 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,49 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 40 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 188 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 40 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 186 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 40 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 185 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 40 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 183 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 40 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 181 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,94 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,4 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,34 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,28 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 990 10 Cáceres From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 874 10 Cáceres From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 828 10 Cáceres From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 976 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 867 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 822 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 958 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 857 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 815 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 948 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 851 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 805 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 847 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 798 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 10 Cáceres From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 10 Cáceres From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 10 Cáceres From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,59 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,2 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,28 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,77 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,05 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,43 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,76 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,37 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,22 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,91 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,38 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 943 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 726 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 518 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 929 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 720 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 513 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 911 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 711 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 509 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 901 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 706 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 502 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 704 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 497 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,52 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,17 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,03 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,61 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,93 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,26 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,55 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,25 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,91 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,97 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,95 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 47 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 148 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 310 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 47 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 147 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 309 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 47 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 146 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 306 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 47 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 145 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 303 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 143 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 301 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,32 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,68 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,65 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,71 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,97 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,74 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,62 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 97,1 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 1.004 10 Cáceres From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 938 10 Cáceres From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 887 10 Cáceres From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 982 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 922 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 878 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 967 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 912 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 863 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 905 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 854 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 898 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 848 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 10 Cáceres From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 10 Cáceres From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 10 Cáceres From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,81 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,29 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,99 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,31 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,23 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,29 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,48 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,28 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,74 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,6 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 993 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 899 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 650 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 971 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 884 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 644 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 956 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 874 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 633 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 867 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 625 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 860 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 620 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,78 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,33 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,08 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,27 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,22 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,38 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,44 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,15 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,66 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,38 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 11 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 39 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 237 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 11 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 38 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 234 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 11 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 38 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 230 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 38 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 229 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 38 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 228 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,44 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,73 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,44 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,05 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,44 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,62 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 97,44 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,2 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 1.007 10 Cáceres From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 959 10 Cáceres From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 903 10 Cáceres From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 997 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 949 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 889 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 945 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 879 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 931 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 871 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 921 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 863 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 10 Cáceres From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 10 Cáceres From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 10 Cáceres From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,01 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,96 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,45 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,54 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,34 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,08 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,46 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,04 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,57 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 995 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 920 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 673 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 985 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 910 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 660 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 906 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 652 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 893 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 645 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 883 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 640 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,99 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,91 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,07 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,48 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,88 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,07 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,84 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,98 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,1 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 12 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 39 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 230 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 12 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 39 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 229 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 39 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 227 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 38 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 226 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 38 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 223 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,57 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,7 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,44 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,26 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 97,44 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,96 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 36 10 Cáceres from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 30 10 Cáceres from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 28 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 36 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 29 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 28 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 35 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 29 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 28 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 35 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 29 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 27 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 35 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 29 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 27 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 10 Cáceres from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 10 Cáceres from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 96,67 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,22 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,67 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,22 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,67 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,43 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,22 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,67 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,43 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 36 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 24 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 36 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 23 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 35 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 23 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 35 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 23 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 35 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 23 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 95,83 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,22 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 95,83 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,22 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,83 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,22 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,83 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 0 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 6 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 0 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 6 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 0 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 6 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 0 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 6 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 0 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 6 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI .. 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI .. 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII .. 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII .. 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 0 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 33 10 Cáceres from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 27 10 Cáceres from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 29 10 Cáceres from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 32 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 27 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 29 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 32 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 27 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 28 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 32 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 27 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 28 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 27 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 27 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 10 Cáceres from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 10 Cáceres from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 10 Cáceres from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 96,97 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,97 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 96,55 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,97 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,55 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 93,1 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 33 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 22 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 22 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 32 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 22 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 22 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 32 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 22 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 21 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 32 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 22 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 21 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 22 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 20 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 96,97 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,97 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 95,45 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,97 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,45 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 90,91 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 0 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 5 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 7 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 0 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 5 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 7 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 0 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 5 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 7 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 0 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 5 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 7 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 5 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 7 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII .. 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII .. 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII .. 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 0 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 34 10 Cáceres from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 29 10 Cáceres from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 29 10 Cáceres from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 33 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 29 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 28 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 33 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 29 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 28 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 29 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 27 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 29 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 27 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 10 Cáceres from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 10 Cáceres from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 10 Cáceres from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,06 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 96,55 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,06 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 96,55 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 93,1 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 93,1 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 34 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 26 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 24 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 33 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 26 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 23 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 33 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 26 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 23 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 26 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 22 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 26 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 22 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,06 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,83 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,06 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 95,83 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 91,67 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 91,67 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 3 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 5 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 3 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 5 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 3 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 5 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 3 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 5 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 3 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 5 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII .. 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII .. 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 37 10 Cáceres from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 33 10 Cáceres from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 31 10 Cáceres from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 37 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 33 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 30 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 33 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 29 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 33 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 29 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 33 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 29 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 10 Cáceres from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 10 Cáceres from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 10 Cáceres from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 96,77 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 93,55 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 93,55 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 93,55 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 37 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 30 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 26 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 37 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 30 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 25 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 30 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 24 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 30 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 24 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 30 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 24 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 96,15 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 92,31 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 92,31 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 92,31 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 3 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 5 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 3 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 5 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 3 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 5 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 3 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 5 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 3 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 5 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 16 10 Cáceres De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 13 10 Cáceres De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 14 10 Cáceres De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 16 10 Cáceres De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 13 10 Cáceres De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 14 10 Cáceres De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 16 10 Cáceres De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 13 10 Cáceres De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 14 10 Cáceres De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 16 10 Cáceres De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 13 10 Cáceres De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 14 10 Cáceres De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 16 10 Cáceres De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 13 10 Cáceres De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 14 10 Cáceres De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 10 Cáceres De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 10 Cáceres De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 14 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 7 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 14 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 7 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 14 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 7 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 14 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 7 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 14 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 7 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2 10 Cáceres De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 6 10 Cáceres De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 6 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 6 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 6 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 6 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 10 Cáceres De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 10 Cáceres De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 15 10 Cáceres De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 14 10 Cáceres De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 13 10 Cáceres De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 15 10 Cáceres De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 14 10 Cáceres De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 13 10 Cáceres De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 15 10 Cáceres De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 14 10 Cáceres De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 13 10 Cáceres De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 15 10 Cáceres De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 14 10 Cáceres De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 13 10 Cáceres De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 14 10 Cáceres De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 13 10 Cáceres De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 10 Cáceres De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 10 Cáceres De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 10 Cáceres De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 10 Cáceres De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 14 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 8 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 7 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 14 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 8 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 7 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 14 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 8 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 7 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 14 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 8 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 7 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 8 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 7 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1 10 Cáceres De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 6 10 Cáceres De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 6 10 Cáceres De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 6 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 6 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 6 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 6 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 6 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 6 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 6 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 6 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 10 Cáceres De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 10 Cáceres De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 10 Cáceres De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 15 10 Cáceres De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 15 10 Cáceres De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 14 10 Cáceres De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 15 10 Cáceres De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 15 10 Cáceres De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 14 10 Cáceres De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 15 10 Cáceres De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 15 10 Cáceres De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 14 10 Cáceres De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 15 10 Cáceres De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 14 10 Cáceres De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 15 10 Cáceres De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 14 10 Cáceres De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 10 Cáceres De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 10 Cáceres De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 10 Cáceres De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 10 Cáceres De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 10 Cáceres De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 10 Cáceres De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 15 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 14 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 8 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 15 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 14 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 8 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 15 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 14 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 8 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 14 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 8 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 14 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 8 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 10 Cáceres De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1 10 Cáceres De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 6 10 Cáceres De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 6 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 6 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 6 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 6 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII .. 10 Cáceres De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 10 Cáceres De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 10 Cáceres De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII .. 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 13 10 Cáceres De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 15 10 Cáceres De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 14 10 Cáceres De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 13 10 Cáceres De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 15 10 Cáceres De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 14 10 Cáceres De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 15 10 Cáceres De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 14 10 Cáceres De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 15 10 Cáceres De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 14 10 Cáceres De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 15 10 Cáceres De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 14 10 Cáceres De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 10 Cáceres De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 10 Cáceres De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 10 Cáceres De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 10 Cáceres De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 10 Cáceres De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 10 Cáceres De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 10 Cáceres De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 13 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 14 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 8 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 13 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 14 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 8 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 14 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 8 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 14 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 8 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 14 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 8 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 10 Cáceres De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1 10 Cáceres De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 6 10 Cáceres De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 6 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 6 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 6 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 6 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 10 Cáceres De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 10 Cáceres De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 10 Cáceres De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 10 Cáceres De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz Total Cohort January 1 Total Number at the start of the quarter 2022QI 25.690 11 Cádiz Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz Total Cohort January 1 Total Number at the start of the quarter 2021QI 24.440 11 Cádiz Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz Total Cohort January 1 Total Number at the start of the quarter 2020QI 25.879 11 Cádiz Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 11 Cádiz Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 11 Cádiz Total Cohort January 1 Total Survival in the first trimester 2022QII "" 11 Cádiz Total Cohort January 1 Total Survival in the first trimester 2022QI 23.778 11 Cádiz Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 11 Cádiz Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 11 Cádiz Total Cohort January 1 Total Survival in the first trimester 2021QII "" 11 Cádiz Total Cohort January 1 Total Survival in the first trimester 2021QI 22.566 11 Cádiz Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 11 Cádiz Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 11 Cádiz Total Cohort January 1 Total Survival in the first trimester 2020QII "" 11 Cádiz Total Cohort January 1 Total Survival in the first trimester 2020QI 21.182 11 Cádiz Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 11 Cádiz Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 11 Cádiz Total Cohort January 1 Total Survival in the second trimester 2022QII 22.587 11 Cádiz Total Cohort January 1 Total Survival in the second trimester 2022QI "" 11 Cádiz Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 11 Cádiz Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 11 Cádiz Total Cohort January 1 Total Survival in the second trimester 2021QII 21.620 11 Cádiz Total Cohort January 1 Total Survival in the second trimester 2021QI "" 11 Cádiz Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 11 Cádiz Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 11 Cádiz Total Cohort January 1 Total Survival in the second trimester 2020QII 20.374 11 Cádiz Total Cohort January 1 Total Survival in the second trimester 2020QI "" 11 Cádiz Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz Total Cohort January 1 Total Survival in the third trimester 2022QIII 21.712 11 Cádiz Total Cohort January 1 Total Survival in the third trimester 2022QII "" 11 Cádiz Total Cohort January 1 Total Survival in the third trimester 2022QI "" 11 Cádiz Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz Total Cohort January 1 Total Survival in the third trimester 2021QIII 20.830 11 Cádiz Total Cohort January 1 Total Survival in the third trimester 2021QII "" 11 Cádiz Total Cohort January 1 Total Survival in the third trimester 2021QI "" 11 Cádiz Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz Total Cohort January 1 Total Survival in the third trimester 2020QIII 19.733 11 Cádiz Total Cohort January 1 Total Survival in the third trimester 2020QII "" 11 Cádiz Total Cohort January 1 Total Survival in the third trimester 2020QI "" 11 Cádiz Total Cohort January 1 Total Survival in the third trimester 2022QIV 20.930 11 Cádiz Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz Total Cohort January 1 Total Survival in the third trimester 2022QII "" 11 Cádiz Total Cohort January 1 Total Survival in the third trimester 2022QI "" 11 Cádiz Total Cohort January 1 Total Survival in the third trimester 2021QIV 20.191 11 Cádiz Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz Total Cohort January 1 Total Survival in the third trimester 2021QII "" 11 Cádiz Total Cohort January 1 Total Survival in the third trimester 2021QI "" 11 Cádiz Total Cohort January 1 Total Survival in the third trimester 2020QIV 18.995 11 Cádiz Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz Total Cohort January 1 Total Survival in the third trimester 2020QII "" 11 Cádiz Total Cohort January 1 Total Survival in the third trimester 2020QI "" 11 Cádiz Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 11 Cádiz Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 11 Cádiz Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 92,56 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 92,33 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 81,85 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 87,92 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 88,46 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 78,73 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 84,52 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 85,23 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 76,25 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 81,47 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 82,61 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 73,4 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 24.497 11 Cádiz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 21.976 11 Cádiz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 22.633 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 20.171 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 21.484 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 19.280 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 20.641 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 18.541 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 19.881 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 17.957 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 11 Cádiz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 11 Cádiz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,39 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 91,79 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 87,7 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 87,73 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 84,26 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 84,37 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 81,16 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 81,71 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.193 11 Cádiz Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2.464 11 Cádiz Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.145 11 Cádiz Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2.395 11 Cádiz Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.103 11 Cádiz Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2.340 11 Cádiz Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.071 11 Cádiz Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2.289 11 Cádiz Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.049 11 Cádiz Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2.234 11 Cádiz Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 11 Cádiz Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 11 Cádiz Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,98 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,2 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,46 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,97 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 89,77 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,9 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 87,93 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 90,67 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz Total Cohort April 1 Total Number at the start of the quarter 2022QII 25.802 11 Cádiz Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz Total Cohort April 1 Total Number at the start of the quarter 2021QII 24.422 11 Cádiz Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz Total Cohort April 1 Total Number at the start of the quarter 2020QII 22.457 11 Cádiz Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 11 Cádiz Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 11 Cádiz Total Cohort April 1 Total Survival in the first trimester 2022QII 24.216 11 Cádiz Total Cohort April 1 Total Survival in the first trimester 2022QI "" 11 Cádiz Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 11 Cádiz Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 11 Cádiz Total Cohort April 1 Total Survival in the first trimester 2021QII 23.159 11 Cádiz Total Cohort April 1 Total Survival in the first trimester 2021QI "" 11 Cádiz Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 11 Cádiz Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 11 Cádiz Total Cohort April 1 Total Survival in the first trimester 2020QII 21.471 11 Cádiz Total Cohort April 1 Total Survival in the first trimester 2020QI "" 11 Cádiz Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 11 Cádiz Total Cohort April 1 Total Survival in the second trimester 2022QIII 23.080 11 Cádiz Total Cohort April 1 Total Survival in the second trimester 2022QII "" 11 Cádiz Total Cohort April 1 Total Survival in the second trimester 2022QI "" 11 Cádiz Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 11 Cádiz Total Cohort April 1 Total Survival in the second trimester 2021QIII 22.156 11 Cádiz Total Cohort April 1 Total Survival in the second trimester 2021QII "" 11 Cádiz Total Cohort April 1 Total Survival in the second trimester 2021QI "" 11 Cádiz Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 11 Cádiz Total Cohort April 1 Total Survival in the second trimester 2020QIII 20.666 11 Cádiz Total Cohort April 1 Total Survival in the second trimester 2020QII "" 11 Cádiz Total Cohort April 1 Total Survival in the second trimester 2020QI "" 11 Cádiz Total Cohort April 1 Total Survival in the third trimester 2022QIV 21.937 11 Cádiz Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz Total Cohort April 1 Total Survival in the third trimester 2022QII "" 11 Cádiz Total Cohort April 1 Total Survival in the third trimester 2022QI "" 11 Cádiz Total Cohort April 1 Total Survival in the third trimester 2021QIV 21.187 11 Cádiz Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz Total Cohort April 1 Total Survival in the third trimester 2021QII "" 11 Cádiz Total Cohort April 1 Total Survival in the third trimester 2021QI "" 11 Cádiz Total Cohort April 1 Total Survival in the third trimester 2020QIV 19.766 11 Cádiz Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz Total Cohort April 1 Total Survival in the third trimester 2020QII "" 11 Cádiz Total Cohort April 1 Total Survival in the third trimester 2020QI "" 11 Cádiz Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz Total Cohort April 1 Total Survival in the third trimester 2022QII "" 11 Cádiz Total Cohort April 1 Total Survival in the third trimester 2022QI 20.254 11 Cádiz Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz Total Cohort April 1 Total Survival in the third trimester 2021QII "" 11 Cádiz Total Cohort April 1 Total Survival in the third trimester 2021QI 18.856 11 Cádiz Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz Total Cohort April 1 Total Survival in the third trimester 2020QII "" 11 Cádiz Total Cohort April 1 Total Survival in the third trimester 2020QI "" 11 Cádiz Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 11 Cádiz Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 11 Cádiz Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 11 Cádiz Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,85 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,83 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,61 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,45 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,72 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,02 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 85,02 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 86,75 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,02 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 82,93 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 83,96 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 24.650 11 Cádiz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 21.989 11 Cádiz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 17.413 11 Cádiz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 23.115 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 20.779 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 16.487 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 22.011 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 19.825 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 15.784 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 20.904 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 18.908 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 15.059 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 18.040 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 14.318 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 11 Cádiz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 11 Cádiz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 11 Cádiz Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,77 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,5 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,68 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 89,29 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 90,16 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,64 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 84,8 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 85,99 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 86,48 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 82,04 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 82,23 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.152 11 Cádiz Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 2.433 11 Cádiz Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 5.044 11 Cádiz Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.101 11 Cádiz Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 2.380 11 Cádiz Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 4.984 11 Cádiz Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.069 11 Cádiz Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 2.331 11 Cádiz Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 4.882 11 Cádiz Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.033 11 Cádiz Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 2.279 11 Cádiz Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 4.707 11 Cádiz Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 2.214 11 Cádiz Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 4.538 11 Cádiz Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 11 Cádiz Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 11 Cádiz Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 11 Cádiz Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,57 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,82 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,81 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 92,8 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,81 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,79 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 89,67 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,67 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,32 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 91 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 89,97 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz Total Cohort July 1 Total Number at the start of the quarter 2022QIII 26.978 11 Cádiz Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz Total Cohort July 1 Total Number at the start of the quarter 2021QIII 26.251 11 Cádiz Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz Total Cohort July 1 Total Number at the start of the quarter 2020QIII 24.988 11 Cádiz Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 11 Cádiz Total Cohort July 1 Total Survival in the first trimester 2022QIII 24.977 11 Cádiz Total Cohort July 1 Total Survival in the first trimester 2022QII "" 11 Cádiz Total Cohort July 1 Total Survival in the first trimester 2022QI "" 11 Cádiz Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 11 Cádiz Total Cohort July 1 Total Survival in the first trimester 2021QIII 24.331 11 Cádiz Total Cohort July 1 Total Survival in the first trimester 2021QII "" 11 Cádiz Total Cohort July 1 Total Survival in the first trimester 2021QI "" 11 Cádiz Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 11 Cádiz Total Cohort July 1 Total Survival in the first trimester 2020QIII 23.308 11 Cádiz Total Cohort July 1 Total Survival in the first trimester 2020QII "" 11 Cádiz Total Cohort July 1 Total Survival in the first trimester 2020QI "" 11 Cádiz Total Cohort July 1 Total Survival in the second trimester 2022QIV 23.126 11 Cádiz Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 11 Cádiz Total Cohort July 1 Total Survival in the second trimester 2022QII "" 11 Cádiz Total Cohort July 1 Total Survival in the second trimester 2022QI "" 11 Cádiz Total Cohort July 1 Total Survival in the second trimester 2021QIV 22.614 11 Cádiz Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 11 Cádiz Total Cohort July 1 Total Survival in the second trimester 2021QII "" 11 Cádiz Total Cohort July 1 Total Survival in the second trimester 2021QI "" 11 Cádiz Total Cohort July 1 Total Survival in the second trimester 2020QIV 21.690 11 Cádiz Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 11 Cádiz Total Cohort July 1 Total Survival in the second trimester 2020QII "" 11 Cádiz Total Cohort July 1 Total Survival in the second trimester 2020QI "" 11 Cádiz Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz Total Cohort July 1 Total Survival in the third trimester 2022QII "" 11 Cádiz Total Cohort July 1 Total Survival in the third trimester 2022QI 21.449 11 Cádiz Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz Total Cohort July 1 Total Survival in the third trimester 2021QII "" 11 Cádiz Total Cohort July 1 Total Survival in the third trimester 2021QI 20.541 11 Cádiz Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz Total Cohort July 1 Total Survival in the third trimester 2020QII "" 11 Cádiz Total Cohort July 1 Total Survival in the third trimester 2020QI "" 11 Cádiz Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz Total Cohort July 1 Total Survival in the third trimester 2022QII 20.709 11 Cádiz Total Cohort July 1 Total Survival in the third trimester 2022QI "" 11 Cádiz Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz Total Cohort July 1 Total Survival in the third trimester 2021QII 19.925 11 Cádiz Total Cohort July 1 Total Survival in the third trimester 2021QI "" 11 Cádiz Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz Total Cohort July 1 Total Survival in the third trimester 2020QII "" 11 Cádiz Total Cohort July 1 Total Survival in the third trimester 2020QI "" 11 Cádiz Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 11 Cádiz Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 11 Cádiz Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 11 Cádiz Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,58 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,69 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 93,28 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 85,72 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 86,15 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 86,8 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 81,71 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 82,2 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 78,89 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 79,74 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 26.353 11 Cádiz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 25.462 11 Cádiz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 22.148 11 Cádiz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 24.369 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 23.558 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 20.532 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 22.539 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 21.854 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 19.001 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 20.709 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 17.933 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 19.990 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 17.367 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 11 Cádiz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 11 Cádiz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 11 Cádiz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,47 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,52 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 92,7 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 85,53 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 85,83 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 85,79 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 81,33 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 80,97 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 78,51 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 78,41 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 625 11 Cádiz Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 789 11 Cádiz Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2.840 11 Cádiz Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 608 11 Cádiz Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 773 11 Cádiz Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2.776 11 Cádiz Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 587 11 Cádiz Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 760 11 Cádiz Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 2.689 11 Cádiz Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 740 11 Cádiz Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2.608 11 Cádiz Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 719 11 Cádiz Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 2.558 11 Cádiz Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 11 Cádiz Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 11 Cádiz Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 11 Cádiz Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,28 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,97 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,75 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,92 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,32 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,68 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93,79 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 91,83 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 91,13 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 90,07 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz Total Cohort October 1 Total Number at the start of the quarter 2022QIV 26.540 11 Cádiz Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz Total Cohort October 1 Total Number at the start of the quarter 2021QIV 26.067 11 Cádiz Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz Total Cohort October 1 Total Number at the start of the quarter 2020QIV 25.230 11 Cádiz Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz Total Cohort October 1 Total Survival in the first trimester 2022QIV 24.291 11 Cádiz Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 11 Cádiz Total Cohort October 1 Total Survival in the first trimester 2022QII "" 11 Cádiz Total Cohort October 1 Total Survival in the first trimester 2022QI "" 11 Cádiz Total Cohort October 1 Total Survival in the first trimester 2021QIV 23.875 11 Cádiz Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 11 Cádiz Total Cohort October 1 Total Survival in the first trimester 2021QII "" 11 Cádiz Total Cohort October 1 Total Survival in the first trimester 2021QI "" 11 Cádiz Total Cohort October 1 Total Survival in the first trimester 2020QIV 23.005 11 Cádiz Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 11 Cádiz Total Cohort October 1 Total Survival in the first trimester 2020QII "" 11 Cádiz Total Cohort October 1 Total Survival in the first trimester 2020QI "" 11 Cádiz Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 11 Cádiz Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 11 Cádiz Total Cohort October 1 Total Survival in the second trimester 2022QII "" 11 Cádiz Total Cohort October 1 Total Survival in the second trimester 2022QI 22.485 11 Cádiz Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 11 Cádiz Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 11 Cádiz Total Cohort October 1 Total Survival in the second trimester 2021QII "" 11 Cádiz Total Cohort October 1 Total Survival in the second trimester 2021QI 21.591 11 Cádiz Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 11 Cádiz Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 11 Cádiz Total Cohort October 1 Total Survival in the second trimester 2020QII "" 11 Cádiz Total Cohort October 1 Total Survival in the second trimester 2020QI "" 11 Cádiz Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz Total Cohort October 1 Total Survival in the third trimester 2022QII 21.559 11 Cádiz Total Cohort October 1 Total Survival in the third trimester 2022QI "" 11 Cádiz Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz Total Cohort October 1 Total Survival in the third trimester 2021QII 20.837 11 Cádiz Total Cohort October 1 Total Survival in the third trimester 2021QI "" 11 Cádiz Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz Total Cohort October 1 Total Survival in the third trimester 2020QII "" 11 Cádiz Total Cohort October 1 Total Survival in the third trimester 2020QI "" 11 Cádiz Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz Total Cohort October 1 Total Survival in the third trimester 2022QIII 20.844 11 Cádiz Total Cohort October 1 Total Survival in the third trimester 2022QII "" 11 Cádiz Total Cohort October 1 Total Survival in the third trimester 2022QI "" 11 Cádiz Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz Total Cohort October 1 Total Survival in the third trimester 2021QIII 20.174 11 Cádiz Total Cohort October 1 Total Survival in the third trimester 2021QII "" 11 Cádiz Total Cohort October 1 Total Survival in the third trimester 2021QI "" 11 Cádiz Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz Total Cohort October 1 Total Survival in the third trimester 2020QII "" 11 Cádiz Total Cohort October 1 Total Survival in the third trimester 2020QI "" 11 Cádiz Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 11 Cádiz Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 11 Cádiz Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 11 Cádiz Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 91,53 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 91,59 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 91,18 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 86,26 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 85,58 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 82,71 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 82,59 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 79,96 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 79,96 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 25.995 11 Cádiz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 24.760 11 Cádiz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 22.553 11 Cádiz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 23.765 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 22.606 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 20.417 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 21.265 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 19.079 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 20.382 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 18.381 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 19.698 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 17.772 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 11 Cádiz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 11 Cádiz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 11 Cádiz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 91,42 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 91,3 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 90,53 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 85,88 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 84,6 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 82,32 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 81,5 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 79,56 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 78,8 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 545 11 Cádiz Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.307 11 Cádiz Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 2.677 11 Cádiz Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 526 11 Cádiz Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.269 11 Cádiz Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2.588 11 Cádiz Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.220 11 Cádiz Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2.512 11 Cádiz Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.177 11 Cádiz Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2.456 11 Cádiz Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.146 11 Cádiz Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2.402 11 Cádiz Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 11 Cádiz Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 11 Cádiz Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 11 Cádiz Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,51 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,09 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,68 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,34 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 93,84 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 90,05 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 91,74 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 87,68 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 89,73 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 19.706 11 Cádiz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 19.133 11 Cádiz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 19.978 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 17.895 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 17.358 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 15.679 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 16.809 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 16.483 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 14.949 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 16.018 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 15.752 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 14.377 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 15.307 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 15.167 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 13.728 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 11 Cádiz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 11 Cádiz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 90,81 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 90,72 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 78,48 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 85,3 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 86,15 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 74,83 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 81,28 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 82,33 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 71,96 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 77,68 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 79,27 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 68,72 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 18.919 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 17.830 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 17.151 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 16.114 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 16.102 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 15.282 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 15.337 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 14.592 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 14.645 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 14.050 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 90,65 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 90,38 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 85,11 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 85,71 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 81,07 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 81,84 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 77,41 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 78,8 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 787 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.303 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 744 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.244 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 707 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.201 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 681 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.160 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 662 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.117 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,54 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,47 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 89,83 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 92,17 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 86,53 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 89,03 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 84,12 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 85,73 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 19.708 11 Cádiz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 18.990 11 Cádiz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 17.616 11 Cádiz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 18.215 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 17.790 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 16.677 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 17.161 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 16.845 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 15.925 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 16.147 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 15.993 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 15.097 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 15.161 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 14.281 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 11 Cádiz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 11 Cádiz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 11 Cádiz From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 92,42 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 93,68 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,67 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 87,08 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 88,7 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 90,4 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 81,93 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 84,22 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 85,7 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 79,84 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 81,07 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 18.946 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 17.641 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 14.529 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 17.494 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 16.483 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 13.634 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 16.465 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 15.577 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 12.964 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 15.481 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 14.762 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 12.274 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 13.982 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 11.596 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 92,34 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 93,44 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 93,84 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 86,9 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 88,3 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 89,23 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 81,71 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 83,68 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 84,48 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 79,26 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 79,81 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 762 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.349 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 3.087 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 721 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.307 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 3.043 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 696 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.268 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.961 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 666 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.231 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.823 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.179 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.685 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 94,62 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,89 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,57 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,34 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,92 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 87,4 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 91,25 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,45 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 87,4 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 86,98 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 20.089 11 Cádiz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 19.862 11 Cádiz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 19.152 11 Cádiz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 18.279 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 18.067 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 17.640 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 16.780 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 16.659 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 16.247 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 15.632 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 15.234 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 14.975 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 14.678 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 11 Cádiz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 11 Cádiz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 11 Cádiz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 90,99 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 90,96 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 92,11 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 83,53 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 83,87 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 84,83 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 78,7 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 79,54 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 75,4 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 76,64 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 19.676 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 19.406 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 17.710 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 17.879 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 17.626 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 16.250 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 16.390 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 16.228 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 14.920 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 15.217 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 13.969 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 14.578 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 13.452 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 90,87 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 90,83 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 91,76 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 83,3 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 83,62 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 84,25 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 78,41 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 78,88 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 75,12 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 75,96 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 413 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 456 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.442 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 400 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 441 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.390 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 390 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 431 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.327 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 415 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.265 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 397 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.226 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,85 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,71 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,39 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,43 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 94,52 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 92,02 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 91,01 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 87,73 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 87,06 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 85,02 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 20.003 11 Cádiz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 19.897 11 Cádiz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 19.499 11 Cádiz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 18.010 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 17.936 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 17.467 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 16.667 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 16.182 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 15.825 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 15.497 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 15.190 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 14.892 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 11 Cádiz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 11 Cádiz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 11 Cádiz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 90,04 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 90,14 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 89,58 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 83,77 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 82,99 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 79,53 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 79,48 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 76,34 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 76,37 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 19.645 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 19.013 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 18.101 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 17.666 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 17.083 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 16.142 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 15.857 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 14.921 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 15.056 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 14.279 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 14.444 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 13.717 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 89,93 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 89,85 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 89,18 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 83,4 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 82,43 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 79,19 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 78,89 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 75,97 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 75,78 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 358 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 884 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.398 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 344 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 853 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.325 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 810 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.261 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 769 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.218 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 746 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.175 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,09 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,49 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 94,78 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91,63 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 90,2 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 86,99 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 87,12 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 84,39 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 84,05 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 2.793 11 Cádiz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 2.529 11 Cádiz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 2.717 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 2.738 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 2.464 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 2.475 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 2.670 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 2.418 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 2.430 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 2.612 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 2.384 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 2.388 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 2.570 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 2.351 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 2.333 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 11 Cádiz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 11 Cádiz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,03 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 97,43 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 91,09 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 95,6 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 95,61 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 89,44 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 93,52 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 94,27 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 87,89 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 92,02 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 92,96 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 85,87 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.617 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.085 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.564 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2.028 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.499 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.984 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.445 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.952 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.405 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.928 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 97,97 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97,27 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 95,49 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 95,16 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 93,43 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 93,62 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 91,9 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 92,47 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 176 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 444 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 174 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 436 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 171 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 434 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 167 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 432 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 165 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 423 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,86 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,2 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,16 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,75 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 94,89 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,3 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 93,75 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,27 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 2.816 11 Cádiz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 2.549 11 Cádiz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 2.265 11 Cádiz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 2.759 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 2.509 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 2.235 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 2.703 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 2.480 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 2.201 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 2.620 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 2.399 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 2.159 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 2.327 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 2.100 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 11 Cádiz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 11 Cádiz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 11 Cádiz From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,98 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,43 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,68 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 95,99 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,29 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,17 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 93,04 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 94,12 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,32 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 91,29 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 92,72 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.652 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.117 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.433 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.601 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.081 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.412 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.551 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.056 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.390 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.470 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.985 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.364 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.921 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.326 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,08 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,3 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,53 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,19 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,12 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 93,14 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 93,76 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,18 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 90,74 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 92,53 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 164 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 432 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 832 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 158 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 428 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 823 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 152 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 424 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 811 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 150 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 414 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 795 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 406 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 774 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,34 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,07 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,92 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 92,68 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,15 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,48 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,46 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 95,83 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,55 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 93,98 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 93,03 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 3.150 11 Cádiz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 2.917 11 Cádiz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 2.710 11 Cádiz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 3.039 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 2.855 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 2.607 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 2.857 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 2.695 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 2.492 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 2.612 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 2.404 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 2.564 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 2.372 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 11 Cádiz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 11 Cádiz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 11 Cádiz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 96,48 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 97,87 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 96,2 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 90,7 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 92,39 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 91,96 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 89,54 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 88,71 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 87,9 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 87,53 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 3.046 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.784 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2.205 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.939 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.722 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.110 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.762 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.562 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.007 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.480 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.932 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.434 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.904 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 96,49 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 97,77 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,69 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 90,68 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 92,03 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 91,02 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 89,08 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 87,62 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 87,43 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 86,35 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 104 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 133 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 505 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 100 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 133 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 497 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 95 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 133 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 485 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 132 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 472 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 130 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 468 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,15 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,42 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 91,35 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,04 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 99,25 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,47 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 97,74 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,67 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 3.053 11 Cádiz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 2.869 11 Cádiz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 2.707 11 Cádiz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 2.896 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 2.729 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 2.580 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 2.661 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 2.494 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 2.615 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 2.460 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 2.559 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 2.429 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 11 Cádiz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 11 Cádiz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 11 Cádiz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,86 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,12 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 95,31 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 92,75 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 92,13 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 91,15 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 90,88 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 89,19 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 89,73 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.970 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.688 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2.229 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.814 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.553 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2.108 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.488 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.031 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.444 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2.002 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.394 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.973 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,75 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,98 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,57 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 92,56 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 91,12 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 90,92 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 89,82 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 89,06 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 88,52 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 83 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 181 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 478 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 82 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 176 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 472 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 173 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 463 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 171 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 458 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 165 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 456 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,8 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,24 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,74 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 95,58 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,86 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 94,48 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,82 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 91,16 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 95,4 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 3.044 11 Cádiz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 2.649 11 Cádiz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 3.041 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 2.998 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 2.615 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 2.887 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 2.961 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 2.590 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 2.855 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 2.935 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 2.565 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 2.828 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 2.906 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 2.544 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 2.794 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 11 Cádiz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 11 Cádiz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,49 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,72 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 94,94 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,27 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,77 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 93,88 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,42 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,83 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 93 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,47 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,04 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 91,88 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.824 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.969 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.781 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.937 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.746 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.922 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.722 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.905 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.694 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.887 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,48 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,37 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,24 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,61 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,39 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,75 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,4 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,84 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 220 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 680 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 217 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 678 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 215 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 668 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 213 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 660 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 212 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 657 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,64 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,71 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,73 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,24 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,82 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,06 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,36 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,62 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 3.130 11 Cádiz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 2.752 11 Cádiz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 2.444 11 Cádiz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 3.094 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 2.729 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 2.427 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 3.068 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 2.700 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 2.408 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 3.022 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 2.664 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 2.378 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 2.635 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 2.344 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 11 Cádiz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 11 Cádiz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 11 Cádiz From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,85 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,16 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,3 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,02 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,11 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,53 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,55 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,8 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,3 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 95,75 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,91 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.912 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.137 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.360 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.880 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.121 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.350 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.855 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.098 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.339 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.813 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.067 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.330 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.043 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.306 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,9 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,25 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,26 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,04 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,18 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,46 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,6 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,72 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,79 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,6 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,03 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 218 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 615 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.084 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 214 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 608 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.077 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 213 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 602 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.069 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 209 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 597 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.048 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 592 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.038 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,17 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,86 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,35 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,71 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,89 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,62 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 95,87 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,07 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,68 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,26 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,76 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 3.573 11 Cádiz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 3.328 11 Cádiz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 2.990 11 Cádiz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 3.493 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 3.265 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 2.925 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 3.323 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 3.116 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 2.815 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 3.061 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 2.767 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 3.026 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 2.739 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 11 Cádiz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 11 Cádiz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 11 Cádiz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,76 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,11 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 97,83 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 93 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 93,63 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 94,15 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 91,98 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 92,54 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 90,93 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 91,61 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 3.470 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 3.142 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2.139 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 3.390 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 3.080 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.078 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 3.226 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.934 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.980 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.882 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.938 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.848 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.917 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,69 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,03 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 97,15 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 92,97 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 93,38 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 92,57 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 91,73 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 90,6 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 90,64 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 89,62 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 103 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 186 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 851 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 103 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 185 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 847 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 97 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 182 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 835 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 179 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 829 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 178 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 822 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,46 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,53 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,17 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,85 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,12 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 96,24 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,41 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 95,7 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,59 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 3.325 11 Cádiz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 3.155 11 Cádiz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 2.884 11 Cádiz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 3.226 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 3.064 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 2.818 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 3.011 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 2.775 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 2.973 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 2.740 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 2.949 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 2.713 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 11 Cádiz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 11 Cádiz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 11 Cádiz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,02 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 97,12 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 97,71 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 95,44 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,22 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 94,23 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 95,01 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 93,47 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 94,07 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 3.226 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.924 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2.121 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 3.131 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.835 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2.065 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.785 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.025 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.747 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.998 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.725 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.980 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,06 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 96,96 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,36 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 95,25 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 95,47 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 93,95 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 94,2 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 93,19 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,35 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 99 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 231 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 763 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 95 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 229 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 753 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 226 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 750 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 226 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 742 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 224 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 733 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 95,96 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,13 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,69 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 97,84 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,3 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,84 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,25 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96,97 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,07 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 112 11 Cádiz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 98 11 Cádiz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 108 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 112 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 98 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 106 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 112 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 98 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 106 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 112 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 98 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 106 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 112 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 98 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 106 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 11 Cádiz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 11 Cádiz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,15 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,15 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,15 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,15 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 104 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 67 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 104 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 67 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 104 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 67 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 104 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 67 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 104 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 67 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 8 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 31 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 8 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 31 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 8 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 31 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 8 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 31 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 8 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 31 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 109 11 Cádiz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 98 11 Cádiz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 98 11 Cádiz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 109 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 98 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 98 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 109 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 98 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 98 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 109 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 98 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 98 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 98 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 97 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 11 Cádiz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 11 Cádiz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 11 Cádiz from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,98 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 103 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 69 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 66 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 103 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 69 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 66 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 103 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 69 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 66 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 103 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 69 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 66 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 69 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 65 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 98,48 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 6 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 29 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 32 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 6 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 29 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 32 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 6 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 29 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 32 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 6 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 29 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 32 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 29 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 32 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 122 11 Cádiz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 106 11 Cádiz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 102 11 Cádiz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 122 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 106 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 102 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 122 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 106 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 102 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 106 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 102 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 106 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 102 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 11 Cádiz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 11 Cádiz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 11 Cádiz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 119 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 96 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 70 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 119 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 96 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 70 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 119 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 96 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 70 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 96 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 70 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 96 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 70 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 3 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 10 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 32 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 3 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 10 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 32 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 3 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 10 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 32 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 10 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 32 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 10 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 32 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 119 11 Cádiz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 107 11 Cádiz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 101 11 Cádiz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 119 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 107 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 101 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 107 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 101 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 107 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 101 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 107 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 101 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 11 Cádiz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 11 Cádiz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 11 Cádiz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 116 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 98 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 73 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 116 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 98 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 73 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 98 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 73 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 98 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 73 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 98 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 73 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 3 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 9 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 28 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 3 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 9 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 28 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 9 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 28 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 9 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 28 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 9 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 28 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 35 11 Cádiz De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 31 11 Cádiz De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 35 11 Cádiz De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 35 11 Cádiz De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 31 11 Cádiz De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 35 11 Cádiz De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 35 11 Cádiz De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 31 11 Cádiz De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 34 11 Cádiz De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 35 11 Cádiz De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 31 11 Cádiz De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 34 11 Cádiz De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 35 11 Cádiz De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 31 11 Cádiz De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 34 11 Cádiz De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 11 Cádiz De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 11 Cádiz De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,14 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,14 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,14 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 33 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 25 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 33 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 25 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 33 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 25 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 33 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 25 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 33 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 25 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2 11 Cádiz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 6 11 Cádiz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 6 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 6 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 6 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 6 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 11 Cádiz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 11 Cádiz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 39 11 Cádiz De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 33 11 Cádiz De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 34 11 Cádiz De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 39 11 Cádiz De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 33 11 Cádiz De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 34 11 Cádiz De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 39 11 Cádiz De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 33 11 Cádiz De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 34 11 Cádiz De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 39 11 Cádiz De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 33 11 Cádiz De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 34 11 Cádiz De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 33 11 Cádiz De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 34 11 Cádiz De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 11 Cádiz De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 11 Cádiz De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 11 Cádiz De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 11 Cádiz De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 37 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 25 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 25 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 37 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 25 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 25 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 37 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 25 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 25 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 37 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 25 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 25 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 25 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 25 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 2 11 Cádiz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 8 11 Cádiz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 9 11 Cádiz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 2 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 8 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 9 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 2 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 8 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 9 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 2 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 8 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 9 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 8 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 9 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 11 Cádiz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 11 Cádiz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 11 Cádiz De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 44 11 Cádiz De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 38 11 Cádiz De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 34 11 Cádiz De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 44 11 Cádiz De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 38 11 Cádiz De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 34 11 Cádiz De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 44 11 Cádiz De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 38 11 Cádiz De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 34 11 Cádiz De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 38 11 Cádiz De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 34 11 Cádiz De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 38 11 Cádiz De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 34 11 Cádiz De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 11 Cádiz De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 11 Cádiz De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 11 Cádiz De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 11 Cádiz De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 11 Cádiz De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 11 Cádiz De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 42 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 34 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 24 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 42 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 34 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 24 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 42 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 34 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 24 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 34 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 24 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 34 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 24 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 2 11 Cádiz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 4 11 Cádiz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 10 11 Cádiz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 2 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 4 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 10 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 2 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 4 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 10 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 4 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 10 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 4 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 10 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 11 Cádiz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 11 Cádiz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 11 Cádiz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 40 11 Cádiz De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 39 11 Cádiz De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 39 11 Cádiz De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 40 11 Cádiz De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 39 11 Cádiz De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 39 11 Cádiz De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 39 11 Cádiz De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 39 11 Cádiz De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 39 11 Cádiz De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 39 11 Cádiz De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 39 11 Cádiz De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 39 11 Cádiz De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 11 Cádiz De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 11 Cádiz De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 11 Cádiz De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 11 Cádiz De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 11 Cádiz De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 11 Cádiz De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 11 Cádiz De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 38 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 37 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 29 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 38 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 37 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 29 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 37 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 29 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 37 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 29 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 37 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 29 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 2 11 Cádiz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 2 11 Cádiz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 10 11 Cádiz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 2 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 2 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 10 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 2 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 10 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 2 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 10 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 2 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 10 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 11 Cádiz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 11 Cádiz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 11 Cádiz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 11 Cádiz De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2022QI 14.388 39 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2021QI 13.790 39 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2020QI 14.505 39 Cantabria Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 39 Cantabria Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 39 Cantabria Total Cohort January 1 Total Survival in the first trimester 2022QII "" 39 Cantabria Total Cohort January 1 Total Survival in the first trimester 2022QI 13.710 39 Cantabria Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 39 Cantabria Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 39 Cantabria Total Cohort January 1 Total Survival in the first trimester 2021QII "" 39 Cantabria Total Cohort January 1 Total Survival in the first trimester 2021QI 13.171 39 Cantabria Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 39 Cantabria Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 39 Cantabria Total Cohort January 1 Total Survival in the first trimester 2020QII "" 39 Cantabria Total Cohort January 1 Total Survival in the first trimester 2020QI 13.081 39 Cantabria Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 39 Cantabria Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 39 Cantabria Total Cohort January 1 Total Survival in the second trimester 2022QII 13.152 39 Cantabria Total Cohort January 1 Total Survival in the second trimester 2022QI "" 39 Cantabria Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 39 Cantabria Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 39 Cantabria Total Cohort January 1 Total Survival in the second trimester 2021QII 12.767 39 Cantabria Total Cohort January 1 Total Survival in the second trimester 2021QI "" 39 Cantabria Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 39 Cantabria Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 39 Cantabria Total Cohort January 1 Total Survival in the second trimester 2020QII 12.713 39 Cantabria Total Cohort January 1 Total Survival in the second trimester 2020QI "" 39 Cantabria Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria Total Cohort January 1 Total Survival in the third trimester 2022QIII 12.771 39 Cantabria Total Cohort January 1 Total Survival in the third trimester 2022QII "" 39 Cantabria Total Cohort January 1 Total Survival in the third trimester 2022QI "" 39 Cantabria Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria Total Cohort January 1 Total Survival in the third trimester 2021QIII 12.442 39 Cantabria Total Cohort January 1 Total Survival in the third trimester 2021QII "" 39 Cantabria Total Cohort January 1 Total Survival in the third trimester 2021QI "" 39 Cantabria Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria Total Cohort January 1 Total Survival in the third trimester 2020QIII 12.360 39 Cantabria Total Cohort January 1 Total Survival in the third trimester 2020QII "" 39 Cantabria Total Cohort January 1 Total Survival in the third trimester 2020QI "" 39 Cantabria Total Cohort January 1 Total Survival in the third trimester 2022QIV 12.441 39 Cantabria Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria Total Cohort January 1 Total Survival in the third trimester 2022QII "" 39 Cantabria Total Cohort January 1 Total Survival in the third trimester 2022QI "" 39 Cantabria Total Cohort January 1 Total Survival in the third trimester 2021QIV 12.152 39 Cantabria Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria Total Cohort January 1 Total Survival in the third trimester 2021QII "" 39 Cantabria Total Cohort January 1 Total Survival in the third trimester 2021QI "" 39 Cantabria Total Cohort January 1 Total Survival in the third trimester 2020QIV 11.979 39 Cantabria Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria Total Cohort January 1 Total Survival in the third trimester 2020QII "" 39 Cantabria Total Cohort January 1 Total Survival in the third trimester 2020QI "" 39 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 39 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 39 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,29 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,51 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 90,18 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 91,41 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 92,58 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 87,65 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 88,76 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 90,22 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 85,21 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 86,47 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 88,12 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 82,59 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 13.915 39 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 12.529 39 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 13.252 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 11.940 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 12.701 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 11.550 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 12.329 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 11.249 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 12.003 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 10.985 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 39 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 39 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 95,24 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 95,3 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 91,28 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 92,19 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 88,6 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 89,78 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 86,26 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 87,68 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 473 39 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.261 39 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 458 39 Cantabria Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.231 39 Cantabria Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 451 39 Cantabria Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.217 39 Cantabria Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 442 39 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.193 39 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 438 39 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.167 39 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 39 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 39 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,83 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,62 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 95,35 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,51 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 93,45 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,61 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 92,6 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 92,55 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2022QII 14.469 39 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2021QII 13.963 39 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2020QII 13.608 39 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 39 Cantabria Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 39 Cantabria Total Cohort April 1 Total Survival in the first trimester 2022QII 13.796 39 Cantabria Total Cohort April 1 Total Survival in the first trimester 2022QI "" 39 Cantabria Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 39 Cantabria Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 39 Cantabria Total Cohort April 1 Total Survival in the first trimester 2021QII 13.422 39 Cantabria Total Cohort April 1 Total Survival in the first trimester 2021QI "" 39 Cantabria Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 39 Cantabria Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 39 Cantabria Total Cohort April 1 Total Survival in the first trimester 2020QII 13.172 39 Cantabria Total Cohort April 1 Total Survival in the first trimester 2020QI "" 39 Cantabria Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 39 Cantabria Total Cohort April 1 Total Survival in the second trimester 2022QIII 13.321 39 Cantabria Total Cohort April 1 Total Survival in the second trimester 2022QII "" 39 Cantabria Total Cohort April 1 Total Survival in the second trimester 2022QI "" 39 Cantabria Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 39 Cantabria Total Cohort April 1 Total Survival in the second trimester 2021QIII 13.008 39 Cantabria Total Cohort April 1 Total Survival in the second trimester 2021QII "" 39 Cantabria Total Cohort April 1 Total Survival in the second trimester 2021QI "" 39 Cantabria Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 39 Cantabria Total Cohort April 1 Total Survival in the second trimester 2020QIII 12.761 39 Cantabria Total Cohort April 1 Total Survival in the second trimester 2020QII "" 39 Cantabria Total Cohort April 1 Total Survival in the second trimester 2020QI "" 39 Cantabria Total Cohort April 1 Total Survival in the third trimester 2022QIV 12.855 39 Cantabria Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria Total Cohort April 1 Total Survival in the third trimester 2022QII "" 39 Cantabria Total Cohort April 1 Total Survival in the third trimester 2022QI "" 39 Cantabria Total Cohort April 1 Total Survival in the third trimester 2021QIV 12.615 39 Cantabria Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria Total Cohort April 1 Total Survival in the third trimester 2021QII "" 39 Cantabria Total Cohort April 1 Total Survival in the third trimester 2021QI "" 39 Cantabria Total Cohort April 1 Total Survival in the third trimester 2020QIV 12.305 39 Cantabria Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria Total Cohort April 1 Total Survival in the third trimester 2020QII "" 39 Cantabria Total Cohort April 1 Total Survival in the third trimester 2020QI "" 39 Cantabria Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria Total Cohort April 1 Total Survival in the third trimester 2022QII "" 39 Cantabria Total Cohort April 1 Total Survival in the third trimester 2022QI 12.236 39 Cantabria Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria Total Cohort April 1 Total Survival in the third trimester 2021QII "" 39 Cantabria Total Cohort April 1 Total Survival in the third trimester 2021QI 11.939 39 Cantabria Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria Total Cohort April 1 Total Survival in the third trimester 2020QII "" 39 Cantabria Total Cohort April 1 Total Survival in the third trimester 2020QI "" 39 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 39 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 39 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 39 Cantabria Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,35 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,13 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,8 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 92,07 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 93,16 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,78 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 88,85 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 90,35 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,42 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 87,63 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87,74 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 13.987 39 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 12.643 39 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 11.340 39 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 13.323 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 12.117 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 10.936 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 12.857 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 11.726 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 10.578 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 12.402 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 11.359 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 10.186 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 11.008 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 9.870 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 39 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 39 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 39 Cantabria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,25 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,84 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 96,44 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,92 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,75 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 93,28 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 88,67 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 89,84 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 89,82 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 87,07 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 87,04 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 482 39 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.320 39 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.268 39 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 473 39 Cantabria Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.305 39 Cantabria Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.236 39 Cantabria Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 464 39 Cantabria Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.282 39 Cantabria Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.183 39 Cantabria Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 453 39 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.256 39 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.119 39 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.228 39 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.069 39 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 39 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 39 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 39 Cantabria Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,13 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,86 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,59 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 96,27 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,12 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,25 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 93,98 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 95,15 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,43 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 93,03 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,23 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2022QIII 14.857 39 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2021QIII 14.635 39 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2020QIII 14.192 39 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 39 Cantabria Total Cohort July 1 Total Survival in the first trimester 2022QIII 14.036 39 Cantabria Total Cohort July 1 Total Survival in the first trimester 2022QII "" 39 Cantabria Total Cohort July 1 Total Survival in the first trimester 2022QI "" 39 Cantabria Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 39 Cantabria Total Cohort July 1 Total Survival in the first trimester 2021QIII 13.845 39 Cantabria Total Cohort July 1 Total Survival in the first trimester 2021QII "" 39 Cantabria Total Cohort July 1 Total Survival in the first trimester 2021QI "" 39 Cantabria Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 39 Cantabria Total Cohort July 1 Total Survival in the first trimester 2020QIII 13.494 39 Cantabria Total Cohort July 1 Total Survival in the first trimester 2020QII "" 39 Cantabria Total Cohort July 1 Total Survival in the first trimester 2020QI "" 39 Cantabria Total Cohort July 1 Total Survival in the second trimester 2022QIV 13.341 39 Cantabria Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 39 Cantabria Total Cohort July 1 Total Survival in the second trimester 2022QII "" 39 Cantabria Total Cohort July 1 Total Survival in the second trimester 2022QI "" 39 Cantabria Total Cohort July 1 Total Survival in the second trimester 2021QIV 13.165 39 Cantabria Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 39 Cantabria Total Cohort July 1 Total Survival in the second trimester 2021QII "" 39 Cantabria Total Cohort July 1 Total Survival in the second trimester 2021QI "" 39 Cantabria Total Cohort July 1 Total Survival in the second trimester 2020QIV 12.787 39 Cantabria Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 39 Cantabria Total Cohort July 1 Total Survival in the second trimester 2020QII "" 39 Cantabria Total Cohort July 1 Total Survival in the second trimester 2020QI "" 39 Cantabria Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria Total Cohort July 1 Total Survival in the third trimester 2022QII "" 39 Cantabria Total Cohort July 1 Total Survival in the third trimester 2022QI 12.714 39 Cantabria Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria Total Cohort July 1 Total Survival in the third trimester 2021QII "" 39 Cantabria Total Cohort July 1 Total Survival in the third trimester 2021QI 12.371 39 Cantabria Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria Total Cohort July 1 Total Survival in the third trimester 2020QII "" 39 Cantabria Total Cohort July 1 Total Survival in the third trimester 2020QI "" 39 Cantabria Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria Total Cohort July 1 Total Survival in the third trimester 2022QII 12.378 39 Cantabria Total Cohort July 1 Total Survival in the third trimester 2022QI "" 39 Cantabria Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria Total Cohort July 1 Total Survival in the third trimester 2021QII 12.125 39 Cantabria Total Cohort July 1 Total Survival in the third trimester 2021QI "" 39 Cantabria Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria Total Cohort July 1 Total Survival in the third trimester 2020QII "" 39 Cantabria Total Cohort July 1 Total Survival in the third trimester 2020QI "" 39 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 39 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 39 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 39 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,47 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,6 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,08 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,8 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,96 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,1 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 86,87 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 87,17 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 84,58 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 85,44 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 14.691 39 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 14.282 39 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 12.831 39 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 13.875 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 13.500 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 12.164 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 13.186 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 12.830 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 11.487 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 12.386 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 11.100 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 12.053 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 10.870 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 39 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 39 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 39 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,45 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,52 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,8 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,76 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,83 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,53 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 86,72 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,51 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 84,39 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 84,72 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 166 39 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 353 39 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.361 39 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 161 39 Cantabria Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 345 39 Cantabria Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.330 39 Cantabria Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 155 39 Cantabria Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 335 39 Cantabria Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.300 39 Cantabria Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 328 39 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.271 39 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 325 39 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.255 39 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 39 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 39 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 39 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,99 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,73 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,72 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,37 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 94,9 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,52 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 92,92 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,39 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 92,07 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,21 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2022QIV 14.642 39 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2021QIV 14.554 39 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2020QIV 14.226 39 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria Total Cohort October 1 Total Survival in the first trimester 2022QIV 13.774 39 Cantabria Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 39 Cantabria Total Cohort October 1 Total Survival in the first trimester 2022QII "" 39 Cantabria Total Cohort October 1 Total Survival in the first trimester 2022QI "" 39 Cantabria Total Cohort October 1 Total Survival in the first trimester 2021QIV 13.682 39 Cantabria Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 39 Cantabria Total Cohort October 1 Total Survival in the first trimester 2021QII "" 39 Cantabria Total Cohort October 1 Total Survival in the first trimester 2021QI "" 39 Cantabria Total Cohort October 1 Total Survival in the first trimester 2020QIV 13.253 39 Cantabria Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 39 Cantabria Total Cohort October 1 Total Survival in the first trimester 2020QII "" 39 Cantabria Total Cohort October 1 Total Survival in the first trimester 2020QI "" 39 Cantabria Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 39 Cantabria Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 39 Cantabria Total Cohort October 1 Total Survival in the second trimester 2022QII "" 39 Cantabria Total Cohort October 1 Total Survival in the second trimester 2022QI 13.159 39 Cantabria Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 39 Cantabria Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 39 Cantabria Total Cohort October 1 Total Survival in the second trimester 2021QII "" 39 Cantabria Total Cohort October 1 Total Survival in the second trimester 2021QI 12.767 39 Cantabria Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 39 Cantabria Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 39 Cantabria Total Cohort October 1 Total Survival in the second trimester 2020QII "" 39 Cantabria Total Cohort October 1 Total Survival in the second trimester 2020QI "" 39 Cantabria Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria Total Cohort October 1 Total Survival in the third trimester 2022QII 12.738 39 Cantabria Total Cohort October 1 Total Survival in the third trimester 2022QI "" 39 Cantabria Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria Total Cohort October 1 Total Survival in the third trimester 2021QII 12.460 39 Cantabria Total Cohort October 1 Total Survival in the third trimester 2021QI "" 39 Cantabria Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria Total Cohort October 1 Total Survival in the third trimester 2020QII "" 39 Cantabria Total Cohort October 1 Total Survival in the third trimester 2020QI "" 39 Cantabria Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria Total Cohort October 1 Total Survival in the third trimester 2022QIII 12.428 39 Cantabria Total Cohort October 1 Total Survival in the third trimester 2022QII "" 39 Cantabria Total Cohort October 1 Total Survival in the third trimester 2022QI "" 39 Cantabria Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria Total Cohort October 1 Total Survival in the third trimester 2021QIII 12.168 39 Cantabria Total Cohort October 1 Total Survival in the third trimester 2021QII "" 39 Cantabria Total Cohort October 1 Total Survival in the third trimester 2021QI "" 39 Cantabria Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria Total Cohort October 1 Total Survival in the third trimester 2020QII "" 39 Cantabria Total Cohort October 1 Total Survival in the third trimester 2020QI "" 39 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 39 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 39 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 39 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,07 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,01 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,16 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,42 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,74 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,52 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 87,59 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 85,39 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 85,53 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 14.524 39 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 14.030 39 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 12.884 39 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 13.659 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 13.171 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 11.944 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 12.669 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 11.490 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 12.259 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 11.196 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 11.957 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 10.923 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 39 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 39 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 39 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,04 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 93,88 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,7 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,3 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,18 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 87,38 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,9 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 85,22 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 84,78 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 118 39 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 524 39 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.342 39 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 115 39 Cantabria Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 511 39 Cantabria Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.309 39 Cantabria Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 490 39 Cantabria Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.277 39 Cantabria Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 479 39 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.264 39 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 471 39 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.245 39 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 39 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 39 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 39 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,46 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,52 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,54 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,51 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,16 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 91,41 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,19 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 89,89 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 92,77 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 11.091 39 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 10.731 39 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 11.173 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 10.449 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 10.131 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 9.834 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 9.950 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 9.768 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 9.499 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 9.592 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 9.468 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 9.176 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 9.283 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 9.197 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 8.829 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 39 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 39 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,21 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,41 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 88,02 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,71 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,03 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 85,02 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,48 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 88,23 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 82,13 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 83,7 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,7 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 79,02 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 10.777 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 10.043 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 10.149 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 9.467 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 9.655 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 9.115 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 9.306 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 8.833 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 9.001 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 8.587 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,17 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,26 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,59 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,76 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,35 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,95 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 83,52 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,5 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 314 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 688 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 300 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 664 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 295 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 653 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 286 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 635 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 282 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 610 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,54 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,51 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,95 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,91 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 91,08 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,3 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 89,81 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 88,66 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 11.123 39 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 10.864 39 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 10.570 39 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 10.505 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 10.366 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 10.163 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 10.052 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 9.972 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 9.779 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 9.622 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 9.598 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 9.351 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 9.257 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 9.005 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 39 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 39 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 39 Cantabria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,44 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,42 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,15 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,37 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,79 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,52 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 86,51 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 88,35 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,47 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 85,21 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,19 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 10.797 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 10.147 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 9.202 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 10.187 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 9.661 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 8.819 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 9.742 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 9.287 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 8.482 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 9.323 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 8.938 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 8.110 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 8.618 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 7.808 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,35 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,21 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,84 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,23 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,52 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,18 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 86,35 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 88,09 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,13 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 84,93 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,85 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 326 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 717 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.368 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 318 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 705 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.344 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 310 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 685 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.297 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 299 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 660 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.241 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 639 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.197 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,55 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,33 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,25 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 95,09 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,54 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,81 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,72 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 92,05 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 90,72 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 89,12 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 87,5 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 11.244 39 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 11.191 39 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 10.938 39 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 10.459 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 10.444 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 10.274 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 9.862 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 9.835 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 9.636 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 9.436 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 9.247 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 9.134 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 9.027 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 39 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 39 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 39 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,02 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,32 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 93,93 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 87,71 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 87,88 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 88,1 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 84,32 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 84,54 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 81,62 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 82,53 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 11.112 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 11.015 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 10.254 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 10.331 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 10.276 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 9.617 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 9.739 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 9.676 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 9.003 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 9.282 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 8.639 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 8.983 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 8.431 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,97 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,29 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,79 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,64 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 87,84 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 87,8 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 84,27 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 84,25 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 81,55 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 82,22 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 132 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 176 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 684 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 128 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 168 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 657 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 123 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 159 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 633 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 154 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 608 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 151 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 596 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,97 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 95,45 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,05 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,18 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 90,34 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 92,54 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 87,5 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 88,89 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 85,8 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 87,13 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 11.122 39 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 11.150 39 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 11.006 39 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 10.327 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 10.333 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 10.087 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 9.859 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 9.626 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 9.476 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 9.346 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 9.187 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 9.081 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 39 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 39 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 39 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 92,85 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 92,67 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 91,65 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,42 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 87,46 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 84,99 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 84,92 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 82,39 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 82,51 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 11.018 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 10.796 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 10.354 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 10.226 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 9.991 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 9.462 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 9.536 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 9.027 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 9.164 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 8.757 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 8.881 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 8.504 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 92,81 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 92,54 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 91,38 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,33 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 87,18 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 84,88 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 84,58 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 82,26 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 82,13 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 104 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 354 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 652 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 101 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 342 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 625 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 323 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 599 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 312 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 589 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 306 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 577 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,12 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,61 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 95,86 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91,24 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 91,87 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 88,14 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 90,34 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 86,44 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 88,5 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 1.391 39 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 1.310 39 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 1.363 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 1.366 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 1.298 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 1.318 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 1.339 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 1.272 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 1.294 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 1.326 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 1.260 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 1.275 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 1.310 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 1.249 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 1.254 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 39 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 39 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,2 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,08 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,7 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,26 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,1 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 94,94 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 95,33 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,18 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 93,54 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 94,18 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,34 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 92 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.321 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.094 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.297 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.086 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.271 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.061 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.258 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.053 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.242 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.042 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,18 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,27 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,21 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,98 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,23 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,25 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 94,02 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,25 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 70 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 216 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 69 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 212 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 68 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 211 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 68 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 207 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 68 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 207 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,57 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,15 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,14 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,69 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,14 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,83 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 97,14 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,83 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 1.374 39 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 1.299 39 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 1.246 39 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 1.352 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 1.276 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 1.227 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 1.336 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 1.270 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 1.208 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 1.314 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 1.258 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 1.194 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 1.231 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 1.181 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 39 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 39 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 39 Cantabria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,4 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,23 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,48 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,23 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,77 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 96,95 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,63 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,84 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,83 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,77 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,78 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.314 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.078 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 887 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.292 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.056 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 873 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.276 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.051 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 858 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.254 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.039 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 848 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.016 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 839 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,33 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 97,96 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,42 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,11 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,5 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 96,73 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,43 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,38 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,6 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 94,25 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,59 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 60 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 221 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 359 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 60 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 220 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 354 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 60 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 219 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 350 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 60 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 219 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 346 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 215 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 342 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,55 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,61 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,1 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,49 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 99,1 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,38 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,29 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,26 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 1.485 39 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 1.448 39 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 1.360 39 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 1.464 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 1.426 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 1.337 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 1.407 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 1.381 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 1.296 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 1.348 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 1.277 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 1.333 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 1.264 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 39 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 39 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 39 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,59 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,48 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,31 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 94,75 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 95,37 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 95,29 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 93,09 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 93,9 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 92,06 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 92,94 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.470 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.384 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.122 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.450 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.362 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.102 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.394 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.318 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.063 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.287 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.047 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.272 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.036 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,64 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,41 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,22 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 94,83 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 95,23 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 94,74 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 92,99 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 93,32 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 91,91 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 92,34 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 15 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 64 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 238 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 14 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 64 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 235 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 13 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 63 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 233 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 61 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 230 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 61 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 228 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 93,33 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,74 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 86,67 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,44 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,9 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,31 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,64 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 95,31 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,8 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 1.464 39 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 1.452 39 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 1.339 39 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 1.419 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 1.415 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 1.305 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 1.384 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 1.289 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 1.366 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 1.274 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 1.357 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 1.262 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 39 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 39 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 39 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 96,93 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 97,45 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 97,46 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 95,32 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,27 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 94,08 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 95,15 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 93,46 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 94,25 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.455 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.387 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.093 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.410 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.350 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.065 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.321 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.053 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.303 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.039 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.295 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.031 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 96,91 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 97,33 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,44 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 95,24 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,34 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 93,94 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,06 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 93,37 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 94,33 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 9 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 65 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 246 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 9 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 65 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 240 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 63 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 236 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 63 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 235 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 62 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 231 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,56 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 96,92 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,93 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,92 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,53 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 95,38 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,9 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 1.781 39 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 1.629 39 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 1.837 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 1.770 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 1.622 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 1.798 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 1.738 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 1.607 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 1.789 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 1.728 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 1.594 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 1.781 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 1.723 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 1.587 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 1.769 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 39 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 39 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,38 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,57 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,88 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,59 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,65 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,39 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,02 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,85 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,95 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,74 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,42 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,3 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.701 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.305 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.690 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.300 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.659 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.287 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.649 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.276 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.644 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.270 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,35 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,62 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,53 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,62 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,94 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,78 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,65 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,32 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 80 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 324 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 80 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 322 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 79 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 320 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 79 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 318 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 79 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 317 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,38 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,75 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,77 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 98,75 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,15 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 98,75 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,84 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 1.840 39 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 1.679 39 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 1.673 39 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 1.807 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 1.659 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 1.663 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 1.801 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 1.645 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 1.657 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 1.787 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 1.639 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 1.644 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 1.628 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 1.637 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 39 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 39 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 39 Cantabria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,21 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,81 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,4 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,88 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,97 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,04 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,12 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,62 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,27 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,96 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,85 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.752 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.328 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.163 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.720 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.310 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.156 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.715 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.298 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.151 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.701 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.293 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.142 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.285 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.137 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,17 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,64 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,4 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,89 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,74 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,97 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,09 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,36 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,19 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,76 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,76 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 88 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 351 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 510 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 87 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 349 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 507 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 86 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 347 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 506 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 86 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 346 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 502 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 343 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 500 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,86 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,43 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,41 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,73 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,86 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,22 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,73 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,58 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,43 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,72 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,04 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 2.005 39 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 1.874 39 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.776 39 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 1.990 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 1.853 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 1.766 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 1.949 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 1.828 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 1.739 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 1.809 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 1.731 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 1.790 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 1.718 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 39 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 39 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 39 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,25 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,88 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,44 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,21 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,55 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,92 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,53 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,47 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,52 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,73 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.986 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.772 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.371 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.971 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.751 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.362 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.930 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.726 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.339 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.707 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.332 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.688 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.321 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,24 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,81 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,34 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,18 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,4 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,67 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,33 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,16 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,26 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,35 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 19 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 102 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 405 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 19 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 102 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 404 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 19 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 102 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 400 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 102 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 399 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 102 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 397 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,75 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,77 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,52 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,02 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 1.925 39 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 1.827 39 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.759 39 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 1.897 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 1.810 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 1.740 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 1.792 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 1.731 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 1.772 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 1.719 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 1.760 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 1.704 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 39 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 39 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 39 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,55 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,07 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,92 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,08 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,41 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,99 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,73 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,33 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,87 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.920 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.734 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.354 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.892 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.718 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.335 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.700 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.328 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.680 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.318 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.669 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.306 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,54 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,08 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,6 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,04 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,08 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,89 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,34 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,25 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,45 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 5 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 93 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 405 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 5 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 92 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 405 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 92 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 403 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 92 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 401 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 91 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 398 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,92 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,92 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 99,51 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 98,92 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 99,01 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 97,85 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,27 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 82 39 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 78 39 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 84 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 82 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 78 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 84 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 82 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 78 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 84 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 82 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 78 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 82 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 82 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 78 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 81 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 39 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 39 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,62 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,43 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 76 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 55 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 76 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 55 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 76 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 55 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 76 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 55 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 76 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 55 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 6 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 23 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 6 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 23 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 6 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 23 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 6 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 23 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 6 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 23 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 89 39 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 79 39 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 77 39 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 89 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 79 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 77 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 89 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 79 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 76 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 89 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 79 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 75 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 79 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 75 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 39 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 39 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 39 Cantabria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,7 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,4 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,4 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 84 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 57 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 57 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 84 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 57 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 57 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 84 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 57 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 56 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 84 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 57 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 55 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 57 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 55 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,25 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,49 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,49 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 5 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 22 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 20 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 5 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 22 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 20 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 5 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 22 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 20 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 5 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 22 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 20 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 22 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 20 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 79 39 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 80 39 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 78 39 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 79 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 80 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 77 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 79 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 80 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 76 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 80 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 76 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 80 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 76 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 39 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 39 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 39 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,72 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,44 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,44 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,44 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 79 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 74 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 56 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 79 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 74 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 55 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 79 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 74 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 54 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 74 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 54 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 74 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 54 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,21 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,43 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,43 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,43 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 6 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 22 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 6 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 22 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 6 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 22 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 6 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 22 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 6 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 22 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII .. 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII .. 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 88 39 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 82 39 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 78 39 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 88 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 82 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 77 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 82 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 77 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 82 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 77 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 82 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 77 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 39 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 39 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 39 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,72 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,72 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,72 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,72 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 88 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 75 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 54 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 88 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 75 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 53 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 75 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 53 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 75 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 53 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 75 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 53 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,15 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,15 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,15 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,15 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 7 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 24 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 7 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 24 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 7 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 24 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 7 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 24 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 7 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 24 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 43 39 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 42 39 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 48 39 Cantabria De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 43 39 Cantabria De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 42 39 Cantabria De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 47 39 Cantabria De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 43 39 Cantabria De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 42 39 Cantabria De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 47 39 Cantabria De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 43 39 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 42 39 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 46 39 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 43 39 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 41 39 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 46 39 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 39 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 39 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,92 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,92 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,83 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,62 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 95,83 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 40 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 32 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 40 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 32 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 40 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 32 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 40 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 32 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 40 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 31 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,88 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 3 39 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 10 39 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 3 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 10 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 3 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 10 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 3 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 10 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 3 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 10 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 39 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 39 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 43 39 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 42 39 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 42 39 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 43 39 Cantabria De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 42 39 Cantabria De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 42 39 Cantabria De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 43 39 Cantabria De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 42 39 Cantabria De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 41 39 Cantabria De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 43 39 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 41 39 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 41 39 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 41 39 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 41 39 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 39 Cantabria De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 39 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 39 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 39 Cantabria De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,62 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,62 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,62 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,62 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,62 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 40 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 33 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 31 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 40 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 33 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 31 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 40 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 33 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 31 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 40 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 32 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 31 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 32 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 31 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,97 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,97 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 3 39 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 9 39 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 11 39 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 3 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 9 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 11 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 3 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 9 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 10 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 3 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 9 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 10 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 9 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 10 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 39 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 39 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 39 Cantabria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 90,91 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 90,91 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 90,91 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 44 39 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 42 39 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 40 39 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 44 39 Cantabria De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 42 39 Cantabria De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 40 39 Cantabria De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 44 39 Cantabria De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 41 39 Cantabria De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 40 39 Cantabria De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 41 39 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 40 39 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 41 39 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 40 39 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 39 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 39 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 39 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 39 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 39 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 39 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,62 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,62 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,62 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 44 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 37 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 28 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 44 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 37 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 28 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 44 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 36 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 28 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 36 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 28 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 36 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 28 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,3 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,3 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,3 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 39 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 5 39 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 12 39 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 5 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 12 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 5 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 12 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 5 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 12 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 5 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 12 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII .. 39 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 39 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 39 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII .. 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 43 39 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 43 39 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 44 39 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 43 39 Cantabria De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 42 39 Cantabria De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 44 39 Cantabria De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 42 39 Cantabria De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 44 39 Cantabria De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 42 39 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 44 39 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 42 39 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 44 39 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 39 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 39 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 39 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 39 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 39 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 39 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 39 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 97,67 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,67 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,67 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,67 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 43 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 38 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 29 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 43 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 37 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 29 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 37 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 29 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 37 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 29 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 37 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 29 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 97,37 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,37 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,37 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,37 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 39 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 5 39 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 15 39 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 5 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 15 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 5 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 15 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 5 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 15 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 5 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 15 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 39 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 39 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 39 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 39 Cantabria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló Total Cohort January 1 Total Number at the start of the quarter 2022QI 15.812 12 Castellón/Castelló Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló Total Cohort January 1 Total Number at the start of the quarter 2021QI 15.456 12 Castellón/Castelló Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Total Number at the start of the quarter 2020QI 15.980 12 Castellón/Castelló Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the first trimester 2022QII "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the first trimester 2022QI 14.947 12 Castellón/Castelló Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the first trimester 2021QII "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the first trimester 2021QI 14.514 12 Castellón/Castelló Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the first trimester 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the first trimester 2020QI 14.202 12 Castellón/Castelló Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the second trimester 2022QII 14.255 12 Castellón/Castelló Total Cohort January 1 Total Survival in the second trimester 2022QI "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the second trimester 2021QII 13.958 12 Castellón/Castelló Total Cohort January 1 Total Survival in the second trimester 2021QI "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the second trimester 2020QII 13.723 12 Castellón/Castelló Total Cohort January 1 Total Survival in the second trimester 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the third trimester 2022QIII 13.765 12 Castellón/Castelló Total Cohort January 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the third trimester 2021QIII 13.504 12 Castellón/Castelló Total Cohort January 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the third trimester 2020QIII 13.260 12 Castellón/Castelló Total Cohort January 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the third trimester 2022QIV 13.393 12 Castellón/Castelló Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the third trimester 2021QIV 13.163 12 Castellón/Castelló Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the third trimester 2020QIV 12.902 12 Castellón/Castelló Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 12 Castellón/Castelló Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 12 Castellón/Castelló Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,53 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,91 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 88,87 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,15 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,31 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 85,88 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 87,05 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,37 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 82,98 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 84,7 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,16 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 80,74 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 14.906 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 13.627 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 14.077 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 12.740 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 13.411 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 12.224 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 12.950 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 11.804 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 12.589 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 11.504 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,44 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,49 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,97 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,7 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,88 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,62 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 84,46 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 84,42 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 906 12 Castellón/Castelló Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.829 12 Castellón/Castelló Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 870 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.774 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 844 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.734 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 815 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.700 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 804 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.659 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 12 Castellón/Castelló Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 12 Castellón/Castelló Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,03 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,99 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,16 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,81 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 89,96 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,95 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,74 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 90,71 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló Total Cohort April 1 Total Number at the start of the quarter 2022QII 15.886 12 Castellón/Castelló Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló Total Cohort April 1 Total Number at the start of the quarter 2021QII 15.372 12 Castellón/Castelló Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló Total Cohort April 1 Total Number at the start of the quarter 2020QII 14.945 12 Castellón/Castelló Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the first trimester 2022QII 15.043 12 Castellón/Castelló Total Cohort April 1 Total Survival in the first trimester 2022QI "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the first trimester 2021QII 14.699 12 Castellón/Castelló Total Cohort April 1 Total Survival in the first trimester 2021QI "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the first trimester 2020QII 14.378 12 Castellón/Castelló Total Cohort April 1 Total Survival in the first trimester 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the second trimester 2022QIII 14.435 12 Castellón/Castelló Total Cohort April 1 Total Survival in the second trimester 2022QII "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the second trimester 2022QI "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the second trimester 2021QIII 14.116 12 Castellón/Castelló Total Cohort April 1 Total Survival in the second trimester 2021QII "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the second trimester 2021QI "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the second trimester 2020QIII 13.835 12 Castellón/Castelló Total Cohort April 1 Total Survival in the second trimester 2020QII "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the second trimester 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the third trimester 2022QIV 13.914 12 Castellón/Castelló Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the third trimester 2021QIV 13.630 12 Castellón/Castelló Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the third trimester 2020QIV 13.382 12 Castellón/Castelló Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the third trimester 2022QI 13.163 12 Castellón/Castelló Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the third trimester 2021QI 12.865 12 Castellón/Castelló Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló Total Cohort April 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 12 Castellón/Castelló Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 12 Castellón/Castelló Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 12 Castellón/Castelló Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,69 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,62 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,21 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,87 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,83 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,57 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,59 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 88,67 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,54 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 85,63 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 86,08 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 15.016 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 13.492 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 11.442 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 14.204 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 12.863 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 10.920 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 13.621 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 12.329 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 10.468 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 13.123 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 11.890 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 10.149 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 11.480 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 9.742 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,59 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,34 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,44 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,71 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,38 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,49 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,39 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 88,13 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,7 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 85,09 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 85,14 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 870 12 Castellón/Castelló Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.880 12 Castellón/Castelló Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 3.503 12 Castellón/Castelló Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 839 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.836 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 3.458 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 814 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.787 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 3.367 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 791 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.740 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 3.233 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.683 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 3.123 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 12 Castellón/Castelló Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 12 Castellón/Castelló Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 12 Castellón/Castelló Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,44 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,66 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,72 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,56 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,05 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,12 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 90,92 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 92,55 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 92,29 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 89,52 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 89,15 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló Total Cohort July 1 Total Number at the start of the quarter 2022QIII 16.277 12 Castellón/Castelló Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló Total Cohort July 1 Total Number at the start of the quarter 2021QIII 16.054 12 Castellón/Castelló Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló Total Cohort July 1 Total Number at the start of the quarter 2020QIII 15.588 12 Castellón/Castelló Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the first trimester 2022QIII 15.226 12 Castellón/Castelló Total Cohort July 1 Total Survival in the first trimester 2022QII "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the first trimester 2022QI "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the first trimester 2021QIII 15.014 12 Castellón/Castelló Total Cohort July 1 Total Survival in the first trimester 2021QII "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the first trimester 2021QI "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the first trimester 2020QIII 14.669 12 Castellón/Castelló Total Cohort July 1 Total Survival in the first trimester 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the first trimester 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the second trimester 2022QIV 14.419 12 Castellón/Castelló Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the second trimester 2022QII "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the second trimester 2022QI "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the second trimester 2021QIV 14.273 12 Castellón/Castelló Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the second trimester 2021QII "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the second trimester 2021QI "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the second trimester 2020QIV 13.997 12 Castellón/Castelló Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the second trimester 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the second trimester 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the third trimester 2022QI 13.726 12 Castellón/Castelló Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the third trimester 2021QI 13.381 12 Castellón/Castelló Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the third trimester 2022QII 13.342 12 Castellón/Castelló Total Cohort July 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the third trimester 2021QII 13.053 12 Castellón/Castelló Total Cohort July 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 12 Castellón/Castelló Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 12 Castellón/Castelló Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 12 Castellón/Castelló Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,54 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,52 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,1 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 88,59 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 88,91 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 89,79 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 85,5 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 85,84 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 83,11 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 83,74 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 15.951 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 15.340 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 13.474 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 14.912 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 14.323 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 12.606 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 14.118 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 13.602 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 11.999 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 13.073 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 11.449 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 12.697 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 11.164 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,49 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,37 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,56 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 88,51 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 88,67 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,05 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 85,22 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 84,97 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 82,77 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 82,86 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 326 12 Castellón/Castelló Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 714 12 Castellón/Castelló Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2.114 12 Castellón/Castelló Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 314 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 691 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2.063 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 301 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 671 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.998 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 653 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.932 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 645 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.889 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 12 Castellón/Castelló Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 12 Castellón/Castelló Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 12 Castellón/Castelló Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,32 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,78 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,59 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 92,33 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,98 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,51 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 91,46 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 91,39 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 90,34 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 89,36 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Total Number at the start of the quarter 2022QIV 15.965 12 Castellón/Castelló Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló Total Cohort October 1 Total Number at the start of the quarter 2021QIV 15.782 12 Castellón/Castelló Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló Total Cohort October 1 Total Number at the start of the quarter 2020QIV 15.545 12 Castellón/Castelló Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the first trimester 2022QIV 15.011 12 Castellón/Castelló Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the first trimester 2022QII "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the first trimester 2022QI "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the first trimester 2021QIV 14.888 12 Castellón/Castelló Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the first trimester 2021QII "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the first trimester 2021QI "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the first trimester 2020QIV 14.643 12 Castellón/Castelló Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the first trimester 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the first trimester 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the second trimester 2022QII "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the second trimester 2022QI 14.247 12 Castellón/Castelló Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the second trimester 2021QII "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the second trimester 2021QI 13.932 12 Castellón/Castelló Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the second trimester 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the second trimester 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the third trimester 2022QII 13.743 12 Castellón/Castelló Total Cohort October 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the third trimester 2021QII 13.509 12 Castellón/Castelló Total Cohort October 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the third trimester 2022QIII 13.335 12 Castellón/Castelló Total Cohort October 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the third trimester 2021QIII 13.128 12 Castellón/Castelló Total Cohort October 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 12 Castellón/Castelló Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 12 Castellón/Castelló Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 12 Castellón/Castelló Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,02 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,34 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,2 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,27 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,62 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,08 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 86,9 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 84,49 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 84,45 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 15.714 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 14.852 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 13.267 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 14.771 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 13.985 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 12.434 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 13.388 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 11.789 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 12.905 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 11.413 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 12.530 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 11.075 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,16 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,72 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,14 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88,86 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 86,89 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,03 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 84,37 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 83,48 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 251 12 Castellón/Castelló Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 930 12 Castellón/Castelló Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 2.278 12 Castellón/Castelló Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 240 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 903 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2.209 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 859 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2.143 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 838 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2.096 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 805 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2.053 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 12 Castellón/Castelló Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 12 Castellón/Castelló Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 12 Castellón/Castelló Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 95,62 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,1 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,97 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 92,37 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,07 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 90,11 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,01 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 86,56 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 90,12 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 11.923 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 11.797 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 12.110 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 11.109 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 10.914 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 10.461 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 10.480 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 10.397 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 10.034 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 10.023 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 9.986 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 9.617 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 9.683 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 9.674 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 9.287 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,17 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 92,52 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 86,38 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 87,9 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 88,13 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 82,86 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 84,06 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 84,65 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 79,41 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 81,21 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 82 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 76,69 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 11.326 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 10.763 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 10.545 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 9.922 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 9.940 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 9.436 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 9.509 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 9.050 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 9.178 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 8.771 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,1 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 92,19 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 87,76 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 87,67 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 83,96 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 84,08 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 81,03 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 81,49 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 597 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.034 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 564 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 992 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 540 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 961 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 514 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 936 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 505 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 903 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,47 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,94 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,45 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 92,94 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 86,1 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 90,52 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 84,59 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 87,33 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 11.929 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 11.727 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 11.388 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 11.145 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 11.097 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 10.870 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 10.581 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 10.564 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 10.368 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 10.115 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 10.131 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 9.950 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 9.708 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 9.480 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,43 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,63 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,45 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 88,7 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,08 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,04 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 84,79 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 86,39 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 87,37 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 82,78 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 83,25 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 11.362 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 10.566 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 9.029 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 10.606 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 9.974 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 8.545 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 10.065 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 9.481 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 8.122 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 9.619 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 9.088 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 7.814 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 8.714 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 7.436 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,35 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,4 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,64 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 88,58 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,73 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 89,95 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 84,66 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 86,01 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 86,54 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 82,47 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 82,36 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 567 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.161 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.359 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 539 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.123 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.325 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 516 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.083 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.246 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 496 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.043 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.136 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 994 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.044 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,06 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,73 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,56 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,01 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,28 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,21 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 87,48 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 89,84 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 90,55 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 85,62 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 86,65 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 12.010 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 12.018 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 11.851 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 11.069 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 11.064 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 11.007 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 10.406 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 10.450 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 10.411 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 9.967 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 9.853 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 9.615 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 9.558 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,16 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,06 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 92,88 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 86,64 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 86,95 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 87,85 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 82,93 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 83,14 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 80 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 80,65 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 11.764 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 11.612 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 10.632 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 10.835 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 10.677 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 9.831 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 10.183 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 10.076 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 9.287 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 9.606 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 8.778 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 9.261 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 8.516 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,1 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 91,95 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 92,47 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 86,56 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 86,77 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 87,35 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 82,72 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 82,56 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 79,75 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 80,1 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 246 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 406 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.219 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 234 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 387 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.176 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 223 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 374 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.124 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 361 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.075 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 354 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.042 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,12 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 95,32 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,47 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 90,65 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 92,12 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 92,21 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 88,92 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 88,19 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 87,19 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 85,48 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 11.956 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 11.918 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 11.874 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 11.102 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 11.101 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 11.027 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 10.512 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 10.376 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 10.052 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 9.986 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 9.670 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 9.643 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 92,86 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,14 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 92,87 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,2 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 87,38 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 84,34 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 84,1 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 81,14 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 81,21 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 11.768 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 11.302 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 10.608 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 10.925 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 10.507 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 9.820 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 9.956 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 9.221 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 9.516 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 8.867 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 9.164 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 8.553 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 92,84 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 92,97 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,57 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,09 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 86,92 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 84,2 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 83,59 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 81,08 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 80,63 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 188 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 616 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.266 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 177 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 594 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.207 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 556 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.155 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 536 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.119 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 506 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.090 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 94,15 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,43 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 95,34 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 90,26 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 91,23 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 87,01 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 88,39 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 82,14 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 86,1 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 1.640 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 1.538 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 1.665 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 1.615 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 1.510 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 1.584 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 1.579 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 1.488 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 1.550 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 1.558 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 1.468 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 1.520 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 1.538 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 1.454 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 1.502 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,48 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,18 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 95,14 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,28 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,75 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 93,09 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 95 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,45 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 91,29 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,78 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,54 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 90,21 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.515 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.261 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.491 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.242 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.455 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.224 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.437 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.206 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.417 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.196 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,42 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,49 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,04 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,07 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,85 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,64 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,53 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,85 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 125 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 277 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 124 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 268 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 124 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 264 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 121 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 262 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 121 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 258 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,2 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,75 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 99,2 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,31 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,8 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,58 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,8 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 93,14 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 1.688 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 1.535 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 1.527 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 1.658 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 1.507 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 1.498 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 1.633 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 1.482 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 1.470 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 1.597 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 1.452 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 1.445 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 1.432 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 1.420 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,22 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,18 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,1 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,74 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,55 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 96,27 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 94,61 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 94,59 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 94,63 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,29 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 92,99 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.572 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.262 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.009 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.543 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.239 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 986 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.520 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.217 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 968 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.485 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.190 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 961 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.173 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 946 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,16 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,18 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 97,72 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,69 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,43 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 95,94 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 94,47 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 94,29 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,24 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 92,95 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 93,76 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 116 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 273 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 518 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 115 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 268 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 512 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 113 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 265 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 502 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 112 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 262 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 484 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 259 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 474 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,14 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,17 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,84 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,41 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,07 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,91 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,55 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 95,97 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,44 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 94,87 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,51 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 1.843 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 1.728 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 1.658 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 1.785 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 1.687 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 1.614 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 1.711 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 1.615 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 1.567 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 1.580 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 1.535 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 1.562 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 1.517 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 96,85 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 97,63 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 97,35 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 92,84 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 93,46 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 94,51 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 91,44 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 92,58 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 90,39 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 91,5 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.810 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.612 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.310 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.752 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.573 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.272 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.680 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.504 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.231 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.472 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.210 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.454 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.198 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 96,8 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 97,58 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 97,1 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 92,82 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 93,3 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 93,97 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 91,32 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 92,37 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 90,2 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 91,45 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 33 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 116 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 348 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 33 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 114 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 342 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 31 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 111 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 336 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 108 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 325 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 108 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 319 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,28 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,28 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,94 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,69 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,55 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93,1 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,39 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,1 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,67 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 1.715 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 1.682 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 1.596 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 1.652 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 1.636 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 1.558 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 1.607 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 1.530 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 1.578 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 1.513 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 1.560 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 1.497 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 96,33 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 97,27 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 97,62 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 95,54 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 95,86 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 93,82 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 94,8 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 92,75 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 93,8 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.695 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.557 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.235 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.632 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.515 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.202 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.491 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.182 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.462 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.170 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.447 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.159 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 96,28 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 97,3 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,33 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 95,76 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 95,71 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 93,9 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 94,74 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 92,94 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,85 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 20 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 125 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 361 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 20 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 121 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 356 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 116 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 348 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 116 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 343 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 113 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 338 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,8 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,61 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 92,8 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,4 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 92,8 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,01 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 90,4 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,63 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 2.071 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 1.956 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 2.031 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 2.047 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 1.929 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 1.984 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 2.020 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 1.913 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 1.966 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 2.009 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 1.894 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 1.953 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 1.997 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 1.880 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 1.943 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,84 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,62 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,69 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,54 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,8 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,8 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,01 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,83 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,16 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,43 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,11 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 95,67 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.904 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.495 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.882 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.471 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.857 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.460 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.846 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.447 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.836 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.437 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,84 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,39 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,53 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,66 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,95 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,79 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,43 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,12 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 167 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 461 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 165 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 458 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 163 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 453 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 163 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 447 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 161 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 443 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,8 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,35 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,6 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,26 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,6 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,96 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,41 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,1 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 2.089 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 1.943 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 1.868 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 2.062 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 1.930 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 1.850 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 2.047 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 1.911 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 1.839 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 2.029 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 1.889 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 1.829 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 1.865 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 1.811 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,71 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,33 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,04 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,99 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,35 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,45 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,13 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,22 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,91 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 95,99 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,95 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.929 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.550 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.276 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.904 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.538 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.263 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.889 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.524 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.253 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.873 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.506 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.249 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.487 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.239 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,7 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,23 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,98 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,93 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,32 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,2 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,1 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,16 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,88 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,94 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,1 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 160 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 393 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 592 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 158 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 392 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 587 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 158 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 387 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 586 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 156 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 383 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 580 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 378 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 572 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,75 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,75 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,16 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,75 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,47 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,99 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,5 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,46 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,97 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,18 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,62 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 2.250 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 2.146 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.920 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 2.200 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 2.102 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 1.891 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 2.131 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 2.048 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 1.863 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 2.019 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 1.841 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 2.005 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 1.826 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,78 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 97,95 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,49 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 94,71 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 95,43 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,03 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 94,08 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,89 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 93,43 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,1 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.215 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.977 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.437 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.165 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.934 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.410 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.096 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.884 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.389 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.857 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.372 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.844 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.361 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,74 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 97,82 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,12 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 94,63 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 95,3 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,66 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 93,93 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,48 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 93,27 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,71 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 35 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 169 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 483 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 35 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 168 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 481 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 35 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 164 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 474 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 162 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 469 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 161 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 465 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,41 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,59 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,04 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,14 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,86 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,1 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 95,27 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,27 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 2.123 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 2.013 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.912 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 2.087 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 1.985 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 1.899 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 1.962 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 1.872 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 1.947 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 1.856 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 1.939 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 1.837 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,3 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,61 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,32 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,47 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,91 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,72 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,07 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,32 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,08 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.090 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.853 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.325 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.054 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.826 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.317 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.804 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.295 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.790 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.285 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.782 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.274 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,28 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,54 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,4 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,36 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,74 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,6 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,98 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,17 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,15 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 33 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 160 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 587 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 33 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 159 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 582 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 158 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 577 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 157 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 571 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 157 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 563 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,38 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,15 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,75 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,3 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 98,13 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,27 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 98,13 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 95,91 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 115 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 106 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 111 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 114 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 103 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 111 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 114 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 102 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 111 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 114 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 101 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 109 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 114 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 100 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 109 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,13 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 97,17 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,13 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,23 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 99,13 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,28 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,2 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 99,13 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,34 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,2 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 108 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 66 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 107 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 64 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 107 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 63 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 107 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 63 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 107 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 62 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,07 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 96,97 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,07 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 95,45 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 99,07 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,45 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 99,07 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 93,94 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 7 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 40 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 7 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 39 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 7 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 39 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 7 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 38 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 7 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 38 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,5 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,5 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 114 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 111 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 104 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 113 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 109 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 102 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 112 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 104 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 101 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 111 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 103 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 101 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 103 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 99 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,12 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,2 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,08 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,25 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 93,69 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,12 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,37 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 92,79 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,12 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 92,79 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,19 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 99 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 75 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 78 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 98 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 73 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 76 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 97 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 69 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 76 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 96 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 68 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 76 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 68 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 74 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,99 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 97,33 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 97,44 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,98 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,44 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,97 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 90,67 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,44 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 90,67 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,87 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 15 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 36 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 26 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 15 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 36 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 26 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 15 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 35 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 25 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 15 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 35 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 25 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 35 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 25 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,22 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,15 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,22 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,15 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,22 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,15 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 115 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 106 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 107 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 114 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 105 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 105 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 113 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 104 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 105 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 104 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 102 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 104 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 102 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,13 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,06 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,13 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,26 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,11 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,13 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,11 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,33 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,11 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,33 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 108 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 91 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 62 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 107 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 91 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 60 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 106 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 90 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 60 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 90 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 58 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 90 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 58 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,07 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 96,77 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,15 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,9 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,77 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,9 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 93,55 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,9 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 93,55 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 7 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 15 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 45 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 7 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 14 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 45 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 7 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 14 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 45 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 14 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 44 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 14 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 44 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 93,33 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,33 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93,33 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,78 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,33 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,78 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 109 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 110 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 105 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 108 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 108 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 104 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 108 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 100 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 108 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 100 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 108 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 98 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,08 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,18 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,05 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,18 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 95,24 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,18 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 95,24 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,18 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 93,33 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 104 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 93 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 61 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 103 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 91 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 60 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 91 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 57 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 91 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 57 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 91 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 56 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,04 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 97,85 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,36 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,85 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 93,44 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,85 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 93,44 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,85 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 91,8 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 5 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 17 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 44 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 5 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 17 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 44 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 17 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 43 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 17 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 43 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 17 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 42 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,73 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,73 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 95,45 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 63 12 Castellón/Castelló De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 59 12 Castellón/Castelló De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 63 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 62 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 58 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 62 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 62 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 58 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 62 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 61 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 55 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 61 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 61 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 55 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 61 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 12 Castellón/Castelló De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 12 Castellón/Castelló De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,41 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,31 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,41 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,41 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,31 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,41 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,83 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 93,22 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,83 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,83 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 93,22 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,83 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 53 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 42 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 52 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 41 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 52 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 41 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 51 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 38 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 51 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 38 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,11 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97,62 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,11 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,62 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,23 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 90,48 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,23 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 90,48 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 10 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 17 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 10 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 17 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 10 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 17 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 10 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 17 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 10 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 17 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 66 12 Castellón/Castelló De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 56 12 Castellón/Castelló De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 58 12 Castellón/Castelló De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 65 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 56 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 58 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 62 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 55 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 57 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 62 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 55 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 57 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 55 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 55 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 12 Castellón/Castelló De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 12 Castellón/Castelló De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 12 Castellón/Castelló De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,48 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 93,94 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,21 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,28 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 93,94 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,21 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,28 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,21 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,83 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 54 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 39 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 50 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 53 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 39 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 50 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 50 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 38 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 49 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 50 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 38 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 49 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 38 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 47 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,15 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 92,59 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,44 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 92,59 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,44 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,44 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 12 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 17 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 8 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 12 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 17 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 8 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 12 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 17 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 8 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 12 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 17 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 8 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 17 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 8 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 59 12 Castellón/Castelló De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 56 12 Castellón/Castelló De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 52 12 Castellón/Castelló De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 58 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 56 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 52 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 58 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 56 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 51 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 56 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 50 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 56 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 50 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 12 Castellón/Castelló De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 12 Castellón/Castelló De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 12 Castellón/Castelló De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,31 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,31 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,08 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,15 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,15 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 54 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 48 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 33 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 53 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 48 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 33 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 53 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 48 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 32 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 48 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 31 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 48 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 31 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,15 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,15 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,97 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 93,94 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 93,94 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 5 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 8 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 19 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 5 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 8 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 19 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 5 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 8 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 19 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 8 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 19 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 8 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 19 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 62 12 Castellón/Castelló De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 59 12 Castellón/Castelló De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 58 12 Castellón/Castelló De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 62 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 58 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 55 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 58 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 54 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 58 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 54 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 58 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 53 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 12 Castellón/Castelló De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 12 Castellón/Castelló De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 12 Castellón/Castelló De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,31 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,83 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,31 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 93,1 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,31 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 93,1 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,31 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 91,38 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 57 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 47 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 38 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 57 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 46 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 35 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 46 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 34 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 46 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 34 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 46 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 33 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 97,87 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,11 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,87 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,47 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,87 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 89,47 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,87 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 86,84 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 5 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 12 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 20 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 5 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 12 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 20 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 12 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 20 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 12 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 20 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 12 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 20 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 12 Castellón/Castelló De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real Total Cohort January 1 Total Number at the start of the quarter 2022QI 11.300 13 Ciudad Real Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real Total Cohort January 1 Total Number at the start of the quarter 2021QI 10.895 13 Ciudad Real Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real Total Cohort January 1 Total Number at the start of the quarter 2020QI 11.450 13 Ciudad Real Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 13 Ciudad Real Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 13 Ciudad Real Total Cohort January 1 Total Survival in the first trimester 2022QII "" 13 Ciudad Real Total Cohort January 1 Total Survival in the first trimester 2022QI 10.632 13 Ciudad Real Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 13 Ciudad Real Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 13 Ciudad Real Total Cohort January 1 Total Survival in the first trimester 2021QII "" 13 Ciudad Real Total Cohort January 1 Total Survival in the first trimester 2021QI 10.240 13 Ciudad Real Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 13 Ciudad Real Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 13 Ciudad Real Total Cohort January 1 Total Survival in the first trimester 2020QII "" 13 Ciudad Real Total Cohort January 1 Total Survival in the first trimester 2020QI 9.639 13 Ciudad Real Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 13 Ciudad Real Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 13 Ciudad Real Total Cohort January 1 Total Survival in the second trimester 2022QII 10.121 13 Ciudad Real Total Cohort January 1 Total Survival in the second trimester 2022QI "" 13 Ciudad Real Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 13 Ciudad Real Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 13 Ciudad Real Total Cohort January 1 Total Survival in the second trimester 2021QII 9.857 13 Ciudad Real Total Cohort January 1 Total Survival in the second trimester 2021QI "" 13 Ciudad Real Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 13 Ciudad Real Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 13 Ciudad Real Total Cohort January 1 Total Survival in the second trimester 2020QII 9.371 13 Ciudad Real Total Cohort January 1 Total Survival in the second trimester 2020QI "" 13 Ciudad Real Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real Total Cohort January 1 Total Survival in the third trimester 2022QIII 9.766 13 Ciudad Real Total Cohort January 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real Total Cohort January 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real Total Cohort January 1 Total Survival in the third trimester 2021QIII 9.529 13 Ciudad Real Total Cohort January 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real Total Cohort January 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real Total Cohort January 1 Total Survival in the third trimester 2020QIII 9.103 13 Ciudad Real Total Cohort January 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real Total Cohort January 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real Total Cohort January 1 Total Survival in the third trimester 2022QIV 9.503 13 Ciudad Real Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real Total Cohort January 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real Total Cohort January 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real Total Cohort January 1 Total Survival in the third trimester 2021QIV 9.281 13 Ciudad Real Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real Total Cohort January 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real Total Cohort January 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real Total Cohort January 1 Total Survival in the third trimester 2020QIV 8.844 13 Ciudad Real Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real Total Cohort January 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real Total Cohort January 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 13 Ciudad Real Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 13 Ciudad Real Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,09 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,99 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 84,18 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,57 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,47 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 81,84 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,42 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,46 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 79,5 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 84,1 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,19 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 77,24 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 10.571 13 Ciudad Real Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 9.447 13 Ciudad Real Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 9.923 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 8.821 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 9.442 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 8.462 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 9.107 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 8.165 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 8.854 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 7.937 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 13 Ciudad Real Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 13 Ciudad Real Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,87 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,37 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,32 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,57 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,15 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,43 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 83,76 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 84,02 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 729 13 Ciudad Real Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.448 13 Ciudad Real Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 709 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.419 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 679 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.395 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 659 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.364 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 649 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.344 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 13 Ciudad Real Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 13 Ciudad Real Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,26 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,14 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,34 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,4 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,2 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 89,03 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 92,82 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real Total Cohort April 1 Total Number at the start of the quarter 2022QII 11.331 13 Ciudad Real Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real Total Cohort April 1 Total Number at the start of the quarter 2021QII 11.001 13 Ciudad Real Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real Total Cohort April 1 Total Number at the start of the quarter 2020QII 10.073 13 Ciudad Real Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 13 Ciudad Real Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 13 Ciudad Real Total Cohort April 1 Total Survival in the first trimester 2022QII 10.683 13 Ciudad Real Total Cohort April 1 Total Survival in the first trimester 2022QI "" 13 Ciudad Real Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 13 Ciudad Real Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 13 Ciudad Real Total Cohort April 1 Total Survival in the first trimester 2021QII 10.474 13 Ciudad Real Total Cohort April 1 Total Survival in the first trimester 2021QI "" 13 Ciudad Real Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 13 Ciudad Real Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 13 Ciudad Real Total Cohort April 1 Total Survival in the first trimester 2020QII 9.738 13 Ciudad Real Total Cohort April 1 Total Survival in the first trimester 2020QI "" 13 Ciudad Real Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 13 Ciudad Real Total Cohort April 1 Total Survival in the second trimester 2022QIII 10.231 13 Ciudad Real Total Cohort April 1 Total Survival in the second trimester 2022QII "" 13 Ciudad Real Total Cohort April 1 Total Survival in the second trimester 2022QI "" 13 Ciudad Real Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 13 Ciudad Real Total Cohort April 1 Total Survival in the second trimester 2021QIII 10.042 13 Ciudad Real Total Cohort April 1 Total Survival in the second trimester 2021QII "" 13 Ciudad Real Total Cohort April 1 Total Survival in the second trimester 2021QI "" 13 Ciudad Real Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 13 Ciudad Real Total Cohort April 1 Total Survival in the second trimester 2020QIII 9.427 13 Ciudad Real Total Cohort April 1 Total Survival in the second trimester 2020QII "" 13 Ciudad Real Total Cohort April 1 Total Survival in the second trimester 2020QI "" 13 Ciudad Real Total Cohort April 1 Total Survival in the third trimester 2022QIV 9.898 13 Ciudad Real Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real Total Cohort April 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real Total Cohort April 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real Total Cohort April 1 Total Survival in the third trimester 2021QIV 9.677 13 Ciudad Real Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real Total Cohort April 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real Total Cohort April 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real Total Cohort April 1 Total Survival in the third trimester 2020QIV 9.124 13 Ciudad Real Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real Total Cohort April 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real Total Cohort April 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real Total Cohort April 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real Total Cohort April 1 Total Survival in the third trimester 2022QI 9.321 13 Ciudad Real Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real Total Cohort April 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real Total Cohort April 1 Total Survival in the third trimester 2021QI 8.812 13 Ciudad Real Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real Total Cohort April 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real Total Cohort April 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 13 Ciudad Real Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 13 Ciudad Real Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 13 Ciudad Real Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,28 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,21 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,67 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,29 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,28 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,59 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,35 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 87,96 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,58 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 84,73 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87,48 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 10.615 13 Ciudad Real Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 9.634 13 Ciudad Real Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 7.776 13 Ciudad Real Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 10.001 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 9.136 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 7.458 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 9.565 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 8.732 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 7.190 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 9.245 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 8.390 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 6.936 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 8.062 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 6.672 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 13 Ciudad Real Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 13 Ciudad Real Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 13 Ciudad Real Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,22 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,83 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,91 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,11 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 90,64 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,46 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,09 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 87,09 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 89,2 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 83,68 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 85,8 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 716 13 Ciudad Real Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.367 13 Ciudad Real Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.297 13 Ciudad Real Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 682 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.338 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.280 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 666 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.310 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.237 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 653 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.287 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.188 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.259 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.140 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 13 Ciudad Real Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 13 Ciudad Real Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 13 Ciudad Real Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,25 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,88 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,26 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,02 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,83 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,39 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,2 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,15 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,25 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 92,1 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 93,16 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real Total Cohort July 1 Total Number at the start of the quarter 2022QIII 11.416 13 Ciudad Real Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real Total Cohort July 1 Total Number at the start of the quarter 2021QIII 11.391 13 Ciudad Real Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real Total Cohort July 1 Total Number at the start of the quarter 2020QIII 10.885 13 Ciudad Real Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 13 Ciudad Real Total Cohort July 1 Total Survival in the first trimester 2022QIII 10.716 13 Ciudad Real Total Cohort July 1 Total Survival in the first trimester 2022QII "" 13 Ciudad Real Total Cohort July 1 Total Survival in the first trimester 2022QI "" 13 Ciudad Real Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 13 Ciudad Real Total Cohort July 1 Total Survival in the first trimester 2021QIII 10.667 13 Ciudad Real Total Cohort July 1 Total Survival in the first trimester 2021QII "" 13 Ciudad Real Total Cohort July 1 Total Survival in the first trimester 2021QI "" 13 Ciudad Real Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 13 Ciudad Real Total Cohort July 1 Total Survival in the first trimester 2020QIII 10.322 13 Ciudad Real Total Cohort July 1 Total Survival in the first trimester 2020QII "" 13 Ciudad Real Total Cohort July 1 Total Survival in the first trimester 2020QI "" 13 Ciudad Real Total Cohort July 1 Total Survival in the second trimester 2022QIV 10.250 13 Ciudad Real Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 13 Ciudad Real Total Cohort July 1 Total Survival in the second trimester 2022QII "" 13 Ciudad Real Total Cohort July 1 Total Survival in the second trimester 2022QI "" 13 Ciudad Real Total Cohort July 1 Total Survival in the second trimester 2021QIV 10.142 13 Ciudad Real Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 13 Ciudad Real Total Cohort July 1 Total Survival in the second trimester 2021QII "" 13 Ciudad Real Total Cohort July 1 Total Survival in the second trimester 2021QI "" 13 Ciudad Real Total Cohort July 1 Total Survival in the second trimester 2020QIV 9.769 13 Ciudad Real Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 13 Ciudad Real Total Cohort July 1 Total Survival in the second trimester 2020QII "" 13 Ciudad Real Total Cohort July 1 Total Survival in the second trimester 2020QI "" 13 Ciudad Real Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real Total Cohort July 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real Total Cohort July 1 Total Survival in the third trimester 2022QI 9.719 13 Ciudad Real Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real Total Cohort July 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real Total Cohort July 1 Total Survival in the third trimester 2021QI 9.393 13 Ciudad Real Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real Total Cohort July 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real Total Cohort July 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real Total Cohort July 1 Total Survival in the third trimester 2022QII 9.411 13 Ciudad Real Total Cohort July 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real Total Cohort July 1 Total Survival in the third trimester 2021QII 9.171 13 Ciudad Real Total Cohort July 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real Total Cohort July 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real Total Cohort July 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 13 Ciudad Real Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 13 Ciudad Real Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 13 Ciudad Real Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,87 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,64 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,83 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,79 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,04 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 89,75 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 85,32 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,29 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 82,62 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,25 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 11.168 13 Ciudad Real Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 10.883 13 Ciudad Real Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 9.187 13 Ciudad Real Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 10.478 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 10.168 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 8.655 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 10.015 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 9.651 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 8.141 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 9.236 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 7.798 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 8.941 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 7.601 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 13 Ciudad Real Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 13 Ciudad Real Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 13 Ciudad Real Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,82 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,43 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,21 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,68 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 88,68 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 88,61 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 84,87 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 84,88 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 82,16 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 82,74 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 248 13 Ciudad Real Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 508 13 Ciudad Real Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.698 13 Ciudad Real Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 238 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 499 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.667 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 235 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 491 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.628 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 483 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.595 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 470 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.570 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 13 Ciudad Real Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 13 Ciudad Real Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 13 Ciudad Real Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,97 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,23 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,17 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,76 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,65 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,88 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,08 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,93 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 92,52 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,46 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real Total Cohort October 1 Total Number at the start of the quarter 2022QIV 11.271 13 Ciudad Real Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real Total Cohort October 1 Total Number at the start of the quarter 2021QIV 11.267 13 Ciudad Real Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real Total Cohort October 1 Total Number at the start of the quarter 2020QIV 11.018 13 Ciudad Real Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real Total Cohort October 1 Total Survival in the first trimester 2022QIV 10.652 13 Ciudad Real Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 13 Ciudad Real Total Cohort October 1 Total Survival in the first trimester 2022QII "" 13 Ciudad Real Total Cohort October 1 Total Survival in the first trimester 2022QI "" 13 Ciudad Real Total Cohort October 1 Total Survival in the first trimester 2021QIV 10.580 13 Ciudad Real Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 13 Ciudad Real Total Cohort October 1 Total Survival in the first trimester 2021QII "" 13 Ciudad Real Total Cohort October 1 Total Survival in the first trimester 2021QI "" 13 Ciudad Real Total Cohort October 1 Total Survival in the first trimester 2020QIV 10.244 13 Ciudad Real Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 13 Ciudad Real Total Cohort October 1 Total Survival in the first trimester 2020QII "" 13 Ciudad Real Total Cohort October 1 Total Survival in the first trimester 2020QI "" 13 Ciudad Real Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 13 Ciudad Real Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 13 Ciudad Real Total Cohort October 1 Total Survival in the second trimester 2022QII "" 13 Ciudad Real Total Cohort October 1 Total Survival in the second trimester 2022QI 10.096 13 Ciudad Real Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 13 Ciudad Real Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 13 Ciudad Real Total Cohort October 1 Total Survival in the second trimester 2021QII "" 13 Ciudad Real Total Cohort October 1 Total Survival in the second trimester 2021QI 9.771 13 Ciudad Real Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 13 Ciudad Real Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 13 Ciudad Real Total Cohort October 1 Total Survival in the second trimester 2020QII "" 13 Ciudad Real Total Cohort October 1 Total Survival in the second trimester 2020QI "" 13 Ciudad Real Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real Total Cohort October 1 Total Survival in the third trimester 2022QII 9.718 13 Ciudad Real Total Cohort October 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real Total Cohort October 1 Total Survival in the third trimester 2021QII 9.489 13 Ciudad Real Total Cohort October 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real Total Cohort October 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real Total Cohort October 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real Total Cohort October 1 Total Survival in the third trimester 2022QIII 9.420 13 Ciudad Real Total Cohort October 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real Total Cohort October 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real Total Cohort October 1 Total Survival in the third trimester 2021QIII 9.206 13 Ciudad Real Total Cohort October 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real Total Cohort October 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real Total Cohort October 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real Total Cohort October 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 13 Ciudad Real Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 13 Ciudad Real Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 13 Ciudad Real Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,51 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,9 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 92,98 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,61 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 88,68 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 86,25 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 86,12 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 83,61 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 83,55 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 11.053 13 Ciudad Real Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 10.505 13 Ciudad Real Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 9.462 13 Ciudad Real Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 10.435 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 9.842 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 8.723 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 9.381 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 8.284 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 9.032 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 8.025 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 8.750 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 7.773 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 13 Ciudad Real Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 13 Ciudad Real Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 13 Ciudad Real Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,41 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 93,69 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,19 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,3 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 87,55 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 85,98 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 84,81 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 83,29 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 82,15 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 218 13 Ciudad Real Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 762 13 Ciudad Real Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.556 13 Ciudad Real Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 217 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 738 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.521 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 715 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.487 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 686 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.464 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 670 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.433 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 13 Ciudad Real Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 13 Ciudad Real Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 13 Ciudad Real Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,54 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,85 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,75 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,83 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,57 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 90,03 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,09 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 87,93 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 92,1 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 8.691 13 Ciudad Real From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 8.504 13 Ciudad Real From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 8.881 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 8.060 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 7.879 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 7.203 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 7.597 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 7.529 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 6.965 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 7.266 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 7.233 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 6.722 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 7.015 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 7.004 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 6.487 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 13 Ciudad Real From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 13 Ciudad Real From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 92,74 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 92,65 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 81,11 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 87,41 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 88,53 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 78,43 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 83,6 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 85,05 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 75,69 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 80,72 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 82,36 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 73,04 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 8.181 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 7.674 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 7.569 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 7.073 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 7.133 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 6.742 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 6.821 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 6.466 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 6.579 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 6.253 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,52 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 92,17 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 87,19 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 87,86 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 83,38 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 84,26 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 80,42 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 81,48 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 510 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 830 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 491 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 806 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 464 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 787 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 445 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 767 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 436 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 751 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,27 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,11 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,98 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,82 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 87,25 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,41 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 85,49 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 90,48 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 8.715 13 Ciudad Real From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 8.558 13 Ciudad Real From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 7.911 13 Ciudad Real From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 8.109 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 8.066 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 7.591 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 7.684 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 7.664 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 7.295 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 7.367 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 7.327 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 7.009 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 7.003 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 6.725 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 13 Ciudad Real From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 13 Ciudad Real From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 13 Ciudad Real From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,05 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,25 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,95 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 88,17 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 89,55 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,21 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 84,53 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 85,62 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,6 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 81,83 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,01 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 8.236 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 7.760 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 6.471 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 7.661 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 7.292 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 6.163 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 7.251 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 6.909 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 5.901 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 6.943 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 6.591 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 5.659 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 6.291 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 5.411 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,02 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 93,97 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,24 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 88,04 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,03 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,19 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 84,3 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 84,94 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 87,45 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 81,07 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 83,62 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 479 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 798 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.440 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 448 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 774 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.428 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 433 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 755 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.394 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 424 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 736 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.350 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 712 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.314 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 93,53 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,99 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,17 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 90,4 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,61 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,81 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,52 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 92,23 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,75 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 89,22 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,25 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 8.722 13 Ciudad Real From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 8.791 13 Ciudad Real From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 8.477 13 Ciudad Real From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 8.065 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 8.110 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 7.940 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 7.629 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 7.630 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 7.420 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 7.240 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 7.085 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 6.957 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 6.881 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 13 Ciudad Real From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 13 Ciudad Real From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 13 Ciudad Real From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,47 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,25 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 93,67 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 87,47 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 86,79 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 87,53 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 82,36 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 83,58 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 79,14 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 81,17 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 8.526 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 8.488 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 7.524 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 7.877 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 7.814 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 7.011 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 7.443 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 7.341 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 6.524 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 6.958 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 6.211 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 6.687 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 6.027 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,39 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,06 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,18 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,3 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 86,49 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 86,71 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 81,97 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 82,55 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 78,78 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 80,1 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 196 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 303 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 953 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 188 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 296 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 929 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 186 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 289 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 896 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 282 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 874 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 270 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 854 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,92 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,69 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,48 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,9 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,38 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,02 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93,07 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 91,71 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 89,11 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 89,61 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 8.574 13 Ciudad Real From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 8.672 13 Ciudad Real From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 8.553 13 Ciudad Real From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 7.985 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 8.028 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 7.815 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 7.581 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 7.379 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 7.240 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 7.121 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 6.959 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 6.865 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 13 Ciudad Real From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 13 Ciudad Real From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 13 Ciudad Real From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,13 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 92,57 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 91,37 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 87,42 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 86,27 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 83,49 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 83,26 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 80,25 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 80,26 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 8.404 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 8.133 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 7.677 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 7.816 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 7.511 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 6.970 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 7.085 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 6.559 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 6.770 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 6.319 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 6.504 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 6.084 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 92,35 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 90,79 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 87,11 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 85,44 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 83,24 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 82,31 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 79,97 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 79,25 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 170 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 539 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 876 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 169 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 517 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 845 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 496 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 820 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 470 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 802 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 455 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 781 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,41 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,92 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,46 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 92,02 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 93,61 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 87,2 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 91,55 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 84,42 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 89,16 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 1.165 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 1.077 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 1.160 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 1.143 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 1.064 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 1.075 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 1.117 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 1.046 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 1.062 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 1.104 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 1.025 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 1.047 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 1.096 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 1.014 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 1.030 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,11 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,79 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 92,67 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 95,88 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,12 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 91,55 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,76 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,17 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 90,26 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 94,08 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,15 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 88,79 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.065 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 832 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.044 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 820 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.020 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 804 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.007 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 789 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.000 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 780 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,03 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,56 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 95,77 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,63 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,55 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 94,83 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,9 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 93,75 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 245 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 99 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 244 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 97 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 242 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 97 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 236 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 96 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 234 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,59 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,78 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,33 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,51 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 1.150 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 1.097 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 963 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 1.129 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 1.080 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 960 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 1.115 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 1.059 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 951 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 1.105 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 1.041 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 939 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 1.023 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 926 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,17 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,45 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,69 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,96 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,54 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,75 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,09 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 94,9 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,51 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,25 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,16 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.050 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 875 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 564 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.031 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 859 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 561 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.017 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 843 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 558 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.010 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 827 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 550 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 811 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 542 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,19 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,17 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,47 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,86 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,34 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,94 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,19 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 94,51 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,52 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 92,69 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,1 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 222 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 399 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 98 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 221 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 399 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 98 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 216 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 393 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 95 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 214 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 389 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 212 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 384 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,55 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,3 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,5 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 95 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,4 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,49 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 95,5 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,24 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 1.190 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 1.161 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 1.087 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 1.167 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 1.137 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 1.074 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 1.146 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 1.110 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 1.051 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 1.095 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 1.028 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 1.085 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 1.018 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,07 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 97,93 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,8 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,3 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 95,61 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 96,69 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 94,32 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 94,57 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 93,45 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 93,65 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.164 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.071 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 789 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.142 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.048 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 780 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.122 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.021 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 762 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.007 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 745 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 997 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 736 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,11 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 97,85 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,86 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,39 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 95,33 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,58 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 94,02 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 94,42 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 93,09 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 93,28 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 26 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 90 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 298 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 25 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 89 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 294 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 24 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 89 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 289 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 88 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 283 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 88 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 282 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,15 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,89 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,66 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 92,31 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,89 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,98 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,78 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,97 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 97,78 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 94,63 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 1.211 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 1.150 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 1.088 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 1.191 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 1.125 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 1.065 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 1.105 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 1.044 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 1.087 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 1.030 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 1.078 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 1.017 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,35 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 97,83 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 97,89 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,09 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 95,96 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 94,52 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 94,67 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 93,74 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 93,47 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.186 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.052 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 807 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.166 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.029 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 786 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.010 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 770 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 993 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 758 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 984 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 751 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,31 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 97,81 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,4 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,01 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 95,42 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 94,39 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 93,93 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 93,54 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,06 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 25 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 98 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 281 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 25 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 96 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 279 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 95 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 274 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 94 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 272 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 94 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 266 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,96 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,29 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 96,94 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,51 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 95,92 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 96,8 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 95,92 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 94,66 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 1.384 13 Ciudad Real From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 1.258 13 Ciudad Real From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 1.350 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 1.369 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 1.241 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 1.303 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 1.347 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 1.226 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 1.286 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 1.336 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 1.215 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 1.276 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 1.332 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 1.207 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 1.269 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 13 Ciudad Real From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 13 Ciudad Real From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,92 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,65 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,52 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,33 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,46 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,26 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,53 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,58 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,52 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,24 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,95 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.272 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 903 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.257 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 890 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.236 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 878 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.226 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 872 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.222 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 866 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,82 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,56 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,17 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,23 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,38 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,57 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,07 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,9 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 112 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 355 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 112 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 351 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 111 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 348 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 110 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 343 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 110 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 341 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,87 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 99,11 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,03 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 98,21 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,62 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 98,21 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,06 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 1.404 13 Ciudad Real From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 1.290 13 Ciudad Real From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 1.144 13 Ciudad Real From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 1.383 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 1.272 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 1.132 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 1.370 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 1.263 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 1.126 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 1.364 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 1.253 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 1.121 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 1.239 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 1.106 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 13 Ciudad Real From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 13 Ciudad Real From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 13 Ciudad Real From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,5 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,6 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,95 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,58 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,91 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,43 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,15 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,13 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,99 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,05 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,68 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.276 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 958 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 698 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.256 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 944 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 691 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.244 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 939 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 688 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.239 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 931 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 684 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 919 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 676 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,43 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,54 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,49 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,02 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,57 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,1 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,18 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,99 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,93 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,85 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 128 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 332 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 446 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 127 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 328 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 441 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 126 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 324 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 438 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 125 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 322 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 437 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 320 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 430 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,22 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,8 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,88 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,44 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,59 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,21 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,66 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,99 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,98 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,39 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,41 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 1.440 13 Ciudad Real From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 1.381 13 Ciudad Real From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.267 13 Ciudad Real From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 1.421 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 1.362 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 1.254 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 1.412 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 1.344 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 1.244 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 1.326 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 1.226 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 1.311 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 1.218 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 13 Ciudad Real From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 13 Ciudad Real From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 13 Ciudad Real From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,68 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,62 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,97 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,06 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,32 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,18 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,02 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,76 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 94,93 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,13 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.416 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.272 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 840 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.398 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.254 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 830 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.389 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.237 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 821 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.219 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 808 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.205 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 804 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,73 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,58 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,81 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,09 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,25 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,74 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,83 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,19 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,73 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,71 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 24 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 109 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 427 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 23 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 108 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 424 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 23 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 107 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 423 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 107 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 418 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 106 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 414 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,83 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,08 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,3 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95,83 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,17 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,06 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 98,17 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,89 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 97,25 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,96 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 1.418 13 Ciudad Real From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 1.383 13 Ciudad Real From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.322 13 Ciudad Real From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 1.408 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 1.365 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 1.309 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 1.348 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 1.293 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 1.329 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 1.283 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 1.321 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 1.269 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 13 Ciudad Real From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 13 Ciudad Real From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 13 Ciudad Real From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,29 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,7 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,02 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,47 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,81 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,1 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,05 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,52 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,99 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.397 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.267 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 940 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.387 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.249 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 929 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.233 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 917 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.216 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 910 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.209 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 900 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,28 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,58 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,83 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,32 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,55 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,97 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,81 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,42 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,74 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 21 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 116 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 382 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 21 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 116 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 380 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 115 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 376 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 113 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 373 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 112 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 369 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,48 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 99,14 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,43 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,41 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,64 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96,55 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,6 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 45 13 Ciudad Real from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 43 13 Ciudad Real from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 45 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 45 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 43 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 44 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 45 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 43 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 44 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 45 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 43 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 44 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 45 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 43 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 44 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 13 Ciudad Real from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 13 Ciudad Real from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,78 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,78 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,78 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,78 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 39 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 29 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 39 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 29 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 39 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 29 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 39 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 29 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 39 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 29 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 6 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 14 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 6 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 14 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 6 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 14 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 6 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 14 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 6 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 14 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 49 13 Ciudad Real from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 43 13 Ciudad Real from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 41 13 Ciudad Real from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 49 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 43 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 41 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 49 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 43 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 41 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 49 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 43 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 41 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 43 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 41 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 42 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 31 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 32 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 42 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 31 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 32 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 42 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 31 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 32 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 42 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 31 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 32 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 31 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 32 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 7 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 12 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 9 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 7 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 12 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 9 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 7 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 12 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 9 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 7 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 12 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 9 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 12 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 9 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 49 13 Ciudad Real from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 45 13 Ciudad Real from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 40 13 Ciudad Real from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 48 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 45 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 40 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 48 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 45 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 40 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 45 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 40 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 45 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 40 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 13 Ciudad Real from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 13 Ciudad Real from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 13 Ciudad Real from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,96 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,96 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 48 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 40 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 25 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 47 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 40 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 25 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 47 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 40 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 25 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 40 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 25 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 40 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 25 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,92 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,92 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 5 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 15 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 5 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 15 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 5 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 15 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 5 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 15 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 5 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 15 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 52 13 Ciudad Real from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 47 13 Ciudad Real from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 41 13 Ciudad Real from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 52 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 47 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 41 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 47 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 41 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 47 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 41 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 47 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 41 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 13 Ciudad Real from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 13 Ciudad Real from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 13 Ciudad Real from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 51 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 40 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 28 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 51 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 40 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 28 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 40 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 28 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 40 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 28 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 40 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 28 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 7 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 13 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 7 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 13 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 7 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 13 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 7 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 13 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 7 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 13 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 15 13 Ciudad Real De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 13 13 Ciudad Real De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 14 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 15 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 13 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 14 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 15 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 13 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 14 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 15 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 13 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 14 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 15 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 13 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 14 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 13 Ciudad Real De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 13 Ciudad Real De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 14 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 9 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 14 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 9 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 14 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 9 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 14 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 9 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 14 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 9 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 4 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 4 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 4 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 4 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 4 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 13 13 Ciudad Real De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 13 13 Ciudad Real De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 14 13 Ciudad Real De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 13 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 13 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 14 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 13 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 13 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 14 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 13 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 13 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 14 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 13 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 14 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 13 Ciudad Real De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 13 Ciudad Real De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 13 Ciudad Real De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 11 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 10 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 11 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 11 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 10 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 11 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 11 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 10 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 11 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 11 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 10 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 11 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 10 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 11 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 2 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 3 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 3 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 2 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 3 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 3 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 2 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 3 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 3 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 2 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 3 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 3 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 3 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 3 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 15 13 Ciudad Real De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 13 13 Ciudad Real De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 14 13 Ciudad Real De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 15 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 13 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 14 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 15 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 13 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 14 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 13 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 14 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 13 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 14 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 13 Ciudad Real De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 13 Ciudad Real De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 13 Ciudad Real De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 14 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 12 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 9 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 14 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 12 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 9 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 14 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 12 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 9 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 12 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 9 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 12 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 9 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 5 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 5 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 5 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 5 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 5 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 16 13 Ciudad Real De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 15 13 Ciudad Real De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 14 13 Ciudad Real De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 16 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 15 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 14 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 15 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 14 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 15 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 14 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 15 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 14 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 13 Ciudad Real De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 13 Ciudad Real De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 13 Ciudad Real De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 15 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 13 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 10 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 15 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 13 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 10 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 13 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 10 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 13 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 10 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 13 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 10 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 2 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 4 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 2 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 4 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 2 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 4 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 2 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 4 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 2 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 4 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 13 Ciudad Real De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba Total Cohort January 1 Total Number at the start of the quarter 2022QI 17.117 14 Córdoba Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba Total Cohort January 1 Total Number at the start of the quarter 2021QI 16.422 14 Córdoba Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba Total Cohort January 1 Total Number at the start of the quarter 2020QI 17.499 14 Córdoba Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 14 Córdoba Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 14 Córdoba Total Cohort January 1 Total Survival in the first trimester 2022QII "" 14 Córdoba Total Cohort January 1 Total Survival in the first trimester 2022QI 16.036 14 Córdoba Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 14 Córdoba Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 14 Córdoba Total Cohort January 1 Total Survival in the first trimester 2021QII "" 14 Córdoba Total Cohort January 1 Total Survival in the first trimester 2021QI 15.374 14 Córdoba Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 14 Córdoba Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 14 Córdoba Total Cohort January 1 Total Survival in the first trimester 2020QII "" 14 Córdoba Total Cohort January 1 Total Survival in the first trimester 2020QI 14.558 14 Córdoba Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 14 Córdoba Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 14 Córdoba Total Cohort January 1 Total Survival in the second trimester 2022QII 15.302 14 Córdoba Total Cohort January 1 Total Survival in the second trimester 2022QI "" 14 Córdoba Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 14 Córdoba Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 14 Córdoba Total Cohort January 1 Total Survival in the second trimester 2021QII 14.779 14 Córdoba Total Cohort January 1 Total Survival in the second trimester 2021QI "" 14 Córdoba Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 14 Córdoba Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 14 Córdoba Total Cohort January 1 Total Survival in the second trimester 2020QII 14.017 14 Córdoba Total Cohort January 1 Total Survival in the second trimester 2020QI "" 14 Córdoba Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba Total Cohort January 1 Total Survival in the third trimester 2022QIII 14.721 14 Córdoba Total Cohort January 1 Total Survival in the third trimester 2022QII "" 14 Córdoba Total Cohort January 1 Total Survival in the third trimester 2022QI "" 14 Córdoba Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba Total Cohort January 1 Total Survival in the third trimester 2021QIII 14.287 14 Córdoba Total Cohort January 1 Total Survival in the third trimester 2021QII "" 14 Córdoba Total Cohort January 1 Total Survival in the third trimester 2021QI "" 14 Córdoba Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba Total Cohort January 1 Total Survival in the third trimester 2020QIII 13.548 14 Córdoba Total Cohort January 1 Total Survival in the third trimester 2020QII "" 14 Córdoba Total Cohort January 1 Total Survival in the third trimester 2020QI "" 14 Córdoba Total Cohort January 1 Total Survival in the third trimester 2022QIV 14.256 14 Córdoba Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba Total Cohort January 1 Total Survival in the third trimester 2022QII "" 14 Córdoba Total Cohort January 1 Total Survival in the third trimester 2022QI "" 14 Córdoba Total Cohort January 1 Total Survival in the third trimester 2021QIV 13.898 14 Córdoba Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba Total Cohort January 1 Total Survival in the third trimester 2021QII "" 14 Córdoba Total Cohort January 1 Total Survival in the third trimester 2021QI "" 14 Córdoba Total Cohort January 1 Total Survival in the third trimester 2020QIV 13.121 14 Córdoba Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba Total Cohort January 1 Total Survival in the third trimester 2020QII "" 14 Córdoba Total Cohort January 1 Total Survival in the third trimester 2020QI "" 14 Córdoba Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 14 Córdoba Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 14 Córdoba Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,68 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,62 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 83,19 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,4 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 80,1 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 77,42 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 83,29 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 84,63 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 74,98 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 16.942 14 Córdoba Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 15.841 14 Córdoba Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 15.867 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 14.807 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 15.141 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 14.220 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 14.565 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 13.740 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 14.103 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 13.364 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 14 Córdoba Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 14 Córdoba Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,65 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,47 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,37 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,77 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 85,97 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,74 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 83,24 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 84,36 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 175 14 Córdoba Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 581 14 Córdoba Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 169 14 Córdoba Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 567 14 Córdoba Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 161 14 Córdoba Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 559 14 Córdoba Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 156 14 Córdoba Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 547 14 Córdoba Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 153 14 Córdoba Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 534 14 Córdoba Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 14 Córdoba Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 14 Córdoba Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,57 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,59 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,21 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 89,14 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,15 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 87,43 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 91,91 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba Total Cohort April 1 Total Number at the start of the quarter 2022QII 17.216 14 Córdoba Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba Total Cohort April 1 Total Number at the start of the quarter 2021QII 16.484 14 Córdoba Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba Total Cohort April 1 Total Number at the start of the quarter 2020QII 15.279 14 Córdoba Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 14 Córdoba Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 14 Córdoba Total Cohort April 1 Total Survival in the first trimester 2022QII 16.197 14 Córdoba Total Cohort April 1 Total Survival in the first trimester 2022QI "" 14 Córdoba Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 14 Córdoba Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 14 Córdoba Total Cohort April 1 Total Survival in the first trimester 2021QII 15.620 14 Córdoba Total Cohort April 1 Total Survival in the first trimester 2021QI "" 14 Córdoba Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 14 Córdoba Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 14 Córdoba Total Cohort April 1 Total Survival in the first trimester 2020QII 14.616 14 Córdoba Total Cohort April 1 Total Survival in the first trimester 2020QI "" 14 Córdoba Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 14 Córdoba Total Cohort April 1 Total Survival in the second trimester 2022QIII 15.434 14 Córdoba Total Cohort April 1 Total Survival in the second trimester 2022QII "" 14 Córdoba Total Cohort April 1 Total Survival in the second trimester 2022QI "" 14 Córdoba Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 14 Córdoba Total Cohort April 1 Total Survival in the second trimester 2021QIII 14.988 14 Córdoba Total Cohort April 1 Total Survival in the second trimester 2021QII "" 14 Córdoba Total Cohort April 1 Total Survival in the second trimester 2021QI "" 14 Córdoba Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 14 Córdoba Total Cohort April 1 Total Survival in the second trimester 2020QIII 14.057 14 Córdoba Total Cohort April 1 Total Survival in the second trimester 2020QII "" 14 Córdoba Total Cohort April 1 Total Survival in the second trimester 2020QI "" 14 Córdoba Total Cohort April 1 Total Survival in the third trimester 2022QIV 14.846 14 Córdoba Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba Total Cohort April 1 Total Survival in the third trimester 2022QII "" 14 Córdoba Total Cohort April 1 Total Survival in the third trimester 2022QI "" 14 Córdoba Total Cohort April 1 Total Survival in the third trimester 2021QIV 14.478 14 Córdoba Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba Total Cohort April 1 Total Survival in the third trimester 2021QII "" 14 Córdoba Total Cohort April 1 Total Survival in the third trimester 2021QI "" 14 Córdoba Total Cohort April 1 Total Survival in the third trimester 2020QIV 13.559 14 Córdoba Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba Total Cohort April 1 Total Survival in the third trimester 2020QII "" 14 Córdoba Total Cohort April 1 Total Survival in the third trimester 2020QI "" 14 Córdoba Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba Total Cohort April 1 Total Survival in the third trimester 2022QII "" 14 Córdoba Total Cohort April 1 Total Survival in the third trimester 2022QI 13.976 14 Córdoba Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba Total Cohort April 1 Total Survival in the third trimester 2021QII "" 14 Córdoba Total Cohort April 1 Total Survival in the third trimester 2021QI 13.062 14 Córdoba Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba Total Cohort April 1 Total Survival in the third trimester 2020QII "" 14 Córdoba Total Cohort April 1 Total Survival in the third trimester 2020QI "" 14 Córdoba Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 14 Córdoba Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 14 Córdoba Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 14 Córdoba Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,08 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,76 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,66 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,65 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,92 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 86,23 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 87,83 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,74 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 84,79 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,49 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 17.053 14 Córdoba Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 15.933 14 Córdoba Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 15.097 14 Córdoba Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 16.038 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 15.077 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 14.435 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 15.282 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 14.456 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 13.885 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 14.699 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 13.960 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 13.391 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 13.474 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 12.898 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 14 Córdoba Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 14 Córdoba Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 14 Córdoba Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,05 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,63 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,62 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 89,61 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 90,73 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,97 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 86,2 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 87,62 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,7 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 84,57 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 85,43 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 163 14 Córdoba Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 551 14 Córdoba Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 182 14 Córdoba Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 159 14 Córdoba Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 543 14 Córdoba Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 181 14 Córdoba Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 152 14 Córdoba Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 532 14 Córdoba Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 172 14 Córdoba Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 147 14 Córdoba Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 518 14 Córdoba Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 168 14 Córdoba Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 502 14 Córdoba Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 164 14 Córdoba Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 14 Córdoba Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 14 Córdoba Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 14 Córdoba Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,55 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,55 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,45 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,25 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,55 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,51 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 90,18 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,01 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 92,31 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 91,11 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 90,11 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba Total Cohort July 1 Total Number at the start of the quarter 2022QIII 17.434 14 Córdoba Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba Total Cohort July 1 Total Number at the start of the quarter 2021QIII 17.036 14 Córdoba Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba Total Cohort July 1 Total Number at the start of the quarter 2020QIII 16.515 14 Córdoba Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 14 Córdoba Total Cohort July 1 Total Survival in the first trimester 2022QIII 16.277 14 Córdoba Total Cohort July 1 Total Survival in the first trimester 2022QII "" 14 Córdoba Total Cohort July 1 Total Survival in the first trimester 2022QI "" 14 Córdoba Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 14 Córdoba Total Cohort July 1 Total Survival in the first trimester 2021QIII 15.988 14 Córdoba Total Cohort July 1 Total Survival in the first trimester 2021QII "" 14 Córdoba Total Cohort July 1 Total Survival in the first trimester 2021QI "" 14 Córdoba Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 14 Córdoba Total Cohort July 1 Total Survival in the first trimester 2020QIII 15.503 14 Córdoba Total Cohort July 1 Total Survival in the first trimester 2020QII "" 14 Córdoba Total Cohort July 1 Total Survival in the first trimester 2020QI "" 14 Córdoba Total Cohort July 1 Total Survival in the second trimester 2022QIV 15.443 14 Córdoba Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 14 Córdoba Total Cohort July 1 Total Survival in the second trimester 2022QII "" 14 Córdoba Total Cohort July 1 Total Survival in the second trimester 2022QI "" 14 Córdoba Total Cohort July 1 Total Survival in the second trimester 2021QIV 15.249 14 Córdoba Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 14 Córdoba Total Cohort July 1 Total Survival in the second trimester 2021QII "" 14 Córdoba Total Cohort July 1 Total Survival in the second trimester 2021QI "" 14 Córdoba Total Cohort July 1 Total Survival in the second trimester 2020QIV 14.641 14 Córdoba Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 14 Córdoba Total Cohort July 1 Total Survival in the second trimester 2020QII "" 14 Córdoba Total Cohort July 1 Total Survival in the second trimester 2020QI "" 14 Córdoba Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba Total Cohort July 1 Total Survival in the third trimester 2022QII "" 14 Córdoba Total Cohort July 1 Total Survival in the third trimester 2022QI 14.634 14 Córdoba Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba Total Cohort July 1 Total Survival in the third trimester 2021QII "" 14 Córdoba Total Cohort July 1 Total Survival in the third trimester 2021QI 14.026 14 Córdoba Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba Total Cohort July 1 Total Survival in the third trimester 2020QII "" 14 Córdoba Total Cohort July 1 Total Survival in the third trimester 2020QI "" 14 Córdoba Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba Total Cohort July 1 Total Survival in the third trimester 2022QII 14.186 14 Córdoba Total Cohort July 1 Total Survival in the third trimester 2022QI "" 14 Córdoba Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba Total Cohort July 1 Total Survival in the third trimester 2021QII 13.671 14 Córdoba Total Cohort July 1 Total Survival in the third trimester 2021QI "" 14 Córdoba Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba Total Cohort July 1 Total Survival in the third trimester 2020QII "" 14 Córdoba Total Cohort July 1 Total Survival in the third trimester 2020QI "" 14 Córdoba Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 14 Córdoba Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 14 Córdoba Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 14 Córdoba Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,36 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,85 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 93,87 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 88,58 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,51 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 88,65 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 85,9 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 84,93 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 83,27 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 82,78 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 17.371 14 Córdoba Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 16.878 14 Córdoba Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 16.348 14 Córdoba Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 16.216 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 15.836 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 15.345 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 15.385 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 15.098 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 14.488 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 14.487 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 13.875 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 14.045 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 13.521 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 14 Córdoba Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 14 Córdoba Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 14 Córdoba Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,35 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,83 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,86 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 88,57 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,45 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 88,62 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 85,83 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 84,87 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 83,21 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 82,71 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 63 14 Córdoba Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 158 14 Córdoba Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 167 14 Córdoba Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 61 14 Córdoba Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 152 14 Córdoba Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 158 14 Córdoba Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 58 14 Córdoba Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 151 14 Córdoba Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 153 14 Córdoba Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 147 14 Córdoba Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 151 14 Córdoba Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 141 14 Córdoba Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 150 14 Córdoba Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 14 Córdoba Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 14 Córdoba Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 14 Córdoba Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,83 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,2 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 94,61 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 92,06 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,57 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 91,62 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93,04 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 90,42 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 89,24 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 89,82 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba Total Cohort October 1 Total Number at the start of the quarter 2022QIV 17.243 14 Córdoba Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba Total Cohort October 1 Total Number at the start of the quarter 2021QIV 16.989 14 Córdoba Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba Total Cohort October 1 Total Number at the start of the quarter 2020QIV 16.632 14 Córdoba Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba Total Cohort October 1 Total Survival in the first trimester 2022QIV 16.121 14 Córdoba Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 14 Córdoba Total Cohort October 1 Total Survival in the first trimester 2022QII "" 14 Córdoba Total Cohort October 1 Total Survival in the first trimester 2022QI "" 14 Córdoba Total Cohort October 1 Total Survival in the first trimester 2021QIV 15.938 14 Córdoba Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 14 Córdoba Total Cohort October 1 Total Survival in the first trimester 2021QII "" 14 Córdoba Total Cohort October 1 Total Survival in the first trimester 2021QI "" 14 Córdoba Total Cohort October 1 Total Survival in the first trimester 2020QIV 15.381 14 Córdoba Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 14 Córdoba Total Cohort October 1 Total Survival in the first trimester 2020QII "" 14 Córdoba Total Cohort October 1 Total Survival in the first trimester 2020QI "" 14 Córdoba Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 14 Córdoba Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 14 Córdoba Total Cohort October 1 Total Survival in the second trimester 2022QII "" 14 Córdoba Total Cohort October 1 Total Survival in the second trimester 2022QI 15.183 14 Córdoba Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 14 Córdoba Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 14 Córdoba Total Cohort October 1 Total Survival in the second trimester 2021QII "" 14 Córdoba Total Cohort October 1 Total Survival in the second trimester 2021QI 14.635 14 Córdoba Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 14 Córdoba Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 14 Córdoba Total Cohort October 1 Total Survival in the second trimester 2020QII "" 14 Córdoba Total Cohort October 1 Total Survival in the second trimester 2020QI "" 14 Córdoba Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba Total Cohort October 1 Total Survival in the third trimester 2022QII 14.642 14 Córdoba Total Cohort October 1 Total Survival in the third trimester 2022QI "" 14 Córdoba Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba Total Cohort October 1 Total Survival in the third trimester 2021QII 14.193 14 Córdoba Total Cohort October 1 Total Survival in the third trimester 2021QI "" 14 Córdoba Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba Total Cohort October 1 Total Survival in the third trimester 2020QII "" 14 Córdoba Total Cohort October 1 Total Survival in the third trimester 2020QI "" 14 Córdoba Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba Total Cohort October 1 Total Survival in the third trimester 2022QIII 14.164 14 Córdoba Total Cohort October 1 Total Survival in the third trimester 2022QII "" 14 Córdoba Total Cohort October 1 Total Survival in the third trimester 2022QI "" 14 Córdoba Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba Total Cohort October 1 Total Survival in the third trimester 2021QIII 13.795 14 Córdoba Total Cohort October 1 Total Survival in the third trimester 2021QII "" 14 Córdoba Total Cohort October 1 Total Survival in the third trimester 2021QI "" 14 Córdoba Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba Total Cohort October 1 Total Survival in the third trimester 2020QII "" 14 Córdoba Total Cohort October 1 Total Survival in the third trimester 2020QI "" 14 Córdoba Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 14 Córdoba Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 14 Córdoba Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 14 Córdoba Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,49 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,81 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 92,48 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,37 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 87,99 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 86,19 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 85,34 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 83,37 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 82,94 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 17.185 14 Córdoba Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 16.781 14 Córdoba Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 16.468 14 Córdoba Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 16.066 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 15.738 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 15.223 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 14.987 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 14.479 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 14.454 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 14.037 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 13.980 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 13.642 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 14 Córdoba Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 14 Córdoba Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 14 Córdoba Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,49 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 93,78 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,44 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,31 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 87,92 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 86,13 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 85,24 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 83,31 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 82,84 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 58 14 Córdoba Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 208 14 Córdoba Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 164 14 Córdoba Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 55 14 Córdoba Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 200 14 Córdoba Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 158 14 Córdoba Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 196 14 Córdoba Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 156 14 Córdoba Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 188 14 Córdoba Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 156 14 Córdoba Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 184 14 Córdoba Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 153 14 Córdoba Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 14 Córdoba Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 14 Córdoba Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 14 Córdoba Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 94,83 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,15 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,34 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,23 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,12 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 90,38 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,12 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 88,46 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,29 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 13.074 14 Córdoba From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 12.678 14 Córdoba From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 13.467 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 12.054 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 11.682 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 10.705 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 11.378 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 11.132 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 10.221 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 10.845 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 10.670 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 9.799 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 10.432 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 10.311 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 9.417 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 14 Córdoba From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 14 Córdoba From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 92,2 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 92,14 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 79,49 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 87,03 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 87,81 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 75,9 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 82,95 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 84,16 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 72,76 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 79,79 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 81,33 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 69,93 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 12.968 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 12.403 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 11.952 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 11.418 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 11.282 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 10.874 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 10.752 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 10.419 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 10.341 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 10.068 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,17 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 92,06 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 87 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 87,67 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 82,91 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 84 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 79,74 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 81,17 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 106 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 275 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 102 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 264 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 96 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 258 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 93 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 251 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 91 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 243 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,23 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,57 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 93,82 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 87,74 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 91,27 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 85,85 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 88,36 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 13.146 14 Córdoba From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 12.723 14 Córdoba From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 11.817 14 Córdoba From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 12.190 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 11.906 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 11.193 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 11.476 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 11.308 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 10.666 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 10.953 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 10.833 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 10.198 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 10.382 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 9.740 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 14 Córdoba From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 14 Córdoba From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 14 Córdoba From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 92,73 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 93,58 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,72 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 87,3 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 88,88 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 90,26 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 83,32 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 85,15 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 86,3 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 81,6 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 82,42 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 13.049 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 12.453 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 11.748 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 12.096 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 11.644 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 11.125 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 11.385 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 11.053 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 10.602 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 10.865 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 10.587 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 10.136 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 10.147 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 9.680 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 92,7 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 93,5 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,7 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 87,25 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 88,76 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,25 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 83,26 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 85,02 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 86,28 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 81,48 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 82,4 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 97 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 270 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 69 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 94 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 262 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 68 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 91 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 255 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 64 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 88 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 246 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 62 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 235 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 60 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,91 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,04 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,55 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,81 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,44 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 92,75 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 90,72 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 91,11 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 89,86 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 87,04 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 86,96 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 13.284 14 Córdoba From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 13.088 14 Córdoba From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 12.792 14 Córdoba From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 12.186 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 12.087 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 11.821 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 11.433 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 11.387 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 11.011 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 10.832 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 10.449 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 10.426 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 10.125 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 14 Córdoba From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 14 Córdoba From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 14 Córdoba From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 91,73 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,35 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 92,41 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 86,07 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 87 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 86,08 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 82,76 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 81,68 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 79,66 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 79,15 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 13.238 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 13.004 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 12.737 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 12.142 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 12.007 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 11.771 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 11.390 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 11.308 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 10.965 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 10.756 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 10.404 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 10.353 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 10.080 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 91,72 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,33 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 92,42 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 86,04 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 86,96 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 86,09 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 82,71 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 81,68 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 79,61 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 79,14 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 46 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 84 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 55 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 44 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 80 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 50 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 43 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 79 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 46 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 76 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 45 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 73 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 45 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,65 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 95,24 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 90,91 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,48 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 94,05 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 83,64 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 90,48 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 81,82 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 86,9 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 81,82 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 13.166 14 Córdoba From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 13.039 14 Córdoba From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 12.802 14 Córdoba From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 12.133 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 12.044 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 11.611 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 11.348 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 10.921 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 10.859 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 10.517 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 10.423 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 10.148 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 14 Córdoba From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 14 Córdoba From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 14 Córdoba From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 92,15 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 92,37 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 90,7 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 87,03 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 85,31 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 83,28 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 82,15 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 79,94 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 79,27 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 13.125 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 12.897 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 12.755 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 12.093 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 11.910 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 11.569 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 11.218 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 10.880 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 10.735 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 10.476 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 10.301 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 10.108 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 92,14 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 92,35 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 90,7 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 86,98 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 85,3 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 83,24 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 82,13 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 79,87 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 79,25 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 41 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 142 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 47 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 40 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 134 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 42 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 130 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 41 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 124 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 41 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 122 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 40 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,56 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 94,37 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 89,36 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91,55 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 87,23 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 87,32 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 87,23 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 85,92 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 85,11 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 1.762 14 Córdoba From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 1.632 14 Córdoba From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 1.713 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 1.720 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 1.603 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 1.594 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 1.693 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 1.578 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 1.568 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 1.668 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 1.563 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 1.541 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 1.639 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 1.548 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 1.516 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 14 Córdoba From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 14 Córdoba From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 97,62 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,22 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 93,05 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,08 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,69 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 91,54 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,67 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,77 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 89,96 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,02 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,85 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 88,5 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.740 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.535 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.699 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.506 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.672 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.482 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.647 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.469 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.619 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.455 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 97,64 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,11 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,09 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,55 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,66 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,7 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,05 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,79 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 22 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 97 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 21 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 97 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 21 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 96 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 21 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 94 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 20 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 93 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,45 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 95,45 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,97 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 95,45 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,91 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 90,91 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,88 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 1.774 14 Córdoba From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 1.659 14 Córdoba From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 1.487 14 Córdoba From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 1.748 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 1.628 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 1.474 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 1.722 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 1.610 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 1.457 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 1.685 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 1.589 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 1.441 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 1.559 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 1.424 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 14 Córdoba From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 14 Córdoba From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 14 Córdoba From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,53 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,13 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,13 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,07 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,05 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,98 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 94,98 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,78 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,91 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,97 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,76 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.752 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.564 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.457 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.726 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.533 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.444 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.701 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.517 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.429 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.666 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.499 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.415 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.473 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.398 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,52 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,02 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,11 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,09 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,99 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,08 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,09 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,84 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,12 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 94,18 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,95 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 22 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 95 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 30 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 22 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 95 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 30 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 21 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 93 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 28 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 19 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 90 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 26 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 86 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 26 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 95,45 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,89 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 93,33 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 86,36 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,74 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 86,67 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 90,53 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 86,67 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 1.831 14 Córdoba From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 1.738 14 Córdoba From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 1.644 14 Córdoba From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 1.796 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 1.711 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 1.621 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 1.750 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 1.693 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 1.588 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 1.654 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 1.556 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 1.632 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 1.539 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 14 Córdoba From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 14 Córdoba From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 14 Córdoba From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,09 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,45 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,6 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 95,58 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,41 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 96,59 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,17 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 94,65 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 93,9 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 93,61 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.822 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.714 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.626 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.787 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.687 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.604 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.742 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.669 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.572 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.630 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.540 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.610 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.523 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,08 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,42 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,65 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 95,61 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,37 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,68 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,1 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 94,71 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 93,93 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 93,67 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 9 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 24 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 18 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 9 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 24 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 17 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 8 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 24 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 16 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 24 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 16 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 22 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 16 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 94,44 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 88,89 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 88,89 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 88,89 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 91,67 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 88,89 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 1.782 14 Córdoba From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 1.760 14 Córdoba From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 1.702 14 Córdoba From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 1.731 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 1.725 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 1.662 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 1.683 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 1.627 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 1.656 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 1.605 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 1.637 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 1.592 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 14 Córdoba From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 14 Córdoba From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 14 Córdoba From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,14 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,01 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 97,65 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 95,63 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 95,59 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 94,09 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 94,3 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 93,01 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 93,54 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.775 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.735 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.682 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.725 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.700 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.642 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.658 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.607 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.631 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.585 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.613 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.573 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,18 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 97,98 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,62 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 95,56 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 95,54 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 94,01 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 94,23 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 92,97 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,52 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 7 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 25 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 20 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 6 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 25 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 20 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 25 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 20 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 25 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 20 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 24 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 19 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 85,71 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 95 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 2.156 14 Córdoba From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 2.008 14 Córdoba From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 2.205 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 2.137 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 1.985 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 2.145 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 2.106 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 1.965 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 2.114 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 2.084 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 1.950 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 2.096 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 2.063 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 1.935 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 2.076 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 14 Córdoba From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 14 Córdoba From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,12 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,85 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,28 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,68 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,86 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,87 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,66 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,11 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,06 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,69 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,36 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,15 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.113 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.810 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.095 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.790 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.066 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.771 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.046 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.759 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.025 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.748 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,15 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,9 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,78 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,85 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,83 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,18 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,84 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,57 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 43 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 198 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 42 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 195 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 40 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 194 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 38 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 191 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 38 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 187 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,67 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,48 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,02 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,98 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 88,37 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,46 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,37 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 94,44 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 2.171 14 Córdoba From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 1.994 14 Córdoba From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 1.878 14 Córdoba From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 2.134 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 1.978 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 1.852 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 2.112 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 1.962 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 1.838 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 2.086 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 1.948 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 1.824 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 1.927 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 1.802 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 14 Córdoba From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 14 Córdoba From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 14 Córdoba From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,3 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,2 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,62 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,28 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,4 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,87 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,08 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,69 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,12 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,64 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,95 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.131 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.818 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.801 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.095 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.802 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.775 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.076 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.788 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.764 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.050 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.776 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.750 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.756 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.730 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,31 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,12 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,56 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,42 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,35 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,95 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,2 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,69 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,17 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,59 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,06 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 40 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 176 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 77 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 39 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 176 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 77 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 36 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 174 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 74 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 36 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 172 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 74 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 171 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 72 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,5 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 90 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,86 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,1 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 90 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,73 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,1 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,16 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 93,51 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 2.196 14 Córdoba From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 2.102 14 Córdoba From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.984 14 Córdoba From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 2.173 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 2.082 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 1.966 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 2.139 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 2.061 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 1.947 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 2.040 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 1.926 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 2.020 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 1.913 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 14 Córdoba From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 14 Córdoba From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 14 Córdoba From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,95 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,05 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,09 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,4 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,05 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,14 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,05 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,08 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,1 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,42 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.189 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.056 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.900 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.166 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.038 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.885 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.133 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.017 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.866 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.997 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.846 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.978 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.833 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,95 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,12 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,21 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,44 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,1 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,21 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,13 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,16 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,21 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,47 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 7 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 46 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 84 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 7 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 44 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 81 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 6 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 44 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 81 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 43 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 80 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 42 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 80 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 95,65 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,43 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 85,71 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,65 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,43 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93,48 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95,24 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 91,3 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,24 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 2.169 14 Córdoba From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 2.074 14 Córdoba From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 2.026 14 Córdoba From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 2.132 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 2.053 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 2.006 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 2.036 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 1.985 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 2.011 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 1.969 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 1.989 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 1.954 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 14 Córdoba From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 14 Córdoba From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 14 Córdoba From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,29 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,99 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,01 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,17 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,98 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,96 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,19 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,9 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,45 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.160 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.036 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.938 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.124 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.015 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.919 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.998 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.899 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.975 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.883 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.954 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.869 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,33 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,97 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,02 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,13 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,99 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,16 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,97 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,44 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 9 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 38 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 88 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 8 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 38 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 87 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 38 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 86 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 36 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 86 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 35 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 85 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 88,89 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,86 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,73 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 94,74 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,73 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 92,11 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,59 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 80 14 Córdoba from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 63 14 Córdoba from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 70 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 80 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 63 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 70 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 80 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 63 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 70 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 80 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 63 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 69 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 78 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 63 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 69 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 14 Córdoba from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 14 Córdoba from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,57 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,5 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,57 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 77 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 56 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 77 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 56 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 77 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 56 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 77 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 56 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 75 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 56 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,4 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 3 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 7 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 3 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 7 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 3 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 7 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 3 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 7 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 3 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 7 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 77 14 Córdoba from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 69 14 Córdoba from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 54 14 Córdoba from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 77 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 69 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 54 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 77 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 69 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 54 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 75 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 69 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 54 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 69 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 54 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 14 Córdoba from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 14 Córdoba from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 14 Córdoba from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,4 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 73 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 62 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 50 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 73 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 62 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 50 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 73 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 62 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 50 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 71 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 62 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 50 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 62 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 50 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,26 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 4 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 7 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 4 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 4 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 7 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 4 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 4 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 7 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 4 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 4 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 7 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 4 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 7 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 4 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 80 14 Córdoba from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 69 14 Córdoba from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 58 14 Córdoba from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 79 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 69 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 58 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 78 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 69 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 58 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 69 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 58 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 69 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 57 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 14 Córdoba from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 14 Córdoba from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 14 Córdoba from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,75 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,5 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,28 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 79 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 66 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 51 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 78 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 66 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 51 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 77 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 66 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 51 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 66 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 51 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 66 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 51 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,73 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,47 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 3 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 7 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 3 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 7 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 3 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 7 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 3 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 7 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 3 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 6 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 85,71 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 83 14 Córdoba from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 75 14 Córdoba from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 63 14 Córdoba from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 82 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 75 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 63 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 75 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 63 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 75 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 63 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 75 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 62 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 14 Córdoba from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 14 Córdoba from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 14 Córdoba from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,8 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,41 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 82 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 73 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 57 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 81 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 73 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 57 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 73 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 57 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 73 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 57 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 73 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 56 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,78 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,25 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 2 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 6 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 2 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 6 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 2 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 6 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 2 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 6 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 2 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 6 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 45 14 Córdoba De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 41 14 Córdoba De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 44 14 Córdoba De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 45 14 Córdoba De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 41 14 Córdoba De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 44 14 Córdoba De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 45 14 Córdoba De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 41 14 Córdoba De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 44 14 Córdoba De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 44 14 Córdoba De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 41 14 Córdoba De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 43 14 Córdoba De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 44 14 Córdoba De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 41 14 Córdoba De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 43 14 Córdoba De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 14 Córdoba De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 14 Córdoba De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,78 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,73 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,78 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,73 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 44 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 37 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 44 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 37 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 44 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 37 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 43 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 37 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 43 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 37 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,73 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,73 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1 14 Córdoba De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 4 14 Córdoba De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 4 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 4 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 4 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 4 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 14 Córdoba De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 14 Córdoba De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 48 14 Córdoba De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 39 14 Córdoba De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 43 14 Córdoba De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 48 14 Córdoba De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 39 14 Córdoba De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 43 14 Córdoba De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 47 14 Córdoba De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 39 14 Córdoba De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 42 14 Córdoba De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 47 14 Córdoba De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 39 14 Córdoba De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 42 14 Córdoba De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 39 14 Córdoba De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 42 14 Córdoba De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 14 Córdoba De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 14 Córdoba De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 14 Córdoba De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 14 Córdoba De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,92 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,67 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,92 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,67 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,67 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 48 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 36 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 41 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 48 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 36 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 41 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 47 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 36 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 40 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 47 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 36 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 40 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 36 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 40 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,92 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,56 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,92 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,56 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,56 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 0 14 Córdoba De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 3 14 Córdoba De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2 14 Córdoba De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 0 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 3 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 0 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 3 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 0 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 3 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 3 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII .. 14 Córdoba De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 14 Córdoba De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 14 Córdoba De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII .. 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII .. 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 0 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 43 14 Córdoba De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 39 14 Córdoba De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 37 14 Córdoba De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 43 14 Córdoba De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 39 14 Córdoba De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 37 14 Córdoba De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 43 14 Córdoba De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 39 14 Córdoba De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 37 14 Córdoba De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 39 14 Córdoba De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 37 14 Córdoba De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 39 14 Córdoba De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 37 14 Córdoba De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 14 Córdoba De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 14 Córdoba De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 14 Córdoba De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 14 Córdoba De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 14 Córdoba De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 14 Córdoba De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 43 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 38 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 34 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 43 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 38 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 34 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 43 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 38 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 34 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 38 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 34 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 38 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 34 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 14 Córdoba De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1 14 Córdoba De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 3 14 Córdoba De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 3 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 3 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 3 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 3 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII .. 14 Córdoba De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 14 Córdoba De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 14 Córdoba De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII .. 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 43 14 Córdoba De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 41 14 Córdoba De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 39 14 Córdoba De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 43 14 Córdoba De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 41 14 Córdoba De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 39 14 Córdoba De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 41 14 Córdoba De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 39 14 Córdoba De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 41 14 Córdoba De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 39 14 Córdoba De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 40 14 Córdoba De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 39 14 Córdoba De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 14 Córdoba De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 14 Córdoba De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 14 Córdoba De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 14 Córdoba De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 14 Córdoba De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 14 Córdoba De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 14 Córdoba De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,56 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 43 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 40 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 36 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 43 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 40 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 36 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 40 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 36 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 40 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 36 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 39 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 36 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,5 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 14 Córdoba De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1 14 Córdoba De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 3 14 Córdoba De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 3 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 3 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 3 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 3 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 14 Córdoba De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 14 Córdoba De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 14 Córdoba De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 14 Córdoba De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A Total Cohort January 1 Total Number at the start of the quarter 2022QI 28.969 15 Coruña, A Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A Total Cohort January 1 Total Number at the start of the quarter 2021QI 28.228 15 Coruña, A Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A Total Cohort January 1 Total Number at the start of the quarter 2020QI 29.483 15 Coruña, A Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 15 Coruña, A Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 15 Coruña, A Total Cohort January 1 Total Survival in the first trimester 2022QII "" 15 Coruña, A Total Cohort January 1 Total Survival in the first trimester 2022QI 27.605 15 Coruña, A Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 15 Coruña, A Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 15 Coruña, A Total Cohort January 1 Total Survival in the first trimester 2021QII "" 15 Coruña, A Total Cohort January 1 Total Survival in the first trimester 2021QI 26.902 15 Coruña, A Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 15 Coruña, A Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 15 Coruña, A Total Cohort January 1 Total Survival in the first trimester 2020QII "" 15 Coruña, A Total Cohort January 1 Total Survival in the first trimester 2020QI 26.869 15 Coruña, A Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 15 Coruña, A Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 15 Coruña, A Total Cohort January 1 Total Survival in the second trimester 2022QII 26.565 15 Coruña, A Total Cohort January 1 Total Survival in the second trimester 2022QI "" 15 Coruña, A Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 15 Coruña, A Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 15 Coruña, A Total Cohort January 1 Total Survival in the second trimester 2021QII 26.115 15 Coruña, A Total Cohort January 1 Total Survival in the second trimester 2021QI "" 15 Coruña, A Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 15 Coruña, A Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 15 Coruña, A Total Cohort January 1 Total Survival in the second trimester 2020QII 26.011 15 Coruña, A Total Cohort January 1 Total Survival in the second trimester 2020QI "" 15 Coruña, A Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A Total Cohort January 1 Total Survival in the third trimester 2022QIII 25.716 15 Coruña, A Total Cohort January 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A Total Cohort January 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A Total Cohort January 1 Total Survival in the third trimester 2021QIII 25.403 15 Coruña, A Total Cohort January 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A Total Cohort January 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A Total Cohort January 1 Total Survival in the third trimester 2020QIII 25.252 15 Coruña, A Total Cohort January 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A Total Cohort January 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A Total Cohort January 1 Total Survival in the third trimester 2022QIV 25.010 15 Coruña, A Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A Total Cohort January 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A Total Cohort January 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A Total Cohort January 1 Total Survival in the third trimester 2021QIV 24.826 15 Coruña, A Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A Total Cohort January 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A Total Cohort January 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A Total Cohort January 1 Total Survival in the third trimester 2020QIV 24.563 15 Coruña, A Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A Total Cohort January 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A Total Cohort January 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 15 Coruña, A Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 15 Coruña, A Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,29 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,3 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 91,13 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 91,7 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 92,51 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 88,22 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 88,77 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 89,99 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 85,65 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 86,33 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 87,95 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 83,31 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 27.553 15 Coruña, A Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 24.498 15 Coruña, A Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 26.235 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 23.246 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 25.241 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 22.521 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 24.418 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 21.871 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 23.745 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 21.352 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 15 Coruña, A Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 15 Coruña, A Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 95,22 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,89 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 91,61 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 91,93 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 88,62 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 89,28 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 86,18 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 87,16 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.416 15 Coruña, A Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 3.730 15 Coruña, A Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.370 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 3.656 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.324 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 3.594 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.298 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 3.532 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.265 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 3.474 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 15 Coruña, A Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 15 Coruña, A Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,75 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,02 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,5 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,35 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 91,67 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,69 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 89,34 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 93,14 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A Total Cohort April 1 Total Number at the start of the quarter 2022QII 28.871 15 Coruña, A Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A Total Cohort April 1 Total Number at the start of the quarter 2021QII 28.075 15 Coruña, A Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A Total Cohort April 1 Total Number at the start of the quarter 2020QII 27.929 15 Coruña, A Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 15 Coruña, A Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 15 Coruña, A Total Cohort April 1 Total Survival in the first trimester 2022QII 27.616 15 Coruña, A Total Cohort April 1 Total Survival in the first trimester 2022QI "" 15 Coruña, A Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 15 Coruña, A Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 15 Coruña, A Total Cohort April 1 Total Survival in the first trimester 2021QII 27.107 15 Coruña, A Total Cohort April 1 Total Survival in the first trimester 2021QI "" 15 Coruña, A Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 15 Coruña, A Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 15 Coruña, A Total Cohort April 1 Total Survival in the first trimester 2020QII 26.936 15 Coruña, A Total Cohort April 1 Total Survival in the first trimester 2020QI "" 15 Coruña, A Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 15 Coruña, A Total Cohort April 1 Total Survival in the second trimester 2022QIII 26.649 15 Coruña, A Total Cohort April 1 Total Survival in the second trimester 2022QII "" 15 Coruña, A Total Cohort April 1 Total Survival in the second trimester 2022QI "" 15 Coruña, A Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 15 Coruña, A Total Cohort April 1 Total Survival in the second trimester 2021QIII 26.271 15 Coruña, A Total Cohort April 1 Total Survival in the second trimester 2021QII "" 15 Coruña, A Total Cohort April 1 Total Survival in the second trimester 2021QI "" 15 Coruña, A Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 15 Coruña, A Total Cohort April 1 Total Survival in the second trimester 2020QIII 26.058 15 Coruña, A Total Cohort April 1 Total Survival in the second trimester 2020QII "" 15 Coruña, A Total Cohort April 1 Total Survival in the second trimester 2020QI "" 15 Coruña, A Total Cohort April 1 Total Survival in the third trimester 2022QIV 25.792 15 Coruña, A Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A Total Cohort April 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A Total Cohort April 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A Total Cohort April 1 Total Survival in the third trimester 2021QIV 25.565 15 Coruña, A Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A Total Cohort April 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A Total Cohort April 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A Total Cohort April 1 Total Survival in the third trimester 2020QIV 25.286 15 Coruña, A Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A Total Cohort April 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A Total Cohort April 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A Total Cohort April 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A Total Cohort April 1 Total Survival in the third trimester 2022QI 24.769 15 Coruña, A Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A Total Cohort April 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A Total Cohort April 1 Total Survival in the third trimester 2021QI 24.461 15 Coruña, A Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A Total Cohort April 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A Total Cohort April 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 15 Coruña, A Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 15 Coruña, A Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 15 Coruña, A Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,65 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,55 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,44 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 92,3 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 93,57 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,3 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 89,34 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 91,06 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,54 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 88,22 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87,58 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 27.482 15 Coruña, A Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 24.396 15 Coruña, A Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 22.319 15 Coruña, A Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 26.272 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 23.495 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 21.397 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 25.338 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 22.733 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 20.653 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 24.511 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 22.092 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 20.014 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 21.390 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 19.334 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 15 Coruña, A Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 15 Coruña, A Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 15 Coruña, A Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,6 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 96,31 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,87 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 92,2 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 93,18 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,54 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 89,19 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 90,56 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 89,67 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 87,68 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 86,63 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.389 15 Coruña, A Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 3.679 15 Coruña, A Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 5.610 15 Coruña, A Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.344 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 3.612 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 5.539 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.311 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 3.538 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 5.405 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.281 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 3.473 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 5.272 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 3.379 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 5.127 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 15 Coruña, A Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 15 Coruña, A Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 15 Coruña, A Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,76 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,18 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,73 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,38 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,17 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,35 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 92,22 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,4 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,98 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 91,85 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,39 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A Total Cohort July 1 Total Number at the start of the quarter 2022QIII 29.259 15 Coruña, A Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A Total Cohort July 1 Total Number at the start of the quarter 2021QIII 28.865 15 Coruña, A Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A Total Cohort July 1 Total Number at the start of the quarter 2020QIII 28.203 15 Coruña, A Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 15 Coruña, A Total Cohort July 1 Total Survival in the first trimester 2022QIII 27.904 15 Coruña, A Total Cohort July 1 Total Survival in the first trimester 2022QII "" 15 Coruña, A Total Cohort July 1 Total Survival in the first trimester 2022QI "" 15 Coruña, A Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 15 Coruña, A Total Cohort July 1 Total Survival in the first trimester 2021QIII 27.595 15 Coruña, A Total Cohort July 1 Total Survival in the first trimester 2021QII "" 15 Coruña, A Total Cohort July 1 Total Survival in the first trimester 2021QI "" 15 Coruña, A Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 15 Coruña, A Total Cohort July 1 Total Survival in the first trimester 2020QIII 27.014 15 Coruña, A Total Cohort July 1 Total Survival in the first trimester 2020QII "" 15 Coruña, A Total Cohort July 1 Total Survival in the first trimester 2020QI "" 15 Coruña, A Total Cohort July 1 Total Survival in the second trimester 2022QIV 26.680 15 Coruña, A Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 15 Coruña, A Total Cohort July 1 Total Survival in the second trimester 2022QII "" 15 Coruña, A Total Cohort July 1 Total Survival in the second trimester 2022QI "" 15 Coruña, A Total Cohort July 1 Total Survival in the second trimester 2021QIV 26.582 15 Coruña, A Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 15 Coruña, A Total Cohort July 1 Total Survival in the second trimester 2021QII "" 15 Coruña, A Total Cohort July 1 Total Survival in the second trimester 2021QI "" 15 Coruña, A Total Cohort July 1 Total Survival in the second trimester 2020QIV 26.018 15 Coruña, A Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 15 Coruña, A Total Cohort July 1 Total Survival in the second trimester 2020QII "" 15 Coruña, A Total Cohort July 1 Total Survival in the second trimester 2020QI "" 15 Coruña, A Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A Total Cohort July 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A Total Cohort July 1 Total Survival in the third trimester 2022QI 25.658 15 Coruña, A Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A Total Cohort July 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A Total Cohort July 1 Total Survival in the third trimester 2021QI 25.106 15 Coruña, A Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A Total Cohort July 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A Total Cohort July 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A Total Cohort July 1 Total Survival in the third trimester 2022QII 24.960 15 Coruña, A Total Cohort July 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A Total Cohort July 1 Total Survival in the third trimester 2021QII 24.569 15 Coruña, A Total Cohort July 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A Total Cohort July 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A Total Cohort July 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 15 Coruña, A Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 15 Coruña, A Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 15 Coruña, A Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 95,37 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,6 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,78 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 91,19 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 92,09 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 92,25 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 88,89 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 89,02 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 86,47 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 87,11 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 28.398 15 Coruña, A Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 27.866 15 Coruña, A Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 24.216 15 Coruña, A Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 27.063 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 26.617 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 23.117 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 25.856 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 25.623 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 22.203 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 24.729 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 21.383 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 24.042 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 20.900 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 15 Coruña, A Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 15 Coruña, A Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 15 Coruña, A Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 95,3 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,52 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,46 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 91,05 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 91,95 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 91,69 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 88,74 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 88,3 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 86,28 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 86,31 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 861 15 Coruña, A Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 999 15 Coruña, A Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 3.987 15 Coruña, A Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 841 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 978 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 3.897 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 824 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 959 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 3.815 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 929 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 3.723 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 918 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 3.669 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 15 Coruña, A Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 15 Coruña, A Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 15 Coruña, A Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,68 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,9 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,74 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95,7 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,69 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 92,99 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,38 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 91,89 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,02 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A Total Cohort October 1 Total Number at the start of the quarter 2022QIV 29.016 15 Coruña, A Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A Total Cohort October 1 Total Number at the start of the quarter 2021QIV 28.968 15 Coruña, A Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A Total Cohort October 1 Total Number at the start of the quarter 2020QIV 28.460 15 Coruña, A Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A Total Cohort October 1 Total Survival in the first trimester 2022QIV 27.525 15 Coruña, A Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 15 Coruña, A Total Cohort October 1 Total Survival in the first trimester 2022QII "" 15 Coruña, A Total Cohort October 1 Total Survival in the first trimester 2022QI "" 15 Coruña, A Total Cohort October 1 Total Survival in the first trimester 2021QIV 27.622 15 Coruña, A Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 15 Coruña, A Total Cohort October 1 Total Survival in the first trimester 2021QII "" 15 Coruña, A Total Cohort October 1 Total Survival in the first trimester 2021QI "" 15 Coruña, A Total Cohort October 1 Total Survival in the first trimester 2020QIV 27.074 15 Coruña, A Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 15 Coruña, A Total Cohort October 1 Total Survival in the first trimester 2020QII "" 15 Coruña, A Total Cohort October 1 Total Survival in the first trimester 2020QI "" 15 Coruña, A Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 15 Coruña, A Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 15 Coruña, A Total Cohort October 1 Total Survival in the second trimester 2022QII "" 15 Coruña, A Total Cohort October 1 Total Survival in the second trimester 2022QI 26.539 15 Coruña, A Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 15 Coruña, A Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 15 Coruña, A Total Cohort October 1 Total Survival in the second trimester 2021QII "" 15 Coruña, A Total Cohort October 1 Total Survival in the second trimester 2021QI 26.006 15 Coruña, A Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 15 Coruña, A Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 15 Coruña, A Total Cohort October 1 Total Survival in the second trimester 2020QII "" 15 Coruña, A Total Cohort October 1 Total Survival in the second trimester 2020QI "" 15 Coruña, A Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A Total Cohort October 1 Total Survival in the third trimester 2022QII 25.687 15 Coruña, A Total Cohort October 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A Total Cohort October 1 Total Survival in the third trimester 2021QII 25.363 15 Coruña, A Total Cohort October 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A Total Cohort October 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A Total Cohort October 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A Total Cohort October 1 Total Survival in the third trimester 2022QIII 24.953 15 Coruña, A Total Cohort October 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A Total Cohort October 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A Total Cohort October 1 Total Survival in the third trimester 2021QIII 24.759 15 Coruña, A Total Cohort October 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A Total Cohort October 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A Total Cohort October 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A Total Cohort October 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 15 Coruña, A Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 15 Coruña, A Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 15 Coruña, A Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,86 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,35 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 95,13 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 91,61 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 91,38 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 88,67 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 89,12 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 86,14 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 87 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 28.257 15 Coruña, A Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 27.469 15 Coruña, A Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 24.879 15 Coruña, A Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 26.781 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 26.167 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 23.566 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 25.143 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 22.573 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 24.332 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 21.975 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 23.621 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 21.427 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 15 Coruña, A Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 15 Coruña, A Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 15 Coruña, A Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,78 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,26 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,72 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 91,53 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 90,73 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 88,58 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 88,33 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 85,99 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 86,12 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 759 15 Coruña, A Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.499 15 Coruña, A Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 3.581 15 Coruña, A Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 744 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.455 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 3.508 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.396 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 3.433 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.355 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 3.388 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.332 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 3.332 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 15 Coruña, A Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 15 Coruña, A Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 15 Coruña, A Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,02 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,06 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,96 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,13 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,87 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 90,39 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,61 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 88,86 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,05 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 22.390 15 Coruña, A From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 22.043 15 Coruña, A From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 22.801 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 21.090 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 20.783 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 20.317 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 20.136 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 20.067 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 19.520 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 19.334 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 19.403 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 18.823 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 18.678 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 18.874 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 18.201 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 15 Coruña, A From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 15 Coruña, A From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,19 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,28 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 89,11 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,93 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,04 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 85,61 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,35 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 88,02 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 82,55 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 83,42 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,62 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 79,83 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 21.442 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 19.945 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 20.184 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 18.741 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 19.272 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 18.075 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 18.493 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 17.465 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 17.868 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 16.979 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,13 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,96 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,88 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,62 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,25 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,57 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 83,33 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,13 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 948 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2.098 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 906 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2.042 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 864 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.992 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 841 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.938 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 810 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.895 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,57 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,33 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 91,14 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,95 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 88,71 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,37 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 85,44 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 90,32 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 22.247 15 Coruña, A From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 21.916 15 Coruña, A From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 21.724 15 Coruña, A From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 21.071 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 21.019 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 20.781 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 20.151 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 20.232 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 19.951 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 19.344 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 19.574 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 19.232 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 18.837 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 18.475 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 15 Coruña, A From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 15 Coruña, A From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 15 Coruña, A From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,71 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,91 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,66 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,58 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,32 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,84 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 86,95 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 89,31 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,53 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 85,95 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,04 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 21.290 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 19.718 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 18.248 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 20.152 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 18.874 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 17.366 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 19.261 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 18.154 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 16.650 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 18.481 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 17.552 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 16.037 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 16.894 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 15.398 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,65 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,72 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,17 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,47 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,07 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,24 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 86,81 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 89,02 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 87,88 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 85,68 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,38 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 957 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 2.198 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 3.476 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 919 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 2.145 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 3.415 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 890 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 2.078 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 3.301 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 863 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 2.022 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 3.195 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.943 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 3.077 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,03 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,59 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,25 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,54 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,97 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 90,18 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 91,99 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,92 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 88,4 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 88,52 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 22.423 15 Coruña, A From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 22.393 15 Coruña, A From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 21.907 15 Coruña, A From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 21.123 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 21.182 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 20.779 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 19.979 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 20.235 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 19.844 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 19.389 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 19.007 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 18.752 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 18.516 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 15 Coruña, A From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 15 Coruña, A From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 15 Coruña, A From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,2 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,59 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,85 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,1 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,36 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,58 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 86,59 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,76 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 83,74 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,52 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 21.823 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 21.854 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 19.798 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 20.543 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 20.661 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 18.740 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 19.414 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 19.732 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 17.868 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 18.913 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 17.100 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 18.283 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 16.646 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,13 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,54 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,66 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 88,96 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 90,29 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,25 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 86,54 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,37 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 83,66 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 84,08 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 600 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 539 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2.109 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 580 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 521 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2.039 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 565 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 503 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.976 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 476 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.907 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 469 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.870 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,67 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,66 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,68 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,17 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,32 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,69 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 88,31 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 90,42 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 87,01 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 88,67 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 22.201 15 Coruña, A From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 22.404 15 Coruña, A From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 22.142 15 Coruña, A From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 20.789 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 21.119 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 20.807 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 20.113 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 19.815 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 19.332 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 19.228 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 18.642 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 18.675 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 15 Coruña, A From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 15 Coruña, A From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 15 Coruña, A From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,64 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,26 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,97 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,77 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,49 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 86,29 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 86,84 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 83,21 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 84,34 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 21.675 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 21.338 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 20.230 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 20.277 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 20.095 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 18.958 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 19.144 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 18.023 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 18.400 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 17.468 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 17.730 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 16.962 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,55 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,17 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,71 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,72 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,09 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 86,23 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,35 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 83,09 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 83,85 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 526 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.066 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.912 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 512 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.024 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.849 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 969 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.792 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 932 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.760 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 912 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.713 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,34 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,06 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,71 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 90,9 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 93,72 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 87,43 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,05 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 85,55 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 89,59 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 2.894 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 2.713 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 2.960 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 2.855 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 2.687 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 2.879 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 2.809 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 2.646 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 2.843 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 2.780 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 2.623 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 2.807 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 2.748 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 2.592 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 2.766 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,65 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,04 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,26 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,06 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,53 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,05 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,06 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,68 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,83 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 94,96 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,54 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 93,45 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.713 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.094 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.676 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2.071 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.631 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.036 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.603 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.018 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.573 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.997 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,64 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,9 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,98 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,23 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,95 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,37 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 94,84 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,37 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 181 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 619 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 179 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 616 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 178 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 610 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 177 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 605 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 175 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 595 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,9 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,52 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,34 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,55 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,79 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,74 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,69 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,12 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 2.867 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 2.656 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 2.696 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 2.825 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 2.613 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 2.667 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 2.801 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 2.587 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 2.641 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 2.774 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 2.556 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 2.606 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 2.526 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 2.579 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,54 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,38 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,92 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,7 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,4 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,96 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,76 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,23 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,66 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 95,11 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,66 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.695 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.105 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.814 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.658 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.071 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.792 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.637 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.048 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.777 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.613 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.023 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.760 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.999 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.741 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,63 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,38 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,79 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,85 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,29 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,96 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,96 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,1 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,02 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 94,96 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,98 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 172 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 551 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 882 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 167 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 542 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 875 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 164 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 539 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 864 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 161 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 533 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 846 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 527 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 838 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,09 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,37 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,21 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 95,35 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,82 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,96 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 93,6 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,73 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,92 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 95,64 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,01 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 2.991 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 2.857 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 2.794 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 2.959 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 2.828 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 2.757 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 2.911 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 2.785 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 2.714 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 2.738 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 2.683 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 2.701 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 2.660 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,93 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,98 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,68 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,33 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,48 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,14 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,83 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,03 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 94,54 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,2 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.872 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.697 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2.102 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.840 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.669 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.079 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.794 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.626 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.048 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.580 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.026 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.546 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.011 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,89 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,96 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,91 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,28 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,37 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,43 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,66 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,38 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,4 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,67 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 119 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 160 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 692 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 119 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 159 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 678 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 117 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 159 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 666 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 158 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 657 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 155 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 649 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,38 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,98 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,32 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,38 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,24 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 98,75 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,94 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,88 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 93,79 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 2.964 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 2.876 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 2.768 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 2.917 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 2.837 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 2.734 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 2.791 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 2.704 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 2.753 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 2.678 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 2.726 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 2.656 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,41 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,64 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,77 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,04 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,69 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95,72 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,75 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 94,78 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,95 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.868 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.697 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2.191 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.822 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.659 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2.161 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.615 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.135 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.579 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2.116 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.554 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.098 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,4 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,59 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,63 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,96 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,44 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,62 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,58 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 94,7 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,76 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 96 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 179 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 577 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 95 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 178 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 573 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 176 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 569 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 174 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 562 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 172 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 558 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,96 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,44 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,31 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,32 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,61 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,21 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,4 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96,09 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,71 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 3.408 15 Coruña, A From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 3.220 15 Coruña, A From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 3.433 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 3.385 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 3.183 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 3.385 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 3.345 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 3.153 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 3.360 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 3.330 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 3.128 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 3.336 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 3.312 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 3.111 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 3.313 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 15 Coruña, A From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 15 Coruña, A From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,33 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,85 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,6 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,15 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,92 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,87 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,71 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,14 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,17 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,18 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,61 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,5 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 3.147 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.282 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 3.126 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2.258 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 3.089 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.234 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 3.075 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.212 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 3.057 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2.200 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,33 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,95 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,16 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,9 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,71 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,93 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,14 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,41 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 261 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 938 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 259 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 925 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 256 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 919 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 255 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 916 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 255 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 911 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,23 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,61 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,08 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,97 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,7 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,65 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 97,7 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,12 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 3.468 15 Coruña, A From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 3.241 15 Coruña, A From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 3.236 15 Coruña, A From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 3.431 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 3.213 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 3.215 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 3.411 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 3.190 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 3.195 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 3.388 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 3.173 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 3.179 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 3.146 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 3.140 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 15 Coruña, A From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 15 Coruña, A From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 15 Coruña, A From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,93 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,14 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,35 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,36 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,43 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,73 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,69 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,9 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,24 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,07 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,03 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 3.229 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.378 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2.074 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 3.194 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.355 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2.056 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 3.175 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.336 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2.044 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 3.152 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.322 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.036 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.304 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.014 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,92 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,03 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,13 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,33 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,23 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,55 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,62 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,65 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,17 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,89 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,11 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 239 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 863 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.162 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 237 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 858 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.159 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 236 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 854 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.151 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 236 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 851 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.143 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 842 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.126 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,16 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,42 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,74 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,74 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,96 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,05 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 98,74 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,61 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,36 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,57 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,9 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 3.548 15 Coruña, A From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 3.348 15 Coruña, A From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 3.240 15 Coruña, A From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 3.528 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 3.318 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 3.218 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 3.496 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 3.295 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 3.202 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 3.266 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 3.160 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 3.243 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 3.137 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 15 Coruña, A From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 15 Coruña, A From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 15 Coruña, A From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,44 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,1 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,32 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,53 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,42 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,83 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,55 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,53 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,86 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,82 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 3.422 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 3.071 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2.149 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 3.402 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 3.043 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.131 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 3.370 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 3.021 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.121 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.994 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.091 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.972 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.077 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,42 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,09 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,16 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,48 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,37 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,7 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,49 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,3 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,78 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,65 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 126 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 277 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.091 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 126 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 275 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.087 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 126 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 274 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.081 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 272 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.069 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 271 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.060 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,28 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,63 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,92 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,08 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 98,19 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,98 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 97,83 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,16 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 3.562 15 Coruña, A From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 3.418 15 Coruña, A From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 3.283 15 Coruña, A From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 3.530 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 3.396 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 3.268 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 3.367 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 3.224 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 3.335 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 3.194 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 3.320 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 3.165 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 15 Coruña, A From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 15 Coruña, A From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 15 Coruña, A From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,1 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,36 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,54 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,51 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,2 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,57 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,29 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,13 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,41 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 3.439 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3.186 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2.280 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 3.407 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 3.165 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2.271 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 3.138 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.239 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 3.108 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2.215 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 3.094 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.191 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,07 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,34 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,61 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,49 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,2 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,55 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,15 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,11 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,1 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 123 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 232 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.003 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 123 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 231 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 997 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 229 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 985 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 227 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 979 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 226 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 974 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,57 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,4 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,71 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,21 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,84 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,61 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 97,41 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 97,11 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 165 15 Coruña, A from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 149 15 Coruña, A from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 179 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 164 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 146 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 178 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 164 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 146 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 178 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 161 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 146 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 176 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 161 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 146 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 174 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 15 Coruña, A from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 15 Coruña, A from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,39 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 97,99 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,44 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,39 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,99 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 99,44 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,58 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,99 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,32 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,58 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,99 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,21 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 147 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 96 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 146 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 95 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 146 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 95 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 144 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 95 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 144 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 95 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,32 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,96 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,32 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,96 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,96 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,96 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,96 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,96 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 18 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 53 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 18 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 51 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 18 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 51 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 17 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 51 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 17 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 51 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,23 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,23 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 94,44 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,23 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,44 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,23 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 180 15 Coruña, A from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 157 15 Coruña, A from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 168 15 Coruña, A from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 180 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 157 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 168 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 177 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 157 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 166 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 177 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 157 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 165 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 155 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 163 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 15 Coruña, A from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 15 Coruña, A from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 15 Coruña, A from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,33 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,81 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,33 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,21 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,73 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,02 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 165 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 113 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 101 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 165 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 113 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 101 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 162 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 113 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 100 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 162 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 113 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 100 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 111 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 100 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,18 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,01 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,18 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 99,01 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 98,23 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 99,01 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 15 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 44 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 67 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 15 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 44 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 67 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 15 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 44 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 66 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 15 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 44 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 65 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 44 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 63 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,51 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,01 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,03 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 188 15 Coruña, A from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 160 15 Coruña, A from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 155 15 Coruña, A from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 185 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 160 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 153 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 185 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 160 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 152 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 159 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 150 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 158 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 150 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 15 Coruña, A from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 15 Coruña, A from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 15 Coruña, A from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,4 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,71 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,4 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,06 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 99,38 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,77 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,75 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,77 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 176 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 143 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 88 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 173 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 143 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 88 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 173 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 143 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 88 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 142 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 88 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 141 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 88 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,3 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,3 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 99,3 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,6 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 12 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 17 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 67 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 12 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 17 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 65 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 12 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 17 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 64 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 17 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 62 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 17 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 62 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,01 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,52 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 92,54 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,54 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 180 15 Coruña, A from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 159 15 Coruña, A from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 160 15 Coruña, A from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 180 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 159 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 159 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 158 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 157 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 157 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 157 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 155 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 157 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 15 Coruña, A from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 15 Coruña, A from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 15 Coruña, A from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,38 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,37 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,13 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,74 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,13 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,48 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,13 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 169 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 144 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 95 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 169 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 144 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 94 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 143 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 94 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 142 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 94 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 140 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 94 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,95 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 99,31 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,95 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,61 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,95 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,22 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,95 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 11 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 15 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 65 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 11 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 15 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 65 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 15 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 63 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 15 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 63 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 15 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 63 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,92 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 96,92 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,92 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 112 15 Coruña, A De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 103 15 Coruña, A De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 110 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 111 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 103 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 110 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 111 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 103 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 110 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 111 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 103 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 110 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 111 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 103 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 109 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 15 Coruña, A De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 15 Coruña, A De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,11 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,11 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 99,11 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 99,11 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 99,09 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 104 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 81 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 103 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 81 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 103 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 81 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 103 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 81 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 103 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 81 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,04 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,04 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 99,04 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 99,04 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 8 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 22 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 8 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 22 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 8 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 22 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 8 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 22 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 8 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 22 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 109 15 Coruña, A De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 105 15 Coruña, A De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 105 15 Coruña, A De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 109 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 105 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 105 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 109 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 105 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 105 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 109 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 105 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 104 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 105 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 104 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 15 Coruña, A De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 15 Coruña, A De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 15 Coruña, A De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 99,05 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 99,05 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 103 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 82 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 82 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 103 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 82 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 82 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 103 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 82 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 82 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 103 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 82 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 81 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 82 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 81 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,78 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 98,78 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 6 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 23 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 23 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 6 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 23 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 23 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 6 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 23 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 23 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 6 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 23 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 23 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 23 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 23 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 109 15 Coruña, A De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 107 15 Coruña, A De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 107 15 Coruña, A De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 109 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 107 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 107 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 109 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 107 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 106 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 106 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 106 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 106 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 106 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 15 Coruña, A De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 15 Coruña, A De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 15 Coruña, A De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 15 Coruña, A De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 15 Coruña, A De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 15 Coruña, A De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,07 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 99,07 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 99,07 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 99,07 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 99,07 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 105 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 101 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 79 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 105 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 101 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 79 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 105 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 101 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 78 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 100 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 78 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 100 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 78 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,73 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 99,01 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,73 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 99,01 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 98,73 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 4 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 6 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 28 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 4 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 6 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 28 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 4 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 6 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 28 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 6 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 28 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 6 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 28 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 109 15 Coruña, A De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 111 15 Coruña, A De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 107 15 Coruña, A De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 109 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 111 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 106 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 110 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 106 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 110 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 106 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 110 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 106 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 15 Coruña, A De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 15 Coruña, A De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 15 Coruña, A De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,07 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,1 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 99,07 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 99,1 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 99,07 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 99,1 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 99,07 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 106 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 104 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 83 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 106 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 104 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 82 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 103 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 82 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 103 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 82 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 103 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 82 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,8 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 99,04 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,8 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 99,04 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,8 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 99,04 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,8 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 3 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 7 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 24 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 3 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 7 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 24 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 7 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 24 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 7 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 24 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 7 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 24 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 15 Coruña, A De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca Total Cohort January 1 Total Number at the start of the quarter 2022QI 4.888 16 Cuenca Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca Total Cohort January 1 Total Number at the start of the quarter 2021QI 4.743 16 Cuenca Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca Total Cohort January 1 Total Number at the start of the quarter 2020QI 4.987 16 Cuenca Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 16 Cuenca Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 16 Cuenca Total Cohort January 1 Total Survival in the first trimester 2022QII "" 16 Cuenca Total Cohort January 1 Total Survival in the first trimester 2022QI 4.598 16 Cuenca Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 16 Cuenca Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 16 Cuenca Total Cohort January 1 Total Survival in the first trimester 2021QII "" 16 Cuenca Total Cohort January 1 Total Survival in the first trimester 2021QI 4.471 16 Cuenca Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 16 Cuenca Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 16 Cuenca Total Cohort January 1 Total Survival in the first trimester 2020QII "" 16 Cuenca Total Cohort January 1 Total Survival in the first trimester 2020QI 4.380 16 Cuenca Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 16 Cuenca Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 16 Cuenca Total Cohort January 1 Total Survival in the second trimester 2022QII 4.383 16 Cuenca Total Cohort January 1 Total Survival in the second trimester 2022QI "" 16 Cuenca Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 16 Cuenca Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 16 Cuenca Total Cohort January 1 Total Survival in the second trimester 2021QII 4.310 16 Cuenca Total Cohort January 1 Total Survival in the second trimester 2021QI "" 16 Cuenca Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 16 Cuenca Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 16 Cuenca Total Cohort January 1 Total Survival in the second trimester 2020QII 4.219 16 Cuenca Total Cohort January 1 Total Survival in the second trimester 2020QI "" 16 Cuenca Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca Total Cohort January 1 Total Survival in the third trimester 2022QIII 4.229 16 Cuenca Total Cohort January 1 Total Survival in the third trimester 2022QII "" 16 Cuenca Total Cohort January 1 Total Survival in the third trimester 2022QI "" 16 Cuenca Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca Total Cohort January 1 Total Survival in the third trimester 2021QIII 4.167 16 Cuenca Total Cohort January 1 Total Survival in the third trimester 2021QII "" 16 Cuenca Total Cohort January 1 Total Survival in the third trimester 2021QI "" 16 Cuenca Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca Total Cohort January 1 Total Survival in the third trimester 2020QIII 4.090 16 Cuenca Total Cohort January 1 Total Survival in the third trimester 2020QII "" 16 Cuenca Total Cohort January 1 Total Survival in the third trimester 2020QI "" 16 Cuenca Total Cohort January 1 Total Survival in the third trimester 2022QIV 4.107 16 Cuenca Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca Total Cohort January 1 Total Survival in the third trimester 2022QII "" 16 Cuenca Total Cohort January 1 Total Survival in the third trimester 2022QI "" 16 Cuenca Total Cohort January 1 Total Survival in the third trimester 2021QIV 4.072 16 Cuenca Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca Total Cohort January 1 Total Survival in the third trimester 2021QII "" 16 Cuenca Total Cohort January 1 Total Survival in the third trimester 2021QI "" 16 Cuenca Total Cohort January 1 Total Survival in the third trimester 2020QIV 3.971 16 Cuenca Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca Total Cohort January 1 Total Survival in the third trimester 2020QII "" 16 Cuenca Total Cohort January 1 Total Survival in the third trimester 2020QI "" 16 Cuenca Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 16 Cuenca Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 16 Cuenca Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,07 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,27 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 87,83 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,67 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,87 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 84,6 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,52 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,86 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 82,01 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 84,02 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,85 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 79,63 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 4.789 16 Cuenca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 4.485 16 Cuenca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 4.500 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 4.217 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 4.293 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 4.063 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 4.139 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 3.924 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 4.020 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 3.830 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 16 Cuenca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 16 Cuenca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,97 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,02 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,64 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,59 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,43 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,49 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 83,94 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,4 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 99 16 Cuenca Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 258 16 Cuenca Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 98 16 Cuenca Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 254 16 Cuenca Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 90 16 Cuenca Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 247 16 Cuenca Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 90 16 Cuenca Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 243 16 Cuenca Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 87 16 Cuenca Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 242 16 Cuenca Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 16 Cuenca Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 16 Cuenca Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,99 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,45 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,91 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,74 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,91 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,19 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 87,88 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 93,8 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca Total Cohort April 1 Total Number at the start of the quarter 2022QII 4.860 16 Cuenca Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca Total Cohort April 1 Total Number at the start of the quarter 2021QII 4.731 16 Cuenca Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca Total Cohort April 1 Total Number at the start of the quarter 2020QII 4.569 16 Cuenca Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 16 Cuenca Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 16 Cuenca Total Cohort April 1 Total Survival in the first trimester 2022QII 4.585 16 Cuenca Total Cohort April 1 Total Survival in the first trimester 2022QI "" 16 Cuenca Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 16 Cuenca Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 16 Cuenca Total Cohort April 1 Total Survival in the first trimester 2021QII 4.502 16 Cuenca Total Cohort April 1 Total Survival in the first trimester 2021QI "" 16 Cuenca Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 16 Cuenca Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 16 Cuenca Total Cohort April 1 Total Survival in the first trimester 2020QII 4.378 16 Cuenca Total Cohort April 1 Total Survival in the first trimester 2020QI "" 16 Cuenca Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 16 Cuenca Total Cohort April 1 Total Survival in the second trimester 2022QIII 4.398 16 Cuenca Total Cohort April 1 Total Survival in the second trimester 2022QII "" 16 Cuenca Total Cohort April 1 Total Survival in the second trimester 2022QI "" 16 Cuenca Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 16 Cuenca Total Cohort April 1 Total Survival in the second trimester 2021QIII 4.330 16 Cuenca Total Cohort April 1 Total Survival in the second trimester 2021QII "" 16 Cuenca Total Cohort April 1 Total Survival in the second trimester 2021QI "" 16 Cuenca Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 16 Cuenca Total Cohort April 1 Total Survival in the second trimester 2020QIII 4.235 16 Cuenca Total Cohort April 1 Total Survival in the second trimester 2020QII "" 16 Cuenca Total Cohort April 1 Total Survival in the second trimester 2020QI "" 16 Cuenca Total Cohort April 1 Total Survival in the third trimester 2022QIV 4.250 16 Cuenca Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca Total Cohort April 1 Total Survival in the third trimester 2022QII "" 16 Cuenca Total Cohort April 1 Total Survival in the third trimester 2022QI "" 16 Cuenca Total Cohort April 1 Total Survival in the third trimester 2021QIV 4.210 16 Cuenca Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca Total Cohort April 1 Total Survival in the third trimester 2021QII "" 16 Cuenca Total Cohort April 1 Total Survival in the third trimester 2021QI "" 16 Cuenca Total Cohort April 1 Total Survival in the third trimester 2020QIV 4.103 16 Cuenca Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca Total Cohort April 1 Total Survival in the third trimester 2020QII "" 16 Cuenca Total Cohort April 1 Total Survival in the third trimester 2020QI "" 16 Cuenca Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca Total Cohort April 1 Total Survival in the third trimester 2022QII "" 16 Cuenca Total Cohort April 1 Total Survival in the third trimester 2022QI 4.054 16 Cuenca Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca Total Cohort April 1 Total Survival in the third trimester 2021QII "" 16 Cuenca Total Cohort April 1 Total Survival in the third trimester 2021QI 3.948 16 Cuenca Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca Total Cohort April 1 Total Survival in the third trimester 2020QII "" 16 Cuenca Total Cohort April 1 Total Survival in the third trimester 2020QI "" 16 Cuenca Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 16 Cuenca Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 16 Cuenca Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 16 Cuenca Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,34 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,16 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,82 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,49 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,52 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,69 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,45 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 88,99 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,8 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 85,69 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 86,41 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 4.754 16 Cuenca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 4.507 16 Cuenca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 4.189 16 Cuenca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 4.490 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 4.285 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 4.004 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 4.304 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 4.119 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 3.866 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 4.160 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 4.000 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 3.741 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 3.847 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 3.590 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 16 Cuenca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 16 Cuenca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 16 Cuenca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,45 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,07 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,58 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,53 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,39 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,29 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,51 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 88,75 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 89,31 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 85,36 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 85,7 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 106 16 Cuenca Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 224 16 Cuenca Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 380 16 Cuenca Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 95 16 Cuenca Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 217 16 Cuenca Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 374 16 Cuenca Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 94 16 Cuenca Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 211 16 Cuenca Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 369 16 Cuenca Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 90 16 Cuenca Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 210 16 Cuenca Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 362 16 Cuenca Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 207 16 Cuenca Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 358 16 Cuenca Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 16 Cuenca Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 16 Cuenca Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 16 Cuenca Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 89,62 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,88 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,42 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 88,68 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,2 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,11 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 84,91 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,75 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,26 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 92,41 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,21 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca Total Cohort July 1 Total Number at the start of the quarter 2022QIII 4.908 16 Cuenca Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca Total Cohort July 1 Total Number at the start of the quarter 2021QIII 4.894 16 Cuenca Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca Total Cohort July 1 Total Number at the start of the quarter 2020QIII 4.756 16 Cuenca Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 16 Cuenca Total Cohort July 1 Total Survival in the first trimester 2022QIII 4.597 16 Cuenca Total Cohort July 1 Total Survival in the first trimester 2022QII "" 16 Cuenca Total Cohort July 1 Total Survival in the first trimester 2022QI "" 16 Cuenca Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 16 Cuenca Total Cohort July 1 Total Survival in the first trimester 2021QIII 4.579 16 Cuenca Total Cohort July 1 Total Survival in the first trimester 2021QII "" 16 Cuenca Total Cohort July 1 Total Survival in the first trimester 2021QI "" 16 Cuenca Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 16 Cuenca Total Cohort July 1 Total Survival in the first trimester 2020QIII 4.495 16 Cuenca Total Cohort July 1 Total Survival in the first trimester 2020QII "" 16 Cuenca Total Cohort July 1 Total Survival in the first trimester 2020QI "" 16 Cuenca Total Cohort July 1 Total Survival in the second trimester 2022QIV 4.410 16 Cuenca Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 16 Cuenca Total Cohort July 1 Total Survival in the second trimester 2022QII "" 16 Cuenca Total Cohort July 1 Total Survival in the second trimester 2022QI "" 16 Cuenca Total Cohort July 1 Total Survival in the second trimester 2021QIV 4.408 16 Cuenca Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 16 Cuenca Total Cohort July 1 Total Survival in the second trimester 2021QII "" 16 Cuenca Total Cohort July 1 Total Survival in the second trimester 2021QI "" 16 Cuenca Total Cohort July 1 Total Survival in the second trimester 2020QIV 4.300 16 Cuenca Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 16 Cuenca Total Cohort July 1 Total Survival in the second trimester 2020QII "" 16 Cuenca Total Cohort July 1 Total Survival in the second trimester 2020QI "" 16 Cuenca Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca Total Cohort July 1 Total Survival in the third trimester 2022QII "" 16 Cuenca Total Cohort July 1 Total Survival in the third trimester 2022QI 4.222 16 Cuenca Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca Total Cohort July 1 Total Survival in the third trimester 2021QII "" 16 Cuenca Total Cohort July 1 Total Survival in the third trimester 2021QI 4.123 16 Cuenca Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca Total Cohort July 1 Total Survival in the third trimester 2020QII "" 16 Cuenca Total Cohort July 1 Total Survival in the third trimester 2020QI "" 16 Cuenca Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca Total Cohort July 1 Total Survival in the third trimester 2022QII 4.085 16 Cuenca Total Cohort July 1 Total Survival in the third trimester 2022QI "" 16 Cuenca Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca Total Cohort July 1 Total Survival in the third trimester 2021QII 4.026 16 Cuenca Total Cohort July 1 Total Survival in the third trimester 2021QI "" 16 Cuenca Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca Total Cohort July 1 Total Survival in the third trimester 2020QII "" 16 Cuenca Total Cohort July 1 Total Survival in the third trimester 2020QI "" 16 Cuenca Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 16 Cuenca Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 16 Cuenca Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 16 Cuenca Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,66 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,56 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,51 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,85 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,07 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,41 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 86,27 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,69 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 83,47 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,65 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 4.876 16 Cuenca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 4.812 16 Cuenca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 4.500 16 Cuenca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 4.566 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 4.499 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 4.244 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 4.380 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 4.328 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 4.053 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 4.144 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 3.880 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 4.014 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 3.788 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 16 Cuenca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 16 Cuenca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 16 Cuenca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,64 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,5 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,31 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,83 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,94 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,07 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 86,12 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,22 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 83,42 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 84,18 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 32 16 Cuenca Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 82 16 Cuenca Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 256 16 Cuenca Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 31 16 Cuenca Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 80 16 Cuenca Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 251 16 Cuenca Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 30 16 Cuenca Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 80 16 Cuenca Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 247 16 Cuenca Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 78 16 Cuenca Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 243 16 Cuenca Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 71 16 Cuenca Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 238 16 Cuenca Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 16 Cuenca Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 16 Cuenca Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 16 Cuenca Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,88 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,56 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,05 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,75 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,56 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,48 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,12 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,92 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 86,59 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,97 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca Total Cohort October 1 Total Number at the start of the quarter 2022QIV 4.827 16 Cuenca Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca Total Cohort October 1 Total Number at the start of the quarter 2021QIV 4.853 16 Cuenca Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca Total Cohort October 1 Total Number at the start of the quarter 2020QIV 4.782 16 Cuenca Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca Total Cohort October 1 Total Survival in the first trimester 2022QIV 4.571 16 Cuenca Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 16 Cuenca Total Cohort October 1 Total Survival in the first trimester 2022QII "" 16 Cuenca Total Cohort October 1 Total Survival in the first trimester 2022QI "" 16 Cuenca Total Cohort October 1 Total Survival in the first trimester 2021QIV 4.605 16 Cuenca Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 16 Cuenca Total Cohort October 1 Total Survival in the first trimester 2021QII "" 16 Cuenca Total Cohort October 1 Total Survival in the first trimester 2021QI "" 16 Cuenca Total Cohort October 1 Total Survival in the first trimester 2020QIV 4.497 16 Cuenca Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 16 Cuenca Total Cohort October 1 Total Survival in the first trimester 2020QII "" 16 Cuenca Total Cohort October 1 Total Survival in the first trimester 2020QI "" 16 Cuenca Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 16 Cuenca Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 16 Cuenca Total Cohort October 1 Total Survival in the second trimester 2022QII "" 16 Cuenca Total Cohort October 1 Total Survival in the second trimester 2022QI 4.391 16 Cuenca Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 16 Cuenca Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 16 Cuenca Total Cohort October 1 Total Survival in the second trimester 2021QII "" 16 Cuenca Total Cohort October 1 Total Survival in the second trimester 2021QI 4.278 16 Cuenca Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 16 Cuenca Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 16 Cuenca Total Cohort October 1 Total Survival in the second trimester 2020QII "" 16 Cuenca Total Cohort October 1 Total Survival in the second trimester 2020QI "" 16 Cuenca Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca Total Cohort October 1 Total Survival in the third trimester 2022QII 4.221 16 Cuenca Total Cohort October 1 Total Survival in the third trimester 2022QI "" 16 Cuenca Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca Total Cohort October 1 Total Survival in the third trimester 2021QII 4.156 16 Cuenca Total Cohort October 1 Total Survival in the third trimester 2021QI "" 16 Cuenca Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca Total Cohort October 1 Total Survival in the third trimester 2020QII "" 16 Cuenca Total Cohort October 1 Total Survival in the third trimester 2020QI "" 16 Cuenca Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca Total Cohort October 1 Total Survival in the third trimester 2022QIII 4.100 16 Cuenca Total Cohort October 1 Total Survival in the third trimester 2022QII "" 16 Cuenca Total Cohort October 1 Total Survival in the third trimester 2022QI "" 16 Cuenca Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca Total Cohort October 1 Total Survival in the third trimester 2021QIII 4.043 16 Cuenca Total Cohort October 1 Total Survival in the third trimester 2021QII "" 16 Cuenca Total Cohort October 1 Total Survival in the third trimester 2021QI "" 16 Cuenca Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca Total Cohort October 1 Total Survival in the third trimester 2020QII "" 16 Cuenca Total Cohort October 1 Total Survival in the third trimester 2020QI "" 16 Cuenca Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 16 Cuenca Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 16 Cuenca Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 16 Cuenca Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,7 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,89 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,04 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,48 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,46 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 86,98 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 86,91 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 84,48 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 84,55 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 4.805 16 Cuenca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 4.745 16 Cuenca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 4.545 16 Cuenca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 4.550 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 4.497 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 4.264 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 4.284 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 4.050 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 4.123 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 3.932 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 4.004 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 3.819 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 16 Cuenca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 16 Cuenca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 16 Cuenca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,69 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,77 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,82 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,28 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,11 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 86,89 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,51 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 84,38 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 84,03 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 22 16 Cuenca Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 108 16 Cuenca Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 237 16 Cuenca Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 21 16 Cuenca Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 108 16 Cuenca Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 233 16 Cuenca Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 107 16 Cuenca Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 228 16 Cuenca Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 98 16 Cuenca Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 224 16 Cuenca Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 96 16 Cuenca Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 224 16 Cuenca Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 16 Cuenca Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 16 Cuenca Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 16 Cuenca Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 95,45 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,31 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 99,07 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,2 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 90,74 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,51 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 88,89 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 94,51 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 3.826 16 Cuenca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 3.773 16 Cuenca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 3.940 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 3.546 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 3.511 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 3.364 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 3.350 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 3.361 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 3.220 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 3.201 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 3.228 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 3.102 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 3.087 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 3.141 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 2.988 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 16 Cuenca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 16 Cuenca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 92,68 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,06 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 85,38 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 87,56 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 89,08 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 81,73 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 83,66 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 85,56 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 78,73 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 80,68 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 83,25 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 75,84 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 3.764 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 3.641 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 3.485 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 3.382 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 3.297 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 3.236 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 3.148 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 3.106 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 3.037 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 3.019 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,59 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 92,89 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 87,59 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 88,88 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 83,63 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 85,31 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 80,69 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 82,92 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 62 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 132 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 61 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 129 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 53 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 125 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 53 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 122 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 50 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 122 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,39 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,73 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 85,48 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,7 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 85,48 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,42 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 80,65 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 92,42 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 3.779 16 Cuenca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 3.741 16 Cuenca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 3.620 16 Cuenca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 3.521 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 3.526 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 3.444 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 3.337 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 3.364 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 3.312 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 3.199 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 3.254 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 3.184 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 3.105 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 3.039 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 16 Cuenca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 16 Cuenca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 16 Cuenca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,17 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,25 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,14 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 88,3 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 89,92 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,49 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 84,65 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 86,98 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 87,96 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 83 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 83,95 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 3.713 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 3.608 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 3.439 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 3.466 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 3.397 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 3.269 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 3.283 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 3.240 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 3.139 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 3.149 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 3.130 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 3.017 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.984 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.875 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,35 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,15 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,06 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 88,42 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,8 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,28 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 84,81 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 86,75 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 87,73 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 82,71 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 83,6 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 66 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 133 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 181 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 55 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 129 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 175 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 54 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 124 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 173 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 50 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 124 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 167 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 121 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 164 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 83,33 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,99 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 96,69 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 81,82 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,23 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,58 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 75,76 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,23 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 92,27 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 90,98 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 90,61 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 3.810 16 Cuenca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 3.862 16 Cuenca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 3.776 16 Cuenca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 3.507 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 3.561 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 3.527 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 3.333 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 3.403 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 3.340 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 3.226 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 3.174 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 3.095 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 3.085 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 16 Cuenca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 16 Cuenca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 16 Cuenca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,05 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,21 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 93,41 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 87,48 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 88,11 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 88,45 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 83,53 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 84,06 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 80,14 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 81,7 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 3.788 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 3.807 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 3.667 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 3.486 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 3.508 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 3.420 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 3.313 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 3.350 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 3.236 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 3.175 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 3.074 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 3.051 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.988 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,03 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,15 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,26 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,46 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 88 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 88,25 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 83,4 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 83,83 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 80,14 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 81,48 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 22 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 55 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 109 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 21 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 53 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 107 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 20 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 53 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 104 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 51 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 100 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 44 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 97 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,45 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,36 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,17 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 90,91 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,36 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,41 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 92,73 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 91,74 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 80 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 88,99 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 3.733 16 Cuenca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 3.821 16 Cuenca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 3.770 16 Cuenca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 3.491 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 3.585 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 3.498 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 3.384 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 3.289 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 3.226 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 3.174 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 3.109 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 3.069 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 16 Cuenca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 16 Cuenca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 16 Cuenca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,52 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,82 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 92,79 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,56 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 87,24 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 84,43 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 84,19 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 81,37 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 81,41 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 3.719 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3.746 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 3.662 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 3.478 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 3.510 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 3.393 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 3.310 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 3.188 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 3.161 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 3.076 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 3.046 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.971 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,52 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 93,7 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,65 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,36 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 87,06 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 84,38 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 84 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 81,31 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 81,13 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 14 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 75 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 108 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 13 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 75 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 105 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 74 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 101 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 65 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 98 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 63 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 98 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 92,86 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,22 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,67 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 93,52 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 86,67 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 90,74 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 84 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 90,74 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 454 16 Cuenca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 418 16 Cuenca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 439 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 448 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 412 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 428 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 441 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 408 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 419 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 439 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 403 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 415 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 434 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 401 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 413 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 16 Cuenca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 16 Cuenca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,68 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,56 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,49 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,14 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,61 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,44 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,7 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,41 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,53 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,59 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,93 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,08 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 446 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 370 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 440 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 365 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 433 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 362 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 431 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 357 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 426 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 355 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,65 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,65 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,09 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,84 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,64 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,49 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,52 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,95 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 8 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 48 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 8 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 47 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 8 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 46 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 8 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 46 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 8 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 46 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,92 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,83 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,83 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,83 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 463 16 Cuenca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 423 16 Cuenca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 409 16 Cuenca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 458 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 420 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 402 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 457 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 415 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 396 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 450 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 413 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 393 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 410 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 387 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 16 Cuenca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 16 Cuenca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 16 Cuenca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,92 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,29 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,29 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,7 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,11 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 96,82 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,19 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,64 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,09 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,93 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,62 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 448 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 393 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 337 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 443 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 390 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 330 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 442 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 386 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 324 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 435 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 384 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 322 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 381 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 316 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,88 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,24 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 97,92 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,66 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,22 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 96,14 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,1 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,71 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,55 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,95 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 93,77 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 15 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 30 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 72 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 15 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 30 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 72 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 15 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 29 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 72 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 15 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 29 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 71 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 29 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 71 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,67 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,67 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,61 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,67 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,61 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 462 16 Cuenca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 443 16 Cuenca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 423 16 Cuenca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 457 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 434 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 417 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 450 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 430 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 412 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 425 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 405 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 423 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 400 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 16 Cuenca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 16 Cuenca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 16 Cuenca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,92 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 97,97 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,58 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,4 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,07 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,4 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,94 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,74 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,49 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 94,56 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 458 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 431 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 370 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 453 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 422 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 364 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 446 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 418 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 360 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 413 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 353 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 411 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 349 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,91 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 97,91 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,38 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,38 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 96,98 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,3 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,82 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,41 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,36 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,32 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 4 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 12 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 53 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 4 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 12 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 53 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 4 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 12 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 52 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 12 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 52 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 12 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 51 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,11 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,11 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,23 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 450 16 Cuenca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 429 16 Cuenca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 442 16 Cuenca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 444 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 424 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 435 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 417 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 430 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 413 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 428 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 411 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 425 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 16 Cuenca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 16 Cuenca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 16 Cuenca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,67 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,83 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,42 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,2 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,29 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,27 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,83 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,8 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,15 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 447 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 414 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 397 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 441 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 409 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 391 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 402 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 387 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 398 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 385 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 396 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 382 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,66 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,79 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,49 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,1 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,48 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,14 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,98 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,65 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,22 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 3 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 15 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 45 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 3 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 15 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 44 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 15 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 43 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 15 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 43 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 15 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 43 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,78 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,56 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,56 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 95,56 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 580 16 Cuenca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 524 16 Cuenca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 580 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 576 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 520 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 560 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 564 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 513 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 552 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 561 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 508 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 545 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 558 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 502 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 542 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 16 Cuenca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 16 Cuenca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,31 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,24 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,55 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,24 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,9 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,17 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,72 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,95 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 93,97 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,21 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,8 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 93,45 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 554 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 454 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 550 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 450 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 538 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 445 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 535 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 441 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 532 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 436 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,28 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,12 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,11 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,02 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,57 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,14 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,03 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,04 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 26 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 70 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 26 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 70 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 26 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 68 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 26 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 67 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 26 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 66 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,14 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,71 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 94,29 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 591 16 Cuenca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 539 16 Cuenca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 514 16 Cuenca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 579 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 528 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 506 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 577 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 523 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 501 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 574 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 515 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 500 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 511 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 496 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 16 Cuenca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 16 Cuenca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 16 Cuenca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,97 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 97,96 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,44 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,63 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,03 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,47 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,12 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,55 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,28 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,81 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,5 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 569 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 486 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 391 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 557 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 478 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 383 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 555 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 473 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 381 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 552 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 466 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 380 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 462 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 377 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,89 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,35 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 97,95 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,54 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,33 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,44 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,01 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,88 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,19 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,06 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,42 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 22 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 53 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 123 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 22 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 50 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 123 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 22 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 50 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 120 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 22 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 49 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 120 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 49 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 119 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 94,34 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,34 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,56 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 92,45 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,56 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 92,45 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,75 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 607 16 Cuenca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 561 16 Cuenca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 532 16 Cuenca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 604 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 556 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 526 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 598 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 547 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 523 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 543 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 519 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 539 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 516 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 16 Cuenca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 16 Cuenca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 16 Cuenca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,51 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,11 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,87 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,52 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,5 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,31 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,79 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,56 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,08 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,99 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 601 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 548 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 443 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 598 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 543 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 440 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 592 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 534 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 437 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 530 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 433 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 526 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 431 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,5 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,09 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,32 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,5 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,45 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,65 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,72 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,74 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,99 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,29 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 6 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 13 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 89 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 6 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 13 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 86 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 6 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 13 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 86 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 13 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 86 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 13 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 85 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,63 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,63 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,63 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,51 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 615 16 Cuenca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 575 16 Cuenca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 541 16 Cuenca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 607 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 568 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 535 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 562 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 530 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 554 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 525 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 552 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 520 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 16 Cuenca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 16 Cuenca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 16 Cuenca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,7 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,78 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,89 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,74 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,97 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,35 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,04 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,12 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 610 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 558 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 464 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 602 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 551 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 458 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 545 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 453 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 537 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 449 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 535 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 444 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,69 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,75 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,71 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,67 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,63 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,24 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,77 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,88 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,69 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 5 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 17 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 77 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 5 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 17 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 77 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 17 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 77 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 17 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 76 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 17 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 76 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,7 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,7 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 21 16 Cuenca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 22 16 Cuenca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 21 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 21 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 22 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 21 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 21 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 22 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 21 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 21 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 22 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 21 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 21 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 22 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 21 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 16 Cuenca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 16 Cuenca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 20 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 16 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 20 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 16 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 20 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 16 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 20 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 16 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 20 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 16 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 6 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 6 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 6 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 6 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 6 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 20 16 Cuenca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 22 16 Cuenca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 19 16 Cuenca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 20 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 22 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 19 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 20 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 22 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 19 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 20 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 22 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 19 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 22 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 19 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 16 Cuenca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 16 Cuenca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 16 Cuenca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 19 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 16 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 17 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 19 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 16 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 17 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 19 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 16 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 17 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 19 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 16 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 17 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 16 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 17 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 6 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 6 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 6 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 6 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 6 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 23 16 Cuenca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 23 16 Cuenca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 19 16 Cuenca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 23 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 23 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 19 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 23 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 23 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 19 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 23 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 19 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 23 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 19 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 16 Cuenca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 16 Cuenca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 16 Cuenca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 23 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 21 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 15 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 23 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 21 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 15 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 23 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 21 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 15 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 21 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 15 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 21 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 15 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 2 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 4 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 2 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 4 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 2 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 4 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 2 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 4 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 2 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 4 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII .. 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII .. 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 22 16 Cuenca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 21 16 Cuenca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 22 16 Cuenca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 22 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 21 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 22 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 21 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 22 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 21 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 22 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 21 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 22 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 16 Cuenca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 16 Cuenca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 16 Cuenca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 22 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 21 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 17 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 22 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 21 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 17 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 21 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 17 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 21 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 17 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 21 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 17 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 0 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 5 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 0 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 5 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 0 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 5 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 0 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 5 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 0 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 5 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV .. 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV .. 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI .. 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII .. 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII .. 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 7 16 Cuenca De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 6 16 Cuenca De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 7 16 Cuenca De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 7 16 Cuenca De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 6 16 Cuenca De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 7 16 Cuenca De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 7 16 Cuenca De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 6 16 Cuenca De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 7 16 Cuenca De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 7 16 Cuenca De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 6 16 Cuenca De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 7 16 Cuenca De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 7 16 Cuenca De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 6 16 Cuenca De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 7 16 Cuenca De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 16 Cuenca De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 16 Cuenca De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 5 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 4 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 5 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 4 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 5 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 4 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 5 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 4 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 5 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 4 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2 16 Cuenca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2 16 Cuenca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 16 Cuenca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 16 Cuenca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 7 16 Cuenca De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 6 16 Cuenca De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 7 16 Cuenca De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 7 16 Cuenca De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 6 16 Cuenca De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 7 16 Cuenca De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 7 16 Cuenca De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 6 16 Cuenca De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 7 16 Cuenca De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 7 16 Cuenca De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 6 16 Cuenca De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 7 16 Cuenca De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 6 16 Cuenca De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 7 16 Cuenca De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 16 Cuenca De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 16 Cuenca De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 16 Cuenca De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 16 Cuenca De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 5 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 4 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 5 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 5 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 4 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 5 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 5 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 4 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 5 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 5 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 4 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 5 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 4 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 5 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 2 16 Cuenca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 2 16 Cuenca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2 16 Cuenca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 2 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 2 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 2 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 2 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 2 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 2 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 2 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 16 Cuenca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 16 Cuenca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 16 Cuenca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 6 16 Cuenca De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 5 16 Cuenca De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 6 16 Cuenca De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 6 16 Cuenca De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 5 16 Cuenca De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 6 16 Cuenca De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 6 16 Cuenca De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 5 16 Cuenca De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 6 16 Cuenca De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 5 16 Cuenca De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 6 16 Cuenca De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 5 16 Cuenca De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 6 16 Cuenca De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 16 Cuenca De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 16 Cuenca De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 16 Cuenca De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 16 Cuenca De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 16 Cuenca De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 16 Cuenca De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 6 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 5 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 5 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 6 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 5 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 5 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 6 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 5 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 5 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 5 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 5 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 5 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 5 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 16 Cuenca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 0 16 Cuenca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1 16 Cuenca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 0 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 0 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 0 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 0 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII .. 16 Cuenca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII .. 16 Cuenca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 16 Cuenca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII .. 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII .. 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV .. 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI .. 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII .. 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 7 16 Cuenca De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 7 16 Cuenca De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 7 16 Cuenca De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 7 16 Cuenca De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 7 16 Cuenca De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 7 16 Cuenca De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 7 16 Cuenca De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 7 16 Cuenca De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 7 16 Cuenca De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 7 16 Cuenca De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 7 16 Cuenca De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 7 16 Cuenca De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 16 Cuenca De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 16 Cuenca De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 16 Cuenca De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 16 Cuenca De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 16 Cuenca De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 16 Cuenca De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 16 Cuenca De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 7 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 6 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 5 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 7 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 6 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 5 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 6 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 5 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 6 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 5 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 6 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 5 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 16 Cuenca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1 16 Cuenca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 2 16 Cuenca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 16 Cuenca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 16 Cuenca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 16 Cuenca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 16 Cuenca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa Total Cohort January 1 Total Number at the start of the quarter 2022QI 18.363 20 Gipuzkoa Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa Total Cohort January 1 Total Number at the start of the quarter 2021QI 18.167 20 Gipuzkoa Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa Total Cohort January 1 Total Number at the start of the quarter 2020QI 18.694 20 Gipuzkoa Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the first trimester 2022QII "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the first trimester 2022QI 17.560 20 Gipuzkoa Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the first trimester 2021QII "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the first trimester 2021QI 17.426 20 Gipuzkoa Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the first trimester 2020QII "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the first trimester 2020QI 17.442 20 Gipuzkoa Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the second trimester 2022QII 16.850 20 Gipuzkoa Total Cohort January 1 Total Survival in the second trimester 2022QI "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the second trimester 2021QII 16.876 20 Gipuzkoa Total Cohort January 1 Total Survival in the second trimester 2021QI "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the second trimester 2020QII 16.953 20 Gipuzkoa Total Cohort January 1 Total Survival in the second trimester 2020QI "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the third trimester 2022QIII 16.395 20 Gipuzkoa Total Cohort January 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the third trimester 2021QIII 16.450 20 Gipuzkoa Total Cohort January 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the third trimester 2020QIII 16.524 20 Gipuzkoa Total Cohort January 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the third trimester 2022QIV 16.040 20 Gipuzkoa Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the third trimester 2021QIV 16.080 20 Gipuzkoa Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the third trimester 2020QIV 16.132 20 Gipuzkoa Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa Total Cohort January 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 20 Gipuzkoa Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 20 Gipuzkoa Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,63 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,92 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 93,3 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 91,76 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 92,89 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 90,69 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 89,28 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 90,55 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 88,39 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 87,35 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 88,51 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 86,3 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 17.514 20 Gipuzkoa Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 15.431 20 Gipuzkoa Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 16.739 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 14.755 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 16.042 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 14.253 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 15.597 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 13.865 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 15.254 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 13.535 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 20 Gipuzkoa Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 20 Gipuzkoa Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 95,57 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 95,62 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 91,6 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 92,37 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 89,05 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 89,85 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 87,1 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 87,71 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 849 20 Gipuzkoa Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2.736 20 Gipuzkoa Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 821 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2.671 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 808 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2.623 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 798 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2.585 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 786 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2.545 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 20 Gipuzkoa Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 20 Gipuzkoa Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,7 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,62 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 95,17 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,87 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 93,99 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,48 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 92,58 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 93,02 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa Total Cohort April 1 Total Number at the start of the quarter 2022QII 18.309 20 Gipuzkoa Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa Total Cohort April 1 Total Number at the start of the quarter 2021QII 18.076 20 Gipuzkoa Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa Total Cohort April 1 Total Number at the start of the quarter 2020QII 18.087 20 Gipuzkoa Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the first trimester 2022QII 17.462 20 Gipuzkoa Total Cohort April 1 Total Survival in the first trimester 2022QI "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the first trimester 2021QII 17.428 20 Gipuzkoa Total Cohort April 1 Total Survival in the first trimester 2021QI "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the first trimester 2020QII 17.518 20 Gipuzkoa Total Cohort April 1 Total Survival in the first trimester 2020QI "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the second trimester 2022QIII 16.915 20 Gipuzkoa Total Cohort April 1 Total Survival in the second trimester 2022QII "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the second trimester 2022QI "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the second trimester 2021QIII 16.923 20 Gipuzkoa Total Cohort April 1 Total Survival in the second trimester 2021QII "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the second trimester 2021QI "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the second trimester 2020QIII 17.030 20 Gipuzkoa Total Cohort April 1 Total Survival in the second trimester 2020QII "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the second trimester 2020QI "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the third trimester 2022QIV 16.494 20 Gipuzkoa Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the third trimester 2021QIV 16.486 20 Gipuzkoa Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the third trimester 2020QIV 16.592 20 Gipuzkoa Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the third trimester 2022QI 15.975 20 Gipuzkoa Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the third trimester 2021QI 16.081 20 Gipuzkoa Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa Total Cohort April 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 20 Gipuzkoa Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 20 Gipuzkoa Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 20 Gipuzkoa Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,37 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,42 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,85 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 92,39 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 93,62 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 94,16 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 90,09 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 91,2 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 91,73 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 88,38 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 88,91 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 17.473 20 Gipuzkoa Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 15.283 20 Gipuzkoa Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 13.865 20 Gipuzkoa Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 16.643 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 14.685 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 13.358 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 16.108 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 14.221 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 12.957 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 15.703 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 13.827 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 12.622 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 13.376 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 12.230 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 20 Gipuzkoa Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 20 Gipuzkoa Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 20 Gipuzkoa Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,25 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 96,09 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 96,34 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 92,19 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 93,05 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 93,45 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 89,87 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 90,47 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 91,03 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 87,52 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 88,21 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 836 20 Gipuzkoa Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 2.793 20 Gipuzkoa Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 4.222 20 Gipuzkoa Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 819 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 2.743 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 4.160 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 807 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 2.702 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 4.073 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 791 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 2.659 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 3.970 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 2.599 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 3.851 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 20 Gipuzkoa Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 20 Gipuzkoa Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 20 Gipuzkoa Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,97 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,21 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,53 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 96,53 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,74 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,47 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 94,62 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 95,2 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 94,03 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 93,05 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,21 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa Total Cohort July 1 Total Number at the start of the quarter 2022QIII 18.249 20 Gipuzkoa Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa Total Cohort July 1 Total Number at the start of the quarter 2021QIII 18.263 20 Gipuzkoa Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa Total Cohort July 1 Total Number at the start of the quarter 2020QIII 18.122 20 Gipuzkoa Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the first trimester 2022QIII 17.494 20 Gipuzkoa Total Cohort July 1 Total Survival in the first trimester 2022QII "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the first trimester 2022QI "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the first trimester 2021QIII 17.549 20 Gipuzkoa Total Cohort July 1 Total Survival in the first trimester 2021QII "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the first trimester 2021QI "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the first trimester 2020QIII 17.477 20 Gipuzkoa Total Cohort July 1 Total Survival in the first trimester 2020QII "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the first trimester 2020QI "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the second trimester 2022QIV 16.960 20 Gipuzkoa Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the second trimester 2022QII "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the second trimester 2022QI "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the second trimester 2021QIV 17.016 20 Gipuzkoa Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the second trimester 2021QII "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the second trimester 2021QI "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the second trimester 2020QIV 16.944 20 Gipuzkoa Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the second trimester 2020QII "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the second trimester 2020QI "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the third trimester 2022QI 16.439 20 Gipuzkoa Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the third trimester 2021QI 16.396 20 Gipuzkoa Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the third trimester 2022QII 16.015 20 Gipuzkoa Total Cohort July 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the third trimester 2021QII 16.061 20 Gipuzkoa Total Cohort July 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa Total Cohort July 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 20 Gipuzkoa Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 20 Gipuzkoa Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 20 Gipuzkoa Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 95,86 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 96,09 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 96,44 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 92,94 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 93,17 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 93,5 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 90,01 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 90,48 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 87,69 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 88,63 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 17.506 20 Gipuzkoa Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 17.501 20 Gipuzkoa Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 15.165 20 Gipuzkoa Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 16.762 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 16.803 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 14.574 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 16.242 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 16.284 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 14.106 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 15.724 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 13.636 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 15.312 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 13.346 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 20 Gipuzkoa Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 20 Gipuzkoa Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 20 Gipuzkoa Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 95,75 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 96,01 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 96,1 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 92,78 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 93,05 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 93,02 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 89,85 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 89,92 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 87,49 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 88,01 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 743 20 Gipuzkoa Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 762 20 Gipuzkoa Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2.957 20 Gipuzkoa Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 732 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 746 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2.903 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 718 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 732 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 2.838 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 715 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2.760 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 703 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 2.715 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 20 Gipuzkoa Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 20 Gipuzkoa Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 20 Gipuzkoa Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,52 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,9 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,17 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 96,64 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,06 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,98 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93,83 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,34 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 92,26 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,82 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa Total Cohort October 1 Total Number at the start of the quarter 2022QIV 18.142 20 Gipuzkoa Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa Total Cohort October 1 Total Number at the start of the quarter 2021QIV 18.237 20 Gipuzkoa Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa Total Cohort October 1 Total Number at the start of the quarter 2020QIV 18.182 20 Gipuzkoa Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the first trimester 2022QIV 17.492 20 Gipuzkoa Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the first trimester 2022QII "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the first trimester 2022QI "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the first trimester 2021QIV 17.590 20 Gipuzkoa Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the first trimester 2021QII "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the first trimester 2021QI "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the first trimester 2020QIV 17.510 20 Gipuzkoa Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the first trimester 2020QII "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the first trimester 2020QI "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the second trimester 2022QII "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the second trimester 2022QI 16.954 20 Gipuzkoa Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the second trimester 2021QII "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the second trimester 2021QI 16.898 20 Gipuzkoa Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the second trimester 2020QII "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the second trimester 2020QI "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the third trimester 2022QII 16.388 20 Gipuzkoa Total Cohort October 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the third trimester 2021QII 16.463 20 Gipuzkoa Total Cohort October 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the third trimester 2022QIII 15.987 20 Gipuzkoa Total Cohort October 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the third trimester 2021QIII 16.086 20 Gipuzkoa Total Cohort October 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa Total Cohort October 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 20 Gipuzkoa Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 20 Gipuzkoa Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 20 Gipuzkoa Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 96,42 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 96,45 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 96,3 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 92,96 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 92,94 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 89,86 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 90,55 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 87,66 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 88,47 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 17.445 20 Gipuzkoa Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 17.343 20 Gipuzkoa Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 15.167 20 Gipuzkoa Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 16.808 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 16.711 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 14.556 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 16.095 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 14.015 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 15.546 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 13.623 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 15.167 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 13.291 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 20 Gipuzkoa Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 20 Gipuzkoa Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 20 Gipuzkoa Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 96,35 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 96,36 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 95,97 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 92,8 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 92,4 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 89,64 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 89,82 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 87,45 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 87,63 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 697 20 Gipuzkoa Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 894 20 Gipuzkoa Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 3.015 20 Gipuzkoa Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 684 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 879 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2.954 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 859 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2.883 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 842 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2.840 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 820 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2.795 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 20 Gipuzkoa Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 20 Gipuzkoa Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 20 Gipuzkoa Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,13 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,32 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,98 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 96,09 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,62 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 94,18 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,2 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 91,72 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 92,7 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 12.918 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 12.941 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 13.145 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 12.175 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 12.246 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 11.975 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 11.529 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 11.752 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 11.536 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 11.108 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 11.366 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 11.145 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 10.788 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 11.033 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 10.800 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,25 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,63 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 91,1 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,25 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,81 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 87,76 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 85,99 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,83 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 84,79 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 83,51 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,26 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 82,16 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 12.430 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 11.538 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 11.714 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 10.900 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 11.079 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 10.443 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 10.668 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 10.089 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 10.357 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 9.788 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,24 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,47 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,13 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,51 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 85,82 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,44 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 83,32 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 84,83 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 488 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.403 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 461 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.346 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 450 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.309 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 440 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.277 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 431 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.245 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,47 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,94 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,21 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 93,3 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,16 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 91,02 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,32 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 88,74 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 12.812 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 12.824 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 12.753 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 12.021 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 12.230 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 12.225 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 11.504 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 11.763 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 11.770 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 11.122 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 11.375 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 11.380 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 10.923 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 10.932 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,83 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,37 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,86 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,79 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,73 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,29 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 86,81 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 88,7 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,23 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 85,18 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,72 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 12.353 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 11.428 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 10.199 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 11.576 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 10.874 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 9.720 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 11.071 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 10.441 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 9.343 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 10.702 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 10.085 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 9.037 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 9.677 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 8.685 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,71 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,15 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,3 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 89,62 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,36 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,61 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 86,63 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 88,25 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,61 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 84,68 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 85,16 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 459 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.396 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.554 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 445 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.356 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.505 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 433 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.322 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.427 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 420 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.290 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.343 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.246 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.247 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,95 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,13 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,08 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,34 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,7 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,03 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,5 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 92,41 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,74 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 89,26 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 87,98 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 12.651 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 12.846 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 12.822 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 11.940 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 12.168 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 12.220 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 11.460 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 11.699 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 11.735 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 11.189 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 11.246 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 10.790 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 10.952 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,38 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,72 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,3 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 90,59 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 91,07 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 91,52 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 87,1 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 87,71 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 84 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 85,42 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 12.265 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 12.448 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 11.232 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 11.565 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 11.785 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 10.679 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 11.096 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 11.327 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 10.247 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 10.829 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 9.818 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 10.442 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 9.552 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,29 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,67 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,08 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 90,47 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 90,99 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 91,23 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 86,99 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 87,41 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 83,88 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 85,04 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 386 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 398 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.590 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 375 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 383 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.541 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 364 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 372 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.488 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 360 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.428 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 348 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.400 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,15 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,23 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,92 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,3 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,47 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,58 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 90,45 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 89,81 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 87,44 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 88,05 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 12.632 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 12.844 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 12.862 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 12.028 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 12.251 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 12.238 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 11.680 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 11.682 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 11.156 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 11.295 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 10.787 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 10.957 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,22 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,38 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 95,15 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,94 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,83 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 86,86 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 87,82 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 83,98 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 85,19 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 12.274 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 12.324 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 11.384 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 11.680 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 11.746 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 10.812 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 11.192 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 10.312 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 10.684 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 9.955 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 10.337 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 9.653 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95,16 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,31 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,98 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,81 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 90,58 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 86,69 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 87,45 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 83,88 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 84,79 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 358 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 520 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.478 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 348 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 505 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.426 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 488 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.370 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 472 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.340 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 450 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.304 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,21 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,12 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,48 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,85 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 92,69 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 90,77 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 90,66 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 86,54 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 88,23 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 2.090 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 1.997 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 2.108 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 2.058 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 1.973 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 2.061 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 2.018 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 1.942 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 2.034 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 2.001 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 1.916 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 2.013 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 1.984 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 1.904 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 1.993 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,47 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,8 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,77 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,56 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,25 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,49 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 95,74 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,94 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,49 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 94,93 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,34 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,54 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.978 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.575 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.946 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.554 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.907 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.528 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.890 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.506 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.874 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.495 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,38 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,67 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,41 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,02 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,55 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,62 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 94,74 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,92 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 112 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 422 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 112 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 419 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 111 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 414 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 111 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 410 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 110 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 409 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,29 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 99,11 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,1 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 99,11 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,16 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 98,21 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,92 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 2.080 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 2.005 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 2.007 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 2.049 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 1.977 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 1.984 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 2.035 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 1.960 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 1.968 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 2.015 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 1.936 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 1.945 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 1.900 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 1.912 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,51 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,6 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,85 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,84 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,76 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,06 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,88 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,56 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,91 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,76 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,27 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.974 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.549 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.356 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.944 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.525 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.339 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.930 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.512 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.329 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.911 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.493 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.317 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.466 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.298 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,48 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,45 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,75 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,77 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,61 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,01 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,81 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,38 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,12 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 94,64 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,72 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 106 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 456 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 651 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 105 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 452 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 645 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 105 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 448 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 639 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 104 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 443 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 628 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 434 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 614 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,06 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,12 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,08 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 99,06 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,25 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,16 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 98,11 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,15 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,47 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 95,18 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,32 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 2.074 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 2.091 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 2.008 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 2.050 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 2.071 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 1.987 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 2.022 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 2.039 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 1.964 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 1.995 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 1.933 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 1.980 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 1.912 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,84 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,04 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,95 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,49 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,51 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,81 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,41 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,26 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 94,69 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,22 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.976 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.989 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.554 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.952 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.969 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.535 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.925 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.939 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.518 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.898 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.496 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.883 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.486 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,79 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,99 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,78 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,42 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,49 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,68 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,42 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,27 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,67 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,62 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 98 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 102 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 454 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 98 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 102 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 452 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 97 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 100 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 446 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 97 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 437 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 97 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 426 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,56 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,98 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,04 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,24 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,1 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,26 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 95,1 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 93,83 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 2.050 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 2.072 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 2.029 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 2.023 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 2.039 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 2.003 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 2.000 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 1.976 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 1.977 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 1.955 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 1.959 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 1.934 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,68 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,41 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,72 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,53 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,39 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95,42 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,35 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 94,55 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,32 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.961 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.954 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.559 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.936 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.921 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.538 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.883 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.520 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.860 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.504 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.842 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.487 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,73 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,31 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,65 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,37 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,5 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,19 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,47 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 94,27 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,38 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 89 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 118 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 470 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 87 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 118 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 465 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 117 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 456 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 117 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 451 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 117 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 447 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,75 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,94 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 99,15 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,02 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 99,15 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,96 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 99,15 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 95,11 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 3.105 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 2.988 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 3.183 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 3.077 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 2.967 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 3.150 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 3.053 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 2.942 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 3.128 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 3.036 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 2.929 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 3.113 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 3.019 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 2.907 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 3.087 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,1 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,3 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,96 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,33 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,46 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,27 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,78 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,03 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,8 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,23 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,29 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,98 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.886 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.157 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.859 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2.141 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.836 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.122 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.819 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.111 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.804 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2.096 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,06 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,26 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,27 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,38 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,68 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,87 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,16 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,17 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 219 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 831 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 218 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 826 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 217 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 820 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 217 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 818 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 215 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 811 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,54 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,4 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 99,09 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,68 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 99,09 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,44 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 98,17 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,59 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 3.162 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 3.008 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 3.082 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 3.137 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 2.982 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 3.065 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 3.121 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 2.962 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 3.050 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 3.103 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 2.939 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 3.026 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 2.916 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 2.997 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,21 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,14 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,45 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,7 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,47 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,96 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,13 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,71 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,18 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,94 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,24 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.920 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.149 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2.132 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.897 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.129 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2.121 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.881 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.112 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2.108 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.864 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.095 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.092 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.079 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.072 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,21 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,07 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,48 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,66 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,28 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,87 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,08 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,49 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,12 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,74 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,19 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 242 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 859 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 950 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 240 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 853 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 944 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 240 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 850 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 942 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 239 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 844 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 934 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 837 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 925 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,17 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,3 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,37 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 99,17 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,95 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,16 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 98,76 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,25 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,32 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,44 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 97,37 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 3.277 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 3.087 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 3.057 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 3.257 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 3.072 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 3.037 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 3.231 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 3.043 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 3.013 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 3.020 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 2.986 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 3.010 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 2.966 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,39 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,51 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,35 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,6 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,57 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,56 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,83 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,68 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,51 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,02 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 3.044 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.851 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2.221 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 3.024 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.837 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.203 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 3.000 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.809 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.185 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.788 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.167 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.778 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.153 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,34 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,51 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,19 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,55 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,53 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,38 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,79 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,57 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,44 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,94 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 233 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 236 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 836 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 233 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 235 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 834 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 231 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 234 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 828 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 232 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 819 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 232 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 813 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,58 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,76 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 99,14 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,15 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,04 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 98,31 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,97 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 98,31 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,25 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 3.210 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 3.073 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 3.053 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 3.192 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 3.055 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 3.032 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 3.030 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 3.004 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 3.011 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 2.977 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 2.997 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 2.960 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,44 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,41 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,31 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,6 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,4 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,98 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,51 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,53 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,95 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.986 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.842 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2.071 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.968 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.824 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2.054 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.801 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.032 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.783 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2.013 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.769 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.001 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,4 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,37 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,18 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,56 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,12 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,92 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,2 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,43 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,62 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 224 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 231 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 982 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 224 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 231 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 978 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 229 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 972 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 228 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 964 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 228 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 959 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,59 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 99,13 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,98 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 98,7 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,17 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 98,7 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 97,66 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 181 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 172 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 185 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 181 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 171 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 183 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 181 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 171 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 182 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 181 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 171 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 180 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 180 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 168 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 180 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,42 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,92 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 99,42 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,38 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 99,42 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,3 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 99,45 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,67 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,3 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 158 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 116 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 158 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 115 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 158 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 115 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 158 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 115 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 157 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 112 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,14 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 99,14 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 99,14 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 99,37 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,55 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 23 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 56 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 23 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 56 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 23 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 56 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 23 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 56 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 23 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 56 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 182 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 173 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 176 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 182 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 173 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 175 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 182 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 173 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 173 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 181 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 171 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 173 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 171 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 172 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,43 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,3 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 99,45 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,84 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,3 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,84 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,73 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 160 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 114 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 132 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 160 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 114 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 132 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 160 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 114 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 131 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 160 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 112 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 131 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 112 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 130 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,24 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98,25 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 99,24 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 98,25 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 98,48 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 22 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 59 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 44 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 22 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 59 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 43 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 22 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 59 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 42 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 21 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 59 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 42 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 59 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 42 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,73 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,45 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 95,45 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,45 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,45 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 170 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 170 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 173 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 170 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 170 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 171 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 170 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 167 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 171 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 167 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 170 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 167 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 170 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,84 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,24 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,84 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,24 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,27 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,24 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,27 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 151 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 151 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 118 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 151 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 151 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 117 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 151 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 148 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 117 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 148 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 116 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 148 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 116 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,15 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,01 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 99,15 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,01 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,31 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,01 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 98,31 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 19 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 19 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 55 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 19 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 19 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 54 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 19 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 19 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 54 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 19 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 54 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 19 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 54 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,18 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,18 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,18 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,18 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 175 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 180 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 172 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 174 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 177 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 172 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 176 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 171 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 176 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 171 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 176 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 170 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,43 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,33 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,78 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 99,42 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,78 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 99,42 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,78 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,84 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 156 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 161 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 110 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 156 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 158 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 110 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 157 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 109 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 157 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 109 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 157 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 108 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,14 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,52 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 99,09 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,52 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 99,09 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,52 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,18 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 19 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 19 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 62 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 18 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 19 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 62 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 19 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 62 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 19 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 62 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 19 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 62 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 94,74 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 69 20 Gipuzkoa De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 69 20 Gipuzkoa De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 73 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 69 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 69 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 73 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 69 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 69 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 73 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 69 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 68 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 73 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 69 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 68 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 72 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 20 Gipuzkoa De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 20 Gipuzkoa De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,55 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,55 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,63 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 62 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 45 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 62 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 45 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 62 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 45 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 62 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 44 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 62 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 44 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,78 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,78 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 7 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 24 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 7 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 24 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 7 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 24 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 7 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 24 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 7 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 24 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 73 20 Gipuzkoa De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 66 20 Gipuzkoa De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 69 20 Gipuzkoa De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 73 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 66 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 69 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 73 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 65 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 69 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 73 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 65 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 68 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 65 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 68 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 20 Gipuzkoa De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 20 Gipuzkoa De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 20 Gipuzkoa De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,48 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,48 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,55 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,48 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,55 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 66 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 43 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 46 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 66 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 43 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 46 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 66 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 42 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 46 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 66 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 42 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 45 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 42 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 45 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,67 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,67 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,83 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,67 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,83 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 7 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 23 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 23 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 7 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 23 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 23 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 7 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 23 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 23 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 7 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 23 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 23 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 23 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 23 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 77 20 Gipuzkoa De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 69 20 Gipuzkoa De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 62 20 Gipuzkoa De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 77 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 68 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 62 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 77 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 68 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 61 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 68 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 61 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 68 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 61 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 20 Gipuzkoa De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 20 Gipuzkoa De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 20 Gipuzkoa De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,55 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,55 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,39 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,55 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,39 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,55 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,39 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 70 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 62 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 40 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 70 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 61 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 40 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 70 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 61 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 39 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 61 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 39 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 61 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 39 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,39 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,39 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,5 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,39 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,5 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,39 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,5 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 7 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 7 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 22 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 7 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 7 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 22 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 7 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 7 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 22 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 7 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 22 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 7 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 22 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 75 20 Gipuzkoa De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 68 20 Gipuzkoa De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 66 20 Gipuzkoa De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 75 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 68 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 65 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 68 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 65 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 68 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 65 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 68 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 65 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 20 Gipuzkoa De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 20 Gipuzkoa De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 20 Gipuzkoa De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,48 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,48 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,48 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,48 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 68 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 62 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 43 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 68 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 62 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 42 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 62 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 42 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 62 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 42 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 62 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 42 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,67 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,67 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,67 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,67 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 7 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 6 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 23 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 7 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 6 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 23 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 6 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 23 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 6 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 23 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 6 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 23 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 20 Gipuzkoa De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 17 Girona Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 17 Girona Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 17 Girona Total Cohort January 1 Total Number at the start of the quarter 2022QI 23.112 17 Girona Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 17 Girona Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 17 Girona Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 17 Girona Total Cohort January 1 Total Number at the start of the quarter 2021QI 22.258 17 Girona Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 17 Girona Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 17 Girona Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 17 Girona Total Cohort January 1 Total Number at the start of the quarter 2020QI 23.290 17 Girona Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 17 Girona Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 17 Girona Total Cohort January 1 Total Survival in the first trimester 2022QII "" 17 Girona Total Cohort January 1 Total Survival in the first trimester 2022QI 21.823 17 Girona Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 17 Girona Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 17 Girona Total Cohort January 1 Total Survival in the first trimester 2021QII "" 17 Girona Total Cohort January 1 Total Survival in the first trimester 2021QI 21.241 17 Girona Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 17 Girona Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 17 Girona Total Cohort January 1 Total Survival in the first trimester 2020QII "" 17 Girona Total Cohort January 1 Total Survival in the first trimester 2020QI 20.862 17 Girona Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 17 Girona Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 17 Girona Total Cohort January 1 Total Survival in the second trimester 2022QII 20.949 17 Girona Total Cohort January 1 Total Survival in the second trimester 2022QI "" 17 Girona Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 17 Girona Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 17 Girona Total Cohort January 1 Total Survival in the second trimester 2021QII 20.552 17 Girona Total Cohort January 1 Total Survival in the second trimester 2021QI "" 17 Girona Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 17 Girona Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 17 Girona Total Cohort January 1 Total Survival in the second trimester 2020QII 20.169 17 Girona Total Cohort January 1 Total Survival in the second trimester 2020QI "" 17 Girona Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 17 Girona Total Cohort January 1 Total Survival in the third trimester 2022QIII 20.256 17 Girona Total Cohort January 1 Total Survival in the third trimester 2022QII "" 17 Girona Total Cohort January 1 Total Survival in the third trimester 2022QI "" 17 Girona Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 17 Girona Total Cohort January 1 Total Survival in the third trimester 2021QIII 19.969 17 Girona Total Cohort January 1 Total Survival in the third trimester 2021QII "" 17 Girona Total Cohort January 1 Total Survival in the third trimester 2021QI "" 17 Girona Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 17 Girona Total Cohort January 1 Total Survival in the third trimester 2020QIII 19.574 17 Girona Total Cohort January 1 Total Survival in the third trimester 2020QII "" 17 Girona Total Cohort January 1 Total Survival in the third trimester 2020QI "" 17 Girona Total Cohort January 1 Total Survival in the third trimester 2022QIV 19.676 17 Girona Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 17 Girona Total Cohort January 1 Total Survival in the third trimester 2022QII "" 17 Girona Total Cohort January 1 Total Survival in the third trimester 2022QI "" 17 Girona Total Cohort January 1 Total Survival in the third trimester 2021QIV 19.405 17 Girona Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 17 Girona Total Cohort January 1 Total Survival in the third trimester 2021QII "" 17 Girona Total Cohort January 1 Total Survival in the third trimester 2021QI "" 17 Girona Total Cohort January 1 Total Survival in the third trimester 2020QIV 18.959 17 Girona Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 17 Girona Total Cohort January 1 Total Survival in the third trimester 2020QII "" 17 Girona Total Cohort January 1 Total Survival in the third trimester 2020QI "" 17 Girona Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 17 Girona Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 17 Girona Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 17 Girona Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 17 Girona Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 17 Girona Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 17 Girona Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 17 Girona Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 17 Girona Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 17 Girona Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 17 Girona Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 17 Girona Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 17 Girona Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,42 17 Girona Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,43 17 Girona Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 89,57 17 Girona Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,64 17 Girona Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 92,34 17 Girona Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 86,6 17 Girona Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 87,64 17 Girona Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 89,72 17 Girona Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 84,04 17 Girona Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 85,13 17 Girona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 87,18 17 Girona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 81,4 17 Girona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Girona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Girona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 21.847 17 Girona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 18.683 17 Girona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 20.600 17 Girona Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 17.743 17 Girona Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 19.764 17 Girona Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 17.128 17 Girona Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 19.093 17 Girona Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 16.600 17 Girona Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 18.532 17 Girona Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 16.110 17 Girona Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 17 Girona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 17 Girona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,29 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,97 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,47 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 91,68 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 87,39 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 88,85 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 84,83 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 86,23 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.265 17 Girona Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 3.575 17 Girona Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Girona Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Girona Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 17 Girona Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.223 17 Girona Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Girona Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Girona Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 17 Girona Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 3.498 17 Girona Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Girona Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Girona Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 17 Girona Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 17 Girona Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Girona Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Girona Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.185 17 Girona Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 17 Girona Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Girona Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Girona Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 3.424 17 Girona Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 17 Girona Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Girona Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Girona Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 17 Girona Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 17 Girona Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.163 17 Girona Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 3.369 17 Girona Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.144 17 Girona Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 3.295 17 Girona Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 17 Girona Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 17 Girona Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,68 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,85 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,68 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,78 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 91,94 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,24 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 90,43 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 92,17 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 17 Girona Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 17 Girona Total Cohort April 1 Total Number at the start of the quarter 2022QII 23.471 17 Girona Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 17 Girona Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 17 Girona Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 17 Girona Total Cohort April 1 Total Number at the start of the quarter 2021QII 22.732 17 Girona Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 17 Girona Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 17 Girona Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 17 Girona Total Cohort April 1 Total Number at the start of the quarter 2020QII 21.990 17 Girona Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 17 Girona Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 17 Girona Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 17 Girona Total Cohort April 1 Total Survival in the first trimester 2022QII 22.392 17 Girona Total Cohort April 1 Total Survival in the first trimester 2022QI "" 17 Girona Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 17 Girona Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 17 Girona Total Cohort April 1 Total Survival in the first trimester 2021QII 21.839 17 Girona Total Cohort April 1 Total Survival in the first trimester 2021QI "" 17 Girona Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 17 Girona Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 17 Girona Total Cohort April 1 Total Survival in the first trimester 2020QII 21.174 17 Girona Total Cohort April 1 Total Survival in the first trimester 2020QI "" 17 Girona Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 17 Girona Total Cohort April 1 Total Survival in the second trimester 2022QIII 21.504 17 Girona Total Cohort April 1 Total Survival in the second trimester 2022QII "" 17 Girona Total Cohort April 1 Total Survival in the second trimester 2022QI "" 17 Girona Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 17 Girona Total Cohort April 1 Total Survival in the second trimester 2021QIII 21.053 17 Girona Total Cohort April 1 Total Survival in the second trimester 2021QII "" 17 Girona Total Cohort April 1 Total Survival in the second trimester 2021QI "" 17 Girona Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 17 Girona Total Cohort April 1 Total Survival in the second trimester 2020QIII 20.466 17 Girona Total Cohort April 1 Total Survival in the second trimester 2020QII "" 17 Girona Total Cohort April 1 Total Survival in the second trimester 2020QI "" 17 Girona Total Cohort April 1 Total Survival in the third trimester 2022QIV 20.567 17 Girona Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 17 Girona Total Cohort April 1 Total Survival in the third trimester 2022QII "" 17 Girona Total Cohort April 1 Total Survival in the third trimester 2022QI "" 17 Girona Total Cohort April 1 Total Survival in the third trimester 2021QIV 20.168 17 Girona Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 17 Girona Total Cohort April 1 Total Survival in the third trimester 2021QII "" 17 Girona Total Cohort April 1 Total Survival in the third trimester 2021QI "" 17 Girona Total Cohort April 1 Total Survival in the third trimester 2020QIV 19.662 17 Girona Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 17 Girona Total Cohort April 1 Total Survival in the third trimester 2020QII "" 17 Girona Total Cohort April 1 Total Survival in the third trimester 2020QI "" 17 Girona Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 17 Girona Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 17 Girona Total Cohort April 1 Total Survival in the third trimester 2022QII "" 17 Girona Total Cohort April 1 Total Survival in the third trimester 2022QI 19.433 17 Girona Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 17 Girona Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 17 Girona Total Cohort April 1 Total Survival in the third trimester 2021QII "" 17 Girona Total Cohort April 1 Total Survival in the third trimester 2021QI 19.031 17 Girona Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 17 Girona Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 17 Girona Total Cohort April 1 Total Survival in the third trimester 2020QII "" 17 Girona Total Cohort April 1 Total Survival in the third trimester 2020QI "" 17 Girona Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 17 Girona Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 17 Girona Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 17 Girona Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 17 Girona Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 17 Girona Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 17 Girona Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 17 Girona Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 17 Girona Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 17 Girona Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 17 Girona Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 17 Girona Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,4 17 Girona Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,07 17 Girona Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,29 17 Girona Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 91,62 17 Girona Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,61 17 Girona Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,07 17 Girona Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,63 17 Girona Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 88,72 17 Girona Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,41 17 Girona Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 85,49 17 Girona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 86,54 17 Girona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Girona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Girona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 22.208 17 Girona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 18.998 17 Girona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 16.396 17 Girona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 21.164 17 Girona Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 18.187 17 Girona Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 15.649 17 Girona Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 20.301 17 Girona Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 17.460 17 Girona Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 15.073 17 Girona Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 19.396 17 Girona Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 16.672 17 Girona Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 14.472 17 Girona Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 16.014 17 Girona Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 13.968 17 Girona Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 17 Girona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 17 Girona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 17 Girona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,3 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,73 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,44 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,41 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,9 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,93 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,34 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 87,76 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,27 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 84,29 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 85,19 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.263 17 Girona Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 3.734 17 Girona Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 5.594 17 Girona Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Girona Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Girona Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.228 17 Girona Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 17 Girona Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Girona Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Girona Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 3.652 17 Girona Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 17 Girona Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Girona Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Girona Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 5.525 17 Girona Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 17 Girona Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Girona Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.203 17 Girona Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 17 Girona Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 17 Girona Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Girona Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 3.593 17 Girona Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 17 Girona Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 17 Girona Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Girona Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 5.393 17 Girona Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 17 Girona Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 17 Girona Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.171 17 Girona Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 3.496 17 Girona Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 5.190 17 Girona Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 3.419 17 Girona Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 5.063 17 Girona Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 17 Girona Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 17 Girona Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 17 Girona Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,23 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,8 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,77 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 95,25 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,22 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,41 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 92,72 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,63 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 92,78 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 91,56 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 90,51 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 17 Girona Total Cohort July 1 Total Number at the start of the quarter 2022QIII 25.059 17 Girona Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 17 Girona Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 17 Girona Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 17 Girona Total Cohort July 1 Total Number at the start of the quarter 2021QIII 24.435 17 Girona Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 17 Girona Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 17 Girona Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 17 Girona Total Cohort July 1 Total Number at the start of the quarter 2020QIII 23.248 17 Girona Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 17 Girona Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 17 Girona Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 17 Girona Total Cohort July 1 Total Survival in the first trimester 2022QIII 23.341 17 Girona Total Cohort July 1 Total Survival in the first trimester 2022QII "" 17 Girona Total Cohort July 1 Total Survival in the first trimester 2022QI "" 17 Girona Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 17 Girona Total Cohort July 1 Total Survival in the first trimester 2021QIII 22.820 17 Girona Total Cohort July 1 Total Survival in the first trimester 2021QII "" 17 Girona Total Cohort July 1 Total Survival in the first trimester 2021QI "" 17 Girona Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 17 Girona Total Cohort July 1 Total Survival in the first trimester 2020QIII 21.885 17 Girona Total Cohort July 1 Total Survival in the first trimester 2020QII "" 17 Girona Total Cohort July 1 Total Survival in the first trimester 2020QI "" 17 Girona Total Cohort July 1 Total Survival in the second trimester 2022QIV 21.482 17 Girona Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 17 Girona Total Cohort July 1 Total Survival in the second trimester 2022QII "" 17 Girona Total Cohort July 1 Total Survival in the second trimester 2022QI "" 17 Girona Total Cohort July 1 Total Survival in the second trimester 2021QIV 21.127 17 Girona Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 17 Girona Total Cohort July 1 Total Survival in the second trimester 2021QII "" 17 Girona Total Cohort July 1 Total Survival in the second trimester 2021QI "" 17 Girona Total Cohort July 1 Total Survival in the second trimester 2020QIV 20.475 17 Girona Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 17 Girona Total Cohort July 1 Total Survival in the second trimester 2020QII "" 17 Girona Total Cohort July 1 Total Survival in the second trimester 2020QI "" 17 Girona Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 17 Girona Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 17 Girona Total Cohort July 1 Total Survival in the third trimester 2022QII "" 17 Girona Total Cohort July 1 Total Survival in the third trimester 2022QI 20.220 17 Girona Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 17 Girona Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 17 Girona Total Cohort July 1 Total Survival in the third trimester 2021QII "" 17 Girona Total Cohort July 1 Total Survival in the third trimester 2021QI 19.746 17 Girona Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 17 Girona Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 17 Girona Total Cohort July 1 Total Survival in the third trimester 2020QII "" 17 Girona Total Cohort July 1 Total Survival in the third trimester 2020QI "" 17 Girona Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 17 Girona Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 17 Girona Total Cohort July 1 Total Survival in the third trimester 2022QII 19.655 17 Girona Total Cohort July 1 Total Survival in the third trimester 2022QI "" 17 Girona Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 17 Girona Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 17 Girona Total Cohort July 1 Total Survival in the third trimester 2021QII 19.317 17 Girona Total Cohort July 1 Total Survival in the third trimester 2021QI "" 17 Girona Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 17 Girona Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 17 Girona Total Cohort July 1 Total Survival in the third trimester 2020QII "" 17 Girona Total Cohort July 1 Total Survival in the third trimester 2020QI "" 17 Girona Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 17 Girona Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 17 Girona Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 17 Girona Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 17 Girona Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 17 Girona Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 17 Girona Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 17 Girona Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 17 Girona Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 17 Girona Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 17 Girona Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 17 Girona Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,14 17 Girona Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,39 17 Girona Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,14 17 Girona Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 85,73 17 Girona Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 86,46 17 Girona Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 88,07 17 Girona Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 82,75 17 Girona Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 84,94 17 Girona Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 80,44 17 Girona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 83,09 17 Girona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Girona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Girona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 24.236 17 Girona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 23.276 17 Girona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 19.251 17 Girona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 22.534 17 Girona Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 21.681 17 Girona Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 17.983 17 Girona Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 20.697 17 Girona Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 20.043 17 Girona Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 16.735 17 Girona Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 19.161 17 Girona Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 16.086 17 Girona Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 18.615 17 Girona Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 15.733 17 Girona Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 17 Girona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 17 Girona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 17 Girona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,98 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,15 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,41 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 85,4 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 86,11 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 86,93 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 82,32 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 83,56 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 79,98 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 81,73 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 823 17 Girona Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.159 17 Girona Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 3.997 17 Girona Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Girona Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 807 17 Girona Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 17 Girona Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 17 Girona Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Girona Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.139 17 Girona Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 17 Girona Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 17 Girona Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Girona Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 3.902 17 Girona Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 17 Girona Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 17 Girona Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 785 17 Girona Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Girona Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 17 Girona Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 17 Girona Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1.084 17 Girona Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Girona Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 17 Girona Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 17 Girona Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 3.740 17 Girona Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Girona Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 17 Girona Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 17 Girona Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1.059 17 Girona Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 3.660 17 Girona Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1.040 17 Girona Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 3.584 17 Girona Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 17 Girona Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 17 Girona Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 17 Girona Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,06 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,27 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,62 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95,38 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,53 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,57 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 91,37 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 91,57 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 89,73 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 89,67 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona Total Cohort October 1 Total Number at the start of the quarter 2022QIV 24.357 17 Girona Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 17 Girona Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 17 Girona Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 17 Girona Total Cohort October 1 Total Number at the start of the quarter 2021QIV 23.907 17 Girona Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 17 Girona Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 17 Girona Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 17 Girona Total Cohort October 1 Total Number at the start of the quarter 2020QIV 23.224 17 Girona Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 17 Girona Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 17 Girona Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 17 Girona Total Cohort October 1 Total Survival in the first trimester 2022QIV 22.297 17 Girona Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 17 Girona Total Cohort October 1 Total Survival in the first trimester 2022QII "" 17 Girona Total Cohort October 1 Total Survival in the first trimester 2022QI "" 17 Girona Total Cohort October 1 Total Survival in the first trimester 2021QIV 21.950 17 Girona Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 17 Girona Total Cohort October 1 Total Survival in the first trimester 2021QII "" 17 Girona Total Cohort October 1 Total Survival in the first trimester 2021QI "" 17 Girona Total Cohort October 1 Total Survival in the first trimester 2020QIV 21.344 17 Girona Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 17 Girona Total Cohort October 1 Total Survival in the first trimester 2020QII "" 17 Girona Total Cohort October 1 Total Survival in the first trimester 2020QI "" 17 Girona Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 17 Girona Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 17 Girona Total Cohort October 1 Total Survival in the second trimester 2022QII "" 17 Girona Total Cohort October 1 Total Survival in the second trimester 2022QI 20.910 17 Girona Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 17 Girona Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 17 Girona Total Cohort October 1 Total Survival in the second trimester 2021QII "" 17 Girona Total Cohort October 1 Total Survival in the second trimester 2021QI 20.497 17 Girona Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 17 Girona Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 17 Girona Total Cohort October 1 Total Survival in the second trimester 2020QII "" 17 Girona Total Cohort October 1 Total Survival in the second trimester 2020QI "" 17 Girona Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 17 Girona Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 17 Girona Total Cohort October 1 Total Survival in the third trimester 2022QII 20.226 17 Girona Total Cohort October 1 Total Survival in the third trimester 2022QI "" 17 Girona Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 17 Girona Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 17 Girona Total Cohort October 1 Total Survival in the third trimester 2021QII 19.965 17 Girona Total Cohort October 1 Total Survival in the third trimester 2021QI "" 17 Girona Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 17 Girona Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 17 Girona Total Cohort October 1 Total Survival in the third trimester 2020QII "" 17 Girona Total Cohort October 1 Total Survival in the third trimester 2020QI "" 17 Girona Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 17 Girona Total Cohort October 1 Total Survival in the third trimester 2022QIII 19.637 17 Girona Total Cohort October 1 Total Survival in the third trimester 2022QII "" 17 Girona Total Cohort October 1 Total Survival in the third trimester 2022QI "" 17 Girona Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 17 Girona Total Cohort October 1 Total Survival in the third trimester 2021QIII 19.468 17 Girona Total Cohort October 1 Total Survival in the third trimester 2021QII "" 17 Girona Total Cohort October 1 Total Survival in the third trimester 2021QI "" 17 Girona Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 17 Girona Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 17 Girona Total Cohort October 1 Total Survival in the third trimester 2020QII "" 17 Girona Total Cohort October 1 Total Survival in the third trimester 2020QI "" 17 Girona Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 17 Girona Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 17 Girona Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 17 Girona Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 17 Girona Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 17 Girona Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 17 Girona Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 17 Girona Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 17 Girona Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 17 Girona Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 17 Girona Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 17 Girona Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 91,54 17 Girona Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 91,81 17 Girona Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 91,9 17 Girona Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 87,46 17 Girona Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 88,26 17 Girona Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 84,6 17 Girona Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 85,97 17 Girona Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 82,14 17 Girona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 83,83 17 Girona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Girona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Girona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 23.657 17 Girona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 22.575 17 Girona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 19.179 17 Girona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 21.615 17 Girona Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 20.674 17 Girona Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 17.448 17 Girona Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 19.668 17 Girona Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 16.691 17 Girona Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 19.018 17 Girona Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 16.234 17 Girona Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 18.447 17 Girona Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 15.794 17 Girona Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 17 Girona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 17 Girona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 17 Girona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 91,37 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 91,58 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 90,97 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 87,12 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 87,03 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 84,24 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 84,64 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 81,71 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 82,35 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 700 17 Girona Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.332 17 Girona Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 4.045 17 Girona Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 682 17 Girona Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Girona Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 17 Girona Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 17 Girona Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.276 17 Girona Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Girona Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 17 Girona Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 17 Girona Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 3.896 17 Girona Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Girona Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 17 Girona Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 17 Girona Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Girona Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Girona Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 17 Girona Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.242 17 Girona Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Girona Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Girona Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 17 Girona Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 3.806 17 Girona Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Girona Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Girona Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 17 Girona Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 17 Girona Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.208 17 Girona Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 3.731 17 Girona Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.190 17 Girona Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 3.674 17 Girona Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 17 Girona Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 17 Girona Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 17 Girona Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,43 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,8 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,32 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,24 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,09 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 90,69 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,24 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 89,34 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 90,83 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 17 Girona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 17 Girona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 17 Girona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 17.222 17 Girona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 17 Girona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 17 Girona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 17 Girona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 16.766 17 Girona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 17.353 17 Girona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 16.002 17 Girona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 15.808 17 Girona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 15.063 17 Girona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 15.222 17 Girona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 15.181 17 Girona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 14.412 17 Girona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 14.576 17 Girona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 14.636 17 Girona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 13.882 17 Girona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 14.049 17 Girona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 14.120 17 Girona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 13.337 17 Girona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 17 Girona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 17 Girona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 17 Girona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 17 Girona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 17 Girona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 17 Girona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 17 Girona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 17 Girona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 92,92 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,29 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 86,8 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,39 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,55 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 83,05 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 84,64 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,3 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 80 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 81,58 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 84,22 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 76,86 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 16.497 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 14.867 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 15.314 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 13.977 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 14.560 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 13.404 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 13.932 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 12.905 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 13.421 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 12.449 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,83 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,01 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,26 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,16 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 84,45 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,8 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 81,35 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 83,74 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 725 17 Girona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.899 17 Girona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 688 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.831 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 662 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.777 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 644 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.731 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 628 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.671 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 17 Girona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 17 Girona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,9 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,42 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 91,31 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 93,58 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 88,83 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 91,15 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 86,62 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 87,99 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 17 Girona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 17 Girona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 17.307 17 Girona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 17 Girona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 17 Girona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 17 Girona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 17.023 17 Girona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 17 Girona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 17 Girona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 17 Girona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 16.430 17 Girona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 16.317 17 Girona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 16.189 17 Girona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 15.648 17 Girona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 15.482 17 Girona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 15.452 17 Girona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 14.995 17 Girona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 14.663 17 Girona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 14.681 17 Girona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 14.265 17 Girona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 14.014 17 Girona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 13.693 17 Girona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 17 Girona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 17 Girona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 17 Girona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 17 Girona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 17 Girona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 17 Girona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 17 Girona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 17 Girona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 17 Girona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 17 Girona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 17 Girona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 17 Girona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,28 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,1 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,24 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,46 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,77 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,27 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 84,72 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 86,24 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 86,82 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 82,32 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 83,34 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 16.593 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 15.079 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 13.068 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 15.630 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 14.305 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 12.346 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 14.817 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 13.616 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 11.803 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 14.018 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 12.918 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 11.235 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 12.318 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 10.772 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,2 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,87 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,48 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 89,3 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 90,3 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,32 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 84,48 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 85,67 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 85,97 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 81,69 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 82,43 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 714 17 Girona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.944 17 Girona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 3.362 17 Girona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 687 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.884 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 3.302 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 665 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.836 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 3.192 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 645 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.763 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 3.030 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.696 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.921 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 17 Girona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 17 Girona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 17 Girona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,22 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,91 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,22 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,14 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,44 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,94 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 90,34 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 90,69 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 90,12 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 87,24 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 86,88 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 17 Girona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 17.941 17 Girona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 17 Girona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 17 Girona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 17 Girona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 17.785 17 Girona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 17 Girona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 17 Girona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 17 Girona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 17.153 17 Girona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 16.386 17 Girona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 16.312 17 Girona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 15.913 17 Girona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 14.966 17 Girona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 14.974 17 Girona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 14.730 17 Girona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 14.176 17 Girona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 14.076 17 Girona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 13.663 17 Girona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 13.700 17 Girona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 17 Girona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 17 Girona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 17 Girona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 17 Girona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 17 Girona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 17 Girona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 17 Girona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 17 Girona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 17 Girona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 17 Girona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 91,33 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 91,72 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 92,77 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 83,42 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 84,19 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 85,87 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 79,71 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 82,06 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 76,82 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 79,87 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 17.469 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 17.240 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 15.055 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 15.927 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 15.781 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 13.888 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 14.516 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 14.468 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 12.801 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 13.693 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 12.212 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 13.196 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 11.889 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 91,17 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 91,54 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 92,25 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 83,1 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 83,92 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 85,03 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 79,43 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 81,12 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 76,54 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 78,97 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 472 17 Girona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 545 17 Girona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2.098 17 Girona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 459 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 531 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2.025 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 450 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 506 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.929 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 483 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.864 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 467 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.811 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 17 Girona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 17 Girona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 17 Girona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,25 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,43 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,52 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95,34 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 92,84 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 91,94 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 88,62 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 88,85 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 85,69 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 86,32 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 17.809 17 Girona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 17 Girona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 17 Girona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 17.685 17 Girona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 17 Girona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 17 Girona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 17.284 17 Girona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 16.036 17 Girona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 15.965 17 Girona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 15.599 17 Girona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 15.008 17 Girona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 14.826 17 Girona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 14.385 17 Girona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 14.354 17 Girona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 13.840 17 Girona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 13.896 17 Girona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 17 Girona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 17 Girona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 17 Girona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 17 Girona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 17 Girona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 17 Girona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 17 Girona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 90,04 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 90,27 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 90,25 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 84,86 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 85,78 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 81,34 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 83,05 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 78,26 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 80,4 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 17.421 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 16.894 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 15.211 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 15.659 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 15.213 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 13.622 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 14.288 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 12.924 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 13.692 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 12.508 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 13.163 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 12.096 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 89,89 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 90,05 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 89,55 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 84,57 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 84,96 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 81,05 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 82,23 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 77,92 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 79,52 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 388 17 Girona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 791 17 Girona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 2.073 17 Girona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 377 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 752 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.977 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 720 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.902 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 693 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.846 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 677 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.800 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 17 Girona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 17 Girona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 17 Girona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,16 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,07 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 95,37 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91,02 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 91,75 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 87,61 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 89,05 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 85,59 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 86,83 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 2.469 17 Girona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 2.348 17 Girona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 2.571 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 2.429 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 2.312 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 2.489 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 2.381 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 2.279 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 2.463 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 2.355 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 2.259 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 2.420 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 2.327 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 2.236 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 2.380 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 17 Girona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 17 Girona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,38 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,47 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,81 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,44 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,06 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,8 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 95,38 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,21 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,13 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 94,25 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,23 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 92,57 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.279 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.760 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.244 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.729 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.201 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.705 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.177 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.689 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.152 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.670 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,46 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,24 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,58 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,88 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,52 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,97 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 94,43 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,89 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 190 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 588 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 185 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 583 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 180 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 574 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 178 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 570 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 175 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 566 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,37 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,15 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 94,74 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,62 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 93,68 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,94 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 92,11 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,26 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 2.546 17 Girona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 2.403 17 Girona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 2.349 17 Girona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 2.507 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 2.373 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 2.328 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 2.477 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 2.348 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 2.294 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 2.416 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 2.280 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 2.256 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 2.238 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 2.219 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 17 Girona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 17 Girona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 17 Girona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,47 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,75 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,11 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,29 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,71 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,66 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 94,89 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 94,88 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,04 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,13 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,47 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.353 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.791 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.480 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.316 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.772 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.466 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.287 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.752 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.445 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.231 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.693 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.426 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.659 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.401 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,43 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,94 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,05 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,2 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,82 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,64 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 94,82 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 94,53 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,35 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 92,63 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,66 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 193 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 612 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 869 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 191 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 601 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 862 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 190 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 596 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 849 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 185 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 587 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 830 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 579 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 818 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,96 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,2 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,19 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,45 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,39 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,7 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 95,85 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 95,92 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,51 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 94,61 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,13 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 2.963 17 Girona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 2.760 17 Girona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 2.593 17 Girona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 2.876 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 2.682 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 2.514 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 2.651 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 2.484 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 2.395 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 2.415 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 2.350 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 2.393 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 2.320 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 17 Girona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 17 Girona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 17 Girona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,06 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 97,17 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 96,95 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,47 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 92,36 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 87,5 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 90,63 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 86,7 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 89,47 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.824 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.573 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.938 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.738 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.498 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.872 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.520 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.312 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.777 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.245 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.740 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.224 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.720 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 96,95 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 97,09 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 96,59 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,24 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,86 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 91,69 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 87,25 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 89,78 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 86,44 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 88,75 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 139 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 187 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 655 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 138 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 184 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 642 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 131 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 172 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 618 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 170 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 610 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 169 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 600 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,28 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,4 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,02 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,24 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 91,98 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,35 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 90,91 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,13 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 90,37 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,6 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 2.731 17 Girona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 2.586 17 Girona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 2.536 17 Girona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 2.575 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 2.448 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 2.428 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 2.395 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 2.381 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 2.364 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 2.345 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 2.338 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 2.321 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 17 Girona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 17 Girona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 17 Girona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,29 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,66 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 95,74 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 92,61 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 93,89 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 91,42 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 92,47 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 90,41 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 91,52 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.614 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.410 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.876 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.461 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.282 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.787 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.230 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.747 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.202 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.721 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.176 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.702 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,15 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,69 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 95,26 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 92,53 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 93,12 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 91,37 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 91,74 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 90,29 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 90,72 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 117 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 176 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 660 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 114 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 166 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 641 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 165 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 634 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 162 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 624 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 162 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 619 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,44 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 94,32 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,12 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,75 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,06 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 92,05 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,55 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 92,05 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,79 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 17 Girona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 17 Girona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 17 Girona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 3.218 17 Girona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 17 Girona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 17 Girona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 17 Girona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 2.959 17 Girona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 3.168 17 Girona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 3.189 17 Girona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 2.938 17 Girona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 3.114 17 Girona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 3.144 17 Girona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 2.909 17 Girona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 3.098 17 Girona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 3.123 17 Girona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 2.891 17 Girona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 3.077 17 Girona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 3.099 17 Girona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 2.866 17 Girona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 3.049 17 Girona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 17 Girona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 17 Girona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 17 Girona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 17 Girona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 17 Girona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 17 Girona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 17 Girona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 17 Girona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,1 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,29 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,3 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,7 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,31 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,79 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,05 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,7 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,13 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,3 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,86 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,24 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.889 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.948 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.860 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.930 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.822 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.912 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.803 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.899 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.779 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.884 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,08 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,68 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,15 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,02 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,48 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,19 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,71 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 329 17 Girona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.011 17 Girona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 329 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.008 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 322 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 997 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 320 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 992 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 320 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 982 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 17 Girona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 17 Girona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,7 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,87 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,62 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,26 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,12 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 97,26 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,13 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 17 Girona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 17 Girona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 3.407 17 Girona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 17 Girona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 17 Girona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 17 Girona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 3.119 17 Girona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 17 Girona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 17 Girona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 17 Girona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 3.017 17 Girona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 3.357 17 Girona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 3.090 17 Girona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 3.004 17 Girona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 3.334 17 Girona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 3.066 17 Girona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 2.983 17 Girona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 3.278 17 Girona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 3.020 17 Girona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 2.947 17 Girona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 2.994 17 Girona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 2.927 17 Girona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 17 Girona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 17 Girona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 17 Girona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 17 Girona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 17 Girona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 17 Girona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 17 Girona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 17 Girona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 17 Girona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 17 Girona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 17 Girona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 17 Girona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,53 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,07 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,57 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,86 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,3 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,87 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,21 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,83 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,68 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 95,99 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,02 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 3.082 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.017 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.722 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 3.038 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.999 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.711 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 3.017 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.981 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.699 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.968 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.950 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.685 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.926 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.670 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,57 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,11 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,36 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,89 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,22 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,66 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,3 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,68 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,85 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,49 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,98 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 325 17 Girona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.102 17 Girona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.295 17 Girona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 319 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.091 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.293 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 317 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.085 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.284 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 310 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.070 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.262 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.068 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.257 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 17 Girona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 17 Girona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 17 Girona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,15 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,85 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,54 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,46 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,15 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 95,38 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,1 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,45 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,91 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 97,07 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 17 Girona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 3.918 17 Girona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 17 Girona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 17 Girona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 17 Girona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 3.682 17 Girona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 17 Girona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 17 Girona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 17 Girona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 3.305 17 Girona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 3.842 17 Girona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 3.618 17 Girona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 3.261 17 Girona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 3.629 17 Girona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 3.461 17 Girona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 3.153 17 Girona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 3.421 17 Girona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 3.126 17 Girona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 3.392 17 Girona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 3.103 17 Girona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 17 Girona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 17 Girona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 17 Girona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 17 Girona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 17 Girona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 17 Girona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 17 Girona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 17 Girona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 17 Girona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 17 Girona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,06 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,26 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,67 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 92,62 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 94 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 95,4 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 92,91 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 94,58 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 92,12 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 93,89 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 3.725 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 3.297 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2.144 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 3.651 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 3.236 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.109 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 3.444 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 3.097 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.043 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 3.057 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.022 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 3.029 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.012 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,01 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,15 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,37 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 92,46 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 93,93 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 95,29 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 92,72 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 94,31 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 91,87 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 93,84 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 193 17 Girona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 385 17 Girona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.161 17 Girona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 191 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 382 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.152 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 185 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 364 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.110 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 364 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.104 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 363 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.091 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 17 Girona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 17 Girona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 17 Girona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,96 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,22 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,22 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95,85 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 94,55 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,61 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 94,55 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95,09 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 94,29 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 93,97 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 3.597 17 Girona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 17 Girona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 17 Girona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 3.435 17 Girona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 17 Girona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 17 Girona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 3.210 17 Girona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 3.466 17 Girona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 3.336 17 Girona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 3.123 17 Girona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 3.306 17 Girona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 3.098 17 Girona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 3.277 17 Girona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 3.074 17 Girona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 3.259 17 Girona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 3.059 17 Girona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 17 Girona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 17 Girona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 17 Girona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 17 Girona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 17 Girona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 17 Girona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 17 Girona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 96,36 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 97,12 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 97,29 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,24 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,51 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95,4 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 95,76 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 94,88 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,3 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 3.420 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3.096 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.988 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 3.293 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 3.004 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.935 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.975 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.917 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.949 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.902 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.933 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.893 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 96,29 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 97,03 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,33 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,09 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,43 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,25 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,67 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 94,74 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,22 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 177 17 Girona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 339 17 Girona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.222 17 Girona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 173 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 332 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.188 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 331 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.181 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 328 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.172 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 326 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.166 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 17 Girona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 17 Girona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 17 Girona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,74 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,94 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,22 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 97,64 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,64 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,76 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,91 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96,17 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 95,42 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 17 Girona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 17 Girona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 17 Girona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 139 17 Girona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 17 Girona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 17 Girona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 17 Girona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 128 17 Girona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 143 17 Girona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 139 17 Girona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 126 17 Girona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 141 17 Girona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 138 17 Girona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 126 17 Girona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 141 17 Girona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 138 17 Girona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 126 17 Girona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 140 17 Girona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 137 17 Girona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 126 17 Girona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 138 17 Girona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 17 Girona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 17 Girona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 17 Girona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 17 Girona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 17 Girona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 17 Girona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 17 Girona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 17 Girona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,44 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,6 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,28 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,44 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,6 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 99,28 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,44 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,9 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,56 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,44 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,5 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 123 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 73 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 123 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 72 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 122 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 72 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 122 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 72 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 121 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 72 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,63 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,19 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,63 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 99,19 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,63 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,37 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,63 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 16 17 Girona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 55 17 Girona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 16 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 54 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 16 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 54 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 16 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 54 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 16 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 54 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 17 Girona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 17 Girona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,18 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,18 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,18 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,18 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 17 Girona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 17 Girona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 146 17 Girona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 17 Girona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 17 Girona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 17 Girona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 131 17 Girona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 17 Girona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 17 Girona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 17 Girona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 142 17 Girona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 146 17 Girona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 131 17 Girona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 142 17 Girona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 146 17 Girona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 131 17 Girona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 142 17 Girona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 145 17 Girona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 131 17 Girona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 142 17 Girona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 131 17 Girona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 140 17 Girona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 17 Girona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 17 Girona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 17 Girona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 17 Girona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 17 Girona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 17 Girona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 17 Girona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 17 Girona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 17 Girona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 17 Girona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 17 Girona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 17 Girona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 99,32 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,59 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Girona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 126 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 73 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 89 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 126 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 73 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 89 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 126 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 73 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 89 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 125 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 73 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 89 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 73 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 88 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 99,21 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 98,88 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 20 17 Girona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 58 17 Girona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 53 17 Girona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 20 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 58 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 53 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 20 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 58 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 53 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 20 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 58 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 53 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 58 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 52 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 17 Girona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 17 Girona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 17 Girona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,11 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 17 Girona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 171 17 Girona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 17 Girona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 17 Girona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 17 Girona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 148 17 Girona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 17 Girona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 17 Girona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 17 Girona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 142 17 Girona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 171 17 Girona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 148 17 Girona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 142 17 Girona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 170 17 Girona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 148 17 Girona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 142 17 Girona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 148 17 Girona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 139 17 Girona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 147 17 Girona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 139 17 Girona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 17 Girona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 17 Girona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 17 Girona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 17 Girona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 17 Girona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 17 Girona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 17 Girona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 17 Girona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 17 Girona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 17 Girona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 99,42 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,89 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 99,32 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,89 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 158 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 115 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 79 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 158 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 115 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 79 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 157 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 115 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 79 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 115 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 77 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 115 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 77 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 99,37 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,47 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,47 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 13 17 Girona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 33 17 Girona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 63 17 Girona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 13 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 33 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 63 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 13 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 33 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 63 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 33 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 62 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 32 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 62 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 17 Girona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 17 Girona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 17 Girona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,41 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,97 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,41 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 155 17 Girona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 17 Girona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 17 Girona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 140 17 Girona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 17 Girona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 17 Girona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 140 17 Girona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 155 17 Girona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 140 17 Girona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 140 17 Girona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 140 17 Girona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 138 17 Girona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 139 17 Girona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 138 17 Girona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 139 17 Girona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 138 17 Girona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 17 Girona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 17 Girona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 17 Girona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 17 Girona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 17 Girona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 17 Girona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 17 Girona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,57 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 99,29 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,57 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 99,29 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,57 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 142 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 119 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 72 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 142 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 119 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 72 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 119 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 71 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 119 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 71 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 119 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 71 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,61 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,61 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,61 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 13 17 Girona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 21 17 Girona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 68 17 Girona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 13 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 21 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 68 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 21 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 67 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 20 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 67 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 20 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 67 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 17 Girona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 17 Girona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 17 Girona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,53 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 95,24 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,53 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 95,24 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,53 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 17 Girona De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 17 Girona De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 17 Girona De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 64 17 Girona De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 17 Girona De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 17 Girona De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 17 Girona De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 57 17 Girona De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 17 Girona De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 17 Girona De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 17 Girona De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 55 17 Girona De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 17 Girona De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 17 Girona De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 17 Girona De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 64 17 Girona De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 17 Girona De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 17 Girona De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 17 Girona De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 57 17 Girona De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 17 Girona De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 17 Girona De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 17 Girona De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 55 17 Girona De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 17 Girona De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 17 Girona De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 64 17 Girona De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 17 Girona De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 17 Girona De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 17 Girona De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 57 17 Girona De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 17 Girona De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 17 Girona De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 17 Girona De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 55 17 Girona De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 17 Girona De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 17 Girona De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 64 17 Girona De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 17 Girona De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 17 Girona De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 17 Girona De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 57 17 Girona De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 17 Girona De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 17 Girona De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 17 Girona De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 55 17 Girona De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 17 Girona De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 17 Girona De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 64 17 Girona De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 17 Girona De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 17 Girona De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 17 Girona De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 57 17 Girona De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 17 Girona De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 17 Girona De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 17 Girona De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 55 17 Girona De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 17 Girona De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 17 Girona De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 17 Girona De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 17 Girona De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 17 Girona De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 17 Girona De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 17 Girona De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 17 Girona De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 17 Girona De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 17 Girona De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 17 Girona De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 17 Girona De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 17 Girona De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 17 Girona De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Girona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 59 17 Girona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 35 17 Girona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 59 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 35 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 59 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 35 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 59 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 35 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 59 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 35 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 17 Girona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 17 Girona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 5 17 Girona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 22 17 Girona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 5 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 22 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 5 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 22 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 5 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 22 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 5 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 22 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 17 Girona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 17 Girona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 17 Girona De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 17 Girona De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 65 17 Girona De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 17 Girona De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 17 Girona De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 17 Girona De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 56 17 Girona De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 17 Girona De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 17 Girona De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 17 Girona De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 52 17 Girona De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 17 Girona De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 17 Girona De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 17 Girona De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 65 17 Girona De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 17 Girona De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 17 Girona De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 17 Girona De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 56 17 Girona De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 17 Girona De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 17 Girona De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 17 Girona De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 52 17 Girona De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 17 Girona De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 17 Girona De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 65 17 Girona De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 17 Girona De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 17 Girona De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 17 Girona De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 56 17 Girona De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 17 Girona De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 17 Girona De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 17 Girona De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 52 17 Girona De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 17 Girona De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 17 Girona De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 65 17 Girona De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 17 Girona De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 17 Girona De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 17 Girona De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 56 17 Girona De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 17 Girona De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 17 Girona De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 17 Girona De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 52 17 Girona De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 17 Girona De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 17 Girona De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 17 Girona De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 17 Girona De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 17 Girona De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 17 Girona De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 56 17 Girona De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 17 Girona De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 17 Girona De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 17 Girona De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 52 17 Girona De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 17 Girona De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 17 Girona De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 17 Girona De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 17 Girona De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 17 Girona De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 17 Girona De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 17 Girona De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 17 Girona De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 17 Girona De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 17 Girona De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 17 Girona De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 17 Girona De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 17 Girona De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 17 Girona De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 17 Girona De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Girona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 54 17 Girona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 38 17 Girona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 37 17 Girona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 54 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 38 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 37 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 54 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 38 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 37 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 54 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 38 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 37 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 38 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 37 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 17 Girona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 17 Girona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 17 Girona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 11 17 Girona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 18 17 Girona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 15 17 Girona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 11 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 18 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 15 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 11 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 18 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 15 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 11 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 18 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 15 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 18 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 15 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 17 Girona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 17 Girona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 17 Girona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 17 Girona De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 66 17 Girona De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 17 Girona De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 17 Girona De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 17 Girona De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 60 17 Girona De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 17 Girona De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 17 Girona De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 17 Girona De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 55 17 Girona De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 17 Girona De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 17 Girona De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 17 Girona De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 66 17 Girona De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 17 Girona De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 17 Girona De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 17 Girona De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 60 17 Girona De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 17 Girona De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 17 Girona De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 17 Girona De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 55 17 Girona De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 17 Girona De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 17 Girona De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 66 17 Girona De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 17 Girona De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 17 Girona De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 17 Girona De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 60 17 Girona De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 17 Girona De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 17 Girona De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 17 Girona De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 55 17 Girona De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 17 Girona De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 17 Girona De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 17 Girona De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 17 Girona De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 17 Girona De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 17 Girona De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 60 17 Girona De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 17 Girona De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 17 Girona De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 17 Girona De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 55 17 Girona De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 17 Girona De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 17 Girona De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 17 Girona De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 17 Girona De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 17 Girona De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 17 Girona De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 60 17 Girona De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 17 Girona De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 17 Girona De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 17 Girona De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 55 17 Girona De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 17 Girona De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 17 Girona De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 17 Girona De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 17 Girona De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 17 Girona De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 17 Girona De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 17 Girona De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 17 Girona De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 17 Girona De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 17 Girona De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 17 Girona De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 17 Girona De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 17 Girona De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 17 Girona De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 17 Girona De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 17 Girona De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Girona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 60 17 Girona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 51 17 Girona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 35 17 Girona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 60 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 51 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 35 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 60 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 51 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 35 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 51 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 35 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 51 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 35 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 17 Girona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 17 Girona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 17 Girona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 6 17 Girona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 9 17 Girona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 20 17 Girona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 6 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 9 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 20 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 6 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 9 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 20 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 9 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 20 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 9 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 20 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 17 Girona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 17 Girona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 17 Girona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 17 Girona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 17 Girona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 17 Girona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 65 17 Girona De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 17 Girona De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 17 Girona De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 17 Girona De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 61 17 Girona De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 17 Girona De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 17 Girona De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 17 Girona De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 54 17 Girona De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 17 Girona De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 17 Girona De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 17 Girona De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 65 17 Girona De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 17 Girona De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 17 Girona De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 17 Girona De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 61 17 Girona De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 17 Girona De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 17 Girona De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 17 Girona De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 54 17 Girona De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 17 Girona De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 17 Girona De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 17 Girona De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 17 Girona De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 17 Girona De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 17 Girona De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 61 17 Girona De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 17 Girona De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 17 Girona De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 17 Girona De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 54 17 Girona De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 17 Girona De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 17 Girona De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 17 Girona De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 17 Girona De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 17 Girona De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 17 Girona De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 61 17 Girona De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 17 Girona De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 17 Girona De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 17 Girona De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 54 17 Girona De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 17 Girona De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 17 Girona De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 17 Girona De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 17 Girona De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 17 Girona De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 17 Girona De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 61 17 Girona De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 17 Girona De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 17 Girona De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 17 Girona De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 54 17 Girona De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 17 Girona De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 17 Girona De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 17 Girona De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 17 Girona De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 17 Girona De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 17 Girona De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 17 Girona De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 17 Girona De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 17 Girona De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 17 Girona De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 17 Girona De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 17 Girona De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 17 Girona De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 17 Girona De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 17 Girona De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 17 Girona De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 17 Girona De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 17 Girona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 60 17 Girona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 56 17 Girona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 32 17 Girona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 60 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 56 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 32 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 56 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 32 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 56 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 32 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 56 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 32 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 17 Girona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 17 Girona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 17 Girona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 5 17 Girona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 5 17 Girona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 22 17 Girona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 5 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 5 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 22 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 5 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 22 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 5 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 22 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 5 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 22 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 17 Girona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 17 Girona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 17 Girona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 17 Girona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 18 Granada Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 18 Granada Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 18 Granada Total Cohort January 1 Total Number at the start of the quarter 2022QI 20.922 18 Granada Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 18 Granada Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 18 Granada Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 18 Granada Total Cohort January 1 Total Number at the start of the quarter 2021QI 19.724 18 Granada Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 18 Granada Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 18 Granada Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 18 Granada Total Cohort January 1 Total Number at the start of the quarter 2020QI 21.330 18 Granada Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 18 Granada Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 18 Granada Total Cohort January 1 Total Survival in the first trimester 2022QII "" 18 Granada Total Cohort January 1 Total Survival in the first trimester 2022QI 19.499 18 Granada Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 18 Granada Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 18 Granada Total Cohort January 1 Total Survival in the first trimester 2021QII "" 18 Granada Total Cohort January 1 Total Survival in the first trimester 2021QI 18.495 18 Granada Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 18 Granada Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 18 Granada Total Cohort January 1 Total Survival in the first trimester 2020QII "" 18 Granada Total Cohort January 1 Total Survival in the first trimester 2020QI 17.525 18 Granada Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 18 Granada Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 18 Granada Total Cohort January 1 Total Survival in the second trimester 2022QII 18.396 18 Granada Total Cohort January 1 Total Survival in the second trimester 2022QI "" 18 Granada Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 18 Granada Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 18 Granada Total Cohort January 1 Total Survival in the second trimester 2021QII 17.602 18 Granada Total Cohort January 1 Total Survival in the second trimester 2021QI "" 18 Granada Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 18 Granada Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 18 Granada Total Cohort January 1 Total Survival in the second trimester 2020QII 16.777 18 Granada Total Cohort January 1 Total Survival in the second trimester 2020QI "" 18 Granada Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 18 Granada Total Cohort January 1 Total Survival in the third trimester 2022QIII 17.572 18 Granada Total Cohort January 1 Total Survival in the third trimester 2022QII "" 18 Granada Total Cohort January 1 Total Survival in the third trimester 2022QI "" 18 Granada Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 18 Granada Total Cohort January 1 Total Survival in the third trimester 2021QIII 16.909 18 Granada Total Cohort January 1 Total Survival in the third trimester 2021QII "" 18 Granada Total Cohort January 1 Total Survival in the third trimester 2021QI "" 18 Granada Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 18 Granada Total Cohort January 1 Total Survival in the third trimester 2020QIII 16.138 18 Granada Total Cohort January 1 Total Survival in the third trimester 2020QII "" 18 Granada Total Cohort January 1 Total Survival in the third trimester 2020QI "" 18 Granada Total Cohort January 1 Total Survival in the third trimester 2022QIV 17.013 18 Granada Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 18 Granada Total Cohort January 1 Total Survival in the third trimester 2022QII "" 18 Granada Total Cohort January 1 Total Survival in the third trimester 2022QI "" 18 Granada Total Cohort January 1 Total Survival in the third trimester 2021QIV 16.361 18 Granada Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 18 Granada Total Cohort January 1 Total Survival in the third trimester 2021QII "" 18 Granada Total Cohort January 1 Total Survival in the third trimester 2021QI "" 18 Granada Total Cohort January 1 Total Survival in the third trimester 2020QIV 15.498 18 Granada Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 18 Granada Total Cohort January 1 Total Survival in the third trimester 2020QII "" 18 Granada Total Cohort January 1 Total Survival in the third trimester 2020QI "" 18 Granada Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 18 Granada Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 18 Granada Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 18 Granada Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 18 Granada Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 18 Granada Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 18 Granada Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 18 Granada Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 18 Granada Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 18 Granada Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 18 Granada Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 18 Granada Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 18 Granada Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,2 18 Granada Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,77 18 Granada Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 82,16 18 Granada Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 87,93 18 Granada Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 89,24 18 Granada Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 78,65 18 Granada Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 83,99 18 Granada Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 85,73 18 Granada Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 75,66 18 Granada Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 81,32 18 Granada Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 82,95 18 Granada Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 72,66 18 Granada Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Granada Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Granada Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 20.140 18 Granada Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 17.303 18 Granada Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 18.746 18 Granada Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 16.148 18 Granada Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 17.674 18 Granada Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 15.328 18 Granada Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 16.879 18 Granada Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 14.686 18 Granada Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 16.331 18 Granada Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 14.204 18 Granada Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 18 Granada Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 18 Granada Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,08 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,32 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 87,76 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 88,59 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 83,81 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 84,88 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 81,09 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 82,09 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 782 18 Granada Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2.421 18 Granada Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Granada Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Granada Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 18 Granada Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 753 18 Granada Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Granada Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Granada Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 18 Granada Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2.347 18 Granada Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Granada Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Granada Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 18 Granada Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 18 Granada Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Granada Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Granada Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 722 18 Granada Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 18 Granada Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Granada Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Granada Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2.274 18 Granada Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 18 Granada Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Granada Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Granada Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 18 Granada Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 18 Granada Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 693 18 Granada Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2.223 18 Granada Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 682 18 Granada Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2.157 18 Granada Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 18 Granada Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 18 Granada Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,29 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,94 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,33 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 93,93 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 88,62 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 91,82 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 87,21 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 89,1 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 18 Granada Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 18 Granada Total Cohort April 1 Total Number at the start of the quarter 2022QII 21.067 18 Granada Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 18 Granada Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 18 Granada Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 18 Granada Total Cohort April 1 Total Number at the start of the quarter 2021QII 20.052 18 Granada Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 18 Granada Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 18 Granada Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 18 Granada Total Cohort April 1 Total Number at the start of the quarter 2020QII 18.592 18 Granada Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 18 Granada Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 18 Granada Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 18 Granada Total Cohort April 1 Total Survival in the first trimester 2022QII 19.637 18 Granada Total Cohort April 1 Total Survival in the first trimester 2022QI "" 18 Granada Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 18 Granada Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 18 Granada Total Cohort April 1 Total Survival in the first trimester 2021QII 18.849 18 Granada Total Cohort April 1 Total Survival in the first trimester 2021QI "" 18 Granada Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 18 Granada Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 18 Granada Total Cohort April 1 Total Survival in the first trimester 2020QII 17.668 18 Granada Total Cohort April 1 Total Survival in the first trimester 2020QI "" 18 Granada Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 18 Granada Total Cohort April 1 Total Survival in the second trimester 2022QIII 18.596 18 Granada Total Cohort April 1 Total Survival in the second trimester 2022QII "" 18 Granada Total Cohort April 1 Total Survival in the second trimester 2022QI "" 18 Granada Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 18 Granada Total Cohort April 1 Total Survival in the second trimester 2021QIII 17.924 18 Granada Total Cohort April 1 Total Survival in the second trimester 2021QII "" 18 Granada Total Cohort April 1 Total Survival in the second trimester 2021QI "" 18 Granada Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 18 Granada Total Cohort April 1 Total Survival in the second trimester 2020QIII 16.918 18 Granada Total Cohort April 1 Total Survival in the second trimester 2020QII "" 18 Granada Total Cohort April 1 Total Survival in the second trimester 2020QI "" 18 Granada Total Cohort April 1 Total Survival in the third trimester 2022QIV 17.839 18 Granada Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 18 Granada Total Cohort April 1 Total Survival in the third trimester 2022QII "" 18 Granada Total Cohort April 1 Total Survival in the third trimester 2022QI "" 18 Granada Total Cohort April 1 Total Survival in the third trimester 2021QIV 17.174 18 Granada Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 18 Granada Total Cohort April 1 Total Survival in the third trimester 2021QII "" 18 Granada Total Cohort April 1 Total Survival in the third trimester 2021QI "" 18 Granada Total Cohort April 1 Total Survival in the third trimester 2020QIV 16.136 18 Granada Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 18 Granada Total Cohort April 1 Total Survival in the third trimester 2020QII "" 18 Granada Total Cohort April 1 Total Survival in the third trimester 2020QI "" 18 Granada Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 18 Granada Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 18 Granada Total Cohort April 1 Total Survival in the third trimester 2022QII "" 18 Granada Total Cohort April 1 Total Survival in the third trimester 2022QI 16.450 18 Granada Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 18 Granada Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 18 Granada Total Cohort April 1 Total Survival in the third trimester 2021QII "" 18 Granada Total Cohort April 1 Total Survival in the third trimester 2021QI 15.534 18 Granada Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 18 Granada Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 18 Granada Total Cohort April 1 Total Survival in the third trimester 2020QII "" 18 Granada Total Cohort April 1 Total Survival in the third trimester 2020QI "" 18 Granada Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 18 Granada Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 18 Granada Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 18 Granada Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 18 Granada Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 18 Granada Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 18 Granada Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 18 Granada Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 18 Granada Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 18 Granada Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 18 Granada Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 18 Granada Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,21 18 Granada Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94 18 Granada Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,03 18 Granada Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 88,27 18 Granada Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 89,39 18 Granada Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91 18 Granada Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 84,68 18 Granada Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 85,65 18 Granada Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 86,79 18 Granada Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 82,04 18 Granada Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 83,55 18 Granada Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Granada Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Granada Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 20.280 18 Granada Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 18.256 18 Granada Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 14.635 18 Granada Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 18.897 18 Granada Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 17.129 18 Granada Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 13.773 18 Granada Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 17.887 18 Granada Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 16.248 18 Granada Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 13.126 18 Granada Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 17.153 18 Granada Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 15.547 18 Granada Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 12.483 18 Granada Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 14.877 18 Granada Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 11.983 18 Granada Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 18 Granada Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 18 Granada Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 18 Granada Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,18 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 93,83 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,11 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 88,2 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 89,69 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 84,58 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 85,16 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 85,3 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 81,49 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 81,88 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 787 18 Granada Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.796 18 Granada Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 3.957 18 Granada Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Granada Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Granada Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 740 18 Granada Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 18 Granada Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Granada Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Granada Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.720 18 Granada Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 18 Granada Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Granada Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Granada Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 3.895 18 Granada Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 18 Granada Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Granada Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 709 18 Granada Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 18 Granada Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 18 Granada Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Granada Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.676 18 Granada Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 18 Granada Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 18 Granada Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Granada Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 3.792 18 Granada Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 18 Granada Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 18 Granada Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 686 18 Granada Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.627 18 Granada Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 3.653 18 Granada Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.573 18 Granada Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 3.551 18 Granada Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 18 Granada Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 18 Granada Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 18 Granada Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 94,03 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 95,77 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,43 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 90,09 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,32 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,83 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 87,17 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 90,59 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 92,32 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 87,58 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 89,74 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 18 Granada Total Cohort July 1 Total Number at the start of the quarter 2022QIII 21.224 18 Granada Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 18 Granada Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 18 Granada Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 18 Granada Total Cohort July 1 Total Number at the start of the quarter 2021QIII 20.643 18 Granada Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 18 Granada Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 18 Granada Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 18 Granada Total Cohort July 1 Total Number at the start of the quarter 2020QIII 19.846 18 Granada Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 18 Granada Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 18 Granada Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 18 Granada Total Cohort July 1 Total Survival in the first trimester 2022QIII 19.715 18 Granada Total Cohort July 1 Total Survival in the first trimester 2022QII "" 18 Granada Total Cohort July 1 Total Survival in the first trimester 2022QI "" 18 Granada Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 18 Granada Total Cohort July 1 Total Survival in the first trimester 2021QIII 19.175 18 Granada Total Cohort July 1 Total Survival in the first trimester 2021QII "" 18 Granada Total Cohort July 1 Total Survival in the first trimester 2021QI "" 18 Granada Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 18 Granada Total Cohort July 1 Total Survival in the first trimester 2020QIII 18.549 18 Granada Total Cohort July 1 Total Survival in the first trimester 2020QII "" 18 Granada Total Cohort July 1 Total Survival in the first trimester 2020QI "" 18 Granada Total Cohort July 1 Total Survival in the second trimester 2022QIV 18.688 18 Granada Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 18 Granada Total Cohort July 1 Total Survival in the second trimester 2022QII "" 18 Granada Total Cohort July 1 Total Survival in the second trimester 2022QI "" 18 Granada Total Cohort July 1 Total Survival in the second trimester 2021QIV 18.143 18 Granada Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 18 Granada Total Cohort July 1 Total Survival in the second trimester 2021QII "" 18 Granada Total Cohort July 1 Total Survival in the second trimester 2021QI "" 18 Granada Total Cohort July 1 Total Survival in the second trimester 2020QIV 17.349 18 Granada Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 18 Granada Total Cohort July 1 Total Survival in the second trimester 2020QII "" 18 Granada Total Cohort July 1 Total Survival in the second trimester 2020QI "" 18 Granada Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 18 Granada Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 18 Granada Total Cohort July 1 Total Survival in the third trimester 2022QII "" 18 Granada Total Cohort July 1 Total Survival in the third trimester 2022QI 17.295 18 Granada Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 18 Granada Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 18 Granada Total Cohort July 1 Total Survival in the third trimester 2021QII "" 18 Granada Total Cohort July 1 Total Survival in the third trimester 2021QI 16.613 18 Granada Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 18 Granada Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 18 Granada Total Cohort July 1 Total Survival in the third trimester 2020QII "" 18 Granada Total Cohort July 1 Total Survival in the third trimester 2020QI "" 18 Granada Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 18 Granada Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 18 Granada Total Cohort July 1 Total Survival in the third trimester 2022QII 16.709 18 Granada Total Cohort July 1 Total Survival in the third trimester 2022QI "" 18 Granada Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 18 Granada Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 18 Granada Total Cohort July 1 Total Survival in the third trimester 2021QII 16.137 18 Granada Total Cohort July 1 Total Survival in the third trimester 2021QI "" 18 Granada Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 18 Granada Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 18 Granada Total Cohort July 1 Total Survival in the third trimester 2020QII "" 18 Granada Total Cohort July 1 Total Survival in the third trimester 2020QI "" 18 Granada Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 18 Granada Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 18 Granada Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 18 Granada Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 18 Granada Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 18 Granada Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 18 Granada Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 18 Granada Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 18 Granada Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 18 Granada Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 18 Granada Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 18 Granada Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,89 18 Granada Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,89 18 Granada Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 93,46 18 Granada Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 88,05 18 Granada Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 87,89 18 Granada Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 87,42 18 Granada Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 83,78 18 Granada Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 83,71 18 Granada Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 80,94 18 Granada Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 81,31 18 Granada Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Granada Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Granada Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 20.635 18 Granada Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 20.048 18 Granada Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 17.132 18 Granada Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 19.147 18 Granada Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 18.606 18 Granada Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 15.906 18 Granada Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 18.140 18 Granada Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 17.588 18 Granada Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 14.786 18 Granada Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 16.758 18 Granada Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 14.125 18 Granada Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 16.191 18 Granada Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 13.715 18 Granada Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 18 Granada Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 18 Granada Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 18 Granada Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,79 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,81 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 92,84 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,91 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 87,73 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 86,31 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 83,59 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 82,45 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 80,76 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 80,05 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 589 18 Granada Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 595 18 Granada Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2.714 18 Granada Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Granada Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 568 18 Granada Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 18 Granada Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 18 Granada Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Granada Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 569 18 Granada Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 18 Granada Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 18 Granada Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Granada Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2.643 18 Granada Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 18 Granada Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 18 Granada Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 548 18 Granada Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Granada Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 18 Granada Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 18 Granada Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 555 18 Granada Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Granada Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 18 Granada Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 18 Granada Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 2.563 18 Granada Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Granada Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 18 Granada Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 18 Granada Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 537 18 Granada Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2.488 18 Granada Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 518 18 Granada Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 2.422 18 Granada Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 18 Granada Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 18 Granada Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 18 Granada Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,43 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 95,63 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,38 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,04 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,28 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,44 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 90,25 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 91,67 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 87,06 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 89,24 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada Total Cohort October 1 Total Number at the start of the quarter 2022QIV 20.944 18 Granada Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 18 Granada Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 18 Granada Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 18 Granada Total Cohort October 1 Total Number at the start of the quarter 2021QIV 20.543 18 Granada Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 18 Granada Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 18 Granada Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 18 Granada Total Cohort October 1 Total Number at the start of the quarter 2020QIV 20.085 18 Granada Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 18 Granada Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 18 Granada Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 18 Granada Total Cohort October 1 Total Survival in the first trimester 2022QIV 19.609 18 Granada Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 18 Granada Total Cohort October 1 Total Survival in the first trimester 2022QII "" 18 Granada Total Cohort October 1 Total Survival in the first trimester 2022QI "" 18 Granada Total Cohort October 1 Total Survival in the first trimester 2021QIV 19.169 18 Granada Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 18 Granada Total Cohort October 1 Total Survival in the first trimester 2021QII "" 18 Granada Total Cohort October 1 Total Survival in the first trimester 2021QI "" 18 Granada Total Cohort October 1 Total Survival in the first trimester 2020QIV 18.343 18 Granada Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 18 Granada Total Cohort October 1 Total Survival in the first trimester 2020QII "" 18 Granada Total Cohort October 1 Total Survival in the first trimester 2020QI "" 18 Granada Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 18 Granada Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 18 Granada Total Cohort October 1 Total Survival in the second trimester 2022QII "" 18 Granada Total Cohort October 1 Total Survival in the second trimester 2022QI 18.157 18 Granada Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 18 Granada Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 18 Granada Total Cohort October 1 Total Survival in the second trimester 2021QII "" 18 Granada Total Cohort October 1 Total Survival in the second trimester 2021QI 17.443 18 Granada Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 18 Granada Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 18 Granada Total Cohort October 1 Total Survival in the second trimester 2020QII "" 18 Granada Total Cohort October 1 Total Survival in the second trimester 2020QI "" 18 Granada Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 18 Granada Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 18 Granada Total Cohort October 1 Total Survival in the third trimester 2022QII 17.419 18 Granada Total Cohort October 1 Total Survival in the third trimester 2022QI "" 18 Granada Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 18 Granada Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 18 Granada Total Cohort October 1 Total Survival in the third trimester 2021QII 16.849 18 Granada Total Cohort October 1 Total Survival in the third trimester 2021QI "" 18 Granada Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 18 Granada Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 18 Granada Total Cohort October 1 Total Survival in the third trimester 2020QII "" 18 Granada Total Cohort October 1 Total Survival in the third trimester 2020QI "" 18 Granada Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 18 Granada Total Cohort October 1 Total Survival in the third trimester 2022QIII 16.768 18 Granada Total Cohort October 1 Total Survival in the third trimester 2022QII "" 18 Granada Total Cohort October 1 Total Survival in the third trimester 2022QI "" 18 Granada Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 18 Granada Total Cohort October 1 Total Survival in the third trimester 2021QIII 16.288 18 Granada Total Cohort October 1 Total Survival in the third trimester 2021QII "" 18 Granada Total Cohort October 1 Total Survival in the third trimester 2021QI "" 18 Granada Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 18 Granada Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 18 Granada Total Cohort October 1 Total Survival in the third trimester 2020QII "" 18 Granada Total Cohort October 1 Total Survival in the third trimester 2020QI "" 18 Granada Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 18 Granada Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 18 Granada Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 18 Granada Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 18 Granada Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 18 Granada Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 18 Granada Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 18 Granada Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 18 Granada Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 18 Granada Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 18 Granada Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 18 Granada Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,63 18 Granada Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,31 18 Granada Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 91,33 18 Granada Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,39 18 Granada Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 86,85 18 Granada Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 84,79 18 Granada Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 83,89 18 Granada Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 81,62 18 Granada Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 81,1 18 Granada Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Granada Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Granada Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 20.405 18 Granada Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 19.662 18 Granada Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 17.472 18 Granada Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 19.090 18 Granada Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 18.322 18 Granada Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 15.823 18 Granada Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 17.349 18 Granada Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 14.999 18 Granada Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 16.651 18 Granada Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 14.468 18 Granada Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 16.028 18 Granada Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 13.960 18 Granada Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 18 Granada Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 18 Granada Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 18 Granada Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,56 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 93,18 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 90,56 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,24 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 85,85 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 84,69 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 82,81 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 81,52 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 79,9 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 539 18 Granada Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 881 18 Granada Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 2.613 18 Granada Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 519 18 Granada Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Granada Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 18 Granada Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 18 Granada Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 847 18 Granada Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Granada Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 18 Granada Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 18 Granada Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2.520 18 Granada Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Granada Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 18 Granada Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 18 Granada Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Granada Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Granada Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 18 Granada Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 808 18 Granada Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Granada Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Granada Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 18 Granada Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2.444 18 Granada Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Granada Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Granada Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 18 Granada Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 18 Granada Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 768 18 Granada Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2.381 18 Granada Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 740 18 Granada Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2.328 18 Granada Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 18 Granada Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 18 Granada Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 18 Granada Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,29 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,14 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,44 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91,71 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 93,53 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 87,17 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 91,12 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 84 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 89,09 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 18 Granada From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 18 Granada From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 18 Granada From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 16.244 18 Granada From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 18 Granada From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 18 Granada From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 18 Granada From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 15.656 18 Granada From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 16.677 18 Granada From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 14.894 18 Granada From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 14.482 18 Granada From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 13.113 18 Granada From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 13.933 18 Granada From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 13.671 18 Granada From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 12.451 18 Granada From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 13.174 18 Granada From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 13.029 18 Granada From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 11.868 18 Granada From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 12.663 18 Granada From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 12.522 18 Granada From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 11.303 18 Granada From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 18 Granada From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 18 Granada From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 18 Granada From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 18 Granada From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 18 Granada From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 18 Granada From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 18 Granada From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 18 Granada From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 91,69 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 92,5 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 78,63 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 85,77 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 87,32 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 74,66 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 81,1 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 83,22 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 71,16 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 77,95 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 79,98 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 67,78 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 15.703 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 14.266 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 14.381 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 13.154 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 13.445 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 12.405 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 12.713 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 11.803 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 12.212 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 11.346 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 91,58 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 92,21 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 85,62 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 86,95 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 80,96 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 82,74 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 77,77 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 79,53 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 541 18 Granada From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.390 18 Granada From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 513 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.328 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 488 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.266 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 461 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.226 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 451 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.176 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 18 Granada From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 18 Granada From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,82 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,54 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,2 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 91,08 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 85,21 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 88,2 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 83,36 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 84,6 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 18 Granada From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 18 Granada From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 16.369 18 Granada From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 18 Granada From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 18 Granada From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 18 Granada From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 15.904 18 Granada From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 18 Granada From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 18 Granada From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 18 Granada From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 14.701 18 Granada From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 15.065 18 Granada From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 14.792 18 Granada From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 13.834 18 Granada From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 14.088 18 Granada From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 13.926 18 Granada From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 13.124 18 Granada From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 13.398 18 Granada From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 13.227 18 Granada From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 12.399 18 Granada From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 12.568 18 Granada From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 11.850 18 Granada From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 18 Granada From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 18 Granada From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 18 Granada From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 18 Granada From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 18 Granada From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 18 Granada From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 18 Granada From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 18 Granada From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 18 Granada From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 18 Granada From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 18 Granada From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 18 Granada From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 92,03 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 93,01 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,1 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 86,07 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 87,56 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 89,27 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 81,85 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 83,17 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 84,34 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 79,02 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 80,61 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 15.806 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 14.814 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 12.249 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 14.542 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 13.761 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 11.433 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 13.595 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 12.931 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 10.817 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 12.927 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 12.273 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 10.212 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 11.658 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 9.747 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 92 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 92,89 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 93,34 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 86,01 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 87,29 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 88,31 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 81,79 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 82,85 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 83,37 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 78,7 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 79,57 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 563 18 Granada From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.090 18 Granada From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.452 18 Granada From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 523 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.031 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.401 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 493 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 995 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.307 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 471 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 954 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.187 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 910 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.103 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 18 Granada From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 18 Granada From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 18 Granada From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 92,9 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 94,59 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,92 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 87,57 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 91,28 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,09 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 83,66 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 87,52 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 89,19 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 83,49 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 85,77 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 18 Granada From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 16.483 18 Granada From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 18 Granada From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 18 Granada From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 18 Granada From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 16.263 18 Granada From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 18 Granada From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 18 Granada From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 18 Granada From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 15.681 18 Granada From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 15.039 18 Granada From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 14.859 18 Granada From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 14.435 18 Granada From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 14.103 18 Granada From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 13.906 18 Granada From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 13.320 18 Granada From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 13.131 18 Granada From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 12.647 18 Granada From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 12.595 18 Granada From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 12.204 18 Granada From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 18 Granada From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 18 Granada From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 18 Granada From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 18 Granada From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 18 Granada From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 18 Granada From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 18 Granada From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 18 Granada From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 18 Granada From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 18 Granada From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 91,24 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 91,37 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 92,05 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 85,56 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 85,51 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 84,94 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 80,74 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 80,65 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 77,45 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 77,83 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 16.092 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 15.895 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 14.158 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 14.669 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 14.512 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 12.976 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 13.750 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 13.571 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 11.927 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 12.813 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 11.316 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 12.293 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 10.927 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 91,16 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 91,3 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 91,65 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 85,45 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 85,38 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 84,24 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 80,61 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 79,93 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 77,34 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 77,18 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 391 18 Granada From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 368 18 Granada From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.523 18 Granada From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 370 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 347 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.459 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 353 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 335 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.393 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 318 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.331 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 302 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.277 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 18 Granada From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 18 Granada From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 18 Granada From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 94,63 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 94,29 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 95,8 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 90,28 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 91,03 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 91,46 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 86,41 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 87,39 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 82,07 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 83,85 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 16.225 18 Granada From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 18 Granada From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 18 Granada From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 16.097 18 Granada From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 18 Granada From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 18 Granada From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 15.879 18 Granada From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 14.969 18 Granada From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 14.785 18 Granada From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 14.209 18 Granada From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 13.851 18 Granada From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 13.373 18 Granada From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 13.187 18 Granada From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 12.826 18 Granada From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 12.578 18 Granada From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 12.311 18 Granada From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 18 Granada From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 18 Granada From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 18 Granada From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 18 Granada From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 18 Granada From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 18 Granada From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 18 Granada From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 92,26 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 91,85 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 89,48 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 86,05 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 84,22 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 81,92 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 80,77 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 78,14 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 77,53 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 15.882 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 15.441 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 14.429 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 14.644 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 14.159 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 12.837 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 13.261 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 12.063 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 12.635 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 11.572 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 12.052 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 11.096 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 92,21 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 91,7 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 88,97 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 85,88 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 83,6 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 81,83 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 80,2 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 78,05 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 76,9 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 343 18 Granada From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 656 18 Granada From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.450 18 Granada From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 325 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 626 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.372 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 590 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.310 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 552 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.254 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 526 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.215 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 18 Granada From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 18 Granada From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 18 Granada From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 94,75 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,43 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 94,62 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 89,94 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 90,34 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 84,15 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 86,48 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 80,18 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 83,79 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 2.112 18 Granada From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 1.850 18 Granada From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 2.085 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 2.070 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 1.818 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 1.922 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 1.991 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 1.769 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 1.873 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 1.949 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 1.740 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 1.843 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 1.921 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 1.717 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 1.813 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 18 Granada From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 18 Granada From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,01 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,27 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 92,18 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 94,27 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 95,62 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 89,83 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 92,28 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 94,05 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 88,39 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 90,96 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 92,81 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 86,95 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.022 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.454 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.981 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.428 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.904 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.380 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.863 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.355 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.836 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.339 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 97,97 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,21 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 94,16 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 94,91 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 92,14 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 93,19 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 90,8 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 92,09 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 90 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 396 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 89 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 390 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 87 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 389 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 86 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 385 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 85 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 378 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,89 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,48 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96,67 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,23 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 95,56 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,22 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,44 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,45 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 2.111 18 Granada From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 1.883 18 Granada From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 1.716 18 Granada From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 2.036 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 1.832 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 1.682 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 1.993 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 1.795 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 1.662 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 1.949 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 1.767 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 1.630 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 1.732 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 1.591 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 18 Granada From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 18 Granada From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 18 Granada From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 96,45 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 97,29 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,02 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 94,41 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 95,33 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 96,85 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 92,33 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 93,84 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 94,99 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 91,98 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 92,72 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.032 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.615 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.092 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.960 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.566 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.065 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.918 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.533 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.050 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.874 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.509 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.030 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.478 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.004 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 96,46 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 96,97 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 97,53 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 94,39 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 94,92 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 96,15 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 92,22 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 93,44 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 94,32 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 91,52 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 91,94 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 79 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 268 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 624 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 76 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 266 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 617 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 75 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 262 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 612 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 75 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 258 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 600 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 254 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 587 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,2 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,25 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,88 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,94 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,76 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,08 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 94,94 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,27 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,15 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 94,78 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,07 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 2.091 18 Granada From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 1.998 18 Granada From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 1.906 18 Granada From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 2.049 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 1.956 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 1.877 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 1.996 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 1.907 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 1.824 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 1.871 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 1.779 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 1.845 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 1.761 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 18 Granada From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 18 Granada From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 18 Granada From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,99 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 97,9 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,48 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 95,46 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 95,45 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 95,7 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 93,64 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 93,34 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 92,34 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 92,39 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.028 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.909 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.437 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.986 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.868 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.412 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.933 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.820 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.367 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.785 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.331 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.760 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.316 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,93 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 97,85 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,26 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 95,32 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 95,34 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 95,13 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 93,5 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 92,62 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 92,19 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 91,58 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 63 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 89 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 469 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 63 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 88 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 465 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 63 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 87 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 457 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 86 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 448 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 85 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 445 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,88 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,15 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,75 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,44 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 96,63 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95,52 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 95,51 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 94,88 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 2.075 18 Granada From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 1.983 18 Granada From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 1.920 18 Granada From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 2.026 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 1.945 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 1.879 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 1.904 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 1.834 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 1.861 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 1.806 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 1.836 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 1.782 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 18 Granada From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 18 Granada From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 18 Granada From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,64 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,08 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 97,86 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,02 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 95,52 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 93,85 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 94,06 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 92,59 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 92,81 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.008 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.903 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.451 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.960 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.867 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.417 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.827 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.382 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.785 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.356 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.761 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.340 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,61 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,11 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,66 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,01 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 95,24 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 93,8 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 93,45 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 92,54 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 92,35 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 67 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 80 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 469 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 66 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 78 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 462 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 77 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 452 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 76 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 450 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 75 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 442 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,51 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,5 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,51 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 96,25 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,38 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 95 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,95 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 93,75 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 94,24 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 18 Granada From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 18 Granada From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 18 Granada From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 2.438 18 Granada From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 18 Granada From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 18 Granada From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 18 Granada From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 2.104 18 Granada From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 2.449 18 Granada From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 2.407 18 Granada From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 2.081 18 Granada From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 2.372 18 Granada From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 2.345 18 Granada From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 2.048 18 Granada From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 2.335 18 Granada From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 2.322 18 Granada From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 2.026 18 Granada From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 2.309 18 Granada From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 2.302 18 Granada From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 2.009 18 Granada From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 2.264 18 Granada From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 18 Granada From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 18 Granada From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 18 Granada From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 18 Granada From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 18 Granada From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 18 Granada From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 18 Granada From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 18 Granada From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,73 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,91 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,86 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,19 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,34 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,35 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 95,24 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,29 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,28 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 94,42 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,48 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 92,45 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.296 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.505 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.265 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.488 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.207 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.465 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.185 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.450 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.165 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.442 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,65 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,87 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,12 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,34 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,17 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,35 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 94,29 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,81 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 142 18 Granada From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 599 18 Granada From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 142 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 593 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 138 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 583 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 137 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 576 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 137 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 567 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 18 Granada From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 18 Granada From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,18 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,33 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,48 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,16 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,48 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 94,66 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 18 Granada From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 18 Granada From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 2.461 18 Granada From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 18 Granada From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 18 Granada From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 18 Granada From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 2.156 18 Granada From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 18 Granada From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 18 Granada From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 18 Granada From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 2.068 18 Granada From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 2.411 18 Granada From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 2.116 18 Granada From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 2.045 18 Granada From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 2.390 18 Granada From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 2.094 18 Granada From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 2.025 18 Granada From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 2.367 18 Granada From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 2.072 18 Granada From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 2.001 18 Granada From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 2.042 18 Granada From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 1.987 18 Granada From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 18 Granada From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 18 Granada From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 18 Granada From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 18 Granada From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 18 Granada From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 18 Granada From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 18 Granada From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 18 Granada From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 18 Granada From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 18 Granada From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 18 Granada From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 18 Granada From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,97 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,14 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,89 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,11 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,12 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,92 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,18 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,1 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,76 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,71 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,08 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.332 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.746 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.224 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.286 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.721 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.205 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.265 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.703 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.189 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.243 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.685 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.171 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.661 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.162 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,03 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,57 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,45 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,13 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,54 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,14 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,18 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,51 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,67 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,13 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,93 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 129 18 Granada From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 410 18 Granada From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 844 18 Granada From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 125 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 395 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 840 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 125 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 391 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 836 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 124 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 387 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 830 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 381 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 825 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 18 Granada From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 18 Granada From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 18 Granada From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,9 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,34 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,53 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 96,9 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,37 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,05 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,12 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,39 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,34 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 92,93 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 97,75 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 18 Granada From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 2.520 18 Granada From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 18 Granada From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 18 Granada From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 18 Granada From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 2.266 18 Granada From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 18 Granada From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 18 Granada From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 18 Granada From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 2.159 18 Granada From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 2.497 18 Granada From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 2.244 18 Granada From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 2.137 18 Granada From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 2.459 18 Granada From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 2.215 18 Granada From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 2.106 18 Granada From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 2.178 18 Granada From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 2.088 18 Granada From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 2.154 18 Granada From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 2.073 18 Granada From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 18 Granada From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 18 Granada From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 18 Granada From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 18 Granada From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 18 Granada From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 18 Granada From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 18 Granada From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 18 Granada From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 18 Granada From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 18 Granada From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,09 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,03 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,98 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,58 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,75 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,55 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,12 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,71 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,06 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,02 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.398 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.140 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.471 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.375 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.122 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.452 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.340 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.094 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.426 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.057 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.412 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.035 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.406 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,04 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,16 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,71 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,58 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,85 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,94 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,12 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,99 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,09 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,58 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 122 18 Granada From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 126 18 Granada From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 688 18 Granada From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 122 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 122 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 685 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 119 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 121 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 680 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 121 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 676 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 119 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 667 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 18 Granada From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 18 Granada From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 18 Granada From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,83 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,56 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,54 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,03 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,84 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 96,03 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,26 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 94,44 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,95 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 2.504 18 Granada From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 18 Granada From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 18 Granada From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 2.342 18 Granada From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 18 Granada From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 18 Granada From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 2.171 18 Granada From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 2.474 18 Granada From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 2.319 18 Granada From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 2.142 18 Granada From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 2.282 18 Granada From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 2.123 18 Granada From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 2.251 18 Granada From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 2.104 18 Granada From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 2.234 18 Granada From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 2.082 18 Granada From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 18 Granada From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 18 Granada From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 18 Granada From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 18 Granada From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 18 Granada From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 18 Granada From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 18 Granada From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,8 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,02 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,66 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,44 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,79 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,11 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,91 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,39 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,9 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.389 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.209 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.516 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.360 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.188 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.494 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.153 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.479 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.123 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.465 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.107 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.449 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,79 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,05 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,55 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,46 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,56 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,11 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,64 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,38 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,58 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 115 18 Granada From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 133 18 Granada From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 655 18 Granada From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 114 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 131 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 648 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 129 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 644 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 128 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 639 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 127 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 633 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 18 Granada From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 18 Granada From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 18 Granada From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,13 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,5 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,93 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 96,99 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,32 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,24 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,56 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 95,49 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,64 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 18 Granada from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 18 Granada from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 18 Granada from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 92 18 Granada from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 18 Granada from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 18 Granada from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 18 Granada from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 77 18 Granada from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 83 18 Granada from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 92 18 Granada from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 77 18 Granada from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 82 18 Granada from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 91 18 Granada from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 77 18 Granada from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 82 18 Granada from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 91 18 Granada from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 77 18 Granada from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 82 18 Granada from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 91 18 Granada from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 76 18 Granada from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 82 18 Granada from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 18 Granada from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 18 Granada from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 18 Granada from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 18 Granada from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 18 Granada from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 18 Granada from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 18 Granada from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 18 Granada from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,8 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,91 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,8 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,91 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,8 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,91 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,7 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,8 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 86 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 54 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 86 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 54 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 85 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 54 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 85 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 54 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 85 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 53 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,84 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,84 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,84 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,15 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 6 18 Granada from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 23 18 Granada from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 6 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 23 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 6 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 23 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 6 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 23 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 6 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 23 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 18 Granada from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 18 Granada from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 18 Granada from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 18 Granada from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 87 18 Granada from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 18 Granada from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 18 Granada from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 18 Granada from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 75 18 Granada from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 18 Granada from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 18 Granada from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 18 Granada from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 74 18 Granada from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 86 18 Granada from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 75 18 Granada from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 74 18 Granada from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 86 18 Granada from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 75 18 Granada from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 74 18 Granada from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 86 18 Granada from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 74 18 Granada from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 73 18 Granada from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 74 18 Granada from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 73 18 Granada from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 18 Granada from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 18 Granada from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 18 Granada from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 18 Granada from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 18 Granada from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 18 Granada from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 18 Granada from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 18 Granada from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 18 Granada from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 18 Granada from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 18 Granada from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 18 Granada from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,85 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,85 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,85 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,67 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,65 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,67 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,65 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Granada from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 77 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 58 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 51 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 76 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 58 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 51 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 76 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 58 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 51 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 76 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 57 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 51 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 57 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 51 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,7 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,7 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,7 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98,28 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 98,28 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 10 18 Granada from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 17 18 Granada from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 23 18 Granada from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 10 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 17 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 23 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 10 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 17 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 23 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 10 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 17 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 22 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 17 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 22 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 18 Granada from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 18 Granada from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 18 Granada from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,65 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,65 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 18 Granada from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 97 18 Granada from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 18 Granada from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 18 Granada from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 18 Granada from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 85 18 Granada from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 18 Granada from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 18 Granada from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 18 Granada from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 75 18 Granada from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 97 18 Granada from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 85 18 Granada from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 75 18 Granada from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 97 18 Granada from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 84 18 Granada from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 74 18 Granada from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 84 18 Granada from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 74 18 Granada from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 84 18 Granada from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 74 18 Granada from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 18 Granada from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 18 Granada from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 18 Granada from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 18 Granada from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 18 Granada from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 18 Granada from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 18 Granada from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 18 Granada from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 18 Granada from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 18 Granada from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,82 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,67 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,82 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,67 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,82 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,67 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 89 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 76 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 52 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 89 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 76 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 52 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 89 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 75 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 52 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 75 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 52 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 75 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 52 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,68 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,68 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,68 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 8 18 Granada from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 9 18 Granada from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 23 18 Granada from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 8 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 9 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 23 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 8 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 9 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 22 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 9 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 22 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 9 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 22 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 18 Granada from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 18 Granada from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 18 Granada from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,65 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95,65 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,65 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 103 18 Granada from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 18 Granada from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 18 Granada from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 89 18 Granada from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 18 Granada from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 18 Granada from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 84 18 Granada from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 103 18 Granada from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 88 18 Granada from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 82 18 Granada from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 88 18 Granada from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 82 18 Granada from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 88 18 Granada from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 82 18 Granada from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 88 18 Granada from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 82 18 Granada from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 18 Granada from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 18 Granada from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 18 Granada from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 18 Granada from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 18 Granada from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 18 Granada from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 18 Granada from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,88 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 97,62 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,88 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,62 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,88 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,62 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,88 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,62 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 95 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 81 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 57 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 95 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 80 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 56 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 80 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 56 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 80 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 56 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 80 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 56 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,77 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,25 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,77 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,25 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,77 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,25 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,77 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,25 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 8 18 Granada from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 8 18 Granada from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 27 18 Granada from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 8 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 8 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 26 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 8 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 26 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 8 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 26 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 8 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 26 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 18 Granada from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 18 Granada from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 18 Granada from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,3 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,3 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 96,3 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,3 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 18 Granada De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 18 Granada De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 18 Granada De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 36 18 Granada De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 18 Granada De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 18 Granada De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 18 Granada De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 37 18 Granada De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 18 Granada De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 18 Granada De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 18 Granada De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 36 18 Granada De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 18 Granada De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 18 Granada De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 18 Granada De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 36 18 Granada De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 18 Granada De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 18 Granada De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 18 Granada De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 37 18 Granada De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 18 Granada De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 18 Granada De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 18 Granada De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 36 18 Granada De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 18 Granada De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 18 Granada De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 36 18 Granada De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 18 Granada De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 18 Granada De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 18 Granada De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 37 18 Granada De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 18 Granada De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 18 Granada De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 18 Granada De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 36 18 Granada De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 18 Granada De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 18 Granada De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 36 18 Granada De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 18 Granada De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 18 Granada De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 18 Granada De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 37 18 Granada De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 18 Granada De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 18 Granada De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 18 Granada De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 36 18 Granada De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 18 Granada De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 18 Granada De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 36 18 Granada De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 18 Granada De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 18 Granada De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 18 Granada De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 37 18 Granada De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 18 Granada De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 18 Granada De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 18 Granada De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 36 18 Granada De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 18 Granada De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 18 Granada De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 18 Granada De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 18 Granada De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 18 Granada De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 18 Granada De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 18 Granada De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 18 Granada De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 18 Granada De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 18 Granada De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 18 Granada De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 18 Granada De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 18 Granada De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 18 Granada De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Granada De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 33 18 Granada De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 24 18 Granada De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 33 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 24 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 33 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 24 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 33 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 24 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 33 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 24 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 18 Granada De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 18 Granada De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 3 18 Granada De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 13 18 Granada De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 3 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 13 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 3 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 13 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 3 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 13 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 3 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 13 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 18 Granada De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 18 Granada De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 18 Granada De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 18 Granada De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 39 18 Granada De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 18 Granada De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 18 Granada De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 18 Granada De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 34 18 Granada De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 18 Granada De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 18 Granada De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 18 Granada De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 33 18 Granada De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 18 Granada De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 18 Granada De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 18 Granada De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 39 18 Granada De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 18 Granada De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 18 Granada De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 18 Granada De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 34 18 Granada De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 18 Granada De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 18 Granada De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 18 Granada De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 33 18 Granada De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 18 Granada De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 18 Granada De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 39 18 Granada De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 18 Granada De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 18 Granada De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 18 Granada De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 34 18 Granada De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 18 Granada De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 18 Granada De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 18 Granada De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 33 18 Granada De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 18 Granada De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 18 Granada De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 39 18 Granada De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 18 Granada De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 18 Granada De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 18 Granada De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 34 18 Granada De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 18 Granada De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 18 Granada De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 18 Granada De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 33 18 Granada De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 18 Granada De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 18 Granada De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 18 Granada De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 18 Granada De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 18 Granada De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 18 Granada De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 34 18 Granada De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 18 Granada De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 18 Granada De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 18 Granada De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 33 18 Granada De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 18 Granada De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 18 Granada De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 18 Granada De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 18 Granada De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 18 Granada De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 18 Granada De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 18 Granada De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 18 Granada De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 18 Granada De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 18 Granada De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 18 Granada De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 18 Granada De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 18 Granada De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 18 Granada De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 18 Granada De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Granada De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 33 18 Granada De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 23 18 Granada De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 19 18 Granada De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 33 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 23 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 19 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 33 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 23 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 19 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 33 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 23 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 19 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 23 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 19 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 18 Granada De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 18 Granada De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 18 Granada De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 6 18 Granada De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 11 18 Granada De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 14 18 Granada De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 6 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 11 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 14 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 6 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 11 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 14 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 6 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 11 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 14 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 11 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 14 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 18 Granada De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 18 Granada De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 18 Granada De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 18 Granada De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 33 18 Granada De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 18 Granada De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 18 Granada De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 18 Granada De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 31 18 Granada De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 18 Granada De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 18 Granada De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 18 Granada De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 25 18 Granada De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 18 Granada De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 18 Granada De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 18 Granada De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 33 18 Granada De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 18 Granada De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 18 Granada De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 18 Granada De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 31 18 Granada De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 18 Granada De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 18 Granada De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 18 Granada De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 25 18 Granada De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 18 Granada De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 18 Granada De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 33 18 Granada De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 18 Granada De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 18 Granada De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 18 Granada De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 31 18 Granada De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 18 Granada De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 18 Granada De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 18 Granada De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 25 18 Granada De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 18 Granada De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 18 Granada De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 18 Granada De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 18 Granada De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 18 Granada De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 18 Granada De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 31 18 Granada De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 18 Granada De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 18 Granada De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 18 Granada De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 25 18 Granada De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 18 Granada De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 18 Granada De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 18 Granada De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 18 Granada De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 18 Granada De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 18 Granada De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 31 18 Granada De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 18 Granada De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 18 Granada De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 18 Granada De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 25 18 Granada De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 18 Granada De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 18 Granada De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 18 Granada De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 18 Granada De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 18 Granada De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 18 Granada De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 18 Granada De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 18 Granada De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 18 Granada De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 18 Granada De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 18 Granada De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 18 Granada De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 18 Granada De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 18 Granada De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 18 Granada De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 18 Granada De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Granada De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 28 18 Granada De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 28 18 Granada De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 14 18 Granada De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 28 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 28 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 14 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 28 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 28 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 14 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 28 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 14 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 28 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 14 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 18 Granada De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 18 Granada De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 18 Granada De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 5 18 Granada De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 3 18 Granada De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 11 18 Granada De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 5 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 3 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 11 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 5 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 3 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 11 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 3 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 11 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 3 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 11 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 18 Granada De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 18 Granada De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 18 Granada De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 18 Granada De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 18 Granada De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 18 Granada De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 37 18 Granada De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 18 Granada De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 18 Granada De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 18 Granada De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 32 18 Granada De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 18 Granada De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 18 Granada De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 18 Granada De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 31 18 Granada De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 18 Granada De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 18 Granada De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 18 Granada De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 37 18 Granada De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 18 Granada De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 18 Granada De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 18 Granada De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 32 18 Granada De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 18 Granada De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 18 Granada De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 18 Granada De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 31 18 Granada De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 18 Granada De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 18 Granada De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 18 Granada De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 18 Granada De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 18 Granada De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 18 Granada De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 32 18 Granada De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 18 Granada De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 18 Granada De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 18 Granada De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 31 18 Granada De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 18 Granada De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 18 Granada De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 18 Granada De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 18 Granada De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 18 Granada De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 18 Granada De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 32 18 Granada De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 18 Granada De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 18 Granada De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 18 Granada De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 31 18 Granada De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 18 Granada De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 18 Granada De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 18 Granada De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 18 Granada De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 18 Granada De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 18 Granada De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 32 18 Granada De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 18 Granada De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 18 Granada De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 18 Granada De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 31 18 Granada De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 18 Granada De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 18 Granada De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 18 Granada De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 18 Granada De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 18 Granada De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 18 Granada De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 18 Granada De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 18 Granada De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 18 Granada De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 18 Granada De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 18 Granada De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 18 Granada De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 18 Granada De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 18 Granada De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 18 Granada De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 18 Granada De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 18 Granada De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 18 Granada De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 31 18 Granada De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 28 18 Granada De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 19 18 Granada De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 31 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 28 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 19 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 28 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 19 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 28 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 19 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 28 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 19 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 18 Granada De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 18 Granada De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 18 Granada De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 6 18 Granada De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 4 18 Granada De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 12 18 Granada De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 6 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 4 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 12 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 4 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 12 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 4 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 12 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 4 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 12 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 18 Granada De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 18 Granada De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 18 Granada De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 18 Granada De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara Total Cohort January 1 Total Number at the start of the quarter 2022QI 4.812 19 Guadalajara Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara Total Cohort January 1 Total Number at the start of the quarter 2021QI 4.558 19 Guadalajara Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara Total Cohort January 1 Total Number at the start of the quarter 2020QI 4.744 19 Guadalajara Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 19 Guadalajara Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 19 Guadalajara Total Cohort January 1 Total Survival in the first trimester 2022QII "" 19 Guadalajara Total Cohort January 1 Total Survival in the first trimester 2022QI 4.535 19 Guadalajara Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 19 Guadalajara Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 19 Guadalajara Total Cohort January 1 Total Survival in the first trimester 2021QII "" 19 Guadalajara Total Cohort January 1 Total Survival in the first trimester 2021QI 4.306 19 Guadalajara Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 19 Guadalajara Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 19 Guadalajara Total Cohort January 1 Total Survival in the first trimester 2020QII "" 19 Guadalajara Total Cohort January 1 Total Survival in the first trimester 2020QI 4.166 19 Guadalajara Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 19 Guadalajara Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 19 Guadalajara Total Cohort January 1 Total Survival in the second trimester 2022QII 4.311 19 Guadalajara Total Cohort January 1 Total Survival in the second trimester 2022QI "" 19 Guadalajara Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 19 Guadalajara Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 19 Guadalajara Total Cohort January 1 Total Survival in the second trimester 2021QII 4.161 19 Guadalajara Total Cohort January 1 Total Survival in the second trimester 2021QI "" 19 Guadalajara Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 19 Guadalajara Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 19 Guadalajara Total Cohort January 1 Total Survival in the second trimester 2020QII 4.025 19 Guadalajara Total Cohort January 1 Total Survival in the second trimester 2020QI "" 19 Guadalajara Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara Total Cohort January 1 Total Survival in the third trimester 2022QIII 4.129 19 Guadalajara Total Cohort January 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara Total Cohort January 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara Total Cohort January 1 Total Survival in the third trimester 2021QIII 4.020 19 Guadalajara Total Cohort January 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara Total Cohort January 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara Total Cohort January 1 Total Survival in the third trimester 2020QIII 3.903 19 Guadalajara Total Cohort January 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara Total Cohort January 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara Total Cohort January 1 Total Survival in the third trimester 2022QIV 4.018 19 Guadalajara Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara Total Cohort January 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara Total Cohort January 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara Total Cohort January 1 Total Survival in the third trimester 2021QIV 3.915 19 Guadalajara Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara Total Cohort January 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara Total Cohort January 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara Total Cohort January 1 Total Survival in the third trimester 2020QIV 3.774 19 Guadalajara Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara Total Cohort January 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara Total Cohort January 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 19 Guadalajara Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 19 Guadalajara Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,24 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,47 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 87,82 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,59 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,29 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 84,84 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 85,81 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 88,2 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 82,27 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 83,5 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,89 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 79,55 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 4.577 19 Guadalajara Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 4.033 19 Guadalajara Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 4.305 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 3.796 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 4.088 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 3.657 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 3.912 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 3.532 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 3.803 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 3.435 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 19 Guadalajara Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 19 Guadalajara Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,06 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,12 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,32 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,68 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 85,47 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,58 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 83,09 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,17 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 235 19 Guadalajara Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 525 19 Guadalajara Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 230 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 510 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 223 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 504 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 217 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 488 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 215 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 480 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 19 Guadalajara Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 19 Guadalajara Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,87 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,14 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 94,89 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 92,34 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,95 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 91,49 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 91,43 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara Total Cohort April 1 Total Number at the start of the quarter 2022QII 4.812 19 Guadalajara Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara Total Cohort April 1 Total Number at the start of the quarter 2021QII 4.573 19 Guadalajara Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara Total Cohort April 1 Total Number at the start of the quarter 2020QII 4.361 19 Guadalajara Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 19 Guadalajara Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 19 Guadalajara Total Cohort April 1 Total Survival in the first trimester 2022QII 4.538 19 Guadalajara Total Cohort April 1 Total Survival in the first trimester 2022QI "" 19 Guadalajara Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 19 Guadalajara Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 19 Guadalajara Total Cohort April 1 Total Survival in the first trimester 2021QII 4.367 19 Guadalajara Total Cohort April 1 Total Survival in the first trimester 2021QI "" 19 Guadalajara Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 19 Guadalajara Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 19 Guadalajara Total Cohort April 1 Total Survival in the first trimester 2020QII 4.190 19 Guadalajara Total Cohort April 1 Total Survival in the first trimester 2020QI "" 19 Guadalajara Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 19 Guadalajara Total Cohort April 1 Total Survival in the second trimester 2022QIII 4.320 19 Guadalajara Total Cohort April 1 Total Survival in the second trimester 2022QII "" 19 Guadalajara Total Cohort April 1 Total Survival in the second trimester 2022QI "" 19 Guadalajara Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 19 Guadalajara Total Cohort April 1 Total Survival in the second trimester 2021QIII 4.180 19 Guadalajara Total Cohort April 1 Total Survival in the second trimester 2021QII "" 19 Guadalajara Total Cohort April 1 Total Survival in the second trimester 2021QI "" 19 Guadalajara Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 19 Guadalajara Total Cohort April 1 Total Survival in the second trimester 2020QIII 4.043 19 Guadalajara Total Cohort April 1 Total Survival in the second trimester 2020QII "" 19 Guadalajara Total Cohort April 1 Total Survival in the second trimester 2020QI "" 19 Guadalajara Total Cohort April 1 Total Survival in the third trimester 2022QIV 4.182 19 Guadalajara Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara Total Cohort April 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara Total Cohort April 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara Total Cohort April 1 Total Survival in the third trimester 2021QIV 4.049 19 Guadalajara Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara Total Cohort April 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara Total Cohort April 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara Total Cohort April 1 Total Survival in the third trimester 2020QIV 3.894 19 Guadalajara Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara Total Cohort April 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara Total Cohort April 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara Total Cohort April 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara Total Cohort April 1 Total Survival in the third trimester 2022QI 3.919 19 Guadalajara Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara Total Cohort April 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara Total Cohort April 1 Total Survival in the third trimester 2021QI 3.764 19 Guadalajara Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara Total Cohort April 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara Total Cohort April 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 19 Guadalajara Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 19 Guadalajara Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 19 Guadalajara Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,31 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,5 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,08 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,78 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,41 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,71 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 86,91 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 88,54 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,29 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 85,7 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 86,31 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 4.585 19 Guadalajara Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 4.012 19 Guadalajara Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 3.394 19 Guadalajara Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 4.317 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 3.812 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 3.234 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 4.106 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 3.642 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 3.109 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 3.969 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 3.521 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.993 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 3.402 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.891 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 19 Guadalajara Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 19 Guadalajara Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 19 Guadalajara Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,15 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,01 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,29 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 89,55 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 90,78 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,6 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 86,56 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 87,76 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,19 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 84,8 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 85,18 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 227 19 Guadalajara Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 561 19 Guadalajara Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 967 19 Guadalajara Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 221 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 555 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 956 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 214 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 538 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 934 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 213 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 528 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 901 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 517 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 873 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 19 Guadalajara Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 19 Guadalajara Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 19 Guadalajara Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,36 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,93 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,86 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,27 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,9 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,59 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 93,83 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,12 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,17 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 92,16 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 90,28 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara Total Cohort July 1 Total Number at the start of the quarter 2022QIII 4.847 19 Guadalajara Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara Total Cohort July 1 Total Number at the start of the quarter 2021QIII 4.727 19 Guadalajara Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara Total Cohort July 1 Total Number at the start of the quarter 2020QIII 4.513 19 Guadalajara Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 19 Guadalajara Total Cohort July 1 Total Survival in the first trimester 2022QIII 4.547 19 Guadalajara Total Cohort July 1 Total Survival in the first trimester 2022QII "" 19 Guadalajara Total Cohort July 1 Total Survival in the first trimester 2022QI "" 19 Guadalajara Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 19 Guadalajara Total Cohort July 1 Total Survival in the first trimester 2021QIII 4.429 19 Guadalajara Total Cohort July 1 Total Survival in the first trimester 2021QII "" 19 Guadalajara Total Cohort July 1 Total Survival in the first trimester 2021QI "" 19 Guadalajara Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 19 Guadalajara Total Cohort July 1 Total Survival in the first trimester 2020QIII 4.285 19 Guadalajara Total Cohort July 1 Total Survival in the first trimester 2020QII "" 19 Guadalajara Total Cohort July 1 Total Survival in the first trimester 2020QI "" 19 Guadalajara Total Cohort July 1 Total Survival in the second trimester 2022QIV 4.359 19 Guadalajara Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 19 Guadalajara Total Cohort July 1 Total Survival in the second trimester 2022QII "" 19 Guadalajara Total Cohort July 1 Total Survival in the second trimester 2022QI "" 19 Guadalajara Total Cohort July 1 Total Survival in the second trimester 2021QIV 4.260 19 Guadalajara Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 19 Guadalajara Total Cohort July 1 Total Survival in the second trimester 2021QII "" 19 Guadalajara Total Cohort July 1 Total Survival in the second trimester 2021QI "" 19 Guadalajara Total Cohort July 1 Total Survival in the second trimester 2020QIV 4.100 19 Guadalajara Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 19 Guadalajara Total Cohort July 1 Total Survival in the second trimester 2020QII "" 19 Guadalajara Total Cohort July 1 Total Survival in the second trimester 2020QI "" 19 Guadalajara Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara Total Cohort July 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara Total Cohort July 1 Total Survival in the third trimester 2022QI 4.106 19 Guadalajara Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara Total Cohort July 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara Total Cohort July 1 Total Survival in the third trimester 2021QI 3.946 19 Guadalajara Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara Total Cohort July 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara Total Cohort July 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara Total Cohort July 1 Total Survival in the third trimester 2022QII 3.974 19 Guadalajara Total Cohort July 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara Total Cohort July 1 Total Survival in the third trimester 2021QII 3.846 19 Guadalajara Total Cohort July 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara Total Cohort July 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara Total Cohort July 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 19 Guadalajara Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 19 Guadalajara Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 19 Guadalajara Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,81 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,7 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,95 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,93 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,12 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,85 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 86,86 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 87,44 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 84,07 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 85,22 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 4.650 19 Guadalajara Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 4.525 19 Guadalajara Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 3.887 19 Guadalajara Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 4.356 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 4.235 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 3.672 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 4.169 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 4.070 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 3.503 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 3.921 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 3.365 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 3.793 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 3.271 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 19 Guadalajara Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 19 Guadalajara Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 19 Guadalajara Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,68 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,59 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,47 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,66 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,94 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,12 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 86,65 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,57 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 83,82 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 84,15 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 197 19 Guadalajara Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 202 19 Guadalajara Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 626 19 Guadalajara Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 191 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 194 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 613 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 190 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 190 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 597 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 185 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 581 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 181 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 575 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 19 Guadalajara Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 19 Guadalajara Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 19 Guadalajara Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,95 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,04 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,92 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 96,45 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 94,06 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,37 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 91,58 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 92,81 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 89,6 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,85 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara Total Cohort October 1 Total Number at the start of the quarter 2022QIV 4.788 19 Guadalajara Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara Total Cohort October 1 Total Number at the start of the quarter 2021QIV 4.689 19 Guadalajara Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara Total Cohort October 1 Total Number at the start of the quarter 2020QIV 4.564 19 Guadalajara Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara Total Cohort October 1 Total Survival in the first trimester 2022QIV 4.539 19 Guadalajara Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 19 Guadalajara Total Cohort October 1 Total Survival in the first trimester 2022QII "" 19 Guadalajara Total Cohort October 1 Total Survival in the first trimester 2022QI "" 19 Guadalajara Total Cohort October 1 Total Survival in the first trimester 2021QIV 4.466 19 Guadalajara Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 19 Guadalajara Total Cohort October 1 Total Survival in the first trimester 2021QII "" 19 Guadalajara Total Cohort October 1 Total Survival in the first trimester 2021QI "" 19 Guadalajara Total Cohort October 1 Total Survival in the first trimester 2020QIV 4.299 19 Guadalajara Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 19 Guadalajara Total Cohort October 1 Total Survival in the first trimester 2020QII "" 19 Guadalajara Total Cohort October 1 Total Survival in the first trimester 2020QI "" 19 Guadalajara Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 19 Guadalajara Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 19 Guadalajara Total Cohort October 1 Total Survival in the second trimester 2022QII "" 19 Guadalajara Total Cohort October 1 Total Survival in the second trimester 2022QI 4.279 19 Guadalajara Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 19 Guadalajara Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 19 Guadalajara Total Cohort October 1 Total Survival in the second trimester 2021QII "" 19 Guadalajara Total Cohort October 1 Total Survival in the second trimester 2021QI 4.105 19 Guadalajara Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 19 Guadalajara Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 19 Guadalajara Total Cohort October 1 Total Survival in the second trimester 2020QII "" 19 Guadalajara Total Cohort October 1 Total Survival in the second trimester 2020QI "" 19 Guadalajara Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara Total Cohort October 1 Total Survival in the third trimester 2022QII 4.114 19 Guadalajara Total Cohort October 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara Total Cohort October 1 Total Survival in the third trimester 2021QII 3.985 19 Guadalajara Total Cohort October 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara Total Cohort October 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara Total Cohort October 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara Total Cohort October 1 Total Survival in the third trimester 2022QIII 3.963 19 Guadalajara Total Cohort October 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara Total Cohort October 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara Total Cohort October 1 Total Survival in the third trimester 2021QIII 3.875 19 Guadalajara Total Cohort October 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara Total Cohort October 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara Total Cohort October 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara Total Cohort October 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 19 Guadalajara Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 19 Guadalajara Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 19 Guadalajara Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,8 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,24 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,19 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 91,26 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,94 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,74 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 87,31 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 84,52 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 84,9 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 4.612 19 Guadalajara Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 4.433 19 Guadalajara Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 3.992 19 Guadalajara Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 4.364 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 4.218 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 3.743 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 4.036 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 3.562 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 3.881 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 3.450 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 3.737 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 3.356 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 19 Guadalajara Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 19 Guadalajara Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 19 Guadalajara Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,62 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,15 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,76 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 91,04 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,23 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 87,55 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,42 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 84,3 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 84,07 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 176 19 Guadalajara Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 256 19 Guadalajara Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 572 19 Guadalajara Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 175 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 248 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 556 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 243 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 543 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 233 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 535 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 226 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 519 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 19 Guadalajara Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 19 Guadalajara Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 19 Guadalajara Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,43 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,88 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,2 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,92 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,93 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 91,02 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,53 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 88,28 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 90,73 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 3.724 19 Guadalajara From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 3.566 19 Guadalajara From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 3.663 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 3.456 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 3.322 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 3.134 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 3.258 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 3.186 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 3.013 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 3.096 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 3.058 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 2.902 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 2.991 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 2.967 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 2.787 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 19 Guadalajara From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 19 Guadalajara From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 92,8 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,16 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 85,56 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 87,49 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 89,34 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 82,25 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 83,14 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 85,75 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 79,22 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 80,32 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 83,2 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 76,09 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 3.581 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 3.289 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 3.317 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 3.058 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 3.126 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.928 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.969 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.813 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.866 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2.729 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,63 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 92,98 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 87,29 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,02 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 82,91 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 85,53 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 80,03 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 82,97 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 143 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 277 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 139 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 264 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 132 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 258 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 127 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 245 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 125 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 238 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,2 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,31 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,31 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 93,14 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 88,81 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 88,45 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 87,41 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 85,92 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 3.719 19 Guadalajara From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 3.573 19 Guadalajara From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 3.405 19 Guadalajara From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 3.468 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 3.377 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 3.249 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 3.270 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 3.198 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 3.108 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 3.142 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 3.081 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 2.971 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 2.960 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 2.851 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 19 Guadalajara From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 19 Guadalajara From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 19 Guadalajara From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,25 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,51 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,42 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 87,93 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 89,5 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,28 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 84,49 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 86,23 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 87,25 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 82,84 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 83,73 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 3.573 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 3.256 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2.788 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 3.328 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 3.066 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2.642 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 3.136 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.902 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2.522 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 3.008 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.794 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.412 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.682 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.317 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,14 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,16 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,76 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 87,77 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,13 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,46 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 84,19 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 85,81 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 86,51 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 82,37 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 83,11 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 146 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 317 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 617 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 140 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 311 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 607 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 134 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 296 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 586 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 134 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 287 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 559 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 278 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 534 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,89 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,11 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,38 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,78 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,38 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,98 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,78 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 90,54 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 90,6 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 87,7 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 86,55 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 3.736 19 Guadalajara From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 3.679 19 Guadalajara From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 3.540 19 Guadalajara From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 3.452 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 3.393 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 3.319 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 3.278 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 3.239 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 3.146 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 3.095 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 3.005 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 2.978 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 2.913 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 19 Guadalajara From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 19 Guadalajara From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 19 Guadalajara From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,4 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,23 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 93,76 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 87,74 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 88,04 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 88,87 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 84,13 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 84,89 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 80,95 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 82,29 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 3.608 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 3.565 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 3.210 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 3.330 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 3.286 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 3.001 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 3.156 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 3.135 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.842 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.994 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.713 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.879 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.625 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,29 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,17 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,49 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,47 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 87,94 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 88,54 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 83,98 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 84,52 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 80,76 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 81,78 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 128 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 114 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 330 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 122 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 107 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 318 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 122 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 104 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 304 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 101 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 292 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 99 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 288 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,31 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 93,86 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,36 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95,31 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 91,23 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 92,12 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 88,6 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 88,48 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 86,84 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 87,27 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 3.716 19 Guadalajara From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 3.628 19 Guadalajara From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 3.583 19 Guadalajara From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 3.473 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 3.416 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 3.329 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 3.238 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 3.145 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 3.090 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 3.030 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 2.954 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 2.931 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 19 Guadalajara From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 19 Guadalajara From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 19 Guadalajara From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,46 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,16 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 92,91 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,25 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 87,78 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 85,17 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 84,57 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 81,42 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 81,8 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 3.604 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3.469 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 3.278 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 3.361 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 3.265 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 3.040 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 3.092 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.866 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.953 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2.758 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.823 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.673 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,26 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,12 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,74 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,13 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 87,43 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 85,13 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 84,14 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 81,38 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 81,54 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 112 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 159 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 305 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 112 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 151 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 289 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 146 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 279 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 137 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 272 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 131 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 258 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 94,97 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 94,75 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91,82 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 91,48 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 86,16 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 89,18 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 82,39 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 84,59 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 498 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 444 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 487 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 494 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 440 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 459 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 480 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 436 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 448 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 465 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 426 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 441 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 461 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 418 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 432 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,2 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,1 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 94,25 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,39 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,2 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 91,99 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 93,37 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,95 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 90,55 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 92,57 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,14 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 88,71 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 454 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 353 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 451 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 350 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 437 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 346 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 422 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 338 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 418 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 330 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,34 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,15 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,26 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,02 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 92,95 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,75 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 92,07 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 93,48 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 44 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 91 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 43 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 90 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 43 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 90 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 43 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 88 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 43 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 88 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,73 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,9 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,73 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,9 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,73 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,7 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 97,73 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,7 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 484 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 440 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 426 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 472 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 434 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 417 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 456 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 430 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 415 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 449 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 422 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 406 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 417 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 400 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,52 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,64 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 97,89 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 94,21 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,73 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,42 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 92,77 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,91 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,31 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,77 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 93,9 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 445 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 354 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 268 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 433 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 348 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 259 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 417 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 345 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 257 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 411 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 337 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 254 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 334 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 250 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,3 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,31 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 96,64 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 93,71 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,46 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 95,9 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 92,36 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,2 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 94,78 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 94,35 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 93,28 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 39 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 86 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 158 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 39 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 86 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 158 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 39 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 85 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 158 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 38 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 85 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 152 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 83 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 150 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,84 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,44 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,84 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,2 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,51 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,94 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 481 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 467 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 441 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 472 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 461 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 436 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 463 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 454 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 428 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 447 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 420 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 440 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 416 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,13 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,72 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,87 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,26 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,22 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,05 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,72 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,24 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 94,22 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 94,33 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 453 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 435 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 329 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 444 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 430 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 325 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 436 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 423 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 319 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 418 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 314 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 412 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 310 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,01 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,85 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,78 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,25 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,24 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,96 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,09 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,44 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,71 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,22 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 28 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 32 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 112 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 28 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 31 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 111 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 27 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 31 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 109 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 29 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 106 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 28 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 106 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,88 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,11 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 96,43 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,88 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,32 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 90,63 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,64 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 87,5 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 94,64 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 467 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 484 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 424 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 462 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 478 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 419 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 473 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 414 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 466 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 412 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 457 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 405 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,93 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,76 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,82 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,73 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,64 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,28 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,17 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 94,42 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,52 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 439 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 446 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 340 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 435 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 440 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 335 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 435 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 332 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 428 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 330 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 419 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 324 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,09 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,65 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,53 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,53 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,65 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,96 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,06 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 93,95 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,29 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 28 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 38 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 84 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 27 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 38 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 84 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 38 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 82 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 38 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 82 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 38 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 81 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,43 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,62 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,62 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,43 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 538 19 Guadalajara From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 502 19 Guadalajara From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 543 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 533 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 498 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 523 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 521 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 493 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 514 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 517 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 491 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 510 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 515 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 485 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 505 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 19 Guadalajara From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 19 Guadalajara From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,07 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,2 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,32 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,84 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,21 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 94,66 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,1 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,81 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 93,92 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,72 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,61 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 93 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 495 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 371 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 490 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 368 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 478 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 363 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 474 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 361 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 472 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 356 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,99 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,19 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,57 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,84 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,76 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,3 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,35 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,96 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 43 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 131 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 43 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 130 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 43 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 130 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 43 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 130 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 43 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 129 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,24 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 99,24 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 99,24 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,47 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 556 19 Guadalajara From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 513 19 Guadalajara From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 484 19 Guadalajara From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 545 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 509 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 478 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 542 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 506 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 474 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 539 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 500 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 471 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 496 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 467 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 19 Guadalajara From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 19 Guadalajara From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 19 Guadalajara From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,02 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,22 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,76 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,48 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,64 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,93 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,94 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,47 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,31 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,69 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,49 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 521 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 377 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 308 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 510 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 373 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 303 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 507 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 370 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 300 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 504 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 365 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 297 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 361 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 294 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,89 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,94 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,38 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,31 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,14 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,4 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,74 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,82 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,43 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,76 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,45 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 35 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 136 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 176 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 35 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 136 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 175 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 35 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 136 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 174 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 35 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 135 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 174 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 135 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 173 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,43 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,86 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 99,26 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,86 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 99,26 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,3 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 576 19 Guadalajara From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 532 19 Guadalajara From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 485 19 Guadalajara From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 570 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 526 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 483 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 565 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 519 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 479 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 516 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 474 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 508 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 470 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 19 Guadalajara From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 19 Guadalajara From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 19 Guadalajara From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,96 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,87 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,59 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,09 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,56 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,76 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,99 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,73 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,49 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,91 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 540 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 486 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 325 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 534 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 480 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 323 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 529 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 473 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 319 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 470 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 315 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 463 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 313 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,89 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,77 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,38 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,96 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,33 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,15 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,71 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,92 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,27 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,31 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 36 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 46 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 160 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 36 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 46 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 160 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 36 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 46 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 160 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 46 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 159 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 45 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 157 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 99,38 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 97,83 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,13 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 551 19 Guadalajara From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 526 19 Guadalajara From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 509 19 Guadalajara From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 550 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 521 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 503 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 517 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 498 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 507 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 495 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 502 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 492 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 19 Guadalajara From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 19 Guadalajara From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 19 Guadalajara From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,82 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,05 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,82 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,29 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,84 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,39 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,25 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,44 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,66 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 520 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 476 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 352 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 519 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 471 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 346 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 467 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 342 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 458 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 340 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 453 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 337 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,81 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,95 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,3 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,11 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,16 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,22 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,59 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,17 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,74 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 31 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 50 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 157 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 31 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 50 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 157 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 50 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 156 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 49 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 155 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 49 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 155 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 99,36 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 98 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,73 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 98 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,73 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 35 19 Guadalajara from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 29 19 Guadalajara from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 34 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 35 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 29 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 33 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 35 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 29 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 33 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 34 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 29 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 33 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 34 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 29 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 33 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 19 Guadalajara from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 19 Guadalajara from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,06 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,06 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,14 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,06 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,14 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,06 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 32 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 15 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 32 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 15 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 32 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 15 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 32 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 15 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 32 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 15 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 3 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 14 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 3 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 14 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 3 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 14 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 14 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 14 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 66,67 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 66,67 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 36 19 Guadalajara from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 30 19 Guadalajara from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 30 19 Guadalajara from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 36 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 30 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 30 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 35 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 30 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 30 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 35 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 30 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 30 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 30 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 30 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 19 Guadalajara from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 19 Guadalajara from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 19 Guadalajara from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,22 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,22 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 33 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 19 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 22 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 33 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 19 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 22 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 33 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 19 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 22 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 33 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 19 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 22 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 19 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 22 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 3 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 11 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 8 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 3 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 11 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 8 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 2 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 11 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 8 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 2 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 11 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 8 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 11 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 8 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 66,67 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 66,67 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 37 19 Guadalajara from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 33 19 Guadalajara from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 31 19 Guadalajara from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 36 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 33 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 31 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 36 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 32 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 31 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 32 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 31 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 32 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 31 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 19 Guadalajara from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 19 Guadalajara from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 19 Guadalajara from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,3 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,3 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 96,97 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,97 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,97 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 35 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 27 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 19 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 34 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 27 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 19 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 34 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 27 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 19 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 27 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 19 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 27 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 19 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,14 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,14 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 2 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 6 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 12 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 2 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 6 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 12 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 2 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 5 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 12 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 5 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 12 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 5 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 12 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 83,33 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 83,33 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 83,33 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 37 19 Guadalajara from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 34 19 Guadalajara from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 32 19 Guadalajara from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 37 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 34 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 32 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 34 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 32 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 34 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 32 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 33 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 32 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 19 Guadalajara from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 19 Guadalajara from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 19 Guadalajara from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,06 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 35 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 31 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 17 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 35 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 31 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 17 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 31 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 17 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 31 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 17 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 31 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 17 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 2 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 3 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 15 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 2 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 3 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 15 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 3 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 15 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 3 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 15 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 2 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 15 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 66,67 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 17 19 Guadalajara De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 17 19 Guadalajara De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 17 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 17 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 17 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 17 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 17 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 17 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 17 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 17 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 16 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 17 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 17 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 16 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 17 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 19 Guadalajara De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 19 Guadalajara De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 94,12 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,12 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 15 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 5 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 15 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 5 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 15 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 5 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 15 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 5 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 15 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 5 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 12 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 12 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 12 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 11 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 11 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 91,67 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 91,67 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 17 19 Guadalajara De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 17 19 Guadalajara De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 16 19 Guadalajara De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 17 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 17 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 16 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 17 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 16 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 16 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 17 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 16 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 16 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 16 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 16 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 19 Guadalajara De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 19 Guadalajara De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 19 Guadalajara De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 94,12 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 94,12 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,12 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 13 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 6 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 8 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 13 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 6 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 8 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 13 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 6 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 8 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 13 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 6 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 8 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 6 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 8 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 4 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 11 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 8 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 4 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 11 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 8 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 4 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 10 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 8 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 4 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 10 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 8 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 10 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 8 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 90,91 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 90,91 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 90,91 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 17 19 Guadalajara De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 16 19 Guadalajara De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 16 19 Guadalajara De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 17 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 16 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 16 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 17 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 16 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 16 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 16 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 16 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 16 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 16 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 19 Guadalajara De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 19 Guadalajara De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 19 Guadalajara De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 19 Guadalajara De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 19 Guadalajara De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 19 Guadalajara De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 14 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 12 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 4 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 14 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 12 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 4 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 14 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 12 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 4 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 12 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 4 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 12 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 4 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 3 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 4 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 12 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 3 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 4 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 12 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 3 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 4 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 12 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 4 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 12 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 4 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 12 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 17 19 Guadalajara De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 17 19 Guadalajara De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 16 19 Guadalajara De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 17 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 17 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 16 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 17 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 16 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 17 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 16 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 17 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 15 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 19 Guadalajara De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 19 Guadalajara De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 19 Guadalajara De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 93,75 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 14 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 11 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 5 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 14 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 11 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 5 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 11 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 5 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 11 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 5 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 11 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 5 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 3 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 6 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 11 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 3 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 6 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 11 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 6 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 11 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 6 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 11 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 6 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 10 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 90,91 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 19 Guadalajara De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 21 Huelva Total Cohort January 1 Total Number at the start of the quarter 2022QI 10.057 21 Huelva Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 21 Huelva Total Cohort January 1 Total Number at the start of the quarter 2021QI 9.440 21 Huelva Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 21 Huelva Total Cohort January 1 Total Number at the start of the quarter 2020QI 9.975 21 Huelva Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 21 Huelva Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 21 Huelva Total Cohort January 1 Total Survival in the first trimester 2022QII "" 21 Huelva Total Cohort January 1 Total Survival in the first trimester 2022QI 9.355 21 Huelva Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 21 Huelva Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 21 Huelva Total Cohort January 1 Total Survival in the first trimester 2021QII "" 21 Huelva Total Cohort January 1 Total Survival in the first trimester 2021QI 8.740 21 Huelva Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 21 Huelva Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 21 Huelva Total Cohort January 1 Total Survival in the first trimester 2020QII "" 21 Huelva Total Cohort January 1 Total Survival in the first trimester 2020QI 7.978 21 Huelva Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 21 Huelva Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 21 Huelva Total Cohort January 1 Total Survival in the second trimester 2022QII 8.876 21 Huelva Total Cohort January 1 Total Survival in the second trimester 2022QI "" 21 Huelva Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 21 Huelva Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 21 Huelva Total Cohort January 1 Total Survival in the second trimester 2021QII 8.368 21 Huelva Total Cohort January 1 Total Survival in the second trimester 2021QI "" 21 Huelva Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 21 Huelva Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 21 Huelva Total Cohort January 1 Total Survival in the second trimester 2020QII 7.707 21 Huelva Total Cohort January 1 Total Survival in the second trimester 2020QI "" 21 Huelva Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 21 Huelva Total Cohort January 1 Total Survival in the third trimester 2022QIII 8.505 21 Huelva Total Cohort January 1 Total Survival in the third trimester 2022QII "" 21 Huelva Total Cohort January 1 Total Survival in the third trimester 2022QI "" 21 Huelva Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 21 Huelva Total Cohort January 1 Total Survival in the third trimester 2021QIII 8.058 21 Huelva Total Cohort January 1 Total Survival in the third trimester 2021QII "" 21 Huelva Total Cohort January 1 Total Survival in the third trimester 2021QI "" 21 Huelva Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 21 Huelva Total Cohort January 1 Total Survival in the third trimester 2020QIII 7.455 21 Huelva Total Cohort January 1 Total Survival in the third trimester 2020QII "" 21 Huelva Total Cohort January 1 Total Survival in the third trimester 2020QI "" 21 Huelva Total Cohort January 1 Total Survival in the third trimester 2022QIV 8.168 21 Huelva Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 21 Huelva Total Cohort January 1 Total Survival in the third trimester 2022QII "" 21 Huelva Total Cohort January 1 Total Survival in the third trimester 2022QI "" 21 Huelva Total Cohort January 1 Total Survival in the third trimester 2021QIV 7.791 21 Huelva Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 21 Huelva Total Cohort January 1 Total Survival in the third trimester 2021QII "" 21 Huelva Total Cohort January 1 Total Survival in the third trimester 2021QI "" 21 Huelva Total Cohort January 1 Total Survival in the third trimester 2020QIV 7.182 21 Huelva Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 21 Huelva Total Cohort January 1 Total Survival in the third trimester 2020QII "" 21 Huelva Total Cohort January 1 Total Survival in the third trimester 2020QI "" 21 Huelva Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 21 Huelva Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 21 Huelva Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 21 Huelva Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 21 Huelva Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 21 Huelva Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 21 Huelva Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,02 21 Huelva Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 92,58 21 Huelva Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 79,98 21 Huelva Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,26 21 Huelva Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 88,64 21 Huelva Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 77,26 21 Huelva Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 84,57 21 Huelva Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 85,36 21 Huelva Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 74,74 21 Huelva Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 81,22 21 Huelva Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 82,53 21 Huelva Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 72 21 Huelva Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 21 Huelva Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 21 Huelva Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 9.669 21 Huelva Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 8.569 21 Huelva Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 8.982 21 Huelva Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 7.891 21 Huelva Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 8.517 21 Huelva Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 7.545 21 Huelva Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 8.153 21 Huelva Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 7.250 21 Huelva Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 7.824 21 Huelva Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 6.995 21 Huelva Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 21 Huelva Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 21 Huelva Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,89 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 92,09 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,09 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 88,05 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 84,32 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 84,61 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 80,92 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 81,63 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 388 21 Huelva Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 871 21 Huelva Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 373 21 Huelva Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 849 21 Huelva Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 359 21 Huelva Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 823 21 Huelva Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 352 21 Huelva Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 808 21 Huelva Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 344 21 Huelva Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 796 21 Huelva Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 21 Huelva Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 21 Huelva Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,13 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,47 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,53 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,49 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,72 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,77 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,66 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 91,39 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva Total Cohort April 1 Total Number at the start of the quarter 2022QII 10.227 21 Huelva Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 21 Huelva Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva Total Cohort April 1 Total Number at the start of the quarter 2021QII 9.660 21 Huelva Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 21 Huelva Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva Total Cohort April 1 Total Number at the start of the quarter 2020QII 8.526 21 Huelva Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 21 Huelva Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 21 Huelva Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 21 Huelva Total Cohort April 1 Total Survival in the first trimester 2022QII 9.560 21 Huelva Total Cohort April 1 Total Survival in the first trimester 2022QI "" 21 Huelva Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 21 Huelva Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 21 Huelva Total Cohort April 1 Total Survival in the first trimester 2021QII 9.120 21 Huelva Total Cohort April 1 Total Survival in the first trimester 2021QI "" 21 Huelva Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 21 Huelva Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 21 Huelva Total Cohort April 1 Total Survival in the first trimester 2020QII 8.163 21 Huelva Total Cohort April 1 Total Survival in the first trimester 2020QI "" 21 Huelva Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 21 Huelva Total Cohort April 1 Total Survival in the second trimester 2022QIII 9.046 21 Huelva Total Cohort April 1 Total Survival in the second trimester 2022QII "" 21 Huelva Total Cohort April 1 Total Survival in the second trimester 2022QI "" 21 Huelva Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 21 Huelva Total Cohort April 1 Total Survival in the second trimester 2021QIII 8.652 21 Huelva Total Cohort April 1 Total Survival in the second trimester 2021QII "" 21 Huelva Total Cohort April 1 Total Survival in the second trimester 2021QI "" 21 Huelva Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 21 Huelva Total Cohort April 1 Total Survival in the second trimester 2020QIII 7.830 21 Huelva Total Cohort April 1 Total Survival in the second trimester 2020QII "" 21 Huelva Total Cohort April 1 Total Survival in the second trimester 2020QI "" 21 Huelva Total Cohort April 1 Total Survival in the third trimester 2022QIV 8.551 21 Huelva Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 21 Huelva Total Cohort April 1 Total Survival in the third trimester 2022QII "" 21 Huelva Total Cohort April 1 Total Survival in the third trimester 2022QI "" 21 Huelva Total Cohort April 1 Total Survival in the third trimester 2021QIV 8.238 21 Huelva Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 21 Huelva Total Cohort April 1 Total Survival in the third trimester 2021QII "" 21 Huelva Total Cohort April 1 Total Survival in the third trimester 2021QI "" 21 Huelva Total Cohort April 1 Total Survival in the third trimester 2020QIV 7.482 21 Huelva Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 21 Huelva Total Cohort April 1 Total Survival in the third trimester 2020QII "" 21 Huelva Total Cohort April 1 Total Survival in the third trimester 2020QI "" 21 Huelva Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 21 Huelva Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 21 Huelva Total Cohort April 1 Total Survival in the third trimester 2022QII "" 21 Huelva Total Cohort April 1 Total Survival in the third trimester 2022QI 7.905 21 Huelva Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 21 Huelva Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 21 Huelva Total Cohort April 1 Total Survival in the third trimester 2021QII "" 21 Huelva Total Cohort April 1 Total Survival in the third trimester 2021QI 7.162 21 Huelva Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 21 Huelva Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 21 Huelva Total Cohort April 1 Total Survival in the third trimester 2020QII "" 21 Huelva Total Cohort April 1 Total Survival in the third trimester 2020QI "" 21 Huelva Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 21 Huelva Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 21 Huelva Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 21 Huelva Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 21 Huelva Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 21 Huelva Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,48 21 Huelva Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,41 21 Huelva Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,74 21 Huelva Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 88,45 21 Huelva Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 89,57 21 Huelva Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,84 21 Huelva Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 83,61 21 Huelva Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 85,28 21 Huelva Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 87,76 21 Huelva Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 81,83 21 Huelva Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 84 21 Huelva Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 21 Huelva Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 21 Huelva Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 9.852 21 Huelva Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 8.767 21 Huelva Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 6.842 21 Huelva Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 9.200 21 Huelva Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 8.256 21 Huelva Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 6.499 21 Huelva Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 8.693 21 Huelva Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 7.804 21 Huelva Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 6.187 21 Huelva Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 8.208 21 Huelva Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 7.405 21 Huelva Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 5.902 21 Huelva Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 7.094 21 Huelva Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 5.634 21 Huelva Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 21 Huelva Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 21 Huelva Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 21 Huelva Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,38 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,17 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,99 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 88,24 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,02 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,43 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 83,31 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 84,46 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 86,26 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 80,92 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 82,34 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 375 21 Huelva Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 893 21 Huelva Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.684 21 Huelva Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 360 21 Huelva Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 864 21 Huelva Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.664 21 Huelva Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 353 21 Huelva Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 848 21 Huelva Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.643 21 Huelva Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 343 21 Huelva Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 833 21 Huelva Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.580 21 Huelva Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 811 21 Huelva Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.528 21 Huelva Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 21 Huelva Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 21 Huelva Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 21 Huelva Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,75 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,81 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,13 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,96 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,57 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,47 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,28 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,82 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 90,82 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 90,74 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva Total Cohort July 1 Total Number at the start of the quarter 2022QIII 10.618 21 Huelva Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 21 Huelva Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 21 Huelva Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva Total Cohort July 1 Total Number at the start of the quarter 2021QIII 10.378 21 Huelva Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 21 Huelva Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 21 Huelva Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva Total Cohort July 1 Total Number at the start of the quarter 2020QIII 9.873 21 Huelva Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 21 Huelva Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 21 Huelva Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 21 Huelva Total Cohort July 1 Total Survival in the first trimester 2022QIII 9.685 21 Huelva Total Cohort July 1 Total Survival in the first trimester 2022QII "" 21 Huelva Total Cohort July 1 Total Survival in the first trimester 2022QI "" 21 Huelva Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 21 Huelva Total Cohort July 1 Total Survival in the first trimester 2021QIII 9.418 21 Huelva Total Cohort July 1 Total Survival in the first trimester 2021QII "" 21 Huelva Total Cohort July 1 Total Survival in the first trimester 2021QI "" 21 Huelva Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 21 Huelva Total Cohort July 1 Total Survival in the first trimester 2020QIII 9.050 21 Huelva Total Cohort July 1 Total Survival in the first trimester 2020QII "" 21 Huelva Total Cohort July 1 Total Survival in the first trimester 2020QI "" 21 Huelva Total Cohort July 1 Total Survival in the second trimester 2022QIV 8.944 21 Huelva Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 21 Huelva Total Cohort July 1 Total Survival in the second trimester 2022QII "" 21 Huelva Total Cohort July 1 Total Survival in the second trimester 2022QI "" 21 Huelva Total Cohort July 1 Total Survival in the second trimester 2021QIV 8.784 21 Huelva Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 21 Huelva Total Cohort July 1 Total Survival in the second trimester 2021QII "" 21 Huelva Total Cohort July 1 Total Survival in the second trimester 2021QI "" 21 Huelva Total Cohort July 1 Total Survival in the second trimester 2020QIV 8.347 21 Huelva Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 21 Huelva Total Cohort July 1 Total Survival in the second trimester 2020QII "" 21 Huelva Total Cohort July 1 Total Survival in the second trimester 2020QI "" 21 Huelva Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 21 Huelva Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 21 Huelva Total Cohort July 1 Total Survival in the third trimester 2022QII "" 21 Huelva Total Cohort July 1 Total Survival in the third trimester 2022QI 8.371 21 Huelva Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 21 Huelva Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 21 Huelva Total Cohort July 1 Total Survival in the third trimester 2021QII "" 21 Huelva Total Cohort July 1 Total Survival in the third trimester 2021QI 7.906 21 Huelva Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 21 Huelva Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 21 Huelva Total Cohort July 1 Total Survival in the third trimester 2020QII "" 21 Huelva Total Cohort July 1 Total Survival in the third trimester 2020QI "" 21 Huelva Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 21 Huelva Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 21 Huelva Total Cohort July 1 Total Survival in the third trimester 2022QII 8.110 21 Huelva Total Cohort July 1 Total Survival in the third trimester 2022QI "" 21 Huelva Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 21 Huelva Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 21 Huelva Total Cohort July 1 Total Survival in the third trimester 2021QII 7.681 21 Huelva Total Cohort July 1 Total Survival in the third trimester 2021QI "" 21 Huelva Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 21 Huelva Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 21 Huelva Total Cohort July 1 Total Survival in the third trimester 2020QII "" 21 Huelva Total Cohort July 1 Total Survival in the third trimester 2020QI "" 21 Huelva Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 21 Huelva Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 21 Huelva Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 21 Huelva Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 21 Huelva Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 21 Huelva Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 21 Huelva Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 21 Huelva Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 21 Huelva Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 91,21 21 Huelva Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 90,75 21 Huelva Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 91,66 21 Huelva Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 84,23 21 Huelva Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 84,64 21 Huelva Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 84,54 21 Huelva Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 80,66 21 Huelva Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 80,08 21 Huelva Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 78,15 21 Huelva Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 77,8 21 Huelva Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 21 Huelva Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 21 Huelva Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 10.321 21 Huelva Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 10.090 21 Huelva Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 8.954 21 Huelva Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 9.393 21 Huelva Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 9.134 21 Huelva Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 8.141 21 Huelva Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 8.658 21 Huelva Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 8.506 21 Huelva Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 7.464 21 Huelva Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 8.102 21 Huelva Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 7.048 21 Huelva Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 7.848 21 Huelva Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 6.842 21 Huelva Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 21 Huelva Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 21 Huelva Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 21 Huelva Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 91,01 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 90,53 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 90,92 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 83,89 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 84,3 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 83,36 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 80,3 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 78,71 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 77,78 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 76,41 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 297 21 Huelva Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 288 21 Huelva Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 919 21 Huelva Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 292 21 Huelva Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 284 21 Huelva Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 909 21 Huelva Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 286 21 Huelva Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 278 21 Huelva Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 883 21 Huelva Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 269 21 Huelva Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 858 21 Huelva Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 262 21 Huelva Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 839 21 Huelva Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 21 Huelva Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 21 Huelva Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 21 Huelva Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,32 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,61 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,91 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 96,3 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,53 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,08 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93,4 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,36 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 90,97 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,29 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva Total Cohort October 1 Total Number at the start of the quarter 2022QIV 10.343 21 Huelva Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 21 Huelva Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 21 Huelva Total Cohort October 1 Total Number at the start of the quarter 2021QIV 10.089 21 Huelva Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 21 Huelva Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 21 Huelva Total Cohort October 1 Total Number at the start of the quarter 2020QIV 9.839 21 Huelva Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 21 Huelva Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 21 Huelva Total Cohort October 1 Total Survival in the first trimester 2022QIV 9.411 21 Huelva Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 21 Huelva Total Cohort October 1 Total Survival in the first trimester 2022QII "" 21 Huelva Total Cohort October 1 Total Survival in the first trimester 2022QI "" 21 Huelva Total Cohort October 1 Total Survival in the first trimester 2021QIV 9.262 21 Huelva Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 21 Huelva Total Cohort October 1 Total Survival in the first trimester 2021QII "" 21 Huelva Total Cohort October 1 Total Survival in the first trimester 2021QI "" 21 Huelva Total Cohort October 1 Total Survival in the first trimester 2020QIV 8.834 21 Huelva Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 21 Huelva Total Cohort October 1 Total Survival in the first trimester 2020QII "" 21 Huelva Total Cohort October 1 Total Survival in the first trimester 2020QI "" 21 Huelva Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 21 Huelva Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 21 Huelva Total Cohort October 1 Total Survival in the second trimester 2022QII "" 21 Huelva Total Cohort October 1 Total Survival in the second trimester 2022QI 8.755 21 Huelva Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 21 Huelva Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 21 Huelva Total Cohort October 1 Total Survival in the second trimester 2021QII "" 21 Huelva Total Cohort October 1 Total Survival in the second trimester 2021QI 8.300 21 Huelva Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 21 Huelva Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 21 Huelva Total Cohort October 1 Total Survival in the second trimester 2020QII "" 21 Huelva Total Cohort October 1 Total Survival in the second trimester 2020QI "" 21 Huelva Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 21 Huelva Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 21 Huelva Total Cohort October 1 Total Survival in the third trimester 2022QII 8.424 21 Huelva Total Cohort October 1 Total Survival in the third trimester 2022QI "" 21 Huelva Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 21 Huelva Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 21 Huelva Total Cohort October 1 Total Survival in the third trimester 2021QII 8.024 21 Huelva Total Cohort October 1 Total Survival in the third trimester 2021QI "" 21 Huelva Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 21 Huelva Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 21 Huelva Total Cohort October 1 Total Survival in the third trimester 2020QII "" 21 Huelva Total Cohort October 1 Total Survival in the third trimester 2020QI "" 21 Huelva Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 21 Huelva Total Cohort October 1 Total Survival in the third trimester 2022QIII 8.134 21 Huelva Total Cohort October 1 Total Survival in the third trimester 2022QII "" 21 Huelva Total Cohort October 1 Total Survival in the third trimester 2022QI "" 21 Huelva Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 21 Huelva Total Cohort October 1 Total Survival in the third trimester 2021QIII 7.771 21 Huelva Total Cohort October 1 Total Survival in the third trimester 2021QII "" 21 Huelva Total Cohort October 1 Total Survival in the third trimester 2021QI "" 21 Huelva Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 21 Huelva Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 21 Huelva Total Cohort October 1 Total Survival in the third trimester 2020QII "" 21 Huelva Total Cohort October 1 Total Survival in the third trimester 2020QI "" 21 Huelva Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 21 Huelva Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 21 Huelva Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 21 Huelva Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 21 Huelva Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 21 Huelva Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 21 Huelva Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 21 Huelva Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 21 Huelva Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 90,99 21 Huelva Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 91,8 21 Huelva Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 89,79 21 Huelva Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 86,78 21 Huelva Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 84,36 21 Huelva Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 83,5 21 Huelva Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 81,55 21 Huelva Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 80,62 21 Huelva Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 78,98 21 Huelva Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 21 Huelva Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 21 Huelva Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 10.059 21 Huelva Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 9.659 21 Huelva Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 8.988 21 Huelva Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 9.133 21 Huelva Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 8.841 21 Huelva Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 8.013 21 Huelva Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 8.347 21 Huelva Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 7.501 21 Huelva Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 8.031 21 Huelva Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 7.246 21 Huelva Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 7.751 21 Huelva Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 7.008 21 Huelva Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 21 Huelva Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 21 Huelva Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 21 Huelva Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 90,79 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 91,53 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 89,15 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 86,42 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 83,46 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 83,15 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 80,62 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 80,25 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 77,97 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 284 21 Huelva Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 430 21 Huelva Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 851 21 Huelva Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 278 21 Huelva Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 421 21 Huelva Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 821 21 Huelva Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 408 21 Huelva Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 799 21 Huelva Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 393 21 Huelva Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 778 21 Huelva Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 383 21 Huelva Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 763 21 Huelva Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 21 Huelva Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 21 Huelva Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 21 Huelva Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,89 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,91 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,47 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,88 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 93,89 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 91,4 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 91,42 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 89,07 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 89,66 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 21 Huelva From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 7.877 21 Huelva From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 21 Huelva From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 7.515 21 Huelva From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 7.836 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 7.216 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 6.857 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 6.003 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 6.773 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 6.522 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 5.763 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 6.433 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 6.227 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 5.526 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 6.128 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 5.986 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 5.279 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 21 Huelva From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 21 Huelva From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 21 Huelva From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 21 Huelva From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 91,61 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 91,24 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 76,61 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 85,98 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 86,79 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 73,55 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 81,67 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 82,86 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 70,52 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 77,8 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 79,65 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 67,37 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 7.620 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 7.022 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 6.973 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 6.384 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 6.542 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 6.069 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 6.207 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 5.787 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 5.910 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 5.554 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 91,51 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 90,91 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 85,85 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 86,43 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 81,46 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 82,41 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 77,56 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 79,09 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 257 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 493 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 243 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 473 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 231 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 453 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 226 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 440 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 218 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 432 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,55 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,94 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 89,88 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 91,89 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 87,94 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 89,25 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 84,82 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 87,63 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 7.984 21 Huelva From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 7.651 21 Huelva From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 6.797 21 Huelva From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 7.350 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 7.146 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 6.453 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 6.873 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 6.701 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 6.137 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 6.426 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 6.340 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 5.818 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 6.036 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 5.519 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 21 Huelva From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 21 Huelva From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 21 Huelva From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 21 Huelva From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 92,06 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 93,4 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,94 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 86,08 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 87,58 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 90,29 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 80,49 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 82,86 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 85,6 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 78,89 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 81,2 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 7.739 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 7.117 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 5.691 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 7.119 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 6.638 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 5.364 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 6.647 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 6.207 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 5.066 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 6.209 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 5.857 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 4.801 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 5.571 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 4.548 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 91,99 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 93,27 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,25 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 85,89 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 87,21 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 89,02 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 80,23 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 82,3 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 84,36 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 78,28 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 79,92 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 245 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 534 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.106 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 231 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 508 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.089 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 226 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 494 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.071 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 217 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 483 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.017 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 465 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 971 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 94,29 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 95,13 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,46 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 92,24 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 92,51 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,84 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,57 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 90,45 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,95 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 87,08 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 87,79 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 8.078 21 Huelva From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 7.994 21 Huelva From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 7.713 21 Huelva From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 7.237 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 7.118 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 6.971 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 6.632 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 6.604 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 6.374 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 6.240 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 5.981 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 6.003 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 5.785 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 21 Huelva From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 21 Huelva From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 21 Huelva From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 89,59 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 89,04 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 90,38 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 82,1 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 82,61 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 82,64 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 78,06 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 77,54 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 75,09 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 75 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 7.898 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 7.834 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 7.217 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 7.061 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 6.962 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 6.482 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 6.461 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 6.453 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 5.903 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 6.096 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 5.530 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 5.865 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 5.347 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 89,4 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 88,87 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 89,82 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 81,81 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 82,37 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 81,79 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 77,81 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 76,62 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 74,87 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 74,09 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 180 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 160 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 496 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 176 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 156 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 489 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 171 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 151 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 471 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 144 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 451 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 138 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 438 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,78 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,5 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,59 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 94,38 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,96 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 90 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 90,93 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 86,25 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 88,31 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 8.011 21 Huelva From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 7.859 21 Huelva From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 7.764 21 Huelva From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 7.172 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 7.118 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 6.831 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 6.649 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 6.346 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 6.347 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 6.102 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 6.085 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 5.863 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 21 Huelva From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 21 Huelva From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 21 Huelva From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 89,53 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 90,57 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 87,98 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 84,6 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 81,74 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 80,76 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 78,59 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 77,43 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 75,52 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 7.841 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 7.569 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 7.298 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 7.007 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 6.834 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 6.386 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 6.376 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 5.920 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 6.088 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 5.691 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 5.835 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 5.465 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 89,36 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 90,29 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 87,5 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 84,24 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 81,12 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 80,43 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 77,98 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 77,09 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 74,88 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 170 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 290 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 466 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 165 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 284 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 445 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 273 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 426 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 259 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 411 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 250 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 398 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,06 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,93 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 95,49 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,14 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 91,42 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 89,31 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 88,2 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 86,21 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 85,41 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 1.021 21 Huelva From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 897 21 Huelva From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 1.025 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 996 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 871 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 911 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 970 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 846 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 891 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 949 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 833 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 878 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 929 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 821 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 862 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 21 Huelva From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 21 Huelva From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 97,55 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 97,1 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 88,88 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 95 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 94,31 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 86,93 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 92,95 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 92,87 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 85,66 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 90,99 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 91,53 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 84,1 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 964 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 768 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 939 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 743 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 915 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 722 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 895 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 710 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 875 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 699 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 97,41 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 96,74 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 94,92 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 94,01 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 92,84 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 92,45 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 90,77 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 91,02 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 57 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 129 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 57 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 128 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 55 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 124 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 54 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 123 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 54 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 122 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,22 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96,49 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,12 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 94,74 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,35 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,74 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 94,57 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 1.052 21 Huelva From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 949 21 Huelva From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 772 21 Huelva From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 1.026 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 927 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 761 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 998 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 910 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 748 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 972 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 874 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 729 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 855 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 719 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 21 Huelva From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 21 Huelva From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 21 Huelva From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,53 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 97,68 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,58 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 94,87 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 95,89 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 96,89 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 92,4 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 92,1 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 94,43 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 90,09 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 93,13 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.003 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 819 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 531 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 978 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 800 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 522 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 951 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 784 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 511 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 925 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 749 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 496 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 732 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 489 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,51 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 97,68 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,31 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 94,82 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 95,73 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 96,23 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 92,22 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 91,45 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 93,41 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 89,38 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 92,09 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 49 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 130 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 241 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 48 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 127 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 239 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 47 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 126 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 237 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 47 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 125 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 233 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 123 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 230 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,96 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,69 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,17 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 95,92 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,92 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,34 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 95,92 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,15 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,68 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 94,62 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,44 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 1.187 21 Huelva From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 1.110 21 Huelva From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 1.013 21 Huelva From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 1.131 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 1.054 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 960 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 1.061 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 1.000 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 900 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 967 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 870 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 951 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 850 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 21 Huelva From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 21 Huelva From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 21 Huelva From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 95,28 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,95 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,77 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,39 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,09 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 88,85 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 87,12 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 85,88 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 85,68 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 83,91 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.141 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.068 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 869 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.085 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.012 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 817 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.015 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 959 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 761 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 927 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 733 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 912 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 717 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 95,09 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,76 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,02 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 88,96 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,79 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 87,57 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 86,8 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 84,35 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 85,39 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 82,51 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 46 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 42 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 144 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 46 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 42 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 143 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 46 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 41 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 139 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 40 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 137 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 39 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 133 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,31 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,62 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,53 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,24 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95,14 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 92,86 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,36 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 1.093 21 Huelva From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 1.062 21 Huelva From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 989 21 Huelva From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 1.037 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 1.012 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 938 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 987 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 911 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 962 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 889 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 941 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 880 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 21 Huelva From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 21 Huelva From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 21 Huelva From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,88 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,29 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,84 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 92,94 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 92,11 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 90,58 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 89,89 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 88,61 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 88,98 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.048 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.004 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 853 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 992 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 956 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 808 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 931 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 782 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 907 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 762 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 886 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 754 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,66 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,22 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,72 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 92,73 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 91,68 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 90,34 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 89,33 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 88,25 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 88,39 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 45 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 58 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 136 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 45 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 56 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 130 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 56 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 129 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 55 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 127 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 55 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 126 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,55 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 95,59 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 96,55 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,85 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 94,83 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,38 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 94,83 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 92,65 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 21 Huelva From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 1.102 21 Huelva From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 21 Huelva From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 976 21 Huelva From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 1.053 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 1.088 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 964 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 1.004 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 1.078 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 952 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 993 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 1.068 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 950 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 991 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 1.056 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 936 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 981 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 21 Huelva From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 21 Huelva From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 21 Huelva From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 21 Huelva From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,73 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,77 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 95,35 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,82 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,54 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 94,3 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,91 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,34 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,11 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,83 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,9 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 93,16 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.033 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 737 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.020 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 726 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.010 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 716 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.001 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 715 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 989 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 704 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,74 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,51 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,77 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,15 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,9 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,01 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,74 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,52 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 69 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 239 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 68 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 238 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 68 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 236 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 67 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 235 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 67 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 232 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,55 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,58 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,55 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,74 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,1 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,33 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 97,1 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,07 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 1.135 21 Huelva From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 1.008 21 Huelva From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 903 21 Huelva From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 1.128 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 995 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 895 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 1.119 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 989 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 891 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 1.097 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 973 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 881 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 963 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 871 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 21 Huelva From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 21 Huelva From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 21 Huelva From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 21 Huelva From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,38 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,71 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,11 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,59 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,12 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,67 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,65 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,53 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,56 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 95,54 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,46 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.058 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 788 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 580 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.051 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 775 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 573 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.043 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 770 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 570 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.022 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 757 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 565 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 749 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 558 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,34 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,35 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,79 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,58 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,72 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,28 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,6 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,07 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,41 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,05 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,21 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 77 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 220 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 323 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 77 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 220 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 322 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 76 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 219 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 321 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 75 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 216 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 316 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 214 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 313 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,69 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,7 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,55 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,38 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,4 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,18 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,83 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,27 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,9 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 1.293 21 Huelva From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 1.218 21 Huelva From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.096 21 Huelva From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 1.258 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 1.191 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 1.068 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 1.192 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 1.125 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 1.022 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 1.110 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 1.006 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 1.102 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 997 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 21 Huelva From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 21 Huelva From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 21 Huelva From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,29 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 97,78 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 97,45 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 92,19 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 92,36 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 93,25 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 91,13 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 91,79 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 90,48 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 90,97 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.227 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.140 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 831 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.193 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.113 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 805 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.128 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.047 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 763 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.033 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 750 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.025 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 743 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,23 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 97,63 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 96,87 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 91,93 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 91,84 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 91,82 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 90,61 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 90,25 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 89,91 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 89,41 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 66 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 78 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 265 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 65 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 78 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 263 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 64 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 78 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 259 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 77 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 256 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 77 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 254 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,48 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,25 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 96,97 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,74 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 98,72 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,6 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 98,72 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,85 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 1.178 21 Huelva From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 1.106 21 Huelva From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.028 21 Huelva From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 1.142 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 1.071 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 1.008 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 1.059 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 990 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 1.055 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 980 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 1.048 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 975 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 21 Huelva From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 21 Huelva From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 21 Huelva From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 96,94 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 96,84 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,05 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 95,75 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,3 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95,39 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 95,33 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 94,76 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 94,84 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.113 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.028 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 793 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.078 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 994 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 776 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 984 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 760 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 980 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 754 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 974 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 750 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 96,86 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 96,69 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,86 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 95,72 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 95,84 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,33 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,08 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 94,75 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 94,58 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 65 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 78 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 235 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 64 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 77 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 232 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 75 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 230 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 75 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 226 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 74 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 225 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,46 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,72 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,72 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 96,15 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,87 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,15 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 96,17 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 94,87 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 95,74 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 21 Huelva from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 39 21 Huelva from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 21 Huelva from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 37 21 Huelva from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 40 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 37 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 33 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 39 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 37 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 33 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 39 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 37 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 33 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 39 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 37 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 33 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 39 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 21 Huelva from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 21 Huelva from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 21 Huelva from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 21 Huelva from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,87 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 89,19 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,5 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 94,87 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 89,19 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,5 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,87 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 89,19 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,5 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 94,87 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 89,19 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,5 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 35 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 30 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 33 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 26 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 33 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 26 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 33 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 26 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 33 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 26 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,29 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 86,67 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 94,29 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 86,67 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,29 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,67 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 94,29 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 86,67 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 4 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 7 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 4 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 7 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 4 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 7 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 4 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 7 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 4 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 7 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 36 21 Huelva from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 38 21 Huelva from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 39 21 Huelva from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 36 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 38 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 39 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 36 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 38 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 39 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 36 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 37 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 39 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 37 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 38 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 21 Huelva from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 21 Huelva from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 21 Huelva from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 21 Huelva from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,37 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,37 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,44 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 21 Huelva from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 34 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 32 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 29 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 34 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 32 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 29 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 34 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 32 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 29 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 34 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 31 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 29 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 31 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 28 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,88 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,88 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,55 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 2 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 6 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 10 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 2 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 6 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 10 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 2 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 6 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 10 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 2 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 6 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 10 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 6 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 10 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 41 21 Huelva from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 42 21 Huelva from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 39 21 Huelva from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 40 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 41 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 39 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 40 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 41 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 39 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 40 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 37 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 40 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 37 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 21 Huelva from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 21 Huelva from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 21 Huelva from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,56 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 97,62 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,56 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,62 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,24 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 94,87 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,24 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 94,87 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 38 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 36 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 28 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 37 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 35 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 28 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 37 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 35 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 28 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 34 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 26 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 34 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 26 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,37 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 97,22 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,37 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,22 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 94,44 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 92,86 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,44 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 92,86 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 3 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 6 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 11 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 3 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 6 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 11 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 3 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 6 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 11 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 6 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 11 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 6 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 11 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 42 21 Huelva from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 44 21 Huelva from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 44 21 Huelva from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 41 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 43 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 43 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 42 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 39 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 42 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 39 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 42 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 39 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 21 Huelva from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 21 Huelva from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 21 Huelva from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,62 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 97,73 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 97,73 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 95,45 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 88,64 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95,45 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 88,64 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,45 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 88,64 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 40 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 41 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 34 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 39 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 40 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 33 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 39 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 29 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 39 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 29 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 39 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 29 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,5 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 97,56 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,06 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 95,12 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 85,29 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,12 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 85,29 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,12 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 85,29 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 2 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 3 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 10 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 2 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 3 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 10 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 3 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 10 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 3 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 10 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 3 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 10 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 21 Huelva De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 18 21 Huelva De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 21 Huelva De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 15 21 Huelva De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 21 Huelva De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 21 21 Huelva De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 18 21 Huelva De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 15 21 Huelva De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 21 21 Huelva De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 18 21 Huelva De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 15 21 Huelva De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 21 21 Huelva De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 18 21 Huelva De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 15 21 Huelva De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 21 21 Huelva De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 18 21 Huelva De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 15 21 Huelva De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 21 21 Huelva De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 21 Huelva De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 21 Huelva De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 21 Huelva De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 21 Huelva De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 21 Huelva De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 21 Huelva De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 21 Huelva De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 21 Huelva De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 17 21 Huelva De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 12 21 Huelva De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 17 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 12 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 17 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 12 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 17 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 12 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 17 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 12 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 21 Huelva De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 21 Huelva De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1 21 Huelva De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 3 21 Huelva De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 3 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 3 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 3 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 3 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 21 Huelva De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 21 Huelva De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 20 21 Huelva De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 21 Huelva De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 14 21 Huelva De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 21 Huelva De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 15 21 Huelva De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 20 21 Huelva De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 14 21 Huelva De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 15 21 Huelva De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 20 21 Huelva De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 14 21 Huelva De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 15 21 Huelva De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 20 21 Huelva De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 14 21 Huelva De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 15 21 Huelva De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 14 21 Huelva De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 15 21 Huelva De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 21 Huelva De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 21 Huelva De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 21 Huelva De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 21 Huelva De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 21 Huelva De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 21 Huelva De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 21 Huelva De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 21 Huelva De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 18 21 Huelva De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 11 21 Huelva De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 11 21 Huelva De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 18 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 11 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 11 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 18 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 11 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 11 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 18 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 11 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 11 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 11 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 11 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 21 Huelva De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 21 Huelva De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 21 Huelva De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 2 21 Huelva De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 3 21 Huelva De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 4 21 Huelva De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 2 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 3 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 4 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 2 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 3 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 4 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 2 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 3 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 4 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 3 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 4 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 21 Huelva De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 21 Huelva De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 21 Huelva De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 19 21 Huelva De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 21 Huelva De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 21 Huelva De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 14 21 Huelva De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 21 Huelva De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 21 Huelva De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 12 21 Huelva De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 21 Huelva De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 19 21 Huelva De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 14 21 Huelva De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 12 21 Huelva De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 19 21 Huelva De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 14 21 Huelva De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 12 21 Huelva De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 14 21 Huelva De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 12 21 Huelva De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 14 21 Huelva De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 12 21 Huelva De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 21 Huelva De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 21 Huelva De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 21 Huelva De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 21 Huelva De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 21 Huelva De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 21 Huelva De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 21 Huelva De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 21 Huelva De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 21 Huelva De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 21 Huelva De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 21 Huelva De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 21 Huelva De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 21 Huelva De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 21 Huelva De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 17 21 Huelva De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 12 21 Huelva De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 9 21 Huelva De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 17 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 12 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 9 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 17 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 12 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 9 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 12 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 9 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 12 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 9 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 21 Huelva De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 21 Huelva De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 21 Huelva De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 2 21 Huelva De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 2 21 Huelva De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 3 21 Huelva De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 2 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 2 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 3 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 2 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 2 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 3 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 2 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 3 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 2 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 3 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 21 Huelva De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 21 Huelva De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 21 Huelva De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 19 21 Huelva De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 21 Huelva De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 21 Huelva De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 18 21 Huelva De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 21 Huelva De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 21 Huelva De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 14 21 Huelva De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 21 Huelva De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 19 21 Huelva De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 18 21 Huelva De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 14 21 Huelva De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 18 21 Huelva De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 14 21 Huelva De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 18 21 Huelva De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 14 21 Huelva De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 18 21 Huelva De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 14 21 Huelva De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 21 Huelva De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 21 Huelva De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 21 Huelva De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 21 Huelva De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 21 Huelva De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 21 Huelva De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 21 Huelva De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 21 Huelva De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 21 Huelva De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 21 Huelva De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 21 Huelva De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 21 Huelva De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 21 Huelva De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 17 21 Huelva De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 17 21 Huelva De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 10 21 Huelva De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 17 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 17 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 10 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 17 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 10 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 17 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 10 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 17 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 10 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 21 Huelva De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 21 Huelva De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 21 Huelva De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 2 21 Huelva De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1 21 Huelva De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 4 21 Huelva De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 2 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 4 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 4 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 4 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 4 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 21 Huelva De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 21 Huelva De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 21 Huelva De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 21 Huelva De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 22 Huesca Total Cohort January 1 Total Number at the start of the quarter 2022QI 6.396 22 Huesca Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 22 Huesca Total Cohort January 1 Total Number at the start of the quarter 2021QI 6.150 22 Huesca Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 22 Huesca Total Cohort January 1 Total Number at the start of the quarter 2020QI 6.522 22 Huesca Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 22 Huesca Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 22 Huesca Total Cohort January 1 Total Survival in the first trimester 2022QII "" 22 Huesca Total Cohort January 1 Total Survival in the first trimester 2022QI 6.089 22 Huesca Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 22 Huesca Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 22 Huesca Total Cohort January 1 Total Survival in the first trimester 2021QII "" 22 Huesca Total Cohort January 1 Total Survival in the first trimester 2021QI 5.862 22 Huesca Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 22 Huesca Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 22 Huesca Total Cohort January 1 Total Survival in the first trimester 2020QII "" 22 Huesca Total Cohort January 1 Total Survival in the first trimester 2020QI 5.850 22 Huesca Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 22 Huesca Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 22 Huesca Total Cohort January 1 Total Survival in the second trimester 2022QII 5.789 22 Huesca Total Cohort January 1 Total Survival in the second trimester 2022QI "" 22 Huesca Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 22 Huesca Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 22 Huesca Total Cohort January 1 Total Survival in the second trimester 2021QII 5.649 22 Huesca Total Cohort January 1 Total Survival in the second trimester 2021QI "" 22 Huesca Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 22 Huesca Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 22 Huesca Total Cohort January 1 Total Survival in the second trimester 2020QII 5.645 22 Huesca Total Cohort January 1 Total Survival in the second trimester 2020QI "" 22 Huesca Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 22 Huesca Total Cohort January 1 Total Survival in the third trimester 2022QIII 5.577 22 Huesca Total Cohort January 1 Total Survival in the third trimester 2022QII "" 22 Huesca Total Cohort January 1 Total Survival in the third trimester 2022QI "" 22 Huesca Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 22 Huesca Total Cohort January 1 Total Survival in the third trimester 2021QIII 5.484 22 Huesca Total Cohort January 1 Total Survival in the third trimester 2021QII "" 22 Huesca Total Cohort January 1 Total Survival in the third trimester 2021QI "" 22 Huesca Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 22 Huesca Total Cohort January 1 Total Survival in the third trimester 2020QIII 5.470 22 Huesca Total Cohort January 1 Total Survival in the third trimester 2020QII "" 22 Huesca Total Cohort January 1 Total Survival in the third trimester 2020QI "" 22 Huesca Total Cohort January 1 Total Survival in the third trimester 2022QIV 5.431 22 Huesca Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 22 Huesca Total Cohort January 1 Total Survival in the third trimester 2022QII "" 22 Huesca Total Cohort January 1 Total Survival in the third trimester 2022QI "" 22 Huesca Total Cohort January 1 Total Survival in the third trimester 2021QIV 5.365 22 Huesca Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 22 Huesca Total Cohort January 1 Total Survival in the third trimester 2021QII "" 22 Huesca Total Cohort January 1 Total Survival in the third trimester 2021QI "" 22 Huesca Total Cohort January 1 Total Survival in the third trimester 2020QIV 5.322 22 Huesca Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 22 Huesca Total Cohort January 1 Total Survival in the third trimester 2020QII "" 22 Huesca Total Cohort January 1 Total Survival in the third trimester 2020QI "" 22 Huesca Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 22 Huesca Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 22 Huesca Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 22 Huesca Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 22 Huesca Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 22 Huesca Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 22 Huesca Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,2 22 Huesca Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,32 22 Huesca Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 89,7 22 Huesca Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,51 22 Huesca Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,85 22 Huesca Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 86,55 22 Huesca Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 87,2 22 Huesca Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 89,17 22 Huesca Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 83,87 22 Huesca Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 84,91 22 Huesca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 87,24 22 Huesca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 81,6 22 Huesca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 22 Huesca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 22 Huesca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 6.190 22 Huesca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 5.502 22 Huesca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 5.891 22 Huesca Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 5.234 22 Huesca Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 5.596 22 Huesca Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 5.033 22 Huesca Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 5.397 22 Huesca Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 4.883 22 Huesca Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 5.252 22 Huesca Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 4.779 22 Huesca Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 22 Huesca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 22 Huesca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 95,17 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 95,13 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,4 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 91,48 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 87,19 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 88,75 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 84,85 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 86,86 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 206 22 Huesca Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 648 22 Huesca Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 198 22 Huesca Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 628 22 Huesca Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 193 22 Huesca Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 616 22 Huesca Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 180 22 Huesca Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 601 22 Huesca Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 179 22 Huesca Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 586 22 Huesca Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 22 Huesca Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 22 Huesca Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,12 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,91 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,69 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,06 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 87,38 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,75 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 86,89 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 90,43 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca Total Cohort April 1 Total Number at the start of the quarter 2022QII 6.411 22 Huesca Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 22 Huesca Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca Total Cohort April 1 Total Number at the start of the quarter 2021QII 6.207 22 Huesca Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 22 Huesca Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca Total Cohort April 1 Total Number at the start of the quarter 2020QII 6.101 22 Huesca Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 22 Huesca Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 22 Huesca Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 22 Huesca Total Cohort April 1 Total Survival in the first trimester 2022QII 6.058 22 Huesca Total Cohort April 1 Total Survival in the first trimester 2022QI "" 22 Huesca Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 22 Huesca Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 22 Huesca Total Cohort April 1 Total Survival in the first trimester 2021QII 5.932 22 Huesca Total Cohort April 1 Total Survival in the first trimester 2021QI "" 22 Huesca Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 22 Huesca Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 22 Huesca Total Cohort April 1 Total Survival in the first trimester 2020QII 5.847 22 Huesca Total Cohort April 1 Total Survival in the first trimester 2020QI "" 22 Huesca Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 22 Huesca Total Cohort April 1 Total Survival in the second trimester 2022QIII 5.808 22 Huesca Total Cohort April 1 Total Survival in the second trimester 2022QII "" 22 Huesca Total Cohort April 1 Total Survival in the second trimester 2022QI "" 22 Huesca Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 22 Huesca Total Cohort April 1 Total Survival in the second trimester 2021QIII 5.718 22 Huesca Total Cohort April 1 Total Survival in the second trimester 2021QII "" 22 Huesca Total Cohort April 1 Total Survival in the second trimester 2021QI "" 22 Huesca Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 22 Huesca Total Cohort April 1 Total Survival in the second trimester 2020QIII 5.659 22 Huesca Total Cohort April 1 Total Survival in the second trimester 2020QII "" 22 Huesca Total Cohort April 1 Total Survival in the second trimester 2020QI "" 22 Huesca Total Cohort April 1 Total Survival in the third trimester 2022QIV 5.607 22 Huesca Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 22 Huesca Total Cohort April 1 Total Survival in the third trimester 2022QII "" 22 Huesca Total Cohort April 1 Total Survival in the third trimester 2022QI "" 22 Huesca Total Cohort April 1 Total Survival in the third trimester 2021QIV 5.541 22 Huesca Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 22 Huesca Total Cohort April 1 Total Survival in the third trimester 2021QII "" 22 Huesca Total Cohort April 1 Total Survival in the third trimester 2021QI "" 22 Huesca Total Cohort April 1 Total Survival in the third trimester 2020QIV 5.480 22 Huesca Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 22 Huesca Total Cohort April 1 Total Survival in the third trimester 2020QII "" 22 Huesca Total Cohort April 1 Total Survival in the third trimester 2020QI "" 22 Huesca Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 22 Huesca Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 22 Huesca Total Cohort April 1 Total Survival in the third trimester 2022QII "" 22 Huesca Total Cohort April 1 Total Survival in the third trimester 2022QI 5.371 22 Huesca Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 22 Huesca Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 22 Huesca Total Cohort April 1 Total Survival in the third trimester 2021QII "" 22 Huesca Total Cohort April 1 Total Survival in the third trimester 2021QI 5.318 22 Huesca Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 22 Huesca Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 22 Huesca Total Cohort April 1 Total Survival in the third trimester 2020QII "" 22 Huesca Total Cohort April 1 Total Survival in the third trimester 2020QI "" 22 Huesca Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 22 Huesca Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 22 Huesca Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 22 Huesca Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 22 Huesca Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 22 Huesca Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,49 22 Huesca Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,57 22 Huesca Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,84 22 Huesca Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,59 22 Huesca Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,12 22 Huesca Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,76 22 Huesca Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,46 22 Huesca Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 89,27 22 Huesca Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,82 22 Huesca Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 86,53 22 Huesca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87,17 22 Huesca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 22 Huesca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 22 Huesca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 6.222 22 Huesca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 5.602 22 Huesca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 4.793 22 Huesca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 5.875 22 Huesca Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 5.339 22 Huesca Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 4.570 22 Huesca Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 5.635 22 Huesca Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 5.144 22 Huesca Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 4.419 22 Huesca Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 5.440 22 Huesca Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 4.981 22 Huesca Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 4.280 22 Huesca Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 4.823 22 Huesca Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 4.154 22 Huesca Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 22 Huesca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 22 Huesca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 22 Huesca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,42 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,31 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,35 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,57 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,82 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,2 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,43 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 88,91 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 89,3 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 86,09 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 86,67 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 189 22 Huesca Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 605 22 Huesca Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.308 22 Huesca Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 183 22 Huesca Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 593 22 Huesca Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.277 22 Huesca Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 173 22 Huesca Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 574 22 Huesca Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.240 22 Huesca Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 167 22 Huesca Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 560 22 Huesca Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.200 22 Huesca Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 548 22 Huesca Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.164 22 Huesca Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 22 Huesca Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 22 Huesca Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 22 Huesca Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,83 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,02 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,63 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,53 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,88 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,8 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,36 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 92,56 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,74 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 90,58 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 88,99 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca Total Cohort July 1 Total Number at the start of the quarter 2022QIII 6.517 22 Huesca Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 22 Huesca Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 22 Huesca Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca Total Cohort July 1 Total Number at the start of the quarter 2021QIII 6.453 22 Huesca Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 22 Huesca Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 22 Huesca Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca Total Cohort July 1 Total Number at the start of the quarter 2020QIII 6.318 22 Huesca Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 22 Huesca Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 22 Huesca Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 22 Huesca Total Cohort July 1 Total Survival in the first trimester 2022QIII 6.118 22 Huesca Total Cohort July 1 Total Survival in the first trimester 2022QII "" 22 Huesca Total Cohort July 1 Total Survival in the first trimester 2022QI "" 22 Huesca Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 22 Huesca Total Cohort July 1 Total Survival in the first trimester 2021QIII 6.089 22 Huesca Total Cohort July 1 Total Survival in the first trimester 2021QII "" 22 Huesca Total Cohort July 1 Total Survival in the first trimester 2021QI "" 22 Huesca Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 22 Huesca Total Cohort July 1 Total Survival in the first trimester 2020QIII 6.001 22 Huesca Total Cohort July 1 Total Survival in the first trimester 2020QII "" 22 Huesca Total Cohort July 1 Total Survival in the first trimester 2020QI "" 22 Huesca Total Cohort July 1 Total Survival in the second trimester 2022QIV 5.800 22 Huesca Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 22 Huesca Total Cohort July 1 Total Survival in the second trimester 2022QII "" 22 Huesca Total Cohort July 1 Total Survival in the second trimester 2022QI "" 22 Huesca Total Cohort July 1 Total Survival in the second trimester 2021QIV 5.781 22 Huesca Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 22 Huesca Total Cohort July 1 Total Survival in the second trimester 2021QII "" 22 Huesca Total Cohort July 1 Total Survival in the second trimester 2021QI "" 22 Huesca Total Cohort July 1 Total Survival in the second trimester 2020QIV 5.682 22 Huesca Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 22 Huesca Total Cohort July 1 Total Survival in the second trimester 2020QII "" 22 Huesca Total Cohort July 1 Total Survival in the second trimester 2020QI "" 22 Huesca Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 22 Huesca Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 22 Huesca Total Cohort July 1 Total Survival in the third trimester 2022QII "" 22 Huesca Total Cohort July 1 Total Survival in the third trimester 2022QI 5.590 22 Huesca Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 22 Huesca Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 22 Huesca Total Cohort July 1 Total Survival in the third trimester 2021QII "" 22 Huesca Total Cohort July 1 Total Survival in the third trimester 2021QI 5.489 22 Huesca Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 22 Huesca Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 22 Huesca Total Cohort July 1 Total Survival in the third trimester 2020QII "" 22 Huesca Total Cohort July 1 Total Survival in the third trimester 2020QI "" 22 Huesca Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 22 Huesca Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 22 Huesca Total Cohort July 1 Total Survival in the third trimester 2022QII 5.454 22 Huesca Total Cohort July 1 Total Survival in the third trimester 2022QI "" 22 Huesca Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 22 Huesca Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 22 Huesca Total Cohort July 1 Total Survival in the third trimester 2021QII 5.375 22 Huesca Total Cohort July 1 Total Survival in the third trimester 2021QI "" 22 Huesca Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 22 Huesca Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 22 Huesca Total Cohort July 1 Total Survival in the third trimester 2020QII "" 22 Huesca Total Cohort July 1 Total Survival in the third trimester 2020QI "" 22 Huesca Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 22 Huesca Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 22 Huesca Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 22 Huesca Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 22 Huesca Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 22 Huesca Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 22 Huesca Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 22 Huesca Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 22 Huesca Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,88 22 Huesca Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,36 22 Huesca Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,98 22 Huesca Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89 22 Huesca Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,59 22 Huesca Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 89,93 22 Huesca Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 86,63 22 Huesca Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,88 22 Huesca Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 84,52 22 Huesca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 85,07 22 Huesca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 22 Huesca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 22 Huesca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 6.351 22 Huesca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 6.273 22 Huesca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 5.617 22 Huesca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 5.961 22 Huesca Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 5.919 22 Huesca Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 5.324 22 Huesca Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 5.647 22 Huesca Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 5.615 22 Huesca Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 5.027 22 Huesca Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 5.430 22 Huesca Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 4.856 22 Huesca Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 5.296 22 Huesca Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 4.752 22 Huesca Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 22 Huesca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 22 Huesca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 22 Huesca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,86 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,36 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,78 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 88,92 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,51 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,5 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 86,56 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,45 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 84,43 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 84,6 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 166 22 Huesca Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 180 22 Huesca Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 701 22 Huesca Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 157 22 Huesca Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 170 22 Huesca Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 677 22 Huesca Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 153 22 Huesca Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 166 22 Huesca Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 655 22 Huesca Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 160 22 Huesca Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 633 22 Huesca Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 158 22 Huesca Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 623 22 Huesca Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 22 Huesca Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 22 Huesca Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 22 Huesca Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 94,58 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 94,44 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,58 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 92,17 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 92,22 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,44 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 88,89 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 90,3 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 87,78 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 88,87 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca Total Cohort October 1 Total Number at the start of the quarter 2022QIV 6.369 22 Huesca Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 22 Huesca Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 22 Huesca Total Cohort October 1 Total Number at the start of the quarter 2021QIV 6.374 22 Huesca Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 22 Huesca Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 22 Huesca Total Cohort October 1 Total Number at the start of the quarter 2020QIV 6.312 22 Huesca Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 22 Huesca Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 22 Huesca Total Cohort October 1 Total Survival in the first trimester 2022QIV 5.996 22 Huesca Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 22 Huesca Total Cohort October 1 Total Survival in the first trimester 2022QII "" 22 Huesca Total Cohort October 1 Total Survival in the first trimester 2022QI "" 22 Huesca Total Cohort October 1 Total Survival in the first trimester 2021QIV 6.002 22 Huesca Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 22 Huesca Total Cohort October 1 Total Survival in the first trimester 2021QII "" 22 Huesca Total Cohort October 1 Total Survival in the first trimester 2021QI "" 22 Huesca Total Cohort October 1 Total Survival in the first trimester 2020QIV 5.882 22 Huesca Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 22 Huesca Total Cohort October 1 Total Survival in the first trimester 2020QII "" 22 Huesca Total Cohort October 1 Total Survival in the first trimester 2020QI "" 22 Huesca Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 22 Huesca Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 22 Huesca Total Cohort October 1 Total Survival in the second trimester 2022QII "" 22 Huesca Total Cohort October 1 Total Survival in the second trimester 2022QI 5.776 22 Huesca Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 22 Huesca Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 22 Huesca Total Cohort October 1 Total Survival in the second trimester 2021QII "" 22 Huesca Total Cohort October 1 Total Survival in the second trimester 2021QI 5.656 22 Huesca Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 22 Huesca Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 22 Huesca Total Cohort October 1 Total Survival in the second trimester 2020QII "" 22 Huesca Total Cohort October 1 Total Survival in the second trimester 2020QI "" 22 Huesca Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 22 Huesca Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 22 Huesca Total Cohort October 1 Total Survival in the third trimester 2022QII 5.585 22 Huesca Total Cohort October 1 Total Survival in the third trimester 2022QI "" 22 Huesca Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 22 Huesca Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 22 Huesca Total Cohort October 1 Total Survival in the third trimester 2021QII 5.497 22 Huesca Total Cohort October 1 Total Survival in the third trimester 2021QI "" 22 Huesca Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 22 Huesca Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 22 Huesca Total Cohort October 1 Total Survival in the third trimester 2020QII "" 22 Huesca Total Cohort October 1 Total Survival in the third trimester 2020QI "" 22 Huesca Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 22 Huesca Total Cohort October 1 Total Survival in the third trimester 2022QIII 5.428 22 Huesca Total Cohort October 1 Total Survival in the third trimester 2022QII "" 22 Huesca Total Cohort October 1 Total Survival in the third trimester 2022QI "" 22 Huesca Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 22 Huesca Total Cohort October 1 Total Survival in the third trimester 2021QIII 5.367 22 Huesca Total Cohort October 1 Total Survival in the third trimester 2021QII "" 22 Huesca Total Cohort October 1 Total Survival in the third trimester 2021QI "" 22 Huesca Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 22 Huesca Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 22 Huesca Total Cohort October 1 Total Survival in the third trimester 2020QII "" 22 Huesca Total Cohort October 1 Total Survival in the third trimester 2020QI "" 22 Huesca Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 22 Huesca Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 22 Huesca Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 22 Huesca Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 22 Huesca Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 22 Huesca Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 22 Huesca Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 22 Huesca Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 22 Huesca Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,14 22 Huesca Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,16 22 Huesca Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,19 22 Huesca Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,62 22 Huesca Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,61 22 Huesca Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,62 22 Huesca Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 87,09 22 Huesca Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 85,16 22 Huesca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 85,03 22 Huesca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 22 Huesca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 22 Huesca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 6.224 22 Huesca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 6.179 22 Huesca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 5.631 22 Huesca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 5.854 22 Huesca Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 5.810 22 Huesca Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 5.224 22 Huesca Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 5.592 22 Huesca Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 5.025 22 Huesca Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 5.407 22 Huesca Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 4.878 22 Huesca Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 5.256 22 Huesca Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 4.761 22 Huesca Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 22 Huesca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 22 Huesca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 22 Huesca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,06 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,03 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,77 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,5 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,24 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 87,51 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,63 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 85,06 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 84,55 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 145 22 Huesca Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 195 22 Huesca Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 681 22 Huesca Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 142 22 Huesca Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 192 22 Huesca Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 658 22 Huesca Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 184 22 Huesca Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 631 22 Huesca Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 178 22 Huesca Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 619 22 Huesca Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 172 22 Huesca Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 606 22 Huesca Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 22 Huesca Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 22 Huesca Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 22 Huesca Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,93 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,46 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,62 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,36 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 92,66 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 91,28 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 90,9 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 88,21 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 88,99 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 22 Huesca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 4.722 22 Huesca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 22 Huesca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 4.688 22 Huesca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 4.908 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 4.435 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 4.411 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 4.284 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 4.171 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 4.210 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 4.100 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 3.984 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 4.058 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 3.943 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 3.854 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 3.947 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 3.810 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 22 Huesca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 22 Huesca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 22 Huesca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 22 Huesca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,92 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,09 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 87,29 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,33 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 89,8 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 83,54 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 84,37 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 86,56 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 80,34 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 81,62 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 84,19 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 77,63 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 4.593 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 4.315 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 4.311 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 4.056 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 4.051 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 3.865 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 3.875 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 3.725 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 3.746 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 3.627 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,86 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,2 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,57 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 84,37 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,33 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 81,56 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 84,06 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 129 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 373 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 124 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 355 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 120 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 345 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 109 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 333 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 108 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 320 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,12 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,17 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,02 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 92,49 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 84,5 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 89,28 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 83,72 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 85,79 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 4.748 22 Huesca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 4.724 22 Huesca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 4.626 22 Huesca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 4.432 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 4.463 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 4.392 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 4.199 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 4.260 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 4.216 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 4.014 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 4.097 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 4.051 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 3.942 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 3.904 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 22 Huesca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 22 Huesca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 22 Huesca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 22 Huesca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,34 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,48 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,94 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 88,44 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,18 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,14 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 84,54 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 86,73 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 87,57 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 83,45 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 84,39 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 4.644 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 4.373 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 3.810 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 4.332 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 4.120 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 3.602 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 4.108 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 3.933 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 3.459 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 3.928 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 3.784 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 3.329 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 3.638 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 3.212 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,28 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,21 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,54 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 88,46 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,94 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,79 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 84,58 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 86,53 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 87,38 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 83,19 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,3 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 104 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 351 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 816 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 100 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 343 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 790 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 91 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 327 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 757 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 86 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 313 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 722 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 304 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 692 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,15 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,72 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 96,81 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 87,5 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,16 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 92,77 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 82,69 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 89,17 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 88,48 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 86,61 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 84,8 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 4.773 22 Huesca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 4.806 22 Huesca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 4.747 22 Huesca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 4.396 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 4.461 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 4.449 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 4.130 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 4.184 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 4.161 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 4.013 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 3.985 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 3.885 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 3.876 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 22 Huesca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 22 Huesca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 22 Huesca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,1 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,82 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 93,72 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 86,53 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 87,06 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 87,66 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 83,5 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 83,95 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 80,84 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 81,65 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 4.678 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 4.702 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 4.364 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 4.309 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 4.366 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 4.085 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 4.045 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 4.093 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 3.814 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 3.926 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 3.659 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 3.800 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 3.558 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,11 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,85 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,61 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 86,47 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 87,05 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 87,4 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 83,5 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 83,85 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 80,82 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 81,53 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 95 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 104 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 383 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 87 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 95 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 364 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 85 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 91 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 347 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 87 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 326 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 85 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 318 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 91,58 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 91,35 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 95,04 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 89,47 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 87,5 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 90,6 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 83,65 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 85,12 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 81,73 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 83,03 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 4.715 22 Huesca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 4.760 22 Huesca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 4.754 22 Huesca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 4.375 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 4.414 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 4.350 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 4.207 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 4.142 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 4.024 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 3.993 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 3.879 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 3.877 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 22 Huesca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 22 Huesca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 22 Huesca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 92,79 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 92,73 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 91,5 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,38 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 87,13 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 84,54 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 83,99 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 81,49 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 81,55 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 4.638 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 4.634 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 4.396 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 4.300 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 4.291 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 4.011 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 4.091 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 3.825 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 3.914 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 3.685 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 3.774 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 3.578 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 92,71 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 92,6 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 91,24 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,28 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 87,01 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 84,46 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 83,83 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 81,44 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 81,39 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 77 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 126 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 358 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 75 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 123 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 339 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 116 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 317 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 110 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 308 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 105 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 299 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,4 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,62 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 94,69 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 92,06 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 88,55 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 87,3 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 86,03 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 83,33 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 83,52 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 782 22 Huesca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 659 22 Huesca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 720 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 770 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 653 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 691 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 750 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 646 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 679 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 738 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 640 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 668 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 727 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 637 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 662 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 22 Huesca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 22 Huesca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,47 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,09 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 95,97 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 95,91 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,03 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 94,31 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,37 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,12 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 92,78 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 92,97 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,66 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 91,94 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 742 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 547 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 732 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 542 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 713 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 535 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 702 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 529 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 691 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 527 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,65 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,09 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,09 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,81 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,61 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,71 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,13 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,34 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 40 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 112 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 38 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 111 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 37 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 111 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 36 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 111 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 36 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 110 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,11 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,5 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 99,11 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 99,11 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 90 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,21 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 767 22 Huesca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 655 22 Huesca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 662 22 Huesca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 747 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 648 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 649 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 739 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 643 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 641 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 727 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 634 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 634 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 629 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 626 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 22 Huesca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 22 Huesca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 22 Huesca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,39 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,93 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,04 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,35 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,17 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 96,83 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 94,78 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,79 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,77 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,03 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,56 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 733 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 563 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 447 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 714 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 557 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 437 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 706 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 553 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 430 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 694 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 544 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 426 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 539 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 421 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,41 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,93 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 97,76 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,32 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,22 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 96,2 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 94,68 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,63 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,3 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,74 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,18 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 34 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 92 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 215 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 33 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 91 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 212 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 33 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 90 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 211 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 33 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 90 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 208 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 90 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 205 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,06 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,91 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,6 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,06 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,83 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,14 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,06 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,83 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,74 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,83 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,35 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 776 22 Huesca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 729 22 Huesca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 710 22 Huesca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 764 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 718 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 697 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 730 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 702 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 678 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 694 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 667 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 687 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 665 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 22 Huesca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 22 Huesca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 22 Huesca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,45 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,49 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,17 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 94,07 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 96,3 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 95,49 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,2 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 93,94 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 94,24 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 93,66 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 758 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 702 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 586 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 746 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 691 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 575 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 712 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 675 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 558 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 667 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 548 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 660 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 546 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,42 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,43 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,12 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 93,93 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 96,15 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 95,22 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,01 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 93,52 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,02 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 93,17 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 18 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 27 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 124 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 18 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 27 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 122 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 18 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 27 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 120 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 27 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 119 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 27 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 119 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,39 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,77 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95,97 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,97 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 739 22 Huesca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 729 22 Huesca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 713 22 Huesca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 718 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 717 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 695 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 707 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 682 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 704 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 677 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 699 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 672 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 22 Huesca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 22 Huesca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 22 Huesca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,16 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,35 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 97,48 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,98 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 95,65 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,57 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 94,95 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,88 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 94,25 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 717 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 696 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 589 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 696 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 684 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 573 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 675 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 564 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 672 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 560 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 668 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 557 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,07 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,28 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,28 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,98 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 95,76 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,55 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,08 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,98 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 94,57 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 22 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 33 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 124 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 22 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 33 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 122 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 32 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 118 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 32 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 117 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 31 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 115 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,39 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 96,97 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,16 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,97 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,35 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 93,94 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 92,74 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 22 Huesca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 852 22 Huesca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 22 Huesca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 765 22 Huesca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 859 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 845 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 760 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 840 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 830 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 755 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 831 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 818 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 748 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 824 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 813 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 744 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 815 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 22 Huesca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 22 Huesca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 22 Huesca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 22 Huesca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,18 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,35 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,79 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,42 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,69 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,74 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,01 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,78 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,93 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,42 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,25 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,88 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 817 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 613 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 811 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 609 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 796 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 606 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 785 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 602 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 780 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 598 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,27 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,35 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,43 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,86 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,08 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,21 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,47 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,55 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 35 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 152 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 34 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 151 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 34 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 149 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 33 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 146 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 33 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 146 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,14 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,34 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,14 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,03 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 94,29 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,05 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,29 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,05 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 856 22 Huesca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 792 22 Huesca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 783 22 Huesca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 840 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 785 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 776 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 832 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 779 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 772 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 828 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 776 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 765 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 767 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 758 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 22 Huesca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 22 Huesca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 22 Huesca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 22 Huesca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,13 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,12 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,11 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,2 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,36 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,6 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,73 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,98 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,7 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,84 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,81 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 808 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 640 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 516 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 793 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 636 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 511 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 786 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 632 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 510 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 783 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 629 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 505 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 623 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 501 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,14 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,38 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,03 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,28 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,75 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,84 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,91 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98,28 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,87 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,34 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,09 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 48 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 152 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 267 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 47 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 149 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 265 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 46 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 147 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 262 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 45 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 147 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 260 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 144 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 257 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,92 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,03 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,25 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 95,83 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,71 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,13 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 93,75 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,71 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,38 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 94,74 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,25 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 925 22 Huesca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 879 22 Huesca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 821 22 Huesca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 916 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 871 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 815 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 898 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 858 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 804 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 847 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 798 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 846 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 795 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 22 Huesca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 22 Huesca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 22 Huesca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,03 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,09 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,27 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,08 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,61 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,93 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,36 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,2 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,25 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,83 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 876 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 832 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 636 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 868 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 825 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 633 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 852 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 812 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 625 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 803 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 619 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 802 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 618 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,09 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,16 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,53 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,26 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,6 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,27 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,51 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,33 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,39 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,17 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 49 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 47 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 185 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 48 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 46 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 182 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 46 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 46 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 179 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 44 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 179 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 44 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 177 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,96 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,87 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,38 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,88 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,87 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,76 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93,62 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,76 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,62 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,68 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 874 22 Huesca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 848 22 Huesca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 806 22 Huesca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 862 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 836 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 798 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 828 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 793 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 823 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 788 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 817 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 779 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 22 Huesca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 22 Huesca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 22 Huesca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,63 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,58 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,01 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,64 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,39 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,05 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,77 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,34 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,65 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 832 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 813 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 618 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 821 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 801 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 612 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 793 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 608 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 788 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 605 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 782 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 598 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,68 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,52 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,03 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,54 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,38 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,92 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,9 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,19 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,76 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 42 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 35 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 188 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 41 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 35 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 186 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 35 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 185 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 35 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 183 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 35 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 181 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,62 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,94 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,4 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,34 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,28 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 22 Huesca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 28 22 Huesca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 22 Huesca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 27 22 Huesca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 23 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 28 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 27 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 23 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 27 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 27 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 23 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 26 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 27 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 23 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 26 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 27 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 23 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 22 Huesca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 22 Huesca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 22 Huesca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 22 Huesca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,43 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 92,86 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 92,86 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 26 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 18 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 26 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 18 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 25 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 18 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 24 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 18 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 24 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 18 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,15 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 92,31 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 92,31 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 9 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 9 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 9 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 9 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 9 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 29 22 Huesca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 26 22 Huesca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 19 22 Huesca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 28 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 26 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 19 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 27 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 26 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 19 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 27 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 25 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 19 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 25 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 19 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 22 Huesca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 22 Huesca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 22 Huesca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 22 Huesca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 96,55 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 93,1 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 93,1 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,15 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,15 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 22 Huesca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 26 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 16 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 11 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 25 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 16 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 11 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 24 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 16 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 11 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 24 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 15 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 11 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 15 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 11 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 96,15 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 92,31 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 92,31 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 93,75 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,75 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 3 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 10 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 8 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 3 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 10 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 8 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 3 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 10 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 8 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 3 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 10 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 8 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 10 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 8 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 33 22 Huesca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 27 22 Huesca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 28 22 Huesca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 32 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 27 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 28 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 32 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 26 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 27 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 26 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 27 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 26 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 27 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 22 Huesca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 22 Huesca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 22 Huesca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 96,97 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,97 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 96,3 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 96,43 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,3 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,43 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,3 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,43 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 29 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 25 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 21 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 28 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 25 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 21 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 28 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 24 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 20 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 24 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 20 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 24 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 20 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 96,55 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,55 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 96 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 95,24 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,24 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,24 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 4 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 2 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 7 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 4 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 2 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 7 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 4 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 2 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 7 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 2 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 7 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 2 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 7 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 31 22 Huesca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 25 22 Huesca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 28 22 Huesca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 31 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 24 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 28 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 24 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 28 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 24 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 28 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 23 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 28 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 22 Huesca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 22 Huesca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 22 Huesca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 96 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 92 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 27 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 24 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 19 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 27 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 23 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 19 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 23 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 19 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 23 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 19 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 22 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 19 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,83 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 95,83 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,83 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 91,67 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 4 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 9 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 4 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 9 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 9 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 9 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 9 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 22 Huesca De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 12 22 Huesca De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 22 Huesca De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 11 22 Huesca De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 22 Huesca De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 12 22 Huesca De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 11 22 Huesca De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 11 22 Huesca De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 12 22 Huesca De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 11 22 Huesca De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 11 22 Huesca De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 12 22 Huesca De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 11 22 Huesca De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 11 22 Huesca De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 12 22 Huesca De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 11 22 Huesca De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 10 22 Huesca De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 12 22 Huesca De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 22 Huesca De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 22 Huesca De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 22 Huesca De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 22 Huesca De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 22 Huesca De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 22 Huesca De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 22 Huesca De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 91,67 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 91,67 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 91,67 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 91,67 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 90,91 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 22 Huesca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 12 22 Huesca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 9 22 Huesca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 11 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 9 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 11 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 9 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 11 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 9 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 11 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 9 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 22 Huesca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 22 Huesca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 91,67 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 91,67 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 91,67 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 91,67 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 0 22 Huesca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2 22 Huesca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 0 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 0 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 0 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 0 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI .. 22 Huesca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 22 Huesca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI .. 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII .. 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII .. 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 0 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 50 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 11 22 Huesca De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 22 Huesca De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 10 22 Huesca De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 22 Huesca De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 11 22 Huesca De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 11 22 Huesca De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 10 22 Huesca De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 11 22 Huesca De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 11 22 Huesca De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 10 22 Huesca De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 11 22 Huesca De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 11 22 Huesca De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 9 22 Huesca De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 11 22 Huesca De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 8 22 Huesca De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 11 22 Huesca De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 22 Huesca De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 22 Huesca De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 22 Huesca De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 22 Huesca De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 22 Huesca De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 22 Huesca De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 22 Huesca De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 90 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 80 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 22 Huesca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 11 22 Huesca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 10 22 Huesca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 9 22 Huesca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 11 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 10 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 9 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 11 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 10 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 9 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 11 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 9 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 9 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 8 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 9 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 22 Huesca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 22 Huesca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 22 Huesca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 90 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 80 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 0 22 Huesca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 0 22 Huesca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2 22 Huesca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 0 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 0 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 0 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 0 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 0 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 0 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 0 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII .. 22 Huesca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII .. 22 Huesca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 22 Huesca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII .. 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII .. 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII .. 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII .. 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 0 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV .. 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI .. 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 10 22 Huesca De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 22 Huesca De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 22 Huesca De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 12 22 Huesca De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 22 Huesca De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 22 Huesca De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 12 22 Huesca De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 22 Huesca De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 10 22 Huesca De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 12 22 Huesca De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 12 22 Huesca De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 10 22 Huesca De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 11 22 Huesca De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 12 22 Huesca De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 10 22 Huesca De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 12 22 Huesca De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 10 22 Huesca De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 12 22 Huesca De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 22 Huesca De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 22 Huesca De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 22 Huesca De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 22 Huesca De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 22 Huesca De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 22 Huesca De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 22 Huesca De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 22 Huesca De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 22 Huesca De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 22 Huesca De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 22 Huesca De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 22 Huesca De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 22 Huesca De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 91,67 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 83,33 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 83,33 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 22 Huesca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 10 22 Huesca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 12 22 Huesca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 10 22 Huesca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 10 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 12 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 10 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 10 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 11 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 10 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 10 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 10 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 10 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 10 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 22 Huesca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 22 Huesca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 22 Huesca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 91,67 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 83,33 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 83,33 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 22 Huesca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 0 22 Huesca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2 22 Huesca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 0 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 0 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 2 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 0 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 0 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 2 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII .. 22 Huesca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII .. 22 Huesca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 22 Huesca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII .. 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII .. 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV .. 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI .. 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII .. 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 10 22 Huesca De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 22 Huesca De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 22 Huesca De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 12 22 Huesca De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 22 Huesca De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 22 Huesca De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 11 22 Huesca De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 22 Huesca De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 10 22 Huesca De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 11 22 Huesca De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 11 22 Huesca De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 10 22 Huesca De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 11 22 Huesca De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 10 22 Huesca De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 11 22 Huesca De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 10 22 Huesca De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 11 22 Huesca De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 22 Huesca De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 22 Huesca De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 22 Huesca De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 22 Huesca De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 22 Huesca De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 22 Huesca De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 22 Huesca De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 22 Huesca De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 22 Huesca De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 22 Huesca De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 22 Huesca De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 22 Huesca De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 91,67 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 83,33 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 83,33 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 83,33 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 22 Huesca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 10 22 Huesca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 12 22 Huesca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 9 22 Huesca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 10 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 11 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 9 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 10 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 9 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 10 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 9 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 10 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 9 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 22 Huesca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 22 Huesca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 22 Huesca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 91,67 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 83,33 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 83,33 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 83,33 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 22 Huesca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 0 22 Huesca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 2 22 Huesca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 0 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 0 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 0 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 0 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 22 Huesca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV .. 22 Huesca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 22 Huesca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV .. 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI .. 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII .. 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII .. 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 22 Huesca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 23 Jaén Total Cohort January 1 Total Number at the start of the quarter 2022QI 12.666 23 Jaén Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 23 Jaén Total Cohort January 1 Total Number at the start of the quarter 2021QI 12.067 23 Jaén Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 23 Jaén Total Cohort January 1 Total Number at the start of the quarter 2020QI 12.992 23 Jaén Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 23 Jaén Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 23 Jaén Total Cohort January 1 Total Survival in the first trimester 2022QII "" 23 Jaén Total Cohort January 1 Total Survival in the first trimester 2022QI 11.793 23 Jaén Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 23 Jaén Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 23 Jaén Total Cohort January 1 Total Survival in the first trimester 2021QII "" 23 Jaén Total Cohort January 1 Total Survival in the first trimester 2021QI 11.273 23 Jaén Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 23 Jaén Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 23 Jaén Total Cohort January 1 Total Survival in the first trimester 2020QII "" 23 Jaén Total Cohort January 1 Total Survival in the first trimester 2020QI 10.706 23 Jaén Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 23 Jaén Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 23 Jaén Total Cohort January 1 Total Survival in the second trimester 2022QII 11.278 23 Jaén Total Cohort January 1 Total Survival in the second trimester 2022QI "" 23 Jaén Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 23 Jaén Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 23 Jaén Total Cohort January 1 Total Survival in the second trimester 2021QII 10.805 23 Jaén Total Cohort January 1 Total Survival in the second trimester 2021QI "" 23 Jaén Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 23 Jaén Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 23 Jaén Total Cohort January 1 Total Survival in the second trimester 2020QII 10.363 23 Jaén Total Cohort January 1 Total Survival in the second trimester 2020QI "" 23 Jaén Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 23 Jaén Total Cohort January 1 Total Survival in the third trimester 2022QIII 10.840 23 Jaén Total Cohort January 1 Total Survival in the third trimester 2022QII "" 23 Jaén Total Cohort January 1 Total Survival in the third trimester 2022QI "" 23 Jaén Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 23 Jaén Total Cohort January 1 Total Survival in the third trimester 2021QIII 10.455 23 Jaén Total Cohort January 1 Total Survival in the third trimester 2021QII "" 23 Jaén Total Cohort January 1 Total Survival in the third trimester 2021QI "" 23 Jaén Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 23 Jaén Total Cohort January 1 Total Survival in the third trimester 2020QIII 10.035 23 Jaén Total Cohort January 1 Total Survival in the third trimester 2020QII "" 23 Jaén Total Cohort January 1 Total Survival in the third trimester 2020QI "" 23 Jaén Total Cohort January 1 Total Survival in the third trimester 2022QIV 10.464 23 Jaén Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 23 Jaén Total Cohort January 1 Total Survival in the third trimester 2022QII "" 23 Jaén Total Cohort January 1 Total Survival in the third trimester 2022QI "" 23 Jaén Total Cohort January 1 Total Survival in the third trimester 2021QIV 10.095 23 Jaén Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 23 Jaén Total Cohort January 1 Total Survival in the third trimester 2021QII "" 23 Jaén Total Cohort January 1 Total Survival in the third trimester 2021QI "" 23 Jaén Total Cohort January 1 Total Survival in the third trimester 2020QIV 9.587 23 Jaén Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 23 Jaén Total Cohort January 1 Total Survival in the third trimester 2020QII "" 23 Jaén Total Cohort January 1 Total Survival in the third trimester 2020QI "" 23 Jaén Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 23 Jaén Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 23 Jaén Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 23 Jaén Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 23 Jaén Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 23 Jaén Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 23 Jaén Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,11 23 Jaén Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,42 23 Jaén Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 82,4 23 Jaén Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,04 23 Jaén Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 89,54 23 Jaén Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 79,76 23 Jaén Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 85,58 23 Jaén Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 86,64 23 Jaén Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 77,24 23 Jaén Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 82,61 23 Jaén Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 83,66 23 Jaén Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 73,79 23 Jaén Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 23 Jaén Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 23 Jaén Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 12.310 23 Jaén Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 11.342 23 Jaén Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 11.445 23 Jaén Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 10.554 23 Jaén Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 10.938 23 Jaén Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 10.097 23 Jaén Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 10.508 23 Jaén Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 9.755 23 Jaén Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 10.139 23 Jaén Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 9.412 23 Jaén Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 23 Jaén Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 23 Jaén Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,97 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,05 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,85 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,02 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 85,36 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,01 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 82,36 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 82,98 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 356 23 Jaén Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 725 23 Jaén Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 348 23 Jaén Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 719 23 Jaén Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 340 23 Jaén Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 708 23 Jaén Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 332 23 Jaén Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 700 23 Jaén Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 325 23 Jaén Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 683 23 Jaén Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 23 Jaén Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 23 Jaén Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,75 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,17 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 95,51 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,66 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 93,26 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,55 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 91,29 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 94,21 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén Total Cohort April 1 Total Number at the start of the quarter 2022QII 12.937 23 Jaén Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 23 Jaén Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén Total Cohort April 1 Total Number at the start of the quarter 2021QII 12.374 23 Jaén Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 23 Jaén Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén Total Cohort April 1 Total Number at the start of the quarter 2020QII 11.365 23 Jaén Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 23 Jaén Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 23 Jaén Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 23 Jaén Total Cohort April 1 Total Survival in the first trimester 2022QII 12.209 23 Jaén Total Cohort April 1 Total Survival in the first trimester 2022QI "" 23 Jaén Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 23 Jaén Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 23 Jaén Total Cohort April 1 Total Survival in the first trimester 2021QII 11.724 23 Jaén Total Cohort April 1 Total Survival in the first trimester 2021QI "" 23 Jaén Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 23 Jaén Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 23 Jaén Total Cohort April 1 Total Survival in the first trimester 2020QII 10.909 23 Jaén Total Cohort April 1 Total Survival in the first trimester 2020QI "" 23 Jaén Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 23 Jaén Total Cohort April 1 Total Survival in the second trimester 2022QIII 11.618 23 Jaén Total Cohort April 1 Total Survival in the second trimester 2022QII "" 23 Jaén Total Cohort April 1 Total Survival in the second trimester 2022QI "" 23 Jaén Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 23 Jaén Total Cohort April 1 Total Survival in the second trimester 2021QIII 11.222 23 Jaén Total Cohort April 1 Total Survival in the second trimester 2021QII "" 23 Jaén Total Cohort April 1 Total Survival in the second trimester 2021QI "" 23 Jaén Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 23 Jaén Total Cohort April 1 Total Survival in the second trimester 2020QIII 10.516 23 Jaén Total Cohort April 1 Total Survival in the second trimester 2020QII "" 23 Jaén Total Cohort April 1 Total Survival in the second trimester 2020QI "" 23 Jaén Total Cohort April 1 Total Survival in the third trimester 2022QIV 10.964 23 Jaén Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 23 Jaén Total Cohort April 1 Total Survival in the third trimester 2022QII "" 23 Jaén Total Cohort April 1 Total Survival in the third trimester 2022QI "" 23 Jaén Total Cohort April 1 Total Survival in the third trimester 2021QIV 10.589 23 Jaén Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 23 Jaén Total Cohort April 1 Total Survival in the third trimester 2021QII "" 23 Jaén Total Cohort April 1 Total Survival in the third trimester 2021QI "" 23 Jaén Total Cohort April 1 Total Survival in the third trimester 2020QIV 9.930 23 Jaén Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 23 Jaén Total Cohort April 1 Total Survival in the third trimester 2020QII "" 23 Jaén Total Cohort April 1 Total Survival in the third trimester 2020QI "" 23 Jaén Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 23 Jaén Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 23 Jaén Total Cohort April 1 Total Survival in the third trimester 2022QII "" 23 Jaén Total Cohort April 1 Total Survival in the third trimester 2022QI 10.205 23 Jaén Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 23 Jaén Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 23 Jaén Total Cohort April 1 Total Survival in the third trimester 2021QII "" 23 Jaén Total Cohort April 1 Total Survival in the third trimester 2021QI 9.561 23 Jaén Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 23 Jaén Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 23 Jaén Total Cohort April 1 Total Survival in the third trimester 2020QII "" 23 Jaén Total Cohort April 1 Total Survival in the third trimester 2020QI "" 23 Jaén Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 23 Jaén Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 23 Jaén Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 23 Jaén Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 23 Jaén Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 23 Jaén Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,37 23 Jaén Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,75 23 Jaén Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,99 23 Jaén Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,8 23 Jaén Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,69 23 Jaén Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,53 23 Jaén Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 84,75 23 Jaén Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 85,57 23 Jaén Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 87,37 23 Jaén Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 82,47 23 Jaén Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 84,13 23 Jaén Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 23 Jaén Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 23 Jaén Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 12.609 23 Jaén Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 11.590 23 Jaén Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 10.252 23 Jaén Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 11.887 23 Jaén Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 10.951 23 Jaén Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 9.802 23 Jaén Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 11.306 23 Jaén Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 10.456 23 Jaén Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 9.420 23 Jaén Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 10.662 23 Jaén Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 9.843 23 Jaén Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 8.861 23 Jaén Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 9.471 23 Jaén Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 8.509 23 Jaén Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 23 Jaén Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 23 Jaén Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 23 Jaén Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,27 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,49 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,61 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 89,67 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 90,22 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,88 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 84,56 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 84,93 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 86,43 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 81,72 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 83 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 328 23 Jaén Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 784 23 Jaén Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.113 23 Jaén Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 322 23 Jaén Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 773 23 Jaén Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.107 23 Jaén Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 312 23 Jaén Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 766 23 Jaén Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.096 23 Jaén Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 302 23 Jaén Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 746 23 Jaén Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.069 23 Jaén Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 734 23 Jaén Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.052 23 Jaén Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 23 Jaén Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 23 Jaén Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 23 Jaén Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,17 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,6 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,46 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 95,12 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,7 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,47 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 92,07 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 95,15 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,05 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 93,62 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,52 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén Total Cohort July 1 Total Number at the start of the quarter 2022QIII 13.432 23 Jaén Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 23 Jaén Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 23 Jaén Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén Total Cohort July 1 Total Number at the start of the quarter 2021QIII 13.146 23 Jaén Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 23 Jaén Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 23 Jaén Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén Total Cohort July 1 Total Number at the start of the quarter 2020QIII 12.615 23 Jaén Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 23 Jaén Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 23 Jaén Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 23 Jaén Total Cohort July 1 Total Survival in the first trimester 2022QIII 12.425 23 Jaén Total Cohort July 1 Total Survival in the first trimester 2022QII "" 23 Jaén Total Cohort July 1 Total Survival in the first trimester 2022QI "" 23 Jaén Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 23 Jaén Total Cohort July 1 Total Survival in the first trimester 2021QIII 12.213 23 Jaén Total Cohort July 1 Total Survival in the first trimester 2021QII "" 23 Jaén Total Cohort July 1 Total Survival in the first trimester 2021QI "" 23 Jaén Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 23 Jaén Total Cohort July 1 Total Survival in the first trimester 2020QIII 11.797 23 Jaén Total Cohort July 1 Total Survival in the first trimester 2020QII "" 23 Jaén Total Cohort July 1 Total Survival in the first trimester 2020QI "" 23 Jaén Total Cohort July 1 Total Survival in the second trimester 2022QIV 11.443 23 Jaén Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 23 Jaén Total Cohort July 1 Total Survival in the second trimester 2022QII "" 23 Jaén Total Cohort July 1 Total Survival in the second trimester 2022QI "" 23 Jaén Total Cohort July 1 Total Survival in the second trimester 2021QIV 11.184 23 Jaén Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 23 Jaén Total Cohort July 1 Total Survival in the second trimester 2021QII "" 23 Jaén Total Cohort July 1 Total Survival in the second trimester 2021QI "" 23 Jaén Total Cohort July 1 Total Survival in the second trimester 2020QIV 10.717 23 Jaén Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 23 Jaén Total Cohort July 1 Total Survival in the second trimester 2020QII "" 23 Jaén Total Cohort July 1 Total Survival in the second trimester 2020QI "" 23 Jaén Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 23 Jaén Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 23 Jaén Total Cohort July 1 Total Survival in the third trimester 2022QII "" 23 Jaén Total Cohort July 1 Total Survival in the third trimester 2022QI 10.719 23 Jaén Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 23 Jaén Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 23 Jaén Total Cohort July 1 Total Survival in the third trimester 2021QII "" 23 Jaén Total Cohort July 1 Total Survival in the third trimester 2021QI 10.242 23 Jaén Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 23 Jaén Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 23 Jaén Total Cohort July 1 Total Survival in the third trimester 2020QII "" 23 Jaén Total Cohort July 1 Total Survival in the third trimester 2020QI "" 23 Jaén Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 23 Jaén Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 23 Jaén Total Cohort July 1 Total Survival in the third trimester 2022QII 10.426 23 Jaén Total Cohort July 1 Total Survival in the third trimester 2022QI "" 23 Jaén Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 23 Jaén Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 23 Jaén Total Cohort July 1 Total Survival in the third trimester 2021QII 9.960 23 Jaén Total Cohort July 1 Total Survival in the third trimester 2021QI "" 23 Jaén Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 23 Jaén Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 23 Jaén Total Cohort July 1 Total Survival in the third trimester 2020QII "" 23 Jaén Total Cohort July 1 Total Survival in the third trimester 2020QI "" 23 Jaén Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 23 Jaén Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 23 Jaén Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 23 Jaén Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 23 Jaén Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 23 Jaén Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 23 Jaén Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 23 Jaén Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 23 Jaén Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,5 23 Jaén Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,9 23 Jaén Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 93,52 23 Jaén Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 85,19 23 Jaén Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 85,08 23 Jaén Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 84,95 23 Jaén Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 81,54 23 Jaén Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 81,19 23 Jaén Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 79,31 23 Jaén Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 78,95 23 Jaén Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 23 Jaén Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 23 Jaén Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 13.143 23 Jaén Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 12.890 23 Jaén Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 11.919 23 Jaén Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 12.144 23 Jaén Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 11.961 23 Jaén Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 11.108 23 Jaén Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 11.170 23 Jaén Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 10.938 23 Jaén Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 10.039 23 Jaén Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 10.478 23 Jaén Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 9.570 23 Jaén Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 10.187 23 Jaén Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 9.295 23 Jaén Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 23 Jaén Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 23 Jaén Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 23 Jaén Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,4 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,79 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,2 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 84,99 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 84,86 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 84,23 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 81,29 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 80,29 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 79,03 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 77,98 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 289 23 Jaén Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 256 23 Jaén Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 696 23 Jaén Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 281 23 Jaén Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 252 23 Jaén Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 689 23 Jaén Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 273 23 Jaén Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 246 23 Jaén Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 678 23 Jaén Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 241 23 Jaén Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 672 23 Jaén Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 239 23 Jaén Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 665 23 Jaén Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 23 Jaén Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 23 Jaén Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 23 Jaén Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,23 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,44 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,99 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,46 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,09 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,41 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 94,14 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,55 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,36 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,55 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén Total Cohort October 1 Total Number at the start of the quarter 2022QIV 13.227 23 Jaén Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 23 Jaén Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 23 Jaén Total Cohort October 1 Total Number at the start of the quarter 2021QIV 13.089 23 Jaén Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 23 Jaén Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 23 Jaén Total Cohort October 1 Total Number at the start of the quarter 2020QIV 12.774 23 Jaén Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 23 Jaén Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 23 Jaén Total Cohort October 1 Total Survival in the first trimester 2022QIV 11.943 23 Jaén Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 23 Jaén Total Cohort October 1 Total Survival in the first trimester 2022QII "" 23 Jaén Total Cohort October 1 Total Survival in the first trimester 2022QI "" 23 Jaén Total Cohort October 1 Total Survival in the first trimester 2021QIV 11.758 23 Jaén Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 23 Jaén Total Cohort October 1 Total Survival in the first trimester 2021QII "" 23 Jaén Total Cohort October 1 Total Survival in the first trimester 2021QI "" 23 Jaén Total Cohort October 1 Total Survival in the first trimester 2020QIV 11.278 23 Jaén Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 23 Jaén Total Cohort October 1 Total Survival in the first trimester 2020QII "" 23 Jaén Total Cohort October 1 Total Survival in the first trimester 2020QI "" 23 Jaén Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 23 Jaén Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 23 Jaén Total Cohort October 1 Total Survival in the second trimester 2022QII "" 23 Jaén Total Cohort October 1 Total Survival in the second trimester 2022QI 11.178 23 Jaén Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 23 Jaén Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 23 Jaén Total Cohort October 1 Total Survival in the second trimester 2021QII "" 23 Jaén Total Cohort October 1 Total Survival in the second trimester 2021QI 10.714 23 Jaén Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 23 Jaén Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 23 Jaén Total Cohort October 1 Total Survival in the second trimester 2020QII "" 23 Jaén Total Cohort October 1 Total Survival in the second trimester 2020QI "" 23 Jaén Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 23 Jaén Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 23 Jaén Total Cohort October 1 Total Survival in the third trimester 2022QII 10.799 23 Jaén Total Cohort October 1 Total Survival in the third trimester 2022QI "" 23 Jaén Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 23 Jaén Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 23 Jaén Total Cohort October 1 Total Survival in the third trimester 2021QII 10.366 23 Jaén Total Cohort October 1 Total Survival in the third trimester 2021QI "" 23 Jaén Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 23 Jaén Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 23 Jaén Total Cohort October 1 Total Survival in the third trimester 2020QII "" 23 Jaén Total Cohort October 1 Total Survival in the third trimester 2020QI "" 23 Jaén Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 23 Jaén Total Cohort October 1 Total Survival in the third trimester 2022QIII 10.445 23 Jaén Total Cohort October 1 Total Survival in the third trimester 2022QII "" 23 Jaén Total Cohort October 1 Total Survival in the third trimester 2022QI "" 23 Jaén Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 23 Jaén Total Cohort October 1 Total Survival in the third trimester 2021QIII 10.100 23 Jaén Total Cohort October 1 Total Survival in the third trimester 2021QII "" 23 Jaén Total Cohort October 1 Total Survival in the third trimester 2021QI "" 23 Jaén Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 23 Jaén Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 23 Jaén Total Cohort October 1 Total Survival in the third trimester 2020QII "" 23 Jaén Total Cohort October 1 Total Survival in the third trimester 2020QI "" 23 Jaén Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 23 Jaén Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 23 Jaén Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 23 Jaén Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 23 Jaén Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 23 Jaén Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 23 Jaén Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 23 Jaén Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 23 Jaén Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 90,29 23 Jaén Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 89,83 23 Jaén Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 88,29 23 Jaén Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 85,4 23 Jaén Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 83,87 23 Jaén Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 82,5 23 Jaén Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 81,15 23 Jaén Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 79,8 23 Jaén Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 79,07 23 Jaén Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 23 Jaén Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 23 Jaén Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 12.947 23 Jaén Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 12.700 23 Jaén Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 11.997 23 Jaén Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 11.671 23 Jaén Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 11.377 23 Jaén Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 10.518 23 Jaén Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 10.804 23 Jaén Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 9.958 23 Jaén Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 10.431 23 Jaén Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 9.619 23 Jaén Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 10.088 23 Jaén Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 9.361 23 Jaén Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 23 Jaén Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 23 Jaén Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 23 Jaén Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 90,14 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 89,58 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 87,67 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 85,07 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 83 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 82,13 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 80,18 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 79,43 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 78,03 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 280 23 Jaén Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 389 23 Jaén Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 777 23 Jaén Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 272 23 Jaén Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 381 23 Jaén Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 760 23 Jaén Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 374 23 Jaén Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 756 23 Jaén Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 368 23 Jaén Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 747 23 Jaén Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 357 23 Jaén Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 739 23 Jaén Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 23 Jaén Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 23 Jaén Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 23 Jaén Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,14 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,94 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,81 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 96,14 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,3 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 94,6 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 96,14 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 91,77 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 95,11 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 23 Jaén From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 9.962 23 Jaén From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 23 Jaén From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 9.620 23 Jaén From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 10.331 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 9.125 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 8.863 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 8.173 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 8.648 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 8.427 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 7.856 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 8.239 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 8.104 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 7.545 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 7.892 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 7.767 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 7.130 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 23 Jaén From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 23 Jaén From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 23 Jaén From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 23 Jaén From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 91,6 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 92,13 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 79,11 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 86,81 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 87,6 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 76,04 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 82,7 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 84,24 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 73,03 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 79,22 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 80,74 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 69,02 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 9.759 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 9.299 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 8.929 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 8.547 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 8.458 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 8.119 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 8.056 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 7.801 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 7.716 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 7.476 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 91,5 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 91,91 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 86,67 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 87,31 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 82,55 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 83,89 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 79,07 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 80,4 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 203 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 321 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 196 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 316 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 190 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 308 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 183 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 303 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 176 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 291 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,55 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,44 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,6 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,95 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,15 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,39 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 86,7 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 90,65 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 10.294 23 Jaén From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 9.913 23 Jaén From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 9.151 23 Jaén From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 9.597 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 9.293 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 8.712 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 9.035 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 8.823 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 8.329 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 8.422 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 8.237 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 7.774 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 7.878 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 7.434 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 23 Jaén From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 23 Jaén From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 23 Jaén From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 23 Jaén From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,23 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 93,75 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,2 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 87,77 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 89 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,02 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 81,81 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 83,09 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 84,95 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 79,47 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 81,24 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 10.102 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 9.549 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 8.665 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 9.410 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 8.937 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 8.230 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 8.858 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 8.472 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 7.857 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 8.255 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 7.901 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 7.318 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 7.552 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 6.989 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,15 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 93,59 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,98 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 87,69 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 88,72 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,68 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 81,72 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 82,74 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 84,45 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 79,09 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 80,66 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 192 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 364 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 486 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 187 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 356 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 482 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 177 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 351 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 472 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 167 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 336 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 456 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 326 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 445 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,4 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,8 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,18 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 92,19 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,43 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,12 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 86,98 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 92,31 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,83 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 89,56 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,56 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 10.649 23 Jaén From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 10.529 23 Jaén From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 10.146 23 Jaén From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 9.684 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 9.639 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 9.340 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 8.777 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 8.685 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 8.332 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 8.249 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 7.895 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 7.984 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 7.640 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 23 Jaén From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 23 Jaén From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 23 Jaén From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 90,94 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 91,55 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 92,06 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 82,42 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 82,49 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 82,12 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 78,35 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 77,81 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 75,83 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 75,3 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 10.496 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 10.406 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 9.898 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 9.539 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 9.520 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 9.098 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 8.639 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 8.570 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 8.095 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 8.137 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 7.661 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 7.874 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 7.410 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 90,88 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 91,49 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 91,92 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 82,31 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 82,36 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 81,78 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 78,2 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 77,4 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 75,67 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 74,86 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 153 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 123 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 248 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 145 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 119 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 242 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 138 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 115 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 237 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 112 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 234 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 110 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 230 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 94,77 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,75 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,58 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 90,2 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,5 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,56 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 91,06 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,35 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 89,43 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,74 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 10.451 23 Jaén From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 10.444 23 Jaén From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 10.236 23 Jaén From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 9.244 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 9.197 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 8.813 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 8.647 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 8.293 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 8.301 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 7.970 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 7.972 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 7.732 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 23 Jaén From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 23 Jaén From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 23 Jaén From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 88,45 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 88,06 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 86,1 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 82,79 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 81,02 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 79,48 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 77,86 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 76,33 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 75,54 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 10.311 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 10.218 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 9.924 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 9.111 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 8.979 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 8.513 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 8.436 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 7.994 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 8.095 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 7.676 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 7.775 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 7.443 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 88,36 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 87,87 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 85,78 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 82,56 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 80,55 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 79,22 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 77,35 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 76,09 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 75 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 140 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 226 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 312 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 133 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 218 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 300 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 211 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 299 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 206 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 294 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 197 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 289 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 95 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,46 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,15 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,36 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,83 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 91,15 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,23 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 87,17 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 92,63 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 1.188 23 Jaén From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 1.050 23 Jaén From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 1.229 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 1.167 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 1.027 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 1.137 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 1.147 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 1.004 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 1.116 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 1.129 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 994 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 1.105 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 1.115 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 982 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 1.083 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 23 Jaén From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 23 Jaén From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,23 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 97,81 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 92,51 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,55 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 95,62 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 90,81 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 95,03 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 94,67 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 89,91 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,86 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 93,52 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 88,12 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.135 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 914 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.115 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 892 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.097 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 870 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.080 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 860 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.066 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 852 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,24 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97,59 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,65 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 95,19 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,15 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 94,09 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,92 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 93,22 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 53 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 136 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 52 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 135 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 50 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 134 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 49 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 134 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 49 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 130 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,11 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,26 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 94,34 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,53 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 92,45 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,53 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 92,45 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,59 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 1.199 23 Jaén From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 1.106 23 Jaén From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 1.010 23 Jaén From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 1.181 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 1.087 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 998 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 1.165 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 1.073 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 993 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 1.142 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 1.039 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 969 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 1.023 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 956 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 23 Jaén From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 23 Jaén From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 23 Jaén From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,5 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,28 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,81 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,16 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,02 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,32 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,25 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 93,94 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,94 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 92,5 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,65 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.156 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 960 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 769 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.139 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 943 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 758 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.123 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 929 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 753 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.100 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 898 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 736 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 884 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 725 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,53 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,23 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,57 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,15 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,77 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,92 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,16 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 93,54 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,71 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 92,08 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,28 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 43 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 146 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 241 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 42 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 144 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 240 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 42 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 144 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 240 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 42 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 141 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 233 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 139 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 231 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,67 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,63 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,59 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,67 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,63 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,59 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,67 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,58 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,68 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 95,21 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,85 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 1.271 23 Jaén From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 1.187 23 Jaén From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 1.151 23 Jaén From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 1.240 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 1.162 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 1.147 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 1.190 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 1.107 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 1.092 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 1.092 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 1.074 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 1.077 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 1.056 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 23 Jaén From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 23 Jaén From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 23 Jaén From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,56 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 97,89 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,65 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 93,63 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 93,26 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 94,87 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 92 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 93,31 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 90,73 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 91,75 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.228 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.141 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.004 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.197 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.116 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.000 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.147 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.062 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 950 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.049 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 933 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.034 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 915 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,48 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 97,81 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,6 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 93,4 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 93,08 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 94,62 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 91,94 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 92,93 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 90,62 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 91,14 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 43 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 46 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 147 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 43 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 46 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 147 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 43 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 45 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 142 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 43 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 141 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 43 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 141 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,83 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,6 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93,48 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95,92 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,48 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,92 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 1.243 23 Jaén From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 1.194 23 Jaén From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 1.183 23 Jaén From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 1.193 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 1.129 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 1.121 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 1.107 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 1.098 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 1.089 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 1.083 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 1.076 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 1.070 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 23 Jaén From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 23 Jaén From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 23 Jaén From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,98 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,56 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,76 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 92,71 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 92,81 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 91,21 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 91,55 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 90,12 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 90,45 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.199 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.143 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.022 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.149 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.078 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 965 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.056 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 945 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.039 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 932 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.027 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 919 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95,83 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,31 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,42 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 92,39 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 92,47 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 90,9 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 91,19 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 89,85 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 89,92 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 44 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 51 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 161 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 44 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 51 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 156 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 51 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 153 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 50 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 151 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 49 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 151 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,89 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,03 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 98,04 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,79 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96,08 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,79 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 23 Jaén From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 1.449 23 Jaén From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 23 Jaén From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 1.338 23 Jaén From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 1.371 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 1.435 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 1.325 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 1.335 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 1.417 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 1.316 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 1.330 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 1.407 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 1.299 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 1.325 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 1.392 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 1.288 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 1.314 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 23 Jaén From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 23 Jaén From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 23 Jaén From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 23 Jaén From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,03 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,03 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,37 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,79 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,36 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,01 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,1 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,09 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,64 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,07 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,26 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 95,84 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.353 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.087 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.339 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.074 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.321 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.067 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.311 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.053 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.296 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.043 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,97 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,8 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,63 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,16 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,9 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,87 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,79 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,95 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 96 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 251 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 96 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 251 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 96 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 249 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 96 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 246 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 96 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 245 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 99,2 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,01 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,61 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 1.377 23 Jaén From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 1.294 23 Jaén From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 1.146 23 Jaén From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 1.364 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 1.283 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 1.141 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 1.352 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 1.265 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 1.137 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 1.334 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 1.252 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 1.130 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 1.244 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 1.115 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 23 Jaén From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 23 Jaén From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 23 Jaén From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 23 Jaén From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,06 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,15 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,56 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,18 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,76 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,21 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,88 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,75 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,6 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,14 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,29 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.286 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.038 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 780 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.273 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.028 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 776 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.261 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.012 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 773 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.243 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.001 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 770 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 993 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 759 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,99 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,04 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,49 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,06 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,5 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,1 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,66 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,44 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,72 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,66 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,31 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 91 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 256 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 366 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 91 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 255 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 365 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 91 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 253 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 364 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 91 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 251 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 360 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 251 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 356 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,61 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,73 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,83 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,45 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,05 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,36 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 98,05 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 97,27 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 1.444 23 Jaén From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 1.368 23 Jaén From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.259 23 Jaén From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 1.434 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 1.350 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 1.251 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 1.409 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 1.330 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 1.234 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 1.317 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 1.215 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 1.304 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 1.206 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 23 Jaén From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 23 Jaén From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 23 Jaén From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,31 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,68 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,36 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,58 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,22 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,01 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,27 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,51 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,32 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,79 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.353 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.286 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 976 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.343 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.268 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 969 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.319 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.249 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 953 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.236 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 936 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.223 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 930 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,26 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,6 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,28 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,49 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,12 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,64 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,11 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,9 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,1 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,29 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 91 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 82 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 283 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 91 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 82 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 282 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 90 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 81 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 281 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 81 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 279 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 81 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 276 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,65 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,9 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,78 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,29 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 98,78 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,59 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 98,78 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,53 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 1.465 23 Jaén From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 1.391 23 Jaén From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.293 23 Jaén From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 1.438 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 1.372 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 1.282 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 1.365 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 1.262 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 1.350 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 1.252 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 1.339 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 1.237 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 23 Jaén From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 23 Jaén From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 23 Jaén From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,16 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,63 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,15 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,13 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,6 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,05 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,83 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,26 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,67 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.371 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.284 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.010 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.345 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.265 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 999 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.258 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 979 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.243 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 971 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.233 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 959 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,1 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,52 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,91 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,98 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,93 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,81 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,14 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,03 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 94,95 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 94 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 107 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 283 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 93 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 107 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 283 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 107 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 283 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 107 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 281 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 106 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 278 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,94 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 99,29 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 99,07 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,23 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 23 Jaén from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 47 23 Jaén from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 23 Jaén from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 42 23 Jaén from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 45 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 47 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 41 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 45 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 47 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 41 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 45 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 47 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 41 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 45 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 47 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 41 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 45 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 23 Jaén from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 23 Jaén from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 23 Jaén from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 23 Jaén from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 97,62 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,62 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,62 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,62 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 44 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 29 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 44 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 28 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 44 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 28 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 44 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 28 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 44 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 28 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 96,55 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,55 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,55 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,55 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 3 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 13 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 3 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 13 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 3 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 13 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 3 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 13 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 3 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 13 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 49 23 Jaén from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 44 23 Jaén from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 41 23 Jaén from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 49 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 44 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 41 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 49 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 44 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 41 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 49 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 44 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 41 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 44 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 40 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 23 Jaén from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 23 Jaén from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 23 Jaén from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 23 Jaén from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,56 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 23 Jaén from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 47 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 30 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 24 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 47 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 30 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 24 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 47 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 30 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 24 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 47 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 30 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 24 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 30 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 23 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,83 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 2 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 14 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 17 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 2 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 14 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 17 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 2 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 14 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 17 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 2 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 14 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 17 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 14 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 17 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 49 23 Jaén from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 43 23 Jaén from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 42 23 Jaén from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 49 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 43 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 42 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 49 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 43 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 42 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 43 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 41 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 43 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 41 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 23 Jaén from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 23 Jaén from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 23 Jaén from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,62 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,62 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 47 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 40 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 30 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 47 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 40 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 30 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 47 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 40 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 30 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 40 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 29 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 40 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 29 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,67 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,67 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 2 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 3 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 12 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 2 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 3 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 12 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 2 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 3 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 12 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 3 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 12 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 3 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 12 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 52 23 Jaén from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 40 23 Jaén from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 45 23 Jaén from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 52 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 40 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 45 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 40 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 44 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 40 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 44 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 40 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 44 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 23 Jaén from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 23 Jaén from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 23 Jaén from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,78 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,78 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,78 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 50 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 35 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 31 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 50 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 35 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 31 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 35 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 30 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 35 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 30 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 35 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 30 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,77 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,77 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,77 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 2 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 5 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 14 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 2 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 5 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 14 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 5 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 14 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 5 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 14 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 5 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 14 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 23 Jaén De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 20 23 Jaén De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 23 Jaén De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 17 23 Jaén De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 23 Jaén De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 16 23 Jaén De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 19 23 Jaén De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 17 23 Jaén De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 16 23 Jaén De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 19 23 Jaén De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 17 23 Jaén De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 16 23 Jaén De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 18 23 Jaén De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 17 23 Jaén De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 15 23 Jaén De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 18 23 Jaén De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 17 23 Jaén De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 15 23 Jaén De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 23 Jaén De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 23 Jaén De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 23 Jaén De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 23 Jaén De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 23 Jaén De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 23 Jaén De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 23 Jaén De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 95 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 90 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 93,75 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 90 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 93,75 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 23 Jaén De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 19 23 Jaén De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 13 23 Jaén De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 18 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 13 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 18 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 13 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 17 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 13 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 17 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 13 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 23 Jaén De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 23 Jaén De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,74 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 94,74 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 89,47 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 89,47 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1 23 Jaén De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 4 23 Jaén De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 4 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 4 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 4 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 4 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 23 Jaén De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 23 Jaén De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 18 23 Jaén De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 23 Jaén De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 17 23 Jaén De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 23 Jaén De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 17 23 Jaén De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 18 23 Jaén De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 17 23 Jaén De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 17 23 Jaén De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 17 23 Jaén De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 17 23 Jaén De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 16 23 Jaén De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 17 23 Jaén De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 17 23 Jaén De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 16 23 Jaén De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 16 23 Jaén De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 16 23 Jaén De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 23 Jaén De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 23 Jaén De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 23 Jaén De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 23 Jaén De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 23 Jaén De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 23 Jaén De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 23 Jaén De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 94,44 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 94,12 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 94,44 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 94,12 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,12 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,12 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 23 Jaén De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 18 23 Jaén De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 13 23 Jaén De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 14 23 Jaén De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 18 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 13 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 14 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 17 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 13 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 13 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 17 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 13 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 13 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 12 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 13 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 23 Jaén De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 23 Jaén De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 23 Jaén De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 94,44 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,86 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 94,44 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 92,86 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 92,31 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 92,86 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 0 23 Jaén De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 4 23 Jaén De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 3 23 Jaén De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 0 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 4 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 3 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 0 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 4 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 3 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 0 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 4 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 3 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 4 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 3 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII .. 23 Jaén De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 23 Jaén De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 23 Jaén De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII .. 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII .. 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 0 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 19 23 Jaén De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 23 Jaén De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 23 Jaén De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 19 23 Jaén De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 23 Jaén De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 23 Jaén De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 17 23 Jaén De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 23 Jaén De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 18 23 Jaén De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 19 23 Jaén De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 17 23 Jaén De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 18 23 Jaén De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 19 23 Jaén De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 17 23 Jaén De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 18 23 Jaén De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 17 23 Jaén De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 18 23 Jaén De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 17 23 Jaén De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 23 Jaén De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 23 Jaén De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 23 Jaén De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 23 Jaén De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 23 Jaén De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 23 Jaén De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 23 Jaén De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 23 Jaén De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 23 Jaén De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 23 Jaén De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 23 Jaén De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 23 Jaén De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 23 Jaén De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,74 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 94,74 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 94,74 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 94,74 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 23 Jaén De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 19 23 Jaén De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 17 23 Jaén De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 11 23 Jaén De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 18 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 17 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 11 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 18 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 17 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 11 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 16 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 11 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 16 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 11 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 23 Jaén De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 23 Jaén De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 23 Jaén De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,74 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 94,74 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 94,12 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,12 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 23 Jaén De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 2 23 Jaén De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 6 23 Jaén De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 2 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 6 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 2 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 6 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 2 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 6 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 2 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 6 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII .. 23 Jaén De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 23 Jaén De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 23 Jaén De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII .. 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 16 23 Jaén De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 23 Jaén De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 23 Jaén De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 20 23 Jaén De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 23 Jaén De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 23 Jaén De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 17 23 Jaén De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 23 Jaén De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 16 23 Jaén De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 20 23 Jaén De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 17 23 Jaén De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 19 23 Jaén De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 17 23 Jaén De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 19 23 Jaén De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 17 23 Jaén De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 18 23 Jaén De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 17 23 Jaén De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 23 Jaén De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 23 Jaén De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 23 Jaén De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 23 Jaén De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 23 Jaén De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 23 Jaén De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 23 Jaén De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 23 Jaén De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 23 Jaén De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 23 Jaén De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 23 Jaén De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 23 Jaén De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 95 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 90 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 23 Jaén De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 16 23 Jaén De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 20 23 Jaén De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 10 23 Jaén De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 16 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 20 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 10 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 19 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 10 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 19 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 10 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 18 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 10 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 23 Jaén De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 23 Jaén De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 23 Jaén De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 95 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 90 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 23 Jaén De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 0 23 Jaén De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 7 23 Jaén De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 0 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 7 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 0 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 7 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 0 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 7 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 0 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 7 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 23 Jaén De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV .. 23 Jaén De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 23 Jaén De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV .. 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI .. 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII .. 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII .. 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 23 Jaén De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 24 León Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 24 León Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 24 León Total Cohort January 1 Total Number at the start of the quarter 2022QI 10.346 24 León Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 24 León Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 24 León Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 24 León Total Cohort January 1 Total Number at the start of the quarter 2021QI 10.102 24 León Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 24 León Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 24 León Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 24 León Total Cohort January 1 Total Number at the start of the quarter 2020QI 10.724 24 León Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 24 León Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 24 León Total Cohort January 1 Total Survival in the first trimester 2022QII "" 24 León Total Cohort January 1 Total Survival in the first trimester 2022QI 9.865 24 León Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 24 León Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 24 León Total Cohort January 1 Total Survival in the first trimester 2021QII "" 24 León Total Cohort January 1 Total Survival in the first trimester 2021QI 9.653 24 León Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 24 León Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 24 León Total Cohort January 1 Total Survival in the first trimester 2020QII "" 24 León Total Cohort January 1 Total Survival in the first trimester 2020QI 9.668 24 León Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 24 León Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 24 León Total Cohort January 1 Total Survival in the second trimester 2022QII 9.483 24 León Total Cohort January 1 Total Survival in the second trimester 2022QI "" 24 León Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 24 León Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 24 León Total Cohort January 1 Total Survival in the second trimester 2021QII 9.348 24 León Total Cohort January 1 Total Survival in the second trimester 2021QI "" 24 León Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 24 León Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 24 León Total Cohort January 1 Total Survival in the second trimester 2020QII 9.331 24 León Total Cohort January 1 Total Survival in the second trimester 2020QI "" 24 León Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 24 León Total Cohort January 1 Total Survival in the third trimester 2022QIII 9.216 24 León Total Cohort January 1 Total Survival in the third trimester 2022QII "" 24 León Total Cohort January 1 Total Survival in the third trimester 2022QI "" 24 León Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 24 León Total Cohort January 1 Total Survival in the third trimester 2021QIII 9.102 24 León Total Cohort January 1 Total Survival in the third trimester 2021QII "" 24 León Total Cohort January 1 Total Survival in the third trimester 2021QI "" 24 León Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 24 León Total Cohort January 1 Total Survival in the third trimester 2020QIII 9.072 24 León Total Cohort January 1 Total Survival in the third trimester 2020QII "" 24 León Total Cohort January 1 Total Survival in the third trimester 2020QI "" 24 León Total Cohort January 1 Total Survival in the third trimester 2022QIV 8.946 24 León Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 24 León Total Cohort January 1 Total Survival in the third trimester 2022QII "" 24 León Total Cohort January 1 Total Survival in the third trimester 2022QI "" 24 León Total Cohort January 1 Total Survival in the third trimester 2021QIV 8.897 24 León Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 24 León Total Cohort January 1 Total Survival in the third trimester 2021QII "" 24 León Total Cohort January 1 Total Survival in the third trimester 2021QI "" 24 León Total Cohort January 1 Total Survival in the third trimester 2020QIV 8.818 24 León Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 24 León Total Cohort January 1 Total Survival in the third trimester 2020QII "" 24 León Total Cohort January 1 Total Survival in the third trimester 2020QI "" 24 León Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 24 León Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 24 León Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 24 León Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 24 León Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 24 León Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 24 León Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 24 León Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 24 León Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 24 León Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 24 León Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 24 León Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 24 León Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 24 León Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 24 León Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 24 León Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,35 24 León Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 24 León Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 24 León Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 24 León Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,56 24 León Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 24 León Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 24 León Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 24 León Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 90,15 24 León Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 24 León Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 24 León Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 91,66 24 León Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 24 León Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 24 León Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 24 León Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 92,54 24 León Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 24 León Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 24 León Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 24 León Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 87,01 24 León Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 24 León Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 24 León Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 89,08 24 León Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 24 León Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 24 León Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 24 León Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 90,1 24 León Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 24 León Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 24 León Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 24 León Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 84,6 24 León Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 24 León Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 24 León Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 86,47 24 León Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 24 León Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 24 León Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 24 León Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 88,07 24 León Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 24 León Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 24 León Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 24 León Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 82,23 24 León Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 24 León Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 24 León Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 24 León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 9.954 24 León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 8.840 24 León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 24 León Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 24 León Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 24 León Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 9.488 24 León Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 24 León Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 24 León Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 24 León Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 8.425 24 León Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 24 León Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 24 León Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 24 León Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 24 León Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 24 León Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 24 León Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 9.117 24 León Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 24 León Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 24 León Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 24 León Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 8.153 24 León Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 24 León Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 24 León Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 24 León Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 24 León Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 24 León Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 8.861 24 León Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 7.933 24 León Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 8.600 24 León Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 7.748 24 León Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 24 León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 24 León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 95,32 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 95,31 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 91,59 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 92,23 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 89,02 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 89,74 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 86,4 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 87,65 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 392 24 León Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.262 24 León Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 24 León Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 24 León Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 24 León Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 377 24 León Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 24 León Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 24 León Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 24 León Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.228 24 León Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 24 León Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 24 León Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 24 León Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 24 León Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 24 León Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 24 León Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 366 24 León Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 24 León Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 24 León Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 24 León Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.195 24 León Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 24 León Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 24 León Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 24 León Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 24 León Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 24 León Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 355 24 León Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 24 León Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 24 León Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.169 24 León Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 24 León Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 24 León Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 24 León Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 24 León Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 346 24 León Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 24 León Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 24 León Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.149 24 León Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 24 León Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 24 León Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 24 León Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 24 León Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 24 León Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 24 León Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,17 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,31 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,37 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,69 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,56 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,63 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,27 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 91,05 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 24 León Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 24 León Total Cohort April 1 Total Number at the start of the quarter 2022QII 10.353 24 León Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 24 León Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 24 León Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 24 León Total Cohort April 1 Total Number at the start of the quarter 2021QII 10.140 24 León Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 24 León Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 24 León Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 24 León Total Cohort April 1 Total Number at the start of the quarter 2020QII 10.007 24 León Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 24 León Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 24 León Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 24 León Total Cohort April 1 Total Survival in the first trimester 2022QII 9.866 24 León Total Cohort April 1 Total Survival in the first trimester 2022QI "" 24 León Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 24 León Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 24 León Total Cohort April 1 Total Survival in the first trimester 2021QII 9.744 24 León Total Cohort April 1 Total Survival in the first trimester 2021QI "" 24 León Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 24 León Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 24 León Total Cohort April 1 Total Survival in the first trimester 2020QII 9.626 24 León Total Cohort April 1 Total Survival in the first trimester 2020QI "" 24 León Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 24 León Total Cohort April 1 Total Survival in the second trimester 2022QIII 9.540 24 León Total Cohort April 1 Total Survival in the second trimester 2022QII "" 24 León Total Cohort April 1 Total Survival in the second trimester 2022QI "" 24 León Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 24 León Total Cohort April 1 Total Survival in the second trimester 2021QIII 9.438 24 León Total Cohort April 1 Total Survival in the second trimester 2021QII "" 24 León Total Cohort April 1 Total Survival in the second trimester 2021QI "" 24 León Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 24 León Total Cohort April 1 Total Survival in the second trimester 2020QIII 9.335 24 León Total Cohort April 1 Total Survival in the second trimester 2020QII "" 24 León Total Cohort April 1 Total Survival in the second trimester 2020QI "" 24 León Total Cohort April 1 Total Survival in the third trimester 2022QIV 9.218 24 León Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 24 León Total Cohort April 1 Total Survival in the third trimester 2022QII "" 24 León Total Cohort April 1 Total Survival in the third trimester 2022QI "" 24 León Total Cohort April 1 Total Survival in the third trimester 2021QIV 9.157 24 León Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 24 León Total Cohort April 1 Total Survival in the third trimester 2021QII "" 24 León Total Cohort April 1 Total Survival in the third trimester 2021QI "" 24 León Total Cohort April 1 Total Survival in the third trimester 2020QIV 9.054 24 León Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 24 León Total Cohort April 1 Total Survival in the third trimester 2020QII "" 24 León Total Cohort April 1 Total Survival in the third trimester 2020QI "" 24 León Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 24 León Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 24 León Total Cohort April 1 Total Survival in the third trimester 2022QII "" 24 León Total Cohort April 1 Total Survival in the third trimester 2022QI 8.889 24 León Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 24 León Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 24 León Total Cohort April 1 Total Survival in the third trimester 2021QII "" 24 León Total Cohort April 1 Total Survival in the third trimester 2021QI 8.788 24 León Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 24 León Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 24 León Total Cohort April 1 Total Survival in the third trimester 2020QII "" 24 León Total Cohort April 1 Total Survival in the third trimester 2020QI "" 24 León Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 24 León Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 24 León Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 24 León Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 24 León Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 24 León Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 24 León Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 24 León Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 24 León Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 24 León Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 24 León Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 24 León Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 24 León Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 24 León Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 24 León Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,3 24 León Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 24 León Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 24 León Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 24 León Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,09 24 León Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 24 León Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 24 León Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 24 León Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,19 24 León Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 24 León Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 24 León Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 92,15 24 León Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 24 León Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 24 León Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 24 León Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 93,08 24 León Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 24 León Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 24 León Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 24 León Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,28 24 León Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 24 León Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 24 León Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 89,04 24 León Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 24 León Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 24 León Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 24 León Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 90,31 24 León Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 24 León Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 24 León Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 24 León Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,48 24 León Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 24 León Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 24 León Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 24 León Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 24 León Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 24 León Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 24 León Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 87,66 24 León Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 24 León Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 24 León Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 24 León Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87,82 24 León Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 24 León Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 24 León Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 24 León Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 24 León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 9.994 24 León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 9.057 24 León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 7.607 24 León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 24 León Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 24 León Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 9.517 24 León Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 24 León Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 24 León Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 24 León Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 8.693 24 León Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 24 León Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 24 León Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 24 León Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 7.266 24 León Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 24 León Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 24 León Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 9.200 24 León Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 24 León Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 24 León Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 24 León Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 8.410 24 León Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 24 León Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 24 León Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 24 León Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 7.041 24 León Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 24 León Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 24 León Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 8.890 24 León Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 8.147 24 León Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 6.821 24 León Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 7.898 24 León Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 6.609 24 León Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 24 León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 24 León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 24 León Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,23 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,98 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,52 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 92,06 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,86 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,56 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 88,95 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 89,95 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 89,67 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 87,2 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 86,88 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 359 24 León Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.083 24 León Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.400 24 León Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 24 León Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 24 León Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 349 24 León Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 24 León Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 24 León Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 24 León Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.051 24 León Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 24 León Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 24 León Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 24 León Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.360 24 León Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 24 León Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 24 León Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 340 24 León Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 24 León Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 24 León Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 24 León Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.028 24 León Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 24 León Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 24 León Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 24 León Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.294 24 León Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 24 León Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 24 León Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 328 24 León Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 24 León Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 24 León Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.010 24 León Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 24 León Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 24 León Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.233 24 León Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 24 León Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 24 León Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 24 León Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 991 24 León Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 24 León Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.179 24 León Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 24 León Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 24 León Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 24 León Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 24 León Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 24 León Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,21 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,05 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,33 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,71 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,92 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,58 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,36 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,26 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,04 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 91,51 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 90,79 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 24 León Total Cohort July 1 Total Number at the start of the quarter 2022QIII 10.557 24 León Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 24 León Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 24 León Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 24 León Total Cohort July 1 Total Number at the start of the quarter 2021QIII 10.399 24 León Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 24 León Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 24 León Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 24 León Total Cohort July 1 Total Number at the start of the quarter 2020QIII 10.209 24 León Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 24 León Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 24 León Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 24 León Total Cohort July 1 Total Survival in the first trimester 2022QIII 10.016 24 León Total Cohort July 1 Total Survival in the first trimester 2022QII "" 24 León Total Cohort July 1 Total Survival in the first trimester 2022QI "" 24 León Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 24 León Total Cohort July 1 Total Survival in the first trimester 2021QIII 9.902 24 León Total Cohort July 1 Total Survival in the first trimester 2021QII "" 24 León Total Cohort July 1 Total Survival in the first trimester 2021QI "" 24 León Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 24 León Total Cohort July 1 Total Survival in the first trimester 2020QIII 9.765 24 León Total Cohort July 1 Total Survival in the first trimester 2020QII "" 24 León Total Cohort July 1 Total Survival in the first trimester 2020QI "" 24 León Total Cohort July 1 Total Survival in the second trimester 2022QIV 9.537 24 León Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 24 León Total Cohort July 1 Total Survival in the second trimester 2022QII "" 24 León Total Cohort July 1 Total Survival in the second trimester 2022QI "" 24 León Total Cohort July 1 Total Survival in the second trimester 2021QIV 9.503 24 León Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 24 León Total Cohort July 1 Total Survival in the second trimester 2021QII "" 24 León Total Cohort July 1 Total Survival in the second trimester 2021QI "" 24 León Total Cohort July 1 Total Survival in the second trimester 2020QIV 9.370 24 León Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 24 León Total Cohort July 1 Total Survival in the second trimester 2020QII "" 24 León Total Cohort July 1 Total Survival in the second trimester 2020QI "" 24 León Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 24 León Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 24 León Total Cohort July 1 Total Survival in the third trimester 2022QII "" 24 León Total Cohort July 1 Total Survival in the third trimester 2022QI 9.194 24 León Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 24 León Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 24 León Total Cohort July 1 Total Survival in the third trimester 2021QII "" 24 León Total Cohort July 1 Total Survival in the third trimester 2021QI 9.073 24 León Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 24 León Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 24 León Total Cohort July 1 Total Survival in the third trimester 2020QII "" 24 León Total Cohort July 1 Total Survival in the third trimester 2020QI "" 24 León Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 24 León Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 24 León Total Cohort July 1 Total Survival in the third trimester 2022QII 8.961 24 León Total Cohort July 1 Total Survival in the third trimester 2022QI "" 24 León Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 24 León Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 24 León Total Cohort July 1 Total Survival in the third trimester 2021QII 8.889 24 León Total Cohort July 1 Total Survival in the third trimester 2021QI "" 24 León Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 24 León Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 24 León Total Cohort July 1 Total Survival in the third trimester 2020QII "" 24 León Total Cohort July 1 Total Survival in the third trimester 2020QI "" 24 León Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 24 León Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 24 León Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 24 León Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 24 León Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 24 León Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 24 León Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 24 León Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 24 León Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 24 León Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 24 León Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 24 León Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 24 León Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 24 León Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,88 24 León Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 24 León Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 24 León Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 24 León Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,22 24 León Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 24 León Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 24 León Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 24 León Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,65 24 León Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 24 León Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 24 León Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 90,34 24 León Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 24 León Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 24 León Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 24 León Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 91,38 24 León Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 24 León Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 24 León Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 24 León Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 91,78 24 León Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 24 León Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 24 León Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 24 León Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 24 León Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 24 León Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 24 León Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 88,41 24 León Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 24 León Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 24 León Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 24 León Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 88,87 24 León Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 24 León Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 24 León Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 24 León Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 24 León Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 24 León Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 24 León Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 86,17 24 León Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 24 León Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 24 León Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 24 León Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 87,07 24 León Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 24 León Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 24 León Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 24 León Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 24 León Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 24 León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 10.256 24 León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 10.082 24 León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 8.856 24 León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 24 León Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 9.722 24 León Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 24 León Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 24 León Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 24 León Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 9.595 24 León Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 24 León Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 24 León Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 24 León Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 8.445 24 León Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 24 León Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 24 León Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 9.253 24 León Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 24 León Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 24 León Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 24 León Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 9.206 24 León Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 24 León Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 24 León Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 24 León Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 8.080 24 León Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 24 León Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 24 León Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 24 León Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 8.901 24 León Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 7.808 24 León Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 8.678 24 León Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 7.650 24 León Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 24 León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 24 León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 24 León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,79 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,17 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,36 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 90,22 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 91,31 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 91,24 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 88,29 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 88,17 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 86,07 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 86,38 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 301 24 León Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 317 24 León Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.353 24 León Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 24 León Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 294 24 León Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 24 León Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 24 León Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 24 León Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 307 24 León Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 24 León Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 24 León Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 24 León Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.320 24 León Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 24 León Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 24 León Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 284 24 León Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 24 León Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 24 León Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 24 León Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 297 24 León Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 24 León Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 24 León Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 24 León Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.290 24 León Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 24 León Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 24 León Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 24 León Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 24 León Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 293 24 León Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 24 León Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.265 24 León Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 24 León Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 24 León Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 283 24 León Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 24 León Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.239 24 León Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 24 León Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 24 León Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 24 León Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 24 León Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 24 León Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 24 León Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,67 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,85 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,56 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,35 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,69 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,34 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 92,43 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,5 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 89,27 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,57 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León Total Cohort October 1 Total Number at the start of the quarter 2022QIV 10.411 24 León Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 24 León Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 24 León Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 24 León Total Cohort October 1 Total Number at the start of the quarter 2021QIV 10.390 24 León Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 24 León Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 24 León Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 24 León Total Cohort October 1 Total Number at the start of the quarter 2020QIV 10.328 24 León Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 24 León Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 24 León Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 24 León Total Cohort October 1 Total Survival in the first trimester 2022QIV 9.818 24 León Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 24 León Total Cohort October 1 Total Survival in the first trimester 2022QII "" 24 León Total Cohort October 1 Total Survival in the first trimester 2022QI "" 24 León Total Cohort October 1 Total Survival in the first trimester 2021QIV 9.849 24 León Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 24 León Total Cohort October 1 Total Survival in the first trimester 2021QII "" 24 León Total Cohort October 1 Total Survival in the first trimester 2021QI "" 24 León Total Cohort October 1 Total Survival in the first trimester 2020QIV 9.750 24 León Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 24 León Total Cohort October 1 Total Survival in the first trimester 2020QII "" 24 León Total Cohort October 1 Total Survival in the first trimester 2020QI "" 24 León Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 24 León Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 24 León Total Cohort October 1 Total Survival in the second trimester 2022QII "" 24 León Total Cohort October 1 Total Survival in the second trimester 2022QI 9.486 24 León Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 24 León Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 24 León Total Cohort October 1 Total Survival in the second trimester 2021QII "" 24 León Total Cohort October 1 Total Survival in the second trimester 2021QI 9.393 24 León Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 24 León Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 24 León Total Cohort October 1 Total Survival in the second trimester 2020QII "" 24 León Total Cohort October 1 Total Survival in the second trimester 2020QI "" 24 León Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 24 León Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 24 León Total Cohort October 1 Total Survival in the third trimester 2022QII 9.205 24 León Total Cohort October 1 Total Survival in the third trimester 2022QI "" 24 León Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 24 León Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 24 León Total Cohort October 1 Total Survival in the third trimester 2021QII 9.156 24 León Total Cohort October 1 Total Survival in the third trimester 2021QI "" 24 León Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 24 León Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 24 León Total Cohort October 1 Total Survival in the third trimester 2020QII "" 24 León Total Cohort October 1 Total Survival in the third trimester 2020QI "" 24 León Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 24 León Total Cohort October 1 Total Survival in the third trimester 2022QIII 8.977 24 León Total Cohort October 1 Total Survival in the third trimester 2022QII "" 24 León Total Cohort October 1 Total Survival in the third trimester 2022QI "" 24 León Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 24 León Total Cohort October 1 Total Survival in the third trimester 2021QIII 8.937 24 León Total Cohort October 1 Total Survival in the third trimester 2021QII "" 24 León Total Cohort October 1 Total Survival in the third trimester 2021QI "" 24 León Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 24 León Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 24 León Total Cohort October 1 Total Survival in the third trimester 2020QII "" 24 León Total Cohort October 1 Total Survival in the third trimester 2020QI "" 24 León Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 24 León Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 24 León Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 24 León Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 24 León Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 24 León Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 24 León Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 24 León Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 24 León Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 24 León Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 24 León Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 24 León Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 24 León Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,3 24 León Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 24 León Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 24 León Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 24 León Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,79 24 León Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 24 León Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 24 León Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 24 León Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,4 24 León Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 24 León Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 24 León Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 24 León Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 24 León Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 24 León Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 24 León Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 91,3 24 León Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 24 León Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 24 León Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 24 León Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,95 24 León Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 24 León Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 24 León Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 24 León Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 24 León Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 24 León Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 24 León Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 88,59 24 León Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 24 León Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 24 León Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 24 León Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 88,65 24 León Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 24 León Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 24 León Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 24 León Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 24 León Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 24 León Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 24 León Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 86,4 24 León Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 24 León Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 24 León Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 24 León Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 86,53 24 León Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 24 León Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 24 León Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 24 León Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 24 León Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 24 León Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 24 León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 10.124 24 León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 9.971 24 León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 8.895 24 León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 9.540 24 León Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 24 León Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 24 León Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 24 León Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 9.438 24 León Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 24 León Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 24 León Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 24 León Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 8.349 24 León Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 24 León Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 24 León Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 24 León Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 24 León Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 24 León Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 24 León Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 9.087 24 León Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 24 León Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 24 León Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 24 León Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 8.023 24 León Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 24 León Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 24 León Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 24 León Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 24 León Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 8.818 24 León Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 7.816 24 León Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 8.601 24 León Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 7.622 24 León Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 24 León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 24 León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 24 León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,23 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,65 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,86 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 91,13 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 90,2 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 88,44 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 87,87 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 86,26 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 85,69 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 287 24 León Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 419 24 León Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.433 24 León Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 278 24 León Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 24 León Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 24 León Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 24 León Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 411 24 León Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 24 León Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 24 León Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 24 León Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.401 24 León Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 24 León Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 24 León Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 24 León Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 24 León Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 24 León Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 24 León Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 399 24 León Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 24 León Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 24 León Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 24 León Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.370 24 León Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 24 León Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 24 León Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 24 León Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 24 León Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 387 24 León Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 24 León Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.340 24 León Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 24 León Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 24 León Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 24 León Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 376 24 León Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 24 León Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 24 León Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.315 24 León Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 24 León Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 24 León Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 24 León Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 24 León Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 24 León Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 24 León Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 24 León Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,86 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,09 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,77 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 95,23 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,6 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 92,36 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,51 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 89,74 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 91,77 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 24 León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 24 León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 24 León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 8.044 24 León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 24 León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 24 León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 24 León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 7.986 24 León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 24 León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 24 León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 24 León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 8.400 24 León From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 24 León From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 24 León From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 24 León From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 7.591 24 León From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 24 León From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 24 León From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 24 León From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 7.554 24 León From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 24 León From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 24 León From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 24 León From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 7.393 24 León From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 24 León From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 24 León From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 7.238 24 León From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 24 León From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 24 León From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 24 León From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 7.270 24 León From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 24 León From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 24 León From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 24 León From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 7.086 24 León From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 24 León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 24 León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 6.989 24 León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 24 León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 24 León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 24 León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 7.034 24 León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 24 León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 24 León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 24 León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 6.844 24 León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 24 León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 24 León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 6.737 24 León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 24 León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 24 León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 24 León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 6.839 24 León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 24 León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 24 León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 24 León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 6.604 24 León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 24 León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 24 León From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 24 León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 24 León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 24 León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 24 León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 24 León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 24 León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 24 León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 24 León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 24 León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 24 León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 24 León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 24 León From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,37 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,59 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 88,01 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,98 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,03 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 84,36 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,88 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 88,08 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 81,48 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 83,75 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,64 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 78,62 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 24 León From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 7.756 24 León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 7.218 24 León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 7.317 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 6.815 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 6.971 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 6.558 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 6.732 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 6.343 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 6.488 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 6.167 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 24 León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 24 León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,34 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,42 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,88 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,86 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,8 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,88 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 83,65 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,44 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 288 24 León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 768 24 León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 274 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 739 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 267 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 712 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 257 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 691 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 249 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 672 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 24 León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 24 León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 24 León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,14 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,22 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,71 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 92,71 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 89,24 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 89,97 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 86,46 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 87,5 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 24 León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 24 León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 8.037 24 León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 24 León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 24 León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 24 León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 7.996 24 León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 24 León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 24 León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 24 León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 7.866 24 León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 24 León From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 24 León From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 24 León From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 7.574 24 León From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 24 León From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 24 León From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 24 León From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 7.620 24 León From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 24 León From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 24 León From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 24 León From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 7.506 24 León From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 24 León From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 24 León From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 7.267 24 León From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 24 León From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 24 León From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 24 León From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 7.324 24 León From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 24 León From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 24 León From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 24 León From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 7.227 24 León From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 24 León From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 24 León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 6.963 24 León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 24 León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 24 León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 24 León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 7.053 24 León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 24 León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 24 León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 24 León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 6.956 24 León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 24 León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 24 León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 24 León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 24 León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 24 León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 24 León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 6.809 24 León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 24 León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 24 León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 24 León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 6.715 24 León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 24 León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 24 León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 24 León From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 24 León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 24 León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 24 León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 24 León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 24 León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 24 León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 24 León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 24 León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 24 León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 24 León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 24 León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 24 León From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,24 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,3 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,42 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,42 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,6 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,88 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 86,64 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 88,21 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,43 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 85,16 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,37 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 24 León From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 7.790 24 León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 7.332 24 León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 6.263 24 León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 7.336 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 6.981 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 5.934 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 7.037 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 6.705 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 5.714 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 6.744 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 6.451 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 5.501 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 6.222 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 5.306 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 24 León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 24 León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 24 León From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,17 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,21 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,75 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,33 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,45 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,23 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 86,57 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 87,98 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 87,83 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 84,86 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,72 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 247 24 León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 664 24 León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.603 24 León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 238 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 639 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.572 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 230 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 619 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.513 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 219 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 602 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.455 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 587 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.409 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 24 León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 24 León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 24 León From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,36 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,23 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,07 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,12 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,22 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,39 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,66 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 90,66 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 90,77 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 88,4 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 87,9 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 24 León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 8.158 24 León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 24 León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 24 León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 24 León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 8.144 24 León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 24 León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 24 León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 24 León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 8.059 24 León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 24 León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 24 León From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 24 León From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 7.639 24 León From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 24 León From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 24 León From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 24 León From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 7.663 24 León From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 24 León From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 24 León From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 24 León From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 7.626 24 León From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 24 León From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 24 León From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 7.191 24 León From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 24 León From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 24 León From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 24 León From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 7.275 24 León From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 24 León From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 24 León From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 24 León From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 7.242 24 León From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 24 León From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 24 León From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 24 León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 24 León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 24 León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 24 León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 6.990 24 León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 24 León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 24 León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 24 León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 6.968 24 León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 24 León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 24 León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 24 León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 24 León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 24 León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 24 León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 6.772 24 León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 24 León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 24 León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 24 León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 6.803 24 León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 24 León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 24 León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 24 León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 24 León From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 24 León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 24 León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 24 León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 24 León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 24 León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 24 León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 24 León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 24 León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 24 León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 24 León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 24 León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 24 León From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,64 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,09 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,63 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 88,15 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,33 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 89,86 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 85,83 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,46 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 83,15 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,41 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 24 León From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 7.964 24 León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 7.941 24 León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 7.249 24 León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 7.451 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 7.470 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 6.844 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 7.012 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 7.090 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 6.488 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 6.808 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 6.235 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 6.597 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 6.089 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 24 León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 24 León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 24 León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,56 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,07 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,41 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 88,05 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,28 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,5 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 85,73 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,01 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 83,08 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 84 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 194 24 León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 203 24 León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 810 24 León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 188 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 193 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 782 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 179 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 185 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 754 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 182 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 733 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 175 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 714 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 24 León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 24 León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 24 León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,91 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 95,07 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,54 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 92,27 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 91,13 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,09 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 89,66 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 90,49 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 86,21 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 88,15 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 8.022 24 León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 24 León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 24 León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 24 León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 8.104 24 León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 24 León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 24 León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 24 León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 8.124 24 León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 24 León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 24 León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 24 León From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 7.464 24 León From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 24 León From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 24 León From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 24 León From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 7.573 24 León From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 24 León From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 24 León From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 24 León From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 7.561 24 León From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 24 León From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 24 León From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 24 León From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 24 León From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 24 León From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 24 León From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 7.236 24 León From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 24 León From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 24 León From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 24 León From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 7.227 24 León From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 24 León From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 24 León From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 24 León From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 24 León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 24 León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 24 León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 6.975 24 León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 24 León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 24 León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 24 León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 7.009 24 León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 24 León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 24 León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 24 León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 24 León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 24 León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 24 León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 6.763 24 León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 24 León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 24 León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 24 León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 6.801 24 León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 24 León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 24 León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 24 León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 24 León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 24 León From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 24 León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 24 León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 24 León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 24 León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 24 León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 24 León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 24 León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 24 León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 24 León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 24 León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 24 León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 24 León From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,04 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,45 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,07 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,29 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 88,96 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 86,07 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 86,28 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 83,45 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 83,71 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 24 León From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 7.837 24 León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 7.806 24 León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 7.286 24 León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 7.287 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 7.283 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 6.752 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 6.955 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 6.445 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 6.703 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 6.250 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 6.501 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 6.062 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 24 León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 24 León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 24 León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 92,98 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 93,3 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,67 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,1 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88,46 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 85,87 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 85,78 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 83,28 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 83,2 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 185 24 León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 298 24 León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 838 24 León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 177 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 290 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 809 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 281 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 782 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 272 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 759 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 262 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 739 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 24 León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 24 León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 24 León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 95,68 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,32 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,54 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,3 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 93,32 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 91,28 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 90,57 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 87,92 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 88,19 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 24 León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 24 León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 24 León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 1.016 24 León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 24 León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 24 León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 24 León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 969 24 León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 1.040 24 León From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 999 24 León From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 960 24 León From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 1.009 24 León From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 981 24 León From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 946 24 León From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 989 24 León From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 971 24 León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 940 24 León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 977 24 León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 959 24 León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 933 24 León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 970 24 León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 24 León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 24 León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 24 León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 24 León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 24 León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 24 León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 24 León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 24 León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,33 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,07 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,02 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,56 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,63 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,1 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 95,57 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,01 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 93,94 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 94,39 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,28 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 93,27 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 975 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 779 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 959 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 773 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 943 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 763 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 934 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 760 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 923 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 753 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,36 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,23 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,72 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,95 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,79 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,56 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 94,67 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,66 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 41 24 León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 190 24 León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 40 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 187 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 38 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 183 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 37 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 180 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 36 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 180 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 24 León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 24 León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,56 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,42 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,68 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,32 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,24 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,74 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 87,8 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 94,74 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 24 León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 24 León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 1.023 24 León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 24 León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 24 León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 24 León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 967 24 León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 24 León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 24 León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 24 León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 975 24 León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 1.010 24 León From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 951 24 León From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 959 24 León From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 998 24 León From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 943 24 León From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 950 24 León From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 986 24 León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 938 24 León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 945 24 León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 925 24 León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 925 24 León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 24 León From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 24 León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 24 León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 24 León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 24 León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 24 León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 24 León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 24 León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 24 León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 24 León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 24 León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 24 León From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,73 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,35 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,36 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,56 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,52 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,44 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,38 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,92 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 95,66 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,87 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 24 León From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 987 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 818 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 634 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 974 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 807 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 626 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 962 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 801 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 624 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 950 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 796 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 621 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 784 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 608 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,68 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,66 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,74 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,47 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,92 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,42 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,25 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,31 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,95 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,84 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,9 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 36 24 León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 149 24 León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 341 24 León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 36 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 144 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 333 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 36 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 142 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 326 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 36 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 142 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 324 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 141 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 317 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 24 León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 24 León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 24 León From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,64 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,65 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,3 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,6 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 95,3 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,01 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 94,63 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 92,96 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 24 León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 1.039 24 León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 24 León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 24 León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 24 León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 1.010 24 León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 24 León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 24 León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 24 León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 975 24 León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 1.024 24 León From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 1.001 24 León From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 967 24 León From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 1.006 24 León From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 994 24 León From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 963 24 León From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 981 24 León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 946 24 León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 971 24 León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 934 24 León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 24 León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 24 León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 24 León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 24 León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 24 León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 24 León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 24 León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 24 León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 24 León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 24 León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,56 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,11 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,18 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,82 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,42 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,77 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,13 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,03 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,14 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,79 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.004 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 967 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 771 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 989 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 958 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 768 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 971 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 952 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 765 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 939 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 751 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 931 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 743 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,51 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,07 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,61 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,71 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,45 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 99,22 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,1 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,41 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,28 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,37 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 35 24 León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 43 24 León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 204 24 León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 35 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 43 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 199 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 35 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 42 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 198 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 42 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 195 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 40 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 191 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 24 León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 24 León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 24 León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,55 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,67 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,06 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,67 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95,59 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,02 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 93,63 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 1.043 24 León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 24 León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 24 León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 1.022 24 León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 24 León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 24 León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 1.011 24 León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 1.019 24 León From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 1.017 24 León From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 1.003 24 León From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 1.002 24 León From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 990 24 León From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 990 24 León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 976 24 León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 981 24 León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 970 24 León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 24 León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 24 León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 24 León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 24 León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 24 León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 24 León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 24 León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,7 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,51 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,21 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,04 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,92 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,87 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,54 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,99 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,94 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.011 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 970 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 780 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 987 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 965 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 772 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 952 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 760 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 942 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 751 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 933 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 746 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,63 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,48 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,97 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,14 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,44 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,11 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,28 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,19 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,64 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 32 24 León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 52 24 León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 231 24 León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 32 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 52 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 231 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 50 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 230 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 48 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 225 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 48 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 224 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 24 León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 24 León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 24 León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 96,15 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 99,57 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 92,31 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,4 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 92,31 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,97 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 24 León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 24 León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 24 León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 1.208 24 León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 24 León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 24 León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 24 León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 1.074 24 León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 24 León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 24 León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 24 León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 1.210 24 León From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 24 León From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 24 León From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 24 León From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 1.197 24 León From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 24 León From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 24 León From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 24 León From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 1.066 24 León From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 24 León From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 24 León From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 24 León From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 1.194 24 León From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 24 León From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 24 León From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 1.186 24 León From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 24 León From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 24 León From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 24 León From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 1.059 24 León From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 24 León From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 24 León From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 24 León From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 1.184 24 León From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 24 León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 24 León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 1.178 24 León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 24 León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 24 León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 24 León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 1.055 24 León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 24 León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 24 León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 24 León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 1.179 24 León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 24 León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 24 León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 1.173 24 León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 24 León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 24 León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 24 León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 1.052 24 León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 24 León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 24 León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 24 León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 1.172 24 León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 24 León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 24 León From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 24 León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 24 León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 24 León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 24 León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 24 León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 24 León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 24 León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 24 León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 24 León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 24 León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 24 León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 24 León From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,09 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,26 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,68 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,18 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,6 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,85 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,52 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,23 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,44 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,1 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,95 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,86 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 24 León From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.152 24 León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 798 24 León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.141 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 792 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.132 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 787 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.124 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 785 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.119 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 783 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 24 León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 24 León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,05 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,25 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,26 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,62 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,57 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,37 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,14 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,12 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 56 24 León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 276 24 León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 56 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 274 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 54 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 272 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 54 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 270 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 54 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 269 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 24 León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 24 León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 24 León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,28 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96,43 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,55 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,43 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,83 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,43 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,46 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 24 León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 24 León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 1.209 24 León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 24 León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 24 León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 24 León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 1.106 24 León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 24 León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 24 León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 24 León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 1.098 24 León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 24 León From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 24 León From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 24 León From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 1.198 24 León From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 24 León From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 24 León From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 24 León From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 1.102 24 León From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 24 León From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 24 León From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 24 León From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 1.093 24 León From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 24 León From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 24 León From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 1.191 24 León From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 24 León From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 24 León From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 24 León From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 1.100 24 León From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 24 León From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 24 León From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 24 León From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 1.090 24 León From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 24 León From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 24 León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 1.186 24 León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 24 León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 24 León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 24 León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 1.095 24 León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 24 León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 24 León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 24 León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 1.085 24 León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 24 León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 24 León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 24 León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 24 León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 24 León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 24 León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 1.084 24 León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 24 León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 24 León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 24 León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 1.080 24 León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 24 León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 24 León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 24 León From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 24 León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 24 León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 24 León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 24 León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 24 León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 24 León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 24 León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 24 León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 24 León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 24 León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 24 León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 24 León From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,09 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,64 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,54 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,51 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,46 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,27 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,1 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 99,01 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,82 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,01 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,36 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 24 León From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.139 24 León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 862 24 León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 667 24 León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.129 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 860 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 663 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.123 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 859 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 660 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.119 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 855 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 656 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 847 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 652 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 24 León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 24 León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 24 León From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,12 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,77 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,4 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,6 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 99,65 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,95 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,24 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 99,19 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,35 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 98,26 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,75 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 70 24 León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 244 24 León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 431 24 León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 69 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 242 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 430 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 68 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 241 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 430 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 67 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 240 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 429 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 237 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 428 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 24 León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 24 León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 24 León From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,57 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,18 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,77 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,14 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,77 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,77 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 95,71 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,36 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 99,54 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,13 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 99,3 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 24 León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 1.283 24 León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 24 León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 24 León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 24 León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 1.172 24 León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 24 León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 24 León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 24 León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.105 24 León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 24 León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 24 León From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 24 León From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 1.276 24 León From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 24 León From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 24 León From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 24 León From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 1.165 24 León From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 24 León From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 24 León From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 24 León From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 1.102 24 León From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 24 León From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 24 León From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 1.264 24 León From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 24 León From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 24 León From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 24 León From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 1.161 24 León From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 24 León From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 24 León From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 24 León From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 1.095 24 León From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 24 León From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 24 León From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 24 León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 24 León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 24 León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 24 León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 1.150 24 León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 24 León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 24 León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 24 León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 1.089 24 León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 24 León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 24 León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 24 León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 24 León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 24 León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 24 León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 1.145 24 León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 24 León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 24 León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 24 León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 1.082 24 León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 24 León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 24 León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 24 León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 24 León From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 24 León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 24 León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 24 León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 24 León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 24 León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 24 León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 24 León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 24 León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 24 León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 24 León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 24 León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 24 León From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,45 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,4 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,73 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,52 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,06 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,1 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,12 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,55 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,7 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,92 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 24 León From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.215 24 León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.109 24 León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 790 24 León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.209 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.102 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 787 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.198 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.099 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 781 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.089 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 776 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.085 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 772 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 24 León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 24 León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 24 León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,51 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,37 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,62 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,6 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 99,1 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,86 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,2 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,23 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,84 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,72 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 68 24 León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 63 24 León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 315 24 León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 67 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 63 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 315 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 66 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 62 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 314 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 61 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 313 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 60 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 310 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 24 León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 24 León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 24 León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,53 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,06 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,41 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,68 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 96,83 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 99,37 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 95,24 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,41 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 1.264 24 León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 24 León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 24 León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 24 León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 1.188 24 León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 24 León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 24 León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 24 León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.122 24 León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 24 León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 24 León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 24 León From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 1.254 24 León From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 24 León From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 24 León From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 24 León From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 1.183 24 León From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 24 León From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 24 León From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 24 León From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 1.115 24 León From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 24 León From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 24 León From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 24 León From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 24 León From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 24 León From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 24 León From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 1.172 24 León From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 24 León From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 24 León From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 24 León From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 1.105 24 León From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 24 León From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 24 León From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 24 León From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 24 León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 24 León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 24 León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 1.164 24 León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 24 León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 24 León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 24 León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 1.100 24 León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 24 León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 24 León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 24 León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 24 León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 24 León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 24 León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 1.157 24 León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 24 León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 24 León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 24 León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 1.095 24 León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 24 León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 24 León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 24 León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 24 León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 24 León From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 24 León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 24 León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 24 León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 24 León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 24 León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 24 León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 24 León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 24 León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 24 León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 24 León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 24 León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 24 León From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,21 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,58 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,38 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,65 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,48 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,98 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,04 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,39 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,59 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 24 León From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.200 24 León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.126 24 León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 785 24 León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.191 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.121 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 781 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.111 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 774 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.104 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 771 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.098 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 770 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 24 León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 24 León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 24 León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,25 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,56 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,49 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,67 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,6 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,05 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,22 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,51 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,09 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 64 24 León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 62 24 León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 337 24 León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 63 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 62 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 334 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 61 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 331 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 60 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 329 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 59 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 325 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 24 León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 24 León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 24 León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,44 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,11 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,39 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,22 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,77 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,63 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 95,16 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,44 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 24 León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 24 León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 24 León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 55 24 León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 24 León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 24 León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 24 León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 52 24 León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 24 León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 24 León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 24 León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 54 24 León from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 24 León from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 24 León from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 24 León from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 55 24 León from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 24 León from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 24 León from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 24 León from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 52 24 León from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 24 León from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 24 León from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 24 León from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 52 24 León from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 24 León from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 24 León from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 55 24 León from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 24 León from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 24 León from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 24 León from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 52 24 León from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 24 León from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 24 León from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 24 León from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 52 24 León from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 24 León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 24 León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 55 24 León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 24 León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 24 León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 24 León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 52 24 León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 24 León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 24 León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 24 León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 52 24 León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 24 León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 24 León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 55 24 León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 24 León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 24 León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 24 León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 52 24 León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 24 León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 24 León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 24 León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 52 24 León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 24 León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 24 León from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 24 León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 24 León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 24 León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 24 León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 24 León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 24 León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 24 León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 24 León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 24 León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 24 León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 24 León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 24 León from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,3 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,3 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,3 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,3 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 24 León from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 49 24 León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 34 24 León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 49 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 34 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 49 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 34 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 49 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 34 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 49 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 34 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 24 León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 24 León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 6 24 León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 18 24 León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 6 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 18 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 6 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 18 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 6 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 18 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 6 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 18 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 24 León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 24 León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 24 León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 24 León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 24 León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 61 24 León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 24 León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 24 León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 24 León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 49 24 León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 24 León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 24 León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 24 León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 49 24 León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 24 León from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 24 León from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 24 León from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 61 24 León from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 24 León from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 24 León from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 24 León from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 49 24 León from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 24 León from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 24 León from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 24 León from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 49 24 León from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 24 León from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 24 León from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 61 24 León from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 24 León from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 24 León from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 24 León from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 49 24 León from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 24 León from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 24 León from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 24 León from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 49 24 León from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 24 León from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 24 León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 61 24 León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 24 León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 24 León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 24 León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 49 24 León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 24 León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 24 León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 24 León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 49 24 León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 24 León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 24 León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 24 León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 24 León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 24 León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 24 León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 49 24 León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 24 León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 24 León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 24 León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 49 24 León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 24 León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 24 León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 24 León from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 24 León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 24 León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 24 León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 24 León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 24 León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 24 León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 24 León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 24 León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 24 León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 24 León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 24 León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 24 León from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 24 León from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 59 24 León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 33 24 León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 30 24 León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 59 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 33 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 30 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 59 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 33 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 30 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 59 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 33 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 30 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 33 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 30 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 24 León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 24 León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 24 León from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 2 24 León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 16 24 León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 19 24 León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 2 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 16 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 19 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 2 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 16 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 19 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 2 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 16 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 19 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 16 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 19 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 24 León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 24 León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 24 León from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 24 León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 55 24 León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 24 León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 24 León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 24 León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 52 24 León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 24 León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 24 León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 24 León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 51 24 León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 24 León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 24 León from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 24 León from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 55 24 León from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 24 León from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 24 León from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 24 León from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 52 24 León from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 24 León from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 24 León from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 24 León from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 51 24 León from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 24 León from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 24 León from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 55 24 León from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 24 León from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 24 León from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 24 León from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 52 24 León from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 24 León from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 24 León from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 24 León from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 51 24 León from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 24 León from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 24 León from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 24 León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 24 León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 24 León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 24 León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 52 24 León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 24 León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 24 León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 24 León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 51 24 León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 24 León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 24 León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 24 León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 24 León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 24 León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 24 León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 52 24 León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 24 León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 24 León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 24 León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 51 24 León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 24 León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 24 León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 24 León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 24 León from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 24 León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 24 León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 24 León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 24 León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 24 León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 24 León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 24 León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 24 León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 24 León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 24 León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 24 León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 24 León from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 24 León from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 54 24 León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 48 24 León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 33 24 León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 54 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 48 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 33 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 54 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 48 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 33 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 48 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 33 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 48 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 33 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 24 León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 24 León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 24 León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1 24 León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 4 24 León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 18 24 León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 4 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 18 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 4 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 18 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 4 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 18 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 4 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 18 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 24 León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 24 León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 24 León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 59 24 León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 24 León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 24 León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 24 León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 53 24 León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 24 León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 24 León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 24 León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 49 24 León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 24 León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 24 León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 24 León from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 59 24 León from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 24 León from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 24 León from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 24 León from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 53 24 León from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 24 León from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 24 León from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 24 León from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 49 24 León from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 24 León from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 24 León from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 24 León from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 24 León from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 24 León from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 24 León from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 53 24 León from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 24 León from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 24 León from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 24 León from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 49 24 León from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 24 León from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 24 León from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 24 León from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 24 León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 24 León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 24 León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 53 24 León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 24 León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 24 León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 24 León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 49 24 León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 24 León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 24 León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 24 León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 24 León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 24 León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 24 León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 53 24 León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 24 León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 24 León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 24 León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 49 24 León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 24 León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 24 León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 24 León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 24 León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 24 León from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 24 León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 24 León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 24 León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 24 León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 24 León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 24 León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 24 León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 24 León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 24 León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 24 León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 24 León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 24 León from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 24 León from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 57 24 León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 47 24 León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 31 24 León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 57 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 47 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 31 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 47 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 31 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 47 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 31 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 47 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 31 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 24 León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 24 León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 24 León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 2 24 León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 6 24 León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 18 24 León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 2 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 6 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 18 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 6 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 18 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 6 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 18 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 6 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 18 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 24 León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 24 León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 24 León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 24 León De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 24 León De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 24 León De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 23 24 León De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 24 León De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 24 León De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 24 León De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 21 24 León De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 24 León De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 24 León De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 24 León De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 20 24 León De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 24 León De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 24 León De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 24 León De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 23 24 León De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 24 León De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 24 León De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 24 León De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 21 24 León De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 24 León De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 24 León De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 24 León De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 20 24 León De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 24 León De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 24 León De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 23 24 León De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 24 León De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 24 León De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 24 León De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 21 24 León De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 24 León De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 24 León De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 24 León De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 20 24 León De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 24 León De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 24 León De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 23 24 León De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 24 León De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 24 León De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 24 León De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 21 24 León De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 24 León De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 24 León De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 24 León De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 20 24 León De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 24 León De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 24 León De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 22 24 León De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 24 León De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 24 León De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 24 León De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 21 24 León De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 24 León De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 24 León De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 24 León De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 20 24 León De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 24 León De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 24 León De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 24 León De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 24 León De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 24 León De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 24 León De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 24 León De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 24 León De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 24 León De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 24 León De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 24 León De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 24 León De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 24 León De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 24 León De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,65 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 24 León De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 24 León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 22 24 León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 11 24 León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 22 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 11 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 22 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 11 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 22 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 11 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 21 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 11 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 24 León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 24 León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,45 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1 24 León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 10 24 León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1 24 León De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 10 24 León De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1 24 León De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 10 24 León De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1 24 León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 10 24 León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1 24 León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 10 24 León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 24 León De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 24 León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 24 León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 24 León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 24 León De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 24 León De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 23 24 León De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 24 León De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 24 León De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 24 León De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 22 24 León De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 24 León De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 24 León De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 24 León De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 19 24 León De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 24 León De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 24 León De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 24 León De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 23 24 León De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 24 León De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 24 León De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 24 León De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 22 24 León De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 24 León De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 24 León De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 24 León De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 19 24 León De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 24 León De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 24 León De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 23 24 León De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 24 León De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 24 León De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 24 León De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 22 24 León De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 24 León De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 24 León De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 24 León De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 19 24 León De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 24 León De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 24 León De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 22 24 León De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 24 León De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 24 León De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 24 León De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 22 24 León De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 24 León De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 24 León De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 24 León De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 19 24 León De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 24 León De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 24 León De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 24 León De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 24 León De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 24 León De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 24 León De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 22 24 León De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 24 León De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 24 León De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 24 León De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 19 24 León De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 24 León De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 24 León De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 24 León De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 24 León De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 24 León De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 24 León De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 24 León De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 24 León De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 24 León De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 24 León De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 24 León De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 24 León De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 24 León De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 24 León De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 24 León De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,65 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 24 León De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 19 24 León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 12 24 León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 13 24 León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 19 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 12 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 13 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 19 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 12 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 13 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 18 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 12 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 13 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 12 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 13 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 24 León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 24 León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 24 León De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 94,74 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 4 24 León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 10 24 León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 6 24 León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 4 24 León De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 10 24 León De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 6 24 León De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 4 24 León De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 10 24 León De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 6 24 León De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 4 24 León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 10 24 León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 6 24 León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 10 24 León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 6 24 León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 24 León De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 24 León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 24 León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 24 León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 24 León De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 24 León De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 22 24 León De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 24 León De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 24 León De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 24 León De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 21 24 León De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 24 León De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 24 León De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 24 León De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 19 24 León De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 24 León De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 24 León De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 24 León De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 22 24 León De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 24 León De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 24 León De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 24 León De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 21 24 León De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 24 León De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 24 León De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 24 León De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 19 24 León De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 24 León De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 24 León De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 21 24 León De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 24 León De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 24 León De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 24 León De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 21 24 León De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 24 León De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 24 León De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 24 León De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 19 24 León De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 24 León De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 24 León De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 24 León De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 24 León De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 24 León De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 24 León De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 21 24 León De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 24 León De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 24 León De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 24 León De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 19 24 León De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 24 León De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 24 León De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 24 León De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 24 León De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 24 León De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 24 León De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 21 24 León De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 24 León De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 24 León De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 24 León De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 19 24 León De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 24 León De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 24 León De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 24 León De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 24 León De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 24 León De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 24 León De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 24 León De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 24 León De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 24 León De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 24 León De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 24 León De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 24 León De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 24 León De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 24 León De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 24 León De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 24 León De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 95,45 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 24 León De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 19 24 León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 17 24 León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 13 24 León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 19 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 17 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 13 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 18 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 17 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 13 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 17 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 13 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 17 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 13 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 24 León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 24 León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 24 León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 24 León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 24 León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 24 León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 94,74 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 3 24 León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 4 24 León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 6 24 León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 3 24 León De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 4 24 León De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 6 24 León De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 3 24 León De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 4 24 León De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 6 24 León De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 4 24 León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 6 24 León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 4 24 León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 6 24 León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 24 León De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 24 León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 24 León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 24 León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 24 León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 24 León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 24 León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 24 León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 23 24 León De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 24 León De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 24 León De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 24 León De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 23 24 León De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 24 León De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 24 León De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 24 León De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 22 24 León De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 24 León De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 24 León De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 24 León De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 22 24 León De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 24 León De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 24 León De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 24 León De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 23 24 León De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 24 León De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 24 León De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 24 León De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 22 24 León De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 24 León De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 24 León De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 24 León De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 24 León De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 24 León De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 24 León De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 23 24 León De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 24 León De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 24 León De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 24 León De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 22 24 León De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 24 León De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 24 León De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 24 León De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 24 León De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 24 León De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 24 León De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 23 24 León De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 24 León De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 24 León De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 24 León De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 22 24 León De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 24 León De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 24 León De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 24 León De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 24 León De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 24 León De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 24 León De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 23 24 León De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 24 León De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 24 León De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 24 León De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 22 24 León De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 24 León De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 24 León De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 24 León De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 24 León De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 24 León De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 24 León De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 24 León De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 24 León De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 24 León De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 24 León De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 24 León De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 24 León De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 24 León De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 24 León De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 24 León De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 24 León De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 24 León De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,65 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 24 León De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 19 24 León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 22 24 León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 13 24 León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 18 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 22 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 13 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 22 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 13 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 22 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 13 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 22 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 13 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 24 León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 24 León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 24 León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,74 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 24 León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 4 24 León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1 24 León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 9 24 León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 4 24 León De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1 24 León De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 9 24 León De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1 24 León De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 9 24 León De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1 24 León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 9 24 León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1 24 León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 9 24 León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 24 León De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 24 León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 24 León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 24 León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 24 León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 24 León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 24 León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 24 León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 24 León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 24 León De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 24 León De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 25 Lleida Total Cohort January 1 Total Number at the start of the quarter 2022QI 12.101 25 Lleida Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 25 Lleida Total Cohort January 1 Total Number at the start of the quarter 2021QI 11.688 25 Lleida Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 25 Lleida Total Cohort January 1 Total Number at the start of the quarter 2020QI 12.218 25 Lleida Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 25 Lleida Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 25 Lleida Total Cohort January 1 Total Survival in the first trimester 2022QII "" 25 Lleida Total Cohort January 1 Total Survival in the first trimester 2022QI 11.524 25 Lleida Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 25 Lleida Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 25 Lleida Total Cohort January 1 Total Survival in the first trimester 2021QII "" 25 Lleida Total Cohort January 1 Total Survival in the first trimester 2021QI 11.172 25 Lleida Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 25 Lleida Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 25 Lleida Total Cohort January 1 Total Survival in the first trimester 2020QII "" 25 Lleida Total Cohort January 1 Total Survival in the first trimester 2020QI 11.101 25 Lleida Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 25 Lleida Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 25 Lleida Total Cohort January 1 Total Survival in the second trimester 2022QII 11.004 25 Lleida Total Cohort January 1 Total Survival in the second trimester 2022QI "" 25 Lleida Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 25 Lleida Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 25 Lleida Total Cohort January 1 Total Survival in the second trimester 2021QII 10.773 25 Lleida Total Cohort January 1 Total Survival in the second trimester 2021QI "" 25 Lleida Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 25 Lleida Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 25 Lleida Total Cohort January 1 Total Survival in the second trimester 2020QII 10.715 25 Lleida Total Cohort January 1 Total Survival in the second trimester 2020QI "" 25 Lleida Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 25 Lleida Total Cohort January 1 Total Survival in the third trimester 2022QIII 10.625 25 Lleida Total Cohort January 1 Total Survival in the third trimester 2022QII "" 25 Lleida Total Cohort January 1 Total Survival in the third trimester 2022QI "" 25 Lleida Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 25 Lleida Total Cohort January 1 Total Survival in the third trimester 2021QIII 10.484 25 Lleida Total Cohort January 1 Total Survival in the third trimester 2021QII "" 25 Lleida Total Cohort January 1 Total Survival in the third trimester 2021QI "" 25 Lleida Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 25 Lleida Total Cohort January 1 Total Survival in the third trimester 2020QIII 10.368 25 Lleida Total Cohort January 1 Total Survival in the third trimester 2020QII "" 25 Lleida Total Cohort January 1 Total Survival in the third trimester 2020QI "" 25 Lleida Total Cohort January 1 Total Survival in the third trimester 2022QIV 10.353 25 Lleida Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 25 Lleida Total Cohort January 1 Total Survival in the third trimester 2022QII "" 25 Lleida Total Cohort January 1 Total Survival in the third trimester 2022QI "" 25 Lleida Total Cohort January 1 Total Survival in the third trimester 2021QIV 10.248 25 Lleida Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 25 Lleida Total Cohort January 1 Total Survival in the third trimester 2021QII "" 25 Lleida Total Cohort January 1 Total Survival in the third trimester 2021QI "" 25 Lleida Total Cohort January 1 Total Survival in the third trimester 2020QIV 10.078 25 Lleida Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 25 Lleida Total Cohort January 1 Total Survival in the third trimester 2020QII "" 25 Lleida Total Cohort January 1 Total Survival in the third trimester 2020QI "" 25 Lleida Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 25 Lleida Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 25 Lleida Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 25 Lleida Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 25 Lleida Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 25 Lleida Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 25 Lleida Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,23 25 Lleida Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,59 25 Lleida Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 90,86 25 Lleida Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,93 25 Lleida Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 92,17 25 Lleida Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 87,7 25 Lleida Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 87,8 25 Lleida Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 89,7 25 Lleida Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 84,86 25 Lleida Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 85,55 25 Lleida Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 87,68 25 Lleida Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 82,48 25 Lleida Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 25 Lleida Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 25 Lleida Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 11.753 25 Lleida Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 10.619 25 Lleida Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 11.183 25 Lleida Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 10.127 25 Lleida Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 10.676 25 Lleida Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 9.746 25 Lleida Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 10.305 25 Lleida Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 9.472 25 Lleida Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 10.040 25 Lleida Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 9.255 25 Lleida Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 25 Lleida Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 25 Lleida Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 95,15 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 95,37 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,84 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 91,78 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 87,68 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 89,2 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 85,42 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 87,16 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 348 25 Lleida Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.069 25 Lleida Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 341 25 Lleida Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.045 25 Lleida Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 328 25 Lleida Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.027 25 Lleida Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 320 25 Lleida Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.012 25 Lleida Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 313 25 Lleida Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 993 25 Lleida Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 25 Lleida Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 25 Lleida Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,99 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,75 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 94,25 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,07 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 91,95 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,67 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 89,94 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 92,89 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida Total Cohort April 1 Total Number at the start of the quarter 2022QII 12.085 25 Lleida Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 25 Lleida Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida Total Cohort April 1 Total Number at the start of the quarter 2021QII 11.736 25 Lleida Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 25 Lleida Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida Total Cohort April 1 Total Number at the start of the quarter 2020QII 11.581 25 Lleida Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 25 Lleida Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 25 Lleida Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 25 Lleida Total Cohort April 1 Total Survival in the first trimester 2022QII 11.500 25 Lleida Total Cohort April 1 Total Survival in the first trimester 2022QI "" 25 Lleida Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 25 Lleida Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 25 Lleida Total Cohort April 1 Total Survival in the first trimester 2021QII 11.253 25 Lleida Total Cohort April 1 Total Survival in the first trimester 2021QI "" 25 Lleida Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 25 Lleida Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 25 Lleida Total Cohort April 1 Total Survival in the first trimester 2020QII 11.116 25 Lleida Total Cohort April 1 Total Survival in the first trimester 2020QI "" 25 Lleida Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 25 Lleida Total Cohort April 1 Total Survival in the second trimester 2022QIII 11.052 25 Lleida Total Cohort April 1 Total Survival in the second trimester 2022QII "" 25 Lleida Total Cohort April 1 Total Survival in the second trimester 2022QI "" 25 Lleida Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 25 Lleida Total Cohort April 1 Total Survival in the second trimester 2021QIII 10.894 25 Lleida Total Cohort April 1 Total Survival in the second trimester 2021QII "" 25 Lleida Total Cohort April 1 Total Survival in the second trimester 2021QI "" 25 Lleida Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 25 Lleida Total Cohort April 1 Total Survival in the second trimester 2020QIII 10.723 25 Lleida Total Cohort April 1 Total Survival in the second trimester 2020QII "" 25 Lleida Total Cohort April 1 Total Survival in the second trimester 2020QI "" 25 Lleida Total Cohort April 1 Total Survival in the third trimester 2022QIV 10.733 25 Lleida Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 25 Lleida Total Cohort April 1 Total Survival in the third trimester 2022QII "" 25 Lleida Total Cohort April 1 Total Survival in the third trimester 2022QI "" 25 Lleida Total Cohort April 1 Total Survival in the third trimester 2021QIV 10.591 25 Lleida Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 25 Lleida Total Cohort April 1 Total Survival in the third trimester 2021QII "" 25 Lleida Total Cohort April 1 Total Survival in the third trimester 2021QI "" 25 Lleida Total Cohort April 1 Total Survival in the third trimester 2020QIV 10.394 25 Lleida Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 25 Lleida Total Cohort April 1 Total Survival in the third trimester 2020QII "" 25 Lleida Total Cohort April 1 Total Survival in the third trimester 2020QI "" 25 Lleida Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 25 Lleida Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 25 Lleida Total Cohort April 1 Total Survival in the third trimester 2022QII "" 25 Lleida Total Cohort April 1 Total Survival in the third trimester 2022QI 10.269 25 Lleida Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 25 Lleida Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 25 Lleida Total Cohort April 1 Total Survival in the third trimester 2021QII "" 25 Lleida Total Cohort April 1 Total Survival in the third trimester 2021QI 10.075 25 Lleida Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 25 Lleida Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 25 Lleida Total Cohort April 1 Total Survival in the third trimester 2020QII "" 25 Lleida Total Cohort April 1 Total Survival in the third trimester 2020QI "" 25 Lleida Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 25 Lleida Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 25 Lleida Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 25 Lleida Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 25 Lleida Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 25 Lleida Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,16 25 Lleida Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,88 25 Lleida Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,98 25 Lleida Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 91,45 25 Lleida Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,83 25 Lleida Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,59 25 Lleida Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 88,81 25 Lleida Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 90,24 25 Lleida Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,75 25 Lleida Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 87,5 25 Lleida Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87 25 Lleida Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 25 Lleida Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 25 Lleida Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 11.744 25 Lleida Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 10.756 25 Lleida Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 9.906 25 Lleida Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 11.169 25 Lleida Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 10.296 25 Lleida Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 9.475 25 Lleida Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 10.731 25 Lleida Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 9.957 25 Lleida Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 9.123 25 Lleida Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 10.418 25 Lleida Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 9.673 25 Lleida Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 8.828 25 Lleida Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 9.370 25 Lleida Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 8.542 25 Lleida Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 25 Lleida Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 25 Lleida Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 25 Lleida Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,1 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,72 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,65 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,37 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,57 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,1 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 88,71 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 89,93 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 89,12 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 87,11 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 86,23 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 341 25 Lleida Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 980 25 Lleida Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.675 25 Lleida Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 331 25 Lleida Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 957 25 Lleida Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.641 25 Lleida Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 321 25 Lleida Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 937 25 Lleida Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.600 25 Lleida Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 315 25 Lleida Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 918 25 Lleida Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.566 25 Lleida Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 899 25 Lleida Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.533 25 Lleida Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 25 Lleida Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 25 Lleida Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 25 Lleida Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,07 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,65 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,97 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,13 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,61 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,52 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 92,38 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,67 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,49 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 91,73 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,52 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida Total Cohort July 1 Total Number at the start of the quarter 2022QIII 12.156 25 Lleida Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 25 Lleida Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 25 Lleida Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida Total Cohort July 1 Total Number at the start of the quarter 2021QIII 11.999 25 Lleida Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 25 Lleida Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 25 Lleida Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida Total Cohort July 1 Total Number at the start of the quarter 2020QIII 11.706 25 Lleida Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 25 Lleida Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 25 Lleida Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 25 Lleida Total Cohort July 1 Total Survival in the first trimester 2022QIII 11.489 25 Lleida Total Cohort July 1 Total Survival in the first trimester 2022QII "" 25 Lleida Total Cohort July 1 Total Survival in the first trimester 2022QI "" 25 Lleida Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 25 Lleida Total Cohort July 1 Total Survival in the first trimester 2021QIII 11.407 25 Lleida Total Cohort July 1 Total Survival in the first trimester 2021QII "" 25 Lleida Total Cohort July 1 Total Survival in the first trimester 2021QI "" 25 Lleida Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 25 Lleida Total Cohort July 1 Total Survival in the first trimester 2020QIII 11.156 25 Lleida Total Cohort July 1 Total Survival in the first trimester 2020QII "" 25 Lleida Total Cohort July 1 Total Survival in the first trimester 2020QI "" 25 Lleida Total Cohort July 1 Total Survival in the second trimester 2022QIV 11.073 25 Lleida Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 25 Lleida Total Cohort July 1 Total Survival in the second trimester 2022QII "" 25 Lleida Total Cohort July 1 Total Survival in the second trimester 2022QI "" 25 Lleida Total Cohort July 1 Total Survival in the second trimester 2021QIV 10.996 25 Lleida Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 25 Lleida Total Cohort July 1 Total Survival in the second trimester 2021QII "" 25 Lleida Total Cohort July 1 Total Survival in the second trimester 2021QI "" 25 Lleida Total Cohort July 1 Total Survival in the second trimester 2020QIV 10.710 25 Lleida Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 25 Lleida Total Cohort July 1 Total Survival in the second trimester 2020QII "" 25 Lleida Total Cohort July 1 Total Survival in the second trimester 2020QI "" 25 Lleida Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 25 Lleida Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 25 Lleida Total Cohort July 1 Total Survival in the third trimester 2022QII "" 25 Lleida Total Cohort July 1 Total Survival in the third trimester 2022QI 10.626 25 Lleida Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 25 Lleida Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 25 Lleida Total Cohort July 1 Total Survival in the third trimester 2021QII "" 25 Lleida Total Cohort July 1 Total Survival in the third trimester 2021QI 10.366 25 Lleida Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 25 Lleida Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 25 Lleida Total Cohort July 1 Total Survival in the third trimester 2020QII "" 25 Lleida Total Cohort July 1 Total Survival in the third trimester 2020QI "" 25 Lleida Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 25 Lleida Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 25 Lleida Total Cohort July 1 Total Survival in the third trimester 2022QII 10.354 25 Lleida Total Cohort July 1 Total Survival in the third trimester 2022QI "" 25 Lleida Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 25 Lleida Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 25 Lleida Total Cohort July 1 Total Survival in the third trimester 2021QII 10.160 25 Lleida Total Cohort July 1 Total Survival in the third trimester 2021QI "" 25 Lleida Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 25 Lleida Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 25 Lleida Total Cohort July 1 Total Survival in the third trimester 2020QII "" 25 Lleida Total Cohort July 1 Total Survival in the third trimester 2020QI "" 25 Lleida Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 25 Lleida Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 25 Lleida Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 25 Lleida Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 25 Lleida Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 25 Lleida Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 25 Lleida Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 25 Lleida Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 25 Lleida Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,51 25 Lleida Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,07 25 Lleida Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,3 25 Lleida Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 91,09 25 Lleida Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 91,64 25 Lleida Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 91,49 25 Lleida Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 88,56 25 Lleida Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 88,55 25 Lleida Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 86,29 25 Lleida Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 86,79 25 Lleida Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 25 Lleida Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 25 Lleida Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 11.867 25 Lleida Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 11.707 25 Lleida Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 10.843 25 Lleida Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 11.208 25 Lleida Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 11.120 25 Lleida Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 10.312 25 Lleida Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 10.798 25 Lleida Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 10.717 25 Lleida Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 9.890 25 Lleida Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 10.352 25 Lleida Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 9.564 25 Lleida Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 10.086 25 Lleida Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 9.368 25 Lleida Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 25 Lleida Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 25 Lleida Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 25 Lleida Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,45 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,99 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,1 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 90,99 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 91,54 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 91,21 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 88,43 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 88,2 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 86,15 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 86,4 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 289 25 Lleida Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 292 25 Lleida Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 863 25 Lleida Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 281 25 Lleida Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 287 25 Lleida Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 844 25 Lleida Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 275 25 Lleida Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 279 25 Lleida Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 820 25 Lleida Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 274 25 Lleida Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 802 25 Lleida Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 268 25 Lleida Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 792 25 Lleida Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 25 Lleida Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 25 Lleida Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 25 Lleida Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,23 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,29 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,8 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95,16 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,55 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,02 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93,84 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 92,93 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 91,78 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,77 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida Total Cohort October 1 Total Number at the start of the quarter 2022QIV 12.002 25 Lleida Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 25 Lleida Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 25 Lleida Total Cohort October 1 Total Number at the start of the quarter 2021QIV 11.921 25 Lleida Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 25 Lleida Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 25 Lleida Total Cohort October 1 Total Number at the start of the quarter 2020QIV 11.746 25 Lleida Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 25 Lleida Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 25 Lleida Total Cohort October 1 Total Survival in the first trimester 2022QIV 11.483 25 Lleida Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 25 Lleida Total Cohort October 1 Total Survival in the first trimester 2022QII "" 25 Lleida Total Cohort October 1 Total Survival in the first trimester 2022QI "" 25 Lleida Total Cohort October 1 Total Survival in the first trimester 2021QIV 11.401 25 Lleida Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 25 Lleida Total Cohort October 1 Total Survival in the first trimester 2021QII "" 25 Lleida Total Cohort October 1 Total Survival in the first trimester 2021QI "" 25 Lleida Total Cohort October 1 Total Survival in the first trimester 2020QIV 11.150 25 Lleida Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 25 Lleida Total Cohort October 1 Total Survival in the first trimester 2020QII "" 25 Lleida Total Cohort October 1 Total Survival in the first trimester 2020QI "" 25 Lleida Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 25 Lleida Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 25 Lleida Total Cohort October 1 Total Survival in the second trimester 2022QII "" 25 Lleida Total Cohort October 1 Total Survival in the second trimester 2022QI 10.976 25 Lleida Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 25 Lleida Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 25 Lleida Total Cohort October 1 Total Survival in the second trimester 2021QII "" 25 Lleida Total Cohort October 1 Total Survival in the second trimester 2021QI 10.749 25 Lleida Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 25 Lleida Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 25 Lleida Total Cohort October 1 Total Survival in the second trimester 2020QII "" 25 Lleida Total Cohort October 1 Total Survival in the second trimester 2020QI "" 25 Lleida Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 25 Lleida Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 25 Lleida Total Cohort October 1 Total Survival in the third trimester 2022QII 10.618 25 Lleida Total Cohort October 1 Total Survival in the third trimester 2022QI "" 25 Lleida Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 25 Lleida Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 25 Lleida Total Cohort October 1 Total Survival in the third trimester 2021QII 10.459 25 Lleida Total Cohort October 1 Total Survival in the third trimester 2021QI "" 25 Lleida Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 25 Lleida Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 25 Lleida Total Cohort October 1 Total Survival in the third trimester 2020QII "" 25 Lleida Total Cohort October 1 Total Survival in the third trimester 2020QI "" 25 Lleida Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 25 Lleida Total Cohort October 1 Total Survival in the third trimester 2022QIII 10.308 25 Lleida Total Cohort October 1 Total Survival in the third trimester 2022QII "" 25 Lleida Total Cohort October 1 Total Survival in the third trimester 2022QI "" 25 Lleida Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 25 Lleida Total Cohort October 1 Total Survival in the third trimester 2021QIII 10.219 25 Lleida Total Cohort October 1 Total Survival in the third trimester 2021QII "" 25 Lleida Total Cohort October 1 Total Survival in the third trimester 2021QI "" 25 Lleida Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 25 Lleida Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 25 Lleida Total Cohort October 1 Total Survival in the third trimester 2020QII "" 25 Lleida Total Cohort October 1 Total Survival in the third trimester 2020QI "" 25 Lleida Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 25 Lleida Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 25 Lleida Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 25 Lleida Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 25 Lleida Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 25 Lleida Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 25 Lleida Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 25 Lleida Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 25 Lleida Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,68 25 Lleida Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,64 25 Lleida Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,93 25 Lleida Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 92,07 25 Lleida Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 91,51 25 Lleida Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 89,07 25 Lleida Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 89,04 25 Lleida Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 86,47 25 Lleida Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 87 25 Lleida Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 25 Lleida Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 25 Lleida Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 11.749 25 Lleida Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 11.537 25 Lleida Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 10.485 25 Lleida Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 11.236 25 Lleida Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 11.025 25 Lleida Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 9.916 25 Lleida Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 10.613 25 Lleida Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 9.537 25 Lleida Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 10.264 25 Lleida Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 9.264 25 Lleida Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 9.965 25 Lleida Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 9.043 25 Lleida Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 25 Lleida Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 25 Lleida Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 25 Lleida Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95,63 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,56 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,57 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 91,99 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 90,96 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 88,97 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 88,35 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 86,37 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 86,25 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 253 25 Lleida Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 384 25 Lleida Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.261 25 Lleida Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 247 25 Lleida Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 376 25 Lleida Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.234 25 Lleida Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 363 25 Lleida Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.212 25 Lleida Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 354 25 Lleida Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.195 25 Lleida Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 343 25 Lleida Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.176 25 Lleida Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 25 Lleida Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 25 Lleida Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 25 Lleida Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,63 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,92 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,86 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,53 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,11 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 92,19 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,77 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 89,32 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,26 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 25 Lleida From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 8.899 25 Lleida From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 25 Lleida From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 8.724 25 Lleida From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 9.135 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 8.364 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 8.236 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 8.095 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 7.915 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 7.894 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 7.736 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 7.579 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 7.621 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 7.417 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 7.332 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 7.409 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 7.150 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 25 Lleida From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 25 Lleida From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 25 Lleida From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 25 Lleida From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,99 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,41 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 88,62 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,94 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,49 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 84,69 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 85,17 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,36 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 81,19 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 82,39 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 84,93 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 78,27 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 8.711 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 8.138 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 8.183 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 7.671 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 7.743 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 7.343 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 7.412 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 7.081 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 7.170 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 6.884 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,94 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,26 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,89 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,23 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 85,09 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,01 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 82,31 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 84,59 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 188 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 586 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 181 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 565 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 172 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 551 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 167 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 540 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 162 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 525 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,28 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,42 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 91,49 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,03 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 88,83 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,15 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 86,17 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 89,59 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 8.871 25 Lleida From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 8.756 25 Lleida From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 8.687 25 Lleida From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 8.347 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 8.328 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 8.251 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 7.937 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 7.983 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 7.880 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 7.642 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 7.702 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 7.574 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 7.406 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 7.280 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 25 Lleida From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 25 Lleida From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 25 Lleida From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 25 Lleida From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,09 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,11 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,98 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,47 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,17 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 90,71 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 86,15 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 87,96 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 87,19 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 84,58 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 83,8 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 8.685 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 8.222 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 7.699 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 8.169 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 7.813 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 7.292 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 7.766 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 7.484 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 6.954 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 7.475 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 7.218 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 6.675 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 6.938 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 6.411 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,06 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,03 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,71 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 89,42 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,02 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,32 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 86,07 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 87,79 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 86,7 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 84,38 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 83,27 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 186 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 534 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 988 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 178 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 515 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 959 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 171 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 499 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 926 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 167 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 484 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 899 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 468 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 869 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,7 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,44 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,06 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,94 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,45 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 93,72 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 89,78 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 90,64 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 90,99 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 87,64 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 87,96 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 8.951 25 Lleida From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 8.919 25 Lleida From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 8.753 25 Lleida From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 8.324 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 8.349 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 8.230 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 7.949 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 7.973 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 7.815 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 7.638 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 7.500 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 7.395 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 7.316 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 25 Lleida From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 25 Lleida From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 25 Lleida From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,61 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,02 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 88,81 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,39 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 89,28 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 85,64 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 85,68 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 82,91 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 83,58 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 8.801 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 8.768 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 8.301 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 8.181 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 8.201 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 7.796 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 7.809 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 7.833 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 7.402 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 7.502 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 7.102 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 7.264 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 6.925 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,96 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,53 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,92 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 88,73 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,34 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,17 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 85,56 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 85,56 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 82,85 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 83,42 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 150 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 151 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 452 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 143 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 148 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 434 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 140 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 140 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 413 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 136 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 398 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 131 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 391 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,33 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,01 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,02 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,33 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 92,72 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 91,37 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 90,07 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 88,05 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 86,75 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 86,5 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 8.857 25 Lleida From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 8.854 25 Lleida From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 8.772 25 Lleida From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 8.364 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 8.361 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 8.205 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 7.965 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 7.839 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 7.648 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 7.583 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 7.371 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 7.355 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 25 Lleida From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 25 Lleida From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 25 Lleida From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,43 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,43 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,54 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,96 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,36 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 86,38 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 86,45 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 83,25 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 83,85 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 8.729 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 8.613 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 8.099 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 8.241 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 8.127 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 7.557 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 7.743 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 7.210 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 7.434 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 6.968 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 7.164 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 6.754 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,41 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,36 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,31 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,9 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,02 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 86,31 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,04 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 83,18 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 83,39 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 128 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 241 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 673 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 123 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 234 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 648 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 222 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 629 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 214 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 615 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 207 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 601 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,09 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,1 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,29 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 92,12 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 93,46 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 88,8 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 91,38 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 85,89 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 89,3 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 1.351 25 Lleida From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 1.245 25 Lleida From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 1.297 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 1.330 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 1.226 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 1.246 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 1.294 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 1.194 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 1.234 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 1.274 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 1.182 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 1.220 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 1.257 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 1.168 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 1.211 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 25 Lleida From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 25 Lleida From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,45 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,47 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,07 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 95,78 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 95,9 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,14 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,3 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 94,94 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,06 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,04 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 93,82 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 93,37 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.300 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.094 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.279 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.078 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.245 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.048 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.227 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.038 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.210 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.025 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,38 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,54 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 95,77 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 95,8 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,38 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 94,88 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,08 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 93,69 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 51 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 151 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 51 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 148 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 49 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 146 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 47 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 144 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 47 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 143 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,01 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96,08 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,69 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 92,16 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,36 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 92,16 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 94,7 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 1.376 25 Lleida From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 1.257 25 Lleida From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 1.201 25 Lleida From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 1.343 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 1.222 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 1.188 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 1.322 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 1.214 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 1.179 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 1.308 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 1.200 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 1.170 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 1.188 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 1.155 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 25 Lleida From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 25 Lleida From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 25 Lleida From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,6 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 97,22 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,92 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,08 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,58 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,17 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,06 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,47 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,42 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,51 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,17 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.330 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.120 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 964 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.298 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.088 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 953 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.280 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.083 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 947 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.266 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.071 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 940 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.060 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 926 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,59 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 97,14 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,86 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,24 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,7 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,24 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,19 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,63 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,51 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 94,64 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,06 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 46 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 137 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 237 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 45 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 134 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 235 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 42 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 131 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 232 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 42 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 129 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 230 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 128 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 229 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,83 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,81 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,16 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,3 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,62 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,89 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,3 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,16 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,05 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 93,43 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,62 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 1.344 25 Lleida From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 1.282 25 Lleida From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 1.232 25 Lleida From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 1.320 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 1.267 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 1.218 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 1.296 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 1.250 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 1.201 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 1.230 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 1.185 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 1.215 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 1.170 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 25 Lleida From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 25 Lleida From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 25 Lleida From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,21 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,83 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,86 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,43 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,5 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,48 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,94 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,19 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 94,77 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 94,97 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.302 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.247 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.095 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.279 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.233 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.081 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.256 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.216 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.066 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.196 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.052 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.182 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.038 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,23 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,88 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,72 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,47 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,51 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,35 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,91 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,07 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,79 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,79 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 42 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 35 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 137 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 41 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 34 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 137 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 40 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 34 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 135 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 34 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 133 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 33 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 132 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,62 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,14 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95,24 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,14 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,54 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,14 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,08 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 94,29 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,35 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 1.327 25 Lleida From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 1.293 25 Lleida From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 1.242 25 Lleida From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 1.311 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 1.278 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 1.222 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 1.263 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 1.199 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 1.243 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 1.178 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 1.224 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 1.170 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 25 Lleida From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 25 Lleida From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 25 Lleida From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,79 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,84 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,39 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,68 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,54 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,13 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 94,85 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 94,66 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 94,2 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.296 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.245 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.066 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.280 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.230 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.047 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.215 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.026 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.195 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.006 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.179 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.000 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,77 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,8 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,22 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,59 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,25 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,98 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 94,37 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 94,7 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,81 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 31 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 48 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 176 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 31 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 48 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 175 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 48 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 173 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 48 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 172 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 45 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 170 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,43 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,3 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,73 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 93,75 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,59 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 25 Lleida From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 1.726 25 Lleida From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 25 Lleida From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 1.603 25 Lleida From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 1.675 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 1.705 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 1.594 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 1.650 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 1.670 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 1.569 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 1.636 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 1.648 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 1.565 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 1.624 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 1.640 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 1.555 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 1.610 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 25 Lleida From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 25 Lleida From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 25 Lleida From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 25 Lleida From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,78 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,44 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,51 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,76 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,88 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,67 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 95,48 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,63 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,96 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,02 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,01 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,12 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.627 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.301 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.606 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.292 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.573 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.269 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.552 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.267 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.546 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.260 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,71 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,31 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,68 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,54 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,39 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,39 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,02 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,85 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 99 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 302 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 99 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 302 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 97 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 300 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 96 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 298 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 94 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 295 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,98 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 99,34 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,97 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,68 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,95 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,68 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 1.712 25 Lleida From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 1.604 25 Lleida From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 1.586 25 Lleida From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 1.685 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 1.584 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 1.571 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 1.669 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 1.578 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 1.559 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 1.659 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 1.570 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 1.545 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 1.556 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 1.535 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 25 Lleida From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 25 Lleida From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 25 Lleida From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 25 Lleida From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,42 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,75 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,05 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,49 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,38 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,3 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,9 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,88 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,41 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,01 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,78 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.614 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.327 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.169 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.588 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.308 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.157 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.572 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.303 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.150 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.564 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.297 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.141 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.285 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.133 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,39 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,57 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,97 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,4 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,19 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,37 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,9 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,74 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,6 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,83 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,92 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 98 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 277 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 417 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 97 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 276 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 414 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 97 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 275 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 409 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 95 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 273 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 404 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 271 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 402 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,98 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,64 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,28 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,98 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,28 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,08 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,94 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,56 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,88 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,83 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,4 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 1.727 25 Lleida From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 1.670 25 Lleida From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.599 25 Lleida From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 1.712 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 1.663 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 1.587 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 1.696 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 1.646 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 1.574 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 1.631 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 1.562 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 1.617 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 1.555 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 25 Lleida From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 25 Lleida From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 25 Lleida From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,13 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,58 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,25 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,2 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,56 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,44 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,66 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,69 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,83 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,25 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.640 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.578 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.355 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.625 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.572 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.344 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.611 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.555 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.332 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.541 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.321 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.527 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.316 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,09 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,62 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,19 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,23 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,54 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,3 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,66 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,49 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,77 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,12 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 87 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 92 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 244 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 87 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 91 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 243 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 85 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 91 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 242 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 90 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 241 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 90 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 239 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,91 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,59 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,7 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,91 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,18 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,83 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,77 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 97,83 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,95 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 1.685 25 Lleida From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 1.646 25 Lleida From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.612 25 Lleida From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 1.676 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 1.635 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 1.604 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 1.621 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 1.592 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 1.600 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 1.579 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 1.587 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 1.575 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 25 Lleida From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 25 Lleida From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 25 Lleida From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,47 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,33 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,5 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,48 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,76 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,21 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,95 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,42 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,7 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.602 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.567 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.240 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.594 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.557 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.233 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.544 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.222 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.524 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.211 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.512 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.210 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,5 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,36 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,44 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,53 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,55 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,26 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,66 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,49 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,58 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 83 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 79 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 372 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 82 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 78 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 371 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 77 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 370 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 76 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 368 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 75 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 365 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,8 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,73 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,73 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 97,47 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 99,46 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,2 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,92 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 94,94 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,12 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 25 Lleida from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 86 25 Lleida from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 25 Lleida from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 84 25 Lleida from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 77 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 86 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 84 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 76 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 86 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 84 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 75 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 86 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 84 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 74 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 86 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 84 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 74 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 25 Lleida from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 25 Lleida from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 25 Lleida from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 25 Lleida from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,7 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,4 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,1 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,1 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 81 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 64 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 81 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 64 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 81 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 64 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 81 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 64 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 81 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 64 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 5 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 20 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 5 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 20 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 5 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 20 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 5 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 20 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 5 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 20 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 89 25 Lleida from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 86 25 Lleida from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 77 25 Lleida from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 88 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 86 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 76 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 88 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 86 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 76 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 88 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 86 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 76 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 86 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 76 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 25 Lleida from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 25 Lleida from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 25 Lleida from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 25 Lleida from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,88 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,7 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,88 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,7 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,88 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,7 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,7 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 25 Lleida from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 82 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 66 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 54 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 81 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 66 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 53 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 81 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 66 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 53 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 81 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 66 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 53 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 66 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 53 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,78 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,15 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,78 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,15 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,78 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,15 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 98,15 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 7 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 20 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 23 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 7 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 20 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 23 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 7 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 20 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 23 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 7 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 20 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 23 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 20 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 23 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 96 25 Lleida from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 88 25 Lleida from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 87 25 Lleida from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 96 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 88 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 87 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 96 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 88 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 87 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 88 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 86 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 88 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 86 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 25 Lleida from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 25 Lleida from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 25 Lleida from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,85 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,85 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 90 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 78 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 67 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 90 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 78 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 67 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 90 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 78 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 67 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 78 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 66 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 78 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 66 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,51 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 98,51 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 6 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 10 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 20 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 6 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 10 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 20 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 6 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 10 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 20 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 10 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 20 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 10 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 20 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 96 25 Lleida from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 93 25 Lleida from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 91 25 Lleida from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 95 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 92 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 90 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 92 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 90 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 92 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 90 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 92 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 90 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 25 Lleida from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 25 Lleida from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 25 Lleida from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,96 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,92 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,9 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,92 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,9 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,92 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,9 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,92 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,9 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 89 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 82 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 63 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 88 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 81 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 62 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 81 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 62 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 81 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 62 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 81 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 62 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,88 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,78 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,41 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,78 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,41 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,78 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,41 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,78 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,41 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 7 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 11 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 28 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 7 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 11 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 28 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 11 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 28 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 11 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 28 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 11 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 28 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 25 Lleida De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 39 25 Lleida De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 25 Lleida De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 32 25 Lleida De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 25 Lleida De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 34 25 Lleida De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 39 25 Lleida De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 32 25 Lleida De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 34 25 Lleida De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 39 25 Lleida De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 32 25 Lleida De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 34 25 Lleida De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 38 25 Lleida De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 32 25 Lleida De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 33 25 Lleida De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 38 25 Lleida De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 32 25 Lleida De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 33 25 Lleida De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 25 Lleida De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 25 Lleida De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 25 Lleida De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 25 Lleida De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 25 Lleida De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 25 Lleida De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 25 Lleida De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,44 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,06 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,44 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,06 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 25 Lleida De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 34 25 Lleida De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 22 25 Lleida De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 34 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 22 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 34 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 22 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 33 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 22 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 33 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 22 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 25 Lleida De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 25 Lleida De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,06 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,06 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 5 25 Lleida De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 10 25 Lleida De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 5 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 10 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 5 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 10 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 5 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 10 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 5 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 10 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 25 Lleida De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 25 Lleida De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 37 25 Lleida De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 25 Lleida De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 33 25 Lleida De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 25 Lleida De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 30 25 Lleida De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 37 25 Lleida De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 33 25 Lleida De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 30 25 Lleida De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 36 25 Lleida De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 33 25 Lleida De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 29 25 Lleida De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 36 25 Lleida De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 33 25 Lleida De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 29 25 Lleida De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 33 25 Lleida De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 29 25 Lleida De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 25 Lleida De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 25 Lleida De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 25 Lleida De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 25 Lleida De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 25 Lleida De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 25 Lleida De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 25 Lleida De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,3 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 96,67 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,3 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,67 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,67 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 25 Lleida De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 33 25 Lleida De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 21 25 Lleida De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 20 25 Lleida De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 33 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 21 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 20 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 32 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 21 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 19 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 32 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 21 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 19 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 21 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 19 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 25 Lleida De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 25 Lleida De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 25 Lleida De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,97 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 95 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,97 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 4 25 Lleida De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 12 25 Lleida De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 10 25 Lleida De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 4 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 12 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 10 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 4 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 12 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 10 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 4 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 12 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 10 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 12 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 10 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 25 Lleida De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 25 Lleida De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 25 Lleida De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 38 25 Lleida De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 25 Lleida De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 25 Lleida De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 40 25 Lleida De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 25 Lleida De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 25 Lleida De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 35 25 Lleida De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 25 Lleida De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 37 25 Lleida De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 40 25 Lleida De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 34 25 Lleida De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 36 25 Lleida De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 39 25 Lleida De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 33 25 Lleida De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 39 25 Lleida De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 33 25 Lleida De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 39 25 Lleida De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 33 25 Lleida De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 25 Lleida De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 25 Lleida De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 25 Lleida De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 25 Lleida De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 25 Lleida De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 25 Lleida De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 25 Lleida De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 25 Lleida De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 25 Lleida De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 25 Lleida De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 25 Lleida De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 25 Lleida De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 25 Lleida De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,37 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 97,14 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 94,74 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,5 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 94,29 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,5 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 94,29 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,5 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 94,29 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 25 Lleida De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 34 25 Lleida De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 36 25 Lleida De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 25 25 Lleida De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 33 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 36 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 24 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 32 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 35 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 23 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 35 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 23 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 35 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 23 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 25 Lleida De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 25 Lleida De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 25 Lleida De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,06 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 96 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 94,12 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,22 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 92 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,22 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 92 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,22 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 92 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 4 25 Lleida De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 4 25 Lleida De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 10 25 Lleida De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 4 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 4 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 10 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 4 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 4 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 10 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 4 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 10 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 4 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 10 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 25 Lleida De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 25 Lleida De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 25 Lleida De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 37 25 Lleida De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 25 Lleida De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 25 Lleida De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 35 25 Lleida De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 25 Lleida De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 25 Lleida De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 29 25 Lleida De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 25 Lleida De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 37 25 Lleida De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 35 25 Lleida De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 29 25 Lleida De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 35 25 Lleida De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 29 25 Lleida De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 35 25 Lleida De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 29 25 Lleida De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 34 25 Lleida De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 29 25 Lleida De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 25 Lleida De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 25 Lleida De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 25 Lleida De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 25 Lleida De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 25 Lleida De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 25 Lleida De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 25 Lleida De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 25 Lleida De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 25 Lleida De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 25 Lleida De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 25 Lleida De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 25 Lleida De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,14 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 25 Lleida De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 33 25 Lleida De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 30 25 Lleida De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 17 25 Lleida De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 33 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 30 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 17 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 30 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 17 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 30 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 17 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 29 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 17 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 25 Lleida De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 25 Lleida De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 25 Lleida De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,67 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 4 25 Lleida De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 5 25 Lleida De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 12 25 Lleida De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 4 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 5 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 12 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 5 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 12 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 5 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 12 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 5 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 12 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 25 Lleida De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 25 Lleida De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 25 Lleida De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 25 Lleida De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 27 Lugo Total Cohort January 1 Total Number at the start of the quarter 2022QI 8.927 27 Lugo Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 27 Lugo Total Cohort January 1 Total Number at the start of the quarter 2021QI 8.843 27 Lugo Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 27 Lugo Total Cohort January 1 Total Number at the start of the quarter 2020QI 9.266 27 Lugo Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 27 Lugo Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 27 Lugo Total Cohort January 1 Total Survival in the first trimester 2022QII "" 27 Lugo Total Cohort January 1 Total Survival in the first trimester 2022QI 8.462 27 Lugo Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 27 Lugo Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 27 Lugo Total Cohort January 1 Total Survival in the first trimester 2021QII "" 27 Lugo Total Cohort January 1 Total Survival in the first trimester 2021QI 8.434 27 Lugo Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 27 Lugo Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 27 Lugo Total Cohort January 1 Total Survival in the first trimester 2020QII "" 27 Lugo Total Cohort January 1 Total Survival in the first trimester 2020QI 8.488 27 Lugo Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 27 Lugo Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 27 Lugo Total Cohort January 1 Total Survival in the second trimester 2022QII 8.101 27 Lugo Total Cohort January 1 Total Survival in the second trimester 2022QI "" 27 Lugo Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 27 Lugo Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 27 Lugo Total Cohort January 1 Total Survival in the second trimester 2021QII 8.130 27 Lugo Total Cohort January 1 Total Survival in the second trimester 2021QI "" 27 Lugo Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 27 Lugo Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 27 Lugo Total Cohort January 1 Total Survival in the second trimester 2020QII 8.216 27 Lugo Total Cohort January 1 Total Survival in the second trimester 2020QI "" 27 Lugo Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 27 Lugo Total Cohort January 1 Total Survival in the third trimester 2022QIII 7.868 27 Lugo Total Cohort January 1 Total Survival in the third trimester 2022QII "" 27 Lugo Total Cohort January 1 Total Survival in the third trimester 2022QI "" 27 Lugo Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 27 Lugo Total Cohort January 1 Total Survival in the third trimester 2021QIII 7.932 27 Lugo Total Cohort January 1 Total Survival in the third trimester 2021QII "" 27 Lugo Total Cohort January 1 Total Survival in the third trimester 2021QI "" 27 Lugo Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 27 Lugo Total Cohort January 1 Total Survival in the third trimester 2020QIII 7.985 27 Lugo Total Cohort January 1 Total Survival in the third trimester 2020QII "" 27 Lugo Total Cohort January 1 Total Survival in the third trimester 2020QI "" 27 Lugo Total Cohort January 1 Total Survival in the third trimester 2022QIV 7.632 27 Lugo Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 27 Lugo Total Cohort January 1 Total Survival in the third trimester 2022QII "" 27 Lugo Total Cohort January 1 Total Survival in the third trimester 2022QI "" 27 Lugo Total Cohort January 1 Total Survival in the third trimester 2021QIV 7.743 27 Lugo Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 27 Lugo Total Cohort January 1 Total Survival in the third trimester 2021QII "" 27 Lugo Total Cohort January 1 Total Survival in the third trimester 2021QI "" 27 Lugo Total Cohort January 1 Total Survival in the third trimester 2020QIV 7.742 27 Lugo Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 27 Lugo Total Cohort January 1 Total Survival in the third trimester 2020QII "" 27 Lugo Total Cohort January 1 Total Survival in the third trimester 2020QI "" 27 Lugo Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 27 Lugo Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 27 Lugo Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 27 Lugo Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 27 Lugo Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 27 Lugo Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 27 Lugo Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,79 27 Lugo Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,37 27 Lugo Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 91,6 27 Lugo Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,75 27 Lugo Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,94 27 Lugo Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 88,67 27 Lugo Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 88,14 27 Lugo Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 89,7 27 Lugo Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 86,18 27 Lugo Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 85,49 27 Lugo Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 87,56 27 Lugo Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 83,55 27 Lugo Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 27 Lugo Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 27 Lugo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 8.585 27 Lugo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 8.092 27 Lugo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 8.136 27 Lugo Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 7.708 27 Lugo Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 7.789 27 Lugo Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 7.417 27 Lugo Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 7.564 27 Lugo Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 7.225 27 Lugo Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 7.334 27 Lugo Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 7.047 27 Lugo Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 27 Lugo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 27 Lugo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,77 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 95,25 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,73 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 91,66 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 88,11 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 89,29 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 85,43 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 87,09 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 342 27 Lugo Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 751 27 Lugo Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 326 27 Lugo Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 726 27 Lugo Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 312 27 Lugo Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 713 27 Lugo Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 304 27 Lugo Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 707 27 Lugo Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 298 27 Lugo Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 696 27 Lugo Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 27 Lugo Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 27 Lugo Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,32 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,67 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 91,23 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,94 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 88,89 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,14 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 87,13 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 92,68 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo Total Cohort April 1 Total Number at the start of the quarter 2022QII 8.848 27 Lugo Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 27 Lugo Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo Total Cohort April 1 Total Number at the start of the quarter 2021QII 8.750 27 Lugo Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 27 Lugo Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo Total Cohort April 1 Total Number at the start of the quarter 2020QII 8.835 27 Lugo Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 27 Lugo Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 27 Lugo Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 27 Lugo Total Cohort April 1 Total Survival in the first trimester 2022QII 8.422 27 Lugo Total Cohort April 1 Total Survival in the first trimester 2022QI "" 27 Lugo Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 27 Lugo Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 27 Lugo Total Cohort April 1 Total Survival in the first trimester 2021QII 8.383 27 Lugo Total Cohort April 1 Total Survival in the first trimester 2021QI "" 27 Lugo Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 27 Lugo Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 27 Lugo Total Cohort April 1 Total Survival in the first trimester 2020QII 8.523 27 Lugo Total Cohort April 1 Total Survival in the first trimester 2020QI "" 27 Lugo Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 27 Lugo Total Cohort April 1 Total Survival in the second trimester 2022QIII 8.154 27 Lugo Total Cohort April 1 Total Survival in the second trimester 2022QII "" 27 Lugo Total Cohort April 1 Total Survival in the second trimester 2022QI "" 27 Lugo Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 27 Lugo Total Cohort April 1 Total Survival in the second trimester 2021QIII 8.152 27 Lugo Total Cohort April 1 Total Survival in the second trimester 2021QII "" 27 Lugo Total Cohort April 1 Total Survival in the second trimester 2021QI "" 27 Lugo Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 27 Lugo Total Cohort April 1 Total Survival in the second trimester 2020QIII 8.267 27 Lugo Total Cohort April 1 Total Survival in the second trimester 2020QII "" 27 Lugo Total Cohort April 1 Total Survival in the second trimester 2020QI "" 27 Lugo Total Cohort April 1 Total Survival in the third trimester 2022QIV 7.846 27 Lugo Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 27 Lugo Total Cohort April 1 Total Survival in the third trimester 2022QII "" 27 Lugo Total Cohort April 1 Total Survival in the third trimester 2022QI "" 27 Lugo Total Cohort April 1 Total Survival in the third trimester 2021QIV 7.926 27 Lugo Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 27 Lugo Total Cohort April 1 Total Survival in the third trimester 2021QII "" 27 Lugo Total Cohort April 1 Total Survival in the third trimester 2021QI "" 27 Lugo Total Cohort April 1 Total Survival in the third trimester 2020QIV 7.984 27 Lugo Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 27 Lugo Total Cohort April 1 Total Survival in the third trimester 2020QII "" 27 Lugo Total Cohort April 1 Total Survival in the third trimester 2020QI "" 27 Lugo Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 27 Lugo Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 27 Lugo Total Cohort April 1 Total Survival in the third trimester 2022QII "" 27 Lugo Total Cohort April 1 Total Survival in the third trimester 2022QI 7.625 27 Lugo Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 27 Lugo Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 27 Lugo Total Cohort April 1 Total Survival in the third trimester 2021QII "" 27 Lugo Total Cohort April 1 Total Survival in the third trimester 2021QI 7.726 27 Lugo Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 27 Lugo Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 27 Lugo Total Cohort April 1 Total Survival in the third trimester 2020QII "" 27 Lugo Total Cohort April 1 Total Survival in the third trimester 2020QI "" 27 Lugo Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 27 Lugo Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 27 Lugo Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 27 Lugo Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 27 Lugo Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 27 Lugo Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,19 27 Lugo Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,81 27 Lugo Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,47 27 Lugo Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 92,16 27 Lugo Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 93,17 27 Lugo Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,57 27 Lugo Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 88,68 27 Lugo Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 90,58 27 Lugo Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,37 27 Lugo Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 87,14 27 Lugo Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87,45 27 Lugo Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 27 Lugo Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 27 Lugo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 8.532 27 Lugo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 7.919 27 Lugo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 7.438 27 Lugo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 8.114 27 Lugo Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 7.571 27 Lugo Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 7.150 27 Lugo Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 7.857 27 Lugo Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 7.349 27 Lugo Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 6.919 27 Lugo Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 7.556 27 Lugo Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 7.140 27 Lugo Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 6.673 27 Lugo Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 6.853 27 Lugo Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 6.460 27 Lugo Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 27 Lugo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 27 Lugo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 27 Lugo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,1 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,61 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 96,13 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 92,09 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,8 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 93,02 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 88,56 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 90,16 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 89,71 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 86,54 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 86,85 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 316 27 Lugo Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 831 27 Lugo Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.397 27 Lugo Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 308 27 Lugo Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 812 27 Lugo Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.373 27 Lugo Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 297 27 Lugo Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 803 27 Lugo Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.348 27 Lugo Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 290 27 Lugo Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 786 27 Lugo Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.311 27 Lugo Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 772 27 Lugo Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.266 27 Lugo Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 27 Lugo Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 27 Lugo Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 27 Lugo Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,47 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,71 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,28 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,99 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,63 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,49 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,77 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,58 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,84 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 92,9 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 90,62 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo Total Cohort July 1 Total Number at the start of the quarter 2022QIII 8.935 27 Lugo Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 27 Lugo Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 27 Lugo Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo Total Cohort July 1 Total Number at the start of the quarter 2021QIII 8.920 27 Lugo Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 27 Lugo Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 27 Lugo Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo Total Cohort July 1 Total Number at the start of the quarter 2020QIII 8.858 27 Lugo Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 27 Lugo Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 27 Lugo Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 27 Lugo Total Cohort July 1 Total Survival in the first trimester 2022QIII 8.530 27 Lugo Total Cohort July 1 Total Survival in the first trimester 2022QII "" 27 Lugo Total Cohort July 1 Total Survival in the first trimester 2022QI "" 27 Lugo Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 27 Lugo Total Cohort July 1 Total Survival in the first trimester 2021QIII 8.562 27 Lugo Total Cohort July 1 Total Survival in the first trimester 2021QII "" 27 Lugo Total Cohort July 1 Total Survival in the first trimester 2021QI "" 27 Lugo Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 27 Lugo Total Cohort July 1 Total Survival in the first trimester 2020QIII 8.515 27 Lugo Total Cohort July 1 Total Survival in the first trimester 2020QII "" 27 Lugo Total Cohort July 1 Total Survival in the first trimester 2020QI "" 27 Lugo Total Cohort July 1 Total Survival in the second trimester 2022QIV 8.082 27 Lugo Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 27 Lugo Total Cohort July 1 Total Survival in the second trimester 2022QII "" 27 Lugo Total Cohort July 1 Total Survival in the second trimester 2022QI "" 27 Lugo Total Cohort July 1 Total Survival in the second trimester 2021QIV 8.205 27 Lugo Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 27 Lugo Total Cohort July 1 Total Survival in the second trimester 2021QII "" 27 Lugo Total Cohort July 1 Total Survival in the second trimester 2021QI "" 27 Lugo Total Cohort July 1 Total Survival in the second trimester 2020QIV 8.178 27 Lugo Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 27 Lugo Total Cohort July 1 Total Survival in the second trimester 2020QII "" 27 Lugo Total Cohort July 1 Total Survival in the second trimester 2020QI "" 27 Lugo Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 27 Lugo Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 27 Lugo Total Cohort July 1 Total Survival in the third trimester 2022QII "" 27 Lugo Total Cohort July 1 Total Survival in the third trimester 2022QI 7.869 27 Lugo Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 27 Lugo Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 27 Lugo Total Cohort July 1 Total Survival in the third trimester 2021QII "" 27 Lugo Total Cohort July 1 Total Survival in the third trimester 2021QI 7.904 27 Lugo Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 27 Lugo Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 27 Lugo Total Cohort July 1 Total Survival in the third trimester 2020QII "" 27 Lugo Total Cohort July 1 Total Survival in the third trimester 2020QI "" 27 Lugo Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 27 Lugo Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 27 Lugo Total Cohort July 1 Total Survival in the third trimester 2022QII 7.663 27 Lugo Total Cohort July 1 Total Survival in the third trimester 2022QI "" 27 Lugo Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 27 Lugo Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 27 Lugo Total Cohort July 1 Total Survival in the third trimester 2021QII 7.727 27 Lugo Total Cohort July 1 Total Survival in the third trimester 2021QI "" 27 Lugo Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 27 Lugo Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 27 Lugo Total Cohort July 1 Total Survival in the third trimester 2020QII "" 27 Lugo Total Cohort July 1 Total Survival in the third trimester 2020QI "" 27 Lugo Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 27 Lugo Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 27 Lugo Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 27 Lugo Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 27 Lugo Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 27 Lugo Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 27 Lugo Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 27 Lugo Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 27 Lugo Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 95,47 27 Lugo Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,99 27 Lugo Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 96,13 27 Lugo Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 90,45 27 Lugo Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 91,98 27 Lugo Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 92,32 27 Lugo Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 88,22 27 Lugo Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 89,23 27 Lugo Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 85,91 27 Lugo Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 87,23 27 Lugo Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 27 Lugo Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 27 Lugo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 8.665 27 Lugo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 8.695 27 Lugo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 7.968 27 Lugo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 8.268 27 Lugo Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 8.339 27 Lugo Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 7.640 27 Lugo Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 7.827 27 Lugo Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 7.986 27 Lugo Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 7.324 27 Lugo Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 7.654 27 Lugo Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 7.077 27 Lugo Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 7.454 27 Lugo Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 6.915 27 Lugo Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 27 Lugo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 27 Lugo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 27 Lugo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 95,42 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,91 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,88 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 90,33 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 91,85 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 91,92 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 88,03 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 88,82 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 85,73 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 86,78 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 270 27 Lugo Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 225 27 Lugo Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 890 27 Lugo Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 262 27 Lugo Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 223 27 Lugo Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 875 27 Lugo Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 255 27 Lugo Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 219 27 Lugo Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 854 27 Lugo Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 215 27 Lugo Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 827 27 Lugo Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 209 27 Lugo Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 812 27 Lugo Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 27 Lugo Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 27 Lugo Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 27 Lugo Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,04 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,11 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,31 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,44 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,33 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,96 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,56 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 92,92 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 92,89 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,24 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo Total Cohort October 1 Total Number at the start of the quarter 2022QIV 8.934 27 Lugo Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 27 Lugo Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 27 Lugo Total Cohort October 1 Total Number at the start of the quarter 2021QIV 9.016 27 Lugo Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 27 Lugo Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 27 Lugo Total Cohort October 1 Total Number at the start of the quarter 2020QIV 8.968 27 Lugo Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 27 Lugo Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 27 Lugo Total Cohort October 1 Total Survival in the first trimester 2022QIV 8.382 27 Lugo Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 27 Lugo Total Cohort October 1 Total Survival in the first trimester 2022QII "" 27 Lugo Total Cohort October 1 Total Survival in the first trimester 2022QI "" 27 Lugo Total Cohort October 1 Total Survival in the first trimester 2021QIV 8.546 27 Lugo Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 27 Lugo Total Cohort October 1 Total Survival in the first trimester 2021QII "" 27 Lugo Total Cohort October 1 Total Survival in the first trimester 2021QI "" 27 Lugo Total Cohort October 1 Total Survival in the first trimester 2020QIV 8.513 27 Lugo Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 27 Lugo Total Cohort October 1 Total Survival in the first trimester 2020QII "" 27 Lugo Total Cohort October 1 Total Survival in the first trimester 2020QI "" 27 Lugo Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 27 Lugo Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 27 Lugo Total Cohort October 1 Total Survival in the second trimester 2022QII "" 27 Lugo Total Cohort October 1 Total Survival in the second trimester 2022QI 8.174 27 Lugo Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 27 Lugo Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 27 Lugo Total Cohort October 1 Total Survival in the second trimester 2021QII "" 27 Lugo Total Cohort October 1 Total Survival in the second trimester 2021QI 8.188 27 Lugo Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 27 Lugo Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 27 Lugo Total Cohort October 1 Total Survival in the second trimester 2020QII "" 27 Lugo Total Cohort October 1 Total Survival in the second trimester 2020QI "" 27 Lugo Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 27 Lugo Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 27 Lugo Total Cohort October 1 Total Survival in the third trimester 2022QII 7.868 27 Lugo Total Cohort October 1 Total Survival in the third trimester 2022QI "" 27 Lugo Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 27 Lugo Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 27 Lugo Total Cohort October 1 Total Survival in the third trimester 2021QII 7.939 27 Lugo Total Cohort October 1 Total Survival in the third trimester 2021QI "" 27 Lugo Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 27 Lugo Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 27 Lugo Total Cohort October 1 Total Survival in the third trimester 2020QII "" 27 Lugo Total Cohort October 1 Total Survival in the third trimester 2020QI "" 27 Lugo Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 27 Lugo Total Cohort October 1 Total Survival in the third trimester 2022QIII 7.661 27 Lugo Total Cohort October 1 Total Survival in the third trimester 2022QII "" 27 Lugo Total Cohort October 1 Total Survival in the third trimester 2022QI "" 27 Lugo Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 27 Lugo Total Cohort October 1 Total Survival in the third trimester 2021QIII 7.769 27 Lugo Total Cohort October 1 Total Survival in the third trimester 2021QII "" 27 Lugo Total Cohort October 1 Total Survival in the third trimester 2021QI "" 27 Lugo Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 27 Lugo Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 27 Lugo Total Cohort October 1 Total Survival in the third trimester 2020QII "" 27 Lugo Total Cohort October 1 Total Survival in the third trimester 2020QI "" 27 Lugo Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 27 Lugo Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 27 Lugo Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 27 Lugo Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 27 Lugo Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 27 Lugo Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 27 Lugo Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 27 Lugo Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 27 Lugo Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,82 27 Lugo Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,79 27 Lugo Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,93 27 Lugo Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,66 27 Lugo Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 91,3 27 Lugo Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,27 27 Lugo Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 88,53 27 Lugo Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 84,97 27 Lugo Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 86,63 27 Lugo Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 27 Lugo Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 27 Lugo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 8.688 27 Lugo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 8.640 27 Lugo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 8.110 27 Lugo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 8.141 27 Lugo Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 8.184 27 Lugo Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 7.680 27 Lugo Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 7.831 27 Lugo Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 7.380 27 Lugo Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 7.541 27 Lugo Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 7.143 27 Lugo Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 7.346 27 Lugo Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 6.982 27 Lugo Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 27 Lugo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 27 Lugo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 27 Lugo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,7 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,72 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,7 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,64 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 91 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 87,28 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 88,08 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 85,02 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 86,09 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 246 27 Lugo Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 376 27 Lugo Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 858 27 Lugo Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 241 27 Lugo Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 362 27 Lugo Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 833 27 Lugo Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 343 27 Lugo Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 808 27 Lugo Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 327 27 Lugo Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 796 27 Lugo Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 315 27 Lugo Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 787 27 Lugo Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 27 Lugo Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 27 Lugo Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 27 Lugo Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,97 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,28 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,09 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91,22 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,17 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 86,97 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,77 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 83,78 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 91,72 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 27 Lugo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 7.091 27 Lugo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 27 Lugo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 7.123 27 Lugo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 7.443 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 6.650 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 6.732 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 6.696 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 6.333 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 6.470 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 6.445 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 6.113 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 6.285 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 6.233 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 5.898 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 6.105 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 6.010 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 27 Lugo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 27 Lugo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 27 Lugo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 27 Lugo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,78 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,51 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 89,96 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,31 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,83 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 86,59 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,21 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 88,24 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 83,74 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 83,18 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,71 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 80,75 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 6.837 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 6.720 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 6.412 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 6.351 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 6.107 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 6.097 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 5.893 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 5.918 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 5.682 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 5.746 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,78 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,51 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,32 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,73 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,19 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 88,07 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 83,11 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,51 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 254 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 403 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 238 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 381 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 226 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 373 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 220 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 367 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 216 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 359 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 93,7 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 94,54 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 88,98 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 92,56 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 86,61 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 91,07 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 85,04 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 89,08 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 7.003 27 Lugo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 7.035 27 Lugo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 7.117 27 Lugo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 6.615 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 6.715 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 6.824 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 6.360 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 6.495 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 6.586 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 6.072 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 6.282 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 6.319 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 6.004 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 6.075 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 27 Lugo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 27 Lugo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 27 Lugo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 27 Lugo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,46 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,45 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,88 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,82 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,32 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,54 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 86,71 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 89,3 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,79 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 85,34 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,36 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 6.780 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 6.546 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 6.215 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 6.398 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 6.239 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 5.943 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 6.152 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 6.028 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 5.724 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 5.870 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 5.828 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 5.489 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 5.563 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 5.286 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,37 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,31 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,62 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,74 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,09 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,1 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 86,58 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 89,03 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,32 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 84,98 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 85,05 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 223 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 489 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 902 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 217 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 476 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 881 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 208 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 467 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 862 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 202 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 454 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 830 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 441 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 789 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,31 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,34 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,67 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,27 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,5 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,57 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 90,58 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 92,84 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 92,02 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 90,18 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 87,47 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 7.033 27 Lugo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 7.125 27 Lugo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 7.127 27 Lugo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 6.642 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 6.782 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 6.801 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 6.231 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 6.446 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 6.479 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 6.132 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 6.221 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 5.944 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 6.063 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 27 Lugo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 27 Lugo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 27 Lugo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,44 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,19 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,43 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 88,6 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,47 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,91 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 86,06 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 87,29 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 83,42 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 85,07 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 6.846 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 6.980 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 6.634 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 6.462 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 6.639 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 6.319 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 6.057 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 6.306 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 6.015 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 5.996 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 5.781 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 5.812 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 5.631 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,39 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,11 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,25 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 88,48 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 90,34 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,67 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 85,9 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 87,14 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 83,27 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 84,88 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 187 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 145 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 493 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 180 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 143 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 482 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 174 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 140 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 464 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 136 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 440 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 132 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 432 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,26 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,62 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,77 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,05 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,55 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,12 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93,79 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 89,25 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 91,03 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 87,63 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 7.026 27 Lugo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 7.163 27 Lugo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 7.197 27 Lugo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 6.505 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 6.713 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 6.761 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 6.366 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 6.452 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 6.100 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 6.237 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 5.907 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 6.081 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 27 Lugo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 27 Lugo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 27 Lugo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 92,58 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,72 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,94 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,87 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,65 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 85,16 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 86,66 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 82,47 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 84,49 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 6.854 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 6.888 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 6.739 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 6.338 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 6.451 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 6.322 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 6.122 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 6.034 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 5.870 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 5.827 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 5.688 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 5.677 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 92,47 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 93,66 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,81 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,88 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,54 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 85,22 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,47 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 82,58 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 84,24 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 172 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 275 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 458 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 167 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 262 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 439 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 244 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 418 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 230 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 410 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 219 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 404 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,09 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,27 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 95,85 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 88,73 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 91,27 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 83,64 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 89,52 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 79,64 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 88,21 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 876 27 Lugo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 823 27 Lugo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 869 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 862 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 814 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 844 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 835 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 785 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 832 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 827 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 776 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 822 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 813 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 772 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 806 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 27 Lugo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 27 Lugo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,4 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,91 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,12 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 95,32 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 95,38 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,74 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,41 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 94,29 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,59 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 92,81 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 93,8 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 92,75 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 845 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 697 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 831 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 689 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 804 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 662 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 797 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 653 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 784 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 649 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,34 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,85 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 95,15 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 94,98 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,32 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 93,69 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 92,78 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 93,11 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 31 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 126 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 31 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 125 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 31 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 123 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 30 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 123 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 29 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 123 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,21 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,62 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,77 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,62 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 93,55 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,62 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 875 27 Lugo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 812 27 Lugo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 821 27 Lugo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 850 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 779 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 809 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 841 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 771 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 800 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 832 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 763 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 788 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 748 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 781 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 27 Lugo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 27 Lugo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 27 Lugo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,14 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,94 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,54 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,11 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 94,95 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,44 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,09 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 93,97 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,98 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 92,12 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,13 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 840 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 683 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 602 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 815 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 654 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 593 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 807 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 646 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 589 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 799 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 639 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 580 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 625 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 576 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,02 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,75 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,5 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,07 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 94,58 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,84 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,12 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 93,56 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,35 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 91,51 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,68 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 35 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 129 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 219 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 35 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 125 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 216 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 34 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 125 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 211 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 33 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 124 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 208 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 123 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 205 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,9 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,63 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,14 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,9 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,35 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 94,29 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,12 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 94,98 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 95,35 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 93,61 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 928 27 Lugo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 870 27 Lugo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 831 27 Lugo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 920 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 858 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 822 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 895 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 844 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 814 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 830 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 805 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 820 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 792 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 27 Lugo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 27 Lugo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 27 Lugo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,14 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,62 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,92 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,44 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,01 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,95 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,4 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,87 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 94,25 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,31 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 893 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 843 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 674 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 885 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 831 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 668 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 861 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 817 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 662 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 803 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 654 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 794 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 645 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,1 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,58 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,11 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,42 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 96,92 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,22 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,26 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,03 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,19 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,7 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 35 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 27 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 157 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 35 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 27 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 154 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 34 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 27 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 152 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 27 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 151 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 26 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 147 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,09 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,14 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,82 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,18 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,3 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 93,63 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 922 27 Lugo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 887 27 Lugo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 851 27 Lugo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 899 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 874 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 838 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 857 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 830 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 833 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 809 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 824 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 800 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 27 Lugo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 27 Lugo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 27 Lugo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,51 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,53 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,47 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,62 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,53 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 93,91 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 95,06 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 92,9 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 94,01 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 900 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 845 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 693 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 877 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 832 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 683 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 816 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 677 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 793 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 658 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 784 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 651 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,44 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,46 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,56 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,57 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,69 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 93,85 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 94,95 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 92,78 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,94 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 22 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 42 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 158 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 22 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 42 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 155 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 41 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 153 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 40 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 151 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 40 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 149 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,1 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 97,62 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,84 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 95,24 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,57 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 95,24 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 94,3 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 27 Lugo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 914 27 Lugo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 27 Lugo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 859 27 Lugo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 911 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 904 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 850 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 905 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 889 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 837 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 896 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 885 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 833 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 888 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 879 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 828 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 884 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 27 Lugo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 27 Lugo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 27 Lugo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 27 Lugo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,91 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,95 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,34 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,26 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,44 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,35 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,83 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,97 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,48 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,17 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,39 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,04 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 863 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 652 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 853 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 645 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 838 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 635 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 834 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 631 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 829 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 629 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,84 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,93 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,1 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,39 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,64 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,78 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,06 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,47 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 51 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 207 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 51 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 205 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 51 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 202 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 51 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 202 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 50 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 199 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,03 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,58 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,58 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 98,04 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,14 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 926 27 Lugo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 863 27 Lugo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 858 27 Lugo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 915 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 849 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 851 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 912 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 846 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 843 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 901 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 841 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 839 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 833 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 832 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 27 Lugo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 27 Lugo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 27 Lugo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 27 Lugo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,81 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,38 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,18 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,49 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,03 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,25 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,3 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,45 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,79 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,52 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,97 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 875 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 666 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 594 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 864 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 654 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 587 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 861 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 651 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 580 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 850 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 649 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 578 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 641 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 572 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,74 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,2 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,82 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,4 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,75 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,64 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,14 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,45 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,31 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,25 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,3 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 51 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 197 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 264 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 51 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 195 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 264 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 51 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 195 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 263 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 51 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 192 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 261 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 192 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 260 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,98 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,98 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,62 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,46 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,86 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,46 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,48 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 933 27 Lugo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 884 27 Lugo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 862 27 Lugo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 928 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 881 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 855 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 916 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 874 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 848 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 866 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 841 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 860 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 835 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 27 Lugo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 27 Lugo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 27 Lugo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,46 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,66 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,19 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,18 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,87 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,38 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,96 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,56 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,29 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,87 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 890 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 835 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 635 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 885 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 832 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 629 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 873 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 826 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 623 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 818 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 618 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 812 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 615 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,44 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,64 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,06 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,09 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,92 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,11 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,96 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,32 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,25 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,85 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 43 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 49 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 227 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 43 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 49 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 226 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 43 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 48 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 225 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 48 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 223 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 48 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 220 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,56 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,96 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,12 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,96 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,24 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 97,96 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,92 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 948 27 Lugo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 923 27 Lugo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 881 27 Lugo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 940 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 916 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 875 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 908 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 867 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 894 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 854 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 890 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 849 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 27 Lugo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 27 Lugo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 27 Lugo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,16 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,24 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,32 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,37 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,41 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,86 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,94 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,42 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,37 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 899 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 868 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 654 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 891 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 862 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 651 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 854 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 645 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 840 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 634 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 836 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 630 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,11 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,31 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,54 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,39 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,62 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,77 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,94 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,31 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,33 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 49 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 55 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 227 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 49 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 54 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 224 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 54 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 222 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 54 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 220 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 54 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 219 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,18 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,68 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,18 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,8 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 98,18 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 96,92 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 98,18 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,48 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 27 Lugo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 29 27 Lugo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 27 Lugo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 21 27 Lugo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 24 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 29 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 21 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 24 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 28 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 21 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 24 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 28 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 21 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 24 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 27 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 21 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 24 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 27 Lugo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 27 Lugo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 27 Lugo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 27 Lugo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,55 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,55 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,1 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 26 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 14 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 26 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 14 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 26 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 14 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 26 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 14 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 25 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 14 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,15 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 3 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 7 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 3 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 7 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 7 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 7 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 7 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 66,67 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 66,67 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 66,67 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 27 27 Lugo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 23 27 Lugo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 21 27 Lugo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 26 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 23 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 21 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 26 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 23 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 21 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 26 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 23 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 21 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 23 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 21 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 27 Lugo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 27 Lugo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 27 Lugo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 27 Lugo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 96,3 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,3 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,3 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 27 Lugo from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 23 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 15 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 16 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 23 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 15 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 16 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 23 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 15 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 16 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 23 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 15 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 16 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 15 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 16 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 4 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 8 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 5 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 3 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 8 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 5 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 3 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 8 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 5 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 3 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 8 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 5 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 8 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 5 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 75 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 75 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 75 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 27 27 Lugo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 26 27 Lugo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 21 27 Lugo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 27 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 26 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 21 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 27 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 26 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 21 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 26 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 21 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 25 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 21 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 27 Lugo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 27 Lugo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 27 Lugo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,15 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 24 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 23 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 15 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 24 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 23 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 15 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 24 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 23 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 15 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 23 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 15 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 23 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 15 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 3 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 3 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 6 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 3 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 3 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 6 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 3 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 3 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 6 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 3 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 6 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 2 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 6 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 66,67 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 23 27 Lugo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 27 27 Lugo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 22 27 Lugo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 23 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 27 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 22 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 27 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 22 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 26 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 22 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 26 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 22 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 27 Lugo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 27 Lugo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 27 Lugo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,3 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,3 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 22 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 25 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 15 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 22 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 25 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 15 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 25 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 15 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 24 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 15 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 24 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 15 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 2 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 7 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 2 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 7 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 2 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 7 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 2 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 7 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 2 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 7 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 27 Lugo De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 17 27 Lugo De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 27 Lugo De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 17 27 Lugo De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 27 Lugo De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 19 27 Lugo De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 17 27 Lugo De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 17 27 Lugo De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 19 27 Lugo De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 16 27 Lugo De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 17 27 Lugo De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 19 27 Lugo De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 15 27 Lugo De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 17 27 Lugo De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 18 27 Lugo De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 15 27 Lugo De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 17 27 Lugo De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 18 27 Lugo De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 27 Lugo De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 27 Lugo De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 27 Lugo De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 27 Lugo De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 27 Lugo De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 27 Lugo De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 27 Lugo De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 94,12 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 88,24 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,74 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 88,24 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,74 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 27 Lugo De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 14 27 Lugo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 9 27 Lugo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 14 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 9 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 14 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 9 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 14 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 9 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 14 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 9 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 27 Lugo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 27 Lugo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 3 27 Lugo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 8 27 Lugo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 3 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 8 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 8 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 8 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 8 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 27 Lugo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 27 Lugo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 66,67 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 33,33 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 33,33 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 17 27 Lugo De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 27 Lugo De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 17 27 Lugo De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 27 Lugo De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 18 27 Lugo De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 16 27 Lugo De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 17 27 Lugo De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 18 27 Lugo De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 15 27 Lugo De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 17 27 Lugo De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 17 27 Lugo De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 15 27 Lugo De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 17 27 Lugo De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 17 27 Lugo De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 17 27 Lugo De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 17 27 Lugo De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 27 Lugo De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 27 Lugo De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 27 Lugo De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 27 Lugo De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 27 Lugo De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 27 Lugo De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 27 Lugo De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,12 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 88,24 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 94,44 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 88,24 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 94,44 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,44 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 27 Lugo De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 14 27 Lugo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 9 27 Lugo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 11 27 Lugo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 14 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 9 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 11 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 14 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 9 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 10 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 14 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 9 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 10 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 9 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 10 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 27 Lugo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 27 Lugo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 27 Lugo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,91 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 90,91 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 90,91 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 3 27 Lugo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 8 27 Lugo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 7 27 Lugo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 2 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 8 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 7 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 8 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 7 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 8 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 7 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 8 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 7 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 27 Lugo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 27 Lugo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 27 Lugo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 66,67 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 33,33 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 33,33 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 14 27 Lugo De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 27 Lugo De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 27 Lugo De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 15 27 Lugo De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 27 Lugo De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 27 Lugo De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 17 27 Lugo De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 27 Lugo De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 13 27 Lugo De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 15 27 Lugo De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 16 27 Lugo De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 13 27 Lugo De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 15 27 Lugo De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 16 27 Lugo De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 15 27 Lugo De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 16 27 Lugo De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 14 27 Lugo De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 16 27 Lugo De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 27 Lugo De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 27 Lugo De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 27 Lugo De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 27 Lugo De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 27 Lugo De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 27 Lugo De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 27 Lugo De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 27 Lugo De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 27 Lugo De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 27 Lugo De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 27 Lugo De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 27 Lugo De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 27 Lugo De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,86 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,12 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 92,86 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 94,12 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 94,12 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 93,33 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 94,12 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 27 Lugo De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 12 27 Lugo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 14 27 Lugo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 10 27 Lugo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 12 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 14 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 9 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 12 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 14 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 9 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 14 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 9 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 13 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 9 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 27 Lugo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 27 Lugo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 27 Lugo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 90 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 90 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 92,86 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 90 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 2 27 Lugo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1 27 Lugo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 7 27 Lugo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 7 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 7 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 7 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 7 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 27 Lugo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 27 Lugo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 27 Lugo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 50 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 50 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 15 27 Lugo De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 27 Lugo De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 27 Lugo De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 16 27 Lugo De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 27 Lugo De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 27 Lugo De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 17 27 Lugo De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 27 Lugo De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 15 27 Lugo De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 16 27 Lugo De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 17 27 Lugo De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 16 27 Lugo De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 17 27 Lugo De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 15 27 Lugo De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 17 27 Lugo De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 14 27 Lugo De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 17 27 Lugo De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 27 Lugo De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 27 Lugo De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 27 Lugo De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 27 Lugo De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 27 Lugo De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 27 Lugo De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 27 Lugo De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 27 Lugo De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 27 Lugo De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 27 Lugo De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 27 Lugo De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 27 Lugo De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 93,75 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 87,5 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 27 Lugo De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 13 27 Lugo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 14 27 Lugo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 9 27 Lugo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 13 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 14 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 9 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 14 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 9 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 14 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 9 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 14 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 9 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 27 Lugo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 27 Lugo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 27 Lugo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 2 27 Lugo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 2 27 Lugo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 8 27 Lugo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 2 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 2 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 8 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 2 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 8 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 8 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 0 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 8 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 27 Lugo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 27 Lugo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 27 Lugo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 50 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 0 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 27 Lugo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 28 Madrid Total Cohort January 1 Total Number at the start of the quarter 2022QI 170.250 28 Madrid Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 28 Madrid Total Cohort January 1 Total Number at the start of the quarter 2021QI 164.017 28 Madrid Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 28 Madrid Total Cohort January 1 Total Number at the start of the quarter 2020QI 170.238 28 Madrid Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 28 Madrid Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 28 Madrid Total Cohort January 1 Total Survival in the first trimester 2022QII "" 28 Madrid Total Cohort January 1 Total Survival in the first trimester 2022QI 161.452 28 Madrid Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 28 Madrid Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 28 Madrid Total Cohort January 1 Total Survival in the first trimester 2021QII "" 28 Madrid Total Cohort January 1 Total Survival in the first trimester 2021QI 155.700 28 Madrid Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 28 Madrid Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 28 Madrid Total Cohort January 1 Total Survival in the first trimester 2020QII "" 28 Madrid Total Cohort January 1 Total Survival in the first trimester 2020QI 151.697 28 Madrid Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 28 Madrid Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 28 Madrid Total Cohort January 1 Total Survival in the second trimester 2022QII 154.760 28 Madrid Total Cohort January 1 Total Survival in the second trimester 2022QI "" 28 Madrid Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 28 Madrid Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 28 Madrid Total Cohort January 1 Total Survival in the second trimester 2021QII 150.224 28 Madrid Total Cohort January 1 Total Survival in the second trimester 2021QI "" 28 Madrid Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 28 Madrid Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 28 Madrid Total Cohort January 1 Total Survival in the second trimester 2020QII 146.492 28 Madrid Total Cohort January 1 Total Survival in the second trimester 2020QI "" 28 Madrid Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 28 Madrid Total Cohort January 1 Total Survival in the third trimester 2022QIII 149.129 28 Madrid Total Cohort January 1 Total Survival in the third trimester 2022QII "" 28 Madrid Total Cohort January 1 Total Survival in the third trimester 2022QI "" 28 Madrid Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 28 Madrid Total Cohort January 1 Total Survival in the third trimester 2021QIII 145.583 28 Madrid Total Cohort January 1 Total Survival in the third trimester 2021QII "" 28 Madrid Total Cohort January 1 Total Survival in the third trimester 2021QI "" 28 Madrid Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 28 Madrid Total Cohort January 1 Total Survival in the third trimester 2020QIII 141.850 28 Madrid Total Cohort January 1 Total Survival in the third trimester 2020QII "" 28 Madrid Total Cohort January 1 Total Survival in the third trimester 2020QI "" 28 Madrid Total Cohort January 1 Total Survival in the third trimester 2022QIV 145.093 28 Madrid Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 28 Madrid Total Cohort January 1 Total Survival in the third trimester 2022QII "" 28 Madrid Total Cohort January 1 Total Survival in the third trimester 2022QI "" 28 Madrid Total Cohort January 1 Total Survival in the third trimester 2021QIV 141.735 28 Madrid Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 28 Madrid Total Cohort January 1 Total Survival in the third trimester 2021QII "" 28 Madrid Total Cohort January 1 Total Survival in the third trimester 2021QI "" 28 Madrid Total Cohort January 1 Total Survival in the third trimester 2020QIV 137.729 28 Madrid Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 28 Madrid Total Cohort January 1 Total Survival in the third trimester 2020QII "" 28 Madrid Total Cohort January 1 Total Survival in the third trimester 2020QI "" 28 Madrid Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 28 Madrid Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 28 Madrid Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 28 Madrid Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 28 Madrid Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 28 Madrid Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 28 Madrid Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,83 28 Madrid Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,93 28 Madrid Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 89,11 28 Madrid Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,9 28 Madrid Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,59 28 Madrid Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 86,05 28 Madrid Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 87,59 28 Madrid Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 88,76 28 Madrid Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 83,32 28 Madrid Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 85,22 28 Madrid Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 86,41 28 Madrid Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 80,9 28 Madrid Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 28 Madrid Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 28 Madrid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 158.529 28 Madrid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 132.874 28 Madrid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 150.133 28 Madrid Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 125.468 28 Madrid Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 143.757 28 Madrid Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 120.699 28 Madrid Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 138.408 28 Madrid Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 116.680 28 Madrid Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 134.584 28 Madrid Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 113.515 28 Madrid Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 28 Madrid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 28 Madrid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,7 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,43 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,68 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,84 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 87,31 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,81 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 84,9 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,43 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 11.721 28 Madrid Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 31.143 28 Madrid Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 11.319 28 Madrid Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 30.232 28 Madrid Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 11.003 28 Madrid Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 29.525 28 Madrid Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 10.721 28 Madrid Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 28.903 28 Madrid Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 10.509 28 Madrid Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 28.220 28 Madrid Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 28 Madrid Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 28 Madrid Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,57 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,07 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,87 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,8 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 91,47 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,81 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 89,66 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 90,61 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid Total Cohort April 1 Total Number at the start of the quarter 2022QII 170.804 28 Madrid Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 28 Madrid Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid Total Cohort April 1 Total Number at the start of the quarter 2021QII 164.129 28 Madrid Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 28 Madrid Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid Total Cohort April 1 Total Number at the start of the quarter 2020QII 158.930 28 Madrid Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 28 Madrid Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 28 Madrid Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 28 Madrid Total Cohort April 1 Total Survival in the first trimester 2022QII 162.475 28 Madrid Total Cohort April 1 Total Survival in the first trimester 2022QI "" 28 Madrid Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 28 Madrid Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 28 Madrid Total Cohort April 1 Total Survival in the first trimester 2021QII 157.281 28 Madrid Total Cohort April 1 Total Survival in the first trimester 2021QI "" 28 Madrid Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 28 Madrid Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 28 Madrid Total Cohort April 1 Total Survival in the first trimester 2020QII 152.732 28 Madrid Total Cohort April 1 Total Survival in the first trimester 2020QI "" 28 Madrid Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 28 Madrid Total Cohort April 1 Total Survival in the second trimester 2022QIII 155.903 28 Madrid Total Cohort April 1 Total Survival in the second trimester 2022QII "" 28 Madrid Total Cohort April 1 Total Survival in the second trimester 2022QI "" 28 Madrid Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 28 Madrid Total Cohort April 1 Total Survival in the second trimester 2021QIII 151.746 28 Madrid Total Cohort April 1 Total Survival in the second trimester 2021QII "" 28 Madrid Total Cohort April 1 Total Survival in the second trimester 2021QI "" 28 Madrid Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 28 Madrid Total Cohort April 1 Total Survival in the second trimester 2020QIII 147.454 28 Madrid Total Cohort April 1 Total Survival in the second trimester 2020QII "" 28 Madrid Total Cohort April 1 Total Survival in the second trimester 2020QI "" 28 Madrid Total Cohort April 1 Total Survival in the third trimester 2022QIV 151.244 28 Madrid Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 28 Madrid Total Cohort April 1 Total Survival in the third trimester 2022QII "" 28 Madrid Total Cohort April 1 Total Survival in the third trimester 2022QI "" 28 Madrid Total Cohort April 1 Total Survival in the third trimester 2021QIV 147.340 28 Madrid Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 28 Madrid Total Cohort April 1 Total Survival in the third trimester 2021QII "" 28 Madrid Total Cohort April 1 Total Survival in the third trimester 2021QI "" 28 Madrid Total Cohort April 1 Total Survival in the third trimester 2020QIV 142.867 28 Madrid Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 28 Madrid Total Cohort April 1 Total Survival in the third trimester 2020QII "" 28 Madrid Total Cohort April 1 Total Survival in the third trimester 2020QI "" 28 Madrid Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 28 Madrid Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 28 Madrid Total Cohort April 1 Total Survival in the third trimester 2022QII "" 28 Madrid Total Cohort April 1 Total Survival in the third trimester 2022QI 141.862 28 Madrid Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 28 Madrid Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 28 Madrid Total Cohort April 1 Total Survival in the third trimester 2021QII "" 28 Madrid Total Cohort April 1 Total Survival in the third trimester 2021QI 137.564 28 Madrid Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 28 Madrid Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 28 Madrid Total Cohort April 1 Total Survival in the third trimester 2020QII "" 28 Madrid Total Cohort April 1 Total Survival in the third trimester 2020QI "" 28 Madrid Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 28 Madrid Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 28 Madrid Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 28 Madrid Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 28 Madrid Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 28 Madrid Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,12 28 Madrid Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,83 28 Madrid Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,1 28 Madrid Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 91,28 28 Madrid Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,46 28 Madrid Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,78 28 Madrid Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 88,55 28 Madrid Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 89,77 28 Madrid Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,89 28 Madrid Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 86,43 28 Madrid Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 86,56 28 Madrid Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 28 Madrid Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 28 Madrid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 159.474 28 Madrid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 133.437 28 Madrid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 117.168 28 Madrid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 151.487 28 Madrid Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 127.315 28 Madrid Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 111.514 28 Madrid Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 145.201 28 Madrid Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 122.422 28 Madrid Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 107.264 28 Madrid Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 140.740 28 Madrid Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 118.715 28 Madrid Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 103.704 28 Madrid Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 114.048 28 Madrid Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 99.625 28 Madrid Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 28 Madrid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 28 Madrid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 28 Madrid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,99 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,41 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,17 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,05 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,75 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,55 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 88,25 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 88,97 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,51 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 85,47 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 85,03 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 11.330 28 Madrid Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 30.692 28 Madrid Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 41.762 28 Madrid Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 10.988 28 Madrid Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 29.966 28 Madrid Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 41.218 28 Madrid Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 10.702 28 Madrid Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 29.324 28 Madrid Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 40.190 28 Madrid Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 10.504 28 Madrid Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 28.625 28 Madrid Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 39.163 28 Madrid Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 27.814 28 Madrid Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 37.939 28 Madrid Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 28 Madrid Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 28 Madrid Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 28 Madrid Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,98 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,63 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,7 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,46 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,54 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,24 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 92,71 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,27 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,78 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 90,62 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 90,85 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid Total Cohort July 1 Total Number at the start of the quarter 2022QIII 171.468 28 Madrid Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 28 Madrid Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 28 Madrid Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid Total Cohort July 1 Total Number at the start of the quarter 2021QIII 166.953 28 Madrid Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 28 Madrid Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 28 Madrid Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid Total Cohort July 1 Total Number at the start of the quarter 2020QIII 161.758 28 Madrid Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 28 Madrid Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 28 Madrid Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 28 Madrid Total Cohort July 1 Total Survival in the first trimester 2022QIII 162.948 28 Madrid Total Cohort July 1 Total Survival in the first trimester 2022QII "" 28 Madrid Total Cohort July 1 Total Survival in the first trimester 2022QI "" 28 Madrid Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 28 Madrid Total Cohort July 1 Total Survival in the first trimester 2021QIII 159.383 28 Madrid Total Cohort July 1 Total Survival in the first trimester 2021QII "" 28 Madrid Total Cohort July 1 Total Survival in the first trimester 2021QI "" 28 Madrid Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 28 Madrid Total Cohort July 1 Total Survival in the first trimester 2020QIII 154.718 28 Madrid Total Cohort July 1 Total Survival in the first trimester 2020QII "" 28 Madrid Total Cohort July 1 Total Survival in the first trimester 2020QI "" 28 Madrid Total Cohort July 1 Total Survival in the second trimester 2022QIV 157.368 28 Madrid Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 28 Madrid Total Cohort July 1 Total Survival in the second trimester 2022QII "" 28 Madrid Total Cohort July 1 Total Survival in the second trimester 2022QI "" 28 Madrid Total Cohort July 1 Total Survival in the second trimester 2021QIV 153.937 28 Madrid Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 28 Madrid Total Cohort July 1 Total Survival in the second trimester 2021QII "" 28 Madrid Total Cohort July 1 Total Survival in the second trimester 2021QI "" 28 Madrid Total Cohort July 1 Total Survival in the second trimester 2020QIV 149.134 28 Madrid Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 28 Madrid Total Cohort July 1 Total Survival in the second trimester 2020QII "" 28 Madrid Total Cohort July 1 Total Survival in the second trimester 2020QI "" 28 Madrid Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 28 Madrid Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 28 Madrid Total Cohort July 1 Total Survival in the third trimester 2022QII "" 28 Madrid Total Cohort July 1 Total Survival in the third trimester 2022QI 147.776 28 Madrid Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 28 Madrid Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 28 Madrid Total Cohort July 1 Total Survival in the third trimester 2021QII "" 28 Madrid Total Cohort July 1 Total Survival in the third trimester 2021QI 143.251 28 Madrid Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 28 Madrid Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 28 Madrid Total Cohort July 1 Total Survival in the third trimester 2020QII "" 28 Madrid Total Cohort July 1 Total Survival in the third trimester 2020QI "" 28 Madrid Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 28 Madrid Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 28 Madrid Total Cohort July 1 Total Survival in the third trimester 2022QII 143.241 28 Madrid Total Cohort July 1 Total Survival in the third trimester 2022QI "" 28 Madrid Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 28 Madrid Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 28 Madrid Total Cohort July 1 Total Survival in the third trimester 2021QII 139.472 28 Madrid Total Cohort July 1 Total Survival in the third trimester 2021QI "" 28 Madrid Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 28 Madrid Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 28 Madrid Total Cohort July 1 Total Survival in the third trimester 2020QII "" 28 Madrid Total Cohort July 1 Total Survival in the third trimester 2020QI "" 28 Madrid Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 28 Madrid Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 28 Madrid Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 28 Madrid Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 28 Madrid Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 28 Madrid Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 28 Madrid Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 28 Madrid Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 28 Madrid Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 95,03 28 Madrid Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,47 28 Madrid Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,65 28 Madrid Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 91,78 28 Madrid Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 92,2 28 Madrid Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 92,2 28 Madrid Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 88,51 28 Madrid Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 88,56 28 Madrid Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 85,8 28 Madrid Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 86,22 28 Madrid Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 28 Madrid Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 28 Madrid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 165.039 28 Madrid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 155.931 28 Madrid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 127.803 28 Madrid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 156.695 28 Madrid Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 148.597 28 Madrid Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 121.548 28 Madrid Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 151.242 28 Madrid Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 143.395 28 Madrid Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 116.788 28 Madrid Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 137.526 28 Madrid Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 111.877 28 Madrid Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 133.230 28 Madrid Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 108.781 28 Madrid Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 28 Madrid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 28 Madrid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 28 Madrid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,94 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,3 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,11 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 91,64 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 91,96 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 91,38 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 88,2 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 87,54 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 85,44 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 85,12 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 6.429 28 Madrid Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 11.022 28 Madrid Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 33.955 28 Madrid Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 6.253 28 Madrid Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 10.786 28 Madrid Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 33.170 28 Madrid Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 6.126 28 Madrid Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 10.542 28 Madrid Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 32.346 28 Madrid Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 10.250 28 Madrid Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 31.374 28 Madrid Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 10.011 28 Madrid Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 30.691 28 Madrid Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 28 Madrid Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 28 Madrid Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 28 Madrid Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,26 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,86 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,69 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95,29 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,65 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,26 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 92,4 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 90,83 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 90,39 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid Total Cohort October 1 Total Number at the start of the quarter 2022QIV 170.560 28 Madrid Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 28 Madrid Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 28 Madrid Total Cohort October 1 Total Number at the start of the quarter 2021QIV 167.679 28 Madrid Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 28 Madrid Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 28 Madrid Total Cohort October 1 Total Number at the start of the quarter 2020QIV 163.090 28 Madrid Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 28 Madrid Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 28 Madrid Total Cohort October 1 Total Survival in the first trimester 2022QIV 163.715 28 Madrid Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 28 Madrid Total Cohort October 1 Total Survival in the first trimester 2022QII "" 28 Madrid Total Cohort October 1 Total Survival in the first trimester 2022QI "" 28 Madrid Total Cohort October 1 Total Survival in the first trimester 2021QIV 160.773 28 Madrid Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 28 Madrid Total Cohort October 1 Total Survival in the first trimester 2021QII "" 28 Madrid Total Cohort October 1 Total Survival in the first trimester 2021QI "" 28 Madrid Total Cohort October 1 Total Survival in the first trimester 2020QIV 155.882 28 Madrid Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 28 Madrid Total Cohort October 1 Total Survival in the first trimester 2020QII "" 28 Madrid Total Cohort October 1 Total Survival in the first trimester 2020QI "" 28 Madrid Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 28 Madrid Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 28 Madrid Total Cohort October 1 Total Survival in the second trimester 2022QII "" 28 Madrid Total Cohort October 1 Total Survival in the second trimester 2022QI 153.765 28 Madrid Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 28 Madrid Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 28 Madrid Total Cohort October 1 Total Survival in the second trimester 2021QII "" 28 Madrid Total Cohort October 1 Total Survival in the second trimester 2021QI 149.146 28 Madrid Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 28 Madrid Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 28 Madrid Total Cohort October 1 Total Survival in the second trimester 2020QII "" 28 Madrid Total Cohort October 1 Total Survival in the second trimester 2020QI "" 28 Madrid Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 28 Madrid Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 28 Madrid Total Cohort October 1 Total Survival in the third trimester 2022QII 148.375 28 Madrid Total Cohort October 1 Total Survival in the third trimester 2022QI "" 28 Madrid Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 28 Madrid Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 28 Madrid Total Cohort October 1 Total Survival in the third trimester 2021QII 144.677 28 Madrid Total Cohort October 1 Total Survival in the third trimester 2021QI "" 28 Madrid Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 28 Madrid Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 28 Madrid Total Cohort October 1 Total Survival in the third trimester 2020QII "" 28 Madrid Total Cohort October 1 Total Survival in the third trimester 2020QI "" 28 Madrid Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 28 Madrid Total Cohort October 1 Total Survival in the third trimester 2022QIII 143.492 28 Madrid Total Cohort October 1 Total Survival in the third trimester 2022QII "" 28 Madrid Total Cohort October 1 Total Survival in the third trimester 2022QI "" 28 Madrid Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 28 Madrid Total Cohort October 1 Total Survival in the third trimester 2021QIII 140.621 28 Madrid Total Cohort October 1 Total Survival in the third trimester 2021QII "" 28 Madrid Total Cohort October 1 Total Survival in the third trimester 2021QI "" 28 Madrid Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 28 Madrid Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 28 Madrid Total Cohort October 1 Total Survival in the third trimester 2020QII "" 28 Madrid Total Cohort October 1 Total Survival in the third trimester 2020QI "" 28 Madrid Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 28 Madrid Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 28 Madrid Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 28 Madrid Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 28 Madrid Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 28 Madrid Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 28 Madrid Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 28 Madrid Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 28 Madrid Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,99 28 Madrid Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,88 28 Madrid Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 95,58 28 Madrid Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 91,7 28 Madrid Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 91,45 28 Madrid Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 88,49 28 Madrid Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 88,71 28 Madrid Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 85,58 28 Madrid Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 86,22 28 Madrid Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 28 Madrid Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 28 Madrid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 164.924 28 Madrid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 155.357 28 Madrid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 127.459 28 Madrid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 158.189 28 Madrid Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 148.794 28 Madrid Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 121.162 28 Madrid Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 142.196 28 Madrid Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 115.456 28 Madrid Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 137.121 28 Madrid Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 111.733 28 Madrid Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 132.517 28 Madrid Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 108.375 28 Madrid Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 28 Madrid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 28 Madrid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 28 Madrid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95,92 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,78 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 95,06 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 91,53 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 90,58 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 88,26 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 87,66 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 85,3 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 85,03 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 5.636 28 Madrid Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 12.322 28 Madrid Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 35.631 28 Madrid Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 5.526 28 Madrid Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 11.979 28 Madrid Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 34.720 28 Madrid Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 11.569 28 Madrid Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 33.690 28 Madrid Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 11.254 28 Madrid Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 32.944 28 Madrid Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 10.975 28 Madrid Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 32.246 28 Madrid Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 28 Madrid Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 28 Madrid Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 28 Madrid Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,05 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,22 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,44 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,89 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,55 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 91,33 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,46 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 89,07 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 90,5 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 28 Madrid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 121.043 28 Madrid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 28 Madrid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 117.693 28 Madrid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 120.832 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 112.854 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 109.964 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 103.903 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 106.894 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 105.040 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 99.281 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 101.885 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 100.912 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 95.236 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 98.339 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 97.552 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 91.640 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 28 Madrid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 28 Madrid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 28 Madrid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 28 Madrid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,23 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,43 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 85,99 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,31 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 89,25 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 82,16 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 84,17 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 85,74 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 78,82 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 81,24 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 82,89 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 75,84 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 114.042 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 101.727 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 106.200 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 94.718 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 100.498 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 90.340 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 95.716 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 86.668 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 92.333 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 83.805 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,12 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,11 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,12 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 88,81 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 83,93 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 85,2 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 80,96 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 82,38 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 7.001 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 15.966 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 6.654 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 15.246 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 6.396 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 14.700 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 6.169 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 14.244 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 6.006 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 13.747 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,04 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,49 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 91,36 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 92,07 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 88,12 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 89,21 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 85,79 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 86,1 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 121.161 28 Madrid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 117.632 28 Madrid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 113.654 28 Madrid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 113.491 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 111.257 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 107.837 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 107.518 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 106.219 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 103.023 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 103.323 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 102.310 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 98.856 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 97.503 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 94.207 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 28 Madrid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 28 Madrid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 28 Madrid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 28 Madrid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,67 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,58 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,88 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 88,74 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,3 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 90,65 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 85,28 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 86,97 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 86,98 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 82,89 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 82,89 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 114.442 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 101.897 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 89.748 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 107.060 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 96.130 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 84.364 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 101.327 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 91.577 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 80.379 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 97.292 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 88.192 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 77.049 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 83.982 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 73.321 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,55 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,34 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 88,54 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,87 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 89,56 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 85,01 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 86,55 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 85,85 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 82,42 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 81,7 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 6.719 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 15.735 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 23.906 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 6.431 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 15.127 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 23.473 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 6.191 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 14.642 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 22.644 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 6.031 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 14.118 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 21.807 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 13.521 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 20.886 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,71 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,14 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,19 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 92,14 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,05 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,72 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 89,76 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 89,72 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,22 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 85,93 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 87,37 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 121.576 28 Madrid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 119.145 28 Madrid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 115.709 28 Madrid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 113.656 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 112.099 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 109.159 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 108.560 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 107.172 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 104.037 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 101.721 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 98.856 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 97.767 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 95.554 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 28 Madrid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 28 Madrid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 28 Madrid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,49 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,09 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,34 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,29 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,95 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 89,91 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 85,38 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 85,44 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 82,06 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 82,58 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 117.778 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 113.369 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 98.174 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 110.016 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 106.522 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 92.249 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 105.029 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 101.800 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 87.779 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 96.569 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 83.301 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 92.794 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 80.505 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,41 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,96 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,96 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,18 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,8 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,41 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 85,18 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 84,85 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 81,85 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 82 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 3.798 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 5.776 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 17.535 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 3.640 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 5.577 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 16.910 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 3.531 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 5.372 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 16.258 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 5.152 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 15.555 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 4.973 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 15.049 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,84 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,55 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,44 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 92,97 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,01 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 92,72 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 89,2 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 88,71 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 86,1 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 85,82 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 121.037 28 Madrid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 119.617 28 Madrid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 116.940 28 Madrid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 114.588 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 113.140 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 110.141 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 106.797 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 104.068 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 102.037 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 100.111 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 97.738 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 96.554 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 28 Madrid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 28 Madrid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 28 Madrid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,67 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,59 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,19 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,28 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 88,99 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 85,3 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 85,61 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 81,71 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 82,57 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 117.795 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 112.031 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 98.600 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 111.446 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 105.867 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 92.565 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 99.880 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 87.268 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 95.388 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 83.875 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 91.318 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 80.825 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,61 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,5 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,88 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,15 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88,51 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 85,14 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 85,07 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 81,51 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 81,97 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 3.242 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 7.586 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 18.340 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 3.142 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 7.273 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 17.576 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 6.917 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 16.800 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 6.649 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 16.236 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 6.420 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 15.729 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,92 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,87 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 95,83 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91,18 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 91,6 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 87,65 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 88,53 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 84,63 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 85,76 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 18.535 28 Madrid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 17.573 28 Madrid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 18.507 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 18.218 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 17.267 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 17.600 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 17.840 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 16.982 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 17.309 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 17.547 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 16.728 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 16.992 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 17.295 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 16.504 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 16.725 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 28 Madrid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 28 Madrid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,29 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,26 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 95,1 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,25 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,64 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 93,53 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,67 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,19 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 91,81 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,31 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 93,92 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 90,37 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 16.845 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 12.435 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 16.560 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 12.228 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 16.211 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 12.017 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 15.943 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 11.838 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 15.715 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 11.696 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,31 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,34 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,24 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,64 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,65 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,2 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,29 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,06 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.690 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 5.138 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.658 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 5.039 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.629 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 4.965 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.604 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 4.890 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.580 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 4.808 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,11 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,07 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96,39 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,63 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 94,91 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,17 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 93,49 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 93,58 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 18.672 28 Madrid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 17.561 28 Madrid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 16.862 28 Madrid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 18.337 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 17.299 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 16.676 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 18.039 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 17.041 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 16.426 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 17.817 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 16.799 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 16.213 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 16.469 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 15.906 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 28 Madrid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 28 Madrid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 28 Madrid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,21 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,51 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,9 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,61 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,04 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,41 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,42 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,66 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,15 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,78 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,33 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 17.059 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 12.447 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 10.032 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 16.746 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 12.252 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 9.892 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 16.473 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 12.074 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 9.762 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 16.272 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 11.915 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 9.647 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 11.679 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 9.490 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,17 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,43 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,6 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,56 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,31 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,39 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,73 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,16 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,83 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,6 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.613 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 5.114 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 6.830 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.591 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 5.047 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 6.784 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.566 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 4.967 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 6.664 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.545 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 4.884 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 6.566 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 4.790 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 6.416 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,64 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,69 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,33 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,09 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,13 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,57 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 95,78 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 95,5 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,13 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 93,66 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 93,94 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 18.584 28 Madrid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 18.033 28 Madrid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 17.445 28 Madrid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 18.304 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 17.778 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 17.178 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 18.074 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 17.531 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 16.937 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 17.176 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 16.598 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 16.882 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 16.360 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 28 Madrid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 28 Madrid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 28 Madrid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,49 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,59 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,47 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,26 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,22 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,09 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,25 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,14 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 93,62 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 93,78 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 17.629 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 16.207 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 11.842 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 17.358 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 15.967 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 11.667 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 17.137 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 15.742 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 11.510 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 15.423 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 11.291 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 15.156 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 11.135 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,46 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,52 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,52 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,21 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,13 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,2 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,16 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,35 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 93,52 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,03 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 955 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.826 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 5.603 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 946 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.811 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 5.511 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 937 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1.789 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 5.427 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1.753 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 5.307 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1.726 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 5.225 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,06 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,18 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,36 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,12 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,97 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,86 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 96 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,72 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 94,52 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 93,25 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 18.303 28 Madrid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 18.045 28 Madrid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 17.367 28 Madrid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 18.113 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 17.828 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 17.142 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 17.499 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 16.805 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 17.181 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 16.554 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 16.908 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 16.318 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 28 Madrid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 28 Madrid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 28 Madrid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,96 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,8 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,7 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,97 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,76 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95,21 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 95,32 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 93,7 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 93,96 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 17.460 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 16.388 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 11.476 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 17.274 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 16.189 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 11.326 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 15.891 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 11.110 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 15.588 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 10.943 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 15.335 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 10.788 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,93 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,79 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,69 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,97 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,81 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,12 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,36 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 93,57 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 94 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 843 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.657 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 5.891 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 839 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.639 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 5.816 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.608 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 5.695 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.593 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 5.611 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.573 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 5.530 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,53 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,91 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,73 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 97,04 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,67 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,14 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,25 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 94,93 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,87 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 28 Madrid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 27.058 28 Madrid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 28 Madrid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 25.345 28 Madrid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 27.356 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 26.799 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 25.078 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 26.679 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 26.462 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 24.821 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 26.397 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 26.159 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 24.579 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 26.132 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 25.939 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 24.338 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 25.891 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 28 Madrid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 28 Madrid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 28 Madrid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 28 Madrid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,04 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,95 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,53 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,8 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,93 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,49 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,68 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,98 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,53 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,86 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,03 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,64 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 24.374 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 16.604 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 24.136 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 16.424 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 23.828 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 16.250 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 23.552 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 16.093 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 23.357 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 15.952 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,02 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,92 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,76 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,87 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,63 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,92 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,83 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,07 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2.684 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 8.741 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2.663 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 8.654 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2.634 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 8.571 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2.607 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 8.486 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2.582 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 8.386 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,22 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,14 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,06 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,13 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,08 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,2 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,94 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 27.304 28 Madrid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 25.525 28 Madrid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 25.028 28 Madrid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 26.994 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 25.321 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 24.838 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 26.721 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 25.098 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 24.632 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 26.503 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 24.864 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 24.441 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 24.561 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 24.114 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 28 Madrid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 28 Madrid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 28 Madrid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 28 Madrid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,86 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,2 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,24 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,86 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,33 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,42 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,07 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,41 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,65 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,22 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,35 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 24.646 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 16.926 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 15.036 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 24.368 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 16.770 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 14.911 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 24.115 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 16.619 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 14.782 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 23.914 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 16.473 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 14.677 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 16.276 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 14.496 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,87 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,08 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,17 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,85 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,19 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,31 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,03 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,32 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,61 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,16 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,41 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 2.658 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 8.599 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 9.992 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 2.626 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 8.551 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 9.927 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 2.606 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 8.479 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 9.850 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 2.589 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 8.391 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 9.764 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 8.285 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 9.618 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,8 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,44 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,35 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,04 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,6 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,58 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,4 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,58 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,72 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,35 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,26 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 27.618 28 Madrid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 26.350 28 Madrid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 25.308 28 Madrid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 27.318 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 26.094 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 25.090 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 27.086 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 25.845 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 24.884 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 25.525 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 24.542 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 25.255 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 24.315 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 28 Madrid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 28 Madrid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 28 Madrid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,91 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,03 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,14 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,07 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,08 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,32 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,87 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,97 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,84 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,08 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 26.099 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 23.369 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 15.803 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 25.808 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 23.132 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 15.652 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 25.585 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 22.899 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 15.526 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 22.612 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 15.325 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 22.374 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 15.189 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,89 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,99 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,04 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,03 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,99 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,25 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,76 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,98 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,74 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,11 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1.519 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 2.981 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 9.505 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1.510 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 2.962 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 9.438 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1.501 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 2.946 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 9.358 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 2.913 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 9.217 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 2.881 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 9.126 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,41 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,36 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,3 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,82 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,83 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,45 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,72 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,97 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,65 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,01 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 27.488 28 Madrid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 26.502 28 Madrid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 25.386 28 Madrid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 27.298 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 26.311 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 25.215 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 26.008 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 24.907 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 25.713 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 24.656 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 25.428 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 24.411 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 28 Madrid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 28 Madrid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 28 Madrid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,31 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,28 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,33 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,14 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,11 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,02 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,12 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,95 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,16 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 26.079 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 23.787 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 15.375 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 25.895 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 23.608 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 15.268 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 23.328 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 15.087 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 23.064 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 14.930 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 22.808 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 14.787 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,29 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,25 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,3 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,07 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,13 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,96 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,11 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,88 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,18 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1.409 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 2.715 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 10.011 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1.403 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 2.703 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 9.947 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 2.680 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 9.820 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 2.649 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 9.726 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 2.620 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 9.624 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,57 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,56 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,36 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,71 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,09 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,57 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,15 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96,5 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,13 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 28 Madrid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 2.048 28 Madrid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 28 Madrid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 1.904 28 Madrid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 1.980 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 2.034 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 1.898 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 1.958 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 2.024 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 1.891 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 1.951 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 2.004 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 1.881 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 1.937 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 1.993 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 1.867 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 1.929 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 28 Madrid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 28 Madrid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 28 Madrid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 28 Madrid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,32 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,68 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,89 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,83 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 99,32 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,54 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,85 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,79 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,83 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,31 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,06 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,42 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.845 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.221 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.832 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.216 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.822 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.211 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.804 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.204 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.793 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.192 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,3 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,59 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,75 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 99,18 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,78 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,61 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,18 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,62 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 203 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 683 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 202 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 682 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 202 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 680 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 200 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 677 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 200 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 675 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,51 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,85 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 99,51 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 99,56 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 98,52 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 99,12 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 98,52 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,83 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 2.100 28 Madrid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 1.921 28 Madrid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 1.877 28 Madrid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 2.091 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 1.916 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 1.873 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 2.068 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 1.907 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 1.866 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 2.051 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 1.895 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 1.859 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 1.880 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 1.850 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 28 Madrid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 28 Madrid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 28 Madrid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 28 Madrid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,57 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,74 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,79 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,48 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,27 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,41 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,67 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,65 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 99,04 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,87 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,56 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 28 Madrid from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.891 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.265 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.311 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.882 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.262 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.307 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.859 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.255 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.302 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.842 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.245 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.298 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.238 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.292 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,52 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,76 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,69 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,31 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 99,21 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,31 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,41 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98,42 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 99,01 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,87 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 98,55 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 209 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 656 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 566 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 209 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 654 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 566 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 209 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 652 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 564 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 209 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 650 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 561 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 642 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 558 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,7 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,39 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,65 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 99,09 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 99,12 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,87 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,59 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 2.108 28 Madrid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 1.932 28 Madrid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.842 28 Madrid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 2.093 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 1.923 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 1.838 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 2.078 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 1.909 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 1.832 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 1.895 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 1.822 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 1.885 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 1.813 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 28 Madrid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 28 Madrid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 28 Madrid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,29 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,53 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,78 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,58 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,81 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,46 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,08 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,91 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,57 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,43 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.003 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.697 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.130 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.988 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.690 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.127 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.973 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.676 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.124 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.665 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.118 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.656 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.111 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,25 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,59 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,73 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,5 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,76 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 99,47 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,11 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,94 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,58 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 98,32 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 105 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 235 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 712 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 105 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 233 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 711 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 105 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 233 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 708 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 230 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 704 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 229 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 702 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,15 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,86 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,15 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,44 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,87 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,88 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 97,45 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,6 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 2.110 28 Madrid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 1.989 28 Madrid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.904 28 Madrid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 2.100 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 1.976 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 1.900 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 1.964 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 1.892 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 1.954 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 1.885 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 1.934 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 1.874 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 28 Madrid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 28 Madrid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 28 Madrid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,53 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,35 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,79 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,74 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 99,37 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,24 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 99 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,23 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,42 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.016 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.786 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.145 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.006 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.773 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.143 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.761 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.137 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.752 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.132 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.733 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.126 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,5 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,27 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,83 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,6 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 99,3 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,1 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,86 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,03 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,34 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 94 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 203 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 759 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 94 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 203 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 757 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 203 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 755 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 202 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 753 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 201 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 748 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,74 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 99,47 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 99,51 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 99,21 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 99,01 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,55 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 28 Madrid De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 1.566 28 Madrid De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 28 Madrid De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 1.502 28 Madrid De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 28 Madrid De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 1.563 28 Madrid De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 1.547 28 Madrid De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 1.493 28 Madrid De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 1.557 28 Madrid De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 1.540 28 Madrid De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 1.490 28 Madrid De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 1.554 28 Madrid De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 1.534 28 Madrid De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 1.483 28 Madrid De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 1.553 28 Madrid De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 1.527 28 Madrid De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 1.474 28 Madrid De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 1.544 28 Madrid De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 28 Madrid De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 28 Madrid De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 28 Madrid De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 28 Madrid De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 28 Madrid De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 28 Madrid De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 28 Madrid De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,79 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,4 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,62 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,34 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 99,2 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 99,42 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,96 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,74 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 99,36 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,51 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,14 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,78 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 28 Madrid De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.423 28 Madrid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 887 28 Madrid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.405 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 882 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.398 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 881 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.393 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 877 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.386 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 870 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 28 Madrid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 28 Madrid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,74 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,44 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,24 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 99,32 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,89 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,87 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,4 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,08 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 143 28 Madrid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 615 28 Madrid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 142 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 611 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 142 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 609 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 141 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 606 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 141 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 604 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 28 Madrid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 28 Madrid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,3 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,35 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 99,3 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 99,02 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 98,6 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,54 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 98,6 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,21 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 1.567 28 Madrid De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 28 Madrid De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 1.490 28 Madrid De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 28 Madrid De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 1.509 28 Madrid De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 1.562 28 Madrid De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 1.488 28 Madrid De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 1.508 28 Madrid De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 1.557 28 Madrid De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 1.481 28 Madrid De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 1.507 28 Madrid De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 1.550 28 Madrid De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 1.472 28 Madrid De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 1.498 28 Madrid De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 1.449 28 Madrid De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 1.487 28 Madrid De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 28 Madrid De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 28 Madrid De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 28 Madrid De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 28 Madrid De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 28 Madrid De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 28 Madrid De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 28 Madrid De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,68 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,87 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,93 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,36 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,4 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,87 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,92 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,79 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 99,27 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,25 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,54 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 28 Madrid De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.436 28 Madrid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 902 28 Madrid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.041 28 Madrid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.431 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 901 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.040 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.427 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 897 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.039 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.420 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 890 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.033 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 873 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.026 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 28 Madrid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 28 Madrid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 28 Madrid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,65 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,89 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,9 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 99,37 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 99,45 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,81 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,89 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98,67 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 99,23 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,78 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 98,56 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 131 28 Madrid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 588 28 Madrid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 468 28 Madrid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 131 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 587 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 468 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 130 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 584 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 468 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 130 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 582 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 465 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 576 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 461 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 28 Madrid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 28 Madrid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 28 Madrid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,83 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 99,24 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,32 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 99,24 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,98 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 99,36 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,96 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,5 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 1.582 28 Madrid De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 28 Madrid De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 28 Madrid De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 1.493 28 Madrid De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 28 Madrid De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 28 Madrid De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 1.454 28 Madrid De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 28 Madrid De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 1.577 28 Madrid De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 1.489 28 Madrid De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 1.453 28 Madrid De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 1.570 28 Madrid De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 1.480 28 Madrid De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 1.444 28 Madrid De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 1.459 28 Madrid De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 1.433 28 Madrid De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 1.452 28 Madrid De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 1.430 28 Madrid De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 28 Madrid De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 28 Madrid De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 28 Madrid De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 28 Madrid De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 28 Madrid De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 28 Madrid De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 28 Madrid De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 28 Madrid De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 28 Madrid De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 28 Madrid De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 28 Madrid De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 28 Madrid De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 28 Madrid De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,68 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,73 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,93 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 99,24 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,13 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,31 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,72 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,56 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,25 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,35 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 28 Madrid De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.530 28 Madrid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.289 28 Madrid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 854 28 Madrid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.525 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.286 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 853 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.518 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.278 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 849 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.257 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 842 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.250 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 841 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 28 Madrid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 28 Madrid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 28 Madrid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,67 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,77 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,88 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 99,22 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 99,15 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 99,41 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,52 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,59 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,97 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 98,48 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 52 28 Madrid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 204 28 Madrid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 600 28 Madrid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 52 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 203 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 600 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 52 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 202 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 595 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 202 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 591 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 202 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 589 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 28 Madrid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 28 Madrid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 28 Madrid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,51 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,02 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,17 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 99,02 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,5 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 99,02 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,17 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 1.622 28 Madrid De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 28 Madrid De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 28 Madrid De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 1.526 28 Madrid De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 28 Madrid De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 28 Madrid De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 1.493 28 Madrid De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 28 Madrid De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 1.616 28 Madrid De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 1.518 28 Madrid De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 1.484 28 Madrid De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 1.497 28 Madrid De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 1.474 28 Madrid De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 1.490 28 Madrid De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 1.471 28 Madrid De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 1.484 28 Madrid De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 1.464 28 Madrid De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 28 Madrid De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 28 Madrid De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 28 Madrid De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 28 Madrid De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 28 Madrid De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 28 Madrid De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 28 Madrid De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 28 Madrid De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 28 Madrid De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 28 Madrid De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 28 Madrid De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 28 Madrid De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,63 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,48 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,4 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,1 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,73 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,64 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,53 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,25 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,06 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 28 Madrid De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.574 28 Madrid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.365 28 Madrid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 863 28 Madrid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.568 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.357 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 860 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.336 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 854 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.329 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 853 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.323 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 849 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 28 Madrid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 28 Madrid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 28 Madrid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,62 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,41 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,65 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,88 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,96 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,36 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,84 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,92 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,38 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 48 28 Madrid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 161 28 Madrid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 630 28 Madrid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 48 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 161 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 624 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 161 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 620 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 161 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 618 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 161 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 615 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 28 Madrid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 28 Madrid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 28 Madrid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,05 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,41 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,1 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 97,62 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 28 Madrid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 29 Málaga Total Cohort January 1 Total Number at the start of the quarter 2022QI 44.808 29 Málaga Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 29 Málaga Total Cohort January 1 Total Number at the start of the quarter 2021QI 42.391 29 Málaga Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 29 Málaga Total Cohort January 1 Total Number at the start of the quarter 2020QI 45.787 29 Málaga Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 29 Málaga Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 29 Málaga Total Cohort January 1 Total Survival in the first trimester 2022QII "" 29 Málaga Total Cohort January 1 Total Survival in the first trimester 2022QI 41.834 29 Málaga Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 29 Málaga Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 29 Málaga Total Cohort January 1 Total Survival in the first trimester 2021QII "" 29 Málaga Total Cohort January 1 Total Survival in the first trimester 2021QI 39.376 29 Málaga Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 29 Málaga Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 29 Málaga Total Cohort January 1 Total Survival in the first trimester 2020QII "" 29 Málaga Total Cohort January 1 Total Survival in the first trimester 2020QI 37.736 29 Málaga Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 29 Málaga Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 29 Málaga Total Cohort January 1 Total Survival in the second trimester 2022QII 39.816 29 Málaga Total Cohort January 1 Total Survival in the second trimester 2022QI "" 29 Málaga Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 29 Málaga Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 29 Málaga Total Cohort January 1 Total Survival in the second trimester 2021QII 37.792 29 Málaga Total Cohort January 1 Total Survival in the second trimester 2021QI "" 29 Málaga Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 29 Málaga Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 29 Málaga Total Cohort January 1 Total Survival in the second trimester 2020QII 36.120 29 Málaga Total Cohort January 1 Total Survival in the second trimester 2020QI "" 29 Málaga Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 29 Málaga Total Cohort January 1 Total Survival in the third trimester 2022QIII 38.257 29 Málaga Total Cohort January 1 Total Survival in the third trimester 2022QII "" 29 Málaga Total Cohort January 1 Total Survival in the third trimester 2022QI "" 29 Málaga Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 29 Málaga Total Cohort January 1 Total Survival in the third trimester 2021QIII 36.373 29 Málaga Total Cohort January 1 Total Survival in the third trimester 2021QII "" 29 Málaga Total Cohort January 1 Total Survival in the third trimester 2021QI "" 29 Málaga Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 29 Málaga Total Cohort January 1 Total Survival in the third trimester 2020QIII 34.833 29 Málaga Total Cohort January 1 Total Survival in the third trimester 2020QII "" 29 Málaga Total Cohort January 1 Total Survival in the third trimester 2020QI "" 29 Málaga Total Cohort January 1 Total Survival in the third trimester 2022QIV 36.812 29 Málaga Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 29 Málaga Total Cohort January 1 Total Survival in the third trimester 2022QII "" 29 Málaga Total Cohort January 1 Total Survival in the third trimester 2022QI "" 29 Málaga Total Cohort January 1 Total Survival in the third trimester 2021QIV 35.198 29 Málaga Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 29 Málaga Total Cohort January 1 Total Survival in the third trimester 2021QII "" 29 Málaga Total Cohort January 1 Total Survival in the third trimester 2021QI "" 29 Málaga Total Cohort January 1 Total Survival in the third trimester 2020QIV 33.356 29 Málaga Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 29 Málaga Total Cohort January 1 Total Survival in the third trimester 2020QII "" 29 Málaga Total Cohort January 1 Total Survival in the third trimester 2020QI "" 29 Málaga Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 29 Málaga Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 29 Málaga Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 29 Málaga Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 29 Málaga Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 29 Málaga Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 29 Málaga Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,36 29 Málaga Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 92,89 29 Málaga Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 82,42 29 Málaga Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,86 29 Málaga Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 89,15 29 Málaga Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 78,89 29 Málaga Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 85,38 29 Málaga Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 85,8 29 Málaga Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 76,08 29 Málaga Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 82,15 29 Málaga Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 83,03 29 Málaga Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 72,85 29 Málaga Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 29 Málaga Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 29 Málaga Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 41.348 29 Málaga Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 33.683 29 Málaga Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 38.510 29 Málaga Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 31.035 29 Málaga Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 36.610 29 Málaga Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 29.642 29 Málaga Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 35.138 29 Málaga Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 28.408 29 Málaga Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 33.777 29 Málaga Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 27.436 29 Málaga Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 29 Málaga Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 29 Málaga Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,14 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 92,14 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,54 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 88 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 84,98 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 84,34 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 81,69 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 81,45 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 3.460 29 Málaga Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 8.708 29 Málaga Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 3.324 29 Málaga Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 8.341 29 Málaga Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 3.206 29 Málaga Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 8.150 29 Málaga Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 3.119 29 Málaga Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 7.965 29 Málaga Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 3.035 29 Málaga Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 7.762 29 Málaga Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 29 Málaga Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 29 Málaga Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,07 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,79 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,66 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 93,59 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,14 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 91,47 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 87,72 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 89,14 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga Total Cohort April 1 Total Number at the start of the quarter 2022QII 45.401 29 Málaga Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 29 Málaga Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga Total Cohort April 1 Total Number at the start of the quarter 2021QII 42.316 29 Málaga Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 29 Málaga Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga Total Cohort April 1 Total Number at the start of the quarter 2020QII 40.152 29 Málaga Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 29 Málaga Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 29 Málaga Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 29 Málaga Total Cohort April 1 Total Survival in the first trimester 2022QII 42.817 29 Málaga Total Cohort April 1 Total Survival in the first trimester 2022QI "" 29 Málaga Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 29 Málaga Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 29 Málaga Total Cohort April 1 Total Survival in the first trimester 2021QII 40.193 29 Málaga Total Cohort April 1 Total Survival in the first trimester 2021QI "" 29 Málaga Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 29 Málaga Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 29 Málaga Total Cohort April 1 Total Survival in the first trimester 2020QII 38.173 29 Málaga Total Cohort April 1 Total Survival in the first trimester 2020QI "" 29 Málaga Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 29 Málaga Total Cohort April 1 Total Survival in the second trimester 2022QIII 40.854 29 Málaga Total Cohort April 1 Total Survival in the second trimester 2022QII "" 29 Málaga Total Cohort April 1 Total Survival in the second trimester 2022QI "" 29 Málaga Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 29 Málaga Total Cohort April 1 Total Survival in the second trimester 2021QIII 38.421 29 Málaga Total Cohort April 1 Total Survival in the second trimester 2021QII "" 29 Málaga Total Cohort April 1 Total Survival in the second trimester 2021QI "" 29 Málaga Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 29 Málaga Total Cohort April 1 Total Survival in the second trimester 2020QIII 36.625 29 Málaga Total Cohort April 1 Total Survival in the second trimester 2020QII "" 29 Málaga Total Cohort April 1 Total Survival in the second trimester 2020QI "" 29 Málaga Total Cohort April 1 Total Survival in the third trimester 2022QIV 38.828 29 Málaga Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 29 Málaga Total Cohort April 1 Total Survival in the third trimester 2022QII "" 29 Málaga Total Cohort April 1 Total Survival in the third trimester 2022QI "" 29 Málaga Total Cohort April 1 Total Survival in the third trimester 2021QIV 36.859 29 Málaga Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 29 Málaga Total Cohort April 1 Total Survival in the third trimester 2021QII "" 29 Málaga Total Cohort April 1 Total Survival in the third trimester 2021QI "" 29 Málaga Total Cohort April 1 Total Survival in the third trimester 2020QIV 34.828 29 Málaga Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 29 Málaga Total Cohort April 1 Total Survival in the third trimester 2020QII "" 29 Málaga Total Cohort April 1 Total Survival in the third trimester 2020QI "" 29 Málaga Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 29 Málaga Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 29 Málaga Total Cohort April 1 Total Survival in the third trimester 2022QII "" 29 Málaga Total Cohort April 1 Total Survival in the third trimester 2022QI 35.335 29 Málaga Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 29 Málaga Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 29 Málaga Total Cohort April 1 Total Survival in the third trimester 2021QII "" 29 Málaga Total Cohort April 1 Total Survival in the third trimester 2021QI 33.203 29 Málaga Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 29 Málaga Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 29 Málaga Total Cohort April 1 Total Survival in the third trimester 2020QII "" 29 Málaga Total Cohort April 1 Total Survival in the third trimester 2020QI "" 29 Málaga Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 29 Málaga Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 29 Málaga Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 29 Málaga Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 29 Málaga Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 29 Málaga Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,31 29 Málaga Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,98 29 Málaga Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,07 29 Málaga Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,98 29 Málaga Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,8 29 Málaga Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,22 29 Málaga Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 85,52 29 Málaga Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 87,1 29 Málaga Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 86,74 29 Málaga Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 83,5 29 Málaga Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 82,69 29 Málaga Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 29 Málaga Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 29 Málaga Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 41.978 29 Málaga Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 34.790 29 Málaga Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 29.611 29 Málaga Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 39.508 29 Málaga Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 32.859 29 Málaga Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 27.758 29 Málaga Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 37.644 29 Málaga Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 31.270 29 Málaga Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 26.549 29 Málaga Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 35.739 29 Málaga Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 29.930 29 Málaga Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 25.258 29 Málaga Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 28.617 29 Málaga Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 24.025 29 Málaga Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 29 Málaga Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 29 Málaga Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 29 Málaga Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,12 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,45 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 93,74 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 89,68 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,88 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 89,66 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 85,14 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 86,03 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 85,3 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 82,26 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 81,14 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 3.423 29 Málaga Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 7.526 29 Málaga Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 10.541 29 Málaga Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 3.309 29 Málaga Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 7.334 29 Málaga Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 10.415 29 Málaga Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 3.210 29 Málaga Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 7.151 29 Málaga Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 10.076 29 Málaga Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 3.089 29 Málaga Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 6.929 29 Málaga Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 9.570 29 Málaga Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 6.718 29 Málaga Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 9.178 29 Málaga Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 29 Málaga Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 29 Málaga Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 29 Málaga Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,67 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,45 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,8 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,78 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,02 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,59 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 90,24 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 92,07 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 90,79 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 89,26 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 87,07 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga Total Cohort July 1 Total Number at the start of the quarter 2022QIII 47.133 29 Málaga Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 29 Málaga Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 29 Málaga Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga Total Cohort July 1 Total Number at the start of the quarter 2021QIII 44.780 29 Málaga Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 29 Málaga Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 29 Málaga Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga Total Cohort July 1 Total Number at the start of the quarter 2020QIII 42.670 29 Málaga Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 29 Málaga Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 29 Málaga Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 29 Málaga Total Cohort July 1 Total Survival in the first trimester 2022QIII 44.163 29 Málaga Total Cohort July 1 Total Survival in the first trimester 2022QII "" 29 Málaga Total Cohort July 1 Total Survival in the first trimester 2022QI "" 29 Málaga Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 29 Málaga Total Cohort July 1 Total Survival in the first trimester 2021QIII 41.949 29 Málaga Total Cohort July 1 Total Survival in the first trimester 2021QII "" 29 Málaga Total Cohort July 1 Total Survival in the first trimester 2021QI "" 29 Málaga Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 29 Málaga Total Cohort July 1 Total Survival in the first trimester 2020QIII 40.177 29 Málaga Total Cohort July 1 Total Survival in the first trimester 2020QII "" 29 Málaga Total Cohort July 1 Total Survival in the first trimester 2020QI "" 29 Málaga Total Cohort July 1 Total Survival in the second trimester 2022QIV 41.231 29 Málaga Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 29 Málaga Total Cohort July 1 Total Survival in the second trimester 2022QII "" 29 Málaga Total Cohort July 1 Total Survival in the second trimester 2022QI "" 29 Málaga Total Cohort July 1 Total Survival in the second trimester 2021QIV 39.482 29 Málaga Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 29 Málaga Total Cohort July 1 Total Survival in the second trimester 2021QII "" 29 Málaga Total Cohort July 1 Total Survival in the second trimester 2021QI "" 29 Málaga Total Cohort July 1 Total Survival in the second trimester 2020QIV 37.636 29 Málaga Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 29 Málaga Total Cohort July 1 Total Survival in the second trimester 2020QII "" 29 Málaga Total Cohort July 1 Total Survival in the second trimester 2020QI "" 29 Málaga Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 29 Málaga Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 29 Málaga Total Cohort July 1 Total Survival in the third trimester 2022QII "" 29 Málaga Total Cohort July 1 Total Survival in the third trimester 2022QI 37.615 29 Málaga Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 29 Málaga Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 29 Málaga Total Cohort July 1 Total Survival in the third trimester 2021QII "" 29 Málaga Total Cohort July 1 Total Survival in the third trimester 2021QI 35.647 29 Málaga Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 29 Málaga Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 29 Málaga Total Cohort July 1 Total Survival in the third trimester 2020QII "" 29 Málaga Total Cohort July 1 Total Survival in the third trimester 2020QI "" 29 Málaga Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 29 Málaga Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 29 Málaga Total Cohort July 1 Total Survival in the third trimester 2022QII 36.289 29 Málaga Total Cohort July 1 Total Survival in the third trimester 2022QI "" 29 Málaga Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 29 Málaga Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 29 Málaga Total Cohort July 1 Total Survival in the third trimester 2021QII 34.604 29 Málaga Total Cohort July 1 Total Survival in the third trimester 2021QI "" 29 Málaga Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 29 Málaga Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 29 Málaga Total Cohort July 1 Total Survival in the third trimester 2020QII "" 29 Málaga Total Cohort July 1 Total Survival in the third trimester 2020QI "" 29 Málaga Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 29 Málaga Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 29 Málaga Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 29 Málaga Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 29 Málaga Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 29 Málaga Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 29 Málaga Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 29 Málaga Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 29 Málaga Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,7 29 Málaga Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,68 29 Málaga Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,16 29 Málaga Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 87,48 29 Málaga Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 88,17 29 Málaga Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 88,2 29 Málaga Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 84 29 Málaga Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 83,54 29 Málaga Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 81,04 29 Málaga Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 81,1 29 Málaga Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 29 Málaga Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 29 Málaga Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 44.414 29 Málaga Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 42.134 29 Málaga Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 31.842 29 Málaga Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 41.530 29 Málaga Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 39.377 29 Málaga Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 29.675 29 Málaga Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 38.705 29 Málaga Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 36.990 29 Málaga Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 27.643 29 Málaga Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 35.213 29 Málaga Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 26.060 29 Málaga Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 33.942 29 Málaga Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 25.220 29 Málaga Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 29 Málaga Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 29 Málaga Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 29 Málaga Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,51 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,46 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,19 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,15 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 87,79 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 86,81 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 83,57 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 81,84 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 80,56 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 79,2 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 2.719 29 Málaga Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 2.646 29 Málaga Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 10.828 29 Málaga Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 2.633 29 Málaga Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 2.572 29 Málaga Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 10.502 29 Málaga Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 2.526 29 Málaga Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 2.492 29 Málaga Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 9.993 29 Málaga Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 2.402 29 Málaga Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 9.587 29 Málaga Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 2.347 29 Málaga Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 9.384 29 Málaga Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 29 Málaga Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 29 Málaga Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 29 Málaga Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,84 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,2 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,99 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 92,9 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 94,18 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 92,29 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 90,78 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 88,54 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 88,7 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 86,66 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga Total Cohort October 1 Total Number at the start of the quarter 2022QIV 46.840 29 Málaga Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 29 Málaga Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 29 Málaga Total Cohort October 1 Total Number at the start of the quarter 2021QIV 45.054 29 Málaga Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 29 Málaga Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 29 Málaga Total Cohort October 1 Total Number at the start of the quarter 2020QIV 43.631 29 Málaga Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 29 Málaga Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 29 Málaga Total Cohort October 1 Total Survival in the first trimester 2022QIV 43.264 29 Málaga Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 29 Málaga Total Cohort October 1 Total Survival in the first trimester 2022QII "" 29 Málaga Total Cohort October 1 Total Survival in the first trimester 2022QI "" 29 Málaga Total Cohort October 1 Total Survival in the first trimester 2021QIV 41.761 29 Málaga Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 29 Málaga Total Cohort October 1 Total Survival in the first trimester 2021QII "" 29 Málaga Total Cohort October 1 Total Survival in the first trimester 2021QI "" 29 Málaga Total Cohort October 1 Total Survival in the first trimester 2020QIV 39.987 29 Málaga Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 29 Málaga Total Cohort October 1 Total Survival in the first trimester 2020QII "" 29 Málaga Total Cohort October 1 Total Survival in the first trimester 2020QI "" 29 Málaga Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 29 Málaga Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 29 Málaga Total Cohort October 1 Total Survival in the second trimester 2022QII "" 29 Málaga Total Cohort October 1 Total Survival in the second trimester 2022QI 39.504 29 Málaga Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 29 Málaga Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 29 Málaga Total Cohort October 1 Total Survival in the second trimester 2021QII "" 29 Málaga Total Cohort October 1 Total Survival in the second trimester 2021QI 37.585 29 Málaga Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 29 Málaga Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 29 Málaga Total Cohort October 1 Total Survival in the second trimester 2020QII "" 29 Málaga Total Cohort October 1 Total Survival in the second trimester 2020QI "" 29 Málaga Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 29 Málaga Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 29 Málaga Total Cohort October 1 Total Survival in the third trimester 2022QII 37.921 29 Málaga Total Cohort October 1 Total Survival in the third trimester 2022QI "" 29 Málaga Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 29 Málaga Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 29 Málaga Total Cohort October 1 Total Survival in the third trimester 2021QII 36.324 29 Málaga Total Cohort October 1 Total Survival in the third trimester 2021QI "" 29 Málaga Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 29 Málaga Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 29 Málaga Total Cohort October 1 Total Survival in the third trimester 2020QII "" 29 Málaga Total Cohort October 1 Total Survival in the third trimester 2020QI "" 29 Málaga Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 29 Málaga Total Cohort October 1 Total Survival in the third trimester 2022QIII 36.611 29 Málaga Total Cohort October 1 Total Survival in the third trimester 2022QII "" 29 Málaga Total Cohort October 1 Total Survival in the third trimester 2022QI "" 29 Málaga Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 29 Málaga Total Cohort October 1 Total Survival in the third trimester 2021QIII 35.116 29 Málaga Total Cohort October 1 Total Survival in the third trimester 2021QII "" 29 Málaga Total Cohort October 1 Total Survival in the third trimester 2021QI "" 29 Málaga Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 29 Málaga Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 29 Málaga Total Cohort October 1 Total Survival in the third trimester 2020QII "" 29 Málaga Total Cohort October 1 Total Survival in the third trimester 2020QI "" 29 Málaga Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 29 Málaga Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 29 Málaga Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 29 Málaga Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 29 Málaga Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 29 Málaga Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 29 Málaga Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 29 Málaga Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 29 Málaga Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 92,37 29 Málaga Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 92,69 29 Málaga Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 91,65 29 Málaga Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 87,68 29 Málaga Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 86,14 29 Málaga Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 84,17 29 Málaga Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 83,25 29 Málaga Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 81,26 29 Málaga Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 80,48 29 Málaga Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 29 Málaga Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 29 Málaga Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 44.490 29 Málaga Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 41.284 29 Málaga Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 34.159 29 Málaga Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 41.000 29 Málaga Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 38.160 29 Málaga Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 30.995 29 Málaga Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 36.038 29 Málaga Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 28.973 29 Málaga Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 34.564 29 Málaga Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 27.897 29 Málaga Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 33.345 29 Málaga Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 26.879 29 Málaga Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 29 Málaga Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 29 Málaga Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 29 Málaga Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 92,16 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 92,43 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 90,74 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 87,29 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 84,82 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 83,72 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 81,67 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 80,77 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 78,69 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 2.350 29 Málaga Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 3.770 29 Málaga Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 9.472 29 Málaga Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 2.264 29 Málaga Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 3.601 29 Málaga Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 8.992 29 Málaga Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 3.466 29 Málaga Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 8.612 29 Málaga Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 3.357 29 Málaga Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 8.427 29 Málaga Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 3.266 29 Málaga Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 8.237 29 Málaga Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 29 Málaga Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 29 Málaga Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 29 Málaga Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,34 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,52 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 94,93 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91,94 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 90,92 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 89,05 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 88,97 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 86,63 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 86,96 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 29 Málaga From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 34.420 29 Málaga From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 29 Málaga From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 33.174 29 Málaga From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 35.100 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 31.608 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 30.304 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 27.566 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 29.785 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 28.859 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 26.080 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 28.363 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 27.553 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 24.927 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 27.060 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 26.473 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 23.650 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 29 Málaga From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 29 Málaga From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 29 Málaga From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 29 Málaga From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 91,83 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 91,35 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 78,54 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 86,53 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 86,99 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 74,3 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 82,4 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 83,06 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 71,02 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 78,62 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 79,8 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 67,38 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 32.042 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 28.044 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 29.350 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 25.493 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 27.629 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 24.196 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 26.280 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 23.037 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 25.047 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 22.126 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 91,6 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 90,9 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 86,23 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 86,28 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 82,02 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 82,15 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 78,17 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 78,9 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2.378 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 5.130 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2.258 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 4.811 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2.156 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 4.663 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2.083 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 4.516 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2.013 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 4.347 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,95 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 93,78 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,66 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 90,9 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 87,59 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 88,03 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 84,65 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 84,74 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 34.588 29 Málaga From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 32.959 29 Málaga From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 30.907 29 Málaga From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 32.178 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 30.953 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 29.010 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 30.354 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 29.303 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 27.575 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 28.593 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 27.895 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 25.976 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 26.522 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 24.512 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 29 Málaga From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 29 Málaga From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 29 Málaga From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 29 Málaga From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,03 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 93,91 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 93,86 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 87,76 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 88,91 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 89,22 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 82,67 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 84,64 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 84,05 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 80,47 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 79,31 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 32.300 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 28.421 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 24.455 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 29.991 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 26.573 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 22.661 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 28.255 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 25.069 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 21.516 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 26.577 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 23.831 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 20.309 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 22.630 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 19.171 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 92,85 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 93,5 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 92,66 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 87,48 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 88,21 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 87,98 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 82,28 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 83,85 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 83,05 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 79,62 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 78,39 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 2.288 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 4.538 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 6.452 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 2.187 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 4.380 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 6.349 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 2.099 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 4.234 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 6.059 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 2.016 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 4.064 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 5.667 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 3.892 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 5.341 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,59 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,52 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,4 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,74 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,3 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 93,91 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,11 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 89,55 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 87,83 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 85,76 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 82,78 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 35.417 29 Málaga From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 34.415 29 Málaga From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 32.895 29 Málaga From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 32.596 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 31.728 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 30.533 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 30.109 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 29.585 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 28.303 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 27.903 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 26.511 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 26.728 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 25.592 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 29 Málaga From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 29 Málaga From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 29 Málaga From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,03 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,19 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 92,82 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 85,01 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 85,97 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 86,04 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 81,08 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 80,59 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 77,66 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 77,8 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 33.687 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 32.809 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 26.479 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 30.944 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 30.186 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 24.403 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 28.529 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 28.097 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 22.556 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 26.488 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 21.095 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 25.356 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 20.325 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 91,86 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,01 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 92,16 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 84,69 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 85,64 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 85,18 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 80,73 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 79,67 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 77,28 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 76,76 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1.730 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.606 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 6.416 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1.652 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.542 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 6.130 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1.580 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1.488 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 5.747 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1.415 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 5.416 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1.372 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 5.267 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,49 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,01 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 95,54 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 91,33 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 92,65 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 89,57 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 88,11 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 84,41 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 85,43 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 82,09 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 35.348 29 Málaga From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 34.513 29 Málaga From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 33.806 29 Málaga From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 32.156 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 31.513 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 30.418 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 29.439 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 28.199 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 28.034 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 27.074 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 26.858 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 25.981 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 29 Málaga From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 29 Málaga From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 29 Málaga From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 90,97 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 91,31 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 89,98 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 85,3 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 83,41 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 81,23 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 80,09 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 77,82 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 76,85 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 33.884 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 31.928 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 28.367 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 30.751 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 29.059 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 25.364 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 27.101 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 23.462 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 25.788 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 22.475 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 24.689 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 21.530 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 90,75 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 91,01 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 89,41 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 84,88 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 82,71 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 80,77 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 79,23 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 77,33 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 75,9 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1.464 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 2.585 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 5.439 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1.405 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 2.454 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 5.054 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 2.338 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 4.737 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 2.246 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 4.599 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 2.169 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 4.451 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 95,97 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 94,93 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 92,92 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 90,44 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 87,09 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 86,89 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 84,56 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 83,91 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 81,83 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 4.582 29 Málaga From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 4.174 29 Málaga From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 4.720 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 4.485 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 4.099 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 4.396 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 4.367 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 4.013 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 4.326 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 4.279 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 3.945 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 4.253 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 4.198 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 3.899 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 4.141 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 29 Málaga From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 29 Málaga From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 97,88 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,2 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 93,14 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 95,31 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,14 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 91,65 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 93,39 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 94,51 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 90,11 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 91,62 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 93,41 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 87,73 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 4.138 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.782 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 4.052 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2.729 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 3.943 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.665 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 3.864 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.614 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 3.791 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2.584 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 97,92 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,09 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 95,29 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 95,79 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 93,38 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 93,96 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 91,61 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 92,88 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 444 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.392 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 433 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.370 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 424 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.348 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 415 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.331 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 407 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.315 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,52 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,42 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 95,5 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,84 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 93,47 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,62 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 91,67 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 94,47 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 4.775 29 Málaga From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 4.229 29 Málaga From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 4.165 29 Málaga From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 4.667 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 4.160 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 4.124 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 4.576 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 4.085 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 4.053 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 4.422 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 4.001 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 3.936 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 3.911 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 3.849 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 29 Málaga From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 29 Málaga From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 29 Málaga From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,74 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,37 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,02 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 95,83 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,59 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,31 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 92,61 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 94,61 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 94,5 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 92,48 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 92,41 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 4.307 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 3.075 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2.491 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 4.204 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 3.024 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2.460 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 4.122 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.969 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2.422 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 3.990 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.913 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.373 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.845 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.321 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,61 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,34 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,76 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 95,7 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,55 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,23 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 92,64 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 94,73 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,26 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 92,52 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 93,18 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 468 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.154 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.674 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 463 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.136 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.664 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 454 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.116 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.631 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 432 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.088 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.563 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.066 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.528 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,93 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,44 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,4 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,01 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,71 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,43 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 92,31 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,28 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,37 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 92,37 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,28 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 5.029 29 Málaga From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 4.543 29 Málaga From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 4.370 29 Málaga From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 4.941 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 4.464 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 4.289 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 4.724 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 4.309 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 4.115 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 4.213 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 4.012 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 4.128 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 3.945 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 29 Málaga From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 29 Málaga From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 29 Málaga From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,25 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,26 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,15 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 93,94 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 94,85 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 94,16 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 92,74 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 91,81 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 90,87 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 90,27 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 4.647 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 4.153 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2.651 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 4.564 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 4.078 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.596 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 4.357 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 3.930 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.487 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 3.841 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.423 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 3.765 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.387 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,21 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,19 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 97,93 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 93,76 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 94,63 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 93,81 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 92,49 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 91,4 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 90,66 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 90,04 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 382 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 390 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.719 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 377 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 386 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.693 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 367 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 379 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.628 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 372 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.589 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 363 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.558 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,69 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,97 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,49 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 96,07 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,18 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,71 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,38 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 92,44 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,08 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 90,63 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 4.993 29 Málaga From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 4.618 29 Málaga From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 4.461 29 Málaga From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 4.785 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 4.469 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 4.299 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 4.367 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 4.201 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 4.262 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 4.125 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 4.175 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 4.058 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 29 Málaga From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 29 Málaga From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 29 Málaga From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,83 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 96,77 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 96,37 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 94,56 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 94,17 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 92,29 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 92,47 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 90,41 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 90,97 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 4.660 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 4.119 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2.871 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 4.461 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 3.985 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2.768 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 3.894 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.701 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 3.799 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2.651 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 3.722 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.609 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95,73 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 96,75 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 96,41 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 94,54 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 94,08 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 92,23 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 92,34 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 90,36 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 90,87 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 333 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 499 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.590 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 324 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 484 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.531 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 473 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.500 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 463 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.474 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 453 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.449 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,3 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,99 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,29 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,79 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,34 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 92,79 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,7 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 90,78 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 91,13 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 29 Málaga From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 5.522 29 Málaga From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 29 Málaga From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 4.781 29 Málaga From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 5.674 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 5.461 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 4.714 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 5.485 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 5.384 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 4.661 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 5.426 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 5.336 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 4.620 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 5.368 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 5.277 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 4.573 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 5.280 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 29 Málaga From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 29 Málaga From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 29 Málaga From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 29 Málaga From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,9 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,6 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,67 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,5 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,49 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,63 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,63 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,63 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,61 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,56 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,65 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 93,06 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 4.917 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.714 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 4.861 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2.672 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 4.791 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.640 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 4.748 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.618 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 4.695 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2.587 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,86 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,45 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,44 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,27 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,56 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,46 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,49 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,32 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 605 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2.067 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 600 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2.042 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 593 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2.021 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 588 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2.002 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 582 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.986 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,17 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,79 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,02 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,77 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,19 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,86 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,2 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,08 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 5.738 29 Málaga From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 4.883 29 Málaga From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 4.826 29 Málaga From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 5.672 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 4.835 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 4.785 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 5.626 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 4.792 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 4.746 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 5.517 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 4.725 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 4.665 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 4.667 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 4.593 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 29 Málaga From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 29 Málaga From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 29 Málaga From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 29 Málaga From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,85 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,02 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,15 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,05 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,14 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,34 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,15 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,76 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,66 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 95,58 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,17 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 5.092 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 3.152 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2.529 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 5.034 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 3.120 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2.501 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 4.990 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 3.092 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2.478 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 4.897 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 3.047 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.443 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 3.006 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.402 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,86 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,98 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,89 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,1 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,98 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,17 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,67 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,6 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,37 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,98 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 646 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.731 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.297 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 638 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.715 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.284 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 636 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.700 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.268 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 620 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.678 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.222 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.661 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.191 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,76 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,08 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,43 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,45 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,21 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,74 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 95,98 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,94 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,73 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 95,96 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,39 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 6.361 29 Málaga From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 5.552 29 Málaga From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 5.157 29 Málaga From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 6.302 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 5.488 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 5.109 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 6.077 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 5.323 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 4.972 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 5.239 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 4.880 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 5.173 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 4.823 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 29 Málaga From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 29 Málaga From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 29 Málaga From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,07 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,85 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,07 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 95,54 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 95,88 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 96,41 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 94,36 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 94,63 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 93,17 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 93,52 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 5.777 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 4.933 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2.593 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 5.721 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 4.875 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.558 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 5.521 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 4.729 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.482 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 4.655 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.425 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 4.592 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.391 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,03 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,82 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,65 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 95,57 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 95,86 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 95,72 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 94,36 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 93,52 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 93,09 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 92,21 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 584 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 619 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2.564 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 581 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 613 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2.551 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 556 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 594 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 2.490 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 584 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2.455 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 581 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 2.432 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,49 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,03 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,49 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95,21 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,96 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,11 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 94,35 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95,75 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,86 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 94,85 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 6.174 29 Málaga From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 5.638 29 Málaga From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 5.097 29 Málaga From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 6.002 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 5.499 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 5.004 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 5.423 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 4.922 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 5.350 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 4.862 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 5.305 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 4.815 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 29 Málaga From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 29 Málaga From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 29 Málaga From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,21 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 97,53 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,18 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,19 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,57 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 94,89 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 95,39 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 94,09 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 94,47 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 5.639 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 4.979 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2.783 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 5.485 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 4.863 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2.726 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 4.795 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.675 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 4.729 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2.636 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 4.688 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.605 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,27 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 97,67 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,95 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,3 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,12 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 94,98 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 94,72 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 94,16 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,6 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 535 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 659 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 2.314 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 517 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 636 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2.278 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 628 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2.247 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 621 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2.226 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 617 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2.210 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,64 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,51 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,44 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 95,3 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,1 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 94,23 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 96,2 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 93,63 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 95,51 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 29 Málaga from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 190 29 Málaga from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 29 Málaga from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 176 29 Málaga from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 205 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 189 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 174 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 201 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 189 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 174 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 200 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 188 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 170 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 198 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 186 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 168 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 198 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 29 Málaga from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 29 Málaga from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 29 Málaga from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 29 Málaga from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,47 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,86 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,05 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,47 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,86 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,56 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,95 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,59 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,59 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,89 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,45 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,59 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 169 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 94 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 168 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 93 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 168 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 93 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 167 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 91 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 165 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 91 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,41 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,94 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,41 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,94 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,82 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,81 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,63 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,81 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 21 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 82 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 21 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 81 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 21 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 81 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 21 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 79 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 21 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 77 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,78 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,78 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,34 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 93,9 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 204 29 Málaga from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 155 29 Málaga from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 174 29 Málaga from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 204 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 155 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 174 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 202 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 151 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 173 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 200 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 148 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 173 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 148 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 171 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 29 Málaga from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 29 Málaga from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 29 Málaga from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 29 Málaga from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,02 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,42 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,43 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,04 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,48 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 99,43 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 95,48 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,28 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 29 Málaga from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 190 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 88 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 87 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 190 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 88 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 87 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 188 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 86 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 86 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 186 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 85 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 86 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 85 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 84 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,95 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,73 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,85 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,89 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,59 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,85 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,59 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,55 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 14 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 67 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 87 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 14 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 67 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 87 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 14 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 65 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 87 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 14 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 63 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 87 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 63 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 87 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,01 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,03 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 94,03 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 233 29 Málaga from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 184 29 Málaga from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 169 29 Málaga from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 231 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 183 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 168 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 228 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 179 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 168 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 176 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 166 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 176 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 166 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 29 Málaga from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 29 Málaga from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 29 Málaga from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,14 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,46 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,41 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,85 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,28 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,41 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,65 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,22 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,65 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,22 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 214 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 162 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 75 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 212 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 161 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 75 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 209 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 157 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 75 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 154 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 74 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 154 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 74 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,07 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,38 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,66 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 96,91 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,06 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,67 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,06 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 98,67 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 19 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 22 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 94 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 19 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 22 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 93 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 19 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 22 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 93 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 22 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 92 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 22 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 92 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,94 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,94 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,87 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,87 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 225 29 Málaga from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 194 29 Málaga from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 183 29 Málaga from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 221 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 189 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 182 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 188 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 179 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 188 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 179 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 186 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 178 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 29 Málaga from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 29 Málaga from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 29 Málaga from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,22 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 97,42 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,45 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,91 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,81 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,91 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,81 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,88 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,27 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 210 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 176 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 90 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 206 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 171 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 89 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 170 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 87 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 170 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 87 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 168 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 87 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,1 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 97,16 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,89 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,59 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,67 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,59 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,67 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,45 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,67 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 15 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 18 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 93 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 15 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 18 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 93 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 18 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 92 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 18 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 92 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 18 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 91 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,92 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,92 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 97,85 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 29 Málaga De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 94 29 Málaga De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 29 Málaga De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 86 29 Málaga De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 29 Málaga De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 88 29 Málaga De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 91 29 Málaga De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 85 29 Málaga De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 88 29 Málaga De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 91 29 Málaga De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 85 29 Málaga De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 88 29 Málaga De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 91 29 Málaga De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 85 29 Málaga De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 87 29 Málaga De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 91 29 Málaga De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 85 29 Málaga De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 87 29 Málaga De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 29 Málaga De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 29 Málaga De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 29 Málaga De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 29 Málaga De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 29 Málaga De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 29 Málaga De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 29 Málaga De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 96,81 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,84 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,81 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,84 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,81 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,84 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,86 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,81 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,84 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,86 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 29 Málaga De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 82 29 Málaga De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 49 29 Málaga De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 79 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 48 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 79 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 48 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 79 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 48 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 79 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 48 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 29 Málaga De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 29 Málaga De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 96,34 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97,96 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,34 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,96 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,34 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,96 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,34 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,96 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 12 29 Málaga De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 37 29 Málaga De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 12 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 37 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 12 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 37 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 12 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 37 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 12 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 37 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 29 Málaga De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 29 Málaga De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 96 29 Málaga De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 29 Málaga De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 90 29 Málaga De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 29 Málaga De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 80 29 Málaga De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 96 29 Málaga De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 90 29 Málaga De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 80 29 Málaga De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 96 29 Málaga De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 90 29 Málaga De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 78 29 Málaga De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 96 29 Málaga De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 90 29 Málaga De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 78 29 Málaga De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 87 29 Málaga De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 78 29 Málaga De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 29 Málaga De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 29 Málaga De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 29 Málaga De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 29 Málaga De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 29 Málaga De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 29 Málaga De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 29 Málaga De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,5 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,5 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,67 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,5 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 29 Málaga De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 89 29 Málaga De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 54 29 Málaga De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 49 29 Málaga De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 89 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 54 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 49 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 89 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 54 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 47 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 89 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 54 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 47 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 51 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 47 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 29 Málaga De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 29 Málaga De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 29 Málaga De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 95,92 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,92 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 94,44 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,92 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 7 29 Málaga De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 36 29 Málaga De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 31 29 Málaga De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 7 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 36 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 31 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 7 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 36 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 31 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 7 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 36 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 31 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 36 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 31 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 29 Málaga De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 29 Málaga De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 29 Málaga De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 93 29 Málaga De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 29 Málaga De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 29 Málaga De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 86 29 Málaga De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 29 Málaga De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 29 Málaga De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 79 29 Málaga De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 29 Málaga De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 93 29 Málaga De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 86 29 Málaga De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 78 29 Málaga De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 93 29 Málaga De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 86 29 Málaga De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 78 29 Málaga De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 84 29 Málaga De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 78 29 Málaga De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 84 29 Málaga De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 78 29 Málaga De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 29 Málaga De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 29 Málaga De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 29 Málaga De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 29 Málaga De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 29 Málaga De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 29 Málaga De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 29 Málaga De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 29 Málaga De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 29 Málaga De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 29 Málaga De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 29 Málaga De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 29 Málaga De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 29 Málaga De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,73 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,73 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,67 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,73 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,67 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,73 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 29 Málaga De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 89 29 Málaga De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 77 29 Málaga De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 44 29 Málaga De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 89 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 77 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 43 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 89 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 77 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 43 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 75 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 43 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 75 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 43 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 29 Málaga De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 29 Málaga De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 29 Málaga De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 97,73 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,73 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,4 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,73 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,4 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,73 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 4 29 Málaga De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 9 29 Málaga De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 35 29 Málaga De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 4 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 9 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 35 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 4 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 9 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 35 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 9 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 35 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 9 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 35 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 29 Málaga De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 29 Málaga De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 29 Málaga De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 29 Málaga De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 29 Málaga De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 29 Málaga De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 91 29 Málaga De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 29 Málaga De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 29 Málaga De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 84 29 Málaga De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 29 Málaga De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 100 29 Málaga De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 91 29 Málaga De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 84 29 Málaga De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 87 29 Málaga De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 84 29 Málaga De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 87 29 Málaga De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 84 29 Málaga De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 87 29 Málaga De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 84 29 Málaga De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 29 Málaga De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 29 Málaga De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 29 Málaga De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 29 Málaga De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 29 Málaga De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 29 Málaga De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 29 Málaga De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 29 Málaga De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 29 Málaga De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 29 Málaga De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 29 Málaga De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 29 Málaga De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 95,6 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95,6 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,6 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 29 Málaga De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 97 29 Málaga De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 82 29 Málaga De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 48 29 Málaga De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 97 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 82 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 48 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 78 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 48 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 78 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 48 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 78 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 48 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 29 Málaga De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 29 Málaga De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 29 Málaga De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 95,12 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,12 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,12 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 3 29 Málaga De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 9 29 Málaga De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 36 29 Málaga De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 3 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 9 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 36 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 9 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 36 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 9 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 36 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 9 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 36 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 29 Málaga De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 29 Málaga De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 29 Málaga De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 29 Málaga De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 30 Murcia Total Cohort January 1 Total Number at the start of the quarter 2022QI 35.351 30 Murcia Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 30 Murcia Total Cohort January 1 Total Number at the start of the quarter 2021QI 33.961 30 Murcia Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 30 Murcia Total Cohort January 1 Total Number at the start of the quarter 2020QI 35.373 30 Murcia Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 30 Murcia Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 30 Murcia Total Cohort January 1 Total Survival in the first trimester 2022QII "" 30 Murcia Total Cohort January 1 Total Survival in the first trimester 2022QI 33.397 30 Murcia Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 30 Murcia Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 30 Murcia Total Cohort January 1 Total Survival in the first trimester 2021QII "" 30 Murcia Total Cohort January 1 Total Survival in the first trimester 2021QI 32.056 30 Murcia Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 30 Murcia Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 30 Murcia Total Cohort January 1 Total Survival in the first trimester 2020QII "" 30 Murcia Total Cohort January 1 Total Survival in the first trimester 2020QI 30.905 30 Murcia Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 30 Murcia Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 30 Murcia Total Cohort January 1 Total Survival in the second trimester 2022QII 31.869 30 Murcia Total Cohort January 1 Total Survival in the second trimester 2022QI "" 30 Murcia Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 30 Murcia Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 30 Murcia Total Cohort January 1 Total Survival in the second trimester 2021QII 30.916 30 Murcia Total Cohort January 1 Total Survival in the second trimester 2021QI "" 30 Murcia Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 30 Murcia Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 30 Murcia Total Cohort January 1 Total Survival in the second trimester 2020QII 29.808 30 Murcia Total Cohort January 1 Total Survival in the second trimester 2020QI "" 30 Murcia Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 30 Murcia Total Cohort January 1 Total Survival in the third trimester 2022QIII 30.682 30 Murcia Total Cohort January 1 Total Survival in the third trimester 2022QII "" 30 Murcia Total Cohort January 1 Total Survival in the third trimester 2022QI "" 30 Murcia Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 30 Murcia Total Cohort January 1 Total Survival in the third trimester 2021QIII 29.945 30 Murcia Total Cohort January 1 Total Survival in the third trimester 2021QII "" 30 Murcia Total Cohort January 1 Total Survival in the third trimester 2021QI "" 30 Murcia Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 30 Murcia Total Cohort January 1 Total Survival in the third trimester 2020QIII 28.853 30 Murcia Total Cohort January 1 Total Survival in the third trimester 2020QII "" 30 Murcia Total Cohort January 1 Total Survival in the third trimester 2020QI "" 30 Murcia Total Cohort January 1 Total Survival in the third trimester 2022QIV 29.801 30 Murcia Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 30 Murcia Total Cohort January 1 Total Survival in the third trimester 2022QII "" 30 Murcia Total Cohort January 1 Total Survival in the third trimester 2022QI "" 30 Murcia Total Cohort January 1 Total Survival in the third trimester 2021QIV 29.199 30 Murcia Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 30 Murcia Total Cohort January 1 Total Survival in the third trimester 2021QII "" 30 Murcia Total Cohort January 1 Total Survival in the third trimester 2021QI "" 30 Murcia Total Cohort January 1 Total Survival in the third trimester 2020QIV 28.031 30 Murcia Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 30 Murcia Total Cohort January 1 Total Survival in the third trimester 2020QII "" 30 Murcia Total Cohort January 1 Total Survival in the third trimester 2020QI "" 30 Murcia Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 30 Murcia Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 30 Murcia Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 30 Murcia Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 30 Murcia Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 30 Murcia Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 30 Murcia Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,47 30 Murcia Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,39 30 Murcia Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 87,37 30 Murcia Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,15 30 Murcia Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,03 30 Murcia Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 84,27 30 Murcia Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,79 30 Murcia Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 88,17 30 Murcia Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 81,57 30 Murcia Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 84,3 30 Murcia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,98 30 Murcia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 79,24 30 Murcia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 30 Murcia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 30 Murcia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 34.007 30 Murcia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 31.017 30 Murcia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 32.104 30 Murcia Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 29.196 30 Murcia Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 30.617 30 Murcia Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 28.119 30 Murcia Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 29.465 30 Murcia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 27.212 30 Murcia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 28.616 30 Murcia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 26.523 30 Murcia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 30 Murcia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 30 Murcia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,4 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,13 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,03 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,66 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,64 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,73 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 84,15 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,51 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.344 30 Murcia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2.944 30 Murcia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.293 30 Murcia Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2.860 30 Murcia Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.252 30 Murcia Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2.797 30 Murcia Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.217 30 Murcia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2.733 30 Murcia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.185 30 Murcia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2.676 30 Murcia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 30 Murcia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 30 Murcia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,21 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,15 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,15 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,01 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,55 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,83 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,17 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 90,9 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia Total Cohort April 1 Total Number at the start of the quarter 2022QII 35.420 30 Murcia Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 30 Murcia Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia Total Cohort April 1 Total Number at the start of the quarter 2021QII 34.026 30 Murcia Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 30 Murcia Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia Total Cohort April 1 Total Number at the start of the quarter 2020QII 32.456 30 Murcia Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 30 Murcia Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 30 Murcia Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 30 Murcia Total Cohort April 1 Total Survival in the first trimester 2022QII 33.491 30 Murcia Total Cohort April 1 Total Survival in the first trimester 2022QI "" 30 Murcia Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 30 Murcia Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 30 Murcia Total Cohort April 1 Total Survival in the first trimester 2021QII 32.541 30 Murcia Total Cohort April 1 Total Survival in the first trimester 2021QI "" 30 Murcia Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 30 Murcia Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 30 Murcia Total Cohort April 1 Total Survival in the first trimester 2020QII 31.083 30 Murcia Total Cohort April 1 Total Survival in the first trimester 2020QI "" 30 Murcia Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 30 Murcia Total Cohort April 1 Total Survival in the second trimester 2022QIII 32.056 30 Murcia Total Cohort April 1 Total Survival in the second trimester 2022QII "" 30 Murcia Total Cohort April 1 Total Survival in the second trimester 2022QI "" 30 Murcia Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 30 Murcia Total Cohort April 1 Total Survival in the second trimester 2021QIII 31.307 30 Murcia Total Cohort April 1 Total Survival in the second trimester 2021QII "" 30 Murcia Total Cohort April 1 Total Survival in the second trimester 2021QI "" 30 Murcia Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 30 Murcia Total Cohort April 1 Total Survival in the second trimester 2020QIII 29.977 30 Murcia Total Cohort April 1 Total Survival in the second trimester 2020QII "" 30 Murcia Total Cohort April 1 Total Survival in the second trimester 2020QI "" 30 Murcia Total Cohort April 1 Total Survival in the third trimester 2022QIV 30.966 30 Murcia Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 30 Murcia Total Cohort April 1 Total Survival in the third trimester 2022QII "" 30 Murcia Total Cohort April 1 Total Survival in the third trimester 2022QI "" 30 Murcia Total Cohort April 1 Total Survival in the third trimester 2021QIV 30.345 30 Murcia Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 30 Murcia Total Cohort April 1 Total Survival in the third trimester 2021QII "" 30 Murcia Total Cohort April 1 Total Survival in the third trimester 2021QI "" 30 Murcia Total Cohort April 1 Total Survival in the third trimester 2020QIV 29.024 30 Murcia Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 30 Murcia Total Cohort April 1 Total Survival in the third trimester 2020QII "" 30 Murcia Total Cohort April 1 Total Survival in the third trimester 2020QI "" 30 Murcia Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 30 Murcia Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 30 Murcia Total Cohort April 1 Total Survival in the third trimester 2022QII "" 30 Murcia Total Cohort April 1 Total Survival in the third trimester 2022QI 29.304 30 Murcia Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 30 Murcia Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 30 Murcia Total Cohort April 1 Total Survival in the third trimester 2021QII "" 30 Murcia Total Cohort April 1 Total Survival in the third trimester 2021QI 27.940 30 Murcia Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 30 Murcia Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 30 Murcia Total Cohort April 1 Total Survival in the third trimester 2020QII "" 30 Murcia Total Cohort April 1 Total Survival in the third trimester 2020QI "" 30 Murcia Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 30 Murcia Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 30 Murcia Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 30 Murcia Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 30 Murcia Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 30 Murcia Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,55 30 Murcia Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,64 30 Murcia Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,77 30 Murcia Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,5 30 Murcia Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,01 30 Murcia Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,36 30 Murcia Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,43 30 Murcia Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 89,18 30 Murcia Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,43 30 Murcia Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 86,12 30 Murcia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 86,09 30 Murcia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 30 Murcia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 30 Murcia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 34.106 30 Murcia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 31.055 30 Murcia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 26.779 30 Murcia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 32.228 30 Murcia Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 29.637 30 Murcia Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 25.491 30 Murcia Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 30.839 30 Murcia Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 28.474 30 Murcia Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 24.523 30 Murcia Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 29.775 30 Murcia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 27.569 30 Murcia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 23.748 30 Murcia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 26.612 30 Murcia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 22.840 30 Murcia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 30 Murcia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 30 Murcia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 30 Murcia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,49 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,43 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,19 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,42 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,69 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,58 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,3 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 88,77 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,68 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 85,69 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 85,29 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.314 30 Murcia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 2.971 30 Murcia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 5.677 30 Murcia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.263 30 Murcia Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 2.904 30 Murcia Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 5.592 30 Murcia Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.217 30 Murcia Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 2.833 30 Murcia Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 5.454 30 Murcia Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.191 30 Murcia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 2.776 30 Murcia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 5.276 30 Murcia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 2.692 30 Murcia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 5.100 30 Murcia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 30 Murcia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 30 Murcia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 30 Murcia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,12 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,74 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,5 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 92,62 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,36 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,07 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 90,64 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,44 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 92,94 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 90,61 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 89,84 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia Total Cohort July 1 Total Number at the start of the quarter 2022QIII 35.662 30 Murcia Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 30 Murcia Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 30 Murcia Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia Total Cohort July 1 Total Number at the start of the quarter 2021QIII 34.995 30 Murcia Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 30 Murcia Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 30 Murcia Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia Total Cohort July 1 Total Number at the start of the quarter 2020QIII 34.000 30 Murcia Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 30 Murcia Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 30 Murcia Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 30 Murcia Total Cohort July 1 Total Survival in the first trimester 2022QIII 33.598 30 Murcia Total Cohort July 1 Total Survival in the first trimester 2022QII "" 30 Murcia Total Cohort July 1 Total Survival in the first trimester 2022QI "" 30 Murcia Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 30 Murcia Total Cohort July 1 Total Survival in the first trimester 2021QIII 33.068 30 Murcia Total Cohort July 1 Total Survival in the first trimester 2021QII "" 30 Murcia Total Cohort July 1 Total Survival in the first trimester 2021QI "" 30 Murcia Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 30 Murcia Total Cohort July 1 Total Survival in the first trimester 2020QIII 32.134 30 Murcia Total Cohort July 1 Total Survival in the first trimester 2020QII "" 30 Murcia Total Cohort July 1 Total Survival in the first trimester 2020QI "" 30 Murcia Total Cohort July 1 Total Survival in the second trimester 2022QIV 32.137 30 Murcia Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 30 Murcia Total Cohort July 1 Total Survival in the second trimester 2022QII "" 30 Murcia Total Cohort July 1 Total Survival in the second trimester 2022QI "" 30 Murcia Total Cohort July 1 Total Survival in the second trimester 2021QIV 31.747 30 Murcia Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 30 Murcia Total Cohort July 1 Total Survival in the second trimester 2021QII "" 30 Murcia Total Cohort July 1 Total Survival in the second trimester 2021QI "" 30 Murcia Total Cohort July 1 Total Survival in the second trimester 2020QIV 30.753 30 Murcia Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 30 Murcia Total Cohort July 1 Total Survival in the second trimester 2020QII "" 30 Murcia Total Cohort July 1 Total Survival in the second trimester 2020QI "" 30 Murcia Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 30 Murcia Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 30 Murcia Total Cohort July 1 Total Survival in the third trimester 2022QII "" 30 Murcia Total Cohort July 1 Total Survival in the third trimester 2022QI 30.525 30 Murcia Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 30 Murcia Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 30 Murcia Total Cohort July 1 Total Survival in the third trimester 2021QII "" 30 Murcia Total Cohort July 1 Total Survival in the third trimester 2021QI 29.500 30 Murcia Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 30 Murcia Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 30 Murcia Total Cohort July 1 Total Survival in the third trimester 2020QII "" 30 Murcia Total Cohort July 1 Total Survival in the third trimester 2020QI "" 30 Murcia Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 30 Murcia Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 30 Murcia Total Cohort July 1 Total Survival in the third trimester 2022QII 29.552 30 Murcia Total Cohort July 1 Total Survival in the third trimester 2022QI "" 30 Murcia Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 30 Murcia Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 30 Murcia Total Cohort July 1 Total Survival in the third trimester 2021QII 28.763 30 Murcia Total Cohort July 1 Total Survival in the third trimester 2021QI "" 30 Murcia Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 30 Murcia Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 30 Murcia Total Cohort July 1 Total Survival in the third trimester 2020QII "" 30 Murcia Total Cohort July 1 Total Survival in the third trimester 2020QI "" 30 Murcia Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 30 Murcia Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 30 Murcia Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 30 Murcia Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 30 Murcia Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 30 Murcia Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 30 Murcia Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 30 Murcia Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 30 Murcia Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,21 30 Murcia Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,49 30 Murcia Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,51 30 Murcia Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 90,12 30 Murcia Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,72 30 Murcia Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,45 30 Murcia Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 87,23 30 Murcia Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,76 30 Murcia Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 84,45 30 Murcia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,6 30 Murcia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 30 Murcia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 30 Murcia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 34.543 30 Murcia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 33.917 30 Murcia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 30.804 30 Murcia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 32.519 30 Murcia Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 32.022 30 Murcia Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 29.011 30 Murcia Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 31.082 30 Murcia Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 30.723 30 Murcia Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 27.733 30 Murcia Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 29.527 30 Murcia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 26.568 30 Murcia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 28.575 30 Murcia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 25.884 30 Murcia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 30 Murcia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 30 Murcia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 30 Murcia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,14 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,41 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,18 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,98 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 90,58 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,03 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 87,06 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,25 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 84,25 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 84,03 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1.119 30 Murcia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.078 30 Murcia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 3.196 30 Murcia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1.079 30 Murcia Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.046 30 Murcia Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 3.123 30 Murcia Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1.055 30 Murcia Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1.024 30 Murcia Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 3.020 30 Murcia Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 998 30 Murcia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2.932 30 Murcia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 977 30 Murcia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 2.879 30 Murcia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 30 Murcia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 30 Murcia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 30 Murcia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,43 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,03 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,72 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,28 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 94,99 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,49 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 92,58 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 91,74 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 90,63 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 90,08 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia Total Cohort October 1 Total Number at the start of the quarter 2022QIV 35.285 30 Murcia Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 30 Murcia Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 30 Murcia Total Cohort October 1 Total Number at the start of the quarter 2021QIV 34.897 30 Murcia Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 30 Murcia Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 30 Murcia Total Cohort October 1 Total Number at the start of the quarter 2020QIV 33.910 30 Murcia Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 30 Murcia Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 30 Murcia Total Cohort October 1 Total Survival in the first trimester 2022QIV 33.473 30 Murcia Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 30 Murcia Total Cohort October 1 Total Survival in the first trimester 2022QII "" 30 Murcia Total Cohort October 1 Total Survival in the first trimester 2022QI "" 30 Murcia Total Cohort October 1 Total Survival in the first trimester 2021QIV 33.168 30 Murcia Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 30 Murcia Total Cohort October 1 Total Survival in the first trimester 2021QII "" 30 Murcia Total Cohort October 1 Total Survival in the first trimester 2021QI "" 30 Murcia Total Cohort October 1 Total Survival in the first trimester 2020QIV 32.111 30 Murcia Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 30 Murcia Total Cohort October 1 Total Survival in the first trimester 2020QII "" 30 Murcia Total Cohort October 1 Total Survival in the first trimester 2020QI "" 30 Murcia Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 30 Murcia Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 30 Murcia Total Cohort October 1 Total Survival in the second trimester 2022QII "" 30 Murcia Total Cohort October 1 Total Survival in the second trimester 2022QI 31.730 30 Murcia Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 30 Murcia Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 30 Murcia Total Cohort October 1 Total Survival in the second trimester 2021QII "" 30 Murcia Total Cohort October 1 Total Survival in the second trimester 2021QI 30.657 30 Murcia Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 30 Murcia Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 30 Murcia Total Cohort October 1 Total Survival in the second trimester 2020QII "" 30 Murcia Total Cohort October 1 Total Survival in the second trimester 2020QI "" 30 Murcia Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 30 Murcia Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 30 Murcia Total Cohort October 1 Total Survival in the third trimester 2022QII 30.557 30 Murcia Total Cohort October 1 Total Survival in the third trimester 2022QI "" 30 Murcia Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 30 Murcia Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 30 Murcia Total Cohort October 1 Total Survival in the third trimester 2021QII 29.773 30 Murcia Total Cohort October 1 Total Survival in the third trimester 2021QI "" 30 Murcia Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 30 Murcia Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 30 Murcia Total Cohort October 1 Total Survival in the third trimester 2020QII "" 30 Murcia Total Cohort October 1 Total Survival in the third trimester 2020QI "" 30 Murcia Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 30 Murcia Total Cohort October 1 Total Survival in the third trimester 2022QIII 29.587 30 Murcia Total Cohort October 1 Total Survival in the third trimester 2022QII "" 30 Murcia Total Cohort October 1 Total Survival in the third trimester 2022QI "" 30 Murcia Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 30 Murcia Total Cohort October 1 Total Survival in the third trimester 2021QIII 28.971 30 Murcia Total Cohort October 1 Total Survival in the third trimester 2021QII "" 30 Murcia Total Cohort October 1 Total Survival in the third trimester 2021QI "" 30 Murcia Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 30 Murcia Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 30 Murcia Total Cohort October 1 Total Survival in the third trimester 2020QII "" 30 Murcia Total Cohort October 1 Total Survival in the third trimester 2020QI "" 30 Murcia Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 30 Murcia Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 30 Murcia Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 30 Murcia Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 30 Murcia Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 30 Murcia Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 30 Murcia Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 30 Murcia Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 30 Murcia Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,86 30 Murcia Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,05 30 Murcia Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,69 30 Murcia Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,92 30 Murcia Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,41 30 Murcia Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,56 30 Murcia Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 87,8 30 Murcia Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 84,78 30 Murcia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 85,43 30 Murcia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 30 Murcia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 30 Murcia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 34.279 30 Murcia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 33.478 30 Murcia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 30.534 30 Murcia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 32.487 30 Murcia Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 31.777 30 Murcia Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 28.849 30 Murcia Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 30.386 30 Murcia Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 27.494 30 Murcia Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 29.246 30 Murcia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 26.674 30 Murcia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 28.313 30 Murcia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 25.943 30 Murcia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 30 Murcia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 30 Murcia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 30 Murcia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,77 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,92 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,48 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,76 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 90,04 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 87,36 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 87,36 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 84,57 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 84,96 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1.006 30 Murcia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.419 30 Murcia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 3.376 30 Murcia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 986 30 Murcia Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.391 30 Murcia Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 3.262 30 Murcia Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.344 30 Murcia Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 3.163 30 Murcia Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.311 30 Murcia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 3.099 30 Murcia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.274 30 Murcia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 3.028 30 Murcia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 30 Murcia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 30 Murcia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 30 Murcia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,01 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,03 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,62 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,71 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 93,69 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 92,39 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 91,8 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 89,78 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 89,69 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 30 Murcia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 25.693 30 Murcia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 30 Murcia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 24.981 30 Murcia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 25.774 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 23.861 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 23.224 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 21.650 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 22.479 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 22.184 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 20.659 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 21.404 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 21.293 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 19.818 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 20.623 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 20.630 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 19.096 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 30 Murcia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 30 Murcia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 30 Murcia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 30 Murcia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 92,87 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 92,97 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 84 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 87,49 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 88,8 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 80,15 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 83,31 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 85,24 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 76,89 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 80,27 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 82,58 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 74,09 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 24.900 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 23.533 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 23.112 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 21.847 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 21.766 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 20.858 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 20.720 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 20.016 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 19.965 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 19.398 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,82 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 92,84 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 87,41 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 88,63 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 83,21 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 85,06 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 80,18 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 82,43 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 793 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.448 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 749 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.377 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 713 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.326 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 684 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.277 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 658 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.232 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,45 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,1 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 89,91 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 91,57 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 86,25 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 88,19 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 82,98 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 85,08 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 25.695 30 Murcia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 24.982 30 Murcia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 23.866 30 Murcia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 23.911 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 23.606 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 22.576 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 22.589 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 22.450 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 21.558 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 21.615 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 21.590 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 20.676 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 20.661 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 19.741 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 30 Murcia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 30 Murcia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 30 Murcia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 30 Murcia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,06 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,49 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,59 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 87,91 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 89,86 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 90,33 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 84,12 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 86,42 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 86,63 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 82,7 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 82,72 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 24.926 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 23.433 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 20.503 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 23.188 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 22.115 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 19.288 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 21.908 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 21.023 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 18.390 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 20.955 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 20.211 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 17.657 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 19.353 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 16.863 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,03 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,38 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,07 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 87,89 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,72 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 89,69 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 84,07 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 86,25 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 86,12 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 82,59 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 82,25 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 769 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.549 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 3.363 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 723 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.491 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 3.288 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 681 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.427 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 3.168 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 660 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.379 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 3.019 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.308 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.878 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 94,02 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,26 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,77 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 88,56 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 92,12 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,2 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 85,83 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 89,03 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 89,77 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 84,44 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 85,58 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 25.562 30 Murcia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 25.380 30 Murcia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 24.897 30 Murcia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 23.666 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 23.570 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 23.158 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 22.409 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 22.414 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 21.899 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 21.315 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 20.806 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 20.448 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 20.142 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 30 Murcia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 30 Murcia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 30 Murcia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,58 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,87 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 93,02 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 87,67 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 88,31 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 87,96 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 83,98 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 83,57 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 80,57 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 80,9 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 24.946 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 24.843 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 23.338 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 23.086 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 23.062 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 21.667 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 21.848 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 21.925 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 20.494 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 20.847 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 19.473 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 19.995 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 18.850 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,54 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,83 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 92,84 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,58 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 88,25 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 87,81 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 83,91 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 83,44 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 80,49 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 80,77 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 616 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 537 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.559 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 580 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 508 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.491 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 561 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 489 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.405 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 468 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.333 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 453 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.292 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 94,16 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 94,6 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 95,64 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 91,07 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 91,06 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 90,12 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 87,15 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 85,5 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 84,36 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 82,87 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 25.491 30 Murcia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 25.462 30 Murcia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 24.886 30 Murcia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 23.824 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 23.846 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 23.181 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 22.525 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 21.883 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 21.471 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 21.083 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 20.604 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 20.354 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 30 Murcia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 30 Murcia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 30 Murcia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,46 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,65 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,15 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,47 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 87,93 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 84,33 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 84,72 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 80,92 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 81,79 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 24.965 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 24.592 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 23.231 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 23.314 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 22.999 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 21.627 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 21.722 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 20.408 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 20.697 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 19.660 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 19.864 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 18.983 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,39 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 93,52 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,1 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,33 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 87,85 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 84,16 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 84,63 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 80,77 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 81,71 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 526 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 870 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.655 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 510 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 847 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.554 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 803 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.475 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 774 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.423 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 740 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.371 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,96 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,36 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 93,9 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 92,3 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 89,12 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 88,97 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 85,98 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 85,06 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 82,84 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 4.038 30 Murcia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 3.819 30 Murcia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 4.060 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 3.981 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 3.750 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 3.849 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 3.907 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 3.693 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 3.793 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 3.854 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 3.642 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 3.729 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 3.798 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 3.600 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 3.668 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 30 Murcia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 30 Murcia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,59 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,19 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 94,8 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,76 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,7 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 93,42 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 95,44 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,37 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 91,85 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 94,06 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,27 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 90,34 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 3.824 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 3.282 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 3.769 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 3.219 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 3.698 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 3.168 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 3.647 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 3.127 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 3.594 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 3.092 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,56 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,08 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,71 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,53 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,37 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,28 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,99 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,21 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 214 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 537 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 212 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 531 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 209 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 525 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 207 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 515 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 204 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 508 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,07 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,88 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,66 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,77 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,73 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,9 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 95,33 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 94,6 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 4.039 30 Murcia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 3.836 30 Murcia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 3.614 30 Murcia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 3.967 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 3.766 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 3.576 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 3.907 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 3.720 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 3.529 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 3.838 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 3.665 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 3.485 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 3.605 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 3.403 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 30 Murcia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 30 Murcia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 30 Murcia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,22 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,18 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,95 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,73 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,98 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,65 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,02 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,54 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,43 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,98 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,16 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 3.827 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 3.328 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2.690 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 3.758 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 3.264 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2.656 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 3.701 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 3.221 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2.617 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 3.633 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 3.171 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.592 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 3.117 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.527 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,2 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,08 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,74 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,71 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,78 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,29 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 94,93 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,28 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,36 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,66 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 93,94 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 212 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 508 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 924 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 209 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 502 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 920 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 206 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 499 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 912 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 205 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 494 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 893 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 488 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 876 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,58 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,82 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,57 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,17 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,23 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,7 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,7 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,24 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,65 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,06 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,81 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 4.201 30 Murcia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 4.083 30 Murcia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 3.889 30 Murcia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 4.105 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 4.015 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 3.821 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 3.984 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 3.915 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 3.741 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 3.851 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 3.659 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 3.798 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 3.610 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 30 Murcia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 30 Murcia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 30 Murcia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,71 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,33 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,25 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 94,83 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 95,89 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 96,19 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 94,32 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 94,09 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 93,02 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 92,83 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 4.022 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 3.895 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 3.310 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 3.929 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 3.829 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 3.247 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 3.809 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 3.731 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 3.175 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 3.667 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 3.100 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 3.618 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 3.055 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,69 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,31 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,1 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 94,7 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 95,79 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 95,92 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 94,15 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 93,66 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 92,89 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 92,3 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 179 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 188 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 579 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 176 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 186 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 574 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 175 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 184 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 566 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 184 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 559 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 180 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 555 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,32 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,94 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,14 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,77 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,87 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,75 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,87 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,55 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 95,74 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,85 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 4.087 30 Murcia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 3.981 30 Murcia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 3.878 30 Murcia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 3.991 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 3.921 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 3.818 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 3.852 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 3.733 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 3.793 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 3.681 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 3.740 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 3.640 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 30 Murcia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 30 Murcia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 30 Murcia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,65 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,49 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,45 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,76 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,26 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95,28 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 94,92 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 93,95 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 93,86 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 3.913 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3.773 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 3.247 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 3.819 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 3.716 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 3.195 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 3.650 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 3.122 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 3.594 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 3.075 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 3.542 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 3.044 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,6 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,49 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,4 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,74 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,15 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,26 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 94,7 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 93,88 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,75 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 174 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 208 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 631 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 172 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 205 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 623 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 202 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 611 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 199 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 606 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 198 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 596 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,85 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,56 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,73 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 97,12 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,83 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 95,67 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 96,04 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 95,19 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 94,45 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 30 Murcia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 5.313 30 Murcia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 30 Murcia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 4.847 30 Murcia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 5.231 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 5.250 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 4.773 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 5.101 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 5.181 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 4.732 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 5.053 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 5.126 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 4.707 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 5.006 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 5.086 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 4.668 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 4.969 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 30 Murcia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 30 Murcia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 30 Murcia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 30 Murcia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,81 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,47 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,51 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,52 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,63 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,6 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,48 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,11 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,7 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,73 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,31 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,99 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 4.999 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 3.965 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 4.941 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 3.897 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 4.874 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 3.862 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 4.823 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 3.842 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 4.786 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 3.808 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,84 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,28 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,5 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,4 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,48 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,9 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,74 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,04 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 314 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 882 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 309 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 876 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 307 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 870 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 303 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 865 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 300 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 860 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,41 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,32 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,77 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,64 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,5 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,07 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 95,54 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,51 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 5.366 30 Murcia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 4.901 30 Murcia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 4.681 30 Murcia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 5.298 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 4.862 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 4.638 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 5.249 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 4.836 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 4.600 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 5.206 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 4.791 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 4.575 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 4.739 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 4.512 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 30 Murcia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 30 Murcia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 30 Murcia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 30 Murcia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,73 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,2 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,08 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,82 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,67 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,27 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,02 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,76 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,74 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,69 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,39 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 5.056 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 4.059 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 3.359 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 4.990 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 4.023 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 3.322 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 4.941 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 4.001 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 3.294 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 4.902 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 3.960 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 3.279 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 3.915 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 3.233 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,69 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,11 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,9 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,73 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,57 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,06 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,95 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,56 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,62 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,45 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,25 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 310 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 842 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.322 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 308 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 839 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.316 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 308 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 835 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.306 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 304 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 831 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.296 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 824 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.279 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,35 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,64 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,55 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 99,35 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,17 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,79 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 98,06 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,69 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,03 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,86 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,75 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 5.561 30 Murcia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 5.213 30 Murcia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 4.916 30 Murcia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 5.495 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 5.169 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 4.865 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 5.416 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 5.107 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 4.824 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 5.050 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 4.751 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 4.998 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 4.727 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 30 Murcia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 30 Murcia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 30 Murcia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,81 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,16 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,96 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,39 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,97 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,13 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,87 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,64 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,88 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,16 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 5.259 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 4.885 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 3.930 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 5.193 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 4.842 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 3.879 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 5.118 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 4.781 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 3.847 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 4.729 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 3.782 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 4.679 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 3.766 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,75 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,12 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,7 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,32 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,87 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,89 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,81 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,23 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,78 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,83 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 302 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 328 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 986 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 302 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 327 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 986 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 298 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 326 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 977 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 321 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 969 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 319 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 961 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,7 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,68 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,39 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,09 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,87 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,28 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 97,26 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,46 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 5.385 30 Murcia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 5.153 30 Murcia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 4.845 30 Murcia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 5.340 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 5.105 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 4.812 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 5.059 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 4.745 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 5.001 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 4.715 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 4.953 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 4.686 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 30 Murcia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 30 Murcia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 30 Murcia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,16 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,07 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,32 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,18 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,94 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,05 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,32 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,12 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,72 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 5.096 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 4.830 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 3.833 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 5.053 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 4.784 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 3.805 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 4.738 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 3.745 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 4.681 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 3.722 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 4.635 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 3.701 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,16 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,05 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,27 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,1 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,7 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,92 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,1 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,96 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,56 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 289 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 323 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.012 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 287 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 321 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.007 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 321 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.000 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 320 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 993 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 318 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 985 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,31 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,38 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,51 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 99,38 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,81 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 99,07 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,12 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 98,45 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 97,33 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 30 Murcia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 206 30 Murcia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 30 Murcia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 217 30 Murcia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 215 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 204 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 212 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 213 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 201 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 210 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 211 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 198 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 206 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 209 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 195 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 205 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 207 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 30 Murcia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 30 Murcia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 30 Murcia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 30 Murcia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,03 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 97,7 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,07 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,57 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,77 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,14 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,12 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 94,93 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,21 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 94,66 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,47 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,28 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 188 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 162 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 186 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 158 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 183 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 156 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 180 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 152 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 177 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 151 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,94 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97,53 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,34 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,3 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,74 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 93,83 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 94,15 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 93,21 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 18 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 55 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 18 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 54 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 18 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 54 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 18 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 54 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 18 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 54 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,18 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,18 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,18 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,18 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 217 30 Murcia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 207 30 Murcia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 201 30 Murcia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 212 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 207 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 199 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 209 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 201 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 199 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 206 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 200 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 197 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 200 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 193 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 30 Murcia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 30 Murcia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 30 Murcia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 30 Murcia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,7 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,31 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,1 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 94,93 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,62 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,01 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,62 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,02 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 30 Murcia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 199 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 156 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 156 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 194 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 156 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 154 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 192 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 150 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 154 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 189 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 149 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 152 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 149 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 149 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,49 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,72 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,48 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,15 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,72 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 94,97 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,51 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,44 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,51 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,51 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 18 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 51 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 45 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 18 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 51 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 45 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 17 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 51 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 45 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 17 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 51 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 45 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 51 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 44 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,44 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 94,44 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 97,78 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 229 30 Murcia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 228 30 Murcia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 203 30 Murcia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 225 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 223 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 199 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 223 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 221 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 198 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 219 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 193 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 218 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 193 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 30 Murcia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 30 Murcia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 30 Murcia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,25 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 97,81 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,03 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,38 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 96,93 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,54 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,05 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,07 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,61 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,07 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 213 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 212 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 151 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 210 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 207 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 147 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 208 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 205 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 146 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 203 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 142 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 202 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 142 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,59 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 97,64 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 97,35 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,65 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 96,7 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,69 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,75 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 94,04 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,28 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,04 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 16 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 16 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 52 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 15 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 16 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 52 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 15 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 16 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 52 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 16 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 51 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 16 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 51 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 93,75 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,75 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,08 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,08 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 217 30 Murcia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 210 30 Murcia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 208 30 Murcia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 215 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 205 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 207 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 203 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 203 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 202 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 201 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 200 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 198 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 30 Murcia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 30 Murcia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 30 Murcia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,08 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 97,62 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,52 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,67 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,6 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,19 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,63 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,24 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,19 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 206 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 200 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 150 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 204 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 195 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 149 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 193 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 146 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 192 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 144 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 190 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 142 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,03 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 97,5 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,33 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,5 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,33 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 94,67 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 11 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 10 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 58 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 11 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 10 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 58 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 10 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 57 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 10 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 57 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 10 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 56 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,28 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,28 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,55 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 30 Murcia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 101 30 Murcia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 30 Murcia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 97 30 Murcia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 30 Murcia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 93 30 Murcia De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 101 30 Murcia De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 97 30 Murcia De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 92 30 Murcia De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 101 30 Murcia De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 97 30 Murcia De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 92 30 Murcia De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 100 30 Murcia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 97 30 Murcia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 91 30 Murcia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 99 30 Murcia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 96 30 Murcia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 91 30 Murcia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 30 Murcia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 30 Murcia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 30 Murcia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 30 Murcia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 30 Murcia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 30 Murcia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 30 Murcia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,92 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,92 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 99,01 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,85 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,02 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,97 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,85 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 30 Murcia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 96 30 Murcia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 75 30 Murcia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 96 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 75 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 96 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 75 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 95 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 75 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 94 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 74 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 30 Murcia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 30 Murcia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,96 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,92 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,67 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 5 30 Murcia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 22 30 Murcia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 5 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 22 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 5 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 22 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 5 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 22 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 5 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 22 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 30 Murcia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 30 Murcia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 103 30 Murcia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 30 Murcia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 30 Murcia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 30 Murcia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 94 30 Murcia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 103 30 Murcia De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 100 30 Murcia De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 94 30 Murcia De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 102 30 Murcia De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 100 30 Murcia De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 91 30 Murcia De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 101 30 Murcia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 99 30 Murcia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 91 30 Murcia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 99 30 Murcia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 91 30 Murcia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 30 Murcia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 30 Murcia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 30 Murcia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 30 Murcia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 30 Murcia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 30 Murcia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 30 Murcia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,03 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 96,81 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,06 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 99 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,81 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 99 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,81 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 30 Murcia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 98 30 Murcia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 79 30 Murcia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 71 30 Murcia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 98 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 79 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 71 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 97 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 79 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 68 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 96 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 78 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 68 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 78 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 68 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 30 Murcia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 30 Murcia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 30 Murcia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,98 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 95,77 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,96 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98,73 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,77 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 98,73 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,77 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 5 30 Murcia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 21 30 Murcia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 23 30 Murcia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 5 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 21 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 23 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 5 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 21 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 23 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 5 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 21 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 23 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 21 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 23 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 30 Murcia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 30 Murcia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 30 Murcia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 109 30 Murcia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 30 Murcia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 30 Murcia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 91 30 Murcia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 30 Murcia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 30 Murcia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 95 30 Murcia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 30 Murcia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 107 30 Murcia De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 91 30 Murcia De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 91 30 Murcia De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 105 30 Murcia De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 90 30 Murcia De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 91 30 Murcia De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 90 30 Murcia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 91 30 Murcia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 90 30 Murcia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 91 30 Murcia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 30 Murcia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 30 Murcia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 30 Murcia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 30 Murcia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 30 Murcia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 30 Murcia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 30 Murcia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 30 Murcia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 30 Murcia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 30 Murcia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 30 Murcia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 30 Murcia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 30 Murcia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,17 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,79 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,33 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,9 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 95,79 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,9 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,79 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,9 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,79 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 30 Murcia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 103 30 Murcia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 82 30 Murcia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 75 30 Murcia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 101 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 82 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 71 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 99 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 81 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 71 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 81 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 71 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 81 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 71 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 30 Murcia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 30 Murcia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 30 Murcia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,06 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,67 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,12 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,78 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 94,67 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,78 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 94,67 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,78 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,67 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 6 30 Murcia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 9 30 Murcia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 20 30 Murcia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 6 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 9 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 20 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 6 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 9 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 20 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 9 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 20 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 9 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 20 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 30 Murcia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 30 Murcia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 30 Murcia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 105 30 Murcia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 30 Murcia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 30 Murcia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 91 30 Murcia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 30 Murcia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 30 Murcia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 93 30 Murcia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 30 Murcia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 103 30 Murcia De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 91 30 Murcia De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 93 30 Murcia De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 91 30 Murcia De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 93 30 Murcia De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 90 30 Murcia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 93 30 Murcia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 90 30 Murcia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 93 30 Murcia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 30 Murcia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 30 Murcia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 30 Murcia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 30 Murcia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 30 Murcia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 30 Murcia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 30 Murcia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 30 Murcia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 30 Murcia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 30 Murcia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 30 Murcia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 30 Murcia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,1 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,9 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,9 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 30 Murcia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 99 30 Murcia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 83 30 Murcia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 73 30 Murcia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 97 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 83 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 73 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 83 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 73 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 82 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 73 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 82 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 73 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 30 Murcia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 30 Murcia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 30 Murcia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,98 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,8 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,8 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 6 30 Murcia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 8 30 Murcia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 20 30 Murcia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 6 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 8 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 20 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 8 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 20 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 8 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 20 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 8 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 20 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 30 Murcia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 30 Murcia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 30 Murcia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 30 Murcia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 31 Navarra Total Cohort January 1 Total Number at the start of the quarter 2022QI 14.719 31 Navarra Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 31 Navarra Total Cohort January 1 Total Number at the start of the quarter 2021QI 14.334 31 Navarra Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 31 Navarra Total Cohort January 1 Total Number at the start of the quarter 2020QI 14.803 31 Navarra Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 31 Navarra Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 31 Navarra Total Cohort January 1 Total Survival in the first trimester 2022QII "" 31 Navarra Total Cohort January 1 Total Survival in the first trimester 2022QI 13.988 31 Navarra Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 31 Navarra Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 31 Navarra Total Cohort January 1 Total Survival in the first trimester 2021QII "" 31 Navarra Total Cohort January 1 Total Survival in the first trimester 2021QI 13.696 31 Navarra Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 31 Navarra Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 31 Navarra Total Cohort January 1 Total Survival in the first trimester 2020QII "" 31 Navarra Total Cohort January 1 Total Survival in the first trimester 2020QI 13.609 31 Navarra Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 31 Navarra Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 31 Navarra Total Cohort January 1 Total Survival in the second trimester 2022QII 13.410 31 Navarra Total Cohort January 1 Total Survival in the second trimester 2022QI "" 31 Navarra Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 31 Navarra Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 31 Navarra Total Cohort January 1 Total Survival in the second trimester 2021QII 13.163 31 Navarra Total Cohort January 1 Total Survival in the second trimester 2021QI "" 31 Navarra Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 31 Navarra Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 31 Navarra Total Cohort January 1 Total Survival in the second trimester 2020QII 13.140 31 Navarra Total Cohort January 1 Total Survival in the second trimester 2020QI "" 31 Navarra Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 31 Navarra Total Cohort January 1 Total Survival in the third trimester 2022QIII 13.055 31 Navarra Total Cohort January 1 Total Survival in the third trimester 2022QII "" 31 Navarra Total Cohort January 1 Total Survival in the third trimester 2022QI "" 31 Navarra Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 31 Navarra Total Cohort January 1 Total Survival in the third trimester 2021QIII 12.850 31 Navarra Total Cohort January 1 Total Survival in the third trimester 2021QII "" 31 Navarra Total Cohort January 1 Total Survival in the third trimester 2021QI "" 31 Navarra Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 31 Navarra Total Cohort January 1 Total Survival in the third trimester 2020QIII 12.817 31 Navarra Total Cohort January 1 Total Survival in the third trimester 2020QII "" 31 Navarra Total Cohort January 1 Total Survival in the third trimester 2020QI "" 31 Navarra Total Cohort January 1 Total Survival in the third trimester 2022QIV 12.713 31 Navarra Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 31 Navarra Total Cohort January 1 Total Survival in the third trimester 2022QII "" 31 Navarra Total Cohort January 1 Total Survival in the third trimester 2022QI "" 31 Navarra Total Cohort January 1 Total Survival in the third trimester 2021QIV 12.540 31 Navarra Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 31 Navarra Total Cohort January 1 Total Survival in the third trimester 2021QII "" 31 Navarra Total Cohort January 1 Total Survival in the third trimester 2021QI "" 31 Navarra Total Cohort January 1 Total Survival in the third trimester 2020QIV 12.512 31 Navarra Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 31 Navarra Total Cohort January 1 Total Survival in the third trimester 2020QII "" 31 Navarra Total Cohort January 1 Total Survival in the third trimester 2020QI "" 31 Navarra Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 31 Navarra Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 31 Navarra Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 31 Navarra Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 31 Navarra Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 31 Navarra Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 31 Navarra Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,03 31 Navarra Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,55 31 Navarra Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 91,93 31 Navarra Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 91,11 31 Navarra Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,83 31 Navarra Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 88,77 31 Navarra Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 88,69 31 Navarra Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 89,65 31 Navarra Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 86,58 31 Navarra Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 86,37 31 Navarra Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 87,48 31 Navarra Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 84,52 31 Navarra Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 31 Navarra Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 31 Navarra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 14.108 31 Navarra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 12.698 31 Navarra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 13.392 31 Navarra Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 12.092 31 Navarra Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 12.827 31 Navarra Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 11.589 31 Navarra Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 12.486 31 Navarra Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 11.302 31 Navarra Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 12.152 31 Navarra Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 11.019 31 Navarra Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 31 Navarra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 31 Navarra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,92 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 95,23 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,92 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 91,27 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 88,5 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 89,01 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 86,14 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 86,78 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 611 31 Navarra Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.636 31 Navarra Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 596 31 Navarra Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.604 31 Navarra Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 583 31 Navarra Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.574 31 Navarra Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 569 31 Navarra Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.548 31 Navarra Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 561 31 Navarra Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.521 31 Navarra Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 31 Navarra Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 31 Navarra Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,55 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,04 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 95,42 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,21 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 93,13 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,62 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 91,82 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 92,97 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra Total Cohort April 1 Total Number at the start of the quarter 2022QII 14.673 31 Navarra Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 31 Navarra Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra Total Cohort April 1 Total Number at the start of the quarter 2021QII 14.342 31 Navarra Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 31 Navarra Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra Total Cohort April 1 Total Number at the start of the quarter 2020QII 14.120 31 Navarra Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 31 Navarra Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 31 Navarra Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 31 Navarra Total Cohort April 1 Total Survival in the first trimester 2022QII 13.946 31 Navarra Total Cohort April 1 Total Survival in the first trimester 2022QI "" 31 Navarra Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 31 Navarra Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 31 Navarra Total Cohort April 1 Total Survival in the first trimester 2021QII 13.690 31 Navarra Total Cohort April 1 Total Survival in the first trimester 2021QI "" 31 Navarra Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 31 Navarra Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 31 Navarra Total Cohort April 1 Total Survival in the first trimester 2020QII 13.567 31 Navarra Total Cohort April 1 Total Survival in the first trimester 2020QI "" 31 Navarra Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 31 Navarra Total Cohort April 1 Total Survival in the second trimester 2022QIII 13.504 31 Navarra Total Cohort April 1 Total Survival in the second trimester 2022QII "" 31 Navarra Total Cohort April 1 Total Survival in the second trimester 2022QI "" 31 Navarra Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 31 Navarra Total Cohort April 1 Total Survival in the second trimester 2021QIII 13.289 31 Navarra Total Cohort April 1 Total Survival in the second trimester 2021QII "" 31 Navarra Total Cohort April 1 Total Survival in the second trimester 2021QI "" 31 Navarra Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 31 Navarra Total Cohort April 1 Total Survival in the second trimester 2020QIII 13.189 31 Navarra Total Cohort April 1 Total Survival in the second trimester 2020QII "" 31 Navarra Total Cohort April 1 Total Survival in the second trimester 2020QI "" 31 Navarra Total Cohort April 1 Total Survival in the third trimester 2022QIV 13.101 31 Navarra Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 31 Navarra Total Cohort April 1 Total Survival in the third trimester 2022QII "" 31 Navarra Total Cohort April 1 Total Survival in the third trimester 2022QI "" 31 Navarra Total Cohort April 1 Total Survival in the third trimester 2021QIV 12.921 31 Navarra Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 31 Navarra Total Cohort April 1 Total Survival in the third trimester 2021QII "" 31 Navarra Total Cohort April 1 Total Survival in the third trimester 2021QI "" 31 Navarra Total Cohort April 1 Total Survival in the third trimester 2020QIV 12.845 31 Navarra Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 31 Navarra Total Cohort April 1 Total Survival in the third trimester 2020QII "" 31 Navarra Total Cohort April 1 Total Survival in the third trimester 2020QI "" 31 Navarra Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 31 Navarra Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 31 Navarra Total Cohort April 1 Total Survival in the third trimester 2022QII "" 31 Navarra Total Cohort April 1 Total Survival in the third trimester 2022QI 12.536 31 Navarra Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 31 Navarra Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 31 Navarra Total Cohort April 1 Total Survival in the third trimester 2021QII "" 31 Navarra Total Cohort April 1 Total Survival in the third trimester 2021QI 12.472 31 Navarra Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 31 Navarra Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 31 Navarra Total Cohort April 1 Total Survival in the third trimester 2020QII "" 31 Navarra Total Cohort April 1 Total Survival in the third trimester 2020QI "" 31 Navarra Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 31 Navarra Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 31 Navarra Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 31 Navarra Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 31 Navarra Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 31 Navarra Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,05 31 Navarra Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,45 31 Navarra Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,08 31 Navarra Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 92,03 31 Navarra Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,66 31 Navarra Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,41 31 Navarra Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 89,29 31 Navarra Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 90,09 31 Navarra Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,97 31 Navarra Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 87,41 31 Navarra Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 88,33 31 Navarra Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 31 Navarra Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 31 Navarra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 14.078 31 Navarra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 12.717 31 Navarra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 10.727 31 Navarra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 13.366 31 Navarra Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 12.096 31 Navarra Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 10.242 31 Navarra Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 12.932 31 Navarra Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 11.722 31 Navarra Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 9.927 31 Navarra Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 12.548 31 Navarra Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 11.382 31 Navarra Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 9.658 31 Navarra Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 11.036 31 Navarra Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 9.355 31 Navarra Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 31 Navarra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 31 Navarra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 31 Navarra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,94 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,12 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,48 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,86 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,18 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,54 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 89,13 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 89,5 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 90,03 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 86,78 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 87,21 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 595 31 Navarra Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.625 31 Navarra Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 3.393 31 Navarra Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 580 31 Navarra Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.594 31 Navarra Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 3.325 31 Navarra Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 572 31 Navarra Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.567 31 Navarra Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 3.262 31 Navarra Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 553 31 Navarra Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.539 31 Navarra Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 3.187 31 Navarra Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.500 31 Navarra Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 3.117 31 Navarra Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 31 Navarra Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 31 Navarra Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 31 Navarra Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,48 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,09 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 96,13 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,43 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,14 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 92,94 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,71 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,93 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 92,31 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,87 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra Total Cohort July 1 Total Number at the start of the quarter 2022QIII 14.761 31 Navarra Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 31 Navarra Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 31 Navarra Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra Total Cohort July 1 Total Number at the start of the quarter 2021QIII 14.530 31 Navarra Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 31 Navarra Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 31 Navarra Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra Total Cohort July 1 Total Number at the start of the quarter 2020QIII 14.245 31 Navarra Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 31 Navarra Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 31 Navarra Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 31 Navarra Total Cohort July 1 Total Survival in the first trimester 2022QIII 14.068 31 Navarra Total Cohort July 1 Total Survival in the first trimester 2022QII "" 31 Navarra Total Cohort July 1 Total Survival in the first trimester 2022QI "" 31 Navarra Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 31 Navarra Total Cohort July 1 Total Survival in the first trimester 2021QIII 13.870 31 Navarra Total Cohort July 1 Total Survival in the first trimester 2021QII "" 31 Navarra Total Cohort July 1 Total Survival in the first trimester 2021QI "" 31 Navarra Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 31 Navarra Total Cohort July 1 Total Survival in the first trimester 2020QIII 13.693 31 Navarra Total Cohort July 1 Total Survival in the first trimester 2020QII "" 31 Navarra Total Cohort July 1 Total Survival in the first trimester 2020QI "" 31 Navarra Total Cohort July 1 Total Survival in the second trimester 2022QIV 13.554 31 Navarra Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 31 Navarra Total Cohort July 1 Total Survival in the second trimester 2022QII "" 31 Navarra Total Cohort July 1 Total Survival in the second trimester 2022QI "" 31 Navarra Total Cohort July 1 Total Survival in the second trimester 2021QIV 13.387 31 Navarra Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 31 Navarra Total Cohort July 1 Total Survival in the second trimester 2021QII "" 31 Navarra Total Cohort July 1 Total Survival in the second trimester 2021QI "" 31 Navarra Total Cohort July 1 Total Survival in the second trimester 2020QIV 13.245 31 Navarra Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 31 Navarra Total Cohort July 1 Total Survival in the second trimester 2020QII "" 31 Navarra Total Cohort July 1 Total Survival in the second trimester 2020QI "" 31 Navarra Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 31 Navarra Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 31 Navarra Total Cohort July 1 Total Survival in the third trimester 2022QII "" 31 Navarra Total Cohort July 1 Total Survival in the third trimester 2022QI 12.939 31 Navarra Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 31 Navarra Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 31 Navarra Total Cohort July 1 Total Survival in the third trimester 2021QII "" 31 Navarra Total Cohort July 1 Total Survival in the third trimester 2021QI 12.829 31 Navarra Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 31 Navarra Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 31 Navarra Total Cohort July 1 Total Survival in the third trimester 2020QII "" 31 Navarra Total Cohort July 1 Total Survival in the third trimester 2020QI "" 31 Navarra Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 31 Navarra Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 31 Navarra Total Cohort July 1 Total Survival in the third trimester 2022QII 12.622 31 Navarra Total Cohort July 1 Total Survival in the third trimester 2022QI "" 31 Navarra Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 31 Navarra Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 31 Navarra Total Cohort July 1 Total Survival in the third trimester 2021QII 12.519 31 Navarra Total Cohort July 1 Total Survival in the third trimester 2021QI "" 31 Navarra Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 31 Navarra Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 31 Navarra Total Cohort July 1 Total Survival in the third trimester 2020QII "" 31 Navarra Total Cohort July 1 Total Survival in the third trimester 2020QI "" 31 Navarra Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 31 Navarra Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 31 Navarra Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 31 Navarra Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 31 Navarra Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 31 Navarra Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 31 Navarra Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 31 Navarra Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 31 Navarra Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 95,31 31 Navarra Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,46 31 Navarra Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 96,12 31 Navarra Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 91,82 31 Navarra Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 92,13 31 Navarra Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 92,98 31 Navarra Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 89,05 31 Navarra Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 90,06 31 Navarra Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 86,87 31 Navarra Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 87,88 31 Navarra Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 31 Navarra Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 31 Navarra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 14.272 31 Navarra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 13.920 31 Navarra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 12.635 31 Navarra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 13.586 31 Navarra Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 13.271 31 Navarra Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 12.111 31 Navarra Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 13.086 31 Navarra Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 12.798 31 Navarra Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 11.697 31 Navarra Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 12.360 31 Navarra Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 11.313 31 Navarra Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 12.049 31 Navarra Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 11.028 31 Navarra Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 31 Navarra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 31 Navarra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 31 Navarra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 95,19 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,34 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,85 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 91,69 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 91,94 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 92,58 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 88,79 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 89,54 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 86,56 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 87,28 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 489 31 Navarra Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 610 31 Navarra Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.610 31 Navarra Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 482 31 Navarra Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 599 31 Navarra Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.582 31 Navarra Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 468 31 Navarra Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 589 31 Navarra Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.548 31 Navarra Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 579 31 Navarra Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.516 31 Navarra Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 573 31 Navarra Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.491 31 Navarra Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 31 Navarra Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 31 Navarra Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 31 Navarra Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,57 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,2 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,26 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95,71 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,56 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,15 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 94,92 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,16 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,93 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,61 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra Total Cohort October 1 Total Number at the start of the quarter 2022QIV 14.686 31 Navarra Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 31 Navarra Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 31 Navarra Total Cohort October 1 Total Number at the start of the quarter 2021QIV 14.648 31 Navarra Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 31 Navarra Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 31 Navarra Total Cohort October 1 Total Number at the start of the quarter 2020QIV 14.376 31 Navarra Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 31 Navarra Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 31 Navarra Total Cohort October 1 Total Survival in the first trimester 2022QIV 14.029 31 Navarra Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 31 Navarra Total Cohort October 1 Total Survival in the first trimester 2022QII "" 31 Navarra Total Cohort October 1 Total Survival in the first trimester 2022QI "" 31 Navarra Total Cohort October 1 Total Survival in the first trimester 2021QIV 14.017 31 Navarra Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 31 Navarra Total Cohort October 1 Total Survival in the first trimester 2021QII "" 31 Navarra Total Cohort October 1 Total Survival in the first trimester 2021QI "" 31 Navarra Total Cohort October 1 Total Survival in the first trimester 2020QIV 13.741 31 Navarra Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 31 Navarra Total Cohort October 1 Total Survival in the first trimester 2020QII "" 31 Navarra Total Cohort October 1 Total Survival in the first trimester 2020QI "" 31 Navarra Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 31 Navarra Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 31 Navarra Total Cohort October 1 Total Survival in the second trimester 2022QII "" 31 Navarra Total Cohort October 1 Total Survival in the second trimester 2022QI 13.461 31 Navarra Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 31 Navarra Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 31 Navarra Total Cohort October 1 Total Survival in the second trimester 2021QII "" 31 Navarra Total Cohort October 1 Total Survival in the second trimester 2021QI 13.255 31 Navarra Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 31 Navarra Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 31 Navarra Total Cohort October 1 Total Survival in the second trimester 2020QII "" 31 Navarra Total Cohort October 1 Total Survival in the second trimester 2020QI "" 31 Navarra Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 31 Navarra Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 31 Navarra Total Cohort October 1 Total Survival in the third trimester 2022QII 13.002 31 Navarra Total Cohort October 1 Total Survival in the third trimester 2022QI "" 31 Navarra Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 31 Navarra Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 31 Navarra Total Cohort October 1 Total Survival in the third trimester 2021QII 12.829 31 Navarra Total Cohort October 1 Total Survival in the third trimester 2021QI "" 31 Navarra Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 31 Navarra Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 31 Navarra Total Cohort October 1 Total Survival in the third trimester 2020QII "" 31 Navarra Total Cohort October 1 Total Survival in the third trimester 2020QI "" 31 Navarra Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 31 Navarra Total Cohort October 1 Total Survival in the third trimester 2022QIII 12.704 31 Navarra Total Cohort October 1 Total Survival in the third trimester 2022QII "" 31 Navarra Total Cohort October 1 Total Survival in the third trimester 2022QI "" 31 Navarra Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 31 Navarra Total Cohort October 1 Total Survival in the third trimester 2021QIII 12.573 31 Navarra Total Cohort October 1 Total Survival in the third trimester 2021QII "" 31 Navarra Total Cohort October 1 Total Survival in the third trimester 2021QI "" 31 Navarra Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 31 Navarra Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 31 Navarra Total Cohort October 1 Total Survival in the third trimester 2020QII "" 31 Navarra Total Cohort October 1 Total Survival in the third trimester 2020QI "" 31 Navarra Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 31 Navarra Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 31 Navarra Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 31 Navarra Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 31 Navarra Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 31 Navarra Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 31 Navarra Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 31 Navarra Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 31 Navarra Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,53 31 Navarra Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,69 31 Navarra Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 95,58 31 Navarra Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 91,9 31 Navarra Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 92,2 31 Navarra Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 88,76 31 Navarra Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 89,24 31 Navarra Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 86,73 31 Navarra Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 87,46 31 Navarra Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 31 Navarra Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 31 Navarra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 14.237 31 Navarra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 14.033 31 Navarra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 12.592 31 Navarra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 13.593 31 Navarra Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 13.419 31 Navarra Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 11.993 31 Navarra Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 12.878 31 Navarra Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 11.539 31 Navarra Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 12.433 31 Navarra Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 11.144 31 Navarra Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 12.144 31 Navarra Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 10.913 31 Navarra Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 31 Navarra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 31 Navarra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 31 Navarra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95,48 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,62 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 95,24 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 91,77 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 91,64 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 88,6 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 88,5 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 86,54 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 86,67 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 449 31 Navarra Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 615 31 Navarra Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.784 31 Navarra Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 436 31 Navarra Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 598 31 Navarra Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.748 31 Navarra Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 583 31 Navarra Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.716 31 Navarra Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 569 31 Navarra Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.685 31 Navarra Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 560 31 Navarra Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.660 31 Navarra Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 31 Navarra Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 31 Navarra Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 31 Navarra Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,1 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,24 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,98 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,8 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,19 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 92,52 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,45 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 91,06 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,05 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 31 Navarra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 10.364 31 Navarra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 31 Navarra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 10.218 31 Navarra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 10.475 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 9.665 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 9.611 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 9.367 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 9.156 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 9.138 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 8.949 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 8.828 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 8.845 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 8.655 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 8.520 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 8.563 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 8.383 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 31 Navarra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 31 Navarra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 31 Navarra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 31 Navarra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,26 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,06 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 89,42 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,34 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 89,43 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 85,43 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 85,18 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 86,56 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 82,63 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 82,21 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 83,8 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 80,03 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 10.042 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 9.462 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 9.357 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 8.882 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 8.857 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 8.430 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 8.542 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 8.161 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 8.240 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 7.900 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,18 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,87 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,2 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,09 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 85,06 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,25 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 82,06 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 83,49 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 322 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 756 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 308 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 729 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 299 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 708 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 286 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 684 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 280 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 663 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,65 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,43 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,86 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 93,65 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 88,82 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 90,48 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 86,96 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 87,7 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 10.305 31 Navarra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 10.216 31 Navarra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 9.981 31 Navarra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 9.647 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 9.625 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 9.477 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 9.233 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 9.246 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 9.123 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 8.865 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 8.910 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 8.810 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 8.554 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 8.473 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 31 Navarra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 31 Navarra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 31 Navarra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 31 Navarra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,61 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,21 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,95 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,6 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,51 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,4 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 86,03 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 87,22 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,27 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 83,73 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 84,89 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 10.005 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 9.468 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 8.069 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 9.359 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 8.899 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 7.621 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 8.953 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 8.546 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 7.322 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 8.599 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 8.231 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 7.070 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 7.908 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 6.792 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,54 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 93,99 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,45 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 89,49 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 90,26 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,74 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 85,95 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 86,93 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 87,62 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 83,52 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,17 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 300 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 748 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.912 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 288 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 726 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.856 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 280 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 700 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.801 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 266 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 679 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.740 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 646 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.681 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,06 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,07 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,33 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,58 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,19 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,67 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 90,78 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 86,36 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 87,92 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 10.353 31 Navarra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 10.278 31 Navarra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 10.114 31 Navarra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 9.692 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 9.647 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 9.593 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 9.223 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 9.197 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 9.179 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 8.782 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 8.798 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 8.493 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 8.515 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 31 Navarra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 31 Navarra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 31 Navarra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,62 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,86 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,85 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,09 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,48 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,76 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 85,44 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,99 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 82,63 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,19 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 10.126 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 10.009 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 9.375 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 9.471 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 9.389 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 8.879 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 9.012 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 8.947 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 8.493 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 8.540 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 8.138 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 8.256 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 7.873 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,53 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,81 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,71 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,39 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,59 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 85,32 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,81 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 82,49 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 83,98 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 227 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 269 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 739 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 221 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 258 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 714 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 211 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 250 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 686 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 242 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 660 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 237 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 642 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,36 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 95,91 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,62 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 92,95 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 92,94 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 92,83 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 89,96 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 89,31 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 88,1 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 86,87 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 10.262 31 Navarra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 10.346 31 Navarra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 10.182 31 Navarra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 9.649 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 9.749 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 9.580 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 9.224 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 9.130 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 8.820 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 8.750 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 8.547 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 8.508 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 31 Navarra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 31 Navarra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 31 Navarra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,03 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,23 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,09 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,16 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,67 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 85,25 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 85,94 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 82,61 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 83,56 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 10.064 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 10.023 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 9.419 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 9.462 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 9.442 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 8.844 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 8.931 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 8.422 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 8.540 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 8.062 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 8.275 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 7.845 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,02 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,2 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,9 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,11 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,42 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 85,2 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 85,59 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 82,56 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 83,29 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 198 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 323 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 763 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 187 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 307 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 736 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 293 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 708 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 280 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 688 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 272 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 663 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 94,44 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,05 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,46 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 90,71 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 92,79 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 86,69 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 90,17 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 84,21 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 86,89 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 1.621 31 Navarra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 1.510 31 Navarra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 1.576 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 1.605 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 1.494 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 1.532 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 1.570 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 1.459 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 1.507 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 1.558 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 1.448 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 1.493 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 1.542 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 1.435 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 1.477 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 31 Navarra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 31 Navarra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,01 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,94 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,21 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,85 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,62 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,62 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,11 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,89 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,73 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,13 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,03 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 93,72 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.545 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.220 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.529 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.207 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.497 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.178 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.486 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.169 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.470 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.157 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,96 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,93 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,89 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,56 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,18 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,82 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,15 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,84 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 76 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 290 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 76 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 287 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 73 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 281 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 72 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 279 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 72 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 278 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,97 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96,05 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,9 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 94,74 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,21 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,74 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,86 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 1.569 31 Navarra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 1.487 31 Navarra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 1.517 31 Navarra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 1.533 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 1.451 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 1.491 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 1.521 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 1.439 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 1.481 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 1.507 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 1.421 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 1.464 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 1.407 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 1.445 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 31 Navarra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 31 Navarra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 31 Navarra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,71 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 97,58 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,29 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,94 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,77 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,63 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,05 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,56 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,51 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,62 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,25 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.470 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.197 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 977 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.436 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.167 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 957 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.424 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.156 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 949 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.412 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.141 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 943 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.127 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 931 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,69 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 97,49 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 97,95 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,87 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,57 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,13 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,05 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,32 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,52 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 94,15 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,29 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 99 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 290 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 540 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 97 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 284 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 534 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 97 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 283 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 532 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 95 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 280 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 521 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 280 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 514 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,98 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,93 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,89 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,98 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,59 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,52 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 95,96 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,55 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,48 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,55 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,19 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 1.607 31 Navarra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 1.573 31 Navarra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 1.537 31 Navarra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 1.591 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 1.559 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 1.519 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 1.568 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 1.544 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 1.503 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 1.524 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 1.485 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 1.514 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 1.471 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 31 Navarra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 31 Navarra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 31 Navarra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,11 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,83 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,57 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,16 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,79 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,88 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,62 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,25 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,71 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.524 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.470 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.270 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.509 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.456 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.252 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.487 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.442 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.240 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.422 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.225 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.412 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.215 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,02 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,05 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,58 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,57 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,1 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,64 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,73 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,46 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,05 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,67 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 83 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 103 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 267 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 82 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 103 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 267 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 81 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 102 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 263 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 102 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 260 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 102 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 256 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,8 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,59 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,03 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,5 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 99,03 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,38 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 99,03 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,88 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 1.612 31 Navarra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 1.569 31 Navarra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 1.548 31 Navarra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 1.590 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 1.552 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 1.531 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 1.540 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 1.512 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 1.515 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 1.489 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 1.503 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 1.483 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 31 Navarra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 31 Navarra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 31 Navarra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,64 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,92 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,9 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,15 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,67 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,56 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,19 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,79 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,8 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.523 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.478 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.219 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.502 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.461 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.208 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.449 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.192 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.425 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.174 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.414 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.168 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,62 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,85 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,1 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,04 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,79 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,41 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,31 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,67 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,82 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 89 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 91 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 329 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 88 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 91 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 323 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 91 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 320 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 90 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 315 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 89 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 315 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,88 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,18 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,26 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 98,9 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,74 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 97,8 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 95,74 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 31 Navarra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 2.480 31 Navarra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 31 Navarra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 2.366 31 Navarra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 2.503 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 2.465 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 2.352 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 2.463 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 2.432 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 2.328 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 2.438 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 2.418 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 2.319 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 2.424 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 2.400 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 2.305 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 2.408 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 31 Navarra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 31 Navarra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 31 Navarra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 31 Navarra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,4 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,41 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,4 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,06 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,39 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,4 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,5 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,01 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,84 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,77 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,42 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,2 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.299 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.846 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.285 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.834 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.253 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.813 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.239 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.804 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.223 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.794 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,39 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,35 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,21 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,39 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,72 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,69 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,18 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 181 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 520 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 180 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 518 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 179 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 515 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 179 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 515 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 177 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 511 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,45 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,62 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,9 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 99,04 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 98,9 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 99,04 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 97,79 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,27 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 2.535 31 Navarra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 2.401 31 Navarra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 2.387 31 Navarra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 2.503 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 2.377 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 2.364 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 2.488 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 2.367 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 2.351 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 2.467 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 2.354 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 2.338 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 2.339 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 2.321 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 31 Navarra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 31 Navarra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 31 Navarra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 31 Navarra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,74 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,04 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,15 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,58 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,49 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,32 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,04 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,95 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,42 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,24 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.362 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.881 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.517 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.331 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.860 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.500 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.316 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.850 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.493 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.298 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.840 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.483 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.831 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.470 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,69 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,88 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,88 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,05 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,35 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,42 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,29 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,82 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,76 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,34 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,9 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 173 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 520 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 870 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 172 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 517 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 864 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 172 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 517 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 858 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 169 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 514 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 855 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 508 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 851 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,42 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,42 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,31 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 99,42 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,42 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,62 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,69 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,85 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,28 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,69 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 97,82 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 2.534 31 Navarra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 2.437 31 Navarra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 2.364 31 Navarra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 2.519 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 2.422 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 2.352 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 2.497 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 2.405 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 2.335 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 2.392 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 2.319 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 2.374 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 2.306 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 31 Navarra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 31 Navarra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 31 Navarra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,41 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,38 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,49 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,54 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,69 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,77 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,15 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,1 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,41 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,55 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.376 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.225 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.831 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.361 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.210 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.822 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.342 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.193 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.807 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.182 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.794 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.165 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.784 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,37 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,33 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,51 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,57 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,56 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,69 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,07 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,98 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,3 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,43 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 158 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 212 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 533 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 158 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 212 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 530 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 155 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 212 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 528 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 210 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 525 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 209 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 522 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,44 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,1 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,06 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 99,06 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,5 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 98,58 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,94 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 2.540 31 Navarra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 2.471 31 Navarra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 2.404 31 Navarra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 2.518 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 2.455 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 2.389 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 2.437 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 2.373 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 2.407 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 2.350 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 2.395 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 2.342 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 31 Navarra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 31 Navarra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 31 Navarra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,13 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,35 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,38 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,62 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,71 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,41 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,75 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,92 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,42 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.401 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.297 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.792 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.380 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.281 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.780 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.264 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.765 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.234 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.748 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.222 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.740 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,13 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,3 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,33 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,56 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,49 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,26 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,54 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,73 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,1 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 139 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 174 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 612 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 138 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 174 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 609 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 173 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 608 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 173 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 602 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 173 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 602 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,28 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,51 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 99,43 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 99,35 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 99,43 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,37 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 99,43 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,37 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 31 Navarra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 172 31 Navarra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 31 Navarra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 162 31 Navarra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 170 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 172 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 161 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 169 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 171 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 160 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 168 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 170 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 160 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 168 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 170 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 159 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 168 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 31 Navarra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 31 Navarra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 31 Navarra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 31 Navarra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,38 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,41 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,42 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,77 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,82 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,84 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,77 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,82 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,84 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,15 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,82 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 146 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 113 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 146 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 112 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 145 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 111 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 144 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 111 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 144 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 111 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,12 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,32 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,23 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,63 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,23 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,63 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,23 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 26 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 49 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 26 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 49 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 26 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 49 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 26 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 49 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 26 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 48 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,96 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 179 31 Navarra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 161 31 Navarra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 155 31 Navarra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 178 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 160 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 155 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 177 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 160 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 155 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 177 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 159 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 155 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 159 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 155 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 31 Navarra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 31 Navarra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 31 Navarra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 31 Navarra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,44 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,38 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,88 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,38 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,88 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,76 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,76 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 31 Navarra from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 163 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 115 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 106 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 162 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 114 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 106 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 161 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 114 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 106 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 161 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 114 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 106 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 114 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 106 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,39 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,13 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,77 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 99,13 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,77 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 99,13 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 99,13 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 16 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 46 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 49 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 16 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 46 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 49 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 16 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 46 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 49 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 16 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 45 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 49 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 45 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 49 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,83 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,83 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 179 31 Navarra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 162 31 Navarra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 149 31 Navarra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 178 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 162 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 149 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 178 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 161 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 149 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 161 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 149 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 161 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 149 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 31 Navarra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 31 Navarra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 31 Navarra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,44 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 99,44 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,38 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 99,38 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 99,38 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 164 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 143 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 103 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 163 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 143 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 103 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 163 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 143 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 103 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 143 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 103 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 143 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 103 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,39 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 99,39 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 15 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 19 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 46 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 15 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 19 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 46 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 15 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 18 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 46 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 18 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 46 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 18 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 46 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 94,74 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 94,74 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 94,74 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 184 31 Navarra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 181 31 Navarra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 163 31 Navarra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 184 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 180 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 163 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 180 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 163 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 180 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 163 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 179 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 163 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 31 Navarra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 31 Navarra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 31 Navarra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,45 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,45 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 99,45 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,9 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 167 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 160 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 108 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 167 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 160 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 108 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 160 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 108 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 160 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 108 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 159 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 108 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 99,38 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 17 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 21 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 55 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 17 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 20 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 55 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 20 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 55 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 20 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 55 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 20 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 55 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,24 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 95,24 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 95,24 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 95,24 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 31 Navarra De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 82 31 Navarra De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 31 Navarra De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 78 31 Navarra De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 31 Navarra De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 79 31 Navarra De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 81 31 Navarra De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 78 31 Navarra De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 78 31 Navarra De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 81 31 Navarra De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 78 31 Navarra De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 78 31 Navarra De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 81 31 Navarra De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 78 31 Navarra De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 77 31 Navarra De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 81 31 Navarra De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 78 31 Navarra De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 76 31 Navarra De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 31 Navarra De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 31 Navarra De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 31 Navarra De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 31 Navarra De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 31 Navarra De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 31 Navarra De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 31 Navarra De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,78 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,73 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,78 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,73 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,78 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,47 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,78 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,2 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 31 Navarra De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 76 31 Navarra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 57 31 Navarra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 75 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 57 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 75 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 57 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 75 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 57 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 75 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 57 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 31 Navarra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 31 Navarra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,68 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,68 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,68 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,68 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 6 31 Navarra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 21 31 Navarra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 6 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 21 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 6 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 21 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 6 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 21 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 6 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 21 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 31 Navarra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 31 Navarra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 85 31 Navarra De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 31 Navarra De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 77 31 Navarra De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 31 Navarra De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 80 31 Navarra De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 85 31 Navarra De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 77 31 Navarra De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 80 31 Navarra De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 85 31 Navarra De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 77 31 Navarra De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 79 31 Navarra De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 85 31 Navarra De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 77 31 Navarra De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 78 31 Navarra De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 77 31 Navarra De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 78 31 Navarra De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 31 Navarra De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 31 Navarra De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 31 Navarra De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 31 Navarra De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 31 Navarra De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 31 Navarra De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 31 Navarra De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,75 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,5 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,5 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 31 Navarra De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 78 31 Navarra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 56 31 Navarra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 58 31 Navarra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 78 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 56 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 58 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 78 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 56 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 57 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 78 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 56 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 56 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 56 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 56 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 31 Navarra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 31 Navarra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 31 Navarra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,28 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,55 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,55 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 7 31 Navarra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 21 31 Navarra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 22 31 Navarra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 7 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 21 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 22 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 7 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 21 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 22 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 7 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 21 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 22 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 21 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 22 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 31 Navarra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 31 Navarra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 31 Navarra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 88 31 Navarra De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 31 Navarra De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 31 Navarra De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 80 31 Navarra De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 31 Navarra De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 31 Navarra De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 81 31 Navarra De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 31 Navarra De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 88 31 Navarra De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 80 31 Navarra De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 80 31 Navarra De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 88 31 Navarra De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 80 31 Navarra De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 79 31 Navarra De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 80 31 Navarra De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 78 31 Navarra De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 80 31 Navarra De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 78 31 Navarra De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 31 Navarra De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 31 Navarra De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 31 Navarra De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 31 Navarra De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 31 Navarra De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 31 Navarra De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 31 Navarra De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 31 Navarra De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 31 Navarra De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 31 Navarra De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 31 Navarra De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 31 Navarra De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 31 Navarra De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,77 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,53 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,3 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,3 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 31 Navarra De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 82 31 Navarra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 73 31 Navarra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 56 31 Navarra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 82 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 73 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 55 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 82 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 73 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 54 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 73 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 53 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 73 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 53 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 31 Navarra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 31 Navarra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 31 Navarra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,21 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,43 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 94,64 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,64 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 6 31 Navarra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 7 31 Navarra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 25 31 Navarra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 6 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 7 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 25 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 6 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 7 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 25 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 7 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 25 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 7 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 25 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 31 Navarra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 31 Navarra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 31 Navarra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 88 31 Navarra De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 31 Navarra De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 31 Navarra De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 81 31 Navarra De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 31 Navarra De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 31 Navarra De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 79 31 Navarra De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 31 Navarra De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 88 31 Navarra De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 81 31 Navarra De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 78 31 Navarra De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 80 31 Navarra De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 77 31 Navarra De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 80 31 Navarra De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 77 31 Navarra De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 80 31 Navarra De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 77 31 Navarra De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 31 Navarra De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 31 Navarra De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 31 Navarra De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 31 Navarra De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 31 Navarra De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 31 Navarra De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 31 Navarra De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 31 Navarra De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 31 Navarra De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 31 Navarra De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 31 Navarra De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 31 Navarra De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,73 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,77 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,47 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,77 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,47 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,77 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,47 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 31 Navarra De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 82 31 Navarra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 75 31 Navarra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 54 31 Navarra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 82 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 75 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 53 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 74 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 52 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 74 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 52 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 74 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 52 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 31 Navarra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 31 Navarra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 31 Navarra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,15 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,67 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,3 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,67 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,3 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,67 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,3 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 6 31 Navarra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 6 31 Navarra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 25 31 Navarra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 6 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 6 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 25 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 6 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 25 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 6 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 25 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 6 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 25 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 31 Navarra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 31 Navarra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 31 Navarra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 31 Navarra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 32 Ourense Total Cohort January 1 Total Number at the start of the quarter 2022QI 8.130 32 Ourense Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 32 Ourense Total Cohort January 1 Total Number at the start of the quarter 2021QI 8.071 32 Ourense Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 32 Ourense Total Cohort January 1 Total Number at the start of the quarter 2020QI 8.462 32 Ourense Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 32 Ourense Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 32 Ourense Total Cohort January 1 Total Survival in the first trimester 2022QII "" 32 Ourense Total Cohort January 1 Total Survival in the first trimester 2022QI 7.678 32 Ourense Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 32 Ourense Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 32 Ourense Total Cohort January 1 Total Survival in the first trimester 2021QII "" 32 Ourense Total Cohort January 1 Total Survival in the first trimester 2021QI 7.657 32 Ourense Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 32 Ourense Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 32 Ourense Total Cohort January 1 Total Survival in the first trimester 2020QII "" 32 Ourense Total Cohort January 1 Total Survival in the first trimester 2020QI 7.706 32 Ourense Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 32 Ourense Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 32 Ourense Total Cohort January 1 Total Survival in the second trimester 2022QII 7.395 32 Ourense Total Cohort January 1 Total Survival in the second trimester 2022QI "" 32 Ourense Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 32 Ourense Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 32 Ourense Total Cohort January 1 Total Survival in the second trimester 2021QII 7.417 32 Ourense Total Cohort January 1 Total Survival in the second trimester 2021QI "" 32 Ourense Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 32 Ourense Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 32 Ourense Total Cohort January 1 Total Survival in the second trimester 2020QII 7.496 32 Ourense Total Cohort January 1 Total Survival in the second trimester 2020QI "" 32 Ourense Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 32 Ourense Total Cohort January 1 Total Survival in the third trimester 2022QIII 7.127 32 Ourense Total Cohort January 1 Total Survival in the third trimester 2022QII "" 32 Ourense Total Cohort January 1 Total Survival in the third trimester 2022QI "" 32 Ourense Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 32 Ourense Total Cohort January 1 Total Survival in the third trimester 2021QIII 7.182 32 Ourense Total Cohort January 1 Total Survival in the third trimester 2021QII "" 32 Ourense Total Cohort January 1 Total Survival in the third trimester 2021QI "" 32 Ourense Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 32 Ourense Total Cohort January 1 Total Survival in the third trimester 2020QIII 7.252 32 Ourense Total Cohort January 1 Total Survival in the third trimester 2020QII "" 32 Ourense Total Cohort January 1 Total Survival in the third trimester 2020QI "" 32 Ourense Total Cohort January 1 Total Survival in the third trimester 2022QIV 6.949 32 Ourense Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 32 Ourense Total Cohort January 1 Total Survival in the third trimester 2022QII "" 32 Ourense Total Cohort January 1 Total Survival in the third trimester 2022QI "" 32 Ourense Total Cohort January 1 Total Survival in the third trimester 2021QIV 6.978 32 Ourense Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 32 Ourense Total Cohort January 1 Total Survival in the third trimester 2021QII "" 32 Ourense Total Cohort January 1 Total Survival in the third trimester 2021QI "" 32 Ourense Total Cohort January 1 Total Survival in the third trimester 2020QIV 7.038 32 Ourense Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 32 Ourense Total Cohort January 1 Total Survival in the third trimester 2020QII "" 32 Ourense Total Cohort January 1 Total Survival in the third trimester 2020QI "" 32 Ourense Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 32 Ourense Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 32 Ourense Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 32 Ourense Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 32 Ourense Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 32 Ourense Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 32 Ourense Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,44 32 Ourense Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,87 32 Ourense Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 91,07 32 Ourense Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,96 32 Ourense Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,9 32 Ourense Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 88,58 32 Ourense Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 87,66 32 Ourense Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 88,99 32 Ourense Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 85,7 32 Ourense Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 85,47 32 Ourense Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 86,46 32 Ourense Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 83,17 32 Ourense Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 32 Ourense Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 32 Ourense Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 7.752 32 Ourense Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 7.154 32 Ourense Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 7.316 32 Ourense Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 6.771 32 Ourense Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 7.044 32 Ourense Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 6.550 32 Ourense Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 6.783 32 Ourense Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 6.334 32 Ourense Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 6.609 32 Ourense Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 6.151 32 Ourense Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 32 Ourense Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 32 Ourense Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,38 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,65 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,87 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 91,56 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 87,5 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 88,54 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 85,26 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,98 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 378 32 Ourense Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 917 32 Ourense Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 362 32 Ourense Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 886 32 Ourense Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 351 32 Ourense Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 867 32 Ourense Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 344 32 Ourense Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 848 32 Ourense Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 340 32 Ourense Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 827 32 Ourense Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 32 Ourense Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 32 Ourense Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,77 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,62 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,86 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,55 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 91,01 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,48 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 89,95 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 90,19 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense Total Cohort April 1 Total Number at the start of the quarter 2022QII 8.010 32 Ourense Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 32 Ourense Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense Total Cohort April 1 Total Number at the start of the quarter 2021QII 7.965 32 Ourense Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 32 Ourense Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense Total Cohort April 1 Total Number at the start of the quarter 2020QII 7.997 32 Ourense Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 32 Ourense Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 32 Ourense Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 32 Ourense Total Cohort April 1 Total Survival in the first trimester 2022QII 7.665 32 Ourense Total Cohort April 1 Total Survival in the first trimester 2022QI "" 32 Ourense Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 32 Ourense Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 32 Ourense Total Cohort April 1 Total Survival in the first trimester 2021QII 7.677 32 Ourense Total Cohort April 1 Total Survival in the first trimester 2021QI "" 32 Ourense Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 32 Ourense Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 32 Ourense Total Cohort April 1 Total Survival in the first trimester 2020QII 7.754 32 Ourense Total Cohort April 1 Total Survival in the first trimester 2020QI "" 32 Ourense Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 32 Ourense Total Cohort April 1 Total Survival in the second trimester 2022QIII 7.359 32 Ourense Total Cohort April 1 Total Survival in the second trimester 2022QII "" 32 Ourense Total Cohort April 1 Total Survival in the second trimester 2022QI "" 32 Ourense Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 32 Ourense Total Cohort April 1 Total Survival in the second trimester 2021QIII 7.399 32 Ourense Total Cohort April 1 Total Survival in the second trimester 2021QII "" 32 Ourense Total Cohort April 1 Total Survival in the second trimester 2021QI "" 32 Ourense Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 32 Ourense Total Cohort April 1 Total Survival in the second trimester 2020QIII 7.479 32 Ourense Total Cohort April 1 Total Survival in the second trimester 2020QII "" 32 Ourense Total Cohort April 1 Total Survival in the second trimester 2020QI "" 32 Ourense Total Cohort April 1 Total Survival in the third trimester 2022QIV 7.155 32 Ourense Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 32 Ourense Total Cohort April 1 Total Survival in the third trimester 2022QII "" 32 Ourense Total Cohort April 1 Total Survival in the third trimester 2022QI "" 32 Ourense Total Cohort April 1 Total Survival in the third trimester 2021QIV 7.161 32 Ourense Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 32 Ourense Total Cohort April 1 Total Survival in the third trimester 2021QII "" 32 Ourense Total Cohort April 1 Total Survival in the third trimester 2021QI "" 32 Ourense Total Cohort April 1 Total Survival in the third trimester 2020QIV 7.242 32 Ourense Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 32 Ourense Total Cohort April 1 Total Survival in the third trimester 2020QII "" 32 Ourense Total Cohort April 1 Total Survival in the third trimester 2020QI "" 32 Ourense Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 32 Ourense Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 32 Ourense Total Cohort April 1 Total Survival in the third trimester 2022QII "" 32 Ourense Total Cohort April 1 Total Survival in the third trimester 2022QI 6.898 32 Ourense Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 32 Ourense Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 32 Ourense Total Cohort April 1 Total Survival in the third trimester 2021QII "" 32 Ourense Total Cohort April 1 Total Survival in the third trimester 2021QI 6.976 32 Ourense Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 32 Ourense Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 32 Ourense Total Cohort April 1 Total Survival in the third trimester 2020QII "" 32 Ourense Total Cohort April 1 Total Survival in the third trimester 2020QI "" 32 Ourense Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 32 Ourense Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 32 Ourense Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 32 Ourense Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 32 Ourense Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 32 Ourense Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,69 32 Ourense Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,38 32 Ourense Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,96 32 Ourense Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 91,87 32 Ourense Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,89 32 Ourense Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,52 32 Ourense Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 89,33 32 Ourense Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 89,91 32 Ourense Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,56 32 Ourense Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 86,6 32 Ourense Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87,23 32 Ourense Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 32 Ourense Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 32 Ourense Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 7.648 32 Ourense Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 7.008 32 Ourense Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 6.200 32 Ourense Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 7.318 32 Ourense Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 6.742 32 Ourense Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 5.978 32 Ourense Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 7.022 32 Ourense Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 6.484 32 Ourense Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 5.745 32 Ourense Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 6.827 32 Ourense Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 6.269 32 Ourense Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 5.547 32 Ourense Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 6.033 32 Ourense Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 5.330 32 Ourense Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 32 Ourense Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 32 Ourense Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 32 Ourense Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,69 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 96,2 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 96,42 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,81 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,52 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,66 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 89,27 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 89,45 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 89,47 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 86,09 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 85,97 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 362 32 Ourense Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 957 32 Ourense Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.797 32 Ourense Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 347 32 Ourense Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 935 32 Ourense Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.776 32 Ourense Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 337 32 Ourense Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 915 32 Ourense Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.734 32 Ourense Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 328 32 Ourense Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 892 32 Ourense Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.695 32 Ourense Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 865 32 Ourense Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.646 32 Ourense Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 32 Ourense Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 32 Ourense Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 32 Ourense Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,86 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,7 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,83 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,09 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,61 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,49 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 90,61 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,21 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 94,32 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 90,39 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,6 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense Total Cohort July 1 Total Number at the start of the quarter 2022QIII 8.063 32 Ourense Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 32 Ourense Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 32 Ourense Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense Total Cohort July 1 Total Number at the start of the quarter 2021QIII 8.127 32 Ourense Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 32 Ourense Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 32 Ourense Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense Total Cohort July 1 Total Number at the start of the quarter 2020QIII 8.110 32 Ourense Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 32 Ourense Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 32 Ourense Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 32 Ourense Total Cohort July 1 Total Survival in the first trimester 2022QIII 7.642 32 Ourense Total Cohort July 1 Total Survival in the first trimester 2022QII "" 32 Ourense Total Cohort July 1 Total Survival in the first trimester 2022QI "" 32 Ourense Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 32 Ourense Total Cohort July 1 Total Survival in the first trimester 2021QIII 7.726 32 Ourense Total Cohort July 1 Total Survival in the first trimester 2021QII "" 32 Ourense Total Cohort July 1 Total Survival in the first trimester 2021QI "" 32 Ourense Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 32 Ourense Total Cohort July 1 Total Survival in the first trimester 2020QIII 7.758 32 Ourense Total Cohort July 1 Total Survival in the first trimester 2020QII "" 32 Ourense Total Cohort July 1 Total Survival in the first trimester 2020QI "" 32 Ourense Total Cohort July 1 Total Survival in the second trimester 2022QIV 7.373 32 Ourense Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 32 Ourense Total Cohort July 1 Total Survival in the second trimester 2022QII "" 32 Ourense Total Cohort July 1 Total Survival in the second trimester 2022QI "" 32 Ourense Total Cohort July 1 Total Survival in the second trimester 2021QIV 7.423 32 Ourense Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 32 Ourense Total Cohort July 1 Total Survival in the second trimester 2021QII "" 32 Ourense Total Cohort July 1 Total Survival in the second trimester 2021QI "" 32 Ourense Total Cohort July 1 Total Survival in the second trimester 2020QIV 7.464 32 Ourense Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 32 Ourense Total Cohort July 1 Total Survival in the second trimester 2020QII "" 32 Ourense Total Cohort July 1 Total Survival in the second trimester 2020QI "" 32 Ourense Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 32 Ourense Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 32 Ourense Total Cohort July 1 Total Survival in the third trimester 2022QII "" 32 Ourense Total Cohort July 1 Total Survival in the third trimester 2022QI 7.117 32 Ourense Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 32 Ourense Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 32 Ourense Total Cohort July 1 Total Survival in the third trimester 2021QII "" 32 Ourense Total Cohort July 1 Total Survival in the third trimester 2021QI 7.173 32 Ourense Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 32 Ourense Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 32 Ourense Total Cohort July 1 Total Survival in the third trimester 2020QII "" 32 Ourense Total Cohort July 1 Total Survival in the third trimester 2020QI "" 32 Ourense Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 32 Ourense Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 32 Ourense Total Cohort July 1 Total Survival in the third trimester 2022QII 6.933 32 Ourense Total Cohort July 1 Total Survival in the third trimester 2022QI "" 32 Ourense Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 32 Ourense Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 32 Ourense Total Cohort July 1 Total Survival in the third trimester 2021QII 7.003 32 Ourense Total Cohort July 1 Total Survival in the third trimester 2021QI "" 32 Ourense Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 32 Ourense Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 32 Ourense Total Cohort July 1 Total Survival in the third trimester 2020QII "" 32 Ourense Total Cohort July 1 Total Survival in the third trimester 2020QI "" 32 Ourense Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 32 Ourense Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 32 Ourense Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 32 Ourense Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 32 Ourense Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 32 Ourense Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 32 Ourense Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 32 Ourense Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 32 Ourense Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,78 32 Ourense Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,07 32 Ourense Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,66 32 Ourense Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 91,44 32 Ourense Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 91,34 32 Ourense Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 92,03 32 Ourense Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 87,57 32 Ourense Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 88,45 32 Ourense Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 85,31 32 Ourense Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 86,35 32 Ourense Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 32 Ourense Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 32 Ourense Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 7.925 32 Ourense Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 7.860 32 Ourense Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 7.000 32 Ourense Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 7.509 32 Ourense Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 7.469 32 Ourense Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 6.668 32 Ourense Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 7.243 32 Ourense Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 7.172 32 Ourense Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 6.398 32 Ourense Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 6.874 32 Ourense Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 6.137 32 Ourense Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 6.696 32 Ourense Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 5.989 32 Ourense Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 32 Ourense Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 32 Ourense Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 32 Ourense Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,75 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,03 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,26 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 91,39 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 91,25 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 91,4 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 87,46 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 87,67 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 85,19 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 85,56 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 138 32 Ourense Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 267 32 Ourense Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.110 32 Ourense Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 133 32 Ourense Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 257 32 Ourense Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.090 32 Ourense Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 130 32 Ourense Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 251 32 Ourense Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.066 32 Ourense Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 243 32 Ourense Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.036 32 Ourense Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 237 32 Ourense Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.014 32 Ourense Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 32 Ourense Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 32 Ourense Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 32 Ourense Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,38 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,25 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,2 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,2 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 94,01 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,04 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 91,01 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,33 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 88,76 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,35 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense Total Cohort October 1 Total Number at the start of the quarter 2022QIV 7.975 32 Ourense Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 32 Ourense Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 32 Ourense Total Cohort October 1 Total Number at the start of the quarter 2021QIV 8.084 32 Ourense Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 32 Ourense Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 32 Ourense Total Cohort October 1 Total Number at the start of the quarter 2020QIV 8.172 32 Ourense Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 32 Ourense Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 32 Ourense Total Cohort October 1 Total Survival in the first trimester 2022QIV 7.629 32 Ourense Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 32 Ourense Total Cohort October 1 Total Survival in the first trimester 2022QII "" 32 Ourense Total Cohort October 1 Total Survival in the first trimester 2022QI "" 32 Ourense Total Cohort October 1 Total Survival in the first trimester 2021QIV 7.700 32 Ourense Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 32 Ourense Total Cohort October 1 Total Survival in the first trimester 2021QII "" 32 Ourense Total Cohort October 1 Total Survival in the first trimester 2021QI "" 32 Ourense Total Cohort October 1 Total Survival in the first trimester 2020QIV 7.774 32 Ourense Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 32 Ourense Total Cohort October 1 Total Survival in the first trimester 2020QII "" 32 Ourense Total Cohort October 1 Total Survival in the first trimester 2020QI "" 32 Ourense Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 32 Ourense Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 32 Ourense Total Cohort October 1 Total Survival in the second trimester 2022QII "" 32 Ourense Total Cohort October 1 Total Survival in the second trimester 2022QI 7.352 32 Ourense Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 32 Ourense Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 32 Ourense Total Cohort October 1 Total Survival in the second trimester 2021QII "" 32 Ourense Total Cohort October 1 Total Survival in the second trimester 2021QI 7.437 32 Ourense Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 32 Ourense Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 32 Ourense Total Cohort October 1 Total Survival in the second trimester 2020QII "" 32 Ourense Total Cohort October 1 Total Survival in the second trimester 2020QI "" 32 Ourense Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 32 Ourense Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 32 Ourense Total Cohort October 1 Total Survival in the third trimester 2022QII 7.129 32 Ourense Total Cohort October 1 Total Survival in the third trimester 2022QI "" 32 Ourense Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 32 Ourense Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 32 Ourense Total Cohort October 1 Total Survival in the third trimester 2021QII 7.236 32 Ourense Total Cohort October 1 Total Survival in the third trimester 2021QI "" 32 Ourense Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 32 Ourense Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 32 Ourense Total Cohort October 1 Total Survival in the third trimester 2020QII "" 32 Ourense Total Cohort October 1 Total Survival in the third trimester 2020QI "" 32 Ourense Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 32 Ourense Total Cohort October 1 Total Survival in the third trimester 2022QIII 6.899 32 Ourense Total Cohort October 1 Total Survival in the third trimester 2022QII "" 32 Ourense Total Cohort October 1 Total Survival in the third trimester 2022QI "" 32 Ourense Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 32 Ourense Total Cohort October 1 Total Survival in the third trimester 2021QIII 7.023 32 Ourense Total Cohort October 1 Total Survival in the third trimester 2021QII "" 32 Ourense Total Cohort October 1 Total Survival in the third trimester 2021QI "" 32 Ourense Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 32 Ourense Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 32 Ourense Total Cohort October 1 Total Survival in the third trimester 2020QII "" 32 Ourense Total Cohort October 1 Total Survival in the third trimester 2020QI "" 32 Ourense Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 32 Ourense Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 32 Ourense Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 32 Ourense Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 32 Ourense Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 32 Ourense Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 32 Ourense Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 32 Ourense Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 32 Ourense Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,66 32 Ourense Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,25 32 Ourense Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 95,13 32 Ourense Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,95 32 Ourense Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 91,01 32 Ourense Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 88,19 32 Ourense Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 88,55 32 Ourense Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 85,34 32 Ourense Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 85,94 32 Ourense Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 32 Ourense Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 32 Ourense Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 7.866 32 Ourense Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 7.677 32 Ourense Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 7.152 32 Ourense Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 7.523 32 Ourense Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 7.307 32 Ourense Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 6.780 32 Ourense Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 6.974 32 Ourense Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 6.472 32 Ourense Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 6.765 32 Ourense Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 6.291 32 Ourense Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 6.545 32 Ourense Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 6.097 32 Ourense Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 32 Ourense Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 32 Ourense Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 32 Ourense Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95,64 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,18 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,8 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,84 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 90,49 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 88,12 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 87,96 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 85,25 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 85,25 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 109 32 Ourense Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 407 32 Ourense Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.020 32 Ourense Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 106 32 Ourense Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 393 32 Ourense Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 994 32 Ourense Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 378 32 Ourense Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 965 32 Ourense Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 364 32 Ourense Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 945 32 Ourense Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 354 32 Ourense Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 926 32 Ourense Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 32 Ourense Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 32 Ourense Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 32 Ourense Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,25 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,56 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,45 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 92,87 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,61 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 89,43 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,65 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 86,98 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 90,78 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 32 Ourense From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 6.542 32 Ourense From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 32 Ourense From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 6.598 32 Ourense From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 6.833 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 6.112 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 6.202 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 6.119 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 5.850 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 5.978 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 5.921 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 5.596 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 5.758 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 5.693 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 5.429 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 5.562 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 5.492 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 32 Ourense From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 32 Ourense From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 32 Ourense From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 32 Ourense From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,43 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 89,55 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,42 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,6 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 86,65 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 85,54 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,27 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 83,32 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 82,99 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 84,3 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 80,37 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 6.271 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 6.029 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 5.856 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 5.661 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 5.603 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 5.452 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 5.355 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 5.248 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 5.192 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 5.072 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,38 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,9 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,35 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,43 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 85,39 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,05 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 82,79 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 84,13 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 271 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 569 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 256 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 541 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 247 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 526 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 241 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 510 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 237 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 490 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,46 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,08 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 91,14 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 92,44 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 88,93 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 89,63 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 87,45 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 86,12 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 6.423 32 Ourense From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 6.493 32 Ourense From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 6.502 32 Ourense From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 6.096 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 6.216 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 6.268 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 5.806 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 5.955 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 6.005 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 5.615 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 5.726 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 5.778 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 5.480 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 5.530 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 32 Ourense From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 32 Ourense From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 32 Ourense From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 32 Ourense From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,91 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,73 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,4 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,39 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,71 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,36 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,42 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 88,19 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,86 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 84,4 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,05 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 6.154 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 5.881 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 5.275 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 5.841 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 5.624 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 5.059 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 5.561 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 5.380 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 4.834 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 5.377 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 5.172 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 4.643 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 4.949 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 4.438 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,91 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,63 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,91 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,36 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,48 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,64 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,37 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 87,94 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,02 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 84,15 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,13 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 269 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 612 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.227 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 255 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 592 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.209 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 245 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 575 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.171 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 238 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 554 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.135 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 531 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.092 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 94,8 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,73 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,53 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,08 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,95 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,44 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,48 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 90,52 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 92,5 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 86,76 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 89 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 6.462 32 Ourense From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 6.589 32 Ourense From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 6.623 32 Ourense From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 6.055 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 6.203 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 6.282 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 5.801 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 5.911 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 5.997 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 5.624 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 5.725 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 5.450 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 5.565 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 32 Ourense From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 32 Ourense From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 32 Ourense From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,7 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,14 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,85 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,77 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,71 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,55 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 85,35 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,44 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 82,71 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,03 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 6.347 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 6.424 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 5.942 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 5.945 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 6.048 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 5.617 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 5.694 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 5.761 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 5.352 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 5.480 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 5.105 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 5.310 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 4.964 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,67 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,15 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,53 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,71 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,68 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,07 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 85,31 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 85,91 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 82,66 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 83,54 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 115 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 165 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 681 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 110 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 155 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 665 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 107 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 150 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 645 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 144 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 620 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 140 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 601 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,65 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 93,94 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,65 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,04 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 90,91 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,71 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 87,27 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 91,04 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 84,85 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 88,25 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 6.363 32 Ourense From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 6.537 32 Ourense From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 6.634 32 Ourense From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 6.029 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 6.161 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 6.244 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 5.831 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 5.926 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 5.624 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 5.740 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 5.410 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 5.541 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 32 Ourense From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 32 Ourense From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 32 Ourense From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,75 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,25 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,12 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,2 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,33 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 86,03 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 86,52 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 82,76 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 83,52 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 6.275 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 6.228 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 6.014 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 5.944 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 5.866 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 5.646 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 5.550 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 5.353 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 5.354 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 5.182 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 5.149 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 4.998 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,73 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,19 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,88 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,11 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,01 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 85,97 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,17 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 82,68 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 83,11 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 88 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 309 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 620 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 85 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 295 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 598 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 281 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 573 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 270 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 558 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 261 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 543 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,59 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,47 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,45 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 90,94 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 92,42 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 87,38 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 90 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 84,47 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 87,58 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 752 32 Ourense From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 694 32 Ourense From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 771 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 741 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 682 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 744 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 729 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 673 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 736 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 724 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 666 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 727 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 719 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 662 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 718 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 32 Ourense From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 32 Ourense From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,54 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,27 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,5 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,94 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,97 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,46 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,28 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,97 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,29 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,61 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,39 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 93,13 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 702 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 543 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 692 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 533 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 681 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 527 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 676 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 520 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 671 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 516 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,58 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,16 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,01 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,05 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,3 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,76 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,58 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,03 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 50 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 151 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 49 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 149 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 48 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 146 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 48 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 146 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 48 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 146 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,68 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,69 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,69 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,69 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 737 32 Ourense From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 681 32 Ourense From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 699 32 Ourense From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 727 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 676 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 693 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 717 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 667 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 686 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 713 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 664 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 680 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 654 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 669 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 32 Ourense From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 32 Ourense From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 32 Ourense From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,64 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,27 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,14 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,29 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,94 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,14 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,74 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,5 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,28 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,04 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,71 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 697 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 538 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 434 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 688 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 534 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 430 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 678 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 525 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 425 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 675 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 522 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 422 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 514 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 416 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,71 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,26 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,08 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,27 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,58 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,93 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,84 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,03 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,24 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,54 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,85 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 40 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 143 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 265 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 39 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 142 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 263 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 39 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 142 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 261 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 38 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 142 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 258 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 140 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 253 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,5 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,3 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,25 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,5 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,3 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,49 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 95 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 99,3 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,36 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,9 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,47 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 733 32 Ourense From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 706 32 Ourense From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 696 32 Ourense From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 727 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 699 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 691 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 720 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 695 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 686 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 683 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 674 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 677 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 669 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 32 Ourense From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 32 Ourense From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 32 Ourense From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,18 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,01 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,28 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,23 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,44 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,56 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,74 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,84 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,89 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,12 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 722 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 667 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 512 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 716 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 660 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 508 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 709 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 656 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 506 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 645 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 498 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 641 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 494 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,17 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,95 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,22 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,2 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,35 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,83 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,7 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,27 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,1 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,48 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 11 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 39 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 184 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 11 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 39 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 183 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 11 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 39 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 180 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 38 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 176 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 36 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 175 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,46 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,83 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,44 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95,65 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 92,31 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,11 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 748 32 Ourense From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 715 32 Ourense From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 730 32 Ourense From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 743 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 712 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 725 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 702 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 712 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 692 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 704 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 683 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 698 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 32 Ourense From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 32 Ourense From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 32 Ourense From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,33 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,58 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,32 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,18 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,53 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,78 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,44 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,52 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,62 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 739 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 674 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 567 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 734 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 671 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 564 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 661 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 554 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 653 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 549 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 645 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 544 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,32 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,55 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,47 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,07 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,71 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,88 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,83 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,7 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,94 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 9 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 41 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 163 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 9 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 41 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 161 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 41 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 158 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 39 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 155 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 38 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 154 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,77 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,93 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 95,12 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,09 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 92,68 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 94,48 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 32 Ourense From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 789 32 Ourense From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 32 Ourense From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 737 32 Ourense From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 818 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 778 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 731 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 803 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 769 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 724 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 799 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 761 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 716 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 792 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 755 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 712 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 788 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 32 Ourense From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 32 Ourense From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 32 Ourense From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 32 Ourense From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,61 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,19 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,17 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,47 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,24 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,68 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,45 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,15 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,82 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,69 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,61 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,33 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 734 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 549 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 723 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 544 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 715 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 538 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 708 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 533 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 702 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 530 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,5 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,09 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,41 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,46 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,09 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,64 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,54 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 55 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 188 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 55 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 187 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 54 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 186 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 53 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 183 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 53 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 182 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,47 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,18 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,94 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,36 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,34 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,36 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,81 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 802 32 Ourense From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 747 32 Ourense From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 754 32 Ourense From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 794 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 741 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 751 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 789 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 733 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 746 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 780 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 727 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 742 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 720 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 735 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 32 Ourense From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 32 Ourense From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 32 Ourense From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 32 Ourense From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,2 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,6 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,38 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,13 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,94 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,26 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,32 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,41 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,39 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,48 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 750 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 554 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 463 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 742 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 549 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 461 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 737 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 544 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 458 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 729 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 540 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 454 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 535 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 448 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,93 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,1 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,57 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,27 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,19 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,92 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,2 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,47 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,06 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,57 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,76 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 52 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 193 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 291 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 52 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 192 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 290 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 52 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 189 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 288 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 51 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 187 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 288 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 185 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 287 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,48 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,66 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,93 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,97 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 98,08 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,89 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,97 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 95,85 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,63 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 818 32 Ourense From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 786 32 Ourense From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 749 32 Ourense From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 811 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 778 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 743 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 803 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 771 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 739 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 764 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 732 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 760 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 727 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 32 Ourense From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 32 Ourense From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 32 Ourense From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,14 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,98 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,2 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,17 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,09 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,66 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,2 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,73 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,69 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,06 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 807 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 728 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 517 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 800 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 720 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 514 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 792 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 714 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 511 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 708 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 505 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 704 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 502 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,13 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,9 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,42 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,14 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,08 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,84 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,25 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,68 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,7 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,1 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 11 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 58 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 232 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 11 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 58 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 229 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 11 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 57 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 228 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 56 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 227 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 56 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 225 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,71 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,28 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,28 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 96,55 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,84 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,55 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,98 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 813 32 Ourense From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 786 32 Ourense From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 764 32 Ourense From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 806 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 781 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 761 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 773 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 755 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 767 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 748 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 761 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 740 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 32 Ourense From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 32 Ourense From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 32 Ourense From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,14 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,36 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,61 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,35 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,82 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,58 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,91 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,82 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,86 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 802 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 731 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 539 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 795 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 726 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 538 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 719 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 533 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 714 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 528 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 708 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 523 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,13 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,32 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,81 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,36 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,89 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,67 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,96 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,85 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,03 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 11 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 55 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 225 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 11 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 55 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 223 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 54 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 222 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 53 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 220 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 53 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 217 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,11 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,18 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,67 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,36 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,78 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96,36 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,44 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 32 Ourense from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 35 32 Ourense from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 32 Ourense from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 29 32 Ourense from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 28 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 35 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 29 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 28 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 35 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 29 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 28 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 34 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 29 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 28 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 34 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 29 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 28 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 32 Ourense from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 32 Ourense from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 32 Ourense from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 32 Ourense from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,14 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,14 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 33 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 27 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 33 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 27 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 33 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 27 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 32 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 27 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 32 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 27 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,97 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,97 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 36 32 Ourense from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 31 32 Ourense from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 30 32 Ourense from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 36 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 31 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 30 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 35 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 31 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 30 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 35 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 31 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 30 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 31 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 30 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 32 Ourense from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 32 Ourense from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 32 Ourense from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 32 Ourense from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,22 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,22 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 32 Ourense from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 36 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 29 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 21 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 36 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 29 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 21 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 35 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 29 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 21 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 35 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 29 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 21 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 29 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 21 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,22 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,22 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 0 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 2 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 9 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 0 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 2 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 9 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 0 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 2 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 9 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 0 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 2 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 9 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 2 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 9 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII .. 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII .. 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII .. 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 0 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 37 32 Ourense from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 34 32 Ourense from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 30 32 Ourense from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 36 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 34 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 30 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 36 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 34 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 30 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 34 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 30 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 34 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 30 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 32 Ourense from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 32 Ourense from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 32 Ourense from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,3 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,3 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 37 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 33 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 23 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 36 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 33 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 23 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 36 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 33 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 23 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 33 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 23 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 33 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 23 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,3 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,3 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 7 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 7 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 7 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 7 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 7 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII .. 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII .. 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 38 32 Ourense from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 33 32 Ourense from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 30 32 Ourense from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 38 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 33 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 30 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 33 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 30 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 33 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 30 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 32 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 30 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 32 Ourense from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 32 Ourense from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 32 Ourense from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,97 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 38 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 33 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 25 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 38 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 33 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 25 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 33 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 25 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 33 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 25 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 32 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 25 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,97 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 0 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 5 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 0 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 5 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 0 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 5 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 0 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 5 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 0 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 5 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV .. 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV .. 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI .. 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII .. 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII .. 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 32 Ourense De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 12 32 Ourense De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 32 Ourense De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 13 32 Ourense De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 32 Ourense De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 12 32 Ourense De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 12 32 Ourense De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 13 32 Ourense De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 12 32 Ourense De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 12 32 Ourense De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 13 32 Ourense De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 12 32 Ourense De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 12 32 Ourense De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 13 32 Ourense De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 12 32 Ourense De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 12 32 Ourense De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 13 32 Ourense De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 12 32 Ourense De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 32 Ourense De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 32 Ourense De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 32 Ourense De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 32 Ourense De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 32 Ourense De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 32 Ourense De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 32 Ourense De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 32 Ourense De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 12 32 Ourense De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 6 32 Ourense De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 12 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 6 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 12 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 6 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 12 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 6 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 12 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 6 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 32 Ourense De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 32 Ourense De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 0 32 Ourense De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 7 32 Ourense De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 0 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 7 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 0 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 7 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 0 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 7 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 0 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 7 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI .. 32 Ourense De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 32 Ourense De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI .. 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII .. 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII .. 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 0 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 12 32 Ourense De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 32 Ourense De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 13 32 Ourense De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 32 Ourense De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 12 32 Ourense De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 12 32 Ourense De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 13 32 Ourense De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 12 32 Ourense De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 12 32 Ourense De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 13 32 Ourense De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 12 32 Ourense De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 12 32 Ourense De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 13 32 Ourense De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 12 32 Ourense De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 13 32 Ourense De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 12 32 Ourense De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 32 Ourense De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 32 Ourense De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 32 Ourense De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 32 Ourense De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 32 Ourense De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 32 Ourense De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 32 Ourense De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 32 Ourense De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 11 32 Ourense De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 6 32 Ourense De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 7 32 Ourense De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 11 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 6 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 7 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 11 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 6 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 7 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 11 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 6 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 7 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 6 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 7 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 32 Ourense De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 32 Ourense De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 32 Ourense De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1 32 Ourense De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 7 32 Ourense De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 5 32 Ourense De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 7 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 5 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 7 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 5 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 7 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 5 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 7 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 5 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 32 Ourense De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 32 Ourense De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 32 Ourense De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 13 32 Ourense De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 32 Ourense De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 32 Ourense De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 12 32 Ourense De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 32 Ourense De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 32 Ourense De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 12 32 Ourense De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 32 Ourense De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 13 32 Ourense De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 12 32 Ourense De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 12 32 Ourense De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 13 32 Ourense De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 12 32 Ourense De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 12 32 Ourense De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 12 32 Ourense De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 12 32 Ourense De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 12 32 Ourense De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 12 32 Ourense De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 32 Ourense De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 32 Ourense De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 32 Ourense De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 32 Ourense De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 32 Ourense De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 32 Ourense De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 32 Ourense De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 32 Ourense De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 32 Ourense De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 32 Ourense De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 32 Ourense De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 32 Ourense De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 32 Ourense De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 32 Ourense De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 12 32 Ourense De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 8 32 Ourense De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 6 32 Ourense De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 12 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 8 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 6 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 12 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 8 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 6 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 8 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 6 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 8 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 6 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 32 Ourense De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 32 Ourense De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 32 Ourense De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1 32 Ourense De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 4 32 Ourense De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 6 32 Ourense De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 4 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 6 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 4 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 6 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 4 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 6 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 4 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 6 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 32 Ourense De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 32 Ourense De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 32 Ourense De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 13 32 Ourense De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 32 Ourense De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 32 Ourense De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 13 32 Ourense De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 32 Ourense De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 32 Ourense De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 14 32 Ourense De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 32 Ourense De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 13 32 Ourense De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 13 32 Ourense De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 14 32 Ourense De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 13 32 Ourense De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 14 32 Ourense De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 13 32 Ourense De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 14 32 Ourense De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 13 32 Ourense De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 14 32 Ourense De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 32 Ourense De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 32 Ourense De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 32 Ourense De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 32 Ourense De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 32 Ourense De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 32 Ourense De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 32 Ourense De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 32 Ourense De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 32 Ourense De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 32 Ourense De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 32 Ourense De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 32 Ourense De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 32 Ourense De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 12 32 Ourense De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 11 32 Ourense De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 7 32 Ourense De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 12 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 11 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 7 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 11 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 7 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 11 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 7 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 11 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 7 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 32 Ourense De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 32 Ourense De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 32 Ourense De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1 32 Ourense De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 2 32 Ourense De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 7 32 Ourense De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 2 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 7 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 2 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 7 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 2 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 7 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 2 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 7 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 32 Ourense De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 32 Ourense De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 32 Ourense De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 32 Ourense De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 34 Palencia Total Cohort January 1 Total Number at the start of the quarter 2022QI 3.486 34 Palencia Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 34 Palencia Total Cohort January 1 Total Number at the start of the quarter 2021QI 3.397 34 Palencia Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 34 Palencia Total Cohort January 1 Total Number at the start of the quarter 2020QI 3.598 34 Palencia Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 34 Palencia Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 34 Palencia Total Cohort January 1 Total Survival in the first trimester 2022QII "" 34 Palencia Total Cohort January 1 Total Survival in the first trimester 2022QI 3.297 34 Palencia Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 34 Palencia Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 34 Palencia Total Cohort January 1 Total Survival in the first trimester 2021QII "" 34 Palencia Total Cohort January 1 Total Survival in the first trimester 2021QI 3.257 34 Palencia Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 34 Palencia Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 34 Palencia Total Cohort January 1 Total Survival in the first trimester 2020QII "" 34 Palencia Total Cohort January 1 Total Survival in the first trimester 2020QI 3.291 34 Palencia Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 34 Palencia Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 34 Palencia Total Cohort January 1 Total Survival in the second trimester 2022QII 3.195 34 Palencia Total Cohort January 1 Total Survival in the second trimester 2022QI "" 34 Palencia Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 34 Palencia Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 34 Palencia Total Cohort January 1 Total Survival in the second trimester 2021QII 3.155 34 Palencia Total Cohort January 1 Total Survival in the second trimester 2021QI "" 34 Palencia Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 34 Palencia Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 34 Palencia Total Cohort January 1 Total Survival in the second trimester 2020QII 3.205 34 Palencia Total Cohort January 1 Total Survival in the second trimester 2020QI "" 34 Palencia Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 34 Palencia Total Cohort January 1 Total Survival in the third trimester 2022QIII 3.103 34 Palencia Total Cohort January 1 Total Survival in the third trimester 2022QII "" 34 Palencia Total Cohort January 1 Total Survival in the third trimester 2022QI "" 34 Palencia Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 34 Palencia Total Cohort January 1 Total Survival in the third trimester 2021QIII 3.096 34 Palencia Total Cohort January 1 Total Survival in the third trimester 2021QII "" 34 Palencia Total Cohort January 1 Total Survival in the third trimester 2021QI "" 34 Palencia Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 34 Palencia Total Cohort January 1 Total Survival in the third trimester 2020QIII 3.127 34 Palencia Total Cohort January 1 Total Survival in the third trimester 2020QII "" 34 Palencia Total Cohort January 1 Total Survival in the third trimester 2020QI "" 34 Palencia Total Cohort January 1 Total Survival in the third trimester 2022QIV 3.006 34 Palencia Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 34 Palencia Total Cohort January 1 Total Survival in the third trimester 2022QII "" 34 Palencia Total Cohort January 1 Total Survival in the third trimester 2022QI "" 34 Palencia Total Cohort January 1 Total Survival in the third trimester 2021QIV 3.027 34 Palencia Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 34 Palencia Total Cohort January 1 Total Survival in the third trimester 2021QII "" 34 Palencia Total Cohort January 1 Total Survival in the third trimester 2021QI "" 34 Palencia Total Cohort January 1 Total Survival in the third trimester 2020QIV 3.040 34 Palencia Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 34 Palencia Total Cohort January 1 Total Survival in the third trimester 2020QII "" 34 Palencia Total Cohort January 1 Total Survival in the third trimester 2020QI "" 34 Palencia Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 34 Palencia Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 34 Palencia Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 34 Palencia Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 34 Palencia Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 34 Palencia Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 34 Palencia Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,58 34 Palencia Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,88 34 Palencia Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 91,47 34 Palencia Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 91,65 34 Palencia Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 92,88 34 Palencia Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 89,08 34 Palencia Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 89,01 34 Palencia Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 91,14 34 Palencia Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 86,91 34 Palencia Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 86,23 34 Palencia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 89,11 34 Palencia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 84,49 34 Palencia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 34 Palencia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 34 Palencia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 3.358 34 Palencia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.995 34 Palencia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 3.172 34 Palencia Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2.860 34 Palencia Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 3.074 34 Palencia Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.767 34 Palencia Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.984 34 Palencia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.713 34 Palencia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.889 34 Palencia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2.650 34 Palencia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 34 Palencia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 34 Palencia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,46 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 95,49 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 91,54 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 92,39 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 88,86 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 90,58 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 86,03 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 88,48 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 128 34 Palencia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 402 34 Palencia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 125 34 Palencia Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 397 34 Palencia Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 121 34 Palencia Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 388 34 Palencia Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 119 34 Palencia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 383 34 Palencia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 117 34 Palencia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 377 34 Palencia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 34 Palencia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 34 Palencia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,66 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,76 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 94,53 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,52 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 92,97 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,27 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 91,41 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 93,78 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia Total Cohort April 1 Total Number at the start of the quarter 2022QII 3.442 34 Palencia Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 34 Palencia Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia Total Cohort April 1 Total Number at the start of the quarter 2021QII 3.404 34 Palencia Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 34 Palencia Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia Total Cohort April 1 Total Number at the start of the quarter 2020QII 3.398 34 Palencia Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 34 Palencia Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 34 Palencia Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 34 Palencia Total Cohort April 1 Total Survival in the first trimester 2022QII 3.311 34 Palencia Total Cohort April 1 Total Survival in the first trimester 2022QI "" 34 Palencia Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 34 Palencia Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 34 Palencia Total Cohort April 1 Total Survival in the first trimester 2021QII 3.275 34 Palencia Total Cohort April 1 Total Survival in the first trimester 2021QI "" 34 Palencia Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 34 Palencia Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 34 Palencia Total Cohort April 1 Total Survival in the first trimester 2020QII 3.302 34 Palencia Total Cohort April 1 Total Survival in the first trimester 2020QI "" 34 Palencia Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 34 Palencia Total Cohort April 1 Total Survival in the second trimester 2022QIII 3.206 34 Palencia Total Cohort April 1 Total Survival in the second trimester 2022QII "" 34 Palencia Total Cohort April 1 Total Survival in the second trimester 2022QI "" 34 Palencia Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 34 Palencia Total Cohort April 1 Total Survival in the second trimester 2021QIII 3.200 34 Palencia Total Cohort April 1 Total Survival in the second trimester 2021QII "" 34 Palencia Total Cohort April 1 Total Survival in the second trimester 2021QI "" 34 Palencia Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 34 Palencia Total Cohort April 1 Total Survival in the second trimester 2020QIII 3.209 34 Palencia Total Cohort April 1 Total Survival in the second trimester 2020QII "" 34 Palencia Total Cohort April 1 Total Survival in the second trimester 2020QI "" 34 Palencia Total Cohort April 1 Total Survival in the third trimester 2022QIV 3.088 34 Palencia Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 34 Palencia Total Cohort April 1 Total Survival in the third trimester 2022QII "" 34 Palencia Total Cohort April 1 Total Survival in the third trimester 2022QI "" 34 Palencia Total Cohort April 1 Total Survival in the third trimester 2021QIV 3.116 34 Palencia Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 34 Palencia Total Cohort April 1 Total Survival in the third trimester 2021QII "" 34 Palencia Total Cohort April 1 Total Survival in the third trimester 2021QI "" 34 Palencia Total Cohort April 1 Total Survival in the third trimester 2020QIV 3.107 34 Palencia Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 34 Palencia Total Cohort April 1 Total Survival in the third trimester 2020QII "" 34 Palencia Total Cohort April 1 Total Survival in the third trimester 2020QI "" 34 Palencia Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 34 Palencia Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 34 Palencia Total Cohort April 1 Total Survival in the third trimester 2022QII "" 34 Palencia Total Cohort April 1 Total Survival in the third trimester 2022QI 3.010 34 Palencia Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 34 Palencia Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 34 Palencia Total Cohort April 1 Total Survival in the third trimester 2021QII "" 34 Palencia Total Cohort April 1 Total Survival in the third trimester 2021QI 3.017 34 Palencia Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 34 Palencia Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 34 Palencia Total Cohort April 1 Total Survival in the third trimester 2020QII "" 34 Palencia Total Cohort April 1 Total Survival in the third trimester 2020QI "" 34 Palencia Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 34 Palencia Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 34 Palencia Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 34 Palencia Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 34 Palencia Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 34 Palencia Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 96,19 34 Palencia Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,21 34 Palencia Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 97,17 34 Palencia Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 93,14 34 Palencia Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 94,01 34 Palencia Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 94,44 34 Palencia Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 89,72 34 Palencia Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 91,54 34 Palencia Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 91,44 34 Palencia Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 88,43 34 Palencia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 88,79 34 Palencia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 34 Palencia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 34 Palencia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 3.305 34 Palencia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.980 34 Palencia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2.621 34 Palencia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 3.179 34 Palencia Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.862 34 Palencia Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2.534 34 Palencia Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 3.078 34 Palencia Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.792 34 Palencia Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2.453 34 Palencia Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.963 34 Palencia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.714 34 Palencia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.372 34 Palencia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.616 34 Palencia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.296 34 Palencia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 34 Palencia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 34 Palencia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 34 Palencia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 96,19 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 96,04 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 96,68 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 93,13 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 93,69 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 93,59 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 89,65 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 91,07 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 90,5 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 87,79 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 87,6 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 137 34 Palencia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 424 34 Palencia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 777 34 Palencia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 132 34 Palencia Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 413 34 Palencia Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 768 34 Palencia Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 128 34 Palencia Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 408 34 Palencia Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 756 34 Palencia Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 125 34 Palencia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 402 34 Palencia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 735 34 Palencia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 394 34 Palencia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 721 34 Palencia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 34 Palencia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 34 Palencia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 34 Palencia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,35 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,41 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,84 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,43 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,23 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,3 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,24 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,81 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 94,59 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 92,92 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 92,79 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia Total Cohort July 1 Total Number at the start of the quarter 2022QIII 3.519 34 Palencia Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 34 Palencia Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 34 Palencia Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia Total Cohort July 1 Total Number at the start of the quarter 2021QIII 3.495 34 Palencia Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 34 Palencia Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 34 Palencia Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia Total Cohort July 1 Total Number at the start of the quarter 2020QIII 3.459 34 Palencia Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 34 Palencia Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 34 Palencia Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 34 Palencia Total Cohort July 1 Total Survival in the first trimester 2022QIII 3.346 34 Palencia Total Cohort July 1 Total Survival in the first trimester 2022QII "" 34 Palencia Total Cohort July 1 Total Survival in the first trimester 2022QI "" 34 Palencia Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 34 Palencia Total Cohort July 1 Total Survival in the first trimester 2021QIII 3.357 34 Palencia Total Cohort July 1 Total Survival in the first trimester 2021QII "" 34 Palencia Total Cohort July 1 Total Survival in the first trimester 2021QI "" 34 Palencia Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 34 Palencia Total Cohort July 1 Total Survival in the first trimester 2020QIII 3.326 34 Palencia Total Cohort July 1 Total Survival in the first trimester 2020QII "" 34 Palencia Total Cohort July 1 Total Survival in the first trimester 2020QI "" 34 Palencia Total Cohort July 1 Total Survival in the second trimester 2022QIV 3.190 34 Palencia Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 34 Palencia Total Cohort July 1 Total Survival in the second trimester 2022QII "" 34 Palencia Total Cohort July 1 Total Survival in the second trimester 2022QI "" 34 Palencia Total Cohort July 1 Total Survival in the second trimester 2021QIV 3.234 34 Palencia Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 34 Palencia Total Cohort July 1 Total Survival in the second trimester 2021QII "" 34 Palencia Total Cohort July 1 Total Survival in the second trimester 2021QI "" 34 Palencia Total Cohort July 1 Total Survival in the second trimester 2020QIV 3.187 34 Palencia Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 34 Palencia Total Cohort July 1 Total Survival in the second trimester 2020QII "" 34 Palencia Total Cohort July 1 Total Survival in the second trimester 2020QI "" 34 Palencia Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 34 Palencia Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 34 Palencia Total Cohort July 1 Total Survival in the third trimester 2022QII "" 34 Palencia Total Cohort July 1 Total Survival in the third trimester 2022QI 3.114 34 Palencia Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 34 Palencia Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 34 Palencia Total Cohort July 1 Total Survival in the third trimester 2021QII "" 34 Palencia Total Cohort July 1 Total Survival in the third trimester 2021QI 3.091 34 Palencia Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 34 Palencia Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 34 Palencia Total Cohort July 1 Total Survival in the third trimester 2020QII "" 34 Palencia Total Cohort July 1 Total Survival in the third trimester 2020QI "" 34 Palencia Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 34 Palencia Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 34 Palencia Total Cohort July 1 Total Survival in the third trimester 2022QII 3.042 34 Palencia Total Cohort July 1 Total Survival in the third trimester 2022QI "" 34 Palencia Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 34 Palencia Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 34 Palencia Total Cohort July 1 Total Survival in the third trimester 2021QII 3.022 34 Palencia Total Cohort July 1 Total Survival in the third trimester 2021QI "" 34 Palencia Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 34 Palencia Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 34 Palencia Total Cohort July 1 Total Survival in the third trimester 2020QII "" 34 Palencia Total Cohort July 1 Total Survival in the third trimester 2020QI "" 34 Palencia Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 34 Palencia Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 34 Palencia Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 34 Palencia Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 34 Palencia Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 34 Palencia Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 34 Palencia Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 34 Palencia Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 34 Palencia Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 95,08 34 Palencia Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 96,05 34 Palencia Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 96,15 34 Palencia Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 90,65 34 Palencia Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 92,53 34 Palencia Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 92,14 34 Palencia Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 89,1 34 Palencia Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 89,36 34 Palencia Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 87,04 34 Palencia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 87,37 34 Palencia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 34 Palencia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 34 Palencia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 3.472 34 Palencia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 3.389 34 Palencia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2.974 34 Palencia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 3.299 34 Palencia Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 3.254 34 Palencia Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.848 34 Palencia Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 3.145 34 Palencia Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 3.134 34 Palencia Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.720 34 Palencia Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 3.016 34 Palencia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.631 34 Palencia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.945 34 Palencia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.571 34 Palencia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 34 Palencia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 34 Palencia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 34 Palencia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 95,02 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 96,02 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,76 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 90,58 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 92,48 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 91,46 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 88,99 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 88,47 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 86,9 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 86,45 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 47 34 Palencia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 106 34 Palencia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 485 34 Palencia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 47 34 Palencia Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 103 34 Palencia Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 478 34 Palencia Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 45 34 Palencia Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 100 34 Palencia Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 467 34 Palencia Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 98 34 Palencia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 460 34 Palencia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 97 34 Palencia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 451 34 Palencia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 34 Palencia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 34 Palencia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 34 Palencia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,17 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,56 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95,74 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 94,34 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,29 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 92,45 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,85 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 91,51 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,99 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia Total Cohort October 1 Total Number at the start of the quarter 2022QIV 3.472 34 Palencia Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 34 Palencia Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 34 Palencia Total Cohort October 1 Total Number at the start of the quarter 2021QIV 3.502 34 Palencia Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 34 Palencia Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 34 Palencia Total Cohort October 1 Total Number at the start of the quarter 2020QIV 3.479 34 Palencia Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 34 Palencia Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 34 Palencia Total Cohort October 1 Total Survival in the first trimester 2022QIV 3.284 34 Palencia Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 34 Palencia Total Cohort October 1 Total Survival in the first trimester 2022QII "" 34 Palencia Total Cohort October 1 Total Survival in the first trimester 2022QI "" 34 Palencia Total Cohort October 1 Total Survival in the first trimester 2021QIV 3.341 34 Palencia Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 34 Palencia Total Cohort October 1 Total Survival in the first trimester 2021QII "" 34 Palencia Total Cohort October 1 Total Survival in the first trimester 2021QI "" 34 Palencia Total Cohort October 1 Total Survival in the first trimester 2020QIV 3.285 34 Palencia Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 34 Palencia Total Cohort October 1 Total Survival in the first trimester 2020QII "" 34 Palencia Total Cohort October 1 Total Survival in the first trimester 2020QI "" 34 Palencia Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 34 Palencia Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 34 Palencia Total Cohort October 1 Total Survival in the second trimester 2022QII "" 34 Palencia Total Cohort October 1 Total Survival in the second trimester 2022QI 3.201 34 Palencia Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 34 Palencia Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 34 Palencia Total Cohort October 1 Total Survival in the second trimester 2021QII "" 34 Palencia Total Cohort October 1 Total Survival in the second trimester 2021QI 3.174 34 Palencia Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 34 Palencia Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 34 Palencia Total Cohort October 1 Total Survival in the second trimester 2020QII "" 34 Palencia Total Cohort October 1 Total Survival in the second trimester 2020QI "" 34 Palencia Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 34 Palencia Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 34 Palencia Total Cohort October 1 Total Survival in the third trimester 2022QII 3.122 34 Palencia Total Cohort October 1 Total Survival in the third trimester 2022QI "" 34 Palencia Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 34 Palencia Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 34 Palencia Total Cohort October 1 Total Survival in the third trimester 2021QII 3.097 34 Palencia Total Cohort October 1 Total Survival in the third trimester 2021QI "" 34 Palencia Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 34 Palencia Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 34 Palencia Total Cohort October 1 Total Survival in the third trimester 2020QII "" 34 Palencia Total Cohort October 1 Total Survival in the third trimester 2020QI "" 34 Palencia Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 34 Palencia Total Cohort October 1 Total Survival in the third trimester 2022QIII 3.037 34 Palencia Total Cohort October 1 Total Survival in the third trimester 2022QII "" 34 Palencia Total Cohort October 1 Total Survival in the third trimester 2022QI "" 34 Palencia Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 34 Palencia Total Cohort October 1 Total Survival in the third trimester 2021QIII 3.041 34 Palencia Total Cohort October 1 Total Survival in the third trimester 2021QII "" 34 Palencia Total Cohort October 1 Total Survival in the third trimester 2021QI "" 34 Palencia Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 34 Palencia Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 34 Palencia Total Cohort October 1 Total Survival in the third trimester 2020QII "" 34 Palencia Total Cohort October 1 Total Survival in the third trimester 2020QI "" 34 Palencia Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 34 Palencia Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 34 Palencia Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 34 Palencia Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 34 Palencia Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 34 Palencia Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 34 Palencia Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 34 Palencia Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 34 Palencia Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,59 34 Palencia Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,4 34 Palencia Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,42 34 Palencia Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 91,4 34 Palencia Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 91,23 34 Palencia Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 89,15 34 Palencia Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 89,02 34 Palencia Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 86,72 34 Palencia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 87,41 34 Palencia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 34 Palencia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 34 Palencia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 3.431 34 Palencia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3.368 34 Palencia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 3.016 34 Palencia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 3.244 34 Palencia Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 3.210 34 Palencia Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2.835 34 Palencia Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 3.075 34 Palencia Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.732 34 Palencia Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.999 34 Palencia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2.668 34 Palencia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.917 34 Palencia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.618 34 Palencia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 34 Palencia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 34 Palencia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 34 Palencia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,55 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,31 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 91,3 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 90,58 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 89,04 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 88,46 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 86,61 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 86,8 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 41 34 Palencia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 134 34 Palencia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 463 34 Palencia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 40 34 Palencia Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 131 34 Palencia Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 450 34 Palencia Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 126 34 Palencia Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 442 34 Palencia Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 123 34 Palencia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 429 34 Palencia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 120 34 Palencia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 423 34 Palencia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 34 Palencia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 34 Palencia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 34 Palencia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,56 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,76 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,19 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,03 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,46 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 91,79 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,66 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 89,55 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 91,36 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 34 Palencia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 2.775 34 Palencia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 34 Palencia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 2.711 34 Palencia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 2.851 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 2.590 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 2.573 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 2.556 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 2.498 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 2.481 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 2.476 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 2.414 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 2.430 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 2.401 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 2.324 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 2.367 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 2.322 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 34 Palencia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 34 Palencia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 34 Palencia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 34 Palencia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,33 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,91 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 89,65 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,02 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,52 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 86,85 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,99 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 89,63 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 84,22 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 83,75 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 87,31 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 81,45 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.697 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.473 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.515 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2.340 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.426 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.254 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.343 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.206 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.255 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2.148 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,25 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,62 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,95 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 91,14 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,87 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 89,2 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 83,61 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 86,86 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 78 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 238 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 75 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 233 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 72 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 227 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 71 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 224 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 69 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 219 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,15 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,9 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,31 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,38 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 91,03 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,12 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,46 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 92,02 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 2.714 34 Palencia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 2.697 34 Palencia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 2.692 34 Palencia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 2.595 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 2.578 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 2.601 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 2.496 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 2.512 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 2.511 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 2.386 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 2.436 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 2.416 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 2.338 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 2.329 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 34 Palencia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 34 Palencia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 34 Palencia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 34 Palencia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,62 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,59 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,62 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 91,97 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 93,14 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,28 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,91 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 90,32 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,75 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 86,69 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 86,52 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.627 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.440 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2.187 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.513 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.331 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2.103 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.417 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.269 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2.024 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.310 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.198 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.947 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.105 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.874 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,66 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,53 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 96,16 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 92,01 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,99 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,55 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,93 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 90,08 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 89,03 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 86,27 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 85,69 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 87 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 257 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 505 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 82 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 247 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 498 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 79 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 243 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 487 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 76 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 238 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 469 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 233 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 455 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 94,25 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,11 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,61 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 90,8 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,55 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,44 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 87,36 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 92,61 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 92,87 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 90,66 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 90,1 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 2.754 34 Palencia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 2.780 34 Palencia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 2.748 34 Palencia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 2.588 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 2.649 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 2.617 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 2.444 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 2.535 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 2.488 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 2.424 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 2.395 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 2.358 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 2.335 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 34 Palencia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 34 Palencia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 34 Palencia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,97 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,29 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,23 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 88,74 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 91,19 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,54 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 87,19 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 87,15 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 84,82 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,97 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.724 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.714 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2.469 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.558 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.586 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.345 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.416 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.475 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.223 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.365 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.137 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.300 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.083 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,91 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,28 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,98 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 88,69 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 91,19 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,04 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 87,14 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,55 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 84,75 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 84,37 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 30 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 66 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 279 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 30 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 63 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 272 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 28 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 60 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 265 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 59 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 258 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 58 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 252 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 95,45 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,49 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,33 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 90,91 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,98 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 89,39 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 92,47 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 87,88 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 90,32 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 2.740 34 Palencia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 2.794 34 Palencia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 2.759 34 Palencia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 2.564 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 2.640 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 2.576 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 2.508 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 2.466 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 2.436 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 2.397 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 2.357 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 2.350 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 34 Palencia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 34 Palencia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 34 Palencia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,58 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,49 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,37 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,76 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,38 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,19 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 86,88 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 84,36 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 85,18 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.712 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.707 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2.486 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.537 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.554 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2.310 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.426 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.208 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.357 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2.149 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.281 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.106 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,55 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,35 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,92 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,62 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88,82 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 87,07 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,44 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 84,26 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 84,71 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 28 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 87 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 273 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 27 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 86 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 266 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 82 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 258 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 79 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 248 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 76 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 244 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,43 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,85 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,44 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,25 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,51 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 90,8 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 90,84 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 87,36 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 89,38 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 305 34 Palencia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 281 34 Palencia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 318 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 304 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 279 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 311 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 297 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 276 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 306 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 294 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 271 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 305 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 290 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 267 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 302 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 34 Palencia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 34 Palencia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,67 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,29 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,8 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,38 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,22 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,23 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,39 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,44 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,91 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,08 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,02 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,97 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 286 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 225 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 285 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 223 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 279 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 221 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 276 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 218 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 272 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 215 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,65 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,11 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,55 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,22 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,5 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,89 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,1 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,56 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 19 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 56 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 19 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 56 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 18 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 55 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 18 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 53 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 18 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 52 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 94,74 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,21 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 94,74 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,64 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,74 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 92,86 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 315 34 Palencia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 305 34 Palencia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 304 34 Palencia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 307 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 302 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 301 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 305 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 295 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 300 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 299 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 288 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 296 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 286 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 293 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 34 Palencia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 34 Palencia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 34 Palencia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,46 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,02 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,01 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,83 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,72 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,68 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 94,92 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 94,43 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,37 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,77 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,38 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 296 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 249 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 196 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 288 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 246 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 194 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 286 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 240 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 194 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 280 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 234 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 191 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 233 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 188 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,3 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,8 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,98 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,62 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,39 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,98 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 94,59 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 93,98 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,45 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,57 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,92 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 19 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 56 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 108 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 19 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 56 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 107 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 19 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 55 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 106 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 19 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 54 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 105 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 53 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 105 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,07 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,21 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,15 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,43 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,22 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 94,64 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 97,22 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 338 34 Palencia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 298 34 Palencia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 301 34 Palencia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 335 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 294 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 301 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 329 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 288 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 294 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 285 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 291 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 280 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 287 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 34 Palencia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 34 Palencia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 34 Palencia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,11 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,66 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,34 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 96,64 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,67 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,64 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,68 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 93,96 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,35 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 333 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 290 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 227 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 330 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 286 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 227 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 324 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 280 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 224 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 277 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 221 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 272 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 218 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,1 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,62 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,3 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 96,55 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,68 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,52 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,36 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 93,79 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,04 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 5 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 8 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 74 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 5 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 8 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 74 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 5 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 8 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 70 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 8 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 70 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 8 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 69 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,59 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,59 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 93,24 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 324 34 Palencia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 303 34 Palencia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 303 34 Palencia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 317 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 300 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 297 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 298 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 296 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 293 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 294 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 292 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 289 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 34 Palencia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 34 Palencia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 34 Palencia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,84 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,01 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,02 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,35 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,69 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,7 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,03 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,37 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,38 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 320 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 286 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 236 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 313 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 284 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 233 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 282 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 232 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 277 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 231 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 276 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 227 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,81 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,3 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,73 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,6 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,31 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,85 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,88 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,5 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,19 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 4 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 17 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 67 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 4 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 16 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 64 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 16 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 64 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 16 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 63 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 16 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 62 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 94,12 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 95,52 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,12 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,52 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 94,12 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,03 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 94,12 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 92,54 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 34 Palencia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 373 34 Palencia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 34 Palencia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 370 34 Palencia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 392 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 371 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 370 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 387 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 368 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 363 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 387 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 363 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 361 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 385 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 360 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 359 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 380 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 34 Palencia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 34 Palencia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 34 Palencia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 34 Palencia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,46 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,72 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,66 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,11 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,72 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,32 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,57 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,21 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,51 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,03 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,94 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 344 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 273 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 342 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 273 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 339 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 268 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 335 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 266 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 332 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 264 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,42 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,55 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,17 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,38 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,44 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,51 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,7 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 29 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 97 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 29 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 97 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 29 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 95 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 28 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 95 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 28 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 95 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,94 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,55 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,94 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,55 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,94 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 381 34 Palencia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 369 34 Palencia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 366 34 Palencia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 377 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 362 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 365 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 373 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 361 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 363 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 371 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 360 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 360 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 355 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 360 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 34 Palencia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 34 Palencia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 34 Palencia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 34 Palencia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,95 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,1 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,73 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,9 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,83 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,18 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,38 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,56 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,36 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,21 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,36 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 351 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 268 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 214 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 347 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 262 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 214 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 344 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 261 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 212 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 342 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 260 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 211 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 257 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 211 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,86 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 97,76 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,01 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,39 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,07 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,44 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,01 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,6 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,9 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 98,6 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 30 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 101 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 152 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 30 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 100 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 151 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 29 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 100 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 151 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 29 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 100 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 149 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 98 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 149 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,01 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,34 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 96,67 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,01 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,34 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,67 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 99,01 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,03 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,03 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,03 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 393 34 Palencia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 384 34 Palencia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 375 34 Palencia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 389 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 382 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 373 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 383 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 379 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 370 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 374 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 370 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 373 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 365 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 34 Palencia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 34 Palencia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 34 Palencia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,98 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,48 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,47 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,46 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,7 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,67 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,4 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,67 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,14 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,33 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 382 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 355 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 256 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 378 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 353 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 254 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 372 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 350 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 251 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 346 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 251 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 345 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 248 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,95 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,44 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,22 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,38 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,59 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,05 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,46 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,05 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,18 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,88 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 11 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 29 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 119 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 11 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 29 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 119 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 11 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 29 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 119 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 28 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 119 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 28 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 117 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 96,55 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,55 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,32 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 372 34 Palencia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 373 34 Palencia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 383 34 Palencia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 367 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 369 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 378 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 364 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 378 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 362 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 372 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 357 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 369 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 34 Palencia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 34 Palencia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 34 Palencia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,66 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,93 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,69 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,59 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,69 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,05 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,13 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,71 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,34 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 364 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 345 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 271 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 359 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 342 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 269 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 338 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 269 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 336 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 265 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 331 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 263 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,63 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,13 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,26 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,97 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 99,26 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,39 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,79 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,94 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,05 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 8 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 28 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 112 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 8 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 27 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 109 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 26 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 109 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 26 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 107 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 26 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 106 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,43 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,32 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 92,86 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,32 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 92,86 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,54 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 92,86 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 94,64 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 34 Palencia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 21 34 Palencia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 34 Palencia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 23 34 Palencia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 25 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 20 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 23 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 25 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 20 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 23 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 25 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 20 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 22 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 25 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 20 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 22 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 25 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 34 Palencia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 34 Palencia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 34 Palencia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 34 Palencia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,24 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 95,24 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 95,24 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,65 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,24 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,65 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 19 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 14 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 18 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 14 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 18 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 14 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 18 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 13 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 18 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 13 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,74 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 94,74 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,74 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 92,86 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 94,74 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 92,86 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 9 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 9 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 9 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 9 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 9 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 19 34 Palencia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 20 34 Palencia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 24 34 Palencia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 19 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 20 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 23 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 19 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 19 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 23 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 19 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 19 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 23 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 18 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 23 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 34 Palencia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 34 Palencia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 34 Palencia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 34 Palencia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,83 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 95 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 95,83 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,83 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 90 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,83 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 34 Palencia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 18 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 12 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 14 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 18 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 12 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 13 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 18 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 11 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 13 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 18 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 11 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 13 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 10 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 13 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 92,86 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,67 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,86 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 91,67 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 92,86 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 83,33 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 92,86 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 8 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 10 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 8 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 10 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 8 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 10 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 8 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 10 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 8 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 10 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 20 34 Palencia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 20 34 Palencia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 23 34 Palencia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 20 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 19 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 23 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 20 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 19 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 23 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 18 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 23 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 18 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 23 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 34 Palencia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 34 Palencia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 34 Palencia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 95 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 90 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 90 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 19 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 17 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 13 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 19 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 16 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 13 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 19 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 16 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 13 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 15 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 13 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 15 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 13 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,12 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 94,12 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 88,24 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 88,24 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 3 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 10 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 3 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 10 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 3 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 10 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 3 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 10 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 3 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 10 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 21 34 Palencia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 20 34 Palencia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 22 34 Palencia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 21 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 20 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 22 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 19 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 22 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 19 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 22 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 19 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 21 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 34 Palencia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 34 Palencia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 34 Palencia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 95 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,45 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 20 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 18 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 13 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 20 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 18 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 13 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 17 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 13 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 17 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 13 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 17 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 12 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 94,44 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 94,44 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 94,44 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 92,31 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 2 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 9 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 2 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 9 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 2 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 9 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 2 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 9 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 2 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 9 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 34 Palencia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 12 34 Palencia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 34 Palencia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 12 34 Palencia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 34 Palencia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 12 34 Palencia De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 12 34 Palencia De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 12 34 Palencia De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 12 34 Palencia De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 12 34 Palencia De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 12 34 Palencia De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 11 34 Palencia De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 12 34 Palencia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 12 34 Palencia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 11 34 Palencia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 12 34 Palencia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 12 34 Palencia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 11 34 Palencia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 34 Palencia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 34 Palencia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 34 Palencia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 34 Palencia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 34 Palencia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 34 Palencia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 34 Palencia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 91,67 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 91,67 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 91,67 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 34 Palencia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 12 34 Palencia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 10 34 Palencia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 12 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 10 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 12 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 10 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 12 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 10 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 12 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 10 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 34 Palencia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 34 Palencia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 0 34 Palencia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2 34 Palencia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 0 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 0 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 0 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 0 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI .. 34 Palencia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 34 Palencia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI .. 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII .. 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII .. 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 0 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 13 34 Palencia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 34 Palencia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 13 34 Palencia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 34 Palencia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 12 34 Palencia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 13 34 Palencia De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 13 34 Palencia De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 12 34 Palencia De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 13 34 Palencia De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 13 34 Palencia De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 12 34 Palencia De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 13 34 Palencia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 13 34 Palencia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 12 34 Palencia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 13 34 Palencia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 12 34 Palencia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 34 Palencia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 34 Palencia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 34 Palencia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 34 Palencia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 34 Palencia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 34 Palencia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 34 Palencia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 34 Palencia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 13 34 Palencia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 11 34 Palencia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 10 34 Palencia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 13 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 11 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 10 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 13 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 11 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 10 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 13 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 11 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 10 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 11 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 10 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 34 Palencia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 34 Palencia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 34 Palencia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 0 34 Palencia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 2 34 Palencia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2 34 Palencia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 0 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 2 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 0 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 2 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 0 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 2 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 2 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII .. 34 Palencia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 34 Palencia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 34 Palencia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII .. 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII .. 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 0 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 14 34 Palencia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 34 Palencia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 34 Palencia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 13 34 Palencia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 34 Palencia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 34 Palencia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 12 34 Palencia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 34 Palencia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 14 34 Palencia De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 13 34 Palencia De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 12 34 Palencia De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 14 34 Palencia De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 13 34 Palencia De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 12 34 Palencia De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 13 34 Palencia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 12 34 Palencia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 13 34 Palencia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 12 34 Palencia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 34 Palencia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 34 Palencia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 34 Palencia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 34 Palencia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 34 Palencia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 34 Palencia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 34 Palencia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 34 Palencia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 34 Palencia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 34 Palencia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 34 Palencia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 34 Palencia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 34 Palencia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 34 Palencia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 14 34 Palencia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 13 34 Palencia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 9 34 Palencia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 14 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 13 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 9 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 14 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 13 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 9 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 13 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 9 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 13 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 9 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 34 Palencia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 34 Palencia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 34 Palencia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 34 Palencia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 0 34 Palencia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 3 34 Palencia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 0 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 3 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 0 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 3 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 0 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 3 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 0 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 3 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII .. 34 Palencia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII .. 34 Palencia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 34 Palencia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII .. 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII .. 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV .. 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI .. 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII .. 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 15 34 Palencia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 34 Palencia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 34 Palencia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 12 34 Palencia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 34 Palencia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 34 Palencia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 12 34 Palencia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 34 Palencia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 15 34 Palencia De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 12 34 Palencia De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 12 34 Palencia De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 12 34 Palencia De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 12 34 Palencia De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 12 34 Palencia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 12 34 Palencia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 12 34 Palencia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 12 34 Palencia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 34 Palencia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 34 Palencia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 34 Palencia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 34 Palencia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 34 Palencia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 34 Palencia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 34 Palencia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 34 Palencia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 34 Palencia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 34 Palencia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 34 Palencia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 34 Palencia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 34 Palencia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 15 34 Palencia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 12 34 Palencia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 10 34 Palencia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 15 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 12 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 10 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 12 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 10 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 12 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 10 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 12 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 10 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 34 Palencia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 34 Palencia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 34 Palencia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 34 Palencia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 0 34 Palencia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 2 34 Palencia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 0 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 0 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 0 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 0 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 34 Palencia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV .. 34 Palencia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 34 Palencia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV .. 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI .. 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII .. 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII .. 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 34 Palencia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las Total Cohort January 1 Total Number at the start of the quarter 2022QI 27.460 35 Palmas, Las Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las Total Cohort January 1 Total Number at the start of the quarter 2021QI 26.629 35 Palmas, Las Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las Total Cohort January 1 Total Number at the start of the quarter 2020QI 28.508 35 Palmas, Las Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 35 Palmas, Las Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 35 Palmas, Las Total Cohort January 1 Total Survival in the first trimester 2022QII "" 35 Palmas, Las Total Cohort January 1 Total Survival in the first trimester 2022QI 25.941 35 Palmas, Las Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 35 Palmas, Las Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 35 Palmas, Las Total Cohort January 1 Total Survival in the first trimester 2021QII "" 35 Palmas, Las Total Cohort January 1 Total Survival in the first trimester 2021QI 25.011 35 Palmas, Las Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 35 Palmas, Las Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 35 Palmas, Las Total Cohort January 1 Total Survival in the first trimester 2020QII "" 35 Palmas, Las Total Cohort January 1 Total Survival in the first trimester 2020QI 24.749 35 Palmas, Las Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 35 Palmas, Las Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 35 Palmas, Las Total Cohort January 1 Total Survival in the second trimester 2022QII 24.677 35 Palmas, Las Total Cohort January 1 Total Survival in the second trimester 2022QI "" 35 Palmas, Las Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 35 Palmas, Las Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 35 Palmas, Las Total Cohort January 1 Total Survival in the second trimester 2021QII 24.144 35 Palmas, Las Total Cohort January 1 Total Survival in the second trimester 2021QI "" 35 Palmas, Las Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 35 Palmas, Las Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 35 Palmas, Las Total Cohort January 1 Total Survival in the second trimester 2020QII 23.819 35 Palmas, Las Total Cohort January 1 Total Survival in the second trimester 2020QI "" 35 Palmas, Las Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las Total Cohort January 1 Total Survival in the third trimester 2022QIII 23.749 35 Palmas, Las Total Cohort January 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las Total Cohort January 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las Total Cohort January 1 Total Survival in the third trimester 2021QIII 23.354 35 Palmas, Las Total Cohort January 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las Total Cohort January 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las Total Cohort January 1 Total Survival in the third trimester 2020QIII 23.097 35 Palmas, Las Total Cohort January 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las Total Cohort January 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las Total Cohort January 1 Total Survival in the third trimester 2022QIV 23.052 35 Palmas, Las Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las Total Cohort January 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las Total Cohort January 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las Total Cohort January 1 Total Survival in the third trimester 2021QIV 22.676 35 Palmas, Las Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las Total Cohort January 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las Total Cohort January 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las Total Cohort January 1 Total Survival in the third trimester 2020QIV 22.372 35 Palmas, Las Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las Total Cohort January 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las Total Cohort January 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 35 Palmas, Las Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 35 Palmas, Las Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,47 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,92 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 86,81 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,87 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,67 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 83,55 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,49 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,7 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 81,02 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 83,95 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,16 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 78,48 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 26.184 35 Palmas, Las Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 21.080 35 Palmas, Las Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 24.712 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 19.645 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 23.495 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 18.892 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 22.600 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 18.209 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 21.934 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 17.676 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 35 Palmas, Las Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 35 Palmas, Las Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,38 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,19 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,73 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,62 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,31 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,38 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 83,77 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 83,85 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.276 35 Palmas, Las Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 5.549 35 Palmas, Las Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.229 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 5.366 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.182 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 5.252 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.149 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 5.145 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.118 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 5.000 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 35 Palmas, Las Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 35 Palmas, Las Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,32 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,7 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,63 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,65 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,05 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,72 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 87,62 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 90,11 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las Total Cohort April 1 Total Number at the start of the quarter 2022QII 27.467 35 Palmas, Las Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las Total Cohort April 1 Total Number at the start of the quarter 2021QII 26.173 35 Palmas, Las Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las Total Cohort April 1 Total Number at the start of the quarter 2020QII 25.938 35 Palmas, Las Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 35 Palmas, Las Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 35 Palmas, Las Total Cohort April 1 Total Survival in the first trimester 2022QII 25.922 35 Palmas, Las Total Cohort April 1 Total Survival in the first trimester 2022QI "" 35 Palmas, Las Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 35 Palmas, Las Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 35 Palmas, Las Total Cohort April 1 Total Survival in the first trimester 2021QII 25.085 35 Palmas, Las Total Cohort April 1 Total Survival in the first trimester 2021QI "" 35 Palmas, Las Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 35 Palmas, Las Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 35 Palmas, Las Total Cohort April 1 Total Survival in the first trimester 2020QII 24.848 35 Palmas, Las Total Cohort April 1 Total Survival in the first trimester 2020QI "" 35 Palmas, Las Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 35 Palmas, Las Total Cohort April 1 Total Survival in the second trimester 2022QIII 24.803 35 Palmas, Las Total Cohort April 1 Total Survival in the second trimester 2022QII "" 35 Palmas, Las Total Cohort April 1 Total Survival in the second trimester 2022QI "" 35 Palmas, Las Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 35 Palmas, Las Total Cohort April 1 Total Survival in the second trimester 2021QIII 24.160 35 Palmas, Las Total Cohort April 1 Total Survival in the second trimester 2021QII "" 35 Palmas, Las Total Cohort April 1 Total Survival in the second trimester 2021QI "" 35 Palmas, Las Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 35 Palmas, Las Total Cohort April 1 Total Survival in the second trimester 2020QIII 24.010 35 Palmas, Las Total Cohort April 1 Total Survival in the second trimester 2020QII "" 35 Palmas, Las Total Cohort April 1 Total Survival in the second trimester 2020QI "" 35 Palmas, Las Total Cohort April 1 Total Survival in the third trimester 2022QIV 24.016 35 Palmas, Las Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las Total Cohort April 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las Total Cohort April 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las Total Cohort April 1 Total Survival in the third trimester 2021QIV 23.402 35 Palmas, Las Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las Total Cohort April 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las Total Cohort April 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las Total Cohort April 1 Total Survival in the third trimester 2020QIV 23.200 35 Palmas, Las Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las Total Cohort April 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las Total Cohort April 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las Total Cohort April 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las Total Cohort April 1 Total Survival in the third trimester 2022QI 22.533 35 Palmas, Las Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las Total Cohort April 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las Total Cohort April 1 Total Survival in the third trimester 2021QI 22.256 35 Palmas, Las Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las Total Cohort April 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las Total Cohort April 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 35 Palmas, Las Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 35 Palmas, Las Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 35 Palmas, Las Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,38 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,84 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,8 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,3 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,31 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,57 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,44 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 89,41 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,44 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 86,09 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,8 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 26.207 35 Palmas, Las Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 22.569 35 Palmas, Las Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 19.012 35 Palmas, Las Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 24.718 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 21.579 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 18.015 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 23.631 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 20.740 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 17.312 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 22.871 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 20.088 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 16.673 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 19.327 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 15.955 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 35 Palmas, Las Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 35 Palmas, Las Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 35 Palmas, Las Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,32 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,61 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,76 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,17 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,9 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,06 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,27 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 89,01 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 87,7 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 85,64 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 83,92 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.260 35 Palmas, Las Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 3.604 35 Palmas, Las Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 6.926 35 Palmas, Las Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.204 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 3.506 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 6.833 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.172 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 3.420 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 6.698 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.145 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 3.314 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 6.527 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 3.206 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 6.301 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 35 Palmas, Las Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 35 Palmas, Las Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 35 Palmas, Las Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,56 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,28 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,66 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,02 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,89 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,71 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 90,87 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 91,95 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 94,24 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 88,96 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 90,98 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las Total Cohort July 1 Total Number at the start of the quarter 2022QIII 27.445 35 Palmas, Las Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las Total Cohort July 1 Total Number at the start of the quarter 2021QIII 26.447 35 Palmas, Las Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las Total Cohort July 1 Total Number at the start of the quarter 2020QIII 26.131 35 Palmas, Las Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 35 Palmas, Las Total Cohort July 1 Total Survival in the first trimester 2022QIII 26.043 35 Palmas, Las Total Cohort July 1 Total Survival in the first trimester 2022QII "" 35 Palmas, Las Total Cohort July 1 Total Survival in the first trimester 2022QI "" 35 Palmas, Las Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 35 Palmas, Las Total Cohort July 1 Total Survival in the first trimester 2021QIII 25.239 35 Palmas, Las Total Cohort July 1 Total Survival in the first trimester 2021QII "" 35 Palmas, Las Total Cohort July 1 Total Survival in the first trimester 2021QI "" 35 Palmas, Las Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 35 Palmas, Las Total Cohort July 1 Total Survival in the first trimester 2020QIII 25.047 35 Palmas, Las Total Cohort July 1 Total Survival in the first trimester 2020QII "" 35 Palmas, Las Total Cohort July 1 Total Survival in the first trimester 2020QI "" 35 Palmas, Las Total Cohort July 1 Total Survival in the second trimester 2022QIV 25.110 35 Palmas, Las Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 35 Palmas, Las Total Cohort July 1 Total Survival in the second trimester 2022QII "" 35 Palmas, Las Total Cohort July 1 Total Survival in the second trimester 2022QI "" 35 Palmas, Las Total Cohort July 1 Total Survival in the second trimester 2021QIV 24.348 35 Palmas, Las Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 35 Palmas, Las Total Cohort July 1 Total Survival in the second trimester 2021QII "" 35 Palmas, Las Total Cohort July 1 Total Survival in the second trimester 2021QI "" 35 Palmas, Las Total Cohort July 1 Total Survival in the second trimester 2020QIV 24.077 35 Palmas, Las Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 35 Palmas, Las Total Cohort July 1 Total Survival in the second trimester 2020QII "" 35 Palmas, Las Total Cohort July 1 Total Survival in the second trimester 2020QI "" 35 Palmas, Las Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las Total Cohort July 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las Total Cohort July 1 Total Survival in the third trimester 2022QI 23.366 35 Palmas, Las Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las Total Cohort July 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las Total Cohort July 1 Total Survival in the third trimester 2021QI 23.032 35 Palmas, Las Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las Total Cohort July 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las Total Cohort July 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las Total Cohort July 1 Total Survival in the third trimester 2022QII 22.548 35 Palmas, Las Total Cohort July 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las Total Cohort July 1 Total Survival in the third trimester 2021QII 22.434 35 Palmas, Las Total Cohort July 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las Total Cohort July 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las Total Cohort July 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 35 Palmas, Las Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 35 Palmas, Las Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 35 Palmas, Las Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,89 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,43 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,85 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 91,49 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 92,06 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 92,14 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 88,35 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 88,14 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 85,26 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 85,85 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 27.016 35 Palmas, Las Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 25.158 35 Palmas, Las Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 20.044 35 Palmas, Las Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 25.626 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 23.991 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 19.069 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 24.705 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 23.144 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 18.247 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 22.205 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 17.398 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 21.424 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 16.915 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 35 Palmas, Las Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 35 Palmas, Las Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 35 Palmas, Las Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,85 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,36 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,14 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 91,45 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 91,99 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 91,03 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 88,26 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,8 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 85,16 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 84,39 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 429 35 Palmas, Las Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.289 35 Palmas, Las Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 6.087 35 Palmas, Las Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 417 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.248 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 5.978 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 405 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1.204 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 5.830 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1.161 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 5.634 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1.124 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 5.519 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 35 Palmas, Las Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 35 Palmas, Las Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 35 Palmas, Las Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,2 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,82 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,21 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,41 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,41 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,78 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 90,07 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 92,56 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 87,2 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 90,67 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las Total Cohort October 1 Total Number at the start of the quarter 2022QIV 27.539 35 Palmas, Las Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las Total Cohort October 1 Total Number at the start of the quarter 2021QIV 26.869 35 Palmas, Las Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las Total Cohort October 1 Total Number at the start of the quarter 2020QIV 26.561 35 Palmas, Las Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las Total Cohort October 1 Total Survival in the first trimester 2022QIV 26.355 35 Palmas, Las Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 35 Palmas, Las Total Cohort October 1 Total Survival in the first trimester 2022QII "" 35 Palmas, Las Total Cohort October 1 Total Survival in the first trimester 2022QI "" 35 Palmas, Las Total Cohort October 1 Total Survival in the first trimester 2021QIV 25.690 35 Palmas, Las Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 35 Palmas, Las Total Cohort October 1 Total Survival in the first trimester 2021QII "" 35 Palmas, Las Total Cohort October 1 Total Survival in the first trimester 2021QI "" 35 Palmas, Las Total Cohort October 1 Total Survival in the first trimester 2020QIV 25.295 35 Palmas, Las Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 35 Palmas, Las Total Cohort October 1 Total Survival in the first trimester 2020QII "" 35 Palmas, Las Total Cohort October 1 Total Survival in the first trimester 2020QI "" 35 Palmas, Las Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 35 Palmas, Las Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 35 Palmas, Las Total Cohort October 1 Total Survival in the second trimester 2022QII "" 35 Palmas, Las Total Cohort October 1 Total Survival in the second trimester 2022QI 24.520 35 Palmas, Las Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 35 Palmas, Las Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 35 Palmas, Las Total Cohort October 1 Total Survival in the second trimester 2021QII "" 35 Palmas, Las Total Cohort October 1 Total Survival in the second trimester 2021QI 24.029 35 Palmas, Las Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 35 Palmas, Las Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 35 Palmas, Las Total Cohort October 1 Total Survival in the second trimester 2020QII "" 35 Palmas, Las Total Cohort October 1 Total Survival in the second trimester 2020QI "" 35 Palmas, Las Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las Total Cohort October 1 Total Survival in the third trimester 2022QII 23.529 35 Palmas, Las Total Cohort October 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las Total Cohort October 1 Total Survival in the third trimester 2021QII 23.316 35 Palmas, Las Total Cohort October 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las Total Cohort October 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las Total Cohort October 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las Total Cohort October 1 Total Survival in the third trimester 2022QIII 22.726 35 Palmas, Las Total Cohort October 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las Total Cohort October 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las Total Cohort October 1 Total Survival in the third trimester 2021QIII 22.632 35 Palmas, Las Total Cohort October 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las Total Cohort October 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las Total Cohort October 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las Total Cohort October 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 35 Palmas, Las Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 35 Palmas, Las Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 35 Palmas, Las Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,7 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,61 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 95,23 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 91,26 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,47 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,57 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 87,78 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 84,58 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 85,21 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 27.256 35 Palmas, Las Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 25.135 35 Palmas, Las Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 20.779 35 Palmas, Las Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 26.080 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 24.021 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 19.661 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 22.911 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 18.580 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 21.995 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 17.978 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 21.250 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 17.403 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 35 Palmas, Las Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 35 Palmas, Las Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 35 Palmas, Las Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95,69 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,57 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,62 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 91,15 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,42 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 87,51 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,52 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 84,54 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 83,75 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 283 35 Palmas, Las Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.734 35 Palmas, Las Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 5.782 35 Palmas, Las Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 275 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.669 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 5.634 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.609 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 5.449 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.534 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 5.338 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.476 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 5.229 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 35 Palmas, Las Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 35 Palmas, Las Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 35 Palmas, Las Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,17 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,25 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,44 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 92,79 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,24 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 88,47 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,32 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 85,12 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 90,44 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 20.038 35 Palmas, Las From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 19.673 35 Palmas, Las From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 20.670 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 18.633 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 18.154 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 17.257 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 17.505 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 17.361 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 16.435 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 16.672 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 16.639 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 15.793 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 16.060 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 16.041 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 15.158 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 35 Palmas, Las From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 35 Palmas, Las From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 92,99 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 92,28 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 83,49 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 87,36 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 88,25 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 79,51 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 83,2 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 84,58 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 76,41 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 80,15 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 81,54 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 73,33 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 19.199 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 16.875 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 17.833 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 15.500 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 16.744 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 14.796 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 15.938 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 14.159 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 15.351 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 13.674 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,89 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 91,85 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 87,21 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 87,68 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 83,01 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 83,91 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 79,96 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 81,03 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 839 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2.798 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 800 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2.654 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 761 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2.565 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 734 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2.480 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 709 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2.367 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,35 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 94,85 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,7 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 91,67 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 87,49 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 88,63 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 84,51 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 84,6 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 20.023 35 Palmas, Las From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 19.424 35 Palmas, Las From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 19.035 35 Palmas, Las From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 18.608 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 18.406 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 18.003 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 17.580 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 17.545 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 17.219 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 16.878 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 16.862 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 16.488 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 16.096 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 15.643 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 35 Palmas, Las From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 35 Palmas, Las From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 35 Palmas, Las From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 92,93 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,76 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,58 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 87,8 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,33 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 90,46 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 84,29 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 86,81 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 86,62 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 82,87 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 82,18 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 19.231 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 17.417 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 15.247 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 17.865 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 16.477 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 14.295 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 16.866 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 15.693 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 13.630 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 16.186 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 15.103 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 13.034 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 14.419 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 12.366 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 92,9 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,6 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 93,76 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 87,7 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 90,1 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 89,39 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 84,17 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 86,71 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 85,49 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 82,79 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 81,1 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 792 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 2.007 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 3.788 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 743 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.929 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 3.708 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 714 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.852 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 3.589 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 692 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.759 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 3.454 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.677 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 3.277 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 93,81 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,11 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,89 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 90,15 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 92,28 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,75 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 87,37 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 87,64 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,18 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 83,56 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 86,51 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 19.980 35 Palmas, Las From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 19.454 35 Palmas, Las From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 19.165 35 Palmas, Las From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 18.657 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 18.298 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 18.128 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 17.802 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 17.490 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 17.243 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 16.620 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 16.303 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 15.905 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 15.767 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 35 Palmas, Las From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 35 Palmas, Las From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 35 Palmas, Las From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,38 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,06 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,59 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,1 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,9 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 89,97 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 85,43 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 85,07 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 81,76 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 82,27 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 19.663 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 18.687 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 16.102 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 18.352 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 17.570 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 15.163 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 17.508 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 16.798 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 14.393 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 15.963 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 13.605 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 15.278 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 13.158 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,33 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,02 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,17 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,04 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,89 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,39 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 85,42 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 84,49 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 81,76 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 81,72 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 317 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 767 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 3.063 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 305 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 728 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2.965 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 294 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 692 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 2.850 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 657 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2.698 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 627 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 2.609 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,21 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 94,92 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,8 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 92,74 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 90,22 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,05 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 85,66 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 88,08 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 81,75 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 85,18 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 19.967 35 Palmas, Las From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 19.673 35 Palmas, Las From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 19.564 35 Palmas, Las From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 18.846 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 18.567 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 18.365 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 17.512 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 17.203 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 16.628 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 16.562 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 15.916 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 15.946 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 35 Palmas, Las From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 35 Palmas, Las From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 35 Palmas, Las From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,39 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,38 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,87 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,02 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 87,93 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 84,52 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 84,66 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 80,9 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 81,51 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 19.769 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 18.427 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 16.618 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 18.656 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 17.384 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 15.544 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 16.386 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 14.529 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 15.569 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 13.970 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 14.907 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 13.442 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,37 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,34 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,54 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,92 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 87,43 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 84,49 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 84,07 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 80,9 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 80,89 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 198 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.246 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 2.946 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 190 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.183 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2.821 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.126 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2.674 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.059 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2.592 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.009 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2.504 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 95,96 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 94,94 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 95,76 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 90,37 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 90,77 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 84,99 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 87,98 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 80,98 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 85 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 3.163 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 3.047 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 3.393 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 3.100 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 2.975 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 3.161 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 3.016 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 2.927 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 3.098 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 2.959 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 2.880 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 3.047 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 2.910 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 2.832 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 2.996 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,01 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 97,64 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 93,16 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 95,35 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,06 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 91,31 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 93,55 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 94,52 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 89,8 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 92 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 92,94 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 88,3 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.999 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.090 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.939 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2.044 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.862 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.009 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.808 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.978 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.762 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.950 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97,8 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 95,43 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,12 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 93,63 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 94,64 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 92,1 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 93,3 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 164 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 957 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 161 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 931 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 154 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 918 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 151 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 902 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 148 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 882 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,17 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,28 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,9 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,92 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 92,07 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,25 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 90,24 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 92,16 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 3.143 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 2.908 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 2.981 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 3.059 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 2.865 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 2.946 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 3.006 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 2.820 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 2.908 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 2.954 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 2.773 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 2.853 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 2.715 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 2.793 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,33 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,52 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,83 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 95,64 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,97 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,55 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 93,99 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,36 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,71 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,36 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 93,69 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.961 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.370 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.816 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.880 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.340 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.785 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.829 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.301 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.758 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.780 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.261 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.729 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.217 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.695 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,26 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,73 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,29 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 95,54 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,09 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 96,81 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 93,89 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,4 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,21 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,54 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 93,34 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 182 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 538 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.165 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 179 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 525 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.161 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 177 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 519 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.150 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 174 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 512 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.124 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 498 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.098 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,35 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,58 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,66 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,25 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,47 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,71 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 95,6 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 95,17 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,48 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 92,57 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,25 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 3.128 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 3.036 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 3.012 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 3.087 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 3.001 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 2.980 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 3.041 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 2.950 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 2.925 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 2.881 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 2.861 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 2.819 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 2.821 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,69 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,85 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,94 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,22 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,17 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,11 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 94,89 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 94,99 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 92,85 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 93,66 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 3.075 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.842 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.966 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 3.034 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.809 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.940 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.989 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.764 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.908 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.697 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.870 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.640 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.846 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,67 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,84 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,68 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,2 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,26 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,05 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 94,9 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,12 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 92,89 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 93,9 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 53 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 194 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.046 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 53 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 192 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.040 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 52 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 186 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.017 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 184 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 991 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 179 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 975 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,97 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,43 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98,11 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,88 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,23 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 94,85 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,74 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 92,27 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 93,21 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 3.144 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 3.084 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 3.029 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 3.108 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 3.043 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 2.985 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 2.974 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 2.913 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 2.912 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 2.867 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 2.856 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 2.824 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,85 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,67 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,55 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,43 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,17 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 94,42 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 94,65 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 92,61 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 93,23 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 3.108 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.895 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2.058 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 3.072 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.855 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2.028 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.787 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.980 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.728 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.951 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.677 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.921 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,84 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,62 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,54 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,27 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,21 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 94,23 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 94,8 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 92,47 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,34 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 36 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 189 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 971 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 36 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 188 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 957 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 187 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 933 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 184 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 916 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 179 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 903 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,47 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,56 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,94 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,09 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,35 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,34 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 94,71 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 3.926 35 Palmas, Las From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 3.610 35 Palmas, Las From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 4.095 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 3.876 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 3.585 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 3.981 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 3.824 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 3.559 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 3.938 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 3.787 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 3.538 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 3.909 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 3.753 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 3.506 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 3.872 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 35 Palmas, Las From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 35 Palmas, Las From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,73 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,31 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,22 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,4 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,59 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,17 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,46 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,01 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,46 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,59 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,12 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,55 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 3.675 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.002 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 3.630 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.989 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 3.579 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.975 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 3.545 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.960 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 3.514 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.940 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,78 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,35 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,39 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,65 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,46 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,9 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,62 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,9 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 251 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.608 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 246 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.596 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 245 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.584 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 242 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.578 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 239 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.566 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,01 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,25 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,61 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,51 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,41 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,13 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 95,22 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,39 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 3.952 35 Palmas, Las From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 3.548 35 Palmas, Las From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 3.611 35 Palmas, Las From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 3.906 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 3.521 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 3.589 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 3.870 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 3.502 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 3.573 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 3.839 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 3.474 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 3.550 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 3.431 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 3.513 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 35 Palmas, Las From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 35 Palmas, Las From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 35 Palmas, Las From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,84 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,24 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,39 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,93 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,7 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,95 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,14 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,91 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,31 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,7 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,29 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 3.683 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.616 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.827 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 3.641 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.596 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.813 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 3.606 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.580 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.802 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 3.576 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.558 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.788 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.526 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.773 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,86 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,24 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,23 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,91 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,62 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,63 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,09 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,78 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,87 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,56 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,04 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 269 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 932 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.784 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 265 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 925 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.776 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 264 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 922 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.771 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 263 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 916 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.762 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 905 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.740 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,51 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,25 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,55 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,14 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,93 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,27 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,77 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,28 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,77 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,1 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 97,53 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 3.995 35 Palmas, Las From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 3.668 35 Palmas, Las From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 3.656 35 Palmas, Las From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 3.958 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 3.651 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 3.641 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 3.928 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 3.619 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 3.611 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 3.578 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 3.572 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 3.537 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 3.550 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 35 Palmas, Las From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 35 Palmas, Las From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 35 Palmas, Las From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,07 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,54 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,59 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,32 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,66 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,77 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,55 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,7 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,43 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,1 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 3.939 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 3.375 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.877 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 3.902 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 3.358 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.867 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 3.872 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 3.328 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.847 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 3.293 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.825 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 3.254 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.813 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,06 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,5 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,47 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,3 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,61 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,4 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,57 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,23 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,41 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,59 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 56 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 293 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.779 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 56 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 293 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.774 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 56 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 291 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.764 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 285 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.747 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 283 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.737 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,72 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,32 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,16 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,27 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,2 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,59 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,64 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 4.073 35 Palmas, Las From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 3.794 35 Palmas, Las From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 3.663 35 Palmas, Las From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 4.046 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 3.762 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 3.640 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 3.718 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 3.610 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 3.673 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 3.584 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 3.639 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 3.559 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 35 Palmas, Las From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 35 Palmas, Las From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 35 Palmas, Las From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,34 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,16 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,37 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,55 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,81 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,84 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,91 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,16 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 4.028 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3.518 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.994 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 4.001 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 3.487 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.980 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 3.445 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.963 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 3.405 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.949 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 3.374 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.932 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,33 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,12 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,3 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,92 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,45 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,79 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,74 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,91 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,89 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 45 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 276 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.669 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 45 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 275 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.660 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 273 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.647 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 268 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.635 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 265 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.627 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,64 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,46 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,91 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,68 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,1 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,96 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96,01 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 97,48 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 236 35 Palmas, Las from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 221 35 Palmas, Las from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 259 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 236 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 220 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 259 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 236 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 220 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 257 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 235 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 220 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 257 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 234 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 220 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 255 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 35 Palmas, Las from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 35 Palmas, Las from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,55 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 99,55 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 99,23 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 99,58 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 99,55 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 99,23 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 99,15 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 99,55 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,46 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 219 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 81 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 219 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 81 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 219 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 81 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 218 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 81 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 217 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 81 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 99,54 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 99,09 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 17 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 140 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 17 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 139 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 17 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 139 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 17 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 139 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 17 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 139 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,29 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 99,29 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 99,29 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 99,29 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 252 35 Palmas, Las from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 214 35 Palmas, Las from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 223 35 Palmas, Las from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 252 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 214 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 222 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 250 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 214 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 222 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 249 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 214 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 221 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 213 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 220 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 35 Palmas, Las from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 35 Palmas, Las from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 35 Palmas, Las from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,55 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,21 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,55 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,81 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 99,1 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 99,53 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,65 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 239 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 126 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 85 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 239 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 126 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 85 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 237 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 126 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 85 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 236 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 126 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 85 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 126 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 85 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 99,16 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,74 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 13 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 88 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 138 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 13 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 88 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 137 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 13 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 88 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 137 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 13 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 88 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 136 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 87 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 135 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,28 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,28 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,55 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 98,86 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 97,83 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 240 35 Palmas, Las from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 207 35 Palmas, Las from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 211 35 Palmas, Las from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 239 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 207 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 211 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 237 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 207 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 211 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 206 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 210 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 206 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 210 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 35 Palmas, Las from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 35 Palmas, Las from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 35 Palmas, Las from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,58 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,75 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 99,52 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 99,53 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 99,52 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 99,53 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 238 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 185 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 70 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 237 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 185 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 70 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 235 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 185 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 70 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 184 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 70 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 184 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 70 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,58 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,74 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 99,46 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 99,46 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 2 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 22 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 141 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 2 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 22 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 141 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 2 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 22 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 141 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 22 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 140 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 22 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 140 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 99,29 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 99,29 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 248 35 Palmas, Las from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 225 35 Palmas, Las from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 221 35 Palmas, Las from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 248 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 225 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 221 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 224 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 220 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 224 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 220 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 223 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 220 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 35 Palmas, Las from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 35 Palmas, Las from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 35 Palmas, Las from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,56 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 99,55 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 99,56 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 99,55 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 99,11 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 99,55 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 245 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 212 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 81 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 245 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 212 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 81 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 211 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 81 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 211 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 81 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 210 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 81 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 99,53 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 99,53 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 99,06 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 3 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 13 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 140 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 3 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 13 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 140 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 13 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 139 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 13 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 139 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 13 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 139 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 99,29 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 99,29 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 99,29 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 97 35 Palmas, Las De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 78 35 Palmas, Las De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 91 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 96 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 77 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 91 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 96 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 77 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 91 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 96 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 77 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 91 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 95 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 77 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 91 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 35 Palmas, Las De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 35 Palmas, Las De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,97 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,72 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,97 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,72 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,97 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,72 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,94 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,72 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 92 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 32 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 91 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 31 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 91 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 31 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 91 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 31 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 90 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 31 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,91 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 96,88 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,91 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,88 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,91 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,88 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,83 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,88 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 5 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 46 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 5 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 46 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 5 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 46 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 5 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 46 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 5 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 46 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 97 35 Palmas, Las De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 79 35 Palmas, Las De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 88 35 Palmas, Las De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 97 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 79 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 88 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 97 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 79 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 88 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 96 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 79 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 88 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 78 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 87 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 35 Palmas, Las De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 35 Palmas, Las De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 35 Palmas, Las De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,97 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,73 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,86 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 93 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 40 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 37 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 93 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 40 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 37 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 93 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 40 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 37 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 93 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 40 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 37 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 39 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 36 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,5 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,3 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 4 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 39 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 51 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 4 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 39 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 51 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 4 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 39 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 51 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 3 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 39 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 51 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 39 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 51 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 75 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 102 35 Palmas, Las De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 82 35 Palmas, Las De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 87 35 Palmas, Las De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 102 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 82 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 87 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 102 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 82 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 87 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 81 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 86 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 81 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 86 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 35 Palmas, Las De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 35 Palmas, Las De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 35 Palmas, Las De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,78 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,85 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,78 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,85 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 101 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 69 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 29 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 101 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 69 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 29 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 101 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 69 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 29 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 68 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 28 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 68 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 28 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,55 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,55 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,55 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,55 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 13 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 58 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 13 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 58 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 13 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 58 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 13 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 58 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 13 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 58 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 107 35 Palmas, Las De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 93 35 Palmas, Las De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 84 35 Palmas, Las De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 107 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 93 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 84 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 92 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 83 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 92 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 83 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 92 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 83 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 35 Palmas, Las De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 35 Palmas, Las De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 35 Palmas, Las De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,92 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,81 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,92 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,81 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,92 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,81 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 106 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 83 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 28 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 106 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 83 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 28 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 82 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 27 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 82 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 27 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 82 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 27 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,8 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,43 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,8 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,43 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,8 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,43 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 10 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 56 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 10 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 56 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 10 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 56 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 10 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 56 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 10 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 56 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 35 Palmas, Las De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra Total Cohort January 1 Total Number at the start of the quarter 2022QI 25.664 36 Pontevedra Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra Total Cohort January 1 Total Number at the start of the quarter 2021QI 24.860 36 Pontevedra Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra Total Cohort January 1 Total Number at the start of the quarter 2020QI 25.886 36 Pontevedra Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 36 Pontevedra Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 36 Pontevedra Total Cohort January 1 Total Survival in the first trimester 2022QII "" 36 Pontevedra Total Cohort January 1 Total Survival in the first trimester 2022QI 24.381 36 Pontevedra Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 36 Pontevedra Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 36 Pontevedra Total Cohort January 1 Total Survival in the first trimester 2021QII "" 36 Pontevedra Total Cohort January 1 Total Survival in the first trimester 2021QI 23.640 36 Pontevedra Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 36 Pontevedra Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 36 Pontevedra Total Cohort January 1 Total Survival in the first trimester 2020QII "" 36 Pontevedra Total Cohort January 1 Total Survival in the first trimester 2020QI 23.442 36 Pontevedra Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 36 Pontevedra Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 36 Pontevedra Total Cohort January 1 Total Survival in the second trimester 2022QII 23.456 36 Pontevedra Total Cohort January 1 Total Survival in the second trimester 2022QI "" 36 Pontevedra Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 36 Pontevedra Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 36 Pontevedra Total Cohort January 1 Total Survival in the second trimester 2021QII 22.945 36 Pontevedra Total Cohort January 1 Total Survival in the second trimester 2021QI "" 36 Pontevedra Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 36 Pontevedra Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 36 Pontevedra Total Cohort January 1 Total Survival in the second trimester 2020QII 22.768 36 Pontevedra Total Cohort January 1 Total Survival in the second trimester 2020QI "" 36 Pontevedra Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra Total Cohort January 1 Total Survival in the third trimester 2022QIII 22.718 36 Pontevedra Total Cohort January 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra Total Cohort January 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra Total Cohort January 1 Total Survival in the third trimester 2021QIII 22.323 36 Pontevedra Total Cohort January 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra Total Cohort January 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra Total Cohort January 1 Total Survival in the third trimester 2020QIII 22.163 36 Pontevedra Total Cohort January 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra Total Cohort January 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra Total Cohort January 1 Total Survival in the third trimester 2022QIV 22.114 36 Pontevedra Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra Total Cohort January 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra Total Cohort January 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra Total Cohort January 1 Total Survival in the third trimester 2021QIV 21.825 36 Pontevedra Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra Total Cohort January 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra Total Cohort January 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra Total Cohort January 1 Total Survival in the third trimester 2020QIV 21.548 36 Pontevedra Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra Total Cohort January 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra Total Cohort January 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 36 Pontevedra Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 36 Pontevedra Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,09 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 90,56 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 91,4 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 92,3 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 87,95 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 88,52 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 89,79 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 85,62 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 86,17 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 87,79 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 83,24 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 24.308 36 Pontevedra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 21.744 36 Pontevedra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 23.074 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 20.593 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 22.202 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 19.953 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 21.501 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 19.377 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 20.916 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 18.936 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 36 Pontevedra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 36 Pontevedra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,92 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,71 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 91,34 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 91,76 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 88,45 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 89,11 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 86,05 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 87,09 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.356 36 Pontevedra Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 3.116 36 Pontevedra Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.307 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 3.047 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.254 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2.992 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.217 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2.946 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.198 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2.889 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 36 Pontevedra Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 36 Pontevedra Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,39 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,79 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,48 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,02 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 89,75 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,54 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,35 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 92,72 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra Total Cohort April 1 Total Number at the start of the quarter 2022QII 25.583 36 Pontevedra Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra Total Cohort April 1 Total Number at the start of the quarter 2021QII 24.893 36 Pontevedra Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra Total Cohort April 1 Total Number at the start of the quarter 2020QII 24.479 36 Pontevedra Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 36 Pontevedra Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 36 Pontevedra Total Cohort April 1 Total Survival in the first trimester 2022QII 24.450 36 Pontevedra Total Cohort April 1 Total Survival in the first trimester 2022QI "" 36 Pontevedra Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 36 Pontevedra Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 36 Pontevedra Total Cohort April 1 Total Survival in the first trimester 2021QII 23.996 36 Pontevedra Total Cohort April 1 Total Survival in the first trimester 2021QI "" 36 Pontevedra Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 36 Pontevedra Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 36 Pontevedra Total Cohort April 1 Total Survival in the first trimester 2020QII 23.653 36 Pontevedra Total Cohort April 1 Total Survival in the first trimester 2020QI "" 36 Pontevedra Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 36 Pontevedra Total Cohort April 1 Total Survival in the second trimester 2022QIII 23.564 36 Pontevedra Total Cohort April 1 Total Survival in the second trimester 2022QII "" 36 Pontevedra Total Cohort April 1 Total Survival in the second trimester 2022QI "" 36 Pontevedra Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 36 Pontevedra Total Cohort April 1 Total Survival in the second trimester 2021QIII 23.224 36 Pontevedra Total Cohort April 1 Total Survival in the second trimester 2021QII "" 36 Pontevedra Total Cohort April 1 Total Survival in the second trimester 2021QI "" 36 Pontevedra Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 36 Pontevedra Total Cohort April 1 Total Survival in the second trimester 2020QIII 22.945 36 Pontevedra Total Cohort April 1 Total Survival in the second trimester 2020QII "" 36 Pontevedra Total Cohort April 1 Total Survival in the second trimester 2020QI "" 36 Pontevedra Total Cohort April 1 Total Survival in the third trimester 2022QIV 22.797 36 Pontevedra Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra Total Cohort April 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra Total Cohort April 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra Total Cohort April 1 Total Survival in the third trimester 2021QIV 22.580 36 Pontevedra Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra Total Cohort April 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra Total Cohort April 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra Total Cohort April 1 Total Survival in the third trimester 2020QIV 22.250 36 Pontevedra Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra Total Cohort April 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra Total Cohort April 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra Total Cohort April 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra Total Cohort April 1 Total Survival in the third trimester 2022QI 21.876 36 Pontevedra Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra Total Cohort April 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra Total Cohort April 1 Total Survival in the third trimester 2021QI 21.509 36 Pontevedra Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra Total Cohort April 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra Total Cohort April 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 36 Pontevedra Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 36 Pontevedra Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 36 Pontevedra Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,57 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,4 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,63 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 92,11 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 93,3 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,73 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 89,11 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 90,71 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,89 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 87,88 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87,87 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 24.266 36 Pontevedra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 21.522 36 Pontevedra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 19.302 36 Pontevedra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 23.178 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 20.692 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 18.535 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 22.323 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 19.973 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 17.943 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 21.580 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 19.396 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 17.379 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 18.765 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 16.765 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 36 Pontevedra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 36 Pontevedra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 36 Pontevedra Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,52 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 96,14 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 96,03 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,99 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,8 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,96 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 88,93 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 90,12 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 90,04 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 87,19 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 86,86 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.317 36 Pontevedra Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 3.371 36 Pontevedra Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 5.177 36 Pontevedra Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.272 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 3.304 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 5.118 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.241 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 3.251 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 5.002 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.217 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 3.184 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 4.871 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 3.111 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 4.744 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 36 Pontevedra Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 36 Pontevedra Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 36 Pontevedra Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,58 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,01 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,86 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,23 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,44 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,62 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 92,41 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,45 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 94,09 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 92,29 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,64 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra Total Cohort July 1 Total Number at the start of the quarter 2022QIII 26.089 36 Pontevedra Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra Total Cohort July 1 Total Number at the start of the quarter 2021QIII 25.936 36 Pontevedra Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra Total Cohort July 1 Total Number at the start of the quarter 2020QIII 25.107 36 Pontevedra Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 36 Pontevedra Total Cohort July 1 Total Survival in the first trimester 2022QIII 24.671 36 Pontevedra Total Cohort July 1 Total Survival in the first trimester 2022QII "" 36 Pontevedra Total Cohort July 1 Total Survival in the first trimester 2022QI "" 36 Pontevedra Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 36 Pontevedra Total Cohort July 1 Total Survival in the first trimester 2021QIII 24.515 36 Pontevedra Total Cohort July 1 Total Survival in the first trimester 2021QII "" 36 Pontevedra Total Cohort July 1 Total Survival in the first trimester 2021QI "" 36 Pontevedra Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 36 Pontevedra Total Cohort July 1 Total Survival in the first trimester 2020QIII 23.966 36 Pontevedra Total Cohort July 1 Total Survival in the first trimester 2020QII "" 36 Pontevedra Total Cohort July 1 Total Survival in the first trimester 2020QI "" 36 Pontevedra Total Cohort July 1 Total Survival in the second trimester 2022QIV 23.553 36 Pontevedra Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 36 Pontevedra Total Cohort July 1 Total Survival in the second trimester 2022QII "" 36 Pontevedra Total Cohort July 1 Total Survival in the second trimester 2022QI "" 36 Pontevedra Total Cohort July 1 Total Survival in the second trimester 2021QIV 23.522 36 Pontevedra Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 36 Pontevedra Total Cohort July 1 Total Survival in the second trimester 2021QII "" 36 Pontevedra Total Cohort July 1 Total Survival in the second trimester 2021QI "" 36 Pontevedra Total Cohort July 1 Total Survival in the second trimester 2020QIV 22.954 36 Pontevedra Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 36 Pontevedra Total Cohort July 1 Total Survival in the second trimester 2020QII "" 36 Pontevedra Total Cohort July 1 Total Survival in the second trimester 2020QI "" 36 Pontevedra Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra Total Cohort July 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra Total Cohort July 1 Total Survival in the third trimester 2022QI 22.701 36 Pontevedra Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra Total Cohort July 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra Total Cohort July 1 Total Survival in the third trimester 2021QI 22.133 36 Pontevedra Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra Total Cohort July 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra Total Cohort July 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra Total Cohort July 1 Total Survival in the third trimester 2022QII 22.058 36 Pontevedra Total Cohort July 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra Total Cohort July 1 Total Survival in the third trimester 2021QII 21.638 36 Pontevedra Total Cohort July 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra Total Cohort July 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra Total Cohort July 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 36 Pontevedra Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 36 Pontevedra Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 36 Pontevedra Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,56 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,52 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,46 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 90,28 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,69 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 91,42 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 87,53 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 88,15 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 85,05 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 86,18 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 25.255 36 Pontevedra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 24.740 36 Pontevedra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 20.527 36 Pontevedra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 23.865 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 23.341 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 19.473 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 22.764 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 22.376 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 18.568 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 21.580 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 17.847 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 20.970 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 17.422 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 36 Pontevedra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 36 Pontevedra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 36 Pontevedra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,5 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,35 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,87 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 90,14 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 90,44 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,46 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 87,23 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,94 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 84,76 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 84,87 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 834 36 Pontevedra Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.196 36 Pontevedra Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 4.580 36 Pontevedra Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 806 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.174 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 4.493 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 789 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1.146 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 4.386 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1.121 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 4.286 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1.088 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 4.216 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 36 Pontevedra Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 36 Pontevedra Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 36 Pontevedra Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,64 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,16 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,1 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,6 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,82 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,76 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93,73 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,58 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 90,97 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,05 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra Total Cohort October 1 Total Number at the start of the quarter 2022QIV 25.714 36 Pontevedra Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra Total Cohort October 1 Total Number at the start of the quarter 2021QIV 25.739 36 Pontevedra Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra Total Cohort October 1 Total Number at the start of the quarter 2020QIV 25.289 36 Pontevedra Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra Total Cohort October 1 Total Survival in the first trimester 2022QIV 24.334 36 Pontevedra Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 36 Pontevedra Total Cohort October 1 Total Survival in the first trimester 2022QII "" 36 Pontevedra Total Cohort October 1 Total Survival in the first trimester 2022QI "" 36 Pontevedra Total Cohort October 1 Total Survival in the first trimester 2021QIV 24.436 36 Pontevedra Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 36 Pontevedra Total Cohort October 1 Total Survival in the first trimester 2021QII "" 36 Pontevedra Total Cohort October 1 Total Survival in the first trimester 2021QI "" 36 Pontevedra Total Cohort October 1 Total Survival in the first trimester 2020QIV 23.841 36 Pontevedra Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 36 Pontevedra Total Cohort October 1 Total Survival in the first trimester 2020QII "" 36 Pontevedra Total Cohort October 1 Total Survival in the first trimester 2020QI "" 36 Pontevedra Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 36 Pontevedra Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 36 Pontevedra Total Cohort October 1 Total Survival in the second trimester 2022QII "" 36 Pontevedra Total Cohort October 1 Total Survival in the second trimester 2022QI 23.484 36 Pontevedra Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 36 Pontevedra Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 36 Pontevedra Total Cohort October 1 Total Survival in the second trimester 2021QII "" 36 Pontevedra Total Cohort October 1 Total Survival in the second trimester 2021QI 22.874 36 Pontevedra Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 36 Pontevedra Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 36 Pontevedra Total Cohort October 1 Total Survival in the second trimester 2020QII "" 36 Pontevedra Total Cohort October 1 Total Survival in the second trimester 2020QI "" 36 Pontevedra Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra Total Cohort October 1 Total Survival in the third trimester 2022QII 22.723 36 Pontevedra Total Cohort October 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra Total Cohort October 1 Total Survival in the third trimester 2021QII 22.305 36 Pontevedra Total Cohort October 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra Total Cohort October 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra Total Cohort October 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra Total Cohort October 1 Total Survival in the third trimester 2022QIII 22.089 36 Pontevedra Total Cohort October 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra Total Cohort October 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra Total Cohort October 1 Total Survival in the third trimester 2021QIII 21.784 36 Pontevedra Total Cohort October 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra Total Cohort October 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra Total Cohort October 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra Total Cohort October 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 36 Pontevedra Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 36 Pontevedra Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 36 Pontevedra Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,63 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,94 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,27 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 91,24 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,45 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 88,28 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 88,2 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 85,82 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 86,14 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 24.948 36 Pontevedra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 24.310 36 Pontevedra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 22.072 36 Pontevedra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 23.585 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 23.040 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 20.700 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 22.146 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 19.805 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 21.435 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 19.290 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 20.837 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 18.819 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 36 Pontevedra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 36 Pontevedra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 36 Pontevedra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,54 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,78 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,78 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 91,1 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,73 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 88,17 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 87,4 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 85,71 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 85,26 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 766 36 Pontevedra Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.429 36 Pontevedra Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 3.217 36 Pontevedra Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 749 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.396 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 3.141 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.338 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 3.069 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.288 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 3.015 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.252 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2.965 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 36 Pontevedra Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 36 Pontevedra Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 36 Pontevedra Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,78 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,69 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,64 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,63 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,4 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 90,13 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,72 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 87,61 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 92,17 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 19.652 36 Pontevedra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 19.301 36 Pontevedra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 19.908 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 18.416 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 18.131 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 17.593 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 17.570 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 17.501 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 16.962 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 16.879 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 16.917 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 16.406 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 16.317 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 16.456 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 15.849 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 36 Pontevedra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 36 Pontevedra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,71 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,94 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 88,37 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,41 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,67 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 85,2 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 85,89 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,65 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 82,41 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 83,03 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,26 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 79,61 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 18.752 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 17.496 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 17.563 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 16.385 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 16.763 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 15.801 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 16.105 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 15.253 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 15.562 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 14.835 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,66 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,65 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,39 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,31 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 85,88 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,18 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 82,99 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 84,79 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 900 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.805 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 853 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.746 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 807 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.700 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 774 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.664 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 755 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.621 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,78 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,73 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 89,67 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,18 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 86 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,19 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 83,89 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 89,81 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 19.504 36 Pontevedra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 19.272 36 Pontevedra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 18.990 36 Pontevedra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 18.440 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 18.440 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 18.194 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 17.599 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 17.705 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 17.522 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 16.890 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 17.102 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 16.873 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 16.445 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 16.190 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 36 Pontevedra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 36 Pontevedra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 36 Pontevedra From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,54 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,68 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,81 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,23 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,87 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,27 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 86,6 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 88,74 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,85 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 85,33 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,26 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 18.654 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 17.276 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 15.632 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 17.633 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 16.501 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 14.886 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 16.820 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 15.811 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 14.316 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 16.131 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 15.263 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 13.785 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 14.667 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 13.209 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,53 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,51 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,23 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,17 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,52 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,58 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 86,47 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 88,35 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,18 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 84,9 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,5 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 850 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.996 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 3.358 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 807 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.939 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 3.308 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 779 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.894 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 3.206 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 759 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.839 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 3.088 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.778 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.981 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 94,94 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,14 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,51 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,65 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,89 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,47 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 89,29 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 92,13 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,96 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 89,08 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 88,77 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 19.719 36 Pontevedra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 19.873 36 Pontevedra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 19.401 36 Pontevedra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 18.378 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 18.534 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 18.319 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 17.388 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 17.653 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 17.390 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 16.890 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 16.634 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 16.300 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 16.187 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 36 Pontevedra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 36 Pontevedra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 36 Pontevedra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,2 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,26 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,42 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 88,18 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 88,83 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 89,63 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 84,99 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 85,74 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 82,02 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 83,43 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 19.140 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 19.171 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 16.704 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 17.823 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 17.852 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 15.697 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 16.845 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 16.992 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 14.860 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 16.249 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 14.185 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 15.687 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 13.793 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,12 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,12 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,97 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 88,01 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 88,63 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 88,96 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 84,76 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 84,92 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 81,83 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 82,57 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 579 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 702 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2.697 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 555 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 682 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2.622 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 543 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 661 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 2.530 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 641 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2.449 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 613 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 2.394 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,85 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,15 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,22 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,78 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 94,16 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,81 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 91,31 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 90,8 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 87,32 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 88,77 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 19.459 36 Pontevedra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 19.745 36 Pontevedra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 19.551 36 Pontevedra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 18.179 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 18.522 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 18.159 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 17.618 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 17.254 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 16.926 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 16.743 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 16.336 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 16.255 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 36 Pontevedra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 36 Pontevedra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 36 Pontevedra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,42 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,81 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 92,88 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,23 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 88,25 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 85,72 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 85,64 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 82,73 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 83,14 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 18.925 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 18.761 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 17.759 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 17.660 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 17.564 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 16.434 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 16.715 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 15.589 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 16.067 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 15.121 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 15.506 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 14.670 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,32 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 93,62 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,54 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,09 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 87,78 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 85,64 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 85,15 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 82,65 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 82,61 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 534 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 984 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.792 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 519 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 958 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.725 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 903 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.665 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 859 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.622 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 830 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.585 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,19 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,36 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,26 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91,77 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 92,91 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 87,3 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 90,51 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 84,35 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 88,45 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 2.667 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 2.434 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 2.642 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 2.641 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 2.410 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 2.561 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 2.596 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 2.376 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 2.536 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 2.570 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 2.354 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 2.502 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 2.550 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 2.335 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 2.468 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,03 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,01 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,93 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,34 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,62 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,99 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,36 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,71 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,7 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,61 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,93 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 93,41 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.470 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.965 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.444 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.948 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.402 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.919 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.378 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.904 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.358 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.891 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,95 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,13 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,25 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,66 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,28 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,9 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,47 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,23 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 197 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 469 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 197 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 462 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 194 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 457 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 192 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 450 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 192 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 444 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,51 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,48 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,44 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,46 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,95 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 97,46 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 94,67 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 2.735 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 2.503 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 2.397 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 2.690 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 2.467 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 2.377 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 2.664 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 2.444 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 2.353 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 2.628 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 2.423 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 2.324 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 2.395 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 2.290 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,35 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,56 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,17 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,4 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,64 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,16 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,09 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,8 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,95 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 95,69 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,54 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.549 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.003 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.634 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.506 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.971 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.619 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.482 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.954 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.606 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.449 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.937 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.584 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.913 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.561 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,31 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,4 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,08 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,37 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,55 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,29 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,08 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,7 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,94 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,51 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,53 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 186 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 500 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 763 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 184 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 496 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 758 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 182 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 490 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 747 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 179 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 486 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 740 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 482 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 729 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,92 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,2 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,34 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,85 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,9 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,24 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,2 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,99 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,4 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,54 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 2.821 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 2.722 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 2.527 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 2.768 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 2.662 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 2.481 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 2.687 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 2.582 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 2.427 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 2.547 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 2.395 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 2.516 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 2.372 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,12 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 97,8 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,18 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 95,25 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 94,86 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 96,04 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 93,57 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 94,78 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 92,43 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 93,87 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.705 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.544 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.786 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.655 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.485 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.750 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.576 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.409 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.705 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.377 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.684 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.349 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.668 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,15 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 97,68 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 97,98 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 95,23 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 94,69 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 95,46 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 93,44 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 94,29 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 92,33 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 93,39 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 116 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 178 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 741 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 113 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 177 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 731 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 111 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 173 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 722 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 170 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 711 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 167 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 704 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,41 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,44 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,65 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95,69 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,19 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,44 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,51 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95,95 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,82 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,01 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 2.789 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 2.664 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 2.540 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 2.722 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 2.610 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 2.502 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 2.581 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 2.473 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 2.539 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 2.443 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 2.513 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 2.426 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,6 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 97,97 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,5 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,88 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,36 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95,31 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,18 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 94,33 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,51 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.687 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.504 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2.027 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.621 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.455 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.995 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.427 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.975 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.388 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.952 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.369 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.943 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,54 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,04 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,42 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,92 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,43 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,37 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,3 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 94,61 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,86 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 102 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 160 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 513 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 101 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 155 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 507 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 154 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 498 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 151 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 491 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 144 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 483 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,02 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,88 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,83 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 96,25 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,08 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 94,38 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,71 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 90 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 94,15 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 3.152 36 Pontevedra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 2.940 36 Pontevedra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 3.133 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 3.131 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 2.915 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 3.085 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 3.098 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 2.884 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 3.068 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 3.077 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 2.868 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 3.053 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 3.055 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 2.851 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 3.029 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 36 Pontevedra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 36 Pontevedra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,33 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,15 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,47 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,29 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,1 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,93 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,62 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,55 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,45 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,92 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,97 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,68 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.916 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.164 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.897 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2.142 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.868 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.115 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.849 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.102 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.827 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2.093 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,35 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,98 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,35 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,74 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,7 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,13 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,95 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,72 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 236 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 776 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 234 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 773 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 230 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 769 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 228 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 766 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 228 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 758 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,15 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,61 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,46 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 99,1 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,61 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,71 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,61 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,68 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 3.141 36 Pontevedra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 2.934 36 Pontevedra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 2.900 36 Pontevedra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 3.117 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 2.905 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 2.890 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 3.098 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 2.891 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 2.878 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 3.076 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 2.872 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 2.861 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 2.854 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 2.838 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 36 Pontevedra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 36 Pontevedra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 36 Pontevedra From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,24 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,01 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,66 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,63 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,53 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,24 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,93 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,89 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,66 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,27 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,86 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.881 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.121 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.909 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.857 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.098 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.903 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.839 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.086 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.894 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.818 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.075 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.883 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.064 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.869 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,17 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,92 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,69 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,54 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,35 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,21 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,81 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,83 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,64 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,31 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,9 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 260 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 813 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 991 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 260 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 807 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 987 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 259 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 805 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 984 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 258 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 797 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 978 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 790 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 969 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,26 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,6 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 99,62 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,02 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,29 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 99,23 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,03 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,69 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,17 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 97,78 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 3.344 36 Pontevedra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 3.152 36 Pontevedra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 2.982 36 Pontevedra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 3.320 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 3.130 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 2.969 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 3.273 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 3.099 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 2.940 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 3.077 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 2.908 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 3.056 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 2.883 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 36 Pontevedra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 36 Pontevedra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 36 Pontevedra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,28 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,3 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,56 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,88 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,32 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,59 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,62 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,52 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,95 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,68 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 3.218 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.863 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.915 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 3.195 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.842 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.904 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 3.151 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.814 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.881 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.794 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.857 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.775 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.840 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,29 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,27 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,43 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,92 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,29 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,22 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,59 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,97 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,93 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,08 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 126 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 289 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.067 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 125 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 288 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.065 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 122 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 285 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.059 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 283 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.051 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 281 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.043 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,21 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,65 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,81 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 96,83 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,62 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,25 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,92 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,5 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 97,23 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,75 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 3.249 36 Pontevedra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 3.136 36 Pontevedra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 2.999 36 Pontevedra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 3.216 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 3.111 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 2.981 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 3.093 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 2.949 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 3.067 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 2.921 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 3.049 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 2.905 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 36 Pontevedra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 36 Pontevedra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 36 Pontevedra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,98 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,2 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,4 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,63 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,33 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,8 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,4 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,23 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,87 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 3.131 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.873 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2.166 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 3.099 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.850 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2.151 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.833 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.122 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.810 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2.098 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.792 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.087 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,98 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,2 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,31 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,61 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,97 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,81 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,86 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,18 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,35 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 118 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 263 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 833 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 117 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 261 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 830 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 260 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 827 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 257 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 823 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 257 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 818 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,15 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,24 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,64 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,86 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 99,28 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,72 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,8 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 97,72 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,2 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 128 36 Pontevedra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 122 36 Pontevedra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 145 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 128 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 122 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 145 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 128 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 122 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 144 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 128 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 122 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 144 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 128 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 122 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 144 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 36 Pontevedra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 36 Pontevedra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 99,31 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 99,31 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 99,31 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 115 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 81 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 115 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 81 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 115 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 81 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 115 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 81 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 115 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 81 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 13 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 41 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 13 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 41 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 13 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 41 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 13 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 41 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 13 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 41 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 138 36 Pontevedra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 123 36 Pontevedra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 136 36 Pontevedra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 138 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 123 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 136 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 138 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 123 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 136 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 138 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 123 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 136 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 122 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 136 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 36 Pontevedra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 36 Pontevedra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 36 Pontevedra from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 99,19 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 125 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 85 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 93 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 125 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 85 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 93 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 125 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 85 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 93 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 125 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 85 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 93 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 85 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 93 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 13 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 38 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 43 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 13 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 38 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 43 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 13 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 38 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 43 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 13 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 38 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 43 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 37 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 43 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,37 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 138 36 Pontevedra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 123 36 Pontevedra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 141 36 Pontevedra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 138 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 123 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 141 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 138 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 123 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 141 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 122 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 141 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 122 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 141 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 36 Pontevedra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 36 Pontevedra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 36 Pontevedra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 99,19 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 99,19 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 128 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 111 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 89 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 128 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 111 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 89 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 128 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 111 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 89 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 110 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 89 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 110 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 89 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 99,1 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 99,1 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 10 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 12 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 52 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 10 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 12 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 52 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 10 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 12 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 52 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 12 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 52 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 12 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 52 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 147 36 Pontevedra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 127 36 Pontevedra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 135 36 Pontevedra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 147 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 127 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 135 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 126 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 135 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 126 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 135 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 126 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 135 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 36 Pontevedra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 36 Pontevedra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 36 Pontevedra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,21 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 99,21 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 99,21 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 138 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 115 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 85 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 138 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 115 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 85 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 115 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 85 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 115 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 85 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 115 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 85 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 9 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 12 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 50 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 9 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 12 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 50 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 11 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 50 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 11 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 50 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 11 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 50 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91,67 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 91,67 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 91,67 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 65 36 Pontevedra De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 63 36 Pontevedra De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 58 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 65 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 62 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 58 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 64 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 62 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 58 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 64 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 62 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 58 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 64 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 61 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 58 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 36 Pontevedra De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 36 Pontevedra De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,41 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,46 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,41 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,46 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,41 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,46 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,83 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 55 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 38 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 55 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 37 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 54 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 37 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 54 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 37 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 54 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 36 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97,37 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,18 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,37 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,18 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,37 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,18 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,74 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 10 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 25 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 10 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 25 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 10 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 25 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 10 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 25 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 10 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 25 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 65 36 Pontevedra De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 61 36 Pontevedra De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 56 36 Pontevedra De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 65 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 61 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 56 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 65 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 61 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 56 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 65 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 60 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 56 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 60 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 55 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 36 Pontevedra De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 36 Pontevedra De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 36 Pontevedra De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,36 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,36 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,21 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 57 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 37 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 34 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 57 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 37 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 34 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 57 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 37 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 34 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 57 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 36 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 34 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 36 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 33 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,3 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,3 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,06 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 8 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 24 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 22 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 8 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 24 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 22 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 8 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 24 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 22 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 8 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 24 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 22 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 24 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 22 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 67 36 Pontevedra De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 66 36 Pontevedra De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 56 36 Pontevedra De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 67 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 66 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 56 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 67 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 65 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 56 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 65 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 55 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 64 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 55 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 36 Pontevedra De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 36 Pontevedra De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 36 Pontevedra De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 36 Pontevedra De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 36 Pontevedra De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 36 Pontevedra De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,48 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,48 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,21 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,97 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,21 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 64 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 51 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 33 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 64 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 51 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 33 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 64 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 50 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 33 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 50 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 32 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 49 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 32 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,04 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,04 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,97 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,08 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,97 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 3 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 15 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 23 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 3 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 15 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 23 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 3 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 15 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 23 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 15 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 23 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 15 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 23 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 70 36 Pontevedra De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 67 36 Pontevedra De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 64 36 Pontevedra De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 70 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 66 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 64 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 66 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 63 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 65 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 63 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 65 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 63 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 36 Pontevedra De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 36 Pontevedra De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 36 Pontevedra De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,51 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,51 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,44 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,01 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,44 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,01 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,44 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 67 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 57 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 35 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 67 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 56 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 35 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 56 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 34 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 55 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 34 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 55 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 34 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,25 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,25 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,14 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,49 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,14 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,49 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,14 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 3 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 10 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 29 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 3 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 10 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 29 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 10 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 29 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 10 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 29 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 10 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 29 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 36 Pontevedra De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2022QI 8.360 26 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2021QI 8.229 26 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2020QI 8.653 26 Rioja, La Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 26 Rioja, La Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 26 Rioja, La Total Cohort January 1 Total Survival in the first trimester 2022QII "" 26 Rioja, La Total Cohort January 1 Total Survival in the first trimester 2022QI 7.982 26 Rioja, La Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 26 Rioja, La Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 26 Rioja, La Total Cohort January 1 Total Survival in the first trimester 2021QII "" 26 Rioja, La Total Cohort January 1 Total Survival in the first trimester 2021QI 7.822 26 Rioja, La Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 26 Rioja, La Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 26 Rioja, La Total Cohort January 1 Total Survival in the first trimester 2020QII "" 26 Rioja, La Total Cohort January 1 Total Survival in the first trimester 2020QI 7.856 26 Rioja, La Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 26 Rioja, La Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 26 Rioja, La Total Cohort January 1 Total Survival in the second trimester 2022QII 7.678 26 Rioja, La Total Cohort January 1 Total Survival in the second trimester 2022QI "" 26 Rioja, La Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 26 Rioja, La Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 26 Rioja, La Total Cohort January 1 Total Survival in the second trimester 2021QII 7.595 26 Rioja, La Total Cohort January 1 Total Survival in the second trimester 2021QI "" 26 Rioja, La Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 26 Rioja, La Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 26 Rioja, La Total Cohort January 1 Total Survival in the second trimester 2020QII 7.629 26 Rioja, La Total Cohort January 1 Total Survival in the second trimester 2020QI "" 26 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2022QIII 7.441 26 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2021QIII 7.390 26 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2020QIII 7.413 26 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2022QIV 7.277 26 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2021QIV 7.254 26 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2020QIV 7.211 26 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La Total Cohort January 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 26 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 26 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,48 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,05 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 90,79 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 91,84 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 92,3 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 88,17 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 89,01 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 89,8 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 85,67 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 87,05 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 88,15 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 83,34 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 7.781 26 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 7.262 26 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 7.420 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 6.885 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 7.138 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 6.675 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 6.916 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 6.490 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 6.762 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 6.376 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 26 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 26 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 95,36 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,81 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 91,74 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 91,92 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 88,88 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 89,37 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 86,9 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 87,8 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 579 26 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 967 26 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 562 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 937 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 540 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 920 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 525 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 900 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 515 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 878 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 26 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 26 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,06 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,9 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,26 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,14 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,67 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 93,07 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,95 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 90,8 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2022QII 8.375 26 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2021QII 8.140 26 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2020QII 8.115 26 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 26 Rioja, La Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 26 Rioja, La Total Cohort April 1 Total Survival in the first trimester 2022QII 7.987 26 Rioja, La Total Cohort April 1 Total Survival in the first trimester 2022QI "" 26 Rioja, La Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 26 Rioja, La Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 26 Rioja, La Total Cohort April 1 Total Survival in the first trimester 2021QII 7.840 26 Rioja, La Total Cohort April 1 Total Survival in the first trimester 2021QI "" 26 Rioja, La Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 26 Rioja, La Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 26 Rioja, La Total Cohort April 1 Total Survival in the first trimester 2020QII 7.838 26 Rioja, La Total Cohort April 1 Total Survival in the first trimester 2020QI "" 26 Rioja, La Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 26 Rioja, La Total Cohort April 1 Total Survival in the second trimester 2022QIII 7.708 26 Rioja, La Total Cohort April 1 Total Survival in the second trimester 2022QII "" 26 Rioja, La Total Cohort April 1 Total Survival in the second trimester 2022QI "" 26 Rioja, La Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 26 Rioja, La Total Cohort April 1 Total Survival in the second trimester 2021QIII 7.604 26 Rioja, La Total Cohort April 1 Total Survival in the second trimester 2021QII "" 26 Rioja, La Total Cohort April 1 Total Survival in the second trimester 2021QI "" 26 Rioja, La Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 26 Rioja, La Total Cohort April 1 Total Survival in the second trimester 2020QIII 7.595 26 Rioja, La Total Cohort April 1 Total Survival in the second trimester 2020QII "" 26 Rioja, La Total Cohort April 1 Total Survival in the second trimester 2020QI "" 26 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2022QIV 7.507 26 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2021QIV 7.432 26 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2020QIV 7.378 26 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2022QI 7.231 26 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2021QI 7.123 26 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La Total Cohort April 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 26 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 26 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 26 Rioja, La Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,37 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,31 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,59 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 92,04 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 93,42 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,59 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 89,64 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 91,3 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,92 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 88,83 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87,78 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 7.829 26 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 6.935 26 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 6.386 26 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 7.459 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 6.658 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 6.142 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 7.197 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 6.449 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 5.931 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 7.007 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 6.302 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 5.753 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 6.127 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 5.552 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 26 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 26 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 26 Rioja, La Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,27 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 96,01 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 96,18 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,93 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,99 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,88 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 89,5 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 90,87 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 90,09 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 88,35 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 86,94 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 546 26 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.205 26 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.729 26 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 528 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.182 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.696 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 511 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.155 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.664 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 500 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.130 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.625 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.104 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.571 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 26 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 26 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 26 Rioja, La Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,7 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,09 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,09 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,59 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,85 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,24 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,58 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,78 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,98 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 91,62 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 90,86 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2022QIII 8.401 26 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2021QIII 8.266 26 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2020QIII 8.260 26 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 26 Rioja, La Total Cohort July 1 Total Survival in the first trimester 2022QIII 8.002 26 Rioja, La Total Cohort July 1 Total Survival in the first trimester 2022QII "" 26 Rioja, La Total Cohort July 1 Total Survival in the first trimester 2022QI "" 26 Rioja, La Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 26 Rioja, La Total Cohort July 1 Total Survival in the first trimester 2021QIII 7.883 26 Rioja, La Total Cohort July 1 Total Survival in the first trimester 2021QII "" 26 Rioja, La Total Cohort July 1 Total Survival in the first trimester 2021QI "" 26 Rioja, La Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 26 Rioja, La Total Cohort July 1 Total Survival in the first trimester 2020QIII 7.905 26 Rioja, La Total Cohort July 1 Total Survival in the first trimester 2020QII "" 26 Rioja, La Total Cohort July 1 Total Survival in the first trimester 2020QI "" 26 Rioja, La Total Cohort July 1 Total Survival in the second trimester 2022QIV 7.732 26 Rioja, La Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 26 Rioja, La Total Cohort July 1 Total Survival in the second trimester 2022QII "" 26 Rioja, La Total Cohort July 1 Total Survival in the second trimester 2022QI "" 26 Rioja, La Total Cohort July 1 Total Survival in the second trimester 2021QIV 7.647 26 Rioja, La Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 26 Rioja, La Total Cohort July 1 Total Survival in the second trimester 2021QII "" 26 Rioja, La Total Cohort July 1 Total Survival in the second trimester 2021QI "" 26 Rioja, La Total Cohort July 1 Total Survival in the second trimester 2020QIV 7.631 26 Rioja, La Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 26 Rioja, La Total Cohort July 1 Total Survival in the second trimester 2020QII "" 26 Rioja, La Total Cohort July 1 Total Survival in the second trimester 2020QI "" 26 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2022QI 7.421 26 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2021QI 7.348 26 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2022QII 7.240 26 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2021QII 7.212 26 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La Total Cohort July 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 26 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 26 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 26 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 95,25 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,37 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,7 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 92,04 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 92,51 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 92,38 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 89,78 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 88,96 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 87,59 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 87,31 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 7.920 26 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 7.903 26 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 7.345 26 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 7.538 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 7.529 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 7.006 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 7.277 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 7.301 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 6.747 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 7.078 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 6.490 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 6.907 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 6.368 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 26 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 26 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 26 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 95,18 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,27 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,38 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 91,88 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 92,38 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 91,86 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 89,56 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 88,36 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 87,4 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 86,7 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 481 26 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 363 26 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 915 26 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 464 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 354 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 899 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 455 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 346 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 884 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 343 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 858 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 333 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 844 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 26 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 26 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 26 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,47 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,52 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,25 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,59 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,32 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,61 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 94,49 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,77 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 91,74 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,24 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2022QIV 8.336 26 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2021QIV 8.243 26 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2020QIV 8.271 26 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La Total Cohort October 1 Total Survival in the first trimester 2022QIV 7.988 26 Rioja, La Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 26 Rioja, La Total Cohort October 1 Total Survival in the first trimester 2022QII "" 26 Rioja, La Total Cohort October 1 Total Survival in the first trimester 2022QI "" 26 Rioja, La Total Cohort October 1 Total Survival in the first trimester 2021QIV 7.908 26 Rioja, La Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 26 Rioja, La Total Cohort October 1 Total Survival in the first trimester 2021QII "" 26 Rioja, La Total Cohort October 1 Total Survival in the first trimester 2021QI "" 26 Rioja, La Total Cohort October 1 Total Survival in the first trimester 2020QIV 7.884 26 Rioja, La Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 26 Rioja, La Total Cohort October 1 Total Survival in the first trimester 2020QII "" 26 Rioja, La Total Cohort October 1 Total Survival in the first trimester 2020QI "" 26 Rioja, La Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 26 Rioja, La Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 26 Rioja, La Total Cohort October 1 Total Survival in the second trimester 2022QII "" 26 Rioja, La Total Cohort October 1 Total Survival in the second trimester 2022QI 7.643 26 Rioja, La Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 26 Rioja, La Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 26 Rioja, La Total Cohort October 1 Total Survival in the second trimester 2021QII "" 26 Rioja, La Total Cohort October 1 Total Survival in the second trimester 2021QI 7.562 26 Rioja, La Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 26 Rioja, La Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 26 Rioja, La Total Cohort October 1 Total Survival in the second trimester 2020QII "" 26 Rioja, La Total Cohort October 1 Total Survival in the second trimester 2020QI "" 26 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2022QII 7.415 26 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2021QII 7.389 26 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2022QIII 7.227 26 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2021QIII 7.226 26 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La Total Cohort October 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 26 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 26 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 26 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,83 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,94 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 95,32 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 92,72 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 91,43 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 89,96 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 89,34 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 87,67 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 87,37 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 7.913 26 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 7.660 26 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 7.065 26 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 7.572 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 7.336 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 6.703 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 7.085 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 6.419 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 6.882 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 6.264 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 6.707 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 6.120 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 26 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 26 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 26 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95,69 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,77 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,88 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 92,49 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 90,86 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 89,84 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 88,66 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 87,56 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 86,62 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 423 26 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 583 26 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.206 26 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 416 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 572 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.181 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 558 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.143 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 533 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.125 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 520 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.106 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 26 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 26 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 26 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,35 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,11 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,93 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 95,71 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,78 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 91,42 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,28 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 89,19 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 91,71 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 6.141 26 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 6.166 26 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 6.381 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 5.776 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 5.780 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 5.634 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 5.521 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 5.580 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 5.440 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 5.307 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 5.396 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 5.251 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 5.161 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 5.271 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 5.069 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 26 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 26 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,06 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,74 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 88,29 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,9 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,5 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 85,25 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,42 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,51 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 82,29 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 84,04 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,48 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 79,44 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 5.744 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 5.698 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 5.394 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 5.333 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 5.155 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 5.144 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 4.954 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 4.977 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 4.816 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 4.867 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,91 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,59 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,75 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,28 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,25 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,35 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 83,84 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,42 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 397 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 468 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 382 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 447 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 366 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 436 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 353 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 419 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 345 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 404 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,22 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,51 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,19 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 93,16 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 88,92 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 89,53 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 86,9 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 86,32 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 6.109 26 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 6.083 26 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 6.031 26 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 5.770 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 5.811 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 5.783 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 5.514 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 5.595 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 5.564 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 5.330 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 5.438 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 5.362 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 5.253 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 5.126 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 26 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 26 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 26 Rioja, La From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,45 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,53 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,89 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,26 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,98 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,26 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,25 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 89,4 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,91 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 86,36 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 84,99 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 5.739 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 5.416 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 5.038 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 5.415 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 5.161 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 4.813 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 5.173 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 4.969 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 4.618 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 4.997 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 4.830 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 4.451 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 4.669 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 4.259 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,35 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,29 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,53 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,14 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,75 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,66 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,07 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 89,18 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,35 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 86,21 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,54 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 370 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 667 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 993 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 355 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 650 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 970 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 341 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 626 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 946 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 333 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 608 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 911 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 584 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 867 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,95 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,45 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,68 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 92,16 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,85 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,27 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 90 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 91,15 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,74 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 87,56 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 87,31 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 6.143 26 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 6.137 26 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 6.168 26 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 5.767 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 5.777 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 5.837 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 5.515 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 5.560 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 5.582 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 5.356 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 5.319 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 5.194 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 5.197 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 26 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 26 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 26 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,88 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,13 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,63 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,78 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,6 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,5 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 87,27 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,24 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 84,63 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,26 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 5.819 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 5.936 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 5.729 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 5.458 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 5.585 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 5.408 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 5.213 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 5.375 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 5.164 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 5.174 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 4.920 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 5.021 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 4.807 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,8 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,09 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,4 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,59 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 90,55 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,14 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 87,16 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 85,88 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 84,59 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 83,91 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 324 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 201 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 439 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 309 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 192 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 429 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 302 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 185 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 418 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 182 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 399 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 173 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 390 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,37 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 95,52 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,72 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,21 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 92,04 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,22 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 90,55 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 90,89 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 86,07 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 88,84 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 6.084 26 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 6.082 26 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 6.171 26 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 5.765 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 5.768 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 5.803 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 5.522 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 5.501 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 5.326 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 5.345 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 5.154 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 5.194 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 26 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 26 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 26 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,76 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,84 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,04 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,79 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,14 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,57 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 86,61 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 84,74 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 84,17 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 5.810 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 5.682 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 5.576 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 5.496 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 5.379 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 5.227 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 5.147 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 4.951 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 4.969 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 4.806 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 4.805 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 4.671 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,6 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,67 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,74 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,58 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88,79 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 87,45 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,19 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 84,57 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 83,77 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 274 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 400 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 595 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 269 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 389 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 576 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 375 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 550 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 357 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 539 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 349 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 523 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,18 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,25 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,81 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,75 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 92,44 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 89,25 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 90,59 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 87,25 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 87,9 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 926 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 821 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 939 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 919 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 811 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 903 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 892 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 800 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 884 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 879 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 788 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 866 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 869 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 778 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 854 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,24 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,78 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,17 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,33 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,44 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 94,14 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,92 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,98 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 92,23 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,84 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,76 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 90,95 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 841 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 635 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 836 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 628 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 813 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 619 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 801 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 607 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 792 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 604 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,41 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,9 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,67 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,48 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,24 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,59 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 94,17 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,12 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 85 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 186 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 83 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 183 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 79 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 181 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 78 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 181 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 77 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 174 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,65 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,39 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,94 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,31 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 91,76 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,31 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 90,59 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 93,55 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 940 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 825 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 847 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 916 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 811 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 832 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 901 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 802 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 817 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 891 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 789 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 811 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 778 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 802 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,45 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,3 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,23 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 95,85 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,21 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 96,46 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 94,79 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,64 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,75 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,3 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,69 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 861 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 623 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 547 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 837 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 611 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 536 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 824 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 602 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 525 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 816 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 596 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 520 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 586 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 515 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,21 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,07 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 97,99 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 95,7 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,63 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 95,98 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 94,77 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,67 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,06 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 94,06 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,15 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 79 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 202 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 300 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 79 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 200 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 296 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 77 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 200 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 292 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 75 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 193 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 291 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 192 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 287 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,01 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,67 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,47 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,01 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,33 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 94,94 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 95,54 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 95,05 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,67 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 920 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 880 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 853 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 906 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 868 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 837 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 899 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 854 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 828 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 837 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 817 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 825 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 809 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,48 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,64 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,12 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,72 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,05 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,07 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,11 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,78 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 93,75 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 94,84 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 853 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 814 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 678 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 840 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 802 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 665 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 834 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 789 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 657 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 772 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 648 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 761 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 644 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,48 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,53 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,08 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,77 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 96,93 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,9 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 94,84 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,58 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 93,49 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,99 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 67 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 66 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 175 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 66 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 66 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 172 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 65 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 65 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 171 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 65 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 169 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 64 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 165 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,51 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,29 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,01 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,48 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,71 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 98,48 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,57 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,97 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 94,29 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 909 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 874 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 821 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 890 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 862 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 813 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 849 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 803 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 830 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 795 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 823 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 787 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,91 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,63 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,03 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,14 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,81 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 94,97 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,83 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 94,16 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,86 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 844 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 791 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 602 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 826 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 779 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 597 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 766 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 593 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 751 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 588 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 744 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 581 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,87 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,48 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,17 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,84 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,5 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 94,94 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,67 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 94,06 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,51 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 65 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 83 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 219 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 64 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 83 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 216 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 83 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 210 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 79 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 207 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 79 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 206 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,46 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,63 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,89 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 95,18 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,52 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 95,18 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 94,06 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 1.220 26 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 1.169 26 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 1.255 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 1.214 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 1.159 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 1.241 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 1.192 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 1.143 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 1.227 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 1.182 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 1.134 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 1.219 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 1.174 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 1.133 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 1.212 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 26 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 26 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,51 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,14 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,88 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,7 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,78 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,77 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,89 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,01 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,13 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,23 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,92 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,57 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.130 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 882 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.124 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 878 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.104 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 866 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.095 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 860 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.088 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 859 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,47 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,55 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,7 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,19 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,9 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,51 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,28 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,39 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 90 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 287 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 90 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 281 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 88 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 277 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 87 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 274 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 86 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 274 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,91 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,78 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,52 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,67 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,47 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 95,56 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,47 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 1.251 26 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 1.163 26 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 1.162 26 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 1.226 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 1.149 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 1.148 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 1.218 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 1.138 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 1.140 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 1.211 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 1.136 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 1.132 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 1.131 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 1.122 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 26 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 26 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 26 Rioja, La From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,8 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,8 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,36 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,85 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,11 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,8 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,68 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,42 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,25 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,56 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.161 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 853 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 748 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.139 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 843 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 740 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.132 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 835 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 735 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.126 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 833 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 730 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 829 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 726 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,11 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,83 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,93 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,5 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,89 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,26 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,99 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,66 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,59 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,19 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,06 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 90 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 310 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 414 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 87 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 306 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 408 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 86 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 303 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 405 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 85 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 303 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 402 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 302 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 396 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,67 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,71 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,55 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 95,56 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,74 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,83 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 94,44 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,74 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,1 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,42 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,65 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 1.262 26 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 1.177 26 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.167 26 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 1.253 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 1.166 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 1.160 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 1.242 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 1.161 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 1.151 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 1.156 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 1.143 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 1.149 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 1.137 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 26 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 26 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 26 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,29 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,07 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,4 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,42 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,64 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,63 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,22 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,94 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,62 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,43 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.179 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.091 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 892 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.171 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.080 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 887 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.161 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.075 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 881 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.070 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 878 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.063 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 873 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,32 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,99 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,44 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,47 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,53 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,77 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,08 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,43 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,43 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,87 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 83 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 86 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 275 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 82 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 86 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 273 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 81 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 86 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 270 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 86 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 265 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 86 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 264 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,8 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,27 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,59 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,18 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,36 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 1.263 26 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 1.215 26 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.205 26 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 1.253 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 1.206 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 1.195 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 1.200 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 1.186 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 1.187 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 1.177 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 1.178 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 1.173 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 26 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 26 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 26 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,21 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,26 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,17 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,77 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,42 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,7 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,68 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,95 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,34 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.186 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.123 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 837 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.177 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.114 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 830 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.108 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 827 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.098 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 822 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.094 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 820 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,24 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,2 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,16 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,66 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,81 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,77 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,21 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,42 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,97 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 77 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 92 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 368 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 76 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 92 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 365 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 92 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 359 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 89 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 355 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 84 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 353 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,7 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,18 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,55 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,74 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 96,47 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 91,3 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 95,92 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 53 26 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 58 26 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 60 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 53 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 57 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 60 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 53 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 57 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 60 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 53 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 57 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 60 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 53 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 57 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 60 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 26 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 26 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,28 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,28 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,28 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,28 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 48 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 37 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 48 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 36 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 48 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 36 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 48 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 36 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 48 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 36 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97,3 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,3 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,3 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,3 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 5 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 21 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 5 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 21 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 5 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 21 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 5 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 21 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 5 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 21 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 54 26 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 52 26 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 58 26 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 54 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 52 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 58 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 54 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 52 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 58 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 54 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 52 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 57 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 52 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 57 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 26 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 26 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 26 Rioja, La from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,28 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,28 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 50 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 31 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 42 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 50 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 31 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 42 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 50 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 31 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 42 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 50 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 31 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 41 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 31 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 41 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,62 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,62 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 4 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 21 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 16 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 4 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 21 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 16 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 4 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 21 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 16 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 4 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 21 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 16 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 21 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 16 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 55 26 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 54 26 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 55 26 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 55 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 54 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 54 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 55 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 54 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 53 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 54 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 52 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 54 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 52 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 26 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 26 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 26 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,18 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 96,36 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 94,55 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 94,55 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 51 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 46 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 35 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 51 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 46 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 35 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 51 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 46 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 34 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 46 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 33 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 46 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 33 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,14 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 94,29 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,29 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 4 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 8 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 20 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 4 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 8 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 19 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 4 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 8 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 19 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 8 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 19 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 8 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 19 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 95 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 57 26 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 54 26 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 58 26 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 57 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 54 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 57 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 54 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 56 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 54 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 56 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 54 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 56 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 26 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 26 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 26 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,28 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,55 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,55 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,55 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 52 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 47 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 40 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 52 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 47 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 39 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 47 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 38 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 47 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 38 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 47 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 38 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,5 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 95 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 5 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 7 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 18 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 5 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 7 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 18 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 7 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 18 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 7 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 18 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 7 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 18 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 20 26 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 15 26 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 18 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 20 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 15 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 18 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 20 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 15 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 18 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 20 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 15 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 17 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 20 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 15 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 16 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 26 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 26 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,44 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 88,89 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 18 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 10 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 18 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 10 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 18 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 10 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 18 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 10 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 18 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 10 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 5 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 5 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 5 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 5 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 5 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 21 26 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 17 26 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 17 26 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 21 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 17 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 17 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 21 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 17 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 16 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 21 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 17 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 16 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 17 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 16 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 26 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 26 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 26 Rioja, La De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 94,12 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 94,12 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,12 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 18 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 12 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 11 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 18 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 12 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 11 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 18 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 12 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 11 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 18 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 12 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 11 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 12 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 11 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 3 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 5 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 6 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 3 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 5 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 6 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 3 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 5 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 5 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 3 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 5 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 5 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 5 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 5 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 83,33 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 83,33 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 83,33 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 21 26 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 18 26 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 17 26 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 21 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 18 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 17 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 21 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 18 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 17 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 18 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 17 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 18 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 17 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 26 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 26 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 26 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 26 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 26 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 26 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 18 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 16 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 11 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 18 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 16 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 11 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 18 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 16 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 11 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 16 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 11 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 16 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 11 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 3 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 2 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 6 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 3 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 2 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 6 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 3 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 2 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 6 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 2 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 6 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 2 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 6 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 23 26 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 18 26 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 16 26 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 23 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 18 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 16 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 18 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 16 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 18 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 16 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 18 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 16 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 26 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 26 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 26 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 21 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 17 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 10 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 21 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 17 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 10 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 17 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 10 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 17 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 10 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 17 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 10 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 2 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 6 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 2 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 6 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 6 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 6 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 6 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 26 Rioja, La De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca Total Cohort January 1 Total Number at the start of the quarter 2022QI 7.725 37 Salamanca Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca Total Cohort January 1 Total Number at the start of the quarter 2021QI 7.570 37 Salamanca Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca Total Cohort January 1 Total Number at the start of the quarter 2020QI 8.025 37 Salamanca Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 37 Salamanca Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 37 Salamanca Total Cohort January 1 Total Survival in the first trimester 2022QII "" 37 Salamanca Total Cohort January 1 Total Survival in the first trimester 2022QI 7.398 37 Salamanca Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 37 Salamanca Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 37 Salamanca Total Cohort January 1 Total Survival in the first trimester 2021QII "" 37 Salamanca Total Cohort January 1 Total Survival in the first trimester 2021QI 7.221 37 Salamanca Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 37 Salamanca Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 37 Salamanca Total Cohort January 1 Total Survival in the first trimester 2020QII "" 37 Salamanca Total Cohort January 1 Total Survival in the first trimester 2020QI 7.207 37 Salamanca Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 37 Salamanca Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 37 Salamanca Total Cohort January 1 Total Survival in the second trimester 2022QII 7.134 37 Salamanca Total Cohort January 1 Total Survival in the second trimester 2022QI "" 37 Salamanca Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 37 Salamanca Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 37 Salamanca Total Cohort January 1 Total Survival in the second trimester 2021QII 7.001 37 Salamanca Total Cohort January 1 Total Survival in the second trimester 2021QI "" 37 Salamanca Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 37 Salamanca Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 37 Salamanca Total Cohort January 1 Total Survival in the second trimester 2020QII 6.971 37 Salamanca Total Cohort January 1 Total Survival in the second trimester 2020QI "" 37 Salamanca Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca Total Cohort January 1 Total Survival in the third trimester 2022QIII 6.949 37 Salamanca Total Cohort January 1 Total Survival in the third trimester 2022QII "" 37 Salamanca Total Cohort January 1 Total Survival in the third trimester 2022QI "" 37 Salamanca Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca Total Cohort January 1 Total Survival in the third trimester 2021QIII 6.845 37 Salamanca Total Cohort January 1 Total Survival in the third trimester 2021QII "" 37 Salamanca Total Cohort January 1 Total Survival in the third trimester 2021QI "" 37 Salamanca Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca Total Cohort January 1 Total Survival in the third trimester 2020QIII 6.781 37 Salamanca Total Cohort January 1 Total Survival in the third trimester 2020QII "" 37 Salamanca Total Cohort January 1 Total Survival in the third trimester 2020QI "" 37 Salamanca Total Cohort January 1 Total Survival in the third trimester 2022QIV 6.759 37 Salamanca Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca Total Cohort January 1 Total Survival in the third trimester 2022QII "" 37 Salamanca Total Cohort January 1 Total Survival in the third trimester 2022QI "" 37 Salamanca Total Cohort January 1 Total Survival in the third trimester 2021QIV 6.699 37 Salamanca Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca Total Cohort January 1 Total Survival in the third trimester 2021QII "" 37 Salamanca Total Cohort January 1 Total Survival in the third trimester 2021QI "" 37 Salamanca Total Cohort January 1 Total Survival in the third trimester 2020QIV 6.614 37 Salamanca Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca Total Cohort January 1 Total Survival in the third trimester 2020QII "" 37 Salamanca Total Cohort January 1 Total Survival in the third trimester 2020QI "" 37 Salamanca Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 37 Salamanca Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 37 Salamanca Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,77 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,39 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 89,81 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 92,35 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 92,48 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 86,87 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 89,95 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 90,42 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 84,5 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 87,5 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 88,49 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 82,42 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 7.431 37 Salamanca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 6.526 37 Salamanca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 7.115 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 6.201 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 6.853 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 6.012 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 6.679 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 5.871 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 6.500 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 5.742 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 37 Salamanca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 37 Salamanca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 95,75 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 95,02 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 92,22 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 92,12 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 89,88 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 89,96 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 87,47 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 87,99 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 294 37 Salamanca Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.044 37 Salamanca Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 283 37 Salamanca Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.020 37 Salamanca Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 281 37 Salamanca Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 989 37 Salamanca Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 270 37 Salamanca Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 974 37 Salamanca Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 259 37 Salamanca Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 957 37 Salamanca Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 37 Salamanca Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 37 Salamanca Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,26 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,7 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 95,58 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,73 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 91,84 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 93,3 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,1 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 91,67 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca Total Cohort April 1 Total Number at the start of the quarter 2022QII 7.731 37 Salamanca Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca Total Cohort April 1 Total Number at the start of the quarter 2021QII 7.557 37 Salamanca Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca Total Cohort April 1 Total Number at the start of the quarter 2020QII 7.462 37 Salamanca Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 37 Salamanca Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 37 Salamanca Total Cohort April 1 Total Survival in the first trimester 2022QII 7.400 37 Salamanca Total Cohort April 1 Total Survival in the first trimester 2022QI "" 37 Salamanca Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 37 Salamanca Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 37 Salamanca Total Cohort April 1 Total Survival in the first trimester 2021QII 7.262 37 Salamanca Total Cohort April 1 Total Survival in the first trimester 2021QI "" 37 Salamanca Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 37 Salamanca Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 37 Salamanca Total Cohort April 1 Total Survival in the first trimester 2020QII 7.179 37 Salamanca Total Cohort April 1 Total Survival in the first trimester 2020QI "" 37 Salamanca Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 37 Salamanca Total Cohort April 1 Total Survival in the second trimester 2022QIII 7.178 37 Salamanca Total Cohort April 1 Total Survival in the second trimester 2022QII "" 37 Salamanca Total Cohort April 1 Total Survival in the second trimester 2022QI "" 37 Salamanca Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 37 Salamanca Total Cohort April 1 Total Survival in the second trimester 2021QIII 7.063 37 Salamanca Total Cohort April 1 Total Survival in the second trimester 2021QII "" 37 Salamanca Total Cohort April 1 Total Survival in the second trimester 2021QI "" 37 Salamanca Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 37 Salamanca Total Cohort April 1 Total Survival in the second trimester 2020QIII 6.968 37 Salamanca Total Cohort April 1 Total Survival in the second trimester 2020QII "" 37 Salamanca Total Cohort April 1 Total Survival in the second trimester 2020QI "" 37 Salamanca Total Cohort April 1 Total Survival in the third trimester 2022QIV 6.945 37 Salamanca Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca Total Cohort April 1 Total Survival in the third trimester 2022QII "" 37 Salamanca Total Cohort April 1 Total Survival in the third trimester 2022QI "" 37 Salamanca Total Cohort April 1 Total Survival in the third trimester 2021QIV 6.888 37 Salamanca Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca Total Cohort April 1 Total Survival in the third trimester 2021QII "" 37 Salamanca Total Cohort April 1 Total Survival in the third trimester 2021QI "" 37 Salamanca Total Cohort April 1 Total Survival in the third trimester 2020QIV 6.784 37 Salamanca Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca Total Cohort April 1 Total Survival in the third trimester 2020QII "" 37 Salamanca Total Cohort April 1 Total Survival in the third trimester 2020QI "" 37 Salamanca Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca Total Cohort April 1 Total Survival in the third trimester 2022QII "" 37 Salamanca Total Cohort April 1 Total Survival in the third trimester 2022QI 6.706 37 Salamanca Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca Total Cohort April 1 Total Survival in the third trimester 2021QII "" 37 Salamanca Total Cohort April 1 Total Survival in the third trimester 2021QI 6.577 37 Salamanca Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca Total Cohort April 1 Total Survival in the third trimester 2020QII "" 37 Salamanca Total Cohort April 1 Total Survival in the third trimester 2020QI "" 37 Salamanca Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 37 Salamanca Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 37 Salamanca Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 37 Salamanca Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,72 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,1 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,21 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 92,85 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 93,46 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,38 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 89,83 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 91,15 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,91 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 88,74 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 88,14 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 7.453 37 Salamanca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 6.603 37 Salamanca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 5.904 37 Salamanca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 7.128 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 6.335 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 5.639 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 6.915 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 6.152 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 5.466 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 6.692 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 5.992 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 5.321 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 5.828 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 5.151 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 37 Salamanca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 37 Salamanca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 37 Salamanca Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,64 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,94 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,51 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 92,78 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 93,17 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,58 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 89,79 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 90,75 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 90,13 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 88,26 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 87,25 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 278 37 Salamanca Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 954 37 Salamanca Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.558 37 Salamanca Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 272 37 Salamanca Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 927 37 Salamanca Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.540 37 Salamanca Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 263 37 Salamanca Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 911 37 Salamanca Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.502 37 Salamanca Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 253 37 Salamanca Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 896 37 Salamanca Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.463 37 Salamanca Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 878 37 Salamanca Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.426 37 Salamanca Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 37 Salamanca Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 37 Salamanca Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 37 Salamanca Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,84 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,17 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,84 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,6 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,49 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,41 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,01 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,92 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,9 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 92,03 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,53 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca Total Cohort July 1 Total Number at the start of the quarter 2022QIII 7.818 37 Salamanca Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca Total Cohort July 1 Total Number at the start of the quarter 2021QIII 7.745 37 Salamanca Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca Total Cohort July 1 Total Number at the start of the quarter 2020QIII 7.626 37 Salamanca Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 37 Salamanca Total Cohort July 1 Total Survival in the first trimester 2022QIII 7.441 37 Salamanca Total Cohort July 1 Total Survival in the first trimester 2022QII "" 37 Salamanca Total Cohort July 1 Total Survival in the first trimester 2022QI "" 37 Salamanca Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 37 Salamanca Total Cohort July 1 Total Survival in the first trimester 2021QIII 7.371 37 Salamanca Total Cohort July 1 Total Survival in the first trimester 2021QII "" 37 Salamanca Total Cohort July 1 Total Survival in the first trimester 2021QI "" 37 Salamanca Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 37 Salamanca Total Cohort July 1 Total Survival in the first trimester 2020QIII 7.286 37 Salamanca Total Cohort July 1 Total Survival in the first trimester 2020QII "" 37 Salamanca Total Cohort July 1 Total Survival in the first trimester 2020QI "" 37 Salamanca Total Cohort July 1 Total Survival in the second trimester 2022QIV 7.147 37 Salamanca Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 37 Salamanca Total Cohort July 1 Total Survival in the second trimester 2022QII "" 37 Salamanca Total Cohort July 1 Total Survival in the second trimester 2022QI "" 37 Salamanca Total Cohort July 1 Total Survival in the second trimester 2021QIV 7.115 37 Salamanca Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 37 Salamanca Total Cohort July 1 Total Survival in the second trimester 2021QII "" 37 Salamanca Total Cohort July 1 Total Survival in the second trimester 2021QI "" 37 Salamanca Total Cohort July 1 Total Survival in the second trimester 2020QIV 7.012 37 Salamanca Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 37 Salamanca Total Cohort July 1 Total Survival in the second trimester 2020QII "" 37 Salamanca Total Cohort July 1 Total Survival in the second trimester 2020QI "" 37 Salamanca Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca Total Cohort July 1 Total Survival in the third trimester 2022QII "" 37 Salamanca Total Cohort July 1 Total Survival in the third trimester 2022QI 6.910 37 Salamanca Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca Total Cohort July 1 Total Survival in the third trimester 2021QII "" 37 Salamanca Total Cohort July 1 Total Survival in the third trimester 2021QI 6.787 37 Salamanca Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca Total Cohort July 1 Total Survival in the third trimester 2020QII "" 37 Salamanca Total Cohort July 1 Total Survival in the third trimester 2020QI "" 37 Salamanca Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca Total Cohort July 1 Total Survival in the third trimester 2022QII 6.751 37 Salamanca Total Cohort July 1 Total Survival in the third trimester 2022QI "" 37 Salamanca Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca Total Cohort July 1 Total Survival in the third trimester 2021QII 6.630 37 Salamanca Total Cohort July 1 Total Survival in the third trimester 2021QI "" 37 Salamanca Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca Total Cohort July 1 Total Survival in the third trimester 2020QII "" 37 Salamanca Total Cohort July 1 Total Survival in the third trimester 2020QI "" 37 Salamanca Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 37 Salamanca Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 37 Salamanca Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 37 Salamanca Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 95,18 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,17 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,54 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 91,42 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 91,87 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 91,95 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 89,22 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 89 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 87,17 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 86,94 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 7.660 37 Salamanca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 7.505 37 Salamanca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 6.433 37 Salamanca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 7.289 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 7.140 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 6.119 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 7.002 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 6.892 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 5.872 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 6.690 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 5.676 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 6.534 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 5.549 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 37 Salamanca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 37 Salamanca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 37 Salamanca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 95,16 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,14 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,12 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 91,41 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 91,83 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 91,28 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 89,14 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 88,23 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 87,06 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 86,26 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 158 37 Salamanca Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 240 37 Salamanca Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.193 37 Salamanca Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 152 37 Salamanca Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 231 37 Salamanca Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.167 37 Salamanca Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 145 37 Salamanca Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 223 37 Salamanca Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.140 37 Salamanca Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 220 37 Salamanca Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.111 37 Salamanca Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 217 37 Salamanca Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.081 37 Salamanca Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 37 Salamanca Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 37 Salamanca Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 37 Salamanca Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,2 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,25 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,82 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 91,77 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 92,92 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,56 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 91,67 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,13 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 90,42 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 90,61 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca Total Cohort October 1 Total Number at the start of the quarter 2022QIV 7.727 37 Salamanca Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca Total Cohort October 1 Total Number at the start of the quarter 2021QIV 7.685 37 Salamanca Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca Total Cohort October 1 Total Number at the start of the quarter 2020QIV 7.645 37 Salamanca Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca Total Cohort October 1 Total Survival in the first trimester 2022QIV 7.362 37 Salamanca Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 37 Salamanca Total Cohort October 1 Total Survival in the first trimester 2022QII "" 37 Salamanca Total Cohort October 1 Total Survival in the first trimester 2022QI "" 37 Salamanca Total Cohort October 1 Total Survival in the first trimester 2021QIV 7.335 37 Salamanca Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 37 Salamanca Total Cohort October 1 Total Survival in the first trimester 2021QII "" 37 Salamanca Total Cohort October 1 Total Survival in the first trimester 2021QI "" 37 Salamanca Total Cohort October 1 Total Survival in the first trimester 2020QIV 7.268 37 Salamanca Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 37 Salamanca Total Cohort October 1 Total Survival in the first trimester 2020QII "" 37 Salamanca Total Cohort October 1 Total Survival in the first trimester 2020QI "" 37 Salamanca Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 37 Salamanca Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 37 Salamanca Total Cohort October 1 Total Survival in the second trimester 2022QII "" 37 Salamanca Total Cohort October 1 Total Survival in the second trimester 2022QI 7.095 37 Salamanca Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 37 Salamanca Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 37 Salamanca Total Cohort October 1 Total Survival in the second trimester 2021QII "" 37 Salamanca Total Cohort October 1 Total Survival in the second trimester 2021QI 7.005 37 Salamanca Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 37 Salamanca Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 37 Salamanca Total Cohort October 1 Total Survival in the second trimester 2020QII "" 37 Salamanca Total Cohort October 1 Total Survival in the second trimester 2020QI "" 37 Salamanca Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca Total Cohort October 1 Total Survival in the third trimester 2022QII 6.896 37 Salamanca Total Cohort October 1 Total Survival in the third trimester 2022QI "" 37 Salamanca Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca Total Cohort October 1 Total Survival in the third trimester 2021QII 6.825 37 Salamanca Total Cohort October 1 Total Survival in the third trimester 2021QI "" 37 Salamanca Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca Total Cohort October 1 Total Survival in the third trimester 2020QII "" 37 Salamanca Total Cohort October 1 Total Survival in the third trimester 2020QI "" 37 Salamanca Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca Total Cohort October 1 Total Survival in the third trimester 2022QIII 6.755 37 Salamanca Total Cohort October 1 Total Survival in the third trimester 2022QII "" 37 Salamanca Total Cohort October 1 Total Survival in the third trimester 2022QI "" 37 Salamanca Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca Total Cohort October 1 Total Survival in the third trimester 2021QIII 6.702 37 Salamanca Total Cohort October 1 Total Survival in the third trimester 2021QII "" 37 Salamanca Total Cohort October 1 Total Survival in the third trimester 2021QI "" 37 Salamanca Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca Total Cohort October 1 Total Survival in the third trimester 2020QII "" 37 Salamanca Total Cohort October 1 Total Survival in the third trimester 2020QI "" 37 Salamanca Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 37 Salamanca Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 37 Salamanca Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 37 Salamanca Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,28 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,45 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 95,07 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 92,32 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 91,63 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 89,73 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 89,27 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 87,9 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 87,67 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 7.592 37 Salamanca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 7.359 37 Salamanca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 6.491 37 Salamanca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 7.233 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 7.019 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 6.144 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 6.787 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 5.909 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 6.595 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 5.758 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 6.460 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 5.652 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 37 Salamanca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 37 Salamanca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 37 Salamanca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95,27 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,38 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,65 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 92,23 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 91,03 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 89,62 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 88,71 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 87,78 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 87,07 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 135 37 Salamanca Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 326 37 Salamanca Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.154 37 Salamanca Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 129 37 Salamanca Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 316 37 Salamanca Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.124 37 Salamanca Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 308 37 Salamanca Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.096 37 Salamanca Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 301 37 Salamanca Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.067 37 Salamanca Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 295 37 Salamanca Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.050 37 Salamanca Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 37 Salamanca Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 37 Salamanca Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 37 Salamanca Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 95,56 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,93 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,4 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,48 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,97 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 92,33 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,46 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 90,49 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 90,99 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 5.850 37 Salamanca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 5.825 37 Salamanca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 6.102 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 5.540 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 5.493 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 5.319 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 5.298 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 5.298 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 5.104 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 5.125 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 5.152 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 4.932 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 4.950 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 5.016 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 4.789 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 37 Salamanca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 37 Salamanca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,7 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,3 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 87,17 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,56 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,95 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 83,64 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 87,61 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 88,45 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 80,83 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 84,62 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 86,11 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 78,48 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 5.668 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 5.273 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 5.367 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 4.959 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 5.125 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 4.786 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 4.963 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 4.652 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 4.798 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 4.532 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,69 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,05 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,42 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,76 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 87,56 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 88,22 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 84,65 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,95 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 182 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 552 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 173 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 534 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 173 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 512 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 162 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 500 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 152 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 484 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,05 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,74 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 95,05 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 92,75 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 89,01 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 90,58 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 83,52 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 87,68 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 5.808 37 Salamanca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 5.781 37 Salamanca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 5.710 37 Salamanca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 5.505 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 5.515 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 5.443 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 5.296 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 5.327 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 5.243 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 5.085 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 5.166 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 5.078 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 5.002 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 4.884 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 37 Salamanca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 37 Salamanca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 37 Salamanca From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,78 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,4 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,32 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 91,18 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,15 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,82 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,55 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 89,36 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,93 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 86,52 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,53 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 5.634 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 5.266 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 4.750 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 5.335 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 5.019 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 4.498 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 5.135 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 4.845 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 4.332 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 4.933 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 4.699 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 4.196 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 4.546 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 4.032 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,69 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,31 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,69 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,14 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,01 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,2 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,56 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 89,23 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,34 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 86,33 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,88 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 174 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 515 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 960 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 170 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 496 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 945 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 161 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 482 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 911 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 152 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 467 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 882 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 456 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 852 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,7 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,31 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,44 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 92,53 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,59 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,9 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 87,36 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 90,68 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,88 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 88,54 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 88,75 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 5.878 37 Salamanca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 5.931 37 Salamanca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 5.869 37 Salamanca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 5.525 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 5.578 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 5.546 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 5.260 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 5.346 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 5.297 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 5.159 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 5.085 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 5.009 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 4.945 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 37 Salamanca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 37 Salamanca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 37 Salamanca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,99 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,05 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,5 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,49 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,14 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,25 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 86,98 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,64 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 84,45 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,26 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 5.781 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 5.795 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 5.228 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 5.434 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 5.450 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 4.927 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 5.175 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 5.226 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 4.699 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 5.042 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 4.510 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 4.894 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 4.391 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,05 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,24 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,52 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 90,18 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,88 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 87,01 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,27 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 84,45 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 83,99 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 97 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 136 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 641 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 91 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 128 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 619 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 85 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 120 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 598 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 117 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 575 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 115 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 554 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 93,81 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 94,12 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,57 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 87,63 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 88,24 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,29 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 86,03 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 89,7 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 84,56 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 86,43 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 5.803 37 Salamanca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 5.821 37 Salamanca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 5.866 37 Salamanca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 5.462 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 5.488 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 5.510 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 5.266 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 5.264 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 5.080 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 5.100 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 4.950 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 4.985 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 37 Salamanca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 37 Salamanca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 37 Salamanca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,12 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,28 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,93 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,47 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,74 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,27 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 86,94 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 85,04 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 84,98 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 5.722 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 5.611 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 5.251 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 5.386 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 5.288 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 4.919 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 5.072 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 4.694 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 4.892 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 4.552 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 4.768 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 4.451 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,13 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,24 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,68 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,39 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,39 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 87,19 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,69 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 84,98 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 84,76 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 81 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 210 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 615 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 76 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 200 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 591 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 194 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 570 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 188 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 548 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 182 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 534 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 93,83 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,24 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,1 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 92,38 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 92,68 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 89,52 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 89,11 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 86,67 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 86,83 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 819 37 Salamanca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 776 37 Salamanca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 845 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 810 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 765 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 826 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 797 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 751 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 819 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 792 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 744 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 808 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 784 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 737 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 793 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 37 Salamanca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 37 Salamanca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,9 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,58 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,75 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,31 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,78 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,92 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,7 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,88 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,62 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,73 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,97 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 93,85 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 772 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 583 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 764 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 576 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 753 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 566 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 748 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 562 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 741 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 556 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,96 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,8 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,54 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,08 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,89 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,4 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,98 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,37 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 47 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 193 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 46 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 189 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 44 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 185 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 44 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 182 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 43 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 181 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,87 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,93 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,62 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,85 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 93,62 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,3 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 91,49 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 93,78 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 847 37 Salamanca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 807 37 Salamanca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 783 37 Salamanca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 829 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 794 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 778 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 823 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 786 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 770 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 811 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 775 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 759 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 763 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 753 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 37 Salamanca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 37 Salamanca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 37 Salamanca From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,87 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,39 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,36 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,17 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,4 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,34 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,75 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,03 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,93 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,55 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,17 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 807 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 638 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 526 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 791 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 629 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 521 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 785 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 623 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 515 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 774 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 612 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 509 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 606 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 507 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,02 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,59 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,05 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,27 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,65 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,91 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,91 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,92 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,77 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 94,98 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,39 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 40 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 169 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 257 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 38 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 165 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 257 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 38 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 163 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 255 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 37 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 163 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 250 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 157 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 246 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,63 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 95 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,45 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,22 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 92,5 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,45 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,28 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 92,9 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,72 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 827 37 Salamanca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 804 37 Salamanca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 781 37 Salamanca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 814 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 786 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 769 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 795 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 773 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 755 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 763 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 748 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 758 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 740 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 37 Salamanca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 37 Salamanca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 37 Salamanca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,43 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 97,76 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,46 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,13 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 96,14 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 96,67 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 94,9 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,77 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 94,28 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 94,75 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 803 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 764 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 559 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 790 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 747 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 549 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 772 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 734 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 537 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 724 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 534 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 719 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 530 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,38 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 97,77 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,21 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,14 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 96,07 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,06 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 94,76 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,53 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,11 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,81 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 24 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 40 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 222 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 24 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 39 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 220 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 23 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 39 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 218 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 39 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 214 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 39 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 210 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,5 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,1 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95,83 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,5 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,2 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,5 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,4 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 97,5 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 94,59 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 806 37 Salamanca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 837 37 Salamanca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 796 37 Salamanca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 789 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 827 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 783 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 818 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 772 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 812 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 763 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 805 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 758 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 37 Salamanca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 37 Salamanca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 37 Salamanca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,89 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,81 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,37 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,73 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,98 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,01 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 95,85 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,18 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,23 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 788 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 791 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 581 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 772 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 781 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 570 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 773 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 564 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 767 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 558 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 760 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 556 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,97 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,74 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,11 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,72 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,07 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,97 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,04 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,08 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,7 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 18 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 46 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 215 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 17 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 46 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 213 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 45 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 208 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 45 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 205 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 45 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 202 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 94,44 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,07 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 97,83 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,74 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,83 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,35 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 97,83 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,95 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 1.009 37 Salamanca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 924 37 Salamanca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 1.032 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 1.001 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 918 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 1.016 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 992 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 907 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 1.002 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 985 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 904 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 995 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 978 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 901 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 987 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 37 Salamanca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 37 Salamanca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,21 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,35 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,45 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,32 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,16 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,09 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,62 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,84 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,41 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,93 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,51 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 95,64 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 947 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 642 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 940 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 638 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 931 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 632 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 924 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 629 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 917 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 626 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,26 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,38 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,31 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,44 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,57 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,98 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,83 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,51 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 62 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 282 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 61 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 280 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 61 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 275 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 61 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 275 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 61 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 275 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,39 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,29 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,39 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,52 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 98,39 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,52 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 98,39 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,52 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 1.031 37 Salamanca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 926 37 Salamanca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 924 37 Salamanca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 1.021 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 910 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 913 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 1.014 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 907 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 910 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 1.004 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 904 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 903 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 898 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 896 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 37 Salamanca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 37 Salamanca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 37 Salamanca From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,03 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,27 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,81 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,35 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,95 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,48 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,38 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,62 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,73 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,98 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,97 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 970 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 669 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 602 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 960 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 657 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 594 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 953 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 654 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 593 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 943 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 651 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 590 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 646 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 586 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,97 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,21 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,67 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,25 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,76 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,5 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,22 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,31 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,01 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,56 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,34 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 61 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 257 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 322 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 61 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 253 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 319 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 61 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 253 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 317 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 61 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 253 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 313 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 252 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 310 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,44 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,07 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,44 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,45 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,44 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,2 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 98,05 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,27 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 1.067 37 Salamanca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 968 37 Salamanca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 935 37 Salamanca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 1.056 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 965 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 930 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 1.046 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 954 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 920 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 946 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 914 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 942 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 905 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 37 Salamanca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 37 Salamanca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 37 Salamanca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,97 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,69 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,47 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,03 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,55 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,4 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,73 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,75 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,31 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,79 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.033 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 908 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 624 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.022 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 905 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 621 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.012 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 894 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 614 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 886 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 610 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 883 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 606 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,94 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,67 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,52 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,97 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,46 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,4 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,58 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,76 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,25 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,12 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 34 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 60 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 311 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 34 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 60 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 309 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 34 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 60 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 306 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 60 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 304 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 59 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 299 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,36 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,39 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,75 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 98,33 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,14 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 1.071 37 Salamanca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 982 37 Salamanca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 940 37 Salamanca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 1.064 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 975 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 933 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 966 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 927 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 959 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 920 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 955 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 917 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 37 Salamanca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 37 Salamanca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 37 Salamanca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,35 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,29 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,26 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,37 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,62 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,66 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,87 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,25 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,55 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.037 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 914 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 632 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.030 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 907 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 628 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 899 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 624 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 893 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 621 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 889 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 618 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,32 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,23 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,37 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,36 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,73 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,7 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,26 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,26 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,78 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 34 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 68 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 308 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 34 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 68 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 305 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 67 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 303 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 66 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 299 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 66 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 299 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,03 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,53 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,38 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,06 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,08 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 97,06 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 97,08 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 29 37 Salamanca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 27 37 Salamanca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 28 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 29 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 27 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 28 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 29 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 27 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 28 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 29 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 27 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 28 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 29 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 27 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 27 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 37 Salamanca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 37 Salamanca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,43 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 27 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 17 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 27 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 17 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 27 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 17 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 27 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 17 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 27 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 17 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 10 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 10 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 10 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 2 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 10 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 2 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 10 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 27 37 Salamanca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 26 37 Salamanca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 28 37 Salamanca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 27 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 26 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 28 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 27 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 26 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 28 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 27 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 26 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 27 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 26 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 27 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 37 Salamanca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 37 Salamanca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 37 Salamanca from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,43 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,43 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 26 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 19 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 17 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 26 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 19 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 17 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 26 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 19 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 17 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 26 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 19 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 17 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 19 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 17 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 7 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 11 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 7 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 11 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 7 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 11 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 7 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 10 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 7 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 10 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 90,91 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 90,91 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 28 37 Salamanca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 25 37 Salamanca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 25 37 Salamanca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 28 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 25 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 25 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 28 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 25 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 24 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 25 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 24 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 25 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 24 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 37 Salamanca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 37 Salamanca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 37 Salamanca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 96 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 27 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 24 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 12 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 27 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 24 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 12 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 27 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 24 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 12 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 24 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 12 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 24 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 12 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 13 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 13 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 12 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 12 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 12 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 92,31 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 92,31 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,31 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 30 37 Salamanca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 28 37 Salamanca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 28 37 Salamanca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 30 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 28 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 27 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 28 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 27 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 28 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 27 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 28 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 27 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 37 Salamanca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 37 Salamanca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 37 Salamanca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 96,43 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,43 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,43 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,43 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 29 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 28 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 18 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 29 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 28 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 18 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 28 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 18 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 28 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 18 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 28 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 18 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 0 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 10 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 0 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 9 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 0 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 9 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 0 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 9 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 0 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 9 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV .. 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV .. 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 90 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI .. 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 90 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII .. 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 90 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII .. 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 90 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 18 37 Salamanca De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 18 37 Salamanca De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 18 37 Salamanca De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 18 37 Salamanca De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 18 37 Salamanca De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 18 37 Salamanca De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 18 37 Salamanca De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 18 37 Salamanca De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 18 37 Salamanca De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 18 37 Salamanca De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 18 37 Salamanca De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 18 37 Salamanca De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 18 37 Salamanca De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 18 37 Salamanca De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 18 37 Salamanca De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 37 Salamanca De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 37 Salamanca De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 17 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 11 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 17 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 11 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 17 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 11 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 17 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 11 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 17 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 11 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1 37 Salamanca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 7 37 Salamanca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 7 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 7 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 7 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 7 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 37 Salamanca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 37 Salamanca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 18 37 Salamanca De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 17 37 Salamanca De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 17 37 Salamanca De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 18 37 Salamanca De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 17 37 Salamanca De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 17 37 Salamanca De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 18 37 Salamanca De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 17 37 Salamanca De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 17 37 Salamanca De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 18 37 Salamanca De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 17 37 Salamanca De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 17 37 Salamanca De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 17 37 Salamanca De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 17 37 Salamanca De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 37 Salamanca De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 37 Salamanca De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 37 Salamanca De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 37 Salamanca De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 16 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 11 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 9 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 16 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 11 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 9 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 16 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 11 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 9 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 16 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 11 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 9 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 11 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 9 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 2 37 Salamanca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 6 37 Salamanca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 8 37 Salamanca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 2 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 6 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 8 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 2 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 6 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 8 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 2 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 6 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 8 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 6 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 8 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 37 Salamanca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 37 Salamanca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 37 Salamanca De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 18 37 Salamanca De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 17 37 Salamanca De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 16 37 Salamanca De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 18 37 Salamanca De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 17 37 Salamanca De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 16 37 Salamanca De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 18 37 Salamanca De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 17 37 Salamanca De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 16 37 Salamanca De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 17 37 Salamanca De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 16 37 Salamanca De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 17 37 Salamanca De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 16 37 Salamanca De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 37 Salamanca De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 37 Salamanca De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 37 Salamanca De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 37 Salamanca De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 37 Salamanca De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 37 Salamanca De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 16 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 14 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 10 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 16 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 14 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 10 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 16 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 14 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 10 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 14 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 10 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 14 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 10 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 2 37 Salamanca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 3 37 Salamanca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 6 37 Salamanca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 2 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 3 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 6 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 2 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 3 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 6 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 3 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 6 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 3 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 6 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 37 Salamanca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 37 Salamanca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 37 Salamanca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 17 37 Salamanca De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 17 37 Salamanca De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 15 37 Salamanca De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 17 37 Salamanca De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 17 37 Salamanca De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 15 37 Salamanca De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 17 37 Salamanca De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 15 37 Salamanca De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 17 37 Salamanca De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 15 37 Salamanca De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 17 37 Salamanca De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 15 37 Salamanca De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 37 Salamanca De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 37 Salamanca De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 37 Salamanca De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 37 Salamanca De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 37 Salamanca De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 37 Salamanca De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 37 Salamanca De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 16 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 15 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 9 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 16 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 15 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 9 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 15 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 9 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 15 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 9 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 15 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 9 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1 37 Salamanca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 2 37 Salamanca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 6 37 Salamanca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 2 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 6 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 2 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 6 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 2 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 6 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 2 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 6 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 37 Salamanca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 37 Salamanca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 37 Salamanca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 37 Salamanca De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Number at the start of the quarter 2022QI 26.246 38 Santa Cruz de Tenerife Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Number at the start of the quarter 2021QI 25.208 38 Santa Cruz de Tenerife Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Number at the start of the quarter 2020QI 27.126 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the first trimester 2022QI 24.710 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the first trimester 2021QI 23.672 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the first trimester 2020QI 23.130 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the second trimester 2022QII 23.584 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the second trimester 2021QII 22.786 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the second trimester 2020QII 22.165 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the third trimester 2022QIII 22.624 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the third trimester 2021QIII 22.036 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the third trimester 2020QIII 21.477 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the third trimester 2022QIV 21.970 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the third trimester 2021QIV 21.401 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the third trimester 2020QIV 20.856 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 38 Santa Cruz de Tenerife Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 38 Santa Cruz de Tenerife Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,15 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,91 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 85,27 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,86 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,39 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 81,71 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,2 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,42 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 79,17 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 83,71 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 84,9 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 76,89 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 24.958 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 20.445 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 23.472 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 19.075 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 22.384 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 18.305 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 21.459 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 17.645 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 20.835 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 17.133 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,05 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,3 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,69 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,53 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 85,98 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,3 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 83,48 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 83,8 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.288 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 4.763 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.238 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 4.597 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.200 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 4.481 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.165 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 4.391 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.135 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 4.268 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,12 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,51 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,17 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,08 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,45 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,19 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,12 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 89,61 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Number at the start of the quarter 2022QII 26.226 38 Santa Cruz de Tenerife Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Number at the start of the quarter 2021QII 24.946 38 Santa Cruz de Tenerife Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Number at the start of the quarter 2020QII 24.239 38 Santa Cruz de Tenerife Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the first trimester 2022QII 24.809 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the first trimester 2021QII 23.815 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the first trimester 2020QII 23.120 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the second trimester 2022QIII 23.675 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the second trimester 2021QIII 22.912 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the second trimester 2020QIII 22.332 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the third trimester 2022QIV 22.928 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the third trimester 2021QIV 22.204 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the third trimester 2020QIV 21.626 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the third trimester 2022QI 21.352 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the third trimester 2021QI 20.743 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 38 Santa Cruz de Tenerife Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 38 Santa Cruz de Tenerife Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 38 Santa Cruz de Tenerife Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,6 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,47 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,38 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,27 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,85 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,13 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,42 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 89,01 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,22 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 85,59 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,58 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 24.987 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 21.614 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 18.162 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 23.610 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 20.577 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 17.113 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 22.517 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 19.743 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 16.455 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 21.792 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 19.131 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 15.898 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 18.373 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 15.217 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,49 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,2 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,22 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,11 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,34 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,6 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,21 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 88,51 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 87,53 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 85,01 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 83,78 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.239 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 3.332 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 6.077 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.199 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 3.238 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 6.007 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.158 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 3.169 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 5.877 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.136 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 3.073 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 5.728 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 2.979 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 5.526 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,77 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,18 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,85 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,46 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,11 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,71 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,69 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 92,23 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 94,26 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 89,41 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 90,93 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Number at the start of the quarter 2022QIII 26.277 38 Santa Cruz de Tenerife Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Number at the start of the quarter 2021QIII 25.322 38 Santa Cruz de Tenerife Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Number at the start of the quarter 2020QIII 24.573 38 Santa Cruz de Tenerife Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the first trimester 2022QIII 24.830 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the first trimester 2021QIII 24.097 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the first trimester 2020QIII 23.497 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the second trimester 2022QIV 23.941 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the second trimester 2021QIV 23.230 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the second trimester 2020QIV 22.588 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the third trimester 2022QI 22.268 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the third trimester 2021QI 21.587 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the third trimester 2022QII 21.537 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the third trimester 2021QII 20.982 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 38 Santa Cruz de Tenerife Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 38 Santa Cruz de Tenerife Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 38 Santa Cruz de Tenerife Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,49 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,16 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,62 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 91,11 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 91,74 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 91,92 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 87,94 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 87,85 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 85,05 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 85,39 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 25.513 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 24.107 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 19.480 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 24.090 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 22.915 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 18.509 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 23.214 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 22.081 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 17.721 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 21.150 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 16.884 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 20.443 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 16.384 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,42 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,06 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,02 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 90,99 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 91,6 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,97 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 87,73 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,67 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 84,8 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 84,11 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 764 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.215 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 5.093 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 740 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.182 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 4.988 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 727 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1.149 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 4.867 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1.118 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 4.703 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1.094 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 4.598 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,86 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,28 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,94 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95,16 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 94,57 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,56 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 92,02 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 92,34 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 90,04 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 90,28 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Number at the start of the quarter 2022QIV 26.313 38 Santa Cruz de Tenerife Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Number at the start of the quarter 2021QIV 25.708 38 Santa Cruz de Tenerife Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Number at the start of the quarter 2020QIV 25.230 38 Santa Cruz de Tenerife Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the first trimester 2022QIV 25.143 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the first trimester 2021QIV 24.536 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the first trimester 2020QIV 23.953 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the second trimester 2022QI 23.393 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the second trimester 2021QI 22.734 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the third trimester 2022QII 22.505 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the third trimester 2021QII 22.006 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the third trimester 2022QIII 21.680 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the third trimester 2021QIII 21.356 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 38 Santa Cruz de Tenerife Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 38 Santa Cruz de Tenerife Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 38 Santa Cruz de Tenerife Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,55 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,44 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,94 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 91 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,11 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,54 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 87,22 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 84,33 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 84,65 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 25.788 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 24.102 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 20.171 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 24.627 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 22.987 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 19.015 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 21.900 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 17.963 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 21.071 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 17.350 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 20.292 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 16.792 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95,5 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,37 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,27 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,86 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,05 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 87,42 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,01 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 84,19 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 83,25 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 525 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.606 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 5.059 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 516 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.549 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 4.938 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.493 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 4.771 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.434 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 4.656 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.388 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 4.564 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,29 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,45 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,61 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 92,96 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,31 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 89,29 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,03 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 86,43 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 90,22 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 19.595 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 19.060 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 20.221 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 18.157 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 17.619 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 16.499 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 17.117 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 16.806 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 15.606 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 16.268 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 16.122 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 14.991 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 15.684 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 15.557 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 14.451 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 92,66 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 92,44 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 81,59 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 87,35 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 88,17 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 77,18 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 83,02 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 84,59 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 74,14 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 80,04 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 81,62 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 71,47 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 18.765 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 16.483 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 17.373 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 15.177 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 16.367 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 14.456 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 15.545 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 13.840 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 14.988 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 13.375 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,58 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 92,08 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 87,22 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 87,7 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 82,84 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 83,97 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 79,87 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 81,14 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 830 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2.577 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 784 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2.442 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 750 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2.350 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 723 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2.282 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 696 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2.182 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,46 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 94,76 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,36 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 91,19 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 87,11 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 88,55 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 83,86 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 84,67 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 19.564 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 18.837 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 18.256 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 18.228 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 17.775 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 17.179 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 17.193 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 16.944 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 16.441 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 16.521 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 16.304 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 15.804 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 15.546 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 15.022 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,17 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,36 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,1 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 87,88 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 89,95 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 90,06 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 84,45 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 86,55 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 86,57 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 82,53 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 82,29 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 18.761 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 16.889 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 14.760 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 17.463 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 15.906 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 13.740 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 16.462 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 15.131 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 13.112 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 15.811 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 14.574 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 12.599 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 13.890 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 11.976 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,08 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,18 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 93,09 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 87,75 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,59 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 88,83 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 84,28 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 86,29 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 85,36 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 82,24 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 81,14 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 803 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.948 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 3.496 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 765 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.869 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 3.439 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 731 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.813 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 3.329 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 710 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.730 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 3.205 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.656 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 3.046 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,27 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 95,94 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,37 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,03 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,07 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,22 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,42 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 88,81 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,68 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 85,01 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 87,13 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 19.526 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 19.084 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 18.494 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 18.174 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 17.919 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 17.469 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 17.360 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 17.120 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 16.636 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 16.256 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 15.729 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 15.595 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 15.190 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,08 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,9 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,46 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 88,91 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,71 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 89,95 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 85,18 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 85,05 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 81,72 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 82,13 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 19.015 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 18.352 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 15.843 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 17.684 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 17.218 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 14.910 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 16.882 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 16.448 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 14.172 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 15.610 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 13.386 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 14.969 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 12.925 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,82 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,11 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 88,78 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,63 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,45 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 85,06 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 84,49 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 81,57 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 81,58 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 511 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 732 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2.651 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 490 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 701 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2.559 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 478 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 672 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 2.464 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 646 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2.343 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 626 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 2.265 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,89 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 95,77 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,53 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,54 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 91,8 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 92,95 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 88,25 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 88,38 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 85,52 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 85,44 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 19.524 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 19.206 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 18.982 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 18.424 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 18.090 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 17.777 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 17.049 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 16.663 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 16.244 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 16.009 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 15.521 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 15.434 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,37 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,19 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,65 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,77 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 87,78 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 84,58 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 84,34 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 80,81 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 81,31 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 19.194 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 18.060 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 16.297 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 18.103 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 16.997 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 15.190 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 16.008 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 14.202 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 15.257 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 13.637 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 14.572 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 13.123 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,32 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,11 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,21 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,64 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 87,14 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 84,48 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 83,68 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 80,69 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 80,52 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 330 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.146 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 2.685 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 321 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.093 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2.587 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.041 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2.461 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 987 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2.372 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 949 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2.311 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,27 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,38 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,35 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 90,84 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 91,66 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 86,13 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 88,34 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 82,81 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 86,07 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 3.020 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 2.773 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 3.046 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 2.962 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 2.717 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 2.873 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 2.910 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 2.676 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 2.827 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 2.846 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 2.636 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 2.783 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 2.803 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 2.593 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 2.739 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,08 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 97,98 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 94,32 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,36 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,5 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 92,81 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,24 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,06 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 91,37 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 92,81 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 93,51 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 89,92 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.833 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.006 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.779 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.963 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.728 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.932 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.668 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.902 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.628 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.871 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,09 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97,86 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,29 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,31 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,18 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 94,82 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 92,76 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 93,27 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 187 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 767 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 183 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 754 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 182 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 744 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 178 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 734 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 175 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 722 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,86 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,31 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,33 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 95,19 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,7 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 93,58 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 94,13 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 2.987 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 2.797 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 2.617 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 2.940 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 2.752 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 2.587 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 2.884 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 2.703 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 2.555 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 2.842 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 2.660 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 2.517 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 2.601 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 2.460 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,43 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,39 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,85 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,55 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,64 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,63 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,15 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,1 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,18 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 92,99 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.813 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.305 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.611 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.767 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.268 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.588 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.715 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.230 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.570 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.674 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.195 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.544 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.148 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.509 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,36 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,39 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,57 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,52 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,75 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,45 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,06 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,23 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,84 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,19 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 93,67 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 174 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 492 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.006 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 173 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 484 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 999 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 169 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 473 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 985 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 168 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 465 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 973 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 453 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 951 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,43 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,37 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,3 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,13 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,14 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,91 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,55 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,51 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,72 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 92,07 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,53 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 3.039 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 2.834 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 2.696 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 2.981 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 2.793 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 2.668 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 2.935 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 2.754 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 2.624 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 2.694 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 2.570 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 2.651 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 2.525 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,09 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,55 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,96 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,58 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,18 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,33 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,06 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,33 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 93,54 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 93,66 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.950 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.660 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.808 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.894 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.620 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.789 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.849 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.583 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.754 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.528 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.724 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.486 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.695 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,1 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,5 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,95 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,58 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,11 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,01 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,04 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,35 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 93,46 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 93,75 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 89 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 174 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 888 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 87 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 173 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 879 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 86 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 171 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 870 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 166 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 846 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 165 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 830 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,75 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,43 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,99 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 96,63 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,28 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,97 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,4 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95,27 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 94,83 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 93,47 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 2.988 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 2.931 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 2.794 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 2.946 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 2.904 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 2.748 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 2.841 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 2.686 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 2.789 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 2.638 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 2.732 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 2.592 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,59 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,08 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,35 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,93 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,13 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95,16 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 94,42 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 93,21 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 92,77 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.924 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.738 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.946 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.882 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.713 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.913 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.652 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.873 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.603 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.840 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.549 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.811 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,56 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,09 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,3 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,86 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,25 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,07 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 94,55 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 93,1 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,06 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 64 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 193 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 848 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 64 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 191 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 835 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 189 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 813 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 186 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 798 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 183 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 781 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,96 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,47 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 97,93 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,87 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,37 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,1 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 94,82 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 92,1 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 3.405 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 3.159 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 3.621 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 3.366 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 3.121 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 3.522 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 3.333 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 3.089 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 3.496 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 3.287 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 3.064 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 3.467 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 3.262 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 3.037 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 3.431 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,85 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,8 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,27 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,89 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,78 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,55 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,53 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,99 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,75 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,8 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,14 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,75 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 3.149 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.864 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 3.110 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.844 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 3.080 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.826 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 3.038 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.813 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 3.013 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.797 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,76 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,93 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,81 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,96 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,48 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,26 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,68 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,41 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 256 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.295 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 256 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.277 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 253 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.263 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 249 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.251 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 249 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.240 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,61 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,83 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,53 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,27 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,6 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 97,27 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,75 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 3.440 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 3.103 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 3.154 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 3.407 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 3.080 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 3.142 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 3.366 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 3.059 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 3.124 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 3.335 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 3.034 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 3.094 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 3.000 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 3.051 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,04 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,26 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,62 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,85 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,58 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,05 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,95 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,78 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,1 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,68 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,73 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 3.194 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.303 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.692 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 3.162 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.287 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.686 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 3.124 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.268 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.674 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 3.093 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.248 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.656 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.221 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.634 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,31 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,65 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,81 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,48 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,94 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,84 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,61 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,87 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,44 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,57 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 246 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 800 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.462 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 245 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 793 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.456 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 242 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 791 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.450 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 242 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 786 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.438 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 779 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.417 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,59 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,13 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,59 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,37 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,88 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,18 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 98,37 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,25 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,36 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,38 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,92 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 3.482 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 3.206 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 3.174 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 3.445 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 3.187 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 3.151 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 3.418 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 3.158 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 3.120 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 3.121 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 3.081 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 3.094 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 3.060 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,94 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,41 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,28 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,16 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,5 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,3 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,35 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,07 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,51 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,41 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 3.331 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.935 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.746 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 3.295 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.917 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.727 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 3.268 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.890 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.712 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.853 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.692 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.829 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.682 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,92 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,39 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,91 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,11 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,47 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,05 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,21 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,91 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,39 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,33 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 151 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 271 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.428 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 150 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 270 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.424 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 150 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 268 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.408 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 268 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.389 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 265 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.378 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,34 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,63 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,72 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 99,34 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,89 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,6 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 98,89 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,27 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 97,79 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,5 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 3.557 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 3.357 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 3.242 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 3.531 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 3.329 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 3.217 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 3.291 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 3.175 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 3.260 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 3.149 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 3.216 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 3.120 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,27 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,17 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,23 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,03 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,93 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,11 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,13 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,8 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,24 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 3.435 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3.110 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.840 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 3.409 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 3.084 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.824 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 3.048 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.801 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 3.019 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.786 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.980 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.771 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,24 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,16 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,13 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,01 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,88 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,07 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,07 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,82 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,25 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 122 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 247 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.402 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 122 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 245 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.393 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 243 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.374 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 241 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.363 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 236 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.349 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,19 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,36 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,38 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,57 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,22 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 95,55 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,22 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 147 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 151 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 165 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 146 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 150 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 163 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 146 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 150 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 163 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 145 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 149 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 163 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 143 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 149 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 163 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,32 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,34 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,79 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,32 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 99,34 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,79 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,64 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,68 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,79 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,28 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,68 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,79 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 139 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 72 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 138 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 71 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 138 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 71 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 137 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 70 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 135 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 70 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,28 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,61 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,28 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,61 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,56 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,22 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,12 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,22 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 8 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 79 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 8 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 79 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 8 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 79 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 8 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 79 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 8 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 79 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 157 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 147 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 148 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 156 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 147 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 148 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 154 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 145 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 148 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 152 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 145 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 148 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 144 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 147 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,36 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,09 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,64 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,82 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,64 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,96 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 99,32 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 147 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 88 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 77 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 146 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 88 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 77 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 144 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 86 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 77 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 142 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 86 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 77 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 86 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 76 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,32 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,96 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,73 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,6 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,73 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,73 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 98,7 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 10 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 59 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 71 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 10 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 59 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 71 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 10 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 59 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 71 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 10 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 59 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 71 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 58 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 71 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 98,31 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 153 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 136 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 145 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 153 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 136 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 145 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 151 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 136 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 145 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 135 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 144 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 135 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 144 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,69 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 99,26 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 99,31 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 99,26 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 99,31 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 144 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 117 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 64 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 144 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 117 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 64 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 142 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 117 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 64 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 116 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 63 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 116 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 63 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,61 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 99,15 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,44 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 99,15 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 98,44 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 9 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 19 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 81 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 9 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 19 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 81 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 9 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 19 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 81 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 19 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 81 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 19 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 81 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 165 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 146 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 149 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 163 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 145 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 149 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 144 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 148 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 144 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 148 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 143 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 148 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,79 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,32 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,63 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 99,33 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,63 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 99,33 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,95 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 99,33 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 161 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 138 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 67 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 159 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 137 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 67 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 136 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 66 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 136 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 66 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 135 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 66 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,76 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,28 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,55 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,51 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,55 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,51 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,83 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,51 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 4 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 8 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 82 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 4 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 8 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 82 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 8 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 82 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 8 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 82 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 8 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 82 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 79 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 65 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 73 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 79 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 65 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 73 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 78 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 65 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 73 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 78 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 65 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 73 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 78 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 65 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 72 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,73 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,73 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,73 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,63 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 72 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 20 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 72 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 20 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 71 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 20 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 71 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 20 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 71 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 20 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,61 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,61 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,61 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 7 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 45 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 7 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 45 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 7 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 45 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 7 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 45 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 7 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 45 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 78 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 62 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 64 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 78 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 61 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 64 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 78 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 61 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 64 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 78 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 61 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 63 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 61 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 63 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,39 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,39 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,39 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,44 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,39 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,44 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 72 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 29 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 22 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 72 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 28 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 22 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 72 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 28 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 22 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 72 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 28 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 22 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 28 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 22 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 96,55 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,55 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,55 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,55 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 6 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 33 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 42 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 6 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 33 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 42 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 6 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 33 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 42 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 6 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 33 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 41 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 33 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 41 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,62 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 97,62 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 77 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 62 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 64 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 77 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 62 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 64 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 77 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 62 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 63 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 62 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 63 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 62 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 63 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,44 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,44 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,44 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 73 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 43 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 19 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 73 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 43 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 19 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 73 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 43 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 19 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 43 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 19 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 43 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 19 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 4 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 19 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 45 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 4 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 19 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 45 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 4 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 19 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 44 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 19 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 44 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 19 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 44 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,78 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,78 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,78 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 79 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 68 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 63 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 79 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 68 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 62 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 68 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 62 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 68 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 62 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 68 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 62 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,41 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,41 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,41 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,41 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 74 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 56 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 21 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 74 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 56 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 21 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 56 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 21 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 56 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 21 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 56 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 21 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 5 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 12 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 42 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 5 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 12 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 41 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 12 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 41 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 12 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 41 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 12 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 41 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,62 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,62 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,62 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 97,62 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 38 Santa Cruz de Tenerife De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 40 Segovia Total Cohort January 1 Total Number at the start of the quarter 2022QI 4.038 40 Segovia Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 40 Segovia Total Cohort January 1 Total Number at the start of the quarter 2021QI 3.913 40 Segovia Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 40 Segovia Total Cohort January 1 Total Number at the start of the quarter 2020QI 4.052 40 Segovia Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 40 Segovia Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 40 Segovia Total Cohort January 1 Total Survival in the first trimester 2022QII "" 40 Segovia Total Cohort January 1 Total Survival in the first trimester 2022QI 3.848 40 Segovia Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 40 Segovia Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 40 Segovia Total Cohort January 1 Total Survival in the first trimester 2021QII "" 40 Segovia Total Cohort January 1 Total Survival in the first trimester 2021QI 3.725 40 Segovia Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 40 Segovia Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 40 Segovia Total Cohort January 1 Total Survival in the first trimester 2020QII "" 40 Segovia Total Cohort January 1 Total Survival in the first trimester 2020QI 3.723 40 Segovia Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 40 Segovia Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 40 Segovia Total Cohort January 1 Total Survival in the second trimester 2022QII 3.722 40 Segovia Total Cohort January 1 Total Survival in the second trimester 2022QI "" 40 Segovia Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 40 Segovia Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 40 Segovia Total Cohort January 1 Total Survival in the second trimester 2021QII 3.612 40 Segovia Total Cohort January 1 Total Survival in the second trimester 2021QI "" 40 Segovia Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 40 Segovia Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 40 Segovia Total Cohort January 1 Total Survival in the second trimester 2020QII 3.618 40 Segovia Total Cohort January 1 Total Survival in the second trimester 2020QI "" 40 Segovia Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 40 Segovia Total Cohort January 1 Total Survival in the third trimester 2022QIII 3.599 40 Segovia Total Cohort January 1 Total Survival in the third trimester 2022QII "" 40 Segovia Total Cohort January 1 Total Survival in the third trimester 2022QI "" 40 Segovia Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 40 Segovia Total Cohort January 1 Total Survival in the third trimester 2021QIII 3.515 40 Segovia Total Cohort January 1 Total Survival in the third trimester 2021QII "" 40 Segovia Total Cohort January 1 Total Survival in the third trimester 2021QI "" 40 Segovia Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 40 Segovia Total Cohort January 1 Total Survival in the third trimester 2020QIII 3.517 40 Segovia Total Cohort January 1 Total Survival in the third trimester 2020QII "" 40 Segovia Total Cohort January 1 Total Survival in the third trimester 2020QI "" 40 Segovia Total Cohort January 1 Total Survival in the third trimester 2022QIV 3.495 40 Segovia Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 40 Segovia Total Cohort January 1 Total Survival in the third trimester 2022QII "" 40 Segovia Total Cohort January 1 Total Survival in the third trimester 2022QI "" 40 Segovia Total Cohort January 1 Total Survival in the third trimester 2021QIV 3.446 40 Segovia Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 40 Segovia Total Cohort January 1 Total Survival in the third trimester 2021QII "" 40 Segovia Total Cohort January 1 Total Survival in the third trimester 2021QI "" 40 Segovia Total Cohort January 1 Total Survival in the third trimester 2020QIV 3.427 40 Segovia Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 40 Segovia Total Cohort January 1 Total Survival in the third trimester 2020QII "" 40 Segovia Total Cohort January 1 Total Survival in the third trimester 2020QI "" 40 Segovia Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 40 Segovia Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 40 Segovia Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 40 Segovia Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 40 Segovia Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 40 Segovia Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 40 Segovia Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,29 40 Segovia Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,2 40 Segovia Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 91,88 40 Segovia Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 92,17 40 Segovia Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 92,31 40 Segovia Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 89,29 40 Segovia Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 89,13 40 Segovia Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 89,83 40 Segovia Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 86,8 40 Segovia Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 86,55 40 Segovia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 88,07 40 Segovia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 84,58 40 Segovia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 40 Segovia Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 40 Segovia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 3.893 40 Segovia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 3.446 40 Segovia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 3.711 40 Segovia Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 3.268 40 Segovia Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 3.590 40 Segovia Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 3.165 40 Segovia Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 3.471 40 Segovia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 3.077 40 Segovia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 3.370 40 Segovia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 3.016 40 Segovia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 40 Segovia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 40 Segovia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 95,32 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,83 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 92,22 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 91,85 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 89,16 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 89,29 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 86,57 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 87,52 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 145 40 Segovia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 467 40 Segovia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 137 40 Segovia Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 457 40 Segovia Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 132 40 Segovia Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 447 40 Segovia Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 128 40 Segovia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 438 40 Segovia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 125 40 Segovia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 430 40 Segovia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 40 Segovia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 40 Segovia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,48 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,86 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 91,03 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,72 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 88,28 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 93,79 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 86,21 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 92,08 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia Total Cohort April 1 Total Number at the start of the quarter 2022QII 4.028 40 Segovia Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 40 Segovia Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia Total Cohort April 1 Total Number at the start of the quarter 2021QII 3.883 40 Segovia Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 40 Segovia Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia Total Cohort April 1 Total Number at the start of the quarter 2020QII 3.859 40 Segovia Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 40 Segovia Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 40 Segovia Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 40 Segovia Total Cohort April 1 Total Survival in the first trimester 2022QII 3.883 40 Segovia Total Cohort April 1 Total Survival in the first trimester 2022QI "" 40 Segovia Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 40 Segovia Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 40 Segovia Total Cohort April 1 Total Survival in the first trimester 2021QII 3.744 40 Segovia Total Cohort April 1 Total Survival in the first trimester 2021QI "" 40 Segovia Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 40 Segovia Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 40 Segovia Total Cohort April 1 Total Survival in the first trimester 2020QII 3.728 40 Segovia Total Cohort April 1 Total Survival in the first trimester 2020QI "" 40 Segovia Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 40 Segovia Total Cohort April 1 Total Survival in the second trimester 2022QIII 3.739 40 Segovia Total Cohort April 1 Total Survival in the second trimester 2022QII "" 40 Segovia Total Cohort April 1 Total Survival in the second trimester 2022QI "" 40 Segovia Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 40 Segovia Total Cohort April 1 Total Survival in the second trimester 2021QIII 3.629 40 Segovia Total Cohort April 1 Total Survival in the second trimester 2021QII "" 40 Segovia Total Cohort April 1 Total Survival in the second trimester 2021QI "" 40 Segovia Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 40 Segovia Total Cohort April 1 Total Survival in the second trimester 2020QIII 3.617 40 Segovia Total Cohort April 1 Total Survival in the second trimester 2020QII "" 40 Segovia Total Cohort April 1 Total Survival in the second trimester 2020QI "" 40 Segovia Total Cohort April 1 Total Survival in the third trimester 2022QIV 3.614 40 Segovia Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 40 Segovia Total Cohort April 1 Total Survival in the third trimester 2022QII "" 40 Segovia Total Cohort April 1 Total Survival in the third trimester 2022QI "" 40 Segovia Total Cohort April 1 Total Survival in the third trimester 2021QIV 3.540 40 Segovia Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 40 Segovia Total Cohort April 1 Total Survival in the third trimester 2021QII "" 40 Segovia Total Cohort April 1 Total Survival in the third trimester 2021QI "" 40 Segovia Total Cohort April 1 Total Survival in the third trimester 2020QIV 3.515 40 Segovia Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 40 Segovia Total Cohort April 1 Total Survival in the third trimester 2020QII "" 40 Segovia Total Cohort April 1 Total Survival in the third trimester 2020QI "" 40 Segovia Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 40 Segovia Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 40 Segovia Total Cohort April 1 Total Survival in the third trimester 2022QII "" 40 Segovia Total Cohort April 1 Total Survival in the third trimester 2022QI 3.448 40 Segovia Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 40 Segovia Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 40 Segovia Total Cohort April 1 Total Survival in the third trimester 2021QII "" 40 Segovia Total Cohort April 1 Total Survival in the third trimester 2021QI 3.393 40 Segovia Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 40 Segovia Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 40 Segovia Total Cohort April 1 Total Survival in the third trimester 2020QII "" 40 Segovia Total Cohort April 1 Total Survival in the third trimester 2020QI "" 40 Segovia Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 40 Segovia Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 40 Segovia Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 40 Segovia Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 40 Segovia Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 40 Segovia Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 96,4 40 Segovia Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,42 40 Segovia Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,61 40 Segovia Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 92,83 40 Segovia Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 93,46 40 Segovia Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,73 40 Segovia Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 89,72 40 Segovia Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 91,17 40 Segovia Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 91,09 40 Segovia Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 88,8 40 Segovia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87,92 40 Segovia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 40 Segovia Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 40 Segovia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 3.889 40 Segovia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 3.407 40 Segovia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 3.091 40 Segovia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 3.747 40 Segovia Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 3.278 40 Segovia Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2.969 40 Segovia Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 3.605 40 Segovia Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 3.171 40 Segovia Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2.871 40 Segovia Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 3.482 40 Segovia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 3.091 40 Segovia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.781 40 Segovia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 3.009 40 Segovia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.683 40 Segovia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 40 Segovia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 40 Segovia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 40 Segovia Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 96,35 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 96,21 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 96,05 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 92,7 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 93,07 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,88 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 89,53 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 90,72 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 89,97 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 88,32 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 86,8 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 139 40 Segovia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 476 40 Segovia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 768 40 Segovia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 136 40 Segovia Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 466 40 Segovia Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 759 40 Segovia Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 134 40 Segovia Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 458 40 Segovia Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 746 40 Segovia Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 132 40 Segovia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 449 40 Segovia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 734 40 Segovia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 439 40 Segovia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 710 40 Segovia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 40 Segovia Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 40 Segovia Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 40 Segovia Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,84 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,9 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,83 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 96,4 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,22 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,14 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 94,96 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,33 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,57 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 92,23 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 92,45 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia Total Cohort July 1 Total Number at the start of the quarter 2022QIII 4.141 40 Segovia Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 40 Segovia Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 40 Segovia Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia Total Cohort July 1 Total Number at the start of the quarter 2021QIII 4.036 40 Segovia Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 40 Segovia Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 40 Segovia Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia Total Cohort July 1 Total Number at the start of the quarter 2020QIII 3.942 40 Segovia Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 40 Segovia Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 40 Segovia Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 40 Segovia Total Cohort July 1 Total Survival in the first trimester 2022QIII 3.890 40 Segovia Total Cohort July 1 Total Survival in the first trimester 2022QII "" 40 Segovia Total Cohort July 1 Total Survival in the first trimester 2022QI "" 40 Segovia Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 40 Segovia Total Cohort July 1 Total Survival in the first trimester 2021QIII 3.822 40 Segovia Total Cohort July 1 Total Survival in the first trimester 2021QII "" 40 Segovia Total Cohort July 1 Total Survival in the first trimester 2021QI "" 40 Segovia Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 40 Segovia Total Cohort July 1 Total Survival in the first trimester 2020QIII 3.768 40 Segovia Total Cohort July 1 Total Survival in the first trimester 2020QII "" 40 Segovia Total Cohort July 1 Total Survival in the first trimester 2020QI "" 40 Segovia Total Cohort July 1 Total Survival in the second trimester 2022QIV 3.729 40 Segovia Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 40 Segovia Total Cohort July 1 Total Survival in the second trimester 2022QII "" 40 Segovia Total Cohort July 1 Total Survival in the second trimester 2022QI "" 40 Segovia Total Cohort July 1 Total Survival in the second trimester 2021QIV 3.685 40 Segovia Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 40 Segovia Total Cohort July 1 Total Survival in the second trimester 2021QII "" 40 Segovia Total Cohort July 1 Total Survival in the second trimester 2021QI "" 40 Segovia Total Cohort July 1 Total Survival in the second trimester 2020QIV 3.627 40 Segovia Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 40 Segovia Total Cohort July 1 Total Survival in the second trimester 2020QII "" 40 Segovia Total Cohort July 1 Total Survival in the second trimester 2020QI "" 40 Segovia Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 40 Segovia Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 40 Segovia Total Cohort July 1 Total Survival in the third trimester 2022QII "" 40 Segovia Total Cohort July 1 Total Survival in the third trimester 2022QI 3.574 40 Segovia Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 40 Segovia Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 40 Segovia Total Cohort July 1 Total Survival in the third trimester 2021QII "" 40 Segovia Total Cohort July 1 Total Survival in the third trimester 2021QI 3.497 40 Segovia Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 40 Segovia Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 40 Segovia Total Cohort July 1 Total Survival in the third trimester 2020QII "" 40 Segovia Total Cohort July 1 Total Survival in the third trimester 2020QI "" 40 Segovia Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 40 Segovia Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 40 Segovia Total Cohort July 1 Total Survival in the third trimester 2022QII 3.500 40 Segovia Total Cohort July 1 Total Survival in the third trimester 2022QI "" 40 Segovia Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 40 Segovia Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 40 Segovia Total Cohort July 1 Total Survival in the third trimester 2021QII 3.419 40 Segovia Total Cohort July 1 Total Survival in the third trimester 2021QI "" 40 Segovia Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 40 Segovia Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 40 Segovia Total Cohort July 1 Total Survival in the third trimester 2020QII "" 40 Segovia Total Cohort July 1 Total Survival in the third trimester 2020QI "" 40 Segovia Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 40 Segovia Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 40 Segovia Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 40 Segovia Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 40 Segovia Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 40 Segovia Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 40 Segovia Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 40 Segovia Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 40 Segovia Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,94 40 Segovia Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,7 40 Segovia Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,59 40 Segovia Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 90,05 40 Segovia Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 91,3 40 Segovia Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 92,01 40 Segovia Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 88,55 40 Segovia Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 88,71 40 Segovia Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 86,72 40 Segovia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 86,73 40 Segovia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 40 Segovia Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 40 Segovia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 4.093 40 Segovia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 3.924 40 Segovia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 3.411 40 Segovia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 3.844 40 Segovia Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 3.712 40 Segovia Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 3.246 40 Segovia Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 3.684 40 Segovia Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 3.578 40 Segovia Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 3.114 40 Segovia Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 3.470 40 Segovia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.995 40 Segovia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 3.397 40 Segovia Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.927 40 Segovia Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 40 Segovia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 40 Segovia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 40 Segovia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,92 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,6 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,16 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 90,01 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 91,18 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 91,29 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 88,43 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 87,8 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 86,57 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 85,81 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 48 40 Segovia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 112 40 Segovia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 531 40 Segovia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 46 40 Segovia Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 110 40 Segovia Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 522 40 Segovia Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 45 40 Segovia Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 107 40 Segovia Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 513 40 Segovia Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 104 40 Segovia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 502 40 Segovia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 103 40 Segovia Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 492 40 Segovia Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 40 Segovia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 40 Segovia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 40 Segovia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,83 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,21 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,31 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,75 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,54 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,61 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 92,86 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,54 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 91,96 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,66 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia Total Cohort October 1 Total Number at the start of the quarter 2022QIV 4.049 40 Segovia Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 40 Segovia Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 40 Segovia Total Cohort October 1 Total Number at the start of the quarter 2021QIV 4.011 40 Segovia Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 40 Segovia Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 40 Segovia Total Cohort October 1 Total Number at the start of the quarter 2020QIV 3.979 40 Segovia Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 40 Segovia Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 40 Segovia Total Cohort October 1 Total Survival in the first trimester 2022QIV 3.847 40 Segovia Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 40 Segovia Total Cohort October 1 Total Survival in the first trimester 2022QII "" 40 Segovia Total Cohort October 1 Total Survival in the first trimester 2022QI "" 40 Segovia Total Cohort October 1 Total Survival in the first trimester 2021QIV 3.830 40 Segovia Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 40 Segovia Total Cohort October 1 Total Survival in the first trimester 2021QII "" 40 Segovia Total Cohort October 1 Total Survival in the first trimester 2021QI "" 40 Segovia Total Cohort October 1 Total Survival in the first trimester 2020QIV 3.774 40 Segovia Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 40 Segovia Total Cohort October 1 Total Survival in the first trimester 2020QII "" 40 Segovia Total Cohort October 1 Total Survival in the first trimester 2020QI "" 40 Segovia Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 40 Segovia Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 40 Segovia Total Cohort October 1 Total Survival in the second trimester 2022QII "" 40 Segovia Total Cohort October 1 Total Survival in the second trimester 2022QI 3.696 40 Segovia Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 40 Segovia Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 40 Segovia Total Cohort October 1 Total Survival in the second trimester 2021QII "" 40 Segovia Total Cohort October 1 Total Survival in the second trimester 2021QI 3.617 40 Segovia Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 40 Segovia Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 40 Segovia Total Cohort October 1 Total Survival in the second trimester 2020QII "" 40 Segovia Total Cohort October 1 Total Survival in the second trimester 2020QI "" 40 Segovia Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 40 Segovia Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 40 Segovia Total Cohort October 1 Total Survival in the third trimester 2022QII 3.601 40 Segovia Total Cohort October 1 Total Survival in the third trimester 2022QI "" 40 Segovia Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 40 Segovia Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 40 Segovia Total Cohort October 1 Total Survival in the third trimester 2021QII 3.526 40 Segovia Total Cohort October 1 Total Survival in the third trimester 2021QI "" 40 Segovia Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 40 Segovia Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 40 Segovia Total Cohort October 1 Total Survival in the third trimester 2020QII "" 40 Segovia Total Cohort October 1 Total Survival in the third trimester 2020QI "" 40 Segovia Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 40 Segovia Total Cohort October 1 Total Survival in the third trimester 2022QIII 3.494 40 Segovia Total Cohort October 1 Total Survival in the third trimester 2022QII "" 40 Segovia Total Cohort October 1 Total Survival in the third trimester 2022QI "" 40 Segovia Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 40 Segovia Total Cohort October 1 Total Survival in the third trimester 2021QIII 3.445 40 Segovia Total Cohort October 1 Total Survival in the third trimester 2021QII "" 40 Segovia Total Cohort October 1 Total Survival in the third trimester 2021QI "" 40 Segovia Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 40 Segovia Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 40 Segovia Total Cohort October 1 Total Survival in the third trimester 2020QII "" 40 Segovia Total Cohort October 1 Total Survival in the third trimester 2020QI "" 40 Segovia Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 40 Segovia Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 40 Segovia Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 40 Segovia Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 40 Segovia Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 40 Segovia Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 40 Segovia Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 40 Segovia Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 40 Segovia Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,01 40 Segovia Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,49 40 Segovia Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,85 40 Segovia Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 92,15 40 Segovia Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,9 40 Segovia Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 89,78 40 Segovia Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 88,62 40 Segovia Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 87,11 40 Segovia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 86,58 40 Segovia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 40 Segovia Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 40 Segovia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 4.010 40 Segovia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3.859 40 Segovia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 3.511 40 Segovia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 3.809 40 Segovia Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 3.683 40 Segovia Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 3.314 40 Segovia Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 3.552 40 Segovia Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 3.166 40 Segovia Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 3.461 40 Segovia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 3.085 40 Segovia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 3.357 40 Segovia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 3.012 40 Segovia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 40 Segovia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 40 Segovia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 40 Segovia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,99 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,44 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,39 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 92,04 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 90,17 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 89,69 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 87,87 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 86,99 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 85,79 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 39 40 Segovia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 152 40 Segovia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 468 40 Segovia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 38 40 Segovia Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 147 40 Segovia Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 460 40 Segovia Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 144 40 Segovia Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 451 40 Segovia Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 140 40 Segovia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 441 40 Segovia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 137 40 Segovia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 433 40 Segovia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 40 Segovia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 40 Segovia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 40 Segovia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,44 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,71 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,29 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,74 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,37 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 92,11 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,23 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 90,13 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 92,52 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 40 Segovia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 3.140 40 Segovia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 40 Segovia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 3.085 40 Segovia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 3.134 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 2.958 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 2.906 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 2.821 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 2.837 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 2.802 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 2.726 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 2.722 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 2.713 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 2.634 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 2.625 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 2.646 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 2.554 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 40 Segovia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 40 Segovia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 40 Segovia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 40 Segovia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,2 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,2 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 90,01 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,35 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,83 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 86,98 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,69 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,94 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 84,05 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 83,6 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,77 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 81,49 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 3.033 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.806 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.859 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2.637 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.742 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.539 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.631 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.456 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.537 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2.396 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,26 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,98 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,41 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,48 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,75 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,53 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 83,65 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,39 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 107 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 279 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 99 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 269 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 95 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 263 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 91 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 257 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 88 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 250 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 92,52 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,42 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 88,79 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,27 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 85,05 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,11 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 82,24 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 89,61 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 3.113 40 Segovia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 3.046 40 Segovia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 3.005 40 Segovia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 2.972 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 2.917 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 2.883 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 2.835 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 2.808 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 2.781 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 2.717 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 2.720 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 2.683 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 2.636 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 2.569 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 40 Segovia From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 40 Segovia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 40 Segovia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 40 Segovia From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,47 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,76 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,94 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 91,07 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,19 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,55 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,28 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 89,3 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,28 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 86,54 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,49 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 3.025 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.758 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2.526 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.887 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.635 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2.413 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.752 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.533 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2.322 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.636 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.454 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.234 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.378 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.143 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,44 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,54 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,53 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,98 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,84 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,92 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,14 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 88,98 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,44 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 86,22 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,84 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 88 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 288 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 479 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 85 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 282 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 470 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 83 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 275 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 459 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 81 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 266 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 449 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 258 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 426 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,59 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,92 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,12 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,32 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,49 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,82 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 92,05 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 92,36 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,74 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 89,58 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 88,94 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 3.170 40 Segovia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 3.118 40 Segovia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 3.090 40 Segovia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 2.935 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 2.915 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 2.926 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 2.784 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 2.783 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 2.791 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 2.680 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 2.669 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 2.609 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 2.599 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 40 Segovia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 40 Segovia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 40 Segovia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,59 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,49 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,69 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 87,82 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,26 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,32 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 85,95 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,38 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 83,68 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,11 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 3.129 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 3.052 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2.776 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.896 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.849 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.619 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.746 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.720 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.490 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.620 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.378 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.550 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.313 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,55 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,35 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,34 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,76 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,12 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,7 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 85,85 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 85,66 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 83,55 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 83,32 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 41 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 66 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 314 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 39 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 66 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 307 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 38 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 63 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 301 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 60 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 291 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 59 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 286 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,12 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,77 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 92,68 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,45 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,86 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 90,91 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 92,68 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 89,39 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,08 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 3.118 40 Segovia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 3.109 40 Segovia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 3.129 40 Segovia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 2.923 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 2.931 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 2.928 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 2.806 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 2.778 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 2.714 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 2.695 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 2.614 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 2.621 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 40 Segovia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 40 Segovia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 40 Segovia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,75 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,27 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,58 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,25 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 88,78 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,29 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 86,13 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 84,08 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 83,76 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 3.085 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3.004 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2.865 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.891 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.831 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2.670 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.709 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.529 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.621 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2.451 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.524 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.382 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,71 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,24 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,19 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,18 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88,27 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 87,25 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 85,55 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 84,02 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 83,14 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 33 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 105 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 264 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 32 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 100 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 258 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 97 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 249 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 93 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 244 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 90 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 239 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,97 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,24 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,73 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 92,38 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,32 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 88,57 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,42 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 85,71 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 90,53 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 399 40 Segovia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 373 40 Segovia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 423 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 395 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 367 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 412 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 392 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 362 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 403 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 387 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 356 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 397 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 384 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 354 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 391 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 40 Segovia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 40 Segovia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,39 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,4 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,25 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,05 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,27 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,99 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,44 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 93,85 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,24 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,91 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 92,43 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 390 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 306 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 386 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 300 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 384 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 296 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 379 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 292 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 376 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 291 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,97 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,04 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,46 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,73 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,18 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,42 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,41 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,1 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 9 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 67 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 9 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 67 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 8 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 66 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 8 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 64 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 8 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 63 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 88,89 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,51 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 88,89 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,52 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,89 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 94,03 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 413 40 Segovia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 367 40 Segovia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 386 40 Segovia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 410 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 361 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 379 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 408 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 357 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 372 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 404 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 356 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 370 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 351 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 367 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 40 Segovia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 40 Segovia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 40 Segovia From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,27 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,37 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,19 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,79 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,28 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 96,37 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,82 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,85 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 95,64 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,08 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 394 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 300 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 249 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 391 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 295 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 242 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 389 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 291 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 237 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 385 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 290 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 237 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 285 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 235 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,24 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,33 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 97,19 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,73 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 95,18 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,72 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,67 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,18 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,38 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 19 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 67 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 137 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 19 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 66 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 137 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 19 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 66 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 135 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 19 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 66 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 133 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 66 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 132 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,51 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,51 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,54 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,51 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,08 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 98,51 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,35 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 449 40 Segovia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 429 40 Segovia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 382 40 Segovia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 437 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 422 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 374 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 432 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 417 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 371 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 413 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 368 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 411 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 365 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 40 Segovia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 40 Segovia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 40 Segovia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,33 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,37 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 97,91 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,21 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,2 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,12 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,27 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,34 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,8 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,55 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 446 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 414 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 295 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 434 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 408 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 289 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 429 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 403 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 288 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 399 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 286 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 397 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 285 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,31 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,55 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 97,97 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,19 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,34 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,63 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,38 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,95 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,89 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,61 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 3 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 15 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 87 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 3 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 14 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 85 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 3 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 14 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 83 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 14 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 82 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 14 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 80 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 93,33 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,7 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,33 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,4 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93,33 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,25 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,33 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,95 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 416 40 Segovia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 402 40 Segovia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 393 40 Segovia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 412 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 399 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 391 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 394 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 388 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 393 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 384 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 391 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 379 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 40 Segovia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 40 Segovia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 40 Segovia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,04 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,25 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,49 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,01 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,73 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,76 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,71 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,26 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,44 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 413 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 383 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 316 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 409 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 380 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 316 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 375 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 313 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 374 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 311 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 372 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 308 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,03 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,22 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,91 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 99,05 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,65 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,42 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,13 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,47 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 3 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 19 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 77 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 3 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 19 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 75 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 19 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 75 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 19 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 73 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 19 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 71 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,4 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,4 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,81 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 92,21 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 40 Segovia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 480 40 Segovia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 40 Segovia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 437 40 Segovia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 476 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 477 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 434 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 471 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 475 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 430 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 470 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 472 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 428 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 467 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 468 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 428 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 463 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 40 Segovia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 40 Segovia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 40 Segovia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 40 Segovia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,38 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,31 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,95 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,96 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,4 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,74 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,33 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,94 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,11 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,5 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,94 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,27 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 453 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 322 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 450 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 319 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 448 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 318 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 445 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 317 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 441 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 317 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,34 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,07 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,9 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,76 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,23 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,45 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,35 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,45 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 27 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 115 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 27 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 115 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 27 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 112 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 27 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 111 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 27 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 111 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,39 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,52 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,52 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 482 40 Segovia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 451 40 Segovia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 449 40 Segovia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 481 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 447 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 447 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 476 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 445 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 445 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 473 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 445 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 443 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 443 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 438 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 40 Segovia From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 40 Segovia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 40 Segovia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 40 Segovia From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,79 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,11 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,55 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,76 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,67 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,11 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,13 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,67 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,66 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,23 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,55 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 453 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 336 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 302 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 452 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 335 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 300 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 447 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 334 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 298 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 444 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 334 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 296 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 334 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 291 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,78 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,7 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,34 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,68 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 99,4 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,68 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,01 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 99,4 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,01 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 99,4 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,36 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 29 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 115 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 147 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 29 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 112 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 147 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 29 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 111 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 147 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 29 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 111 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 147 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 109 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 147 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,39 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,52 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,52 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 94,78 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 500 40 Segovia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 470 40 Segovia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 451 40 Segovia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 496 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 466 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 449 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 491 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 466 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 446 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 463 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 441 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 462 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 436 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 40 Segovia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 40 Segovia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 40 Segovia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,2 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,15 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,56 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,2 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,15 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,89 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,51 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,78 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,3 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,67 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 497 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 443 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 326 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 493 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 440 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 324 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 488 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 440 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 322 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 437 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 317 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 436 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 315 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,2 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,32 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,39 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,19 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 99,32 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,77 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,65 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,24 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,42 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,63 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 3 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 27 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 125 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 3 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 26 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 125 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 3 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 26 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 124 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 26 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 124 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 26 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 121 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,3 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,3 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,2 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 96,3 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 99,2 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,3 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,8 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 492 40 Segovia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 481 40 Segovia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 439 40 Segovia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 489 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 481 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 437 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 478 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 433 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 476 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 429 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 471 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 427 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 40 Segovia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 40 Segovia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 40 Segovia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,39 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,54 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,38 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,63 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,96 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,72 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,92 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,27 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 489 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 457 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 318 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 486 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 457 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 316 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 454 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 312 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 452 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 311 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 447 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 310 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,39 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,37 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 99,34 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,11 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,91 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,8 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,81 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,48 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 3 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 24 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 121 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 3 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 24 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 121 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 24 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 121 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 24 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 118 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 24 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 117 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,52 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,69 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 40 Segovia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 13 40 Segovia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 40 Segovia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 12 40 Segovia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 13 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 12 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 12 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 13 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 12 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 12 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 13 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 12 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 12 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 13 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 12 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 12 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 13 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 40 Segovia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 40 Segovia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 40 Segovia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 40 Segovia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 92,31 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 92,31 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 92,31 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 92,31 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 12 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 8 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 11 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 8 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 11 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 8 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 11 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 8 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 11 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 8 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 91,67 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 91,67 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 91,67 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 91,67 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 4 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 4 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 4 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 4 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 4 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 14 40 Segovia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 13 40 Segovia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 14 40 Segovia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 14 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 13 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 14 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 14 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 13 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 14 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 14 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 13 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 14 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 12 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 14 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 40 Segovia from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 40 Segovia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 40 Segovia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 40 Segovia from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 92,31 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 40 Segovia from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 11 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 9 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 10 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 11 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 9 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 10 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 11 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 9 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 10 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 11 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 9 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 10 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 8 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 10 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 88,89 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 3 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 4 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 4 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 3 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 4 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 4 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 3 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 4 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 4 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 3 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 4 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 4 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 4 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 4 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 16 40 Segovia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 14 40 Segovia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 14 40 Segovia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 16 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 14 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 14 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 16 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 14 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 14 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 13 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 14 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 13 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 14 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 40 Segovia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 40 Segovia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 40 Segovia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 92,86 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 92,86 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 15 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 11 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 10 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 15 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 11 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 10 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 15 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 11 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 10 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 10 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 10 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 10 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 10 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 90,91 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 90,91 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 3 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 4 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 3 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 4 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 3 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 4 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 3 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 4 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 3 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 4 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 16 40 Segovia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 13 40 Segovia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 13 40 Segovia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 16 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 13 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 13 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 12 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 13 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 12 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 13 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 12 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 13 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 40 Segovia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 40 Segovia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 40 Segovia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 92,31 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 92,31 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 92,31 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 16 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 10 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 8 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 16 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 10 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 8 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 9 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 8 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 9 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 8 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 9 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 8 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 90 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 90 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 3 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 5 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 3 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 5 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 3 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 5 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 3 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 5 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 3 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 5 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 40 Segovia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 6 40 Segovia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 40 Segovia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 6 40 Segovia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 40 Segovia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 6 40 Segovia De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 6 40 Segovia De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 6 40 Segovia De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 6 40 Segovia De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 6 40 Segovia De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 6 40 Segovia De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 6 40 Segovia De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 6 40 Segovia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 6 40 Segovia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 6 40 Segovia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 6 40 Segovia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 6 40 Segovia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 6 40 Segovia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 40 Segovia De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 40 Segovia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 40 Segovia De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 40 Segovia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 40 Segovia De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 40 Segovia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 40 Segovia De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 40 Segovia De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 5 40 Segovia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 4 40 Segovia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 5 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 4 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 5 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 4 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 5 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 4 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 5 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 4 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 40 Segovia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 40 Segovia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1 40 Segovia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2 40 Segovia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 40 Segovia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 40 Segovia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 6 40 Segovia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 40 Segovia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 6 40 Segovia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 40 Segovia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 5 40 Segovia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 6 40 Segovia De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 6 40 Segovia De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 5 40 Segovia De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 6 40 Segovia De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 6 40 Segovia De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 5 40 Segovia De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 6 40 Segovia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 6 40 Segovia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 5 40 Segovia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 6 40 Segovia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 5 40 Segovia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 40 Segovia De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 40 Segovia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 40 Segovia De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 40 Segovia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 40 Segovia De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 40 Segovia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 40 Segovia De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 40 Segovia De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 6 40 Segovia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 4 40 Segovia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 4 40 Segovia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 6 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 4 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 4 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 6 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 4 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 4 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 6 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 4 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 4 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 4 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 4 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 40 Segovia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 40 Segovia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 40 Segovia De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 0 40 Segovia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 2 40 Segovia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1 40 Segovia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 0 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 2 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 0 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 2 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 0 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 2 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 2 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII .. 40 Segovia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 40 Segovia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 40 Segovia De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII .. 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII .. 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 0 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 6 40 Segovia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 40 Segovia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 40 Segovia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 5 40 Segovia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 40 Segovia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 40 Segovia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 5 40 Segovia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 40 Segovia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 6 40 Segovia De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 5 40 Segovia De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 5 40 Segovia De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 6 40 Segovia De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 5 40 Segovia De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 5 40 Segovia De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 5 40 Segovia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 5 40 Segovia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 5 40 Segovia De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 5 40 Segovia De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 40 Segovia De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 40 Segovia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 40 Segovia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 40 Segovia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 40 Segovia De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 40 Segovia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 40 Segovia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 40 Segovia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 40 Segovia De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 40 Segovia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 40 Segovia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 40 Segovia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 40 Segovia De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 40 Segovia De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 6 40 Segovia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 4 40 Segovia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 4 40 Segovia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 6 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 4 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 4 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 6 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 4 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 4 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 4 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 4 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 4 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 4 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 40 Segovia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 40 Segovia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 40 Segovia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 40 Segovia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1 40 Segovia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1 40 Segovia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII .. 40 Segovia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 40 Segovia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 40 Segovia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII .. 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 7 40 Segovia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 40 Segovia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 40 Segovia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 6 40 Segovia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 40 Segovia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 40 Segovia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 5 40 Segovia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 40 Segovia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 7 40 Segovia De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 6 40 Segovia De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 5 40 Segovia De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 6 40 Segovia De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 5 40 Segovia De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 6 40 Segovia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 5 40 Segovia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 6 40 Segovia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 5 40 Segovia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 40 Segovia De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 40 Segovia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 40 Segovia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 40 Segovia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 40 Segovia De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 40 Segovia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 40 Segovia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 40 Segovia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 40 Segovia De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 40 Segovia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 40 Segovia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 40 Segovia De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 40 Segovia De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 7 40 Segovia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 5 40 Segovia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 4 40 Segovia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 7 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 5 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 4 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 5 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 4 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 5 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 4 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 5 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 4 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 40 Segovia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 40 Segovia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 40 Segovia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 40 Segovia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1 40 Segovia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1 40 Segovia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 40 Segovia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 40 Segovia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 40 Segovia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 40 Segovia De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla Total Cohort January 1 Total Number at the start of the quarter 2022QI 44.265 41 Sevilla Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla Total Cohort January 1 Total Number at the start of the quarter 2021QI 42.332 41 Sevilla Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla Total Cohort January 1 Total Number at the start of the quarter 2020QI 44.449 41 Sevilla Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 41 Sevilla Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 41 Sevilla Total Cohort January 1 Total Survival in the first trimester 2022QII "" 41 Sevilla Total Cohort January 1 Total Survival in the first trimester 2022QI 41.465 41 Sevilla Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 41 Sevilla Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 41 Sevilla Total Cohort January 1 Total Survival in the first trimester 2021QII "" 41 Sevilla Total Cohort January 1 Total Survival in the first trimester 2021QI 39.766 41 Sevilla Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 41 Sevilla Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 41 Sevilla Total Cohort January 1 Total Survival in the first trimester 2020QII "" 41 Sevilla Total Cohort January 1 Total Survival in the first trimester 2020QI 36.972 41 Sevilla Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 41 Sevilla Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 41 Sevilla Total Cohort January 1 Total Survival in the second trimester 2022QII 39.368 41 Sevilla Total Cohort January 1 Total Survival in the second trimester 2022QI "" 41 Sevilla Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 41 Sevilla Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 41 Sevilla Total Cohort January 1 Total Survival in the second trimester 2021QII 38.086 41 Sevilla Total Cohort January 1 Total Survival in the second trimester 2021QI "" 41 Sevilla Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 41 Sevilla Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 41 Sevilla Total Cohort January 1 Total Survival in the second trimester 2020QII 35.617 41 Sevilla Total Cohort January 1 Total Survival in the second trimester 2020QI "" 41 Sevilla Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla Total Cohort January 1 Total Survival in the third trimester 2022QIII 37.699 41 Sevilla Total Cohort January 1 Total Survival in the third trimester 2022QII "" 41 Sevilla Total Cohort January 1 Total Survival in the third trimester 2022QI "" 41 Sevilla Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla Total Cohort January 1 Total Survival in the third trimester 2021QIII 36.774 41 Sevilla Total Cohort January 1 Total Survival in the third trimester 2021QII "" 41 Sevilla Total Cohort January 1 Total Survival in the third trimester 2021QI "" 41 Sevilla Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla Total Cohort January 1 Total Survival in the third trimester 2020QIII 34.459 41 Sevilla Total Cohort January 1 Total Survival in the third trimester 2020QII "" 41 Sevilla Total Cohort January 1 Total Survival in the third trimester 2020QI "" 41 Sevilla Total Cohort January 1 Total Survival in the third trimester 2022QIV 36.455 41 Sevilla Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla Total Cohort January 1 Total Survival in the third trimester 2022QII "" 41 Sevilla Total Cohort January 1 Total Survival in the third trimester 2022QI "" 41 Sevilla Total Cohort January 1 Total Survival in the third trimester 2021QIV 35.677 41 Sevilla Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla Total Cohort January 1 Total Survival in the third trimester 2021QII "" 41 Sevilla Total Cohort January 1 Total Survival in the third trimester 2021QI "" 41 Sevilla Total Cohort January 1 Total Survival in the third trimester 2020QIV 33.309 41 Sevilla Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla Total Cohort January 1 Total Survival in the third trimester 2020QII "" 41 Sevilla Total Cohort January 1 Total Survival in the third trimester 2020QI "" 41 Sevilla Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 41 Sevilla Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 41 Sevilla Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,67 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,94 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 83,18 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,94 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 89,97 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 80,13 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 85,17 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 86,87 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 77,52 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 82,36 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 84,28 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 74,94 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 42.120 41 Sevilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 36.625 41 Sevilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 39.393 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 34.223 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 37.355 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 32.662 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 35.739 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 31.451 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 34.539 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 30.467 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 41 Sevilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 41 Sevilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,53 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,44 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,69 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,18 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 84,85 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 85,87 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 82 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 83,19 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2.145 41 Sevilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 5.707 41 Sevilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2.072 41 Sevilla Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 5.543 41 Sevilla Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 2.013 41 Sevilla Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 5.424 41 Sevilla Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.960 41 Sevilla Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 5.323 41 Sevilla Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.916 41 Sevilla Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 5.210 41 Sevilla Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 41 Sevilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 41 Sevilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,6 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,13 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,85 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,04 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 91,38 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 93,27 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 89,32 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 91,29 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla Total Cohort April 1 Total Number at the start of the quarter 2022QII 44.621 41 Sevilla Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla Total Cohort April 1 Total Number at the start of the quarter 2021QII 42.673 41 Sevilla Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla Total Cohort April 1 Total Number at the start of the quarter 2020QII 39.065 41 Sevilla Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 41 Sevilla Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 41 Sevilla Total Cohort April 1 Total Survival in the first trimester 2022QII 41.793 41 Sevilla Total Cohort April 1 Total Survival in the first trimester 2022QI "" 41 Sevilla Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 41 Sevilla Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 41 Sevilla Total Cohort April 1 Total Survival in the first trimester 2021QII 40.375 41 Sevilla Total Cohort April 1 Total Survival in the first trimester 2021QI "" 41 Sevilla Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 41 Sevilla Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 41 Sevilla Total Cohort April 1 Total Survival in the first trimester 2020QII 37.361 41 Sevilla Total Cohort April 1 Total Survival in the first trimester 2020QI "" 41 Sevilla Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 41 Sevilla Total Cohort April 1 Total Survival in the second trimester 2022QIII 39.696 41 Sevilla Total Cohort April 1 Total Survival in the second trimester 2022QII "" 41 Sevilla Total Cohort April 1 Total Survival in the second trimester 2022QI "" 41 Sevilla Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 41 Sevilla Total Cohort April 1 Total Survival in the second trimester 2021QIII 38.694 41 Sevilla Total Cohort April 1 Total Survival in the second trimester 2021QII "" 41 Sevilla Total Cohort April 1 Total Survival in the second trimester 2021QI "" 41 Sevilla Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 41 Sevilla Total Cohort April 1 Total Survival in the second trimester 2020QIII 35.960 41 Sevilla Total Cohort April 1 Total Survival in the second trimester 2020QII "" 41 Sevilla Total Cohort April 1 Total Survival in the second trimester 2020QI "" 41 Sevilla Total Cohort April 1 Total Survival in the third trimester 2022QIV 38.202 41 Sevilla Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla Total Cohort April 1 Total Survival in the third trimester 2022QII "" 41 Sevilla Total Cohort April 1 Total Survival in the third trimester 2022QI "" 41 Sevilla Total Cohort April 1 Total Survival in the third trimester 2021QIV 37.321 41 Sevilla Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla Total Cohort April 1 Total Survival in the third trimester 2021QII "" 41 Sevilla Total Cohort April 1 Total Survival in the third trimester 2021QI "" 41 Sevilla Total Cohort April 1 Total Survival in the third trimester 2020QIV 34.608 41 Sevilla Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla Total Cohort April 1 Total Survival in the third trimester 2020QII "" 41 Sevilla Total Cohort April 1 Total Survival in the third trimester 2020QI "" 41 Sevilla Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla Total Cohort April 1 Total Survival in the third trimester 2022QII "" 41 Sevilla Total Cohort April 1 Total Survival in the third trimester 2022QI 35.877 41 Sevilla Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla Total Cohort April 1 Total Survival in the third trimester 2021QII "" 41 Sevilla Total Cohort April 1 Total Survival in the third trimester 2021QI 33.308 41 Sevilla Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla Total Cohort April 1 Total Survival in the third trimester 2020QII "" 41 Sevilla Total Cohort April 1 Total Survival in the third trimester 2020QI "" 41 Sevilla Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 41 Sevilla Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 41 Sevilla Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 41 Sevilla Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,66 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,61 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,64 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 88,96 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 90,68 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,05 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 85,61 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 87,46 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,59 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 84,07 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,26 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 42.561 41 Sevilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 37.861 41 Sevilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 30.383 41 Sevilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 39.797 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 35.680 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 28.771 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 37.771 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 34.090 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 27.542 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 36.326 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 32.826 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 26.436 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 31.503 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 25.370 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 41 Sevilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 41 Sevilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 41 Sevilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,51 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,24 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,69 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 88,75 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 90,04 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,65 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 85,35 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 86,7 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 87,01 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 83,21 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 83,5 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 2.060 41 Sevilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 4.812 41 Sevilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 8.682 41 Sevilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.996 41 Sevilla Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 4.695 41 Sevilla Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 8.590 41 Sevilla Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.925 41 Sevilla Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 4.604 41 Sevilla Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 8.418 41 Sevilla Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.876 41 Sevilla Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 4.495 41 Sevilla Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 8.172 41 Sevilla Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 4.374 41 Sevilla Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 7.938 41 Sevilla Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 41 Sevilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 41 Sevilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 41 Sevilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,89 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,57 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,94 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,45 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,68 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,96 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,07 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,41 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 94,13 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 90,9 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,43 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla Total Cohort July 1 Total Number at the start of the quarter 2022QIII 44.661 41 Sevilla Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla Total Cohort July 1 Total Number at the start of the quarter 2021QIII 43.659 41 Sevilla Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla Total Cohort July 1 Total Number at the start of the quarter 2020QIII 41.973 41 Sevilla Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 41 Sevilla Total Cohort July 1 Total Survival in the first trimester 2022QIII 41.772 41 Sevilla Total Cohort July 1 Total Survival in the first trimester 2022QII "" 41 Sevilla Total Cohort July 1 Total Survival in the first trimester 2022QI "" 41 Sevilla Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 41 Sevilla Total Cohort July 1 Total Survival in the first trimester 2021QIII 41.095 41 Sevilla Total Cohort July 1 Total Survival in the first trimester 2021QII "" 41 Sevilla Total Cohort July 1 Total Survival in the first trimester 2021QI "" 41 Sevilla Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 41 Sevilla Total Cohort July 1 Total Survival in the first trimester 2020QIII 39.614 41 Sevilla Total Cohort July 1 Total Survival in the first trimester 2020QII "" 41 Sevilla Total Cohort July 1 Total Survival in the first trimester 2020QI "" 41 Sevilla Total Cohort July 1 Total Survival in the second trimester 2022QIV 39.853 41 Sevilla Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 41 Sevilla Total Cohort July 1 Total Survival in the second trimester 2022QII "" 41 Sevilla Total Cohort July 1 Total Survival in the second trimester 2022QI "" 41 Sevilla Total Cohort July 1 Total Survival in the second trimester 2021QIV 39.243 41 Sevilla Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 41 Sevilla Total Cohort July 1 Total Survival in the second trimester 2021QII "" 41 Sevilla Total Cohort July 1 Total Survival in the second trimester 2021QI "" 41 Sevilla Total Cohort July 1 Total Survival in the second trimester 2020QIV 37.547 41 Sevilla Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 41 Sevilla Total Cohort July 1 Total Survival in the second trimester 2020QII "" 41 Sevilla Total Cohort July 1 Total Survival in the second trimester 2020QI "" 41 Sevilla Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla Total Cohort July 1 Total Survival in the third trimester 2022QII "" 41 Sevilla Total Cohort July 1 Total Survival in the third trimester 2022QI 37.549 41 Sevilla Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla Total Cohort July 1 Total Survival in the third trimester 2021QII "" 41 Sevilla Total Cohort July 1 Total Survival in the third trimester 2021QI 35.942 41 Sevilla Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla Total Cohort July 1 Total Survival in the third trimester 2020QII "" 41 Sevilla Total Cohort July 1 Total Survival in the third trimester 2020QI "" 41 Sevilla Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla Total Cohort July 1 Total Survival in the third trimester 2022QII 36.305 41 Sevilla Total Cohort July 1 Total Survival in the third trimester 2022QI "" 41 Sevilla Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla Total Cohort July 1 Total Survival in the third trimester 2021QII 34.920 41 Sevilla Total Cohort July 1 Total Survival in the third trimester 2021QI "" 41 Sevilla Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla Total Cohort July 1 Total Survival in the third trimester 2020QII "" 41 Sevilla Total Cohort July 1 Total Survival in the third trimester 2020QI "" 41 Sevilla Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 41 Sevilla Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 41 Sevilla Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 41 Sevilla Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,53 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,13 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,38 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,23 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,89 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 89,46 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 86,01 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 85,63 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 83,16 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 83,2 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 44.091 41 Sevilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 41.987 41 Sevilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 35.041 41 Sevilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 41.233 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 39.457 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 32.809 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 39.337 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 37.647 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 30.919 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 35.999 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 29.509 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 34.789 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 28.626 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 41 Sevilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 41 Sevilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 41 Sevilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,52 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,97 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,63 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,22 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,66 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 88,24 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 85,74 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 84,21 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 82,86 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 81,69 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 570 41 Sevilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.672 41 Sevilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 6.932 41 Sevilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 539 41 Sevilla Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.638 41 Sevilla Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 6.805 41 Sevilla Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 516 41 Sevilla Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1.596 41 Sevilla Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 6.628 41 Sevilla Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1.550 41 Sevilla Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 6.433 41 Sevilla Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1.516 41 Sevilla Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 6.294 41 Sevilla Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 41 Sevilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 41 Sevilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 41 Sevilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 94,56 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,97 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,17 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 90,53 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,45 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,61 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 92,7 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 92,8 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 90,67 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 90,8 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla Total Cohort October 1 Total Number at the start of the quarter 2022QIV 44.243 41 Sevilla Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla Total Cohort October 1 Total Number at the start of the quarter 2021QIV 43.710 41 Sevilla Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla Total Cohort October 1 Total Number at the start of the quarter 2020QIV 42.488 41 Sevilla Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla Total Cohort October 1 Total Survival in the first trimester 2022QIV 41.711 41 Sevilla Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 41 Sevilla Total Cohort October 1 Total Survival in the first trimester 2022QII "" 41 Sevilla Total Cohort October 1 Total Survival in the first trimester 2022QI "" 41 Sevilla Total Cohort October 1 Total Survival in the first trimester 2021QIV 41.182 41 Sevilla Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 41 Sevilla Total Cohort October 1 Total Survival in the first trimester 2021QII "" 41 Sevilla Total Cohort October 1 Total Survival in the first trimester 2021QI "" 41 Sevilla Total Cohort October 1 Total Survival in the first trimester 2020QIV 39.614 41 Sevilla Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 41 Sevilla Total Cohort October 1 Total Survival in the first trimester 2020QII "" 41 Sevilla Total Cohort October 1 Total Survival in the first trimester 2020QI "" 41 Sevilla Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 41 Sevilla Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 41 Sevilla Total Cohort October 1 Total Survival in the second trimester 2022QII "" 41 Sevilla Total Cohort October 1 Total Survival in the second trimester 2022QI 39.149 41 Sevilla Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 41 Sevilla Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 41 Sevilla Total Cohort October 1 Total Survival in the second trimester 2021QII "" 41 Sevilla Total Cohort October 1 Total Survival in the second trimester 2021QI 37.680 41 Sevilla Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 41 Sevilla Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 41 Sevilla Total Cohort October 1 Total Survival in the second trimester 2020QII "" 41 Sevilla Total Cohort October 1 Total Survival in the second trimester 2020QI "" 41 Sevilla Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla Total Cohort October 1 Total Survival in the third trimester 2022QII 37.578 41 Sevilla Total Cohort October 1 Total Survival in the third trimester 2022QI "" 41 Sevilla Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla Total Cohort October 1 Total Survival in the third trimester 2021QII 36.428 41 Sevilla Total Cohort October 1 Total Survival in the third trimester 2021QI "" 41 Sevilla Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla Total Cohort October 1 Total Survival in the third trimester 2020QII "" 41 Sevilla Total Cohort October 1 Total Survival in the third trimester 2020QI "" 41 Sevilla Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla Total Cohort October 1 Total Survival in the third trimester 2022QIII 36.218 41 Sevilla Total Cohort October 1 Total Survival in the third trimester 2022QII "" 41 Sevilla Total Cohort October 1 Total Survival in the third trimester 2022QI "" 41 Sevilla Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla Total Cohort October 1 Total Survival in the third trimester 2021QIII 35.363 41 Sevilla Total Cohort October 1 Total Survival in the third trimester 2021QII "" 41 Sevilla Total Cohort October 1 Total Survival in the third trimester 2021QI "" 41 Sevilla Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla Total Cohort October 1 Total Survival in the third trimester 2020QII "" 41 Sevilla Total Cohort October 1 Total Survival in the third trimester 2020QI "" 41 Sevilla Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 41 Sevilla Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 41 Sevilla Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 41 Sevilla Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,28 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,22 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,24 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,57 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 88,68 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 85,97 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 85,74 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 82,86 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 83,23 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 43.809 41 Sevilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 41.425 41 Sevilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 36.021 41 Sevilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 41.296 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 38.972 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 33.318 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 37.011 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 31.559 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 35.514 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 30.441 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 34.219 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 29.483 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 41 Sevilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 41 Sevilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 41 Sevilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,26 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,08 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,5 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,34 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 87,61 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 85,73 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 84,51 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 82,6 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 81,85 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 434 41 Sevilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 2.285 41 Sevilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 6.467 41 Sevilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 415 41 Sevilla Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 2.210 41 Sevilla Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 6.296 41 Sevilla Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 2.138 41 Sevilla Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 6.121 41 Sevilla Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 2.064 41 Sevilla Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 5.987 41 Sevilla Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.999 41 Sevilla Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 5.880 41 Sevilla Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 41 Sevilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 41 Sevilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 41 Sevilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 95,62 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,72 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,36 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,57 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,65 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 90,33 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,58 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 87,48 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 90,92 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 33.120 41 Sevilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 32.177 41 Sevilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 33.292 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 30.470 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 29.757 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 26.418 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 28.569 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 28.206 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 25.198 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 27.044 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 26.988 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 24.149 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 25.927 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 26.016 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 23.146 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 41 Sevilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 41 Sevilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 92 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 92,48 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 79,35 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 86,26 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 87,66 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 75,69 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 81,65 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 83,87 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 72,54 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 78,28 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 80,85 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 69,52 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 31.764 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 29.214 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 29.178 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 26.925 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 27.328 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 25.470 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 25.848 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 24.324 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 24.775 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 23.436 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 91,86 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 92,16 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 86,03 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 87,18 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 81,38 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 83,26 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 78 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 80,22 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1.356 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2.963 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1.292 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2.832 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.241 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2.736 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.196 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2.664 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.152 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2.580 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,28 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,58 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 91,52 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 92,34 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 88,2 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 89,91 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 84,96 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 87,07 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 33.300 41 Sevilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 32.374 41 Sevilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 29.538 41 Sevilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 30.680 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 30.207 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 27.918 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 28.727 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 28.625 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 26.611 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 27.373 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 27.374 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 25.379 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 26.092 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 24.228 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 41 Sevilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 41 Sevilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 41 Sevilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 92,13 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 93,31 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,52 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 86,27 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 88,42 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 90,09 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 82,2 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 84,56 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 85,92 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 80,6 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 82,02 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 32.026 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 29.797 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 24.422 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 29.459 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 27.727 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 22.874 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 27.570 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 26.218 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 21.719 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 26.262 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 25.056 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 20.677 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 23.862 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 19.701 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 91,98 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 93,05 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 93,66 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 86,09 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 87,99 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 88,93 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 82 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 84,09 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 84,67 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 80,08 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 80,67 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1.274 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 2.577 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 5.116 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.221 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 2.480 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 5.044 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.157 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 2.407 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 4.892 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.111 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 2.318 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 4.702 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 2.230 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 4.527 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,84 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,24 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,59 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 90,82 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,4 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,62 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 87,21 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 89,95 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,91 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 86,53 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 88,49 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 33.249 41 Sevilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 32.827 41 Sevilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 31.586 41 Sevilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 30.510 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 30.391 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 29.354 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 28.772 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 28.701 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 27.483 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 27.185 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 26.055 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 26.061 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 25.146 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 41 Sevilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 41 Sevilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 41 Sevilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 91,76 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,58 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 92,93 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 86,53 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 87,43 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 87,01 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 82,81 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 82,49 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 79,39 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 79,61 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 32.779 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 31.910 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 27.922 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 30.069 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 29.502 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 25.803 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 28.354 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 27.846 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 24.065 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 26.363 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 22.778 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 25.262 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 21.972 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 91,73 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,45 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 92,41 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 86,5 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 87,26 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 86,19 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 82,62 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 81,58 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 79,17 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 78,69 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 470 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 917 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 3.664 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 441 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 889 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 3.551 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 418 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 855 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 3.418 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 822 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 3.277 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 799 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 3.174 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 93,83 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,95 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,92 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 88,94 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,24 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,29 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 89,64 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 89,44 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 87,13 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 86,63 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 32.938 41 Sevilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 32.827 41 Sevilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 32.024 41 Sevilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 30.575 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 30.448 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 29.317 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 28.590 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 27.555 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 27.164 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 26.425 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 25.932 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 25.446 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 41 Sevilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 41 Sevilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 41 Sevilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 92,83 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 92,75 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 91,55 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 87,09 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 86,04 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 82,75 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 82,52 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 79 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 79,46 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 32.572 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 31.296 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 28.682 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 30.228 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 28.989 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 26.113 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 27.192 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 24.480 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 25.829 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 23.453 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 24.650 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 22.554 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 92,8 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 92,63 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 91,04 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 86,89 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 85,35 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 82,53 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 81,77 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 78,76 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 78,63 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 366 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1.531 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 3.342 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 347 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1.459 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 3.204 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1.398 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 3.075 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1.335 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2.972 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.282 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2.892 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 94,81 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,3 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 95,87 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91,31 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 92,01 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 87,2 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 88,93 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 83,74 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 86,54 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 4.746 41 Sevilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 4.470 41 Sevilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 4.743 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 4.652 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 4.391 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 4.374 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 4.543 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 4.314 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 4.284 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 4.462 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 4.264 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 4.226 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 4.392 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 4.189 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 4.156 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 41 Sevilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 41 Sevilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,02 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,23 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 92,22 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 95,72 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,51 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 90,32 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,02 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,39 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 89,1 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 92,54 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 93,71 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 87,62 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 4.433 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 3.380 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 4.347 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 3.320 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 4.241 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 3.260 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 4.163 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 3.222 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 4.093 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 3.163 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,06 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,22 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 95,67 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,45 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 93,91 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,33 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 92,33 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 93,58 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 313 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.090 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 305 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.071 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 302 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.054 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 299 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.042 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 299 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.026 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,44 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,26 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96,49 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,7 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 95,53 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,6 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 95,53 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 94,13 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 4.766 41 Sevilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 4.485 41 Sevilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 4.127 41 Sevilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 4.653 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 4.405 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 4.071 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 4.570 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 4.348 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 4.008 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 4.486 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 4.277 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 3.941 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 4.183 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 3.863 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 41 Sevilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 41 Sevilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 41 Sevilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,63 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,22 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,64 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 95,89 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,95 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,12 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 94,13 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,36 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,49 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,27 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 93,6 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 4.468 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 3.610 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2.603 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 4.360 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 3.544 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2.560 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 4.283 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 3.494 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2.509 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 4.201 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 3.431 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.476 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 3.358 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.424 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,58 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,17 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,35 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 95,86 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,79 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 96,39 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 94,02 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,04 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,12 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,02 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 93,12 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 298 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 875 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.524 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 293 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 861 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.511 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 287 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 854 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.499 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 285 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 846 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.465 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 825 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.439 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,32 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,4 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,15 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 96,31 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,6 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,36 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 95,64 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,69 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,13 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 94,29 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,42 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 4.852 41 Sevilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 4.699 41 Sevilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 4.507 41 Sevilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 4.761 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 4.619 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 4.431 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 4.656 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 4.527 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 4.303 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 4.416 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 4.220 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 4.347 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 4.161 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 41 Sevilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 41 Sevilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 41 Sevilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,12 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,3 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,31 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 95,96 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 96,34 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 95,47 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 93,98 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 93,63 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 92,51 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 92,32 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 4.802 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 4.414 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 3.272 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 4.712 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 4.336 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 3.204 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 4.607 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 4.248 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 3.104 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 4.147 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 3.042 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 4.086 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 3.005 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,13 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,23 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 97,92 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 95,94 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 96,24 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 94,87 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 93,95 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 92,97 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 92,57 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 91,84 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 50 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 285 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.235 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 49 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 283 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.227 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 49 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 279 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.199 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 269 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.178 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 261 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.156 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,3 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,35 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 98 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,89 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,09 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 94,39 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95,38 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 91,58 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 93,6 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 4.771 41 Sevilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 4.679 41 Sevilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 4.526 41 Sevilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 4.672 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 4.584 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 4.422 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 4.472 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 4.334 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 4.392 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 4.264 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 4.327 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 4.218 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 41 Sevilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 41 Sevilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 41 Sevilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,92 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 97,97 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 97,7 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 95,58 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 95,76 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 93,87 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 94,21 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 92,48 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 93,19 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 4.736 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 4.395 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 3.332 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 4.637 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 4.302 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 3.247 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 4.199 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 3.180 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 4.122 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 3.128 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 4.064 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 3.093 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,91 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 97,88 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,45 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 95,54 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 95,44 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 93,79 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 93,88 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 92,47 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 92,83 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 35 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 284 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.194 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 35 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 282 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.175 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 273 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.154 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 270 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.136 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 263 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.125 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,3 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,41 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 96,13 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,65 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 95,07 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,14 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 92,61 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 94,22 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 6.011 41 Sevilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 5.317 41 Sevilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 6.031 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 5.958 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 5.252 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 5.805 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 5.873 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 5.200 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 5.762 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 5.811 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 5.156 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 5.713 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 5.754 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 5.107 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 5.638 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 41 Sevilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 41 Sevilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,12 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,78 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,25 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,7 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,8 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,54 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,67 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,97 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,73 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,72 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,05 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 93,48 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 5.576 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 3.776 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 5.524 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 3.725 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 5.443 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 3.679 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 5.386 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 3.652 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 5.329 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 3.616 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,07 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,65 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,61 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,43 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,59 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,72 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,57 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,76 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 435 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.541 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 434 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.527 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 430 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.521 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 425 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.504 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 425 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.491 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,77 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,09 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,85 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,7 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,7 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,6 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 97,7 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,76 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 6.159 41 Sevilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 5.450 41 Sevilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 5.044 41 Sevilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 6.065 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 5.399 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 5.018 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 6.005 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 5.357 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 4.988 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 5.949 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 5.307 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 4.937 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 5.241 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 4.868 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 41 Sevilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 41 Sevilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 41 Sevilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,47 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,06 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,48 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,5 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,29 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,89 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,59 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,38 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,88 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,17 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,51 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 5.717 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 4.196 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 3.090 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 5.629 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 4.151 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 3.071 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 5.570 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 4.120 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 3.049 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 5.515 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 4.082 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 3.020 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 4.028 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.983 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,46 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,93 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,39 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,43 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,19 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,67 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,47 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,28 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,73 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,54 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 442 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.254 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.954 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 436 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.248 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.947 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 435 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.237 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.939 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 434 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.225 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.917 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.213 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.885 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,64 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,52 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,64 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 98,42 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,64 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 99,23 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 98,19 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,69 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,11 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,73 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,47 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 6.154 41 Sevilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 5.770 41 Sevilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 5.540 41 Sevilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 6.096 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 5.722 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 5.490 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 6.020 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 5.654 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 5.424 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 5.589 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 5.333 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 5.539 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 5.279 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 41 Sevilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 41 Sevilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 41 Sevilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,06 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,17 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,1 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,82 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,99 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,91 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,86 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,26 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,29 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 6.111 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 5.339 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 3.631 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 6.054 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 5.295 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 3.587 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 5.978 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 5.231 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 3.537 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 5.169 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 3.478 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 5.122 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 3.438 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,07 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,18 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,79 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,82 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,98 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,41 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,82 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,79 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,94 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,68 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 43 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 431 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.909 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 42 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 427 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.903 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 42 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 423 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.887 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 420 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.855 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 417 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.841 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,67 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,07 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,69 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,67 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,14 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,85 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,45 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,17 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,75 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,44 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 6.119 41 Sevilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 5.817 41 Sevilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 5.566 41 Sevilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 6.050 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 5.765 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 5.505 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 5.704 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 5.423 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 5.642 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 5.371 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 5.580 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 5.331 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 41 Sevilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 41 Sevilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 41 Sevilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,87 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,11 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,9 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,06 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,43 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,99 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,5 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,93 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,78 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 6.089 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 5.386 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 3.758 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 6.020 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 5.335 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 3.711 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 5.276 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 3.653 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 5.221 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 3.614 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 5.164 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 3.590 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,87 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,05 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,75 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,96 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,21 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,94 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,17 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,88 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,53 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 30 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 431 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.808 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 30 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 430 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.794 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 428 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.770 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 421 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.757 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 416 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.741 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,77 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,23 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 99,3 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,9 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,68 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,18 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96,52 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,29 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 250 41 Sevilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 243 41 Sevilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 246 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 249 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 241 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 241 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 248 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 241 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 241 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 247 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 241 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 240 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 247 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 240 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 238 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 41 Sevilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 41 Sevilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,6 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,18 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,97 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,2 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 99,18 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,97 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,8 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 99,18 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,56 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,8 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,77 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,75 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 222 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 175 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 221 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 173 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 221 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 173 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 220 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 173 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 220 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 172 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,55 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,86 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,55 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,86 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 99,1 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,86 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 99,1 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,29 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 28 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 68 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 28 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 68 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 27 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 68 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 27 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 68 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 27 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 68 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96,43 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,43 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,43 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 255 41 Sevilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 241 41 Sevilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 228 41 Sevilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 255 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 241 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 227 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 254 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 241 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 227 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 254 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 240 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 226 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 239 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 224 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 41 Sevilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 41 Sevilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 41 Sevilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,56 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,61 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,56 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 99,61 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 99,59 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 99,12 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 99,17 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,25 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 224 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 177 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 170 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 224 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 177 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 169 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 223 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 177 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 169 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 223 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 176 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 168 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 175 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 167 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,41 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 99,55 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,41 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 99,55 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 99,44 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,82 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 98,87 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 98,24 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 31 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 64 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 58 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 31 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 64 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 58 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 31 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 64 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 58 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 31 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 64 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 58 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 64 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 57 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,28 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 271 41 Sevilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 241 41 Sevilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 216 41 Sevilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 270 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 241 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 216 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 270 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 239 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 215 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 238 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 212 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 237 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 212 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 41 Sevilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 41 Sevilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 41 Sevilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,63 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 99,63 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,17 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,54 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,76 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,15 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,34 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,15 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 268 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 214 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 138 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 267 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 214 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 138 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 267 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 212 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 137 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 211 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 135 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 210 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 135 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,63 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 99,63 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 99,07 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 99,28 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,6 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,83 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,13 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,83 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 3 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 27 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 78 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 3 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 27 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 78 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 3 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 27 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 78 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 27 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 77 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 27 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 77 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,72 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,72 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 271 41 Sevilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 256 41 Sevilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 244 41 Sevilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 270 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 254 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 242 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 253 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 240 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 251 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 240 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 250 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 240 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 41 Sevilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 41 Sevilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 41 Sevilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,63 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,22 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,18 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,83 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,36 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,05 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,36 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,66 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,36 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 270 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 226 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 168 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 269 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 224 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 166 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 223 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 165 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 222 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 165 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 221 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 165 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,63 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,12 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,81 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,67 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,21 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,23 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,21 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,79 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,21 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 30 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 76 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 30 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 76 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 30 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 75 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 29 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 75 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 29 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 75 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,68 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,67 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,68 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96,67 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,68 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 138 41 Sevilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 125 41 Sevilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 137 41 Sevilla De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 136 41 Sevilla De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 125 41 Sevilla De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 134 41 Sevilla De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 135 41 Sevilla De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 125 41 Sevilla De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 132 41 Sevilla De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 135 41 Sevilla De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 125 41 Sevilla De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 131 41 Sevilla De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 135 41 Sevilla De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 125 41 Sevilla De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 131 41 Sevilla De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 41 Sevilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 41 Sevilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,55 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,81 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,83 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,35 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,83 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,62 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,83 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 95,62 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 125 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 80 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 123 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 80 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 122 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 80 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 122 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 80 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 122 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 80 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,4 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,6 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,6 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,6 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 13 41 Sevilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 45 41 Sevilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 13 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 45 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 13 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 45 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 13 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 45 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 13 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 45 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 41 Sevilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 41 Sevilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 141 41 Sevilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 123 41 Sevilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 128 41 Sevilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 140 41 Sevilla De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 123 41 Sevilla De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 127 41 Sevilla De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 140 41 Sevilla De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 123 41 Sevilla De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 126 41 Sevilla De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 140 41 Sevilla De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 123 41 Sevilla De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 125 41 Sevilla De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 122 41 Sevilla De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 125 41 Sevilla De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 41 Sevilla De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 41 Sevilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 41 Sevilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 41 Sevilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,29 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,22 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,29 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,44 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 99,29 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,66 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 99,19 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,66 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 126 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 81 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 98 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 125 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 81 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 97 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 125 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 81 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 96 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 125 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 81 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 95 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 80 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 95 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,21 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,98 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 99,21 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,96 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 99,21 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,94 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 98,77 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,94 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 15 41 Sevilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 42 41 Sevilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 30 41 Sevilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 15 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 42 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 30 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 15 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 42 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 30 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 15 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 42 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 30 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 42 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 30 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 41 Sevilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 41 Sevilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 41 Sevilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 135 41 Sevilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 122 41 Sevilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 124 41 Sevilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 135 41 Sevilla De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 122 41 Sevilla De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 123 41 Sevilla De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 135 41 Sevilla De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 122 41 Sevilla De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 122 41 Sevilla De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 121 41 Sevilla De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 122 41 Sevilla De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 121 41 Sevilla De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 122 41 Sevilla De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 41 Sevilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 41 Sevilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 41 Sevilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 41 Sevilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 41 Sevilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 41 Sevilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,19 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,39 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 99,18 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,39 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 99,18 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,39 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 131 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 110 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 78 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 131 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 110 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 77 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 131 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 110 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 76 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 109 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 76 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 109 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 76 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,72 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,44 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 99,09 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,44 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 99,09 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,44 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 4 41 Sevilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 12 41 Sevilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 46 41 Sevilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 4 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 12 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 46 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 4 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 12 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 46 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 12 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 46 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 12 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 46 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 41 Sevilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 41 Sevilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 41 Sevilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 144 41 Sevilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 131 41 Sevilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 128 41 Sevilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 144 41 Sevilla De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 131 41 Sevilla De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 128 41 Sevilla De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 130 41 Sevilla De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 128 41 Sevilla De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 129 41 Sevilla De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 128 41 Sevilla De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 129 41 Sevilla De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 128 41 Sevilla De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 41 Sevilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 41 Sevilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 41 Sevilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 41 Sevilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 41 Sevilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 41 Sevilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 41 Sevilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,24 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,47 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,47 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 142 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 122 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 81 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 142 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 122 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 81 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 121 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 81 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 120 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 81 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 120 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 81 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 99,18 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,36 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,36 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 2 41 Sevilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 9 41 Sevilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 47 41 Sevilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 2 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 9 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 47 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 9 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 47 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 9 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 47 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 9 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 47 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 41 Sevilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 41 Sevilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 41 Sevilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 41 Sevilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 42 Soria Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 42 Soria Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 42 Soria Total Cohort January 1 Total Number at the start of the quarter 2022QI 2.181 42 Soria Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 42 Soria Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 42 Soria Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 42 Soria Total Cohort January 1 Total Number at the start of the quarter 2021QI 2.130 42 Soria Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 42 Soria Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 42 Soria Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 42 Soria Total Cohort January 1 Total Number at the start of the quarter 2020QI 2.248 42 Soria Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 42 Soria Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 42 Soria Total Cohort January 1 Total Survival in the first trimester 2022QII "" 42 Soria Total Cohort January 1 Total Survival in the first trimester 2022QI 2.084 42 Soria Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 42 Soria Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 42 Soria Total Cohort January 1 Total Survival in the first trimester 2021QII "" 42 Soria Total Cohort January 1 Total Survival in the first trimester 2021QI 2.051 42 Soria Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 42 Soria Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 42 Soria Total Cohort January 1 Total Survival in the first trimester 2020QII "" 42 Soria Total Cohort January 1 Total Survival in the first trimester 2020QI 2.043 42 Soria Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 42 Soria Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 42 Soria Total Cohort January 1 Total Survival in the second trimester 2022QII 2.005 42 Soria Total Cohort January 1 Total Survival in the second trimester 2022QI "" 42 Soria Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 42 Soria Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 42 Soria Total Cohort January 1 Total Survival in the second trimester 2021QII 1.983 42 Soria Total Cohort January 1 Total Survival in the second trimester 2021QI "" 42 Soria Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 42 Soria Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 42 Soria Total Cohort January 1 Total Survival in the second trimester 2020QII 1.979 42 Soria Total Cohort January 1 Total Survival in the second trimester 2020QI "" 42 Soria Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 42 Soria Total Cohort January 1 Total Survival in the third trimester 2022QIII 1.956 42 Soria Total Cohort January 1 Total Survival in the third trimester 2022QII "" 42 Soria Total Cohort January 1 Total Survival in the third trimester 2022QI "" 42 Soria Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 42 Soria Total Cohort January 1 Total Survival in the third trimester 2021QIII 1.932 42 Soria Total Cohort January 1 Total Survival in the third trimester 2021QII "" 42 Soria Total Cohort January 1 Total Survival in the third trimester 2021QI "" 42 Soria Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 42 Soria Total Cohort January 1 Total Survival in the third trimester 2020QIII 1.925 42 Soria Total Cohort January 1 Total Survival in the third trimester 2020QII "" 42 Soria Total Cohort January 1 Total Survival in the third trimester 2020QI "" 42 Soria Total Cohort January 1 Total Survival in the third trimester 2022QIV 1.905 42 Soria Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 42 Soria Total Cohort January 1 Total Survival in the third trimester 2022QII "" 42 Soria Total Cohort January 1 Total Survival in the third trimester 2022QI "" 42 Soria Total Cohort January 1 Total Survival in the third trimester 2021QIV 1.885 42 Soria Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 42 Soria Total Cohort January 1 Total Survival in the third trimester 2021QII "" 42 Soria Total Cohort January 1 Total Survival in the third trimester 2021QI "" 42 Soria Total Cohort January 1 Total Survival in the third trimester 2020QIV 1.859 42 Soria Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 42 Soria Total Cohort January 1 Total Survival in the third trimester 2020QII "" 42 Soria Total Cohort January 1 Total Survival in the third trimester 2020QI "" 42 Soria Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 42 Soria Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 42 Soria Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 42 Soria Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 42 Soria Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 42 Soria Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 42 Soria Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 42 Soria Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 42 Soria Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 42 Soria Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 42 Soria Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 42 Soria Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 42 Soria Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,55 42 Soria Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 96,29 42 Soria Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 90,88 42 Soria Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 91,93 42 Soria Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 93,1 42 Soria Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 88,03 42 Soria Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 89,68 42 Soria Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 90,7 42 Soria Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 85,63 42 Soria Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 87,35 42 Soria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 88,5 42 Soria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 82,7 42 Soria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 42 Soria Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 42 Soria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.108 42 Soria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.880 42 Soria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.012 42 Soria Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.807 42 Soria Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.933 42 Soria Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.744 42 Soria Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.886 42 Soria Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.699 42 Soria Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.836 42 Soria Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.655 42 Soria Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 42 Soria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 42 Soria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 95,45 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 96,12 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 91,7 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 92,77 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 89,47 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 90,37 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 87,1 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 88,03 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 73 42 Soria Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 250 42 Soria Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 42 Soria Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 42 Soria Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 42 Soria Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 72 42 Soria Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 42 Soria Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 42 Soria Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 42 Soria Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 244 42 Soria Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 42 Soria Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 42 Soria Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 42 Soria Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 42 Soria Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 42 Soria Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 42 Soria Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 72 42 Soria Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 42 Soria Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 42 Soria Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 42 Soria Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 239 42 Soria Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 42 Soria Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 42 Soria Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 42 Soria Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 42 Soria Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 42 Soria Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 70 42 Soria Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 233 42 Soria Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 69 42 Soria Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 230 42 Soria Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 42 Soria Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 42 Soria Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,63 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,6 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,63 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,6 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 95,89 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 93,2 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,52 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 92 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 42 Soria Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 42 Soria Total Cohort April 1 Total Number at the start of the quarter 2022QII 2.191 42 Soria Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 42 Soria Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 42 Soria Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 42 Soria Total Cohort April 1 Total Number at the start of the quarter 2021QII 2.146 42 Soria Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 42 Soria Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 42 Soria Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 42 Soria Total Cohort April 1 Total Number at the start of the quarter 2020QII 2.105 42 Soria Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 42 Soria Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 42 Soria Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 42 Soria Total Cohort April 1 Total Survival in the first trimester 2022QII 2.093 42 Soria Total Cohort April 1 Total Survival in the first trimester 2022QI "" 42 Soria Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 42 Soria Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 42 Soria Total Cohort April 1 Total Survival in the first trimester 2021QII 2.065 42 Soria Total Cohort April 1 Total Survival in the first trimester 2021QI "" 42 Soria Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 42 Soria Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 42 Soria Total Cohort April 1 Total Survival in the first trimester 2020QII 2.036 42 Soria Total Cohort April 1 Total Survival in the first trimester 2020QI "" 42 Soria Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 42 Soria Total Cohort April 1 Total Survival in the second trimester 2022QIII 2.033 42 Soria Total Cohort April 1 Total Survival in the second trimester 2022QII "" 42 Soria Total Cohort April 1 Total Survival in the second trimester 2022QI "" 42 Soria Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 42 Soria Total Cohort April 1 Total Survival in the second trimester 2021QIII 2.001 42 Soria Total Cohort April 1 Total Survival in the second trimester 2021QII "" 42 Soria Total Cohort April 1 Total Survival in the second trimester 2021QI "" 42 Soria Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 42 Soria Total Cohort April 1 Total Survival in the second trimester 2020QIII 1.969 42 Soria Total Cohort April 1 Total Survival in the second trimester 2020QII "" 42 Soria Total Cohort April 1 Total Survival in the second trimester 2020QI "" 42 Soria Total Cohort April 1 Total Survival in the third trimester 2022QIV 1.969 42 Soria Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 42 Soria Total Cohort April 1 Total Survival in the third trimester 2022QII "" 42 Soria Total Cohort April 1 Total Survival in the third trimester 2022QI "" 42 Soria Total Cohort April 1 Total Survival in the third trimester 2021QIV 1.935 42 Soria Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 42 Soria Total Cohort April 1 Total Survival in the third trimester 2021QII "" 42 Soria Total Cohort April 1 Total Survival in the third trimester 2021QI "" 42 Soria Total Cohort April 1 Total Survival in the third trimester 2020QIV 1.897 42 Soria Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 42 Soria Total Cohort April 1 Total Survival in the third trimester 2020QII "" 42 Soria Total Cohort April 1 Total Survival in the third trimester 2020QI "" 42 Soria Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 42 Soria Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 42 Soria Total Cohort April 1 Total Survival in the third trimester 2022QII "" 42 Soria Total Cohort April 1 Total Survival in the third trimester 2022QI 1.883 42 Soria Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 42 Soria Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 42 Soria Total Cohort April 1 Total Survival in the third trimester 2021QII "" 42 Soria Total Cohort April 1 Total Survival in the third trimester 2021QI 1.853 42 Soria Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 42 Soria Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 42 Soria Total Cohort April 1 Total Survival in the third trimester 2020QII "" 42 Soria Total Cohort April 1 Total Survival in the third trimester 2020QI "" 42 Soria Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 42 Soria Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 42 Soria Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 42 Soria Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 42 Soria Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 42 Soria Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 42 Soria Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 42 Soria Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 42 Soria Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 42 Soria Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 42 Soria Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 42 Soria Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,53 42 Soria Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,23 42 Soria Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,72 42 Soria Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 92,79 42 Soria Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 93,24 42 Soria Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,54 42 Soria Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 89,87 42 Soria Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 90,17 42 Soria Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,12 42 Soria Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 87,74 42 Soria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 88,03 42 Soria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 42 Soria Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 42 Soria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.128 42 Soria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.899 42 Soria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.575 42 Soria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.031 42 Soria Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.823 42 Soria Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.516 42 Soria Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.973 42 Soria Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.765 42 Soria Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.457 42 Soria Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.909 42 Soria Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.703 42 Soria Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.402 42 Soria Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.657 42 Soria Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.366 42 Soria Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 42 Soria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 42 Soria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 42 Soria Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,44 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 96 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 96,25 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 92,72 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,94 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,51 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 89,71 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 89,68 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 89,02 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 87,26 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 86,73 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 63 42 Soria Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 247 42 Soria Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 530 42 Soria Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 42 Soria Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 42 Soria Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 62 42 Soria Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 42 Soria Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 42 Soria Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 42 Soria Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 242 42 Soria Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 42 Soria Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 42 Soria Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 42 Soria Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 520 42 Soria Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 42 Soria Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 42 Soria Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 60 42 Soria Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 42 Soria Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 42 Soria Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 42 Soria Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 236 42 Soria Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 42 Soria Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 42 Soria Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 42 Soria Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 512 42 Soria Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 42 Soria Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 42 Soria Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 60 42 Soria Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 232 42 Soria Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 495 42 Soria Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 226 42 Soria Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 487 42 Soria Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 42 Soria Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 42 Soria Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 42 Soria Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,41 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,98 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,11 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 95,24 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,55 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,6 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 95,24 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,93 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,4 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 91,5 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,89 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 42 Soria Total Cohort July 1 Total Number at the start of the quarter 2022QIII 2.252 42 Soria Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 42 Soria Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 42 Soria Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 42 Soria Total Cohort July 1 Total Number at the start of the quarter 2021QIII 2.200 42 Soria Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 42 Soria Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 42 Soria Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 42 Soria Total Cohort July 1 Total Number at the start of the quarter 2020QIII 2.157 42 Soria Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 42 Soria Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 42 Soria Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 42 Soria Total Cohort July 1 Total Survival in the first trimester 2022QIII 2.136 42 Soria Total Cohort July 1 Total Survival in the first trimester 2022QII "" 42 Soria Total Cohort July 1 Total Survival in the first trimester 2022QI "" 42 Soria Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 42 Soria Total Cohort July 1 Total Survival in the first trimester 2021QIII 2.095 42 Soria Total Cohort July 1 Total Survival in the first trimester 2021QII "" 42 Soria Total Cohort July 1 Total Survival in the first trimester 2021QI "" 42 Soria Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 42 Soria Total Cohort July 1 Total Survival in the first trimester 2020QIII 2.052 42 Soria Total Cohort July 1 Total Survival in the first trimester 2020QII "" 42 Soria Total Cohort July 1 Total Survival in the first trimester 2020QI "" 42 Soria Total Cohort July 1 Total Survival in the second trimester 2022QIV 2.053 42 Soria Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 42 Soria Total Cohort July 1 Total Survival in the second trimester 2022QII "" 42 Soria Total Cohort July 1 Total Survival in the second trimester 2022QI "" 42 Soria Total Cohort July 1 Total Survival in the second trimester 2021QIV 2.009 42 Soria Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 42 Soria Total Cohort July 1 Total Survival in the second trimester 2021QII "" 42 Soria Total Cohort July 1 Total Survival in the second trimester 2021QI "" 42 Soria Total Cohort July 1 Total Survival in the second trimester 2020QIV 1.962 42 Soria Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 42 Soria Total Cohort July 1 Total Survival in the second trimester 2020QII "" 42 Soria Total Cohort July 1 Total Survival in the second trimester 2020QI "" 42 Soria Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 42 Soria Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 42 Soria Total Cohort July 1 Total Survival in the third trimester 2022QII "" 42 Soria Total Cohort July 1 Total Survival in the third trimester 2022QI 1.948 42 Soria Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 42 Soria Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 42 Soria Total Cohort July 1 Total Survival in the third trimester 2021QII "" 42 Soria Total Cohort July 1 Total Survival in the third trimester 2021QI 1.913 42 Soria Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 42 Soria Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 42 Soria Total Cohort July 1 Total Survival in the third trimester 2020QII "" 42 Soria Total Cohort July 1 Total Survival in the third trimester 2020QI "" 42 Soria Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 42 Soria Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 42 Soria Total Cohort July 1 Total Survival in the third trimester 2022QII 1.905 42 Soria Total Cohort July 1 Total Survival in the third trimester 2022QI "" 42 Soria Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 42 Soria Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 42 Soria Total Cohort July 1 Total Survival in the third trimester 2021QII 1.871 42 Soria Total Cohort July 1 Total Survival in the third trimester 2021QI "" 42 Soria Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 42 Soria Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 42 Soria Total Cohort July 1 Total Survival in the third trimester 2020QII "" 42 Soria Total Cohort July 1 Total Survival in the third trimester 2020QI "" 42 Soria Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 42 Soria Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 42 Soria Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 42 Soria Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 42 Soria Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 42 Soria Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 42 Soria Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 42 Soria Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 42 Soria Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 42 Soria Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 42 Soria Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 42 Soria Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,85 42 Soria Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,23 42 Soria Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,13 42 Soria Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 91,16 42 Soria Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 91,32 42 Soria Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,96 42 Soria Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 88,55 42 Soria Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 88,69 42 Soria Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 86,59 42 Soria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 86,74 42 Soria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 42 Soria Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 42 Soria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.236 42 Soria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.143 42 Soria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.878 42 Soria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.121 42 Soria Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.042 42 Soria Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.775 42 Soria Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.038 42 Soria Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.957 42 Soria Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.696 42 Soria Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.896 42 Soria Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.651 42 Soria Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.853 42 Soria Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.614 42 Soria Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 42 Soria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 42 Soria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 42 Soria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,86 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,29 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,52 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 91,14 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 91,32 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,31 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 88,47 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 87,91 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 86,47 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 85,94 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 16 42 Soria Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 57 42 Soria Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 279 42 Soria Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 42 Soria Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 15 42 Soria Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 42 Soria Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 42 Soria Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 42 Soria Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 53 42 Soria Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 42 Soria Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 42 Soria Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 42 Soria Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 277 42 Soria Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 42 Soria Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 42 Soria Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 15 42 Soria Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 42 Soria Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 42 Soria Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 42 Soria Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 52 42 Soria Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 42 Soria Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 42 Soria Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 42 Soria Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 266 42 Soria Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 42 Soria Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 42 Soria Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 42 Soria Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 52 42 Soria Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 262 42 Soria Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 52 42 Soria Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 257 42 Soria Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 42 Soria Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 42 Soria Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 42 Soria Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 93,75 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 92,98 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,28 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,75 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 91,23 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,34 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 91,23 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,91 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 91,23 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,11 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria Total Cohort October 1 Total Number at the start of the quarter 2022QIV 2.213 42 Soria Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 42 Soria Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 42 Soria Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 42 Soria Total Cohort October 1 Total Number at the start of the quarter 2021QIV 2.200 42 Soria Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 42 Soria Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 42 Soria Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 42 Soria Total Cohort October 1 Total Number at the start of the quarter 2020QIV 2.164 42 Soria Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 42 Soria Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 42 Soria Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 42 Soria Total Cohort October 1 Total Survival in the first trimester 2022QIV 2.110 42 Soria Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 42 Soria Total Cohort October 1 Total Survival in the first trimester 2022QII "" 42 Soria Total Cohort October 1 Total Survival in the first trimester 2022QI "" 42 Soria Total Cohort October 1 Total Survival in the first trimester 2021QIV 2.080 42 Soria Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 42 Soria Total Cohort October 1 Total Survival in the first trimester 2021QII "" 42 Soria Total Cohort October 1 Total Survival in the first trimester 2021QI "" 42 Soria Total Cohort October 1 Total Survival in the first trimester 2020QIV 2.046 42 Soria Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 42 Soria Total Cohort October 1 Total Survival in the first trimester 2020QII "" 42 Soria Total Cohort October 1 Total Survival in the first trimester 2020QI "" 42 Soria Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 42 Soria Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 42 Soria Total Cohort October 1 Total Survival in the second trimester 2022QII "" 42 Soria Total Cohort October 1 Total Survival in the second trimester 2022QI 2.012 42 Soria Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 42 Soria Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 42 Soria Total Cohort October 1 Total Survival in the second trimester 2021QII "" 42 Soria Total Cohort October 1 Total Survival in the second trimester 2021QI 1.987 42 Soria Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 42 Soria Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 42 Soria Total Cohort October 1 Total Survival in the second trimester 2020QII "" 42 Soria Total Cohort October 1 Total Survival in the second trimester 2020QI "" 42 Soria Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 42 Soria Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 42 Soria Total Cohort October 1 Total Survival in the third trimester 2022QII 1.951 42 Soria Total Cohort October 1 Total Survival in the third trimester 2022QI "" 42 Soria Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 42 Soria Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 42 Soria Total Cohort October 1 Total Survival in the third trimester 2021QII 1.929 42 Soria Total Cohort October 1 Total Survival in the third trimester 2021QI "" 42 Soria Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 42 Soria Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 42 Soria Total Cohort October 1 Total Survival in the third trimester 2020QII "" 42 Soria Total Cohort October 1 Total Survival in the third trimester 2020QI "" 42 Soria Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 42 Soria Total Cohort October 1 Total Survival in the third trimester 2022QIII 1.914 42 Soria Total Cohort October 1 Total Survival in the third trimester 2022QII "" 42 Soria Total Cohort October 1 Total Survival in the third trimester 2022QI "" 42 Soria Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 42 Soria Total Cohort October 1 Total Survival in the third trimester 2021QIII 1.887 42 Soria Total Cohort October 1 Total Survival in the third trimester 2021QII "" 42 Soria Total Cohort October 1 Total Survival in the third trimester 2021QI "" 42 Soria Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 42 Soria Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 42 Soria Total Cohort October 1 Total Survival in the third trimester 2020QII "" 42 Soria Total Cohort October 1 Total Survival in the third trimester 2020QI "" 42 Soria Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 42 Soria Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 42 Soria Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 42 Soria Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 42 Soria Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 42 Soria Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 42 Soria Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 42 Soria Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 42 Soria Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 42 Soria Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 42 Soria Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 42 Soria Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,35 42 Soria Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,55 42 Soria Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,55 42 Soria Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 91,45 42 Soria Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 91,82 42 Soria Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 88,68 42 Soria Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 89,14 42 Soria Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 87 42 Soria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 87,2 42 Soria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 42 Soria Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 42 Soria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.202 42 Soria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.130 42 Soria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.877 42 Soria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.099 42 Soria Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.011 42 Soria Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.768 42 Soria Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.944 42 Soria Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.714 42 Soria Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.883 42 Soria Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.661 42 Soria Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.851 42 Soria Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.622 42 Soria Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 42 Soria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 42 Soria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 42 Soria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95,32 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,41 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,19 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 91,27 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 91,32 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 88,4 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 88,49 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 86,9 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 86,41 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 11 42 Soria Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 70 42 Soria Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 287 42 Soria Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 11 42 Soria Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 42 Soria Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 42 Soria Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 42 Soria Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 69 42 Soria Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 42 Soria Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 42 Soria Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 42 Soria Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 278 42 Soria Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 42 Soria Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 42 Soria Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 42 Soria Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 42 Soria Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 42 Soria Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 42 Soria Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 68 42 Soria Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 42 Soria Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 42 Soria Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 42 Soria Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 273 42 Soria Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 42 Soria Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 42 Soria Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 42 Soria Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 42 Soria Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 68 42 Soria Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 268 42 Soria Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 63 42 Soria Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 265 42 Soria Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 42 Soria Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 42 Soria Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 42 Soria Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,57 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,86 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 97,14 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,12 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,14 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,38 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 90 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 92,33 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 42 Soria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 42 Soria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 42 Soria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 1.610 42 Soria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 42 Soria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 42 Soria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 42 Soria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 1.605 42 Soria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 1.697 42 Soria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 1.516 42 Soria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 1.526 42 Soria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 1.501 42 Soria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 1.440 42 Soria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 1.461 42 Soria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 1.439 42 Soria From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 1.395 42 Soria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 1.414 42 Soria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 1.389 42 Soria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 1.346 42 Soria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 1.369 42 Soria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 1.327 42 Soria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 42 Soria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 42 Soria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 42 Soria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 42 Soria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 42 Soria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 42 Soria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 42 Soria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 42 Soria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,16 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,08 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 88,45 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,44 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,03 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 84,8 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,65 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 88,1 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 81,85 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 83,6 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,3 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 78,2 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.566 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.450 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.473 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.377 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.397 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.317 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.354 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.276 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.306 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.234 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,06 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,97 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,21 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,83 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,46 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 88 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 83,4 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,1 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 44 42 Soria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 155 42 Soria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 43 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 149 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 43 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 144 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 41 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 138 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 40 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 135 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 42 Soria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 42 Soria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,73 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,13 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,73 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 92,9 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 93,18 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 89,03 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 90,91 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 87,1 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 42 Soria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 42 Soria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 1.623 42 Soria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 42 Soria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 42 Soria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 42 Soria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 1.607 42 Soria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 42 Soria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 42 Soria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 42 Soria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 1.596 42 Soria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 1.528 42 Soria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 1.528 42 Soria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 1.529 42 Soria From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 1.472 42 Soria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 1.468 42 Soria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 1.466 42 Soria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 1.410 42 Soria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 1.404 42 Soria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 1.397 42 Soria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 1.354 42 Soria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 1.354 42 Soria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 42 Soria From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 42 Soria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 42 Soria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 42 Soria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 42 Soria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 42 Soria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 42 Soria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 42 Soria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 42 Soria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 42 Soria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 42 Soria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 42 Soria From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,15 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,08 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,8 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,7 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,35 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,85 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 86,88 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 87,37 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 87,53 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 84,26 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 84,84 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.588 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.454 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.252 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.494 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.380 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.195 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.440 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.326 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.138 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.378 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.266 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.085 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.220 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.050 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,08 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,91 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,45 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,68 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,2 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,89 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 86,78 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 87,07 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 86,66 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 83,91 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 83,87 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 35 42 Soria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 153 42 Soria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 344 42 Soria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 34 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 148 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 334 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 32 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 142 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 328 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 32 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 138 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 312 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 134 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 304 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 42 Soria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 42 Soria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 42 Soria From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,14 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,73 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,09 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,43 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 92,81 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,35 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,43 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 90,2 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 90,7 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 87,58 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 88,37 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 42 Soria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 1.667 42 Soria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 42 Soria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 42 Soria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 42 Soria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 1.652 42 Soria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 42 Soria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 42 Soria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 42 Soria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.631 42 Soria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 1.557 42 Soria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 1.552 42 Soria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 1.529 42 Soria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 1.478 42 Soria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 1.470 42 Soria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 1.443 42 Soria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 1.411 42 Soria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 1.396 42 Soria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 1.371 42 Soria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 1.356 42 Soria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 42 Soria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 42 Soria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 42 Soria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 42 Soria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 42 Soria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 42 Soria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 42 Soria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 42 Soria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 42 Soria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 42 Soria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,4 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,95 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 93,75 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 88,66 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 88,98 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 88,47 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 85,41 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 85,59 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 82,99 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 83,14 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.657 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.616 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.475 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.548 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.520 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.375 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.469 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.439 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.299 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.380 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.256 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.340 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.221 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,42 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,06 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,22 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 88,65 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,05 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 88,07 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 85,4 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 85,15 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 82,92 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 82,78 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 10 42 Soria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 36 42 Soria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 156 42 Soria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 9 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 32 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 154 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 9 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 31 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 144 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 31 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 140 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 31 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 135 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 42 Soria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 42 Soria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 42 Soria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 90 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 88,89 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,72 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 90 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 86,11 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 92,31 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 86,11 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 89,74 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 86,11 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 86,54 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 1.638 42 Soria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 42 Soria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 42 Soria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 1.635 42 Soria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 42 Soria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 42 Soria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.631 42 Soria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 1.537 42 Soria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 1.520 42 Soria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 1.516 42 Soria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 1.454 42 Soria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 1.460 42 Soria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 1.396 42 Soria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 1.404 42 Soria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 1.362 42 Soria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 1.367 42 Soria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 42 Soria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 42 Soria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 42 Soria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 42 Soria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 42 Soria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 42 Soria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 42 Soria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,83 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 92,97 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 92,95 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,93 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,52 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 85,38 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 86,08 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 83,3 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 83,81 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.630 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.586 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.470 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.529 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.472 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.363 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.407 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.312 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.349 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.261 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.320 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.227 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,8 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 92,81 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,72 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,71 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,25 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 85,06 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 85,78 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 83,23 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 83,47 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 8 42 Soria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 49 42 Soria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 161 42 Soria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 8 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 48 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 153 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 47 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 148 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 47 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 143 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 42 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 140 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 42 Soria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 42 Soria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 42 Soria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,96 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 95,03 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 95,92 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 91,93 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 95,92 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 88,82 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 85,71 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 86,96 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 244 42 Soria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 226 42 Soria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 227 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 241 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 226 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 221 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 239 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 223 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 220 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 236 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 222 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 219 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 234 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 222 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 217 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 42 Soria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 42 Soria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,77 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,36 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,95 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,67 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,92 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,72 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,23 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,48 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,9 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,23 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 95,59 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 237 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 189 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 234 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 189 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 232 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 186 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 229 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 185 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 227 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 185 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,73 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,89 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,41 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,62 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,88 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,78 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,88 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 7 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 37 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 7 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 37 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 7 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 37 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 7 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 37 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 7 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 37 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 248 42 Soria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 233 42 Soria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 203 42 Soria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 246 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 233 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 201 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 243 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 232 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 200 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 241 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 231 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 198 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 229 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 197 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 42 Soria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 42 Soria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 42 Soria From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,19 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,01 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,98 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,57 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,52 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,18 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 99,14 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,54 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,28 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,04 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 236 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 191 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 127 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 234 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 191 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 125 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 231 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 190 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 124 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 229 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 189 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 122 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 189 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 121 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,15 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,43 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,88 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 99,48 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,64 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,03 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98,95 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,06 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 98,95 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,28 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 12 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 42 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 76 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 12 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 42 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 76 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 12 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 42 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 76 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 12 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 42 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 76 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 40 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 76 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 95,24 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 245 42 Soria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 227 42 Soria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 223 42 Soria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 241 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 225 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 222 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 239 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 222 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 219 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 220 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 217 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 219 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 215 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 42 Soria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 42 Soria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 42 Soria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,37 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,12 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,55 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,55 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,8 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,21 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,92 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,31 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,48 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,41 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 241 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 220 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 172 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 237 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 218 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 171 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 235 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 215 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 168 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 213 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 166 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 212 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 164 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,34 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,09 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,42 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,51 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,73 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,67 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,82 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,51 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,36 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,35 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 4 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 7 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 51 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 4 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 7 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 51 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 4 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 7 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 51 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 7 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 51 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 7 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 51 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 246 42 Soria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 243 42 Soria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 233 42 Soria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 244 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 239 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 231 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 237 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 228 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 236 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 226 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 234 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 224 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 42 Soria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 42 Soria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 42 Soria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,19 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,35 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,14 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,53 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,85 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,12 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,3 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,14 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 244 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 237 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 177 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 242 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 233 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 175 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 231 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 172 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 230 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 170 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 228 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 168 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,18 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,31 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,87 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,47 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,18 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,05 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,05 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,2 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 94,92 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 2 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 6 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 56 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 2 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 6 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 56 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 6 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 56 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 6 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 56 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 6 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 56 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 42 Soria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 42 Soria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 42 Soria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 304 42 Soria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 42 Soria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 42 Soria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 42 Soria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 275 42 Soria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 298 42 Soria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 304 42 Soria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 275 42 Soria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 295 42 Soria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 303 42 Soria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 275 42 Soria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 294 42 Soria From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 302 42 Soria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 272 42 Soria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 291 42 Soria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 302 42 Soria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 270 42 Soria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 289 42 Soria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 42 Soria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 42 Soria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 42 Soria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 42 Soria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 42 Soria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 42 Soria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 42 Soria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 42 Soria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,99 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,67 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,66 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 99,34 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,91 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,65 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 99,34 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,18 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,98 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 283 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 220 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 283 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 220 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 282 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 220 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 281 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 217 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 281 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 215 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,65 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 99,29 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,64 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 99,29 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,73 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 21 42 Soria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 55 42 Soria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 21 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 55 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 21 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 55 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 21 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 55 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 21 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 55 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 42 Soria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 42 Soria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 42 Soria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 42 Soria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 298 42 Soria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 42 Soria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 42 Soria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 42 Soria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 282 42 Soria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 42 Soria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 42 Soria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 42 Soria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 279 42 Soria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 297 42 Soria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 280 42 Soria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 279 42 Soria From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 296 42 Soria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 277 42 Soria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 276 42 Soria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 296 42 Soria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 276 42 Soria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 275 42 Soria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 276 42 Soria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 275 42 Soria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 42 Soria From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 42 Soria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 42 Soria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 42 Soria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 42 Soria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 42 Soria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 42 Soria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 42 Soria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 42 Soria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 42 Soria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 42 Soria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 42 Soria From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,66 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,29 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,33 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,23 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,92 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 99,33 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,87 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,57 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,87 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,57 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 282 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 233 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 176 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 281 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 231 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 176 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 280 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 228 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 175 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 280 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 227 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 175 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 227 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 175 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,65 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,14 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 99,29 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,85 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,43 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 99,29 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,42 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 99,43 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,42 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 99,43 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 16 42 Soria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 49 42 Soria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 103 42 Soria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 16 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 49 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 103 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 16 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 49 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 101 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 16 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 49 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 100 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 49 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 100 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 42 Soria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 42 Soria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 42 Soria From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,06 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,09 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 97,09 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 42 Soria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 316 42 Soria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 42 Soria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 42 Soria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 42 Soria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 298 42 Soria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 42 Soria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 42 Soria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 42 Soria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 279 42 Soria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 314 42 Soria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 295 42 Soria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 277 42 Soria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 312 42 Soria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 294 42 Soria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 276 42 Soria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 294 42 Soria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 276 42 Soria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 292 42 Soria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 276 42 Soria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 42 Soria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 42 Soria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 42 Soria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 42 Soria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 42 Soria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 42 Soria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 42 Soria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 42 Soria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 42 Soria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 42 Soria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,37 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,99 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,28 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,73 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,66 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,92 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,66 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,92 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,99 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,92 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 314 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 285 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 212 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 312 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 282 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 210 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 310 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 281 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 210 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 281 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 210 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 279 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 210 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,36 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,95 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,06 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,73 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,6 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 99,06 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,6 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 99,06 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,89 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 99,06 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 2 42 Soria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 13 42 Soria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 67 42 Soria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 2 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 13 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 67 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 2 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 13 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 66 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 13 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 66 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 13 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 66 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 42 Soria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 42 Soria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 42 Soria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,51 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,51 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,51 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 304 42 Soria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 42 Soria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 42 Soria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 300 42 Soria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 42 Soria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 42 Soria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 276 42 Soria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 304 42 Soria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 299 42 Soria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 275 42 Soria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 299 42 Soria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 275 42 Soria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 297 42 Soria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 275 42 Soria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 296 42 Soria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 272 42 Soria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 42 Soria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 42 Soria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 42 Soria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 42 Soria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 42 Soria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 42 Soria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 42 Soria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,67 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,64 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,67 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 99,64 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 99 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 99,64 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,67 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,55 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 303 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 286 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 211 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 303 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 285 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 211 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 285 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 211 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 283 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 211 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 282 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 208 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,65 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 99,65 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,95 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,6 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,58 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1 42 Soria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 14 42 Soria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 65 42 Soria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 14 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 64 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 14 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 64 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 14 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 64 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 14 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 64 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 42 Soria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 42 Soria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 42 Soria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,46 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,46 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,46 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,46 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 42 Soria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 42 Soria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 42 Soria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 17 42 Soria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 42 Soria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 42 Soria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 42 Soria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 18 42 Soria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 19 42 Soria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 17 42 Soria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 18 42 Soria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 19 42 Soria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 17 42 Soria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 18 42 Soria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 19 42 Soria from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 17 42 Soria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 18 42 Soria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 19 42 Soria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 17 42 Soria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 18 42 Soria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 19 42 Soria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 42 Soria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 42 Soria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 42 Soria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 42 Soria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 42 Soria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 42 Soria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 42 Soria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 42 Soria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 16 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 16 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 16 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 16 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 16 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 16 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 16 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 16 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 16 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 16 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1 42 Soria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2 42 Soria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 42 Soria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 42 Soria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 42 Soria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 42 Soria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 14 42 Soria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 42 Soria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 42 Soria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 42 Soria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 18 42 Soria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 42 Soria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 42 Soria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 42 Soria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 21 42 Soria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 14 42 Soria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 18 42 Soria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 21 42 Soria from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 14 42 Soria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 18 42 Soria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 21 42 Soria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 14 42 Soria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 18 42 Soria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 21 42 Soria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 18 42 Soria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 21 42 Soria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 42 Soria from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 42 Soria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 42 Soria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 42 Soria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 42 Soria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 42 Soria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 42 Soria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 42 Soria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 42 Soria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 42 Soria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 42 Soria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 42 Soria from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 42 Soria from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 14 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 16 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 17 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 14 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 16 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 17 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 14 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 16 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 17 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 14 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 16 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 17 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 16 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 17 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 0 42 Soria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 2 42 Soria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 4 42 Soria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 0 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 2 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 4 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 0 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 2 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 4 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 0 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 2 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 4 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 2 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 4 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII .. 42 Soria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 42 Soria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 42 Soria from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII .. 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII .. 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 0 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 42 Soria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 18 42 Soria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 42 Soria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 42 Soria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 42 Soria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 17 42 Soria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 42 Soria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 42 Soria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 42 Soria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 18 42 Soria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 18 42 Soria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 17 42 Soria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 18 42 Soria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 18 42 Soria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 17 42 Soria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 18 42 Soria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 17 42 Soria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 18 42 Soria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 17 42 Soria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 18 42 Soria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 42 Soria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 42 Soria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 42 Soria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 42 Soria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 42 Soria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 42 Soria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 42 Soria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 42 Soria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 42 Soria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 42 Soria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 18 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 17 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 16 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 18 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 17 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 16 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 18 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 17 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 16 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 17 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 16 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 17 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 16 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 42 Soria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 0 42 Soria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2 42 Soria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 0 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 0 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 2 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 0 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 0 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 2 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII .. 42 Soria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII .. 42 Soria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 42 Soria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII .. 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII .. 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV .. 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI .. 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII .. 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 18 42 Soria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 42 Soria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 42 Soria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 16 42 Soria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 42 Soria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 42 Soria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 18 42 Soria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 18 42 Soria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 16 42 Soria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 18 42 Soria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 16 42 Soria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 18 42 Soria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 16 42 Soria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 18 42 Soria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 16 42 Soria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 18 42 Soria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 42 Soria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 42 Soria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 42 Soria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 42 Soria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 42 Soria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 42 Soria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 42 Soria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 18 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 15 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 15 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 18 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 15 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 15 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 15 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 15 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 15 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 15 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 15 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 15 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 42 Soria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1 42 Soria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 3 42 Soria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 3 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 3 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 3 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 3 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 42 Soria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 42 Soria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 42 Soria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 42 Soria De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 42 Soria De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 42 Soria De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 6 42 Soria De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 42 Soria De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 42 Soria De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 42 Soria De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 6 42 Soria De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 42 Soria De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 42 Soria De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 42 Soria De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 7 42 Soria De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 42 Soria De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 42 Soria De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 42 Soria De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 6 42 Soria De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 42 Soria De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 42 Soria De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 42 Soria De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 6 42 Soria De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 42 Soria De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 42 Soria De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 42 Soria De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 7 42 Soria De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 42 Soria De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 42 Soria De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 6 42 Soria De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 42 Soria De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 42 Soria De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 42 Soria De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 6 42 Soria De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 42 Soria De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 42 Soria De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 42 Soria De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 7 42 Soria De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 42 Soria De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 42 Soria De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 6 42 Soria De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 42 Soria De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 42 Soria De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 42 Soria De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 6 42 Soria De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 42 Soria De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 42 Soria De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 42 Soria De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 7 42 Soria De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 42 Soria De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 42 Soria De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 6 42 Soria De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 42 Soria De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 42 Soria De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 42 Soria De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 6 42 Soria De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 42 Soria De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 42 Soria De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 42 Soria De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 7 42 Soria De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 42 Soria De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 42 Soria De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 42 Soria De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 42 Soria De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 42 Soria De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 42 Soria De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 42 Soria De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 42 Soria De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 42 Soria De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 42 Soria De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 42 Soria De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 42 Soria De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 42 Soria De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 42 Soria De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 42 Soria De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 6 42 Soria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 5 42 Soria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 6 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 5 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 6 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 5 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 6 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 5 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 6 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 5 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 42 Soria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 42 Soria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 0 42 Soria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1 42 Soria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 0 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 0 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 0 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 0 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI .. 42 Soria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 42 Soria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI .. 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII .. 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII .. 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 0 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 42 Soria De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 42 Soria De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 8 42 Soria De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 42 Soria De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 42 Soria De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 42 Soria De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 6 42 Soria De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 42 Soria De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 42 Soria De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 42 Soria De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 6 42 Soria De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 42 Soria De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 42 Soria De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 42 Soria De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 8 42 Soria De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 42 Soria De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 42 Soria De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 42 Soria De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 6 42 Soria De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 42 Soria De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 42 Soria De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 42 Soria De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 6 42 Soria De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 42 Soria De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 42 Soria De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 8 42 Soria De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 42 Soria De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 42 Soria De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 42 Soria De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 6 42 Soria De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 42 Soria De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 42 Soria De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 42 Soria De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 6 42 Soria De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 42 Soria De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 42 Soria De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 8 42 Soria De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 42 Soria De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 42 Soria De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 42 Soria De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 6 42 Soria De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 42 Soria De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 42 Soria De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 42 Soria De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 6 42 Soria De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 42 Soria De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 42 Soria De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 42 Soria De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 42 Soria De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 42 Soria De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 42 Soria De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 6 42 Soria De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 42 Soria De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 42 Soria De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 42 Soria De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 6 42 Soria De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 42 Soria De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 42 Soria De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 42 Soria De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 42 Soria De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 42 Soria De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 42 Soria De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 42 Soria De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 42 Soria De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 42 Soria De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 42 Soria De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 42 Soria De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 42 Soria De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 42 Soria De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 42 Soria De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 42 Soria De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 42 Soria De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 8 42 Soria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 5 42 Soria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 3 42 Soria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 8 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 5 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 3 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 8 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 5 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 3 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 8 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 5 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 3 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 5 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 3 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 42 Soria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 42 Soria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 42 Soria De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 0 42 Soria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1 42 Soria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 3 42 Soria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 0 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 3 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 0 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 3 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 0 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 3 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 3 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII .. 42 Soria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 42 Soria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 42 Soria De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII .. 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII .. 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 0 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 42 Soria De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 6 42 Soria De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 42 Soria De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 42 Soria De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 42 Soria De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 6 42 Soria De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 42 Soria De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 42 Soria De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 42 Soria De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 6 42 Soria De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 42 Soria De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 42 Soria De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 42 Soria De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 6 42 Soria De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 42 Soria De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 42 Soria De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 42 Soria De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 6 42 Soria De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 42 Soria De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 42 Soria De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 42 Soria De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 6 42 Soria De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 42 Soria De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 42 Soria De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 6 42 Soria De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 42 Soria De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 42 Soria De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 42 Soria De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 6 42 Soria De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 42 Soria De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 42 Soria De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 42 Soria De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 6 42 Soria De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 42 Soria De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 42 Soria De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 42 Soria De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 42 Soria De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 42 Soria De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 42 Soria De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 6 42 Soria De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 42 Soria De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 42 Soria De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 42 Soria De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 6 42 Soria De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 42 Soria De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 42 Soria De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 42 Soria De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 42 Soria De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 42 Soria De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 42 Soria De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 6 42 Soria De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 42 Soria De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 42 Soria De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 42 Soria De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 6 42 Soria De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 42 Soria De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 42 Soria De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 42 Soria De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 42 Soria De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 42 Soria De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 42 Soria De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 42 Soria De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 42 Soria De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 42 Soria De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 42 Soria De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 42 Soria De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 42 Soria De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 42 Soria De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 42 Soria De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 42 Soria De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 42 Soria De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 42 Soria De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 6 42 Soria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 5 42 Soria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 3 42 Soria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 6 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 5 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 3 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 6 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 5 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 3 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 5 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 3 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 5 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 3 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 42 Soria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 42 Soria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 42 Soria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 42 Soria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1 42 Soria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 3 42 Soria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 3 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 3 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 3 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 3 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 42 Soria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII .. 42 Soria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 42 Soria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 42 Soria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 42 Soria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 42 Soria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII .. 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 7 42 Soria De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 42 Soria De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 42 Soria De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 42 Soria De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 6 42 Soria De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 42 Soria De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 42 Soria De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 42 Soria De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 6 42 Soria De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 42 Soria De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 42 Soria De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 42 Soria De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 7 42 Soria De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 42 Soria De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 42 Soria De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 42 Soria De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 6 42 Soria De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 42 Soria De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 42 Soria De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 42 Soria De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 6 42 Soria De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 42 Soria De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 42 Soria De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 42 Soria De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 42 Soria De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 42 Soria De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 42 Soria De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 6 42 Soria De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 42 Soria De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 42 Soria De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 42 Soria De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 6 42 Soria De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 42 Soria De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 42 Soria De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 42 Soria De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 42 Soria De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 42 Soria De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 42 Soria De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 6 42 Soria De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 42 Soria De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 42 Soria De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 42 Soria De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 6 42 Soria De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 42 Soria De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 42 Soria De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 42 Soria De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 42 Soria De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 42 Soria De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 42 Soria De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 6 42 Soria De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 42 Soria De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 42 Soria De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 42 Soria De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 6 42 Soria De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 42 Soria De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 42 Soria De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 42 Soria De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 42 Soria De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 42 Soria De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 42 Soria De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 42 Soria De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 42 Soria De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 42 Soria De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 42 Soria De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 42 Soria De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 42 Soria De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 42 Soria De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 42 Soria De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 42 Soria De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 42 Soria De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 42 Soria De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 42 Soria De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 7 42 Soria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 6 42 Soria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 4 42 Soria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 7 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 6 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 4 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 6 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 4 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 6 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 4 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 6 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 4 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 42 Soria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 42 Soria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 42 Soria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 42 Soria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 0 42 Soria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 2 42 Soria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 0 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 0 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 0 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 0 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 42 Soria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV .. 42 Soria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 42 Soria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV .. 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI .. 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII .. 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII .. 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 42 Soria De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona Total Cohort January 1 Total Number at the start of the quarter 2022QI 19.382 43 Tarragona Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona Total Cohort January 1 Total Number at the start of the quarter 2021QI 18.732 43 Tarragona Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona Total Cohort January 1 Total Number at the start of the quarter 2020QI 19.615 43 Tarragona Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 43 Tarragona Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 43 Tarragona Total Cohort January 1 Total Survival in the first trimester 2022QII "" 43 Tarragona Total Cohort January 1 Total Survival in the first trimester 2022QI 18.272 43 Tarragona Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 43 Tarragona Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 43 Tarragona Total Cohort January 1 Total Survival in the first trimester 2021QII "" 43 Tarragona Total Cohort January 1 Total Survival in the first trimester 2021QI 17.721 43 Tarragona Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 43 Tarragona Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 43 Tarragona Total Cohort January 1 Total Survival in the first trimester 2020QII "" 43 Tarragona Total Cohort January 1 Total Survival in the first trimester 2020QI 17.381 43 Tarragona Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 43 Tarragona Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 43 Tarragona Total Cohort January 1 Total Survival in the second trimester 2022QII 17.433 43 Tarragona Total Cohort January 1 Total Survival in the second trimester 2022QI "" 43 Tarragona Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 43 Tarragona Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 43 Tarragona Total Cohort January 1 Total Survival in the second trimester 2021QII 17.015 43 Tarragona Total Cohort January 1 Total Survival in the second trimester 2021QI "" 43 Tarragona Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 43 Tarragona Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 43 Tarragona Total Cohort January 1 Total Survival in the second trimester 2020QII 16.758 43 Tarragona Total Cohort January 1 Total Survival in the second trimester 2020QI "" 43 Tarragona Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona Total Cohort January 1 Total Survival in the third trimester 2022QIII 16.780 43 Tarragona Total Cohort January 1 Total Survival in the third trimester 2022QII "" 43 Tarragona Total Cohort January 1 Total Survival in the third trimester 2022QI "" 43 Tarragona Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona Total Cohort January 1 Total Survival in the third trimester 2021QIII 16.429 43 Tarragona Total Cohort January 1 Total Survival in the third trimester 2021QII "" 43 Tarragona Total Cohort January 1 Total Survival in the third trimester 2021QI "" 43 Tarragona Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona Total Cohort January 1 Total Survival in the third trimester 2020QIII 16.234 43 Tarragona Total Cohort January 1 Total Survival in the third trimester 2020QII "" 43 Tarragona Total Cohort January 1 Total Survival in the third trimester 2020QI "" 43 Tarragona Total Cohort January 1 Total Survival in the third trimester 2022QIV 16.228 43 Tarragona Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona Total Cohort January 1 Total Survival in the third trimester 2022QII "" 43 Tarragona Total Cohort January 1 Total Survival in the third trimester 2022QI "" 43 Tarragona Total Cohort January 1 Total Survival in the third trimester 2021QIV 15.936 43 Tarragona Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona Total Cohort January 1 Total Survival in the third trimester 2021QII "" 43 Tarragona Total Cohort January 1 Total Survival in the third trimester 2021QI "" 43 Tarragona Total Cohort January 1 Total Survival in the third trimester 2020QIV 15.660 43 Tarragona Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona Total Cohort January 1 Total Survival in the third trimester 2020QII "" 43 Tarragona Total Cohort January 1 Total Survival in the third trimester 2020QI "" 43 Tarragona Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 43 Tarragona Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 43 Tarragona Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,27 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,6 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 88,61 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,94 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,83 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 85,43 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,58 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,71 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 82,76 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 83,73 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,07 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 79,84 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 18.527 43 Tarragona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 16.175 43 Tarragona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 17.438 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 15.245 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 16.625 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 14.598 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 15.990 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 14.074 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 15.459 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 13.642 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 43 Tarragona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 43 Tarragona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,12 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,25 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,73 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,25 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,31 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,01 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 83,44 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 84,34 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 855 43 Tarragona Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2.557 43 Tarragona Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 834 43 Tarragona Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2.476 43 Tarragona Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 808 43 Tarragona Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2.417 43 Tarragona Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 790 43 Tarragona Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2.355 43 Tarragona Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 769 43 Tarragona Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2.294 43 Tarragona Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 43 Tarragona Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 43 Tarragona Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,54 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,83 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 94,5 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,52 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 92,4 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,1 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 89,94 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 89,71 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona Total Cohort April 1 Total Number at the start of the quarter 2022QII 19.645 43 Tarragona Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona Total Cohort April 1 Total Number at the start of the quarter 2021QII 19.028 43 Tarragona Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona Total Cohort April 1 Total Number at the start of the quarter 2020QII 18.396 43 Tarragona Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 43 Tarragona Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 43 Tarragona Total Cohort April 1 Total Survival in the first trimester 2022QII 18.595 43 Tarragona Total Cohort April 1 Total Survival in the first trimester 2022QI "" 43 Tarragona Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 43 Tarragona Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 43 Tarragona Total Cohort April 1 Total Survival in the first trimester 2021QII 18.139 43 Tarragona Total Cohort April 1 Total Survival in the first trimester 2021QI "" 43 Tarragona Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 43 Tarragona Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 43 Tarragona Total Cohort April 1 Total Survival in the first trimester 2020QII 17.632 43 Tarragona Total Cohort April 1 Total Survival in the first trimester 2020QI "" 43 Tarragona Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 43 Tarragona Total Cohort April 1 Total Survival in the second trimester 2022QIII 17.783 43 Tarragona Total Cohort April 1 Total Survival in the second trimester 2022QII "" 43 Tarragona Total Cohort April 1 Total Survival in the second trimester 2022QI "" 43 Tarragona Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 43 Tarragona Total Cohort April 1 Total Survival in the second trimester 2021QIII 17.373 43 Tarragona Total Cohort April 1 Total Survival in the second trimester 2021QII "" 43 Tarragona Total Cohort April 1 Total Survival in the second trimester 2021QI "" 43 Tarragona Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 43 Tarragona Total Cohort April 1 Total Survival in the second trimester 2020QIII 17.011 43 Tarragona Total Cohort April 1 Total Survival in the second trimester 2020QII "" 43 Tarragona Total Cohort April 1 Total Survival in the second trimester 2020QI "" 43 Tarragona Total Cohort April 1 Total Survival in the third trimester 2022QIV 17.012 43 Tarragona Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona Total Cohort April 1 Total Survival in the third trimester 2022QII "" 43 Tarragona Total Cohort April 1 Total Survival in the third trimester 2022QI "" 43 Tarragona Total Cohort April 1 Total Survival in the third trimester 2021QIV 16.624 43 Tarragona Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona Total Cohort April 1 Total Survival in the third trimester 2021QII "" 43 Tarragona Total Cohort April 1 Total Survival in the third trimester 2021QI "" 43 Tarragona Total Cohort April 1 Total Survival in the third trimester 2020QIV 16.293 43 Tarragona Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona Total Cohort April 1 Total Survival in the third trimester 2020QII "" 43 Tarragona Total Cohort April 1 Total Survival in the third trimester 2020QI "" 43 Tarragona Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona Total Cohort April 1 Total Survival in the third trimester 2022QII "" 43 Tarragona Total Cohort April 1 Total Survival in the third trimester 2022QI 16.012 43 Tarragona Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona Total Cohort April 1 Total Survival in the third trimester 2021QII "" 43 Tarragona Total Cohort April 1 Total Survival in the third trimester 2021QI 15.668 43 Tarragona Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona Total Cohort April 1 Total Survival in the third trimester 2020QII "" 43 Tarragona Total Cohort April 1 Total Survival in the third trimester 2020QI "" 43 Tarragona Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 43 Tarragona Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 43 Tarragona Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 43 Tarragona Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,66 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,33 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,85 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,52 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,3 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,47 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 86,6 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 87,37 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,57 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 84,15 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,17 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 18.790 43 Tarragona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 17.001 43 Tarragona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 13.883 43 Tarragona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 17.765 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 16.167 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 13.205 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 16.977 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 15.454 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 12.686 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 16.231 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 14.768 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 12.164 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 14.199 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 11.656 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 43 Tarragona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 43 Tarragona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 43 Tarragona Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,54 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,09 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,12 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,35 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 90,9 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,38 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 86,38 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 86,87 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 87,62 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 83,52 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 83,96 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 855 43 Tarragona Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 2.027 43 Tarragona Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 4.513 43 Tarragona Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 830 43 Tarragona Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.972 43 Tarragona Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 4.427 43 Tarragona Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 806 43 Tarragona Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.919 43 Tarragona Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 4.325 43 Tarragona Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 781 43 Tarragona Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.856 43 Tarragona Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 4.129 43 Tarragona Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.813 43 Tarragona Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 4.012 43 Tarragona Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 43 Tarragona Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 43 Tarragona Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 43 Tarragona Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,08 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,29 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,09 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,27 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,67 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,83 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,35 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 91,56 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,49 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 89,44 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 88,9 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona Total Cohort July 1 Total Number at the start of the quarter 2022QIII 20.471 43 Tarragona Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona Total Cohort July 1 Total Number at the start of the quarter 2021QIII 20.092 43 Tarragona Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona Total Cohort July 1 Total Number at the start of the quarter 2020QIII 19.281 43 Tarragona Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 43 Tarragona Total Cohort July 1 Total Survival in the first trimester 2022QIII 19.081 43 Tarragona Total Cohort July 1 Total Survival in the first trimester 2022QII "" 43 Tarragona Total Cohort July 1 Total Survival in the first trimester 2022QI "" 43 Tarragona Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 43 Tarragona Total Cohort July 1 Total Survival in the first trimester 2021QIII 18.711 43 Tarragona Total Cohort July 1 Total Survival in the first trimester 2021QII "" 43 Tarragona Total Cohort July 1 Total Survival in the first trimester 2021QI "" 43 Tarragona Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 43 Tarragona Total Cohort July 1 Total Survival in the first trimester 2020QIII 18.132 43 Tarragona Total Cohort July 1 Total Survival in the first trimester 2020QII "" 43 Tarragona Total Cohort July 1 Total Survival in the first trimester 2020QI "" 43 Tarragona Total Cohort July 1 Total Survival in the second trimester 2022QIV 17.741 43 Tarragona Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 43 Tarragona Total Cohort July 1 Total Survival in the second trimester 2022QII "" 43 Tarragona Total Cohort July 1 Total Survival in the second trimester 2022QI "" 43 Tarragona Total Cohort July 1 Total Survival in the second trimester 2021QIV 17.475 43 Tarragona Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 43 Tarragona Total Cohort July 1 Total Survival in the second trimester 2021QII "" 43 Tarragona Total Cohort July 1 Total Survival in the second trimester 2021QI "" 43 Tarragona Total Cohort July 1 Total Survival in the second trimester 2020QIV 17.046 43 Tarragona Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 43 Tarragona Total Cohort July 1 Total Survival in the second trimester 2020QII "" 43 Tarragona Total Cohort July 1 Total Survival in the second trimester 2020QI "" 43 Tarragona Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona Total Cohort July 1 Total Survival in the third trimester 2022QII "" 43 Tarragona Total Cohort July 1 Total Survival in the third trimester 2022QI 16.732 43 Tarragona Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona Total Cohort July 1 Total Survival in the third trimester 2021QII "" 43 Tarragona Total Cohort July 1 Total Survival in the third trimester 2021QI 16.345 43 Tarragona Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona Total Cohort July 1 Total Survival in the third trimester 2020QII "" 43 Tarragona Total Cohort July 1 Total Survival in the third trimester 2020QI "" 43 Tarragona Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona Total Cohort July 1 Total Survival in the third trimester 2022QII 16.230 43 Tarragona Total Cohort July 1 Total Survival in the third trimester 2022QI "" 43 Tarragona Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona Total Cohort July 1 Total Survival in the third trimester 2021QII 15.904 43 Tarragona Total Cohort July 1 Total Survival in the third trimester 2021QI "" 43 Tarragona Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona Total Cohort July 1 Total Survival in the third trimester 2020QII "" 43 Tarragona Total Cohort July 1 Total Survival in the third trimester 2020QI "" 43 Tarragona Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 43 Tarragona Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 43 Tarragona Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 43 Tarragona Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,21 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,13 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,04 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 86,66 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 86,97 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 88,41 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 83,28 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 84,77 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 80,78 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 82,49 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 20.160 43 Tarragona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 19.360 43 Tarragona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 16.337 43 Tarragona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 18.779 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 18.003 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 15.251 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 17.450 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 16.796 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 14.282 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 16.070 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 13.663 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 15.582 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 13.286 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 43 Tarragona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 43 Tarragona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 43 Tarragona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,15 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,99 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,35 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 86,56 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 86,76 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 87,42 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 83,01 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 83,63 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 80,49 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 81,32 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 311 43 Tarragona Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 732 43 Tarragona Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2.944 43 Tarragona Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 302 43 Tarragona Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 708 43 Tarragona Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2.881 43 Tarragona Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 291 43 Tarragona Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 679 43 Tarragona Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 2.764 43 Tarragona Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 662 43 Tarragona Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2.682 43 Tarragona Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 648 43 Tarragona Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 2.618 43 Tarragona Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 43 Tarragona Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 43 Tarragona Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 43 Tarragona Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,11 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,72 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,86 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,57 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 92,76 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,89 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 90,44 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 91,1 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 88,52 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 88,93 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona Total Cohort October 1 Total Number at the start of the quarter 2022QIV 20.072 43 Tarragona Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona Total Cohort October 1 Total Number at the start of the quarter 2021QIV 19.766 43 Tarragona Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona Total Cohort October 1 Total Number at the start of the quarter 2020QIV 19.306 43 Tarragona Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona Total Cohort October 1 Total Survival in the first trimester 2022QIV 18.518 43 Tarragona Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 43 Tarragona Total Cohort October 1 Total Survival in the first trimester 2022QII "" 43 Tarragona Total Cohort October 1 Total Survival in the first trimester 2022QI "" 43 Tarragona Total Cohort October 1 Total Survival in the first trimester 2021QIV 18.277 43 Tarragona Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 43 Tarragona Total Cohort October 1 Total Survival in the first trimester 2021QII "" 43 Tarragona Total Cohort October 1 Total Survival in the first trimester 2021QI "" 43 Tarragona Total Cohort October 1 Total Survival in the first trimester 2020QIV 17.873 43 Tarragona Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 43 Tarragona Total Cohort October 1 Total Survival in the first trimester 2020QII "" 43 Tarragona Total Cohort October 1 Total Survival in the first trimester 2020QI "" 43 Tarragona Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 43 Tarragona Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 43 Tarragona Total Cohort October 1 Total Survival in the second trimester 2022QII "" 43 Tarragona Total Cohort October 1 Total Survival in the second trimester 2022QI 17.431 43 Tarragona Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 43 Tarragona Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 43 Tarragona Total Cohort October 1 Total Survival in the second trimester 2021QII "" 43 Tarragona Total Cohort October 1 Total Survival in the second trimester 2021QI 17.059 43 Tarragona Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 43 Tarragona Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 43 Tarragona Total Cohort October 1 Total Survival in the second trimester 2020QII "" 43 Tarragona Total Cohort October 1 Total Survival in the second trimester 2020QI "" 43 Tarragona Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona Total Cohort October 1 Total Survival in the third trimester 2022QII 16.762 43 Tarragona Total Cohort October 1 Total Survival in the third trimester 2022QI "" 43 Tarragona Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona Total Cohort October 1 Total Survival in the third trimester 2021QII 16.477 43 Tarragona Total Cohort October 1 Total Survival in the third trimester 2021QI "" 43 Tarragona Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona Total Cohort October 1 Total Survival in the third trimester 2020QII "" 43 Tarragona Total Cohort October 1 Total Survival in the third trimester 2020QI "" 43 Tarragona Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona Total Cohort October 1 Total Survival in the third trimester 2022QIII 16.227 43 Tarragona Total Cohort October 1 Total Survival in the third trimester 2022QII "" 43 Tarragona Total Cohort October 1 Total Survival in the third trimester 2022QI "" 43 Tarragona Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona Total Cohort October 1 Total Survival in the third trimester 2021QIII 15.983 43 Tarragona Total Cohort October 1 Total Survival in the third trimester 2021QII "" 43 Tarragona Total Cohort October 1 Total Survival in the third trimester 2021QI "" 43 Tarragona Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona Total Cohort October 1 Total Survival in the third trimester 2020QII "" 43 Tarragona Total Cohort October 1 Total Survival in the third trimester 2020QI "" 43 Tarragona Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 43 Tarragona Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 43 Tarragona Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 43 Tarragona Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 92,26 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 92,47 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 92,58 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,19 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 88,36 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 84,8 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 85,35 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 82,1 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 82,79 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 19.861 43 Tarragona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 18.842 43 Tarragona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 16.381 43 Tarragona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 18.314 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 17.395 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 15.066 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 16.569 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 14.339 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 15.933 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 13.814 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 15.419 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 13.383 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 43 Tarragona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 43 Tarragona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 43 Tarragona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 92,21 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 92,32 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 91,97 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 87,94 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 87,53 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 84,56 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 84,33 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 81,83 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 81,7 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 211 43 Tarragona Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 924 43 Tarragona Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 2.925 43 Tarragona Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 204 43 Tarragona Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 882 43 Tarragona Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2.807 43 Tarragona Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 862 43 Tarragona Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2.720 43 Tarragona Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 829 43 Tarragona Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2.663 43 Tarragona Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 808 43 Tarragona Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2.600 43 Tarragona Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 43 Tarragona Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 43 Tarragona Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 43 Tarragona Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,68 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,45 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 95,97 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,29 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 92,99 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 89,72 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 91,04 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 87,45 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 88,89 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 14.842 43 Tarragona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 14.537 43 Tarragona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 15.107 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 13.793 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 13.579 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 13.006 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 13.018 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 12.933 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 12.434 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 12.408 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 12.391 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 11.949 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 11.910 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 11.938 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 11.421 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 43 Tarragona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 43 Tarragona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 92,93 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,41 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 86,09 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 87,71 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 88,97 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 82,31 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 83,6 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 85,24 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 79,1 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 80,25 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 82,12 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 75,6 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 14.289 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 13.018 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 13.260 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 12.129 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 12.510 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 11.535 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 11.918 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 11.042 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 11.439 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 10.640 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,8 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,17 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 87,55 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 88,61 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 83,41 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 84,82 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 80,05 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 81,73 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 553 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.519 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 533 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.450 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 508 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.398 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 490 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.349 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 471 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.298 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,38 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 95,46 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 91,86 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 92,03 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 88,61 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 88,81 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 85,17 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 85,45 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 14.902 43 Tarragona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 14.658 43 Tarragona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 14.255 43 Tarragona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 13.909 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 13.830 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 13.533 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 13.142 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 13.110 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 12.949 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 12.459 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 12.446 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 12.286 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 11.890 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 11.725 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 43 Tarragona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 43 Tarragona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 43 Tarragona From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,34 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,35 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 94,94 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 88,19 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 89,44 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 90,84 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 83,61 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 84,91 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 86,19 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 81,12 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 82,25 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 14.365 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 13.446 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 11.371 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 13.395 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 12.667 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 10.716 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 12.652 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 11.991 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 10.217 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 11.987 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 11.378 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 9.720 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 10.860 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 9.255 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,25 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,21 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,24 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 88,08 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,18 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 89,85 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 83,45 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 84,62 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 85,48 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 80,77 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 81,39 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 537 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.212 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.884 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 514 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.163 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.817 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 490 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.119 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.732 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 472 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.068 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.566 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.030 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.470 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,72 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 95,96 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,68 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,25 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 92,33 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,73 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 87,9 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 88,12 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 88,97 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 84,98 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 85,64 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 15.227 43 Tarragona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 15.197 43 Tarragona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 14.813 43 Tarragona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 13.930 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 13.924 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 13.752 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 12.871 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 12.909 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 12.786 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 12.241 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 12.154 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 11.777 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 11.753 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 43 Tarragona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 43 Tarragona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 43 Tarragona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 91,48 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 91,62 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 92,84 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 84,53 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 84,94 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 86,32 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 80,55 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 82,05 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 77,5 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 79,34 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 15.001 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 14.776 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 13.093 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 13.713 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 13.525 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 12.084 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 12.659 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 12.530 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 11.210 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 11.876 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 10.641 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 11.426 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 10.294 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 91,41 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 91,53 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 92,29 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 84,39 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 84,8 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 85,62 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 80,37 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 81,27 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 77,33 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 78,62 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 226 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 421 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.720 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 217 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 399 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.668 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 212 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 379 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.576 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 365 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.513 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 351 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.459 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,02 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 94,77 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,98 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,81 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 90,02 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 91,63 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 86,7 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 87,97 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 83,37 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 84,83 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 15.151 43 Tarragona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 15.074 43 Tarragona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 14.927 43 Tarragona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 13.801 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 13.742 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 13.594 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 12.961 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 12.840 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 12.349 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 12.317 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 11.853 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 11.863 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 43 Tarragona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 43 Tarragona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 43 Tarragona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 91,09 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 91,16 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 91,07 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 85,98 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 86,02 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 81,92 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 82,51 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 78,63 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 79,47 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 15.001 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 14.451 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 13.235 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 13.654 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 13.156 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 12.001 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 12.391 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 11.319 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 11.809 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 10.844 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 11.334 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 10.440 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 91,02 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 91,04 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 90,68 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 85,74 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 85,52 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 81,72 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 81,93 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 78,43 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 78,88 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 150 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 623 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.692 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 147 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 586 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.593 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 570 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.521 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 540 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.473 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 519 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.423 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 94,06 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 94,15 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 91,49 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 89,89 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 86,68 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 87,06 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 83,31 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 84,1 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 2.010 43 Tarragona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 1.853 43 Tarragona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 1.987 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 1.974 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 1.834 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 1.900 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 1.933 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 1.798 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 1.871 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 1.908 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 1.772 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 1.848 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 1.875 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 1.747 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 1.824 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 43 Tarragona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 43 Tarragona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,21 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,97 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 95,62 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,17 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,03 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 94,16 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,93 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,63 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 93 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,28 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,28 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 91,8 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.890 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.456 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.855 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.442 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.815 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.413 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.790 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.392 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.758 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.374 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,15 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,04 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,03 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,05 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,71 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,6 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,02 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,37 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 120 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 397 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 119 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 392 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 118 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 385 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 118 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 380 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 117 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 373 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,17 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,74 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,33 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,98 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 98,33 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,72 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 97,5 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 93,95 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 2.055 43 Tarragona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 1.958 43 Tarragona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 1.795 43 Tarragona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 2.019 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 1.920 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 1.773 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 1.996 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 1.897 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 1.746 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 1.940 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 1.841 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 1.710 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 1.804 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 1.683 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 43 Tarragona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 43 Tarragona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 43 Tarragona From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,25 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,06 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,77 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,13 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,88 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,27 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 94,4 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 94,02 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,26 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 92,13 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 93,76 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.936 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.658 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.107 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.901 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.624 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.094 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.878 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.603 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.077 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.828 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.554 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.059 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.522 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.041 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,19 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 97,95 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,83 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,68 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,29 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 94,42 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 93,73 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,66 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 91,8 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,04 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 119 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 300 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 688 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 118 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 296 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 679 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 118 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 294 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 669 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 112 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 287 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 651 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 282 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 642 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,16 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,67 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,69 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 99,16 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,24 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 94,12 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 95,67 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 94,62 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 94 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 93,31 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 2.210 43 Tarragona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 2.101 43 Tarragona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 1.947 43 Tarragona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 2.153 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 2.034 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 1.891 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 2.019 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 1.917 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 1.826 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 1.871 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 1.796 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 1.845 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 1.769 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 43 Tarragona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 43 Tarragona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 43 Tarragona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,42 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 96,81 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 97,12 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 91,36 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 91,24 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 93,79 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 89,05 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 92,24 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 87,82 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 90,86 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.174 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.004 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.487 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.117 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.938 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.436 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.985 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.824 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.382 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.780 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.360 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.754 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.341 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,38 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 96,71 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 96,57 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 91,31 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 91,02 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 92,94 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 88,82 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 91,46 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 87,52 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 90,18 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 36 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 97 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 460 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 36 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 96 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 455 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 34 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 93 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 444 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 91 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 436 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 91 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 428 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,97 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,91 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,44 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,88 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,52 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93,81 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,78 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,81 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 93,04 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 2.108 43 Tarragona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 2.050 43 Tarragona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 1.891 43 Tarragona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 1.978 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 1.948 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 1.828 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 1.908 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 1.802 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 1.869 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 1.769 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 1.845 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 1.742 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 43 Tarragona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 43 Tarragona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 43 Tarragona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,83 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,02 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 96,67 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 93,07 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 95,29 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 91,17 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 93,55 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 90 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 92,12 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.076 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.932 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.448 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.949 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.834 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.394 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.798 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.374 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.761 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.348 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.737 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.327 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,88 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,93 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 96,27 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 93,06 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 94,89 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 91,15 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 93,09 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 89,91 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 91,64 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 32 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 118 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 443 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 29 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 114 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 434 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 110 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 428 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 108 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 421 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 108 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 415 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 90,63 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,61 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,97 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,22 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,61 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 91,53 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,03 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 91,53 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,68 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 2.349 43 Tarragona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 2.165 43 Tarragona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 2.344 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 2.326 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 2.135 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 2.298 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 2.304 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 2.114 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 2.277 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 2.287 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 2.097 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 2.262 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 2.266 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 2.083 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 2.241 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 43 Tarragona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 43 Tarragona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,02 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,61 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,04 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,08 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,64 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,14 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,36 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,86 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,5 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,47 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,21 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 95,61 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.187 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.580 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.164 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.556 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.142 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.535 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.125 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.526 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.105 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.514 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,95 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,48 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,94 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,15 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,17 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,58 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,25 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,82 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 162 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 585 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 162 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 579 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 162 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 579 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 162 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 571 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 161 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 569 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,97 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,97 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,61 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 99,38 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,26 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 2.503 43 Tarragona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 2.235 43 Tarragona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 2.179 43 Tarragona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 2.482 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 2.214 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 2.160 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 2.462 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 2.193 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 2.151 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 2.430 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 2.165 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 2.133 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 2.149 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 2.098 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 43 Tarragona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 43 Tarragona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 43 Tarragona From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,16 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,06 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,13 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,36 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,12 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,72 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,08 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,87 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,89 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,15 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,28 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.325 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.770 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.286 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.305 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.751 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.277 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.285 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.737 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.275 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.254 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.713 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.269 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.697 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.246 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,14 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,93 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,3 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,28 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,14 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,14 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,95 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,78 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,68 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,88 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,89 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 178 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 465 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 893 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 177 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 463 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 883 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 177 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 456 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 876 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 176 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 452 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 864 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 452 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 852 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 99,44 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,57 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,88 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 99,44 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,06 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,1 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 98,88 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,2 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,75 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,2 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,41 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 2.820 43 Tarragona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 2.601 43 Tarragona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 2.353 43 Tarragona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 2.785 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 2.560 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 2.321 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 2.640 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 2.457 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 2.267 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 2.431 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 2.230 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 2.419 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 2.219 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 43 Tarragona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 43 Tarragona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 43 Tarragona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,76 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,42 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,64 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 93,62 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 94,46 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 96,35 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 93,46 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 94,77 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 93 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 94,31 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.780 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.412 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.643 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.745 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.372 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.617 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.604 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.274 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.577 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.249 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.550 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.237 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.541 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,74 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,34 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,42 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 93,67 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 94,28 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 95,98 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 93,24 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 94,34 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 92,74 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 93,79 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 40 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 189 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 710 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 40 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 188 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 704 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 36 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 183 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 690 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 182 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 680 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 182 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 678 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,47 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,15 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 90 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,83 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,18 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 96,3 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95,77 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,3 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,49 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 2.606 43 Tarragona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 2.455 43 Tarragona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 2.312 43 Tarragona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 2.532 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 2.401 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 2.276 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 2.379 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 2.244 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 2.361 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 2.220 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 2.347 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 2.207 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 43 Tarragona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 43 Tarragona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 43 Tarragona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,16 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 97,8 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,44 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,9 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,06 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,17 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,02 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,6 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,46 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.583 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.288 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.584 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.510 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.235 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.558 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.213 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.534 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.196 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.512 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.182 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.506 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,17 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 97,68 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,36 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,72 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,84 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,98 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,45 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,37 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,08 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 23 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 167 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 728 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 22 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 166 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 718 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 166 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 710 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 165 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 708 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 165 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 701 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 95,65 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,4 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,63 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 99,4 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,53 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 98,8 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,25 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 98,8 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,29 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 119 43 Tarragona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 110 43 Tarragona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 111 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 118 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 106 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 111 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 117 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 105 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 110 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 117 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 105 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 109 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 117 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 105 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 108 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 43 Tarragona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 43 Tarragona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,16 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 96,36 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,32 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 95,45 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 99,1 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,32 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,45 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,2 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,32 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,45 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,3 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 106 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 82 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 105 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 79 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 104 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 78 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 104 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 78 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 104 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 78 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,06 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 96,34 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,11 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 95,12 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,11 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,12 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,11 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,12 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 13 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 28 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 13 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 27 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 13 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 27 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 13 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 27 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 13 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 27 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,43 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,43 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,43 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,43 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 122 43 Tarragona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 112 43 Tarragona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 102 43 Tarragona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 122 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 112 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 101 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 121 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 110 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 100 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 121 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 110 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 99 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 110 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 97 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 43 Tarragona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 43 Tarragona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 43 Tarragona from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,02 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,18 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,21 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,04 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 99,18 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,21 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,06 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,21 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,1 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 108 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 86 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 72 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 108 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 86 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 71 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 107 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 84 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 70 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 107 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 84 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 69 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 84 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 67 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,61 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 99,07 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,67 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,22 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 99,07 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,67 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,83 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,67 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 93,06 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 14 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 26 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 30 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 14 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 26 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 30 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 14 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 26 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 30 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 14 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 26 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 30 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 26 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 30 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 144 43 Tarragona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 126 43 Tarragona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 107 43 Tarragona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 144 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 126 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 107 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 142 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 126 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 106 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 125 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 104 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 125 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 104 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 43 Tarragona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 43 Tarragona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 43 Tarragona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,61 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,07 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 99,21 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,2 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 99,21 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,2 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 137 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 114 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 79 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 137 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 114 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 79 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 135 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 114 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 78 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 113 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 77 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 113 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 77 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,54 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,73 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 99,12 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,47 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 99,12 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,47 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 7 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 12 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 28 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 7 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 12 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 28 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 7 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 12 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 28 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 12 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 27 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 12 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 27 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,43 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,43 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 137 43 Tarragona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 121 43 Tarragona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 114 43 Tarragona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 137 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 121 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 113 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 120 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 111 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 120 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 111 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 120 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 111 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 43 Tarragona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 43 Tarragona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 43 Tarragona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,12 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,17 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,37 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 99,17 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,37 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 99,17 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,37 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 133 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 112 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 80 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 133 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 112 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 79 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 111 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 78 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 111 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 78 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 111 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 78 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,75 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 99,11 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,5 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 99,11 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 97,5 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 99,11 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,5 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 4 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 9 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 34 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 4 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 9 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 34 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 9 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 33 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 9 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 33 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 9 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 33 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,06 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,06 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 97,06 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 62 43 Tarragona De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 67 43 Tarragona De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 66 43 Tarragona De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 61 43 Tarragona De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 67 43 Tarragona De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 66 43 Tarragona De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 61 43 Tarragona De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 65 43 Tarragona De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 66 43 Tarragona De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 60 43 Tarragona De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 64 43 Tarragona De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 66 43 Tarragona De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 60 43 Tarragona De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 63 43 Tarragona De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 66 43 Tarragona De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 43 Tarragona De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 43 Tarragona De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,39 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,39 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,01 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,77 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,52 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,77 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,03 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 55 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 39 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 54 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 39 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 54 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 37 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 53 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 36 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 53 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 36 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,18 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,18 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 94,87 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,36 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 92,31 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,36 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 92,31 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 7 43 Tarragona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 28 43 Tarragona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 7 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 28 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 7 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 28 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 7 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 28 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 7 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 27 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 43 Tarragona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 43 Tarragona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,43 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 63 43 Tarragona De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 65 43 Tarragona De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 65 43 Tarragona De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 63 43 Tarragona De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 63 43 Tarragona De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 65 43 Tarragona De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 62 43 Tarragona De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 63 43 Tarragona De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 65 43 Tarragona De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 62 43 Tarragona De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 62 43 Tarragona De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 65 43 Tarragona De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 59 43 Tarragona De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 65 43 Tarragona De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 43 Tarragona De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 43 Tarragona De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 43 Tarragona De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 43 Tarragona De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,92 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,41 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,92 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,41 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,38 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 90,77 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 56 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 41 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 47 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 56 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 39 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 47 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 55 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 39 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 47 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 55 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 39 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 47 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 36 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 47 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,12 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,21 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 95,12 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,21 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,12 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 87,8 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 7 43 Tarragona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 24 43 Tarragona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 18 43 Tarragona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 7 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 24 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 18 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 7 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 24 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 18 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 7 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 23 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 18 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 23 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 18 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 43 Tarragona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 43 Tarragona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 43 Tarragona De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 95,83 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 95,83 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 70 43 Tarragona De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 67 43 Tarragona De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 61 43 Tarragona De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 69 43 Tarragona De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 67 43 Tarragona De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 61 43 Tarragona De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 69 43 Tarragona De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 66 43 Tarragona De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 61 43 Tarragona De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 64 43 Tarragona De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 61 43 Tarragona De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 64 43 Tarragona De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 59 43 Tarragona De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 43 Tarragona De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 43 Tarragona De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 43 Tarragona De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 43 Tarragona De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 43 Tarragona De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 43 Tarragona De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,57 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,57 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,51 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,52 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,52 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,72 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 68 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 54 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 35 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 67 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 54 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 35 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 67 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 54 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 35 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 52 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 35 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 52 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 33 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,53 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,53 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,3 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,3 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,29 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 2 43 Tarragona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 13 43 Tarragona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 26 43 Tarragona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 2 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 13 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 26 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 2 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 12 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 26 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 12 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 26 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 12 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 26 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 43 Tarragona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 43 Tarragona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 43 Tarragona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 92,31 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 92,31 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 92,31 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 70 43 Tarragona De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 66 43 Tarragona De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 62 43 Tarragona De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 70 43 Tarragona De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 65 43 Tarragona De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 62 43 Tarragona De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 63 43 Tarragona De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 62 43 Tarragona De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 63 43 Tarragona De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 60 43 Tarragona De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 62 43 Tarragona De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 60 43 Tarragona De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 43 Tarragona De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 43 Tarragona De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 43 Tarragona De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 43 Tarragona De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 43 Tarragona De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 43 Tarragona De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 43 Tarragona De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,48 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 95,45 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95,45 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,77 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 93,94 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,77 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 68 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 59 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 34 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 68 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 58 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 34 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 56 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 34 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 56 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 32 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 55 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 32 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,31 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 94,92 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 94,92 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 94,12 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 93,22 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 94,12 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 2 43 Tarragona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 7 43 Tarragona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 28 43 Tarragona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 2 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 7 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 28 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 7 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 28 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 7 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 28 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 7 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 28 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 43 Tarragona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 43 Tarragona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 43 Tarragona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 43 Tarragona De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 44 Teruel Total Cohort January 1 Total Number at the start of the quarter 2022QI 3.525 44 Teruel Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 44 Teruel Total Cohort January 1 Total Number at the start of the quarter 2021QI 3.424 44 Teruel Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 44 Teruel Total Cohort January 1 Total Number at the start of the quarter 2020QI 3.624 44 Teruel Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 44 Teruel Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 44 Teruel Total Cohort January 1 Total Survival in the first trimester 2022QII "" 44 Teruel Total Cohort January 1 Total Survival in the first trimester 2022QI 3.320 44 Teruel Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 44 Teruel Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 44 Teruel Total Cohort January 1 Total Survival in the first trimester 2021QII "" 44 Teruel Total Cohort January 1 Total Survival in the first trimester 2021QI 3.246 44 Teruel Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 44 Teruel Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 44 Teruel Total Cohort January 1 Total Survival in the first trimester 2020QII "" 44 Teruel Total Cohort January 1 Total Survival in the first trimester 2020QI 3.298 44 Teruel Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 44 Teruel Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 44 Teruel Total Cohort January 1 Total Survival in the second trimester 2022QII 3.185 44 Teruel Total Cohort January 1 Total Survival in the second trimester 2022QI "" 44 Teruel Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 44 Teruel Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 44 Teruel Total Cohort January 1 Total Survival in the second trimester 2021QII 3.158 44 Teruel Total Cohort January 1 Total Survival in the second trimester 2021QI "" 44 Teruel Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 44 Teruel Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 44 Teruel Total Cohort January 1 Total Survival in the second trimester 2020QII 3.177 44 Teruel Total Cohort January 1 Total Survival in the second trimester 2020QI "" 44 Teruel Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 44 Teruel Total Cohort January 1 Total Survival in the third trimester 2022QIII 3.077 44 Teruel Total Cohort January 1 Total Survival in the third trimester 2022QII "" 44 Teruel Total Cohort January 1 Total Survival in the third trimester 2022QI "" 44 Teruel Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 44 Teruel Total Cohort January 1 Total Survival in the third trimester 2021QIII 3.079 44 Teruel Total Cohort January 1 Total Survival in the third trimester 2021QII "" 44 Teruel Total Cohort January 1 Total Survival in the third trimester 2021QI "" 44 Teruel Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 44 Teruel Total Cohort January 1 Total Survival in the third trimester 2020QIII 3.079 44 Teruel Total Cohort January 1 Total Survival in the third trimester 2020QII "" 44 Teruel Total Cohort January 1 Total Survival in the third trimester 2020QI "" 44 Teruel Total Cohort January 1 Total Survival in the third trimester 2022QIV 2.980 44 Teruel Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 44 Teruel Total Cohort January 1 Total Survival in the third trimester 2022QII "" 44 Teruel Total Cohort January 1 Total Survival in the third trimester 2022QI "" 44 Teruel Total Cohort January 1 Total Survival in the third trimester 2021QIV 3.016 44 Teruel Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 44 Teruel Total Cohort January 1 Total Survival in the third trimester 2021QII "" 44 Teruel Total Cohort January 1 Total Survival in the third trimester 2021QI "" 44 Teruel Total Cohort January 1 Total Survival in the third trimester 2020QIV 3.003 44 Teruel Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 44 Teruel Total Cohort January 1 Total Survival in the third trimester 2020QII "" 44 Teruel Total Cohort January 1 Total Survival in the third trimester 2020QI "" 44 Teruel Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 44 Teruel Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 44 Teruel Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 44 Teruel Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 44 Teruel Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 44 Teruel Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 44 Teruel Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,18 44 Teruel Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,8 44 Teruel Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 91 44 Teruel Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,35 44 Teruel Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 92,23 44 Teruel Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 87,67 44 Teruel Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 87,29 44 Teruel Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 89,92 44 Teruel Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 84,96 44 Teruel Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 84,54 44 Teruel Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 88,08 44 Teruel Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 82,86 44 Teruel Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 44 Teruel Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 44 Teruel Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 3.448 44 Teruel Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 3.113 44 Teruel Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 3.243 44 Teruel Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2.946 44 Teruel Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 3.113 44 Teruel Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.865 44 Teruel Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 3.008 44 Teruel Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.793 44 Teruel Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.912 44 Teruel Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2.733 44 Teruel Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 44 Teruel Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 44 Teruel Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,05 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,64 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,28 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 92,03 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 87,24 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 89,72 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 84,45 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 87,79 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 77 44 Teruel Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 311 44 Teruel Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 77 44 Teruel Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 300 44 Teruel Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 72 44 Teruel Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 293 44 Teruel Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 69 44 Teruel Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 286 44 Teruel Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 68 44 Teruel Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 283 44 Teruel Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 44 Teruel Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 44 Teruel Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,46 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,51 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,21 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 89,61 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 91,96 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,31 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 91 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel Total Cohort April 1 Total Number at the start of the quarter 2022QII 3.463 44 Teruel Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 44 Teruel Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel Total Cohort April 1 Total Number at the start of the quarter 2021QII 3.368 44 Teruel Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 44 Teruel Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel Total Cohort April 1 Total Number at the start of the quarter 2020QII 3.437 44 Teruel Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 44 Teruel Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 44 Teruel Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 44 Teruel Total Cohort April 1 Total Survival in the first trimester 2022QII 3.307 44 Teruel Total Cohort April 1 Total Survival in the first trimester 2022QI "" 44 Teruel Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 44 Teruel Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 44 Teruel Total Cohort April 1 Total Survival in the first trimester 2021QII 3.253 44 Teruel Total Cohort April 1 Total Survival in the first trimester 2021QI "" 44 Teruel Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 44 Teruel Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 44 Teruel Total Cohort April 1 Total Survival in the first trimester 2020QII 3.298 44 Teruel Total Cohort April 1 Total Survival in the first trimester 2020QI "" 44 Teruel Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 44 Teruel Total Cohort April 1 Total Survival in the second trimester 2022QIII 3.182 44 Teruel Total Cohort April 1 Total Survival in the second trimester 2022QII "" 44 Teruel Total Cohort April 1 Total Survival in the second trimester 2022QI "" 44 Teruel Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 44 Teruel Total Cohort April 1 Total Survival in the second trimester 2021QIII 3.163 44 Teruel Total Cohort April 1 Total Survival in the second trimester 2021QII "" 44 Teruel Total Cohort April 1 Total Survival in the second trimester 2021QI "" 44 Teruel Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 44 Teruel Total Cohort April 1 Total Survival in the second trimester 2020QIII 3.186 44 Teruel Total Cohort April 1 Total Survival in the second trimester 2020QII "" 44 Teruel Total Cohort April 1 Total Survival in the second trimester 2020QI "" 44 Teruel Total Cohort April 1 Total Survival in the third trimester 2022QIV 3.071 44 Teruel Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 44 Teruel Total Cohort April 1 Total Survival in the third trimester 2022QII "" 44 Teruel Total Cohort April 1 Total Survival in the third trimester 2022QI "" 44 Teruel Total Cohort April 1 Total Survival in the third trimester 2021QIV 3.089 44 Teruel Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 44 Teruel Total Cohort April 1 Total Survival in the third trimester 2021QII "" 44 Teruel Total Cohort April 1 Total Survival in the third trimester 2021QI "" 44 Teruel Total Cohort April 1 Total Survival in the third trimester 2020QIV 3.095 44 Teruel Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 44 Teruel Total Cohort April 1 Total Survival in the third trimester 2020QII "" 44 Teruel Total Cohort April 1 Total Survival in the third trimester 2020QI "" 44 Teruel Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 44 Teruel Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 44 Teruel Total Cohort April 1 Total Survival in the third trimester 2022QII "" 44 Teruel Total Cohort April 1 Total Survival in the third trimester 2022QI 2.978 44 Teruel Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 44 Teruel Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 44 Teruel Total Cohort April 1 Total Survival in the third trimester 2021QII "" 44 Teruel Total Cohort April 1 Total Survival in the third trimester 2021QI 2.974 44 Teruel Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 44 Teruel Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 44 Teruel Total Cohort April 1 Total Survival in the third trimester 2020QII "" 44 Teruel Total Cohort April 1 Total Survival in the third trimester 2020QI "" 44 Teruel Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 44 Teruel Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 44 Teruel Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 44 Teruel Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 44 Teruel Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 44 Teruel Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,5 44 Teruel Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,59 44 Teruel Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,96 44 Teruel Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 91,89 44 Teruel Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 93,91 44 Teruel Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,7 44 Teruel Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 88,68 44 Teruel Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 91,72 44 Teruel Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,05 44 Teruel Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 88,42 44 Teruel Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 86,53 44 Teruel Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 44 Teruel Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 44 Teruel Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 3.377 44 Teruel Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 3.154 44 Teruel Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2.777 44 Teruel Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 3.227 44 Teruel Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 3.041 44 Teruel Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2.647 44 Teruel Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 3.102 44 Teruel Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.957 44 Teruel Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2.551 44 Teruel Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.992 44 Teruel Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.886 44 Teruel Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.477 44 Teruel Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.782 44 Teruel Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.373 44 Teruel Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 44 Teruel Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 44 Teruel Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 44 Teruel Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,56 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 96,42 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,32 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,86 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 93,75 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,86 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 88,6 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 91,5 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 89,2 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 88,21 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 85,45 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 86 44 Teruel Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 214 44 Teruel Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 660 44 Teruel Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 80 44 Teruel Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 212 44 Teruel Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 651 44 Teruel Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 80 44 Teruel Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 206 44 Teruel Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 635 44 Teruel Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 79 44 Teruel Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 203 44 Teruel Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 618 44 Teruel Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 196 44 Teruel Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 601 44 Teruel Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 44 Teruel Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 44 Teruel Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 44 Teruel Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 93,02 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,07 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,64 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,02 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,26 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,21 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,86 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 94,86 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,64 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 91,59 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,06 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel Total Cohort July 1 Total Number at the start of the quarter 2022QIII 3.513 44 Teruel Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 44 Teruel Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 44 Teruel Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel Total Cohort July 1 Total Number at the start of the quarter 2021QIII 3.495 44 Teruel Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 44 Teruel Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 44 Teruel Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel Total Cohort July 1 Total Number at the start of the quarter 2020QIII 3.466 44 Teruel Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 44 Teruel Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 44 Teruel Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 44 Teruel Total Cohort July 1 Total Survival in the first trimester 2022QIII 3.310 44 Teruel Total Cohort July 1 Total Survival in the first trimester 2022QII "" 44 Teruel Total Cohort July 1 Total Survival in the first trimester 2022QI "" 44 Teruel Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 44 Teruel Total Cohort July 1 Total Survival in the first trimester 2021QIII 3.319 44 Teruel Total Cohort July 1 Total Survival in the first trimester 2021QII "" 44 Teruel Total Cohort July 1 Total Survival in the first trimester 2021QI "" 44 Teruel Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 44 Teruel Total Cohort July 1 Total Survival in the first trimester 2020QIII 3.318 44 Teruel Total Cohort July 1 Total Survival in the first trimester 2020QII "" 44 Teruel Total Cohort July 1 Total Survival in the first trimester 2020QI "" 44 Teruel Total Cohort July 1 Total Survival in the second trimester 2022QIV 3.166 44 Teruel Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 44 Teruel Total Cohort July 1 Total Survival in the second trimester 2022QII "" 44 Teruel Total Cohort July 1 Total Survival in the second trimester 2022QI "" 44 Teruel Total Cohort July 1 Total Survival in the second trimester 2021QIV 3.206 44 Teruel Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 44 Teruel Total Cohort July 1 Total Survival in the second trimester 2021QII "" 44 Teruel Total Cohort July 1 Total Survival in the second trimester 2021QI "" 44 Teruel Total Cohort July 1 Total Survival in the second trimester 2020QIV 3.187 44 Teruel Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 44 Teruel Total Cohort July 1 Total Survival in the second trimester 2020QII "" 44 Teruel Total Cohort July 1 Total Survival in the second trimester 2020QI "" 44 Teruel Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 44 Teruel Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 44 Teruel Total Cohort July 1 Total Survival in the third trimester 2022QII "" 44 Teruel Total Cohort July 1 Total Survival in the third trimester 2022QI 3.076 44 Teruel Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 44 Teruel Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 44 Teruel Total Cohort July 1 Total Survival in the third trimester 2021QII "" 44 Teruel Total Cohort July 1 Total Survival in the third trimester 2021QI 3.058 44 Teruel Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 44 Teruel Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 44 Teruel Total Cohort July 1 Total Survival in the third trimester 2020QII "" 44 Teruel Total Cohort July 1 Total Survival in the third trimester 2020QI "" 44 Teruel Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 44 Teruel Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 44 Teruel Total Cohort July 1 Total Survival in the third trimester 2022QII 3.000 44 Teruel Total Cohort July 1 Total Survival in the third trimester 2022QI "" 44 Teruel Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 44 Teruel Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 44 Teruel Total Cohort July 1 Total Survival in the third trimester 2021QII 3.004 44 Teruel Total Cohort July 1 Total Survival in the third trimester 2021QI "" 44 Teruel Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 44 Teruel Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 44 Teruel Total Cohort July 1 Total Survival in the third trimester 2020QII "" 44 Teruel Total Cohort July 1 Total Survival in the third trimester 2020QI "" 44 Teruel Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 44 Teruel Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 44 Teruel Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 44 Teruel Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 44 Teruel Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 44 Teruel Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 44 Teruel Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 44 Teruel Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 44 Teruel Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,22 44 Teruel Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,96 44 Teruel Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,73 44 Teruel Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 90,12 44 Teruel Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 91,73 44 Teruel Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 91,95 44 Teruel Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 88,01 44 Teruel Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 88,23 44 Teruel Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 85,84 44 Teruel Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 86,67 44 Teruel Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 44 Teruel Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 44 Teruel Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 3.488 44 Teruel Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 3.436 44 Teruel Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 3.112 44 Teruel Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 3.285 44 Teruel Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 3.262 44 Teruel Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.972 44 Teruel Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 3.141 44 Teruel Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 3.151 44 Teruel Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.852 44 Teruel Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 3.022 44 Teruel Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.732 44 Teruel Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.948 44 Teruel Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.688 44 Teruel Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 44 Teruel Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 44 Teruel Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 44 Teruel Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,18 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,94 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,5 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 90,05 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 91,71 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 91,65 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 87,95 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 87,79 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 85,8 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 86,38 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 25 44 Teruel Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 59 44 Teruel Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 354 44 Teruel Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 25 44 Teruel Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 57 44 Teruel Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 346 44 Teruel Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 25 44 Teruel Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 55 44 Teruel Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 335 44 Teruel Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 54 44 Teruel Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 326 44 Teruel Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 52 44 Teruel Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 316 44 Teruel Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 44 Teruel Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 44 Teruel Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 44 Teruel Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,61 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,74 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,22 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,63 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 91,53 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 92,09 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 88,14 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 89,27 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel Total Cohort October 1 Total Number at the start of the quarter 2022QIV 3.469 44 Teruel Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 44 Teruel Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 44 Teruel Total Cohort October 1 Total Number at the start of the quarter 2021QIV 3.474 44 Teruel Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 44 Teruel Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 44 Teruel Total Cohort October 1 Total Number at the start of the quarter 2020QIV 3.477 44 Teruel Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 44 Teruel Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 44 Teruel Total Cohort October 1 Total Survival in the first trimester 2022QIV 3.287 44 Teruel Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 44 Teruel Total Cohort October 1 Total Survival in the first trimester 2022QII "" 44 Teruel Total Cohort October 1 Total Survival in the first trimester 2022QI "" 44 Teruel Total Cohort October 1 Total Survival in the first trimester 2021QIV 3.326 44 Teruel Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 44 Teruel Total Cohort October 1 Total Survival in the first trimester 2021QII "" 44 Teruel Total Cohort October 1 Total Survival in the first trimester 2021QI "" 44 Teruel Total Cohort October 1 Total Survival in the first trimester 2020QIV 3.294 44 Teruel Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 44 Teruel Total Cohort October 1 Total Survival in the first trimester 2020QII "" 44 Teruel Total Cohort October 1 Total Survival in the first trimester 2020QI "" 44 Teruel Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 44 Teruel Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 44 Teruel Total Cohort October 1 Total Survival in the second trimester 2022QII "" 44 Teruel Total Cohort October 1 Total Survival in the second trimester 2022QI 3.176 44 Teruel Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 44 Teruel Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 44 Teruel Total Cohort October 1 Total Survival in the second trimester 2021QII "" 44 Teruel Total Cohort October 1 Total Survival in the second trimester 2021QI 3.146 44 Teruel Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 44 Teruel Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 44 Teruel Total Cohort October 1 Total Survival in the second trimester 2020QII "" 44 Teruel Total Cohort October 1 Total Survival in the second trimester 2020QI "" 44 Teruel Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 44 Teruel Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 44 Teruel Total Cohort October 1 Total Survival in the third trimester 2022QII 3.080 44 Teruel Total Cohort October 1 Total Survival in the third trimester 2022QI "" 44 Teruel Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 44 Teruel Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 44 Teruel Total Cohort October 1 Total Survival in the third trimester 2021QII 3.081 44 Teruel Total Cohort October 1 Total Survival in the third trimester 2021QI "" 44 Teruel Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 44 Teruel Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 44 Teruel Total Cohort October 1 Total Survival in the third trimester 2020QII "" 44 Teruel Total Cohort October 1 Total Survival in the third trimester 2020QI "" 44 Teruel Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 44 Teruel Total Cohort October 1 Total Survival in the third trimester 2022QIII 2.995 44 Teruel Total Cohort October 1 Total Survival in the third trimester 2022QII "" 44 Teruel Total Cohort October 1 Total Survival in the third trimester 2022QI "" 44 Teruel Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 44 Teruel Total Cohort October 1 Total Survival in the third trimester 2021QIII 3.011 44 Teruel Total Cohort October 1 Total Survival in the third trimester 2021QII "" 44 Teruel Total Cohort October 1 Total Survival in the third trimester 2021QI "" 44 Teruel Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 44 Teruel Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 44 Teruel Total Cohort October 1 Total Survival in the third trimester 2020QII "" 44 Teruel Total Cohort October 1 Total Survival in the third trimester 2020QI "" 44 Teruel Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 44 Teruel Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 44 Teruel Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 44 Teruel Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 44 Teruel Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 44 Teruel Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 44 Teruel Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 44 Teruel Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 44 Teruel Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,75 44 Teruel Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,74 44 Teruel Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,74 44 Teruel Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 91,42 44 Teruel Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,48 44 Teruel Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 88,66 44 Teruel Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 88,61 44 Teruel Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 86,21 44 Teruel Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 86,6 44 Teruel Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 44 Teruel Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 44 Teruel Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 3.447 44 Teruel Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3.388 44 Teruel Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 3.107 44 Teruel Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 3.265 44 Teruel Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 3.242 44 Teruel Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2.936 44 Teruel Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 3.096 44 Teruel Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.800 44 Teruel Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 3.004 44 Teruel Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2.742 44 Teruel Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.919 44 Teruel Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.681 44 Teruel Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 44 Teruel Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 44 Teruel Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 44 Teruel Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,72 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,69 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,5 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 91,38 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 90,12 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 88,67 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 88,25 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 86,16 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 86,29 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 22 44 Teruel Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 86 44 Teruel Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 370 44 Teruel Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 22 44 Teruel Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 84 44 Teruel Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 358 44 Teruel Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 80 44 Teruel Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 346 44 Teruel Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 76 44 Teruel Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 339 44 Teruel Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 76 44 Teruel Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 330 44 Teruel Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 44 Teruel Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 44 Teruel Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 44 Teruel Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,67 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,76 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,02 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 93,51 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 88,37 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 91,62 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 88,37 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 89,19 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 44 Teruel From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 2.735 44 Teruel From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 44 Teruel From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 2.682 44 Teruel From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 2.845 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 2.549 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 2.509 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 2.534 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 2.420 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 2.426 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 2.417 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 2.319 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 2.350 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 2.329 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 2.228 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 2.291 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 2.258 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 44 Teruel From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 44 Teruel From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 44 Teruel From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 44 Teruel From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,2 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,55 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 89,07 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,48 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,45 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 84,96 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 84,79 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,62 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 81,86 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 81,46 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,42 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 79,37 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.674 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.500 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.488 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2.338 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.364 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.262 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.266 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.193 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.176 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2.136 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,04 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,52 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,41 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,48 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 84,74 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,72 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 81,38 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,44 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 61 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 182 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 61 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 171 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 56 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 164 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 53 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 157 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 52 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 155 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 93,96 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 91,8 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 90,11 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 86,89 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 86,26 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 85,25 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 85,16 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 2.662 44 Teruel From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 2.624 44 Teruel From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 2.692 44 Teruel From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 2.515 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 2.516 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 2.561 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 2.398 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 2.430 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 2.455 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 2.296 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 2.362 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 2.368 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 2.262 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 2.253 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 44 Teruel From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 44 Teruel From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 44 Teruel From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 44 Teruel From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,48 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,88 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,13 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,08 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 92,61 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,2 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 86,25 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 90,02 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 87,96 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 86,2 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 83,69 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.599 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.504 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2.266 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.458 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.398 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2.143 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.341 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.318 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2.052 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.240 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.252 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.980 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.155 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.880 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,57 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,77 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,57 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,07 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,57 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,56 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 86,19 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 89,94 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 87,38 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 86,06 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 82,97 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 63 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 120 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 426 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 57 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 118 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 418 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 57 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 112 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 403 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 56 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 110 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 388 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 107 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 373 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 90,48 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,33 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,12 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 90,48 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,33 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,6 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,89 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 91,67 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,08 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 89,17 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 87,56 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 2.702 44 Teruel From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 2.702 44 Teruel From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 2.724 44 Teruel From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 2.509 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 2.530 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 2.582 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 2.373 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 2.424 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 2.455 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 2.308 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 2.331 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 2.235 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 2.282 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 44 Teruel From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 44 Teruel From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 44 Teruel From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,86 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 93,63 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,79 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 87,82 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,71 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,12 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 85,42 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 85,57 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 82,72 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 83,77 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.682 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.665 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2.508 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.489 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.495 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.372 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.353 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.391 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.255 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.276 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.139 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.205 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.099 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,8 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,62 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,58 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,73 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,72 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,91 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 85,4 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 85,29 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 82,74 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 83,69 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 20 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 37 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 216 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 20 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 35 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 210 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 20 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 33 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 200 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 32 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 192 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 30 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 183 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 94,59 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,22 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 89,19 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 92,59 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 86,49 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 88,89 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 81,08 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 84,72 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 2.671 44 Teruel From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 2.689 44 Teruel From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 2.716 44 Teruel From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 2.497 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 2.546 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 2.538 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 2.407 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 2.395 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 2.315 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 2.336 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 2.237 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 2.271 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 44 Teruel From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 44 Teruel From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 44 Teruel From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,49 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,68 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,45 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,51 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 88,18 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 86,09 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 86,01 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 83,19 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 83,62 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.652 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.630 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2.508 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.478 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.489 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2.342 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.352 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.210 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.264 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2.155 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.186 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.099 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,44 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,64 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,38 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,43 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88,12 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 86,08 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 85,93 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 83,12 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 83,69 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 19 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 59 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 208 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 19 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 57 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 196 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 55 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 185 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 51 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 181 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 51 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 172 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,61 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 94,23 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,22 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 88,94 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 86,44 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 87,02 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 86,44 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 82,69 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 349 44 Teruel From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 345 44 Teruel From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 358 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 344 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 343 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 352 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 342 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 340 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 350 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 339 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 338 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 348 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 337 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 337 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 345 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 44 Teruel From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 44 Teruel From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,57 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,42 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,32 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,99 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,55 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,77 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,13 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,97 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,21 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,56 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,68 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,37 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 346 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 297 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 341 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 295 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 339 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 292 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 336 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 290 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 334 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 289 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,55 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,33 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,98 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,32 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,11 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,64 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,53 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,31 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 3 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 48 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 3 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 48 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 3 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 48 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 3 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 48 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 3 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 48 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 367 44 Teruel From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 330 44 Teruel From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 348 44 Teruel From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 361 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 326 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 344 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 357 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 324 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 343 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 352 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 320 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 339 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 316 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 334 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 44 Teruel From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 44 Teruel From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 44 Teruel From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,37 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,79 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,85 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,28 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,18 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,56 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,91 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,97 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,41 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 95,76 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,98 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 361 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 301 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 242 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 355 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 297 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 239 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 351 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 295 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 239 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 346 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 292 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 237 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 289 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 234 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,34 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,67 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,76 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,23 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,01 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,76 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,84 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,01 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,93 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,01 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,69 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 6 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 29 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 106 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 6 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 29 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 105 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 6 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 29 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 104 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 6 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 28 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 102 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 27 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 100 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,06 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,11 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,55 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,23 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 93,1 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,34 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 353 44 Teruel From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 362 44 Teruel From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 340 44 Teruel From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 346 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 359 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 338 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 343 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 354 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 334 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 347 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 330 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 345 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 325 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 44 Teruel From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 44 Teruel From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 44 Teruel From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,02 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,17 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,41 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,17 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,79 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,24 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,86 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,06 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,3 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,59 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 351 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 356 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 286 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 344 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 353 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 285 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 341 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 348 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 282 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 341 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 279 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 339 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 275 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,01 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,16 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,65 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,15 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,75 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,6 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,79 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,55 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,22 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,15 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 2 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 6 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 54 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 2 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 6 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 53 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 2 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 6 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 52 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 6 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 51 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 6 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 50 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,15 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,3 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,44 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,59 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 355 44 Teruel From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 345 44 Teruel From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 354 44 Teruel From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 351 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 342 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 350 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 338 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 347 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 336 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 341 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 331 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 337 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 44 Teruel From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 44 Teruel From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 44 Teruel From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,87 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,13 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,87 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,97 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,02 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,39 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,33 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,94 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,2 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 354 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 337 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 289 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 350 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 334 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 285 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 330 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 283 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 328 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 280 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 323 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 276 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,87 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,11 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,62 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,92 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,92 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,33 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,89 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,85 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,5 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 8 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 65 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 8 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 65 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 8 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 64 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 8 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 61 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 8 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 61 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,46 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,85 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,85 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 44 Teruel From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 422 44 Teruel From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 44 Teruel From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 379 44 Teruel From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 402 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 408 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 376 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 393 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 404 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 374 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 391 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 400 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 373 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 383 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 396 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 370 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 381 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 44 Teruel From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 44 Teruel From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 44 Teruel From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 44 Teruel From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 96,68 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,21 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,76 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 95,73 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,68 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,26 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,79 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,42 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,27 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,84 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,63 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,78 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 411 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 303 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 397 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 300 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 393 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 298 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 389 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 297 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 385 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 295 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 96,59 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,01 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 95,62 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,35 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,65 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,02 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,67 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,36 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 11 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 76 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 11 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 76 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 11 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 76 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 11 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 76 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 11 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 75 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,68 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 416 44 Teruel From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 396 44 Teruel From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 377 44 Teruel From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 413 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 393 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 373 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 409 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 391 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 368 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 405 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 389 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 368 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 382 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 367 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 44 Teruel From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 44 Teruel From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 44 Teruel From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 44 Teruel From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,28 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,24 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,94 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,32 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,74 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,61 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,36 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,23 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,61 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,46 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,35 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 401 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 336 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 257 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 398 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 333 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 253 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 394 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 331 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 248 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 390 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 329 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 248 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 325 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 247 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,25 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,11 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,44 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,25 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,51 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 96,5 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,26 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,92 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,5 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,73 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,11 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 15 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 60 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 120 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 15 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 60 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 120 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 15 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 60 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 120 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 15 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 60 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 120 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 57 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 120 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 95 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 437 44 Teruel From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 412 44 Teruel From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 384 44 Teruel From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 434 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 411 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 380 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 429 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 409 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 380 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 402 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 379 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 401 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 379 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 44 Teruel From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 44 Teruel From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 44 Teruel From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,31 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,76 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,96 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,17 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,27 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,96 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,57 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,7 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,33 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 98,7 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 435 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 397 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 304 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 432 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 396 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 301 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 427 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 394 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 301 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 387 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 300 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 386 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 300 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,31 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,75 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,01 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,16 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 99,24 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 99,01 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,48 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,68 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,23 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 98,68 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 2 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 15 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 80 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 2 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 15 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 79 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 2 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 15 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 79 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 15 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 79 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 15 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 79 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,75 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,75 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,75 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,75 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 421 44 Teruel From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 420 44 Teruel From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 388 44 Teruel From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 417 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 418 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 387 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 411 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 385 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 409 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 385 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 407 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 384 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 44 Teruel From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 44 Teruel From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 44 Teruel From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,05 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,52 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,74 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,86 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 99,23 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,38 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 99,23 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,9 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,97 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 419 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 403 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 295 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 415 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 401 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 294 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 396 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 292 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 394 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 292 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 392 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 291 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,05 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,5 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,66 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,26 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,98 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,77 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,98 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,27 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,64 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 2 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 17 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 93 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 2 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 17 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 93 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 15 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 93 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 15 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 93 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 15 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 93 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 88,24 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 88,24 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 88,24 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 44 Teruel from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 14 44 Teruel from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 44 Teruel from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 13 44 Teruel from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 14 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 14 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 13 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 14 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 14 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 13 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 14 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 14 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 13 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 14 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 14 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 13 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 14 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 44 Teruel from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 44 Teruel from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 44 Teruel from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 44 Teruel from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 13 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 10 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 13 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 10 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 13 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 10 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 13 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 10 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 13 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 10 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 3 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 3 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 3 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 3 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 3 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 13 44 Teruel from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 13 44 Teruel from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 15 44 Teruel from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 13 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 13 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 15 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 13 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 13 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 15 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 13 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 13 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 15 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 13 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 15 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 44 Teruel from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 44 Teruel from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 44 Teruel from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 44 Teruel from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 44 Teruel from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 12 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 10 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 10 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 12 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 10 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 10 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 12 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 10 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 10 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 12 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 10 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 10 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 10 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 10 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 3 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 5 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 3 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 5 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 3 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 5 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 3 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 5 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 3 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 5 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 16 44 Teruel from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 14 44 Teruel from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 13 44 Teruel from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 16 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 14 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 13 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 16 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 14 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 13 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 14 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 13 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 14 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 13 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 44 Teruel from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 44 Teruel from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 44 Teruel from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 15 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 13 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 12 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 15 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 13 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 12 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 15 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 13 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 12 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 13 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 12 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 13 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 12 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 17 44 Teruel from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 15 44 Teruel from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 14 44 Teruel from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 17 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 15 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 14 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 15 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 14 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 15 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 14 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 15 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 14 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 44 Teruel from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 44 Teruel from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 44 Teruel from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 17 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 15 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 12 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 17 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 15 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 12 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 15 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 12 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 15 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 12 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 15 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 12 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 0 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 2 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 0 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 0 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 0 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 0 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV .. 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV .. 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI .. 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII .. 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII .. 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 44 Teruel De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 5 44 Teruel De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 44 Teruel De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 5 44 Teruel De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 44 Teruel De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 5 44 Teruel De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 5 44 Teruel De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 5 44 Teruel De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 5 44 Teruel De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 5 44 Teruel De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 5 44 Teruel De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 5 44 Teruel De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 5 44 Teruel De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 5 44 Teruel De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 5 44 Teruel De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 5 44 Teruel De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 5 44 Teruel De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 5 44 Teruel De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 44 Teruel De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 44 Teruel De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 44 Teruel De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 44 Teruel De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 44 Teruel De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 44 Teruel De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 44 Teruel De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 44 Teruel De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 4 44 Teruel De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 3 44 Teruel De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 4 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 3 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 4 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 3 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 4 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 3 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 4 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 3 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 44 Teruel De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 44 Teruel De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 1 44 Teruel De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2 44 Teruel De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 1 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 44 Teruel De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 44 Teruel De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 5 44 Teruel De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 44 Teruel De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 5 44 Teruel De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 44 Teruel De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 5 44 Teruel De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 5 44 Teruel De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 5 44 Teruel De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 5 44 Teruel De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 5 44 Teruel De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 5 44 Teruel De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 5 44 Teruel De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 5 44 Teruel De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 5 44 Teruel De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 5 44 Teruel De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 5 44 Teruel De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 5 44 Teruel De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 44 Teruel De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 44 Teruel De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 44 Teruel De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 44 Teruel De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 44 Teruel De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 44 Teruel De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 44 Teruel De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 44 Teruel De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 4 44 Teruel De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 3 44 Teruel De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2 44 Teruel De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 4 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 3 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 4 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 3 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 4 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 3 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 3 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 44 Teruel De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 44 Teruel De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 44 Teruel De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 1 44 Teruel De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 2 44 Teruel De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 3 44 Teruel De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 2 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 3 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 2 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 3 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 2 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 3 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 2 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 3 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 44 Teruel De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 44 Teruel De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 44 Teruel De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 5 44 Teruel De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 44 Teruel De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 44 Teruel De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 5 44 Teruel De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 44 Teruel De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 44 Teruel De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 5 44 Teruel De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 44 Teruel De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 5 44 Teruel De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 5 44 Teruel De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 5 44 Teruel De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 5 44 Teruel De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 5 44 Teruel De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 5 44 Teruel De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 5 44 Teruel De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 5 44 Teruel De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 5 44 Teruel De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 5 44 Teruel De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 44 Teruel De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 44 Teruel De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 44 Teruel De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 44 Teruel De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 44 Teruel De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 44 Teruel De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 44 Teruel De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 44 Teruel De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 44 Teruel De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 44 Teruel De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 44 Teruel De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 44 Teruel De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 44 Teruel De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 44 Teruel De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 5 44 Teruel De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 5 44 Teruel De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2 44 Teruel De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 5 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 5 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 5 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 5 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 5 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 5 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 44 Teruel De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 44 Teruel De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 44 Teruel De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 44 Teruel De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 0 44 Teruel De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 3 44 Teruel De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 0 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 3 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 0 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 3 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 0 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 3 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 0 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 3 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII .. 44 Teruel De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII .. 44 Teruel De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 44 Teruel De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII .. 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII .. 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV .. 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI .. 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII .. 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 5 44 Teruel De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 44 Teruel De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 44 Teruel De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 5 44 Teruel De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 44 Teruel De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 44 Teruel De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 5 44 Teruel De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 44 Teruel De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 5 44 Teruel De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 5 44 Teruel De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 5 44 Teruel De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 5 44 Teruel De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 5 44 Teruel De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 5 44 Teruel De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 5 44 Teruel De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 5 44 Teruel De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 5 44 Teruel De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 44 Teruel De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 44 Teruel De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 44 Teruel De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 44 Teruel De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 44 Teruel De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 44 Teruel De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 44 Teruel De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 44 Teruel De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 44 Teruel De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 44 Teruel De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 44 Teruel De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 44 Teruel De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 44 Teruel De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 5 44 Teruel De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3 44 Teruel De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 3 44 Teruel De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 5 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 3 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 3 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 3 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 3 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 3 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 3 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 3 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 3 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 44 Teruel De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 44 Teruel De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 44 Teruel De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 44 Teruel De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 2 44 Teruel De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 2 44 Teruel De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 2 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 2 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 2 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 2 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 44 Teruel De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 44 Teruel De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 44 Teruel De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 44 Teruel De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 45 Toledo Total Cohort January 1 Total Number at the start of the quarter 2022QI 15.595 45 Toledo Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 45 Toledo Total Cohort January 1 Total Number at the start of the quarter 2021QI 15.016 45 Toledo Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 45 Toledo Total Cohort January 1 Total Number at the start of the quarter 2020QI 15.672 45 Toledo Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 45 Toledo Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 45 Toledo Total Cohort January 1 Total Survival in the first trimester 2022QII "" 45 Toledo Total Cohort January 1 Total Survival in the first trimester 2022QI 14.704 45 Toledo Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 45 Toledo Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 45 Toledo Total Cohort January 1 Total Survival in the first trimester 2021QII "" 45 Toledo Total Cohort January 1 Total Survival in the first trimester 2021QI 14.217 45 Toledo Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 45 Toledo Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 45 Toledo Total Cohort January 1 Total Survival in the first trimester 2020QII "" 45 Toledo Total Cohort January 1 Total Survival in the first trimester 2020QI 13.575 45 Toledo Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 45 Toledo Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 45 Toledo Total Cohort January 1 Total Survival in the second trimester 2022QII 14.089 45 Toledo Total Cohort January 1 Total Survival in the second trimester 2022QI "" 45 Toledo Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 45 Toledo Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 45 Toledo Total Cohort January 1 Total Survival in the second trimester 2021QII 13.726 45 Toledo Total Cohort January 1 Total Survival in the second trimester 2021QI "" 45 Toledo Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 45 Toledo Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 45 Toledo Total Cohort January 1 Total Survival in the second trimester 2020QII 13.153 45 Toledo Total Cohort January 1 Total Survival in the second trimester 2020QI "" 45 Toledo Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 45 Toledo Total Cohort January 1 Total Survival in the third trimester 2022QIII 13.586 45 Toledo Total Cohort January 1 Total Survival in the third trimester 2022QII "" 45 Toledo Total Cohort January 1 Total Survival in the third trimester 2022QI "" 45 Toledo Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 45 Toledo Total Cohort January 1 Total Survival in the third trimester 2021QIII 13.291 45 Toledo Total Cohort January 1 Total Survival in the third trimester 2021QII "" 45 Toledo Total Cohort January 1 Total Survival in the third trimester 2021QI "" 45 Toledo Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 45 Toledo Total Cohort January 1 Total Survival in the third trimester 2020QIII 12.768 45 Toledo Total Cohort January 1 Total Survival in the third trimester 2020QII "" 45 Toledo Total Cohort January 1 Total Survival in the third trimester 2020QI "" 45 Toledo Total Cohort January 1 Total Survival in the third trimester 2022QIV 13.200 45 Toledo Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 45 Toledo Total Cohort January 1 Total Survival in the third trimester 2022QII "" 45 Toledo Total Cohort January 1 Total Survival in the third trimester 2022QI "" 45 Toledo Total Cohort January 1 Total Survival in the third trimester 2021QIV 12.902 45 Toledo Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 45 Toledo Total Cohort January 1 Total Survival in the third trimester 2021QII "" 45 Toledo Total Cohort January 1 Total Survival in the third trimester 2021QI "" 45 Toledo Total Cohort January 1 Total Survival in the third trimester 2020QIV 12.436 45 Toledo Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 45 Toledo Total Cohort January 1 Total Survival in the third trimester 2020QII "" 45 Toledo Total Cohort January 1 Total Survival in the third trimester 2020QI "" 45 Toledo Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 45 Toledo Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 45 Toledo Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 45 Toledo Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 45 Toledo Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 45 Toledo Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 45 Toledo Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,29 45 Toledo Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,68 45 Toledo Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 86,62 45 Toledo Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,34 45 Toledo Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,41 45 Toledo Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 83,93 45 Toledo Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 87,12 45 Toledo Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 88,51 45 Toledo Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 81,47 45 Toledo Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 84,64 45 Toledo Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,92 45 Toledo Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 79,35 45 Toledo Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 45 Toledo Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 45 Toledo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 14.839 45 Toledo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 13.175 45 Toledo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 13.983 45 Toledo Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 12.425 45 Toledo Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 13.383 45 Toledo Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 11.968 45 Toledo Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 12.895 45 Toledo Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 11.569 45 Toledo Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 12.526 45 Toledo Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 11.214 45 Toledo Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 45 Toledo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 45 Toledo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,23 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,31 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,19 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,84 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,9 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,81 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 84,41 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,12 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 756 45 Toledo Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.841 45 Toledo Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 721 45 Toledo Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.792 45 Toledo Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 706 45 Toledo Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.758 45 Toledo Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 691 45 Toledo Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.722 45 Toledo Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 674 45 Toledo Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.688 45 Toledo Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 45 Toledo Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 45 Toledo Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,37 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,34 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,39 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,49 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 91,4 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 93,54 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 89,15 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 91,69 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo Total Cohort April 1 Total Number at the start of the quarter 2022QII 15.610 45 Toledo Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 45 Toledo Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo Total Cohort April 1 Total Number at the start of the quarter 2021QII 15.119 45 Toledo Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 45 Toledo Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo Total Cohort April 1 Total Number at the start of the quarter 2020QII 14.181 45 Toledo Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 45 Toledo Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 45 Toledo Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 45 Toledo Total Cohort April 1 Total Survival in the first trimester 2022QII 14.822 45 Toledo Total Cohort April 1 Total Survival in the first trimester 2022QI "" 45 Toledo Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 45 Toledo Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 45 Toledo Total Cohort April 1 Total Survival in the first trimester 2021QII 14.436 45 Toledo Total Cohort April 1 Total Survival in the first trimester 2021QI "" 45 Toledo Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 45 Toledo Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 45 Toledo Total Cohort April 1 Total Survival in the first trimester 2020QII 13.666 45 Toledo Total Cohort April 1 Total Survival in the first trimester 2020QI "" 45 Toledo Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 45 Toledo Total Cohort April 1 Total Survival in the second trimester 2022QIII 14.204 45 Toledo Total Cohort April 1 Total Survival in the second trimester 2022QII "" 45 Toledo Total Cohort April 1 Total Survival in the second trimester 2022QI "" 45 Toledo Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 45 Toledo Total Cohort April 1 Total Survival in the second trimester 2021QIII 13.886 45 Toledo Total Cohort April 1 Total Survival in the second trimester 2021QII "" 45 Toledo Total Cohort April 1 Total Survival in the second trimester 2021QI "" 45 Toledo Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 45 Toledo Total Cohort April 1 Total Survival in the second trimester 2020QIII 13.215 45 Toledo Total Cohort April 1 Total Survival in the second trimester 2020QII "" 45 Toledo Total Cohort April 1 Total Survival in the second trimester 2020QI "" 45 Toledo Total Cohort April 1 Total Survival in the third trimester 2022QIV 13.736 45 Toledo Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 45 Toledo Total Cohort April 1 Total Survival in the third trimester 2022QII "" 45 Toledo Total Cohort April 1 Total Survival in the third trimester 2022QI "" 45 Toledo Total Cohort April 1 Total Survival in the third trimester 2021QIV 13.401 45 Toledo Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 45 Toledo Total Cohort April 1 Total Survival in the third trimester 2021QII "" 45 Toledo Total Cohort April 1 Total Survival in the third trimester 2021QI "" 45 Toledo Total Cohort April 1 Total Survival in the third trimester 2020QIV 12.837 45 Toledo Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 45 Toledo Total Cohort April 1 Total Survival in the third trimester 2020QII "" 45 Toledo Total Cohort April 1 Total Survival in the third trimester 2020QI "" 45 Toledo Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 45 Toledo Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 45 Toledo Total Cohort April 1 Total Survival in the third trimester 2022QII "" 45 Toledo Total Cohort April 1 Total Survival in the third trimester 2022QI 12.912 45 Toledo Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 45 Toledo Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 45 Toledo Total Cohort April 1 Total Survival in the third trimester 2021QII "" 45 Toledo Total Cohort April 1 Total Survival in the third trimester 2021QI 12.398 45 Toledo Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 45 Toledo Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 45 Toledo Total Cohort April 1 Total Survival in the third trimester 2020QII "" 45 Toledo Total Cohort April 1 Total Survival in the third trimester 2020QI "" 45 Toledo Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 45 Toledo Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 45 Toledo Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 45 Toledo Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 45 Toledo Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 45 Toledo Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,95 45 Toledo Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,48 45 Toledo Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,37 45 Toledo Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,99 45 Toledo Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,84 45 Toledo Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,19 45 Toledo Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,99 45 Toledo Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 88,64 45 Toledo Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,52 45 Toledo Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 85,4 45 Toledo Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87,43 45 Toledo Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 45 Toledo Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 45 Toledo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 14.866 45 Toledo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 13.240 45 Toledo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 10.823 45 Toledo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 14.102 45 Toledo Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 12.595 45 Toledo Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 10.335 45 Toledo Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 13.501 45 Toledo Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 12.087 45 Toledo Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 9.959 45 Toledo Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 13.053 45 Toledo Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 11.635 45 Toledo Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 9.643 45 Toledo Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 11.197 45 Toledo Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 9.300 45 Toledo Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 45 Toledo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 45 Toledo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 45 Toledo Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,86 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,13 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,49 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,82 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,29 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,02 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,8 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 87,88 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 89,1 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 84,57 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 85,93 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 744 45 Toledo Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.879 45 Toledo Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 3.358 45 Toledo Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 720 45 Toledo Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.841 45 Toledo Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 3.331 45 Toledo Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 703 45 Toledo Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.799 45 Toledo Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 3.256 45 Toledo Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 683 45 Toledo Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.766 45 Toledo Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 3.194 45 Toledo Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.715 45 Toledo Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 3.098 45 Toledo Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 45 Toledo Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 45 Toledo Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 45 Toledo Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,77 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,98 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,2 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,49 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,74 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,96 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,8 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,99 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,12 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 91,27 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 92,26 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo Total Cohort July 1 Total Number at the start of the quarter 2022QIII 15.785 45 Toledo Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 45 Toledo Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 45 Toledo Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo Total Cohort July 1 Total Number at the start of the quarter 2021QIII 15.588 45 Toledo Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 45 Toledo Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 45 Toledo Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo Total Cohort July 1 Total Number at the start of the quarter 2020QIII 14.915 45 Toledo Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 45 Toledo Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 45 Toledo Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 45 Toledo Total Cohort July 1 Total Survival in the first trimester 2022QIII 14.851 45 Toledo Total Cohort July 1 Total Survival in the first trimester 2022QII "" 45 Toledo Total Cohort July 1 Total Survival in the first trimester 2022QI "" 45 Toledo Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 45 Toledo Total Cohort July 1 Total Survival in the first trimester 2021QIII 14.668 45 Toledo Total Cohort July 1 Total Survival in the first trimester 2021QII "" 45 Toledo Total Cohort July 1 Total Survival in the first trimester 2021QI "" 45 Toledo Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 45 Toledo Total Cohort July 1 Total Survival in the first trimester 2020QIII 14.113 45 Toledo Total Cohort July 1 Total Survival in the first trimester 2020QII "" 45 Toledo Total Cohort July 1 Total Survival in the first trimester 2020QI "" 45 Toledo Total Cohort July 1 Total Survival in the second trimester 2022QIV 14.247 45 Toledo Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 45 Toledo Total Cohort July 1 Total Survival in the second trimester 2022QII "" 45 Toledo Total Cohort July 1 Total Survival in the second trimester 2022QI "" 45 Toledo Total Cohort July 1 Total Survival in the second trimester 2021QIV 14.023 45 Toledo Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 45 Toledo Total Cohort July 1 Total Survival in the second trimester 2021QII "" 45 Toledo Total Cohort July 1 Total Survival in the second trimester 2021QI "" 45 Toledo Total Cohort July 1 Total Survival in the second trimester 2020QIV 13.564 45 Toledo Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 45 Toledo Total Cohort July 1 Total Survival in the second trimester 2020QII "" 45 Toledo Total Cohort July 1 Total Survival in the second trimester 2020QI "" 45 Toledo Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 45 Toledo Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 45 Toledo Total Cohort July 1 Total Survival in the third trimester 2022QII "" 45 Toledo Total Cohort July 1 Total Survival in the third trimester 2022QI 13.457 45 Toledo Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 45 Toledo Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 45 Toledo Total Cohort July 1 Total Survival in the third trimester 2021QII "" 45 Toledo Total Cohort July 1 Total Survival in the third trimester 2021QI 13.048 45 Toledo Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 45 Toledo Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 45 Toledo Total Cohort July 1 Total Survival in the third trimester 2020QII "" 45 Toledo Total Cohort July 1 Total Survival in the third trimester 2020QI "" 45 Toledo Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 45 Toledo Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 45 Toledo Total Cohort July 1 Total Survival in the third trimester 2022QII 13.085 45 Toledo Total Cohort July 1 Total Survival in the third trimester 2022QI "" 45 Toledo Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 45 Toledo Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 45 Toledo Total Cohort July 1 Total Survival in the third trimester 2021QII 12.752 45 Toledo Total Cohort July 1 Total Survival in the third trimester 2021QI "" 45 Toledo Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 45 Toledo Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 45 Toledo Total Cohort July 1 Total Survival in the third trimester 2020QII "" 45 Toledo Total Cohort July 1 Total Survival in the third trimester 2020QI "" 45 Toledo Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 45 Toledo Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 45 Toledo Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 45 Toledo Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 45 Toledo Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 45 Toledo Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 45 Toledo Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 45 Toledo Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 45 Toledo Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,08 45 Toledo Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,1 45 Toledo Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,62 45 Toledo Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 90,26 45 Toledo Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,96 45 Toledo Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,94 45 Toledo Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 86,33 45 Toledo Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 87,48 45 Toledo Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 83,94 45 Toledo Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 85,5 45 Toledo Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 45 Toledo Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 45 Toledo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 15.540 45 Toledo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 14.942 45 Toledo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 12.759 45 Toledo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 14.616 45 Toledo Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 14.037 45 Toledo Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 11.999 45 Toledo Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 14.018 45 Toledo Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 13.406 45 Toledo Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 11.493 45 Toledo Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 12.859 45 Toledo Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 11.032 45 Toledo Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 12.500 45 Toledo Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 10.772 45 Toledo Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 45 Toledo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 45 Toledo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 45 Toledo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,05 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 93,94 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,04 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 90,21 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,72 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,08 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 86,06 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,46 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 83,66 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 84,43 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 245 45 Toledo Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 646 45 Toledo Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2.156 45 Toledo Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 235 45 Toledo Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 631 45 Toledo Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2.114 45 Toledo Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 229 45 Toledo Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 617 45 Toledo Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 2.071 45 Toledo Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 598 45 Toledo Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2.016 45 Toledo Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 585 45 Toledo Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.980 45 Toledo Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 45 Toledo Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 45 Toledo Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 45 Toledo Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,92 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,68 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,05 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,47 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,51 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,06 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 92,57 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,51 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 90,56 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,84 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo Total Cohort October 1 Total Number at the start of the quarter 2022QIV 15.581 45 Toledo Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 45 Toledo Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 45 Toledo Total Cohort October 1 Total Number at the start of the quarter 2021QIV 15.507 45 Toledo Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 45 Toledo Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 45 Toledo Total Cohort October 1 Total Number at the start of the quarter 2020QIV 14.974 45 Toledo Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 45 Toledo Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 45 Toledo Total Cohort October 1 Total Survival in the first trimester 2022QIV 14.787 45 Toledo Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 45 Toledo Total Cohort October 1 Total Survival in the first trimester 2022QII "" 45 Toledo Total Cohort October 1 Total Survival in the first trimester 2022QI "" 45 Toledo Total Cohort October 1 Total Survival in the first trimester 2021QIV 14.638 45 Toledo Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 45 Toledo Total Cohort October 1 Total Survival in the first trimester 2021QII "" 45 Toledo Total Cohort October 1 Total Survival in the first trimester 2021QI "" 45 Toledo Total Cohort October 1 Total Survival in the first trimester 2020QIV 14.210 45 Toledo Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 45 Toledo Total Cohort October 1 Total Survival in the first trimester 2020QII "" 45 Toledo Total Cohort October 1 Total Survival in the first trimester 2020QI "" 45 Toledo Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 45 Toledo Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 45 Toledo Total Cohort October 1 Total Survival in the second trimester 2022QII "" 45 Toledo Total Cohort October 1 Total Survival in the second trimester 2022QI 13.982 45 Toledo Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 45 Toledo Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 45 Toledo Total Cohort October 1 Total Survival in the second trimester 2021QII "" 45 Toledo Total Cohort October 1 Total Survival in the second trimester 2021QI 13.590 45 Toledo Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 45 Toledo Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 45 Toledo Total Cohort October 1 Total Survival in the second trimester 2020QII "" 45 Toledo Total Cohort October 1 Total Survival in the second trimester 2020QI "" 45 Toledo Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 45 Toledo Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 45 Toledo Total Cohort October 1 Total Survival in the third trimester 2022QII 13.526 45 Toledo Total Cohort October 1 Total Survival in the third trimester 2022QI "" 45 Toledo Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 45 Toledo Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 45 Toledo Total Cohort October 1 Total Survival in the third trimester 2021QII 13.217 45 Toledo Total Cohort October 1 Total Survival in the third trimester 2021QI "" 45 Toledo Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 45 Toledo Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 45 Toledo Total Cohort October 1 Total Survival in the third trimester 2020QII "" 45 Toledo Total Cohort October 1 Total Survival in the third trimester 2020QI "" 45 Toledo Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 45 Toledo Total Cohort October 1 Total Survival in the third trimester 2022QIII 13.126 45 Toledo Total Cohort October 1 Total Survival in the third trimester 2022QII "" 45 Toledo Total Cohort October 1 Total Survival in the third trimester 2022QI "" 45 Toledo Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 45 Toledo Total Cohort October 1 Total Survival in the third trimester 2021QIII 12.860 45 Toledo Total Cohort October 1 Total Survival in the third trimester 2021QII "" 45 Toledo Total Cohort October 1 Total Survival in the third trimester 2021QI "" 45 Toledo Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 45 Toledo Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 45 Toledo Total Cohort October 1 Total Survival in the third trimester 2020QII "" 45 Toledo Total Cohort October 1 Total Survival in the third trimester 2020QI "" 45 Toledo Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 45 Toledo Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 45 Toledo Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 45 Toledo Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 45 Toledo Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 45 Toledo Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 45 Toledo Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 45 Toledo Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 45 Toledo Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,9 45 Toledo Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,4 45 Toledo Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,9 45 Toledo Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,17 45 Toledo Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,76 45 Toledo Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,23 45 Toledo Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 88,27 45 Toledo Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 84,65 45 Toledo Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 85,88 45 Toledo Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 45 Toledo Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 45 Toledo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 15.376 45 Toledo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 14.675 45 Toledo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 12.852 45 Toledo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 14.587 45 Toledo Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 13.830 45 Toledo Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 12.139 45 Toledo Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 13.216 45 Toledo Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 11.570 45 Toledo Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 12.785 45 Toledo Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 11.234 45 Toledo Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 12.403 45 Toledo Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 10.913 45 Toledo Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 45 Toledo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 45 Toledo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 45 Toledo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,87 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,24 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,45 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,06 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 90,02 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 87,12 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 87,41 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 84,52 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 84,91 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 205 45 Toledo Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 832 45 Toledo Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 2.122 45 Toledo Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 200 45 Toledo Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 808 45 Toledo Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2.071 45 Toledo Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 766 45 Toledo Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2.020 45 Toledo Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 741 45 Toledo Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.983 45 Toledo Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 723 45 Toledo Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.947 45 Toledo Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 45 Toledo Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 45 Toledo Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 45 Toledo Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,56 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,12 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,6 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 92,07 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,19 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 89,06 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,45 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 86,9 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 91,75 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 45 Toledo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 11.797 45 Toledo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 45 Toledo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 11.476 45 Toledo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 11.859 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 10.959 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 10.729 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 9.900 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 10.406 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 10.269 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 9.517 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 9.942 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 9.865 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 9.169 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 9.591 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 9.512 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 8.877 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 45 Toledo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 45 Toledo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 45 Toledo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 45 Toledo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 92,9 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,49 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 83,48 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 88,21 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 89,48 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 80,25 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 84,28 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 85,96 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 77,32 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 81,3 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 82,89 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 74,85 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 11.326 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 10.481 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 10.520 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 9.771 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 9.979 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 9.341 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 9.527 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 8.966 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 9.192 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 8.638 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,88 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,23 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,11 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,12 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 84,12 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 85,55 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 81,16 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 82,42 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 471 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 995 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 439 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 958 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 427 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 928 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 415 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 899 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 399 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 874 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 93,21 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,28 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,66 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 93,27 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 88,11 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 90,35 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 84,71 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 87,84 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 11.796 45 Toledo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 11.586 45 Toledo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 10.805 45 Toledo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 11.065 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 10.939 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 10.310 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 10.488 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 10.422 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 9.884 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 10.047 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 9.974 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 9.535 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 9.532 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 9.142 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 45 Toledo From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 45 Toledo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 45 Toledo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 45 Toledo From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,8 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,42 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,42 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 88,91 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 89,95 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,48 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 85,17 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 86,09 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,25 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 82,27 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 84,61 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 11.345 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 10.532 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 8.719 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 10.633 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 9.919 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 8.248 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 10.071 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 9.436 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 7.886 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 9.649 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 9.013 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 7.587 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 8.616 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 7.269 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,72 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,18 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,6 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 88,77 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,59 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,45 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 85,05 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 85,58 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 87,02 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 81,81 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 83,37 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 451 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.054 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.086 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 432 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.020 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.062 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 417 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 986 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.998 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 398 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 961 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.948 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 916 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.873 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,79 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,77 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,85 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 92,46 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,55 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,78 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,25 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 91,18 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,38 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 86,91 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 89,79 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 11.910 45 Toledo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 11.865 45 Toledo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 11.365 45 Toledo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 11.032 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 10.989 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 10.597 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 10.465 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 10.386 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 10.086 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 9.870 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 9.630 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 9.538 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 9.365 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 45 Toledo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 45 Toledo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 45 Toledo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,63 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,62 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 93,24 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 87,87 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 87,53 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 88,75 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 83,19 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 84,73 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 80,39 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 82,4 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 11.717 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 11.494 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 10.210 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 10.848 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 10.630 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 9.479 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 10.287 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 10.039 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 9.001 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 9.537 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 8.584 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 9.216 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 8.345 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,58 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,48 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 92,84 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,8 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 87,34 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 88,16 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 82,97 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 84,07 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 80,18 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 81,73 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 193 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 371 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.155 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 184 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 359 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.118 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 178 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 347 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.085 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 333 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.046 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 322 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.020 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,34 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,77 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,8 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 92,23 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,53 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,94 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 89,76 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 90,56 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 86,79 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 88,31 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 11.760 45 Toledo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 11.776 45 Toledo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 11.389 45 Toledo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 11.007 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 10.945 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 10.661 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 10.347 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 10.098 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 9.937 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 9.758 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 9.570 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 9.427 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 45 Toledo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 45 Toledo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 45 Toledo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,6 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 92,94 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,61 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 87,87 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 88,66 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 84,38 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 85,68 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 81,27 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 82,77 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 11.596 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 11.228 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 10.238 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 10.848 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 10.417 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 9.550 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 9.856 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 9.025 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 9.466 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 8.715 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 9.116 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 8.412 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,55 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 92,78 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,28 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 87,78 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88,15 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 84,31 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 85,12 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 81,19 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 82,16 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 164 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 548 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.151 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 159 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 528 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.111 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 491 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.073 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 471 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.043 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 454 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.015 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,95 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,35 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,52 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 89,6 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 93,22 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 85,95 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 90,62 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 82,85 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 88,18 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 1.675 45 Toledo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 1.539 45 Toledo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 1.651 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 1.637 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 1.514 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 1.571 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 1.597 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 1.504 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 1.548 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 1.578 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 1.489 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 1.528 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 1.555 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 1.468 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 1.505 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 45 Toledo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 45 Toledo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 97,73 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,38 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 95,15 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 95,34 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,73 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 93,76 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,21 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,75 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 92,55 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 92,84 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,39 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 91,16 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.566 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.218 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.529 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.199 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.491 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.189 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.475 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.178 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.453 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.160 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 97,64 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,44 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 95,21 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,62 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,19 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,72 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 92,78 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,24 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 109 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 321 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 108 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 315 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 106 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 315 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 103 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 311 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 102 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 308 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,08 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,13 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,25 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,13 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 94,5 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,88 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 93,58 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,95 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 1.672 45 Toledo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 1.534 45 Toledo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 1.450 45 Toledo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 1.637 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 1.520 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 1.436 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 1.615 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 1.504 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 1.422 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 1.601 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 1.481 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 1.405 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 1.445 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 1.384 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 45 Toledo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 45 Toledo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 45 Toledo From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,91 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,09 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,03 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,59 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,04 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,07 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,75 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,54 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,9 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,2 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,45 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.544 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.214 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 898 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.511 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.201 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 886 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.490 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.190 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 877 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.477 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.170 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 867 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.138 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 856 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,86 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,93 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,66 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,5 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,02 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,66 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,66 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,38 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,55 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,74 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,32 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 128 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 320 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 552 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 126 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 319 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 550 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 125 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 314 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 545 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 124 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 311 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 538 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 307 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 528 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,44 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,69 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,64 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,66 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,13 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,73 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,88 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,19 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,46 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 95,94 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,65 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 1.679 45 Toledo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 1.646 45 Toledo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 1.542 45 Toledo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 1.647 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 1.623 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 1.526 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 1.623 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 1.595 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 1.501 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 1.564 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 1.473 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 1.541 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 1.461 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 45 Toledo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 45 Toledo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 45 Toledo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,09 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,6 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,96 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,66 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 96,9 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,34 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,02 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,53 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 93,62 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 94,75 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.647 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.534 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.153 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.616 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.511 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.140 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.592 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.484 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.122 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.455 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.101 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.434 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.094 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,12 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,5 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,87 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,66 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 96,74 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,31 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 94,85 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,49 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 93,48 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,88 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 32 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 112 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 389 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 31 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 112 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 386 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 31 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 111 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 379 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 109 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 372 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 107 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 367 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,88 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,23 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 96,88 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,11 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,43 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 97,32 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95,63 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 95,54 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 94,34 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 1.618 45 Toledo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 1.626 45 Toledo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 1.529 45 Toledo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 1.588 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 1.603 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 1.506 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 1.563 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 1.478 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 1.533 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 1.466 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 1.516 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 1.454 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 45 Toledo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 45 Toledo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 45 Toledo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,15 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,59 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,5 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,13 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,66 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 94,28 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 95,88 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 93,23 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,09 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.596 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.515 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.153 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.566 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.493 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.137 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.457 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.116 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.430 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.107 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.414 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.099 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,12 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,55 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,61 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,17 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,79 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 94,39 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,01 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 93,33 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,32 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 22 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 111 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 376 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 22 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 110 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 369 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 106 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 362 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 103 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 359 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 102 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 355 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,1 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,14 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 95,5 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,28 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 92,79 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 95,48 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 91,89 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 94,41 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 45 Toledo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 2.014 45 Toledo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 45 Toledo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 1.906 45 Toledo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 2.062 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 2.000 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 1.880 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 2.004 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 1.978 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 1.860 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 1.988 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 1.958 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 1.844 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 1.971 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 1.946 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 1.829 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 1.954 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 45 Toledo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 45 Toledo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 45 Toledo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 45 Toledo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,3 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,64 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,19 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,21 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,59 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,41 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,22 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,75 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,59 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,62 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,96 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,76 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.852 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.407 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.840 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.387 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.819 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.371 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.799 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.358 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.787 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.349 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,35 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,58 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,22 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,44 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,14 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,52 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,49 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,88 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 162 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 499 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 160 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 493 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 159 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 489 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 159 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 486 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 159 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 480 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,77 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,8 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 98,15 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 98,15 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,39 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 98,15 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,19 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 2.032 45 Toledo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 1.900 45 Toledo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 1.831 45 Toledo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 2.010 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 1.879 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 1.825 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 1.991 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 1.862 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 1.814 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 1.978 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 1.848 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 1.802 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 1.838 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 1.778 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 45 Toledo From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 45 Toledo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 45 Toledo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 45 Toledo From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,92 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,89 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,67 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,98 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,07 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,34 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,26 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,42 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,74 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,11 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.879 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.423 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.137 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.860 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.405 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.132 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.842 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.391 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.127 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.829 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.382 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.120 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.374 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.107 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,99 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,74 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,56 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,03 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,75 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,12 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,34 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,12 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,5 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,56 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,36 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 153 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 477 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 694 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 150 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 474 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 693 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 149 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 471 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 687 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 149 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 466 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 682 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 464 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 671 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,04 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,37 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,86 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,39 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,74 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,99 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,39 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,69 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,27 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,27 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,69 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 2.086 45 Toledo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 1.974 45 Toledo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.911 45 Toledo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 2.062 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 1.953 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 1.893 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 2.049 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 1.939 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 1.880 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 1.921 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 1.849 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 1.904 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 1.831 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 45 Toledo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 45 Toledo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 45 Toledo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,85 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,94 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,06 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,23 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,23 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,38 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,32 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,76 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,45 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,81 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.068 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.824 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.330 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.044 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.806 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.314 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.031 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.793 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.304 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.778 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.282 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.761 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.269 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,84 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,01 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,8 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,21 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,3 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,05 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,48 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,39 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,55 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,41 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 18 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 150 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 581 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 18 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 147 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 579 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 18 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 146 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 576 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 143 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 567 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 143 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 562 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,66 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,33 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,14 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,33 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,59 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 95,33 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,73 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 2.084 45 Toledo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 1.998 45 Toledo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.959 45 Toledo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 2.073 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 1.983 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 1.946 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 1.966 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 1.918 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 1.950 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 1.898 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 1.934 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 1.884 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 45 Toledo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 45 Toledo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 45 Toledo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,47 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,25 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,34 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,4 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,91 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,6 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,89 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,8 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,17 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.067 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.837 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.389 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.056 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.825 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.380 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.809 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.358 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.795 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.342 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.779 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.332 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,47 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,35 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,35 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,48 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,77 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,71 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,62 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,84 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,9 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 17 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 161 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 570 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 17 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 158 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 566 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 157 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 560 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 155 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 556 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 155 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 552 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,14 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,3 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 97,52 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,25 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,27 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,54 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96,27 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,84 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 45 Toledo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 74 45 Toledo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 45 Toledo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 62 45 Toledo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 68 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 73 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 61 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 68 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 73 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 60 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 68 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 73 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 60 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 68 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 73 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 60 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 68 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 45 Toledo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 45 Toledo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 45 Toledo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 45 Toledo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,65 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,39 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,65 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,77 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,65 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,77 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,65 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,77 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 63 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 45 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 62 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 44 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 62 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 43 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 62 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 43 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 62 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 43 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,41 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97,78 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,41 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 95,56 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,41 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,56 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,41 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,56 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 11 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 17 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 11 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 17 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 11 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 17 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 11 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 17 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 11 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 17 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 73 45 Toledo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 62 45 Toledo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 64 45 Toledo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 73 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 61 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 64 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 73 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 61 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 64 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 73 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 61 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 64 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 60 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 63 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 45 Toledo from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 45 Toledo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 45 Toledo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 45 Toledo from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,39 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,39 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,39 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,77 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 98,44 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 45 Toledo from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 64 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 45 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 44 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 64 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 44 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 44 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 64 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 44 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 44 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 64 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 44 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 44 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 43 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 43 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 97,78 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,78 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,78 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,56 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,73 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 9 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 17 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 20 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 9 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 17 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 20 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 9 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 17 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 20 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 9 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 17 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 20 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 17 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 20 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 71 45 Toledo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 65 45 Toledo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 66 45 Toledo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 71 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 65 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 66 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 71 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 65 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 66 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 64 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 65 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 64 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 64 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 45 Toledo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 45 Toledo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 45 Toledo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,46 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,48 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,46 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,97 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 69 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 58 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 44 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 69 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 58 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 44 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 69 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 58 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 44 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 57 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 43 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 57 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 42 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,28 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,73 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,28 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,45 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 2 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 7 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 22 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 2 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 7 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 22 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 2 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 7 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 22 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 7 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 22 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 7 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 22 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 82 45 Toledo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 69 45 Toledo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 64 45 Toledo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 82 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 69 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 64 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 68 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 63 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 68 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 62 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 68 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 62 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 45 Toledo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 45 Toledo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 45 Toledo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,55 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,44 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,55 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,88 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,55 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,88 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 80 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 61 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 50 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 80 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 61 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 50 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 60 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 49 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 60 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 48 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 60 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 48 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,36 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,36 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,36 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 2 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 8 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 14 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 2 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 8 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 14 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 8 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 14 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 8 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 14 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 8 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 14 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 45 Toledo De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 35 45 Toledo De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 45 Toledo De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 33 45 Toledo De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 45 Toledo De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 32 45 Toledo De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 35 45 Toledo De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 33 45 Toledo De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 32 45 Toledo De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 35 45 Toledo De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 33 45 Toledo De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 32 45 Toledo De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 35 45 Toledo De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 33 45 Toledo De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 32 45 Toledo De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 35 45 Toledo De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 33 45 Toledo De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 32 45 Toledo De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 45 Toledo De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 45 Toledo De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 45 Toledo De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 45 Toledo De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 45 Toledo De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 45 Toledo De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 45 Toledo De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 45 Toledo De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 32 45 Toledo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 24 45 Toledo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 32 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 24 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 32 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 24 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 32 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 24 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 32 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 24 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 45 Toledo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 45 Toledo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 3 45 Toledo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 9 45 Toledo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 3 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 9 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 3 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 9 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 3 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 9 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 3 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 9 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 45 Toledo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 45 Toledo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 37 45 Toledo De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 45 Toledo De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 37 45 Toledo De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 45 Toledo De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 31 45 Toledo De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 37 45 Toledo De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 37 45 Toledo De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 31 45 Toledo De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 37 45 Toledo De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 37 45 Toledo De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 31 45 Toledo De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 37 45 Toledo De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 37 45 Toledo De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 31 45 Toledo De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 37 45 Toledo De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 31 45 Toledo De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 45 Toledo De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 45 Toledo De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 45 Toledo De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 45 Toledo De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 45 Toledo De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 45 Toledo De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 45 Toledo De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 45 Toledo De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 34 45 Toledo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 26 45 Toledo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 25 45 Toledo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 34 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 26 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 25 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 34 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 26 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 25 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 34 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 26 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 25 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 26 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 25 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 45 Toledo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 45 Toledo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 45 Toledo De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 3 45 Toledo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 11 45 Toledo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 6 45 Toledo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 3 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 11 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 6 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 3 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 11 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 6 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 3 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 11 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 6 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 11 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 6 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 45 Toledo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 45 Toledo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 45 Toledo De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 39 45 Toledo De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 45 Toledo De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 45 Toledo De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 38 45 Toledo De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 45 Toledo De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 45 Toledo De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 31 45 Toledo De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 45 Toledo De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 39 45 Toledo De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 38 45 Toledo De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 31 45 Toledo De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 39 45 Toledo De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 38 45 Toledo De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 31 45 Toledo De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 38 45 Toledo De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 31 45 Toledo De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 38 45 Toledo De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 31 45 Toledo De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 45 Toledo De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 45 Toledo De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 45 Toledo De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 45 Toledo De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 45 Toledo De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 45 Toledo De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 45 Toledo De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 45 Toledo De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 45 Toledo De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 45 Toledo De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 45 Toledo De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 45 Toledo De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 45 Toledo De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 45 Toledo De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 39 45 Toledo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 32 45 Toledo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 22 45 Toledo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 39 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 32 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 22 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 39 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 32 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 22 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 32 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 22 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 32 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 22 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 45 Toledo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 45 Toledo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 45 Toledo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 45 Toledo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 6 45 Toledo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 9 45 Toledo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 6 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 9 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 6 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 9 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 6 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 9 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 6 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 9 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII .. 45 Toledo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 45 Toledo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 45 Toledo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII .. 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 37 45 Toledo De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 45 Toledo De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 45 Toledo De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 38 45 Toledo De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 45 Toledo De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 45 Toledo De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 33 45 Toledo De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 45 Toledo De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 37 45 Toledo De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 38 45 Toledo De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 33 45 Toledo De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 38 45 Toledo De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 33 45 Toledo De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 38 45 Toledo De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 33 45 Toledo De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 38 45 Toledo De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 33 45 Toledo De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 45 Toledo De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 45 Toledo De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 45 Toledo De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 45 Toledo De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 45 Toledo De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 45 Toledo De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 45 Toledo De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 45 Toledo De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 45 Toledo De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 45 Toledo De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 45 Toledo De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 45 Toledo De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 45 Toledo De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 37 45 Toledo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 34 45 Toledo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 22 45 Toledo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 37 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 34 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 22 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 34 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 22 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 34 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 22 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 34 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 22 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 45 Toledo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 45 Toledo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 45 Toledo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 45 Toledo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 4 45 Toledo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 11 45 Toledo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 4 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 11 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 4 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 11 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 4 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 11 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 4 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 11 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 45 Toledo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 45 Toledo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 45 Toledo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 45 Toledo De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València Total Cohort January 1 Total Number at the start of the quarter 2022QI 66.017 46 Valencia/València Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València Total Cohort January 1 Total Number at the start of the quarter 2021QI 64.029 46 Valencia/València Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València Total Cohort January 1 Total Number at the start of the quarter 2020QI 66.014 46 Valencia/València Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 46 Valencia/València Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 46 Valencia/València Total Cohort January 1 Total Survival in the first trimester 2022QII "" 46 Valencia/València Total Cohort January 1 Total Survival in the first trimester 2022QI 62.372 46 Valencia/València Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 46 Valencia/València Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 46 Valencia/València Total Cohort January 1 Total Survival in the first trimester 2021QII "" 46 Valencia/València Total Cohort January 1 Total Survival in the first trimester 2021QI 60.110 46 Valencia/València Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 46 Valencia/València Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 46 Valencia/València Total Cohort January 1 Total Survival in the first trimester 2020QII "" 46 Valencia/València Total Cohort January 1 Total Survival in the first trimester 2020QI 58.474 46 Valencia/València Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 46 Valencia/València Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 46 Valencia/València Total Cohort January 1 Total Survival in the second trimester 2022QII 59.604 46 Valencia/València Total Cohort January 1 Total Survival in the second trimester 2022QI "" 46 Valencia/València Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 46 Valencia/València Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 46 Valencia/València Total Cohort January 1 Total Survival in the second trimester 2021QII 57.754 46 Valencia/València Total Cohort January 1 Total Survival in the second trimester 2021QI "" 46 Valencia/València Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 46 Valencia/València Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 46 Valencia/València Total Cohort January 1 Total Survival in the second trimester 2020QII 56.414 46 Valencia/València Total Cohort January 1 Total Survival in the second trimester 2020QI "" 46 Valencia/València Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València Total Cohort January 1 Total Survival in the third trimester 2022QIII 57.337 46 Valencia/València Total Cohort January 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València Total Cohort January 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València Total Cohort January 1 Total Survival in the third trimester 2021QIII 55.864 46 Valencia/València Total Cohort January 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València Total Cohort January 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València Total Cohort January 1 Total Survival in the third trimester 2020QIII 54.645 46 Valencia/València Total Cohort January 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València Total Cohort January 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València Total Cohort January 1 Total Survival in the third trimester 2022QIV 55.657 46 Valencia/València Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València Total Cohort January 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València Total Cohort January 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València Total Cohort January 1 Total Survival in the third trimester 2021QIV 54.439 46 Valencia/València Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València Total Cohort January 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València Total Cohort January 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València Total Cohort January 1 Total Survival in the third trimester 2020QIV 53.045 46 Valencia/València Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València Total Cohort January 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València Total Cohort January 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 46 Valencia/València Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 46 Valencia/València Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,48 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,88 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 88,58 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 90,29 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,2 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 85,46 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,85 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,25 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 82,78 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 84,31 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,02 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 80,35 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 62.510 46 Valencia/València Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 56.213 46 Valencia/València Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 58.992 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 52.569 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 56.321 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 50.386 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 54.137 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 48.637 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 52.542 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 47.367 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 46 Valencia/València Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 46 Valencia/València Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,37 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,52 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,1 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,63 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,61 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,52 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 84,05 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 84,26 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 3.507 46 Valencia/València Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 7.816 46 Valencia/València Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 3.380 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 7.541 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 3.283 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 7.368 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 3.200 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 7.227 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 3.115 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 7.072 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 46 Valencia/València Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 46 Valencia/València Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,38 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,48 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 93,61 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,27 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 91,25 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,46 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,82 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 90,48 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València Total Cohort April 1 Total Number at the start of the quarter 2022QII 66.036 46 Valencia/València Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València Total Cohort April 1 Total Number at the start of the quarter 2021QII 63.518 46 Valencia/València Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València Total Cohort April 1 Total Number at the start of the quarter 2020QII 61.508 46 Valencia/València Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 46 Valencia/València Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 46 Valencia/València Total Cohort April 1 Total Survival in the first trimester 2022QII 62.597 46 Valencia/València Total Cohort April 1 Total Survival in the first trimester 2022QI "" 46 Valencia/València Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 46 Valencia/València Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 46 Valencia/València Total Cohort April 1 Total Survival in the first trimester 2021QII 60.567 46 Valencia/València Total Cohort April 1 Total Survival in the first trimester 2021QI "" 46 Valencia/València Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 46 Valencia/València Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 46 Valencia/València Total Cohort April 1 Total Survival in the first trimester 2020QII 59.037 46 Valencia/València Total Cohort April 1 Total Survival in the first trimester 2020QI "" 46 Valencia/València Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 46 Valencia/València Total Cohort April 1 Total Survival in the second trimester 2022QIII 59.851 46 Valencia/València Total Cohort April 1 Total Survival in the second trimester 2022QII "" 46 Valencia/València Total Cohort April 1 Total Survival in the second trimester 2022QI "" 46 Valencia/València Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 46 Valencia/València Total Cohort April 1 Total Survival in the second trimester 2021QIII 58.227 46 Valencia/València Total Cohort April 1 Total Survival in the second trimester 2021QII "" 46 Valencia/València Total Cohort April 1 Total Survival in the second trimester 2021QI "" 46 Valencia/València Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 46 Valencia/València Total Cohort April 1 Total Survival in the second trimester 2020QIII 56.950 46 Valencia/València Total Cohort April 1 Total Survival in the second trimester 2020QII "" 46 Valencia/València Total Cohort April 1 Total Survival in the second trimester 2020QI "" 46 Valencia/València Total Cohort April 1 Total Survival in the third trimester 2022QIV 57.827 46 Valencia/València Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València Total Cohort April 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València Total Cohort April 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València Total Cohort April 1 Total Survival in the third trimester 2021QIV 56.509 46 Valencia/València Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València Total Cohort April 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València Total Cohort April 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València Total Cohort April 1 Total Survival in the third trimester 2020QIV 55.074 46 Valencia/València Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València Total Cohort April 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València Total Cohort April 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València Total Cohort April 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València Total Cohort April 1 Total Survival in the third trimester 2022QI 54.480 46 Valencia/València Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València Total Cohort April 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València Total Cohort April 1 Total Survival in the third trimester 2021QI 52.835 46 Valencia/València Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València Total Cohort April 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València Total Cohort April 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 46 Valencia/València Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 46 Valencia/València Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 46 Valencia/València Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,79 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,35 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,98 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,63 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,67 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,59 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,57 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 88,97 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,54 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 85,77 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,9 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 62.617 46 Valencia/València Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 55.334 46 Valencia/València Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 47.095 46 Valencia/València Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 59.287 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 52.595 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 44.807 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 56.640 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 50.426 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 43.129 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 54.686 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 48.880 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 41.666 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 47.035 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 39.955 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 46 Valencia/València Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 46 Valencia/València Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 46 Valencia/València Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,68 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,05 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,14 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,45 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,13 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,58 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 87,33 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 88,34 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,47 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 85 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,84 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 3.419 46 Valencia/València Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 8.184 46 Valencia/València Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 14.413 46 Valencia/València Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 3.310 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 7.972 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 14.230 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 3.211 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 7.801 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 13.821 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 3.141 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 7.629 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 13.408 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 7.445 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 12.880 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 46 Valencia/València Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 46 Valencia/València Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 46 Valencia/València Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,81 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,41 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,73 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,92 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 95,32 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,89 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,87 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,22 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,03 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 90,97 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 89,36 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València Total Cohort July 1 Total Number at the start of the quarter 2022QIII 66.738 46 Valencia/València Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València Total Cohort July 1 Total Number at the start of the quarter 2021QIII 65.334 46 Valencia/València Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València Total Cohort July 1 Total Number at the start of the quarter 2020QIII 63.383 46 Valencia/València Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 46 Valencia/València Total Cohort July 1 Total Survival in the first trimester 2022QIII 62.789 46 Valencia/València Total Cohort July 1 Total Survival in the first trimester 2022QII "" 46 Valencia/València Total Cohort July 1 Total Survival in the first trimester 2022QI "" 46 Valencia/València Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 46 Valencia/València Total Cohort July 1 Total Survival in the first trimester 2021QIII 61.630 46 Valencia/València Total Cohort July 1 Total Survival in the first trimester 2021QII "" 46 Valencia/València Total Cohort July 1 Total Survival in the first trimester 2021QI "" 46 Valencia/València Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 46 Valencia/València Total Cohort July 1 Total Survival in the first trimester 2020QIII 60.129 46 Valencia/València Total Cohort July 1 Total Survival in the first trimester 2020QII "" 46 Valencia/València Total Cohort July 1 Total Survival in the first trimester 2020QI "" 46 Valencia/València Total Cohort July 1 Total Survival in the second trimester 2022QIV 60.176 46 Valencia/València Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 46 Valencia/València Total Cohort July 1 Total Survival in the second trimester 2022QII "" 46 Valencia/València Total Cohort July 1 Total Survival in the second trimester 2022QI "" 46 Valencia/València Total Cohort July 1 Total Survival in the second trimester 2021QIV 59.303 46 Valencia/València Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 46 Valencia/València Total Cohort July 1 Total Survival in the second trimester 2021QII "" 46 Valencia/València Total Cohort July 1 Total Survival in the second trimester 2021QI "" 46 Valencia/València Total Cohort July 1 Total Survival in the second trimester 2020QIV 57.705 46 Valencia/València Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 46 Valencia/València Total Cohort July 1 Total Survival in the second trimester 2020QII "" 46 Valencia/València Total Cohort July 1 Total Survival in the second trimester 2020QI "" 46 Valencia/València Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València Total Cohort July 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València Total Cohort July 1 Total Survival in the third trimester 2022QI 56.956 46 Valencia/València Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València Total Cohort July 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València Total Cohort July 1 Total Survival in the third trimester 2021QI 55.098 46 Valencia/València Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València Total Cohort July 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València Total Cohort July 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València Total Cohort July 1 Total Survival in the third trimester 2022QII 55.289 46 Valencia/València Total Cohort July 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València Total Cohort July 1 Total Survival in the third trimester 2021QII 53.635 46 Valencia/València Total Cohort July 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València Total Cohort July 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València Total Cohort July 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 46 Valencia/València Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 46 Valencia/València Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 46 Valencia/València Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,08 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,33 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,87 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 90,17 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,77 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 91,04 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 87,18 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,93 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 84,63 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,62 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 64.277 46 Valencia/València Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 62.531 46 Valencia/València Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 54.098 46 Valencia/València Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 60.404 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 58.907 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 51.073 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 57.836 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 56.638 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 48.901 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 54.359 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 46.599 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 52.748 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 45.323 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 46 Valencia/València Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 46 Valencia/València Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 46 Valencia/València Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,97 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,2 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,41 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,98 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 90,58 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,39 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 86,93 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,14 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 84,35 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 83,78 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 2.461 46 Valencia/València Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 2.803 46 Valencia/València Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 9.285 46 Valencia/València Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 2.385 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 2.723 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 9.056 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 2.340 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 2.665 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 8.804 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 2.597 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 8.499 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 2.541 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 8.312 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 46 Valencia/València Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 46 Valencia/València Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 46 Valencia/València Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,91 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,15 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,53 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 95,08 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,08 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,82 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 92,65 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 91,53 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 90,65 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 89,52 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València Total Cohort October 1 Total Number at the start of the quarter 2022QIV 65.873 46 Valencia/València Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València Total Cohort October 1 Total Number at the start of the quarter 2021QIV 65.020 46 Valencia/València Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València Total Cohort October 1 Total Number at the start of the quarter 2020QIV 63.652 46 Valencia/València Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València Total Cohort October 1 Total Survival in the first trimester 2022QIV 62.645 46 Valencia/València Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 46 Valencia/València Total Cohort October 1 Total Survival in the first trimester 2022QII "" 46 Valencia/València Total Cohort October 1 Total Survival in the first trimester 2022QI "" 46 Valencia/València Total Cohort October 1 Total Survival in the first trimester 2021QIV 62.010 46 Valencia/València Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 46 Valencia/València Total Cohort October 1 Total Survival in the first trimester 2021QII "" 46 Valencia/València Total Cohort October 1 Total Survival in the first trimester 2021QI "" 46 Valencia/València Total Cohort October 1 Total Survival in the first trimester 2020QIV 60.471 46 Valencia/València Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 46 Valencia/València Total Cohort October 1 Total Survival in the first trimester 2020QII "" 46 Valencia/València Total Cohort October 1 Total Survival in the first trimester 2020QI "" 46 Valencia/València Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 46 Valencia/València Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 46 Valencia/València Total Cohort October 1 Total Survival in the second trimester 2022QII "" 46 Valencia/València Total Cohort October 1 Total Survival in the second trimester 2022QI 59.277 46 Valencia/València Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 46 Valencia/València Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 46 Valencia/València Total Cohort October 1 Total Survival in the second trimester 2021QII "" 46 Valencia/València Total Cohort October 1 Total Survival in the second trimester 2021QI 57.384 46 Valencia/València Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 46 Valencia/València Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 46 Valencia/València Total Cohort October 1 Total Survival in the second trimester 2020QII "" 46 Valencia/València Total Cohort October 1 Total Survival in the second trimester 2020QI "" 46 Valencia/València Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València Total Cohort October 1 Total Survival in the third trimester 2022QII 57.190 46 Valencia/València Total Cohort October 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València Total Cohort October 1 Total Survival in the third trimester 2021QII 55.565 46 Valencia/València Total Cohort October 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València Total Cohort October 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València Total Cohort October 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València Total Cohort October 1 Total Survival in the third trimester 2022QIII 55.270 46 Valencia/València Total Cohort October 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València Total Cohort October 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València Total Cohort October 1 Total Survival in the third trimester 2021QIII 54.043 46 Valencia/València Total Cohort October 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València Total Cohort October 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València Total Cohort October 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València Total Cohort October 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 46 Valencia/València Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 46 Valencia/València Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 46 Valencia/València Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,1 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,37 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 95 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 91,17 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,15 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,96 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 87,29 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 85 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 84,9 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 63.790 46 Valencia/València Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 61.427 46 Valencia/València Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 54.051 46 Valencia/València Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 60.596 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 58.517 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 51.149 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 55.891 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 48.396 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 53.889 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 46.780 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 52.061 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 45.410 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 46 Valencia/València Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 46 Valencia/València Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 46 Valencia/València Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,99 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,26 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,63 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,99 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,54 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 87,73 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,55 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 84,75 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 84,01 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 2.083 46 Valencia/València Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 3.593 46 Valencia/València Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 9.601 46 Valencia/València Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 2.049 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 3.493 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 9.322 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 3.386 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 8.988 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 3.301 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 8.785 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 3.209 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 8.633 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 46 Valencia/València Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 46 Valencia/València Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 46 Valencia/València Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,37 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,22 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,09 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,24 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 93,62 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 91,87 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 91,5 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 89,31 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 89,92 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 48.910 46 Valencia/València From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 47.990 46 Valencia/València From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 49.108 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 45.493 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 44.304 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 42.079 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 43.022 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 42.202 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 40.289 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 40.985 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 40.478 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 38.725 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 39.464 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 39.184 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 37.323 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 46 Valencia/València From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 46 Valencia/València From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,01 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 92,32 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 85,69 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 87,96 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 87,94 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 82,04 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 83,8 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 84,35 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 78,86 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 80,69 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 81,65 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 76 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 46.779 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 43.964 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 43.471 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 40.505 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 41.084 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 38.534 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 39.117 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 36.921 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 37.667 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 35.754 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 92,93 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 92,13 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 87,83 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 87,65 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 83,62 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 83,98 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 80,52 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 81,33 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 2.131 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 4.026 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 2.022 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 3.799 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 1.938 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 3.668 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 1.868 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 3.557 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 1.797 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 3.430 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 94,89 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 94,36 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,94 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 91,11 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 87,66 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 88,35 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 84,33 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 85,2 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 48.847 46 Valencia/València From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 47.695 46 Valencia/València From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 45.958 46 Valencia/València From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 45.694 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 44.967 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 43.706 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 43.173 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 42.811 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 41.788 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 41.325 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 41.243 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 40.095 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 39.415 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 38.076 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 46 Valencia/València From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 46 Valencia/València From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 46 Valencia/València From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,55 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 94,28 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,1 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 88,38 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 89,76 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 90,93 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 84,6 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 86,47 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 87,24 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 82,64 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 82,85 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 46.782 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 43.167 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 37.012 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 43.721 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 40.612 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 34.912 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 41.277 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 38.601 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 33.344 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 39.491 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 37.181 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 31.984 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 35.498 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 30.403 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,46 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,08 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,33 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 88,23 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,42 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,09 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 84,41 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 86,13 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 86,42 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 82,23 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 82,14 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 2.065 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 4.528 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 8.946 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 1.973 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 4.355 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 8.794 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 1.896 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 4.210 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 8.444 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 1.834 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 4.062 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 8.111 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 3.917 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 7.673 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,54 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,18 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,3 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 91,82 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 92,98 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,39 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,81 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 89,71 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 90,67 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 86,51 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 85,77 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 49.202 46 Valencia/València From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 48.630 46 Valencia/València From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 47.508 46 Valencia/València From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 45.533 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 45.183 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 44.466 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 43.194 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 43.103 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 42.299 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 40.989 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 39.939 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 39.474 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 38.630 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 46 Valencia/València From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 46 Valencia/València From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 46 Valencia/València From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 92,54 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,91 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 93,6 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 87,79 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 88,63 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 89,04 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 84,29 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 84,07 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 81,17 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 81,31 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 47.673 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 47.118 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 42.735 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 44.070 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 43.736 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 39.882 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 41.771 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 41.704 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 37.902 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 39.642 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 35.777 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 38.174 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 34.607 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 92,44 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,82 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 93,32 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,62 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 88,51 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 88,69 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 84,13 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 83,72 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 81,02 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 80,98 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1.529 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1.512 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 4.773 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1.463 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1.447 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 4.584 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1.423 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1.399 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 4.397 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1.347 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 4.162 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1.300 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 4.023 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 95,68 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 95,7 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,04 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 93,07 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 92,53 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 92,12 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 89,09 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 87,2 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 85,98 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 84,29 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 48.631 46 Valencia/València From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 48.359 46 Valencia/València From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 47.769 46 Valencia/València From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 45.599 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 45.528 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 44.787 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 43.018 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 41.953 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 41.145 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 40.330 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 39.413 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 38.946 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 46 Valencia/València From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 46 Valencia/València From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 46 Valencia/València From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,77 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,15 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,76 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,96 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 87,82 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 85,08 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 84,43 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 81,5 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 81,53 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 47.389 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 46.076 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 42.784 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 44.388 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 43.338 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 40.023 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 40.914 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 37.459 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 39.116 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 35.986 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 37.460 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 34.720 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,67 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,06 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,55 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,8 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 87,55 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 84,89 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 84,11 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 81,3 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 81,15 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1.242 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 2.283 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 4.985 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1.211 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 2.190 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 4.764 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 2.104 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 4.494 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 2.029 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 4.344 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1.953 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 4.226 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,5 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,93 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 95,57 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 92,16 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 90,15 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 88,87 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 87,14 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 85,55 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 84,77 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 6.970 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 6.618 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 6.939 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 6.856 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 6.492 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 6.640 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 6.710 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 6.368 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 6.511 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 6.586 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 6.279 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 6.410 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 6.498 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 6.209 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 6.293 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,36 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,1 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 95,69 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,27 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,22 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 93,83 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,49 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 94,88 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 92,38 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,23 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 93,82 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 90,69 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 6.463 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 5.309 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 6.359 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 5.208 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 6.217 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 5.104 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 6.099 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 5.027 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 6.018 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 4.975 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,39 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,1 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,19 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,14 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,37 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 94,69 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,11 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 93,71 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 507 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.309 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 497 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.284 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 493 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.264 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 487 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.252 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 480 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.234 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,03 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,09 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,24 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,56 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,06 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,65 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 94,67 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 94,27 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 6.891 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 6.434 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 6.367 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 6.747 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 6.319 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 6.264 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 6.620 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 6.222 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 6.183 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 6.522 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 6.140 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 6.080 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 6.035 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 5.960 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,91 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,21 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,38 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,07 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,71 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,11 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 94,65 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,43 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,49 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,8 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 93,61 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 6.400 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 5.125 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 4.091 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 6.263 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 5.029 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 4.008 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 6.148 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 4.942 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 3.957 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 6.055 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 4.875 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 3.897 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 4.788 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 3.823 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,86 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,13 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 97,97 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,06 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,43 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 96,72 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 94,61 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,12 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,26 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,42 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 93,45 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 491 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.309 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.276 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 484 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.290 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.256 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 472 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.280 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.226 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 467 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.265 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.183 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.247 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.137 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,57 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,55 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,12 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 96,13 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,78 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,8 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 95,11 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,64 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,91 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 95,26 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 93,89 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 7.077 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 6.899 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 6.671 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 6.917 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 6.753 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 6.557 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 6.771 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 6.623 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 6.418 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 6.501 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 6.276 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 6.423 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 6.194 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,74 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 97,88 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,29 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 95,68 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 96 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 96,21 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 94,23 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 94,08 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 93,1 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 92,85 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 6.709 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 6.439 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 5.077 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 6.554 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 6.299 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 4.984 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 6.413 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 6.176 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 4.876 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 6.059 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 4.771 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 5.985 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 4.716 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,69 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 97,83 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,17 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 95,59 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 95,92 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,04 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 94,1 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 93,97 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 92,95 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 92,89 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 368 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 460 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.594 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 363 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 454 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.573 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 358 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 447 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.542 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 442 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.505 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 438 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.478 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,64 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,7 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,68 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,28 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,17 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,74 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 96,09 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,42 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 95,22 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,72 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 6.927 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 6.816 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 6.594 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 6.812 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 6.721 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 6.476 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 6.609 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 6.339 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 6.505 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 6.241 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 6.398 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 6.170 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,34 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,61 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,21 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,96 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,13 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95,44 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 94,65 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 93,87 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 93,57 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 6.601 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 6.336 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 4.985 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 6.489 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 6.246 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 4.899 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 6.144 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 4.794 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 6.045 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 4.721 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 5.945 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 4.662 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,3 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,58 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,27 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,97 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,17 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,41 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 94,7 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 93,83 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,52 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 326 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 480 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.609 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 323 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 475 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.577 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 465 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.545 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 460 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.520 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 453 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.508 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,08 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,96 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,01 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 96,88 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,02 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 95,83 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,47 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 94,38 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,72 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 9.395 46 Valencia/València From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 8.734 46 Valencia/València From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 9.266 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 9.286 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 8.636 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 9.061 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 9.143 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 8.511 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 8.924 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 9.046 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 8.440 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 8.829 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 8.979 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 8.383 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 8.753 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 46 Valencia/València From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 46 Valencia/València From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,84 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,88 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,79 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,32 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,45 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 96,31 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,29 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,63 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,28 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,57 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 95,98 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,46 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 8.597 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 6.488 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 8.496 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 6.412 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 8.362 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 6.308 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 8.272 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 6.255 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 8.212 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 6.208 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,83 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,83 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,27 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 97,23 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,22 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,41 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,52 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 95,68 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 798 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2.246 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 790 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2.224 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 781 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2.203 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 774 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2.185 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 767 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 2.175 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,02 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,87 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,09 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,99 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,28 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,12 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,84 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 9.555 46 Valencia/València From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 8.709 46 Valencia/València From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 8.514 46 Valencia/València From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 9.417 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 8.605 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 8.400 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 9.328 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 8.528 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 8.324 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 9.256 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 8.467 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 8.260 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 8.374 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 8.166 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 46 Valencia/València From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 46 Valencia/València From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 46 Valencia/València From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,56 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,81 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,66 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,62 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,92 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,77 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,87 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,22 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,02 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,15 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,91 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 8.766 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 6.583 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 5.516 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 8.637 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 6.498 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 5.412 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 8.558 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 6.436 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 5.365 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 8.489 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 6.384 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 5.337 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 6.311 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 5.287 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,53 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,71 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,11 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,63 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,77 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,26 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,84 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,98 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,75 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,87 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,85 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 789 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 2.126 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.998 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 780 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 2.107 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.988 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 770 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 2.092 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.959 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 767 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 2.083 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.923 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 2.063 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.879 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,86 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,11 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,67 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 97,59 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,4 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,7 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 97,21 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,98 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,5 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,04 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,03 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 9.712 46 Valencia/València From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 9.138 46 Valencia/València From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 8.584 46 Valencia/València From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 9.596 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 9.032 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 8.492 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 9.471 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 8.919 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 8.382 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 8.813 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 8.282 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 8.743 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 8.212 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 46 Valencia/València From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 46 Valencia/València From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 46 Valencia/València From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,81 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,84 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,93 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,52 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,6 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,65 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,44 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,48 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,68 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,67 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 9.178 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 8.378 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 5.917 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 9.067 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 8.281 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 5.843 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 8.942 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 8.171 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 5.767 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 8.076 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 5.699 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 8.011 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 5.650 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,79 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,84 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,75 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,43 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,53 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,46 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,4 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,32 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,62 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,49 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 534 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 760 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2.667 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 529 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 751 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2.649 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 529 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 748 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 2.615 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 737 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2.583 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 732 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 2.562 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 99,06 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,82 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,33 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 99,06 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 98,42 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,05 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 96,97 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,85 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,32 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,06 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 9.573 46 Valencia/València From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 9.161 46 Valencia/València From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 8.631 46 Valencia/València From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 9.497 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 9.081 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 8.563 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 8.975 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 8.452 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 8.872 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 8.359 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 8.798 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 8.295 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 46 Valencia/València From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 46 Valencia/València From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 46 Valencia/València From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,21 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,13 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,21 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,97 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,93 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,85 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,85 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,04 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,11 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 9.085 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 8.409 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 5.878 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 9.009 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 8.331 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 5.835 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 8.236 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 5.755 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 8.138 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 5.689 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 8.073 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 5.647 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,16 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,07 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,27 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,94 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,91 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,78 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,78 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,07 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 488 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 752 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 2.753 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 488 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 750 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2.728 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 739 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 2.697 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 734 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 2.670 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 725 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 2.648 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 99,73 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,09 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,27 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,97 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,61 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 96,99 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96,41 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,19 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 501 46 Valencia/València from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 448 46 Valencia/València from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 460 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 498 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 445 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 456 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 492 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 442 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 453 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 488 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 440 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 449 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 485 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 436 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 447 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 46 Valencia/València from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 46 Valencia/València from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,4 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,33 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 99,13 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,2 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,66 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,48 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,41 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,21 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,61 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,81 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,32 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,17 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 450 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 305 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 447 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 302 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 441 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 299 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 437 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 297 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 434 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 293 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,33 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,02 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,03 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,11 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,38 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,44 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,07 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 51 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 143 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 51 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 143 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 51 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 143 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 51 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 143 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 51 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 143 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 501 46 Valencia/València from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 447 46 Valencia/València from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 446 46 Valencia/València from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 498 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 445 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 445 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 492 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 438 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 437 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 486 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 433 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 426 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 431 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 425 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 46 Valencia/València from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 46 Valencia/València from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 46 Valencia/València from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,4 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,55 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,78 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,2 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,99 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,98 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,01 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,87 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,52 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,42 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,29 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 454 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 310 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 319 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 451 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 308 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 318 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 445 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 302 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 310 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 439 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 297 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 299 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 295 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 298 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,34 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,35 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,69 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,02 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,42 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,18 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 96,7 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,81 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 93,73 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,16 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 93,42 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 47 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 137 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 127 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 47 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 137 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 127 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 47 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 136 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 127 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 47 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 136 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 127 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 136 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 127 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,27 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 99,27 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 99,27 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 515 46 Valencia/València from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 446 46 Valencia/València from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 420 46 Valencia/València from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 511 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 441 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 414 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 508 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 438 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 409 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 436 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 407 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 433 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 406 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 46 Valencia/València from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 46 Valencia/València from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 46 Valencia/València from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,22 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,88 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,57 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,64 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,21 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,38 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,76 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,9 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,09 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,67 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 493 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 401 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 250 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 489 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 396 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 245 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 486 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 393 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 240 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 391 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 238 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 388 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 237 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,19 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,75 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,58 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,51 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,2 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,76 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,8 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 22 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 45 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 170 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 22 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 45 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 169 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 22 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 45 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 169 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 45 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 169 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 45 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 169 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,41 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 99,41 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 99,41 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 99,41 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 498 46 Valencia/València from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 454 46 Valencia/València from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 445 46 Valencia/València from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 495 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 451 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 435 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 449 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 433 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 444 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 430 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 439 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 429 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 46 Valencia/València from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 46 Valencia/València from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 46 Valencia/València from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,4 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,34 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 97,75 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,9 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,3 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,8 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,63 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,7 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,4 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 479 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 404 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 280 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 476 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 401 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 271 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 399 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 269 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 394 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 266 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 389 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 265 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,37 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,26 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 96,79 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,76 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,07 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,52 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,29 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 94,64 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 19 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 50 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 165 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 19 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 50 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 164 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 50 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 164 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 50 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 164 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 50 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 164 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,39 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 99,39 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 99,39 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 99,39 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 241 46 Valencia/València De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 239 46 Valencia/València De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 241 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 239 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 233 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 238 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 237 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 231 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 237 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 232 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 227 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 232 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 231 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 227 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 229 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 46 Valencia/València De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 46 Valencia/València De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,17 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 97,49 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,76 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,34 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,65 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,34 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,27 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 94,98 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,27 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 95,85 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,98 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 95,02 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 221 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 147 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 219 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 142 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 217 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 141 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 212 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 137 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 211 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 137 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,1 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 96,6 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,19 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 95,92 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 95,93 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 93,2 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 95,48 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 93,2 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 20 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 92 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 20 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 91 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 20 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 90 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 20 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 90 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 20 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 90 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,91 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,83 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,83 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,83 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 242 46 Valencia/València De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 233 46 Valencia/València De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 223 46 Valencia/València De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 241 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 231 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 222 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 238 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 228 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 218 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 238 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 226 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 213 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 225 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 208 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 46 Valencia/València De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 46 Valencia/València De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 46 Valencia/València De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 99,59 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,14 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,55 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,35 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,85 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,76 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,35 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,52 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,57 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 93,27 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 215 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 149 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 157 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 215 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 148 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 157 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 212 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 145 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 153 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 212 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 143 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 149 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 143 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 144 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,33 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,6 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,32 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,45 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,6 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,97 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 94,9 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,97 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 91,72 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 27 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 84 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 66 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 26 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 83 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 65 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 26 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 83 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 65 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 26 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 83 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 64 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 82 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 64 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,3 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,81 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,48 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 96,3 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,81 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,48 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,3 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,81 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,97 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,62 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,97 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 232 46 Valencia/València De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 221 46 Valencia/València De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 200 46 Valencia/València De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 232 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 221 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 200 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 232 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 220 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 197 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 217 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 194 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 216 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 193 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 46 Valencia/València De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 46 Valencia/València De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 46 Valencia/València De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 46 Valencia/València De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 46 Valencia/València De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 46 Valencia/València De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,55 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,5 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,19 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,74 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,5 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 224 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 195 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 119 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 224 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 195 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 119 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 224 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 194 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 116 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 191 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 114 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 190 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 113 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 99,49 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,48 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,95 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,8 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,44 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,96 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 8 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 26 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 81 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 8 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 26 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 81 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 8 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 26 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 81 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 26 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 80 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 26 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 80 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,77 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,77 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 244 46 Valencia/València De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 230 46 Valencia/València De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 213 46 Valencia/València De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 242 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 229 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 210 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 226 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 207 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 224 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 205 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 222 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 203 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 46 Valencia/València De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 46 Valencia/València De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 46 Valencia/València De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,18 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,57 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,59 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,26 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,18 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,39 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,24 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,52 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,31 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 236 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 202 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 124 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 234 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 201 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 121 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 198 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 119 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 196 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 118 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 194 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 116 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,15 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,5 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,58 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,02 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 95,97 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,03 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,16 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,04 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,55 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 8 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 28 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 89 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 8 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 28 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 89 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 28 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 88 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 28 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 87 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 28 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 87 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,88 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,75 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 97,75 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 46 Valencia/València De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid Total Cohort January 1 Total Number at the start of the quarter 2022QI 11.991 47 Valladolid Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid Total Cohort January 1 Total Number at the start of the quarter 2021QI 11.699 47 Valladolid Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid Total Cohort January 1 Total Number at the start of the quarter 2020QI 12.278 47 Valladolid Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 47 Valladolid Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 47 Valladolid Total Cohort January 1 Total Survival in the first trimester 2022QII "" 47 Valladolid Total Cohort January 1 Total Survival in the first trimester 2022QI 11.428 47 Valladolid Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 47 Valladolid Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 47 Valladolid Total Cohort January 1 Total Survival in the first trimester 2021QII "" 47 Valladolid Total Cohort January 1 Total Survival in the first trimester 2021QI 11.199 47 Valladolid Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 47 Valladolid Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 47 Valladolid Total Cohort January 1 Total Survival in the first trimester 2020QII "" 47 Valladolid Total Cohort January 1 Total Survival in the first trimester 2020QI 11.120 47 Valladolid Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 47 Valladolid Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 47 Valladolid Total Cohort January 1 Total Survival in the second trimester 2022QII 10.951 47 Valladolid Total Cohort January 1 Total Survival in the second trimester 2022QI "" 47 Valladolid Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 47 Valladolid Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 47 Valladolid Total Cohort January 1 Total Survival in the second trimester 2021QII 10.828 47 Valladolid Total Cohort January 1 Total Survival in the second trimester 2021QI "" 47 Valladolid Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 47 Valladolid Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 47 Valladolid Total Cohort January 1 Total Survival in the second trimester 2020QII 10.739 47 Valladolid Total Cohort January 1 Total Survival in the second trimester 2020QI "" 47 Valladolid Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid Total Cohort January 1 Total Survival in the third trimester 2022QIII 10.598 47 Valladolid Total Cohort January 1 Total Survival in the third trimester 2022QII "" 47 Valladolid Total Cohort January 1 Total Survival in the third trimester 2022QI "" 47 Valladolid Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid Total Cohort January 1 Total Survival in the third trimester 2021QIII 10.546 47 Valladolid Total Cohort January 1 Total Survival in the third trimester 2021QII "" 47 Valladolid Total Cohort January 1 Total Survival in the third trimester 2021QI "" 47 Valladolid Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid Total Cohort January 1 Total Survival in the third trimester 2020QIII 10.443 47 Valladolid Total Cohort January 1 Total Survival in the third trimester 2020QII "" 47 Valladolid Total Cohort January 1 Total Survival in the third trimester 2020QI "" 47 Valladolid Total Cohort January 1 Total Survival in the third trimester 2022QIV 10.306 47 Valladolid Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid Total Cohort January 1 Total Survival in the third trimester 2022QII "" 47 Valladolid Total Cohort January 1 Total Survival in the third trimester 2022QI "" 47 Valladolid Total Cohort January 1 Total Survival in the third trimester 2021QIV 10.330 47 Valladolid Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid Total Cohort January 1 Total Survival in the third trimester 2021QII "" 47 Valladolid Total Cohort January 1 Total Survival in the third trimester 2021QI "" 47 Valladolid Total Cohort January 1 Total Survival in the third trimester 2020QIV 10.158 47 Valladolid Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid Total Cohort January 1 Total Survival in the third trimester 2020QII "" 47 Valladolid Total Cohort January 1 Total Survival in the third trimester 2020QI "" 47 Valladolid Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 47 Valladolid Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 47 Valladolid Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,3 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,73 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 90,57 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 91,33 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 92,55 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 87,47 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 88,38 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 90,14 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 85,05 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 85,95 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 88,3 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 82,73 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 11.357 47 Valladolid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 9.969 47 Valladolid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 10.812 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 9.509 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 10.349 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 9.172 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 10.006 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 8.922 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 9.724 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 8.720 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 47 Valladolid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 47 Valladolid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 95,2 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 95,39 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 91,12 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 92,01 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 88,1 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 89,5 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 85,62 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 87,47 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 634 47 Valladolid Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.730 47 Valladolid Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 616 47 Valladolid Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1.690 47 Valladolid Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 602 47 Valladolid Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1.656 47 Valladolid Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 592 47 Valladolid Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1.624 47 Valladolid Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 582 47 Valladolid Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.610 47 Valladolid Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 47 Valladolid Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 47 Valladolid Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,16 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,69 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 94,95 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,72 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 93,38 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 93,87 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 91,8 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 93,06 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid Total Cohort April 1 Total Number at the start of the quarter 2022QII 11.946 47 Valladolid Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid Total Cohort April 1 Total Number at the start of the quarter 2021QII 11.673 47 Valladolid Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid Total Cohort April 1 Total Number at the start of the quarter 2020QII 11.538 47 Valladolid Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 47 Valladolid Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 47 Valladolid Total Cohort April 1 Total Survival in the first trimester 2022QII 11.361 47 Valladolid Total Cohort April 1 Total Survival in the first trimester 2022QI "" 47 Valladolid Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 47 Valladolid Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 47 Valladolid Total Cohort April 1 Total Survival in the first trimester 2021QII 11.209 47 Valladolid Total Cohort April 1 Total Survival in the first trimester 2021QI "" 47 Valladolid Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 47 Valladolid Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 47 Valladolid Total Cohort April 1 Total Survival in the first trimester 2020QII 11.099 47 Valladolid Total Cohort April 1 Total Survival in the first trimester 2020QI "" 47 Valladolid Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 47 Valladolid Total Cohort April 1 Total Survival in the second trimester 2022QIII 10.934 47 Valladolid Total Cohort April 1 Total Survival in the second trimester 2022QII "" 47 Valladolid Total Cohort April 1 Total Survival in the second trimester 2022QI "" 47 Valladolid Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 47 Valladolid Total Cohort April 1 Total Survival in the second trimester 2021QIII 10.878 47 Valladolid Total Cohort April 1 Total Survival in the second trimester 2021QII "" 47 Valladolid Total Cohort April 1 Total Survival in the second trimester 2021QI "" 47 Valladolid Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 47 Valladolid Total Cohort April 1 Total Survival in the second trimester 2020QIII 10.768 47 Valladolid Total Cohort April 1 Total Survival in the second trimester 2020QII "" 47 Valladolid Total Cohort April 1 Total Survival in the second trimester 2020QI "" 47 Valladolid Total Cohort April 1 Total Survival in the third trimester 2022QIV 10.600 47 Valladolid Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid Total Cohort April 1 Total Survival in the third trimester 2022QII "" 47 Valladolid Total Cohort April 1 Total Survival in the third trimester 2022QI "" 47 Valladolid Total Cohort April 1 Total Survival in the third trimester 2021QIV 10.622 47 Valladolid Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid Total Cohort April 1 Total Survival in the third trimester 2021QII "" 47 Valladolid Total Cohort April 1 Total Survival in the third trimester 2021QI "" 47 Valladolid Total Cohort April 1 Total Survival in the third trimester 2020QIV 10.456 47 Valladolid Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid Total Cohort April 1 Total Survival in the third trimester 2020QII "" 47 Valladolid Total Cohort April 1 Total Survival in the third trimester 2020QI "" 47 Valladolid Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid Total Cohort April 1 Total Survival in the third trimester 2022QII "" 47 Valladolid Total Cohort April 1 Total Survival in the third trimester 2022QI 10.331 47 Valladolid Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid Total Cohort April 1 Total Survival in the third trimester 2021QII "" 47 Valladolid Total Cohort April 1 Total Survival in the third trimester 2021QI 10.151 47 Valladolid Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid Total Cohort April 1 Total Survival in the third trimester 2020QII "" 47 Valladolid Total Cohort April 1 Total Survival in the third trimester 2020QI "" 47 Valladolid Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 47 Valladolid Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 47 Valladolid Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 47 Valladolid Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,1 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,03 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,2 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 91,53 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 93,19 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,33 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 88,73 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 91 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,62 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 88,5 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87,98 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 11.331 47 Valladolid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 9.943 47 Valladolid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 8.934 47 Valladolid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 10.763 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 9.514 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 8.541 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 10.346 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 9.217 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 8.259 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 10.021 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 8.976 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 8.017 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 8.718 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 7.768 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 47 Valladolid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 47 Valladolid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 47 Valladolid Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,99 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,69 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,6 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,31 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,7 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,44 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 88,44 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 90,27 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 89,74 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 87,68 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 86,95 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 615 47 Valladolid Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1.730 47 Valladolid Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 2.604 47 Valladolid Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 598 47 Valladolid Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1.695 47 Valladolid Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 2.558 47 Valladolid Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 588 47 Valladolid Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1.661 47 Valladolid Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.509 47 Valladolid Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 579 47 Valladolid Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.646 47 Valladolid Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.439 47 Valladolid Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.613 47 Valladolid Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.383 47 Valladolid Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 47 Valladolid Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 47 Valladolid Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 47 Valladolid Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,24 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,98 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,23 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 95,61 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,01 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,35 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 94,15 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 95,14 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,66 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 93,24 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,51 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid Total Cohort July 1 Total Number at the start of the quarter 2022QIII 11.948 47 Valladolid Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid Total Cohort July 1 Total Number at the start of the quarter 2021QIII 11.851 47 Valladolid Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid Total Cohort July 1 Total Number at the start of the quarter 2020QIII 11.671 47 Valladolid Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 47 Valladolid Total Cohort July 1 Total Survival in the first trimester 2022QIII 11.345 47 Valladolid Total Cohort July 1 Total Survival in the first trimester 2022QII "" 47 Valladolid Total Cohort July 1 Total Survival in the first trimester 2022QI "" 47 Valladolid Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 47 Valladolid Total Cohort July 1 Total Survival in the first trimester 2021QIII 11.329 47 Valladolid Total Cohort July 1 Total Survival in the first trimester 2021QII "" 47 Valladolid Total Cohort July 1 Total Survival in the first trimester 2021QI "" 47 Valladolid Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 47 Valladolid Total Cohort July 1 Total Survival in the first trimester 2020QIII 11.193 47 Valladolid Total Cohort July 1 Total Survival in the first trimester 2020QII "" 47 Valladolid Total Cohort July 1 Total Survival in the first trimester 2020QI "" 47 Valladolid Total Cohort July 1 Total Survival in the second trimester 2022QIV 10.928 47 Valladolid Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 47 Valladolid Total Cohort July 1 Total Survival in the second trimester 2022QII "" 47 Valladolid Total Cohort July 1 Total Survival in the second trimester 2022QI "" 47 Valladolid Total Cohort July 1 Total Survival in the second trimester 2021QIV 10.983 47 Valladolid Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 47 Valladolid Total Cohort July 1 Total Survival in the second trimester 2021QII "" 47 Valladolid Total Cohort July 1 Total Survival in the second trimester 2021QI "" 47 Valladolid Total Cohort July 1 Total Survival in the second trimester 2020QIV 10.794 47 Valladolid Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 47 Valladolid Total Cohort July 1 Total Survival in the second trimester 2020QII "" 47 Valladolid Total Cohort July 1 Total Survival in the second trimester 2020QI "" 47 Valladolid Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid Total Cohort July 1 Total Survival in the third trimester 2022QII "" 47 Valladolid Total Cohort July 1 Total Survival in the third trimester 2022QI 10.639 47 Valladolid Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid Total Cohort July 1 Total Survival in the third trimester 2021QII "" 47 Valladolid Total Cohort July 1 Total Survival in the third trimester 2021QI 10.459 47 Valladolid Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid Total Cohort July 1 Total Survival in the third trimester 2020QII "" 47 Valladolid Total Cohort July 1 Total Survival in the third trimester 2020QI "" 47 Valladolid Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid Total Cohort July 1 Total Survival in the third trimester 2022QII 10.347 47 Valladolid Total Cohort July 1 Total Survival in the third trimester 2022QI "" 47 Valladolid Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid Total Cohort July 1 Total Survival in the third trimester 2021QII 10.212 47 Valladolid Total Cohort July 1 Total Survival in the third trimester 2021QI "" 47 Valladolid Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid Total Cohort July 1 Total Survival in the third trimester 2020QII "" 47 Valladolid Total Cohort July 1 Total Survival in the third trimester 2020QI "" 47 Valladolid Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 47 Valladolid Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 47 Valladolid Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 47 Valladolid Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,95 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,6 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,9 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 91,46 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 92,68 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 92,49 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 89,77 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 89,62 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 87,31 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 87,5 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 11.761 47 Valladolid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 11.248 47 Valladolid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 9.893 47 Valladolid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 11.163 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 10.735 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 9.444 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 10.748 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 10.393 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 9.091 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 10.059 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 8.791 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 9.776 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 8.572 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 47 Valladolid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 47 Valladolid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 47 Valladolid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,92 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,44 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,46 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 91,39 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 92,4 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 91,89 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 89,43 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 88,86 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 86,91 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 86,65 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 187 47 Valladolid Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 603 47 Valladolid Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.778 47 Valladolid Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 182 47 Valladolid Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 594 47 Valladolid Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.749 47 Valladolid Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 180 47 Valladolid Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 590 47 Valladolid Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.703 47 Valladolid Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 580 47 Valladolid Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.668 47 Valladolid Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 571 47 Valladolid Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1.640 47 Valladolid Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 47 Valladolid Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 47 Valladolid Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 47 Valladolid Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,33 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,51 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,37 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 96,26 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 97,84 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,78 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 96,19 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,81 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 94,69 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 92,24 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid Total Cohort October 1 Total Number at the start of the quarter 2022QIV 11.815 47 Valladolid Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid Total Cohort October 1 Total Number at the start of the quarter 2021QIV 11.839 47 Valladolid Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid Total Cohort October 1 Total Number at the start of the quarter 2020QIV 11.746 47 Valladolid Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid Total Cohort October 1 Total Survival in the first trimester 2022QIV 11.285 47 Valladolid Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 47 Valladolid Total Cohort October 1 Total Survival in the first trimester 2022QII "" 47 Valladolid Total Cohort October 1 Total Survival in the first trimester 2022QI "" 47 Valladolid Total Cohort October 1 Total Survival in the first trimester 2021QIV 11.372 47 Valladolid Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 47 Valladolid Total Cohort October 1 Total Survival in the first trimester 2021QII "" 47 Valladolid Total Cohort October 1 Total Survival in the first trimester 2021QI "" 47 Valladolid Total Cohort October 1 Total Survival in the first trimester 2020QIV 11.200 47 Valladolid Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 47 Valladolid Total Cohort October 1 Total Survival in the first trimester 2020QII "" 47 Valladolid Total Cohort October 1 Total Survival in the first trimester 2020QI "" 47 Valladolid Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 47 Valladolid Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 47 Valladolid Total Cohort October 1 Total Survival in the second trimester 2022QII "" 47 Valladolid Total Cohort October 1 Total Survival in the second trimester 2022QI 10.962 47 Valladolid Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 47 Valladolid Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 47 Valladolid Total Cohort October 1 Total Survival in the second trimester 2021QII "" 47 Valladolid Total Cohort October 1 Total Survival in the second trimester 2021QI 10.807 47 Valladolid Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 47 Valladolid Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 47 Valladolid Total Cohort October 1 Total Survival in the second trimester 2020QII "" 47 Valladolid Total Cohort October 1 Total Survival in the second trimester 2020QI "" 47 Valladolid Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid Total Cohort October 1 Total Survival in the third trimester 2022QII 10.613 47 Valladolid Total Cohort October 1 Total Survival in the third trimester 2022QI "" 47 Valladolid Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid Total Cohort October 1 Total Survival in the third trimester 2021QII 10.523 47 Valladolid Total Cohort October 1 Total Survival in the third trimester 2021QI "" 47 Valladolid Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid Total Cohort October 1 Total Survival in the third trimester 2020QII "" 47 Valladolid Total Cohort October 1 Total Survival in the third trimester 2020QI "" 47 Valladolid Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid Total Cohort October 1 Total Survival in the third trimester 2022QIII 10.319 47 Valladolid Total Cohort October 1 Total Survival in the third trimester 2022QII "" 47 Valladolid Total Cohort October 1 Total Survival in the third trimester 2022QI "" 47 Valladolid Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid Total Cohort October 1 Total Survival in the third trimester 2021QIII 10.278 47 Valladolid Total Cohort October 1 Total Survival in the third trimester 2021QII "" 47 Valladolid Total Cohort October 1 Total Survival in the third trimester 2021QI "" 47 Valladolid Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid Total Cohort October 1 Total Survival in the third trimester 2020QII "" 47 Valladolid Total Cohort October 1 Total Survival in the third trimester 2020QI "" 47 Valladolid Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 47 Valladolid Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 47 Valladolid Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 47 Valladolid Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,51 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 96,06 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 95,35 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 92,59 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 92,01 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 89,64 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 89,59 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 87,16 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 87,5 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 11.663 47 Valladolid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 11.162 47 Valladolid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 9.894 47 Valladolid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 11.135 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 10.704 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 9.400 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 10.311 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 9.043 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 9.978 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 8.791 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 9.695 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 8.578 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 47 Valladolid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 47 Valladolid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 47 Valladolid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95,47 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,9 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 95,01 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 92,38 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 91,4 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 89,39 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 88,85 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 86,86 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 86,7 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 152 47 Valladolid Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 677 47 Valladolid Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1.852 47 Valladolid Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 150 47 Valladolid Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 668 47 Valladolid Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1.800 47 Valladolid Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 651 47 Valladolid Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.764 47 Valladolid Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 635 47 Valladolid Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.732 47 Valladolid Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 624 47 Valladolid Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.700 47 Valladolid Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 47 Valladolid Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 47 Valladolid Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 47 Valladolid Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,68 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,67 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,19 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 96,16 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,25 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 93,8 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,52 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 92,17 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 91,79 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 8.927 47 Valladolid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 8.872 47 Valladolid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 9.218 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 8.389 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 8.406 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 8.121 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 7.956 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 8.064 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 7.785 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 7.647 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 7.808 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 7.524 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 7.381 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 7.613 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 7.261 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 47 Valladolid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 47 Valladolid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,97 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,75 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 88,1 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,12 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,89 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 84,45 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 85,66 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 88,01 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 81,62 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 82,68 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,81 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 78,77 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 8.546 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 7.918 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 8.025 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 7.487 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 7.603 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 7.176 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 7.301 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 6.942 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 7.042 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 6.757 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,9 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,56 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 88,97 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,63 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 85,43 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,67 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 82,4 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,34 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 381 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 954 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 364 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 919 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 353 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 888 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 346 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 866 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 339 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 856 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,54 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,33 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 92,65 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 93,08 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,81 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 90,78 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,98 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 89,73 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 8.882 47 Valladolid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 8.793 47 Valladolid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 8.707 47 Valladolid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 8.341 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 8.361 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 8.299 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 7.960 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 8.055 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 7.998 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 7.649 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 7.819 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 7.704 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 7.546 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 7.435 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 47 Valladolid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 47 Valladolid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 47 Valladolid From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,91 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,09 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,31 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,62 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,61 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,86 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 86,12 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 88,92 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,48 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 85,82 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,39 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 8.521 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 7.872 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 7.153 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 7.992 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 7.472 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 6.784 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 7.617 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 7.190 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 6.521 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 7.311 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 6.965 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 6.285 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 6.720 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 6.062 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,79 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,92 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 94,84 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 89,39 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,34 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,16 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 85,8 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 88,48 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 87,87 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 85,37 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,75 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 361 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 921 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.554 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 349 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 889 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.515 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 343 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 865 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.477 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 338 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 854 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.419 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 826 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.373 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 96,68 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,53 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,49 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 95,01 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,92 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,05 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 93,63 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 92,73 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,31 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 89,69 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 88,35 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 8.816 47 Valladolid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 8.858 47 Valladolid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 8.804 47 Valladolid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 8.258 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 8.360 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 8.355 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 7.870 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 8.035 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 7.978 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 7.716 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 7.681 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 7.450 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 7.461 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 47 Valladolid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 47 Valladolid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 47 Valladolid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,67 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,38 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,9 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,27 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,71 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,62 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 87,11 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 87,24 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 84,1 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,75 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 8.673 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 8.547 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 7.872 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 8.117 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 8.057 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 7.445 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 7.730 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 7.736 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 7.104 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 7.425 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 6.837 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 7.164 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 6.640 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,59 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,27 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,58 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,13 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 90,51 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,24 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 86,87 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,85 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 83,82 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 84,35 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 143 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 311 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 932 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 141 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 303 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 910 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 140 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 299 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 874 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 291 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 844 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 286 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 821 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,6 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 97,43 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,64 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,9 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 96,14 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,78 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 93,57 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 90,56 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 91,96 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 88,09 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 8.721 47 Valladolid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 8.844 47 Valladolid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 8.854 47 Valladolid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 8.219 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 8.393 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 8.330 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 8.010 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 7.974 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 7.689 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 7.715 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 7.432 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 7.496 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 47 Valladolid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 47 Valladolid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 47 Valladolid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,24 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,9 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,08 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,57 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,06 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 86,94 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 87,14 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 84,03 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 84,66 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 8.594 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 8.423 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 7.866 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 8.093 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 7.980 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 7.385 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 7.612 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 7.059 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 7.305 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 6.827 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 7.054 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 6.628 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,17 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,74 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,89 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,37 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,74 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 86,73 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,79 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 83,75 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 84,26 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 127 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 421 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 988 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 126 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 413 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 945 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 398 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 915 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 384 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 888 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 378 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 868 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 99,21 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,1 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 95,65 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,54 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 92,61 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 91,21 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 89,88 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 89,79 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 87,85 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 1.229 47 Valladolid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 1.141 47 Valladolid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 1.247 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 1.218 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 1.120 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 1.214 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 1.191 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 1.103 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 1.185 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 1.165 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 1.093 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 1.169 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 1.153 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 1.079 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 1.157 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 47 Valladolid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 47 Valladolid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,1 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,16 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,35 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,91 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,67 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,03 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,79 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,79 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 93,74 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,82 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,57 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 92,78 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.126 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 865 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.115 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 846 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.089 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 832 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.065 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 828 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.054 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 816 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,02 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 97,8 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,71 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,18 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,58 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,72 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,61 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,34 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 103 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 276 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 103 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 274 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 102 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 271 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 100 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 265 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 99 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 263 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,28 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 99,03 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,19 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,09 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,01 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,12 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,29 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 1.223 47 Valladolid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 1.186 47 Valladolid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 1.149 47 Valladolid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 1.197 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 1.164 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 1.130 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 1.168 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 1.153 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 1.114 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 1.157 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 1.140 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 1.102 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 1.133 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 1.078 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 47 Valladolid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 47 Valladolid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 47 Valladolid From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,87 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,15 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,35 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 95,5 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 97,22 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 96,95 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 94,6 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,12 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 95,91 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 95,53 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 93,82 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.128 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 884 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 730 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.103 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 864 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 715 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.076 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 859 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 706 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.066 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 848 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 702 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 842 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 684 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,78 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 97,74 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 97,95 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 95,39 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,17 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 96,71 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 94,5 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,93 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,16 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 95,25 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 93,7 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 95 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 302 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 419 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 94 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 300 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 415 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 92 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 294 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 408 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 91 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 292 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 400 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 291 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 394 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,95 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,34 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,05 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 96,84 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,35 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,37 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 95,79 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,69 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,47 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,36 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,03 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 1.294 47 Valladolid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 1.230 47 Valladolid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 1.192 47 Valladolid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 1.263 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 1.218 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 1.177 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 1.249 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 1.206 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 1.163 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 1.195 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 1.137 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 1.179 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 1.121 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 47 Valladolid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 47 Valladolid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 47 Valladolid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,6 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,02 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,74 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,52 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,05 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,57 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,15 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,39 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,85 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 94,04 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.271 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.124 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 888 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.242 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.112 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 876 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.228 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.100 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 867 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.089 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 842 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.075 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 828 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,72 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,93 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,65 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,62 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,86 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,64 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,89 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 94,82 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 95,64 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 93,24 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 23 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 106 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 304 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 21 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 106 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 301 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 21 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 106 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 296 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 106 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 295 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 104 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 293 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 91,3 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,01 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 91,3 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,37 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,04 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 98,11 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,38 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 1.241 47 Valladolid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 1.217 47 Valladolid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 1.192 47 Valladolid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 1.227 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 1.206 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 1.180 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 1.194 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 1.158 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 1.180 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 1.144 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 1.159 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 1.133 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 47 Valladolid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 47 Valladolid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 47 Valladolid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,87 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,1 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,99 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,11 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,15 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,96 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 95,97 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,23 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,05 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.228 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.122 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 885 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.214 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.112 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 875 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.100 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 856 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.086 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 844 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.069 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 841 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,86 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,11 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,87 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,04 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,72 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,79 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,37 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,28 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,03 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 13 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 95 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 307 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 13 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 94 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 305 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 94 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 302 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 94 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 300 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 90 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 292 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,95 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,35 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,95 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,37 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 98,95 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,72 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 94,74 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 95,11 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 1.682 47 Valladolid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 1.535 47 Valladolid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 1.674 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 1.669 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 1.523 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 1.646 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 1.653 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 1.513 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 1.630 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 1.636 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 1.499 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 1.613 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 1.622 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 1.496 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 1.603 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 47 Valladolid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 47 Valladolid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,23 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,22 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,33 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,28 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,57 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,37 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,27 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,65 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 96,36 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,43 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,46 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 95,76 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.547 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.093 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.535 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.083 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.521 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.073 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.505 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.062 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.493 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.059 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,22 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,09 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,32 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,17 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,29 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,16 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,51 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,89 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 135 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 442 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 134 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 440 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 132 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 440 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 131 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 437 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 129 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 437 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 99,26 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,55 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,78 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 99,55 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,04 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98,87 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 95,56 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98,87 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 1.689 47 Valladolid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 1.554 47 Valladolid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 1.549 47 Valladolid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 1.672 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 1.545 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 1.537 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 1.656 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 1.533 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 1.525 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 1.644 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 1.527 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 1.519 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 1.517 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 1.508 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 47 Valladolid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 47 Valladolid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 47 Valladolid From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,99 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,42 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,23 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,05 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,65 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,45 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,34 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,26 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,06 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,62 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,35 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.549 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.101 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 975 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.536 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.093 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 966 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.522 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.084 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 957 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.513 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.079 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 955 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.073 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 947 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 99,16 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,27 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,08 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,26 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,46 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,15 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,68 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,95 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,46 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,13 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 140 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 453 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 574 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 136 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 452 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 571 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 134 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 449 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 568 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 131 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 448 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 564 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 444 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 561 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,14 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,78 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,48 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 95,71 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 99,12 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,95 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 93,57 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,9 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 98,26 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 98,01 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 97,74 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 1.687 47 Valladolid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 1.617 47 Valladolid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.542 47 Valladolid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 1.674 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 1.606 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 1.530 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 1.659 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 1.598 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 1.522 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 1.585 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 1.511 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 1.575 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 1.503 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 47 Valladolid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 47 Valladolid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 47 Valladolid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,23 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,32 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,22 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,34 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,82 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,7 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,02 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,99 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,4 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,47 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.669 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.454 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.058 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.657 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.444 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.049 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.643 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.436 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.046 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.425 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.038 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.417 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.033 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,28 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,31 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,15 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,44 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,76 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,87 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,01 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,11 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,46 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,64 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 18 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 163 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 484 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 17 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 162 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 481 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 16 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 162 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 476 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 160 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 473 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 158 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 470 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 94,44 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,39 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,38 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 88,89 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,39 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,35 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 98,16 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,73 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 96,93 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,11 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 1.704 47 Valladolid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 1.628 47 Valladolid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.553 47 Valladolid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 1.690 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 1.623 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 1.543 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 1.609 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 1.529 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 1.595 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 1.521 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 1.580 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 1.508 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 47 Valladolid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 47 Valladolid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 47 Valladolid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,18 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,69 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,36 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,83 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,45 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,97 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,94 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 97,05 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,1 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.693 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.485 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.054 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.680 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.480 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.051 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.468 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.039 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.456 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.034 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.442 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.024 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,23 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,66 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,72 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,86 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,58 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,05 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,1 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,1 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,15 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 11 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 143 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 499 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 10 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 143 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 492 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 141 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 490 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 139 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 487 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 138 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 484 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 90,91 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,6 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,6 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,2 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,2 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,6 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96,5 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,99 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 98 47 Valladolid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 101 47 Valladolid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 91 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 97 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 100 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 91 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 96 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 99 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 91 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 96 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 97 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 90 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 96 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 93 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 90 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 47 Valladolid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 47 Valladolid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,98 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,01 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,96 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,02 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,96 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 96,04 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,9 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,96 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 92,08 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 98,9 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 92 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 64 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 91 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 64 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 90 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 63 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 90 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 62 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 90 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 60 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,91 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,83 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,44 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,83 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,88 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,83 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 93,75 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 6 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 37 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 6 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 36 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 6 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 36 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 6 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 35 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 6 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 33 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,3 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,3 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,59 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 89,19 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 98 47 Valladolid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 88 47 Valladolid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 86 47 Valladolid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 97 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 87 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 86 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 97 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 85 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 85 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 97 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 84 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 85 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 83 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 84 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 47 Valladolid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 47 Valladolid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 47 Valladolid from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,98 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,86 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,98 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,59 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,84 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,98 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,45 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,84 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,32 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,67 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 87 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 56 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 50 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 86 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 55 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 50 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 86 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 54 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 50 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 86 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 54 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 50 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 53 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 50 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,85 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,21 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,85 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,43 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,85 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,43 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 94,64 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 11 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 32 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 36 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 11 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 32 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 36 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 11 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 31 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 35 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 11 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 30 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 35 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 30 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 34 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,88 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,22 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,75 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,22 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 93,75 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,44 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 99 47 Valladolid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 96 47 Valladolid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 86 47 Valladolid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 99 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 95 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 85 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 99 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 94 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 85 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 93 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 84 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 93 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 82 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 47 Valladolid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 47 Valladolid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 47 Valladolid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,96 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,84 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,92 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,84 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,88 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,67 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,88 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,35 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 98 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 81 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 48 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 98 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 80 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 48 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 98 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 79 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 48 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 78 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 48 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 78 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 46 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,77 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,53 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 96,3 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,3 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,83 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 15 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 38 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 15 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 37 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 15 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 37 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 15 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 36 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 15 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 36 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,37 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,37 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,74 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 94,74 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 97 47 Valladolid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 97 47 Valladolid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 95 47 Valladolid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 97 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 97 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 95 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 96 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 94 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 96 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 92 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 96 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 90 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 47 Valladolid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 47 Valladolid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 47 Valladolid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,97 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,95 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,97 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,84 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,97 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 94,74 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 97 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 87 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 60 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 97 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 87 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 60 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 86 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 60 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 86 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 58 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 86 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 57 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,85 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,85 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,67 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,85 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 10 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 35 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 10 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 35 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 10 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 34 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 10 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 34 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 10 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 33 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,14 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,14 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 94,29 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 55 47 Valladolid De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 50 47 Valladolid De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 48 47 Valladolid De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 55 47 Valladolid De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 50 47 Valladolid De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 48 47 Valladolid De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 55 47 Valladolid De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 49 47 Valladolid De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 48 47 Valladolid De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 54 47 Valladolid De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 49 47 Valladolid De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 47 47 Valladolid De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 54 47 Valladolid De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 49 47 Valladolid De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 47 47 Valladolid De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 47 Valladolid De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 47 Valladolid De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,18 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,92 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,18 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,92 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 46 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 29 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 46 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 29 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 46 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 28 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 45 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 28 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 45 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 28 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,55 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,83 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,55 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,83 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,55 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 9 47 Valladolid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 21 47 Valladolid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 9 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 21 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 9 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 21 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 9 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 21 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 9 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 21 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 47 Valladolid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 47 Valladolid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 54 47 Valladolid De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 52 47 Valladolid De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 47 47 Valladolid De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 54 47 Valladolid De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 52 47 Valladolid De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 47 47 Valladolid De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 53 47 Valladolid De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 52 47 Valladolid De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 46 47 Valladolid De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 53 47 Valladolid De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 52 47 Valladolid De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 46 47 Valladolid De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 52 47 Valladolid De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 46 47 Valladolid De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 47 Valladolid De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 47 Valladolid De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 47 Valladolid De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 47 Valladolid De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,15 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,87 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 98,15 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,87 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,87 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 46 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 30 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 26 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 46 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 30 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 26 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 45 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 30 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 25 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 45 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 30 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 25 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 30 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 25 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,83 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 96,15 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,83 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,15 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,15 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 8 47 Valladolid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 22 47 Valladolid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 21 47 Valladolid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 8 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 22 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 21 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 8 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 22 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 21 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 8 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 22 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 21 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 22 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 21 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 47 Valladolid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 47 Valladolid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 47 Valladolid De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 52 47 Valladolid De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 50 47 Valladolid De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 47 47 Valladolid De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 51 47 Valladolid De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 50 47 Valladolid De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 46 47 Valladolid De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 51 47 Valladolid De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 50 47 Valladolid De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 46 47 Valladolid De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 50 47 Valladolid De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 46 47 Valladolid De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 50 47 Valladolid De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 45 47 Valladolid De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 47 Valladolid De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 47 Valladolid De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 47 Valladolid De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 47 Valladolid De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 47 Valladolid De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 47 Valladolid De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,08 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 97,87 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,08 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,87 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,87 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,74 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 50 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 42 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 27 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 49 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 42 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 26 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 49 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 42 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 26 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 42 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 26 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 42 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 25 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 96,3 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,3 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,3 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 92,59 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 2 47 Valladolid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 8 47 Valladolid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 20 47 Valladolid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 2 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 8 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 20 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 2 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 8 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 20 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 8 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 20 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 8 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 20 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 47 Valladolid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 47 Valladolid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 47 Valladolid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 52 47 Valladolid De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 53 47 Valladolid De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 52 47 Valladolid De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 52 47 Valladolid De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 53 47 Valladolid De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 52 47 Valladolid De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 53 47 Valladolid De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 52 47 Valladolid De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 53 47 Valladolid De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 51 47 Valladolid De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 52 47 Valladolid De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 51 47 Valladolid De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 47 Valladolid De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 47 Valladolid De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 47 Valladolid De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 47 Valladolid De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 47 Valladolid De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 47 Valladolid De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 47 Valladolid De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,08 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,11 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,08 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 51 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 45 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 29 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 51 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 45 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 29 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 45 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 29 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 45 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 28 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 44 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 28 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,55 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,78 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,55 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1 47 Valladolid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 8 47 Valladolid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 23 47 Valladolid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 8 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 23 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 8 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 23 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 8 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 23 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 8 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 23 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 47 Valladolid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 47 Valladolid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 47 Valladolid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 47 Valladolid De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 49 Zamora Total Cohort January 1 Total Number at the start of the quarter 2022QI 3.909 49 Zamora Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 49 Zamora Total Cohort January 1 Total Number at the start of the quarter 2021QI 3.706 49 Zamora Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 49 Zamora Total Cohort January 1 Total Number at the start of the quarter 2020QI 3.984 49 Zamora Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 49 Zamora Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 49 Zamora Total Cohort January 1 Total Survival in the first trimester 2022QII "" 49 Zamora Total Cohort January 1 Total Survival in the first trimester 2022QI 3.702 49 Zamora Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 49 Zamora Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 49 Zamora Total Cohort January 1 Total Survival in the first trimester 2021QII "" 49 Zamora Total Cohort January 1 Total Survival in the first trimester 2021QI 3.523 49 Zamora Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 49 Zamora Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 49 Zamora Total Cohort January 1 Total Survival in the first trimester 2020QII "" 49 Zamora Total Cohort January 1 Total Survival in the first trimester 2020QI 3.533 49 Zamora Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 49 Zamora Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 49 Zamora Total Cohort January 1 Total Survival in the second trimester 2022QII 3.565 49 Zamora Total Cohort January 1 Total Survival in the second trimester 2022QI "" 49 Zamora Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 49 Zamora Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 49 Zamora Total Cohort January 1 Total Survival in the second trimester 2021QII 3.428 49 Zamora Total Cohort January 1 Total Survival in the second trimester 2021QI "" 49 Zamora Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 49 Zamora Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 49 Zamora Total Cohort January 1 Total Survival in the second trimester 2020QII 3.413 49 Zamora Total Cohort January 1 Total Survival in the second trimester 2020QI "" 49 Zamora Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 49 Zamora Total Cohort January 1 Total Survival in the third trimester 2022QIII 3.452 49 Zamora Total Cohort January 1 Total Survival in the third trimester 2022QII "" 49 Zamora Total Cohort January 1 Total Survival in the third trimester 2022QI "" 49 Zamora Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 49 Zamora Total Cohort January 1 Total Survival in the third trimester 2021QIII 3.361 49 Zamora Total Cohort January 1 Total Survival in the third trimester 2021QII "" 49 Zamora Total Cohort January 1 Total Survival in the third trimester 2021QI "" 49 Zamora Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 49 Zamora Total Cohort January 1 Total Survival in the third trimester 2020QIII 3.339 49 Zamora Total Cohort January 1 Total Survival in the third trimester 2020QII "" 49 Zamora Total Cohort January 1 Total Survival in the third trimester 2020QI "" 49 Zamora Total Cohort January 1 Total Survival in the third trimester 2022QIV 3.365 49 Zamora Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 49 Zamora Total Cohort January 1 Total Survival in the third trimester 2022QII "" 49 Zamora Total Cohort January 1 Total Survival in the third trimester 2022QI "" 49 Zamora Total Cohort January 1 Total Survival in the third trimester 2021QIV 3.290 49 Zamora Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 49 Zamora Total Cohort January 1 Total Survival in the third trimester 2021QII "" 49 Zamora Total Cohort January 1 Total Survival in the third trimester 2021QI "" 49 Zamora Total Cohort January 1 Total Survival in the third trimester 2020QIV 3.231 49 Zamora Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 49 Zamora Total Cohort January 1 Total Survival in the third trimester 2020QII "" 49 Zamora Total Cohort January 1 Total Survival in the third trimester 2020QI "" 49 Zamora Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 49 Zamora Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 49 Zamora Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 49 Zamora Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 49 Zamora Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 49 Zamora Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 49 Zamora Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,7 49 Zamora Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,06 49 Zamora Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 88,68 49 Zamora Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 91,2 49 Zamora Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 92,5 49 Zamora Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 85,67 49 Zamora Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 88,31 49 Zamora Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 90,69 49 Zamora Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 83,81 49 Zamora Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 86,08 49 Zamora Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 88,77 49 Zamora Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 81,1 49 Zamora Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 49 Zamora Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 49 Zamora Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 3.751 49 Zamora Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 3.303 49 Zamora Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 3.549 49 Zamora Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 3.133 49 Zamora Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 3.413 49 Zamora Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 3.042 49 Zamora Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 3.304 49 Zamora Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.977 49 Zamora Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 3.219 49 Zamora Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2.912 49 Zamora Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 49 Zamora Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 49 Zamora Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,61 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,85 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 90,99 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 92,1 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 88,08 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 90,13 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 85,82 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 88,16 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 158 49 Zamora Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 403 49 Zamora Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 153 49 Zamora Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 390 49 Zamora Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 152 49 Zamora Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 386 49 Zamora Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 148 49 Zamora Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 384 49 Zamora Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 146 49 Zamora Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 378 49 Zamora Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 49 Zamora Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 49 Zamora Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 96,84 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,77 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96,2 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,78 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 93,67 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,29 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 92,41 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 93,8 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora Total Cohort April 1 Total Number at the start of the quarter 2022QII 3.905 49 Zamora Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 49 Zamora Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora Total Cohort April 1 Total Number at the start of the quarter 2021QII 3.756 49 Zamora Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 49 Zamora Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora Total Cohort April 1 Total Number at the start of the quarter 2020QII 3.670 49 Zamora Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 49 Zamora Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 49 Zamora Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 49 Zamora Total Cohort April 1 Total Survival in the first trimester 2022QII 3.729 49 Zamora Total Cohort April 1 Total Survival in the first trimester 2022QI "" 49 Zamora Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 49 Zamora Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 49 Zamora Total Cohort April 1 Total Survival in the first trimester 2021QII 3.629 49 Zamora Total Cohort April 1 Total Survival in the first trimester 2021QI "" 49 Zamora Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 49 Zamora Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 49 Zamora Total Cohort April 1 Total Survival in the first trimester 2020QII 3.528 49 Zamora Total Cohort April 1 Total Survival in the first trimester 2020QI "" 49 Zamora Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 49 Zamora Total Cohort April 1 Total Survival in the second trimester 2022QIII 3.587 49 Zamora Total Cohort April 1 Total Survival in the second trimester 2022QII "" 49 Zamora Total Cohort April 1 Total Survival in the second trimester 2022QI "" 49 Zamora Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 49 Zamora Total Cohort April 1 Total Survival in the second trimester 2021QIII 3.543 49 Zamora Total Cohort April 1 Total Survival in the second trimester 2021QII "" 49 Zamora Total Cohort April 1 Total Survival in the second trimester 2021QI "" 49 Zamora Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 49 Zamora Total Cohort April 1 Total Survival in the second trimester 2020QIII 3.445 49 Zamora Total Cohort April 1 Total Survival in the second trimester 2020QII "" 49 Zamora Total Cohort April 1 Total Survival in the second trimester 2020QI "" 49 Zamora Total Cohort April 1 Total Survival in the third trimester 2022QIV 3.472 49 Zamora Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 49 Zamora Total Cohort April 1 Total Survival in the third trimester 2022QII "" 49 Zamora Total Cohort April 1 Total Survival in the third trimester 2022QI "" 49 Zamora Total Cohort April 1 Total Survival in the third trimester 2021QIV 3.418 49 Zamora Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 49 Zamora Total Cohort April 1 Total Survival in the third trimester 2021QII "" 49 Zamora Total Cohort April 1 Total Survival in the third trimester 2021QI "" 49 Zamora Total Cohort April 1 Total Survival in the third trimester 2020QIV 3.325 49 Zamora Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 49 Zamora Total Cohort April 1 Total Survival in the third trimester 2020QII "" 49 Zamora Total Cohort April 1 Total Survival in the third trimester 2020QI "" 49 Zamora Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 49 Zamora Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 49 Zamora Total Cohort April 1 Total Survival in the third trimester 2022QII "" 49 Zamora Total Cohort April 1 Total Survival in the third trimester 2022QI 3.319 49 Zamora Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 49 Zamora Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 49 Zamora Total Cohort April 1 Total Survival in the third trimester 2021QII "" 49 Zamora Total Cohort April 1 Total Survival in the third trimester 2021QI 3.202 49 Zamora Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 49 Zamora Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 49 Zamora Total Cohort April 1 Total Survival in the third trimester 2020QII "" 49 Zamora Total Cohort April 1 Total Survival in the third trimester 2020QI "" 49 Zamora Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 49 Zamora Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 49 Zamora Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 49 Zamora Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 49 Zamora Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 49 Zamora Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,49 49 Zamora Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,62 49 Zamora Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,13 49 Zamora Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 91,86 49 Zamora Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 94,33 49 Zamora Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,87 49 Zamora Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 88,91 49 Zamora Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 91 49 Zamora Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 90,6 49 Zamora Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 88,37 49 Zamora Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 87,25 49 Zamora Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 49 Zamora Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 49 Zamora Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 3.750 49 Zamora Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 3.354 49 Zamora Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 3.265 49 Zamora Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 3.577 49 Zamora Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 3.231 49 Zamora Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 3.126 49 Zamora Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 3.438 49 Zamora Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 3.148 49 Zamora Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 3.049 49 Zamora Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 3.325 49 Zamora Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 3.029 49 Zamora Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.939 49 Zamora Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.936 49 Zamora Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.823 49 Zamora Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 49 Zamora Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 49 Zamora Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 49 Zamora Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,39 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 96,33 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,74 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,68 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 93,86 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 93,38 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 88,67 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 90,31 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 90,02 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 87,54 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 86,46 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 155 49 Zamora Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 402 49 Zamora Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 405 49 Zamora Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 152 49 Zamora Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 398 49 Zamora Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 402 49 Zamora Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 149 49 Zamora Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 395 49 Zamora Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 396 49 Zamora Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 147 49 Zamora Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 389 49 Zamora Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 386 49 Zamora Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 383 49 Zamora Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 379 49 Zamora Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 49 Zamora Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 49 Zamora Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 49 Zamora Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,06 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,26 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 96,13 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,26 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,78 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 94,84 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 96,77 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,31 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 95,27 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 93,58 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora Total Cohort July 1 Total Number at the start of the quarter 2022QIII 3.979 49 Zamora Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 49 Zamora Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 49 Zamora Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora Total Cohort July 1 Total Number at the start of the quarter 2021QIII 3.910 49 Zamora Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 49 Zamora Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 49 Zamora Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora Total Cohort July 1 Total Number at the start of the quarter 2020QIII 3.813 49 Zamora Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 49 Zamora Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 49 Zamora Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 49 Zamora Total Cohort July 1 Total Survival in the first trimester 2022QIII 3.760 49 Zamora Total Cohort July 1 Total Survival in the first trimester 2022QII "" 49 Zamora Total Cohort July 1 Total Survival in the first trimester 2022QI "" 49 Zamora Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 49 Zamora Total Cohort July 1 Total Survival in the first trimester 2021QIII 3.750 49 Zamora Total Cohort July 1 Total Survival in the first trimester 2021QII "" 49 Zamora Total Cohort July 1 Total Survival in the first trimester 2021QI "" 49 Zamora Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 49 Zamora Total Cohort July 1 Total Survival in the first trimester 2020QIII 3.666 49 Zamora Total Cohort July 1 Total Survival in the first trimester 2020QII "" 49 Zamora Total Cohort July 1 Total Survival in the first trimester 2020QI "" 49 Zamora Total Cohort July 1 Total Survival in the second trimester 2022QIV 3.599 49 Zamora Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 49 Zamora Total Cohort July 1 Total Survival in the second trimester 2022QII "" 49 Zamora Total Cohort July 1 Total Survival in the second trimester 2022QI "" 49 Zamora Total Cohort July 1 Total Survival in the second trimester 2021QIV 3.577 49 Zamora Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 49 Zamora Total Cohort July 1 Total Survival in the second trimester 2021QII "" 49 Zamora Total Cohort July 1 Total Survival in the second trimester 2021QI "" 49 Zamora Total Cohort July 1 Total Survival in the second trimester 2020QIV 3.472 49 Zamora Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 49 Zamora Total Cohort July 1 Total Survival in the second trimester 2020QII "" 49 Zamora Total Cohort July 1 Total Survival in the second trimester 2020QI "" 49 Zamora Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 49 Zamora Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 49 Zamora Total Cohort July 1 Total Survival in the third trimester 2022QII "" 49 Zamora Total Cohort July 1 Total Survival in the third trimester 2022QI 3.456 49 Zamora Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 49 Zamora Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 49 Zamora Total Cohort July 1 Total Survival in the third trimester 2021QII "" 49 Zamora Total Cohort July 1 Total Survival in the third trimester 2021QI 3.339 49 Zamora Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 49 Zamora Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 49 Zamora Total Cohort July 1 Total Survival in the third trimester 2020QII "" 49 Zamora Total Cohort July 1 Total Survival in the third trimester 2020QI "" 49 Zamora Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 49 Zamora Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 49 Zamora Total Cohort July 1 Total Survival in the third trimester 2022QII 3.364 49 Zamora Total Cohort July 1 Total Survival in the third trimester 2022QI "" 49 Zamora Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 49 Zamora Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 49 Zamora Total Cohort July 1 Total Survival in the third trimester 2021QII 3.281 49 Zamora Total Cohort July 1 Total Survival in the third trimester 2021QI "" 49 Zamora Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 49 Zamora Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 49 Zamora Total Cohort July 1 Total Survival in the third trimester 2020QII "" 49 Zamora Total Cohort July 1 Total Survival in the third trimester 2020QI "" 49 Zamora Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 49 Zamora Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 49 Zamora Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 49 Zamora Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 49 Zamora Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 49 Zamora Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 49 Zamora Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 49 Zamora Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 49 Zamora Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,5 49 Zamora Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,91 49 Zamora Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 96,14 49 Zamora Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 90,45 49 Zamora Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 91,48 49 Zamora Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 91,06 49 Zamora Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 88,39 49 Zamora Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 87,57 49 Zamora Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 86,04 49 Zamora Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 86,05 49 Zamora Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 49 Zamora Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 49 Zamora Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 3.927 49 Zamora Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 3.801 49 Zamora Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 3.480 49 Zamora Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 3.709 49 Zamora Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 3.643 49 Zamora Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 3.338 49 Zamora Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 3.549 49 Zamora Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 3.473 49 Zamora Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 3.151 49 Zamora Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 3.352 49 Zamora Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 3.025 49 Zamora Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 3.261 49 Zamora Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.969 49 Zamora Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 49 Zamora Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 49 Zamora Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 49 Zamora Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,45 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,84 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,92 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 90,37 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 91,37 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,55 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 88,19 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,93 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 85,79 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 85,32 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 52 49 Zamora Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 109 49 Zamora Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 333 49 Zamora Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 51 49 Zamora Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 107 49 Zamora Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 328 49 Zamora Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 50 49 Zamora Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 104 49 Zamora Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 321 49 Zamora Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 104 49 Zamora Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 314 49 Zamora Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 103 49 Zamora Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 312 49 Zamora Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 49 Zamora Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 49 Zamora Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 49 Zamora Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 98,08 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,17 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,5 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 96,15 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,41 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,4 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 95,41 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,29 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 94,5 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 93,69 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora Total Cohort October 1 Total Number at the start of the quarter 2022QIV 3.904 49 Zamora Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 49 Zamora Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 49 Zamora Total Cohort October 1 Total Number at the start of the quarter 2021QIV 3.942 49 Zamora Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 49 Zamora Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 49 Zamora Total Cohort October 1 Total Number at the start of the quarter 2020QIV 3.860 49 Zamora Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 49 Zamora Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 49 Zamora Total Cohort October 1 Total Survival in the first trimester 2022QIV 3.697 49 Zamora Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 49 Zamora Total Cohort October 1 Total Survival in the first trimester 2022QII "" 49 Zamora Total Cohort October 1 Total Survival in the first trimester 2022QI "" 49 Zamora Total Cohort October 1 Total Survival in the first trimester 2021QIV 3.721 49 Zamora Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 49 Zamora Total Cohort October 1 Total Survival in the first trimester 2021QII "" 49 Zamora Total Cohort October 1 Total Survival in the first trimester 2021QI "" 49 Zamora Total Cohort October 1 Total Survival in the first trimester 2020QIV 3.588 49 Zamora Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 49 Zamora Total Cohort October 1 Total Survival in the first trimester 2020QII "" 49 Zamora Total Cohort October 1 Total Survival in the first trimester 2020QI "" 49 Zamora Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 49 Zamora Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 49 Zamora Total Cohort October 1 Total Survival in the second trimester 2022QII "" 49 Zamora Total Cohort October 1 Total Survival in the second trimester 2022QI 3.570 49 Zamora Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 49 Zamora Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 49 Zamora Total Cohort October 1 Total Survival in the second trimester 2021QII "" 49 Zamora Total Cohort October 1 Total Survival in the second trimester 2021QI 3.436 49 Zamora Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 49 Zamora Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 49 Zamora Total Cohort October 1 Total Survival in the second trimester 2020QII "" 49 Zamora Total Cohort October 1 Total Survival in the second trimester 2020QI "" 49 Zamora Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 49 Zamora Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 49 Zamora Total Cohort October 1 Total Survival in the third trimester 2022QII 3.461 49 Zamora Total Cohort October 1 Total Survival in the third trimester 2022QI "" 49 Zamora Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 49 Zamora Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 49 Zamora Total Cohort October 1 Total Survival in the third trimester 2021QII 3.362 49 Zamora Total Cohort October 1 Total Survival in the third trimester 2021QI "" 49 Zamora Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 49 Zamora Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 49 Zamora Total Cohort October 1 Total Survival in the third trimester 2020QII "" 49 Zamora Total Cohort October 1 Total Survival in the third trimester 2020QI "" 49 Zamora Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 49 Zamora Total Cohort October 1 Total Survival in the third trimester 2022QIII 3.365 49 Zamora Total Cohort October 1 Total Survival in the third trimester 2022QII "" 49 Zamora Total Cohort October 1 Total Survival in the third trimester 2022QI "" 49 Zamora Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 49 Zamora Total Cohort October 1 Total Survival in the third trimester 2021QIII 3.302 49 Zamora Total Cohort October 1 Total Survival in the third trimester 2021QII "" 49 Zamora Total Cohort October 1 Total Survival in the third trimester 2021QI "" 49 Zamora Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 49 Zamora Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 49 Zamora Total Cohort October 1 Total Survival in the third trimester 2020QII "" 49 Zamora Total Cohort October 1 Total Survival in the third trimester 2020QI "" 49 Zamora Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 49 Zamora Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 49 Zamora Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 49 Zamora Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 49 Zamora Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 49 Zamora Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 49 Zamora Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 49 Zamora Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 49 Zamora Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,7 49 Zamora Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,39 49 Zamora Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 92,95 49 Zamora Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,56 49 Zamora Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,02 49 Zamora Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 87,8 49 Zamora Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 87,1 49 Zamora Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 85,36 49 Zamora Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 85,54 49 Zamora Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 49 Zamora Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 49 Zamora Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 3.857 49 Zamora Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3.764 49 Zamora Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 3.518 49 Zamora Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 3.651 49 Zamora Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 3.548 49 Zamora Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 3.256 49 Zamora Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 3.401 49 Zamora Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 3.112 49 Zamora Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 3.298 49 Zamora Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 3.041 49 Zamora Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 3.204 49 Zamora Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.984 49 Zamora Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 49 Zamora Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 49 Zamora Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 49 Zamora Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,66 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,26 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 92,55 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,36 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88,46 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 87,62 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,44 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 85,12 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 84,82 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 47 49 Zamora Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 178 49 Zamora Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 342 49 Zamora Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 46 49 Zamora Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 173 49 Zamora Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 332 49 Zamora Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 169 49 Zamora Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 324 49 Zamora Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 163 49 Zamora Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 321 49 Zamora Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 161 49 Zamora Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 318 49 Zamora Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 49 Zamora Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 49 Zamora Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 49 Zamora Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,87 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,19 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,08 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,94 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,74 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 91,57 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,86 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 90,45 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 92,98 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 49 Zamora From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 3.180 49 Zamora From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 49 Zamora From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 3.037 49 Zamora From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 3.251 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 2.980 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 2.862 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 2.815 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 2.858 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 2.770 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 2.702 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 2.751 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 2.707 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 2.634 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 2.668 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 2.638 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 2.535 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 49 Zamora From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 49 Zamora From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 49 Zamora From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 49 Zamora From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,71 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,24 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 86,59 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,87 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 91,21 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 83,11 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 86,51 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 89,13 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 81,02 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 83,9 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 86,86 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 77,98 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 3.069 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.792 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.874 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2.626 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.752 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.537 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.648 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.476 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.567 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2.413 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,65 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,05 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,67 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,87 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 86,28 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 88,68 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 83,64 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 86,43 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 111 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 245 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 106 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 236 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 106 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 233 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 103 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 231 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 101 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 225 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,5 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,33 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 95,5 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,1 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 92,79 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 94,29 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 90,99 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 91,84 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 3.163 49 Zamora From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 3.084 49 Zamora From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 2.998 49 Zamora From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 3.003 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 2.960 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 2.862 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 2.866 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 2.878 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 2.784 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 2.754 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 2.757 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 2.669 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 2.663 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 2.557 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 49 Zamora From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 49 Zamora From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 49 Zamora From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 49 Zamora From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,94 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,98 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,46 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 90,61 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 93,32 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,86 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 87,07 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 89,4 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,03 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 86,35 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,29 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 3.052 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.841 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2.784 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.894 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.720 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2.650 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.760 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.641 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2.576 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.650 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.526 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.470 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.436 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.361 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,82 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,74 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,19 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 90,43 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,96 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 92,53 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 86,83 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 88,91 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,72 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 85,74 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,81 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 111 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 243 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 214 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 109 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 240 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 212 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 106 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 237 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 208 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 104 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 231 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 199 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 227 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 196 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 98,2 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,77 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,07 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 95,5 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,53 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,2 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 93,69 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 95,06 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 92,99 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 93,42 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,59 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 3.204 49 Zamora From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 3.206 49 Zamora From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 3.123 49 Zamora From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 2.993 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 3.056 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 2.982 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 2.838 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 2.890 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 2.797 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 2.773 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 2.674 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 2.689 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 2.617 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 49 Zamora From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 49 Zamora From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 49 Zamora From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,41 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,32 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,49 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 88,58 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,14 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 89,56 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 86,49 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 85,62 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 83,87 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 83,8 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 3.165 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 3.142 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2.954 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.954 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.994 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.817 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.800 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.831 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.638 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.714 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.519 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.631 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.464 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,33 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,29 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,36 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 88,47 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 90,1 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 89,3 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 86,38 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 85,27 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 83,74 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 83,41 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 39 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 64 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 169 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 39 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 62 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 165 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 38 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 59 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 159 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 59 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 155 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 58 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 153 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,88 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,63 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,44 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 92,19 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,08 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 92,19 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 91,72 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 90,63 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 90,53 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 3.152 49 Zamora From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 3.217 49 Zamora From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 3.158 49 Zamora From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 2.955 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 3.004 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 2.896 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 2.860 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 2.754 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 2.764 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 2.684 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 2.670 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 2.627 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 49 Zamora From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 49 Zamora From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 49 Zamora From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 93,75 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,38 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 91,7 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,9 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 87,21 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 85,92 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 84,99 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 83 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 83,19 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 3.116 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3.087 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2.984 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.920 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.879 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2.730 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.739 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.593 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.648 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2.525 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.556 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.471 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,71 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 93,26 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 91,49 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,73 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 86,9 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 85,78 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 84,62 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 82,8 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 82,81 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 36 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 130 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 174 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 35 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 125 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 166 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 121 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 161 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 116 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 159 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 114 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 156 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 97,22 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,15 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 95,4 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 93,08 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 92,53 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 89,23 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 91,38 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 87,69 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 89,66 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 332 49 Zamora From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 304 49 Zamora From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 340 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 329 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 301 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 329 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 322 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 299 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 325 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 319 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 297 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 319 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 315 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 297 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 315 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 49 Zamora From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 49 Zamora From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,1 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,01 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,76 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,99 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,36 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,59 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,08 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,7 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 93,82 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 94,88 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,7 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 92,65 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 305 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 241 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 302 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 240 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 296 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 239 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 293 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 237 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 289 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 237 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,02 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,59 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 97,05 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 99,17 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,07 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,34 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 94,75 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 98,34 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 27 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 63 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 27 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 61 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 26 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 60 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 26 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 60 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 26 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 60 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,83 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 96,3 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,24 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 96,3 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,24 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 96,3 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 95,24 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 342 49 Zamora From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 303 49 Zamora From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 311 49 Zamora From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 333 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 302 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 308 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 331 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 300 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 303 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 328 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 297 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 302 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 294 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 294 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 49 Zamora From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 49 Zamora From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 49 Zamora From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,37 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,67 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,04 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,78 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,01 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,43 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,91 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,02 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,11 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,03 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,53 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 323 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 245 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 218 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 315 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 245 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 215 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 313 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 243 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 212 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 310 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 240 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 211 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 238 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 206 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,52 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,62 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,9 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 99,18 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,25 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,98 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,96 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,79 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,14 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,5 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 19 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 58 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 93 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 18 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 57 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 93 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 18 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 57 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 91 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 18 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 57 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 91 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 56 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 88 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 94,74 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,28 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 94,74 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,28 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,85 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 94,74 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 98,28 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,85 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,55 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,62 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 379 49 Zamora From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 309 49 Zamora From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 318 49 Zamora From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 373 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 301 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 313 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 367 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 298 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 309 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 296 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 303 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 293 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 302 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 49 Zamora From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 49 Zamora From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 49 Zamora From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,42 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 97,41 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,43 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,83 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 96,44 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,17 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,79 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,28 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 94,82 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 94,97 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 371 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 293 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 257 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 365 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 285 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 253 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 359 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 282 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 249 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 280 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 245 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 277 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 244 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,38 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 97,27 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,44 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,77 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 96,25 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,89 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,56 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,33 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,54 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,94 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 8 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 16 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 61 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 8 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 16 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 60 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 8 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 16 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 60 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 16 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 58 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 16 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 58 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,36 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,36 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 95,08 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 95,08 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 343 49 Zamora From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 317 49 Zamora From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 312 49 Zamora From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 335 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 312 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 308 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 309 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 303 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 303 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 300 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 302 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 299 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 49 Zamora From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 49 Zamora From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 49 Zamora From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,67 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,42 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,72 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,48 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,12 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95,58 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,15 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,27 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,83 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 337 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 289 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 245 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 329 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 284 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 242 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 281 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 239 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 276 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 237 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 275 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 236 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,63 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,27 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,78 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,23 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,55 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,5 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,73 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,16 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,33 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 6 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 28 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 67 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 6 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 28 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 66 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 28 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 64 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 27 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 63 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 27 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 63 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,51 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,52 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 96,43 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 94,03 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 96,43 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 94,03 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 49 Zamora From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 380 49 Zamora From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 49 Zamora From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 347 49 Zamora From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 376 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 376 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 343 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 372 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 369 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 342 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 369 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 366 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 340 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 369 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 366 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 338 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 364 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 49 Zamora From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 49 Zamora From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 49 Zamora From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 49 Zamora From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,95 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,85 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,94 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 97,11 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,56 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,14 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 96,32 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,98 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 98,14 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,32 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,41 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,81 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 360 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 256 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 356 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 254 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 349 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 253 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 347 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 251 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 347 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 249 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,89 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,22 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,94 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,83 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 96,39 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,05 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,39 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 97,27 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 20 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 91 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 20 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 89 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 20 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 89 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 19 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 89 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 19 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 89 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,8 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,8 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 95 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,8 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 95 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,8 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 382 49 Zamora From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 353 49 Zamora From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 344 49 Zamora From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 376 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 351 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 341 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 373 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 349 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 341 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 373 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 348 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 337 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 346 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 335 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 49 Zamora From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 49 Zamora From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 49 Zamora From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 49 Zamora From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,43 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,43 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,13 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,64 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,87 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,13 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,64 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,58 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,97 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,02 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,38 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 357 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 256 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 250 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 351 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 254 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 248 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 348 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 252 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 248 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 348 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 251 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 245 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 250 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 244 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,32 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,22 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,2 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,48 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,44 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,2 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,48 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 98,05 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,66 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,6 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 25 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 97 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 94 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 25 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 97 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 93 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 25 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 97 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 93 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 25 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 97 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 92 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 96 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 91 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,94 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,94 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 97,87 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 98,97 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 96,81 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 380 49 Zamora From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 378 49 Zamora From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 354 49 Zamora From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 378 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 376 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 353 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 378 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 372 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 348 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 370 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 345 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 366 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 345 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 49 Zamora From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 49 Zamora From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 49 Zamora From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,47 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,47 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,72 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 99,47 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,41 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,31 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,88 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,46 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 96,83 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,46 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 375 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 350 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 255 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 374 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 348 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 254 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 374 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 344 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 250 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 342 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 248 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 338 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 248 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,73 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,43 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,61 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 99,73 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,29 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 98,04 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,71 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,25 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 96,57 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,25 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 5 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 28 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 99 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 4 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 28 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 99 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 4 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 28 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 98 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 28 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 97 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 28 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 97 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 80 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 80 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,99 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,98 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,98 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 392 49 Zamora From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 391 49 Zamora From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 372 49 Zamora From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 390 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 388 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 366 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 384 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 362 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 378 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 361 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 377 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 359 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 49 Zamora From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 49 Zamora From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 49 Zamora From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,49 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,23 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,39 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,21 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,31 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,68 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,04 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,42 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,51 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 387 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 372 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 276 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 385 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 369 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 271 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 365 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 268 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 359 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 267 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 358 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 265 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,48 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,19 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,19 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,12 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,1 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 96,51 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,74 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,24 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 96,01 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 5 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 19 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 96 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 5 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 19 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 95 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 19 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 94 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 19 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 94 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 19 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 94 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 98,96 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 97,92 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,92 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 97,92 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 49 Zamora from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 12 49 Zamora from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 49 Zamora from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 12 49 Zamora from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 10 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 12 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 12 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 10 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 11 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 12 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 10 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 11 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 12 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 10 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 11 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 12 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 10 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 49 Zamora from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 49 Zamora from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 49 Zamora from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 49 Zamora from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 91,67 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 91,67 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 91,67 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 12 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 8 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 12 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 8 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 11 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 8 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 11 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 8 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 11 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 8 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 91,67 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 91,67 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 91,67 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 0 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 4 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 0 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 4 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 0 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 4 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 0 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 4 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 0 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 4 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI .. 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI .. 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII .. 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII .. 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 0 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 13 49 Zamora from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 11 49 Zamora from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 10 49 Zamora from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 12 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 11 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 10 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 12 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 11 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 10 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 12 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 11 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 10 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 11 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 10 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 49 Zamora from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 49 Zamora from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 49 Zamora from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 49 Zamora from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 92,31 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 92,31 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 92,31 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 49 Zamora from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 13 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 7 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 6 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 12 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 7 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 6 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 12 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 7 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 6 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 12 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 7 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 6 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 7 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 6 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 92,31 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 92,31 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 92,31 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 0 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 4 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 4 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 0 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 4 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 4 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 0 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 4 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 4 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 0 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 4 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 4 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 4 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 4 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII .. 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII .. 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII .. 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 0 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 11 49 Zamora from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 12 49 Zamora from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 12 49 Zamora from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 11 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 12 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 12 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 11 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 12 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 12 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 12 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 12 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 11 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 12 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 49 Zamora from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 49 Zamora from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 49 Zamora from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 91,67 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 11 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 11 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 8 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 11 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 11 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 8 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 11 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 11 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 8 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 11 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 8 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 10 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 8 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 90,91 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 4 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 4 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 4 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 4 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 4 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII .. 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII .. 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 12 49 Zamora from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 13 49 Zamora from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 12 49 Zamora from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 12 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 13 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 12 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 13 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 12 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 12 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 12 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 12 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 12 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 49 Zamora from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 49 Zamora from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 49 Zamora from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 92,31 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 92,31 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 12 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 12 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 7 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 12 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 12 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 7 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 12 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 7 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 11 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 7 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 11 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 7 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 91,67 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 91,67 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 1 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 5 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 1 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 5 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 1 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 5 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 1 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 5 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 1 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 5 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 49 Zamora De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 5 49 Zamora De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 49 Zamora De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 6 49 Zamora De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 49 Zamora De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 7 49 Zamora De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 5 49 Zamora De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 5 49 Zamora De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 7 49 Zamora De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 5 49 Zamora De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 5 49 Zamora De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 7 49 Zamora De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 5 49 Zamora De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 5 49 Zamora De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 7 49 Zamora De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 5 49 Zamora De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 5 49 Zamora De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 7 49 Zamora De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 49 Zamora De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 49 Zamora De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 49 Zamora De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 49 Zamora De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 49 Zamora De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 49 Zamora De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 49 Zamora De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 83,33 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 83,33 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 83,33 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 83,33 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 49 Zamora De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 5 49 Zamora De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 6 49 Zamora De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 5 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 5 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 5 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 5 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 5 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 5 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 5 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 5 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 49 Zamora De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 49 Zamora De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 83,33 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 83,33 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 83,33 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 83,33 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 0 49 Zamora De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 0 49 Zamora De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 0 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 0 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 0 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 0 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 0 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 0 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 0 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 0 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI .. 49 Zamora De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI .. 49 Zamora De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI .. 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI .. 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII .. 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII .. 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII .. 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII .. 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 0 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV .. 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 5 49 Zamora De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 49 Zamora De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 5 49 Zamora De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 49 Zamora De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 7 49 Zamora De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 5 49 Zamora De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 5 49 Zamora De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 7 49 Zamora De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 5 49 Zamora De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 5 49 Zamora De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 7 49 Zamora De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 5 49 Zamora De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 5 49 Zamora De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 7 49 Zamora De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 5 49 Zamora De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 6 49 Zamora De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 49 Zamora De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 49 Zamora De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 49 Zamora De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 49 Zamora De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 49 Zamora De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 49 Zamora De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 49 Zamora De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,71 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 49 Zamora De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 5 49 Zamora De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 5 49 Zamora De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 7 49 Zamora De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 5 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 5 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 7 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 5 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 5 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 7 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 5 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 5 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 7 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 5 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 6 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 49 Zamora De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 49 Zamora De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 49 Zamora De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 85,71 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 0 49 Zamora De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 0 49 Zamora De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 0 49 Zamora De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 0 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 0 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 0 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 0 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 0 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 0 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 0 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 0 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 0 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 0 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 0 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII .. 49 Zamora De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII .. 49 Zamora De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII .. 49 Zamora De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII .. 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII .. 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII .. 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII .. 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII .. 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII .. 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 0 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV .. 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV .. 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI .. 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI .. 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 5 49 Zamora De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 49 Zamora De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 49 Zamora De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 5 49 Zamora De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 49 Zamora De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 49 Zamora De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 6 49 Zamora De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 49 Zamora De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 5 49 Zamora De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 5 49 Zamora De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 6 49 Zamora De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 5 49 Zamora De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 5 49 Zamora De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 6 49 Zamora De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 5 49 Zamora De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 5 49 Zamora De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 5 49 Zamora De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 5 49 Zamora De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 49 Zamora De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 49 Zamora De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 49 Zamora De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 49 Zamora De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 49 Zamora De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 49 Zamora De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 49 Zamora De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 49 Zamora De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 49 Zamora De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 49 Zamora De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 49 Zamora De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 49 Zamora De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 49 Zamora De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 83,33 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 83,33 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 49 Zamora De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 5 49 Zamora De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 5 49 Zamora De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 6 49 Zamora De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 5 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 5 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 6 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 5 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 5 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 6 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 5 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 5 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 5 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 5 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 49 Zamora De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 49 Zamora De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 49 Zamora De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 83,33 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 83,33 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 49 Zamora De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 0 49 Zamora De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 0 49 Zamora De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 0 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 0 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 0 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 0 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 0 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 0 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 0 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 0 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII .. 49 Zamora De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII .. 49 Zamora De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII .. 49 Zamora De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII .. 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII .. 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII .. 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV .. 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV .. 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI .. 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI .. 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII .. 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII .. 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 5 49 Zamora De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 49 Zamora De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 49 Zamora De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 4 49 Zamora De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 49 Zamora De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 49 Zamora De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 6 49 Zamora De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 49 Zamora De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 5 49 Zamora De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 4 49 Zamora De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 6 49 Zamora De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 4 49 Zamora De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 5 49 Zamora De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 4 49 Zamora De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 5 49 Zamora De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 4 49 Zamora De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 5 49 Zamora De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 49 Zamora De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 49 Zamora De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 49 Zamora De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 49 Zamora De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 49 Zamora De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 49 Zamora De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 49 Zamora De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 49 Zamora De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 49 Zamora De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 49 Zamora De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 49 Zamora De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 49 Zamora De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 83,33 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 83,33 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 83,33 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 49 Zamora De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 5 49 Zamora De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 4 49 Zamora De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 6 49 Zamora De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 5 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 4 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 6 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 4 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 5 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 4 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 5 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 4 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 5 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 49 Zamora De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 49 Zamora De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 49 Zamora De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 83,33 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 83,33 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 83,33 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 49 Zamora De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 0 49 Zamora De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 0 49 Zamora De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 0 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 0 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 0 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 0 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 0 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 0 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 0 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 0 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 49 Zamora De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV .. 49 Zamora De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV .. 49 Zamora De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV .. 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV .. 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI .. 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI .. 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII .. 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII .. 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII .. 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII .. 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 49 Zamora De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza Total Cohort January 1 Total Number at the start of the quarter 2022QI 22.596 50 Zaragoza Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza Total Cohort January 1 Total Number at the start of the quarter 2021QI 22.140 50 Zaragoza Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza Total Cohort January 1 Total Number at the start of the quarter 2020QI 23.177 50 Zaragoza Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 50 Zaragoza Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 50 Zaragoza Total Cohort January 1 Total Survival in the first trimester 2022QII "" 50 Zaragoza Total Cohort January 1 Total Survival in the first trimester 2022QI 21.512 50 Zaragoza Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 50 Zaragoza Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 50 Zaragoza Total Cohort January 1 Total Survival in the first trimester 2021QII "" 50 Zaragoza Total Cohort January 1 Total Survival in the first trimester 2021QI 21.173 50 Zaragoza Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 50 Zaragoza Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 50 Zaragoza Total Cohort January 1 Total Survival in the first trimester 2020QII "" 50 Zaragoza Total Cohort January 1 Total Survival in the first trimester 2020QI 21.054 50 Zaragoza Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 50 Zaragoza Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 50 Zaragoza Total Cohort January 1 Total Survival in the second trimester 2022QII 20.664 50 Zaragoza Total Cohort January 1 Total Survival in the second trimester 2022QI "" 50 Zaragoza Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 50 Zaragoza Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 50 Zaragoza Total Cohort January 1 Total Survival in the second trimester 2021QII 20.483 50 Zaragoza Total Cohort January 1 Total Survival in the second trimester 2021QI "" 50 Zaragoza Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 50 Zaragoza Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 50 Zaragoza Total Cohort January 1 Total Survival in the second trimester 2020QII 20.409 50 Zaragoza Total Cohort January 1 Total Survival in the second trimester 2020QI "" 50 Zaragoza Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza Total Cohort January 1 Total Survival in the third trimester 2022QIII 20.002 50 Zaragoza Total Cohort January 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza Total Cohort January 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza Total Cohort January 1 Total Survival in the third trimester 2021QIII 19.964 50 Zaragoza Total Cohort January 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza Total Cohort January 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza Total Cohort January 1 Total Survival in the third trimester 2020QIII 19.861 50 Zaragoza Total Cohort January 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza Total Cohort January 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza Total Cohort January 1 Total Survival in the third trimester 2022QIV 19.503 50 Zaragoza Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza Total Cohort January 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza Total Cohort January 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza Total Cohort January 1 Total Survival in the third trimester 2021QIV 19.470 50 Zaragoza Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza Total Cohort January 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza Total Cohort January 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza Total Cohort January 1 Total Survival in the third trimester 2020QIV 19.337 50 Zaragoza Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza Total Cohort January 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza Total Cohort January 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 50 Zaragoza Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 50 Zaragoza Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,2 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 95,63 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 90,84 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 91,45 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 92,52 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 88,06 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 88,52 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 90,17 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 85,69 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 86,31 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 87,94 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 83,43 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 21.924 50 Zaragoza Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 19.987 50 Zaragoza Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 20.859 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 19.088 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 20.031 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 18.440 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 19.379 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 17.956 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 18.887 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 17.512 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 50 Zaragoza Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 50 Zaragoza Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 95,14 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 95,5 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 91,37 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 92,26 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 88,39 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 89,84 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 86,15 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 87,62 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 672 50 Zaragoza Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 2.153 50 Zaragoza Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 653 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 2.085 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 633 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 2.043 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 623 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 2.008 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 616 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1.958 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 50 Zaragoza Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 50 Zaragoza Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,17 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,84 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 94,2 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,89 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 92,71 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 93,27 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 91,67 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 90,94 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza Total Cohort April 1 Total Number at the start of the quarter 2022QII 22.512 50 Zaragoza Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza Total Cohort April 1 Total Number at the start of the quarter 2021QII 22.163 50 Zaragoza Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza Total Cohort April 1 Total Number at the start of the quarter 2020QII 21.819 50 Zaragoza Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 50 Zaragoza Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 50 Zaragoza Total Cohort April 1 Total Survival in the first trimester 2022QII 21.468 50 Zaragoza Total Cohort April 1 Total Survival in the first trimester 2022QI "" 50 Zaragoza Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 50 Zaragoza Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 50 Zaragoza Total Cohort April 1 Total Survival in the first trimester 2021QII 21.303 50 Zaragoza Total Cohort April 1 Total Survival in the first trimester 2021QI "" 50 Zaragoza Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 50 Zaragoza Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 50 Zaragoza Total Cohort April 1 Total Survival in the first trimester 2020QII 21.077 50 Zaragoza Total Cohort April 1 Total Survival in the first trimester 2020QI "" 50 Zaragoza Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 50 Zaragoza Total Cohort April 1 Total Survival in the second trimester 2022QIII 20.671 50 Zaragoza Total Cohort April 1 Total Survival in the second trimester 2022QII "" 50 Zaragoza Total Cohort April 1 Total Survival in the second trimester 2022QI "" 50 Zaragoza Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 50 Zaragoza Total Cohort April 1 Total Survival in the second trimester 2021QIII 20.667 50 Zaragoza Total Cohort April 1 Total Survival in the second trimester 2021QII "" 50 Zaragoza Total Cohort April 1 Total Survival in the second trimester 2021QI "" 50 Zaragoza Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 50 Zaragoza Total Cohort April 1 Total Survival in the second trimester 2020QIII 20.446 50 Zaragoza Total Cohort April 1 Total Survival in the second trimester 2020QII "" 50 Zaragoza Total Cohort April 1 Total Survival in the second trimester 2020QI "" 50 Zaragoza Total Cohort April 1 Total Survival in the third trimester 2022QIV 20.089 50 Zaragoza Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza Total Cohort April 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza Total Cohort April 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza Total Cohort April 1 Total Survival in the third trimester 2021QIV 20.073 50 Zaragoza Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza Total Cohort April 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza Total Cohort April 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza Total Cohort April 1 Total Survival in the third trimester 2020QIV 19.859 50 Zaragoza Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza Total Cohort April 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza Total Cohort April 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza Total Cohort April 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza Total Cohort April 1 Total Survival in the third trimester 2022QI 19.427 50 Zaragoza Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza Total Cohort April 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza Total Cohort April 1 Total Survival in the third trimester 2021QI 19.248 50 Zaragoza Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza Total Cohort April 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza Total Cohort April 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 50 Zaragoza Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 50 Zaragoza Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 50 Zaragoza Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 95,36 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 96,12 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,6 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 91,82 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 93,25 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 93,71 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 89,24 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 90,57 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 91,02 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 87,66 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 88,22 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 21.861 50 Zaragoza Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 20.039 50 Zaragoza Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 18.726 50 Zaragoza Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 20.844 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 19.220 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 18.038 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 20.063 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 18.625 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 17.464 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 19.491 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 18.083 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 16.950 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 17.483 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 16.412 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 50 Zaragoza Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 50 Zaragoza Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 50 Zaragoza Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 95,35 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,91 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 96,33 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 91,78 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 92,94 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 93,26 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 89,16 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 90,24 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 90,52 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 87,24 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 87,64 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 651 50 Zaragoza Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 2.124 50 Zaragoza Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 3.093 50 Zaragoza Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 624 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 2.083 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 3.039 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 608 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 2.042 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 2.982 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 598 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1.990 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 2.909 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1.944 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 2.836 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 50 Zaragoza Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 50 Zaragoza Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 50 Zaragoza Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 95,85 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,07 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,25 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 93,39 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,14 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,41 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 91,86 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 93,69 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 94,05 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 91,53 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,69 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza Total Cohort July 1 Total Number at the start of the quarter 2022QIII 22.565 50 Zaragoza Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza Total Cohort July 1 Total Number at the start of the quarter 2021QIII 22.458 50 Zaragoza Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza Total Cohort July 1 Total Number at the start of the quarter 2020QIII 22.168 50 Zaragoza Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 50 Zaragoza Total Cohort July 1 Total Survival in the first trimester 2022QIII 21.459 50 Zaragoza Total Cohort July 1 Total Survival in the first trimester 2022QII "" 50 Zaragoza Total Cohort July 1 Total Survival in the first trimester 2022QI "" 50 Zaragoza Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 50 Zaragoza Total Cohort July 1 Total Survival in the first trimester 2021QIII 21.526 50 Zaragoza Total Cohort July 1 Total Survival in the first trimester 2021QII "" 50 Zaragoza Total Cohort July 1 Total Survival in the first trimester 2021QI "" 50 Zaragoza Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 50 Zaragoza Total Cohort July 1 Total Survival in the first trimester 2020QIII 21.259 50 Zaragoza Total Cohort July 1 Total Survival in the first trimester 2020QII "" 50 Zaragoza Total Cohort July 1 Total Survival in the first trimester 2020QI "" 50 Zaragoza Total Cohort July 1 Total Survival in the second trimester 2022QIV 20.733 50 Zaragoza Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 50 Zaragoza Total Cohort July 1 Total Survival in the second trimester 2022QII "" 50 Zaragoza Total Cohort July 1 Total Survival in the second trimester 2022QI "" 50 Zaragoza Total Cohort July 1 Total Survival in the second trimester 2021QIV 20.770 50 Zaragoza Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 50 Zaragoza Total Cohort July 1 Total Survival in the second trimester 2021QII "" 50 Zaragoza Total Cohort July 1 Total Survival in the second trimester 2021QI "" 50 Zaragoza Total Cohort July 1 Total Survival in the second trimester 2020QIV 20.514 50 Zaragoza Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 50 Zaragoza Total Cohort July 1 Total Survival in the second trimester 2020QII "" 50 Zaragoza Total Cohort July 1 Total Survival in the second trimester 2020QI "" 50 Zaragoza Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza Total Cohort July 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza Total Cohort July 1 Total Survival in the third trimester 2022QI 20.045 50 Zaragoza Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza Total Cohort July 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza Total Cohort July 1 Total Survival in the third trimester 2021QI 19.843 50 Zaragoza Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza Total Cohort July 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza Total Cohort July 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza Total Cohort July 1 Total Survival in the third trimester 2022QII 19.536 50 Zaragoza Total Cohort July 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza Total Cohort July 1 Total Survival in the third trimester 2021QII 19.415 50 Zaragoza Total Cohort July 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza Total Cohort July 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza Total Cohort July 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 50 Zaragoza Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 50 Zaragoza Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 50 Zaragoza Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 95,1 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,85 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,9 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 91,88 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 92,48 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 92,54 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 89,26 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 89,51 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 86,99 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 87,58 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 22.184 50 Zaragoza Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 21.853 50 Zaragoza Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 19.728 50 Zaragoza Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 21.091 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 20.927 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 18.859 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 20.373 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 20.190 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 18.171 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 19.476 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 17.563 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 18.978 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 17.173 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 50 Zaragoza Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 50 Zaragoza Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 50 Zaragoza Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 95,07 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,76 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 95,6 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 91,84 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 92,39 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 92,11 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 89,12 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 89,03 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 86,84 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 87,05 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 381 50 Zaragoza Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 605 50 Zaragoza Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2.440 50 Zaragoza Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 368 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 599 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2.400 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 360 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 580 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 2.343 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 569 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2.280 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 558 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 2.242 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 50 Zaragoza Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 50 Zaragoza Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 50 Zaragoza Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 96,59 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,01 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,36 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 94,49 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,87 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 96,02 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 94,05 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,44 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 92,23 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,89 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza Total Cohort October 1 Total Number at the start of the quarter 2022QIV 22.432 50 Zaragoza Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza Total Cohort October 1 Total Number at the start of the quarter 2021QIV 22.530 50 Zaragoza Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza Total Cohort October 1 Total Number at the start of the quarter 2020QIV 22.192 50 Zaragoza Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza Total Cohort October 1 Total Survival in the first trimester 2022QIV 21.518 50 Zaragoza Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 50 Zaragoza Total Cohort October 1 Total Survival in the first trimester 2022QII "" 50 Zaragoza Total Cohort October 1 Total Survival in the first trimester 2022QI "" 50 Zaragoza Total Cohort October 1 Total Survival in the first trimester 2021QIV 21.566 50 Zaragoza Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 50 Zaragoza Total Cohort October 1 Total Survival in the first trimester 2021QII "" 50 Zaragoza Total Cohort October 1 Total Survival in the first trimester 2021QI "" 50 Zaragoza Total Cohort October 1 Total Survival in the first trimester 2020QIV 21.219 50 Zaragoza Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 50 Zaragoza Total Cohort October 1 Total Survival in the first trimester 2020QII "" 50 Zaragoza Total Cohort October 1 Total Survival in the first trimester 2020QI "" 50 Zaragoza Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 50 Zaragoza Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 50 Zaragoza Total Cohort October 1 Total Survival in the second trimester 2022QII "" 50 Zaragoza Total Cohort October 1 Total Survival in the second trimester 2022QI 20.721 50 Zaragoza Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 50 Zaragoza Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 50 Zaragoza Total Cohort October 1 Total Survival in the second trimester 2021QII "" 50 Zaragoza Total Cohort October 1 Total Survival in the second trimester 2021QI 20.459 50 Zaragoza Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 50 Zaragoza Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 50 Zaragoza Total Cohort October 1 Total Survival in the second trimester 2020QII "" 50 Zaragoza Total Cohort October 1 Total Survival in the second trimester 2020QI "" 50 Zaragoza Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza Total Cohort October 1 Total Survival in the third trimester 2022QII 20.046 50 Zaragoza Total Cohort October 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza Total Cohort October 1 Total Survival in the third trimester 2021QII 19.912 50 Zaragoza Total Cohort October 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza Total Cohort October 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza Total Cohort October 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza Total Cohort October 1 Total Survival in the third trimester 2022QIII 19.481 50 Zaragoza Total Cohort October 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza Total Cohort October 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza Total Cohort October 1 Total Survival in the third trimester 2021QIII 19.464 50 Zaragoza Total Cohort October 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza Total Cohort October 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza Total Cohort October 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza Total Cohort October 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 50 Zaragoza Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 50 Zaragoza Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 50 Zaragoza Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 95,93 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 95,72 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 95,62 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 91,97 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 92,19 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 88,97 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 89,73 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 86,47 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 87,71 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 22.130 50 Zaragoza Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 21.826 50 Zaragoza Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 20.081 50 Zaragoza Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 21.222 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 20.879 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 19.166 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 20.045 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 18.467 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 19.385 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 17.951 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 18.831 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 17.536 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 50 Zaragoza Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 50 Zaragoza Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 50 Zaragoza Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 95,9 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 95,66 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 95,44 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 91,84 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 91,96 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 88,82 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 89,39 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 86,28 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 87,33 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 302 50 Zaragoza Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 704 50 Zaragoza Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 2.111 50 Zaragoza Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 296 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 687 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 2.053 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 676 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1.992 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 661 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1.961 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 650 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1.928 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 50 Zaragoza Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 50 Zaragoza Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 50 Zaragoza Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 98,01 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,59 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,25 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 96,02 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,36 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 93,89 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,89 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 92,33 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 91,33 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 16.410 50 Zaragoza From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 16.291 50 Zaragoza From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 16.866 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 15.386 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 15.381 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 14.930 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 14.638 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 14.775 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 14.374 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 14.029 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 14.317 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 13.884 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 13.577 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 13.869 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 13.421 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 50 Zaragoza From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 50 Zaragoza From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,76 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 94,41 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 88,52 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,2 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90,69 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 85,22 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 85,49 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,88 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 82,32 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 82,74 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 85,13 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 79,57 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 16.061 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 15.269 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 15.052 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 14.413 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 14.320 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 13.837 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 13.719 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 13.405 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 13.273 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 12.997 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,72 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 94,39 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,16 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 90,62 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 85,42 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 87,79 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 82,64 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 85,12 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 349 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1.022 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 334 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 968 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 318 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 938 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 310 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 912 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 304 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 872 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 95,7 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 94,72 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 91,12 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 91,78 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 88,83 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 89,24 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 87,11 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 85,32 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 16.289 50 Zaragoza From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 16.241 50 Zaragoza From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 15.954 50 Zaragoza From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 15.336 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 15.462 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 15.279 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 14.588 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 14.887 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 14.692 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 14.064 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 14.345 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 14.155 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 13.759 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 13.611 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 50 Zaragoza From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 50 Zaragoza From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 50 Zaragoza From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 94,15 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,2 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 95,77 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,56 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,66 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,09 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 86,34 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 88,33 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 88,72 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 84,72 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,31 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 15.952 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 15.246 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 14.386 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 15.024 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 14.498 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 13.743 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 14.290 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 13.953 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 13.207 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 13.775 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 13.452 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 12.726 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 12.899 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 12.233 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 94,18 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 95,09 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,53 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 89,58 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,52 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,8 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 86,35 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 88,23 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,46 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 84,61 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 85,03 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 337 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 995 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1.568 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 312 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 964 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1.536 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 298 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 934 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1.485 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 289 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 893 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1.429 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 860 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1.378 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 92,58 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,88 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,96 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 88,43 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 93,87 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 94,71 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 85,76 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 89,75 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,14 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 86,43 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 87,88 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 16.340 50 Zaragoza From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 16.392 50 Zaragoza From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 16.283 50 Zaragoza From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 15.281 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 15.516 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 15.414 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 14.621 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 14.817 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 14.717 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 14.165 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 14.115 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 13.706 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 13.729 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 50 Zaragoza From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 50 Zaragoza From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 50 Zaragoza From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,52 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,66 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,66 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,48 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,39 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,38 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 86,41 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 86,69 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 83,61 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 84,31 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 16.111 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 16.102 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 15.161 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 15.064 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 15.230 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 14.326 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 14.412 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 14.547 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 13.669 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 13.904 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 13.110 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 13.455 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 12.754 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,5 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,58 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,49 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,45 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 90,34 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,16 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 86,35 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,47 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 83,56 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 84,12 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 229 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 290 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1.122 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 217 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 286 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1.088 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 209 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 270 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1.048 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 261 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1.005 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 251 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 975 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 94,76 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,62 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 96,97 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 91,27 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,1 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 93,4 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 90 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 89,57 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 86,55 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 86,9 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 16.169 50 Zaragoza From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 16.438 50 Zaragoza From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 16.318 50 Zaragoza From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 15.310 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 15.526 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 15.390 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 14.749 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 14.691 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 14.151 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 14.207 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 13.635 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 13.813 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 50 Zaragoza From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 50 Zaragoza From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 50 Zaragoza From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,69 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,45 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 94,31 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 89,73 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,03 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 86,09 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 87,06 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 82,95 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 84,65 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 15.993 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 16.044 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 15.384 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 15.140 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 15.145 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 14.500 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 14.376 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 13.844 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 13.791 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 13.381 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 13.286 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 13.011 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,67 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,4 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 94,25 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 89,6 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 89,99 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 85,96 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,98 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 82,81 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 84,57 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 176 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 394 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 934 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 170 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 381 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 890 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 373 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 847 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 360 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 826 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 349 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 802 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 96,59 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,7 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 95,29 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 94,67 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 90,69 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 91,37 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 88,44 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 88,58 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 85,87 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 2.386 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 2.268 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 2.447 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 2.350 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 2.236 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 2.365 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 2.293 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 2.190 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 2.324 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 2.258 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 2.154 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 2.293 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 2.237 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 2.132 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 2.254 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 98,49 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,59 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,65 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 96,1 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,56 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 94,97 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 94,64 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 94,97 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 93,71 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,76 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 92,11 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2.290 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.917 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2.256 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.892 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2.201 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.851 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2.167 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.819 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2.147 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.801 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 98,52 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,7 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 96,11 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,56 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 94,63 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 94,89 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,76 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 93,95 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 96 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 351 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 94 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 344 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 92 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 339 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 91 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 335 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 90 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 331 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 97,92 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,01 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 95,83 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,58 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 94,79 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 95,44 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 93,75 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 94,3 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 2.371 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 2.335 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 2.297 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 2.323 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 2.290 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 2.264 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 2.295 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 2.252 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 2.244 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 2.264 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 2.227 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 2.210 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 2.193 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 2.173 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,98 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,07 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,56 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 96,79 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,45 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,69 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 95,49 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 95,37 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,21 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,92 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,6 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2.280 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.996 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.793 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2.234 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.956 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.768 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2.207 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.924 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.748 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2.176 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.903 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.723 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.875 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.695 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,98 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,61 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 96,8 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,39 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 97,49 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,44 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,34 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,1 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,94 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,53 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 91 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 339 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 504 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 89 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 334 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 496 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 88 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 328 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 496 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 88 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 324 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 487 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 318 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 478 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 97,8 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,53 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,41 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 96,7 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 96,76 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 98,41 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 96,7 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 95,58 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,63 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 93,81 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,84 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 2.366 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 2.383 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 2.300 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 2.335 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 2.350 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 2.282 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 2.298 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 2.319 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 2.251 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 2.276 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 2.209 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 2.247 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 2.181 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,69 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,62 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,22 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,13 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,31 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,87 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 95,51 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,04 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 94,29 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 94,83 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 2.320 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2.287 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.895 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 2.290 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2.255 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.878 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 2.253 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2.227 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.857 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2.185 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.825 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2.157 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.801 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,71 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,6 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,1 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,11 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,38 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,99 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,54 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,31 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,32 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,04 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 46 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 96 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 405 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 45 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 95 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 404 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 45 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 92 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 394 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 91 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 384 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 90 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 380 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 97,83 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 98,96 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,75 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 97,83 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 95,83 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,28 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 94,79 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 94,81 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,75 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 93,83 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 2.363 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 2.347 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 2.239 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 2.335 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 2.321 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 2.212 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 2.280 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 2.182 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 2.238 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 2.144 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 2.210 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 2.116 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,82 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,89 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 98,79 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 97,15 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,45 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 95,36 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 95,76 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 94,16 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 94,51 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2.332 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 2.247 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.906 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2.304 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 2.223 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.886 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 2.184 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.865 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 2.143 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.831 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 2.115 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.806 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,8 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,93 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 98,95 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 97,2 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,85 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,37 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 96,07 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 94,13 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 94,75 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 31 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 333 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 31 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 98 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 326 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 96 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 317 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 95 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 313 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 95 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 310 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,9 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 96 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,2 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 95 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,99 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 95 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,09 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 3.484 50 Zaragoza From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 3.285 50 Zaragoza From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 3.547 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 3.461 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 3.261 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 3.451 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 3.418 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 3.224 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 3.403 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 3.402 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 3.200 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 3.378 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 3.376 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 3.177 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 3.357 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 50 Zaragoza From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 50 Zaragoza From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,34 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,27 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,29 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,11 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,14 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,94 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 97,65 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,41 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 95,24 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 96,9 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 96,71 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,64 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 3.286 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2.590 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 3.265 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2.572 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 3.224 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2.542 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 3.209 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2.523 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 3.183 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2.506 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,36 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,31 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,11 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 98,15 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 97,66 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 97,41 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 96,87 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,76 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 198 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 695 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 196 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 689 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 194 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 682 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 193 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 677 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 193 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 671 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 98,99 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 99,14 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 97,98 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98,13 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 97,47 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,41 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 97,47 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,55 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 3.530 50 Zaragoza From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 3.292 50 Zaragoza From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 3.275 50 Zaragoza From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 3.487 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 3.256 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 3.241 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 3.468 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 3.234 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 3.219 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 3.441 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 3.208 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 3.204 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 3.183 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 3.175 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 50 Zaragoza From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 50 Zaragoza From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 50 Zaragoza From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,78 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,91 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,96 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 98,24 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,24 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,29 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 97,48 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,45 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,83 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 96,69 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,95 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 3.336 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2.585 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2.351 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 3.293 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2.554 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2.331 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 3.275 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2.537 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2.315 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 3.249 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2.518 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2.308 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2.499 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2.291 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,71 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 98,8 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,15 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,17 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,14 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,47 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 97,39 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,41 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,17 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,67 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,45 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 194 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 707 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 924 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 194 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 702 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 910 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 193 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 697 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 904 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 192 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 690 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 896 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 684 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 884 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 99,29 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,48 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 99,48 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 98,59 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 97,84 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 98,97 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,6 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 96,97 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 96,75 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,67 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 3.537 50 Zaragoza From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 3.381 50 Zaragoza From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 3.296 50 Zaragoza From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 3.523 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 3.359 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 3.276 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 3.494 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 3.334 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 3.260 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 3.306 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 3.234 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 3.286 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 3.220 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 50 Zaragoza From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 50 Zaragoza From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 50 Zaragoza From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,6 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 99,35 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,39 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 98,78 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 98,61 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,91 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,78 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 98,12 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,19 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,69 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 3.438 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 3.192 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2.485 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 3.424 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 3.171 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2.470 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 3.395 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 3.146 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2.461 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 3.118 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2.444 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 3.098 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2.434 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,59 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 99,34 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,4 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 98,75 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 98,56 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 99,03 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,68 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 98,35 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,06 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,95 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 99 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 189 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 811 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 99 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 188 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 806 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 99 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 188 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 799 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 188 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 790 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 188 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 786 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 99,47 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 99,38 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 99,47 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 98,52 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 99,47 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,41 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 99,47 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,92 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 3.570 50 Zaragoza From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 3.434 50 Zaragoza From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 3.342 50 Zaragoza From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 3.543 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 3.409 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 3.325 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 3.385 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 3.295 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 3.350 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 3.270 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 3.330 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 3.246 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 50 Zaragoza From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 50 Zaragoza From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 50 Zaragoza From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 99,24 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,27 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,49 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,57 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,59 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 97,55 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 97,85 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 96,97 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 97,13 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 3.482 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3.257 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2.588 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 3.455 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 3.234 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2.578 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 3.211 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2.556 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 3.177 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2.537 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 3.157 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2.519 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 99,22 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,29 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,61 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,59 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 98,76 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 97,54 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 98,03 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 96,93 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 97,33 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 88 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 177 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 754 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 88 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 175 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 747 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 174 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 739 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 173 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 733 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 173 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 727 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 98,87 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 99,07 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 98,31 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,01 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 97,74 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 97,21 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 97,74 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,42 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 210 50 Zaragoza from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 197 50 Zaragoza from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 219 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 209 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 196 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 210 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 209 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 195 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 210 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 207 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 195 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 208 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 207 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 195 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 207 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 50 Zaragoza from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 50 Zaragoza from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,52 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,49 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 95,89 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 99,52 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 98,98 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,89 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,57 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,98 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,98 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 98,57 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 98,98 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,52 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 193 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 147 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 192 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 147 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 192 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 146 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 190 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 146 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 190 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 146 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,48 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 99,48 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 99,32 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,45 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 99,32 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 98,45 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 99,32 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 17 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 50 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 17 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 49 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 17 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 49 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 17 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 49 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 17 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 49 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 98 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 98 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 98 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 212 50 Zaragoza from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 196 50 Zaragoza from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 193 50 Zaragoza from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 212 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 196 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 193 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 210 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 196 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 191 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 210 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 196 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 190 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 195 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 189 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 50 Zaragoza from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 50 Zaragoza from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 50 Zaragoza from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 99,06 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,96 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 99,06 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 98,45 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 99,49 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,93 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 196 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 148 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 135 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 196 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 148 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 135 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 194 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 148 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 133 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 194 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 148 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 132 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 148 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 132 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 98,98 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 98,52 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 98,98 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,78 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 97,78 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 16 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 48 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 58 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 16 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 48 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 58 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 16 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 48 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 58 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 16 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 48 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 58 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 47 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 57 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 97,92 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 98,28 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 215 50 Zaragoza from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 203 50 Zaragoza from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 192 50 Zaragoza from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 213 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 203 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 190 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 213 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 203 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 189 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 201 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 188 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 200 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 188 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 50 Zaragoza from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 50 Zaragoza from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 50 Zaragoza from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 99,07 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,96 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 99,07 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,44 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 99,01 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,92 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 98,52 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 97,92 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 212 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 185 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 131 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 210 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 185 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 129 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 210 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 185 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 128 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 184 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 128 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 183 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 128 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 99,06 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,47 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 99,06 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,71 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 99,46 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,71 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 98,92 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 97,71 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 3 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 18 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 61 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 3 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 18 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 61 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 3 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 18 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 61 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 17 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 60 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 17 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 60 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 94,44 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 98,36 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 94,44 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 98,36 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 212 50 Zaragoza from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 208 50 Zaragoza from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 195 50 Zaragoza from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 212 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 208 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 194 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 205 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 193 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 205 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 193 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 204 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 192 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 50 Zaragoza from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 50 Zaragoza from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 50 Zaragoza from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,49 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,56 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,97 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,56 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 98,97 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,08 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,46 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 209 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 189 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 143 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 209 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 189 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 142 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 186 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 142 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 186 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 142 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 185 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 141 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,3 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,41 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 99,3 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,41 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 99,3 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 97,88 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,6 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 3 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 19 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 52 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 3 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 19 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 52 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 19 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 51 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 19 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 51 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 19 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 51 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 98,08 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 98,08 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 98,08 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 106 50 Zaragoza De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 99 50 Zaragoza De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 98 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 106 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 99 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 98 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 106 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 99 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 98 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 106 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 98 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 98 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 106 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 97 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 98 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 50 Zaragoza De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 50 Zaragoza De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 98,99 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,98 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 94 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 64 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 94 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 64 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 94 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 64 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 94 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 63 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 94 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 62 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 98,44 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,88 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 12 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 35 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 12 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 35 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 12 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 35 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 12 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 35 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 12 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 35 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 110 50 Zaragoza De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 99 50 Zaragoza De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 50 Zaragoza De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 110 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 99 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 100 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 110 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 98 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 100 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 110 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 97 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 100 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 97 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 100 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 50 Zaragoza De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 50 Zaragoza De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 50 Zaragoza De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,99 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 97,98 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 97,98 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 97 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 64 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 61 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 97 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 64 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 61 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 97 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 63 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 61 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 97 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 62 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 61 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 62 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 61 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 98,44 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 96,88 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 96,88 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 13 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 35 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 39 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 13 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 35 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 39 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 13 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 35 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 39 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 13 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 35 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 39 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 35 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 39 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 107 50 Zaragoza De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 99 50 Zaragoza De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 97 50 Zaragoza De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 107 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 98 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 97 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 107 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 97 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 97 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 97 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 97 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 97 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 97 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 50 Zaragoza De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 50 Zaragoza De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 50 Zaragoza De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 50 Zaragoza De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 50 Zaragoza De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 50 Zaragoza De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,99 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,98 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 97,98 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,98 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 103 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 87 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 56 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 103 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 86 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 56 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 103 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 85 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 56 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 85 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 56 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 85 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 56 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,85 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,7 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 97,7 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,7 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 4 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 12 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 41 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 4 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 12 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 41 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 4 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 12 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 41 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 12 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 41 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 12 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 41 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 118 50 Zaragoza De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 103 50 Zaragoza De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 98 50 Zaragoza De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 118 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 102 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 98 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 102 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 98 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 102 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 98 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 102 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 97 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 50 Zaragoza De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 50 Zaragoza De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 50 Zaragoza De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,03 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,03 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 99,03 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 99,03 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 98,98 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 114 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 89 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 60 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 114 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 88 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 60 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 88 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 60 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 88 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 60 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 88 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 59 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,88 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,88 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,88 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,88 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 98,33 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 4 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 14 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 38 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 4 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 14 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 38 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 14 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 38 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 14 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 38 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 14 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 38 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 50 Zaragoza De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2022QI 1.504 51 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2021QI 1.500 51 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2020QI 1.543 51 Ceuta Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 51 Ceuta Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 51 Ceuta Total Cohort January 1 Total Survival in the first trimester 2022QII "" 51 Ceuta Total Cohort January 1 Total Survival in the first trimester 2022QI 1.425 51 Ceuta Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 51 Ceuta Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 51 Ceuta Total Cohort January 1 Total Survival in the first trimester 2021QII "" 51 Ceuta Total Cohort January 1 Total Survival in the first trimester 2021QI 1.409 51 Ceuta Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 51 Ceuta Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 51 Ceuta Total Cohort January 1 Total Survival in the first trimester 2020QII "" 51 Ceuta Total Cohort January 1 Total Survival in the first trimester 2020QI 1.379 51 Ceuta Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 51 Ceuta Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 51 Ceuta Total Cohort January 1 Total Survival in the second trimester 2022QII 1.346 51 Ceuta Total Cohort January 1 Total Survival in the second trimester 2022QI "" 51 Ceuta Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 51 Ceuta Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 51 Ceuta Total Cohort January 1 Total Survival in the second trimester 2021QII 1.350 51 Ceuta Total Cohort January 1 Total Survival in the second trimester 2021QI "" 51 Ceuta Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 51 Ceuta Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 51 Ceuta Total Cohort January 1 Total Survival in the second trimester 2020QII 1.343 51 Ceuta Total Cohort January 1 Total Survival in the second trimester 2020QI "" 51 Ceuta Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta Total Cohort January 1 Total Survival in the third trimester 2022QIII 1.291 51 Ceuta Total Cohort January 1 Total Survival in the third trimester 2022QII "" 51 Ceuta Total Cohort January 1 Total Survival in the third trimester 2022QI "" 51 Ceuta Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta Total Cohort January 1 Total Survival in the third trimester 2021QIII 1.310 51 Ceuta Total Cohort January 1 Total Survival in the third trimester 2021QII "" 51 Ceuta Total Cohort January 1 Total Survival in the third trimester 2021QI "" 51 Ceuta Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta Total Cohort January 1 Total Survival in the third trimester 2020QIII 1.297 51 Ceuta Total Cohort January 1 Total Survival in the third trimester 2020QII "" 51 Ceuta Total Cohort January 1 Total Survival in the third trimester 2020QI "" 51 Ceuta Total Cohort January 1 Total Survival in the third trimester 2022QIV 1.243 51 Ceuta Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta Total Cohort January 1 Total Survival in the third trimester 2022QII "" 51 Ceuta Total Cohort January 1 Total Survival in the third trimester 2022QI "" 51 Ceuta Total Cohort January 1 Total Survival in the third trimester 2021QIV 1.258 51 Ceuta Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta Total Cohort January 1 Total Survival in the third trimester 2021QII "" 51 Ceuta Total Cohort January 1 Total Survival in the third trimester 2021QI "" 51 Ceuta Total Cohort January 1 Total Survival in the third trimester 2020QIV 1.262 51 Ceuta Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta Total Cohort January 1 Total Survival in the third trimester 2020QII "" 51 Ceuta Total Cohort January 1 Total Survival in the third trimester 2020QI "" 51 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 51 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 51 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 94,75 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,93 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 89,37 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 89,49 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 90 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 87,04 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 85,84 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 87,33 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 84,06 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 82,65 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 83,87 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 81,79 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.444 51 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.329 51 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.369 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.242 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.295 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.185 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.241 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.151 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.195 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.105 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 51 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 51 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 94,81 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 93,45 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 89,68 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 89,16 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 85,94 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 86,61 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 82,76 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 83,15 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 60 51 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 171 51 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 56 51 Ceuta Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 167 51 Ceuta Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 51 51 Ceuta Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 165 51 Ceuta Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 50 51 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 159 51 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 48 51 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 153 51 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 51 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 51 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 93,33 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,66 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 85 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,49 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 83,33 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 92,98 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 80 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 89,47 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2022QII 1.517 51 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2021QII 1.482 51 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2020QII 1.480 51 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 51 Ceuta Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 51 Ceuta Total Cohort April 1 Total Survival in the first trimester 2022QII 1.424 51 Ceuta Total Cohort April 1 Total Survival in the first trimester 2022QI "" 51 Ceuta Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 51 Ceuta Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 51 Ceuta Total Cohort April 1 Total Survival in the first trimester 2021QII 1.408 51 Ceuta Total Cohort April 1 Total Survival in the first trimester 2021QI "" 51 Ceuta Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 51 Ceuta Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 51 Ceuta Total Cohort April 1 Total Survival in the first trimester 2020QII 1.431 51 Ceuta Total Cohort April 1 Total Survival in the first trimester 2020QI "" 51 Ceuta Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 51 Ceuta Total Cohort April 1 Total Survival in the second trimester 2022QIII 1.356 51 Ceuta Total Cohort April 1 Total Survival in the second trimester 2022QII "" 51 Ceuta Total Cohort April 1 Total Survival in the second trimester 2022QI "" 51 Ceuta Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 51 Ceuta Total Cohort April 1 Total Survival in the second trimester 2021QIII 1.361 51 Ceuta Total Cohort April 1 Total Survival in the second trimester 2021QII "" 51 Ceuta Total Cohort April 1 Total Survival in the second trimester 2021QI "" 51 Ceuta Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 51 Ceuta Total Cohort April 1 Total Survival in the second trimester 2020QIII 1.372 51 Ceuta Total Cohort April 1 Total Survival in the second trimester 2020QII "" 51 Ceuta Total Cohort April 1 Total Survival in the second trimester 2020QI "" 51 Ceuta Total Cohort April 1 Total Survival in the third trimester 2022QIV 1.296 51 Ceuta Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta Total Cohort April 1 Total Survival in the third trimester 2022QII "" 51 Ceuta Total Cohort April 1 Total Survival in the third trimester 2022QI "" 51 Ceuta Total Cohort April 1 Total Survival in the third trimester 2021QIV 1.304 51 Ceuta Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta Total Cohort April 1 Total Survival in the third trimester 2021QII "" 51 Ceuta Total Cohort April 1 Total Survival in the third trimester 2021QI "" 51 Ceuta Total Cohort April 1 Total Survival in the third trimester 2020QIV 1.331 51 Ceuta Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta Total Cohort April 1 Total Survival in the third trimester 2020QII "" 51 Ceuta Total Cohort April 1 Total Survival in the third trimester 2020QI "" 51 Ceuta Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta Total Cohort April 1 Total Survival in the third trimester 2022QII "" 51 Ceuta Total Cohort April 1 Total Survival in the third trimester 2022QI 1.252 51 Ceuta Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta Total Cohort April 1 Total Survival in the third trimester 2021QII "" 51 Ceuta Total Cohort April 1 Total Survival in the third trimester 2021QI 1.265 51 Ceuta Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta Total Cohort April 1 Total Survival in the third trimester 2020QII "" 51 Ceuta Total Cohort April 1 Total Survival in the third trimester 2020QI "" 51 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 51 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 51 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 51 Ceuta Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 93,87 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 95,01 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,69 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 89,39 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 91,84 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 92,7 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 85,43 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 87,99 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 89,93 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 84,48 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 85,47 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.466 51 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.329 51 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.232 51 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.377 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.257 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.184 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.310 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.216 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.132 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.251 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.165 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.096 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.120 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 1.038 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 51 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 51 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 51 Ceuta Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 93,93 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 94,58 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 96,1 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 89,36 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 91,5 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 91,88 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 85,33 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 87,66 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 88,96 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 84,27 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 84,25 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 51 51 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 153 51 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 248 51 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 47 51 Ceuta Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 151 51 Ceuta Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 247 51 Ceuta Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 46 51 Ceuta Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 145 51 Ceuta Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 240 51 Ceuta Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 45 51 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 139 51 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 235 51 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 132 51 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 227 51 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 51 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 51 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 51 Ceuta Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 92,16 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 98,69 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,6 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 90,2 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,77 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,77 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 88,24 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 90,85 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 94,76 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 86,27 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,53 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2022QIII 1.496 51 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2021QIII 1.497 51 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2020QIII 1.486 51 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 51 Ceuta Total Cohort July 1 Total Survival in the first trimester 2022QIII 1.410 51 Ceuta Total Cohort July 1 Total Survival in the first trimester 2022QII "" 51 Ceuta Total Cohort July 1 Total Survival in the first trimester 2022QI "" 51 Ceuta Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 51 Ceuta Total Cohort July 1 Total Survival in the first trimester 2021QIII 1.426 51 Ceuta Total Cohort July 1 Total Survival in the first trimester 2021QII "" 51 Ceuta Total Cohort July 1 Total Survival in the first trimester 2021QI "" 51 Ceuta Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 51 Ceuta Total Cohort July 1 Total Survival in the first trimester 2020QIII 1.414 51 Ceuta Total Cohort July 1 Total Survival in the first trimester 2020QII "" 51 Ceuta Total Cohort July 1 Total Survival in the first trimester 2020QI "" 51 Ceuta Total Cohort July 1 Total Survival in the second trimester 2022QIV 1.337 51 Ceuta Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 51 Ceuta Total Cohort July 1 Total Survival in the second trimester 2022QII "" 51 Ceuta Total Cohort July 1 Total Survival in the second trimester 2022QI "" 51 Ceuta Total Cohort July 1 Total Survival in the second trimester 2021QIV 1.355 51 Ceuta Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 51 Ceuta Total Cohort July 1 Total Survival in the second trimester 2021QII "" 51 Ceuta Total Cohort July 1 Total Survival in the second trimester 2021QI "" 51 Ceuta Total Cohort July 1 Total Survival in the second trimester 2020QIV 1.367 51 Ceuta Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 51 Ceuta Total Cohort July 1 Total Survival in the second trimester 2020QII "" 51 Ceuta Total Cohort July 1 Total Survival in the second trimester 2020QI "" 51 Ceuta Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta Total Cohort July 1 Total Survival in the third trimester 2022QII "" 51 Ceuta Total Cohort July 1 Total Survival in the third trimester 2022QI 1.300 51 Ceuta Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta Total Cohort July 1 Total Survival in the third trimester 2021QII "" 51 Ceuta Total Cohort July 1 Total Survival in the third trimester 2021QI 1.298 51 Ceuta Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta Total Cohort July 1 Total Survival in the third trimester 2020QII "" 51 Ceuta Total Cohort July 1 Total Survival in the third trimester 2020QI "" 51 Ceuta Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta Total Cohort July 1 Total Survival in the third trimester 2022QII 1.245 51 Ceuta Total Cohort July 1 Total Survival in the third trimester 2022QI "" 51 Ceuta Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta Total Cohort July 1 Total Survival in the third trimester 2021QII 1.264 51 Ceuta Total Cohort July 1 Total Survival in the third trimester 2021QI "" 51 Ceuta Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta Total Cohort July 1 Total Survival in the third trimester 2020QII "" 51 Ceuta Total Cohort July 1 Total Survival in the third trimester 2020QI "" 51 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 51 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 51 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 51 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,25 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 95,26 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 95,15 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 89,37 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 90,51 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 91,99 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 86,84 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 87,35 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 83,17 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 85,06 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.484 51 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.434 51 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.303 51 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.398 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.365 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.236 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.325 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.297 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.194 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.247 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.130 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.193 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.098 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 51 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 51 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 51 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,2 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 95,19 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,86 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 89,29 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 90,45 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 91,63 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 86,96 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 86,72 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 83,19 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 84,27 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 12 51 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 63 51 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 183 51 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 12 51 Ceuta Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 61 51 Ceuta Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 178 51 Ceuta Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 12 51 Ceuta Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 58 51 Ceuta Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 173 51 Ceuta Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 53 51 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 168 51 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 52 51 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 166 51 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 51 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 51 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 51 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,83 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,27 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 92,06 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,54 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 84,13 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 91,8 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 82,54 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 90,71 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2022QIV 1.486 51 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2021QIV 1.503 51 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2020QIV 1.489 51 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta Total Cohort October 1 Total Survival in the first trimester 2022QIV 1.399 51 Ceuta Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 51 Ceuta Total Cohort October 1 Total Survival in the first trimester 2022QII "" 51 Ceuta Total Cohort October 1 Total Survival in the first trimester 2022QI "" 51 Ceuta Total Cohort October 1 Total Survival in the first trimester 2021QIV 1.418 51 Ceuta Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 51 Ceuta Total Cohort October 1 Total Survival in the first trimester 2021QII "" 51 Ceuta Total Cohort October 1 Total Survival in the first trimester 2021QI "" 51 Ceuta Total Cohort October 1 Total Survival in the first trimester 2020QIV 1.430 51 Ceuta Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 51 Ceuta Total Cohort October 1 Total Survival in the first trimester 2020QII "" 51 Ceuta Total Cohort October 1 Total Survival in the first trimester 2020QI "" 51 Ceuta Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 51 Ceuta Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 51 Ceuta Total Cohort October 1 Total Survival in the second trimester 2022QII "" 51 Ceuta Total Cohort October 1 Total Survival in the second trimester 2022QI 1.355 51 Ceuta Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 51 Ceuta Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 51 Ceuta Total Cohort October 1 Total Survival in the second trimester 2021QII "" 51 Ceuta Total Cohort October 1 Total Survival in the second trimester 2021QI 1.351 51 Ceuta Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 51 Ceuta Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 51 Ceuta Total Cohort October 1 Total Survival in the second trimester 2020QII "" 51 Ceuta Total Cohort October 1 Total Survival in the second trimester 2020QI "" 51 Ceuta Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta Total Cohort October 1 Total Survival in the third trimester 2022QII 1.289 51 Ceuta Total Cohort October 1 Total Survival in the third trimester 2022QI "" 51 Ceuta Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta Total Cohort October 1 Total Survival in the third trimester 2021QII 1.306 51 Ceuta Total Cohort October 1 Total Survival in the third trimester 2021QI "" 51 Ceuta Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta Total Cohort October 1 Total Survival in the third trimester 2020QII "" 51 Ceuta Total Cohort October 1 Total Survival in the third trimester 2020QI "" 51 Ceuta Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta Total Cohort October 1 Total Survival in the third trimester 2022QIII 1.239 51 Ceuta Total Cohort October 1 Total Survival in the third trimester 2022QII "" 51 Ceuta Total Cohort October 1 Total Survival in the third trimester 2022QI "" 51 Ceuta Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta Total Cohort October 1 Total Survival in the third trimester 2021QIII 1.270 51 Ceuta Total Cohort October 1 Total Survival in the third trimester 2021QII "" 51 Ceuta Total Cohort October 1 Total Survival in the third trimester 2021QI "" 51 Ceuta Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta Total Cohort October 1 Total Survival in the third trimester 2020QII "" 51 Ceuta Total Cohort October 1 Total Survival in the third trimester 2020QI "" 51 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 51 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 51 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 51 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,15 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,34 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 96,04 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 90,15 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 90,73 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 85,76 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 87,71 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 82,44 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 85,29 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.480 51 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.418 51 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.316 51 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.393 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.335 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.261 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.279 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.187 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.216 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.144 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.169 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.113 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 51 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 51 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 51 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 94,12 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,15 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 95,82 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 90,2 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 90,2 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 85,75 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 86,93 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 82,44 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 84,57 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 6 51 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 85 51 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 173 51 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 6 51 Ceuta Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 83 51 Ceuta Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 169 51 Ceuta Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 76 51 Ceuta Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 164 51 Ceuta Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 73 51 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 162 51 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 70 51 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 157 51 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 51 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 51 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 51 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 97,65 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,69 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 89,41 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,8 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 85,88 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,64 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 82,35 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 90,75 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 1.175 51 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 1.179 51 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 1.222 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 1.097 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 1.092 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 1.067 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 1.026 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 1.038 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 1.033 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 976 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 1.000 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 988 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 932 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 949 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 955 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 51 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 51 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 93,36 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 92,62 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 87,32 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 87,32 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 88,04 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 84,53 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 83,06 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 84,82 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 80,85 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 79,32 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 80,49 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 78,15 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.136 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.081 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.062 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 997 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 995 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 945 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 946 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 913 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 904 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 868 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 93,49 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 92,23 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 87,59 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 87,42 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 83,27 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 84,46 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 79,58 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 80,3 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 39 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 98 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 35 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 95 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 31 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 93 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 30 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 87 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 28 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 81 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 89,74 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,94 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 79,49 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 94,9 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 76,92 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 88,78 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 71,79 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 82,65 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 1.187 51 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 1.165 51 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 1.172 51 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 1.101 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 1.095 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 1.127 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 1.040 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 1.048 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 1.072 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 985 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 995 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 1.031 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 945 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 969 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 51 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 51 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 51 Ceuta From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 92,75 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 93,99 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 96,16 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 87,62 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 89,96 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 91,47 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 82,98 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 85,41 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 87,97 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 81,12 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 82,68 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.152 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.075 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.010 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.070 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.007 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 966 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.010 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 966 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 918 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 956 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 919 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 882 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 876 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 826 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 92,88 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 93,67 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 95,64 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 87,67 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 89,86 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 90,89 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 82,99 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 85,49 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 87,33 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 81,49 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 81,78 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 35 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 90 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 162 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 31 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 88 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 161 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 30 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 82 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 154 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 29 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 76 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 149 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 69 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 143 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 88,57 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,78 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 99,38 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 85,71 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 91,11 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,06 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 82,86 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 84,44 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 91,98 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 76,67 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 88,27 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 1.157 51 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 1.166 51 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.160 51 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 1.081 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 1.098 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 1.094 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 1.016 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 1.034 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 1.048 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 982 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 982 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 934 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 951 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 51 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 51 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 51 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,43 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,17 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 94,31 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 87,81 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 88,68 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 90,34 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 84,22 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 84,66 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 80,1 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 81,98 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.151 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.128 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.052 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.075 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.062 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 991 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.010 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.001 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 950 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 954 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 888 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 906 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 859 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,4 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,15 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 94,2 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 87,75 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 88,74 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 90,3 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 84,57 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 84,41 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 80,32 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 81,65 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 6 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 38 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 108 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 6 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 36 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 103 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 6 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 33 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 98 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 28 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 94 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 28 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 92 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 94,74 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 95,37 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 86,84 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 90,74 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 73,68 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 87,04 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 73,68 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 85,19 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 1.145 51 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 1.176 51 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.162 51 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 1.064 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 1.096 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 1.107 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 1.034 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 1.032 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 975 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 992 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 928 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 958 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 51 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 51 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 51 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 92,93 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,2 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 95,27 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 87,93 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 88,81 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 82,91 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 85,37 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 78,91 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 82,44 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.144 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.113 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.062 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.063 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.035 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.011 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 980 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 940 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 924 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 902 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 880 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 873 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 92,92 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 92,99 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 95,2 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,05 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88,51 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 83,02 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 84,93 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 79,07 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 82,2 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 63 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 61 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 96 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 54 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 92 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 51 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 90 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 48 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 85 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 96,83 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 85,71 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 92 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 80,95 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 90 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 76,19 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 85 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 141 51 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 145 51 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 139 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 140 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 143 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 134 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 134 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 140 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 133 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 130 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 138 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 132 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 127 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 137 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 131 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 51 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 51 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99,29 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,62 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,4 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 95,04 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,55 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,68 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 92,2 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,17 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,96 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 90,07 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 94,48 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 94,24 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 132 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 117 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 131 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 116 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 126 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 113 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 122 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 111 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 119 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 110 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,24 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,15 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 95,45 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,58 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 92,42 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 94,87 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 90,15 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 94,02 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 9 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 28 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 9 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 27 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 8 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 27 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 8 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 27 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 8 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 27 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 96,43 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 88,89 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 96,43 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 88,89 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 96,43 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 88,89 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 96,43 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 134 51 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 130 51 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 129 51 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 129 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 129 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 127 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 124 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 129 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 125 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 122 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 125 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 125 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 123 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 122 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 51 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 51 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 51 Ceuta From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 96,27 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 99,23 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,45 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 92,54 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 99,23 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 96,9 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 91,04 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 96,15 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 96,9 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 94,62 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 94,57 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 128 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 110 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 92 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 123 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 109 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 90 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 118 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 109 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 88 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 116 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 105 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 88 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 103 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 87 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 96,09 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 99,09 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 97,83 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 92,19 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 99,09 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 95,65 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 90,63 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 95,45 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 95,65 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,64 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 94,57 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 6 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 20 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 37 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 6 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 20 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 37 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 6 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 20 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 37 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 6 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 20 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 37 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 20 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 35 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 94,59 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 143 51 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 133 51 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 146 51 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 135 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 130 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 142 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 131 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 124 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 142 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 122 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 140 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 118 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 139 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 51 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 51 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 51 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 94,41 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 97,74 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 97,26 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 91,61 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 93,23 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,26 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 91,73 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 95,89 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 88,72 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 95,21 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 140 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 124 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 116 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 132 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 121 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 112 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 128 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 115 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 112 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 113 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 111 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 109 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 110 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 94,29 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 97,58 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 96,55 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 91,43 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 92,74 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 96,55 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 91,13 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 95,69 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 87,9 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,83 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 3 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 9 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 30 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 3 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 9 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 30 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 3 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 9 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 30 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 9 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 29 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 9 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 29 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 96,67 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 96,67 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 146 51 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 138 51 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 145 51 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 143 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 134 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 142 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 133 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 140 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 127 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 138 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 125 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 136 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 51 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 51 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 51 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 97,95 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 97,1 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 97,93 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 96,38 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 96,55 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 92,03 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 95,17 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 90,58 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 93,79 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 145 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 130 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 116 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 142 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 126 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 113 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 125 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 112 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 119 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 110 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 117 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 108 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 97,93 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 96,92 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,41 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 96,15 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 96,55 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 91,54 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 94,83 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 90 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,1 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 1 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 8 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 29 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 1 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 8 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 29 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 8 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 28 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 8 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 28 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 8 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 28 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 96,55 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 96,55 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 96,55 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 175 51 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 166 51 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 174 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 175 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 164 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 170 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 173 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 162 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 169 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 172 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 162 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 169 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 171 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 162 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 168 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 51 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 51 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 98,8 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 97,7 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 98,86 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 97,59 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 97,13 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 98,29 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 97,59 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,13 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 97,71 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 97,59 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 96,55 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 163 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 122 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 163 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 120 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 161 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 118 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 160 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 118 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 159 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 118 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 98,36 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 98,77 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,72 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 98,16 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 96,72 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 97,55 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 96,72 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 12 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 44 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 12 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 44 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 12 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 44 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 12 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 44 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 12 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 44 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 100 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 100 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 100 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 183 51 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 176 51 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 169 51 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 181 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 173 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 167 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 179 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 173 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 165 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 176 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 173 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 165 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 173 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 164 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 51 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 51 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 51 Ceuta From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 98,91 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 98,3 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,82 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 97,81 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 98,3 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 97,63 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 96,17 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 98,3 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,63 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 98,3 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 97,04 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 173 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 134 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 120 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 171 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 131 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 118 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 169 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 131 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 116 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 166 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 131 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 116 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 131 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 115 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 98,84 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 97,76 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 98,33 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 97,69 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 97,76 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 96,67 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 95,95 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 97,76 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 96,67 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 97,76 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,83 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 10 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 42 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 49 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 10 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 42 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 49 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 10 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 42 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 49 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 10 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 42 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 49 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 42 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 49 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 182 51 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 186 51 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 169 51 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 180 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 186 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 167 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 176 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 185 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 166 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 184 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 165 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 181 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 163 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 51 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 51 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 51 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 98,9 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 98,82 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,7 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 99,46 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 98,22 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 98,92 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,63 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 97,31 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,45 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 179 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 171 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 125 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 177 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 171 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 123 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 173 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 170 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 122 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 169 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 121 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 167 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 119 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 98,88 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 98,4 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,65 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 99,42 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,6 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 98,83 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 96,8 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 97,66 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 95,2 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 3 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 15 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 44 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 3 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 15 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 44 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 3 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 15 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 44 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 15 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 44 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 14 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 44 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 93,33 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 181 51 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 176 51 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 170 51 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 178 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 175 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 169 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 175 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 167 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 174 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 164 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 173 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 164 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 51 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 51 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 51 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,34 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 99,43 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 99,41 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 99,43 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,24 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 98,86 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,47 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 98,3 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 96,47 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 177 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 162 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 127 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 174 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 161 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 126 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 161 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 124 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 160 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 121 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 159 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 121 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,31 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 99,38 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 99,21 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 99,38 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,64 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 98,77 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,28 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 98,15 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 95,28 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 4 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 14 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 43 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 4 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 14 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 43 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 14 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 43 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 14 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 43 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 14 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 43 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 10 51 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 8 51 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 5 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 10 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 8 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 5 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 10 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 8 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 5 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 10 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 8 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 5 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 10 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 8 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 5 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 51 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 51 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 10 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 7 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 10 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 7 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 10 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 7 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 10 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 7 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 10 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 7 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 0 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 0 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 0 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 0 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 0 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI .. 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI .. 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII .. 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII .. 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 0 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 11 51 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 9 51 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 7 51 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 11 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 9 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 7 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 11 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 9 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 7 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 11 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 9 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 7 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 9 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 7 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 51 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 51 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 51 Ceuta from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 11 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 8 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 7 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 11 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 8 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 7 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 11 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 8 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 7 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 11 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 8 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 7 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 8 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 7 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 0 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 0 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 0 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 0 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 0 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 0 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 0 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 0 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 0 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII .. 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII .. 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII .. 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII .. 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII .. 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII .. 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 0 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV .. 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI .. 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 11 51 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 9 51 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 8 51 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 11 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 9 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 8 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 11 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 9 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 8 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 9 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 8 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 9 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 8 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 51 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 51 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 51 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 11 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 8 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 8 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 11 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 8 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 8 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 11 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 8 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 8 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 8 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 8 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 8 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 8 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 1 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 0 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 1 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 0 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 1 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 0 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 1 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 0 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 1 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 0 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII .. 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII .. 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII .. 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII .. 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV .. 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI .. 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII .. 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 12 51 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 10 51 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 10 51 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 12 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 10 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 10 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 10 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 10 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 10 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 10 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 10 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 10 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 51 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 51 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 51 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 12 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 10 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 9 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 12 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 10 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 9 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 10 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 9 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 10 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 9 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 10 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 9 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 0 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 1 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 0 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 1 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 0 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 1 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 0 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 1 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 0 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 1 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV .. 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV .. 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI .. 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII .. 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII .. 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 3 51 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 2 51 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 3 51 Ceuta De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 3 51 Ceuta De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 2 51 Ceuta De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 3 51 Ceuta De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 3 51 Ceuta De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 2 51 Ceuta De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 3 51 Ceuta De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 3 51 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 2 51 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 3 51 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 3 51 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 2 51 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 3 51 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 51 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 51 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 3 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 3 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 3 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 3 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 3 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 0 51 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 0 51 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 0 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 0 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 0 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 0 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 0 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 0 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 0 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 0 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI .. 51 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI .. 51 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI .. 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI .. 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII .. 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII .. 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII .. 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII .. 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 0 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV .. 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 2 51 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 2 51 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 3 51 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 2 51 Ceuta De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 2 51 Ceuta De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 3 51 Ceuta De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 2 51 Ceuta De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 2 51 Ceuta De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 3 51 Ceuta De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 2 51 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 2 51 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 3 51 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 2 51 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 3 51 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 51 Ceuta De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 51 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 51 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 51 Ceuta De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 3 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 3 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 3 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 3 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 3 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 0 51 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 0 51 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 0 51 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 0 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 0 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 0 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 0 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 0 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 0 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 0 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 0 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 0 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 0 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 0 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII .. 51 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII .. 51 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII .. 51 Ceuta De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII .. 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII .. 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII .. 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII .. 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII .. 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII .. 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 0 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV .. 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV .. 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI .. 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI .. 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 3 51 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 3 51 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 3 51 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 3 51 Ceuta De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 3 51 Ceuta De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 3 51 Ceuta De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 3 51 Ceuta De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 3 51 Ceuta De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 3 51 Ceuta De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 3 51 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 3 51 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 3 51 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 3 51 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 51 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 51 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 51 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 51 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 51 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 51 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 3 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 3 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 2 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 3 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 3 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 2 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 3 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 3 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 2 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 3 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 2 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 3 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 2 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 51 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 0 51 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 1 51 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 0 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 1 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 0 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 1 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 0 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 1 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 0 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 1 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII .. 51 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII .. 51 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 51 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII .. 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII .. 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV .. 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI .. 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII .. 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 2 51 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 3 51 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 2 51 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 2 51 Ceuta De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 3 51 Ceuta De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 2 51 Ceuta De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 3 51 Ceuta De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 2 51 Ceuta De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 3 51 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 2 51 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 3 51 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 2 51 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 51 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 51 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 51 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 51 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 51 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 51 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 51 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 2 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 2 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 3 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 3 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 3 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 3 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 51 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 0 51 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 0 51 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 0 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 0 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 0 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 0 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 0 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 0 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 0 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 0 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 51 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV .. 51 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV .. 51 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV .. 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV .. 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI .. 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI .. 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII .. 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII .. 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII .. 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII .. 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 51 Ceuta De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 52 Melilla Total Cohort January 1 Total Number at the start of the quarter 2022QI 1.535 52 Melilla Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 52 Melilla Total Cohort January 1 Total Number at the start of the quarter 2021QI 1.485 52 Melilla Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 52 Melilla Total Cohort January 1 Total Number at the start of the quarter 2020QI 1.691 52 Melilla Total Cohort January 1 Total Survival in the first trimester 2022QIV "" 52 Melilla Total Cohort January 1 Total Survival in the first trimester 2022QIII "" 52 Melilla Total Cohort January 1 Total Survival in the first trimester 2022QII "" 52 Melilla Total Cohort January 1 Total Survival in the first trimester 2022QI 1.409 52 Melilla Total Cohort January 1 Total Survival in the first trimester 2021QIV "" 52 Melilla Total Cohort January 1 Total Survival in the first trimester 2021QIII "" 52 Melilla Total Cohort January 1 Total Survival in the first trimester 2021QII "" 52 Melilla Total Cohort January 1 Total Survival in the first trimester 2021QI 1.387 52 Melilla Total Cohort January 1 Total Survival in the first trimester 2020QIV "" 52 Melilla Total Cohort January 1 Total Survival in the first trimester 2020QIII "" 52 Melilla Total Cohort January 1 Total Survival in the first trimester 2020QII "" 52 Melilla Total Cohort January 1 Total Survival in the first trimester 2020QI 1.465 52 Melilla Total Cohort January 1 Total Survival in the second trimester 2022QIV "" 52 Melilla Total Cohort January 1 Total Survival in the second trimester 2022QIII "" 52 Melilla Total Cohort January 1 Total Survival in the second trimester 2022QII 1.319 52 Melilla Total Cohort January 1 Total Survival in the second trimester 2022QI "" 52 Melilla Total Cohort January 1 Total Survival in the second trimester 2021QIV "" 52 Melilla Total Cohort January 1 Total Survival in the second trimester 2021QIII "" 52 Melilla Total Cohort January 1 Total Survival in the second trimester 2021QII 1.317 52 Melilla Total Cohort January 1 Total Survival in the second trimester 2021QI "" 52 Melilla Total Cohort January 1 Total Survival in the second trimester 2020QIV "" 52 Melilla Total Cohort January 1 Total Survival in the second trimester 2020QIII "" 52 Melilla Total Cohort January 1 Total Survival in the second trimester 2020QII 1.342 52 Melilla Total Cohort January 1 Total Survival in the second trimester 2020QI "" 52 Melilla Total Cohort January 1 Total Survival in the third trimester 2022QIV "" 52 Melilla Total Cohort January 1 Total Survival in the third trimester 2022QIII 1.254 52 Melilla Total Cohort January 1 Total Survival in the third trimester 2022QII "" 52 Melilla Total Cohort January 1 Total Survival in the third trimester 2022QI "" 52 Melilla Total Cohort January 1 Total Survival in the third trimester 2021QIV "" 52 Melilla Total Cohort January 1 Total Survival in the third trimester 2021QIII 1.252 52 Melilla Total Cohort January 1 Total Survival in the third trimester 2021QII "" 52 Melilla Total Cohort January 1 Total Survival in the third trimester 2021QI "" 52 Melilla Total Cohort January 1 Total Survival in the third trimester 2020QIV "" 52 Melilla Total Cohort January 1 Total Survival in the third trimester 2020QIII 1.266 52 Melilla Total Cohort January 1 Total Survival in the third trimester 2020QII "" 52 Melilla Total Cohort January 1 Total Survival in the third trimester 2020QI "" 52 Melilla Total Cohort January 1 Total Survival in the third trimester 2022QIV 1.211 52 Melilla Total Cohort January 1 Total Survival in the third trimester 2022QIII "" 52 Melilla Total Cohort January 1 Total Survival in the third trimester 2022QII "" 52 Melilla Total Cohort January 1 Total Survival in the third trimester 2022QI "" 52 Melilla Total Cohort January 1 Total Survival in the third trimester 2021QIV 1.201 52 Melilla Total Cohort January 1 Total Survival in the third trimester 2021QIII "" 52 Melilla Total Cohort January 1 Total Survival in the third trimester 2021QII "" 52 Melilla Total Cohort January 1 Total Survival in the third trimester 2021QI "" 52 Melilla Total Cohort January 1 Total Survival in the third trimester 2020QIV 1.211 52 Melilla Total Cohort January 1 Total Survival in the third trimester 2020QIII "" 52 Melilla Total Cohort January 1 Total Survival in the third trimester 2020QII "" 52 Melilla Total Cohort January 1 Total Survival in the third trimester 2020QI "" 52 Melilla Total Cohort January 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla Total Cohort January 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla Total Cohort January 1 Total Number at the start of the quarter 2022QII "" 52 Melilla Total Cohort January 1 Total Number at the start of the quarter 2022QI 100 52 Melilla Total Cohort January 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla Total Cohort January 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla Total Cohort January 1 Total Number at the start of the quarter 2021QII "" 52 Melilla Total Cohort January 1 Total Number at the start of the quarter 2021QI 100 52 Melilla Total Cohort January 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla Total Cohort January 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla Total Cohort January 1 Total Number at the start of the quarter 2020QII "" 52 Melilla Total Cohort January 1 Total Number at the start of the quarter 2020QI 100 52 Melilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 91,79 52 Melilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 93,4 52 Melilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 86,64 52 Melilla Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the second semester 2022QII 85,93 52 Melilla Total Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the second semester 2021QII 88,69 52 Melilla Total Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the second semester 2020QII 79,36 52 Melilla Total Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 81,69 52 Melilla Total Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 84,31 52 Melilla Total Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 74,87 52 Melilla Total Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 78,89 52 Melilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 80,88 52 Melilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 71,61 52 Melilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 52 Melilla Total Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 52 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.462 52 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 1.280 52 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 1.341 52 Melilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 1.185 52 Melilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 1.258 52 Melilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 1.122 52 Melilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 1.198 52 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 1.061 52 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 1.155 52 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 1.016 52 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla Total Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 52 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 52 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla Total Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 91,72 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 92,58 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 86,05 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 87,66 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 81,94 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 82,89 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 79 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 79,38 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla Total Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 73 52 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 205 52 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the first trimester 2022QI 68 52 Melilla Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the first trimester 2021QI 202 52 Melilla Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the second trimester 2022QII 61 52 Melilla Total Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the second trimester 2021QII 195 52 Melilla Total Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 56 52 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 191 52 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 56 52 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 185 52 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla Total Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 52 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 52 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla Total Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 93,15 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 98,54 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 83,56 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 95,12 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 76,71 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 93,17 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 76,71 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 90,24 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla Total Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla Total Cohort April 1 Total Number at the start of the quarter 2022QII 1.517 52 Melilla Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 52 Melilla Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla Total Cohort April 1 Total Number at the start of the quarter 2021QII 1.501 52 Melilla Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 52 Melilla Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla Total Cohort April 1 Total Number at the start of the quarter 2020QII 1.570 52 Melilla Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 52 Melilla Total Cohort April 1 Total Survival in the first trimester 2022QIV "" 52 Melilla Total Cohort April 1 Total Survival in the first trimester 2022QIII "" 52 Melilla Total Cohort April 1 Total Survival in the first trimester 2022QII 1.406 52 Melilla Total Cohort April 1 Total Survival in the first trimester 2022QI "" 52 Melilla Total Cohort April 1 Total Survival in the first trimester 2021QIV "" 52 Melilla Total Cohort April 1 Total Survival in the first trimester 2021QIII "" 52 Melilla Total Cohort April 1 Total Survival in the first trimester 2021QII 1.400 52 Melilla Total Cohort April 1 Total Survival in the first trimester 2021QI "" 52 Melilla Total Cohort April 1 Total Survival in the first trimester 2020QIV "" 52 Melilla Total Cohort April 1 Total Survival in the first trimester 2020QIII "" 52 Melilla Total Cohort April 1 Total Survival in the first trimester 2020QII 1.421 52 Melilla Total Cohort April 1 Total Survival in the first trimester 2020QI "" 52 Melilla Total Cohort April 1 Total Survival in the second trimester 2022QIV "" 52 Melilla Total Cohort April 1 Total Survival in the second trimester 2022QIII 1.323 52 Melilla Total Cohort April 1 Total Survival in the second trimester 2022QII "" 52 Melilla Total Cohort April 1 Total Survival in the second trimester 2022QI "" 52 Melilla Total Cohort April 1 Total Survival in the second trimester 2021QIV "" 52 Melilla Total Cohort April 1 Total Survival in the second trimester 2021QIII 1.325 52 Melilla Total Cohort April 1 Total Survival in the second trimester 2021QII "" 52 Melilla Total Cohort April 1 Total Survival in the second trimester 2021QI "" 52 Melilla Total Cohort April 1 Total Survival in the second trimester 2020QIV "" 52 Melilla Total Cohort April 1 Total Survival in the second trimester 2020QIII 1.335 52 Melilla Total Cohort April 1 Total Survival in the second trimester 2020QII "" 52 Melilla Total Cohort April 1 Total Survival in the second trimester 2020QI "" 52 Melilla Total Cohort April 1 Total Survival in the third trimester 2022QIV 1.273 52 Melilla Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 52 Melilla Total Cohort April 1 Total Survival in the third trimester 2022QII "" 52 Melilla Total Cohort April 1 Total Survival in the third trimester 2022QI "" 52 Melilla Total Cohort April 1 Total Survival in the third trimester 2021QIV 1.268 52 Melilla Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 52 Melilla Total Cohort April 1 Total Survival in the third trimester 2021QII "" 52 Melilla Total Cohort April 1 Total Survival in the third trimester 2021QI "" 52 Melilla Total Cohort April 1 Total Survival in the third trimester 2020QIV 1.273 52 Melilla Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 52 Melilla Total Cohort April 1 Total Survival in the third trimester 2020QII "" 52 Melilla Total Cohort April 1 Total Survival in the third trimester 2020QI "" 52 Melilla Total Cohort April 1 Total Survival in the third trimester 2022QIV "" 52 Melilla Total Cohort April 1 Total Survival in the third trimester 2022QIII "" 52 Melilla Total Cohort April 1 Total Survival in the third trimester 2022QII "" 52 Melilla Total Cohort April 1 Total Survival in the third trimester 2022QI 1.199 52 Melilla Total Cohort April 1 Total Survival in the third trimester 2021QIV "" 52 Melilla Total Cohort April 1 Total Survival in the third trimester 2021QIII "" 52 Melilla Total Cohort April 1 Total Survival in the third trimester 2021QII "" 52 Melilla Total Cohort April 1 Total Survival in the third trimester 2021QI 1.224 52 Melilla Total Cohort April 1 Total Survival in the third trimester 2020QIV "" 52 Melilla Total Cohort April 1 Total Survival in the third trimester 2020QIII "" 52 Melilla Total Cohort April 1 Total Survival in the third trimester 2020QII "" 52 Melilla Total Cohort April 1 Total Survival in the third trimester 2020QI "" 52 Melilla Total Cohort April 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla Total Cohort April 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla Total Cohort April 1 Total Number at the start of the quarter 2022QII 100 52 Melilla Total Cohort April 1 Total Number at the start of the quarter 2022QI "" 52 Melilla Total Cohort April 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla Total Cohort April 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla Total Cohort April 1 Total Number at the start of the quarter 2021QII 100 52 Melilla Total Cohort April 1 Total Number at the start of the quarter 2021QI "" 52 Melilla Total Cohort April 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla Total Cohort April 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla Total Cohort April 1 Total Number at the start of the quarter 2020QII 100 52 Melilla Total Cohort April 1 Total Number at the start of the quarter 2020QI "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 92,68 52 Melilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 93,27 52 Melilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 90,51 52 Melilla Total Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 87,21 52 Melilla Total Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 88,27 52 Melilla Total Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 85,03 52 Melilla Total Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 83,92 52 Melilla Total Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 84,48 52 Melilla Total Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 81,08 52 Melilla Total Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 79,88 52 Melilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 77,96 52 Melilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 52 Melilla Total Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 52 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.461 52 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.304 52 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.308 52 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 1.355 52 Melilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 1.210 52 Melilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 1.162 52 Melilla Total Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 1.276 52 Melilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 1.139 52 Melilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 1.083 52 Melilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 1.226 52 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 1.087 52 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 1.027 52 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 1.029 52 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 982 52 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla Total Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 52 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 52 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 52 Melilla Total Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 92,74 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 92,79 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 88,84 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 87,34 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 87,35 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 82,8 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 83,92 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 83,36 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 78,52 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 78,91 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 75,08 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla Total Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 56 52 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 197 52 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 262 52 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the first trimester 2022QII 51 52 Melilla Total Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the first trimester 2021QII 190 52 Melilla Total Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the first trimester 2020QII 259 52 Melilla Total Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 47 52 Melilla Total Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 186 52 Melilla Total Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 252 52 Melilla Total Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 47 52 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 181 52 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 246 52 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2022QI 170 52 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2021QI 242 52 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla Total Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 52 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 52 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 52 Melilla Total Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 91,07 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 96,45 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,85 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 83,93 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 94,42 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 96,18 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 83,93 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 91,88 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,89 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 86,29 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 92,37 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla Total Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla Total Cohort July 1 Total Number at the start of the quarter 2022QIII 1.500 52 Melilla Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 52 Melilla Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 52 Melilla Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla Total Cohort July 1 Total Number at the start of the quarter 2021QIII 1.489 52 Melilla Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 52 Melilla Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 52 Melilla Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla Total Cohort July 1 Total Number at the start of the quarter 2020QIII 1.484 52 Melilla Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 52 Melilla Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 52 Melilla Total Cohort July 1 Total Survival in the first trimester 2022QIV "" 52 Melilla Total Cohort July 1 Total Survival in the first trimester 2022QIII 1.397 52 Melilla Total Cohort July 1 Total Survival in the first trimester 2022QII "" 52 Melilla Total Cohort July 1 Total Survival in the first trimester 2022QI "" 52 Melilla Total Cohort July 1 Total Survival in the first trimester 2021QIV "" 52 Melilla Total Cohort July 1 Total Survival in the first trimester 2021QIII 1.403 52 Melilla Total Cohort July 1 Total Survival in the first trimester 2021QII "" 52 Melilla Total Cohort July 1 Total Survival in the first trimester 2021QI "" 52 Melilla Total Cohort July 1 Total Survival in the first trimester 2020QIV "" 52 Melilla Total Cohort July 1 Total Survival in the first trimester 2020QIII 1.380 52 Melilla Total Cohort July 1 Total Survival in the first trimester 2020QII "" 52 Melilla Total Cohort July 1 Total Survival in the first trimester 2020QI "" 52 Melilla Total Cohort July 1 Total Survival in the second trimester 2022QIV 1.331 52 Melilla Total Cohort July 1 Total Survival in the second trimester 2022QIII "" 52 Melilla Total Cohort July 1 Total Survival in the second trimester 2022QII "" 52 Melilla Total Cohort July 1 Total Survival in the second trimester 2022QI "" 52 Melilla Total Cohort July 1 Total Survival in the second trimester 2021QIV 1.336 52 Melilla Total Cohort July 1 Total Survival in the second trimester 2021QIII "" 52 Melilla Total Cohort July 1 Total Survival in the second trimester 2021QII "" 52 Melilla Total Cohort July 1 Total Survival in the second trimester 2021QI "" 52 Melilla Total Cohort July 1 Total Survival in the second trimester 2020QIV 1.306 52 Melilla Total Cohort July 1 Total Survival in the second trimester 2020QIII "" 52 Melilla Total Cohort July 1 Total Survival in the second trimester 2020QII "" 52 Melilla Total Cohort July 1 Total Survival in the second trimester 2020QI "" 52 Melilla Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 52 Melilla Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 52 Melilla Total Cohort July 1 Total Survival in the third trimester 2022QII "" 52 Melilla Total Cohort July 1 Total Survival in the third trimester 2022QI 1.257 52 Melilla Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 52 Melilla Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 52 Melilla Total Cohort July 1 Total Survival in the third trimester 2021QII "" 52 Melilla Total Cohort July 1 Total Survival in the third trimester 2021QI 1.255 52 Melilla Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 52 Melilla Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 52 Melilla Total Cohort July 1 Total Survival in the third trimester 2020QII "" 52 Melilla Total Cohort July 1 Total Survival in the third trimester 2020QI "" 52 Melilla Total Cohort July 1 Total Survival in the third trimester 2022QIV "" 52 Melilla Total Cohort July 1 Total Survival in the third trimester 2022QIII "" 52 Melilla Total Cohort July 1 Total Survival in the third trimester 2022QII 1.206 52 Melilla Total Cohort July 1 Total Survival in the third trimester 2022QI "" 52 Melilla Total Cohort July 1 Total Survival in the third trimester 2021QIV "" 52 Melilla Total Cohort July 1 Total Survival in the third trimester 2021QIII "" 52 Melilla Total Cohort July 1 Total Survival in the third trimester 2021QII 1.209 52 Melilla Total Cohort July 1 Total Survival in the third trimester 2021QI "" 52 Melilla Total Cohort July 1 Total Survival in the third trimester 2020QIV "" 52 Melilla Total Cohort July 1 Total Survival in the third trimester 2020QIII "" 52 Melilla Total Cohort July 1 Total Survival in the third trimester 2020QII "" 52 Melilla Total Cohort July 1 Total Survival in the third trimester 2020QI "" 52 Melilla Total Cohort July 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla Total Cohort July 1 Total Number at the start of the quarter 2022QIII 100 52 Melilla Total Cohort July 1 Total Number at the start of the quarter 2022QII "" 52 Melilla Total Cohort July 1 Total Number at the start of the quarter 2022QI "" 52 Melilla Total Cohort July 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla Total Cohort July 1 Total Number at the start of the quarter 2021QIII 100 52 Melilla Total Cohort July 1 Total Number at the start of the quarter 2021QII "" 52 Melilla Total Cohort July 1 Total Number at the start of the quarter 2021QI "" 52 Melilla Total Cohort July 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla Total Cohort July 1 Total Number at the start of the quarter 2020QIII 100 52 Melilla Total Cohort July 1 Total Number at the start of the quarter 2020QII "" 52 Melilla Total Cohort July 1 Total Number at the start of the quarter 2020QI "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 93,13 52 Melilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 94,22 52 Melilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 92,99 52 Melilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 88,73 52 Melilla Total Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 89,72 52 Melilla Total Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 88,01 52 Melilla Total Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the third semester 2022QI 84,42 52 Melilla Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the third semester 2021QI 84,57 52 Melilla Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 80,99 52 Melilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 81,47 52 Melilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 52 Melilla Total Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 52 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.483 52 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.426 52 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.295 52 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.383 52 Melilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.342 52 Melilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1.194 52 Melilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1.317 52 Melilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 1.277 52 Melilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1.126 52 Melilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 1.203 52 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1.079 52 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 1.155 52 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1.039 52 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla Total Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 52 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 52 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 52 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla Total Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 93,26 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 94,11 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 92,2 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 88,81 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 89,55 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 86,95 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 84,36 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 83,32 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 81 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 80,23 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla Total Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 17 52 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 63 52 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 189 52 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 14 52 Melilla Total Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 61 52 Melilla Total Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 186 52 Melilla Total Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 14 52 Melilla Total Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 59 52 Melilla Total Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 180 52 Melilla Total Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI 54 52 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI 176 52 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2022QII 51 52 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2021QII 170 52 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla Total Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 52 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 52 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 52 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla Total Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 82,35 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 96,83 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,41 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 82,35 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 93,65 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 95,24 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 85,71 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 93,12 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 80,95 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 89,95 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla Total Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla Total Cohort October 1 Total Number at the start of the quarter 2022QIV 1.493 52 Melilla Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 52 Melilla Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 52 Melilla Total Cohort October 1 Total Number at the start of the quarter 2021QIV 1.485 52 Melilla Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 52 Melilla Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 52 Melilla Total Cohort October 1 Total Number at the start of the quarter 2020QIV 1.483 52 Melilla Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 52 Melilla Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 52 Melilla Total Cohort October 1 Total Survival in the first trimester 2022QIV 1.404 52 Melilla Total Cohort October 1 Total Survival in the first trimester 2022QIII "" 52 Melilla Total Cohort October 1 Total Survival in the first trimester 2022QII "" 52 Melilla Total Cohort October 1 Total Survival in the first trimester 2022QI "" 52 Melilla Total Cohort October 1 Total Survival in the first trimester 2021QIV 1.405 52 Melilla Total Cohort October 1 Total Survival in the first trimester 2021QIII "" 52 Melilla Total Cohort October 1 Total Survival in the first trimester 2021QII "" 52 Melilla Total Cohort October 1 Total Survival in the first trimester 2021QI "" 52 Melilla Total Cohort October 1 Total Survival in the first trimester 2020QIV 1.388 52 Melilla Total Cohort October 1 Total Survival in the first trimester 2020QIII "" 52 Melilla Total Cohort October 1 Total Survival in the first trimester 2020QII "" 52 Melilla Total Cohort October 1 Total Survival in the first trimester 2020QI "" 52 Melilla Total Cohort October 1 Total Survival in the second trimester 2022QIV "" 52 Melilla Total Cohort October 1 Total Survival in the second trimester 2022QIII "" 52 Melilla Total Cohort October 1 Total Survival in the second trimester 2022QII "" 52 Melilla Total Cohort October 1 Total Survival in the second trimester 2022QI 1.315 52 Melilla Total Cohort October 1 Total Survival in the second trimester 2021QIV "" 52 Melilla Total Cohort October 1 Total Survival in the second trimester 2021QIII "" 52 Melilla Total Cohort October 1 Total Survival in the second trimester 2021QII "" 52 Melilla Total Cohort October 1 Total Survival in the second trimester 2021QI 1.327 52 Melilla Total Cohort October 1 Total Survival in the second trimester 2020QIV "" 52 Melilla Total Cohort October 1 Total Survival in the second trimester 2020QIII "" 52 Melilla Total Cohort October 1 Total Survival in the second trimester 2020QII "" 52 Melilla Total Cohort October 1 Total Survival in the second trimester 2020QI "" 52 Melilla Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 52 Melilla Total Cohort October 1 Total Survival in the third trimester 2022QIII "" 52 Melilla Total Cohort October 1 Total Survival in the third trimester 2022QII 1.254 52 Melilla Total Cohort October 1 Total Survival in the third trimester 2022QI "" 52 Melilla Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 52 Melilla Total Cohort October 1 Total Survival in the third trimester 2021QIII "" 52 Melilla Total Cohort October 1 Total Survival in the third trimester 2021QII 1.272 52 Melilla Total Cohort October 1 Total Survival in the third trimester 2021QI "" 52 Melilla Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 52 Melilla Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 52 Melilla Total Cohort October 1 Total Survival in the third trimester 2020QII "" 52 Melilla Total Cohort October 1 Total Survival in the third trimester 2020QI "" 52 Melilla Total Cohort October 1 Total Survival in the third trimester 2022QIV "" 52 Melilla Total Cohort October 1 Total Survival in the third trimester 2022QIII 1.201 52 Melilla Total Cohort October 1 Total Survival in the third trimester 2022QII "" 52 Melilla Total Cohort October 1 Total Survival in the third trimester 2022QI "" 52 Melilla Total Cohort October 1 Total Survival in the third trimester 2021QIV "" 52 Melilla Total Cohort October 1 Total Survival in the third trimester 2021QIII 1.216 52 Melilla Total Cohort October 1 Total Survival in the third trimester 2021QII "" 52 Melilla Total Cohort October 1 Total Survival in the third trimester 2021QI "" 52 Melilla Total Cohort October 1 Total Survival in the third trimester 2020QIV "" 52 Melilla Total Cohort October 1 Total Survival in the third trimester 2020QIII "" 52 Melilla Total Cohort October 1 Total Survival in the third trimester 2020QII "" 52 Melilla Total Cohort October 1 Total Survival in the third trimester 2020QI "" 52 Melilla Total Cohort October 1 Total Number at the start of the quarter 2022QIV 100 52 Melilla Total Cohort October 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla Total Cohort October 1 Total Number at the start of the quarter 2022QII "" 52 Melilla Total Cohort October 1 Total Number at the start of the quarter 2022QI "" 52 Melilla Total Cohort October 1 Total Number at the start of the quarter 2021QIV 100 52 Melilla Total Cohort October 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla Total Cohort October 1 Total Number at the start of the quarter 2021QII "" 52 Melilla Total Cohort October 1 Total Number at the start of the quarter 2021QI "" 52 Melilla Total Cohort October 1 Total Number at the start of the quarter 2020QIV 100 52 Melilla Total Cohort October 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla Total Cohort October 1 Total Number at the start of the quarter 2020QII "" 52 Melilla Total Cohort October 1 Total Number at the start of the quarter 2020QI "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 94,04 52 Melilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 94,61 52 Melilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 93,59 52 Melilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the second semester 2022QI 88,55 52 Melilla Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the second semester 2021QI 89,48 52 Melilla Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the third semester 2022QII 84,44 52 Melilla Total Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the third semester 2021QII 85,77 52 Melilla Total Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 80,88 52 Melilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 82 52 Melilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 52 Melilla Total Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 52 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.479 52 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.376 52 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.299 52 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.390 52 Melilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1.301 52 Melilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 1.209 52 Melilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1.217 52 Melilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 1.151 52 Melilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1.166 52 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 1.101 52 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1.116 52 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 1.048 52 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla Total Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 52 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 52 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 52 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla Total Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 93,98 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 94,55 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 93,07 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 88,44 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 88,61 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 84,74 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 84,76 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 81,1 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 80,68 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla Total Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 14 52 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 109 52 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 184 52 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 14 52 Melilla Total Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 104 52 Melilla Total Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 179 52 Melilla Total Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the second trimester 2022QI 98 52 Melilla Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the second trimester 2021QI 176 52 Melilla Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII 88 52 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII 171 52 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 85 52 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 168 52 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla Total Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 52 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 52 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 52 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla Total Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95,41 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 97,28 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 89,91 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 95,65 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 80,73 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 92,93 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 77,98 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 91,3 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla Total Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 52 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 1.133 52 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 52 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 1.120 52 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 1.324 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QII "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2022QI 1.018 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QII "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2021QI 1.028 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the first trimester 2020QI 1.106 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QII 942 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2022QI "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QII 967 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2021QI "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QII 986 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the second trimester 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII 887 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII 907 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII 913 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIV 847 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QII "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2022QI "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIV 865 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QII "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2021QI "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIV 863 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Total Survival in the third trimester 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QII "" 52 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2022QI 100 52 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QII "" 52 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2021QI 100 52 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Total Number at the start of the quarter 2020QI 100 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 89,85 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 91,79 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 83,53 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 83,14 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 86,34 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 74,47 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 78,29 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 80,98 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 68,96 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 74,76 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 77,23 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 65,18 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 1.079 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 996 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 968 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 907 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 898 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 852 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 847 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 796 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 807 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 759 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 89,71 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 91,06 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 83,23 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 85,54 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 78,5 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 79,92 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 74,79 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 76,2 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 54 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 124 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 50 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 121 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 44 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 115 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 40 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 111 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 40 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 106 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 92,59 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 97,58 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 81,48 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 92,74 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 74,07 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 89,52 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 74,07 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 85,48 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 1 to 5 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 1.125 52 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 1.142 52 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 1.232 52 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QII 1.026 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2022QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QII 1.049 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2021QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QII 1.086 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the first trimester 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QIII 956 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QII "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2022QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QIII 980 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QII "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2021QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QIII 1.001 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QII "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the second trimester 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV 909 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV 931 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV 944 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QII "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2022QI 867 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QII "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2021QI 900 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QII "" 52 Melilla From 1 to 5 Cohort April 1 Total Survival in the third trimester 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QII 100 52 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2022QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QII 100 52 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2021QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QII 100 52 Melilla From 1 to 5 Cohort April 1 Total Number at the start of the quarter 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 91,2 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 91,86 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 88,15 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 84,98 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 85,81 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 81,25 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 80,8 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 81,52 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 76,62 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 75,92 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 73,05 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 1 to 5 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 1.089 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 1.021 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 1.060 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 994 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 934 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 916 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 928 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 869 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 837 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 881 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 825 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 784 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 771 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 743 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 91,28 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 91,48 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 86,42 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 85,22 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 85,11 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 78,96 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 80,9 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 80,8 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 73,96 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 75,51 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 70,09 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 1 to 5 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 36 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 121 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 172 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 32 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 115 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 170 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 28 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 111 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 164 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 28 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 106 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 160 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 96 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 157 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 88,89 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 95,04 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 98,84 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 77,78 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 91,74 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,35 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 77,78 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 87,6 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 93,02 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 79,34 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 91,28 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 1 to 5 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 1.119 52 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 1.127 52 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 1.134 52 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QIII 1.025 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2022QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QIII 1.046 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2021QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QIII 1.032 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the first trimester 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIV 961 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2022QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIV 988 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2021QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIV 962 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the second trimester 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI 915 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI 915 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QII 868 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2022QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QII 875 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2021QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Survival in the third trimester 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 52 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2022QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 52 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2021QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 52 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Number at the start of the quarter 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 91,6 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 92,81 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 91,01 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 85,88 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 87,67 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 84,83 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 81,19 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 80,69 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 77,02 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 77,16 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1.108 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 1.081 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1.022 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1.017 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 1.002 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 922 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 953 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 946 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 856 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 878 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 812 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 834 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 778 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 91,79 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 92,69 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 90,22 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 86,01 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 87,51 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 83,76 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 81,22 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 79,45 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 77,15 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 76,13 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 11 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 46 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 112 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 8 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 44 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 110 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 8 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 42 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 106 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 37 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 103 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 34 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 97 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 72,73 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 95,65 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 98,21 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 72,73 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 91,3 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,64 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 80,43 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 91,96 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 73,91 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 86,61 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 1 to 5 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 1.110 52 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 1.126 52 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 1.128 52 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIV 1.024 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2022QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIV 1.054 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2021QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIV 1.037 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the first trimester 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2022QI 969 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2021QI 980 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the second trimester 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII 916 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII 932 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QIII 870 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2022QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QIII 881 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2021QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Survival in the third trimester 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 52 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2022QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 52 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2021QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 52 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Number at the start of the quarter 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 92,25 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 93,61 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 91,93 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 86,06 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 86,88 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 81,35 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 82,62 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 77,26 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 78,1 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1.102 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1.046 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 1.017 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1.016 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 978 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 930 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 898 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 875 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 855 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 832 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 812 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 784 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 92,2 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 93,5 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 91,45 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 85,85 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 86,04 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 81,74 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 81,81 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 77,63 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 77,09 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 8 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 80 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 111 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 8 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 76 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 107 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 71 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 105 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 61 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 100 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 58 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 97 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 95 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,4 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 88,75 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 94,59 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 76,25 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 90,09 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 72,5 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 87,39 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 1 to 5 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 195 52 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 173 52 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 184 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2022QI 186 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2021QI 172 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the first trimester 2020QI 178 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QII 180 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QII 167 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QII 176 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the second trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII 173 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII 166 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII 174 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIV 170 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIV 160 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIV 170 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Survival in the third trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2022QI 100 52 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2021QI 100 52 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Number at the start of the quarter 2020QI 100 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 95,38 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 99,42 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 96,74 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QII 92,31 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QII 96,53 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QII 95,65 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 88,72 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 95,95 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 94,57 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 87,18 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 92,49 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 92,39 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 187 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 138 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 178 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 137 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 173 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 133 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 167 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 132 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 164 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 126 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 95,19 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 99,28 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 92,51 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 96,38 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 89,3 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 95,65 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 87,7 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 91,3 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 8 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 35 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2022QI 8 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2021QI 35 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QII 7 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QII 34 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 6 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 34 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 6 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 34 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 100 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 87,5 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 97,14 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 75 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 97,14 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 75 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,14 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 202 52 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 170 52 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 171 52 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QII 196 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QII 166 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QII 170 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the first trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QIII 189 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QIII 162 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QIII 170 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the second trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV 186 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV 158 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV 166 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2022QI 154 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2021QI 163 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Survival in the third trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QII 100 52 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2022QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QII 100 52 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2021QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QII 100 52 Melilla From 6 to 9 employees Cohort April 1 Total Number at the start of the quarter 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 97,03 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 97,65 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 99,42 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 93,56 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 95,29 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 99,42 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 92,08 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 92,94 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,08 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 90,59 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 95,32 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 192 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 138 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 124 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 187 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 134 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 123 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 180 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 130 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 123 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 177 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 126 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 121 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 122 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 119 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 97,4 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 97,1 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,19 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 93,75 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 94,2 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,19 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 92,19 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 91,3 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 97,58 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 88,41 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 95,97 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 10 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 32 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 47 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QII 9 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QII 32 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QII 47 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 9 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 32 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 47 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 9 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 32 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 45 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2022QI 32 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2021QI 44 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 90 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 90 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 90 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,74 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 93,62 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 195 52 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 177 52 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 180 52 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QIII 190 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QIII 174 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QIII 179 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the first trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIV 188 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIV 168 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIV 175 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the second trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI 164 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI 174 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QII 162 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QII 169 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Survival in the third trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QIII 100 52 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2022QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QIII 100 52 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2021QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QIII 100 52 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Number at the start of the quarter 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,44 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,31 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,44 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 96,41 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 94,92 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 97,22 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2022QI 92,66 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2021QI 96,67 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 91,53 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 93,89 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 193 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 173 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 143 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 188 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 170 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 142 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 186 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 164 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 140 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 160 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 140 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 158 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 135 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,41 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,27 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 99,3 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 96,37 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 94,8 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 97,9 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 92,49 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,9 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 91,33 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 94,41 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 2 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 4 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 37 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 2 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 4 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 37 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 2 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 4 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 35 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI 4 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI 34 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QII 4 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QII 34 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 94,59 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 91,89 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 91,89 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 196 52 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 171 52 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 168 52 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIV 193 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIV 166 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIV 164 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the first trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2022QI 161 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2021QI 163 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the second trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII 157 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII 160 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QIII 151 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QIII 157 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Survival in the third trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIV 100 52 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2022QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIV 100 52 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2021QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIV 100 52 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Number at the start of the quarter 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 98,47 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 97,08 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 97,62 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2022QI 94,15 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2021QI 97,02 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QII 91,81 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QII 95,24 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 88,3 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 93,45 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 194 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 157 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 138 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 191 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 153 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 135 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 149 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 135 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 145 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 132 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 139 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 129 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 98,45 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 97,45 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 97,83 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 94,9 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,83 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 92,36 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 95,65 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 88,54 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,48 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 2 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 14 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 30 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 2 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 13 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 29 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2022QI 12 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2021QI 28 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII 12 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII 28 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 12 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 28 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 92,86 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 96,67 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 85,71 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 93,33 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 85,71 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 93,33 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 85,71 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 93,33 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 6 to 9 employees Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 52 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 201 52 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 52 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 187 52 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 176 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QII "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2022QI 199 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QII "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2021QI 182 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the first trimester 2020QI 174 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QII 191 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2022QI "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QII 178 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2021QI "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QII 173 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the second trimester 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII 188 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII 174 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII 172 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIV 188 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QII "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2022QI "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIV 171 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QII "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2021QI "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIV 171 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Total Survival in the third trimester 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QII "" 52 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2022QI 100 52 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QII "" 52 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2021QI 100 52 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Total Number at the start of the quarter 2020QI 100 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 99 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 97,33 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 98,86 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 95,02 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 95,19 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 98,3 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 93,53 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 93,05 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 97,73 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 93,53 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 91,44 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 97,16 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 190 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 142 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 189 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 137 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 181 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 133 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 178 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 129 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 178 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 127 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 99,47 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 96,48 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 95,26 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 93,66 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 93,68 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 90,85 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 93,68 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 89,44 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 11 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 45 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 10 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 45 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 10 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 45 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 10 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 45 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 10 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 44 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 100 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI 90,91 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII 90,91 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII 90,91 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 90,91 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 97,78 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 10 to 99 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 185 52 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 183 52 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 161 52 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QII 179 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2022QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QII 179 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2021QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QII 159 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the first trimester 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QIII 173 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QII "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2022QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QIII 177 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QII "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2021QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QIII 158 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QII "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the second trimester 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV 173 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV 173 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV 157 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QII "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2022QI 172 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QII "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2021QI 155 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QII "" 52 Melilla From 10 to 99 Cohort April 1 Total Survival in the third trimester 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QII 100 52 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2022QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QII 100 52 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2021QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QII 100 52 Melilla From 10 to 99 Cohort April 1 Total Number at the start of the quarter 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 96,76 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 97,81 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 98,76 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 93,51 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 96,72 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 98,14 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 93,51 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 94,54 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 97,52 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 93,99 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 96,27 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 10 to 99 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 175 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 140 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 119 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 169 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 137 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 118 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 163 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 135 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 118 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 163 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 131 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 117 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 131 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 115 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 96,57 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 97,86 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 99,16 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 93,14 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 96,43 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 99,16 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 93,14 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 93,57 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 98,32 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 93,57 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 96,64 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 10 to 99 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 10 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 43 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 42 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 10 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 42 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 41 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 10 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 42 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 40 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 10 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 42 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 40 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 41 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 40 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 100 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII 100 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 97,67 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 97,62 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII 100 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 97,67 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 95,24 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 100 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 97,67 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 95,24 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 95,35 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 95,24 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 10 to 99 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 180 52 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 181 52 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 164 52 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QIII 176 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2022QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QIII 179 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2021QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QIII 163 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the first trimester 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIV 176 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2022QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIV 176 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2021QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIV 163 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the second trimester 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI 174 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI 160 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QII 172 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2022QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QII 159 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2021QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Survival in the third trimester 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 52 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2022QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 52 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2021QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 52 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Number at the start of the quarter 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 97,78 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 98,9 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 99,39 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 97,78 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 97,24 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 99,39 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 96,13 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 97,56 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 95,03 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 96,95 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 177 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 168 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 126 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 173 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 166 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 126 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 173 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 163 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 126 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 161 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 123 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 159 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 122 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 97,74 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 98,81 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 97,74 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 97,02 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 95,83 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 97,62 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 94,64 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 96,83 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 3 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 13 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 38 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 3 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 13 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 37 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 3 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 13 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 37 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 13 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 37 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 13 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 37 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 100 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII 100 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 97,37 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV 100 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 97,37 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI 100 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 97,37 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII 100 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 97,37 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 10 to 99 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 181 52 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 184 52 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 182 52 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIV 181 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2022QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIV 181 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2021QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIV 182 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the first trimester 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2022QI 181 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2021QI 179 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the second trimester 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII 177 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII 175 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QIII 176 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2022QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QIII 173 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2021QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Survival in the third trimester 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 52 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2022QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 52 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2021QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 52 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Number at the start of the quarter 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 98,37 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 98,37 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 98,35 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 96,2 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 96,15 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 95,65 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 95,05 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 177 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 169 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 139 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 177 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 166 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 139 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 166 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 136 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 162 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 132 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 161 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 130 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 98,22 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 98,22 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 97,84 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 95,86 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 94,96 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 95,27 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 93,53 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 4 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 15 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 43 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 4 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 15 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 43 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 15 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 43 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 15 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 43 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 15 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 43 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 100 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 100 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 100 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 100 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV 100 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV 100 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI 100 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI 100 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII 100 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII 100 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII 100 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII 100 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla From 10 to 99 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 52 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 4 52 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 52 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 3 52 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 6 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QII "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2022QI 4 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QII "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2021QI 3 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the first trimester 2020QI 6 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QII 4 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2022QI "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QII 3 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2021QI "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QII 6 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the second trimester 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII 4 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII 3 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII 6 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIV 4 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QII "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2022QI "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIV 3 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QII "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2021QI "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIV 6 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Total Survival in the third trimester 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QII "" 52 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2022QI 100 52 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QII "" 52 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2021QI 100 52 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Total Number at the start of the quarter 2020QI 100 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 4 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 4 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 4 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 4 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 4 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 0 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 1 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2022QI 0 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2021QI 1 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QII 0 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QII 1 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 0 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 1 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 0 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 1 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2022QI .. 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 100 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI .. 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI 100 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII .. 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII 100 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII .. 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII 100 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 0 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV 100 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla from 100 to 249 Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 3 52 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 4 52 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 4 52 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QII 3 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2022QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QII 4 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2021QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QII 4 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the first trimester 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QIII 3 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QII "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2022QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QIII 4 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QII "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2021QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QIII 4 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QII "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the second trimester 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV 3 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV 4 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV 4 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QII "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2022QI 4 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QII "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2021QI 4 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QII "" 52 Melilla from 100 to 249 Cohort April 1 Total Survival in the third trimester 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QII 100 52 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2022QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QII 100 52 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2021QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QII 100 52 Melilla from 100 to 249 Cohort April 1 Total Number at the start of the quarter 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 52 Melilla from 100 to 249 Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 3 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 3 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 3 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 3 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 3 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 3 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 3 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 3 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 3 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 3 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 3 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 3 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 3 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 3 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla from 100 to 249 Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 0 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 1 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 1 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QII 0 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QII 1 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QII 1 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 0 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 1 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 1 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 0 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 1 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 1 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2022QI 1 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2021QI 1 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QII .. 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 100 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 100 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII .. 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII 100 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII 100 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII .. 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII 100 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII 100 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 0 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV 100 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV 100 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI 100 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI 100 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla from 100 to 249 Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 5 52 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 2 52 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 5 52 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QIII 5 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2022QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QIII 2 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2021QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QIII 5 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the first trimester 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIV 5 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2022QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIV 2 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2021QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIV 5 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the second trimester 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI 2 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI 5 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QII 2 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2022QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QII 5 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2021QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Survival in the third trimester 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QIII 100 52 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2022QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QIII 100 52 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2021QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QIII 100 52 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Number at the start of the quarter 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 4 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 3 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 4 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 3 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 4 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 3 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 3 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 3 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 1 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 0 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 2 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 1 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 0 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 2 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 1 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 0 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 2 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI 0 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI 2 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QII 0 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QII 2 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 100 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII .. 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 100 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII 100 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII .. 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII 100 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 100 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV .. 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV 100 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI .. 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI 100 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII .. 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII 100 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla from 100 to 249 Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 5 52 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 3 52 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 3 52 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIV 5 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2022QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIV 3 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2021QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIV 3 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the first trimester 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2022QI 3 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2021QI 3 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the second trimester 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII 3 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII 3 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QIII 3 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2022QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QIII 3 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2021QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Survival in the third trimester 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIV 100 52 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2022QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIV 100 52 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2021QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIV 100 52 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Number at the start of the quarter 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 5 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 3 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 3 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 5 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 3 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 3 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 3 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 3 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 3 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 3 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 3 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 3 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 0 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 0 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 0 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 0 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2022QI 0 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2021QI 0 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII 0 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII 0 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 0 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 0 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV .. 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV .. 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV .. 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV .. 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI .. 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI .. 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII .. 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII .. 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII .. 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII .. 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla from 100 to 249 Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 52 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 2 52 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 52 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 2 52 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 52 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 1 52 Melilla De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIV "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the first trimester 2022QIII "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the first trimester 2022QII "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the first trimester 2022QI 2 52 Melilla De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIV "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the first trimester 2021QIII "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the first trimester 2021QII "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the first trimester 2021QI 2 52 Melilla De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the first trimester 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the first trimester 2020QII "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the first trimester 2020QI 1 52 Melilla De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIV "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the second trimester 2022QIII "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the second trimester 2022QII 2 52 Melilla De 250 o más Cohort January 1 Total Survival in the second trimester 2022QI "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIV "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the second trimester 2021QIII "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the second trimester 2021QII 2 52 Melilla De 250 o más Cohort January 1 Total Survival in the second trimester 2021QI "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the second trimester 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the second trimester 2020QII 1 52 Melilla De 250 o más Cohort January 1 Total Survival in the second trimester 2020QI "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII 2 52 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII 2 52 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII 1 52 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIV 2 52 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2022QIII "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2022QII "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2022QI "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIV 2 52 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2021QIII "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2021QII "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2021QI "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIV 1 52 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2020QII "" 52 Melilla De 250 o más Cohort January 1 Total Survival in the third trimester 2020QI "" 52 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QII "" 52 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2022QI 100 52 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QII "" 52 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2021QI 100 52 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QII "" 52 Melilla De 250 o más Cohort January 1 Total Number at the start of the quarter 2020QI 100 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIV "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QIII "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QII "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2022QI 100 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIV "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QIII "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QII "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2021QI 100 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QII "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the first trimester 2020QI 100 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIV "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QIII "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QII 100 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2022QI "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIV "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QIII "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QII 100 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2021QI "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QII 100 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the second semester 2020QI "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIV "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QIII 100 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QII "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2022QI "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIV "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QIII 100 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QII "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2021QI "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QIII 100 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QII "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the third semester 2020QI "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIV 100 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QII "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2022QI "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIV 100 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QII "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2021QI "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIV 100 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QII "" 52 Melilla De 250 o más Cohort January 1 Total Percentage of survivals in the fourth semester 2020QI "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 2 52 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 2 52 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2022QI 2 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2021QI 2 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the first trimester 2020QI "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QII 2 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2022QI "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QII 2 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2021QI "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the second trimester 2020QI "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII 2 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII 2 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIV 2 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIV 2 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2022QI 100 52 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2021QI 100 52 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2022QI 100 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2021QI 100 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QII 100 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QII 100 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QIII 100 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QIII 100 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV 100 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV 100 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla De 250 o más Cohort January 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI 0 52 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI 0 52 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2022QI 0 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2021QI 0 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the first trimester 2020QI "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QII 0 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2022QI "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QII 0 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2021QI "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the second trimester 2020QI "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII 0 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII 0 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIV 0 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIV 0 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2022QI .. 52 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2021QI .. 52 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2022QI .. 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2021QI .. 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QII .. 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QII .. 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QIII .. 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QIII .. 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV 0 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV .. 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla De 250 o más Cohort January 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 2 52 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 52 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 2 52 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 52 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 2 52 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIV "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the first trimester 2022QIII "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the first trimester 2022QII 2 52 Melilla De 250 o más Cohort April 1 Total Survival in the first trimester 2022QI "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIV "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the first trimester 2021QIII "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the first trimester 2021QII 2 52 Melilla De 250 o más Cohort April 1 Total Survival in the first trimester 2021QI "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIV "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the first trimester 2020QIII "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the first trimester 2020QII 2 52 Melilla De 250 o más Cohort April 1 Total Survival in the first trimester 2020QI "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIV "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the second trimester 2022QIII 2 52 Melilla De 250 o más Cohort April 1 Total Survival in the second trimester 2022QII "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the second trimester 2022QI "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIV "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the second trimester 2021QIII 2 52 Melilla De 250 o más Cohort April 1 Total Survival in the second trimester 2021QII "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the second trimester 2021QI "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIV "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the second trimester 2020QIII 2 52 Melilla De 250 o más Cohort April 1 Total Survival in the second trimester 2020QII "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the second trimester 2020QI "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV 2 52 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV 2 52 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV 2 52 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIV "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2022QIII "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2022QII "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2022QI 2 52 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIV "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2021QIII "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2021QII "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2021QI 2 52 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIV "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2020QIII "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2020QII "" 52 Melilla De 250 o más Cohort April 1 Total Survival in the third trimester 2020QI "" 52 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QII 100 52 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2022QI "" 52 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QII 100 52 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2021QI "" 52 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QII 100 52 Melilla De 250 o más Cohort April 1 Total Number at the start of the quarter 2020QI "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIV "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QIII "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QII 100 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2022QI "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIV "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QIII "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QII 100 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2021QI "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIV "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QIII "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QII 100 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the first trimester 2020QI "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIV "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QIII 100 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QII "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2022QI "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIV "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QIII 100 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QII "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2021QI "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIV "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QIII 100 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QII "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the second semester 2020QI "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIV 100 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QIII "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QII "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2022QI "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIV 100 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QIII "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QII "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2021QI "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIV 100 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QIII "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QII "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the third semester 2020QI "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QII "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2022QI 100 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QII "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2021QI 100 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QII "" 52 Melilla De 250 o más Cohort April 1 Total Percentage of survivals in the fourth semester 2020QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 2 52 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 2 52 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 2 52 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIV "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QIII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QII 2 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2022QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIV "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QIII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QII 2 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2021QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIV "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QIII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QII 2 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the first trimester 2020QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIV "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QIII 2 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2022QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIV "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QIII 2 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2021QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIV "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QIII 2 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the second trimester 2020QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV 2 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV 2 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV 2 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2022QI 2 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2021QI 2 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QII 100 52 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QII 100 52 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QII 100 52 Melilla De 250 o más Cohort April 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QII 100 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QII 100 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QII 100 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QIII 100 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QIII 100 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QIII 100 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIV 100 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIV 100 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIV 100 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI 100 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI 100 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla De 250 o más Cohort April 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII 0 52 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII 0 52 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII 0 52 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIV "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QIII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QII 0 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2022QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIV "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QIII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QII 0 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2021QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIV "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QIII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QII 0 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the first trimester 2020QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIV "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QIII 0 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2022QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIV "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QIII 0 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2021QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIV "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QIII 0 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the second trimester 2020QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV 0 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV 0 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV 0 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2022QI 0 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2021QI 0 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QII .. 52 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QII .. 52 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QII .. 52 Melilla De 250 o más Cohort April 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QII .. 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QII .. 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QII .. 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QIII .. 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QIII .. 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QIII .. 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIV 0 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIV .. 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIV .. 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2022QI .. 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2021QI .. 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla De 250 o más Cohort April 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 1 52 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 52 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 52 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 2 52 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 52 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 52 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 1 52 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 52 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIV "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the first trimester 2022QIII 1 52 Melilla De 250 o más Cohort July 1 Total Survival in the first trimester 2022QII "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the first trimester 2022QI "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIV "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the first trimester 2021QIII 2 52 Melilla De 250 o más Cohort July 1 Total Survival in the first trimester 2021QII "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the first trimester 2021QI "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIV "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the first trimester 2020QIII 1 52 Melilla De 250 o más Cohort July 1 Total Survival in the first trimester 2020QII "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the first trimester 2020QI "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIV 1 52 Melilla De 250 o más Cohort July 1 Total Survival in the second trimester 2022QIII "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the second trimester 2022QII "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the second trimester 2022QI "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIV 2 52 Melilla De 250 o más Cohort July 1 Total Survival in the second trimester 2021QIII "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the second trimester 2021QII "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the second trimester 2021QI "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIV 1 52 Melilla De 250 o más Cohort July 1 Total Survival in the second trimester 2020QIII "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the second trimester 2020QII "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the second trimester 2020QI "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI 2 52 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI 1 52 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIV "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2022QIII "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2022QII 2 52 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2022QI "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIV "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2021QIII "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2021QII 1 52 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2021QI "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIV "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2020QIII "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2020QII "" 52 Melilla De 250 o más Cohort July 1 Total Survival in the third trimester 2020QI "" 52 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIV "" 52 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QIII 100 52 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QII "" 52 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2022QI "" 52 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIV "" 52 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QIII 100 52 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QII "" 52 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2021QI "" 52 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIV "" 52 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QIII 100 52 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QII "" 52 Melilla De 250 o más Cohort July 1 Total Number at the start of the quarter 2020QI "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIV "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QIII 100 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QII "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2022QI "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIV "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QIII 100 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QII "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2021QI "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIV "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QIII 100 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QII "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the first trimester 2020QI "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIV 100 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QIII "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QII "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2022QI "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIV 100 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QIII "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QII "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2021QI "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIV 100 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QIII "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QII "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the second semester 2020QI "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIV "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QIII "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QII "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2022QI 100 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIV "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QIII "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QII "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2021QI 100 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIV "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QIII "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QII "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the third semester 2020QI "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QII 100 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2022QI "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QII 100 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2021QI "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QII "" 52 Melilla De 250 o más Cohort July 1 Total Percentage of survivals in the fourth semester 2020QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 1 52 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 2 52 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 1 52 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIV "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QIII 1 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2022QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIV "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QIII 2 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2021QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIV "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QIII 1 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the first trimester 2020QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIV 1 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QIII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2022QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIV 2 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QIII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2021QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIV 1 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QIII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the second trimester 2020QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI 2 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI 1 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QII 2 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QII 1 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIV "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QIII 100 52 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIV "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QIII 100 52 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIV "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QIII 100 52 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII 100 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII 100 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII 100 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIV 100 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIV 100 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIV 100 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2022QI 100 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2021QI 100 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII 100 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII 100 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla De 250 o más Cohort July 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII 0 52 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII 0 52 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII 0 52 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIV "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QIII 0 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2022QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIV "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QIII 0 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2021QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIV "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QIII 0 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the first trimester 2020QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIV 0 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QIII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2022QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIV 0 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QIII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2021QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIV 0 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QIII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the second trimester 2020QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI 0 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI 0 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QII 0 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QII 0 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIV "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QIII .. 52 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIV "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QIII .. 52 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIV "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QIII .. 52 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIV "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QIII .. 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIV "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QIII .. 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIV "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QIII .. 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIV 0 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2022QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIV .. 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2021QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIV .. 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2022QI .. 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2021QI .. 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QII .. 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QII .. 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla De 250 o más Cohort July 1 Con ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 1 52 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 52 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 52 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 1 52 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 52 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 52 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 2 52 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 52 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIV 1 52 Melilla De 250 o más Cohort October 1 Total Survival in the first trimester 2022QIII "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the first trimester 2022QII "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the first trimester 2022QI "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIV 1 52 Melilla De 250 o más Cohort October 1 Total Survival in the first trimester 2021QIII "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the first trimester 2021QII "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the first trimester 2021QI "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIV 2 52 Melilla De 250 o más Cohort October 1 Total Survival in the first trimester 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the first trimester 2020QII "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the first trimester 2020QI "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIV "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the second trimester 2022QIII "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the second trimester 2022QII "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the second trimester 2022QI 1 52 Melilla De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIV "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the second trimester 2021QIII "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the second trimester 2021QII "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the second trimester 2021QI 2 52 Melilla De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIV "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the second trimester 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the second trimester 2020QII "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the second trimester 2020QI "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII 1 52 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII 2 52 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIV "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2022QIII 1 52 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2022QII "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2022QI "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIV "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2021QIII 2 52 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2021QII "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2021QI "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIV "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2020QII "" 52 Melilla De 250 o más Cohort October 1 Total Survival in the third trimester 2020QI "" 52 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIV 100 52 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QIII "" 52 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QII "" 52 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2022QI "" 52 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIV 100 52 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QIII "" 52 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QII "" 52 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2021QI "" 52 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIV 100 52 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QII "" 52 Melilla De 250 o más Cohort October 1 Total Number at the start of the quarter 2020QI "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIV 100 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QIII "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QII "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2022QI "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIV 100 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QIII "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QII "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2021QI "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIV 100 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QII "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the first trimester 2020QI "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIV "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QIII "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QII "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2022QI 100 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIV "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QIII "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QII "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2021QI 100 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIV "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QII "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the second semester 2020QI "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIV "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QIII "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QII 100 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2022QI "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIV "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QIII "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QII 100 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2021QI "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIV "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QII "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the third semester 2020QI "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QIII 100 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QII "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2022QI "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QIII 100 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QII "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2021QI "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QII "" 52 Melilla De 250 o más Cohort October 1 Total Percentage of survivals in the fourth semester 2020QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 1 52 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 1 52 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 2 52 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIV 1 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2022QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIV 1 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2021QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIV 2 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the first trimester 2020QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIV "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2022QI 1 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIV "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2021QI 2 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIV "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the second trimester 2020QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII 1 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII 2 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIV "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QIII 1 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2022QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIV "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QIII 2 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2021QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIV "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Survival in the third trimester 2020QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIV 100 52 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2022QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIV 100 52 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2021QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIV 100 52 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Number at the start of the quarter 2020QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIV 100 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIV 100 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIV 100 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2022QI 100 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2021QI 100 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QII 100 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QII 100 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QIII 100 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QIII 100 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla De 250 o más Cohort October 1 Sin ERTE Percentage of survivals in the fourth semester 2020QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 52 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV 0 52 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV 0 52 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIV 0 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2022QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIV 0 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2021QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIV 0 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the first trimester 2020QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIV "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2022QI 0 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIV "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2021QI 0 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIV "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the second trimester 2020QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII 0 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII 0 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIV "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QIII 0 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2022QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIV "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QIII 0 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2021QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIV "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Survival in the third trimester 2020QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIV 0 52 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2022QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIV .. 52 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2021QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIV .. 52 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Number at the start of the quarter 2020QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIV 0 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2022QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIV .. 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2021QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIV .. 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the first trimester 2020QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIV "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2022QI .. 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIV "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2021QI .. 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIV "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the second semester 2020QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIV "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QII .. 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2022QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIV "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QII .. 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2021QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIV "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the third semester 2020QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIV "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QIII .. 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2022QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIV "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QIII .. 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2021QI "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIV "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QIII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QII "" 52 Melilla De 250 o más Cohort October 1 Con ERTE Percentage of survivals in the fourth semester 2020QI ""